ECR2019 Final Programme Web FINAL 190214

THE ANNUAL MEETING OF
W E LCO M E TO E C R C I T Y 2 0 1 9
1 Austria Center Vienna (ACV) 5 The Church
Main Congress Building Women in Focus
Registration Scientific Sessions
Grand Opening
Scientific Sessions 6 DC Box
ESR Connect Studio
2 M Building
International Village (National 7 Tech Gate
Society Booths) Scientific Sessions
Scientific Sessions Rising Stars Lounge
Meeting Rooms Guerbet Patient Pathway and
Educational Programme
3 Expo
Technical Exhibition 8 DC Tower
AIX - Artificial Intelligence Interventional Radiology at the Cube 2.0
Exhibition & Theatre Escape Room
4 Saturn Tower
Sky High Stage: CTiR and MyT3 Sessions
Dedicato a tutti i miei colleghi
e amici e alla mia famiglia
Benvenuti al Congresso
Europeo di Radiologia 2019
Lorenzo E. Derchi
TIMETABLE
08:30 09:00 09:30 10:00 10:30 11:00 11:30 12:00 12:15 13:00 13:30 14:00
Coffee & Talk (open forum): C 1 Clinical Trials in Radiology: CTiR 2 ECR Press Conference
Wednesday, February 27
E3 - ECR Academies: E3 119, E3 121 Coffee & Talk (open forum): C 23 Coffee & Talk (open forum): C 2, C 3
E3 - ECR Master Class: E3 126a, E3 126b E3 - ECR Academies: E3 219, E3 221 E3 - The Beauty of Basic Knowledge:
E3 - Rising Stars Programme: BS 1 E3 - Rising Stars Programme: BS 2 E3 24A, E3 25A
EuroSafe Imaging Sessions: EU 1 Scientific Sessions: SS 201a, SS 201b, Satellite Symposia
Joint Sessions: ESR/EIBALL, ESR/EFSUMB SS 202, SS 203, SS 204, SS 205, SS 207,
Multidisciplinary Sessions: MS 1 SS 208, SS 209, SS 210a, SS 210b,
SS 211a, SS 211b, SS 212, SS 213, SS 2014,
New Horizons Sessions: NH 1 SS 215, SS 216, SS 217
Refresher Courses: RC 101, RC 105,
RC 112, RC 113, RC 114, RC 115, RC 116 Satellite Symposia
1 2
Scientific Sessions: SS 109
Special Focus Sessions: SF 1
Coffee & Talk (open forum): C 6, C 7, C 25 ESR Meets Africa Wilhelm Conrad Röntgen
E3 - ECR Academies: E3 519, E3 520, E3 521 Clinical Trials in Radiology: CTiR 6 Honorary Lecture
Thursday, February 28
E3 - ECR Master Class: E3 526 Coffee & Talk (open forum): C 8 Regina G.H. Beets-Tan; Amsterdam/NL
E3 - Rising Stars Programme: BS 5 E3 - ECR Academies: E3 619, E3 620, E3 621 Coffee & Talk (open forum): C 9, C 26
EFOMP Workshops: EF 1 E3 - Rising Stars Programme: BE 6 E3 - The Beauty of Basic Knowledge:
E3 24B, E3 25B
Hands-on Workshops: HW 530 EFOMP Workshops: EF 2
Joint Sessions: ESR US SC/UES
Joint Sessions: ESR/UEMS Hands-on Workshops: HW 630
Women in Focus: WF 1
My Thesis in 3 Minutes: MY 5 RTF Quiz
Professional Challenges Sessions: PC 5 Scientific Sessions: SS 602, SS 603, Satellite Symposia
Refresher Courses: RC 501, RC 502, SS 604, SS 605, SS 606, SS 607, SS 608,
RC 504, RC 510, RC 512, RC 514, RC 516 SS 609, SS 610, SS 611, SS 612, SS 614,
Scientific Sessions: SS 501 SS 615, SS 616a, SS 616b
Wednesday – Friday: 09:00–17:00 • Saturday: 09:00–16:00 • Sunday: 09:00–13:00

State of the Art Symposia: SA 5
Special Focus Sessions:
SF 5a, SF 5b, SF 5c, SF 5d
5 6
The Voice of EPOS • in the ECR Online & EPOS Lounge

Coffee & Talk (open forum): C 13, C 27 ESR Meets Italy Josef Lissner
E3 - ECR Academies: E3 918, E3 921, E3 922 Clinical Trials in Radiology: CTiR 10 Honorary Lecture
E3 - ECR Master Class: E3 926 Coffee & Talk (open forum): C 14 S. Nahum Goldberg; Jerusalem/IL
E3 - Rising Stars Programme: BR 9, BS 9 E3 - ECR Academies: E3 1018, E3 1022 Coffee & Talk (open forum):
C 15, C 16, C 17
Friday, March 1
ESHIMT Sessions: ESHIMT 2 E3 - Rising Stars Programme: S 2

E3 - The Beauty of Basic Knowledge:
Hands-on Workshops: HW 930 Hands-on Workshops: HW 1030 E3 24C, E3 25C
Joint Sessions: ESR/EFOMP, ESR/ESTRO PIER @ ECR Sessions: PI 2
My Thesis in 3 Minutes: MY 9 Scientific Sessions: SS 1001a, SS 1001b, Satellite Symposia
PIER @ ECR Sessions: PI 1 SS 1002, SS 1003, SS 1004, SS 1005a,
Refresher Courses: RC 901, RC 902, SS 1005b, SS 1007, SS 1008, SS 1009,
RC 904, RC 907, RC 908, RC 910, RC 911, SS 1010, SS 1011a, SS 1011b, SS 1012,
RC 912, RC 915 SS 1013, SS 1014, SS 1016, SS 1017
9 10
Special Focus Sessions:
SF 9a, SF 9b
Coffee & Talk (open forum): C 18, C 29 Coffee & Talk (open forum): C 20 Luigi Oliva
E3 - ECR Academies: E3 3121, E3 1322 E3 - ECR Academies: E3 1421 Honorary Lecture
E3 - ECR Master Class: E3 1326 E3 - European Diploma Prep Sessions: Paul S. Sidhu; London/UK
E3 - European Diploma Prep Sessions: E3 1423 E3 - The Beauty of Basic Knowledge:
E3 1323 ESR Patient Advisory Group: PA 1 E3 24D, E3 25D
Saturday, March 2
E3 - Rising Stars Programme: BR 13, S 3 My Thesis in 3 Minutes: MY 14 EDiR Session

EuroSafe Imaging Sessions: EU 4 Pros & Cons Session: PS 1427 Junior Image Interpretation Quiz
Joint Sessions: ESR/EORTC RTF Highlighted Lectures: TF Satellite Symposia
My Thesis in 3 Minutes: MY 13 Scientific Sessions: SS 1401a, SS 1401b,
Professional Challenges Sessions: PC 13 SS 1402a, SS 1402b, SS 1403, SS 1404,
Refresher Courses: RC 1302, RC 1307, SS 1405, SS 1406, SS 1407, SS 1410,
RC 1308, RC 1310, RC 1311, RC 1313, RC 1315 SS 1411a, SS 1411b, SS 1412, SS 1413,
SS 1414, SS 1416
Scientific Sessions: SS 1314
Transatlantic Course: TC 1428
State of the Art Symposia: SA 13
Special Focus Sessions: Satellite Symposia
13 14
SF 13a, SF 13b
Transatlantic Course:
TC 1328
E3 - ECR Academies: E3 1721 ESR meets Pakistan E3 - Rising Stars Programme: CBDT

E3 - ECR Master Class: E3 1726a, E3 1726b E3 - ECR Academies: E3 1821 E3 - The Beauty of Basic Knowledge:
E3 - European Diploma Prep Sessions: E3 - European Diploma Prep Sessions: E3 24E, E3 25E
E3 1723 E3 1823
Sunday, March 3
E3 - Rising Stars Programme: BR 17 My Thesis in 3 Minutes: MY 18

EuroSafe Imaging Sessions: EU 7 Scientific Sessions: SS 1801a, SS 1801b,
Joint Sessions: ESR/ESMRMB SS 1802a, SS 1802b, SS 1803, SS 1804,
Multidisciplinary Sessions: MS 17 SS 1805a, SS 1805b, SS 1807, SS 1808,
SS 1809, SS 1810, SS 1811a, SS 1811b,
My Thesis in 3 Minutes: MY 17 SS 1813, SS 1814, SS 1815, SS 1816
RC 1703, RC 1704, RC 1708,
RC 1710, RC 1711, RC 1713,
RC 1714, RC 1717
2
Scientific Sessions:
SS 1708, SS 1709, SS 1716
ECR 2019 | Final Programme
17 18 www.myESR.org
TIMETABLE
14:00 14:30 15:00 15:30 16:00 16:30 17:00 17:30 17:45 18:00 18:30 19:00
Coffee & Talk (open forum): C 4, C 24 Coffee & Talk (open forum): C 5 ECR 2019 Grand Opening
E3 - ECR Academies: E3 319, E3 320 E3 - ECR Academies: E3 419, E3 420 Lorenzo E. Derchi; Genoa/IT
E3 - Rising Stars Programme: BE 3 E3 - ECR Master Class: E3 426a, E3 426b
Presentation of ESR Honorary Membership
My Thesis in 3 Minutes: MY 3 E3 - Rising Stars Programme: BE 4
Presentation of ESR Gold Medals
New Horizons Sessions: NH 3 ESHIMT Sessions: ESHIMT 1
Key Lecture: Sir David Adjaye
Refresher Courses: RC 301, RC 314 ESR Audit and Standards Session
ESR US Subcommittee: US 1 Live Concert
Scientific Sessions: SS 301, SS 302,
SS 303, SS 305, SS 306, SS 307, SS 308, My Thesis in 3 Minutes: MY 4
SS 309, SS 310, SS 311, SS 312, SS 314, Refresher Courses: RC 403, RC 405,
SS 315, SS 316, SS 317 RC 410, RC 412, RC 413, RC 417
Scientific Sessions: SS 401, SS 407,
3 4
Satellite Symposia SS 414
Satellite Symposia
Coffee & Talk (open forum): C 10, C 11 Coffee & Talk (open forum): C 12
E3 - ECR Academies: E3 720, E3 721, E3 722 E3 - ECR Academies: E3 820, E3 821, E3 822
E3 - Rising Stars Programme: S 1 E3 - Rising Stars Programme: BS 8
ESOR Session EuroSafe Imaging Sessions: EU 2
Hands-on Workshops: HW 730 Hands-on Workshops: HW 830
My Thesis in 3 Minutes: MY 7 Joint Sessions: EFRS/EORTC
Scientific Sessions: SS 701, SS 702a, Multidisciplinary Sessions: MS 8a, MS 8b
The Voice of EPOS for Radiographers • in Foyer C
Wednesday – Friday: 09:00–16:00 • Saturday: 09:00–13:00
SS 702b, SS 703, SS 704, SS 705, My Thesis in 3 minutes: MY 8

SS 706, SS 707, SS 709, SS 710, SS 711, Refresher Courses: RC 806, RC 810,
SS 713, SS 714a, SS 714b SS 716, SS 717 RC 811, RC 812, RC 814, RC 816, RC 817
Special Focus Sessions: SF 8a, SF 8b,
SF 8c, SF 8d, SF 8e, SF 8f
7 8
EFRS meets Denmark ISRRT meets Africa

Coffee & Talk (open forum): C 28 E3 - ECR Academies: E3 1218, E3 1221,
E3 - ECR Academies: E3 1118 E3 1222
Image Interpretation Quiz E3 - ECR Master Class: E3 1226
Friday, March 1
Joint Sessions: ESR/BBMRI-ERIC E3 - Rising Stars Programme: BR 12,
PIER @ ECR Sessions: PI 3 BS 12
Women in Focus: WF 3 ESR US Subcommittee: US 2
EuroSafe Imaging Sessions: EU 3
Satellite Symposia Refresher Courses: RC 1201, RC 1202,
RC 1204, RC 1206, RC 1207, RC 1208,
RC 1210, RC 1211, RC 1216, RC 1217
11 12
Coffee & Talk (open forum): C 19, C 30 Coffee & Talk (open forum): C 21
E3 - ECR Academies: E3 1521 E3 - ECR Academies: E3 1621
E3 - ECR Master Class: E3 1526 E3 - ECR Master Class: E3 1626a, E3 1626b
E3 - European Diploma Prep Sessions: E3 - European Diploma Prep Sessions:
E3 1523 E3 1623
Saturday, March 2
E3 - Rising Stars Programme: S 4 E3 - Rising Stars Programme: BR 16
EFRS Workshop EuroSafe Imaging Sessions: EU 6
EuroSafe Imaging Sessions: EU 5 Joint Sessions: ESR/EFRS, ESR/ESHIMT
My Thesis in 3 Minutes: MY 15 Multidisciplinary Sessions: MS 16
My Thesis in 3 Minutes: MY 16
RC 1513, RC 1515 New Horizons Sessions: NH 16
Scientific Sessions: SS 1501a, SS 1501b, Professional Challenges Sessions: PC 16
SS 1503, SS 1507, SS 1509, SS 1510, Refresher Courses: RC 1601, RC 1603,
SS 1511, SS 1512 RC 1607, RC 1610, RC 1611
Special Focus Sessions: Scientific Sessions: SS 1604, SS 1605
State of the Art Symposia:
15 16
SF 15a, SF 15b, SF 15c, SF 15d
Transatlantic Course: SA 16
TC 1528 Transatlantic Course:
TC 1628
E3 - ECR Academies: E3 1921

E3 - Rising Stars Programme: CBDT
Scientific Sessions: SS 1901a, SS 1901b,
SS 1902a, SS 1902b, SS 1903a, SS 1903b,
Sunday, March 3
SS 1904, SS 1905a, SS 1905b, SS 1907,

SS 1909, SS 1910a, SS 1910b, SS 1911a,
SS 1911b, SS 1913, SS 1914a, SS 1914b,
SS 1915
www.myESR.org
19 Final Programme | ECR 2019 3
31ST EUROPEAN CONGRESS OF RADIOLOGY
25TH EUROPEAN CONGRESS OF RADIOLOGY IN VIENNA!
CONGRESS VENUE CONGRESS LANGUAGE

Austria Center Vienna (ACV) English
Bruno Kreisky Platz 1
1220 Vienna, Austria
ONSITE OPENING HOURS

Registration Technical Exhibition
Tuesday, February 26 . . . . . . . . . . . . . . . . . . 12:00–18:00 EXPO Halls and EXPO Foyer D
Wednesday, February 27 . . . . . . . . . . . . . . . 07:00–18:00 Thursday, February 28
Thursday, February 28 to Saturday, March 2. . . . . . . . . . . . . . . . . . . 10:00–17:00
to Saturday, March 2. . . . . . . . . . . . . . . . . . . 07:30–18:00 Sunday, March 3 . . . . . . . . . . . . . . . . . . . . . . 10:00–14:00
Sunday, March 3 . . . . . . . . . . . . . . . . . . . . . . 07:30–16:00
EXPO Gallery (First Level)
Preview Centre Wednesday, February 27 . . . . . . . . . . . . . . . 14:00–17:00
Tuesday, February 26 . . . . . . . . . . . . . . . . . . 12:00–18:00 Thursday, February 28
Wednesday, February 27 to Saturday, March 2. . . . . . . . . . . . . . . . . . . 10:00–17:00
to Saturday, March 2 . . . . . . . . . . . . . . . . . . . 07:30–18:00 Sunday, March 3 . . . . . . . . . . . . . . . . . . . . . . 10:00–15:30
Sunday, March 3 . . . . . . . . . . . . . . . . . . . . . . 07:30–16:00
Travel Service
Congress Office Tuesday, February 26 . . . . . . . . . . . . . . . . . . 12:00–18:00
Tuesday, February 26 . . . . . . . . . . . . . . . . . . 12:00–18:00 Wednesday, February 27
Wednesday, February 27 . . . . . . . . . . . . . . . 07:00–18:00 to Saturday, March 2. . . . . . . . . . . . . . . . . . . 08:00–17:30
Thursday, February 28 Sunday, March 3 . . . . . . . . . . . . . . . . . . . . . .08:00–12:00
to Saturday, March 2. . . . . . . . . . . . . . . . . . . 07:30–18:00
Sunday, March 3 . . . . . . . . . . . . . . . . . . . . . . 07:30–16:00 Press Office & Business Centre
ECR Online & EPOS Lounge to Saturday, March 2. . . . . . . . . . . . . . . . . . . 08:00–18:00
EPOS™ – Scientific Exhibition Sunday, March 3 . . . . . . . . . . . . . . . . . . . . . . 08:00–16:00
to Saturday, March 2. . . . . . . . . . . . . . . . . . . 08:00–18:00
Sunday, March 3 . . . . . . . . . . . . . . . . . . . . . . 08:00–15:30
The ESR thanks its member societies and partners for their contributions.
4 ECR 2019 | Final Programme www.myESR.org

TABLE OF
CONTENTS
Foreword by the ESR President . . . . . . . . . . . . . . . . . . . . . 6 SCIENTIFIC PROGRAMME . . . . . . . . . . . . . 71
Foreword by the EFRS President . . . . . . . . . . . . . . . . . . . . 8 ESR/EFRS/ISRRT meets Sessions . . . . . . . . . . . . . . . . . . 73
Headline Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Women in Focus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
Image Interpretation Quizzes . . . . . . . . . . . . . . . . . . . . . . .79
GENERAL INFORMATION . . . . . . . . . . . . . 13 New Horizons Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
Information from A–Z . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
State of the Art Symposia . . . . . . . . . . . . . . . . . . . . . . . . .83
CME at ECR 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .30
Special Focus Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . .85
Green Meeting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .33
Professional Challenges Sessions . . . . . . . . . . . . . . . . . . . 91
Underground Map . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .34
Coffee & Talk Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . .93
FLOOR PLANS . . . . . . . . . . . . . . . . . . . . . . . 35 Multidisciplinary Sessions . . . . . . . . . . . . . . . . . . . . . . . . . 101
Pros & Cons Session . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
ESR DIGNITARIES . . . . . . . . . . . . . . . . . . . . . 45 European Excellence in Education (E3) . . . . . . . . . . . . 105
Honorary Member Federico G. Lubinus . . . . . . . . . . . . . .46 Rising Stars Programme . . . . . . . . . . . . . . . . . . . . . . . 107
Honorary Member Michael G. Kawooya . . . . . . . . . . . . . .46 European Diploma Prep Sessions . . . . . . . . . . . . . . . .113
Honorary Member Vijay M. Rao . . . . . . . . . . . . . . . . . . . . . 47 The Beauty of Basic Knowledge . . . . . . . . . . . . . . . .115
Gold Medallist Anna-Maria Belli . . . . . . . . . . . . . . . . . . . . . 47 ECR Academies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .117
Gold Medallist Luis Donoso-Bach . . . . . . . . . . . . . . . . . . .48 ECR Master Classes . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
Gold Medallist Valentin Sinitsyn. . . . . . . . . . . . . . . . . . . . .48 Hands-on Workshops. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
Honorary Lecturer Regina Beets-Tan . . . . . . . . . . . . . . . .49 Transatlantic Course . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .131
Honorary Lecturer S. Nahum Goldberg . . . . . . . . . . . . . .49 Joint Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
Honorary Lecturer Paul S. Sidhu . . . . . . . . . . . . . . . . . . . .50 Refresher Courses/Scientific Sessions . . . . . . . . . . . . . . 147
Abdominal and Gastrointestinal . . . . . . . . . . . . . . . . 148
COMMITTEES . . . . . . . . . . . . . . . . . . . . . . . . . 51 Breast . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
ESR Executive Council . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52 Cardiac . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
ECR 2019 Programme Planning Committee . . . . . . . . . . 53 Chest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 153
ECR 2019 Scientific Subcommittees. . . . . . . . . . . . . . . . .54 Imaging Informatics . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
ECR 2019 Topic Coordinators . . . . . . . . . . . . . . . . . . . . . . 57 Artificial Intelligence and Machine Learning. . . . . . 155
Hybrid, Molecular and Translational Imaging . . . . . 157
PROGRAMME OVERVIEWS . . . . . . . . . . . . 59
Genitourinary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158
Wednesday, February 27 . . . . . . . . . . . . . . . . . . . . . . . . . . 60
Head and Neck . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159
Thursday, February 28 . . . . . . . . . . . . . . . . . . . . . . . . . . . . .62
Interventional Radiology . . . . . . . . . . . . . . . . . . . . . . . 160
Friday, March 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .64
Musculoskeletal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .161
Saturday, March 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66
Neuro . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
Sunday, March 3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .68
Paediatric . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 165
Physics in Medical Imaging. . . . . . . . . . . . . . . . . . . . . 168
Radiographers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 169
Vascular. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .171
Oncologic Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . 172
Emergency Radiology . . . . . . . . . . . . . . . . . . . . . . . . . 173
My Thesis in 3 Minutes . . . . . . . . . . . . . . . . . . . . . . . . . . . . 175
Clinical Trials in Radiology . . . . . . . . . . . . . . . . . . . . . . . . .191
The Voice of EPOS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195
Stage 1 - EPOS Lounge . . . . . . . . . . . . . . . . . . . . . . . . 196
Stage 2 - EPOS Lounge. . . . . . . . . . . . . . . . . . . . . . . . 198
Stage 3 - EPOS Lounge . . . . . . . . . . . . . . . . . . . . . . 200
Stage 4 - EPOS Lounge . . . . . . . . . . . . . . . . . . . . . . 202
Stage 5 - RADIOGRAPHERS - Foyer C . . . . . . . . . 204
INDUSTRY PROGRAMME
Satellite Symposia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 205 Industry Workshops . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 209
Please note that sessions are marked with a logo to indicate their classification
according to the European Training Curriculum.
First three years of training Fourth and fifth years of training Subspecialty training standard
(general radiologist standard)
www.myESR.org Final Programme | ECR 2019 5

Foreword
FOREWORD BY THE ESR PRESIDENT
WELCOME TO ECR 2019!

WELCOME TO THE 25TH ECR IN VIENNA!
THANKS FOR COMING TO BE
A PART OF ‘THE BIGGER PICTURE’!
ECR 2019 marks an important anniversary. This will be All these session formats have proven successful and will
the 25th ECR congress held in Vienna since 1991: a great be continued, and even expanded, this year. Furthermore,
achievement! Those who have been coming here since an additional new session type will be launched, not only
the beginning will find a meeting that has become bigger for ECR delegates, but also open to anyone who is inter-
over the years, now including not only the Austria Center, ested in joining in. The ‘Women in Focus’ initiative will
but also many of the buildings surrounding it. It is a true explore the challenges encountered by women in our field
‘congress city’, which has grown to accommodate the and in other medical and medical-related professions. It
increasing numbers of delegates from all over the world. will open a debate over gender parity in our profession
Those who are here for the first time will discover a con- and will try to present role models to whom the ever-in-
gress with a wide range of opportunities to learn about creasing number of women entering into radiology can
the different aspects of our specialty, with sessions suited relate.
to all, from beginners to advanced professionals.
The 25th ECR in Vienna can be considered as a chance to
Over the years, the ECR has provided radiologists with reflect on the journey of European radiology through the
a European platform for the presentation of research past years and as a starting point for the future. This is
and debate and has been the key to the creation of a why it has been called ‘the bigger picture’. The concept
community of people working together and advancing is reflected in the educational programme, in which basic
in science and education together. This has been the sessions for students and a state-of-the-art programme
result of the efforts of 24 Congress Presidents and Pro- for residents and young radiologists sit side-by-side with
gramme Planning Committees who, with the help of the discussions on the future of our discipline. The impact of
well-structured and dedicated efforts of the ECR Scien- artificial intelligence on our work, the new diagnostic hori-
tific Programme Department, have worked as in a relay zons provided by liquid biopsy, the need to increase the
team, passing the baton from one to the next and ensur- visibility of radiology and to develop respectful and fruit-
ing continuity of aims and good results over the years. ful relationships with patients in everyday clinical practice,
and the challenges that medical doctors have to meet in
The ECR has always been a creative meeting. It started dealing with humanitarian emergencies, are only a few of
with a ‘classical’ structure, made up of refresher courses, the important topics we will discuss.
scientific presentations and posters, and, over the years,
has incorporated various new ways for contributors to The willingness of the radiological community to play
present scientific work. The first big innovation was in an active part in ‘the bigger picture’ has been demon-
2003, with the introduction of the electronic posters strated by the high number of high-quality abstracts we
EPOS. Then, in 2016, came the new session format ‘the received. I have to deeply thank the many colleagues who
Voice of EPOS’ in which the scientific message of selected have submitted the results of their studies for considera-
posters could be explained in person by their authors. tion at the meeting. We have tried to increase the number
Last year, the ‘MyT3’ presentations, the lounge meetings of scientific sessions in order to accommodate the major-
of ‘Coffee & Talk’ and the hands-on approach to interven- ity of them and give the chance of active participation to
tional radiology of ‘the Cube’ were introduced. as many as possible.

Foreword
FOREWORD BY THE ESR PRESIDENT
A high number of abstracts has been received from the

‘ESR meets’ countries. These will be Italy, my home coun-
try, Pakistan, and the whole African continent. The ‘ESR
meets’ initiative provides the chance to get to know our
colleagues from these places better and, when meeting
radiologic societies from other continents, to learn how
these colleagues work and live, to strengthen relation-
ships and to create friendships with them. This year, for
the first time, we will meet many radiologists from Africa.
We will try to understand what the European Society of
Radiology can do for them and, at the same time, what
we can learn from their experience.
Three well-known leaders in different fields of radiology

will hold this year’s Honorary Lectures. Prof. Paul S.
Sidhu’s lecture is titled ‘Contrast-enhanced US in paedi-
atrics: ready for clinical practice?’ and will address a tech-
nique that is not widely used and whose benefits are not
yet fully explored. Prof. Regina Beets-Tan will discuss the ESR President Prof. Lorenzo E. Derchi
new frontiers of oncologic imaging in her lecture ‘Onco- is Head of the Department of Radiology
logic imaging: a new beginning has just begun’. Finally, at the University of Genoa, Italy.
Prof. S. Nahum Goldberg will explore the extent of the
potentially beneficial and harmful systemic effects of ‘focal’ There will be ample lounges where you can get some rest
interventional oncologic radiology by asking the question and take the opportunity to see those sessions you could
‘Systemic effects of image-guided tumour therapy: have not quite squeeze into your schedule.
we opened Pandora’s Box or found the Holy Grail?’
Above all, everyone will take the opportunity to discuss,
The European Congress of Radiology will see not only ask questions at the end of the presentations, talk with
radiologists taking part, but also delegates working in other colleagues, liaise, and socialise. The annual ECR is
all allied sciences. There will be a number of educational THE place where the European community of all radiol-
and scientific sessions specifically dedicated to radiogra- ogy professionals meets. We all come here to increase our
phers. The European Federation of Radiographer Socie- knowledge; to compare our science and way of practice
ties (EFRS) has made the ECR its flagship meeting and with colleagues of other nations; to grow and learn how to
this year there has been a larger number of abstracts sub- provide a better service to our patients. We can find here
mitted by radiographers than ever before. Once again, an international horizon for our research through the cre-
the ESR/EFRS Joint Radiographer Abstract Awards will ation of links among people and institutions that are not
be presented to the submitters of the best radiographer only professional but have become, for many, personal
abstracts. bonds of respect and friendship. Over the 24 ECRs held
in the past years, we have contributed to creating a com-
If you cannot come to Vienna (someone has to remain munity of radiologists advancing together in science and
home and do the tough work), you can watch ECR care. We have all worked to achieve the harmonisation
Online! Almost all sessions will be broadcast live for you of radiological teaching, practice and research in Europe.
to watch from home. Furthermore, they will be recorded There is still a lot to do. May ‘the bigger picture’ of this 25th
and made available to watch on demand later (often as congress in Vienna be the starting point for further unity.
soon as the same evening). You can even use ECR Online
here in Vienna, to watch presentations you were not able Lorenzo E. Derchi
to attend. ESR President

Foreword
FOREWORD BY THE EFRS PRESIDENT
WELCOMING
ALL RADIOGRAPHERS
TO ECR 2019
Radiographers have long been involved in the European At ECR 2019, Room C on the 2nd level will become the
Congress of Radiology (ECR) and the European Federa- new venue for most of the sessions in the radiographers’
tion of Radiographer Societies (EFRS) has had respon- programme. The Radiographers’ Lounge has also been
sibility for developing the radiographers’ sessions since relocated to Foyer C (outside Room C). In this area, the
ECR 2012, however, it is only in recent years that the ECR EFRS and ESR will welcome 20 national radiographers’
has become the official scientific congress of the EFRS, societies, along with some educational institutions, who
and the European Society of Radiology (ESR), for medi- are members of the EFRS Educational Wing, who will
cal imaging radiographers. all have booths in this area. The radiographers’ Voice of
EPOS stage will also be located in the lounge area, as
Over the past eight congresses, the radiographers’ pro- will a number of research studies, requiring your partic-
gramme has grown considerably, as has the participation ipation, which will take place in the EFRS Radiographers’
of radiographers. A total of 2,177 radiographers and radi- Research Hub (Room 2.96). The Radiographers’ Lounge
ography students, from 75 countries, attended ECR 2018 will thus be a great meeting place and, together with the
and we look forward to welcoming even more to ECR rest of the EFRS Executive Board, I look forward to meet-
2019, which has now become one of the largest interna- ing you in this area and seeing you at the radiographers’
tional gatherings of radiographers. sessions.
In 2018, a total of 22 refresher courses, professional chal- Following the launch of the ESR/EFRS Radiographer
lenges sessions, special focus sessions, joint sessions, Ris- Awards and the Radiographers’ Evening last year, both
ing Stars sessions, MyT3 sessions, and scientific sessions initiatives will continue for ECR 2019. I look forward to
made up the radiographers’ programme. For ECR 2019, jointly presenting, with the congress president Professor
this will rise to 28 sessions, which will truly offer some- Lorenzo E. Derchi, the Best Radiographer Paper Abstract
thing for everyone. A special word of thanks must go to awards, the Magna Cum Laude Radiographer Poster
Dr. Andrew England from the University of Salford, UK, awards, and the Best Radiography Student Abstract
and a member of the EFRS Educational Wing Manage- award during the ECR. Do not miss out on what promises
ment Team, and Dr. Maríanna Garðarsdóttir from Land- to be another fantastic social event for radiographers on
spitali University Hospital, Iceland, who are the co-chairs Thursday, February 28, where Professor Derchi and I look
of the 2019 radiographers’ scientific subcommittee, and forward to hosting over 500 radiographers on the night.
to their team for an excellent educational and scientific
programme. Aside from the above sessions, we also look
forward to the radiographers’ Voice of EPOS sessions, the
involvement of radiographers in a series of sessions at the
Cube 2.0 (a special programme dedicated to interven-
tional radiology), and the EFRS Educational Wing annual
meeting and our student session.

Foreword
FOREWORD BY THE EFRS PRESIDENT
The EFRS represents over 100,000 radiographers and

over 8,000 radiography students, across 35 countries,
through 40 national societies, along with 60 universities
within our Educational Wing. The EFRS is proud to col-
laborate with the ESR on what has become the biggest
and best programme for medical imaging radiographers.
We look forward to continuing our work with the ESR
to grow the radiographers’ programme along with the
participation of radiographers and radiography students EFRS President Assoc.Prof. Jonathan McNulty
from around the world. is Associate Dean of Graduate Studies
at University College Dublin School of Medicine
On behalf of the EFRS and the ESR, we hope that you in Dublin, Ireland.
have a great congress and look forward to meeting with
you over the coming days.
Jonathan McNulty
EFRS President

HEADLINE SESSIONS
ECR 2019 WILHELM CONRAD

GRAND OPENING RÖNTGEN
HONORARY LECTURE
17:45–19:30, Room A Oncologic imaging:
a new beginning has just
LORENZO E. DERCHI begun! [A-0336]
Genoa/IT
ESR PRESIDENT Thursday, February 28
12:15–12:45, Room A
PRESENTATION
REGINA G.H. BEETS-TAN
OF ESR HONORARY MEMBERSHIP
Amsterdam/NL
Federico G. Lubinus; Bucaramanga/CO
Michael G. Kawooya; Kampala/UG
JOSEF LISSNER
Vijay M. Rao; Philadelphia, PA/US
HONORARY LECTURE
PRESENTATION Systemic effects of image
OF ESR GOLD MEDALS guided tumour therapy:
Anna-Maria Belli; London/UK have we opened Pandora’s box
Luis Donoso-Bach; Barcelona/ES or found the Holy Grail? [A-0602]
Valentin E. Sinitsyn; Moscow/RU
Friday, March 1
12:15–12:45, Room A
KEY LECTURE
Building Publics S. NAHUM GOLDBERG
Sir David Adjaye, London/UK Jerusalem/IL
LIVE CONCERT LUIGI OLIVA

Dorretta Carter HONORARY LECTURE
Vienna Arts Orchestra,
conductor Alex Johansson Contrast-enhanced ultrasound
Neue Wiener Stimmen, choir in paediatrics: ready for clinical
Wiener Sängerknaben, choir practice? [A-0847]
Saturday, March 2
12:15–12:45, Room A
PAUL S. SIDHU
London/UK
10
HEADLINE
SESSIONS
IMAGE
INTERPRETATION QUIZ
Greek gods: Mount Olympus
vs The Underworld
Friday, March 1
14:00–15:30, Room A
Moderator:
APOSTOLOS H. KARANTANAS
Iraklion/GR
JUNIOR IMAGE
INTERPRETATION QUIZ
A day in the (future) life
of a young radiologist
Saturday, March 2
12:55–13:55, Room A
Moderator:
BIANCA BIGNOTTI
Genoa/IT
11
EC R 2 0 1 9
G R AND OPENING WEDNESDAY, FEBRUARY 27,
17:45, A
Opening Words
Lo
ore
ren
nzo E.
E Derrch
chi;
hi;; Gen
enoa
oa, It
oa Ital
aly
y
ESR
ES R Pr
Pres
esid
es iden
dennt
Presentation of ESR Honorary Membership

Mich
c ael G. Kawoo
ch ooya
oo ya;; Ka
Kampala, la, Uganda
Federico
co
o G. Lubinu
us; Bucar
uc car
aram
am
aman
man
a ga a, Co
olo
omb
mbia
bia
i
Vija
ja
ay M.
M Rao
a ; Ph
P iladad
del
e ph
phia
ia,, US
USAA
Presentation of ESR Gold Medals

Annaa-Maria Belli; Lond don
n, UK
Lu
uis Donoso- o-Ba
o- Bach
Ba c ; Barcelona, Spa
pain
in
V le
Va lentin E. Si
S nits
tssyn
tsyyn; Mo
M scow, Russsia
i
Key Lecture
Sirr Da
Si avi
v d Adjaye
y ; London, UK
Live Concert
Dorret
Dorr etta Carrter
Vien
Vi enna
na
a Art
rts Orch
ches
estra, con
ondduct
c or
o Ale ex Joohans
ha
ans
nsso
sonn
Neuee Wie
iene
ner St
Stim
imme
men,n,, cho
h irr
Wien
ner Sän
änge
gerknabeben,
n chohoir
i
Concep
Co eptu
tual
a Art
rtisst, Dir
irec
e tor, Stage
ge & Vid
deo
o Des
esig
gne
ner:
r
Amra Berrgm
Am gman
an
Musi
Mu s ca
si cal Direct
ctor
or::
Eric
Er ch Ho ofm
f annn
GENERAL
INFORMATION
13
General Information
INFORMATION FROM A–Z
ARTIFICIAL INTELLIGENCE & MACHINE LEARNING BROADCAST ZONES

Artificial intelligence, machine learning, deep learning – The ECR features specific Broadcast Zones, where you can
terms that seem to be on everybody’s mind. The ECR, listen to sessions and view the corresponding presentation
known for its innovative drive, has again heeded the call material in a relaxed atmosphere when the actual lecture
for an extensive programme dedicated to the most recent rooms are overcrowded. Broadcast Zones are located
research and achievements in these areas. International • In the Austria Center Vienna next to Room B (2nd level),
experts in the field will share their insights in a plethora O and N (1st level), E1 and F2 (entrance level), G and
of sessions delivered throughout the congress. K (lower level)
See separate leaflet ‘All about Artificial Intelligence & • In the M Building next to Rooms M 4 and M 5
Machine Learning’. See Floor Plans on pages 35–44.
ARTS & CULTURE BUSINESS CENTRE

Delegates are encouraged to visit the Arts & Culture Desk The Press Office & Business Centre, located on the entrance
in the entrance hall for information on Vienna’s cultural level, offers copy facilities for a small charge.
events such as exclusive opera performances, delightful Opening hours:
concerts, and the fascinating exhibitions in Vienna’s Wednesday, February 27 to Saturday, March 2: 08:00–18:00
most important and remarkable museums. Pick up your Sunday, March 3: . . . . . . . . . . . . . . . . . . . . . . . 08:00–16:00
personal Arts & Culture Brochure at this counter to find
descriptions of all cultural places. CAFÉS & RESTAURANTS
If you are looking for an ideal meeting point, or if you just
BADGES want to take a short break, try one of the various foyer
For organisational and security reasons, badges must be cafés and restaurants. They are located throughout the
worn at the congress venue. Access to the different areas will congress venue, on all levels of the building, and offer a
only be granted upon presentation of an appropriate badge. variety of tasty hot and cold snacks.
Check out the most delicious dishes at our restaurants
Lost or Forgotten Badges in Foyer A (2nd level) and Foyer F (entrance level) and at
In the case of loss, a replacement badge will only be provided the ‘Café Grand Vienna’ (Foyer D).
on full payment of the applicable onsite registration fee. Please see the ‘coffee-cup’ and ‘knife and fork’ signs on
Forgotten badges will be replaced against a deposit of the Floor Plans on pages 35–44 of this programme to
the full onsite fee. locate the various foyer cafés.
When you are on your way through the ECR City, check out
BOOK OF ABSTRACTS – the ‘Coffeeshop Company Café’ in the Andromeda Tower,
PUBLICATION IN INSIGHTS INTO IMAGING the restaurant ‘Lunchtime’ at Tech Gate or the restaurant
In keeping with the ESR’s commitment to environmental ‘UP’ and the café ‘DO’ on your way to the DC Tower.
sustainability, and due to demand from its members, the
Book of Abstracts is only available online as supplement CASE-BASED DIAGNOSIS TRAINING
issue of the ESR journal Insights into Imaging. Please refer to the E3 – Rising Stars Programme and see
All abstracts can be accessed at http://i3-journal.org/ page 112.
for-readers/.
You can also create your own personal Book of Abstracts
with the help of the popular ECR Interactive Programme
Planner on our platform ECR Online (ecronline.myESR.org).
Abstracts of EPOS™ presentations are not published in
the Book of Abstracts, full posters are published on epos.
myESR.org and can be cited with their DOI.

General Information
CASES OF THE DAY CHURCHES AND RELIGIOUS COMMUNITIES IN VIENNA

From Wednesday to Saturday, five Cases of the Day covering Vienna is a multi-denominational, multi-cultural city.
different sections of radiology are shown on computer We will be pleased to provide you with information on
st
stations in the ECR Online & EPOS Lounge on the 1 level. local religious communities and places of worship at the
Participants are invited to submit their diagnoses. Travel Service Desk.
The winners will be announced on the ESR website.
CLINICAL TRIALS IN RADIOLOGY (CTiR)
We would like to acknowledge the contribution of the For the fifth time, at ECR 2019, Clinical Trials in Radiology
following authors to the Cases of the Day: (CTiR) sessions are taking place. The CTiR sessions are
comprised of presentations on recent trials which are very
Wednesday: likely to have an impact on clinical practice.
Case 1: R. Pedersen; Toensberg/NO Session places are allocated on a first-come, first-served
Case 2: A. Brady; Cork/IE basis. Please refer to pages 191-193 for the programme
Case 3: K. Groven Løitegård, E. Klev, A. Stray-Pedersen, of the sessions.
A.G. Bechensteen, S. Brügmann-Pieper, See separate leaflet ‘All about Clinical Trials in Radiology’.
M. Hellebostad, L.S. Ording Müller, C. de Lange;
Oslo/NO CME ACCREDITATION SYSTEM
Case 4: J. Tsybulskaja, I. Trofimenko; Moscow/RU
The ESR provides you with a fully digital CME acquisition
Case 5: I.S. Gruzdev, V.S. Vdovenko, E.V. Kondratyev,
system for ECR 2019.
G.G. Karmazanovsky; Moscow/RU
Evaluation and CME acquisition will be possible via
Thursday: • The official ECR app, ECR 2019, available via the App
Case 1: T. Gogova, N. Traykova, I. Popov, N. Atanasova, Store (iOS) and Google Play (Android)
M. Dimitrova; Plovdiv/BG • More than 130 laptops in the ECR Online & EPOS
Case 2: B. Márquez, A.B. Barrio; Murcia/ES Lounge located on the 1st level
Case 3: D. Makrakis, S. Veneris, T. Maris, E. Kavroulakis,
E. Papadaki; Iraklion/GR Please note that evaluation of the sessions is only
Case 4: E. Vázquez, A. Sánchez-Montañéz, I. Delgado; possible February 27 – March 3, 2019 (23:59 CET).
Barcelona/ES
Case 5: N. Sideri, G. Velonakis, V. Bizimi, E. Alexopoulou, CME credits will only be awarded if
O. Papakonstantinou; Athens/GR • You are logged into http://eval.myESR.org with your
- Username and Password or
Friday: - Last Name and Personal ID (printed on your badge)
Case 1: E. Kermarrec, M. Bazot, I. Thomassin-Naggara; • You have fully completed the electronic questionnaire
Paris/FR for each session
Case 2: P. Spinnato, R. Clinca, S. Guerri, A. Bazzocchi; • You have completed the electronic ‘Overall Congress
Bologna/IT Evaluation’ questionnaire
Case 3: P. Jagmohan; Singapore/SG, C. Grippo; Rome/IT,
P. Clauser; Vienna/AT See pages 30-31.
Case 4: A. Walsh, Z. Wahab, O. Hulson, A. Scarsbrook;
Leeds/UK CME CONFIRMATION
Case 5: L.M. Dendl, J.L. Babar; Cambridge/UK After the congress, you can go online any time to the
MyUserArea and print out your ‘CME Confirmation’ sheet.
Saturday: This sheet lists in detail all the sessions you visited and
Case 1: B. Akpinar; Istanbul/TR evaluated during the congress as well as the number of
Case 2: G. Božović; Lund/SE hours credited. Your CME Confirmation will be available
Case 3: M. Maas; Amsterdam/NL from March 11, 2019.
Case 4: L.A. Solbiati, N. Gennaro, D. Poretti, M. Tramarin; For more information see pages 30-31.
Milan/IT
Case 5: A. Aracki-Trenkic, M. Simic, D. Stojanov,
Z. Radovanovic; Nis/RS

GET THE
ECR 2019 APP
myESR.org/app
1
U the QR code or th
Use he
URL to download the ‘ESR’
U
app. Alternatively look
a k
f ‘European Society
for y of
R
Radiology’ in your moobile
market place.
m
2
L
Launch the app to acc
cess
t ‘ECR 2019’ event.
the
General Information
COAT CHECK CONGRESS OFFICE

The coat check services are located on the lower level next The Congress Office is situated on the entrance level next
to Rooms D, G and K. In addition, ESR is supplying coat to Foyer E.
check services in all venues of ECR City, in the Church, the Opening hours:
Tech Gate, the DC Tower and the Saturn Tower. Tuesday, February 26: . . . . . . . . . . . . . . . . . . . . 12:00–18:00
This service is free of charge, kindly supported by the ESR. Wednesday, February 27: . . . . . . . . . . . . . . . . .07:00–18:00
Thursday, February 28 to Saturday, March 2: . . 07:30–18:00
COFFEE & TALK SESSIONS Sunday, March 3: . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–16:00
Don’t miss this informal session format, featuring short
lectures and discussions, taking place in various stylish CONGRESS VENUE
nd
lounges: Room Coffee & Talk 1 (2 level, Foyer B, within Austria Center Vienna (ACV)
the ESOR Lounge), Room Coffee & Talk 2 (1st level, Foyer Bruno Kreisky Platz 1
N, next to the EuroSafe Imaging Lounge), and Room 1220 Vienna, Austria
Coffee & Talk 3 (entrance level, Foyer E). Stop by and Phone: (+43 1) 533 40 64–0
contribute to the lively discussions while sipping your To reach the ACV by public transport from the city centre
coffee or tea. (Stephansplatz) take the U1 underground line (red line,
Topics vary from artificial intelligence and research to direction Leopoldau). Get off at Kaisermühlen/Vienna
EuroSafe Imaging (radiation protection), ESR iGuide International Centre and take the exit marked Donau-
(referral guidelines and decision support) and publication City-Straße.
and management tips. Travelling time: approximately eight minutes.
Please refer to pages 93-99 for the programme of the
sessions. ECR CITY
See separate leaflet ‘All about Coffee & Talk Sessions’. The number of delegates and sessions at the ECR has
increased markedly in recent years. That’s why we have
COMMUNICATION AREAS decided to take advantage of surrounding locations to
If you are looking for the perfect place to meet and create our very own ‘ECR City’.
talk with friends or just to relax and browse through In addition to the well-established Austria Center Vienna and
ECR Today, ECR 2019 offers areas perfectly equipped the temporary structure used for the technical exhibition,
for communication and recreation; the ESR Meets the ECR co-opts again the United Nations’ M Building for its
Lounge right in the middle of the entrance hall, the Free entire duration. Due to its enormous popularity last year, the
Publications Area behind the café at the main entrance, dedicated interventional radiology space had to find a new
the EuroSafe Imaging Lounge and the ECR Online & location and the DC Tower is now home to the Cube 2.0.
EPOS Lounge on the 1st level, the Radiographers Lounge The Church, conveniently located between the underground
on the 2nd level in Foyer C, the ESOR Lounge on the exit and the congress venue, is where the brand-new
2nd level in Foyer B, and the Rising Stars Lounge, which initiative Women in Focus will take place. Hosting a variety
welcomes all students, residents and trainees, located on of sessions will be the spectacular Sky High Stage, which
the very top of the new location Tech Gate, providing a overlooks the Austria Center (and the whole of Vienna) from
breath-taking view of Vienna. the top of the neighbouring Saturn Tower. The Tech Gate
will host the Guerbet Patient Pathway as well as scientific
CONFIRMATION OF PAYMENT AND ATTENDANCE sessions; and last but not least, at the DC Box, opposite
Congress-related confirmation will be available during and the Church, the ESR Connect Studio has found its home.
after the congress from the ESR website (www.myESR.org)
‘ECR ONLINE’
via the MyUserArea (login with your Username and Password).
After its success in previous years, the ESR is once again
CONGRESS LANGUAGE providing a live streaming service for ECR 2019, ECR
Online, in an effort to bring the ECR to everyone. Almost
English
all ECR sessions are being broadcast live via the ESR
website, with a social media stream integrated into the
web interface to provide a fully interactive experience.
ECR Online is kindly supported by Siemens Healthineers.
ecronline.myESR.org

ONLINE 2019
WATCH MORE THAN 3000 LECTURES

ONLINE LIVE OR ON DEMAND
Plan and personalise your ECR 2019 experience
with the Interactive Programme Planner.
FREE LIVE VIDEO AND SOCIAL MEDIA STREAM

One platform for all
ecronline.myESR.org
Powered by
General Information
ECR ONLINE & EPOS LOUNGE EPOS™ – SCIENTIFIC EXHIBITION

The ECR Online & EPOS Lounge has 130 computer The ECR 2019 electronic scientific poster exhibition, which
terminals where delegates can watch ECR sessions also presents the EuroSafe Imaging posters on medical
either live or on demand and access the ECR’s electronic radiation protection topics, is open Wednesday to Saturday
poster exhibition. In addition, other material, such as from 08:00 to 18:00, and Sunday from 08:00 to 15:30.
EuroSafe Imaging congress posters, and the Cases of the EPOS™ can be accessed via the 130 workstations in the
Day can be accessed too. ECR Online & EPOS Lounge, which is located on the 1st level.
Enjoy the Lounge’s relaxing atmosphere while you catch Make sure to attend the Voice of EPOS sessions in and
up with the congress sessions. around the ECR Online & EPOS Lounge and the special
Voice of EPOS Radiographers sessions in Foyer C
‘ECR TODAY’ (Radiographers Lounge), where the authors of the best
ECR Today, the popular daily newspaper of the congress, posters will present those in moderated poster sessions.
is published from Wednesday to Sunday and distributed in See pages 195-204.
the entrance hall of the congress venue and in the entrance
area of the Technical Exhibition. In addition, all issues are ESR CONNECT
available online at www.myESR.org/publications At the DC Box, another new addition to the ECR City,
opposite the church, the ESR Connect Studio has found
ECR 2019 APP its home. Providing various reports, video messages and
The ECR 2019 App gives iPhone, iPad and Android users interviews, here we will make sure that all ECR participants
a perfect way to experience the congress. The app is packed and all those that are not able to travel to Vienna will
with features, including general congress information, benefit from the happenings at ECR 2019 via our ECR
scientific and educational programme details, full abstracts, Online platform.
and even floor plans of the Austria Center. You can download
the ECR 2019 App from iTunes/Google Play. ESR iGUIDE
Visit the ESR iGuide booth, located within the EuroSafe
EFRS MEETS SESSION Imaging Lounge (1st level) to find out more about the
The European Federation of Radiographer Societies ESR’s clinical decision support (CDS) software for imaging
th
(EFRS) is hosting for the 7 time a dedicated session with referrals. Provided by the ESR’s Quality and Safety in
one of their member societies. The ‘EFRS meets Denmark’ Imaging GmbH, ESR iGuide utilises referral guidelines
session will deal with machine learning, improvements developed by the ESR in cooperation with the American
in healthcare, technological mediation and MR safety, College of Radiology to provide actionable decision
underlining the essential role of radiographers in medical support for more appropriate imaging referrals.
imaging. Please refer to page 74 for the programme of
the session. ESR JOINT SESSIONS
In addition to the Transatlantic Course of the ESR and
EIBIR LOUNGE RSNA (see page 132), the ESR holds joint sessions with
Visit the EIBIR Lounge in the ACV Business Centre, next to the following related societies during the congress:
Café Motto at the main entrance, to find out more about BBMRI-ERIC (a European research infrastructure for bio-
the future of biomedical research, research funding and banking), EFRS (European Federation of Radiographer
cutting-edge project results and achievements from the Societies), EFOMP (European Federation of Organisations
European Institute for Biomedical Imaging Research. for Medical Physicists), EFSUMB (European Federation of
Societies for Ultrasound in Medicine & Biology), EORTC
EMERGENCY INFORMATION/FIRST AID (European Organisation for Research and Treatment of
Cancer), ESHIMT (European Society for Hybrid, Molecular
For fire, medical or police assistance, please contact
and Translational Imaging), ESMRMB (European Society
ACV (Austria Center Vienna) Information or the nearest
for Magnetic Resonance in Medicine and Biology), ESTRO
available ECR or ACV staff member. A medical specialist
(European Society for Radiotherapy and Oncology) and
trained in emergency medicine will be present for the
the UEMS (European Union of Medical Specialists).
duration of the congress.
For more detailed information please see pages 142-145
See Red Cross sign on the Floor Plan page 37 (entrance level).
or consult the Interactive Programme Planner.

General Information
ESR MEETS LOUNGE EUROPEAN DIPLOMA IN RADIOLOGY (EDIR)

Visit the ESR Meets Lounge in the entrance hall! Whether An examination for the European Diploma in Radiology is
you are looking for an ideal meeting point or just want to being held at ECR 2019. The examination takes place on
take a short break – the ESR Meets Lounge will suit your Tuesday, February 26, in the ECR Online & EPOS Lounge
needs. Free wireless LAN is provided for your convenience. and in the Voice of EPOS Stage 3 area on the 1st level.
Watch out for artistic performances during the lunch Success in the examination certifies a standard of
breaks. radiological knowledge deemed appropriate by the ESR
for independent practice in general radiology.
ESR MEETS SESSIONS Don’t miss the EDiR Session on Saturday, March 2, 12:15–
The purpose of ‘ESR meets’ is to forge closer ties between 13:45 in Room X (2nd level) and the Coffee & Talk Session on
the ESR and its guest societies. The guest nations and EDiR on Friday, March 1, 15:30–16:30 in Room Coffee & Talk 1!
regions of this year’s ECR are Africa, Pakistan and Italy, www.myEBR.org
as a tribute to the home of ESR President Lorenzo E.
Derchi. There are dedicated sessions for the radiological EUROPEAN EXCELLENCE IN EDUCATION (E3)
communities of these nations to demonstrate the The E3 programme emphasises the importance of lifelong
excellence of radiology in their countries. learning. It covers the entire range of educational issues,
Places at these sessions are allocated on a first-come, from undergraduate medical education to subspecialised
first-served basis. Please refer to pages 73-75 for the continuing professional development. The E3 programme
programme of the sessions. is structured according to the different levels defined by
the ESR European Training Curriculum for Radiology.
EUROPEAN BOARD OF RADIOLOGY (EBR) The E3 programme consists of the following five branches,
The EBR has again a special home at the ECR! Visit the which reflect the different levels of education in radiology,
EBR Trailer just to the right of the congress venue’s main as well as the different stages of an individual’s professional
entrance to learn all about the European Diploma in career:
Radiology (EDiR), how to apply, and where and when Rising Stars Programme, European Diploma Prep Sessions,
the next exams will take place. In addition, receive here all The Beauty of Basic Knowledge, ECR Academies, ECR
information about the Accreditation Council in Imaging Master Classes.
(ACI), required criteria, documents and latest news in the
field of radiology accreditation; and about the European The Rising Stars Programme is designed especially
Training Assessment Programme (ETAP), which as ETAP for residents, students, radiographers and trainee
2.0 is now turning physical assessment visits into virtual radiographers.
assessment. It consists of Basic Sessions, Student Sessions, Joint
www.myEBR.org Sessions with ESOR (European School of Radiology),
Case-Based Diagnosis Training, EFRS Radiographers’
EUROPEAN DIPLOMA IN RADIOGRAPHY Basic Sessions, and the Radiology Trainees Forum
Programme including the RTF Highlighted Lectures and
Following a new collaboration between the European
the RTF Quiz.
Board of Radiology (EBR) and the European Federation
of Radiographer Societies (EFRS), there will be for
The European Diploma Prep Sessions aim to prepare
the first time, at ECR 2019, a separate examination for
prospective candidates for the European Diploma in
radiographers to receive the European Diploma in
Radiology (EDiR).
Radiography, taking place on Wednesday, February 27,
They are also suitable for residents who want an overview
in Meeting Rooms 2.15 and 2.17.
of the various topics relevant to imaging and for those
preparing for their national board examinations.
The content of the programme reflects Levels I+II
European Training Curriculum for Radiology (ETC)
learning objectives across a two-year cycle. The sessions
are held in close cooperation with the European Board
of Radiology (EBR).
Each of the six sessions is led by three lecturers and
moderated by one chairperson.

General Information
The Beauty of Basic Knowledge programmes focus on EUROPEAN SCHOOL OF RADIOLOGY (ESOR)
knowledge essential to the daily practice of radiology. For the latest news on the European School of Radiology
The format of these sessions reflects the tradition of visit the ESOR Lounge on the 2nd level in Foyer B.
conventional teaching sessions, in which experienced Don’t miss the ESOR Session ‘Artificial intelligence:
teachers share their insights into a topic of particular presented with new lecture formats’ on Thursday,
relevance with a group of attendees. February 28, 14:00–15:30 in Room M 3 and the following
A Beauty of Basic Knowledge session either consists Coffee & Talk Sessions in Room Coffee & Talk 1:
of one 60-minute lecture or two 30-minute lectures. ‘Meet the professor’ on Wednesday, February 27, 10:00–11:00
The teaching format is usually case-based, and features ‘The scholar and fellow’s experience’ on Wednesday,
some interaction with the attendees. The content of the February 27, 14:00–15:00
sessions is mostly tied to the Level I+II European Training ‘A heart’s matter: cardiac mentoring, tutoring and learning
Curriculum (ETC) learning objectives. The Beauty of Basic within the ESOR community’ on Thursday, February 28,
Knowledge sessions are suited to residents and board- 09:30–10:30
certified radiologists who want to refresh their knowledge ‘What is a fellowship in management’ on Thursday,
in basic topics of imaging and image-guided therapy. February 28, 12:30–13:30
‘How to enhance the role of junior radiologists in Europe’
The ECR Academies consist of a series of four to six on Friday, March 1, 10:00–11:00
sessions relevant to a particular area of radiology. This may ‘The European Diploma in Radiology (EDiR) as an
be a classic organ-based field or a technically oriented area instrument to develop a professional career’ on Friday,
of another field related to radiology, such as management. March 1, 15:30–16:30
Each ECR Academy spans several days, in which the ‘Why are research fellowships important for young
different facets of the area in question are covered by radiologists?’ on Saturday, March 2, 09:30–10:30
experts in the field. An ECR Academy is a coherent course ‘Why it is important to have an academic career’ on
in which the different sessions complement one another Saturday, March 2, 14:00–15:00
in order to reflect the entirety of the field.
The ECR Academies are particularly suited to general EUROSAFE IMAGING
radiologists or radiologists with a subspecialisation.
EuroSafe Imaging, the ESR’s flagship initiative in radiation
protection, celebrates its five-year anniversary at ECR 2019.
The ECR Master Classes focus on continuous professional
The alliance aims to promote the safe and appropriate
development and lifelong learning. The classes are
use of medical imaging in Europe and around the world.
designed for subspecialised radiologists seeking cutting-
Take your EuroSafe Imaging souvenir photo and view
edge information in their particular fields of interest. They
the EuroSafe Imaging Poster Exhibition in the EuroSafe
are held by experts in the field and reflect state-of-the-art
Imaging Lounge on the 1st level, with submissions from
knowledge, as well as emerging trends.
all over Europe and beyond. Stop by the EuroSafe
Imaging Booth in the same Lounge to learn all about
‘EUROPEAN RADIOLOGY’
this important initiative, and visit the ESR iGuide Booth
European Radiology is Europe’s number one journal in for a demonstration of the ESR’s clinical decision support
general radiology. Pick up a free special print issue in the solution utilising the society’s imaging referral guidelines.
Publications Lounge on the 1st level! Don’t miss the Coffee & Talk sessions happening there
(see pages 93-99 for details).
‘EUROPEAN RADIOLOGY EXPERIMENTAL’ See separate leaflet ‘All about EuroSafe Imaging’.
European Radiology Experimental is the youngest member
of the ESR journal family. The online open-access journal
focuses on basic scientific discoveries and novel approaches
in experimental settings. Pick up free special print issues in
the Publications Lounge on the 1st level!

IN MEMORIAM ALEXANDER R. MARGULIS
(1921-2018)
At this year’s ECR, explore and celebrate the

crucial role that women play in healthcare, as a
diverse range of speakers from across the medical
community tackle a range of issues related to
gender, leadership and professional growth.
Four unique interactive sessions

Live audience polling
Extended panel discussions
Special coffee breaks
Dedicated rooms for remote viewing
The Church
Friday, March 1
myESR.org/wif
General Information
EXPO HALLS & EXPO FOYER D HANDS-ON WORKSHOPS

Opening hours: At ECR 2019 educational Hands-on Workshops will
Thursday, February 28 to Saturday, March 2: . . 10:00–17:00 take place dealing with the topic ‘MRI of the Prostate’.
Sunday, March 3: . . . . . . . . . . . . . . . . . . . . . . . . . 10:00–14:00 Participants are asked to bring their own laptops.
The number of participants at each workshop is restricted
Visit the additional technical exhibition area
to 50. Participants have to pre-register online via the
on the 1st level of the congress venue:
myUserArea.
EXPO Gallery (First Level)
Opening hours:
HEADLINE SESSIONS
Wednesday, February 27: . . . . . . . . . . . . . . . . . 14:00–17:00
Thursday, February 28 to Saturday, March 2: . . 10:00–17:00 For details on the ECR 2019 Grand Opening, the Image
Sunday, March 3: . . . . . . . . . . . . . . . . . . . . . . . . . 10:00–15:30 Interpretation Quizzes and the Honorary Lectures by
Regina G.H. Beets-Tan, S. Nahum Goldberg and Paul S.
FREE PUBLICATIONS Sidhu see pages 10-11.
The ESR again presents a ‘Free Publications’ area, in the

HYBRID IMAGING
ACV Business Centre, next to Café Motto at the main
entrance. Pick up free copies of radiology journals and ECR 2019 has been recognised as the official annual
magazines. scientific meeting of the European Society for Hybrid,
Molecular and Translational Imaging (ESHIMT), the
FUTURE MEETINGS DESK fastest growing medical community for hybrid imaging in
Europe, which was inaugurated in 2016 and already boasts
This area – located in the ECR Online & EPOS Lounge on
more than 1,500 members. In the last few years, hybrid
the 1st level – offers you an overview of future meetings
imaging has consistently been a key theme at the ESR’s
in the field of radiology and related disciplines, from all
annual meeting and, through continued cooperation with
over the world. Feel free to contribute flyers and posters
ESHIMT, congress participants can find a comprehensive
to promote your own meetings and courses.
programme with everything there is to know about
this topic at ECR 2019. From high-quality lectures and
GRAND OPENING
speakers to a technical exhibition that features more hybrid
To celebrate our anniversary, the 25th ECR in Vienna,
imaging exhibitors than ever before, the meeting provides
in style, the former traditional opening ceremony will
educational, social and business opportunities for all.
be completely ‘refurbished’, and in its new format as a
See separate leaflet ‘All about Hybrid Imaging’.
magnificent inauguration, it will embody the ECR 2019
slogan ‘the bigger picture’.
INDUSTRY WORKSHOPS
After the introductory speech by ESR President Prof.
At ECR 2019 there are various Industry Workshops
Lorenzo E. Derchi, this year’s ESR Honorary Members
scheduled, organised by Canon, Fujifilm, GE Healthcare,
and Gold Medallists will be awarded.
Guerbet, Hologic, Intrasense, Mammotome, Philips and
The ESR has chosen a specific motto for the Grand
Siemens Healthineers. Please note that Industry Workshops
Opening – ‘Five Senses’. The five senses will permeate
are not CME-accredited.
the whole Grand Opening; special scents will be created to
See separate booklet ‘Industry Programme’ for details.
set a unique atmosphere; the eyes will be entertained with
a spectacular stage & light design by the brilliant visual
‘INSIGHTS INTO IMAGING’
artist Amra Bergman; and there will be music throughout,
with the well-known soul singer Dorretta Carter as main Insights into Imaging is the ESR’s online journal for education
act, reflecting the dignitaries’ favourite tunes. and guidelines. It is open access and PubMed indexed.
And don’t miss the key lecture by the world-famous Pick up free special print issues in the Publications Lounge
architect Sir David Adjaye from London! on the 1st level!
The ECR 2019 Grand Opening will take place Wednesday,
February 27, 17:45–19:30 in Room A (2nd level).

Dive into
interventional
radiology at the
Cube 2.0
Open 8:30-17:30 The Cube offers a holistic, engaging
February 27 - March 2 and hands-on introduction to
at the DC Tower, ECR City IR, covering peripheral, central,
oncological and neurological
interventions, radiation protection,
For more information visit teamwork and innovation.
www.myESR.org/cube
Interactive expert-led presentations,
a massive collection of simulators,
thousands of devices, virtual anatomy
and more await you at ‘the Silicon
Valley of IR education’.
The Cube is located in the cuboid annex

of the DC Tower.
General Information
INTERACTIVE PROGRAMME PLANNER ISRRT MEETS SESSION

As every year, the ESR is proud to present this popular For the first time at ECR 2019, there will be a session
interactive tool for ECR 2019. The IPP provides a hosted by the International Society of Radiographers
convenient way to explore and customise the congress and Radiological Technologists (ISRRT), to underline
programme online, in both traditional browser and mobile the essential role of radiographers in medical imaging.
device versions. The ‘ISSRT meets Africa’ Session will deal with challenges
Featuring various search and browse functions for sessions for radiographers offering imaging services in Africa.
as well as posters, the IPP also includes a ‘My Schedule’ Please refer to page 75 for the programme of the session.
option, which enables users to collate items from the
(JUNIOR) IMAGE INTERPRETATION QUIZ
programme to create their own personal calendar and
The Image Interpretation Quizzes are two traditional
even print a personalised Book of Abstracts. The IPP is
highlights of every ECR. This year’s themes are ‘Greek
integrated into the platform ECR Online.
Gods: Mount Olympus vs. The Underworld’ and ‘A day in
ecronline.myESR.org
the (future) life of a young radiologist’ (see pages 79-80).
INTERNATIONAL VILLAGE LIABILITY

More than 50 national and international radiological The ESR and the Austria Center Vienna are free from
societies present their meetings and societies in the all liabilities that may arise from the delegates’ and
International Village, which is located on the entrance presenters’ participation in ECR 2019 and its activities.
level of the M Building.
LIVE VOTING
Radiographer societies including the European Federation
of Radiographer Societies (EFRS) are represented with ECR offers interactive sessions with live voting.
their booths in Foyer C on the 2 nd
level of the ACV. To take part, follow these steps:
1. Please connect to the WiFi network in the room
INTERVENTIONAL RADIOLOGY AT THE CUBE (at no cost)
2. Depending on your device (smartphone, tablet etc.),
After a hugely successful debut outing, the Cube, the ECRs
please either follow the instructions on your device or
educational space exclusively dedicated to interventional
use the ECR 2019 App
radiology, returns bigger, better and bolder to ECR 2019.
3. Detailed instructions will be displayed on the screen
Due to the huge demand and popularity in 2018, the Cube
prior to the session start
2.0 has moved to a new location, the DC Tower, offering
more than double the space than before. Participants can LOST & FOUND
expect a huge array of simulators, devices, expert-led Lost and found articles may be picked up or handed in at
sessions and more, making the Cube 2.0 the best place the ECR Information Desk located in the entrance area.
to get an immersive, hands-on introduction to IR, in a
MEDITATION & PRAYER ZONE
variety that is offered only at ECR. Please note that the
programme at the Cube is not CME-accredited. The Meditation & Prayer Zone is located on the lower level
See separate leaflet. next to Room G. You will find it marked on the Floor Plan.
MEETING ROOMS
INVEST IN THE YOUTH
Meeting rooms at ECR 2019 are to be found here:
Over the last 16 years, the ESR has invited more than
In the Austria Center Vienna
8,000 young radiology residents, medical physics PhD
2nd level: Meeting Rooms 2.15, 2.17, 2.32, 2.33, 2.34, 2.43, 2.44
students and radiographers in training to the European
Congress of Radiology, investing more than €5 million in In the adjoining M Building
its flagship youth project. Entrance level: Meeting Rooms M6, M7, M8, M9, M11, M12,
M13, M17, M18, M19, M22, M23, M24, M25, M26, M27, M28,
M29, M30, M31, M32, M34.
You will find them marked on the Floor Plans
(see pages 35-44).
Please contact the Info Service Desk in the main lobby of
the M Building for onsite booking of meeting rooms; on
Sunday please contact the Meeting Room Service Desk
at the registration desks.

General Information
MEMBERSHIP PHYSICS IN MEDICAL IMAGING

For membership application and renewal, please go to The ESR is happy to welcome an increasing number of
the membership desk (within the registration area) in medical physicists to its annual meeting every year. ECR
the entrance hall. 2019 offers an innovative, extensive and custom-made
programme for medical physicists, which was developed
MOBILE PHONES in close collaboration with the European Federation of
Please do not forget to turn your mobile phone to silent Organisations for Medical Physics (EFOMP). ESR and
mode during the sessions. Also remember that it is not EFOMP will also hold a joint session on ‘Medical imaging
allowed to take pictures or film during the sessions. and emerging issues in occupational radiation exposure’
(see page 142) and this year’s EFOMP Workshop, which
MULTIDISCIPLINARY SESSIONS is the 21st in its series, will be dedicated to ‘Big data and
the big picture: deep learning in optimisation of medical
The concept of these sessions is to promote a
imaging’ (see page 134). Detailed information about all 48
multidisciplinary approach to detection and treatment,
sessions relevant for medical physicists can be found in the
integrating radiologists and other clinicians to share their
Interactive Programme Planner under the button ‘Physics
expertise.
in Medical Imaging’ as well as in the dedicated leaflet.
The topics that are covered this year are: lung cancer, brain
See separate leaflet ‘All about Physics in Medical Imaging’.
imaging in psychiatry, the ‘prostate unit’, thyroid nodules,
and diabetic foot.
PRESS
sessions. The ECR 2019 Opening Press Conference takes place on
Wednesday, February 27, 12:15–13:45 at the Sky High
MyT3 – MY THESIS IN 3 MINUTES Stage on top of the Saturn Tower nearby the Austria
Center Vienna. For press accreditation, please contact the
Introduced last year, ECR 2019 features again this
Press Office & Business Centre on the entrance level. To
fascinating scientific session format where speakers share
obtain a press badge, you must present an international
their scientific theses in just three minutes!
press ID or a confirmation letter from the relevant medium.
These 12 special sessions will take place at a spectacular
Delegates and exhibitors may display their press kits in
location, the Sky High Stage, overlooking the Austria
the Press Office & Business Centre. There are also several
Center from the top of the nearby Saturn Tower.
publicly available computer terminals as well as workspace
and plug points for you to work with your personal laptop.
sessions.
See separate leaflet ‘All about My Thesis in 3 Minutes’. Opening hours:
Wednesday, February 27 to Saturday, March 2: 08:00–18:00
NEW HORIZONS SESSIONS Sunday, March 3: . . . . . . . . . . . . . . . . . . . . . . . 08:00–16:00
The aim of the New Horizons Sessions is to provide
practitioners with an overview of the new developments PREVIEW CENTRE
in a specific area of practice e.g. specialty, technique, or Speakers are reminded to check in at the Preview Centre’s
disease. These developments may become routine within welcome desk at least three hours prior to their scheduled
a few years, or may indicate a new direction for research presentation, even if they have already uploaded their
and clinical application. There are three New Horizons presentation prior to the congress. Speaker welcome
Sessions at ECR 2019, entitled ‘The role of imaging in the desks will be at the speakers’ disposal.
era of liquid biopsy’, ‘Artificial intelligence (AI): driven Onsite presentation upload procedure:
by radiologists’ and ‘The tumour board of the future’. » Check in at the Preview Centre welcome desks
Session places are allocated on a first-come, first-served » Proceed to a preview station to upload, check and edit
basis. Please refer to pages 81-82 for the programme of your presentation
the sessions.
The Preview Centre is located on the 1st level, next to the
Publications Lounge.
Opening hours:
Tuesday, February 26: . . . . . . . . . . . . . . . . . . . . 12:00–18:00
Wednesday, February 27 to Saturday, March 2: . 07:30–18:00
Sunday, March 3: . . . . . . . . . . . . . . . . . . . . . . . . 07:30–16:00

General Information
Presentations should be saved on a USB memory stick RADIOLOGY TRAINEES FORUM (RTF)
(CD/DVD-ROM are not accepted) and brought to the The RTF promotes and coordinates the efforts of
Preview Centre. radiology trainees at a European level in order to improve
All presentations will be transferred to the session room the progress of radiology and related sciences.
and made available at the time of presentation. Highlighted Lectures organised by the RTF will be given
on Saturday, March 2, 10:30–12:00 in Room Y on the
PROFESSIONAL CHALLENGES SESSIONS
entrance level (see page 112).
These sessions are intended to communicate and The RTF delegates meeting takes place on Friday, March
exchange issues on radiological training and education, 1, 13:30–14:30, in Meeting Room 2.17 (2nd level). For more
research networking, radiological management and detailed information please visit the RTF Meeting Point
professional developments. This year’s topics are in the Rising Stars Lounge at the Tech Gate.
‘Radiology and migrations’, ‘Working in radiology: burnout Don’t miss the Meet & Greet Session with ESR President
and bore-out or engaged and passionate?’, and ‘How to Lorenzo E. Derchi (Friday, March 1, 16:00–16:30) in the
organise nationwide ischaemic stroke care (and make Rising Stars Lounge.
multidisciplinary teams work)’. And join us at the RTF Quiz entitled ‘A new look at the
Places are allocated on a first-come, first-served basis. mediastinum’ with Quizmasters José Cáceres and José
Please refer to pages 91-92 for the sessions’ programme. Vilar on Thursday, February 28, 10:30–12:00 in Room E1
(entrance level).
PROS & CONS SESSION
The Pros & Cons Session examines a controversial topic RECORDING / PHOTOGRAPHY
and is concluded by an interactive discussion. This year’s Video or audio recording of presentations is not allowed
topic is ‘US before CT in the acute abdomen?’ without the speaker’s/exhibitor’s and ECR’s prior permission.
Places are allocated on a first-come, first-served basis. Flash photography is not permitted during presentations.
Please refer to page 103 for the session’s programme. Interviews must take place outside the lecture room.
For queries, please contact the ESR Press Office.
PUBLIC TRANSPORT
Tickets for public transportation are available online at
shop.wienerlinien.at or at any underground station. REFRESHER COURSES
Underground map: see page 34. 74 Refresher Courses have been organised by the various
scientific subcommittees for ECR 2019. Based on the topic
RADIOGRAPHERS
of the session, some refresher courses are presented in
The ECR is recognised as the official annual scientific an ‘integrated’ format with an organised panel discussion,
meeting for medical imaging for radiographers by both similar to Special Focus Sessions.
the European Federation of Radiographer Societies Places are allocated on a first-come, first-served basis.
(EFRS) and the European Society of Radiology (ESR). Please refer to pages 147-174 for the programme of the
In cooperation with the EFRS, a comprehensive and sessions.
perfectly tailored programme for radiographers in various
stages of experience is offered. See separate leaflet REGISTRATION OPENING HOURS
‘All about the Radiographers Programme’. Tuesday, February 26: . . . . . . . . . . . . . . . . . . . . 12:00–18:00
For the second time, at ECR 2019, the three best Wednesday, February 27: . . . . . . . . . . . . . . . . .07:00–18:00
radiographer paper abstracts, the three best radiographer Thursday, February 28: . . . . . . . . . . . . . . . . . . . 07:30–18:00
poster abstracts and the best radiography student Friday, March 1: . . . . . . . . . . . . . . . . . . . . . . . . . . 07:30–18:00
abstract will be awarded by the ESR and the EFRS. Saturday, March 2: . . . . . . . . . . . . . . . . . . . . . . . 07:30–18:00
Sunday, March 3: . . . . . . . . . . . . . . . . . . . . . . . . 07:30–16:00
RADIOGRAPHERS LOUNGE
Visit the Radiographers Lounge on the 2nd level (next RESTAURANT RESERVATIONS
to Room C) to meet and network with your colleagues, Our staff at the Dining & Shopping Desk in the entrance
and the Voice of EPOS Stage 5 in the Lounge, where hall will be pleased to recommend places to eat close to
radiographer colleagues present their posters in person. your hotel or near a certain theatre, and will be happy to
Also, 20 radiographer societies including the EFRS are reserve a table for you.
represented at the Lounge with their booths.

General Information
RISING STARS LOUNGE / RESIDENTS & STUDENTS LOUNGE SECURITY / SAFETY

The Rising Stars Lounge for residents and students is The safety of all congress attendees is of utmost importance
located on the very top of the new location Tech Gate, to the European Society of Radiology. The Austria Center
providing a breath-taking view of Vienna. In the lounge Vienna and the ESR have taken security precautions to
you will find information on the European School of ensure the maximum possible safety for all ECR participants.
Radiology, the European Diploma of Radiology and the Please inform our staff, especially our room attendants,
Radiology Trainees Forum. immediately if security problems occur.
Don’t miss the Meet & Greet Session with ESR President The ESR reserves the right to check your identification upon
Lorenzo E. Derchi (Friday, March 1, 16:00–16:30). admission to the congress centre and/or inside the building.
You may be asked at any time to present adequate proof of
RISING STARS PROGRAMME identity by showing your passport, driver’s licence, national
The E3 – Rising Stars Programme is part of the E3 – European or military identification, or student ID, all with photograph
Excellence in Education programme. and signature.
See pages 107-112.
SESSIONS OF ESR BODIES
SATELLITE SYMPOSIA The following ESR bodies will have dedicated sessions
Industrial Satellite Symposia are presented by international during the congress: ESR Audit & Standards Subcommittee,
companies. Please note that Satellite Symposia are not ESR eHealth Subcommittee, ESR EIBALL (European
CME-accredited. Places are allocated on a first-come, Imaging Biomarkers Alliance) Subcommittee, EuroSafe
first-served basis. Imaging Steering Committee, ESR PIER (Professional
See separate booklet ‘Industry Programme’ for details. Issues and Economics in Radiology) Subcommittee,
ESR RTF (Radiology Trainees Forum) Subcommittee,
SCIENTIFIC PRESENTATION AWARDS ESR Research Committee, ESR Patient Advisory Group,
The authors of the best scientific papers and scientific/ ESR Ultrasound Subcommittee, ESR Undergraduate
educational exhibits will be presented with a certificate Education Subcommittee. Watch out for them in the
and given free ECR 2020 registration. Interactive Programme Planner.
Scientific Papers: The award will be assigned to the

SMOKING
best paper presentation of each topic based on the
evaluation by session moderators and subcommittee Smoking is not permitted inside the Austria Center Vienna.
members. Selection criteria comprise quality of The ECR is a non-smoking congress. Outside the building,
presentation, scientific content and overall impression of we kindly ask you to use the ashtrays provided. Please note
the performance. that smoking is prohibited in front of the main entrance.
The award winners will be informed after the congress
and will be published on the ESR website. SOCIAL MEDIA
Scientific/educational exhibits: The EPOS reviewer team Keep up with goings on at ECR 2019 by following the
and the scientific subcommittee members evaluate all ESR on Twitter and Instagram (both @myESR), as well
submitted posters. Authors of the best-rated posters as Facebook (facebook.com/myESR).
will receive diplomas, which will be awarded on Friday, The official congress hashtag is #ECR2019.
March 1, 16:30–17:00 in the ECR Online & EPOS Lounge.
SPECIAL ASSISTANCE
SCIENTIFIC SESSIONS
Delegates with special needs may park on the lower
Accepted papers for oral presentation are presented in level with direct elevator access to the Austria Center.
the 155 Scientific Sessions. All lecture rooms are accessible by wheelchair.
Several sessions feature keynote lectures with a concise
educational introduction related to the topic.
Places are allocated on a first-come, first-served basis.
sessions.

General Information
SPECIAL FOCUS SESSIONS TRAVEL SERVICE

Special Focus Sessions deal with a topic at the cutting edge The ESR and ECR are proud to offer their delegates
of development and clinical application. The topics of these services that should facilitate their travel arrangements
sessions are presented so as to promote debate and to give and make their stay in Vienna as pleasant as possible.
an in-depth analysis. The chairperson introduces each aspect The ESR’s Travel Service Desk is located in the entrance
of the topic and the panellists then discuss their different hall of the Austria Center Vienna.
perspectives and opinions. The audience is also given the Opening hours:
opportunity to discuss their ideas with the lecturers. Places Tuesday, February 26: . . . . . . . . . . . . . . . . . . . . 12:00–18:00
are allocated on a first-come, first-served basis. Please refer Wednesday, February 27 to Saturday, March 2: 08:00–17:30
to pages 85-90 for the programme of the sessions. Sunday, March 3: . . . . . . . . . . . . . . . . . . . . . . . .08:00–12:00
STATE OF THE ART SYMPOSIA VOICE OF EPOS SESSIONS
These sessions are intended to inform the audience Authors of the best posters will present their work in
about the ‘real state of the art’ of a given subject. Each person. Sessions are grouped by topic or language/region,
of the lecturers is an expert on the topic as a whole or and take place on four different stages in and around
on some specific aspect of the topic, which will be the the ECR Online & EPOS Lounge on the 1st level, from
subject of the respective session. The presentations are Wednesday to Sunday. ECR 2019 will again feature an
followed by a discussion conducted by the panellists, led additional fifth stage dedicated to radiographers in the
by the chairperson. Places are allocated on a first-come, Radiographers Lounge in Foyer C on the 2nd level, from
first-served basis. Please refer to pages 83-84 for the Wednesday to Saturday.
programme of the sessions. Please refer to pages 195-204 for the programme of the
sessions.
STUDENTS’ SESSIONS
At ECR 2019, students have again the chance to WATER BOTTLES
present their own abstracts in front of a huge audience. Attendees will receive a free, refillable water bottle at ECR
The submitters of the best 32 abstracts have been invited 2019. When you check in, you will receive a voucher that
to Vienna to present their work in dedicated sessions. can be exchanged for a water bottle at one of our bottle
See pages 110-112. distribution stations located in Foyer Café G and Foyer
Café K, on the 2nd level of the congress venue. You can
TAXI
then fill and refill your bottle at filling points located at the
There is a taxi stand outside the main entrance.
ESR Meets Lounge and in Foyers B, E, G and K.
TECHNICAL EXHIBITION WIFI
Opening hours: Free wireless LAN access is available throughout the
EXPO Halls and EXPO Foyer D congress venue and all lecture rooms. The name of the
Thursday, February 28 to Saturday, March 2: 10:00–17:00 public WiFi is ‘ECR2019’.
Sunday, March 3: . . . . . . . . . . . . . . . . . . . . . . . . 10:00–14:00 Please be considerate of your colleagues and do not use
EXPO Gallery (First Level) the WiFi excessively.
Wednesday, February 27: . . . . . . . . . . . . . . . . . 14:00–17:00
‘WOMEN IN FOCUS’
Thursday, February 28 to Saturday, March 2: 10:00–17:00
A new project under the leadership of Professor Hedvig
Sunday, March 3: . . . . . . . . . . . . . . . . . . . . . . . . 10:00–15:30
Hricak has been developed to debut at ECR 2019, at
Detailed information on the Technical Exhibition can be
the beautiful setting of ‘the Church’. ‘Women in Focus’
found in the ‘Industry Programme & On-Show Guide’.
will see inspiring speakers share their views on a range
TRANSATLANTIC COURSE of topics related to women working in healthcare.
ECR 2019 features again the joint course of the ESR and The programme will tackle issues such as leadership,
RSNA (Radiological Society of North America), which is mentoring and working in challenging environments. It
called ‘Transatlantic Course’ and which will again focus will explore and celebrate the crucial role that women
on sports imaging. The sessions will be interactive with play in healthcare, whilst offering advice and insights to
live voting. Places for all courses are allocated on a first- those wishing to advance their careers within this sector.
come, first-served basis. Please refer to page 132 for the The entire programme will be held in memoriam of the
course’s programme. late Professor Alexander Margulis.
See separate leaflet ‘All about Women in Focus’.

General Information
CME AT ECR 2019
GENERAL INFORMATION CME ACQUISITION PROCEDURE

Each ECR delegate has access to confirmation of all The ESR is happy to provide you with a fully digital CME
activities attended (CME Confirmation). acquisition system for ECR 2019. Please note that we no
longer provide printed CME stickers.
Europe
For Europe, the event has been accredited by the Evaluation and CME acquisition will be possible via
European Accreditation Council for Continuing Medical » The official ECR app, ECR 2019, available via
Education (EACCME®) of the European Union of Medical the App Store (iOS) and Google play (Android)
Specialists (UEMS) for a maximum of 39 European CME » More than 130 laptops in the ECR Online &
credits (ECMEC®s). Each medical specialist should claim EPOS Lounge located on the 1st level
only those hours of credit that he/she actually spent in
the educational activity. Please note that evaluation of the sessions you attend
Please note that the number of CME credits may differ from is only possible between February 27 and March 3
the maximum number of credits your national jurisdiction (23:59 CET), 2019. After this end date, evaluation will
approves for your continuous medical education. For more not be possible and no CME credits can be obtained.
information, see CME CONFIRMATION below. So please make sure to submit your evaluations of the
sessions during the congress!
The Österreichische Ärztekammer (Austrian Medical
Chamber) has granted a maximum of 48 DFP (Diplom- CME credits will only be awarded if
Fortbildungs-Programm der Österreichischen Akademie » You are logged into http://eval.myESR.org with your
der Ärzte) credits for ECR 2019. - Username and Password or
- Last Name and Personal ID (printed on your badge)
USA and Canada » You have fully completed the electronic questionnaire
Through an agreement between the UEMS and the for each session you attended
American Medical Association, physicians may convert » You have completed the electronic “Overall Congress
EACCME® credits to an equivalent number of AMA PRA Evaluation” questionnaire
Category 1 CreditsTM.
Live educational activities, occurring outside of Canada, The combined participation and evaluation questionnaire
recognised by the UEMS-EACCME® for ECMEC®s are is of great value to the organising committee when
deemed to be Accredited Group Learning Activities selecting topics for future ECRs. Please note that different
(Section 1) as defined by the Maintenance of Certification types of sessions may have different evaluation forms.
Program of the Royal College of Physicians and Surgeons
of Canada.
Worldwide
CME points claimed at the ECR are accepted by the
majority of national CME authorities worldwide where CME
is mandatory for physicians. Please consult your national
jurisdiction for the maximum number of CME points it will
approve following your attendance at ECR 2019.

General Information
CME AT ECR 2019
GUIDANCE CME CONFIRMATION

Confirmation of participation in the scientific programme Each ECR delegate has access to confirmation of all
may be obtained as follows: activities attended (via the document ‘CME Confirmation’)
on the condition that the above procedures have been
Scientific Sessions carried out. From March 11, 2019, delegates can go online
1. Attend the session in full. any time to the MyUserArea and print out their ‘CME
2. Log in to http://eval.myESR.org or use the ECR 2019 Confirmation’ document. This document lists in exact
app to evaluate the session. detail all the sessions visited and evaluated during the
3. Fill out this form completely during or after the session congress as well as the number of hours in attendance.
(by March 3, 23:59 CET at the latest). The number of hours is identical to the number of CME
credits awarded. If you tally the listed hours yourself and
If you do not have a smartphone, tablet or laptop with there is a discrepancy to the ‘Total hours earned’ position,
you, please visit the ECR Online & EPOS Lounge located this may have several reasons.
on the 1st level and evaluate the session(s) you visited on The UEMS-EACCME® has accredited the ECR congress
one of the 130 laptops available. with a maximum of 39 European CME credits (ECMEC®s).
According to the UEMS-EACCME® accreditation, a
Scientific Exhibition maximum of 8 CME credits can be awarded each for
1. Enter EPOS™ (Electronic Presentation Online System) Wednesday to Saturday and up to 7 CME credits for
on one of the 130 laptops in the ECR Online & EPOS Sunday. The maximum for the entire congress is 39 CME
Lounge and view posters. credits, so the ‘Total hours earned’ position on your ‘CME
2. Log in to http://eval.myESR.org or use the ECR 2019 Confirmation’ document will never show more, even if the
app to evaluate the session. sum of all hours attended may be greater.
3. Fill out this form completely after visiting the electronic Please note that there are 0 CME points for industry
scientific exhibition (by March 3, 23:59 CET at the latest). workshops, satellite symposia, and the Cube, though they
are also listed in the ‘CME Confirmation’ document.
A maximum of 3 hours of attendance at the scientific Although participants may partially attend multiple
exhibition will be listed if the participant has completed concurrent sessions, the total number of hours printed
and submitted the electronic evaluation form. at the end of the list limits the credit to the equivalent of
a single session during that time slot.
Overall Congress Evaluation
1. Log in to http://eval.myESR.org or use the ECR 2019 Your CME Confirmation will be available from March 11,
app to evaluate the overall congress. 2019 onwards via the MyUserArea on the ESR website.
2. Fill out this questionnaire at the end of the congress
(by March 3, 23:59 CET at the latest). Please note that your personal Username and Password
are required for login. In case you do not remember them,
please use your Last Name and Personal ID as printed on
your badge to retrieve your login credentials.
The printout of your ‘CME Confirmation’ should be
submitted to your national jurisdiction (usually responsible
for accreditation) for approval of your CME credits. Please
note that the ‘CME Confirmation’ will be issued only to
the participant. It will not be supplied to any accreditation
agency or other organisation.
In case of questions, please contact our ‘App & CME

Helpdesk’ in the entrance hall or in the ECR Online & EPOS
Lounge on the 1st level or write to ESR’s CME support at
cme@myESR.org.

The Artificial
Intelligence
Exhibition (AIX)
Making its grand debut at ECR 2019, the
AIX brings the hottest topic in radiology
to the heart of the technical exhibition.
Meet the innovators applying machine

learning, deep learning and big data to
medical imaging, and take in illuminating
sessions at the AIX Theatre. You can even
start your own deep learning adventure
thanks to self-paced training provided
by Nvidia’s Deep Learning Institute in
partnership with the ESR.
Whether you’re exploring AI for the

ÚVWWLPHUHVHDUFKLQJLWRUMXVWZDQWWR
FKDWDERXWWKHIXWXUHRYHUDIUHHMXLFHDW
Algorithms Bar, the AIX is a must visit at
ECR 2019!
The AIX is located in the X1 hall.

For more details, and the full
AIX Theatre programme, visit
www.myESR.org/ai
General Information
GREEN MEETING
ECR IS
A GREEN MEETING
In 2014, the ECR was awarded the Austrian Ecolabel Encouraging and enabling the use of public transport
(Österreichisches Umweltzeichen) for the first time, by congress attendees is another means by which the
making it the largest officially certified green congress in ECR’s carbon footprint can be diminished. Vienna’s fully
Europe. This achievement followed the implementation integrated public transport network makes getting to
of numerous measures designed to reduce the congress’ and from the congress simple no matter where attendees
environmental impact, and it reflected a deepened stay in the city.
commitment on the part of the ESR to making the congress
sustainable. Every year we strive to expand our efforts by Improving waste management is another important goal
applying our green approach to all major activities related for any green congress. To reduce unnecessary waste,
to the congress. Find some examples below. the ESR works with environmentally certified caterers
who utilise reusable plates, drinking vessels and cutlery.
Minimising the CO2 emissions is of central concern when Exhibitors are encouraged to reuse their stands and
running a green congress. Large congresses are by their decoration and discouraged to distribute giveaways.
nature power hungry events. Our venue, the Austria Center Further, the amount of printed material used at the
Vienna, prioritises green energy, which is essential to congress has been reduced by making more materials,
limiting a congress’ carbon footprint. Among other things, such as the congress’ programme, easily accessible
our venue, which also bears the Austrian Ecolabel, features online. Where paper is used, it is sourced from sustainably
a 120 square metre solar array, which supplies thermal managed forests.
energy used to heat water in its kitchens and toilets.
HOW YOU CAN MAKE A VALUABLE CONTRIBUTION:
• Use public means of transport. Vienna’s public transport network (www.wienerlinien.at) is operating
from 05:00–00.30 daily, with additional services from 00.30–05.00 on Friday and Saturday nights.
» The Austria Center Vienna can be reached using the underground U1 (red) line.
Alight at U1 station Kaisermühlen, VIC and take the Schüttaustrasse exit.
• Calculate and offset the CO2 emissions of your flight or car journey with myclimate.org.
• We recommend choosing one of Vienna’s environmentally certified hotels (www.umweltzeichen-hotels.at).
Otherwise select accommodation which is as close as possible to the venue.
You will find a list at www.acv.at/planen/wien/hotels.html.
• Separate your rubbish. Different bins for plastic, paper and residual waste will be omnipresent across the event’s
premises. Additionally, collection containers for cans and metal will be available at convenient locations.
• Return your badges at the boxes provided at the main entrance after the event.
PLEASE SUPPORT US IN OUR ENDEAVOUR TO KEEP OUR CONGRESS GREEN!
If you have any questions, please contact our Green Event Coordinators:
Maria Doppler, +43-1-5334064-326, maria.doppler@myESR.org
Deirdre Lagomatis, +43-1-5334064-526, deirdre.lagomatis@myESR.org

Underground Line (U-Bahn)
34
Strebersdorf
Commuter Train (S-Bahn)
Jedlersdorf
Urban Train (Lokalbahn) Gerasdorf
Brünner Straße
Nußdorf
City Airport Train
Floridsdorf Siemensstraße Leopoldau Süßenbrunn

Vienna International Neue
ue Donau
General Information
Busterminal Großfeldsiedlung
Heiligenstadt
Customer Service Centre Oberdöbling Aderklaaer Straße
(U3 Erdberg)
Rennbahnweg
Infopoints Krottenbachstr. Jä
äger- Hande
delskai Kagraner Platz
Spittelau strraße
Kagran
A
Ticket Sales Dresdner ECR STOP:
C
Nußdorfer Straße Alte Do
Donau
V
Gersthof
ECR 2019 | Final Programme

Straße Traisengasse
T sse Kaisermühlen /
Park & Ride Währinger Straße Kaisermühlen
ermühlen V
VIC Vienna Int. Centre
V
Volksoper Friedensbrücke
riedens
Do
Donauinsel
Hernals Michelbeuern AKH Hirschstetten
Franz- Roßauer Lände
Roßaue
Erzherzog-
Alser Straße Josefs- Karl-Straße Hausfeld-
Vorgartenstr
orgartenstraße
ße Aspern Nord
Bahnhof straße
Taborstraße
UNDERGROUND MAP
Schottenring Mes
esse
Ottakring Josefstädter Prater
er Aspernstraße
Prater-
Straße Nestroypl.
Nestroy stern
Kendlerstraße
Schottentor Hardeggasse
Hütteldorfer Krieau
au
Thaliastraße Seestadt
Straße Schwedenplatz Donauspital
Stadlau
John-
Breitensee straße Burggasse Rathaus Stadio
dion
Stadthalle Donaustadt-
D nausta
s e brück
b cke
Schwegler- g. as or
ler ng ent
straße eg rre ub
Zi He St Landstraß
andstra e
m (Bhf.
hf. Wien
en Mitte)
riu Penzing Westbahnhof
to g.
na Volks-
V Donaumarina
a au theater Rochusgasse
usgasse
f-S Au ub Stephansplatz
or u orf er Ne
rsd inga rsd n d g- Kardinal-Nagl-Platz
nal-Nag
e l i ei Gumpendorfer Museums-
it w n-
rk eid ade olf
Ve ch Straße te quartier Schlachthausgasse
achthau
Pu W H W re
S t. uns
a e ga
r ar l Erdberg
erg Praterkai
te Br ass M ürte Karlsplatz
Un g g Stadt-
park Gasometer
ometer
g g. - n- Zippereer-
f eit nn ße ld m
or .V zin ru ra se ke se straße
ld St et nb ts
tra nfe lg s r
t te r Hi ö p g e Pi ga üc gas
h u n nb
Hü Obe Sc Ha Lä Niederhof- tte Rennweg
g Ke Taubstummen-
T
lin straße gasse Biocenter Vienna Enkplatz
ie d Haidestraße
M Quartier St. Marx
Speising Bahnhof Meidling Matzleinsdorfer
Platz Belvedere Geisel-
Südtiroler Platz
Hauptbahnhof bergstr.
Simmering
Hetzendorf Schedifkaplatz
Tscherttegasse
T Keplerplatz
Schöpfwerk Zentralfriedhof
Am Schöpfwerk Grillgasse
Atzgersdorf Reumannplatz
for iOS devices
WienMobil
for Android devices
WienMobil
Gutheil-Schoder-Gasse
Alterlaa Troststraße
Inzersdorf Lokalbahn
WIENMOBIL APP - www.wienerlinien.at
Kaiserebersdorf
Erlaaer Straße Altes Landgut Kledering
Liesing Neu Erlaa
Blumental
Alaudagasse
Schönbrunner Allee
Perfektastraße
Neulaa Schwechat
Vösendorf-Siebenhirten
Siebenhirten WLB Wiener Neudorf, Baden (Endstation) Oberlaa
WienMobil can be downloaded free of charge
from the Google Play Store or Apple App Store.
www.myESR.org
FLOOR
PLANS
35
Floor Plans
0 – ENTRANCE LEVEL ACV + M BUILDING

Floor Plans
0 – ENTRANCE LEVEL ACV

Floor Plans
1 – FIRST LEVEL ACV

Floor Plans
2 – SECOND LEVEL ACV

Floor Plans
3 – THIRD LEVEL ACV

Floor Plans
-2 – LOWER LEVEL ACV

Floor Plans
0 – ENTRANCE LEVEL M BUILDING

Floor Plans
1 – FIRST LEVEL M BUILDING

Floor Plans
2 – SECOND LEVEL M BUILDING

ESR
DIGNITARIES
45
ESR Dignitaries
ESR DIGNITARIES
FEDERICO G. MICHAEL G.
LUBINUS KAWOOYA
Bucamaranga, Colombia Kampala, Uganda
HONORARY MEMBER HONORARY MEMBER
In recognition of his tremendous contribution to the development In recognition of his pivotal role in the development of radiology,
of radiology in Latin America, Professor Federico G. Lubinus from in particular ultrasound, in Africa and beyond, Professor Michael
Bucamaranga, Colombia, will receive ESR Honorary Membership G. Kawooya from Kampala, Uganda, will receive ESR Honorary
at ECR 2019. Membership at ECR 2019.
Professor Federico G. Lubinus is full professor of radiology and Professor Michael G. Kawooya is professor emeritus in the Depart-
director of the radiology residency programme at the Autono- ment of Radiology at the School of Medicine, Makerere University,
mous University of Bucaramanga (UNAB) in Colombia. and College of Health Sciences in Kampala, Uganda. He is direc-
Prof. Lubinus trained as a medical student, and in parallel worked tor of ECUREI, an ultrasound-training institute in Kampala that is
as a CT technician and an English teacher. He graduated from affiliated to the JUREI institute in the United States of America.
medical school at the Industrial University of Santander (UIS) in Additionally, he is director of the Centre of Excellence of the World
Bucaramanga in 1993. In 1997, he obtained a masters’ degree in Federation in Ultrasound in Medicine and Biology (WFUMB) in
university teaching from UNAB, where he also completed his radi- Kampala and chairman of the Mengo Hospital Research and Eth-
ology residency in 2000. Prof. Lubinus was the first radiologist to ics Committee, also based in Kampala.
graduate from the newly established radiology programme and In 1988, Prof. Kawooya received his masters’ degree in medicine
was subsequently appointed staff radiologist at Carlos Ardila Lulle in radiology from Makerere University, where he completed his
Hospital. A few years later, he was appointed associate professor PhD ten years later. He also did a fellowship in radiology at Ebert
of radiology and director of the residency programme at UNAB. Karls Universitaet in Tübingen, Germany, from 1989 to 1991, and a
In 2006 Prof. Lubinus earned a scholarship from the Radiological fellowship in ultrasound at Thomas Jefferson University, Philadel-
Society of North America (RSNA) in the ‘Teach the teachers’ pro- phia, U.S., in 2001.
gramme in ultrasound, which was run by Prof. Barry Goldberg at Prof. Kawooya’s area of research is ultrasound and he has tackled
Thomas Jefferson University in Philadelphia. every aspect of its practice. He has published over 55 articles in
Prof. Lubinus has been very active in implementing radiology in peer-reviewed journals, as well as five chapters in books on differ-
Colombia and has held a number of roles within the Asociación ent topics, including imaging of tropical diseases.
Colombiana de Radiología (ACR), where he served on the scien- Prof. Kawooya has served in key roles for prestigious societies,
tific, quality, and educational committees, as well as the board of notably as secretary general of the African Society of Radiology
directors. He was also elected president of ACR for two terms in (ASR) from 2008 to 2017 and as a member of the WFUMB admin-
2014–2015 and in 2015–2016. Prof. Lubinus is now the coordina- istrative council from 2009 to 2011. He is a founding member and
tor of ACR’s scientific committee and heads the Latin American past president of the Uganda Society for the Advancement of
Educational Forum, which brings together the most prestigious Radiology and Imaging (USOFARI). Prof. Kawooya initiated the
radiological societies of Latin America, with a commitment to creation of the Pan African Congress of Radiology and Imaging
addressing educational issues in the region. (PACORI), over which he presided in 2005–2007. He also served
Prof. Lubinus is a member of several national and international as vice president of the Mediterranean and African Society for
societies of radiology, including the European Society of Radi- Ultrasound (MASU) from 2002 to 2008 and is a founding mem-
ology (ESR), the RSNA and the American College of Radiology ber of AFROSAFE.rad, Africa’s continental campaign for radiation
(ACR). He received meritorious recertification from the ACR in safety that kicked off in February 2015 in Nairobi, Kenya.
2010 and 2015. Prof. Kawooya is associate editor of African Health Sciences, a jour-
Prof. Lubinus has been appointed academic peer for the National nal of Makerere University Faculty of Medicine, and sits on the edito-
Accreditation Council of Colombia and has been the tutor for rial board of Ultrasound, a journal of the British Ultrasound Society.
more than 20 theses in radiology and diagnostic imaging. He holds membership in various radiological societies in Uganda,
His main areas of research are Doppler ultrasound, renal trans- as well as the European Society of Radiology (ESR) and the Radi-
plant rejection, erectile dysfunction and thyroid cancer. He has ological Society of North America (RSNA). He has received many
won numerous awards for his research papers presented at the distinctions for his work, including the Mulago Hospital and Com-
Colombian Congress of Radiology in the field of ultrasound. plex Certificate of Merit and Innovativeness in 2007, the Associa-
tion of Radiologists of Uganda Special Award in 2014, the PACORI
Distinguished Service Award in 2013 and honorary fellowship of
the American Institute of Ultrasound in Medicine in March 2015.

ESR Dignitaries
VIJAY M. ANNA-MARIA
RAO BELLI
Philadelphia, PA, United States London, United Kingdom
HONORARY MEMBER GOLD MEDALLIST
In recognition of her amazing accomplishments in the fields of In recognition of her achievements in interventional radiology,
head and neck radiology, education and leadership, Professor which have played a vital role in advancing the subspecialty, Pro-
Vijay M. Rao from Philadelphia, Pennsylvania, United States, will fessor Anna-Maria Belli from London, United Kingdom, will be
receive ESR Honorary Membership at ECR 2019. awarded the ESR Gold Medal at ECR 2019.
Vijay M. Rao, MD, FACR is the David C Levin Professor and Chair Anna-Maria Belli is professor of interventional radiology at St.
of the Department of Radiology at Thomas Jefferson University. George’s Hospital in London, UK.
She is also senior vice-president of Enterprise Radiology, Jeffer- She received her medical degree from the Middlesex Hospital
son Health, and the immediate past president of the Radiological in London in 1980. She then trained in radiology at St. George’s
Society of North America (RSNA). Hospital in London, where she also completed an interventional
Prof. Rao graduated from All India Institute of Medical Sciences, fellowship. From 1987 to 1990, she was appointed senior lecturer
India’s premier medical school, in New Delhi in 1973. She completed and consultant radiologist at the University of Sheffield/Royal Hal-
her radiology residency in 1978 at Thomas Jefferson University lamshire Hospital. Prof. Belli then worked at the Royal Postgrad-
Hospital and has remained on the faculty ever since. During her uate Medical School/Hammersmith Hospital in London for two
time on the faculty, she served as residency programme director, years, before returning to the St. George’s Hospital and Medical
as well as vice chair for education and co-director of the neurora- School in 1992, where she was appointed as a consultant radiolo-
diology/ENT division. In 2002 she was named chair of Jefferson’s gist, becoming the first British female professor of interventional
Department of Radiology, becoming the first woman chair of a clin- radiology in 2008.
ical department in Jefferson’s history. In 2016, Prof. Rao was named Throughout her academic career, Prof. Belli has taken particu-
senior vice president of Enterprise Radiology at Jefferson Health. lar interest in vascular interventional radiology. She has made
Prof. Rao is one of the leading experts in head and neck imaging. substantial contributions to the field of IR, which, thus far, have
She is also widely recognised in health services research in radiol- included over 160 peer-reviewed publications, three books,
ogy. Prof. Rao has published over 220 peer-reviewed articles and numerous book chapters and presentations at invited lectures.
given over 250 presentations at national and international radiol- She has served on the editorial board of several journals in radiol-
ogy meetings, including invited talks and several named lectures. ogy, including Vascular Journal, CardioVascular and Interventional
She has also held many editorial positions for a number of radiol- Radiology, The British Journal of Radiology, European Radiology
ogy journals. and Radiology Now.
Prof. Rao is past president of the American Society of Head and Prof. Belli is also active in committees and societies at a national
Neck Radiology, past president of the Association of Program and international level. She was the first and so far only female
Directors in Radiology and past president of the American Associ- president of the British Society of Interventional Radiology (BSIR)
ation of Women Radiologists. She has served on the RSNA Board in 2001–2003 and served as the first female president of the Car-
and currently serves on the RSNA Research and Education Foun- diovascular and Interventional Radiological Society of Europe
dation Board as well as the Academy of Radiology Board. Prof. (CIRSE) in 2013–2015. Throughout her time at CIRSE, she has
Rao has also served on the Thomas Jefferson University Hospital worked in every role of the executive board and has been a source
System Board since 2012. of inspiration for women interventional radiologists through her
Prof. Rao has received numerous awards for her work. In 2005, active leadership role.
she was honoured by the Philadelphia Business Journal as one She has served on the Interventional Procedures Advisory Com-
of 25 Women of Distinction throughout the region. A year later, mittee of the National Institute for Health and Care Excellence
she received the Achievement Award from the Association of (NICE) and on the Committee of Safety of Devices of the Medi-
Programme Directors for her outstanding contributions to radiol- cines and Healthcare Regulatory Authority (MHRA). She was also
ogy education nationally. In 2010 she received the Distinguished a member of the NICE Clinical Guidelines Group on heavy men-
Radiologist Award from the American Association of Radiologists strual bleeding.
of Indian Origin. She also received the gold medal from the Asso-
Prof. Belli is an honorary member of the Deutsche Gesellschaft
ciation of University Radiologists, the Marie Curie award from the
für Interventionelle Radiologie und Minimal-Invasive Thera-
American Association for Women Radiologists, honorary mem-
pie (DeGIR), the Seldinger Society of Sweden and the Société
bership of the Israel Radiological Society and the gold medal from
Française de Radiologie. She gave the BSIR Wattie Fletcher
the Asian Oceanian Society of Radiology for her outstanding con-
lecture in 2013 and was awarded their Gold Medal in 2015.
tributions to international radiology. In 2018, Prof. Rao received
She received the CIRSE Gold Medal in 2018.
the medal of honour and honorary membership of the French
Society of Radiology.

ESR Dignitaries
LUIS VALENTIN
DONOSO-BACH SINITSYN
Barcelona, Spain Moscow, Russia
GOLD MEDALLIST GOLD MEDALLIST
In recognition of his achievements and long-time commitment to In recognition of his outstanding work in cardiac imaging and
European radiology, Professor Luis Donoso-Bach from Barcelona, the advancement of radiology in Russia and Europe, Professor
Spain, will be awarded the ESR Gold Medal at ECR 2019. Valentin Sinitsyn from Moscow, Russia, will be awarded the ESR
Prof. Luis Donoso-Bach was appointed chairman of the Radiology Gold Medal at ECR 2019.
Department of the UDIAT Diagnostic Centre in 1992, becoming its Professor Valentin Sinitsyn is chair of radiology and head of the
executive director in 1998. Since 2006, he has been chairman of Radiology Department at the medical faculty of Moscow Lomon-
the diagnostic imaging department at the Hospital Clínic of Bar- osov State University, Moscow.
celona and professor of radiology at the University of Barcelona. Born in 1961 in Elizovo, Russia, he graduated from Sechenov Med-
He received his medical degree from the School of Medicine of ical University in Moscow in 1984. He completed his radiology
the Autonomous University of Barcelona in 1981 and completed residency in 1998 in the Radiology Department of the Cardiology
his residency in radiology at the Hospital Sant Pau in Barcelona. Research Centre, Moscow and started working as a researcher and
In addition, he earned a PhD in medicine from the Autonomous radiologist at the same institution.
University of Barcelona in 1992. Prof. Sinitsyn is one of the pioneers in the field of magnetic res-
Prof. Donoso-Bach has been involved in many aspects of research. onance imaging and cardiac radiology in Russia. His research
Early in his career, his activity focused on abdominal imaging, interests have focused on cardiac imaging, abdominal radiology,
especially on liver disease. Later on, his attention shifted to digital oncology, hybrid imaging, contrast media, teleradiology and com-
imaging and the development and implementation of IT in diag- puter applications in radiology.
nostic radiology. Under his leadership, a large R&D team was built Prof. Sinitsyn is president of the Russian Society of Radiology for
at UDIAT, leading to several patents and products that are now the term 2016–2020. He is past president of the European Society
widely used all over Spain. of Cardiac Radiology (ESCR) and also served as president of the
Prof. Donoso-Bach has served as vice-president of the Spanish European Congress of Radiology (ECR) in 2014. He was a member
Society for Diagnostic Radiology (SERAM) from 1998 to 2002 and of the ECR cardiac subcommittee and programme planning com-
as its president from 2002 to 2006. He was also president of the mittee between 2006 and 2014.
Spanish Foundation of Radiology from 2008 to 2016. Prof. Sinitsyn holds membership of the European Society of Radi-
Since 2000, he has served the European Society of Radiology ology (ESR), American College of Radiology, Radiological Soci-
(ESR) in various capacities, including as president in 2015–2016. ety of North America, International Society of Radiology, ESCR,
Recently, Prof. Donoso-Bach was nominated president-elect of European Society of Gastrointestinal Abdominal Radiology, and
the International Society of Strategic Studies in Radiology (IS3R) the Serbian and Belorussian societies of radiology.
and president of the International Society of Radiology, after act- He has authored or co-authored 154 papers, which are all cited
ing as its secretary general from 2012 to 2014. in the Scopus database, and has delivered over 300 lectures in
Prof. Donoso-Bach has received numerous honours for his con- Europe and overseas.
tributions to radiology, including the gold medals of the Spanish Prof. Sinitsyn greatly contributed to the implementation of inter-
Society of Radiology and the Interamerican College of Radiology, national standards of teaching and training in radiology in Russia.
as well as honorary memberships in the Radiological Society of He has organised the translation and promotion of BI-RADS in
North America (RSNA), the Argentinean Society of Radiology, the Russia, as well as textbooks on magnetic resonance, emergency
Italian Society of Radiology, the French Society of Radiology, the radiology and cardiac imaging.
German Society of Radiology and the Mexican Society of Radiol-
ogy, among others. He has also received honorary fellowship of the
American College of Radiology and RSNA honorary membership.
Prof. Donoso-Bach has given numerous lectures at prestigious
universities, congresses, and courses, and has published over 90
articles and seven book chapters.

ESR Dignitaries
REGINA S. NAHUM
BEETS-TAN GOLDBERG
Amsterdam, the Netherlands Jerusalem, Israel
HONORARY LECTURER HONORARY LECTURER
Professor Regina Beets-Tan from Amsterdam, the Netherlands, Professor S. Nahum Goldberg will present the Josef Lissner Hon-
will present the Wilhelm Conrad Röntgen Honorary Lecture orary Lecture, titled ‘Systemic effects of image-guided tumour
titled ‘Oncologic imaging: a new beginning has just begun’ at therapy: have we opened Pandora’s box or found the Holy
ECR 2019. Grail?’ at ECR 2019.
Professor Regina Beets-Tan chairs the Department of Radiology Professor S. Nahum Goldberg is full professor of radiology at
at the Netherlands Cancer Institute in Amsterdam. She is full pro- Hadassah Hebrew University, Jerusalem, Israel and visiting profes-
fessor of radiology at the University of Maastricht and adjunct sor of radiology at Harvard Medical School, Boston, MA. He is head
professor of abdominal and oncological radiology at the Univer- of the interventional oncology unit and director of the Applied
sity of Southern Denmark. Radiology Research Laboratory at Hadassah Medical Centre. He is
She obtained her MD, cum laude, at the Erasmus University Rot- also the vice-chair for research in the Department of Radiology at
terdam. Her PhD thesis on rectal cancer MR imaging, which she Hadassah Hebrew University.
obtained at the University of Maastricht, was awarded the 2001 Prof. Goldberg graduated from Yeshiva University, New York, NY,
Best Thesis Prize. in 1988 and Yale School of Medicine, New Haven, CT, in 1992. He
Prof. Beets-Tan’s main clinical interest has been abdominal and completed his radiology residency and fellowship in abdominal
oncological imaging. She leads research in cancer imaging in the imaging and intervention at Massachusetts General Hospital, Bos-
Netherlands Cancer Institute, focusing on the validation of multi ton, MA, in 1997 and 1998 respectively, and received his master of
parametric and artificial intelligence imaging technology as a science degree in radiologic sciences at Harvard University, Cam-
guidance for interventional, surgical and radiation treatment, and bridge, MA in 2008.
as a biomarker for treatment efficacy in cancer. Her own research Prof. Goldberg’s research interests include over 20 years of expe-
track record is in rectal cancer imaging for better treatment out- rience studying image-guided tumour ablation and imaging stud-
come, for which she collaborates with multidisciplinary expert ies. His independent Applied Radiology Laboratory at Hadassah
teams worldwide, including the Memorial Sloan Kettering Cancer and Minimally Invasive Tumour Therapies Laboratory at Beth Israel
Center, where she was affiliated in 2008. Deaconess Medical Center in Boston are dedicated to uncovering
Prof. Beets-Tan is deeply committed to radiological societies. She methods to improve tumour ablation studies. As the unit chief of
is a member of the ESR Executive Council, the current president Image-guided Therapy at Hadassah Hebrew University Medical
of the European Society of Oncologic Imaging (ESOI) and the Center, he also has considerable experience with clinical trials and
president elect of the European Society of Gastrointestinal and interventional oncologic techniques.
Abdominal Radiology (ESGAR). In the ESR council, she chairs the Prof. Goldberg has authored more than 190 original scientific
ESR Publications Committee. She has also served in numerous manuscripts, 25 book chapters and reviews, six guest editorials in
other ESR committees and is part of the programme planning Radiology and JVIR, and nine patents, and has been the principle
committee of the European School of Radiology (ESOR). investigator of multiple peer-reviewed research grants. These in
Prof. Beets-Tan is involved with several strategic organs of clin- total represent some of the most cited papers in interventional
ical societies and believes that close cooperation between the radiology, with the majority concerning the development and
radiological and clinical societies will work synergistically to the advancement of personalised delivery of image-guided minimally
benefit of the patient. She represents the ESR on the board of invasive techniques, such as radiofrequency ablation for the treat-
the European CanCer Organisation (ECCO), aiming to strengthen ment of cancer.
the voice and visibility of radiology within European cancer and Prof. Goldberg is a fellow of the Society of Interventional Radiol-
patient organisations. ogy (SIR) and has also served on multiple national and interna-
Prof. Beets-Tan has authored or co-authored more than 250 tional committees advancing interventional radiology, including
papers, which have been cited over 8,300 times. She has authored the Cardiovascular and Interventional Radiological Society of
over 35 chapters and edited several books and is also a part of the Europe (CIRSE), the Society of Interventional Oncology (SIO), the
editorial boards of several peer-reviewed journals. RSNA, and the ESR. He is currently a board member of the SIO
and has previously served as section editor for the interventional
Prof. Beets-Tan has delivered more than 400 invited lectures and
oncology series in Radiology.
has received several teaching awards, including the 2013 ESOR
Best Teacher Award and the ISMRM Outstanding Teacher Award
in 2008, 2009 and 2014.

ESR Dignitaries
PAUL S.
SIDHU
London, United Kingdom
HONORARY LECTURER
Professor Paul Sidhu from London, United Kingdom, will present
the Luigi Oliva Honorary Lecture, titled ‘Contrast-enhanced ultra-
sound in paediatrics: ready for clinical practice?’ at ECR 2019.
Paul Sidhu is professor of imaging sciences at King’s College Lon-
don and a consultant radiologist in the Department of Radiology
at King’s College Hospital.
He received his medical degree from St. Mary’s Hospital Medical
School, now part of Imperial College, in 1982, with honours. He
completed his intership at St. Mary’s Hospital in Paddington on
the professorial medical unit, before completing residency posi-
tions at the Brompton Hospital, Hammersmith Hospital, Hospital
for Tropical Diseases and Guy’s Hospital.
Prof. Sidhu spent one year as a fellow in medicine at Guy’s Hospi-
tal, and a year as a lecturer in the University of Malaya, Kuala Lum-
pur, before returning to radiology training at the Hammersmith
Hospital and King’s College Hospital. He was appointed consult-
ant radiologist at King’s College Hospital in 1996, taking on a dual
role in both ultrasound and interventional radiology.
Prof. Sidhu’s research has focused on ultrasound and interventional
radiology, and he has published extensively on many aspects of
ultrasound, particularly in relation to male health and liver trans-
plantation. Prof. Sidhu notably pioneered the introduction of con-
trast-enhanced ultrasound (CEUS) in the United Kingdom in 1996
and is recognised as an authority in the application of this tech-
nique in clinical practice. His current research interests include the
application of CEUS to the testis, radiation dose reduction in chil-
dren and non-invasive ultrasound in the assessment of liver disease.
He is currently the editor of the European Journal of Ultrasound
and was deputy editor of the British Journal of Radiology. He is
past-president of the British Medical Ultrasound Society and
past-president of the section of radiology of the Royal Society
of Medicine. Currently, Prof. Sidhu is president of the European
Federation of Societies in Ultrasound in Medicine and Biology
(EFSUMB). He is an honorary fellow of the American Institute of
Ultrasound and a fellow of the Cardiovascular and Interventional
Radiological Society of Europe (CIRSE).
Prof. Sidhu is the editor of five books and has published over 275
scientific articles, as well as 60 book chapters. He has also organised
numerous teaching courses, predominantly related to ultrasound
imaging. Prof. Sidhu is a renowned teacher, involved with the ESR,
ESGAR, ESUR and EFSUMB teaching courses, and was awarded
the best teacher accolade for the European School of Radiology
(ESOR) in 2013. Prof. Sidhu is an active lecturer who has given over
500 presentations at national and international meetings and has
also been invited to deliver a number of plenary lectures.

COMMITTEES
51
ESR Executive Council
ESR EXECUTIVE COUNCIL
BOARD OF DIRECTORS
Chairperson of the ESR Board of Directors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Bernd Hamm; Berlin/DE
President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Lorenzo E. Derchi; Genoa/IT
1st Vice-President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Boris Brkljačić; Zagreb/HR
2nd Vice-President. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Michael Fuchsjäger; Graz/AT
Immediate Past-President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Paul M. Parizel; Antwerp/BE
COMMITTEE CHAIRS
Communication and External Affairs Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Nikoleta Traykova; Plovdiv/BG
ECR 2019 Programme Planning Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Lorenzo E. Derchi; Genoa/IT
ECR 2020 Programme Planning Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Boris Brkljačić; Zagreb/HR
Education Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Carlo Catalano; Rome/IT
Finance and Internal Affairs Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Deniz Akata; Ankara/TR
National Societies Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Christoph D. Becker; Geneva/CH
Publications Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Regina Beets-Tan; Amsterdam/NL
Quality; Safety and Standards Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Adrian P. Brady; Cork/IE
Research Committee Chairperson . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Olivier Clément; Paris/FR
Subspecialties and Allied Sciences Committee Chairperson. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Afshin Gangi; Strasbourg/FR
NON-VOTING
Director of the European School of Radiology (ESOR) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Valérie Vilgrain; Clichy/FR
Executive Director . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Peter Baierl; Vienna/AT

ECR 2019 Committees
ECR 2019 PROGRAMME PLANNING COMMITTEE
Chairperson (President) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.E. Derchi; Genoa/IT

Deputy Chairperson (1st Vice-President). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B. Brkljačić; Zagreb/HR
President of the preceding congress. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Hamm; Berlin/DE
ESR Executive Director. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Baierl; Vienna/AT
Chairperson of the Finance and Internal Affairs Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .D. Akata; Ankara/TR
Chairperson of the Education Committee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C. Catalano; Rome/IT
POSTGRADUATE EDUCATIONAL PROGRAMME SUBCOMMITTEE EUROPEAN EXCELLENCE IN EDUCATION (E3)
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C. Loewe; Vienna/AT E3 – Rising Stars Programme

Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S.J. Foley; Dublin/IE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Szczerbo-Trojanowska; Lublin/PL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Forrai; Budapest/HU E3 – European Diploma Prep Sessions
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F. A. Gallagher; Cambridge/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Basilico; Chieti/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Iezzi; Rome/IT E3 – The Beauty of Basic Knowledge
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D.J. Lurie; Aberdeen/UK Pancreas. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Manfredi; Rome/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C.W.A. Pfirrmann; Zurich/CH A Survival Guide
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M.-P. Revel; Paris/FR to Musculoskeletal Imaging . . . . . . . . V. Cassar-Pullicino; Oswestry/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Rosendahl; Bergen/NO E3 – ECR Academies
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Sappey-Marinier; Bron/FR Interactive Teaching Sessions for Young
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Stajgis; Poznan/PL (and not so Young) Radiologists . . . . . . . . . . . E. Castañer; Sabadell/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Verbist; Leiden/NL Functional Imaging for Disease Management:
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Zins; Paris/FR Research to Medical Practice . . . . . . . . . . . . . . N. Grenier; Bordeaux/FR
Radiology Leaders’ Bootcamp . . . . . . . . . . . . . S. Morozov; Moscow/RU
SCIENTIFIC PAPERS SUBCOMMITTEE Chest Imaging. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M.-P. Revel; Paris/FR
Hot Topics in GU Cancer . . . . . . . . . . . . . . . . . .A.G. Rockall; London/UK
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Dewey; Berlin/DE
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Bérczi; Budapest/HU
CASES OF THE DAY
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V.J. Goh; London/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N.C. Lugo; Barcelona/ES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Santiago; Lisbon/PT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Prayer; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Reponen; Raahe/FI IMAGE INTERPRETATION QUIZ
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N.I. Traykova; Plovdiv/BG
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.H. Karantanas; Iraklion/GR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . F.M.H.M. Vanhoenacker; Antwerp/BE
JUNIOR IMAGE INTERPRETATION QUIZ

SECTION COORDINATORS
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Bignotti; Genoa/IT
EPOS Editor
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I.G. Lupescu; Bucharest/RO
EVALUATION
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.H. Fuchsjäger; Graz/AT
E-LEARNING
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Barter; Bedford/UK
ESR SUBSPECIALTIES AND

ALLIED SCIENCES COMMITTEE CHAIRPERSON
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Gangi; Strasbourg/FR
ESR ADVISORS
on New Media . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Friedrich; Vienna/AT

on European and International Affairs . . . . . . . . . M. Hierath; Vienna/AT

ECR 2019 Committees
ECR 2019 SCIENTIFIC SUBCOMMITTEES
ABDOMINAL AND GASTROINTESTINAL CARDIAC

The ESR would like to thank ESGAR for their cooperation on this subcommittee The ESR would like to thank the ESCR for their cooperation on this subcommittee
Chairpersons: . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Brancatelli; Palermo/IT Chairperson: . . . . . . . . . . . . . . . . . . . . . . . .K. Gruszczynska; Katowice/PL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S. Schmidt Kobbe; Lausanne/CH
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Croisille; Saint-Etienne/FR
Abdominal Viscera . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P. Donato; Coimbra/PT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .R. Albazaz; Leeds/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O. Duvernoy; Uppsala/SE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Blachar; Tel Aviv/IL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Francone; Rome/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Cieszanowski; Warsaw/PL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Hrabak Paar; Zagreb/HR
. . . . . . . . . . . . . . . . . . . . . . . . . . N.A. Courcoutsakis; Alexandroupolis/GR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Kantarci; Erzurum/TR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .T. Denecke; Berlin/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T. Leiner; Utrecht/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Dresen; Leuven/BE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Lücke; Leipzig/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.M. França; Porto/PT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C.A. Minoiu; Bucharest/RO
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N. Kartalis; Stockholm/SE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F. Pugliese; London/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .E.G. Klompenhouwer; Eindhoven/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Salgado; Antwerp/BE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C.S. Reiner; Zurich/CH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Sommer; Basle/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Ronot; Clichy/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Torregrosa Andrés; Valencia/ES CHEST
The ESR would like to thank ESTI for their cooperation on this subcommittee
GI Tract
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S.R. Desai; London/UK
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Blomqvist; Stockholm/SE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S.M. Ertürk; Istanbul/TR
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Aviram; Tel Aviv/IL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G.G. Karmazanovsky; Moscow/RU
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G.C. Bozovic; Lund/SE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S. Kinner; Essen/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Broncano; Cordoba/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M.J. Lahaye; Amsterdam/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Christe; Berne/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.J.B.S. Madureira; Porto/PT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Hartmann; Rotterdam/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D.E. Malone; Dublin/IE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Lederlin; Rennes/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Radzina; Riga/LV
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .G.H. Mostbeck; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H. Ringl; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Öztürk; Istanbul/TR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G.A. Rollandi; Genoa/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Pirnat; Maribor/SI
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Tolan; Leeds/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Silva; Parma/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Zappa; Clichy/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Snoeckx; Antwerp/BE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M.O. Wielpütz; Heidelberg/DE
BREAST
The ESR would like to thank EUSOBI for their cooperation on this subcommittee
IMAGING INFORMATICS
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U. Bick; Berlin/DE The ESR would like to thank EuSoMII for their cooperation on this subcommittee
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Kotter; Freiburg/DE

Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Athanasiou; Athens/GR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Clauser; Vienna/AT
Members: . . . . . . . . . . . . . . . . . . . . . . . . .A. Alberich-Bayarri; Valencia/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .F. Kilburn-Toppin; Cambridge/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F. Coppola; Bologna/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Perez Rodrigo; Madrid/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .N. Dugar; Doncaster/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Thomassin-Naggara; Paris/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .F. Kainberger; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R.M. Trimboli; Milan/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N. Pyatigorskaya; Paris/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Van Ongeval; Leuven/BE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P.M.A. van Ooijen; Groningen/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Zackrisson; Malmö/SE

ECR 2019 Committees
HYBRID, MOLECULAR AND TRANSLATIONAL IMAGING INTERVENTIONAL RADIOLOGY

The ESR would like to thank ESHIMT for their cooperation on this subcommittee The ESR would like to thank CIRSE for their cooperation on this subcommittee
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C.C. Cyran; Munich/DE Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Köcher; Olomouc/CZ
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Boss; Zurich/CH Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Bharadwaz; Aarhus/DK

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Hakumäki; Kuopio/FI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X. Buy; Bordeaux/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R.J. Méndez; Madrid/ES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .L. Crocetti; Pisa/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Pinker-Domenig; Vienna/AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. de Graaf; Friedrichshafen/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Scarsbrook; Leeds/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Gonçalves; Porto/PT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C. Gonzalez-Junyent; Barcelona/ES
GENITOURINARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Hohl; Siegen/DE
The ESR would like to thank ESUR for their cooperation on this subcommittee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Mizandari; Tbilisi/GE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L. Oguzkurt; Istanbul/TR
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Bertolotto; Trieste/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .T.G. Vrachliotis; Athens/GR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Wojtaszek; Warsaw/PL
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Basta Nikolic; Novi Sad/RS
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. De Visschere; Ghent/BE
MUSCULOSKELETAL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O.F. Donati; Zurich/CH
The ESR would like to thank the ESSR for their cooperation on this subcommittee
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Hörlyck; Aarhus/DK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Horta; Lisbon/PT Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U. Aydingoz; Ankara/TR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .K. Kubin; Salzburg/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Markiet; Gdansk/PL Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Bazzocchi; Bologna/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T. Movsisyan; Moscow/RU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Bierry; Strasbourg/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Notohamiprodjo; Tübingen/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.C. De Jonge; Amsterdam/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P. Puech; Lille/FR . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Fernandez Hernando; Santander/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Richenberg; Brighton/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .R. Lalam; Oswestry/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .E. Rud; Oslo/NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Njagulj; Belgrade/RS
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.M. Patsch; Vienna/AT
HEAD AND NECK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Pedersen; Toensberg/NO
The ESR would like to thank the ESHNR for their cooperation on this subcommittee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Sudol-Szopinska; Warsaw/PL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Sutter; Zurich/CH
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. De Foer; Antwerp/BE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Tzalonikou; Athens/GR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Waldt; Essen/DE
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Ailianou; Neuchâtel/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Connor; London/UK
NEURO
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.R. Eriksen; Stavanger/NO
The ESR would like to thank the ESNR for their cooperation on this subcommittee
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .T.A. Ferreira; Leiden/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Koltowska; Wroclaw/PL Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.M. Thurnher; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Ozgen Mocan; Ankara/TR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Saat; Helsinki/FI Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Calli; Izmir/TR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F. Spagnolli; Trento/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J.H. Gillard; Cambridge/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S. Haller; Carouge/CH
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .O. Jansen; Kiel/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .A. Krainik; Grenoble/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Looby; Dublin/IE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Papadaki; Iraklion/GR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Severino; Genoa/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D.A. Stojanov; Nis/RS
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N.I. Traykova; Plovdiv/BG
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Vernooij; Rotterdam/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N. Zakharova; Moscow/RU

ECR 2019 Committees
PAEDIATRIC VASCULAR
The ESR would like to thank the ESPR for their cooperation on this subcommittee The ESR would like to thank CIRSE for their cooperation on this subcommittee
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Vázquez; Barcelona/ES Chairperson: . . . . . . . . . . . . . . . . . . . . . . . K.A. Hausegger; Klagenfurt/AT
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Alexopoulou; Athens/GR Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Bargellini; Pisa/IT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .C.E. de Lange; Oslo/NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Bérczi; Budapest/HU
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Garel; Paris/FR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P. Chabrot; Clermont-Ferrand/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Halliday; Nottingham/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Duvnjak; Odense/DK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.S. Littooij; Utrecht/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .B. Peynircioglu; Ankara/TR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .H.-J. Mentzel; Jena/DE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . T. Rodt; Hannover/DE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Secinaro; Rome/IT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . G. Sandbaek; Oslo/NO
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Twomey; Dublin/IE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Tsitskari; Athens/GR
PHYSICS IN MEDICAL IMAGING ONCOLOGIC IMAGING

The ESR would like to thank EFOMP for their cooperation on this subcommittee The ESR would like to thank ESOI for their cooperation on this subcommittee
Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .P. Gilligan; Dublin/IE Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . S. Gourtsoyianni; Athens/GR
Members: . . . . . . . . . . . . . . . . . . . . . . . S. Avramova-Cholakova; Sofia/BG Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .T. Bäuerle; Erlangen/DE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Damilakis; Iraklion/GR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. D’Anastasi; Msida/MT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H. Delis; Vienna/AT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . O.V. Kucheruk; Moscow/RU
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Edyvean; London/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Maas; Amsterdam/NL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Kortesniemi; Helsinki/FI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M.E. Mayerhöfer; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E. Samara; Sion/CH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Y. Menu; Paris/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Sechopoulos; Nijmegen/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D. Regge; Turin/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . J. Sjöberg; Stockholm/SE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Vandecaveye; Leuven/BE
RADIOGRAPHERS EMERGENCY IMAGING

The ESR would like to thank the EFRS for their cooperation on this subcommittee The ESR would like to thank ESER for their cooperation on this subcommittee
Chairpersons: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. England; Salford/UK Chairperson: . . . . . . . . . . . . . . . . . . . . . . . . . . . . D.R. Kool; Amsterdam/NL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Gardarsdottir; Reykjavik/IS
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Akpinar; Istanbul/TR
Members: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C. Buissink; Groningen/NL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Blanco Barrio; Murcia/ES
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .G. Ioannidis; Larissa/GR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .E. Dick; London/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L.J.O.C. Lança; Lisbon/PT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .F. Iacobellis; Naples/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .L.A. Rainford; Dublin/IE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K. Katulska; Poznan/PL
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . K.G. Vikestad; Oslo/NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I. Millet; Montpellier/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F. Zarb; Msida/MT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .K.H. Nieboer; Brussels/BE
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A. Platon; Geneva/CH

ECR 2019 Committees
ECR 2019 TOPIC COORDINATORS
E3 – EUROPEAN EXCELLENCE IN EDUCATION WOMEN IN FOCUS
E3 – Rising Stars Programme . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H. Hricak; New York, NY/US

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Szczerbo-Trojanowska; Lublin/PL
Basic Sessions. . . . . . . . . . . . . . . . . M. Szczerbo-Trojanowska; Lublin/PL TRANSATLANTIC COURSE OF ESR AND RSNA
Joint Sessions of the ESR and ESOR (Radiological Society of North America):
(European School of Radiology) M. Szczerbo-Trojanowska; Lublin/PL SPORTS IMAGING
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . V. Vilgrain; Clichy/FR
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .L.W. Bancroft; Orlando, FL/US
EFRS (European Federation of Radiographer Societies)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . A.J. Grainger; Leeds/UK
Radiographers’ Basic Sessions . . . . . . . . . . . . . . A. England; Salford/UK
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M. Gardarsdottir; Reykjavik/IS
PROS AND CONS SESSION
Case-Based Diagnosis Training. . . . . . . . . . . . K.M. Friedrich; Vienna/AT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S. Robinson; Vienna/AT US before CT in the acute abdomen? . . . . . . J. Stoker; Amsterdam/NL
E3 – European Diploma Prep Sessions CLINICAL TRIALS IN RADIOLOGY

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Basilico; Chieti/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Dewey; Berlin/DE
E3 – The Beauty of Basic Knowledge

MY THESIS IN 3 MINUTES
Pancreas. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . R. Manfredi; Rome/IT
A Survival Guide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Dewey; Berlin/DE
to Musculoskeletal Imaging . . . . . . . . V. Cassar-Pullicino; Oswestry/UK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . M. Zins; Paris/FR
E3 – ECR Academies HANDS-ON WORKSHOPS

Interactive Teaching Sessions for Young
(and not so Young) Radiologists . . . . . . . . . . . E. Castañer; Sabadell/ES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P. Asbach; Berlin/DE
Functional Imaging for Disease Management: MRI of the Prostate . . . . . . . . . . . . . . . . . . . . . . . . . . . B. Hamm; Berlin/DE
Research to Medical Practice . . . . . . . . . . . . . . N. Grenier; Bordeaux/FR
Radiology Leaders’ Bootcamp . . . . . . . . . . . . . S. Morozov; Moscow/RU
Chest Imaging. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .M.-P. Revel; Paris/FR
Hot Topics in GU Cancer . . . . . . . . . . . . . . . . . .A.G. Rockall; London/UK
E3 – Master Classes
Abdominal and Gastrointestinal (ESGAR) . . G. Brancatelli; Palermo/IT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .S. Schmidt Kobbe; Lausanne/CH
Breast (EUSOBI). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . U. Bick; Berlin/DE
Cardiac (ESCR). . . . . . . . . . . . . . . . . . . . . .K. Gruszczynska; Katowice/PL
Chest (ESTI) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . S.R. Desai; London/UK
Hybrid, Molecular and Translational Imaging
(ESHIMT) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . C.C. Cyran; Munich/DE
Genitourinary (ESUR) . . . . . . . . . . . . . . . . . . . . . M. Bertolotto; Trieste/IT
Head and Neck (ESHNR) . . . . . . . . . . . . . . . . . . B. De Foer; Antwerp/BE
Musculoskeletal (ESSR) . . . . . . . . . . . . . . . . . . . U. Aydingoz; Ankara/TR
Neuro (ESNR) . . . . . . . . . . . . . . . . . . . . . . . . . . . M.M. Thurnher; Vienna/AT
Paediatric (ESPR). . . . . . . . . . . . . . . . . . . . . . . . E. Vázquez; Barcelona/ES
Vascular (CIRSE) . . . . . . . . . . . . . . . . . . . K.A. Hausegger; Klagenfurt/AT
Oncologic Imaging (ESOI) . . . . . . . . . . . . . S. Gourtsoyianni; Athens/GR
Emergency Imaging (ESER) . . . . . . . . . . . . . . D.R. Kool; Amsterdam/NL

MY THESIS
IN 3 MINUTES
Visit our spectacular location
SKY HIGH STAGE and join 240 daring
colleagues presenting their scientificƫ
theses in just three minutes!
TOPICS:
Oncologic imaging Genitourinary

Chest Hand and neck
Breast Neuro
AI and machine learning Abdominal viscera and GI tract
Interventional radiology Cardiovascular Details at
Musculoskeletal Everyday challenges ipp.myESR.org
Type of session: MyT3
PROGRAMME
OVERVIEWS
59
Programme Overviews
WEDNESDAY, FEBRUARY 27
Coffee Studio Coffee E1 E2 F1
A B C X N O
Room/ & Talk 1 2019 & Talk 2 Entrance Entrance Entrance
2nd Level 2nd Level 2nd Level 2nd Level 1st Level 1st Level
Time 2nd Level 1st Level 1st Level Level Level Level
(ACV) (ACV) (ACV) (ACV) (ACV) (ACV)
(ACV) (ACV) (ACV) (ACV) (ACV) (ACV)
RC 101 RC 114 RC 105 EU 1 RC 115 E3 126a SF 1 BS 1
08:30- Abdominal Radiogra- Imaging EuroSafe Vascular E3 - ECR Special E3 - Rising
09:00 Viscera phers Informatics Imaging Visceral Master Focus Stars
Imaging of Contempo- Mobile Session arteries Class Session Programme:
benign liver rary breast devices in Cardio- C1 How to Screening Basic
09:00- lesions: still imaging radiology vascular implement with Session
Coffee & Talk
difficult? effects after MRI neuro imaging: Musculoskel-
09:30 (open forum)
radiotherapy Clinical audit advanced a new era? etal:
for breast across Europe: techniques bones and
cancer: the how to increase at home soft tissues
09:30- European uptake and
MEDIRAD support BSS
10:00 Project transposition
C 23
10:00- Coffee & Talk
10:30 (open forum)
Meet the
SS 205 SS 214 SS 215 professor SS 210a SS 210b SY 2a SS 201a SS 202 SS 211a BS 2
10:30- Artificial Radiogra- Vascular Musculo- Musculo- Joint Abdominal Breast Neuro E3 - Rising
11:00 Intelligence phers Carotid skeletal skeletal Satellite Viscera Mammog- Neurooncol- Stars
and Professional plaque and Haemato- Musculoskel- Symposium* Focal raphy and ogy: glioma Programme:
Machine issues in neurovascu- logical, met- etal tumour liver lesions: screening Basic
11:00- Learning radiography lar events abolic and imaging characteri- Session
Intelligent endocrine sation Thoracic
11:30 dose and diseases emergencies
quality man-
agement
11:30-
12:00
12:00-
12:30 SY 2b
Joint
E3 24A Satellite C3
12:30- E3 - The Beauty Symposium* Coffee & Talk
of Basic 12:15–13:45
13:00 (open forum)
Knowledge:
Bonn Call
Pancreas
for Action
Acute
Implementation
13:00- pancreatitis
Toolkit: free ac-
cess to a wealth
13:30 of resources
13:30-
14:00
RC 301 RC 314 SS 315 C 24 SS 306 SS 310 SY 2c C4 SS 302 SS 311 BE 3
14:00- Abdominal Radiogra- Vascular Coffee & Talk Hybrid, Musculo- Satellite Coffee & Talk Breast Neuro E3 - Rising
14:30 Viscera phers Advanced (open forum) Molecular skeletal Symposium* (open forum) Digital Stroke: Stars
Tumour Hybrid vascular The scholar and Trans- Upper Radiation breast tomo- interven- Programme:
protection
response imaging: the imaging: and fellow’s lational extremity in paediatric synthesis tional Joint
14:30- assessment best of both cerebral and experience Imaging imaging patients - same (DBT) Sessions
principles, differ-
in abdominal worlds peripheral Clinical with ESOR
15:00 imaging arteries applications
ent approach:
use cases Radiologic
of hybrid anatomy:
15:00- imaging chest
15:30
15:30-
16:00
ESR Audit RC 405 RC 403 SY 2d SS 401 E3 426a SF 4 BE 4
16:00- and Imaging Cardiac Satellite Abdominal E3 - ECR Special Fo- E3 - Rising
16:30 Standards Informatics From Symposium* Viscera Master Class cus Session Stars
Session Everything diagnosis to Liver and The high- My three top Programme:
Audit across you need to prognosis: biliary MRI: risk patient tips in neu- Joint
16:30- Europe: know about how does protocols enigma roimaging Sessions
directive and 3D post-pro- cardiac and techni- (not only for with ESOR
17:00 perspective cessing imaging af- cal frontiers neuroradiol- Radiologic
fect patient ogists) anatomy:
17:00- outcome? abdomen
17:30
17:45–19:30 Room A: ECR 2019 Grand Opening
Registration: Tuesday, Feburary 26: 12:00–18:00 / Wednesday, Feburary 27: 07:00–18:00

Programme Overviews Programme Overviews
RUARY 27 WEDNESDAY, FEBRUARY 27 WEDNESDAY, FEBRUARY 27

Coffee Studio Coffee E1 E2 F1 F2 H Y Coffee D G K ECR Online & Foyer C
X N O Sky High Tech Gate The M1 M2 M3 M4 M5
nd & Talk 1 2019 & Talk 2 Entrance Entrance Entrance Entrance Entrance Entrance & Talk 3 Lower Lower Lower EPOS Lounge Voice of EPOS Room/ Room/
Level 1st Level 1st Level Stage Auditorium Church Entrance Level 1st Level 1st Level 1st Level 2nd Level
2nd Level 1st Level 1st Level Level Level Level Level Level Level Entrance L. Level Level Level Voice of EPOS RADIOGRAPHERS Time Time
(ACV) (ACV) (ACV) (ECR City) (ECR City) (ECR City) 1st Level (ACV) 2nd Level (ACV) (M Building) (M Building) (M Building) (M Building) (M Building)
(ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV) (ACV)
RC 105 EU 1 RC 115 E3 126a SF 1 BS 1 NH 1 ESR US SC/ SS 109 E3 121 RC 113 MS 1 ESR/EIBALL RC 112 RC 116 E3 119 E3 126b
maging EuroSafe Vascular E3 - ECR Special E3 - Rising New EFSUMB Interven- E3 - ECR Physics in Multidis- 08:30- Joint Session Paediatric Oncologic E3 - ECR E3 - ECR Master 08:30-
ormatics Imaging Visceral Master Focus Stars Horizons Joint Session tional Academies: Medical ciplinary of the ESR and Interventional Imaging Academies: Class
of the ESR
09:00 09:00
Mobile Session arteries Class Session Programme: Session Radiology Interactive Imaging Session EIBALL radiology (IR) in Imaging tumour Hot Topics in Functional
Cardio- Ultrasound
evices in C1 How to Screening Basic The role of Vascular Teaching Patient- Lung cancer Imaging children: what response to GU Cancer imaging in
Subcommittee VoE 001 / Stage 1
vascular 09:00- 09:00-
diology Coffee & Talk implement with Session imaging in with EFSUMB interventions Sessions specific team Vascular
biomarkers and a non-interven- immunotherapy Early detection head and neck
effects after MRI neuro imaging: Musculoskel- the era of Ultrasound in visceral for Young dosimetry their combi- tional radiologist of ovarian oncology
(open forum) VoE 031 / Stage 2
09:30 09:30
radiotherapy Clinical audit advanced a new era? etal: liquid biopsy simulation arteries and (and not so Chest nations in the needs to know cancer
for breast across Europe: techniques bones and models in veins (part 1) Young) VoE 061 / Stage 3
VoE 121 / Stage 5
era of artificial
cancer: the CT
how to increase at home soft tissues training and Radiologists Russian intelligence
European uptake and education: VoE 091 / Stage 4 09:30- 09:30-
support BSS Emergency Abdominal
MEDIRAD where are we
Project transposition going?
radiology I Viscera 10:00 10:00
C 23 VoE 002 / Stage 1
Coffee & Talk German 10:00- 10:00-
10:30 10:30
Meet the Greek
VoE 122 / Stage 5
VoE 062 / Stage 3
SS 215 professor SS 210a SS 210b SY 2a SS 201a SS 202 SS 211a BS 2 SS 217 SS 209 SS 208 E3 221 SS 213 SS 204 CT 2 SS 203 SS 201b Musculoskeletal
Image Quality
SS 207 SS 212 SS 216 E3 219 SS 211b
ascular Musculo- Musculo- Joint Abdominal Breast Neuro E3 - Rising Emergency Interven- Head and E3 - ECR Physics in Chest Clinical Cardiac GI Tract VoE 092 / Stage 4 10:30- Genitourinary Paediatric Oncologic E3 - ECR Neuro 10:30-
Carotid skeletal skeletal Satellite Viscera Mammog- Neurooncol- Stars Imaging tional Neck Academies: Medical Lung cancer: Trials in Imaging New devel- Latin America Prostate cancer Paediatric Imaging Academies: Vascular
(Portuguese) 11:00 11:00
aque and Haemato- Musculoskel- Symposium* Focal raphy and ogy: glioma Programme: Best of Radiology Thyroid Interactive Imaging guidelines, Radiology 1 before and opments in cardiothoracic Multiparametric Hot Topics in diseases and the
urovascu- logical, met- etal tumour liver lesions: screening Basic emergency Vascular gland Teaching CT image screening after aortic anorectal imaging imaging for GU Cancer brain
VoE 003 / Stage 1
r events abolic and imaging characteri- Session radiology interventions Sessions quality and and nodule valve repair imaging EuroSafe 11:00- pelvic cancers Early detection 11:00-
endocrine sation Thoracic (part 1): from in oncology for Young optimisation management Imaging of prostate
diseases emergencies mass causal- (and not so VoE 033 / Stage 2
11:30 cancer 11:30
VoE 123 / Stage 5
ity incidents Young) Turkish
Africa
VoE 063 / Stage 3
to incidental Radiologists 11:30- 11:30-
Musculoskele- Japanese
findings and VoE 093 / Stage 4
tal radiology:
errors
inflammation Breast 12:00 12:00
ECR VoE 004 / Stage 1
Press Polish 12:00- 12:00-
VoE 034 / Stage 2
SY 2b Conference Chinese 12:30 12:30
VoE 124 / Stage 5
Joint VoE 064 / Stage 3
Education and
Satellite Neuro
C3 SY 3 C2 E3 25A SY 4 Training
Symposium* Coffee & Talk Satellite Coffee & Talk E3 - The Beauty Satellite
VoE 094 / Stage 4
Artificial Intelli-
12:30- 12:30-
12:15–13:45 of Basic
(open forum) Symposium* (open forum)
Knowledge:
Symposium* gence and Machine 13:00 13:00
Bonn Call Should we Learning
A Survival
for Action really F.E.A.R.
Guide to
Implementation artificial VoE 005 / Stage 1
Musculoskeletal 13:00- 13:00-
Toolkit: free ac- intelligence? Neuro
Imaging
cess to a wealth VoE 035 / Stage 2
Infection: bone 13:30 13:30
of resources Vascular
and soft tissue VoE 125 / Stage 5
VoE 065 / Stage 3
Italian
Arabic
(Middle East) 13:30- 13:30-
VoE 095 / Stage 4
Chest 14:00 14:00
SS 315 C 24 SS 306 SS 310 SY 2c C4 SS 302 SS 311 BE 3 SS 317 SS 309 SS 308 SS 305 SS 313 NH 3 MY 3 SS 303 SS 301 VoE 006 / Stage 1 SS 307 SS 312 SS 316 E3 319 E3 320
ascular Coffee & Talk Hybrid, Musculo- Satellite Coffee & Talk Breast Neuro E3 - Rising Emergency Interven- Head and Artificial Physics in New My Thesis in Cardiac Abdominal ESR meets Italy 14:00- Genitourinary Paediatric Oncologic E3 - ECR E3 - ECR 14:00-
dvanced (open forum) Molecular skeletal Symposium* (open forum) Digital Stroke: Stars Imaging tional Neck Intelligence Medical Horizons 3 Minutes Benefits of Viscera VoE 036 / Stage 2
14:30 Prostate cancer Paediatric Imaging Academies: Academies: 14:30
ascular The scholar and Trans- Upper Radiation breast tomo- interven- Programme: Acute Radiology Temporal and Imaging Session Oncologic cardiac MR Biliary ESR meets Italy VoE 126 / Stage 5 and renal abdominal Myeloma Hot Topics in Functional
protection VoE 066 / Stage 3 Research and
maging: and fellow’s lational extremity in paediatric synthesis tional Joint abdomen Vascular bone Machine CT: cardi- Artificial Imaging mapping for imaging: Breast Patient Safety imaging imaging imaging: GU Cancer Imaging
ebral and experience Imaging imaging patients - same (DBT) Sessions neurointer- Learning ovascular, intelligence myocardial what next? VoE 096 / Stage 4 14:30- latest trends Whole-body for Disease 14:30-
principles, differ-
eripheral Clinical with ESOR ventions Machine calcium, and (AI): characteri- Latin America imaging in Management:
arteries applications
ent approach:
use cases Radiologic learning: iodine driven by sation (Spanish) 15:00 gynaecological Research to 15:00
of hybrid anatomy: chest and radiologists malignancy Medical Practice
VoE 007 / Stage 1
imaging chest cardiac Emergency 15:00- Functional 15:00-
Imaging imaging of the
VoE 037 / Stage 2 15:30 brain 15:30
Oncologic VoE 127 / Stage 5
Imaging Spanish
VoE 067 / Stage 3
Romanian
15:30- 15:30-
VoE 097 / Stage 4
Genitourinary
16:00 16:00
SR Audit RC 405 RC 403 SY 2d SS 401 E3 426a SF 4 BE 4 RC 417 US 1 C5 RC 410 RC 413 SS 414 MY 4 SS 407 VoE 200 / Stage 1 ESHIMT 1 RC 412 E3 426b E3 419 E3 420
and Imaging Cardiac Satellite Abdominal E3 - ECR Special Fo- E3 - Rising Emergency ESR Coffee & Talk Musculo- Physics in Radiogra- My Thesis in Genitouri- Musculoskeletal 16:00- ESHIMT Session Paediatric E3 - ECR Master E3 - ECR E3 - ECR 16:00-
andards Informatics From Symposium* Viscera Master Class cus Session Stars Imaging Ultrasound (open forum) skeletal Medical phers 3 Minutes nary VoE 205 / Stage 2
16:30 Clinical and Imaging in Class Academies: Academies: 16:30
Session Everything diagnosis to Liver and The high- My three top Programme: Imaging Subcommit- #ECR2019: Bone, Imaging MRI Chest Prostate Breast methodological abdominal Novelties in Hot Topics in Functional
VoE 210 / Stage 3
dit across you need to prognosis: biliary MRI: risk patient tips in neu- Joint of ‘foreign tee Session Social media joint and Striking the advances imaging: Abdominal pitfalls in emergencies: an oncologic GU Cancer Imaging
Europe: know about how does protocols enigma roimaging Sessions bodies’ How to in radiology soft tissue balance: new diag- Viscera 16:30- hybrid imaging: (evidence-based) imaging Whole-body for Disease 16:30-
ective and 3D post-pro- cardiac and techni- (not only for with ESOR perform infection image quality nostic tools VoE 215 / Stage 4 problems and update imaging in Management:
rspective cessing imaging af- cal frontiers neuroradiol- Radiologic ultrasound assessment Neuro 17:00 solutions metastatic Research to 17:00
fect patient ogists) anatomy: image fusion in radiolog- urinary tract and Medical Practice
outcome? abdomen ical optimi- 17:00- prostate cancer Functional 17:00-
sation imaging of the
17:30 heart 17:30
Grand Opening Technical Exhibition: EXPO Gallery (First Level): 14:00–17:00
26: 12:00–18:00 / Wednesday, Feburary 27: 07:00–18:00 * Not CME accredited ECR Online & EPOS Lounge / EPOS™ – Scientific Exhibition: 08:00–18:00
www.myESR.org www.myESR.org Final Programme | ECR 2019 61 www.myESR.org

Programme Overviews
TODAY’S HIGHLIGHTS THURSDAY, FEBRUARY 28 THURS

Coffee Studio Coffee E1 E2 F1 F2 H Y Coffee D G K
A B C X N O Sky High Tech Ga
Room/ & Talk 1 2019 & Talk 2 Entrance Entrance Entrance Entrance Entrance Entrance & Talk 3 Lower Lower Lower
Wednesday, February 27 Time
2nd Level
(ACV)
2nd Level
(ACV)
2nd Level
(ACV)
2nd Level
(ACV)
2nd Level
(ACV)
1st Level
(ACV)
1st Level
(ACV)
1st Level
(ACV)
1st Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Entrance L.
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Stage
(ECR City)
Auditori
(ECR Cit
E3 521 RC 501 RC 514 ESR/UEMS SS 501 E3 526 PC 5 RC 502 SA 5 BS 5 SF 5b HW 530 SF 5a C6 RC 510 EF 1 RC 504 MY 5 SF 5d
Room A GRAND OPENING OF ECR 2019 08:30- E3 - ECR Abdominal Radiogra- Joint Abdominal E3 - ECR Professional Breast State E3 - Rising Special Hands-on Special Coffee & Talk Musculo- EFOMP Chest My Thesis in Specia
17:45–19:15 Prof. Derchi officially opens ECR 2019 / 09:00 Academies: Viscera phers Session of Viscera Master Challenges MRI for early of the Art Stars Focus Workshop: Focus (open forum) skeletal Workshop: Pulmonary 3 Minutes Focus
Interactive GI bleeding: Radiography the ESR and Diffuse Class Session detection, Symposium Programme: Session MRI of the Session Modern trends Imaging Big data neuroendo- Breast Session
Tributes / Key Lecture / Concert Teaching how can the audit and UEMS and focal Cardiac Radiology staging and How to face Basic Basic inter- Prostate (1) 7 Tesla MR in undergradu- of chronic and the big crine prolif- Imaging a
09:00- Sessions problem be quality man- Imaging pancreatic imaging in and migra- manage- the tsunami Sessions ventional goes clinical ate teaching of forefoot pain picture: erations and manage
for Young solved? agement profession- disease arrhythmia tions ment of of pancreat- Abdominal radiology for radiology: how deep learn- neoplasms ment of t
Room N EU 1 EuroSafe Imaging Session 09:30 (and not so als in the EU: and sudden breast ic intraductal emergencies non-inter- to explain to ing in op- incident
08:30–10:00 Cardiovascular effects after radiotherapy Young) Ra- radiologists cardiac cancer papillary ventional- students how timisation scrota
diologists without C 25 death mucinous ists: let’s of medical lesions
for breast cancer: 09:30- Coffee & Talk
interesting
Emergency borders neoplasia start with radiology is imaging
the European MEDIRAD Project 10:00 radiology II (open forum) (IPMN) biopsy! (part A)
A heart’s matter:
cardiac men-
Room E2 SF 1 Screening with imaging: a new era? toring, tutoring C7
10:00- and learning Coffee & Talk
08:30–10:00 within the ESOR
(open forum)
10:30 community
EIBIR:
EU-funded
Room F2 NH 1 The role of imaging in the era E3 621 EM 1 SS 614 SS 615 SS 606 SS 610 SS 616a research in RTF Quiz SS 611 ESR/ESOR 1 SS 602 HW 630 SS 609 C8 SS 605 EF 2 SS 604 CT 6 SS 607
10:30- E3 - ECR ESR meets Radiogra- Vascular Hybrid, Musculo- Oncologic imaging and A new look Neuro E3 - Rising Breast Hands-on Interven- Coffee & Talk Artificial EFOMP Chest Clinical Genitou
08:30–10:00 of liquid biopsy Academies: Africa phers Contrast Molecular skeletal Imaging how you can at the medi- MS and de- Stars Magnetic Workshop: tional (open forum) Intelligence Workshop: COPD, Trials in nary
11:00 get funding
Interactive Radiology Fine-tuning medium: and Trans- Chronic in- Advances in astinum myelinating Programme: resonance MRI of the Radiology Virtual and Big data emphysema Radiology 2 Contras
Room Y Joint Session of ESR US Subcommittee and EFSUMB Teaching in Africa: CT dose, timing lational flammatory imaging of disorders Joint imaging Prostate (2) Vascular in- reality from Machine and the big and airways agents f
11:00- Sessions facing chal- and alterna- Imaging diseases liver malig- Sessions (MRI) terventions bench to Learning picture: diseases: imaging:
08:30–10:00 (European Federation of Societies for Young lenges and tives Advanced nancies with ESOR in oncology bedside Machine deep learn- novel only iodi
for Ultrasound in Medicine and Biology) 11:30 (and not so opportuni- MR methods Radiologic (including learning: ing in op- approaches
Ultrasound simulation models in training Young) Ra- ties in exper- anatomy: radioemboli- musculo- timisation
11:30- diologists imental head and sation) skeletal and of medical
and education: where are we going? Oncologic radiology neck diverse imaging
12:00 imaging (part B)
Room K MS 1 Lung Cancer Team
08:30–10:00 12:00-
12:30 HL 1
Headline
Room M 1 Joint Session of the ESR and EIBALL Session E3 24B SY 5 C 26 SY 6 SY 7 C9 SY 9 SY 10 SY 32 E3 25B SY 8
08:30–10:00 (European Imaging Biomarkers Alliance) 12:30- E3 - The Satellite Coffee & Talk Satellite Satellite Coffee & Talk Satellite Satellite Satellite E3 - The Beauty Satellite
of Basic
Imaging biomarkers and their combinations 13:00 Beauty Symposium* (open forum) Symposium* Symposium* (open forum) Symposium* Symposium* Symposium* Knowledge: Symposium*
in the era of artificial intelligence of Basic What is a Dissemina- A Survival
Knowledge: fellowship in tion of ESR Guide to Mus-
13:00- Pancreas manage- iGuide in culoskeletal
Imaging
Room K NH 3 Artificial intelligence (AI): driven by radiologists Chronic ment? Europe: Bone tumours
13:30 pancreatitis use cases
14:00–15:30
13:30-
Sky High Stage MY 3 My Thesis in 3 Minutes
14:00
14:00–15:30 Oncologic Imaging
E3 721 SS 714a SS 714b S1 SS 706 SS 710 SS 716 C 11 SS 702a SS 711 SS 702b SS 717 HW 730 SS 709 C 10 SS 705 SS 713 SS 704 MY 7 SS 707
14:00- E3 - ECR Radiogra- Radiogra- E3 - Rising Hybrid, Musculo- Oncologic Coffee & Talk Breast Neuro Breast Emergency Hands-on Interven- Coffee & Talk Artificial Physics in Chest My Thesis in Genitou
Room X ESR Audit and Standards Session Academies: phers phers Stars Molecular skeletal Imaging (open forum) Decision Stroke: Breast Imaging Workshop: tional (open forum) Intelligence Medical Lung cancer: 3 Minutes nary
16:00–17:30 Audit across Europe: directive and perspective 14:30 Dissemination Ethical traps
Interactive Paediatrics Radiation Programme: and Trans- Imaging How to im- tools and diagnostic ultrasound Chest MRI of the Radiology and Imaging diagnosis, Artificial Prostat
of ESR iGuide in publication:
Teaching and radia- dose Student lational techniques: prove bone in Africa and
artificial imaging emergencies Prostate (3) Vascular in- how to avoid
Machine MRI: safety, staging and Intelligence and blad
14:30- Sessions tion therapy optimisation Session Imaging trauma and metastases the Middle intelligence terventions them from Learning phantoms outcome and Machine tumour
Room E 2 SF 4 My three top tips in neuroimaging for Young in CT and Hybrid cartilage and oste- East: use in breast in visceral concept to Machine and quantifi- Learning
16:00–17:30 (not only for neuroradiologists) 15:00 (and not so projection imaging in osarcoma cases imaging arteries and achievement learning in cation
Young) Ra- radiography oncology: assessment veins neuroradiol-
diologists head to toe (part 2) C 12 ogy: vascu-
Room Y US 1 ESR Ultrasound Subcommittee Session 15:00- Coffee & Talk
Errare hu- lar and mass
15:30 manum est (open forum) lesions
16:00–17:30 How to perform ultrasound image fusion Meet the
Editors
Room M 1 ESHIMT 1 ESHIMT Session 15:30-
16:00–17:30 (European Society for Hybrid, Molecular 16:00
and Translational Imaging)
E3 821 SF 8a RC 814 MS 8b EU 2 SF 8c SF 8d SF 8e RC 811 BS 8 RC 817 HW 830 EFRS/ RC 810 SF 8f SF 8b MY 8 MS 8a
Clinical and methodological pitfalls 16:00- E3 - ECR Special Radiogra- Multidis- EuroSafe Special Fo- Special Special Neuro E3 - Rising Emergency Hands-on EORTC Musculo- Special Special My Thesis in Multidis
in hybrid imaging: problems and solutions 16:30 Academies: Focus phers ciplinary Imaging cus Session Focus Focus State-of- Stars Imaging Workshop: Joint skeletal Focus Focus 3 Minutes ciplinar
Interactive Session Forensic Session Session The art to Session Session the-art Programme: Blunt MRI of the Session of MR imaging Session Session Interventional Session
Teaching Artificial imaging Brain Diagnostic transmit and Non-contrast Breast paediatric Basic polytrauma: Prostate the EFRS of the knee The 3D Challenging Radiology The ‘pro
Sky High Stage MY 4 My Thesis in 3 Minutes 16:30- Sessions intelligence imaging in reference to receive: MR angiog- imaging in neuroradi- Sessions CT proto- (4) and EORTC printing lab HRCT tate unit’
for Young (AI): our psychiatry cols, CT work
16:00–17:30 Chest 17:00 (and not so
levels how to raphy: pre-men- ology Renal, Radiogra- from bench patterns:
future (DRLs) communi- ready to go? opausal adrenal and interpre- phers: at to bedside tips and
Young) cannot be
Radiologists based on cate critical women urinary tract tation and the heart of tricks from
predicted, clinical information pathologies intervention- cancer treat- the experts
17:00- Gastro- but we
intestinal indication to our al radiology ment and
have to be
17:30 radiology prepared patients options research
Registration: 07:30–18:00 Technical Exhibition: EXPO
ECR Online & EPOS Lounge / EPOS™ – Scientific Exhibition: 08:00–18:00 * Not CME accredited Technical Exhibition: EXPO Halls
62 ECR 2019 | Final Programme www.myESR.org www.myESR.org

ARY 28 THURSDAY, FEBRUARY 28 THURSDAY, FEBRUARY 28

R/UEMS SS 501 E3 526 PC 5 RC 502 SA 5 BS 5 SF 5b HW 530 SF 5a C6 RC 510 EF 1 RC 504 MY 5 SF 5d SF 5c RC 512 RC 516 E3 519 E3 520
Joint Abdominal E3 - ECR Professional Breast State E3 - Rising Special Hands-on Special Coffee & Talk Musculo- EFOMP Chest My Thesis in Special 08:30- Special Focus Paediatric Oncologic E3 - ECR E3 - ECR 08:30-
ession of Viscera Master Challenges MRI for early of the Art Stars Focus Workshop: Focus (open forum) skeletal Workshop: Pulmonary 3 Minutes Focus 09:00 Session Intensive care Imaging Academies: Academies: 09:00
ESR and Diffuse Class Session detection, Symposium Programme: Session MRI of the Session Modern trends Imaging Big data neuroendo- Breast Session MSK interven- paediatric radi- Role of imaging Hot Topics in Functional
UEMS and focal Cardiac Radiology staging and How to face Basic Basic inter- Prostate (1) 7 Tesla MR in undergradu- of chronic and the big crine prolif- Imaging and VoE 008 / Stage 1 tion: the road ology: the very in cancer of GU Cancer Imaging
maging pancreatic imaging in and migra- manage- the tsunami Sessions ventional goes clinical ate teaching of forefoot pain picture: erations and manage- EuroSafe 09:00- from low to no sick neonate unknown Tumour relapse for Disease 09:00-
ofession- disease arrhythmia tions ment of of pancreat- Abdominal radiology for radiology: how deep learn- neoplasms ment of the Imaging invasion primary (CUP) in gynaecologi- Management:
in the EU: and sudden breast ic intraductal emergencies non-inter- to explain to ing in op- incidental VoE 038 / Stage 2 09:30 cal cancer Research to 09:30
Latin America VoE 128 / Stage 5
diologists cardiac cancer papillary ventional- students how timisation scrotal (Spanish) Ultrasound Medical Practice
without C 25 death mucinous ists: let’s interesting of medical lesions Functional
Coffee & Talk
VoE 068 / Stage 3
Portugal
09:30- 09:30-
borders neoplasia start with radiology is imaging imaging of the
(open forum) (IPMN) biopsy! (part A) VoE 098 / Stage 4 10:00 lungs 10:00
A heart’s matter: Musculoskeletal
cardiac men-
toring, tutoring C7 VoE 009 / Stage 1
and learning Coffee & Talk Latin America 10:00- 10:00-
within the ESOR (Portuguese)
(open forum) VoE 039 / Stage 2 10:30 10:30
community
EIBIR: Neuro
VoE 129 / Stage 5
EU-funded Interventional
VoE 069 / Stage 3
SS 615 SS 606 SS 610 SS 616a research in RTF Quiz SS 611 ESR/ESOR 1 SS 602 HW 630 SS 609 C8 SS 605 EF 2 SS 604 CT 6 SS 607 SS 608 Musculoskeletal
Radiography SS 603 SS 612 SS 616b E3 619 E3 620
ascular Hybrid, Musculo- Oncologic imaging and A new look Neuro E3 - Rising Breast Hands-on Interven- Coffee & Talk Artificial EFOMP Chest Clinical Genitouri- Head and VoE 099 / Stage 4
10:30- Cardiac Paediatric Oncologic E3 - ECR E3 - ECR 10:30-
ontrast Molecular skeletal Imaging how you can at the medi- MS and de- Stars Magnetic Workshop: tional (open forum) Intelligence Workshop: COPD, Trials in nary Neck Cardiac MR my- Foetal and ob- Imaging Academies: Academies:
Interventional 11:00 11:00
get funding
medium: and Trans- Chronic in- Advances in astinum myelinating Programme: resonance MRI of the Radiology Virtual and Big data emphysema Radiology 2 Contrast Lymph Radiology ocardial feature stetric imaging Abdominal Hot Topics in Functional
se, timing lational flammatory imaging of disorders Joint imaging Prostate (2) Vascular in- reality from Machine and the big and airways agents for nodes and VoE 010 / Stage 1 tracking tumour imaging: GU Cancer Imaging
d alterna- Imaging diseases liver malig- Sessions (MRI) terventions bench to Learning picture: diseases: imaging: not parathyroids Head and Neck 11:00- raising the bar Tumour relapse for disease 11:00-
tives Advanced nancies with ESOR in oncology bedside Machine deep learn- novel only iodine VoE 040 / Stage 2 in urological management:
MR methods Radiologic (including learning: ing in op- approaches Chinese 11:30 cancer Research to 11:30
VoE 070 / Stage 3 VoE 130 / Stage 5
in exper- anatomy: radioemboli- musculo- timisation Professional Japanese Medical Practice
imental head and sation) skeletal and of medical Issues Functional
11:30- 11:30-
radiology neck diverse imaging VoE 100 / Stage 4 imaging of the
(part B) Radioprotection/
Radiation Dose
12:00 liver 12:00
VoE 011 / Stage 1
French 12:00- 12:00-
VoE 041 / Stage 2
Hybrid, Molecular
and Translational 12:30 ESR US SC/UES 12:30
Imaging VoE 131 / Stage 5 Joint Session of
VoE 071 / Stage 3 MRI the ESR Ultrasound
SY 5 C 26 SY 6 SY 7 C9 SY 9 SY 10 SY 32 E3 25B SY 8 WF 1 Abdominal Viscera Subcommittee SY 12 SY 13 SY 14
atellite Coffee & Talk Satellite Satellite Coffee & Talk Satellite Satellite Satellite E3 - The Beauty Satellite Women VoE 101 / Stage 4
12:30- and the Satellite Satellite Satellite 12:30-
of Basic Artificial Intelli- Undergraduate
mposium* (open forum) Symposium* Symposium* (open forum) Symposium* Symposium* Symposium* Knowledge: Symposium* in Focus - gence and Machine 13:00 Symposium* Symposium* Symposium* 13:00
Education
What is a Dissemina- A Survival The Bigger Learning
Subcommittee
fellowship in tion of ESR Guide to Mus- Picture US teaching to
culoskeletal VoE 012 / Stage 1
manage- iGuide in
Imaging
Leading by Paediatric 13:00- undergraduate 13:00-
ment? Europe: example students: why, how
Bone tumours VoE 042 / Stage 2
use cases 12:30-14:00 Turkish 13:30 and from whom? 13:30
VoE 132 / Stage 5
VoE 072 / Stage 3
Italian
Spain
VoE 102 / Stage 4 13:30- 13:30-
Latin America
(Portuguese) 14:00 14:00
S1 SS 706 SS 710 SS 716 C 11 SS 702a SS 711 SS 702b SS 717 HW 730 SS 709 C 10 SS 705 SS 713 SS 704 MY 7 SS 707 VoE 013 / Stage 1 SS 703 SS 701 ESOR E3 722 E3 720
- Rising Hybrid, Musculo- Oncologic Coffee & Talk Breast Neuro Breast Emergency Hands-on Interven- Coffee & Talk Artificial Physics in Chest My Thesis in Genitouri- Korean 14:00- Cardiac Abdominal ESOR Session E3 - ECR E3 - ECR 14:00-
VoE 043 / Stage 2
Stars Molecular skeletal Imaging (open forum) Decision Stroke: Breast Imaging Workshop: tional (open forum) Intelligence Medical Lung cancer: 3 Minutes nary Interventional 14:30 CT-FFR Viscera Artificial Academies: Academies: 14:30
gramme: and Trans- Imaging How to im- Dissemination tools and diagnostic ultrasound Chest MRI of the Radiology Ethical traps and Imaging diagnosis, Artificial Prostate Radiology
VoE 133 / Stage 5 (fractional flow CT technical intelligence: Chest Imaging Functional
of ESR iGuide in publication: Professional
tudent lational techniques: prove bone in Africa and
artificial imaging emergencies Prostate (3) Vascular in- how to avoid
Machine MRI: safety, staging and Intelligence and bladder VoE 073 / Stage 3
Issues reserve) for frontiers in liver presented with Cavitary and Imaging
Session Imaging trauma and metastases intelligence terventions Learning phantoms outcome and Machine tumours Neuro 14:30- assessment of imaging new lecture cystic diseases for Disease 14:30-
the Middle them from
VoE 103 / Stage 4
Hybrid cartilage and oste- East: use in breast in visceral concept to Machine and quantifi- Learning Imaging
coronary artery formats of the lung Management:
imaging in osarcoma cases imaging arteries and achievement learning in cation Informatics
15:00 disease Research to 15:00
oncology: assessment veins neuroradiol- Medical Practice
head to toe (part 2) C 12 ogy: vascu- Functional
Coffee & Talk VoE 014 / Stage 1 15:00- 15:00-
lar and mass Musculoskeletal imaging of the
(open forum) lesions VoE 044 / Stage 2 15:30 kidneys 15:30
Meet the Japanese VoE 134 / Stage 5
Editors VoE 074 / Stage 3 Spanish
India 15:30- 15:30-
VoE 104 / Stage 4
WF 2 Portugal 16:00 16:00
Women
MS 8b EU 2 SF 8c SF 8d SF 8e RC 811 BS 8 RC 817 HW 830 EFRS/ RC 810 SF 8f SF 8b MY 8 MS 8a in Focus - RC 806 RC 812 RC 816 E3 822 E3 820
ultidis- EuroSafe Special Fo- Special Special Neuro E3 - Rising Emergency Hands-on EORTC Musculo- Special Special My Thesis in Multidis- The Bigger VoE 201 / Stage 1 16:00- Hybrid, Paediatric Oncologic E3 - ECR E3 - ECR 16:00-
Neuro
plinary Imaging cus Session Focus Focus State-of- Stars Imaging Workshop: Joint skeletal Focus Focus 3 Minutes ciplinary Picture Molecular and Predicting Imaging Academies: Academies:
Changing the
VoE 206 / Stage 2 16:30 16:30
Session Session The art to Session Session the-art Programme: Blunt MRI of the Session of MR imaging Session Session Interventional Session image of women
Breast Translational fracture risk in Multidisciplinary Chest Imaging Functional
Brain Diagnostic transmit and Non-contrast Breast paediatric Basic polytrauma: Prostate the EFRS of the knee The 3D Challenging Radiology The ‘pros- in leadership: VoE 211 / Stage 3 Imaging children approach to CT and interven- Imaging
aging in reference to receive: MR angiog- imaging in neuroradi- Sessions CT proto- (4) and EORTC printing lab HRCT tate unit’ at generational Vascular 16:30- Merging the cancer care tion in vascular for Disease 16:30-
differences and VoE 216 / Stage 4
ychiatry levels how to raphy: pre-men- ology Renal, cols, CT Radiogra- from bench patterns: work Neuro
best: hybrid pulmonary Management:
(DRLs) communi- ready to go? opausal adrenal and interpre- phers: at to bedside tips and similarities 17:00 imaging diseases Research to 17:00
based on cate critical women urinary tract tation and the heart of tricks from Medical Practice
clinical information pathologies intervention- cancer treat- the experts Functional imag-
17:00- 17:00-
indication to our al radiology ment and ing of breast and
patients options research 17:30 female pelvis 17:30
Technical Exhibition: EXPO Gallery (First Level): 10:00–17:00
POS™ – Scientific Exhibition: 08:00–18:00 * Not CME accredited Technical Exhibition: EXPO Halls and EXPO Foyer D: 10:00–17:00

Programme Overviews
TODAY’S HIGHLIGHTS FRIDAY, MARCH 1

Thursday, February 28 Time
2nd Level
(ACV)
2nd Level
(ACV)
2nd Level
(ACV)
2nd Level
(ACV)
2nd Level
(ACV)
1st Level
(ACV)
1st Level
(ACV)
1st Level
(ACV)
1st Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Entrance L.
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Stage
(ECR City)
Auditori
(ECR Cit
E3 921 RC 901 SF 9b ESR/ESTRO PI 1 RC 915 SF 9a E3 926 RC 911 BS 9 RC 902 HW 930 BR 9 C 13 RC 910 ESR/EFOMP RC 904 MY 9 RC 907
Room B EM 1 ESR meets Africa 08:30- E3 - ECR Abdominal Special Joint PIER @ ECR Vascular Special E3 - ECR Neuro E3 - Rising Breast Hands-on E3 - Rising Coffee & Talk Musculo- Joint Chest My Thesis in Genitou
Academies: Viscera Focus Session of Session Carotid Focus Master Update on Stars Screening Workshop: Stars (open forum) skeletal Session of Lung nodule 3 Minutes nary
10:30–12:00 Radiology in Africa: facing challenges 09:00 (Jointly
Interactive Imaging of Session the ESR and disease 2.0 Session Class cerebro- Programme: for breast MRI of the Programme: Value in Inflamma- the ESR and manage- Musculoskel- Imagin
and opportunities organised
Teaching the compli- Clinical sim- ESTRO with the Pain Post-treat- spinal Basic cancer Prostate (5) EFRS radiology in tory and EFOMP ment in etal strategie
09:00- Sessions cated post- ulation and Current ESR eHealth palliation ment fluid (CSF) Sessions Radiogra- theory and infectious Medical 2019 in rena
for Young operative its role in status Subcommit- in cancer emergencies diseases Neurologic phers’ Basic practice diseases of imaging and tumour
Room A HL 1 WILHELM CONRAD RÖNTGEN 09:30 (and not so abdomen radiography and future tee) patients in oncologic emergencies Sessions the spine: emerging
12:15–12:45 HONORARY LECTURE Young) education challenges in Reporting patients Career how to issues in
Radiologists MR-integrat- and com- planning differentiate occupational
Oncologic imaging: a new beginning has just begun 09:30- munication
Cardiac ed radio- from degen- radiation
Regina G.H. Beets-Tan; Amsterdam/NL 10:00 imaging therapy
today and
eration exposure
tomorrow
Studio 2019 PC 5 Radiology and migrations C 27

08:30–10:00 (open forum)
10:30
How to
EM 2 SS 1007 SS 1014 S2 enhance the PI 2 SS 1010 SS 1005a C 14 SS 1002 SS 1011a SS 1001a SS 1017 HW 1030 SS 1009 SS 1008 SS 1005b SS 1013 SS 1004 CT 10 SS 1001
Room E2 SA 5 How to face the tsunami of pancreatic intraductal
10:30- ESR meets Genitouri- Radiogra- E3 - Rising role of junior PIER @ ECR Musculo- Imaging Coffee & Talk Breast Neuro GI Tract Emergency Hands-on Interven- Head and Artificial Physics in Chest Clinical Abdomin
08:30–10:00 papillary mucinous neoplasia Italy nary phers Stars radiologists Session skeletal Informatics (open forum) Breast den- Paediatric Colonic Imaging Workshop: tional Neck Intelli- Medical Advanced Trials in Viscera
11:00 in Europe Access to the
From Prostate Melange: Programme: (Jointly Hip imaging Hot topics sity and risk brain imaging Best of MRI of the Radiology Head and gence and Imaging methods Radiology 3 Hepatob
medical physics
Room Y SF 5a 7 Tesla MR goes clinical morphology biopsy and nuclear Student organised in machine expert (MPE)
stratification revisited emergency Prostate Vascular neck cancer Machine Innovations for nodule iary contr
11:00- to function intervention medicine Session with the learning: in the imaging radiology (6) interven- Learning in imaging: evaluation agents: fo
08:30–10:00 and inter- ESR Audit from department: (part 2): tions in the Machine machine and diffu
11:30 ventional and radiomics use cases from aorta and learning in learning, liver dise
topics Standards to natural neurological peripheral neuroradi- quality and
Room F2 SF 5b Basic interventional radiology for Subcommit- language emergencies arteries ology: diag- new tech-
08:30–10:00 non-interventionalists: let’s start with biopsy! 11:30- nostic help
tee) analysis to penetrat- niques
12:00 Clinical audit ing injuries and tissue
analysis
Room M 1 SF 5c MSK intervention:
08:30–10:00 the road from low to no invasion 12:00-
12:30 HL 2 C 15
Headline Coffee & Talk
Tech Gate SF 5d Imaging and management of the incidental Session E3 24C SY 15 SY 16 SY 17 SY 18 (open forum) SY 19 SY 20 C 16 E3 25C SY 21 SY 30
08:30–10:00 scrotal lesions 12:30- E3 - The Satellite Satellite Satellite Satellite EuroSafe Joint Satellite Coffee & Talk E3 - The Beauty Satellite Satellit
of Basic
Beauty Symposium* Symposium* Symposium* Symposium* Imaging Satellite Symposium* (open forum) Symposium* Symposiu
13:00 meets Congenital
Knowledge:
A Survival
of Basic Symposium*
Room X Joint Session of the ESR and UEMS Knowledge: Canada Safe heart diseases Guide to
Musculoskele-
(CHD): new
08:30–10:00 (European Union of Medical Specialists) 13:00- Pancreas Imaging responsibilities tal Imaging
Spinal trauma:
Imaging professionals in the EU: Cystic for the paediat- how to get it
13:30 neoplasms ric radiologist right
radiologists without borders
C 17
Room G EFOMP Workshop 14:00 (open forum)
08:30–10:00 EF 1 Big data and the big picture: Team
approach and
10:30–12:00 EF 2 deep learning in optimisation of medical imaging IIQ EM 4 SY 25 PI 3 SY 26 ESR/BBMRI-
14:00- Image EFRS meets Satellite PIER @ ECR Satellite safety culture ERIC
Interpreta- Denmark Symposium* Session Symposium* in the imaging Joint
14:30 (Jointly department
Sky High Stage CT 6 Clinical Trials in Radiology tion Quiz EFRS meets organised Session of
10:30–12:00 Greek gods: Denmark with the ESR and
14:30- Mount the ESR BBMRI-ERIC
Olympus vs Research Will the General
Room E1 RTF Quiz: a new look at the mediastinum 15:00 The Under-
Committee) Data Protection
Professional Regulation
world issues for (GDPR) hamper
10:30–12:00 radiology the secondary
15:00- departments use of clinical
15:30 to enable imaging data
The Church WF 1 Women in Focus: Leading by example research for research?
12:40–14:00 C 28
16:00 (open forum)
Room M 3 ESOR Session (European School of Radiology) The European
Diploma in Ra-
14:00–15:30 Artificial intelligence: presented with new lecture formats
E3 1221 RC 1201 EM 5 diology (EDiR) EU 3 E3 1226 US 2 RC 1202 RC 1211 BS 12 RC 1217 BR 12 RC 1210 SF 12 RC 1204 RC 120
16:00- E3 - ECR Abdominal ISRRT as an instrument EuroSafe E3 - ECR ESR Breast Neuro E3 - Rising Emergency E3 - Rising Musculo- Special Chest Genitou
to develop a Imaging
Academies: Viscera meets Master Ultrasound Minimally-in- Inflamma- Stars Imaging Stars skeletal Focus Fibrotic lung nary
The Church WF 2 Women in Focus: Changing the image of women 16:30 Interactive
professional
career
Session: jointly
Imaging the Africa organised with Class Subcommit- vasive local tory and in- Programme: Why do Programme: The Session diseases Contras
15:45–17:00 in leadership: generational differences and similarities Teaching acute abdo- Radiog- the ISR and the Cone-beam, tee Session treatment fectious CNS Basic I miss EFRS radiological IT-security media
Sessions
16:30- for Young
men: new raphers’ IOMP
Improving radi-
4D and Tips and of breast pathology Sessions fractures in Radiogra- investigation and GDPR guidelin
insights challenges more: new tricks for cancer: the Paediatric emergency? phers’ Basic of muscu-
Room B SF 8a Artificial intelligence (AI): our future cannot be 17:00 (and not so
offering
ation protection
diagnostic abdominal time is now oncology Sessions loskeletal
Young) in medical imag-
16:00–17:30 predicted, but we have to be prepared Radiologists imaging ing in low- and tools for ultrasound Clinical tumours
Advances in services in middle-income vascular dilemmas in
17:00- musculoskeletal countries: past radiography:
Africa actions and fu-
diseases
Room O SF 8c The art to transmit and to receive: how to 17:30 techniques:
ture directions
what graduates
whole-body MR need to know
16:00–17:30 communicate critical information to our patients
Room G SF 8f The 3D printing lab from bench to bedside Registration: 07:30–18:00 Technical Exhibition: EXPO
16:00–17:30
Tech Gate MS 8a The ‘prostate unit’ at work
16:00–17:30

FRIDAY, MARCH 1 FRIDAY, MARCH 1

R/ESTRO PI 1 RC 915 SF 9a E3 926 RC 911 BS 9 RC 902 HW 930 BR 9 C 13 RC 910 ESR/EFOMP RC 904 MY 9 RC 907 ESHIMT 2 E3 918 RC 912 E3 922 RC 908
Joint PIER @ ECR Vascular Special E3 - ECR Neuro E3 - Rising Breast Hands-on E3 - Rising Coffee & Talk Musculo- Joint Chest My Thesis in Genitouri- 08:30- ESHIMT Session E3 - ECR Paediatric E3 - ECR Head and Neck 08:30-
ession of Session Carotid Focus Master Update on Stars Screening Workshop: Stars (open forum) skeletal Session of Lung nodule 3 Minutes nary Artificial Academies: Foetal and Academies: Head and neck
(Jointly 09:00 09:00
ESR and disease 2.0 Session Class cerebro- Programme: for breast MRI of the Programme: Value in Inflamma- the ESR and manage- Musculoskel- Imaging intelligence in Radiology neonatal Chest Imaging imaging: when
organised
ESTRO with the Pain Post-treat- spinal Basic cancer Prostate (5) EFRS radiology in tory and EFOMP ment in etal strategies VoE 015 / Stage 1 hybrid imaging Leaders’ imaging pearls Chronic obstruc- does it become
Current ESR eHealth palliation ment fluid (CSF) Sessions Radiogra- theory and infectious Medical 2019 in renal Imaging 09:00- Bootcamp tive pulmonary abnormal? 09:00-
status Subcommit- in cancer emergencies diseases Neurologic phers’ Basic practice diseases of imaging and tumours Informatics Captain’s disease (COPD)
d future tee) patients in oncologic emergencies Sessions the spine: emerging VoE 045 / Stage 2 09:30 dashboard 09:30
Reporting Emergency VoE 135 / Stage 5
llenges in patients Career how to issues in Imaging Austria
-integrat- and com- planning differentiate occupational
munication
VoE 075 / Stage 3
Korean
09:30- 09:30-
d radio- today and from degen- radiation
herapy tomorrow eration exposure VoE 105 / Stage 4
GI Tract
10:00 10:00
Coffee & Talk Spain 10:00- 10:00-
10:30 10:30
How to Latin America VoE 136 / Stage 5
(Spanish) Advanced
S2 enhance the PI 2 SS 1010 SS 1005a C 14 SS 1002 SS 1011a SS 1001a SS 1017 HW 1030 SS 1009 SS 1008 SS 1005b SS 1013 SS 1004 CT 10 SS 1001b SS 1012 VoE 076 / Stage 3 Practice SS 1003 E3 1018 SS 1016 E3 1022 SS 1011b
- Rising role of junior PIER @ ECR Musculo- Imaging Coffee & Talk Breast Neuro GI Tract Emergency Hands-on Interven- Head and Artificial Physics in Chest Clinical Abdominal Paediatric Cardiac 10:30- Cardiac E3 - ECR Oncologic E3 - ECR Neuro 10:30-
Stars radiologists Session skeletal Informatics (open forum) Breast den- Paediatric Colonic Imaging Workshop: tional Neck Intelli- Medical Advanced Trials in Viscera Paediatric VoE 106 / Stage 4
Cardiac CT Academies: Imaging Academies: Functional MRI
in Europe Access to the Portugal 11:00 11:00
gramme: (Jointly Hip imaging Hot topics sity and risk brain imaging Best of MRI of the Radiology Head and gence and Imaging methods Radiology 3 Hepatobil- musculo- in search of Radiology Lung cancer: Chest Imaging
medical physics
tudent organised in machine expert (MPE)
stratification revisited emergency Prostate Vascular neck cancer Machine Innovations for nodule iary contrast skeletal and VoE 017 / Stage 1 coronary artery Leaders’ screening and Lung cancer in
Session with the learning: in the imaging radiology (6) interven- Learning in imaging: evaluation agents: focal oncologic Genitourinary 11:00- disease Bootcamp beyond the era of molec- 11:00-
ESR Audit from department: (part 2): tions in the Machine machine and diffuse imaging VoE 047 / Stage 2 Dream team ular oncology
and radiomics use cases from aorta and learning in learning, liver disease Oncologic Imaging 11:30 and immune 11:30
VoE 077 / Stage 3 VoE 137 / Stage 5
Standards to natural neurological peripheral neuroradi- quality and therapy
Latin America Portuguese
Subcommit- language emergencies arteries ology: diag- new tech- (Portuguese)
nostic help 11:30- 11:30-
tee) analysis to penetrat- niques VoE 107 / Stage 4
Clinical audit ing injuries and tissue Abdominal 12:00 12:00
analysis Viscera
VoE 018 / Stage 1

Arabic (Egypt) 12:00- 12:00-
VoE 048 / Stage 2
C 15
Arabic VoE 138 / Stage 5
12:30 12:30
Coffee & Talk (North Africa) Radiation
SY 15 SY 16 SY 17 SY 18 (open forum) SY 19 SY 20 C 16 E3 25C SY 21 SY 30 VoE 078 / Stage 3 Protection SY 22 SY 23 SY 24
atellite Satellite Satellite Satellite EuroSafe Joint Satellite Coffee & Talk E3 - The Beauty Satellite Satellite GI Tract 12:30- Satellite Satellite Satellite 12:30-
of Basic
mposium* Symposium* Symposium* Symposium* Imaging Satellite Symposium* (open forum) Symposium* Symposium* VoE 108 / Stage 4
Symposium* Symposium* Symposium*
meets Congenital
Knowledge:
A Survival Korean 13:00 13:00
Symposium*
Canada Safe heart diseases Guide to
(CHD): new Musculoskele-
Imaging VoE 019 / Stage 1
responsibilities tal Imaging
Spinal trauma: Paediatric 13:00- 13:00-
for the paediat- how to get it VoE 049 / Stage 2
ric radiologist right ESR meets Italy 13:30 13:30
VoE 139 / Stage 5
VoE 079 / Stage 3
Japanese
C 17 Japanese
Coffee & Talk VoE 109 / Stage 4 13:30- 13:30-
(open forum) ESR meets
Pakistan 14:00 14:00
Team
SY 25 PI 3 SY 26 approach and ESR/BBMRI- WF 3 VoE 020 / Stage 1 SY 27 E3 1118
atellite PIER @ ECR Satellite safety culture ERIC Women ESR meets Italy 14:00- Satellite E3 - ECR 14:00-
mposium* Session Symposium* in the imaging Joint in Focus -
VoE 050 / Stage 2
Symposium* Academies:
(Jointly department
Emergency
VoE 140 / Stage 5
14:30 14:30
organised Session of The Bigger Imaging Radiology
Nuclear
with the ESR and Picture VoE 080 / Stage 3
Medicine Leaders’
the ESR BBMRI-ERIC Women in Abdominal 14:30- Bootcamp 14:30-
Research Will the General Viscera
challenging Investment
Committee) Data Protection
environ-
VoE 110 / Stage 4
Genitourinary
15:00 strategies 15:00
Professional Regulation
issues for (GDPR) hamper ments
radiology the secondary VoE 021 / Stage 1
15:00- 15:00-
departments use of clinical Radioprotection/
to enable imaging data Radiation Dose
research for research? VoE 051 / Stage 2
15:30 15:30
VoE 141 / Stage 5
Genitourinary
MRI
Coffee & Talk Spain 15:30- 15:30-
VoE 111 / Stage 4
(open forum) 16:00 16:00
The European Head and Neck
Diploma in Ra-
diology (EDiR) EU 3 E3 1226 US 2 RC 1202 RC 1211 BS 12 RC 1217 BR 12 RC 1210 SF 12 RC 1204 RC 1207 WF 4 VoE 202 / Stage 1 RC 1206 E3 1218 RC 1216 E3 1222 RC 1208
as an instrument EuroSafe E3 - ECR ESR Breast Neuro E3 - Rising Emergency E3 - Rising Musculo- Special Chest Genitouri- Women Chest 16:00- Hybrid, E3 - ECR Oncologic E3 - ECR Head and Neck 16:00-
to develop a Imaging VoE 207 / Stage 2
professional
Session: jointly
Master Ultrasound Minimally-in- Inflamma- Stars Imaging Stars skeletal Focus Fibrotic lung nary in Focus - Interventional 16:30 Molecular and Academies: Imaging Academies: Post-treatment 16:30
career Class Subcommit- vasive local tory and in- Programme: Why do Programme: The Session diseases Contrast The Bigger Radiology Translational Radiology Oncological Chest Imaging imaging of the
organised with
the ISR and the Cone-beam, tee Session treatment fectious CNS Basic I miss EFRS radiological IT-security media Picture VoE 212 / Stage 3 Imaging Leaders’ imaging: where The heart head and neck
IOMP 4D and Tips and of breast pathology Sessions fractures in Radiogra- investigation and GDPR guidelines Leadership Musculoskeletal 16:30- Translating Bootcamp are we now? between the 16:30-
Improving radi- VoE 217 / Stage 4
more: new tricks for cancer: the Paediatric emergency? phers’ Basic of muscu- and Interventional
functional and Secrets of lungs
ation protection
in medical imag- diagnostic abdominal time is now oncology Sessions loskeletal mentorship Radiology
17:00 molecular imag- radiology 17:00
ing in low- and tools for ultrasound Clinical tumours ing in oncology communications
middle-income vascular dilemmas in with patients
countries: past radiography: 17:00- 17:00-
actions and fu-
diseases and referring
what graduates
ture directions need to know 17:30 physicians 17:30

Programme Overviews
TODAY’S HIGHLIGHTS SATURDAY, MARCH 2 SA

Friday, March 1 Time
2nd Level
(ACV)
2nd Level
(ACV)
2nd Level
(ACV)
2nd Level
(ACV)
2nd Level
(ACV)
1st Level
(ACV)
1st Level
(ACV)
1st Level
(ACV)
1st Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Entrance L.
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Stage
(ECR City)
Auditori
(ECR Cit
E3 1321 SF 13a PC 13 S3 EU 4 RC 1315 SF 13b RC 1302 RC 1311 E3 1323 SA 13 BR 13 RC 1310 RC 1313 SS 1314 MY 13 RC 130
Room A EM 2 ESR meets Italy 08:30- E3 - ECR Special Professional E3 - Rising EuroSafe Vascular Special Breast Neuro E3 - Europe- State of the E3 - Rising Musculo- Physics in Radiogra- My Thesis Genitou
Academies: Focus Challenges Stars Imaging US and Focus New Altered an Diploma Art Stars skeletal Medical phers in 3 Minutes nary
10:30–12:00 From morphology to function 09:00 Interactive Session Session Programme: Session vascular Session mammogra- mental state Prep Symposium Programme: Imaging of Imaging Radiograph- Genitouri- Imaging
Teaching
Sessions Radiol- Working in Student Advanced disease: Cutting phy: digital Sessions Cardiac: EFRS forgotten Dose man- ic issues nary pregnan
Room A HL 2 JOSEF LISSNER HONORARY LECTURE 09:00- for Young ogy and radiology: Session clinical a perfect edge breast to- Gastroin- recalling the Radiogra- small joints agement in
(and not so pathology: burnout and dosimetry in match imaging and mosynthesis testinal and forgotten phers’ paediatric
12:15–12:45 Systemic effects of image guided tumour therapy: 09:30 Young) will we ever bore-out or intervention- minimally and future abdominal structures Basic radiology
have we opened Pandora’s box or found the Holy Grail? Radiologists be (digitally) engaged al radiology invasive techniques Session
Writing married? and passion- C 29 interven- C 18
S. Nahum Goldberg; Jerusalem/IL 09:30- reports: Coffee & Talk
Radiography
Coffee & Talk
a survival ate? tions of the research: a
10:00 (open forum) spine “how to” guide (open forum)
guide Why are Assessing
Room A IIQ IMAGE INTERPRETATION QUIZ imaging IT in
research fellow- hospitals: an
14:00–15:30 Greek gods: Mount Olympus vs The Underworld 10:00- ships important update on the
digital imaging
for young
10:30 radiologists?
adoption model
(DIAM)
Room C EM 4 EFRS meets Denmark
14:00–15:30 E3 1421 SS 1401a SS 1414 PA SS 1406 SS 1410 SS 1407 SY 33 SS 1402a SS 1411a E3 1423 SS 1402b TF SS 1405 SS 1413 SS 1404 MY 14 SS 1411
10:30- E3 - ECR Abdominal Radiogra- ESR Patient Hybrid, Musculo- Genitouri- Satellite Breast Neuro E3 - Europe- Breast RTF - Artificial Physics in Chest My Thesis Neuro
Academies: Viscera phers Advisory Molecular skeletal nary Symposium* Interven- Brain an Diploma Breast Radiology Intelli- Medical Advanced in 3 Minutes Diffusio
11:00 Interactive
Room C EM 5 ISRRT meets Africa: Radiographers’ challenges Teaching
Assessing Ultra- Group and Trans- Knee Renal and tional breast tumours Prep imaging bio- Trainees gence and Imaging lung im- Head and tensor im
16:00–17:30 offering imaging services in Africa Sessions pancreatic sound and (ESR-PAG) lational imaging adrenal radiology Sessions markers and Forum C 20 Machine Radiation aging: MRI Neck ing (DT
11:00- for Young malignancy computer Communicat- Imaging tumours and high- Neuro radiomics Highlighted Coffee & Talk Learning protection and artificial
(and not so applications ing the role of Advanced risk lesions Lectures (open forum) Imaging technology intelligence
Studio 2019 SF 9a Pain palliation in cancer patients 11:30 Young) in medical the radiologist: methods in informatics: and man-
Structured
Radiologists imaging best practices experimen- manage- agement
08:30–10:00 Genitourinary reporting:
to manage tal radiology ment and
11:30- radiology for how we
the general
patient expec- do it! performance
Room C SF 9b Clinical simulation and its role 12:00 radiologist tations analysis
08:30–10:00 in radiography education
12:00-
12:30 HL 3 EDiR
Room X Joint Session of the ESR and ESTRO Headline Session
08:30–10:00 (European Society for Radiotherapy & Oncology) Session E3 24D EDiR: an SY 28 E3 25D SY 29 SY 31
Current status and future challenges 12:30- E3 - The instrument Satellite E3 - The Satellite Satellit
Beauty to develop Beauty of Basic
in MR-integrated radiotherapy 13:00 Symposium* Knowledge: A
Symposium* Symposiu
of Basic excellence in
Knowledge: Survival Guide
your career to Musculoskel-
JIIQ Pancreas
Room N PI 1 PIER @ ECR (Professional Issues and Economics in Radiology) 13:00- Junior Solid etal Imaging
Arthritis:
08:30–10:00 Reporting and communication today and tomorrow: Image Inter- pancreatic
13:30 pretation neoplasms
an imaging
approach
challenges to implement structured reporting (RS) Quiz
A day in the
and deal with artificial intelligence (AI) 13:30- (future) life
of a young
14:00 radiologist
(12:55-13:55)
Room G Joint Session of the ESR and EFOMP
08:30–10:00 (European Federation of Organisations for Medical Physics) E3 1521 E3 1526 EFRS WS S4 C 30 EU 5 RC 1503 SF 15a SS 1510 SF 15b SF 15c E3 1523 SF 15d SS 1509 C 19 RC 1515 RC 1513 RC 1504 MY 15 SS 1501
14:00- E3 - ECR E3 - ECR EFRS Work- E3 - Rising Coffee & Talk EuroSafe Cardiac Special Musculo- Special Special E3 - Europe- Special Interven- Coffee & Talk Vascular Physics in Chest My Thesis Abdomin
Medical imaging and emerging issues Academies: Master shop: in Stars (open forum) Imaging Cardiac Focus skeletal Focus Focus an Diploma Focus tional (open forum) No time to Medical Back to in 3 Minutes Viscera
in occupational radiation exposure 14:30
Interactive Class association Programme: Why it is Session imaging in Session Musculoskel- Session Session Prep Session Radiology Gadolinium lose: aortic Imaging basics: how Everyday Multimod
Teaching Dual-energy with EIBIR Student important Getting the structural Everything etal inter- Imaging in Abdominal Sessions Navigating Nonvascular deposition in disease, Demysti- to interpret challenges ity imagi
14:30- Sessions CT of the and the Ra- Session to have an balance heart you always ventions Meniere’s emer- Principles of tumour phe- interven- tissues: current revisited fying MRI: a chest radi- for radiog- for asses
Room M 1 ESHIMT 2 ESHIMT Session for Young abdomen: diography academic right: disease wanted to disease: gencies: imaging and notype with tions in evidence and things you ograph? raphers and ment of l
08:30–10:00 (European Society for Hybrid, Molecular 15:00 (and not so the time is Journal career radiation risk know about what to advanced radiation advanced oncology alternatives always radiologists function a
and Translational Imaging) Young) now Growing and imaging metabolic believe and imaging protection imaging (including wanted to portal h
15:00- Radiologists radiography benefit in bone disease how to inter- in daily analysis kidney) know pertensi
Artificial intelligence in hybrid imaging Breast research paediatric (but were pret routine?
15:30 imaging procedures afraid to ask)
Sky High Stage CT 10 Clinical Trials in Radiology
10:30–12:00 15:30-
16:00
Room N PI 2 PIER @ ECR (Professional Issues and Economics in Radiology)
E3 1621 RC 1601 ESR/EFRS EU 6 RC 1603 SA 16 E3 1626a RC 1611 E3 1623 NH 16 BR 16 C 21 RC 1610 SS 1605 SS 1604 MY 16 RC 160
10:30–12:00 Clinical audit: how to deal with the legal and 16:00- E3 - ECR Abdominal Joint EuroSafe Cardiac State of the E3 - ECR Neuro E3 - Europe- New E3 - Rising Coffee & Talk Musculo- Artificial Chest My Thesis Genitou
professional requirements Academies: Viscera Session of Imaging Acute chest Art Master The dean Diploma Horizons Stars (open forum) skeletal Intelli- Inflamma- in 3 Minutes nary
16:30 Interactive Diagnosis the ESR and Session pain and Symposium Class generative Prep Session Programme: How to The old gence and tory, fibrotic Neuro Renal tra
Teaching
Sessions and man- EFRS CT radiation cardiac Breast State-of- cervical Sessions The tumour EFRS enhance the spine: chal- Machine and infec- plantatio
Room N PI 3 PIER @ ECR (Professional Issues and Economics in Radiology) 16:30- for Young agement Patient safe- risk in imaging cancer the-art spine Chest board of the Radiogra- role of junior lenges of Learning tious lung
14:00–15:30 Professional issues for radiology departments (and not so of acute ty in medical children: an screening imaging of future phers’ Basic radiologists imaging and Machine diseases
17:00 Young) pancreatitis imaging overview and treat- postopera- Sessions in Europa treatment learning:
to enable research Radiologists ment: how tive joints Radiation genitouri-
Paediatric much is too protection: nary and
17:00- radiology for
The Church WF 3 Women in Focus: the general much? all you need diverse
17:30 radiologist to know
14:00–15:15 Women in challenging environments
The Church WF 4 Women in Focus: Registration: 07:30–18:00 Technical Exhibition: EXPO

16:00–17:25 Leadership and mentorship
Studio 2019 US 2 ESR Ultrasound Subcommittee Session
16:00–17:30 Tips and tricks for abdominal ultrasound

H2 SATURDAY, MARCH 2 SATURDAY, MARCH 2

S3 EU 4 RC 1315 SF 13b RC 1302 RC 1311 E3 1323 SA 13 BR 13 RC 1310 RC 1313 SS 1314 MY 13 RC 1307 ESR/EORTC E3 1326 RC 1308 E3 1322 TC 1328
- Rising EuroSafe Vascular Special Breast Neuro E3 - Europe- State of the E3 - Rising Musculo- Physics in Radiogra- My Thesis Genitouri- 08:30- Joint Session E3 - ECR Master Head and Neck E3 - ECR Transatlantic 08:30-
Stars Imaging US and Focus New Altered an Diploma Art Stars skeletal Medical phers in 3 Minutes nary 09:00 of the ESR and Class Differential diag- Academies: Course of ESR 09:00
gramme: Session vascular Session mammogra- mental state Prep Symposium Programme: Imaging of Imaging Radiograph- Genitouri- Imaging in EORTC Juvenile idio- noses you don’t Chest Imaging and RSNA
tudent Advanced disease: Cutting phy: digital Sessions Cardiac: EFRS forgotten Dose man- ic issues nary pregnancy VoE 022 / Stage 1 Imaging in onco- pathic arthritis want to miss Pleural neo- (Radiological
Session clinical a perfect edge breast to- Gastroin- recalling the Radiogra- small joints agement in Interventional 09:00- logical trials (JIA) plasms Society of 09:00-
dosimetry in match imaging and mosynthesis testinal and forgotten phers’ paediatric Radiology North America):
intervention- minimally and future abdominal structures Basic radiology VoE 052 / Stage 2 09:30 Sports Imaging 09:30
Chest VoE 142 / Stage 5
al radiology invasive techniques Session VoE 082 / Stage 3 Cardiology Shoulder sports
C 29 interven- Radiography C 18 Latin America injuries and
Coffee & Talk Coffee & Talk (Spanish)
09:30- 09:30-
tions of the research: a postoperative
(open forum) spine “how to” guide (open forum) VoE 112 / Stage 4 10:00 MRI 10:00
Why are Assessing Musculoskeletal
imaging IT in
research fellow- hospitals: an
ships important update on the VoE 023 / Stage 1 10:00- 10:00-
digital imaging Russian
for young
radiologists?
adoption model
(DIAM)
VoE 053 / Stage 2 10:30 10:30
Breast VoE 143 / Stage 5
VoE 083 / Stage 3 Japanese
PA SS 1406 SS 1410 SS 1407 SY 33 SS 1402a SS 1411a E3 1423 SS 1402b TF SS 1405 SS 1413 SS 1404 MY 14 SS 1411b SS 1401b Head and Neck
SS 1403 SS 1412 SS 1416 PS 1427 TC 1428
R Patient Hybrid, Musculo- Genitouri- Satellite Breast Neuro E3 - Europe- Breast RTF - Artificial Physics in Chest My Thesis Neuro GI Tract VoE 113 / Stage 4
10:30- Cardiac Paediatric Oncologic Pros & Cons Transatlantic 10:30-
dvisory Molecular skeletal nary Symposium* Interven- Brain an Diploma Breast Radiology Intelli- Medical Advanced in 3 Minutes Diffusion Gastric Vascular 11:00 Quantification of Paediatric Imaging Session Course of ESR 11:00
Group and Trans- Knee Renal and tional breast tumours Prep imaging bio- Trainees gence and Imaging lung im- Head and tensor imag- cancer and myocardial neuroradiology Neurooncology: US before CT and RSNA
SR-PAG) lational imaging adrenal radiology Sessions markers and Forum C 20 Machine Radiation aging: MRI Neck ing (DTI) beyond perfusion and making the most in the acute (Radiological
VoE 024 / Stage 1
mmunicat- Imaging tumours and high- Neuro radiomics Highlighted Coffee & Talk Learning protection and artificial EuroSafe 11:00- ECV of quantitative abdomen? Society of 11:00-
the role of Advanced risk lesions Lectures (open forum) Imaging technology intelligence Imaging (extracellular imaging North America):
radiologist: methods in informatics: and man- VoE 054 / Stage 2 VoE 144 / Stage 5
11:30 volume fraction) Sports Imaging 11:30
Structured
t practices experimen- manage- agement Paediatric Radiological Wrist and foot/
reporting: VoE 084 / Stage 3 Modalities
manage tal radiology ment and ankle sports
how we Portugal 11:30- 11:30-
ent expec- do it! performance VoE 114 / Stage 4
injuries
tations analysis ESR meets Italy 12:00 12:00
VoE 025 / Stage 1
Latin America 12:00- 12:00-
(Spanish)
EDiR VoE 055 / Stage 2 12:30 12:30
Session Cardiac VoE 145 / Stage 5
DiR: an VoE 085 / Stage 3 Paediatric
SY 28 E3 25D SY 29 SY 31 Neuro
strument Satellite E3 - The Satellite Satellite VoE 115 / Stage 4
12:30- 12:30-
develop Beauty of Basic
Symposium* Knowledge: A
Symposium* Symposium* ESR meets 13:00 13:00
ellence in Survival Guide
Africa
ur career to Musculoskel- VoE 026 / Stage 1
etal Imaging
Arthritis:
Oncologic 13:00- 13:00-
Imaging
an imaging
approach
VoE 056 / Stage 2 13:30 13:30
Spain
VoE 086 / Stage 3
Japanese 13:30- 13:30-
VoE 116 / Stage 4
Radioprotection/
Radiation Dose
14:00 14:00
S4 C 30 EU 5 RC 1503 SF 15a SS 1510 SF 15b SF 15c E3 1523 SF 15d SS 1509 C 19 RC 1515 RC 1513 RC 1504 MY 15 SS 1501b SS 1507 VoE 027 / Stage 1 SS 1503 SS 1512 SS 1511 SS 1501a TC 1528
- Rising Coffee & Talk EuroSafe Cardiac Special Musculo- Special Special E3 - Europe- Special Interven- Coffee & Talk Vascular Physics in Chest My Thesis Abdominal Genitouri- German 14:00- Cardiac Paediatric Neuro GI Tract Transatlantic 14:00-
VoE 057 / Stage 2
Stars (open forum) Imaging Cardiac Focus skeletal Focus Focus an Diploma Focus tional (open forum) No time to Medical Back to in 3 Minutes Viscera nary Physics in 14:30 Coronary calci- Paediatric Neurocognitive Rectal cancer: Course of ESR 14:30
gramme: Why it is Session imaging in Session Musculoskel- Session Session Prep Session Radiology Gadolinium lose: aortic Imaging basics: how Everyday Multimodal- Imaging in Medical um and plaques: radioprotection, impairment what’s new? and RSNA
tudent important Getting the structural Everything etal inter- Imaging in Abdominal Sessions Navigating Nonvascular deposition in disease, Demysti- to interpret challenges ity imaging pregnancy Imaging diagnosis and techniques and and psychiatric (Radiological
Session to have an balance heart you always ventions Meniere’s emer- Principles of tumour phe- interven- tissues: current revisited fying MRI: a chest radi- for radiog- for assess- and female VoE 087 / Stage 3
Breast
14:30- prognosis forensic imaging disorders Society of 14:30-
academic right: disease wanted to disease: gencies: imaging and notype with tions in evidence and things you ograph? raphers and ment of liver tumours North America):
career radiation risk know about what to advanced radiation advanced oncology alternatives always radiologists function and
VoE 117 / Stage 4
Spain
15:00 Sports Imaging 15:00
and imaging metabolic believe and imaging protection imaging (including wanted to portal hy- Knee sports
VoE 203 / Stage 1
benefit in bone disease how to inter- in daily analysis kidney) know pertension Genitourinary 15:00- injuries and 15:00-
paediatric (but were pret routine? VoE 208 / Stage 2 postoperative
procedures afraid to ask) Oncologic 15:30 MRI 15:30
Imaging
VoE 213 / Stage 3
Cardiac 15:30- 15:30-
VoE 218 / Stage 4
Interventional 16:00 16:00
Radiology
EU 6 RC 1603 SA 16 E3 1626a RC 1611 E3 1623 NH 16 BR 16 C 21 RC 1610 SS 1605 SS 1604 MY 16 RC 1607 ESR/ESHIMT PC 16 E3 1626b MS 16 TC 1628
EuroSafe Cardiac State of the E3 - ECR Neuro E3 - Europe- New E3 - Rising Coffee & Talk Musculo- Artificial Chest My Thesis Genitouri- 16:00- Joint Session Professional E3 - ECR Master Multidiscipli- Transatlantic 16:00-
Imaging Acute chest Art Master The dean Diploma Horizons Stars (open forum) skeletal Intelli- Inflamma- in 3 Minutes nary 16:30 of the ESR and Challenges Class nary Session Course of ESR 16:30
Session pain and Symposium Class generative Prep Session Programme: How to The old gence and tory, fibrotic Neuro Renal trans- ESHIMT Session Patterns of pul- How to deal with and RSNA
CT radiation cardiac Breast State-of- cervical Sessions The tumour EFRS enhance the spine: chal- Machine and infec- plantation Hybrid and How to organise monary toxicity the epidemics of (Radiological
risk in imaging cancer the-art spine Chest board of the Radiogra- role of junior lenges of Learning tious lung 16:30- translational nationwide thyroid nodules? Society of 16:30-
children: an screening imaging of future phers’ Basic radiologists imaging and Machine diseases imaging: the ischaemic stroke North America):
overview and treat- postopera- Sessions in Europa treatment learning: 17:00 bigger picture care (and make Sports Imaging 17:00
ment: how tive joints Radiation genitouri- multidisciplinary Musculoskeletal
much is too protection: nary and 17:00- teams work) interventional 17:00-
much? all you need diverse procedures
to know 17:30 17:30

Programme Overviews
TODAY’S HIGHLIGHTS SUNDAY, MARCH 3

Saturday, March 2 Time
2nd Level
(ACV)
2nd Level
(ACV)
2nd Level
(ACV)
2nd Level
(ACV)
2nd Level
(ACV)
1st Level
(ACV)
1st Level
(ACV)
1st Level
(ACV)
1st Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Entrance L.
(ACV)
Level
(ACV)
Level
(ACV)
Level
(ACV)
Stage
(ECR City)
Auditori
(ECR Cit
E3 1721 RC 1701 RC 1714 ESR/ EU 7 RC 1703 SF 17 RC 1702 RC 1711 E3 1723 RC 1717 BR 17 SS 1709 RC 1710 RC 1713 RC 1704 MY 17 E3 1726
Room A HL 3 LUIGI OLIVA HONORARY LECTURE 08:30- E3 - ECR Abdominal Radiogra- ESMRMB EuroSafe Cardiac Special Breast Neuro E3 - Europe- Emergency E3 - Rising Interven- Musculo- Physics in Chest My Thesis E3 - EC
Academies: Viscera phers Joint Imaging Dead Focus Diagnosing Diffuse an Diploma Imaging Stars tional skeletal Medical Thoracic in 3 Minutes Master
12:15–12:45 Contrast-enhanced ultrasound in paediatrics: 09:00 Interactive Programme: Radiology
Hepatocel- Ultrasound: Session of Session or alive: Session ductal carci- low-grade Prep Small bowel Elbow im- Imaging emergencies Abdominal Class
ready for clinical practice? Teaching lular carci- continuing the ESR and Artificial imaging of Late effects noma in situ gliomas: Sessions obstruction: EFRS Nonvascular aging: from Dose Viscera and Prostat
Paul S. Sidhu; London/UK 09:00- Sessions noma: from to make ESMRMB intelli- myocardial in survivors (DCIS) new things Musculoskel- improve Radiogra- liver inter- detailed reduction and Gastrointes- MRI: the
for Young diagnosis to waves A new era of gence and viability of childhood you should etal your reading phers’ Basic ventions anatomy to image quality tinal Tract creditati
09:30 (and not so
treatment gadolini- radiation cancer know and report-
Sessions
pathology implications issue
Young) The future
Room A JIIQ JUNIOR IMAGE INTERPRETATION QUIZ Radiologists um-less MR protection ing compe- of radiology: of iterative
12:55–13:55 A day in the (future) life of a young radiologist tences what it could image re-
09:30- Head mean for new
and neck construction
radiography
10:00 imaging graduates in CT
Room C PC 13 Working in radiology: burnout and bore-out or
08:30–10:00 engaged and passionate? 10:00-
10:30
Room F2 SA 13 Cardiac: recalling the forgotten structures
08:30–10:00 E3 1821 EM 3 SS 1814 SS 1815 SS 1810 SS 1805a SS 1801a SS 1802a SS 1811a E3 1823 SS 1802b SS 1809 SS 1805b SS 1813 SS 1804 MY 18 SS 1811
10:30- E3 - ECR ESR meets Radiogra- Vascular Musculo- Imaging Abdominal Breast Neuro E3 - Europe- Breast Interven- Artificial Physics in Chest My Thesis Neuro
11:00 Academies: Pakistan phers Imaging of skeletal Informatics Viscera Radiation Parkinson an Diploma DWI, spec- tional Intelli- Medical Thoracic im- in 3 Minutes Neurora
Room B SF 13a Radiology and pathology: Interactive The role of CT and the thoracic Knee and Machine Diffuse dose, quality and related Prep troscopy Radiology gence and Imaging aging: new Cardiovas- diology: m
08:30–10:00 will we ever be (digitally) married? Teaching radiology professional aorta muscle learning liver disease: assurance, disorders Sessions and other Nonvascular Machine Radiation approaches cular cellaneo
11:00- Sessions in major issues in imaging in breast fibrosis, and safety Breast advanced musculo- Learning dose optimi- and tech-
for Young healthcare radiography imaging steatosis in breast breast MR skeletal Machine sation in CT niques
Studio 2019 SF 13b Cutting edge imaging and minimally invasive 11:30 (and not so challenges and inflam- imaging techniques interven- learning:
Young) faced by mation tions radiomics
08:30–10:00 interventions of the spine Radiologists Pakistan analysis
11:30-
Imaging of
Room M 1 Joint Session of the ESR and EORTC 12:00 the brain
08:30–10:00 (European Organisation for Research and
Treatment of Cancer) 12:00-
Imaging in oncological trials 12:30
E3 24E ESR General E3 25E
Room N EU 4 EuroSafe Imaging Session 12:30- E3 - The Assembly E3 - The
Beauty Beauty of Basic
08:30–10:00 Advanced clinical dosimetry 13:00 of Basic Knowledge: A
Survival Guide
in interventional radiology Knowledge: to Musculoskel-
Pancreas CB etal Imaging
13:00- Pancreatic Acute trauma:
adenocar- E3 - Rising patterns in
Room M 5 Transatlantic Course of the ESR and the RSNA 13:30 cinoma Stars the peripheral
mimickers skeleton
08:30–10:00 TC 1328 Shoulder sports injuries and postoperative MRI Programme:
Case-Based
10:30–12:00 TC 1428 Wrist and foot/ankle sports injuries 13:30- Diagnosis
14:00–15:30 TC 1528 Knee sports injuries and postoperative MRI Training
14:00
16:00–17:30 TC 1628 Musculoskeletal interventional procedures
Interlude:
E3 1921 SS 1914a SS 1914b SS 1915 SS 1910a SS 1910b SS 1905a SS 1901a Just a Cyst SS 1911a SS 1902a SS 1902b SS 1909 SS 1903a SS 1905b SS 1913 SS 1904 SS 190
14:00- E3 - ECR Radiogra- Radiogra- Vascular Musculo- Musculo- Imaging Abdominal (14:00-14:30) Neuro Breast Breast Interven- Cardiac Artificial Physics in Chest Genitou
Room X ESR Patient Advisory Group Academies: phers phers Vascular im- skeletal skeletal Informatics Viscera Contrast Contrast-en- Breast can- tional Cardiac MR Intelli- Medical Tradition- nary
10:30–12:00 Communicating the role of the radiologist: 14:30 Interactive Educational Mammogra- aging after Spine Spine and Machine Diagnosis of media and hanced cer staging, Radiology in cardio- gence and Imaging al and Imaging
best practices to manage patient expectations Teaching issues in phy quality stent-graft imaging peripheral learning hepato- advances in mammogra- therapy Nonvascular myopathies: Machine Breast imag- advanced the uter
14:30- Sessions radiography assessment and stent nerve in chest cellular neuro MRI phy, breast monitoring interven- tips and Learning ing physics pulmonary
for Young insertion imaging radiology carcinoma: CT, and and recur- tions in the tricks Machine vascular
Room M 4 PS 1427 Pros & Cons Session 15:00 (and not so
the LI-RADS other new rence lung learning: imaging
Young)
10:30–12:00 US before CT in the acute abdomen? Radiologists perspective imaging visceral
15:00- Paediat- techniques organs and
ric brain GI tract
Studio 2019 SF 15a Everything you always wanted to know about 15:30 imaging
14:00–15:30 metabolic bone disease (but were afraid to ask)
Room E1 SF 15b Imaging in Meniere’s disease:

14:00–15:30 what to believe and how to interpret
Room E2 SF 15c Abdominal emergencies:

14:00–15:30 advanced imaging in daily routine?
Studio 2019 SA 16 Breast cancer screening and treatment:

16:00–17:30 how much is too much?
Room F2 NH 16 The tumour board of the future

16:00–17:30
Room M 1 Joint Session of the ESR and ESHIMT Registration: 07:30–16:00 Technical Exhibition: EXPO
16:00–17:30 (European Society for Hybrid, Molecular and
Translational Imaging) ECR Online & EPOS Lounge / EPOS™ – Scientific Exhibition: 08:00–15:30 Technical Exhibition: EXPO Halls
Hybrid and translational imaging:
the bigger picture

SUNDAY, MARCH 3 SUNDAY, MARCH 3

ESR/ EU 7 RC 1703 SF 17 RC 1702 RC 1711 E3 1723 RC 1717 BR 17 SS 1709 RC 1710 RC 1713 RC 1704 MY 17 E3 1726b E3 1726a SS 1708 SS 1716 MS 17 RC 1708
SMRMB EuroSafe Cardiac Special Breast Neuro E3 - Europe- Emergency E3 - Rising Interven- Musculo- Physics in Chest My Thesis E3 - ECR 08:30- E3 - ECR Master Head and Neck Oncologic Multidiscipli- Head and Neck 08:30-
Joint Imaging Dead Focus Diagnosing Diffuse an Diploma Imaging Stars tional skeletal Medical Thoracic in 3 Minutes Master Class Miscellaneous Imaging nary Session Imaging of eye
Programme: Radiology
09:00 09:00
ession of Session or alive: Session ductal carci- low-grade Prep Small bowel Elbow im- Imaging emergencies Abdominal Class Quantitative and orbits Which whole- Multidisciplinary and orbital
ESR and Artificial imaging of Late effects noma in situ gliomas: Sessions obstruction: EFRS Nonvascular aging: from Dose Viscera and Prostate imaging in body exam approach to the pathologies
SMRMB intelli- myocardial in survivors (DCIS) new things Musculoskel- improve Radiogra- liver inter- detailed reduction and Gastrointes- MRI: the ac- VoE 028 / Stage 1
09:00- oncology should I choose? diabetic foot 09:00-
phers’ Basic Cardiac
ew era of gence and viability of childhood you should etal your reading ventions anatomy to image quality tinal Tract creditation VoE 058 / Stage 2
adolini- radiation cancer know and report-
Sessions
pathology implications issue Imaging 09:30 09:30
The future
m-less MR protection ing compe- of radiology: of iterative Informatics
what it could VoE 088 / Stage 3
tences image re-
mean for new Chest 09:30- 09:30-
construction VoE 118 / Stage 4
radiography
graduates in CT Breast 10:00 10:00
VoE 029 / Stage 1

Paediatric 10:00- 10:00-
VoE 059 / Stage 2
Chest 10:30 10:30
VoE 089 / Stage 3
SS 1815 SS 1810 SS 1805a SS 1801a SS 1802a SS 1811a E3 1823 SS 1802b SS 1809 SS 1805b SS 1813 SS 1804 MY 18 SS 1811b Abdominal SS 1803 SS 1808 SS 1816 SS 1801b SS 1807
ascular Musculo- Imaging Abdominal Breast Neuro E3 - Europe- Breast Interven- Artificial Physics in Chest My Thesis Neuro Viscera 10:30- Cardiac Head and Neck Oncologic GI Tract Genitourinary 10:30-
VoE 119 / Stage 4
aging of skeletal Informatics Viscera Radiation Parkinson an Diploma DWI, spec- tional Intelli- Medical Thoracic im- in 3 Minutes Neurora- 11:00 Advanced Imaging Imaging Inflammatory Testicular, renal 11:00
ESR meets Italy
e thoracic Knee and Machine Diffuse dose, quality and related Prep troscopy Radiology gence and Imaging aging: new Cardiovas- diology: mis- cardiac MR for techniques in Improving the bowel disease: and bladder
aorta muscle learning liver disease: assurance, disorders Sessions and other Nonvascular Machine Radiation approaches cular cellaneous evaluation of head and neck prediction of what now? tumours
VoE 030 / Stage 1
imaging in breast fibrosis, and safety Breast advanced musculo- Learning dose optimi- and tech- Head and Neck 11:00- left ventricular radiology head and neck 11:00-
imaging steatosis in breast breast MR skeletal Machine sation in CT niques VoE 060 / Stage 2 structure and malignancies
and inflam- imaging techniques interven- learning: Genitourinary 11:30 function 11:30
mation tions radiomics VoE 090 / Stage 3
analysis Interventional
Radiology 11:30- 11:30-
VoE 120 / Stage 4
Neuro 12:00 12:00
VoE 204 / Stage 1
Physics in 12:00- 12:00-
Medical
Imaging 12:30 12:30
VoE 209 / Stage 2
Cardiac
ESR General E3 25E
Assembly E3 - The VoE 214 / Stage 3
Paediatric
12:30- 12:30-
Beauty of Basic
Knowledge: A
Survival Guide
VoE 219 / Stage 4
Musculoskeletal
13:00 13:00
to Musculoskel-
CB etal Imaging
E3 - Rising
Acute trauma:
patterns in
13:00- 13:00-
Stars the peripheral
13:30 13:30
skeleton
Programme:
Case-Based
Diagnosis 13:30- 13:30-
Training
14:00 14:00
Interlude:
SS 1915 SS 1910a SS 1910b SS 1905a SS 1901a Just a Cyst SS 1911a SS 1902a SS 1902b SS 1909 SS 1903a SS 1905b SS 1913 SS 1904 SS 1907 SS 1903b SS 1901b SS 1911b
ascular Musculo- Musculo- Imaging Abdominal (14:00-14:30) Neuro Breast Breast Interven- Cardiac Artificial Physics in Chest Genitouri- 14:00- Cardiac GI Tract Neuro 14:00-
scular im- skeletal skeletal Informatics Viscera Contrast Contrast-en- Breast can- tional Cardiac MR Intelli- Medical Tradition- nary 14:30 Discovering the Gastro-oesoph- Epilepsy and 14:30
ing after Spine Spine and Machine Diagnosis of media and hanced cer staging, Radiology in cardio- gence and Imaging al and Imaging of right ventricle in ageal imaging: epileptogenic
ent-graft imaging peripheral learning hepato- advances in mammogra- therapy Nonvascular myopathies: Machine Breast imag- advanced the uterus cardiac MR now and next conditions
nd stent nerve in chest cellular neuro MRI phy, breast monitoring interven- tips and Learning ing physics pulmonary 14:30- 14:30-
nsertion imaging radiology carcinoma: CT, and and recur- tions in the tricks Machine vascular
the LI-RADS other new rence lung learning: imaging 15:00 15:00
perspective imaging visceral
techniques organs and 15:00- 15:00-
GI tract
15:30 15:30
POS™ – Scientific Exhibition: 08:00–15:30 Technical Exhibition: EXPO Halls and EXPO Foyer D: 10:00–14:00

TODAY’S HIGHLIGHTS
Sunday, March 3
Room B EM 3 ESR meets Pakistan
10:30–12:00 The role of radiology in major healthcare
challenges faced by Pakistan
Studio 2019 SF 17 Late effects in survivors of childhood cancer

08:30–10:00
Room M 4 MS 17
08:30–10:00
Multidisciplinary approach to the diabetic foot SCIENTIFIC
Room X
08:30–10:00
Joint Session of the ESR and ESMRMB
(European Society for Magnetic Resonance
PROGRAMME
in Medicine and Biology)
A new era of gadolinium-less MR
Room N EU 7 EuroSafe Imaging Session Please note that sessions are marked with a
08:30–10:00 Artificial intelligence and radiation protection their classification according to the Europea
Room M 1 E3 1726a Quantitative imaging in oncology
08:30–10:00

Tech Gate E3 1726b Prostate MRI: the accreditation issue
08:30–10:00
Room A E3 1721 Interactive Teaching Session for Young

08:30–10:00 (and not so Young) Radiologists
Head and neck imaging
ESR/EFRS/ISRRT meets Sessions . . . . . . . . .
Room F1 E3 1723 European Diploma Prep Session
Women in Focus . . . . . . . . . . . . . . . . . . . . . . . . .
08:30–10:00 Musculoskeletal
Image Interpretation Quizzes . . . . . . . . . . . . .
Room A E3 1821 Interactive Teaching Session for Young New Horizons Sessions . . . . . . . . . . . . . . . . . . .
10:30–12:00 (and not so Young) Radiologists
Imaging of the brain
State of the Art Symposia . . . . . . . . . . . . . . . .
Special Focus Sessions . . . . . . . . . . . . . . . . . . .
Room F1 E3 1823 European Diploma Prep Session Professional Challenges Sessions. . . . . . . . . .
10:30–12:00 Breast
Coffee & Talk Sessions . . . . . . . . . . . . . . . . . . .
Room C E3 24E The Beauty of Basic Knowledge: Pancreas Multidisciplinary Sessions . . . . . . . . . . . . . . . . .
12:30–13:30 Pancreatic adenocarcinoma mimickers Pros & Cons Session . . . . . . . . . . . . . . . . . . . . .
Room D E3 25E The Beauty of Basic Knowledge: Musculoskeletal
European Excellence in Education (E3) . . . .
12:30–13:30 Acute trauma: patterns in the peripheral skeleton Rising Stars Programme . . . . . . . . . . . . . . .
European Diploma Prep Sessions. . . . . . .
Room E1 CB Rising Stars Programme:
13:00–15:30 Case-Based Diagnosis Training
The Beauty of Basic Knowledge . . . . . . .
Special programme for residents and general radiologist ECR Academies. . . . . . . . . . . . . . . . . . . . . . .
ECR Master Classes . . . . . . . . . . . . . . . . . . .
Room A E3 1921 Interactive Teaching Session for Young
14:00–15:30 (and not so Young) Radiologists Hands-on Workshops . . . . . . . . . . . . . . . . . . . .
Paediatric brain imaging Transatlantic Course . . . . . . . . . . . . . . . . . . . . .
Joint Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . .
Refresher Courses/Scientific Sessions . . . . .
My Thesis in 3 Minutes . . . . . . . . . . . . . . . . . . .
Clinical Trials in Radiology . . . . . . . . . . . . . . . .
The Voice of EPOS . . . . . . . . . . . . . . . . . . . . . . .
SCIENTIFIC
PROGRAMME
Please note that sessions are marked with a logo to indicate
their classification according to the European Training Curriculum.

ESR/EFRS/ISRRT meets Sessions . . . . . . . . . . . . . . . . . . . . . . . . 73

Women in Focus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
Image Interpretation Quizzes . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
New Horizons Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .81
State of the Art Symposia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
Special Focus Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
Professional Challenges Sessions. . . . . . . . . . . . . . . . . . . . . . . . . .91
Coffee & Talk Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
Multidisciplinary Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
Pros & Cons Session . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
European Excellence in Education (E3) . . . . . . . . . . . . . . . . . . 105
Rising Stars Programme . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
European Diploma Prep Sessions. . . . . . . . . . . . . . . . . . . . . . 113
The Beauty of Basic Knowledge . . . . . . . . . . . . . . . . . . . . . . 115
ECR Academies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
ECR Master Classes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
Hands-on Workshops . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
Transatlantic Course . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
Joint Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
Refresher Courses/Scientific Sessions . . . . . . . . . . . . . . . . . . . 147
My Thesis in 3 Minutes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .175
Clinical Trials in Radiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191
The Voice of EPOS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195
71
COFFEE
& TALK
SESSIONS
Don’t miss this popular informal session format, featuring
short lectures and discussions, taking place in various Stop by and contribute to
stylish lounges: the lively discussions while
sipping your coffee or tea.
Room Coffee & Talk 1 (2nd level, Foyer B, within the
ESOR Lounge)
Room Coffee & Talk 2 (1st level, Foyer N, next to the
EuroSafe Imaging Lounge)
Room Coffee & Talk 3 (entrance level, Foyer E)
TOPICS:
Artificial intelligence Management tips

EuroSafe Imaging Research & research fellowships
Radiation protection Virtual reality
ESR iGuide Undergraduate radiology teaching
Details at
Publication tips Audit ipp.myESR.org
Type of session: C
ESR MEETS SESSIONS
The purpose of ‘ESR meets’ is to forge closer ties between
the ESR and its guest societies. The guest nations and
regions of this year’s ECR are Africa, Pakistan and Italy,
as a tribute to the home of ESR President Lorenzo E. Derchi.
There are dedicated sessions for the radiological communities
of these nations to demonstrate the excellence of radiology
in their countries.
ESR/EFRS/ISRRT
EFRS
MEETS SESSIONS
MEETS SESSIONS
The European Federation of Radiographer Societies (EFRS)
is hosting for the 7th time a dedicated session with one of
their member societies. The ‘EFRS meets Denmark’ session
will deal with machine learning, improvements in healthcare,
technological mediation and MR safety, underlining
the essential role of radiographers in medical imaging.
ISRRT MEETS SESSIONS

For the first time at ECR 2019, there will be a session
hosted by the International Society of Radiographers and
Radiological Technologists (ISRRT), to underline the essential
role of radiographers in medical imaging.
The ‘ISSRT meets Africa’ session will deal with challenges
for radiographers offering imaging services in Africa.
For all sessions places are allocated on a first-come,

first-served basis.
73
Scientific Programme
ESR/EFRS/ISSRT MEETS SESSIONS
28
Feb Thursday, February 28, 10:30–12:00, Room B
1
March Friday, March 1, 10:30–12:00, Room A
ESR meets Africa ESR meets Italy
EM 1 Radiology in Africa: facing challenges EM 2 From morphology to function
and opportunities
Presiding: L.E. Derchi; Genoa/IT
Presiding: L.E. Derchi; Genoa/IT R. Grassi; Naples/IT
H.A. Gharbi; Tunis/TN » Introduction: Radiology in Italy [A-0579]
» Chairpersons’ introduction C. Bibbolino; Rome/IT
L.E. Derchi; Genoa/IT [A-0308] » Italian emergency network [A-0580]
H.A. Gharbi; Tunis/TN [A-0309] V. Miele; Florence/IT
» Structured strategies to combat radiation protection » Interlude: The sirens: myth or reality? [A-0581]
challenges in Africa. What can the ESR do? [A-0310] R. Grassi; Naples/IT
D. Husseiny Salama; Cairo/EG » Emergency interventional radiology: brain and
» Is imaging underused in Africa? East Africa as an body [A-0582]
example. Solutions: what can the ESR do? [A-0311] G. Carrafiello; Varese/IT
S. Vinayak; Nairobi/KE » Interlude: The cyclops: myth or reality? [A-0583]
» Interlude 1: Enjoy the difference between African and R. Grassi; Naples/IT
European music » La Radiologia Medica: the role of the journal
H.A. Gharbi; Tunis/TN in an international setting [A-0584]
» How to promote radiation protection in West Africa. A. Giovagnoni; Ancona/IT
Needs and expected role of the ESR [A-0312] » Panel discussion: How will the radiologists’ profession
E.H. Niang; Dakar Fann/SN evolve?
» Most important challenges for imaging in North
Africa [A-0313]
L. Rezgui Marhoul; Tunis/TN 1
March Friday, March 1, 14:00–15:30, Room C
» Interlude 2: Enjoy the difference between Arabic and
EFRS meets Denmark
European music
H.A. Gharbi; Tunis/TN EM 4 EFRS meets Denmark
» The WHO’s programme in Africa: the past, the present Presiding: J. McNulty; Dublin/IE
and the future [A-0314] H. Precht; Odense/DK
M.D.R. Perez; Geneva/CH
» Session introduction [A-0619]
» Panel discussion: J. McNulty; Dublin/IE
Radiology in Africa, reality and dreams
» Introduction: Across Denmark [A-0620]
G. Frija; Paris/FR [A-0315]
C. Graungaard Falkvard; Frederiksberg/DK
L.E. Derchi; Genoa/IT
H.A. Gharbi; Tunis/TN » Machine learning: a new aspect of
D. Husseiny Salama; Cairo/EG radiography [A-0621]
S. Vinayak; Nairobi/KE L.M. Pehrson; Copenhagen/DK
E.H. Niang; Dakar Fann/SN » Improvements in healthcare [A-0622]
L. Rezgui Marhoul; Tunis/TN P. Blackburn Andersen; Kolding/DK
M.D.R. Perez; Geneva/CH » Technologically mediated patient and radiographer
B. Mansouri; Algiers/DZ experience [A-0623]
K.M. Naidu; Cape Town/ZA S. Holm; Faaborg/DK
» Conclusion » MR safety [A-0624]
L.E. Derchi; Genoa/IT [A-0316] A.D. Blankholm; Aarhus/DK
H.A. Gharbi; Tunis/TN [A-0317]
» Panel discussion
This session is part of the EuroSafe Imaging campaign.

ESR/EFRS/ISSRT MEETS SESSIONS
1
3
March Sunday, March 3, 10:30–12:00, Room B
ISRRT meets Africa ESR meets Pakistan
EM 5 Radiographers’ challenges offering EM 3 The role of radiology
imaging services in Africa in major healthcare challenges
faced by Pakistan
Presiding: D. Newman; Fargo, ND/US
P. Gerson; Paris/FR Presiding: M.H. Akram; Islamabad/PK
» Chairpersons’ introduction L.E. Derchi; Genoa/IT
D. Newman; Fargo, ND/US [A-0651] » Introduction [A-1077]
P. Gerson; Paris/FR [A-0652] M.H. Akram; Islamabad/PK
» Nigeria. Healthcare services in Nigeria: » Imaging of oral cancer [A-1078]
the radiographers’ opportunities and N. Ud Din; Lahore/PK
challenges [A-0653]
» Interlude: Beautiful Pakistan: from sea to sky-high
E. Olasunkanmi Balogun; Lagos/NG
mountains [A-1079]
» South Africa. The South African radiographer: A. Majeed; Islamabad/PK
button pusher or creative thinker? [A-0654]
» Role of radiology in developing a living donor liver
H. Friedrich-Nel; Bloemfontein/ZA
transplant programme [A-1080]
» Côte d’Ivoire. Professional practice of radiology A.I. Rana; Islamabad/PK
and imaging in Africa: radiographers for more
» Interlude: Philanthropic cyber-knife facility in
commitment and responsibility in patients’
Pakistan [A-1081]
safety [A-0655]
T. Mahmood; Karachi/PK
K.B. Yao; Abidjan/CI
» Many faces of tuberculosis [A-1082]
» Kenya. Discovering Kenyan radiographers:
U. Siddique; Peshawar/PK
past, present and future [A-0656]
C. Muchuki; Nairobi/KE » Panel discussion: Why are oral cancer, chronic
hepatitis and tuberculosis more common in Pakistan,
» Panel discussion
and in which scenarios is the role of radiology crucial
This session is part of the EuroSafe Imaging campaign. in the management of these diseases?

The new European Training Assessment Programme (ETAP) 2.0
BE CERTIFIED, BE THE BEST

zÌº"ziȬɒȪÏĈºĄđÏĺđºóÄºĨºááºêº
ÄóĄĄ³ÏóáóÆĩđĄÏêÏêÆ³ºĀĄđèºêđĈÏê
"ėĄóĀºê³«ºĩóê³ɒ
zÌººĄđÏĺđÏóêĀĄóºĈĈÏĈĀºĄÄóĄèº³ĢÏĄđėááĩ
đÌĄóėÆÌđÌº"ziȬɒȪĀáđÄóĄèɌģÌÏÌºê«áºĈ
êºĈĩɌó«ÛºđÏĢºê³ăėÏÞĈĈºĈĈèºêđɒ
zÌº"ziȬɒȪÏĈÛóÏêđÏêÏđÏđÏĢº«ĩđÌº
"ėĄóĀºêóĄ³óÄm³ÏóáóÆĩɠ"mɡê³
đÌº"Qqm³ÏóáóÆĩĈºđÏóêɒ
REASONS TO APPLY:
"ziĀĄóĢÏ³ºĈĩóėĄđĄÏêÏêÆ³ºĀĄđèºêđģÏđÌêó«ÛºđÏĢºĈĈºĈĈèºêđ
"ziĄº³ÏđĈđÌđĩóėĄđĄÏêÏêÆĀĄóÆĄèèºÏĈáÏêºģÏđÌđÌº"qm"ėĄóĀºêzĄÏêÏêÆėĄĄÏėáėè
"ziĈĈºĈĈèºêđĄºĈėáđĈê³ĺêáĄºĀóĄđê«ºėĈºÄėáđóóáÏêóĄ³ºĄđóĈºđĄºÄºĄºêº«ºÄóĄºĩóėĄ
èº³ÏáėđÌóĄÏđÏºĈđóÌÏºĢºđÌºĈđê³Ą³ĈÏêĄ³ÏóáóÆĩº³ėđÏóêÏê"ėĄóĀº
"zi³³Ĉ"ėĄóĀºêê³ÏêđºĄêđÏóêáĄºóÆêÏđÏóêđóĩóėĄđĄÏêÏêÆ³ºĀĄđèºêđ
"ziĈºĄĢºĈĈêÏê³ÏđóĄê³«ºêÌèĄÞóÄĩóėĄđĄÏêÏêÆ³ºĀĄđèºêđèóêÆĄºĈÏ³ºêđĈ
"ziááóģĈđóèÞºêºăėÏĀèºêđê³ĄºĈĈóėĄºĈÏêĢºêđóĄĩɌÄóĄđÌºĄºÄėáóêđĄóáóê
đÌºĄºĈĈóėĄºĈóÄđÌºđĄÏêÏêÆ³ºĀĄđèºêđê³ÄóĄÄėđėĄºė³ÏđĈ
etap@myebr.org
WOMEN
IN FOCUS
In Memoriam of Professor Alexander R. Margulis
New to ECR 2019, Women in Focus will provide a platform

for a diverse range of speakers to share their inspiring
experiences, offer constructive advice and debate
the often-difficult issues surrounding gender and healthcare.
Tackling issues such as female leadership, mentoring,

the generational progression of women in medicine,
and work in challenging environments, the series of sessions
will explore and celebrate the crucial role that women play
in healthcare on a daily basis, whilst offering advice and
insights to all attendees.
With an interactive session style, including live audience

polling and extended panel discussions, Women in Focus
promises to be one of our most exciting events taking place
at the congress this year.
77
WOMEN IN FOCUS
28
Feb Thursday, February 28, 12:30–14:00, The Church
1
March Friday, March 1, 14:00–15:15, The Church
Women in Focus - The Bigger Picture Women in Focus - The Bigger Picture
WF 1 Leading by example WF 3 Women in challenging environments
» Chairperson’s introduction [A-0352] » Chairperson’s introduction [A-0638]

H. Hricak; New York, NY/US R.G.H. Beets-Tan; Amsterdam/NL
» Getting to the top and how to thrive: » It’s the little things that matter [A-0639]
lessons learned [A-0353] L. O’Riordan; Ipswich/UK
C. Palmer; London/UK » Safe spaces for women in challenging environments:
» Dare with Care [A-0354] the example of Women Health Counselling Centres
C. Estrampes; Paris/FR for refugee women and girls [A-0640]
» Insights on Women in Radiology by the ESR Ş. Bahar Özvariş; Ankara/TR
President [A-1103] » Panel discussion: Diversity in healthcare
L.E. Derchi; Genoa/IT delivery [A-0641]
» Panel discussion: Stories to tell and wisdom Ş. Bahar Özvariş; Ankara/TR
to share [A-0355] E. Olasunkanmi Balogun; Lagos/NG
D. Akata; Ankara/TR R.G.H. Beets-Tan; Amsterdam/NL
C. Estrampes; Paris/FR D. Husseiny Salama; Cairo/EG
M.H. Fuchsjäger; Graz/AT S.F. Khan; Islambad/PK
H. Hricak; New York, NY/US L. O’Riordan; Ipswich/UK
L. Leong; Hong Kong/CN
C. Palmer; London/UK 1
March Friday, March 1, 16:00–17:25, The Church
28
Women in Focus - The Bigger Picture
WF 4 Leadership and mentorship
WF 2 Changing the image of women in » Chairperson’s introduction [A-0727]
leadership: generational differences J.E. Husband; London/UK
and similarities » Is mentoring gender-specific? [A-0728]

G.P. Krestin; Rotterdam/NL
» Chairperson’s introduction [A-0386] » The many facets of mentoring - how to find the right
R.A. Kubik-Huch; Baden/CH match? [A-0729]
M. Abdel-Wahab; Vienna/AT
» Women in medicine: past, present and
future [A-0387] » Panel discussion: Reminiscence:
V. Vilgrain; Clichy/FR remembering to pass forward [A-0730]
» Women leaders through the lens of time [A-0388]
C. Beardmore; Guildford/UK
C.P. Hess; San Francisco, CA/US
J.E. Husband; London/UK
» Panel discussion: How far have we come? [A-0389] V.P. Jackson; Tucson, AZ/US
U.I. Attenberger; Mannheim/DE G.P. Krestin; Rotterdam/NL
C.P. Hess; San Francisco, CA/US G. McGinty; New York, NY/US
R.A. Kubik-Huch; Baden/CH
» Closing remarks [A-0731]
E.A. Morris; New York, NY/US
H. Hricak; New York, NY/US
M.F. Reiser; Munich/DE
V. Vilgrain; Clichy/FR
= Interactive session with electronic voting/self assessment

IMAGE INTERPRETATION
QUIZZES
The Image Interpretation Quiz (IIQ) and the Junior Image
Interpretation Quiz (JIIQ) are two traditional highlights of
ECR and provide both education and entertainment. During
these interactive sessions, distinguished panels of radiologists
will share their knowledge and diagnosis strategies with you.
The theme of the IIQ is “Greek gods: Mount Olympus vs

The Underworld” a competition between two teams of
panellists and the audience lead by our moderator Zeus!
The JIIQ will present “A day in the (future) life of a young

radiologist” introducing an interesting feature on Artificial
Intelligence, live on the stage, you need to be there to believe it!
79
IMAGE INTERPRETATION QUIZZES
1
2
March Saturday, March 2, 12:55–13:55, Room A
IIQ Image Interpretation Quiz JIIQ Junior Image Interpretation Quiz
Greek gods: Mount Olympus vs A day in the (future) life
The Underworld of a young radiologist
Moderator: A.H. Karantanas; Iraklion/GR Moderator: B. Bignotti; Genoa/IT

Panellists: Panellists:
Mount Olympus: A. Bello Báez; Candelaria/ES
F.M.H.M. Vanhoenacker; Antwerp/BE K.N. De Paepe; London/UK
S. Gourtsoyianni; Athens/GR R.A.P. Dijkhoff; Amsterdam/NL
S.G.F. Robben; Maastricht/NL R. Lotte; Paris/FR
M. Politi; Bremen/DE M. Reim; Tartu/EE
Z. Snoj; Ljubljana/SI
Underworld:
A.N. Fotiadou; London/UK
R.J. Méndez; Madrid/ES
S. Franchi-Abella; Le Kremlin-Bicêtre/FR
M.A. Lucic; Sremska Kamenica/RS
Judges:
J. Kramer; Linz/AT
M. Maas; Amsterdam/NL

NEW HORIZONS
SESSIONS
The New Horizons Sessions aim to provide practitioners
with an overview of the new developments in a specific
area of practice, whether it is a subspecialty, a particular
technique, or certain diseases. These developments may
become routine within a few years or may indicate a new
direction for research and clinical application.
81
NEW HORIZONS SESSIONS
27
Feb Wednesday, February 27, 08:30–10:00, Room F2
2
March Saturday, March 2, 16:00–17:30, Room F2
NH 1 The role of imaging in the era NH 16 The tumour board of the future
of liquid biopsy
» Chairperson’s introduction [A-0955]
» Chairperson’s introduction [A-0034] M. Prokop; Nijmegen/NL
D. Regge; Turin/IT » How to set up and run a multidisciplinary
» Liquid biopsy in perspective: colorectal cancer as meeting [A-0956]
a model system [A-0035] C. Dromain; Lausanne/CH
A. Bardelli; Turin/IT » Preparation for tumour boards: how to increase
» New imaging tools for cancer detection and efficiency of the radiologist? [A-0957]
characterisation [A-0036] D. Regge; Turin/IT
H.-P. Schlemmer; Heidelberg/DE » Physical or virtual multidisciplinary
» Is there still a role for imaging surveillance? meetings? [A-0958]
And when? [A-0037] E. Neri; Pisa/IT
V.J. Goh; London/UK » Maximising the added value of tumour
» Combining molecular and imaging metrics in cancer boards [A-0959]
(radiogenomics) [A-0038] C.D. Becker; Geneva/CH
K. Pinker-Domenig; Vienna/AT » Panel discussion: How to strengthen the role of
» Panel discussion: Will liquid biopsy be a game the radiologist in multidisciplinary tumour boards
changer for radiologists? while keeping workload under control
27
Feb Wednesday, February 27, 14:00–15:30, Room K
NH 3 Artificial intelligence (AI):
driven by radiologists

E. Kotter; Freiburg/DE
» The impact of AI technologies in patient care:
advantages and limitations [A-0126]
E.L. Siegel; Baltimore, MD/US
» How to integrate AI technology in radiology
today [A-0127]
W.J. Niessen; Rotterdam/NL
» How will the introduction of AI change the role
of the radiologist? [A-0128]
H. Harvey; London/UK
» Panel discussion: The radiologist’s work after
integrating AI

STATE OF THE ART
SYMPOSIA
These sessions will inform the audience about the state of
the art of the most recent developments in subjects such as
anatomical regions, specific diseases or particular techniques.
83
STATE OF THE ART SYMPOSIA
28
Feb Thursday, February 28, 08:30–10:00, Room E2
2
SA 5 How to face the tsunami of pancreatic SA 13 Cardiac: recalling the forgotten
intraductal papillary mucinous structures
neoplasia (IPMN)
» Chairperson’s introduction [A-0236] C. Peebles; Southampton/UK
M. Zins; Paris/FR » Hide and seek: the pericardium [A-0773]
» IPMN: when to watch and when to resect [A-0237] A. Nchimi Longang; Luxemburg/LU
W. Schima; Vienna/AT » Lost chamber: the right ventricle [A-0774]
» Diagnosis of IPMN: the mimickers and how to sort G. Bastarrika; Pamplona/ES
them out [A-0238] » Friend or enemy: epicardial fat [A-0775]
M.-P. Vullierme; Clichy/FR K. Gruszczynska; Katowice/PL
» Follow-up of IPMN: how many MRs do we » Wrong ways: anomalies of cardiac veins and
need? [A-0239] venae cavae [A-0776]
R. Pozzi-Mucelli; Stockholm/SE M. Hrabak Paar; Zagreb/HR
» Panel discussion: Management of IPMN: what is the » Panel discussion: Which test would you use, MRI or CT?
Achilles heel of our current concept? [A-0240]
M. Zins; Paris/FR
2
March Saturday, March 2, 16:00–17:30, Studio 2019
SA 16 Breast cancer screening and treatment:
how much is too much?

G. Forrai; Budapest/HU
» Overdiagnosis in breast cancer screening:
the epidemiologist’s view [A-0942]
S.W. Duffy; London/UK
» What can the radiologist do to limit
overdiagnosis? [A-0943]
R.M. Pijnappel; Utrecht/NL
» Are there breast cancers we do not have to
treat? [A-0944]
M.G. Wallis; Cambridge/UK
» Panel discussion: Which one is the real villain,
overdiagnosis or overtreatment? For what reason
breast screening and diagnostics is blamed?

SPECIAL FOCUS
SESSIONS
The Special Focus sessions deal with topics at the cutting
edge of development and clinical application. The aim of
these sessions is to present the forthright personal views
of the lecturers’ on the topic in a way that gives an in-depth
analysis and promotes debate.
85
SPECIAL FOCUS SESSIONS
27
Feb Wednesday, February 27, 08:30–10:00, Room E2
28
Feb Thursday, February 28, 08:30–10:00, Room Y
SF 1 Screening with imaging: SF 5a 7 Tesla MR goes clinical
a new era?
» Chairperson’s introduction [A-0027] S. Trattnig; Vienna/AT
A. Devaraj; London/UK » Why is there a benefit to higher static magnetic field
» Screening of lung cancer with low dose in MR? [A-0250]
CT [A-0028] P. Jezzard; Oxford/UK
M. Prokop; Nijmegen/NL » Neuroimaging at 7 T: where does it make
» Screening of colorectal cancer with CT the difference? [A-0251]
colonography [A-0029] J. Hendrikse; Utrecht/NL
A. Laghi; Latina/IT » MSK imaging at 7 T: what are the additional clinical
» Screening of breast cancer with abbreviated benefits [A-0252]
MRI [A-0030] S. Trattnig; Vienna/AT
C.K. Kuhl; Aachen/DE » Cardiovascular and abdomen MR at 7 T -
» Panel discussion: Optimising screening and taking it still a challenge? [A-0253]
to the next level J. Schulz-Menger; Berlin/DE
» Panel discussion: Will 7 Tesla become clinical routine?
27 28
Feb Thursday, February 28, 08:30–10:00, Room F2
SF 5b Basic interventional radiology
SF 4 My three top tips in neuroimaging
for non-interventionalists:
(not only for neuroradiologists)
let’s start with biopsy!
M. Stajgis; Poznan/PL » Chairperson’s introduction [A-0244]
J.I. Bilbao; Pamplona/ES
» MRI T2 brain white lesions [A-0153]
A. Krainik; Grenoble/FR » How to decide indications and pre-treatment
evaluation [A-0245]
» Multiple sclerosis [A-0154]
P. Popovic; Ljubljana/SI
K. Katulska; Poznan/PL
» How to guide your procedure [A-0246]
» Acute disseminated encephalomyelitis
L. Crocetti; Pisa/IT
(ADEM) [A-0155]
A. Rovira-Cañellas; Barcelona/ES » How to do your procedure [A-0247]
P. Vilares Morgado; Porto/PT
» Encephalitis [A-0156]
H.R. Jäger; London/UK » How to follow-up on your patients [A-0248]
M. Seidensticker; Munich/DE
» Meningitis [A-0157]
M.M. Thurnher; Vienna/AT » Panel discussion: Deciding to biopsy within
a multidisciplinary board
» Transient ischemic attack [A-0158]
J. Hodel; Créteil/FR
» Venous sinus thrombosis [A-0159]
P. Vilela; Almada/PT
» Hydrocephalus [A-0160]
A. Ramos; Madrid/ES
» Microbleeds [A-0161]
L. van den Hauwe; Antwerp/BE
» Panel discussion: ‘You can ask me for additional tips’
- questions from the audience, answers from experts

28
Feb Thursday, February 28, 08:30–10:00, Room M 1
28
SF 5c MSK intervention: the road from low SF 8a Artificial intelligence (AI):
to no invasion our future cannot be predicted,
but we have to be prepared
J. Hodler; Zurich/CH » Chairperson’s introduction [A-0392]
» Avoiding side effects and complications by using G. Langs; Vienna/AT
MR guided high-intensity focused » Basics of machine learning and deep
ultrasound [A-0272] learning [A-0393]
A. Napoli; Rome/IT B. Van Ginneken; Nijmegen/NL
» The 10 most important side effects and complications » AI for lesion detection and characterisation [A-0394]
in MSK interventions [A-0273] B. Stieltjes; Basle/CH
M. Obradov; Nijmegen/NL
» Machine learning in medical imaging going
» Radiation exposure: from reduction to forward [A-0395]
avoidance [A-0274] P. Golland; Cambridge, MA/US
D.J. Wilson; Oxford/UK
» Which impact does AI have on medicine? [A-0396]
» Preventing side effects and complications S.O. Schönberg; Mannheim/DE
by new procedures: management by
» Panel discussion: What is the future role of
radiologists [A-0275]
a radiologist in the diagnostic process?
A. Bazzocchi; Bologna/IT
» Panel discussion: How minimal can invasiveness
in MSK intervention become? 28
Feb Thursday, February 28, 16:00–17:30, Room K
SF 8b Challenging HRCT patterns:
28
Feb Thursday, February 28, 08:30–10:00, tips and tricks from the experts
Tech Gate Auditorium
SF 5d Imaging and management of J. Babar; Cambridge/UK
the incidental scrotal lesions » The mosaic attenuation pattern [A-0452]
M.-P. Revel; Paris/FR
» Inter-and intralobular septal thickening [A-0453]
M. Bertolotto; Trieste/IT
N. Sverzellati; Parma/IT
» Incidental testicular lesions: can we characterise
» Approach to nodular pattern [A-0454]
them at multiparametric US? [A-0293]
O. Hamer; Regensburg/DE
P.S. Sidhu; London/UK
» Perilobular consolidation [A-0455]
» Incidental extra-testicular lesions:
T. Frauenfelder; Zurich/CH
can we characterise them? [A-0294]
M. Secil; Izmir/TR » Mixed ground-glass opacification and
reticulation [A-0456]
» Incidental testicular lesions: the role of MRI and ESUR
S.J. Copley; London/UK
recommendations [A-0295]
L. Rocher; Le Kremlin-Bicêtre/FR » Questions and panel discussion: The reality of
daily practice - what do experts struggle with on
» Testicular-sparing surgery: a teamwork of radiologist
interpretation of HRCT?
and urologist [A-0296]
N. Pavan; Trieste/IT
» Panel discussion: Multiparametric imaging of the
testis - how and when can we avoid orchidectomy?

28
Feb Thursday, February 28, 16:00–17:30, Room O
28
SF 8c The art to transmit and to receive: SF 8e Breast imaging in pre-menopausal
how to communicate critical women
information to our patients
» Chairpersons’ introduction [A-0414] I. Thomassin-Naggara; Paris/FR
M.H. Fuchsjäger; Graz/AT » Physiological changes and benign breast diseases
» Chairpersons’ introduction (Part 2) [A-0415] in young women [A-0425]
C. Loewe; Vienna/AT F. Kilburn-Toppin; Cambridge/UK
» How patients feel about communication [A-0416] » Breast cancer screening in pre-menopausal
C. Justich; Vienna/AT women [A-0426]
P. Clauser; Vienna/AT
» Fundamentals of physician/patient
communication [A-0417] » Pregnancy-associated breast cancer
L. Fallowfield; Brighton/UK (PABC) [A-0427]
C. Van Ongeval; Leuven/BE
» How can we improve communication with our
patients? [A-0418] » Panel discussion: At what age should we start
F.J. Gilbert; Cambridge/UK to screen women for breast cancer?
» Panel discussion: How to convey that we care
28
Feb Thursday, February 28, 16:00–17:30, Room G
28
Feb Thursday, February 28, 16:00–17:30, Studio 2019 SF 8f The 3D printing lab from bench
SF 8d Non-contrast MR angiography: to bedside
ready to go?
F. Kainberger; Vienna/AT
R. Iezzi; Rome/IT » Creating a 3D printing lab in radiology [A-0447]
F. Moscato; Vienna/AT
» Non-contrast MR angiography techniques [A-0420]
T. Leiner; Utrecht/NL » Cardiovascular applications of 3D printing [A-0448]
M. Tam; Southend/UK
» Non-contrast MR angiography for large
vessels [A-0421] » Supporting the surgeon with 3D printing [A-0449]
T. Hazirolan; Ankara/TR P. Brantner; Basle/CH
» Peripheral non-contrast MR angiography [A-0422] » Challenges of centralised 3D printing [A-0450]
G. Roditi; Glasgow/UK K.A. Eley; Cambridge/UK
» Non-contrast MR angiography in paediatric vascular » Panel discussion: What are real advantages
imaging [A-0423] of 3D printing?
M.I. Argyropoulou; Ioannina/GR
» Panel discussion: Do we really need gadolinium-
enhanced sequences?

1
March Friday, March 1, 08:30–10:00, Studio 2019
1
March Friday, March 1, 16:00–17:30, Room G
SF 9a Pain palliation in cancer SF 12 IT-security and GDPR
patients
Moderators: O. Ratib; Geneva/CH
A. Gangi; Strasbourg/FR » Chairperson’s introduction [A-0695]
» Pain from bone metastases [A-0512]
G. Tsoumakidou; Strasbourg/FR » Understanding the key points of GDPR [A-0696]
C.D. Becker; Geneva/CH
» Abdominal pain management with minimally invasive
techniques [A-0513] » Issues related to patient consent to allow access
D.C. Madoff; New York, NY/US to the data [A-0697]
O. Ratib; Geneva/CH
» Pelvic pain management with minimally invasive
techniques [A-0514] » Security aspects when using mobile devices and/or
B. Kastler; Paris/FR social media [A-0698]
E.R: Ranschaert; Tilburg/NL
» Panel discussion: How to integrate the interventional
radiologist in the “palliative care” team » Panel discussion: Data protection: benefit or burden?
1 2 Saturday, March 2, 08:30–10:00, Room B

March Friday, March 1, 08:30–10:00, Room C March
SF 9b Clinical simulation and its role SF 13a Radiology and pathology: will we ever
in radiography education be (digitally) married?
» Chairpersons’ introduction » Chairperson’s introduction [A-0734]

L. Oleaga Zufiría; Barcelona/ES [A-0489] L. Donoso; Barcelona/ES
F. Zarb; Msida/MT [A-0490] » Are digital pathology and AI the definitive factors
» Clinical radiography education across Europe: for the merging? [A-0735]
an overview [A-0491] P.J. van Diest; Utrecht/NL
J. McNulty; Dublin/IE » How would the integration work?
» Innovation in education: virtual education/computer- P.J. van Diest; Utrecht/NL [A-0736]
based simulator vs patient imaging [A-0492] » What difference would there be for patients?
A. England; Salford/UK R. Palmqvist; Umea/SE [A-0738]
» High fidelity: clinical simulation for undergraduate K. Riklund; Umea/SE [A-0739]
radiography [A-0493] » Panel discussion: What benefits are there to merge
A. Louw; Johannesburg/ZA the two specialties?
» How simulation can help prepare students and
have a positive impact on interprofessional
working [A-0494]
2
A. Henner; Oulu/FI
SF 13b Cutting edge imaging and
» Providing opportunities for practical ultrasound
minimally invasive interventions
training [A-0495]
B. Kraus; Vienna/AT
of the spine
» Panel discussion: Is simulation enough to meet
the current challenges facing radiography education?
J. Van Goethem; Antwerp/BE
Can simulation replace hands-on patient experience?
» Imaging strategies in spine and spinal cord
trauma [A-0756]
P.C. Maly Sundgren; Lund/SE
» Advanced imaging of spinal cord lesions:
do we need DWI, perfusion and
spectroscopy? [A-0757]
M.M. Thurnher; Vienna/AT
» Spinal CSF leaks: the precise “roadmap” for
clinicians [A-0758]
J.S. Ross; Phoenix, AZ/US
» Cutting edge minimally invasive spine
interventions [A-0759]
L. Manfrè; Catania/IT
» Panel discussion: How can we make spinal imaging
better?

2
2
March Saturday, March 2, 14:00–15:30, Room E2
SF 15a Everything you always wanted SF 15c Abdominal emergencies: advanced
to know about metabolic bone disease imaging in daily routine?
(but were afraid to ask)
» Chairperson’s introduction [A-0880] M. Scaglione; Caserta/IT
A. Bazzocchi; Bologna/IT » Routine CT vs dual energy CT in acute
» Could “that” be metabolic? [A-0881] abdominal pain: should we change
M.P. Aparisi Gomez; Valencia/ES our scan protocol? [A-0892]
E. Danse; Brussels/BE
» Unrevealed fractures: from missed diagnosis
to opportunistic screening [A-0882] » CT scan vs MRI in acute abdominal pain:
C.R. Krestan; Vienna/AT who do we have to send to the magnet? [A-0893]
I. Millet; Montpellier/FR
» DXA: a much more powerful imaging tool than you
thought [A-0883] » CEUS in abdominal inflammatory and infectious
C. Messina; Milan/IT conditions (“-itis” and abscesses) [A-0894]
T. Fontanilla; Madrid/ES
» The bone naked: texture analysis [A-0884]
C.M. Phan; Paris/FR » Panel discussion: New techniques in emergency
radiology: where are we now and where are we going?
» Panel discussion: “What lies ahead...?”
The future of diagnosis of metabolic bone disease This session is part of the EuroSafe Imaging campaign.
in clinical practice
2
2
March Saturday, March 2, 14:00–15:30, Room E1 SF 15d Navigating tumour phenotype with
SF 15b Imaging in Meniere’s disease: what to advanced imaging analysis
believe and how to interpret
E. Sala; Cambridge/UK
J.W. Casselman; Bruges/BE » Understanding tumour micro environment:
the role of habitat imaging [A-0900]
» Meniere’s disease: the clinician’s
J. O’Connor; Manchester/UK
perspective [A-0886]
A. Zarowski; Antwerp/BE » Unravelling tumour heterogeneity using
radiomics [A-0901]
» MR hydrops imaging: how to do it? [A-0887]
L.S. Fournier; Paris/FR
A. Attye; Grenoble/FR
» Role of machine learning (ML) and artificial
» MR hydrops imaging: how to interpret it? [A-0888]
intelligence (AI) for quantitative radiomics [A-0902]
B. De Foer; Antwerp/BE
W.J. Niessen; Rotterdam/NL
» MR hydrops imaging: what are the benefits
» Panel discussion: Can advanced imaging analysis and
for the surgeon and the patient? [A-0889]
imaging integration with omics add significant value
A. Zarowski; Antwerp/BE
to standard clinical and genomic data?
» Panel discussion: Did you pick up the
essentials? [A-0890] 3 Sunday, March 3, 08:30–10:00, Studio 2019
J.W. Casselman; Bruges/BE March
SF 17 Late effects in survivors

of childhood cancer

C. Owens; London/UK
» Cardiothoracic complications [A-1022]
A. Secinaro; Rome/IT
» MSK [A-1023]
I.-M. Noebauer-Huhmann; Vienna/AT
» Neuro [A-1024]
R. Gunny; London/UK
» Fertility issues: male and female
L. Rocher; Le Kremlin-Bicêtre/FR [A-1025]
C. Berger; Saint-Etienne/FR [A-1026]
» Panel discussion: How may paediatric radiologists
recognise, monitor and help to minimise the late
effects in survivors of childhood cancer?

PROFESSIONAL
CHALLENGES
SESSIONS
Aiming to communicate and exchange information on topics
of professional value to radiology such as training, education,
research, networking, management and other professional
developments, the Professional Challenges sessions provide
the perfect platform for discussion.
91
PROFESSIONAL CHALLENGES SESSIONS
28
Feb Thursday, February 28, 08:30–10:00, Studio 2019
2
March Saturday, March 2, 08:30–10:00, Room C
PC 5 Radiology and migrations PC 13 Working in radiology:
burnout and bore-out or
» Chairperson’s introduction [A-0227] engaged and passionate?
O. Akhan; Ankara/TR
» Impact of migration on health: WHO » Chairperson’s introduction
perspective [A-0228] M.G.M. Hunink; Rotterdam/NL [A-0740]
S. Severoni; Copenhagen/DK E. Metsala; Helsinki/FI [A-0741]
» Importance of migration for neglected tropical » A personal story [A-0742]
diseases: WHO perspective [A-0229] M.F. Berger; Nottwil/CH
B. Abela-Ridder; Geneva/CH
» The role of technology in the job satisfaction and
» Clinical importance of the diseases related well-being of radiology workers [A-0743]
to migration [A-0230] S. Aarts; Maastricht/NL
T. Junghanss; Heidelberg/DE
» Dealing with daily battles: factors that lead to chronic
» Radiology of the diseases related to stress and burnout [A-0744]
migration [A-0231] A. Montgomery; Thessaloniki/GR
T. Weber; Heidelberg/DE
» From chronic stress and burnout to work engagement,
» Panel discussion: How do we raise awareness among meaningful work and employee well-being [A-0745]
health professionals to recognise diseases related J. Hakanen; Helsinki/FI
to migration? How can we adapt migration and
» Panel discussion: Achieving well-being among
migration related diseases into our education?
radiology staff
2
March Saturday, March 2, 16:00–17:30, Room M 2
PC 16 How to organise nationwide ischaemic
stroke care (and make multidisciplinary
teams work)
» Chairperson’s introduction: Stroke care in Austria:

small country, small challenge? [A-0977]
C. Loewe; Vienna/AT
» What you should know being involved
in a nationwide ischaemic stroke service [A-0978]
P. Papanagiotou; Bremen/DE
» Do you like to travel? Move the patient or the
doctor? [A-0979]
J.-P. Pruvo; Lille/FR
» Are you experienced, trained or certified?
Certification, subspecialisation, specialisation:
friend or foe of the patient? [A-0980]
A. Berlis; Augsburg/DE
» Do you need help? Train the cardiologist,
neurosurgeon, interventional radiologist [A-0981]
T.J. Popiela; Krakow/PL
» Panel discussion: The output (outcome) counts,
not the input (specialisation)

COFFEE & TALK
(OPEN FORUM)
SESSIONS
The Coffee & Talk sessions have the goal of promoting
active discussion on important topics. Three lounges will
offer a variety of topics and the perfect setting for
an informal discussion with the experts while enjoying
a cup of coffee or tea.
93
COFFEE & TALK SESSIONS
27
Feb Wednesday, February 27, 09:00–10:00, Coffee & Talk 2
27
C1 Clinical audit across Europe: C2 Should we really F.E.A.R. artificial
how to increase uptake and support intelligence?
BSS transposition
» Chairperson’s introduction [A-0078] G.P. Krestin; Rotterdam/NL
D.C. Howlett; Eastbourne/UK » AI and radiology workforce [A-0103]
» Clinical audit: what, why, how? [A-0079] A.G. Rockall; London/UK
A. Brady; Cork/IE » Ethical and legal implications of AI [A-0104]
» Clinical audit: regulation [A-0080] N. Forgó; Vienna/AT
S. Ebdon-Jackson; Didcot/UK » Challenges of AI implementation in
» Case example 1: clinical audit template [A-0081] radiology [A-0105]
H.H. Hjemly; Oslo/NO J.A. Brink; Boston, MA/US
» Case example 2: a template for regulatory audit, » Open forum discussion
a subset of clinical audit [A-0082]
S. Ebdon-Jackson; Didcot/UK
27
» Open forum discussion

C 24 The scholar and fellow’s
experience
27
Moderator: B. Brkljačić; Zagreb/HR
» Visiting scholar in Europe [A-0113]
C 23 Meet the professor C. Olchowy; Wroclaw/PL
Moderator: V. Vilgrain; Clichy/FR » Visiting scholar in the USA [A-0114]

M.E. Laino; Rome/IT
» What is ESOR? [A-0083]
V. Vilgrain; Clichy/FR » Exchange fellowship in Europe [A-0115]
L. Ebner; Berne/CH
» How to succeed in academic career? [A-0084]
M. Ronot; Clichy/FR » Nicholas Gourtsoyannis teaching fellowship [A-0116]
I. Blazic; Belgrade/RS
» How can we maintain the link between your
professional career and ESOR? [A-0085] » Open forum discussion
V. Vilgrain; Clichy/FR This session is organised by the European School
» Open forum discussion of Radiology.
This session is organised by the European School

of Radiology. 27
C4 Radiation protection in paediatric
27 Wednesday, February 27, 12:30–13:30, Coffee & Talk 2
Feb patients - same principles, different
C3 Bonn Call for Action Implementation approach: use cases
Toolkit: free access to a wealth
» Chairpersons’ introduction
of resources
D.P. Frush; Durham, NC/US [A-0117]
C. Granata; Genoa/IT [A-0118]
O. Holmberg; Vienna/AT » Children are not small adults: tips for paediatric
radiation protection in plain films and CT [A-0119]
» The Toolkit from a technical
E. Sorantin; Graz/AT
viewpoint [A-0099]
L. Dojcanova; Vienna/AT » Fundamentals of diagnostic reference levels
in children [A-0120]
» The Toolkit from an international organisation’s
R. Seuri; Helsinki/FI
viewpoint [A-0100]
M.D.R. Perez; Geneva/CH » Optimisation of positioning of the paediatric
patient [A-0121]
» The Toolkit from a radiation protection campaign’s
J. Grehan; Dublin/IE
viewpoint [A-0101]
G. Frija; Paris/FR » Open forum discussion
» Open forum discussion: How will the end-user and This session is part of the EuroSafe Imaging campaign.
patient benefit from the Toolkit? What can be done
better?

27
28
Feb Thursday, February 28, 10:00–11:00, Coffee & Talk 2
C5 #ECR2019: C7 EIBIR: EU-funded research in imaging
Social media in radiology and how you can get funding

L.M. Sconfienza; Milan/IT G.P. Krestin; Rotterdam/NL
» Personal blogs and websites in radiology [A-0174] » What does EIBIR do and how can it help you obtain
C. Clarke; Nottingham/UK research funding? [A-0302]
» Do radiologists use social media? [A-0175] P. Zolda; Vienna/AT
E.R. Ranschaert; Tilburg/NL » Case study of EIBIR success: the SOLUS
» Students and trainees’ perspective [A-0176] Project [A-0303]
C. Messina; Milan/IT A. Pifferi; Milan/IT
» Can social media help to involve patients? [A-0177] » Horizon Europe and future funding
L. Robinson; Gatley/UK opportunities [A-0304]
P. Gordebeke; Vienna/AT
» EIBIR Strategic Research Agenda [A-0305]
28
Feb Thursday, February 28, 09:30–10:30, Coffee & Talk 1 » Open forum discussion
C 25 A heart’s matter: cardiac mentoring,

tutoring and learning within the ESOR 28
community
C6 Modern trends in undergraduate
Moderator: C. Loewe; Vienna/AT teaching of radiology:
» Deliver, enhance, enjoy: the idea and the how to explain to students
satisfaction of acting as a tutor/mentor, how interesting radiology is
to host fellows and to follow their career [A-0297]
C. Loewe; Vienna/AT » Chairperson’s introduction [A-0254]
» Receive, improve, create: my professional V. Válek; Brno/CZ
development from former cardiac fellow to » What students expect [A-0255]
designated congress president of the ESCR [A-0298] H.-P. Erasmus; Rome/IT
M. Hrabak Paar; Zagreb/HR
» The flipped classroom/flipped learning approach
» Work, teach, entertain: the story of the tutors behind in radiology training [A-0256]
the official tutor [A-0299] C. Nyhsen; Strasbourg/FR
D. Beitzke; Vienna/AT
» Appropriate use of imaging studies: what students
» Receive, enjoy, deliver: how I enjoyed my fellowship, have to learn [A-0257]
created professional relationships and friendships F. Kainberger; Vienna/AT
and became tutor by myself [A-0300]
» Simulation-based teaching in interventional
M. Petrini; Piacenza/IT
radiology [A-0258]
» Open forum discussion: A heart’s matter: R. Iezzi; Rome/IT
does mentoring matter?
» How to encourage undergraduates to become
This session is organised by the European School radiologists [A-0259]
of Radiology. T. Andrasina; Brno/CZ
» Panel discussion: How new education concepts and
IT tools can contribute to undergraduate teaching
of radiology
» Chairperson’s conclusion [A-0260]
V. Válek; Brno/CZ

28
28
C8 Virtual reality from bench C 11 Dissemination of ESR iGuide in Africa
to bedside and the Middle East: use cases
» Chairperson’s introduction [A-0321] Moderators: G. Frija; Paris/FR

P.M.A. van Ooijen; Groningen/NL B. Mansouri; Algiers/DZ
» Mixed reality in education [A-0322] » Chairperson’s introduction [A-0358]

A. Persson; Linköping/SE B. Mansouri; Algiers/DZ
» Mixed reality in surgical application [A-0323] » ESR iGuide adoption in Egypt [A-0359]
D. Amiras; London/UK D. Husseiny Salama; Cairo/EG
» Open forum discussion » ESR iGuide adoption in Uganda [A-0360]

M.G. Kawooya; Kampala/UG
» ESR iGuide adoption in Tunisia [A-0361]
28
Feb Thursday, February 28, 12:30–13:30, Coffee & Talk 1 L. Rezgui Marhoul; Tunis/TN
» ESR iGuide adoption in Iran [A-0362]
C 26 What is a fellowship
M. Fatehi; Tehran/IR
in management?
» Open forum discussion: Use cases in Africa and
Moderator: H.-U. Kauczor; Heidelberg/DE the Middle East - challenges and solutions
» Challenges for leaders in This session is part of the EuroSafe Imaging campaign.
radiology [A-0342]
H.-U. Kauczor; Heidelberg/DE
» Mentorship for fellows in management [A-0343]
28
O. von Stackelberg; Heidelberg/DE
C 10 Ethical traps in publication:
» What I learned from my fellowship in
how to avoid them from concept
management [A-0344]
M. Buk; Prague/CZ to achievement
» Expertise required: finance or IT? [A-0345]
P. Mildenberger; Mainz/DE
R.G.H. Beets-Tan; Amsterdam/NL
» What I expect from my fellowship in
» Ethical aspects during conception of a study [A-0364]
management [A-0346]
F. Sardanelli; San Donato Milanese/IT
C.A. Minoiu; Bucharest/RO
» What to think about when writing a paper [A-0365]
L. Martí-Bonmatí; Valencia/ES
This session is organised by the European School » Ethical issues during peer review [A-0366]
of Radiology. Y. Menu; Paris/FR
» Ethical problems in scientific publishing [A-0367]
28
M. Kowalczuk; London/UK
C9 Dissemination of ESR iGuide in Europe:
use cases
28
Moderators: L. Donoso; Barcelona/ES
G. Frija; Paris/FR C 12 Meet the Editors
L. Donoso; Barcelona/ES
R.G.H. Beets-Tan; Amsterdam/NL [A-0381]
» ESR iGuide adoption in Croatia [A-0348] Y. Menu; Paris/FR [A-0382]
B. Brkljačić; Zagreb/HR
» How to “polish” a manuscript submission [A-0383]
» ESR iGuide adoption in Sweden [A-0349] Y. Menu; Paris/FR
H. Ståhlbrandt; Eksjö/SE
» How to reply to reviewers’ criticisms [A-0384]
» ESR iGuide adoption in Belgium [A-0350] F. Sardanelli; San Donato Milanese/IT
G.M. Villeirs; Ghent/BE
» How to manage critical reviews [A-0385]
» Open forum discussion: National and regional L. Martí-Bonmatí; Valencia/ES
approaches to ESR iGuide implementation

1
March Friday, March 1, 08:30–09:30, Coffee & Talk 3
1
C 13 Value in radiology in theory and C 14 Access to the medical physics expert
practice (MPE) in the imaging department:
use cases
M.H. Fuchsjäger; Graz/AT Moderators: G. Frija; Paris/FR
» Artificial intelligence and value-based V. Tsapaki; Athens/GR
healthcare [A-0535] » Chairperson’s introduction [A-0590]
P.R. Algra; Alkmaar/NL G. Frija; Paris/FR
» What do patients value? [A-0536] » Reminder of Basic Safety Standards (BSS) Directive
J. Birch; Poole, Dorset/UK requirements [A-0591]
» Value-based pay models for radiology [A-0537] V. Tsapaki; Athens/GR
V.M. Rao; Philadelphia, PA/US » Examples of a EuroSafe Imaging Stars with and
» Quantity vs quality? Different aspects of the value without direct access to a MPE [A-0592]
equation [A-0538] T. De Bondt; Antwerp/BE
L. Lawler; Wellington/NZ » French experience based on private
» Value of radiology: the Canadian services [A-0593]
perspective [A-0539] H. Gabriel; Maxeville/FR
E. Lee; Langley, BC/CA » Open forum discussion
» VBR concepts around the globe: similarities and This session is part of the EuroSafe Imaging campaign.
contrasts [A-0540]
J.A. Brink; Boston, MA/US
» Open forum discussion: International perspectives
1
on value in radiology
C 15 EuroSafe Imaging meets
Canada Safe Imaging
1
C 27 How to enhance the role of junior G. Frija; Paris/FR
radiologists in Europe » Introduction of Canada Safe Imaging
Call for Action [A-0604]
» Chairperson’s introduction [A-0575] D. Wormald; Guelph, ON/CA
C. Catalano; Rome/IT
» Current challenges and obstacles [A-0605]
» The beauty of Europe: my Erasmus+ experience and N. Neuheimer; Ottawa, ON/CA
my thesis abroad [A-0576]
» The pan-Canadian survey: strategy moving
G. De Rubeis; Rome/IT
forward [A-0606]
» My ESOR experience in the United States [A-0577] D.A. Koff; Hamilton, ON/CA
L.A. Carbonaro; San Donato Milanese/IT
» Open forum discussion: Suggestions for the
» I love ESOR: my 1 year fellowship [A-0578] implementation of a national strategy for radiation
M. Lisitskaya; Aalborg/DK protection
of Radiology.

1
2
March Saturday, March 2, 09:30–10:30, Coffee & Talk 1
C 16 Congenital heart diseases (CHD): C 29 Why are research fellowships important
new responsibilities for the paediatric for young radiologists?
radiologist
» Chairperson’s introduction [A-0609] L. Martí-Bonmatí; Valencia/ES
A. Secinaro; Rome/IT » Lessons from my experience: data acquisition and
» Cardiovascular assessment in newborns and infants radiomic signatures [A-0813]
with complex CHDs [A-0610] A. Uysal; Ankara/TR
A.M. Taylor; London/UK » Lessons from my experience: radiogenomics
» Post-surgical patterns [A-0611] correlations [A-0814]
T. Leiner; Utrecht/NL N. Plakhotina; Moscow/RU
» CT in newborns: technical tips and tricks [A-0612] » Lessons from my experience: prediction
C. Loewe; Vienna/AT biomarkers [A-0815]
P. Rodríguez Carnero; Madrid/ES
» MR and CT in the follow-up to adulthood [A-0613]
L.K.R. Suther; Oslo/NO » Open forum discussion
» Open forum discussion This session is organised by the European School
of Radiology.
1
2
C 17 Team approach and safety culture in
the imaging department C 18 Assessing imaging IT in hospitals:
an update on the digital imaging
» Chairperson’s introduction [A-0615] adoption model (DIAM)
J.N. Vassileva; Vienna/AT
» Performing the appropriate procedure: Moderator: P. Mildenberger; Mainz/DE
whose role is it? [A-0616] » Update on DIAM radiology [A-0816]
B. Brkljačić; Zagreb/HR P. Mildenberger; Mainz/DE
» Performing procedure appropriately: whose role is » DIAM Enterprise Imaging (EI): differences and
it? [A-0617] synergies [A-0817]
D. Kostova-Lefterova; Sofia/BG J. Studzinski; Leipzig/DE
» Improving patient safety through learning from » Success stories from DIAM: radiology participants
errors [A-0618] P.M.A. van Ooijen; Groningen/NL [A-0818]
L. Sembele; Riga/LV S. Morozov; Moscow/RU [A-0819]
» Open forum discussion: How to build an effective » Open forum discussion
team to achieve best results?
This session is part of the EuroSafe Imaging campaign. 2

C 20 Structured reporting:
1 Friday, March 1, 15:30–16:30, Coffee & Talk 1
March how we do it!
C 28 The European Diploma in Radiology
» Chairperson’s introduction: The age of structured
(EDiR) as an instrument to develop
reporting [A-0843]
a professional career C.E. Kahn; Philadelphia, PA/US
» ESR and RSNA joint effort through the Template
Library Advisory Board Panel [A-0844]
L. Oleaga Zufiría; Barcelona/ES
» EDiR teaser [A-0643]
» Templates and/or assisted-reporting? [A-0845]
D. Pinto dos Santos; Cologne/DE
» EDiR quiz [A-0644]
» Clinical scenarios: where is structured reporting best
A. van Hoyweghen; Edegem/BE
applicable? [A-0846]
» EDiR holder’s experience [A-0645] E. Neri; Pisa/IT
A. Pons Escoda; Barcelona/ES
» Open forum discussion: Why should we promote
and recommend the trainees to take the European
Diploma in Radiology examination?

of Radiology.

2
C 30 Why it is important to have
an academic career
Moderator: V.J. Goh; London/UK

» Why is imaging research
important? [A-0866]
V.J. Goh; London/UK
» Why should you undertake a PhD? [A-0867]
D. Caruso; Rome/IT
» Research in the artificial intelligence era:
what have I learned? [A-0868]
Z. Elkarghali; Amsterdam/NL
» Not all academic careers are planned! [A-0869]
D. Prezzi; London/UK
» Being an academic radiologist: what does this really
mean in practice? [A-0870]
S. Gourtsoyianni; Athens/GR
» Open forum discussion: So, was it worth it?

of Radiology.
2
C 19 Gadolinium deposition in tissues:
current evidence and alternatives

O. Clément; Paris/FR
» Are all gadolinium chelates made equal?
How to remove them from the body [A-0904]
U. Karst; Muenster/DE
» Is gadolinium deposition a real disease? [A-0905]
A. Radbruch; Heidelberg/DE
» Patient information, lawyers and gadolinium phobia:
how to deal with it [A-0906]
H.S. Thomsen; Herlev/DK
» Open forum discussion: Which future for gadolinium
chelates?
2
C 21 How to enhance the role of junior
radiologists in Europe

» The beauty of Europe: my Erasmus+ experience and
my thesis abroad [A-0966]
» Oh, the United States: a research experience before
radiology [A-0967]
B. Wichtmann; Mannheim/DE
» I love ESOR: my 1 year fellowship [A-0968]
M. Lisitskaya; Aalborg/DK

CLINICAL
TRIALS
IN RADIOLOGY
STRAIGHT FROM THE
RESEARCH CENTRE …
… TO THE WORLD’S MOST

INNOVATIVE IMAGING MEETING
Vienna
Watch and listen to the results

at the SKY HIGH STAGE
Details at
Wednesday to Friday
10:30 – 12:00 ipp.myESR.org
Type of session: CTiR
MULTIDISCIPLINARY
SESSIONS
Different medical specialists and radiologists come together
in these sessions to discuss a multidisciplinary approach
to detection and treatment. In these sessions, the experts
come from the same hospitals or the same countries and
will introduce a multidisciplinary case discussion.
101
MULTIDISCIPLINARY SESSIONS
27
28
Feb Thursday, February 28, 16:00–17:30, Room X
MS 1 Lung cancer team MS 8b Brain imaging in psychiatry

A.R. Larici; Rome/IT J.-P. Pruvo; Lille/FR
» Imaging and staging [A-0051] » The epidemiology of psychiatric disorders: why is
M. Silva; Parma/IT MRI needed? [A-0403]
» Role of the pathologist: making the most of the A. Amad; Lille/FR
sample [A-0052] » Strengths of structural and functional MRI in
G. Rossi; Ravenna/IT psychiatry [A-0404]
» Role of the oncologist: personalising the J.-P. Pruvo; Lille/FR
treatment [A-0053] » Advanced MRI and clinical applications: the
S. Novello; Orbassano/IT structured report [A-0405]
» What the surgeon needs to know [A-0054] R. Lopes; Lille/FR
U. Pastorino; Milan/IT » From fMRI capture of hallucinations to innovative
» Multidisciplinary case presentation and image-guided treatments [A-0406]
discussion [A-0055] R. Jardri; Lille/FR
A.R. Larici; Rome/IT » Multidisciplinary case presentation and
discussion [A-0407]
28
Feb Thursday, February 28, 16:00–17:30,
Tech Gate Auditorium 2
MS 8a The ‘prostate unit’ at work
MS 16 How to deal with the epidemics
» Chairperson’s introduction: ‘My PSA is elevated... of thyroid nodules?
what now?’ [A-0477]
G.M. Villeirs; Ghent/BE » Chairperson’s introduction [A-0985]
» The radiologist: non-invasive explorer of the prostatic A.S. Germano; Amadora/PT
realm [A-0478] » The endocrinologist perspective [A-0986]
P. De Visschere; Ghent/BE I. Sapinho; Amadora/PT
» The pathologist: guardian of the truth [A-0479] » The radiologist role [A-0987]
S. Verbeke; Ghent/BE A.S. Germano; Amadora/PT
» The urologist: knight of swords in the prostatic » The surgeon intervention [A-0988]
badlands [A-0480] M. Allen; Amadora/PT
N. Lumen; Ghent/BE » The pathologist assessment [A-0989]
» The radiation-oncologist: smooth irradiator of the P. Borralho; Amadora Lisbon/PT
rogue elements [A-0481] » Multidisciplinary case presentation and discussion:
V. Fonteyne; Ghent/BE “The thyroid-team decision: when to follow and when
» Multidisciplinary case presentation and to go beyond the guidelines” [A-0990]
discussion [A-0482] A.S. Germano; Amadora/PT
3
March Sunday, March 3, 08:30–10:00, Room M 4
MS 17 Multidisciplinary approach
to the diabetic foot

E.N. Brountzos; Athens/GR
» Diabetic foot: a societal problem [A-1063]
V. Lambadiari; Athens/GR
» Imaging evaluation of the diabetic foot [A-1064]
O. Papakonstantinou; Athens/GR
» Interventional radiological treatment (IR) [A-1065]
S.C. Spiliopoulos; Athens/GR
» Surgical management of the diabetic foot [A-1066]
G. Geroulakos; Athens/GR
» Multidisciplinary case presentation and
discussion [A-1067]
E.N. Brountzos; Athens/GR

PROS & CONS
SESSION
The Pros & Cons session examines a controversial topic
that generates debate among specialists.
2
PS 1427 US before CT
in the acute abdomen?

J. Stoker; Amsterdam/NL
» A. Acute abdomen: US first! [A-0836]
J.B.C.M. Puylaert; The Hague/NL
» B. Acute abdomen: CT of course! [A-0837]
M. Laniado; Dresden/DE
» Discussion [A-0838]
Teaser: M.M. França; Porto/PT
103
ECR 2019
ELECTRONIC SCIENTIFIC EXHIBITION
READ ALL CONGRESS POSTERS AT

epos.myESR.org
OR AT THE
EPOS LOUNGE ON LEVEL 1
EUROPEAN
EXCELLENCE IN
EDUCATION (E3)
The E3 programme emphasises the importance of lifelong learning.
It covers the entire range of educational issues, from undergraduate
medical education to subspecialised continuing professional
development. The E3 programme is structured according to
the different levels defined by the European Training Curriculum
for Radiology. The E3 programme consists of the following
five branches, which reflect the different levels of education
in radiology, as well as the different stages of an individual’s
professional career:
Rising Stars Programme
European Diploma Prep Sessions
The Beauty of Basic Knowledge
ECR Academies
ECR Master Classes
105
EDUCATION IN PARTNERSHIP
Target groups – Trainees

– Radiologists
Formats – Courses
– EDiR preparation courses
– Professorships
– Tutorials
– Scholarships
– Fellowships
Location – Worldwide
Methods – Face-to-Face
– Online
Learn more about ESOR activities

in the ESOR Lounge, second Level, Foyer B,
next to room B!
esor.org
E3 RISING STARS
PROGRAMME
The Rising Stars Programme is designed especially for residents,
students, radiographers and trainee radiographers.
It consists of Basic Sessions, Student Sessions, Joint Sessions
with ESOR (European School of Radiology), Case-Based
Diagnosis Training sessions, EFRS Radiographers’ Basic Session
and the Radiology Trainees Forum Programme including
the RTF Highlighted Lectures and the RTF Quiz.
107
E3 – RISING STARS PROGRAMME
BASIC SESSIONS
Special sessions suitable for residents, students,
radiographers and radiographers-in-training
27
1
March Friday, March 1, 08:30–10:00, Room F1
BS 1 Musculoskeletal: BS 9 Neurologic emergencies
bones and soft tissues
Moderator: J. Walecki; Warsaw/PL
Moderator: A.H. Karantanas; Iraklion/GR » Haemorrhagic stroke (SAH) [A-0523]
» Bone marrow diseases [A-0031] C. Calli; Izmir/TR
K. Verstraete; Ghent/BE » Ischaemic stroke: diagnosis [A-0524]
» Soft tissue tumours [A-0032] M. Taina; Kuopio/FI
V.N. Cassar-Pullicino; Oswestry, Shropshire/UK » Ischaemic stroke: treatment [A-0525]
» Bone tumours [A-0033] T. van der Zijden; Antwerp/BE
J.L. Bloem; Leiden/NL
1
27
Feb Wednesday, February 27, 10:30–12:00, Room F1 BS 12 Paediatric oncology
BS 2 Thoracic emergencies
Moderator: L.-S. Ording Müller; Oslo/NO
Moderator: A.P. Parkar; Bergen/NO » The most common brain tumours [A-0679]
» Acute aortic syndrome [A-0086] E. Vázquez; Barcelona/ES
T. Jargiello; Lublin/PL » The most common chest tumours [A-0680]
» Pulmonary embolism [A-0087] A.S. Littooij; Utrecht/NL
C. Loewe; Vienna/AT » The most common abdominal tumours [A-0681]
» Acute coronary syndrome [A-0088] S. Franchi-Abella; Le Kremlin-Bicêtre/FR
R.M.M. Hinzpeter; Zurich/CH
28
BS 5 Abdominal emergencies
Moderator: B. Marincek; Kilchberg/CH

» Perforation of the GI tract [A-0241]
V. Maniatis; Aabenraa/DK
» Bowel obstruction [A-0242]
A. Filippone; Chieti/IT
» Vascular emergencies [A-0243]
V.E. Sinitsyn; Moscow/RU
28
BS 8 Renal, adrenal and urinary tract
pathologies
Moderator: C.S. Balleyguier; Villejuif/FR

» Renal pathologies [A-0432]
H.C. Thoeny; Fribourg/CH
» Adrenal pathologies [A-0433]
M. Stajgis; Poznan/PL
» Ureter and bladder [A-0434]
M.N. Özmen; Ankara/TR

JOINT SESSIONS EFRS RADIOGRAPHERS’

OF THE ESR AND ESOR BASIC SESSIONS
(European School of Radiology) (European Federation
of Radiographer Societies)
27
1
March Friday, March 1, 08:30–10:00, Room Y
BE 3 Radiologic anatomy: BR 9 Career planning
chest
» Chairperson’s introduction: What do new graduates
Moderator: J. Vilar; Valencia/ES need to look like? [A-0530]
» Mediastinal [A-0122] G. Ioannidis; Larissa/GR
M. Occhipinti; Florence/IT » The role of preceptorship in first post-radiography
» Lungs [A-0123] positions [A-0531]
C.M. Schaefer-Prokop; Amersfoort/NL A. Martin; Manchester/UK
» Vasculature [A-0124] » Practising radiography around the world [A-0532]
M. Francone; Rome/IT C. Buissink; Groningen/NL
» The importance of professional registration
and CPD [A-0533]
of Radiology.
L.A. Rainford; Dublin/IE
» Panel discussion: My best career advice
27
BE 4 Radiologic anatomy: 1
March Friday, March 1, 16:00–17:30, Room Y
abdomen
BR 12 Clinical dilemmas in radiography:
Moderator: A. Palkó; Szeged/HU what graduates need to know
» Small bowel [A-0162]
S.A. Taylor; London/UK » Chairperson’s introduction: What are the current
issues in radiography? [A-0686]
» Anorectal [A-0163]
J. Santos; Coimbra/PT
» Issues surrounding consent [A-0687]
» Peritoneum and mesentery [A-0164]
E. Dodd; Bolton/UK
P. Prassopoulos; Alexandroupolis/GR
» Communication and compliance difficulties
This session is organised by the European School in imaging [A-0688]
of Radiology. S. Kada; Bergen/NO
» Professionalism in an era of social media
28
R. García Gorga; Sabadell/ES [A-0689]
M.A. de la Camara; Linares/ES [A-0690]
BE 6 Radiologic anatomy: » Panel discussion: Promoting high-quality
head and neck patient-centred practice
Moderator: M. Becker; Geneva/CH

» Neck spaces [A-0318]
2
March Saturday, March 2, 08:30–10:00, Room Y
A. Trojanowska; Lublin/PL
BR 13 Radiography research: a “how to” guide
» Temporal bone [A-0319]
J.W. Casselman; Bruges/BE » Chairperson’s introduction: Why is radiography
» Larynx [A-0320] research important? [A-0777]
R. Maroldi; Brescia/IT D. O’Leary; Newcastle/UK
This session is organised by the European School » How to avoid ethical issues [A-0778]
of Radiology. P. Bezzina; Msida/MT
» How to critically appraise a research article [A-0779]
J. Thompson; Salford/UK
» How to write a good scientific abstract [A-0780]
L. Ribeiro; Faro/PT
» How to produce a high-quality scientific or
educational poster [A-0781]
C. Malamateniou; London/UK
» Panel discussion: Ask the experts

EFRS RADIOGRAPHERS’ STUDENT SESSIONS

BASIC SESSIONS Students will present their work
(European Federation
of Radiographer Societies)
2
28
BR 16 Radiation protection: S1 Student Session 1
all you need to know My educational or social project
at my university
» Chairperson’s introduction: Evolving
radiographers’ role in radiation protection [A-0960] Moderator: N.N.
B.R. Mussmann; Odense/DK » Perception of the internship student about
» The Basic Safety Standards Directive: early precocious insertion of radiological anatomy in
experiences of implementing BSS [A-0961] medical graduation
S.J. Foley; Dublin/IE L. Mendes; Salvador/BR
» Enhancing the culture of justification [A-0962] » A proposal of radiology education through social
K.B. Lysdahl; Kongsberg/NO network during medical graduation
» Opportunities for optimising dose in digital A.C. Meireles; Salvador/BR
radiography [A-0963] » Sono4Student as a student initiative for sonography
P.H. Hogg; Salford/UK teaching
» The radiographers’ role in benefit-risk C. Geerling; Bonn/DE
communication [A-0964] » Medical student awareness on radiation dose and
J. Portelli; Msida/MT imaging examination appropriateness: an Italian
» Panel discussion: Teamwork in radiation protection survey
A. Sangiorgio; Mandello del Lario/IT
This session is part of the EuroSafe Imaging campaign. » Case reports: a first step towards introducing medical
students to medical writing and research
3
March Sunday, March 3, 08:30–10:00, Room Y
M.-A. Gaman; Bucharest/RO
» Health literacy in radiology - how students can help
BR 17 The future of radiology: what it could L. Szabó; Oradea/RO
mean for new radiography graduates » The winning combination for greatness in education:
innovative workshops, simulations and committed
» Chairperson’s introduction: What will radiology students
departments look like in the future? [A-1041] I. Albajar Gomez; Pamplona/ES
G. Paulo; Coimbra/PT » Are we truly implementing the Royal College
» Future role extension for radiographers [A-1042] of Radiologist’s (RCR) undergraduate curriculum -
H.H. Hjemly; Oslo/NO a comparison of students’ attitudes towards a career
» Evolving imaging technologies [A-1043] in radiology
J.G. Stowe; Dublin/IE Q. Wadood; Birmingham/UK
» Changing the delivery of radiology, responding to the

needs of our patients [A-1044]
K.G. Vikestad; Oslo/NO
» What will radiology look like in 30 years? [A-1045]
C. Beardmore; London/UK
» Panel discussion: Development needs for the future
radiographer

STUDENT SESSIONS
Students will present their work
1
March Friday, March 1, 10:30–12:00, Room X
2
March Saturday, March 2, 08:30–10:00, Room X
S2 Student Session 2 S3 Student Session 3
My scientific paper in the field My scientific paper in the field
of Doppler ultrasound & My scientific of musculoskeletal imaging
paper in the field of dose optimisation
Moderator: N.N.
in imaging
» Thoracic skeletal muscle area is associated with
Moderator: N.N. long-term overall survival following pneumonectomy
for lung cancer
» The utility of ultrasound examination in follow-up
F.M. Troschel; Muenster/DE
of patients after endovascular repair of abdominal
aortic aneurysm » Diagnosing hand and wrist tendon injuries in patients
M. Nowakowska; Lublin/PL with questionable physical findings
Y. Nikooiyan; Mashhad/IR
» Capabilities of Doppler ultrasound technique in lips
examination for applications in cosmetology » The impact of image analysis errors (IAE) on lumbar
D. Naumova; Novomoskovsk/RU spine (LS) and proximal femur (PF) dual energy x-ray
absorptiometry (DXA)
» The use of elastography to determine the
C. Srinilta; Milan/IT
radiofrequency ablation zone
O. Sukhodolska; Kharkiv/UA » Machine learning classification of soft tissue
lipomatous tumours: preliminary results
» The feasibility of one-stop computed tomography
E. Battistelli; Milan/IT
myocardial perfusion imaging in coronary artery
disease » Lumbosacral transitional vertebrae and the
K. Liu; Chengdu, Sichuan/CN association with low back pain and spine
degeneration: the Rotterdam study
» Image quality using automatic exposure control in
S. Ramcharan; Rotterdam/NL
mammography
L.E. Similä; Oulu/FI » Magnetic resonance imaging of placenta accrete
M. Komajda; Lublin/PL
» Fast thoracic MRI as an alternative to chest x-ray
radiography » MRI pushing boundaries in orthopaedic research:
L. Bonomo; Milan/IT role of imaging in validating a novel approach for
anterior cruciate ligament reconstruction
» Assessment of cultural changes in paediatric trauma
A.O. Adam; Cluj-Napoca/RO
head CT: retrospective study of CT dose dynamics
within 2 year period in regional hospital in Latvia » CRITOL: not for girls?
following educational activities L. Irwin; Glasgow/UK
M. Samma; Riga/LV
» From analogy imaging to improvised teleradiology
A.F. Zuberi; Daressalam/TZ

STUDENT SESSIONS RADIOLOGY TRAINEES

Students will present their work FORUM PROGRAMME
2
28
S4 Student Session 4 RTF Quiz A new look
My scientific paper in the field at the mediastinum
of neuroimaging
Moderators: J. Cáceres; Barcelona/ES
Moderator: N.N. J. Vilar; Valencia/ES
» The limbic system: our pedagogical approach using
anatomic-radiologic correlation 2
F.A. Irurzun; Buenos Aires/AR
» MRI in flow diversion - which sequences are useful? TF Highlighted Lectures
A. Hartmann; Leipzig/DE
Moderators: A. Svare; Riga/LV
» Does the bovine aortic arch variant influence
T. Teneva; Varna/BG
stroke frequency and embolus lateralisation in
cardioembolic stroke patients? » Spinal emergencies: a look beyond trauma [A-0832]
A. Syperek; Greifswald/DE D. Ivanova; Varna/BG
» Diagnostic value of CT swirl sign and hot spot sign » Acute aortic syndrome: intimate knowledge through
to predict hematoma expansion intimate case [A-0833]
B.K. Park; Jeonju/KR G.I. Kirova-Nedialkova; Sofia/BG
» Dense artery sign in early diagnostic of acute stroke » Getting it right: how to report an imaging
and its correlation with NIHSS scores study before the interventional radiology
M. Pēterfelds; Jūrmala/LV procedure [A-0834]
R. Dezman; Ljubljana/SI
» Change in hippocampal volume in suicide patients
M. Sarkinaite; Kaunas/LT
» Prognostic value of 11C-methionine PET parameters CASE-BASED DIAGNOSIS TRAINING
in IDH wild type gliomas
B.R.J. van Dijken; Groningen/NL Special programme for residents and general radiologists
» Cerebrospinal fluid metals and the association with
cerebral small vessel disease in cognitive impairment 3
March Sunday, March 3, 13:00–15:30, Room E1
M. Shams Latifi; Stockholm/SE
CB Case-Based Diagnosis Training
Moderators: K.M. Friedrich; Vienna/AT

S. Robinson; Vienna/AT
» Liver [A-1090]
» Neuro [A-1091]
D. Prayer; Vienna/AT
» Maxillofacial [A-1092]
» Musculoskeletal [A-1093]
» Genitourinary [A-1094]
M. Toepker; Vienna/AT
» Interlude: Just a cyst? [A-1095]
R. Manfredi; Rome/IT
» Head and neck [A-1096]
C. Czerny; Vienna/AT
» Chest [A-1097]
H. Prosch; Vienna/AT
» Spine [A-1098]
K.M. Friedrich; Vienna/AT
» Gastrointestinal [A-1099]
W. Schima; Vienna/AT
» Breast [A-1100]
M.H. Fuchsjäger; Graz/AT

E3 EUROPEAN
DIPLOMA
PREP SESSIONS
The European Diploma Prep Sessions aim to prepare
prospective candidates for the European Diploma
in Radiology (EDiR). They are also suitable for residents who

want an overview of the various topics relevant to imaging
and for those preparing for their national board examinations.
The content of the programme reflects Level I and Level
II European Training Curriculum (ETC) learning objectives
across a two-year cycle. The sessions are held in close
cooperation with the European Board of Radiology (EBR).
113
E3 – EUROPEAN DIPLOMA PREP SESSIONS
2
3
March Sunday, March 3, 08:30–10:00, Room F1
E3 1323 Gastrointestinal and E3 1723 Musculoskeletal
abdominal
» Chairperson’s introduction [A-0768] F. Saez; Barakaldo/ES
C. Stoupis; Männedorf/CH A. Traumatic disorders of the musculoskeletal
A. Hepatobiliary system [A-0769] system [A-1034]
I. Santiago; Lisbon/PT L. Meacock; London/UK
B. Pancreas and spleen [A-0770] B. Bone tumours [A-1035]
W. Schima; Vienna/AT M.-A. Weber; Rostock/DE
C. Imaging of the gastrointestinal tract [A-0771] C. Degenerative and inflammatory disorders of the
D.M. Lambregts; Amsterdam/NL musculoskeletal system [A-1036]
J.-B. Pialat; Lyon/FR
2
March Saturday, March 2, 10:30–12:00, Room F1 3
E3 1423 Neuro
E3 1823 Breast
C. Calli; Izmir/TR » Chairperson’s introduction [A-1083]
A. Congenital and white matter disorders of the
brain [A-0829] A. Fundamentals of mammography [A-1084]
A. Rossi; Genoa/IT F. Kilburn-Toppin; Cambridge/UK
B. Neurovascular disorders and trauma of the B. Breast cancer diagnosis and interventions [A-1085]
brain [A-0830] C. Van Ongeval; Leuven/BE
M. Vernooij; Rotterdam/NL C. Advanced imaging of the female breast [A-1086]
C. Tumours of the brain and spine [A-0831] E.M. Fallenberg; Munich/DE
2
E3 1523 Principles of imaging and
radiation protection

C.J. Caruana; Msida/MT
A. Principles of computed
tomography [A-0896]
M. Kortesniemi; Helsinki/FI
B. Principles of magnetic resonance imaging [A-0897]
D. Sappey-Marinier; Lyon/FR
C. Radiation protection [A-0898]
J. Damilakis; Iraklion/GR
2
E3 1623 Chest

J. Vilar; Valencia/ES
A. Fundamentals of chest imaging [A-0952]
M. Occhipinti; Florence/IT
B. Inflammation and tumours of the lung [A-0953]
A. Nair; London/UK
C. Mediastinum, pleura and chest wall [A-0954]
A.P. Parkar; Bergen/NO

E3 THE BEAUTY OF
BASIC KNOWLEDGE
The Beauty of Basic Knowledge programmes focus on
knowledge essential to the daily practice of radiology.
The teaching format is usually case-based and features
interaction with the attendees. The content of the sessions
is mostly tied to the Level I+II European Training Curriculum
(ETC) learning objectives and suited to residents and board-
certified radiologists who want to refresh their knowledge
of basic topics in imaging and image-guided therapy.
115
E3 – THE BEAUTY OF BASIC KNOWLEDGE
PANCREAS A SURVIVAL GUIDE

TO MUSCULOSKELETAL IMAGING
27
Feb Wednesday, February 27, 12:30–13:30, Room C
Moderator: V.N. Cassar-Pullicino; Oswestry, Shropshire/UK
E3 24A Acute pancreatitis 27

Feb Wednesday, February 27, 12:30–13:30, Room D
Moderator: R. Manfredi; Rome/IT
E3 25A Infection:
» Atlanta Classification of acute pancreatitis [A-0096]
bone and soft tissue
T. Bollen; Nijmegen/NL
» Role of imaging [A-0097] J.L. Bloem; Leiden/NL [A-0106]
C. Triantopoulou; Athens/GR
28 Thursday, February 28, 12:30–13:30, Room D

28
Feb Thursday, February 28, 12:30–13:30, Room C
Feb
E3 25B Bone tumours

E3 24B Chronic pancreatitis I
K. Wörtler; Munich/DE [A-0351]
Moderator: M. Zins; Paris/FR
» How to diagnose and classify [A-0340] 1
G. Zamboni; Verona/IT March Friday, March 1, 12:30–13:30, Room D
» Functional evaluation of chronic E3 25C Spinal trauma:
pancreatitis [A-0341] how to get it right
M. A. Bali; Brussels/BE
A. Leone; Rome/IT [A-0614]
1
2
March Saturday, March 2, 12:30–13:30, Room D
E3 24C Cystic neoplasms
E3 25D Arthritis:
Moderator: T.C. Lauenstein; Düsseldorf/DE
an imaging approach
» Intraductal papillary neoplasms [A-0607]
S. Skehan; Dublin/IE F. Kainberger; Vienna/AT [A-0854]
» Other cystic pancreatic neoplasms [A-0608]
3
March Sunday, March 3, 12:30–13:30, Room D
2
E3 25E Acute trauma: patterns
in the peripheral skeleton
E3 24D Solid pancreatic neoplasms
J. Teh; Oxford/UK [A-1089]
Moderator: I.G. Lupescu; Bucharest/RO
» Diagnosis [A-0852]
M. Zins; Paris/FR
» Staging [A-0853]
N. Kartalis; Stockholm/SE
3
March Sunday, March 3, 12:30–13:30, Room C
E3 24E Pancreatic adenocarcinoma
mimickers
Moderator: A. Ba-Ssalamah; Vienna/AT

» Autoimmune pancreatitis [A-1087]
R. Pozzi Mucelli; Verona/IT
» Paraduodenal pancreatitis [A-1088]
G. Morana; Treviso/IT

E3
ECR ACADEMIES
The ECR Academies consist of a series of four to six sessions
relevant to a particular area of radiology.
This may be a classic organ-based or a technically oriented

area of another radiology related field. An ECR Academy
is a coherent course in which the different sessions complement
one another in order to reflect the entirety of the field and
to show the different facets of the area in question.
The ECR Academies are particularly suited to general
radiologists or radiologists with a subspecialisation.
117
E3 – ECR ACADEMIES
RADIOLOGY LEADERS’ BOOTCAMP HOT TOPICS IN GU CANCER
1
March Friday, March 1, 08:30–10:00, Room M 2
27
Feb Wednesday, February 27, 08:30–10:00, Room M 4
E3 918 Captain’s dashboard E3 119 Early detection
of ovarian cancer
S. Morozov; Moscow/RU
A. Fundamentals of imaging management and R. Forstner; Salzburg/AT
administration [A-0556]
B. Bijan; Sacramento, CA/US A. Current guidance on screening and familial ovarian
cancer
B. Being in a driver’s seat and managing by
A.G. Rockall; London/UK [A-0070]
objectives [A-0557]
Y. Menu; Paris/FR A. George; London/UK [A-0071]
C. Challenging the status quo and making new things B. ORADS: ultrasound and International Ovarian Tumor
happen [A-0558] Analysis (IOTA) group models [A-0072]
P.M.A. van Ooijen; Groningen/NL R.F. Andreotti; Nashville, TN/US
C. ORADS: MRI [A-0073]
1
March Friday, March 1, 10:30–12:00, Room M 2 I. Thomassin-Naggara; Paris/FR
E3 1018 Dream team

27
L. Martí-Bonmatí; Valencia/ES E3 219 Early detection
A. How to find the best people and make them a part of prostate cancer
of a long-time success [A-0595]
J.H. Thrall; Boston, MA/US
B. Leadership in radiology [A-0596]
M. Forsting; Essen/DE
A. Screening for prostate cancer: where are we now?
C. Leading quality improvement projects [A-0597]
B. Baeßler; Mannheim/DE A. George; London/UK [A-0092]
A. Sohaib; London/UK [A-0093]
1
March Friday, March 1, 14:00–15:30, Room M 2 B. Pre-biopsy detection and new techniques
for detection in prostate cancer [A-0094]
E3 1118 Investment strategies S. Punwani; London/UK
C. Active surveillance: best practice [A-0095]
J.J. Fütterer; Nijmegen/NL
A. Budget: all these numbers [A-0635]
A. Giovagnoni; Ancona/IT 27
B. Value-based imaging [A-0636]
M.G.M. Hunink; Rotterdam/NL E3 319 Whole-body imaging
C. Start-up in radiology [A-0637] in gynaecological malignancy
A. Alberich-Bayarri; Valencia/ES
1
March Friday, March 1, 16:00–17:30, Room M 2 L.S. Fournier; Paris/FR
E3 1218 Secrets of radiology communications A. WB MRI for staging and treatment planning
in ovarian cancer [A-0130]
with patients and referring
V. Vandecaveye; Leuven/BE
physicians
B. PET/CT and PET/MRI in cervix and endometrial
cancer: current status [A-0131]
M. Fatehi; Tehran/IR L. Umutlu; Essen/DE
A. Communication is all that really matters [A-0708] C. Advanced imaging techniques in metastatic
J.A. Verschakelen; Leuven/BE gynaecological cancer [A-0132]
B. Marketing channels for radiology E. Sala; Cambridge/UK
promotion [A-0709]
D. Pinto dos Santos; Cologne/DE
C. Personal-branding and promotion for a
radiologist [A-0710]
= Interactive introduction with electronic voting/self assessment

HOT TOPICS IN GU CANCER FUNCTIONAL IMAGING

FOR DISEASE MANAGEMENT:
RESEARCH TO MEDICAL PRACTICE
27
27
E3 419 Whole-body imaging E3 320 Functional imaging
in metastatic urinary tract of the brain
and prostate cancer
» Chairperson’s introduction [A-0194] T.A. Yousry; London/UK
A.R. Padhani; London/UK A. Stroke [A-0134]
A. WB-MRI: technique and reporting system T. Tourdias; Bordeaux/FR
Met Rads P [A-0195] B. Brain tumours [A-0135]
F.E. Lecouvet; Brussels/BE A. Majos; Lodz/PL
B. WB-MRI and response assessment [A-0196] C. Cerebral small vessel diseases [A-0136]
N. Tunariu; London/UK M.A. Van Buchem; Leiden/NL
C. PET and PET/MRI in prostate cancer [A-0197]
I.A. Burger; Zurich/CH
27
28
E3 420 Functional imaging
of the heart
E3 519 Tumour relapse
in gynaecological cancer » Chairperson’s introduction [A-0198]
M. Gutberlet; Leipzig/DE
» Chairperson’s introduction [A-0284] A. Functional techniques for clinical cardiac
R.A. Kubik-Huch; Baden/CH MR [A-0199]
A. Differentiating relapse from post-treatment R. Manka; Zurich/CH
appearances [A-0285] B. Ischaemic diseases [A-0200]
R. Forstner; Salzburg/AT J. Bogaert; Leuven/BE
B. Planning exenterative surgery [A-0286] C. Non-ischaemic cardiopathies [A-0201]
H.A. Vargas; New York, NY/US L. Natale; Rome/IT
C. Salvage treatment with image directed therapy:
high-intensity focused US (HIFU) and
stereotactic RT [A-0287]
28
N.M. deSouza; Sutton/UK
of the lungs
28
E3 619 Tumour relapse C.M. Schaefer-Prokop; Amersfoort/NL
in urological cancer A. Perfusion methods for vascular and airway diseases
(CT/MRI) [A-0289]
» Chairperson’s introduction [A-0328] M. Rémy-Jardin; Lille/FR
V. Logager; Copenhagen/DK B. Quantitative CT-imaging biomarkers in airways
A. Prostate cancer relapse [A-0329] diseases [A-0290]
V. Panebianco; Rome/IT H.-U. Kauczor; Heidelberg/DE
B. Non prostate urological cancer relapse [A-0330] C. Lung cancer, tumour heterogeneity and tumour
H.A. Vargas; New York, NY/US response [A-0291]
C. Theranostics in urological cancer [A-0331] J.M. Goo; Seoul/KR
M. Hartenbach; Vienna/AT

5 Years
of Success
in Medical
Radiation
Protection
EuroSafe Imaging celebrates its fifth anniversary at
ECR 2019. Learn more about radiation protection
and safety in medical imaging and visit the EuroSafe
Imaging Lounge.
Don’t forget to take your souvenir photo in the

EuroSafe Imaging Lounge photo booth!
EuroSafe Imaging Lounge

1st floor - Foyer N
www.eurosafeimaging.org
FUNCTIONAL IMAGING INTERACTIVE TEACHING SESSIONS

FOR DISEASE MANAGEMENT: FOR YOUNG (AND NOT SO YOUNG)
RESEARCH TO MEDICAL PRACTICE RADIOLOGISTS
28
27
E3 620 Functional imaging E3 121 Emergency radiology I
of the liver
A. Acute aortic syndrome [A-0044]
» Chairperson’s introduction [A-0332] H. Alkadhi; Zurich/CH
L. Martí-Bonmatí; Valencia/ES B. Abdominal trauma [A-0045]
A. Diagnostic and staging of diffuse liver diseases using R. Basilico; Chieti/IT
functional MRI [A-0333]
B. van Beers; Clichy/FR
27
B. Diagnostic and staging of diffuse liver diseases using E3 221 Musculoskeletal radiology:
multiparametric US [A-0334]
inflammation
P. Sidhu; London/UK
C. Characterisation of liver tumours and prediction
A. Inflammatory and infections in the soft
of tumour response [A-0335]
tissues [A-0089]
B. Taouli; New York, NY/US
S. Martin; Palma de Mallorca/ES
B. Arthropathies [A-0090]
28
U. Aydingoz; Ankara/TR
E3 720 Functional imaging 28

Feb Thursday, February 28, 08:30–10:00, Room A
of the kidneys
E3 521 Emergency radiology II
A. Urinary system trauma [A-0202]
V. Logager; Copenhagen/DK
A. MR measurement of split renal function [A-0378]
B. Non-traumatic urinary tract emergencies [A-0203]
D. Mandry; Nancy/FR
G. Masselli; Rome/IT
B. Renovascular diseases (RVD) [A-0379]
M. Notohamiprodjo; Tübingen/DE 28
C. Characterisation of chronic kidney diseases
(CKD) [A-0380] E3 621 Oncologic imaging
N. Grenier; Bordeaux/FR
A. Lung cancer: key signs in the new TNM [A-0306]
A.R. Larici; Rome/IT
28 Thursday, February 28, 16:00–17:30, Room M 5
Feb B. Incidental findings in oncologic patients [A-0307]
M.-P. Revel; Paris/FR
of breast and female pelvis 28
» Chairperson’s introduction [A-0473] E3 721 Errare humanum est
K. Kinkel; Chêne-Bougeries/CH
A. Breast tumours [A-0474] A. Errors in chest radiograph [A-0356]
J. Camps Herrero; Valencia/ES D. Tack; Baudour/BE
B. Tumours of the uterus [A-0475] B. Errors in CT of the chest [A-0357]
E. Sala; Cambridge/UK J. Vilar; Valencia/ES
C. Ovarian tumours [A-0476]
A.G. Rockall; London/UK
28
E3 821 Gastrointestinal radiology
A. Inflammatory bowel disease [A-0390]

J. Rimola; Barcelona/ES
B. Rectal cancer staging: key findings [A-0391]
G. Brown; Sutton/UK
= Interactive introduction with electronic voting/self assessment = Interactive session with electronic voting/self assessment

INTERACTIVE TEACHING SESSIONS FOR YOUNG

(AND NOT SO YOUNG) RADIOLOGISTS
1
2
E3 921 Cardiac imaging E3 1621 Paediatric radiology
for the general radiologist
A. Grown-ups with congenital heart disease [A-0483]
A.M. Taylor; London/UK A. Pitfalls in paediatric chest and abdomen [A-0923]
B. Imaging cardiac valves [A-0484] M. Raissaki; Iraklion/GR
R. Salgado; Antwerp/BE B. Paediatric MSK imaging: normal variants or real
injuries? [A-0924]
F. Saez; Barakaldo/ES
1
E3 1221 Advances in musculoskeletal 3
March Sunday, March 3, 08:30–10:00, Room A
techniques: whole-body MR
E3 1721 Head and neck imaging
A. Oncologic application [A-0646]
F.E. Lecouvet; Brussels/BE A. Cystic neck lesions [A-0999]
B. Non-oncologic applications [A-0647] A. Borges; Lisbon/PT
M. Faruch; Toulouse/FR B. Non-traumatic head and neck emergencies [A-1000]
A. Rovira-Cañellas; Barcelona/ES
2 Saturday, March 2, 08:30–10:00, Room A

March
3
E3 1321 Writing reports:
a survival guide E3 1821 Imaging of the brain
A. Lung nodule: managing uncertainty [A-0732] A. Stroke mimics [A-1075]

M. Prokop; Nijmegen/NL M.M. Thurnher; Vienna/AT
B. Interstitial lung disease: searching for B. Acquired toxic-metabolic encephalopathies [A-1076]
clarity [A-0733] K. Karli Oguz; Ankara/TR
3
2
March Saturday, March 2, 10:30–12:00, Room A E3 1921 Paediatric brain imaging
E3 1421 Genitourinary radiology
for the general radiologist A. Head and neck emergencies in children [A-1101]
A. Rossi; Genoa/IT
A. Cystic pelvic masses: differential diagnosis and B. Acute neurological child beyond trauma [A-1102]
management [A-0820] A. Sánchez Montañez; Barcelona/ES
O. Nikolic; Novi Sad/RS
B. Gynaecological emergencies [A-0821]
M. Weston; Leeds/UK
2
E3 1521 Breast imaging
A. Diagnosis and management of common

ductal and nipple-areolar-complex (NAC)
abnormalities [A-0855]
S. Perez Rodrigo; Madrid/ES
B. Techniques, artefacts and pitfalls
in breast MRI [A-0856]
R.M. Trimboli; Milan/IT

CHEST IMAGING
28
1
E3 722 Cavitary and cystic diseases E3 1022 Lung cancer in the era of molecular
of the lung oncology and immune therapy

J. Biederer; Heidelberg/DE H. Prosch; Vienna/AT
A. Cavitary lung lesions [A-0374] A. Lung adenocarcinomas with EGFR
A.P. Parkar; Bergen/NO mutations [A-0599]
B. Langerhans cell histiocytosis (LCH) [A-0375] M. Lederlin; Rennes/FR
A. Devaraj; London/UK B. PD-L1 positive lung tumours [A-0600]
C. Lymphangioleiomyomatosis [A-0376] O.L. Sedlaczek; Heidelberg/DE
A. Oikonomou; Toronto, ON/CA C. ALK-rearranged and other mutations of lung
adenocarcinomas [A-0601]
M. Silva; Parma/IT
28
E3 822 CT and intervention in vascular 1
pulmonary diseases
E3 1222 The heart between the lungs
J.D. Dodd; Dublin/IE » Chairperson’s introduction [A-0715]
J.E. Wildberger; Maastricht/NL
A. CT imaging of pulmonary hypertension [A-0470]
N.J. Screaton; Cambridge/UK A. Cardiomyopathies [A-0716]
D.J. Murphy; Dublin/IE
B. Evaluating the pulmonary vasculitis [A-0471]
E. Castañer; Sabadell/ES B. Coronary artery disease [A-0717]
M. Williams; Edinburgh/UK
C. Rendu-Osler and Behcet’s diseases [A-0472]
B. Peynircioglu; Ankara/TR C. Fat and calcium in the heart [A-0718]
F. Pontana; Lille/FR
1
March Friday, March 1, 08:30–10:00, Room M 4 2
E3 922 Chronic obstructive pulmonary
disease (COPD) E3 1322 Pleural neoplasms

F. Gleeson; Oxford/UK
D. Litmanovich; Boston, MA/US
A. Malignant mesothelioma [A-0801]
A. CT phenotyping and visual assessment [A-0565]
I. Hartmann; Rotterdam/NL
P.A. Grenier; Paris/FR
B. Pleural carcinomatosis of thoracic and extra thoracic
B. Quantitative imaging biomarkers [A-0566]
origin [A-0802]
J.B. Seo; Seoul/KR
C. Beigelman; Lausanne/CH
C. Is there a role for MRI? [A-0567]
C. Other pleural and juxta pleural
M.O. Wielpütz; Heidelberg/DE
malignancies [A-0803]
A. Snoeckx; Antwerp/BE

Clinical Decision Support
ESR iGuide is the European Society of
Radiology’s clinical decision support
solution to deliver evidence-based guidance
for imaging referrals at the point of care.
We would like to
o meet
m you personally
at ECR 2019 for a dem
emonstration of ESR iGuide!
VISIT
T THE ESR iGUIDE BOOTH
EuroSafe
fe Imaging Lounge, 1st Floor ACV
myESR.org/ESRiGuide
E3 ECR MASTER
CLASSES
The ECR Master Classes focus on continuous professional
development and lifelong learning and are designed for
subspecialised radiologists seeking cutting-edge information
in their particular fields of interest. They reflect state-of-the-
art knowledge, as well as emerging trends.
125
E3 – ECR MASTER CLASSES
27
27
Neuro Oncologic Imaging
E3 126a How to implement MRI neuro advanced E3 426b Novelties in oncologic imaging
techniques at home
Moderator: P. Brader; Graz/AT
Moderator: P.C. Maly Sundgren; Lund/SE A. Imaging-guided liver interventions in
A. Practical approach to cerebral perfusion oncology [A-0191]
techniques [A-0024] B. Gebauer; Berlin/DE
H.R. Jäger; London/UK B. Radiomics: the role of imaging [A-0192]
B. How to read susceptibility-weighted imaging S. Rizzo; Milan/IT
(SWI) [A-0025] C. Is PET/MRI better than PET/CT plus MRI? [A-0193]
S. Haller; Carouge/CH H.-P. Schlemmer; Heidelberg/DE
C. How to read diffusion tensor imaging (DTI) [A-0026]
R. Gasparotti; Brescia/IT
28
27
Cardiac
E3 526 Cardiac imaging in arrhythmia
Head and Neck and sudden cardiac death
E3 126b Functional imaging in head and
neck oncology » Chairperson’s introduction [A-0223]
P. Donato; Coimbra/PT
» Chairperson’s introduction [A-0074] A. The role of CMR in sudden cardiac death [A-0224]
F. Bidault; Villejuif/FR D. Piotrowska-Kownacka; Warsaw/PL
A. Functional imaging for locoregional tumour B. Preventing sudden cardiac death with CT:
assessment [A-0075] pure theory or new diagnostic paradigm? [A-0225]
M.G. Mack; Munich/DE K. Nikolaou; Tübingen/DE
B. Incidence and prognosis of synchronous cancer C. Imaging of patients with arrhythmia and
or distant metastases from head and neck implantable devices [A-0226]
tumours [A-0076] G. Pontone; Milan/IT
A.D. King; Hong Kong/CN » Panel discussion: Should we screen, who should we
C. Is functional imaging necessary to detect distant screen and how should we screen in order to prevent
metastases in head and neck cancers? [A-0077] sudden cardiac death?
R. Maroldi; Brescia/IT
» Panel discussion: How to stage head and neck
tumours correctly
1
March Friday, March 1, 08:30–10:00, Room E1
Emergency Imaging
27
E3 926 Post-treatment emergencies
in oncologic patients
Breast
E3 426a The high-risk patient enigma » Chairperson’s introduction: The role of imaging in
the early detection of complications in oncologically
Moderator: F. Kilburn-Toppin; Cambridge/UK treated patients [A-0515]
A. Lesions with an elevated risk for breast D.R. Kool; Amsterdam/NL
cancer [A-0149] A. Chest [A-0516]
G. Forrai; Budapest/HU H. Prosch; Vienna/AT
B. Value of breast MRI. Rate of underestimation B. Abdomen [A-0517]
and impact on treatment decision: is breast MRI R. Basilico; Chieti/IT
increasing the number of high-risk lesions? [A-0150]
C. How can interventional radiologists help
R.M. Mann; Nijmegen/NL
in the management of oncological treatment
C. Can surgery be avoided? [A-0151] complications? [A-0518]
S.J. Vinnicombe; Dundee/UK K.K. Pyra; Lublin/PL
» Panel discussion: What is the impact of complications
findings on the continued management of oncologic
patients?

E3 – ECR MASTER CLASSES
1
March Friday, March 1, 16:00–17:30, Room O
2
Vascular Chest
E3 1226 Cone-beam, 4D and more: E3 1626b Patterns of pulmonary toxicity
new diagnostic tools
Moderator: I.E. Tyurin; Moscow/RU
for vascular diseases
A. Drug-induced lung disease [A-0982]
Moderator: C. Binkert; Winterthur/CH C.M. Schaefer-Prokop; Amersfoort/NL
A. The role of intra-procedural perfusion assessment B. Smoking-related lung disease [A-0983]
in peripheral arterial disease [A-0664] S.R. Desai; London/UK
J.A. Reekers; Amsterdam/NL C. Inhalation: lung injury beyond smoking [A-0984]
B. CT 4D imaging after (T)EVAR [A-0665] J.A. Verschakelen; Leuven/BE
R. Schernthaner; Vienna/AT
C. How cone-beam CT can change your practice 3
in interventional radiology [A-0666]
R. Uberoi; Oxford/UK Hybrid, Molecular and Translational Imaging
E3 1726a Quantitative imaging
2 Saturday, March 2, 08:30–10:00, Room M 2
March in oncology
Paediatric
E3 1326 Juvenile idiopathic arthritis
J. O’Connor; Manchester/UK
(JIA)
A. Intra- and intertumoural heterogeneity and
Moderator: K. Rosendahl; Bergen/NO the impact for cancer diagnostics [A-1058]
M. Eisenblätter; Münster/DE
A. Conventional radiography: still a helpful
method? [A-0794] B. Quantitative image biomarkers for targeted tumour
S.C. Shelmerdine; London/UK therapies [A-1059]
R. García Figueiras; Santiago de Compostela/ES
B. Ultrasound for detecting and grading of inflammation
in JIA [A-0795] C. From quantitative imaging to radiomics and
L. Tanturri de Horatio; Rome/IT deep learning [A-1060]
H.K. Hahn; Bremen/DE
C. MRI and role of contrast in the assessment
of synovitis [A-0796] D. Imaging heterogeneity and genomic variability
L.-S. Ording Müller; Oslo/NO in ovarian cancer [A-1061]
2
March Saturday, March 2, 14:00–15:30, Room B
» Panel discussion: What can we quantify and why is it
essential?
Abdominal and Gastrointestinal
E3 1526 Dual-energy CT of the abdomen: 3
the time is now March Sunday, March 3, 08:30–10:00,
Moderator: J. Sosna; Jerusalem/IL
Genitourinary
A. Basic principles and different approaches [A-0857]
E3 1726b Prostate MRI:
L.S. Guimarães; Toronto, ON/CA
the accreditation issue
B. Applications for genitourinary system [A-0858]
H. Ringl; Vienna/AT
C. Applications for abdominal organs [A-0859] J. Richenberg; Brighton/UK
M. Karcaaltincaba; Ankara/TR
A. Prostate MRI: minimum and optimal
requirements [A-1072]
2
March Saturday, March 2, 16:00–17:30, Room E1 V. Panebianco; Rome/IT
Musculoskeletal B. Towards a European accreditation of prostate

imaging centres [A-1073]
E3 1626a State-of-the-art imaging of
postoperative joints
C. Towards a certified radiologist [A-1074]
Moderator: M.F. Reiser; Munich/DE H.C. Thoeny; Fribourg/CH
A. Postoperative shoulder [A-0945] » Panel discussion: Prostate units: is the radiologist in

C.W.A. Pfirrmann; Zurich/CH or outside the core team?
B. Postoperative knee [A-0946]

E.H.G. Oei; Rotterdam/NL
C. Postoperative ankle and foot [A-0947]
M.J. Ereño Ealo; Galdacano/ES = Interactive session with electronic voting/self assessment

Accreditation
Council in Imaging
ïæČÿÌ¨ĒČÌæÃČïĒæÌĴ·°ªªÿ·°ÌČČÌïæăĥăČ·ä
ÌæÝÝ"Ēÿïû·æªïĒæČÿÌ·ăɌ
Step 1 ûûÝĥ¨ĥĴÝÝÌæÃÌæČÉ·ÁïÿäĞÌÝ¨Ý·Č
www.myEBR.org
Step 2 ïäûÝ·Č·æ°ÿ·ČĒÿæČÉ·°ïªĒä·æČăČÉČ
ĥïĒğÌÝÝÿ·ª·ÌĞ·ÁÿïäČÉ·9Č·äɌ
Step 3 xÉ·9Č·äğÌÝÝæïČÌÁĥĥïĒĞÌä·ăăÃ·
ČÉ·æĒä¨·ÿïÁ"Q"oĥïĒÿ·Ğ·æČ
Éă¨··æÃÿæČ·°Ɉ CME credits
available for your
webinars and
your e-learning
materials!!!
CME
QUICK AND
EASY.
Details at
www.myebr.org
HANDS-ON
WORKSHOPS
At ECR 2019 educational Hands-on Workshops dealing with
the topic ‘MRI of the Prostate’ will take place. The number of
participants at each workshop is restricted to 50.
Participants have to bring their own laptops and need
to pre-register online via the myUserArea.
129
HANDS-ON WORKSHOPS
MRI OF THE PROSTATE

Participants are asked to bring their own laptops.
28
Feb Thursday, February 28, 08:30–09:30, Room H
1
March Friday, March 1, 08:30–09:30, Room H
HW 530 Hands-on Workshop: HW 930 Hands-on Workshop:
MRI of the Prostate (1) MRI of the Prostate (5)
» Instructor: » Instructor:
P. Asbach; Berlin/DE B. Hamm; Berlin/DE
REGISTRATION VIA MyUserArea REGISTRATION VIA MyUserArea
28
1
March Friday, March 1, 10:30–11:30, Room H
HW 630 Hands-on Workshop: HW 1030 Hands-on Workshop:
MRI of the Prostate (2) MRI of the Prostate (6)
» Instructor: » Instructor:
A. Baur; Berlin/DE A.R. Padhani; London/UK
REGISTRATION VIA MyUserArea REGISTRATION VIA MyUserArea
28
HW 730 Hands-on Workshop:
MRI of the Prostate (3)
» Instructor:
REGISTRATION VIA MyUserArea
28
HW 830 Hands-on Workshop:
MRI of the Prostate (4)
» Instructor:
P. Asbach; Berlin/DE
REGISTRATION VIA MyUserArea

TRANSATLANTIC
COURSE
ECR 2019 features again the joint course of the ESR and
RSNA (Radiological Society of North America), which is called
‘Transatlantic Course’ and which will again focus on sports imaging.
The sessions will be interactive with Live Voting.
131
TRANSATLANTIC COURSE
TRANSATLANTIC COURSE OF THE ESR AND RSNA

(RADIOLOGICAL SOCIETY OF NORTH AMERICA):
SPORTS IMAGING
2
2
TC 1328 Shoulder sports injuries and TC 1528 Knee sports injuries and
postoperative MRI postoperative MRI
Moderators: L.W. Bancroft; Orlando, FL/US Moderators: L.W. Bancroft; Orlando, FL/US
A.J. Grainger; Leeds/UK A.J. Grainger; Leeds/UK
A. Shoulder injuries in the throwing athlete [A-0804] A. Sports-related injuries of the knee:
L. Steinbach; San Francisco, CA/US what does the orthopaedic surgeon need to
B. Postoperative shoulder MRI after instability know? [A-0919]
surgery [A-0805] T.T. Miller; New York, NY/US
L.W. Bancroft; Orlando, FL/US B. ACL reconstruction and cartilage repair [A-0920]
C. Interactive case discussion C. Weidekamm; Vienna/AT
L. Steinbach; San Francisco, CA/US [A-0806] C. Interactive case discussion
L.W. Bancroft; Orlando, FL/US [A-0807] T.T. Miller; New York, NY/US [A-0921]
C. Weidekamm; Vienna/AT [A-0922]

March
2
TC 1428 Wrist and foot/ankle
sports injuries TC 1628 Musculoskeletal
interventional procedures
Moderators: L.W. Bancroft; Orlando, FL/US
A.J. Grainger; Leeds/UK Moderators: L.W. Bancroft; Orlando, FL/US
A. Soft tissue wrist injury in the athlete [A-0839] A.J. Grainger; Leeds/UK
C.W.A. Pfirrmann; Zurich/CH A. Diagnostic and therapeutic injections in the athlete:
B. Multimodality imaging of foot and ankle injuries pearls and pitfalls [A-0991]
in the athlete [A-0840] P. Peetrons; Brussels/BE
A.J. Grainger; Leeds/UK B. Injectables, percutaneous tendon fenestration
C. Interactive case discussion and tenotomy: clinical outcomes and current
C.W.A. Pfirrmann; Zurich/CH [A-0841] evidence [A-0992]
A.J. Grainger; Leeds/UK [A-0842] J.A. Jacobson; Ann Arbor, MI/US
C. Interactive case discussion
P. Peetrons; Brussels/BE [A-0993]
J.A. Jacobson; Ann Arbor, MI/US [A-0994]

JOINT
SESSIONS
133
JOINT SESSIONS
EDiR SESSION EFOMP WORKSHOPS

(European Diploma in Radiology) (European Federation of Organisations
This session aims to prepare prospective candidates
for Medical Physics)
for the European Diploma in Radiology (EDiR).
2
28
EDiR Session EDiR: an instrument EF 1 Big data and the big picture:
to develop excellence deep learning in optimisation
in your career of medical imaging (part A)
Moderators: J. Damilakis; Iraklion/GR

» Chairperson’s introduction
P. Gilligan; Dublin/IE
[A-0848]
L. Oleaga Zufiría; Barcelona/ES » Chairperson’s introduction [A-0264]
» EDiR teaser [A-0849]
L. Oleaga Zufiría; Barcelona/ES » Imaging and dose biobanks [A-0265]
E. Neri; Pisa/IT
» CORE examination
F. Saez; Barakaldo/ES [A-0850] » Statistical methods for analysis of multidimensional
L. Oleaga Zufiría; Barcelona/ES [A-0851] imaging data [A-0266]
K. Van Leemput; Copenhagen/DK
» Panel discussion
» The use of radiomics in medical imaging [A-0267]
P. Lambin; Maastricht/NL
28
EF 2 Big data and the big picture:
deep learning in optimisation
of medical imaging (part B)
Moderators: M. Brambilla; Novara/IT

M. Brambilla; Novara/IT
» Computer analysis in chest imaging: from rule-based
to machine learning to deep learning [A-0325]
B. Van Ginneken; Nijmegen/NL
» Deep learning in CT optimisation [A-0326]
M. Kachelrieß; Heidelberg/DE
» From image quality to care outcome [A-0327]

JOINT SESSIONS
EFRS WORKSHOP ESHIMT SESSIONS

(European Federation (European Society for Hybrid,
of Radiographer Societies) Molecular and Translational Imaging)
2
27
EFRS Workshop: in association ESHIMT 1 Clinical and methodological
with EIBIR and the Radiography Journal pitfalls in hybrid imaging:
EFRS WS Growing radiography research problems and solutions
Moderators: J. McNulty; Dublin/IE Moderators: C.C. Cyran; Munich/DE

J.M. Nightingale; Sheffield/UK F.A. Gallagher; Cambridge/UK
» Radiography research: where should we be in 2030? » Artefacts in hybrid imaging [A-0185]
L.A. Rainford; Dublin/IE [A-0860] T. Beyer; Vienna/AT
G. Paulo; Coimbra/PT [A-0861] » Clinical pitfalls in FDG-PET/CT and PET/MR [A-0186]
H. Precht; Odense/DK [A-0862] C. Pfannenberg; Tübingen/DE
» The clinical research radiographer: essential for » Clinical and technical pitfalls in SPECT/CT [A-0187]
our profession or facilitating the research of J. Howard; Manchester/UK
others? [A-0863]
B. Snaith; Wakefield/UK
» Turning your research idea into reality: opportunities 1
for European funding [A-0864]
P. Zolda; Vienna/AT ESHIMT 2 Artificial intelligence
» Research is nothing without effective
in hybrid imaging
dissemination [A-0865]
Moderators: C.C. Cyran; Munich/DE
F. Zarb; Msida/MT
» Panel discussion: What are the biggest barriers
» Radiomics+: prediction model using convergent
to growing radiographer-led research?
data [A-0552]
A. Leimgruber; Lausanne/CH
» AI and Holomics: predicting the truth from hybrid
imaging and non-imaging data [A-0553]
I. Buvat; Orsay/FR
» Sharing is caring: on the need for open research
data [A-0554]
O. Ratib; Geneva/CH
» Panel discussion: AI in HI: incremental value or
feeding the data explosion?

JOINT SESSIONS
ESOR SESSION ESR AUDIT AND STANDARDS

(European School of Radiology) SESSION
28
27
Feb Wednesday, February 27, 16:00–17:30, Room X
ESOR Artificial intelligence: presented ESR Audit Audit across Europe:
with new lecture formats directive and perspective
Moderators: B. Brkljačić; Zagreb/HR » Chairperson’s introduction [A-0137]

V. Vilgrain; Clichy/FR D.C. Howlett; Eastbourne/UK
» Introduction [A-0368] » Clinical audit and inspection:
B. Brkljačić; Zagreb/HR HERCA update [A-0138]
» ESOR in action 2019 [A-0369] S. Ebdon-Jackson; Didcot/UK
V. Vilgrain; Clichy/FR » Implementing a clinical audit programme:
» Artificial intelligence (AI) and machine learning (ML) the Finland experience [A-0139]
in medical imaging [A-0370] T. Autti; Helsinki/FI
W.J. Niessen; Rotterdam/NL » Implementing a clinical audit programme:
» Deep learning (DL) in medical imaging [A-0371] the radiographic perspective [A-0140]
A. Alberich-Bayarri; Valencia/ES M.-L. Ryan; Dublin/IE
» My experience: one-year fellowship [A-0372] » Quality improvement and change management:
Y. Purcell; Dublin/IE audit in industry [A-0141]
» Awards S. Lee; Guildford/UK
» Panel discussion: What are the benefits of good
clinical audit?
of Radiology.

JOINT SESSIONS
ESR PATIENT ADVISORY GROUP ESR ULTRASOUND SUBCOMMITTEE

(ESR-PAG) SESSIONS SESSION
2
27
Feb Wednesday, February 27, 16:00–17:30, Room Y
PA Communicating the role of the US 1 How to perform ultrasound
radiologist: best practices to manage image fusion
patient expectations
Moderator: P.S. Sidhu; London/UK
» Chairpersons’ introduction » Liver [A-0169]
N. Bedlington; Vienna/AT [A-0822] E.M. Jung; Regensburg/DE
N.I. Traykova; Plovdiv/BG [A-0823] » Kidney [A-0170]
» Explaining the radiologist’s role to patients [A-0824] J. Rübenthaler; Munich/DE
A. Brady; Cork/IE » Prostate [A-0171]
» The patient perspective: sharing expectations D.A. Clevert; Munich/DE
and experiences » Minimise the risk of infection transmission and
B. Bauer; Abensberg/DE [A-0825] effective decontamination protocols in the setting
E. Briers; Hasselt/BE [A-0826] of ultrasound fusion [A-0172]
» Best practices: tools to optimise communication C. Nyhsen; Strasbourg/FR
with patients [A-0827] » Panel discussion: How to start ultrasound image
L. Robinson; Gatley/UK fusion
» Panel discussion: How to maintain the human touch
in the radiology department in an era of rapid
technology adoption
1
US 2 Tips and tricks for abdominal
ultrasound
Moderator: S. Delorme; Heidelberg/DE

» Doppler imaging [A-0667]
F. Calliada; Pavia/IT
» CEUS [A-0668]
M. D’Onofrio; Verona/IT
» Elastography [A-0669]
D.A. Clevert; Munich/DE
» Fusion imaging [A-0670]
C. Ewertsen; Copenhagen/DK
» Panel discussion: When do we need additional
imaging techniques and how could we include
them in our workflow?

JOINT SESSIONS
EUROSAFE IMAGING
SESSIONS
27
Feb Wednesday, February 27, 08:30–10:00, Room N
1
March Friday, March 1, 16:00–17:30, Room N
EU 1 Cardiovascular effects after EU 3 Improving radiation protection
radiotherapy for breast cancer: in medical imaging in low- and middle-
the European MEDIRAD Project income countries: past actions and
future directions
A. Crijns; Groningen/NL [A-0014] » Chairpersons’ introduction
G. Frija; Paris/FR [A-0015] L. Donoso; Barcelona/ES [A-0657]
» Overview of dose-effect relationships and their use M.M. Rehani; Boston, MA/US [A-0658]
in strategies for prevention of cardiovascular effects » The International Society of Radiology’s (ISR)
after radiotherapy for breast cancer [A-0016] vision [A-0659]
A. Crijns; Groningen/NL G. Frija; Paris/FR
» Discussion » Patient doses in large part of the LMI countries and
» Optimisation of multivariable prediction models way forward: The International Organization for
for major cardiac events after radiotherapy for breast Medical Physics’ (IOMP) vision [A-0660]
cancer [A-0017] M.M. Rehani; Boston, MA/US
D.S. Spoor; Groningen/NL » The International Atomic Energy Agency’s (IAEA)
» Discussion approach [A-0661]
» The MEDIRAD Early-Heart study [A-0018] D. Gilley; Vienna/AT
S. Jacob; Fontenay aux Roses/FR » The World Health Organization’s (WHO)
» Discussion approach [A-0662]
M.D.R. Perez; Geneva/CH
» Imaging biomarkers of cardiovascular effects of
incidental cardiac radiation [A-0019] » Africa’s vision to improve radiation
E. Mousseaux; Paris/FR protection [A-0663]
B. Mansouri; Algiers/DZ
» Discussion
» Panel discussion: What are the main obstacles for
This session is part of the EuroSafe Imaging campaign. the safe use of imaging in low- and middle-income
countries?
28
Feb Thursday, February 28, 16:00–17:30, Room N
EU 2 Diagnostic reference levels (DRLs)

2 Saturday, March 2, 08:30–10:00, Room N
based on clinical indication March
Moderators: G. Frija; Paris/FR

EU 4 Advanced clinical dosimetry
G. Simeonov; Luxembourg/LU in interventional radiology
G. Frija; Paris/FR » Chairpersons’ introduction
W.R. Jaschke; Innsbruck/AT [A-0746]
» European Commission perspective [A-0409] E. Vaño; Madrid/ES [A-0747]
G. Simeonov; Luxembourg/LU
» The basis of clinical dosimetry in interventional
» One shoe does not fit all: clinical indication based radiology [A-0748]
DRLs [A-0410] K. Bacher; Ghent/BE
G. Frija; Paris/FR
» Real time staff dose monitoring [A-0749]
» Experience from the EUCLID (European study F. Vanhavere; Mol/BE
on clinical DRLs) Project [A-0411]
J. Damilakis; Iraklion/GR » Real time patient dose monitoring [A-0750]
R.M. Sánchez Casanueva; Madrid/ES
» Experience with a national survey based on clinical
indications [A-0412] » Dose management of patients and staff
S.J. Foley; Dublin/IE in interventional radiology [A-0751]
» Update of the national DRLs for CT in
Switzerland [A-0413] » Discussion
S.T. Schindera; Aarau/CH This session is part of the EuroSafe Imaging campaign.
» Discussion

JOINT SESSIONS
EUROSAFE IMAGING
SESSIONS
2
March Saturday, March 2, 14:00–15:30, Room N
3
March Sunday, March 3, 08:30–10:00, Room N
EU 5 Getting the balance right: EU 7 Artificial intelligence and
radiation risk and imaging benefit radiation protection
in paediatric procedures
» Chairperson’s introduction [A-0871] G. Frija; Paris/FR [A-1011]
C. Owens; London/UK C. Hoeschen; Magdeburg/DE [A-1012]
» Guidelines for the use of conventional » Artificial intelligence: a tool for quality and safety
radiographs in children and adolescents [A-0872] improvement in radiation protection [A-1013]
R. Seuri; Helsinki/FI G. Frija; Paris/FR
» Computed tomography: are we doing » Artificial intelligence for scatter reduction and
enough? [A-0873] optimising imaging procedures [A-1014]
E. Castellano; London/UK C. Hoeschen; Magdeburg/DE
» Dose reduction strategies in paediatric PET/CT and » Artificial intelligence for intelligent reconstruction
PET/MR examinations [A-0874] methods for radiation protection measures [A-1015]
J. Schäfer; Tübingen/DE C.T. Whitlow; Winston-Salem, NC/US
» Radiation safety in interventional procedures » Using artificial intelligence for optimising procedures
in children [A-0875] reflecting radiosusceptibility of patients [A-1016]
C. Granata; Genoa/IT C. Hoeschen; Magdeburg/DE
» Discussion » Discussion
This session is part of the EuroSafe Imaging campaign. This session is part of the EuroSafe Imaging campaign.
2
EU 6 CT radiation risk in children:
an overview

E. Cardis; Barcelona/ES
» A literature update [A-0934]
H. Ducou Le Pointe; Paris/FR
» Ongoing studies and first results of the European EPI-
CT study [A-0935]
E. Cardis; Barcelona/ES
» Communicating benefits and risks to parents and
carers [A-0936]
C. Granata; Genoa/IT
» Daily practical challenges in CT for
children [A-0937]
C. Owens; London/UK
» Questions and answers

2;'8'9;'&-28!&-!ধ32683;'$ধ328'9'!8$,S
3-2 R
We aim to advance
1'&-$!£8!&-!ধ32683;'$ধ32
in Europe through
9<9;!-2!#£'8'9'!8$,'ø38;9
Visit the EIBIR lounge in the entrance hall

(38138'-2(381!ধ32!2&$,'$03<;3<8
new website at www.euramed.eu
JOINT SESSIONS
PROFESSIONAL ISSUES AND

ECONOMICS IN RADIOLOGY
(PIER) SESSIONS
1
1
PIER @ ECR Session PIER @ ECR Session
(Jointly organised with the ESR eHealth (Jointly organised with the ESR Audit and
Subcommittee) Standards Subcommittee)
PI 1 Reporting and communication today PI 2 Clinical audit: how to deal
and tomorrow: challenges to implement with the legal and professional
structured reporting (RS) and deal requirements
with artificial intelligence (AI)
Moderators: D.C. Howlett; Eastbourne/UK
G. McGinty; New York, NY/US
A. Brady; Cork/IE [A-0502] » Chairperson’s introduction [A-0585]
E. Neri; Pisa/IT [A-0503] D.C. Howlett; Eastbourne/UK
» Update on developments for structured reporting: » ESR’s concept and tools for clinical audit [A-0586]
Radreport 2.0, TLAP, MRRT [A-0504] K. Drinkwater; London/UK
P. Mildenberger; Mainz/DE » Overview on adoption of BSS throughout
» The concept of common data elements (CDE) Europe [A-0587]
for reporting [A-0505] A. Brady; Cork/IE
C.E. Kahn; Philadelphia, PA/US » Peer review as key for quality improvement:
» Decision support and artificial intelligence (AI) the US experience [A-0588]
to improve reporting in radiology [A-0506] G. McGinty; New York, NY/US
T.K. Alkasab; Boston, MA/US » Can newer IT-developments including artificial
» Communication with referring physicians and intelligence (AI) help to improve quality in
patients: what is relevant? [A-0507] radiology? [A-0589]
J.M.L. Bosmans; Ghent/BE J. Schillebeeckx; Knokke/BE
» Panel discussion: How to use structured reporting » Panel discussion: Why should radiologists care about
and artificial intelligence in reporting clinical audit and peer review?
1
PIER @ ECR Session
(Jointly organised with the ESR Research Committee)
PI 3 Professional issues for radiology
departments to enable research
Moderators: J.K. Bell; Manchester/UK

» How to attract residents to research [A-0626]
H.-U. Kauczor; Heidelberg/DE
» How to organise an imaging department for clinical
research [A-0627]
» How to deal with legal requirements in research
activities [A-0628]
P.M.A. van Ooijen; Groningen/NL
» How to implement research on artificial intelligence
in radiology [A-0629]
K.J. Dreyer; Boston, MA/US
» Panel discussion: Will research in radiology survive?

JOINT SESSIONS
JOINT SESSIONS
WITH RELATED SOCIETIES
28
1
Joint Session of the EFRS and EORTC Joint Session of the ESR and EFOMP
(European Organisation for Research and (European Federation of Organisations
Treatment of Cancer) for Medical Physics)
Radiographers: at the heart of cancer treatment Medical imaging and emerging issues
and research in occupational radiation exposure
Moderators: C. Beardmore; London/UK Moderators: M. Brambilla; Novara/IT

M. Smits; Rotterdam/NL W.R. Jaschke; Innsbruck/AT
» An overview of the roles of radiographers in » Is fear of radiation-induced occupational
research [A-0439] cancer irrational? [A-0544]
J. McNulty; Dublin/IE P. Vock; Spiegel/CH
» Establishing the scientific and clinical value » Eye lens radiation dose and
of advanced imaging [A-0440] cataractogenesis [A-0545]
M. Smits; Rotterdam/NL J. Damilakis; Iraklion/GR
» Fostering excellence in radiation oncology research » Occupational exposure from interventional
through a clinical research culture [A-0441] radiology procedures: how to measure it,
H. McNair; London/UK how to reduce it [A-0546]
» Radiation therapy quality assurance (RTQA) W.R. Jaschke; Innsbruck/AT
in clinical trials: the role of the radiographer/radiation » Selection and usage of personal protective
therapy technologist [A-0442] equipment in the fluoroscopy and interventional
M. van Os; Rotterdam/NL radiology operating room [A-0547]
» Panel discussion: Preparing our departments M. Brambilla; Novara/IT
for high quality clinical trials » Panel discussion: Has the optimisation of
occupational radiation exposure in radiology
procedures reached a plateau?
1
March Friday, March 1, 14:00–15:30, Room E1 This session is part of the EuroSafe Imaging campaign.
Joint Session of the ESR and the BBMRI-ERIC
(Biobanking and BioMolecular resources 2
Research Infrastructure - European Research
Joint Session of the ESR and EFRS
Infrastructure Consortium)
(European Federation of Radiographer Societies)
Will the General Data Protection Regulation
Patient safety in medical imaging
(GDPR) hamper the secondary use
of clinical imaging data for research? Moderators: A. Brady; Cork/IE
J. McNulty; Dublin/IE
Moderators: E. Steinfelder; Graz/AT
» EuroSafe Imaging and the European Basic
A. van der Lugt; Rotterdam/NL
Safety Standards Directive: progressing patient
» Why is secondary use of existing imaging data safety [A-0928]
important for research progress? [A-0630] G. Frija; Paris/FR
E. Steinfelder; Graz/AT
» Patient safety: beyond radiation protection [A-0929]
» Can I reuse, share or give open access to existing K. Azevedo; Faro/PT
imaging data for research? [A-0631]
» Value-based imaging and patient safety [A-0930]
M.T. Mayrhofer; Graz/AT
A. Brady; Cork/IE
» Can I sell or licence imaging data to industry or
» Patient safety related education and
spin-off companies? [A-0632]
training [A-0931]
J.A. Bovenberg; Aerdenhout/NL
» How to anonymise imaging data for
» Patient perspectives on patient safety in medical
research? [A-0633]
imaging [A-0932]
B. Gibaud; Rennes/FR
E. Briers; Hasselt/BE
» Panel discussion: How to overcome the hurdles
» Panel discussion: The role of the ESR and the EFRS
of secondary use of imaging data
in promoting patient safety

JOINT SESSIONS
JOINT SESSIONS
27
2
Joint Session of the ESR and EIBALL Joint Session of the ESR and ESHIMT
(European Imaging Biomarkers Alliance) (European Society for Hybrid, Molecular and
Imaging biomarkers and their combinations Translational Imaging)
in the era of artificial intelligence Hybrid and translational imaging:
the bigger picture
O. Clément; Paris/FR [A-0056] » Chairpersons’ introduction
N.M. deSouza; Sutton/UK [A-0057] O. Ratib; Geneva/CH [A-0972]
» Building and discovering biomarkers C.C. Cyran; Munich/DE [A-0973]
with AI [A-0058] » Prostate-specific membrane antigen (PSMA) PET/
B. Rance; Paris/FR MR: guiding clinical management of prostate
» COST action initiatives as a platform for image cancer [A-0974]
biomarker selection [A-0059] P.A.T. Baltzer; Vienna/AT
A. Caroli; Ranica/IT » On the horizon: novel PET tracers with translational
» Role of AI in the introduction of imaging biomarkers: potential [A-0975]
accelerator or obstacle? [A-0060] G. Cook; London/UK
J.C. Waterton; Manchester/UK » Advances in theragnostics: monitoring radionuclide
» Panel discussion: What infrastructure do we need therapy [A-0976]
to exploit AI for selecting, validating and managing H. Ilhan; Munich/DE
imaging biomarkers? » Panel discussion: Hybrid imaging beyond FDG and
theranostics: is it a clinical reality?
2
3
March Sunday, March 3, 08:30–10:00, Room X
Joint Session of the ESR and EORTC
(European Organisation for Research and Joint Session of the ESR and ESMRMB
Treatment of Cancer) (European Society for Magnetic
Imaging in oncological trials Resonance in Medicine and Biology)
A new era of gadolinium-less MR
Moderators: N.M. deSouza; Sutton/UK
M. Smits; Rotterdam/NL Moderators: D. Sappey-Marinier; Bron/FR
» Chairperson’s introduction [A-0789] M.J.P. van Osch; Leiden/NL
N.M. deSouza; Sutton/UK » Radiomics and multiparametric MRI approaches for
» Trial design and imaging end-points [A-0790] a better contrast in cardiac and prostate
L. Collette; Brussels/BE applications [A-1008]
» Modern imaging-based trials: focus on B. Baeßler; Mannheim/DE
oligometastatic disease and evaluation of metastatic » From native T1 to arterial spin labelling MRI
directed therapies [A-0791] in the heart [A-1009]
F.E. Lecouvet; Brussels/BE F. Kober; Marseille/FR
» Assessing treatment response in the era of » Brain perfusion and angiography using ASL
immunotherapy [A-0792] in comparison with gadolinium based
C. Caramella; Villejuif/FR techniques [A-1010]
» Radiomics in oncology trials [A-0793] H.R. Jäger; London/UK
P. Kickingereder; Heidelberg/DE » Panel discussion: Is it feasible to apply gadolinium-
» Panel discussion: What is the future of image-aware free techniques in clinical practice?
clinical trials? Challenges and opportunities

JOINT SESSIONS
JOINT SESSIONS
1
28
Joint Session of the ESR and ESTRO Joint Session of the ESR and UEMS
(European Society for Radiotherapy and Oncology) (Union Européenne des Médecins Spécialistes)
Current status and future challenges Imaging professionals in the EU:
in MR-integrated radiotherapy radiologists without borders
» Chairpersons’ introduction » Chairpersons’ introduction

L.E. Derchi; Genoa/IT [A-0496] M. Adriaensen; Heerlen/NL [A-0211]
U. Ricardi; Turin/IT [A-0497] L. Bonomo; Rome/IT [A-0212]
» Clinical status of MR-integrated photon » Putting your interests first: UEMS and ESR advocacy
therapy [A-0498] in the EU
L. Boldrini; Rome/IT P.M. Parizel; Antwerp/BE [A-0213]
» Integration of MR and particle therapy: how far are B. Maillet; Brussels/BE [A-0214]
we [A-0499] » Part 1: What does the EU mean for me?
A. Hoffmann; Maastricht/NL A radiologist’s guide
» MR-based functional imaging [A-0500] » To be or not to be at the table: why advocacy matters
R.G.H. Beets-Tan; Amsterdam/NL for radiologists [A-0215]
» Adaptive workflow: current status and K. Riklund; Umea/SE
challenges [A-0501] » Creating a European radiology (or healthcare)
S. Kharuzhyk; Minsk/BY workforce: the value of qualifications across
» Panel discussion: We need more integration than borders [A-0216]
originally thought: how to get there? H. Käfer; Vienna/AT
» Brexit means Brexit: radiologists with
borders? [A-0217]
V. Papalois; London/UK
» Part 2: Educating the next generation of radiologists
» The benefits of harmonised training for the
radiologists of tomorrow [A-0218]
» Making your qualifications count at home and abroad:
the European Diploma in Radiology and
the CESMA [A-0219]
H.J. Lamb; Leiden/NL
» ETAP 2.0 [A-0220]
» Part 3: Staying ahead of the curve with continuing
professional development (CPD)
» Patient safety and job security for life: CME/CPD
in Europe [A-0221]
P. Ricci; Rome/IT
» It’s easier than you think: the many ways to gain
European CME/CPD credits [A-0222]
M.A. Lucic; Sremska Kamenica/RS
» Panel discussion: The state of radiology in the EU:
a diagnosis of “the bigger picture”

JOINT SESSIONS
JOINT SESSIONS
28
27
Joint Session of the ESR Ultrasound Joint Session of the ESR Ultrasound
Subcommittee and the Undergraduate Education Subcommittee with EFSUMB
Subcommittee (European Federation of Societies for
US teaching to undergraduate students: Ultrasound in Medicine and Biology)
why, how and from whom? Ultrasound simulation models in training
and education: where are we going?
Moderators: C. Nyhsen; Strasbourg/FR
V. Válek; Brno/CZ
» Why: US anatomy and pathology teaching, D.A. Clevert; Munich/DE [A-0039]
US in clinical practice and as a career P.S. Sidhu; London/UK [A-0040]
choice [A-0337]
» Needs assessment of simulations-based training
T. Fischer; Berlin/DE
in radiology [A-0041]
» How: US teaching in the radiology department L. Nayahangan; Copenhagen/DK
and hands-on classroom teaching using living models
» Review of the available market of ultrasound
and simulators [A-0338]
simulators [A-0042]
M. Bachmann Nielsen; Copenhagen/DK
» From whom: the importance of radiologists
» Gamification and virtual reality in medical
delivering US teaching and staying experts
simulation [A-0043]
in this field [A-0339]
L. Konge; Copenhagen/DK
K. Rosendahl; Bergen/NO
» Panel discussion: Will there be an option to include
» Panel discussion: How can radiologists use US
these technics in our daily work and how could we
to teach undergraduate students effectively,
improve the outcome?
within time and cost constraints, whilst promoting
their specialty as a career choice?

Be a STAR!
Visit the ESR Connect Studio
Share your ECR story
The ESR Connect Studio

is located at the DC Box
opposite the church
REFRESHER COURSES/
SCIENTIFIC SESSIONS
Refresher Courses aim to refresh knowledge, review and update
the more basic subjects for those who have not kept up
to speed with certain developments, or who just need a reminder
– something of interest not only to young radiologists but also
experienced doctors.
Accepted papers for oral presentation are presented

in the Scientific Sessions. The authors of the best scientific
papers will be presented with a certificate and given free ECR
2019 registration. An award will be assigned to the best paper
presentation of each topic based on the evaluation by session
moderators and subcommittee members. Selection criteria
comprise quality of presentation, scientific content and overall
impression of the performance.
147
REFRESHER COURSES / SCIENTIFIC SESSIONS

27
Feb Wednesday, February 27, 08:30–10:00, Room B
28
RC 101 Imaging of benign liver lesions: RC 501 GI bleeding: how can the problem be
still difficult? solved?

P. Ricci; Rome/IT D. Negru; Iasi/RO
A. Hepatic cysts: always simple? [A-0002] A. Acute GI bleeding [A-0205]
I. Santiago; Lisbon/PT G.H. Mostbeck; Vienna/AT
B. Liver haemangiomas and mimickers [A-0003] B. Occult and overt GI bleeding: the role of
F. Caseiro Alves; Coimbra/PT radiology [A-0206]
C. FNH or adenoma? [A-0004] C. Stroszczynski; Regensburg/DE
A. Ba-Ssalamah; Vienna/AT C. When is the interventional radiologist needed? [A-0207]
» Panel discussion: What imaging strategy for my D.K. Tsetis; Iraklion/GR
routine clinical practice? » Panel discussion: Guidelines for management of GI
bleeding and real life: why are they different?
27 Wednesday, February 27, 10:30–12:00, Coffee & Talk 2
Feb
28
SS 201a Focal liver lesions: characterisation
[B-0067 – B-0076] SS 501 Diffuse and focal pancreatic disease
[B-0448 – B-0458]
Moderators: R. Albazaz; Leeds/UK
M.A. Bali; Brussels/BE Moderators: E. Amosova; Moscow/RU
» Keynote Lecture: [K-01] A. Taibbi; Palermo/IT
D. Weishaupt; Zurich/CH 28
27 Wednesday, February 27, 10:30–12:00, The Church
Feb SS 701 CT technical frontiers in liver imaging
SS 201b New developments in anorectal imaging [B-0790 – B-0800]
[B-0204 – B-0214]
Moderators: A. Blachar; Tel Aviv/IL
Moderators: F. Iacobellis; Naples/IT C. Sofia; Messina/IT
A. Maier; Vienna/AT 1
March Friday, March 1, 08:30–10:00, Room B
27 Wednesday, February 27, 14:00–15:30, Room B
Feb RC 901 Imaging of the complicated
RC 301 Tumour response assessment postoperative abdomen
in abdominal imaging
Moderator: S.M. Ertürk; Istanbul/TR C.J. Zech; Basle/CH
A. Colorectal liver metastases [A-0107] A. Liver [A-0486]
S.K. Venkatesh; Rochester, MN/US C. Ayuso; Barcelona/ES
B. Rectal carcinoma [A-0108] B. Pancreas [A-0487]
M.J. Lahaye; Amsterdam/NL R.M. Gore; Evanston, IL/US
C. Pancreatic adenocarcinoma [A-0109] C. Bowel [A-0488]
M. Zins; Paris/FR D.J.M. Tolan; Leeds/UK
27
Feb Wednesday, February 27, 14:00–15:30, The Church
» Panel discussion: Tips and tricks for my routine
clinical practice
SS 301 Biliary imaging: what next? 1
[B-0385 – B-0395]
SS 1001a Colonic imaging revisited
Moderators: N.A. Courcoutsakis; Alexandroupolis/GR
[B-0935 – B-0945]
S.R. Marticorena Garcia; Berlin/DE
27
Moderators: L. Curvo-Semedo; Coimbra/PT
M. Langenbach; Frankfurt/DE
SS 401 Liver and biliary MRI: 1
March Friday, March 1, 10:30–12:00, Tech Gate Auditorium
protocols and technical frontiers
[B-0396 – B-0405] SS 1001b Hepatobiliary contrast agents:
focal and diffuse liver disease
Moderators: C.S. Reiner; Zurich/CH
[B-1042 – B-1052]
M. Ronot; Clichy/FR
» Keynote Lecture: [K-11] Moderators: A. Torregrosa Andrés; Valencia/ES
M. Ronot; Clichy/FR F. Vernuccio; Palermo/IT


1
March Friday, March 1, 16:00–17:30, Room B
3
RC 1201 Imaging the acute abdomen: RC 1701 Hepatocellular carcinoma:
new insights from diagnosis to treatment
Moderator: D.E. Malone; Dublin/IE » Chairperson’s introduction [A-1001]

A. Acute mesenteric ischaemia [A-0648] G. Brancatelli; Palermo/IT
M. Ronot; Clichy/FR A. How to diagnose HCC: new guidelines [A-1002]
B. Low-dose abdominal CT for evaluating suspected K.J. Fowler; San Diego, CA/US
appendicitis [A-0649] B. Unusual appearances of HCC and lesions that
K.H. Lee; Seoul/KR simulate HCC: can we increase diagnostic
C. Acute colonic diverticulitis [A-0650] confidence? [A-1003]
S. Schmidt Kobbe; Lausanne/CH J.M. Lee; Seoul/KR
C. Interventional techniques (ablation, TACE,
2
March Saturday, March 2, 10:30–12:00, Room B
radioembolisation): when and how to treat [A-1004]
R. Duran; Lausanne/CH
SS 1401a Assessing pancreatic malignancy » Panel discussion: How to improve a patient’s
[B-1094 – B-1104] experience and prognosis
Moderators: N. Kartalis; Stockholm/SE

M. Klauß; Heidelberg/DE 3
March Sunday, March 3, 10:30–12:00, Coffee & Talk 2
SS 1801a Diffuse liver disease:
2 Saturday, March 2, 10:30–12:00, The Church
March fibrosis, steatosis and inflammation
SS 1401b Gastric cancer and beyond [B-1528 – B-1538]
[B-1275 – B-1285]
Moderators: T. Denecke; Berlin/DE
M.M. França; Porto/PT
Moderators: I. Blazic; Belgrade/RS
C. Dromain; Lausanne/CH
3
2
March Saturday, March 2, 14:00–15:30, Room M 4 SS 1801b Inflammatory bowel disease:
SS 1501a Rectal cancer: what’s new? what now?
[B-1339 – B-1346] [B-1646 – B-1655]
Moderators: D. Miletić; Rijeka/HR Moderators: N.N.

N.N. N.N.
» Keynote Lecture:
2
March Saturday, March 2, 14:00–15:30, Tech Gate Auditorium
N.N.
SS 1501b Multimodality imaging for assessment

of liver function and portal hypertension
3
[B-1370 – B-1380] SS 1901a Diagnosis of hepatocellular carcinoma:
Moderators: M. Garbajs; Ljubljana/SI
the LI-RADS perspective
N.N. [B-1762 – B-1772]
Moderators: A. Ba-Ssalamah; Vienna/AT

2
March Saturday, March 2, 16:00–17:30, Room B D. Christodoulou; London/UK
RC 1601 Diagnosis and management

of acute pancreatitis 3
Moderator: C. Triantopoulou; Athens/GR SS 1901b Gastro-oesophageal imaging:
A. The 2012 revised Atlanta Classification: now and next
what has really changed? [A-0925] [B-1871 – B-1880]
T. Bollen; Nijmegen/NL
Moderators: G.H. Mostbeck; Vienna/AT
B. Role of imaging in diagnosis of acute pancreatitis:
T. Rohan; Brno/CZ
new trends [A-0926]
G. Zamboni; Verona/IT
C. Intervention radiology in acute pancreatitis:
why, when and how [A-0927]
M.M. Maher; Cork/IE


Breast
27
1
SS 202 Mammography and screening RC 902 Screening for breast cancer
[B-0077 – B-0087]
Moderators: A.M.J. Bluekens; Breda/NL F.J. Gilbert; Cambridge/UK
V. Lehotská; Bratislava/SK A. Screening with mammography and digital breast
tomosynthesis alone [A-0527]
27
R.M. Pijnappel; Utrecht/NL
B. Combined screening with mammography and
SS 302 Digital breast tomosynthesis (DBT) ultrasound [A-0528]
[B-0247 – B-0257] T.H. Helbich; Vienna/AT
C. Personalised multimodality screening
Moderators: J. Etxano; Vitoria/ES with MRI [A-0529]
P.L. Moyle; Cambridge/UK U. Bick; Berlin/DE
» Panel discussion: What is the best approach to screen
28
for breast cancer?
RC 502 MRI for early detection, staging and

1 Friday, March 1, 10:30–12:00, Room E1
management of breast cancer March
SS 1002 Breast density and risk stratification

» Chairperson’s introduction [A-0232] [B-0915 – B-0924]
P.A.T. Baltzer; Vienna/AT
A. Preoperative staging with MRI: results of Moderators: G. Esen; Istanbul/TR
preoperative MRI (MIPA) trial [A-0233] H. Sartor; Lund/SE
F. Sardanelli; San Donato Milanese/IT » Keynote Lecture: [K-21]
B. MR imaging biomarkers for the clinical A. Vourtsis; Athens/GR
setting [A-0234]
E.A. Morris; New York, NY/US
1
C. Screening with abbreviated protocols [A-0235]
C.K. Kuhl; Aachen/DE RC 1202 Minimally-invasive local treatment of
» Panel discussion: What can we do to improve the breast cancer: the time is now
adoption of MRI in clinical practice?
28
A. Athanasiou; Athens/GR
A. High-intensity focused ultrasound (HIFU)
SS 602 Magnetic resonance imaging (MRI) therapy [A-0672]
[B-0545 – B-0555] F. Pediconi; Rome/IT
B. Radiofrequency ablation therapy [A-0673]
Moderators: P. Clauser; Vienna/AT B. Brkljačić; Zagreb/HR
G. Ivanac; Zagreb/HR
C. Cryotherapy [A-0674]
28
Feb Thursday, February 28, 14:00–15:30, Room E1 » Panel discussion: Will we still need surgery for local
therapy of breast cancer in the future?
SS 702a Decision tools and artificial intelligence
in breast imaging
[B-0695 – B-0704]
Moderators: T. Sella; Jerusalem/IL

N.N.
» Keynote Lecture: [K-16]
F.J. Gilbert; Cambridge/UK
28
SS 702b Breast ultrasound
[B-0716 – B-0726]
Moderators: E. Giannotti; Nottingham/UK

M. Marolt Music; Ljubljana/SI


Breast
2
3
RC 1302 New mammography: RC 1702 Diagnosing ductal carcinoma
digital breast tomosynthesis and in situ (DCIS)
future techniques
Moderator: C. Van Ongeval; Leuven/BE
» Chairperson’s introduction [A-0760] A. New radiologic-pathologic knowledge
E.M. Fallenberg; Munich/DE on DCIS [A-1027]
A. Frigerio; Turin/IT
A. Should we abandon 2D mammography? [A-0761]
S. Zackrisson; Malmö/SE B. Imaging DCIS [A-1028]
J. Camps Herrero; Valencia/ES
B. Clinical validation of digital breast tomosynthesis
and results in the last 10 years: where do we C. Diagnosing DCIS with biopsy [A-1029]
stand? [A-0762] M.G. Wallis; Cambridge/UK
P. Skaane; Oslo/NO
C. Contrast-enhanced mammography and other 3
developing techniques [A-0763]
E. Giannotti; Nottingham/UK SS 1802a Radiation dose, quality assurance,
» Panel discussion: Mammography, digital and safety in breast imaging
breast tomosynthesis and contrast-enhanced [B-1539 – B-1549]
mammography: where will we stand in 10 years?
Moderators: I. Kralik; Zagreb/HR
N.N.
2
SS 1402a Interventional breast radiology and
high-risk lesions
3
[B-1149 – B-1159]
SS 1802b DWI, spectroscopy and other advanced
Moderators: S. Barter; Bedford/UK
A. Jalaguier; Marseille/FR breast MR techniques
[B-1561 – B-1570]
2
Moderators: N. Radovic; Zagreb/AT
N.N.
SS 1402b Breast imaging biomarkers and » Keynote Lecture: [K-36]
radiomics P.A.T. Baltzer; Vienna/AT
[B-1170 – B-1180]
Moderators: D. Djilas-Ivanovic; Sremska Kamenica/RS 3

I.-A. Gheonea; Craiova/RO
SS 1902a Contrast-enhanced mammography,
breast CT, and other new imaging
techniques
[B-1784 – B-1794]
Moderators: M. Bernathova; Vienna/AT

F. Pesapane; Milan/IT
3
SS 1902b Breast cancer staging, therapy
monitoring and recurrence
[B-1795 – B-1805]
Moderators: M.A. Orsi; Milano/IT

N.N.


Cardiac
27
Feb Wednesday, February 27, 10:30–12:00,
1
Tech Gate Auditorium SS 1003 Cardiac CT in search of coronary
SS 203 Imaging before and after aortic artery disease
valve repair [B-1010 – B-1019]
[B-0194 – B-0203]
Moderators: M. Kantarci; Erzurum/TR
Moderators: L. Celeng; Utrecht/NL M. Krupinski; Krakow/PL
N. Gagarina; Moscow/RU » Keynote Lecture: [K-25]
» Keynote Lecture: [K-06] M. Williams; Edinburgh/UK
J.-N. Dacher; Rouen/FR
2
27
SS 1403 Quantification of myocardial perfusion
and ECV (extracellular volume fraction)
[B-1212 – B-1222]
SS 303 Benefits of cardiac MR mapping
for myocardial characterisation Moderators: K. Nikolaou; Tübingen/DE
A. Rossi; Milan/IT
[B-0374 – B-0384]
Moderators: R. Maksimović; Belgrade/RS

2
March Saturday, March 2, 14:00–15:30, Room O
N.N.
RC 1503 Cardiac imaging in structural
heart disease
27
Feb Wednesday, February 27, 16:00–17:30, Room O
RC 403 From diagnosis to prognosis: L. Natale; Rome/IT
how does cardiac imaging affect A. CT-guided planning of minimally invasive
patient outcome? procedures [A-0877]
R. Salgado; Antwerp/BE
Moderator: A. Kallifatidis; Thessaloniki/GR
B. Defining the optimal time to treat valvular heart
A. In myocarditis [A-0146] disease: role of MR [A-0878]
M. Francone; Rome/IT J. Mascherbauer; Vienna/AT
B. In non-ischaemic cardiomyopathy [A-0147] C. Follow-up after minimally invasive valvular
B. Velthuis; Utrecht/NL repair [A-0879]
C. In coronary artery disease [A-0148] H. Alkadhi; Zurich/CH
M. Kantarci; Erzurum/TR » Panel discussion: How to face the challenges of
the increasing demand for imaging evaluation in
28 structural heart disease
SS 603 Cardiac MR myocardial feature tracking March
[B-0588 – B-0598] SS 1503 Coronary calcium and plaques:

diagnosis and prognosis
Moderators: R. Heiß; Erlangen/DE
R. Salgado; Antwerp/BE [B-1306 – B-1316]
Moderators: P. Donato; Coimbra/PT

28
C. Lücke; Leipzig/DE
SS 703 CT-FFR (fractional flow reserve) for 2

assessment of coronary artery disease
RC 1603 Acute chest pain and
[B-0780 – B-0789]
cardiac imaging
Moderators: R.A.P. Minoiu; Bucharest/RO
Moderator: P. Croisille; Saint-Etienne/FR
C.A. Takx; Utrecht/NL
A. Acute chest pain: who should see the patient first,
the doctor or the CT department? [A-0938]
G. Pontone; Milan/IT
M. Gutberlet; Leipzig/DE
B. Myocardial perfusion in acute coronary syndrome
(ACS): necessity or luxury? [A-0939]
R. Vliegenthart; Groningen/NL
C. Late gadolinium enhancement (LGE) and more:
the role of MRI in and after ACS [A-0940]
J. Bremerich; Basle/CH


Cardiac Chest
3
March Sunday, March 3, 08:30–10:00, Room O
27
RC 1703 Dead or alive: imaging SS 204 Lung cancer: guidelines, screening
of myocardial viability and nodule management
[B-0141 – B-0151]
C. Peebles; Southampton/UK Moderators: F.B. Demirkazik; Ankara/TR
A. MRI [A-1018] P. Franchi; Teramo/IT
T. Leiner; Utrecht/NL
B. Hybrid imaging [A-1019] 28
F. Caobelli; Basle/CH
C. CT [A-1020] RC 504 Pulmonary neuroendocrine
F. Bamberg; Tübingen/DE proliferations and neoplasms
» Panel discussion: What imaging test in which patient?
Moderator: M. Silva; Parma/IT
A. Diffuse idiopathic pulmonary neuroendocrine cell
3
March Sunday, March 3, 10:30–12:00, Room M 1 hyperplasia (DIPNECH) [A-0268]
G. Chassagnon; Paris/FR
SS 1803 Advanced cardiac MR for evaluation B. Carcinoid tumours [A-0269]
of left ventricular structure and function H. Prosch; Vienna/AT
[B-1613 – B-1623] C. Small cell lung cancer [A-0270]
M. Das; Duisburg/DE
Moderators: R.G. Chelu; Rotterdam/NL
N.N.
28
3
March Sunday, March 3, 14:00–15:30, Coffee & Talk 3 SS 604 COPD, emphysema and airways
SS 1903a Cardiac MR in cardiomyopathies: diseases: novel approaches
tips and tricks [B-0577 – B-0587]
[B-1816 – B-1826] Moderators: J.D. Dodd; Dublin/IE

N.N.
Moderators: A. Pershina; Moscow/RU
M. Pirnat; Maribor/SI
28
3
March Sunday, March 3, 14:00–15:30, Room M 1 SS 704 Lung cancer:
SS 1903b Discovering the right ventricle diagnosis, staging and outcome
in cardiac MR [B-0769 – B-0779]
[B-1859 – B-1869] Moderators: F. Molinari; Lille/FR

N.N.
Moderators: Z. Olczak; Katowice/PL
1
March Friday, March 1, 08:30–10:00, Room K
RC 904 Lung nodule management
in 2019

A. Devaraj; London/UK
A. Radiological assessment [A-0549]
B. Computer-aided diagnosis and AI
perspective [A-0550]
A.R. Larici; Rome/IT
C. Management guidelines [A-0551]
A.A. Bankier; Boston, MA/US
» Panel discussion: What do radiologists need to better
manage pulmonary nodules?


Chest
1
2
March Saturday, March 2, 16:00–17:30, Room K
SS 1004 Advanced methods for nodule SS 1604 Inflammatory, fibrotic and
evaluation infectious lung diseases
[B-1000 – B-1009] [B-1403 – B-1413]
Moderators: I. Pulzato; Genua/IT Moderators: C. Beigelman; Lausanne/CH

M. Regier; Hamburg/DE M. Benegas; Barcelona/ES
» Keynote Lecture: [K-24] This session is part of the EuroSafe Imaging campaign.
C.J. Herold; Vienna/AT
3
1
March Sunday, March 3, 08:30–10:00, Room K
RC 1704 Thoracic emergencies
RC 1204 Fibrotic lung diseases
Moderator: B. Ghaye; Brussels/BE
» Chairperson’s introduction [A-0699] A. Chest trauma [A-1053]
S.R. Desai; London/UK M. Brink; Nijmegen/NL
A. Idiopathic pulmonary fibrosis [A-0700] B. Haemoptysis [A-1054]
N. Sverzellati; Parma/IT M.-P. Revel; Paris/FR
B. Lung fibrosis in connective tissue and granulomatous C. Diagnosing PE [A-1055]
diseases [A-0701] G. Aviram; Tel Aviv/IL
P.-Y. Brillet; Bobigny/FR
D. Vascular intervention in thoracic
C. Other causes of lung fibrosis [A-0702] emergencies [A-1056]
C.P. Heussel; Heidelberg/DE I. Bargellini; Pisa/IT
» Panel discussion: What is the radiologist’s role
in the evolving spectrum of pulmonary fibrosis?
3
2
SS 1804 Thoracic imaging: new approaches
and techniques
SS 1404 Advanced lung imaging: [B-1603 – B-1612]
MRI and artificial intelligence
[B-1201 – B-1211] Moderators: G. Chassagnon; Paris/FR
E.J. Stern; Seattle, WA/US
Moderators: J. Coolen; Leuven/BE » Keynote Lecture: [K-38]
N.N. E.J. Stern; Seattle, WA/US
2
March Saturday, March 2, 14:00–15:30, Room K 3
RC 1504 Back to basics: how to interpret SS 1904 Traditional and advanced pulmonary
a chest radiograph? vascular imaging
[B-1848 – B-1858]
S.P.G. Padley; London/UK Moderators: A. Nair; London/UK
A. A chest radiography reading guide [A-0914] M. Sánchez; Barcelona/ES
N. Howarth; Chêne-Bougeries/CH
B. Alveolar, interstitial and nodular syndromes [A-0915]
F. Molinari; Lille/FR
C. Lobar atelectasis [A-0916]
D. Tack; Baudour/BE
D. Pleural syndrome [A-0917]
E. Mediastinal syndrome [A-0918]
» Panel discussion: Why does the chest radiograph
remain essential in the context of expanding
cross-sectional imaging?


Imaging Informatics Artificial Intelligence and Machine Learning
27
27
Feb Wednesday, February 27, 10:30–12:00, Room B
RC 105 Mobile devices in radiology SS 205 Intelligent dose and quality
management
O. Ratib; Geneva/CH
A. Security and confidentiality aspects of mobile Moderators: M. Fatehi; Tehran/IR
computing [A-0011] V. Suomi; Turku/FI
E.R. Ranschaert; Tilburg/NL
B. Added value of mobile devices in education [A-0012]
C. Recommendations for reporting on mobile
27
devices [A-0013]
SS 305 Machine learning: chest and cardiac
N.H. Strickland; London/UK
[B-0300 – B-0310]
» Panel discussion: Can mobile technology supplement
stationary technology in radiology? Moderators: C.L. Schlett; Freiburg/DE
N.N.
27
28 Thursday, February 28, 10:30–12:00, Room D
RC 405 Everything you need to know Feb
about 3D post-processing SS 605 Machine learning: musculoskeletal

and diverse
A. 3D post-processing in 2019 [A-0143] Moderators: B. Baeßler; Mannheim/DE
A. Alberich-Bayarri; Valencia/ES R. Blanco Sequeiros; Turku/FI
B. Making better use of your 3D package: tips and
tricks [A-0144] 28
Feb Thursday, February 28, 14:00–15:30, Room D
C. Interpretation of 3D processing results: from image to SS 705 Machine learning in neuroradiology:
volume reading [A-0145] vascular and mass lesions
[B-0748 – B-0758]
» Panel discussion: Will we still look at 2D images in 10
years’ time? Moderators: T.C. Booth; London/UK
K. Egger; Freiburg/DE
1 Friday, March 1, 10:30–12:00, Studio 2019

March
1
March Friday, March 1, 10:30–12:00, Room D
SS 1005a Hot topics in machine learning: from
radiomics to natural language analysis SS 1005b Machine learning in neuroradiology:
[B-0904 – B-0914] diagnostic help and tissue analysis
[B-0978 – B-0988]
Moderators: S.S. Martin; Frankfurt/DE
E. Neri; Pisa/IT Moderators: J. Hirvonen; Turku/FI
N.N.
3 Sunday, March 3, 10:30–12:00, Studio 2019

March
2
SS 1805a Machine learning in breast imaging
[B-1517 – B-1527] SS 1405 Imaging informatics:
management and performance analysis
Moderators: U. Bick; Berlin/DE [B-1181 – B-1190]
O. Diaz; Girona/ES
Moderators: C. Bortolotto; Pavia/IT
3
March Sunday, March 3, 14:00–15:30, Studio 2019 » Keynote Lecture: [K-28]
SS 1905a Machine learning in chest radiology L. Donoso; Barcelona/ES
[B-1751 – B-1761]
Moderators: A. Farchione; Rome/IT

N.N.

Investing over
€5,000,000 in
supporting over
8,000 young
residents in
radiology and
radiographers
in training
over the last
16 years.

Artificial Intelligence and Machine Learning Hybrid, Molecular and Translational Imaging
2
March Saturday, March 2, 16:00–17:30, Room G
27
SS 1605 Machine learning: SS 306 Clinical applications of hybrid imaging
genitourinary and diverse [B-0226 – B-0236]
[B-1392 – B-1402]
Moderators: A. Scarsbrook; Leeds/UK
Moderators: N.N. R. Woitek; Cambridge/UK
N.N. 28
3 SS 606 Advanced MR methods in experimental

March Sunday, March 3, 10:30–12:00, Room D radiology
SS 1805b Machine learning: radiomics analysis [B-0501 – B-0511]
[B-1582 – B-1591]
Moderators: I. Rausch; Vienna/AT
Moderators: W.J. Niessen; Rotterdam/NL N.N.
M.F. Russe; Freiburg/DE 28
H. Brøgger; Oslo/NO SS 706 Hybrid imaging in oncology:
head to toe
3
[B-0664 – B-0673]
SS 1905b Machine learning: Moderators: P.M. Kazmierczak; Munich/DE

B. Tavitian; Paris/FR
visceral organs and GI tract
[B-1827 – B-1837]
J. Ferda; Plzen/CZ
Moderators: D. Pinto dos Santos; Cologne/DE 28
M. Prokop; Nijmegen/NL
RC 806 Merging the best:
hybrid imaging
Moderator: G. Antoch; Düsseldorf/DE

A. Hybrid imaging with SPECT/CT [A-0457]
A. Scarsbrook; Leeds/UK
B. Hybrid imaging with PET/MRI [A-0458]
F.M.A. Kiessling; Aachen/DE
C. Hyperpolarised MRI [A-0459]
F.A. Gallagher; Cambridge/UK
1
RC 1206 Translating functional and molecular
imaging in oncology

R. Méndez; Madrid/ES
A. Functional cancer imaging with MRI [A-0704]
S. Gatidis; Tübingen/DE
B. New PET tracers in oncology [A-0705]
M. Herranz; Santiago de Compostela/ES
C. Optical imaging in cancer [A-0706]
D. Razansky; Zurich/CH
» Panel discussion: Key competences to close
the translational gap more efficiently
2
SS 1406 Advanced methods in experimental
radiology
[B-1116 – B-1126]
Moderators: S. Gatidis; Tübingen/DE

F.M.A. Kiessling; Aachen/DE


Genitourinary
27
1
March Friday, March 1, 08:30–10:00, Tech Gate Auditorium
SS 207 Prostate cancer RC 907 Imaging strategies
[B-0152 – B-0161] in renal tumours
Moderators: P. Puech; Lille/FR » Chairperson’s introduction [A-0571]

N.N. B. Brkljačić; Zagreb/HR
» Keynote Lecture: [K-04] A. CT, contrast-enhanced ultrasound (CEUS) and MRI:
R.H. Oyen; Leuven/BE the best out of them [A-0572]
M. Bertolotto; Trieste/IT
27
B. Differential diagnosis of renal masses [A-0573]
SS 307 Prostate cancer and renal imaging C. Staging and organ-preserving strategies [A-0574]
[B-0322 – B-0332] P. Asbach; Berlin/DE
» Panel discussion: How to implement an optimal renal
Moderators: P. De Visschere; Ghent/BE
imaging protocol?
T. El-Diasty; Mansoura/EG
1 Friday, March 1, 10:30–12:00, Room B

27
March
SS 1007 Prostate biopsy and intervention

[B-0872 – B-0881]
SS 407 Prostate imaging: new diagnostic tools
[B-0437 – B-0447] Moderators: J. Belfield; Liverpool/UK
L. Schimmöller; Düsseldorf/DE
Moderators: J.J. Fütterer; Nijmegen/NL » Keynote Lecture: [K-20]
N.N. B. Gebauer; Berlin/DE
28 1 Friday, March 1, 16:00–17:30, Tech Gate Auditorium

Feb Thursday, February 28, 10:30–12:00, March
Tech Gate Auditorium RC 1207 Contrast media guidelines

SS 607 Contrast agents for imaging:
not only iodine » Chairperson’s introduction [A-0723]
H.S. Thomsen; Herlev/DK
[B-0621 – B-0630]
A. Post-contrast acute kidney injury (PC-AKI) [A-0724]
Moderators: Y. Mytsyk; Lviv/UA A.J. van der Molen; Leiden/NL
N.N. B. Iodine-based contrast media in myeloma
» Keynote Lecture: [K-13] patients [A-0725]
F. Stacul; Trieste/IT F. Stacul; Trieste/IT
C. Ongoing evidence for acute adverse
reactions [A-0726]
28
Feb Thursday, February 28, 14:00–15:30, O. Clément; Paris/FR
Tech Gate Auditorium » Panel discussion: Towards a safer use of contrast media
SS 707 Prostate and bladder tumours
[B-0821 – B-0831] 2
March Saturday, March 2, 08:30–10:00,
Moderators: P. Pavlica; Bologna/IT Tech Gate Auditorium
T. Penzkofer; Berlin/DE RC 1307 Imaging in pregnancy

A. Safety issues in pregnancy:
what radiologists need to know [A-0809]
C. Bourgioti; Athens/GR
B. Imaging acute abdomen in pregnancy [A-0810]
M. Weston; Leeds/UK
C. Imaging the placenta [A-0811]
P. Soyer; Paris/FR
» Panel discussion: How should we image the pregnant
woman, and when?


Genitourinary Head and Neck
2
27
SS 1407 Renal and adrenal tumours SS 208 Thyroid gland
[B-1138 – B-1148] [B-0120 – B-0129]
Moderators: M.-F. Bellin; Le Kremlin-Bicêtre/FR Moderators: E. Scapin; Monserrato/IT

S. Ramanathan; Doha/QA A. Singhal; Gurgaon/IN
» Keynote Lecture:
2 P.-Y. Marcy; Ollioules/FR
March Saturday, March 2, 14:00–15:30, The Church
SS 1507 Imaging in pregnancy and 27
female tumours
[B-1381 – B-1391] SS 308 Temporal bone
[B-0289 – B-0299]
Moderators: M. Basta Nikolic; Novi Sad/RS
G. Masselli; Rome/IT Moderators: K. Markiet; Gdansk/PL
B. Ozgen Mocan; Chicago, IL/US
2

RC 1607 Renal transplantation
28
SS 608 Lymph nodes and parathyroids
[B-0631 – B-0641]
T. El-Diasty; Mansoura/EG
A. Preoperative evaluation of donors Moderators: T. Beale; London/UK
(cadaveric or living) [A-0996] L.M. Lenghel; Cluj-Napoca/RO
C. Nicolau; Barcelona/ES
B. Multiparametric US for diagnosis and
intervention [A-0997]
1
D.Y. Huang; London/UK
RC 908 Head and neck imaging: when does
C. CT/MRI/angiography for diagnosis and
it become abnormal?
intervention [A-0998]
A. Coutinho Santos; Lisbon/PT Moderator: N. Thieme; Berlin/DE
» Panel discussion: Could imaging reduce the need A. Normative measures in the temporal bone [A-0568]
for renal graft biopsy? F. Veillon; Strasbourg/FR
B. Normative measures in the orbit [A-0569]
3
R. Kohler; Sion/CH
C. Anatomical variations in the face and neck [A-0570]
SS 1807 Testicular, renal and bladder tumours E. Vassallo; Msida/MT
[B-1656 – B-1665]
Moderators: F.M. Drudi; Rome/IT 1

O.W. Kozak; Gdansk/PL
SS 1008 Head and neck cancer
[B-0968 – B-0977]
3
March Sunday, March 3, 14:00–15:30, Tech Gate Auditorium
Moderators: A.D. King; Hong Kong/CN
SS 1907 Imaging of the uterus A. van der Hoorn; Groningen/NL
[B-1892 – B-1902] » Keynote Lecture: [K-23]
N.I. Traykova; Plovdiv/BG
Moderators: K. Skrobisz; Gdansk/PL
N.N.


Head and Neck Interventional Radiology
1
27
RC 1208 Post-treatment imaging SS 109 Vascular interventions in visceral
of the head and neck arteries and veins (part 1)
[B-0001 – B-0011]
H.B. Eggesbø; Oslo/NO Moderators: O. Akhan; Ankara/TR
A. Normal findings after radiotherapy [A-0720] M. Tsitskari; Athens/GR
R. Hermans; Leuven/BE
B. Normal findings after surgery [A-0721] 27
C. Treatment monitoring for early detection SS 209 Vascular interventions in oncology
of recurrence [A-0722] [B-0109 – B-0119]
A.D. King; Hong Kong/CN
» Panel discussion: What are the challenges Moderators: R. Duran; Lausanne/CH
in differentiating post-treatment changes N.N.
from tumour recurrence?
2 27
RC 1308 Differential diagnoses SS 309 Vascular neurointerventions
you don’t want to miss [B-0278 – B-0288]
Moderator: E. Arkink; Reykjavik/IS Moderators: J. Caroff; Le Kremlin-Bicêtre/FR

A. Differential diagnoses of nose and paranasal K. Zelenak; Martin/SK
sinus lesions [A-0797]
S. Connor; London/UK 28
B. Differential diagnoses of paediatric neck
lesions [A-0798] SS 609 Vascular interventions in oncology
K. Buch; Boston, MA/US (including radioembolisation)
C. Differential diagnoses of soft tissue masses [B-0556 – B-0565]
in adults [A-0799]
D. Farina; Brescia/IT Moderators: S. Puchner; Vienna/AT
V. Vidjak; Zagreb/HR
3
March Sunday, March 3, 08:30–10:00, Room M 2 » Keynote Lecture: [K-12]
SS 1708 Miscellaneous and orbits
[B-1445 – B-1455]
28 Thursday, February 28, 14:00–15:30, Room Y
Moderators: D. Franceski; Zagreb/HR Feb
N.N. SS 709 Vascular interventions in visceral

3
arteries and veins (part 2)
[B-0737 – B-0747]
RC 1708 Imaging of eye and
Moderators: D. Cvetko; Zagreb/HR
orbital pathologies
P. Heiss; Regensburg/DE
Moderator: M.M. Lemmerling; Ghent/BE
A. Traumatic lesions of the eye and orbit [A-1068] 1
A. Ailianou; Neuchâtel/CH March Friday, March 1, 10:30–12:00, Room Y
B. Infection and inflammation in the eye and SS 1009 Vascular interventions in the aorta
orbit [A-1069] and peripheral arteries
K. Erb-Eigner; Berlin/DE
[B-0957 – B-0967]
C. Benign and malignant masses of the eye and
orbit [A-1070] Moderators: R.F. Dondelinger; Liège/BE
P. De Graaf; Amsterdam/NL F.F. Strobl; Munich/DE
3
SS 1808 Imaging techniques in head and neck
radiology
[B-1624 – B-1634]
Moderators: J. Govindaraj; Chennai/IN

M. Magyar; Graz/AT


Interventional Radiology Musculoskeletal
2
27
SS 1509 Nonvascular interventions in oncology SS 210a Haematological, metabolic and
(including kidney) endocrine diseases
[B-1296 – B-1305] [B-0045 – B-0055]
Moderators: J. Curić; Zagreb/HR Moderators: G.K.O. Aström; Uppsala/SE

R. Dezman; Ljubljana/SI E.H.G. Oei; Rotterdam/NL
N.N. 27
3
SS 210b Musculoskeletal tumour imaging
[B-0056 – B-0066]
SS 1709 Nonvascular liver interventions
Moderators: R. Dominguez Oronoz; Barcelona/ES
[B-1434 – B-1444]
A. Isaac; London/UK
Moderators: T. Albrecht; Berlin/DE
T. Andrasina; Brno/CZ 27
3
March Sunday, March 3, 10:30–12:00, Room Y
SS 310 Upper extremity imaging
[B-0237 – B-0246]
SS 1809 Nonvascular musculoskeletal
Moderators: I. Boric; Zabok/HR
interventions
L. Lassalle; Paris/FR
[B-1571 – B-1581]
Moderators: G. Velonakis; Athens/GR A. Blum; Nancy/FR
N.N.
27
3
March Sunday, March 3, 14:00–15:30, Room Y RC 410 Bone, joint and soft
SS 1909 Nonvascular interventions in the lung tissue infection
[B-1807 – B-1815]
Moderator: V. Njagulj; Novi Sad/RS
Moderators: C. Pusceddu; Cagliari/IT A. Osteomyelitis [A-0178]
Z. Tüdös; Olomouc/CZ K. Verstraete; Ghent/BE
» Keynote Lecture: [K-42] B. Septic arthritis [A-0179]
T.K. Helmberger; Munich/DE M. Zanetti; Zurich/CH
C. Pyomyositis and other soft tissue infections [A-0180]
28
Feb Thursday, February 28, 08:30–10:00, Room D
RC 510 Imaging of chronic
forefoot pain
Moderator: K. Wörtler; Munich/DE

A. Articular disorders [A-0261]
E.G. McNally; Oxford/UK
B. Extra-articular source of pain [A-0262]
G. Bierry; Strasbourg/FR
C. Imaging-guided percutaneous treatment
of forefoot pain [A-0263]
R.L. Cazzato; Strasbourg/FR


Musculoskeletal
28
1
SS 610 Chronic inflammatory diseases RC 1210 The radiological investigation
[B-0512 – B-0522] of musculoskeletal tumours
Moderators: M. Boesen; Copenhagen/DK » Chairperson’s introduction [A-0691]

M. Revelli; Genoa/IT F.M.H.M. Vanhoenacker; Antwerp/BE
A. Radiographs and ultrasound [A-0692]
28
L.M. Sconfienza; Milan/IT
B. MRI and whole-body MRI [A-0693]
SS 710 Imaging techniques: S.L.J. James; Birmingham/UK
trauma and cartilage C. CT and hybrid imaging [A-0694]
[B-0674 – B-0684] T. Bäuerle; Erlangen/DE
» Panel discussion: Guidelines for, and the role
Moderators: S. Choudhary; Birmingham/UK
of, imaging techniques in the management of
U. Fahlenkamp; Berlin/DE
musculoskeletal tumours
28
Feb Thursday, February 28, 16:00–17:30, Room D 2
RC 810 MR imaging of the knee
RC 1310 Imaging of forgotten
Moderator: M. Tzalonikou; Athens/GR small joints
A. Cruciate ligaments: what to know and
Moderator: R. Sutter; Zurich/CH
what to do [A-0443]
A. Alcalá-Galiano; Madrid/ES A. Sterno-Clavicular joints: from trauma to
inflammation [A-0782]
B. Meniscal tears: obvious and subtle [A-0444]
A.-G. Jurik; Aarhus/DK
P. Omoumi; Lausanne/CH
B. Symphysis pubis and its surroundings [A-0783]
C. Looking around the corners: posteromedial and
A. Kassarjian; Pozuelo De Alarcón/ES
posterolateral [A-0445]
U. Aydingoz; Ankara/TR C. Proximal tibio-fibular joint: a cause for lateral knee
pain [A-0784]
A. Cotten; Lille/FR
1
RC 910 Inflammatory and infectious diseases 2
of the spine: how to differentiate
SS 1410 Knee imaging
from degeneration
[B-1127 – B-1137]
Moderator: J.L. Bloem; Leiden/NL
Moderators: R. Guggenberger; Zurich/CH
A. Spondyloarthritis: a diagnostic chameleon [A-0541] V. Vasilevska-Nikodinovska; Skopje/MK
V. Zubler; Zurich/CH
B. Crystals: may also affect the spine [A-0542]
P.J. O’Connor; Leeds/UK
2
C. Infection: imaging, indication and techniques SS 1510 Musculoskeletal interventions
for biopsy [A-0543]
[B-1286 – B-1295]
J.-L. Drapé; Paris/FR
Moderators: A. Alcalá-Galiano; Madrid/ES
1
T. Kaya; Eskisehir/TR
SS 1010 Hip imaging M. Reijnierse; Leiden/NL
[B-0893 – B-0903]
Moderators: F.B. Ergen; Ankara/TR

V. Njagulj; Novi Sad/RS


Musculoskeletal Neuro
2
27
RC 1610 The old spine: challenges of imaging SS 211a Neurooncology: glioma
and treatment [B-0088 – B-0097]
Moderator: R. Pedersen; Toensberg/NO Moderators: N. Bulakbasi; Mersin/TR

A. Degeneration of the old spine: relevance of findings K. Skogen; Oslo/NO
and differential diagnosis [A-0969] » Keynote Lecture: [K-02]
V.N. Cassar-Pullicino; Oswestry, Shropshire/UK J.-F. Meder; Paris/FR
B. Fractures: bone fragility in the elderly, assessing
osteoporosis and bone quality and differential 27
diagnosis [A-0970] Feb Wednesday, February 27, 10:30–12:00, Room M 5
G. Guglielmi; Andria/IT
SS 211b Vascular diseases and the brain
C. Interventional radiology: is there still a place [B-0183 – B-0193]
for vertebroplasty and kypho-/stentoplasty [A-0971]
C. Binkert; Winterthur/CH Moderators: M.M.A. Zaitoun; Zagazig/EG
N.N.
3
27
RC 1710 Elbow imaging: from detailed
anatomy to pathology SS 311 Stroke: interventional
[B-0258 – B-0267]
Moderator: I. Sudoł-Szopińska; Warsaw/PL
A. The medial and lateral epicondyle [A-1046] Moderators: F. Bozzetti; Parma/IT
M.O. De Maeseneer; Brussels/BE I.Q. Grunwald; Southend-on-Sea/UK
B. Biceps and triceps [A-1047] » Keynote Lecture: [K-08]
A. Tagliafico; Genoa/IT K.-O. Lövblad; Geneva/CH
C. Plica and cartilage [A-1048]
L. Cerezal; Santander/ES 28
3 SS 611 MS and demyelinating disorders

March Sunday, March 3, 10:30–12:00, Room O [B-0534 – B-0544]
SS 1810 Knee and muscle imaging
Moderators: A.M. Koc; Izmir/TR
[B-1507 – B-1516]
T.A. Yousry; London/UK
Moderators: M. Nevalainen; Oulu/FI
E. Springer; Vienna/AT 28
» Keynote Lecture:
N.N. SS 711 Stroke: diagnostic imaging
[B-0705 – B-0715]
3
March Sunday, March 3, 14:00–15:30, Room N Moderators: P. Due-Tønnessen; Oslo/NO
P. Thurner; Vienna/AT
SS 1910a Spine imaging
[B-1730 – B-1740]
28
Moderators: T. Akinci D’Antonoli; Basle/CH
A. Feydy; Paris/FR RC 811 State-of-the-art paediatric
neuroradiology
3 Sunday, March 3, 14:00–15:30, Room O
March » Chairperson’s introduction [A-0428]
SS 1910b Spine and peripheral nerve imaging C. Calli; Izmir/TR
[B-1741 – B-1750] A. Imaging myelin maturation disorders [A-0429]

N. Wolf; Amsterdam/NL
Moderators: G. Bodner; Vienna/AT B. Imaging of developmental disorders [A-0430]
N.N. B. Ertl-Wagner; Toronto/CA
» Keynote Lecture: [K-41] C. Imaging in paediatric neuro-oncology [A-0431]
C. Martinoli; Genoa/IT G. Morana; Genoa/IT
» Panel discussion: Ask the expert: what is relevant
for my own daily clinical practice?


Neuro
1
2
RC 911 Update on cerebrospinal fluid RC 1311 Altered mental state
(CSF) diseases
Moderator: Z. Merhemic; Sarajevo/BA M.A. Van Buchem; Leiden/NL
A. Imaging strategies for hydrocephalus [A-0519] A. MRI in the diagnosis of cerebral amyloid angiopathy
C.A.J. Romanowski; Sheffield/UK (CAA) [A-0765]
B. Diagnosis and treatment of intracranial J. Linn; Dresden/DE
hypotension [A-0520] B. Imaging in an altered mental state [A-0766]
E. Papadaki; Iraklion/GR J. Boban; Novi Sad/RS
C. RCVS, PRES and others [A-0521] C. MRI in the diagnosis of Alzheimer’s disease [A-0767]
F. Bonneville; Toulouse/FR M. Vernooij; Rotterdam/NL
D. Hypertension-associated brain changes [A-0522] » Panel discussion: Ask the expert: how can I standardise
A. Krainik; Grenoble/FR my image reading and reporting in order to support
the clinical process in cognitively impaired patients?
1
March Friday, March 1, 10:30–12:00, Room E2 2
SS 1011a Paediatric brain
[B-0925 – B-0932]
SS 1411a Brain tumours
[B-1160 – B-1169]
Moderators: M.C. Diogo; Lisbon/PT
N.N. Moderators: X. Golay; London/UK
E.J. Hendriks; Amsterdam/NL
P.D. Griffiths; Sheffield/UK » Keynote Lecture: [K-27]
N.N.
1
March Friday, March 1, 10:30–12:00, Room M 5 2
SS 1011b Functional MRI Tech Gate Auditorium
[B-1031 – B-1041]
SS 1411b Diffusion tensor imaging (DTI)
Moderators: E. Seliverstova; Moscow/RU [B-1265 – B-1274]
A. Yakimov; Moscow/RU
Moderators: K. Kenigsberg; Minsk/BY
N.N.
1
March Friday, March 1, 16:00–17:30, Room E2 » Keynote Lecture: [K-30]
G. Kasprian; Vienna/AT
RC 1211 Inflammatory and infectious CNS
pathology
2
SS 1511 Neurocognitive impairment and
E.T. Tali; Ankara/TR
psychiatric disorders
A. Autoimmune encephalitis [A-0676]
[B-1328 – B-1338]
P. Demaerel; Leuven/BE
B. Infectious encephalitis [A-0677] Moderators: J. Boban; Novi Sad/RS
A. Zimny; Wroclaw/PL N.N.
C. Inflammatory and infectious myelitis [A-0678]
M.M. Thurnher; Vienna/AT 2
» Panel discussion: Ask the expert: is imaging
the key diagnostic modality for an early and specific RC 1611 The degenerative
diagnosis of infectious diseases, leading to a better cervical spine
functional outcome?
Moderator: N. Chidambaranathan; Chennai/IN
A. Degenerative uncovertebral and facet
disease [A-0948]
B. Cervical spinal stenosis and cervical spondylotic
myelopathy [A-0949]
A.S. Gersing; Munich/DE
C. The postoperative cervical spine [A-0950]
S. Looby; Dublin/IE


Neuro Paediatric
3
27
RC 1711 Diffuse low-grade gliomas: RC 112 Interventional radiology (IR)
new things you should know in children: what a non-interventional
radiologist needs to know
Moderator: I.N. Pronin; Moscow/RU
A. Molecular basis for classification, treatment and Moderator: E. Alexopoulou; Athens/GR
predicting outcome in low-grade gliomas [A-1030] A. Common IR procedures in children:
V.C. Keil; Bonn/DE state-of-the-art [A-0061]
B. Imaging patterns suggestive of different (molecular) A. Barnacle; London/UK
subtypes of low-grade gliomas [A-1031] B. Vascular malformations: diagnosis and
M. Smits; Rotterdam/NL interventions [A-0062]
C. Advanced imaging in low-grade gliomas [A-1032] M. Beeres; Frankfurt a. Main/DE
N. Bulakbasi; Mersin/TR C. Osteoid osteoma: diagnosis and treatment [A-0063]
D. Filippiadis; Athens/GR
3
27
SS 1811a Parkinson and related disorders
[B-1550 – B-1560] SS 212 Paediatric cardiothoracic imaging
[B-0162 – B-0171]
Moderators: S. Cocozza; Naples/IT
M.F. Vasco Aragão; Recife, PE/BR Moderators: L. Riera; Barcelona/ES
T. Yalynska; Kiev/UA
3
March Sunday, March 3, 10:30–12:00,
A. Secinaro; Rome/IT
SS 1811b Neuroradiology: miscellaneous 27
[B-1687 – B-1697]
SS 312 Paediatric abdominal imaging
Moderators: L. Haider; Vienna/AT
[B-0333 – B-0343]
N.N.
Moderators: H.-J. Mentzel; Jena/DE
3 F. Prayer; Vienna/AT
SS 1911a Contrast media and advances 27
in neuro MRI
[B-1773 – B-1783] RC 412 Imaging in abdominal emergencies:
an (evidence-based) update
Moderators: D.A. Stojanov; Nis/RS
N.N. Moderator: C.E. de Lange; Oslo/NO
A. The acute abdomen in neonates [A-0188]
3
A. Coma; Barcelona/ES
B. The acute abdomen in young children [A-0189]
SS 1911b Epilepsy and epileptogenic conditions A.D. Calder; London/UK
[B-1881 – B-1891] C. Polytrauma: differences between adult and
paediatric protocols [A-0190]
Moderators: N. Pyatigorskaya; Paris/FR M. Raissaki; Iraklion/GR
N.N.

AT 20:
AT 20
2 0 ::30
30
S TA R R I N G
AU
A
AUSTRI
AUS
AUSTRIA
US
U ST
S TR
T
TRI
TRIA
RIA
RI
R IA GE
G
GERMAN
GER
GERMANY
ER
ER
RMAN
MA
M
MAN
MANY
AN
A NY IIT
ITA
ITALY
TA
TALY
LY AUS
AU
AUSTRI
AUS
AUSTRIA
USSTRI
TR
T
TRI
TRIA
RIIA
R

Paediatric
28
1
RC 512 Intensive care paediatric radiology: RC 912 Foetal and neonatal
the very sick neonate imaging pearls

S. Stafrace; Doha/QA E. Vázquez; Barcelona/ES
A. Neuroimaging in the neonatal intensive care A. Foetal MRI advanced technics [A-0560]
unit [A-0277] G. Kasprian; Vienna/AT
M.I. Argyropoulou; Ioannina/GR B. Corpus callosum anomalies: pre- and postnatal
B. Chest imaging in the ICU: tubes and correlation [A-0561]
catheters [A-0278] C. Garel; Paris/FR
M.L. Lobo; Lisbon/PT C. Foetal MR imaging of acquired brain
C. The role of imaging in emergencies in the critically pathology [A-0562]
ill neonate: abdominal US applications and P.D. Griffiths; Sheffield/UK
beyond [A-0279] D. Pre- and postnatal congenital cystic renal
M. Riccabona; Graz/AT diseases [A-0563]
» Panel discussion: Is there a role for FAST scan M. Cassart; Brussels/BE
in the paediatric IC unit? » Panel discussion: How to overcome the challenges
in foetal MRI in routine and research
28
1 Friday, March 1, 10:30–12:00, The Church
SS 612 Foetal and obstetric imaging March
[B-0599 – B-0609] SS 1012 Paediatric musculoskeletal and

oncologic imaging
Moderators: R. Llorens; Valencia/ES
D. Prayer; Vienna/AT [B-1053 – B-1062]
Moderators: N. Mitreska; Skopje/MK

28
U. Schwarz-Nemec; Vienna/AT
RC 812 Predicting fracture risk J.M. Patsch; Vienna/AT
in children
» Chairperson’s introduction [A-0460] March
K. Halliday; Nottingham/UK
SS 1412 Paediatric neuroradiology
A. Radiographs and DXA [A-0461] [B-1224 – B-1233]
R.A.J. Nievelstein; Utrecht/NL
B. Quantitative ultrasound [A-0462] Moderators: A. Sánchez Montañez; Barcelona/ES
H.-J. Mentzel; Jena/DE F.M. Triulzi; Milan/IT
C. Bone quantification with MRI [A-0463]
C. Rajapakse; Philadelphia, PA/US 2
D. CT (including HRpQCT) [A-0464]
A.C. Offiah; Sheffield/UK SS 1512 Paediatric radioprotection, techniques
» Panel discussion: Can we really predict fracture risk and forensic imaging
in children? [B-1317 – B-1327]
Moderators: J. Piqueras; Barcelona/ES

N.N.


Physics in Medical Imaging
27
Feb Wednesday, February 27, 08:30–10:00, Room G
28
RC 113 Patient-specific dosimetry SS 713 MRI: safety, phantoms and quantification
[B-0759 – B-0768]
E. Samara; Sion/CH Moderators: D.J. Lurie; Aberdeen/UK
A. Breast imaging dosimetry [A-0047] S. Skornitzke; Heidelberg/DE
I. Sechopoulos; Nijmegen/NL » Keynote Lecture: [K-18]
B. Patient dosimetry in CT and CBCT [A-0048] A. Webb; Leiden/NL
S. Edyvean; London/UK
C. Patient dose in fluoroscopy and 1
interventional [A-0049]
A. Trianni; Udine/IT SS 1013 Innovations in imaging: machine
» Panel discussion: The future of patient-specific learning, quality and new techniques
dosimetry [B-0989 – B-0999]
Moderators: C. Cavedon; Verona/IT
J. Sjöberg; Stockholm/SE
27
Feb Wednesday, February 27, 10:30–12:00, Room G
2 Saturday, March 2, 08:30–10:00, Room G
SS 213 CT image quality and optimisation March
[B-0131 – B-0140] RC 1313 Dose management

in paediatric radiology
Moderators: S. Edyvean; London/UK
E. Samara; Sion/CH
C. Saidléar; Dublin/IE
27
Feb Wednesday, February 27, 14:00–15:30, Room G A. The special case of the paediatric patient:
risks and justification [A-0786]
SS 313 CT: cardiovascular, calcium, and iodine C. Owens; London/UK
[B-0311 – B-0321]
B. Optimisation and technology in paediatric
projection radiography, interventional and CT
Moderators: H. Bosmans; Leuven/BE
scanning [A-0787]
S. Maguire; Dublin/IE
V. Tsapaki; Athens/GR
C. Optimisation in the neonate [A-0788]
27
Feb Wednesday, February 27, 16:00–17:30, Room G H. Delis; Vienna/AT
» Panel discussion: Paediatric dose management:
RC 413 Striking the balance:
are we doing enough for the next generation?
image quality assessment
in radiological optimisation
» Chairperson’s introduction: 2
The big picture, can we be objective
about image quality? [A-0181] SS 1413 Radiation protection
N. Marshall; Leuven/BE technology and management
A. Between a ROC(k) and a hard place: [B-1191 – B-1200]
classical and pragmatic methods of determining
clinical image quality [A-0182] Moderators: L. Bowden; Dublin/IE
O.J. O’Connor; Cork/IE A. Trianni; Udine/IT
B. Bridging the gap between physical and clinical image » Keynote Lecture: [K-29]
quality [A-0183] A. Trianni; Udine/IT
E. Samei; Durham, NC/US
C. Sharing the message: image quality optimisation
for multiple scanners and clinics [A-0184]
» Panel discussion: Can we balance image quality and
dose needs in an objective manner?


Physics in Medical Imaging Radiographers
2
27
RC 1513 Demystifying MRI: things you always RC 114 Contemporary breast imaging
wanted to know
Moderator: I. Seimenis; Alexandropolis/GR E. Metsala; Helsinki/FI [A-0005]
A. Basic MR: the building blocks of pulse G. Ivanac; Zagreb/HR [A-0006]
sequences [A-0910] A. Tomosynthesis [A-0007]
A. Webb; Leiden/NL H. Yule; Cardiff/UK
B. MR imaging basic concepts: how to turn signals into B. Breast imaging in young females:
images [A-0911] the role of MRI [A-0008]
D.J. Lurie; Aberdeen/UK M.M. Ribeiro; Lisbon/PT
C. Practical MRI: a toolkit of standard MR pulse C. Breast screening programmes:
sequences [A-0912] current evidence [A-0009]
G. Hagberg; Tübingen/DE S. Hofvind; Oslo/NO
» Panel discussion: Breast imaging: a true
3
March Sunday, March 3, 08:30–10:00, Room G
multidisciplinary team effort?
RC 1713 Dose reduction and image quality 27

implications of iterative image Feb Wednesday, February 27, 10:30–12:00, Room C
reconstruction in CT SS 214 Professional issues in radiography
[B-0023 – B-0033]
K.N. Bolstad; Bergen/NO Moderators: V. Logager; Copenhagen/DK
B. Snaith; Bradford/UK
A. Basics of iterative image reconstruction
in CT [A-1050]
M. Kortesniemi; Helsinki/FI 27
B. Iterative image reconstruction in clinical practice:
dos and don’ts [A-1051] RC 314 Hybrid imaging:
H. Alkadhi; Zurich/CH the best of both worlds
C. Image quality assessment of iterative reconstruction:
pitfalls and future directions [A-1052] Moderators: K. Riklund; Umea/SE
C. Walsh; Dublin/IE T. Roding; Haarlem/NL
» Panel discussion: How low can we go? A. PET/CT [A-0110]

M. Zeilinger; Wiener Neustadt/AT
B. Clinical impact of hybrid interventional
imaging [A-0111]
3
March Sunday, March 3, 10:30–12:00, Room G
S. Robinson; Manchester/UK
C. Optimisation/dose management in the hybrid
SS 1813 Radiation dose interventional suite [A-0112]
optimisation in CT D Maccagni; Milan/IT
[B-1592 – B-1602] This session is part of the EuroSafe Imaging campaign.
Moderators: K.N. Bolstad; Bergen/NO

G. O’Reilly; Dublin/IE 27
SS 414 MRI advances
[B-0406 – B-0416]
3
March Sunday, March 3, 14:00–15:30, Room G Moderators: I.M. Björkman-Burtscher; Gothenburg/SE
SS 1913 Breast imaging physics C. Malamateniou; London/UK
[B-1838 – B-1847]
Moderators: G. Gennaro; Padua/IT

E. Keavey; Galway/IE
G. Gennaro; Padua/IT


Radiographers
28
Feb Thursday, February 28, 08:30–10:00, Room C
1
RC 514 Radiography audit and quality SS 1014 Melange: nuclear medicine and
management interventional topics
[B-0882 – B-0892]
Moderators: F. Zarb; Msida/MT
E.J. Adam; London/UK Moderators: F. Orsi; Milan/IT
A. Understanding PACS to support radiography quality J. Thompson; Salford/UK
management processes [A-0208]
M. O’Connor; Dublin/IE
2
B. An expert in radiography quality SS 1314 Radiographic issues
management [A-0209] [B-1063 – B-1073]
D. Catania; Milan/IT
C. Back to basics: auditing radiographic Moderators: B.R. Mussmann; Odense/DK
technique [A-0210] N.N.
L. Harding; Warrington/UK
2
SS 1414 Ultrasound and computer applications
in medical imaging
28 Thursday, February 28, 10:30–12:00, Room C
Feb [B-1105 – B-1115]
SS 614 Fine-tuning CT
Moderators: J. Reponen; Oulu/FI
[B-0479 – B-0489] N.N.
Moderators: D. Biddle; Cambridge/UK 3

M. Raissaki; Iraklion/GR
RC 1714 Ultrasound: continuing to make waves
28
Feb Thursday, February 28, 14:00–15:30, Room B Moderators: T. Herlihy; Dublin/IE
S.B. Grover; New Delhi/IN
SS 714a Paediatrics and radiation therapy
A. Technology advances: from 3D to
[B-0642 – B-0652] elastography [A-1005]
M.R.V. Pedersen; Vejle/DK
Moderators: E. Farrugia Wismayer; Floriana/MT
R. Seuri; Helsinki/FI B. Early pregnancy guidelines [A-1006]
S. Riaz; Manchester/UK
C. Role of ultrasound in biomechanics and sports
28
Feb Thursday, February 28, 14:00–15:30, Room C science [A-1007]
R. Santos; Coimbra/PT
SS 714b Radiation dose optimisation in CT
and projection radiography 3
[B-0653 – B-0663]
SS 1814 CT and professional issues
Moderators: L. Bonomo; Rome/IT in radiography
L.J.O.C. Lança; Lisbon/PT [B-1486 – B-1496]
Moderators: R. Demuth; Dudelange/LU

28
Feb Thursday, February 28, 16:00–17:30, Room C J.M. Nightingale; Sheffield/UK
RC 814 Forensic imaging 3

SS 1914a Educational issues in radiography
A. Dominguez; Lausanne/CH [A-0397] [B-1698 – B-1707]
H. Patel; Ahmedab/IN [A-0398]
Moderators: J.M. García Santos; Murcia/ES
A. The chain of evidence [A-0399] R. Santos; Coimbra/PT
M. Davis; Dublin/IE
» Keynote Lecture:
B. Post-mortem cardiac angiography [A-0400] N.N.
H. Precht; Odense/DK
C. Paediatric forensic imaging [A-0401]
3
A.L. Brookes; Fulwood/UK
SS 1914b Mammography quality assessment
» Panel discussion: Safeguarding the wellbeing of staff
[B-1708 – B-1718]
involved in forensic imaging
Moderators: M. Dietzel; Jena/DE
D. Mizzi; Msida/MT


Vascular
27
2
RC 115 Visceral arteries RC 1315 US and vascular disease:
a perfect match
J.A. Reekers; Amsterdam/NL Moderator: V. Bérczi; Budapest/HU
A. Diagnosis of vascular compression A. Abdominal aorta [A-0752]
syndromes [A-0021] D.A. Clevert; Munich/DE
B.E. Cil; Istanbul/TR B. Upper and lower limb: arterial district [A-0753]
B. Acute and chronic mesenteric ischaemia [A-0022] B. Brkljačić; Zagreb/HR
M. Zins; Paris/FR C. Ultrasound as guidance for vascular
C. Endovascular treatment of mesenteric interventions [A-0754]
ischaemia [A-0023] W.K. Matzek; Vienna/AT
R. Morgan; London/UK
» Panel discussion: Radiologists as the best case 2
managers in acute and chronic mesenteric ischaemia
RC 1515 No time to lose:
27
aortic disease, revisited
SS 215 Carotid plaque and neurovascular Moderator: M. Krokidis; Cambridge/UK
events A. Diagnosis and treatment of abdominal aortic

aneurysms [A-0907]
[B-0034 – B-0044]
F. Wolf; Vienna/AT
Moderators: D.L. Tarnoki; Budapest/HU B. Acute diagnosis and imaging in aortic
N.N. dissection [A-0908]
R. Iezzi; Rome/IT
27 C. Endovascular treatment in aortic

Feb Wednesday, February 27, 14:00–15:30, Room X dissection [A-0909]
J.P. Schäfer; Kiel/DE
SS 315 Advanced vascular imaging:
cerebral and peripheral arteries
[B-0215 – B-0225] 3
Moderators: H.A. Deutschmann; Graz/AT SS 1815 Imaging of the thoracic aorta
N.N. [B-1497 – B-1506]
Moderators: P.I. Kalmar; Graz/AT

28
Feb Thursday, February 28, 10:30–12:00, Room X N.N.
SS 615 Contrast medium: » Keynote Lecture:

N.N.
dose, timing and alternatives
[B-0490 – B-0500]
3
Moderators: S. Tresoldi; Milan/IT
N.N. SS 1915 Vascular imaging after stent-graft
and stent insertion
1
[B-1719 – B-1729]
RC 915 Carotid disease 2.0 Moderators: A.D. Annoni; Milan/IT

M. Müller-Eschner; Mainz/DE
Moderator: P. Haage; Wuppertal/DE
A. Carotid plaque imaging: tool or fool? [A-0508]
L. Saba; Cagliari/IT
B. Carotid involvement in inflammatory arterial
disease [A-0509]
M. Edjlali; Paris/FR
C. Carotid stent: medical history or part of the
future? [A-0510]
K.A. Hausegger; Klagenfurt/AT


Oncologic Imaging
27
28
RC 116 Imaging tumour response SS 616a Advances in imaging
to immunotherapy of liver malignancies
[B-0523 – B-0533]
O.L. Sedlaczek; Heidelberg/DE Moderators: L. Grazioli; Brescia/IT
A. Imaging the immune system in cancer [A-0065] A. Luciani; Créteil/FR
B. Monitoring immune response with CT [A-0066] 28
F. Gentili; Siena/IT
C. Monitoring immune response with PET [A-0067] SS 616b Abdominal tumour imaging:
C.C. Cyran; Munich/DE raising the bar
D. Monitoring immune response with MRI [A-0068] [B-0610 – B-0620]
D.-M. Koh; Sutton/UK
Moderators: D. Caruso; Rome/IT
» Panel discussion: What is the best way to monitor
A. Cieszanowski; Warsaw/PL
immunotherapy response?
27 28
SS 716 How to improve bone metastases and
SS 216 Multiparametric imaging for pelvic
osteosarcoma assessment
cancers
[B-0685 – B-0694]
[B-0172 – B-0182]
Moderators: A. Karpenko; St. Petersburg/RU
Moderators: M. Otero-García; Vigo/ES
L. Kintzelé; Heidelberg/DE
B.M. Schaarschmidt; Düsseldorf/DE
T. Bäuerle; Erlangen/DE
27
SS 316 Myeloma imaging: latest trends 28
[B-0344 – B-0353]
RC 816 Multidisciplinary approach
Moderators: M.A. Hall-Craggs; London/UK to cancer care
N.N.
» Keynote Lecture: [K-10] » Chairperson’s introduction [A-0465]
M.A. Hall-Craggs; London/UK R.H. Oyen; Leuven/BE
A. The soft tissues team [A-0466]
E. Khristenko; Heidelberg/DE
28 Thursday, February 28, 08:30–10:00, Room M 3
Feb B. The colorectal team [A-0467]
RC 516 Role of imaging in cancer
of unknown primary (CUP) C. The breast team [A-0468]
C.K. Kuhl; Aachen/DE
» Chairperson’s introduction [A-0280] » Panel discussion: Does the current multidisciplinary
S. Gourtsoyianni; Athens/GR approach need changes?
A. MDCT: the imaging workhorse for suspected
CUP [A-0281] 1
C. Kelly-Morland; Framlingham/UK
B. Role of PET/CT in suspected CUP [A-0282] SS 1016 Lung cancer: screening and beyond
L. Umutlu; Essen/DE [B-1020 – B-1030]
C. The role of the interventional radiologist [A-0283]
F. Cornelis; Paris/FR Moderators: G. Cicchetti; Rome/IT
X. Montet; Geneva/CH
» Panel discussion: How to guide the clinical team
to solve the mystery


Oncologic Imaging Emergency Radiology
1
27
RC 1216 Oncological imaging: SS 217 Best of emergency radiology (part 1):
where are we now? from mass causality incidents
to incidental findings and errors
» Chairperson’s introduction: What are the problems of [B-0098 – B-0108]
morphologic evaluation [A-0711]
E. de Kerviler; Paris/FR Moderators: F.G. Mück; Munich/DE
A. CT perfusion techniques [A-0712] M. Stajgis; Poznan/PL
H. Schöllnast; Graz/AT
B. Functional MRI techniques [A-0713] 27
V.J. Goh; London/UK
C. Assessment by molecular imaging [A-0714] SS 317 Acute abdomen
J. Grimm; New York, NY/US [B-0268 – B-0277]
» Panel discussion: Where are we using functional
evaluations in clinical practice? Moderators: A. Blanco Barrio; Murcia/ES
D.D. Cokkinos; Athens/GR
2
March Saturday, March 2, 10:30–12:00, Room M 3 M. Scaglione; Castel Volturno, Caserta/IT
SS 1416 Neurooncology: making the most

of quantitative imaging 27
[B-1234 – B-1244]
RC 417 Imaging of ‘foreign bodies’
Moderators: E. Papadaki; Iraklion/GR
M. Porcu; Cagliari/IT » Chairperson’s introduction [A-0165]
U. Linsenmaier; Munich/DE
A. Surgical and orthopaedic devices: are they really
3
March Sunday, March 3, 08:30–10:00, Room M 3 properly positioned? [A-0166]
E. Dick; London/UK
SS 1716 Which whole-body exam
B. Did I swallow that? US and CT of sharp foreign bodies
should I choose?
penetrating stomach and bowel [A-0167]
[B-1456 – B-1465] J.B.C.M. Puylaert; The Hague/NL
Moderators: N. Bogveradze; Tbilisi/GE C. The role of interventional radiology in the
G. Cook; London/UK management of foreign bodies and following
complications [A-0168]
H. Leonhardt; Gothenburg/SE
M.E. Mayerhöfer; Vienna/AT
» Panel discussion: Common language with clinicians:
how to report ‘foreign bodies’ presence and indicate
3
March Sunday, March 3, 10:30–12:00, Room M 3 the optimal management
SS 1816 Improving the prediction of head

and neck malignancies
28
[B-1635 – B-1644]
SS 717 Chest emergencies
Moderators: B. Verbist; Leiden/NL [B-0727 – B-0736]
G. Zanirato Rambaldi; Bologna/IT
Moderators: M. Brink; Nijmegen/NL
J.B. Dormagen; Oslo/NO
M. Rémy-Jardin; Lille/FR


Emergency Radiology
28
3
RC 817 Blunt polytrauma: CT protocols, CT RC 1717 Small bowel obstruction:
interpretation and interventional improve your reading and
radiology options reporting competences

K.H. Nieboer; Brussels/BE S. Romano; Naples/IT
A. CT protocols in blunt polytrauma [A-0436] A. Step 1: confirm the mechanical small bowel
E. Kashef; London/UK obstruction (SBO) [A-1038]
B. Solid organs injuries: a tailored approach [A-0437] I. Millet; Montpellier/FR
M. Patlas; Hamilton, ON/CA B. Step 2: identify the SBO cause [A-1039]
C. Interventional radiology in trauma: diagnosis and J.R. Olalla Muñoz; Murcia/ES
management [A-0438] C. Step 3: look for bowel ischaemia [A-1040]
T. Jargiello; Lublin/PL R. Smithuis; Leiderdorp/NL
» Panel discussion: What is the best CT protocol in the » Panel discussion: How important is the role of CT
evaluation of blunt trauma patients? in deciding on operative or non-operative patient
management?
1
SS 1017 Best of emergency radiology (part 2):
from neurological emergencies
to penetrating injuries
[B-0946 – B-0955]
Moderators: B. Erkan; Istanbul/TR

1
RC 1217 Why do I miss fractures
in emergency?

S. Wirth; Munich/DE
A. Missed fractures in children [A-0683]
K.J. Johnson; Birmingham/UK
B. Missed fractures in adults [A-0684]
S. Döring; Brussels/BE
C. Missed musculoskeletal injuries in whole-body
trauma CT [A-0685]
A. Platon; Geneva/CH
» Panel discussion: How to reduce the rate of missed
fractures most effectively and efficiently

MY THESIS
IN 3 MINUTES
Introduced last year, ECR 2019 features again this fascinating
scientific session format where speakers share their scientific
theses in just three minutes!
These 12 special sessions will take place at a spectacular
location, the Sky High Stage, overlooking the Austria Center
from the top of the nearby Saturn Tower.
175
27
Feb Wednesday, February 27, 14:00–15:30, Sky High Stage
MY 3 Oncologic Imaging
Moderators: M. D‘Anastasi; Msida/MT

A. Laghi; Latina/IT
» MRI-based texture analysis has the potential » Preoperative prediction of regional lymph node
to predict response to transarterial radioembolization metastasis in thoracic oesophageal carcinoma with
at baseline [B-0354] 18F-FDG PET/CT and contrast-enhanced CT texture
R.P. Reimer1, P. Reimer2, A.H. Mahnken3; 1Cologne/DE, analysis: a nomogram model [B-0363]
2
Karlsruhe/DE, 3Marburg/DE Z. Xiaochun, W. Shuxia; Guangzhou/CN
» Apparent diffusion coefficient percentage as » Prospective evaluation of modified DWI MRI
an early predictor for evaluation of trans-catheter for improved image quality and tissue differentiation
arterial chemoembolisation efficacy in hepatocellular in oncological follow-up examinations [B-0364]
carcinoma [B-0355] C. Dreher1, T. Kuder1, S. Windhaber1, F. König1, D. Paech1,
R.M. Mousa1, F. Fawzy2, H. Tantawy1, T. Sobhy1; R. Gnirs1, T. Benkert2, H.-P. Schlemmer1, S. Bickelhaupt1;
1
Zagazig/EG, 2Sharkia/EG 1
Heidelberg/DE, 2Erlangen/DE
» Can intravoxel incoherent motion diffusion-weighted » USPIO contrast agents for detecting cancer:
imaging be use for preoperative assessment which one works best? [B-0365]
of microvascular invasion in hepatocellular L. Müller, U. Keber, A.H. Mahnken, R. Mandic,
carcinoma [B-0356] M.-L. Martini, P. Seyfer; Marburg/DE
Y. Wei, B. Song, H. Jiang, J. Chen; Chengdu/CN » Beyond lymph nodes: 18F FDG PET CT in
» Liver surface nodularity score as a new predictor detection of usual and unusual sites of extra nodal
of overall survival in patients with HCC treated by lymphoma [B-0366]
TACE [B-0357] M. Abdel-Kawi, M. Nasr, A. Ibrahim; Cairo/EG
A. Abou Elkassem1, A.M.K. Abdel Aal1, K. Mahmoud1, » Evaluation of STIR, T1 DIXON “in and out of phase”
A. Gunn1, S. lirette2, A. Smith1; 1Birmingham, AL/US, and DWI sequences, to propose a standardised
2
Jackson, MS/US protocol of the MRWB in patients affected by
» Diffusion-weighted imaging of colorectal liver myeloma [B-0367]
metastases: prospective evaluation of apparent A. Trisoglio, E. Soligo, S. Berardo, L. Sukhovei, S. Bor,
diffusion coefficient in correlation with histologic G. Buoni, A. Stecco, A. Carriero; Novara/IT
findings [B-0358] » Optimisation of prostate cancer radiotherapy
M.F.A. Almeida, R. Cruz, M.D.F.S. Begnami, management with MR [B-0368]
P.N.V.P. Barbosa, A.G.V. Bitencourt, F.J.F. Coimbra, F. Currò1, M.C. Ricciardi2, R. Danieli1, M.F. Cavallaro1,
R. Chojniak; Sao Paulo/BR P. Martingano1, M. Bertolotto1, F. Stacul1, M.A. Cova1;
1
» Comparison of intravoxel incoherent motion DWI, Trieste/IT, 2Padua/IT
diffusion kurtosis imaging, and conventional DWI » US and CEUS in ovary assessment of a murine
in predicting the chemotherapeutic response of model: preliminary findings on protective role of
colorectal liver metastases [B-0359] gonadotropin releasing hormone analogue from
H. Zhang, W. Li, T. Tong; Shanghai/CN chemotherapy-induced ovarian damage [B-0369]
» Diffusion kurtosis imaging-derived histogram metrics A. Colarieti, M. Venturini, L. Perani, A. Esposito,
for prediction of KRAS/NRAS/BRAF mutation in A. Del Maschio, F. De Cobelli; Milan/IT
rectal adenocarcinoma [B-0360] » DWI predicts surgical outcome in advanced ovarian
Y. Cui1, Z. Zhuo2, X. Yang1, R. Zhang1; 1Taiyuan/CN, cancer [B-0370]
2
Beijing/CN H. An, E. Lee, J.A. Perucho, K.W. Chiu, M. Chu, K.Y. Tse;
» Prediction of loco-regional treatment failure after Hong Kong/HK
chemo-radiotherapy in anal cancer using FDG PET/CT » IVIM-DWI MRI in meningiomas: a tool to detect early
derived feature analysis [B-0361] microstructural changes during and after proton-
P. Brown1, J. Zhong1, G.M. McDermott1, M. Fronza1, therapy [B-0372]
A. Gilbert1, A. Appelt1, D. Sebag-Montefiore1, S. Currie1, M.V. Raciti1, A. Franconeri1, G. Buizza2, G. Fontana1,
A. Scarsbrook2; 1Leeds/GB, 2York/GB G. Viselner1, A. Iannalfi1, E. D‘Ippolito1, L.M. Farina1,
» Increasing reader confidence in cancer imaging L. Preda1; 1Pavia/IT, 2Milan/IT
using an advanced DWI modification: a prospective » Predictive role of apparent diffusion coefficient
evaluation [B-0362] values from diffusion weighted sequences in patients
C. Dreher1, T. Kuder1, S. Windhaber1, F. König1, D. Paech1, with sacral chordoma treated with carbon ions
R. Gnirs1, T. Benkert2, H.-P. Schlemmer1, S. Bickelhaupt1; radiotherapy alone [B-0373]
1
Heidelberg/DE, 2Erlangen/DE S. Casale1, M. Fanizza1, C. Paganelli2, G. Viselner1,
E. Turpini1, M. Fiore1, I. Fumagalli2, F. Valvo1, L. Preda1;
1
Pavia/IT, 2Milan/IT

27
MY 4 Chest
Moderators: S. Toledano-Massiah; Paris/FR

M.O. Wielpütz; Heidelberg/DE
» Comparison of therapeutic outcome prediction » Late phase lung perfusion by dual energy CT:
among dynamic perfusion area-detector CT, dynamic image quality and clinical findings compared to
perfusion MRI and FDG-PET/CT in small cell lung arterial perfusion [B-0426]
cancer patients with limited disease [B-0417] M.S. May, I. Prael, R. Heiß, M. Kopp, M. Uder, W. Wuest;
Y. Ohno1, Y. Fujisawa2, M. Yui2, Y. Kishida1, S. Seki1, Erlangen/DE
T. Yoshikawa1, T. Murakami1; 1Kobe/JP, 2Otawara/JP » Computed tomography pulmonary angiography
» Correlation between pulmonary function tests, for acute pulmonary embolism: prediction of
histogram-based analysis indexes and visual HRCT adverse outcome and 90-day mortality in a single
scores in a population of IPF patients [B-0418] test [B-0427]
F. Tiralongo1, M. Palermo1, D. Falsaperla1, A. Stefano2, N. Akhoundi, T. Faghihi Langroudi; Tehran/IR
S.E. Torrisi1, P. Foti1, A. Basile1, C. Vancheri1, S. Palmucci1; » Assessment of EGFR mutation status in patients
1
Catania/IT, 2Segrate/IT with non-small-cell lung cancer using different iodine
» Radiomics machine learning classifiers for predicting quantification methods in dual-energy CT:
Ki-67 proliferation index in non-small cell lung areal vs volumetric analyses [B-0430]
cancer [B-0419] X. Xu, X. Sui, L. Song, Y. Huang, Z. Jin, W. Song;
P. Rong, Q. Gu, Z. Feng; Changsha/CN Beijing/CN
» Quantitative perfusion MRI of the lung in COPD: » Systematic review and meta-analysis of randomized
the problem of short-term repeability [B-0420] trials on the impact of lung cancer screening
A. Ter-Karapetyan1, M.O. Wielpütz2, H.-U. Kauczor2, by low-dose computed tomography in populations
S. Triphan2; 1Yerevan/AM, 2Heidelberg/DE highly exposed to tobacco [B-0431]
» The role of 4D flow MRI in evaluating the outcome A. Sadate, B. Occean, A. Larbi, P. Fabbro-Peray,
of balloon pulmonary angioplasty [B-0421] J. Beregi; Nîmes/FR
W. Sun, H. Ota, S. Chibana, H. Sato, K. Sugimura, » Application of LDCT and Lung-RADS classification in
K. Takase; Sendai/JP lung cancer screening of the urban population
» Inspiratory/expiratory 3D pulmonary MRI with UTE: in China [B-0432]
capability for clinical stage classification in smokers Q. Meng; Zhengzhou/CN
as compared with thin-section CT [B-0422] » Single- and dual-energy CT pulmonary angiography
Y. Ohno1, M. Yui2, Y. Kishida1, S. Seki1, T. Yoshikawa1, using second- and third-generation dual-source CT
T. Murakami1; 1Kobe/JP, 2Otawara/JP systems: comparison of radiation dose and image
» Diagnostic value of quantitative dual-source CT quality [B-0434]
dual-energy iodine maps combined with L. Lenga1, C. Booz1, J.L. Wichmann1, J.-E. Scholtz1,
morphological CT features in assessing histological S.S. Martin2, T.J. Vogl1, M.H. Albrecht1, I. Yel1;
1
subtypes of lung cancer [B-0423] Frankfurt/DE, 2Charleston, SC/US
X. Xu, X. Sui, W. Song, L. Song, Y. Huang, Z. Jin; » Percutaneous needle biopsy for lung lesions
Beijing/CN focused on needle angle and lesion depth:
» Ultra-high-resolution CT vs state-of-the-art area- 14-year results [B-0435]
detector CT: can higher spatial resolution improve J. Lee, I. Lee, J. Kim; Anyang/KR
nodule detection capability at same radiation dose » Mare Nostrum and Tuberculosis: the role of
in chest nodule phantom study? [B-0424] chest x-ray and clinical-laboratory data among
D. Takenaka1, K. Fujii2, N. Sugihara2, S. Seki3, Mediterranean migrants on landing [B-0436]
T. Yoshikawa3, Y. Ohno3; 1Akashi/JP, 2Otawara/JP, G. Scavone1, M.V. Raciti2, M.C. Calcagno1,
3
Kobe/JP D.C. Caltabiano1, G. Galvano1, A. Scavone1; 1Catania/IT,
2
» The utility of the ultra-high-resolution CT to evaluate Pavia/IT
the detailed bronchial tree for COPD [B-0425]
D. Takenaka, A. Higashida, Y. Kono, T. Hashimoto,
H. Maeda, S. Sakamoto; Akashi/JP

28
Feb Thursday, February 28, 08:30–10:00, Sky High Stage
MY 5 Breast
Moderators: E.M. Fallenberg; Munich/DE

R.M. Trimboli; Milan/IT
» How preoperative sentinel lymph node contrast- » Can 18 F-FDG PET/CT predict invasive components
enhanced ultrasound helps intraoperative sentinel in DICS of breast diagnosed by needle biopsy?
lymph node biopsy in breast cancer: initial Comparison with variable imaging modalities
experience [B-0459] including mammography, USG and MRI [B-0469]
M. Lu; Chengdu/CN N. Choi1, Y. Kim1, N. Jung1, B. Kang2, J. Lee2;
1
» Contrast-enhanced spectral mammography: Bucheon/KR, 2Seoul/KR
is it useful in predicting invasiveness in suspicious » Reliability of contrast-enhanced spectral
breast micro-calcifications? [B-0460] mammography (CESM) in the pre-surgical evaluation
M. Gomaa, A.F.I. Moustafa; Cairo/EG of breast cancer: CESM vs histological maximum
» Residual fibroglandular tissue (RGT) following diameter [B-0470]
unilateral and bilateral prophylactic mastectomies P. Tonelli, C. Boeri, D. Cirone, S. Bianchi, V. Miele,
in BRCA 1/2 germline-mutation carriers [B-0461] J. Nori Cucchiari; Florence/IT
B. Krug, O. Grinstein, W. Malter, B. Hanstein, F. Siedek, » Impact of 18F-FDG-PET/CT using time-of-flight
R. Schmutzler, D. Maintz, K. Rhiem, M. Hellmich; in evaluating axillary lymph node metastases
Cologne/DE of breast cancer [B-0471]
» Factors that influence performance of the contrast- M. Mori, T. Fujioka, J. Tsuchiya, K. Kubota, U. Tateishi;
enhanced ultrasound prediction model in 1023 breast Bunkyo-City Tokyo/JP
lesions: a multi-center study [B-0462] » The development of a novel manganese dioxide-
L. Tang1, Y. Chen1, Z. Du1, Z. Zhong1, Q. Chen2, J. Luo2, based nanoparticles and real-time monitoring
L. Yang3; 1Fuzhou/CN, 2Sichuan/CN, 3Kunming/CN of its anticancer effect by MRI [B-0472]
» Effect of breast-conserving surgery with radiotherapy X. Zhou, B. Xiao, H. Hu, J. Tang; Zhejiang/CN
on the apparent diffusion coefficient » Survey: imaging surveillance among Belgian breast
of fibroglandular tissue at MRI [B-0463] clinics for primary locoregional breast cancer
N. Radovic, G. Ivanac, I. Biondic Spoljar, E. Divjak, in non-high-risk women [B-0473]
I. Dumic Cule, B. Brkljacic; Zagreb/HR J. Swinnen, M. Keupers, R.M. Prevos, S. Postema,
» Relevance of arbitration in the management M. Lavens, T. Thywissen, P. De Beul, J. Soens,
of discrepant screening mammography: C. Van Ongeval; Leuven/BE
Trieste’sBreastUnit experience in 2013–2014 » Combining ultrafast TWIST VIBE Dixon sequences
biennium [B-0464] with diffusion-weighted imaging: a clinically
C. Sachs, F. Giudici, M. Bortul, F. Zanconati, C. Gasparini, applicable evaluation tool with high accuracy
M. Assante, M. Tonutti, M.A. Cova; Trieste/IT for suspicious masses in breast MRI [B-0474]
» Technique and diagnostic performance of contrast- S. Ellmann, E. Wenkel, S. Peter, M. Dietzel, E. Weiland,
enhanced spectral mammography: a systematic R. Janka, T. Bäuerle, M. Uder; Erlangen/DE
review [B-0465] » Accuracy comparison of breast cancer detection
A. Cozzi1, M. Zanardo1, C.B. Monti1, L.A. Carbonaro2, based on microcalcifications between full field digital
R.M. Trimboli2, F. Sardanelli1; 1Milan/IT, 2San Donato mammograms and synthetic 2D mammograms using
Milanese/IT a deep convolution neural network [B-0475]
» Development and validation of nomograms predictive M. Gurumoorthy1, S. Kaur1, N. Kwan Hoong2, S. Soo1,
of axillary nodal status to guide surgical decision- K. Rahmat1, C. Hongmin3; 1Kuala Lumpur/MY,
2
making in early-stage breast cancer [B-0466] Petaling Jaya/MY, 3Guangzhou/CN
J. Li, W. Ma, Y. Wu, L. Li; Guangzhou/CN » Initial experience of an online mammographic
» Ultrasound-guided vacuum-assisted resection: screening test [B-0477]
could it be enough for the diagnosis and treatment M. Iodice1, B. Brancato2, L.A. Carbonaro1, A. Bert3,
of intraductal papilloma? [B-0467] C. Perassi3, C. Zuiani4, F. Sardanelli1; 1Milan/IT,
2
Z. Wang; Beijing/CN Florence/IT, 3Turin/IT, 4Udine/IT
» Diffusion kurtosis imaging (DKI) in breast cancer: » Imaging characterisation of breast desmoid
diagnostic accuracy of DKI-derived values in tumours [B-0478]
characterization of breast lesions and correlation M. Le Boulc‘h1, A. Lusque1, C.S. Balleyguier2, C. Dratwa3,
with prognostic factors [B-0468] P. Cherel4, M. Kind5, C. Vaysse1, S. Le Guellec1, B. Boulet1;
1
H. Ahmad Ainuddin, S.K. Kirat Singh, K. Rahmat, Toulouse/FR, 2Villejuif/FR, 3Paris/FR, 4Saint Cloud/FR,
5
M. Ramli Hamid, F. Fadzli, H. Ahmad Ainuddin; Bordeaux/FR
Kuala Lumpur/MY

28
MY 7 Artificial Intelligence and Machine
Learning
Moderators: M. Dewey; Berlin/DE

M. Zins; Paris/FR
» Assistant effects of a computer-aided diagnosis » Accurate pulmonary nodule detection in CT images
system based on 3D convolutional neural network using multi-stage 3D deep convolution neural
on LDCT reading [B-0801] networks [B-0812]
S. Wang, Z. Wang, S. Zhang, Y. Fu, T. Hu, W. Peng; X.J. Chen; Zhengzhou/CN
Shanghai/CN » Deep learning for prostate cancer segmentation and
» Automatic prostate segmentation of magnetic detection: diffusion MRI U-net compared to clinical
resonance images using convolutional neural PI-RADS assessment [B-0813]
networks [B-0802] P. Schelb, S. Kohl, J.-P. Radtke, M. Hohenfellner,
N. Aldoj, F. Biavati, M. Rutz, S. Stober, M. Dewey; H.-P. Schlemmer, K. Maier-Hein, D. Bonekamp;
Berlin/DE Heidelberg/DE
» Automated x-ray bone segmentation using » A whole-tumour histogram analysis of apparent
a conditional adversarial network [B-0803] diffusion coefficient maps obtained using 3.0T MRI
J. Haubold, A. Demircioglu, M. Forsting, L. Umutlu, for distinguishing uterine endometrial carcinoma
F. Nensa; Essen/DE from endometrial polyps [B-0814]
» Small (< 4 cm) renal masses: convolutional neural W. Wang, J. Cheng; Zhengzhou/CN
network-based deep-learning approach » A computer-aided detection (CAD) system on
in differentiating fat-poor renal angiomyolipoma low-dose chest CT imagesin concurrent-reader and
from renal cell carcinoma at MSCT [B-0804] second-reader modes: radiologist performance and
X. Li, L. Wang; Nanjing/CN reading time [B-0815]
» Computed tomography based radiomics analysis Q. Hu; Wuhan/CN
to assess treatment response after perioperative » Reproducibility of fully automated liver
neoadjuvant therapy [B-0805] volumetric analyses with artificial intelligence:
Q. Xu1, C. Zhou1, C. Ye1, G. Tao1, W. Zhao1, D. Ren2, X. Li2, towards laboratory radiology [B-0816]
L. Zhao2, G. Lu1; 1Nanjing/CN, 2Beijing/CN D.J. Winkel1, G. Chabin2, J. Cyriac1, B. Stieltjes1,
» A preliminary study of predicting molecular subtypes T.J. Weikert1; 1Basel/CH, 2Princeton, NJ/US
of breast cancer by the radiomics features » Automated detection of lung cancer at ultralow
of contrast-enhanced ultrasound [B-0807] dose PET/CT by deep neural networks: initial
L. Tang, W. Chang, M. Chen; Shanghai/CN results [B-0817]
» The diagnostic value of texture analysis in predicting M. Schwyzer, D. Ferraro, U. Mühlematter, A. Curioni-
WHO grades of meningiomas based on ADC maps: Fontecedro, M. Hüllner, G.K. Von Schulthess,
an attempt using decision tree and decision P.A. Kaufmann, I.A. Burger, M. Messerli; Zurich/CH
forest [B-0808] » Automated lung cancer detection in PET/CT using
Y. Lu, B. Yin; Shanghai/CN a deep learning approach [B-0818]
» Automated stroke detection and profiling on initial M. Müller, C.P. Reinert, K. Nikolaou, C. La Fougère,
non-contrast CT via machine learning and textural C. Pfannenberg, S. Gatidis; Tübingen/DE
analysis [B-0809] » Non-invasive tumor decoding and phenotyping
J.M.A. Alghamdi, S. Raja; Riyadh/SA of cerebral gliomas utilizing multiparametric18F-FET
» A novel improved deep learning framework PET-MRI and MR Fingerprinting [B-0819]
for liver lesion detection [B-0810] J. Haubold, A. Demircioglu, M. Gratz, K. Wrede,
Y. Chen1, J. Ma2, J. Wang1, F. Wang1, S. Feng1; M. Glas, K. Herrmann, M. Forsting, F. Nensa, L. Umutlu;
1
Guangzhou/CN, 2Beijing/CN Essen/DE
» Evaluation of intra-scanner test-retest variability » Deep learning-based automated calcium scoring

of machine learning features in low-dose computed for cardiac computed tomography [B-0820]
tomography of interstitial lung disease [B-0811] S.S. Martin1, M. van Assen2, A.M. Fischer3, S. Rapaka4,
F. Prayer, S. Röhrich, J. Hofmanninger, A. Willenpart, P. Sahbaee1, C. Schwemmer5, M.A. Gulsun4, P. Sharma4,
G. Langs, H. Prosch; Vienna/AT U.J. Schoepf1; 1Charleston, SC/US, 2Groningen/NL,
3
Mannheim/DE, 4Princeton, NJ/US, 5Forchheim/DE

Bringing the future of imaging to you
Details at
www.er-x.org
28
MY 8 Interventional Radiology
Moderators: V. Bérczi; Budapest/HU

P. Haage; Wuppertal/DE
» Perfusion MRI prediction of progrossion-free survival » MR imaging-based response evaluation

in patients with hepatocellular carcinoma treat with of two different transarterial chemoembolisation
TACE [B-0832] protocols using degradable starch micorspheres
Z. Zhu, X. Zhao, C. Zhou; Beijing/CN in therapy of hepatocellular carcinoma [B-0843]
» Evaluation of mismatch diameter between radial M.C. Langenbach, M.H. Albrecht, R. Hammerstingl,
versus distal radial artery in patients suitable for T. Gruber-Rouh, T.J. Vogl; Frankfurt am Main/DE
vascular peripheral procedures [B-0833] » The anatomic options of vessels and haemodynamic
D. Meo, D. Falsaperla, A. Modica, M.C. Calcagno, redistribution of the blood flow at selective
C. Desiderio, F. Libra, P. Foti, S. Palmucci, A. Basile; intra-arterial chemotherapy (SIAC) in children
Catania/IT with an intraocular retinoblastoma [B-0844]
» Image-guided percutaneous techniques in the I. Pogrebnyakov, I. Trofimov, A.V. Kukushkin, E. Virshke,
treatment of aggressive vertebral haemangiomas: B. Dolgushin; Moscow/RU
clinical outcomes and therapeutic strategy [B-0834] » The role of selective intraaterial and intravitreal
A. Ricoeur1, J. Caudrelier2, X. Buy3, J. Garnon2, G. Koch2, chemotherapy in organ-preserving treatment
R. Cazzato2, A. Gangi2; 1Lyon/FR, 2Strasbourg/FR, of the children with an intraocular
3
Bordeaux/FR retinoblastoma [B-0845]
» Does IV-tPA induce thrombus migration? I. Pogrebnyakov, B. Dolgushin, I. Trofimov,
A retrospective study comparing bridging therapy A.V. Kukushkin, E. Virshke; Moscow/RU
and thrombectomy alon [B-0836] » Intermediate-stage HCC, SIRT and balloon-occlusive
C. Cohen1, K. Gaillot2, K. Janot1, J. Cottier1, M. Dejobert1, micro-catheter: the right way? [B-0846]
A.-P. Narata1; 1Tours/FR, 2La Rochelle/FR A. Paladini1, G.E. Vallati2, G. Pizzi2, F. Cappelli2,
» Focal prostate cancer ablation „out of the rectum D. Beomonte Zobel2, E.M. Amodeo2, A. Borzelli3;
1
and out of MRI“: new tools for fusion-guidanceand Novara/IT, 2Rome/IT, 3Naples/IT
„super-activesurveillance“ [B-0837] » Robot-assisted percutaneous placement of K-Wires
S. Xu, V. Anderson, M. Li, J. Peretti, C. Garcia, during minimal-invasive interventions of the
P.L. Choyke, P. Pinto, B. Turkbeyi, B.J. Wood; spine [B-0847]
Bethesda, MD/US M.H. Albrecht1, Y. Croissant1, C. Czerny1, T.J. Vogl1,
» Safety and outcomes of transarterial S. Zangos2; 1Frankfurt a. Main/DE, 2Göppingen/DE
chemoembolization using small- versus medium- » Predictive 99mTc MAA-SPECT/CT dosimetry in patients
sized drug-eluting beads for unresectable with locally advanced inoperable hepatocellular
hepatocellular carcinoma [B-0838] carcinoma treated by selective internal radiotherapy
A.M.K. Abdel Aal, K. Mahmoud, H. El Khudari, with 90Y resin microspheres [B-0848]
N. Aboueldahab, S. Saddekni, A. Gunn; A.-L. Hermann1, A. Dieudonné2, M. Ronot2, M. Sanchez2,
Birmingham, AL/US H. Pereira1, G. Chatellier1, E. Garin3, R. Lebtahi2,
» MRI-CT fusion imaging before high selective lumbar V. Vilgrain2; 1Paris/FR, 2Clichy/FR, 3Rennes/FR
sympathicolysis [B-0839] » Trans arterial embolization of non-variceal upper
B. Reichardt1, A. Örnek1, V. Nicolas2, C. Maier2; gastrointestinal bleeding: is the use of ethylene-vinyl
1
Essen/DE, 2Bochum/DE alcohol Copolymer as safe as Coils? [B-0849]
» Lumbar sympathetic trunk in MRI and CT: M. Tipaldi1, M. Krokidis2, G. Orgera1, A. Rebonato3,
its visibility and distance to two anatomical C. Ambrogi1, M. Rossi1; 1Rome/IT, 2Cambridge/GB,
3
landmarks for pre-interventional planning [B-0840] Perugia/IT
B. Reichardt1, A. Örnek1, V. Nicolas2, C. Maier2; » Prospective monocentre pilot study of intrahepatic
1
Essen/DE, 2Bochum/DE mitomycin C infusion after radioembolisation with
» Bilateral carotid stenting in the same sitting Y-90 in chemo refractory liver dominant metastatic
in high-risk patients: a single-centre study [B-0841] breast cancer patients [B-0850]
L.S.P. Karanam, S.R. Baddam, A. Alurkar, B.M. Aarts1, E.G. Klompenhouwer1, R.C. Dresen2,
V. Pamidimukkala, R. Polavarapu; Guntur/IN C. Deroose2, A. Laenen2, R.G.H. Beets-Tan1, P. Neven2,
H. Wildiers2, G. Maleux2; 1Amsterdam/NL, 2Leuven/BE
» Pneumothorax and pulmonary haemorrhage after
CT-guided lung biopsy: incidence, clinical » In the ablation of colorectal cancer liver metastases
significance and correlation [B-0842] with a new generation MW system nodule size
V. Sabatino, U. Russo, F.V. d‘Amuri, A. Bevilacqua, >2 cm independently predicts worse local tumour
F. Pagnini, G. Milanese, R. Nizzoli, G. Pedrazzi, progression free survival [B-0851]
M. De Filippo; Parma/IT P. Marra1, A. Della Corte2, F. Ratti1, F. Cipriani1,
S. Gusmini1, M. Salvioni3, M. Venturini1, L. Aldrighetti1,
F. De Cobelli1; 1Milan/IT, 2Vimodrone/IT, 3Bergamo/IT

1
March Friday, March 1, 08:30–10:00, Sky High Stage
MY 9 Musculoskeletal
Moderators: M. Adriaensen; Heerlen/NL

C. Martinoli; Genoa/IT
» Perivertebral muscle as index of sarcopenia: » Clinical utility of fat suppressed 3-dimensional

comparison with previous muscle imaging and CAIPIRINHA SPACE MRI of the knee in
functional indexes [B-0852] adults [B-0862]
H.S. Seo; Ansan/KR S. Lee, G.Y. Lee, S. Kim; Seoul/KR
» T2* value analysis of achilles tendons disease » The most accurate measurement of TT-TG distance
with ultra-short echotime (UTE) MRI [B-0853] is through the 2/5 point of femoral trochlear
J.-G. Zhang, Z. Li, C. Xia; Chengdu/CN notch [B-0863]
» Terahertz time-domain spectroscopy of collagen I Y. Qi, Z. Wang; Tianjin/CN
and tendon [B-0854] » Coll-Ha versus bone marrow stimulation for chondral
J. Yuan1, L. Yang2, M. Wang1, Z. Feng1, S. Zhang1; and osteochondral lesion: a 2-year randomized
1
Shanghai/CN, 2Zhengzhou/CN controlled trial [B-0864]
» Investigating the appropriateness of radiological C. Tamburrano1, M. Busacca2; 1bologna/IT, 2Bologna/IT
investigation of lumbar spine and determining » Application of simultaneous multi-slice TSE
relationship between appropriateness and imaging in high-resolution hand and foot imaging [B-0865]
findings in a tertiary hospital [B-0855] G. Feifei1, Y. Ge1, Y. Wei2; 1Zhengzhou/CN, 2Chengdu/CN
S. Suganchand Rikabchand; Jodhpur/IN » Cinematic MRI of the wrist: initial study for instability
» Identification of Scheuermann’s disease with different of the wrist in correlation to fluoroscopy and x-ray
radiological scoringmethods for osteoporotic findings [B-0866]
vertebral fractures: the Rotterdam study [B-0856] B. Reichardt1, A. Örnek1, V. Nicolas2; 1Essen/DE,
2
L. Oei, F. Koromani, S. Breda, S. El Saddy, A. Makurthou, Bochum/DE
F. Rivadeneira, E. Oei; Rotterdam/NL » Comparison of patient satisfaction for wrist
» Feasibility study of reducing artifacts of spine metal examinations in cone beam-computed tomography
implants for patients at 3.0T magnetic resonance and multidetector-computed tomography [B-0867]
imaging [B-0857] J. Neubauer1, C. Reidelbach1, E. Kotter1, S.M. Goerke2;
G. Feifei1, Y. Ge1, Y. Wei2; 1Zhengzhou/CN, 2Chengdu/CN 1
Freiburg/DE, 2Offenburg/DE
» Noise-optimised virtual monoenergetic imaging of » Diagnostic performance of high-resolution ultrasound
dual-energy CT: effect on metal artefact reduction in in the evaluation of intrinsic and extrinsic ligaments
patients with lumbar internal fixation [B-0858] of the wrist in patients with previous trauma or carpal
Y. Zeng1, K. Deng2, H. Yang2, Y. Tan2, J. Liu2, D. Geng1, instability [B-0868]
J. Zhang1; 1Shanghai/CN, 2Changsha/CN S. Gitto1, D. Albano2, C. Messina1, V. Chianca1,
» Increased lateral meniscal slope is associated S. Rapisarda1, A. Corazza3, L.M. Sconfienza1; 1Milan/IT,
2
with greater risk of lateral bone contusion Palermo/IT, 3Genoa/IT
in noncontact ACL injury [B-0859] » Submarine sign of epidermoid cysts:
J. Li, K. Li; Chongqing/CN a diagnostic model based on ultrasound
» Knee MR using a body coil is equivalent feature [B-0869]
to CT in measuring the TTTG distance: D.H. Lee, S. Kim, A.L. Choi, C. Yoon; Seoul/KR
removing the systematic bias [B-0860] » Machine learning classification of low-grade and
L.U. Aivazoglou, M.K. Toma, P.H.C. Arruda, high-grade chondrosarcomas based on magnetic
O.A. Ezzeddine, A. Ormond, M. Nico, F. Silva; resonance imaging-based texture analysis [B-0870]
Sao Paulo/BR S. Gitto1, D. Albano2, V. Chianca1, R. Cuocolo3, L. Ugga4,
» Quantitative magnetic resonance imaging in C. Messina1, L.M. Sconfienza1; 1Milan/IT, 2Palermo/IT,
3
patellar tendon-lateral femoral condyle friction Naples/IT, 4Scafati/IT
syndrome: relationship with subtle patellofemoral » Use of MRI for age verification of U-17 footballers:
instability [B-0861] the Ghana study [B-0871]
J. Li, H.-T. Yang; Chongqing/CN B.D. Sarkodie; Accra/GH

2
March Saturday, March 2, 08:30–10:00, Sky High Stage
MY 13 Genitourinary
Moderators: P. Asbach; Berlin/DE

K. Markiet; Gdansk/PL
» Amide proton transfer MR imaging for cervical » Application of intravoxel incoherent motion imaging
cancer: a preliminary study [B-1074] (IVIM) in patients with hyperuricemia [B-1083]
Y. He, C. Lin, Y. Qi, X. Wang, H. Zhou, H. Xue, Z. Jin; Z. Cheng, X. Cai, Y. Feng; Guangzhou/CN
Beijing/CN » Explorative investigation of whole-lesion histogram
» Correlation of three-dimensional computerized MRI metrics for differentiating uterine degenerative
tomographic renal volumetry with DTPA split leiomyomas and leiomyosarcomas [B-1085]
renal function in prospective donors for renal K. Ma; Zhengzhou/CN
transplantation [B-1075] » Imaging surveillance in operable invasive transitional
G. Choudary, P.G. Kale, S. Peddi; Tirupati/IN cell carcinoma of the bladder [B-1086]
» Prostate magnetic resonance imaging with and S.A. Ahmed, H.A. Taleb, M.M. El Barody; Assiut/EG
without contrast medium: is biparametric MRI » Contrast-enhanced T1 mapping MR imaging
sufficient for routine examinations? [B-1076] for evaluation of myometrial invasion in endometrial
D. Junker1, F. Steinkohl2, B. Sztankay1, U. Nagele1; cancer: initial experience [B-1087]
1
Hall in Tirol/AT, 2Innsbruck/AT Y. He, C. Lin, Y. Qi, X. Wang, H. Zhou, H. Xue, Z. Jin;
» Benefit of diagnostic support of PI-RADS assessment Beijing/CN
by quantitative ADC measurements and radiomics » Evaluation of a semi-automated segmentation
in MR diagnosis of prostate cancer [B-1077] tool for volumetric analysis of the renal cortex
P. Schelb, S. Kohl, J.-P. Radtke, M. Wiesenfarth, and medulla in non-contrast T1-weighted MR
M. Hohenfellner, H.-P. Schlemmer, K. Maier-Hein, images [B-1088]
D. Bonekamp; Heidelberg/DE H. Seuss, R. Janka, P. Dankerl, A. Cavallaro, M. Uder,
» Multiparametric MRI outperforms three popular M. Hammon; Erlangen/DE
clinical models in predicting pT3 prostate cancer » Correlation of erectile dysfunction after radical
in patients undergoing radical prostatectomy with findings of preoperative
prostatectomy [B-1078] multiparametric prostate MRI [B-1089]
E. Zanelli1, L. Cereser1, G. GIannarini1, V. Ficarra2, M. Sauer, P. Tennstedt, C. Berliner, H. Huland, G. Adam,
C. Zuiani1, R. Girometti1; 1Udine/IT, 2Messina/IT D. Beyersdorff; Hamburg/DE
» Do DCE-derived quantitative parameters predict » Can MRI including DCE and DWI
clinically significant prostate cancers? improve characterisation of endometrial
A study on patients referred to radical carcinosarcoma? [B-1090]
prostatectomy [B-1079] L. Rivière1, L. Rossi1, T. Lam Giang2, E. Laas1, G. Bataillon1,
F. Greco, R. Girometti, L. Cereser, G. Como, C. Zuiani; P. Cherel3, H. Brisse1, F. Reyal1, C. Malhaire1; 1Paris/FR,
Udine/IT 2
Genève/CH, 3Saint-Cloud/FR
» Transperineal thermoablation in patients » Prostate cancer lesion characterisation:
with benign prostatic hyperplasia: our rapid acquisition using compressed sensing
experience [B-1080] in combination with semi-automatic lesion
R. Regine1, F. Palmieri2, F. Zanfardino1, G. Fatigati1, segmentation for dual-parameter decision
A. Martino1, M. Cornacchia1, P. Cozzolino1; support [B-1092]
1
San Giorgio a Cremano/IT, 2Caserta/IT D.J. Winkel, T. Heye, M.R. Benz, B. Stieltjes, D. Boll,
» Kidney stone composition analysis using V. Hofmann; Basle/CH
machine learning and spectral detector CT: » Pitfalls in reporting fast biparametric magnetic
an ex-vivo study [B-1081] resonance imaging of the prostate:
N. Grosse Hokamp, J. Salem, S. Lennartz, R.P. Reimer, what kind of cancers do we miss?
A. Heidenreich, D. Maintz, S. Haneder; Cologne/DE A preliminary retrospective analysis [B-1093]
» Comparison between biparametric MRI (bp-MRI) and L. Pusceddu1, G. Giannetto1, V. Romano1, V. Vani2,
multiparametric MRI (mp-MRI) for the diagnosis F. Cortese1, G. Desi2, S. Mazzetti1, D. Regge1, F. Russo2;
1
of prostate cancer (PCa): preliminary results Candiolo/IT, 2Turin/IT
of a prospective randomised trial [B-1082]
G. Giannetto1, L. Pusceddu1, V. Doronzio2, V. Vani1,
V. Romano3, C. Maglia4, S. Mazzetti2, D. Regge5,
F. Russo4; 1Turin/IT, 2Candiolo/IT, 3Candiolo TO/IT,
4
Torino/IT, 5Candiolo-Torino/IT

2
MY 14 Head and Neck
Moderators: M. Lell; Nuremberg/DE

R. Saat; Tallinn/EE
» Perfusion MRI with high spatial and temporal » Visualisation of the trigeminal nerve branches on
resolution in the head and neck region using golden enhanced 3D-SPACE-STIR sequence:
angle radial sampling [B-1245] initial experience [B-1254]
A. Tomppert, M.S. May, M. Wiesmüller, R. Heiß, A. Nagel, C. Chen, H. Haiwei, S. Yunkun, H. Xu; Xiamen/CN
M. Uder, W. Wuest; Erlangen/DE » Three-dimensional shear wave elastography
» Preliminary diffusion kurtosis imaging study for differentiating benign from malignant thyroid
of head and neck squamous cell carcinomas nodules [B-1255]
associated with histologic grades [B-1246] C.-K. Zhao; Shanghai/CN
T. Su, Y. Chen, X. Chen, T. Zhang, X. Shi, H. Xue, » DWI-associated entire-tumor histogram analysis
Z. Zhang, Z. Jin; Beijing/CN for the differentiation of nasopharyngeal carcinoma
» Radiohistological comparison study of temporal bone from nasopharyngeal lymphoma [B-1256]
specimen after CI electrode array insertion: K. Ma, J. Cheng, X. Zhang, C. Song; Zhengzhou/CN
is CBCT superior to MSCT? [B-1247] » Accessing the skull base: CT-guided submaxillary
I. Burck, S. Schneider, I. Yel, A. Lehn, S. Balster, S. Helbig, core needle biopsy for the diagnosis of skull base
T. Stöver, T.J. Vogl, B. Kaltenbach; Frankfurt a. Main/DE lesions [B-1257]
» Utility of histogram analysis of ADC maps I. Burck, M. Rosenzweig, N.-E. Nour Eldin, H. Kvasnicka,
in differential diagnosis of Pleomorphic T. Stöver, V. Jacobi, T.J. Vogl; Frankfurt/DE
adenoma and Acinar cell carcinoma originated » 3D imaging of the paranasal region with
from parotid gland [B-1248] a multipurpose cone beam detector system:
X. Zhang, J. Cheng, K. Ma; Zhengzhou/CN image quality and radiation exposure [B-1259]
» The value of ADC histogram in differentiating S. Ohlmeyer, T. Buder, M. Uder, W. Wuest; Erlangen/DE
nasopharyngeal carcinoma from nasopharyngeal » Structural changes of the disc of temporomandibular
lymphoma [B-1249] joint in the first stage of dysfunctions [B-1260]
K. Ma; Zhengzhou/CN D.V. Dushkova, Y. Vasilev; Moscow/RU
» Prognostic value of restaging 18-FDG PET/CT » Correlation between the size of the inferior orbital
volumetric parameters for post-index irradiation wall defect and treatment tactics in orbital trauma
recurrence of head and neck squamous cell according to the MSCT data [B-1261]
carcinoma [B-1250] O. Pavlova, N.S. Serova, D. Davydov, S.K. Ternovoy;
K. Musaieva, B. Musaiev, Y. Kmetyuk; Kiev/UA Moscow/RU
» Update of old thyroid US reports to EU-TIRADS » Anatomage table: a possible new tool for diagnosis
with AI [B-1251] and classification of Le Fort fractures [B-1262]
A. Mereu, L. Saba; Cagliari/IT Z. Falaschi, S. Cavalieri, I. Valente, G. Mazzucca,
» Application of RESOLVE-DWI ADC maps based on A. Carisio, S. Bor, A. Carriero, F. Boccafoschi, A. Stecco;
whole-tumorhistogram analysis in differentiating Novara/IT
common parotid gland tumours [B-1252] » Functional multi-detector computed tomography
C. Song, J. Cheng, Y. Zhang; Zhengzhou/CN (FMDCT) for various orbital pathologies [B-1263]
» Diagnostic utility of mean peak systolic velocity N.D. Kudryavtsev, M.V. Malakhova, Y.O. Grusha,
of superior thyroid artery (STA PSV) S.S. Danilov, V.V. Khovrin, K.B. Puzakov, T.N. Galyan;
in the differential diagnosis of Moscow/RU
thyrotoxicosis [B-1253] » Value of ADC and DCE-MRI in differentially
P.K. Sarangi, S. Parida, B.K. Mohanty, S. Mangaraj, diagnosing of angiomatous meningioma and solitary
J. Mohanty, B.M. Swain; Cuttack/IN fibrous tumours/hemangiopericytoma [B-1264]
C. Chen, C.-.P. Ren, R.-.C. Zhao, J.-.L. Cheng;
Zhengzhou/CN

2
MY 15 Everyday challenges for radiographers
and radiologists
Moderators: K.K. Pyra; Lublin/PL

» Impact of body mass index on set-up variations and » Artificial intelligence in bone age assessment:
treatment margins for patients receiving radiotherapy accuracy and clinical efficiency of a novel fully
to the prostate [B-1350] automated algorithm for bone age assessment
S. Farrugia, G. van Dijk, S. Mercieca; Msida/MT in comparison to the Greulich Pyle method [B-1362]
» An augmented patient-specific approach C. Booz, I. Yel, L. Lenga, A. Al Kamali, S. Boettger,
to administration of contrast agent for CT renal J.L. Wichmann, T.J. Vogl, M.H. Albrecht, B. Bodelle;
angiography [B-1351] Frankfurt a. Main/DE
C. Saade; Beirut/LB » High-resolution MR imaging of the orbit in patients
» Improving technical quality in with retinoblastoma: prospective study correlated
mammography [B-1352] with histopathological results [B-1363]
V. Risi1, M. Zanardo2, R.M. Trimboli3, C.B. Monti2, Y.S. Habib, A. Youssef, H.A. ElKiki, H.A. ElZomor,
G. Di Leo3, L.A. Carbonaro3, F. Sardanelli2; M.M. Rezk; Cairo/EG
1
Lumezzane/IT, 2Milan/IT, 3San Donato Milanese/IT » Should we still look for a correlation between ADC
» Reflective clinical portfolios as a tool to develop and SUV in lymphoma: a volumetric [18F] FDG-PET/
competence in radiography students [B-1353] MR study of paediatric Hodgkin lymphoma [B-1364]
M. Morris; Limerick/IE M.G. Riga1, G. Orsatti1, A. Varotto1, F. Crimì1, M. Weber2,
R. Stramare1, P. Zucchetta1, E. Quaia1, C. Giraudo1;
» A comparative analysis of local diagnostic reference 1
Padua/IT, 2Vienna/AT
levels for adult projection radiography of the chest,
abdomen and pelvis in Irish centres [B-1354] » Diagnostic value of C-reactive protein and
M. Malone, S.J. Foley, L.A. Rainford, R. Toomey; the influence of visceral fat in patients
Dublin/IE with obesity and acute appendicitis [B-1365]
A.D. Do Amaral Castro1, F.A. Sulla Lupinacci1,
» Dose optimisation in CT for cocaine body
S.P. Pribeiro1, E. Kaiser Ururahy Nunes Fonseca1,
packing: where is the limit of extensive dose
M.R. Peixoto1, T. Larocca Skare2, A.T. Sakuma1,
reduction? [B-1355]
F. Yamauchi1, A. Tachibana1; 1São Paulo/BR,
J. Aissa, L.M. Sawicki, E. Appel, P. Heusch, C. Thomas, 2
Curitiba/BR
G. Antoch, J. Boos; Düsseldorf/DE
» Impact of added CT venography performed
» Obstetric ultrasound - knowledge and perception
in combination with CT pulmonary angiography
of pregnant women in Portugal [B-1357]
on the detection of deep venous thrombosis and
R.A. Santos, R. Fernandes; Coimbra/PT
relevant occult CT findings [B-1366]
» Expectant mothers‘ perception of prenatal P.I. Douek, D.C. Rotzinger, R. Meuli, V. Dunet, S. Schmidt
sonography in southeastern population in Kobbe; Lausanne/CH
Nigeria [B-1358]
» Reliability of on-call radiology residents’
H.C. Elugwu; Nnewi/NG
interpretations in detecting intracranial aneurysms
» Mobile phones as a potential vehicle of nosocomial on 640 slice multidetector computed tomography
pathogens in radiology departments [B-1359] angiography [B-1367]
T.C.P.L. Guerreiro1, L. Ribeiro2, A.F. Abrantes2, M.B.H. Chaudhry, M. Azeemuddin, M.N. Ahmad,
S. Rodrigues2, R. Raposo2, F. Soares2, R.P.P. Almeida2; F. Mubarak, T.U. Haq; Karachi/PK
1
Santiago Do Cacém/PT, 2Faro/PT
» Forensic relevance and diagnostic impact of a novel
» Diffusion tensor imaging of the growth plate: 3D-reconstruction technique (cinematic rendering)
a preliminary study [B-1360] of severe injuries in postmortem computed
O. Kvist1, S. Diaz Ruiz1, T. Dorniok1, J. Sanmartin tomography [B-1368]
Berglund2, C.-E. Flodmark1; 1Stockholm/SE, J. Böven, J. Boos, R.S. Lanzman, P. Kröpil,
2
Karlskrona/SE Y. Klosterkemper, C. Thomas, G. Antoch, J. Aissa;
» Comparison of extremity cone beam-computed Düsseldorf/DE
tomography and multidetector-computed » Neonatal chest X-ray [B-1369]
tomography in injured children [B-1361] S. Johansen; Oslo/NO
S. Tschauner, R. Marterer, E. Nagy, G. Apfaltrer,
G. Singer, M. Riccabona, E. Sorantin; Graz/AT

2
MY 16 Neuro
Moderators: P. Demaerel; Leuven/BE

M. Severino; Genoa/IT
» Correlation of cerebrovascular reserve assessed » Arterial spin-labeling and magnetic resonance

by acetazolamide-stress SPECT with collaterals spectroscopy as imaging biomarkers for detection
on arterial spin-labeling MRI in patients with carotid of epileptogenic zone in non-lesional focal impaired
occlusive disease [B-1414] awareness epilepsy [B-1423]
H. Kang, Y. Kim; Seoul/KR R.E. Mohamed, R.M. Dawoud, A.A. Aboelsafa; Tanta/EG
» Long-term neurodegeneration of substantia nigra » Fully automated segmentation of meningiomas using
secondary to ipsilateral infarct is quantified with deep learning on multiparametric MRI: automated
iron-sensitive imaging and impacts motor segmentation yields accuracies as good as manual
outcome [B-1415] interreader variabilities [B-1424]
P.-A. Linck1, G. Kuchcinski2, F. Munsch3, R. Griffier1, K.R. Laukamp, F. Thiele, L. Pennig, R.P. Reimer,
G. Okubo4, P. Renou1, V. Dousset1, I. Sibon1, T. Tourdias1; G. Shakirin, D. Zopfs, M. Timmer, M. Perkuhn,
1
Bordeaux/FR, 2Lille/FR, 3Boston, MA/US, 4Kyoto/JP J. Borggrefe; Cologne/DE
» Detection and prevalence of cerebral microbleeds » Imaging the seizure onset zone and fast electrical
in middle and old age groups: a clinical-based circuit activity in epilepsy with electrical impedance
approach [B-1416] tomography [B-1425]
S.E.E.E. Elbadawi; Mansoura/EG A. Witkowska-Wrobel, K. Aristovich, M. Faulkner,
» Carotid artery plaque detected on ultrasound J. Avery, D. Holder; London/GB
is associated with impaired cognitive state » Meta-analytic investigations of grey
in the elderly: a population-based study matter alterations in patients with Tourette
in Wakiso district, Uganda [B-1417] syndrome [B-1426]
M. Kenneth1, F. Ameda2, R.K. Byanyima2, N. Nakasujja2; S. Zhang, W. Wang, X. Su, H. Sun, Q. Yue, Q. Gong;
1
Mbarara/UG, 2Kampala/UG Chengdu/CN
» Are aneurysmal subarachnoid hemorrhage scales » Brain MRI characteristics in neuromyelitis optica
applicable to non-aneurysmal subarachnoid spectrum disorders: a multi-center study in
hemorrhage? [B-1418] China [B-1429]
D. Páez Granda, M.J. Martínez Cutillas, J. Díaz Pérez, G. Cao, Y. Duan, W. Zhu, Y. Liu; Beijing/CN
G. Parrilla Reverter, J. Berná-Serna, M. Espinosa de » Less regulated, more segregated ventral visual
Rueda Ruiz, B. Garcia-Villalba, J. Zamarro Parra, network in patients with major depressive
J. Felices Farias; Murcia/ES disorder [B-1430]
» Lactate-weighted imaging of brain tumours using H. Chen, J. Yan, K. Liu, Y. Deng, X. Huang, R. Su,
chemical exchange saturation transfer (CEST) MRI Z. Xiaojun; Guangzhou/CN
at 7 Tesla [B-1419] » Extended memory network degeneration
D. Paech, J.-E. Meissner, M. Wennmann, A. Radbruch, in Parkinson’s disease patients with lean muscle
M. Bendszus, W. Wick, A. Unterberg, M. Ladd, loss [B-1431]
H.-P. Schlemmer; Heidelberg/DE Y.-N. Wu, W.-C. Lin, C.-H. Lu; Kaohsiung/TW
» Analysing impact of sarcopenia to brain: » Dendritic growth and branching of the
using correlation between paraspinal muscle and cortical neurons can be altered by ultrasound
brain volume [B-1420] exposition [B-1432]
H. Lee, H.S. Seo, Y.H. Lee; Ansan/KR Z. Ferenczi, T. Papp, B. Szilagyi, P. Szucs, E. Berenyi,
» Glymphatic pathway of gadolinium-based Z. Meszar; Debrecen/HU
contrast agents through the brain: overlooked and » The relationship between cognitive function and
misinterpreted [B-1421] magnetic resonance spectroscopy findings
K. Deike-Hofmann1, J. Reuter1, D. Paech1, S. Bickelhaupt1, in Parkinson disease patients [B-1433]
R. Gnirs1, M. Forsting2, C. Heussel1, H.-P. Schlemmer1, M. Sanei Taheri, M. ArabAhmadi, H. Haghighatkhah,
A. Radbruch1; 1Heidelberg/DE, 2Essen/DE M. Ranjbar, M. Amiri; Tehran/IR
» Arterial spin labelling for the evaluation of immediate
postoperative residual lesion in adult brain
tumours [B-1422]
C. Cohen1, B. Law-Ye2, D. Dormont2, M. Sanson2,
D. Galanaud2, N. Pyatigorskaya2; 1Tours/FR, 2Paris/FR

3
March Sunday, March 3, 08:30–10:00, Sky High Stage
MY 17 Abdominal Viscera and
Gastrointestinal Tract
Moderators: L.K. Blomqvist; Stockholm/SE

T.C. Lauenstein; Düsseldorf/DE
» Gadoxetic acid-enhanced liver MR can predict tumour » Combination of diffusion kurtosis imaging and
recurrence after curative treatment for small single conventional MRI helps to differentiate fibrotic from
hepatocellular carcinoma [B-1466] inflammatory bowel strictures in patients
D. Lee, J. Lee; Seoul/KR with Crohn’s disease [B-1476]
» Radiomics of gadoxetic acid-enhanced MRI: J. Du, X. Li, L. Huang, S. Huang, Z. Li; Guangzhou/CN
a predictive biomarker for CK19-positive » Perfusion fraction derived from IVIM-DWI may
hepatocellular carcinoma [B-1467] facilitate differentiation of moderate to severe
W. Wang1, Y. Ding1, L. Yang1, M. Zeng1, S.-X. Rao1, J. Tian2; inflammation in ulcerative colitis [B-1477]
1
Shanghai/CN, 2Xi‘an/CN J. Podgorska, K. Pasicz, E. Zagórowicz, A. Mróz,
» Intra-individual comparison of the MRI contrast B. Gołębiewski, P. Kus, J. Jasieniak, W. Skrzyński,
agents gadoxetic acid vs gadoteric acid in A. Cieszanowski; Warsaw/PL
liver MRI of patients with HCC and underlying » Machine learning-based analysis of rectal cancer
cirrhosis [B-1468] MRI radiomics for prediction of metachronous liver
M. Della Seta, F. Collettini, M. Schmelzle, N. Raschzok, metastasis [B-1478]
B. Hamm, T. Denecke; Berlin/DE M. Liang, X. Zhao; Beijing/CN
» MRI of hepatocellular adenomas: is there an » MRI-detected extramural vascular invasion is a strong
additional value of using Gd-EOB for subtype risk factor in predicting distant metastasis in rectal
differentiation? [B-1469] cancer [B-1479]
T.A. Auer1, C. Grieser2, D. Geisel1, B. Hamm1, T. Denecke1; P. Tripathi1, D. Hu1, M. Zeng2, W. Guo2, S. Rao2, B. Rai1;
1
Berlin/DE, 2Bremen/DE 1
Wuhan/CN, 2Shanghai/CN
» Quantification of hepatic steatosis: evaluation of » DWI and high-resolution T2WI-volumetry association
4 MRI techniques vs reference method by with lymphovascular invasion and N-stages in
biopsy [B-1470] resectable rectal cancer [B-1480]
C. Boudinaud, A. Abergel, M. Fontarensky, J. Joubert X. Chen, H. Li; Chengdu/CN
Zakeyh, L. Boyer, B. Magnin; Clermont-Ferrand/FR » Prediction of gastric and esophagogastric junction
» The value of MRI-PDFF in detecting and grading cancer response to neoadjuvant treatment by
hepatic steatosis in patients with nonalcoholic fatty functional imaging with PCT. [B-1482]
liver disease: a meta-analysis [B-1471] J. Kruk-Bachonko, W. Krupski, T. Skoczylas; Lublin/PL
Z. Ye, X. Xiong, J. Chen, L. Cao, T. Duan, Z. Zhang, » Added value of MRI to endoscopic and
B. Song; Chengdu/CN endosonographic response assessment after
» Dual-energy CT in patients with fatty liver disease: neoadjuvant chemoradiotherapy in oesophageal
improved assessment of hypoattenuating liver lesions cancer: a pilot study [B-1483]
using virtual monoenergetic imaging [B-1472] S.E. Vollenbrock, J.M. van Dieren, F.E.M. Voncken,
L. Lenga1, I. Yel1, C. Booz1, S.S. Martin2, J.-E. Scholtz1, S.T. van Turenhout, L.L. Peppelenbosch-Kodach,
T.J. Vogl1, J.L. Wichmann1, M.H. Albrecht1; 1Frankfurt/DE, K.J. Hartemink, B.M.P. Aleman, R.G.H. Beets-Tan,
2
Charleston, SC/US A. Bartels-Rutten; Amsterdam/NL
» CT-based liver surface nodularity score for » Multiparametric combined FDG-PET/CT and MR
noninvasive assessment of clinically significant portal imaging to predict response to chemoradiotherapy
hypertension [B-1473] in rectal cancer: whole tumour versus sub-volume
A. Abou Elkassem1, A.M.K. Abdel Aal1, A. Gunn1, analysis [B-1484]
K. Mahmoud1, S. Lirette2, A. Smith1; 1Birmingham, AL/US, N.W. Schurink1, M. Berbee2, J.J.M. van Griethuysen1,
2
Jackson, MS/US W. van Elmpt2, M. Maas1, M.J. Lahaye1, F.C.H. Bakers2,
» Clinical significance of pancreatic steatosis: R.G.H. Beets-Tan1, D.M. Lambregts1; 1Amsterdam/NL,
2
association between pancreatic exocrine insufficiency Maastricht/NL
and organ fat content [B-1474] » Rectal wall T2 relative signal intensity: a non -invasive
M.-L. Kromrey1, N. Friedrich1, R.-T. Hoffmann2, R. Bülow1, biomarker of gastro-intestinal (GI) toxicity in patients
U. Motosugi3, J.-P. Kühn1; 1Greifswald/DE, 2Dresden/DE, treated with pelvic radiotherapy (RT) [B-1485]
3
Yamanashi/JP G. Della Vecchia, A. Di Chiara, M. Panzeri, A. Palmisano,
» T1 mapping of autoimmune pancreatitis as a A. Esposito, P. Passoni, C. Fiorino, A. Del Maschio,
quantitative outcome biomarker [B-1475] F. De Cobelli; Milan/IT
L. Zhu1, Z.-y. Sun1, Z.-y. Jin1, T.-y. Qian1, D. Nickel2,
M. Makowski3, P. Asbach3, B. Hamm3, H.-d. Xue1;
1
Beijing/CN, 2Erlangen/DE, 3Berlin/DE

3
March Sunday, March 3, 10:30–12:00, Sky High Stage
MY 18 Cardiovascular
Moderators: M. Francone; Rome/IT

F. Wolf; Vienna/AT
» The forecaster of coronary atherosclerosis: » FFRCT vs CAD-RADSTM and its impact on patient
black or white, fat or calcium? [B-1668] management: a retrospective pilot study [B-1679]
R. Khurana, A. Yadav, T.B.S. Buxi, K.S. Rawat, S. Braspenningx1, C. Van Mieghem2, P. Vanhoenacker3;
1
S.S. Ghuman; New Delhi/IN Edegem/BE, 2Kortrijk/BE, 3Aalst/BE
» Treatment of chronic myocardial infarction » Left ventricular function impairment and deformation
with unmodified stem cells at point of care: assessment of post-transcatheter aortic valve
a feasibility study on pigs [B-1669] implantation (TAVI): a systematic review and
A.S. Haenel1, M. Ghosn2, T. Karimi3, J. Vykoukal2, meta-analysis [B-1680]
D.J. Shah2, D. Schulz2, A. Raizner2, C. Schmitz4, E. Alt5; M.-T. Shen, Z. Yang, K. Diao, Q. Zhao, L. Jiang, S. Huang,
1
Luebeck/DE, 2Houston, TX/US, 3New Orleans, LA/US, Y. Guo; Chengdu/CN
4
Munich/DE, 5New Orleans, TX/US » Assessment of left ventricular deformation
» Prevalence of asymptomatic pacemaker and ICD lead in restrictive cardiomyopathy with preserved ejection
perforation on computed tomography [B-1670] fraction by cardiac magnetic resonance tissue
F.F. Aloufi; Riyadh/SA tracking [B-1681]
» Hybrid 123I-mIBG SPECT/CT cardiac imaging for S. Huang, Z.-G. Yang, K. Diao, K. Shi, Y. Gao, M.-T. Shen,
identification of left atrial ganglionated plexi in Y.-K. Guo; Chengdu/CN
patients with atrial fibrillation [B-1672] » Diastolic dysfunction in competitive triathletes
N.A. Nikitin, S.M. Minin, I. Mikheenko, D.V. Losik, following a strenuous endurance sports
S.V. Shaiakhmetova, A.B. Romanov; Novosibirsk/RU event [B-1682]
» Assessment of right ventricular deformation in end J. Stáreková, B. Scherz, M. Avanesov, J.M. Weinrich,
stage renal disease patients by cardiac magnetic K. Müllerleile, U. Radunski, G. Adam, G.K. Lund, E. Tahir;
resonance tissue tracking [B-1673] Hamburg/DE
Y. Zhang, Z.-G. Yang, Y.-K. Guo, H. Xu, W. Peng, C. Xia, » Evaluation of coronary arteries with prospectively-
Z. Li; Chengdu/CN ECG-triggered-High-Pitch-CT in patients undergoing
» Left ventricular global strain analysis in TAVI-planning [B-1683]
arrhythmogenic right ventricular cardiomyopathy P. Seitz, S. Gottschling, M. Abdel-Wahab, H. Thiele,
with or without syncope: a cardiac magnetic M. Borger, D. Holzhey, R.F. Gohmann, C. Krieghoff,
resonance imaging study [B-1674] M. Gutberlet; Leipzig/DE
M.-T. Shen, Z. Yang, K. Diao, L. Jiang, S. Huang, B. Hu, » Relationship between epicardial adipose tissue and
Y. Guo; Chengdu/CN coronary vascular function in patients with normal
» Quantitative T2 mapping for detecting myocardial myocardial perfusion by 82Rb PET/TC [B-1684]
oedema and its association with myocardial injury S. Dell‘Aversana, A. Ponsiglione, C. Nappi, A. Stanzione,
biomarkers in acute myocardial infarction swine M. Puglia, L. D‘Acierno, G. Lassandro, A. Cuocolo,
models [B-1675] M. Imbriaco; Naples/IT
L. Zhang, Y.-K. Guo, Z.-G. Yang, X.-S. Li, C. Fu, H. Xu, » Imaging carotid artery-vulnerable plaque with
M.-X. Yang, R. Xu, L. Xie; Chengdu/CN ultrasound and contrast-enhanced ultrasound:
» Comparison of the incidence of in-stent restenosis correlation of cerebrovascular symptoms with
and the newly developed plaques after stenting quantitative and multi-parametric indexes [B-1685]
between diabetic and non-diabetic patients: V. Rafailidis1, I. Chryssogonidis1, E. Grisan2, C. Xerras1,
evaluation with DSCT angiography [B-1676] G.-A. Cheimariotis1, T. Tegos1, D. Rafailidis1, P. Sidhu2,
R. Shi, Z.-G. Yang, Y.-K. Guo, Q. Zhao, Y. Gao, P.-l. Han; A. Charitanti-Kouridou1; 1Thessaloniki/GR, 2London/GB
Chengdu/CN » Cardiac magnetic resonance with 4D flow imaging
» The correlation between coronary artery stenosis for mitral regurgitation severity assessment [B-1686]
and myocardial perfusion indexes: a prospective M. Guglielmo1, G. Muscogiuri1, A. Baggiano1,
“one-stop” 256-row detector Computed tomography A.I. Guaricci2, D. Andreini1, F. Alamanni1, M. Pepi1,
study [B-1677] G. Pontone1; 1Milan/IT, 2Bari/IT
K. Liu, Z. Li, K. Diao, W. Peng; Chengdu, Sichuan/CN
» Cardiovascular magnetic resonance early predictors
of unfavourable left ventricle remodelling in patients
with acutemyocarditis [B-1678]
A. Palmisano1, G. Benedetti1, D. Palumbo1, G. Peretto1,
R. Faletti2, S. Sala1, M. Gatti2, F. De Cobelli1, A. Esposito1;
1
Milan/IT, 2Turin/IT

Securing
the Future
of Research
Our mission is
your funding success
Visit the EIBIR lounge

in the main entrance hall
CLINICAL TRIALS
IN RADIOLOGY
In Clinical Trials in Radiology (CTiR) sessions, scientific
evidence is presented for imaging tests that will change
the clinical practice of every radiologist in the future.
Each of the clinical trials in radiology presented during
these three sessions is accompanied by a short lecture.
These lectures are given by experts in the respective field
and will allow participants to better understand which
clinical changes should be made based on the CTiR results.
191
CLINICAL TRIALS IN RADIOLOGY
27
28
CT 2 Clinical Trials in Radiology 1 CT 6 Clinical Trials in Radiology 2
Moderators: M. Dewey; Berlin/DE Moderators: V.J. Goh; London/UK

V.P. Jackson; Tucson, AZ/US U. Mahmood; Oak Brook, IL/US
» Primary stenting of superficial femoral artery » Outcome of pneumatosis intestinalis and
in patients with intermittent claudication has durable porto-mesenteric venous gas: a multicentric study
effects on health-related quality of life at 24 months: T.A. Auer; Berlin/DE
results of a randomised controlled trial Discussant: D. Weishaupt; Zurich/CH
H. Lindgren; Helsingborg/SE » Diffusion-weighted MRI in the assessment
Discussant: T.J. Kroencke; Augsburg/DE of nephroblastoma: results of a multi-centre trial
» Ultrasound-guided vs computed tomography-guided A.M. Hötker; Zurich/CH
renal mass biopsy: a prospective randomised study Discussant: K. Rosendahl; Bergen/NO
H. Farg; Mansoura/EG » Validation of deep learning algorithms for the
Discussant: N.N. detection of critical findings in head CT scans
» Self-compression mammography in clinical practice: S. Tanamala; Mumbai/IN
a randomised clinical trial compared to standard Discussant: M. de Bruijne; Rotterdam/NL
compression mammography » Patient preference for coronary CT angiography
V. Iotti; Reggio Emilia/IT and invasive coronary angiography: results from
Discussant: A. Oktay; Izmir/TR a randomised controlled trial
» MRI vs mammography screening for high-risk women: G. Abdala Gehling; Berlin/DE
an RCT - the influence of density and effectiveness Discussant: J.-N. Dacher; Rouen/FR
M. Tilanus-Linthorst; Rotterdam/NL » Perspectives of radiologists and cardiologists about
Discussant: R. Schulz-Wendtland; Erlangen/DE the severity of health events in the multicentre
» Variability in cancer-positive predictive value using DISCHARGE trial - on behalf of the DISCHARGE
PI-RADS v2: a multi-institutional study conducted investigators
by the SAR Prostate Cancer Disease Focused Panel V. Wieske; Berlin/DE
(aim 2) Discussant: M. Hrabak Paar; Zagreb/HR
A. Westphalen; San Francisco, CA/US » A multi-stage randomised clinical trial to reduce
Discussant: H.Y. Kressel; Boston, MA/US variation in computed tomography radiation dose
» Role of PI-RADS v2 in clinical models: R. Smith-Bindman; San Francisco CA/US
a multi-institutional study conducted by the SAR Discussant: A. Trianni; Udine/IT
Prostate Cancer Disease Focused Panel (aim 3)
A. Westphalen; San Francisco, CA/US
Discussant: E. Rud; Oslo/NO

CLINICAL TRIALS IN RADIOLOGY
1
March Friday, March 1, 10:30–12:00, Sky High Stage
CT 10 Clinical Trials in Radiology 3

U. Mahmood; Oak Brook, IL/US
» Lung cancer risk after baseline round of screening:
only 20% of NLST eligibles require annual round
M. Silva; Parma/IT
Discussant: H.-U. Kauczor; Heidelberg/DE
» Clinical trials in Radiology and data sharing:
results from a survey by the European Society
of Radiology research committee
M. Bosserdt; Berlin/DE
Discussant: R. Maksimović; Belgrade/RS
» Carotid stenting with antithrombotic agents and
intracranial thrombectomy leads to the highest
recanalisation rate in acute stroke patients with
tandem lesions
Discussant: K. Compagne; Rotterdam/NL
» Additional MRI screening in women with extremely
dense breasts: primary outcome of the first round
of the randomised DENSE trial
C. van Gils; Utrecht/NL
Discussant: P.A.T. Baltzer; Vienna/AT
» Detection rate for advanced neoplasia of single
round of CT colonography vs three rounds of faecal
immunochemical test in population screening
for colorectal cancer: the SAVE randomised trial
L. Sali; Florence/IT
Discussant: T. Mang; Vienna/AT
» Cost-effectiveness analysis of computed tomography
vs invasive coronary angiography in a randomised
controlled trial
G. Abdala Gehling; Berlin/DE
Discussant: N.N.

Your passport to a better
career in Radiology
Q··ČČÉ·"ÌkČ·äČČÉ·ÌÿÌÿăČÿ·ä
°ĒÿÌæÃ"kÁïÿÁĒÝÝÌæÁïÿäČÌïæ¨ïĒČČÉ·
ĒûªïäÌæÃ·ĤäÌæČÌïæăɌ
oû·ªÌÝ·ĤäÌæČÌïæÁ··ăÁïÿČÉïă·ğÉï
ûûÝĥÁïÿČÉ·"Ìk·ĤäÌæČÌïæ UK
°ĒÿÌæÃ"kȦȤȥȭɌ
45
N° 3
10
Details at
www.myebr.org
THE VOICE
OF EPOS
The Voice of EPOS™ offers a platform for poster authors
to present their work in person to an international audience.
Owing to its great success in previous years, The Voice of
EPOS™ has grown even more and has been expanded to 165
sessions at ECR 2019.
All sessions are moderated, and feature all radiological

subspecialties as well as hot topics such as Artificial Intelligence
and Machine Learning, Imaging Informatics, Radioprotection,
and Hybrid, Molecular and Translational Imaging.
In addition, there will be sessions held and moderated
in the presenters’ native languages in order to strengthen
the exchange within the communities and serve the ECR’s
multilingual and international audience.
Presentations will take place from Wednesday to Sunday

on five different stages in the ECR Online & EPOS Lounge
and in Foyer C; they will be broadcast online via the ECR Live
streaming service and recorded for ECR Online. The stage in
Foyer C is dedicated to Radiographers and will have a special
range of topics relevant for these professionals to facilitate
professional exchange among colleagues from all over the world.
195
THE VOICE OF EPOS

Stage 1 - EPOS Lounge
27
Feb Wednesday, February 27, 09:00–10:00
28
Feb Thursday, February 28, 09:00–10:00
VoE 001 Vascular VoE 008 EuroSafe Imaging
Moderator: A.M. Ierardi; Marsala/IT Moderator: E. Vañó Carruana; Madrid/ES
27
28
VoE 002 German VoE 009 Latin America (Portuguese)
Moderator: A. Mahnken; Marburg/DE Moderator: V.F. Muglia; Ribeirao Preto/BR
27
28
VoE 003 EuroSafe Imaging VoE 010 Head and Neck
Moderator: G. Frija; Paris/FR Moderator: D. Haba; Iasi/RO
27
28
VoE 004 Polish VoE 011 French
Moderator: T. Popiela; Krakow/PL Moderator: S. Franchi-Abella; Le Kremlin-Bicêtre/FR
27
28
VoE 005 Neuro VoE 012 Paediatric
Moderator: C. Calli; Izmir/TR Moderator: G. Pärtan; Vienna/AT
27
28
VoE 006 ESR meets Italy VoE 013 Korean
Moderator: G. Zamboni; Verona/IT Moderator: J.B. Seo; Seoul/KR
27
28
VoE 007 Emergency Imaging VoE 014 Musculoskeletal
Moderator: L. Ebner; Bern/CH Moderator: J.L. del Cura Rodríguez; Bilbao/ES
27
28
VoE 200 Musculoskeletal VoE 201 Neuro
Moderator: A. Barile; L’Aquila/IT Moderator: P. Argyropoulou; Alexandroupolis/GR

THE VOICE OF EPOS

1
March Friday, March 1, 09:00–10:00
2
March Saturday, March 2, 09:00–10:00
VoE 015 Imaging Informatics VoE 022 Interventional Radiology
Moderator: E.L. Kotter; Freiburg/DE Moderator: A.M. Ierardi; Marsala/IT
1 2
VoE 023 Russian
VoE 016 Spain
Moderator: E. Mershina; Moscow/RU
Moderator: A. Rovira-Cañellas; Barcelona/ES
2
1
March Friday, March 1, 11:00–12:00 VoE 024 EuroSafe Imaging
VoE 017 Genitourinary
Moderator: W. Stiller; Heidelberg/DE
Moderator: T. El-Diasty; Mansoura/EG
2
1
March Friday, March 1, 12:00–13:00 VoE 025 Latin America (Spanish)
VoE 018 Arabic (Egypt) Moderator: P. Tapia Puente Arnao; Lima/PE
Moderator: T. El-Diasty; Mansoura/EG 2

1
VoE 026 Oncologic Imaging
Moderator: S. Freeman; Cambridge/UK

VoE 019 Paediatric
Moderator: B. Ahuja; Agra/IN 2

VoE 027 German
1
Moderator: P. Wunderlich; Radebeul/DE
VoE 020 ESR meets Italy
2
Moderator: I. Bargellini; Pisa/IT
1
March Friday, March 1, 15:00–16:00 Moderator: A. Tsili; Ioannina/GR
VoE 021 Radioprotection/Radiation Dose

3
March Sunday, March 3, 09:00–10:00
Moderator: J.T. Heverhagen; Bern/CH
VoE 028 Cardiac
1
Moderator: K.F. Kreitner; Mainz/DE
VoE 202 Chest 3

Moderator: C. Rampinelli; Milan/IT VoE 029 Paediatric
Moderator: G. Pärtan; Vienna/AT
3
VoE 030 Head and Neck
Moderator: M. Palm; Maastricht/NL
3
VoE 204 Physics in Medical Imaging
Moderator: S. Skornitzke; Heidelberg/DE

THE VOICE OF EPOS

27
28
VoE 031 Chest VoE 038 Latin America (Spanish)
Moderator: L. Ebner; Bern/CH Moderator: M.A. Pinochet; Santiago/CL
27
28
VoE 032 Greek VoE 039 Neuro
Moderator: G. Kapsas; Thessaloniki/GR Moderator: G. Kapsas; Thessaloniki/GR
27
28
VoE 033 Turkish VoE 040 Chinese
Moderator: Y. Pekcevik; Izmir/TR Moderator: Z.Y. Jin; Beijing/CN
27
28
VoE 034 Chinese VoE 041 Hybrid, Molecular and Translational
Imaging
Moderator: Z.Y. Jin; Beijing/CN
Moderator: F. Frauscher; Innsbruck/AT
27
28
VoE 035 Vascular
VoE 042 Turkish
Moderator: S. Deftereos; Alexandroupolis/GR
Moderator: C. Calli; Izmir/TR
27
28
VoE 043 Interventional Radiology
Moderator: A. Barile; L’Aquila/IT
Moderator: T. Popiela; Krakow/PL
27
28
VoE 044 Japanese
Moderator: I. Shrainer; Moscow/RU
Moderator: M. Minami; Ibaraki/JP
27
28
VoE 205 Breast
VoE 206 Breast
Moderator: P. Moyle; Cambridge/UK
Moderator: P. Kapetas; Vienna/AT

THE VOICE OF EPOS

1
2
VoE 045 Emergency Imaging VoE 052 Chest
Moderator: S. Upponi; Cambridge/UK Moderator: M. Toepker; Vienna/AT
1 2
VoE 053 Breast
VoE 046 Latin America (Spanish)
Moderator: I. Arkhipova; Moscow/RU
Moderator: M.A. Pinochet; Santiago/CL
2
1
March Friday, March 1, 11:00–12:00 VoE 054 Paediatric
Moderator: S. Deftereos; Alexandroupolis/GR
2
1
March Friday, March 1, 12:00–13:00 VoE 055 Cardiac
VoE 048 Arabic (North Africa) Moderator: E. Mershina; Moscow/RU
Moderator: B. Mansouri; Algiers/DZ 2

1
VoE 056 Spain
Moderator: G. Bastarrika Alemañ; Pamplona/ES

Moderator: G. Zamboni; Verona/IT 2

VoE 057 Physics in Medical Imaging
1
Moderator: J.T. Heverhagen; Bern/CH
VoE 050 Emergency Imaging
2
Moderator: S. Upponi; Cambridge/UK
1
March Friday, March 1, 15:00–16:00 Moderator: A. Zikou; Ioannina/GR

3
Moderator: F. Frauscher; Innsbruck/AT
VoE 058 Imaging Informatics
1
Moderator: D. Wormanns; Berlin/DE
VoE 207 Interventional Radiology 3

Moderator: V. Bizimi; Athens/GR VoE 059 Chest
3
Moderator: L. Pallwein-Prettner; Steyr/AT
3
VoE 209 Cardiac
Moderator: E. Quaia; Padova/IT

THE VOICE OF EPOS

27
28
VoE 061 Russian VoE 068 Portugal
Moderator: M. Vishnyakova; Moscow/RU Moderator: M.L. Biscoito; Lisbon/PT
27
28
VoE 062 Musculoskeletal VoE 069 Musculoskeletal
Moderator: A. Barile; L’Aquila/IT Moderator: C. Schäffeler; Chur/CH
27
28
VoE 063 Japanese VoE 070 Professional Issues
Moderator: M. Minami; Ibaraki/JP Moderator: J.T. Geitung; Norbyhagen/NO
27
28
VoE 064 Neuro VoE 071 Abdominal Viscera
Moderator: P. Sijens; Groningen/NL Moderator: E. Kotter; Freiburg/DE
27
28
VoE 065 Arabic (Middle East) VoE 072 Spain
Moderator: D. Husseiny Salama; Cairo/EG Moderator: A. Rovira-Cañellas; Barcelona/ES
27
28
VoE 066 Breast VoE 073 Neuro
Moderator: P. Sijens; Groningen/NL Moderator: Y. Pekcevik; Izmir/TR
27
28
VoE 067 Romanian VoE 074 India
Moderator: I.G. Lupescu; Bucharest/RO Moderator: B. Ahuja; Agra/IN
27
28
VoE 210 Abdominal Viscera VoE 211 Vascular
Moderator: H.-D. Xue; Beijing/CN Moderator: E. van Beek; Edinburgh/UK

THE VOICE OF EPOS

1
2
VoE 075 Korean VoE 082 Latin America (Spanish)
Moderator: J.M. Goo; Seoul/KR Moderator: P. Tapia Puente Arnao; Lima/PE
1 2
VoE 076 Cardiac
Moderator: M. Palm; Maastricht/NL
Moderator: A. Mahnken; Marburg/DE
2
1
March Friday, March 1, 11:00–12:00 VoE 084 Portugal
VoE 077 Latin America (Portuguese)
Moderator: M.L. Biscoito; Lisbon/PT
Moderator: V.F. Muglia; Ribeirao Preto/BR
2
1
March Friday, March 1, 12:00–13:00 VoE 085 Neuro
VoE 078 GI Tract Moderator: D. Haba; Iasi/RO
Moderator: M. Torkzad; Godalming/UK 2

1
VoE 086 Japanese
Moderator: T. Aoki; Kitakyushu/JP

VoE 079 Japanese
Moderator: T. Aoki; Kitakyushu/JP 2

VoE 087 Breast
1
Moderator: I. Arkhipova; Moscow/RU
VoE 080 Abdominal Viscera
2
Moderator: S. Freeman; Cambridge/UK
VoE 213 Cardiac
1
March Friday, March 1, 15:00–16:00 Moderator: E. Quaia; Padova/IT
VoE 081 Spain

3
Moderator: G. Bastarrika Alemañ; Pamplona/ES
VoE 088 Chest
1
Moderator: M. Toepker; Vienna/AT
VoE 212 Musculoskeletal 3

Moderator: K. Daneshvar Ghorbani; Bern/CH VoE 089 Abdominal Viscera
Moderator: I.G. Lupescu; Bucharest/RO
3
Moderator: M. Krokidis; Cambridge/UK
3
VoE 214 Paediatric
Moderator: M. Raissaki; Heraklion/GR

THE VOICE OF EPOS

27
28
VoE 091 Abdominal Viscera VoE 098 Musculoskeletal
Moderator: J.T. Geitung; Norbyhagen/NO Moderator: J.L. del Cura Rodriguez; Bilbao/ES
27
28
VoE 092 Latin America (Portuguese) VoE 099 Interventional Radiology
Moderator: E. Fleury; Sao Paulo/BR Moderator: I. Shrainer; Moscow/RU
27
28
VoE 093 Breast VoE 100 Radioprotection/Radiation Dose
Moderator: M. Gaskarth; Cambridge/UK Moderator: D. Tack; Braine-L’Alleud/BE
27
28
VoE 094 Artificial Intelligence and Machine VoE 101 Artificial Intelligence and Machine
Learning Learning
Moderator: H. Alkadhi; Zurich/CH Moderator: H. Alkadhi; Zurich/CH
27
28
VoE 095 Chest VoE 102 Latin America (Portuguese)
Moderator: J.B. Seo; Seoul/KR Moderator: E. Fleury; Sao Paulo/BR
27
28
VoE 096 Latin America (Spanish) VoE 103 Imaging Informatics
Moderator: F. Lubinus; Bucaramanga/CO Moderator: D. Wormanns; Berlin/DE
27
28
VoE 097 Genitourinary VoE 104 Portugal
Moderator: M. Gaskarth; Cambridge/UK Moderator: A. Gaivão; Lisbon/PT
27
28
VoE 215 Neuro VoE 216 Neuro
Moderator: P. Argyropoulou; Alexandroupolis/GR Moderator: A. Mazumder; London/UK

THE VOICE OF EPOS

1
2
VoE 105 GI Tract VoE 112 Musculoskeletal
Moderator: M. Torkzad; Godalming/UK Moderator: E. Llopis San Juan; Alzira-Valencia/ES
1 2
VoE 113 Vascular
VoE 106 Portugal
Moderator: M. Krokidis; Cambridge/UK
Moderator: A. Gaivão; Lisbon/PT
2
1
March Friday, March 1, 11:00–12:00 VoE 114 ESR meets Italy
VoE 107 Abdominal Viscera
Moderator: I. Bargellini; Pisa/IT
Moderator: M. Ambrosetti; Verona/IT
2
1
March Friday, March 1, 12:00–13:00 VoE 115 ESR meets Africa
VoE 108 Korean Moderator: B. Mansouri; Algiers/DZ
Moderator: J.M. Goo; Seoul/KR 2

1
VoE 116 Radioprotection/Radiation Dose
Moderator: D. Tack; Braine-L’Alleud/BE

VoE 109 ESR meets Pakistan
Moderator: M.H. Akram; Islamabad/PK 2

VoE 117 Spain
1
Moderator: E. Llopis San Juan; Alzira-Valencia/ES
2
Moderator: A. Tsili; Ioannina/GR
1
March Friday, March 1, 15:00–16:00 Moderator: P. Prassopoulos; Thessaloniki/GR

3
Moderator: M. Lemmerling; Beervelde/BE
VoE 118 Breast
1
Moderator: P. Wunderlich; Radebeul/DE
VoE 217 Interventional Radiology 3

Moderator: P. Prassopoulos; Thessaloniki/GR VoE 119 ESR meets Italy
Moderator: M. Ambrosetti; Verona/IT
3
VoE 120 Neuro
Moderator: A. Zikou; Ioannina/GR
3
VoE 219 Musculoskeletal
Moderator: K. Daneshvar Ghorbani; Bern/CH

THE VOICE OF EPOS - RADIOGRAPHERS

Stage 5 - Foyer C
27
28
VoE 121 CT VoE 134 Spanish
Moderator: L.P. Ribeiro; Parchal/PT Moderator: M. Suárez Hernández; Galdakao/ES

27
1
VoE 122 Image Quality VoE 135 Austria
Moderator: F. Zarb; Msida/MT Moderator: S. Leitner; Berndorf/AT

27
1
VoE 123 Africa VoE 136 Advanced Practice
Moderator: C. Muchuki; Nairobi/KE Moderator: A. England; Manchester/UK

27
1
VoE 124 Education and Training VoE 137 Portuguese
Moderator: M. O’Connor; Dublin/IE Moderator: A.J. Da Cunha; Bragança /PT

27
1
VoE 125 Italian VoE 138 Radiation Protection
Moderator: D. Catania; Milan/IT Moderator: K.B. Yao; Abidjan/CI

27
1
VoE 126 Research and Patient Safety VoE 139 Japanese
Moderator: S. Foley; Dublin/IE Moderator: Y. Nakazawa; Minatoku/JP

27
1
VoE 127 Spanish VoE 140 Nuclear Medicine
Moderator: E.A. Alfayate Sáez; Madrid/ES Moderator: L. Lança; Lisbon/PT

28
1
VoE 128 Ultrasound VoE 141 MRI
Moderator: L.A. Rainford; Dublin/IE Moderator: F. Zarb; Msida/MT

28
2
VoE 129 Interventional Radiography VoE 142 Cardiology
Moderator: L.P. Ribeiro; Parchal/PT Moderator: J. Santos; Coimbra/PT

28
2
VoE 130 Japanese VoE 143 Japanese
Moderator: Y. Nakazawa; Minatoku/JP Moderator: F. Washizuka; Tokyo/JP

28
2
VoE 131 MRI VoE 144 Radiological Modalities
Moderator: L. Lança; Lisbon/PT Moderator: J. Santos; Coimbra/PT

28
2
VoE 132 Italian VoE 145 Paediatric
Moderator: D. Catania; Milan/IT Moderator: L.A. Rainford; Dublin/IE

28
VoE 133 Professional Issues
Moderator: S. Foley; Dublin/IE

SATELLITE
SYMPOSIA
Industrial Satellite Symposia are organised by various
international companies. These sessions are a chance
to get an industry perspective on various scientific subjects,
including technical updates, emerging trends and future
innovations. The symposia vary in length from 60 to 90
minutes, with the number of speakers also differing between
companies and subjects.
For details of the programmes see separate booklet

‘Industry Programme & On-Show Guide’.
205
Industry Programme
SATELLITE SYMPOSIA
27
Feb Wednesday, February 27, 10:30–12:00, Studio 2019
28
SY 2a Satellite Symposium jointly organised by SY 5 Satellite Symposium organised by
Siemens Healthineers and Kheiron Medical Technologies
Bayer
28
27 Wednesday, February 27, 12:15–13:45, Studio 2019
Feb
SY 6 Satellite Symposium organised by
SY 2b Satellite Symposium jointly organised by Siemens Healthineers (MR)
Siemens Healthineers and
Bayer 28
27 SY 7 Satellite Symposium organised by

Feb Wednesday, February 27, 14:00–15:30, Studio 2019 Philips (MR)
SY 2c Satellite Symposium jointly organised by
Siemens Healthineers and 28
Bayer
27 Hologic
Feb Wednesday, February 27, 16:00–17:00, Studio 2019
SY 2d Satellite Symposium jointly organised by 28
Siemens Healthineers and
Bayer SY 9 Satellite Symposium organised by
Bracco
27 Wednesday, February 27, 12:30–13:30, Room F2
Feb
28
GE Healthcare SY 10 Satellite Symposium organised by
Philips (IGT MOS)
27 Wednesday, February 27, 12:30–13:30, Room K
Feb
28
Canon Medical SY 12 Satellite Symposium organised by
Bayer and
Siemens Healthineers (CTEPH)
28
Bayer (MRI 1)
28
Bayer (MRI 2)
28
Elsevier

Industry Programme
SATELLITE SYMPOSIA
1
1
SY 15 Satellite Symposium organised by SY 25 Satellite Symposium organised by
Infinitt GE Healthcare Russia
1
1
Philips (CT) Elsevier
1
1
Philips (US) Carestream
1
2
Samsung Elsevier
1
2
SY 19 Satellite Symposium jointly organised by SY 28 Satellite Symposium organised by
Siemens Healthineers and Philips (DXR)
Bayer
2
1 Friday, March 1, 12:30–13:30, Room Y
March
SY 20 Satellite Symposium organised by Bracco (US)
Olea Medical
2
March Saturday, March 2, 12:30–13:30, Tech Gate Auditorium
1 Friday, March 1, 12:30–13:30, Room G
March
SY 21 Satellite Symposium organised by ICIS
Bracco
1
Bayer (GD)
1
Siemens Healthineers
1
March Friday, March 1, 12:30–13.30, Room M 3
Bayer Russia
1
March Friday, March 1, 12:30–13.30, Tech Gate Auditorium
Guerbet

European Board
of Radiology
Details at
www.myebr.org
INDUSTRY
WORKSHOPS
Intensive practical sessions organised directly by a particular
company or commercial vendor. Classes are conducted on
their own state-of-the-art workstations with expert technical
support provided by company staff. Participants have
the opportunity to learn from experts about using computers
and medical devices in the field of radiology and gain
first-hand knowledge. As a registered attendee for the ECR,
participation is free of charge.
For details of the programmes see separate booklet

‘Industry Programme & On-Show Guide’.
209
The support
initiative of the
ESR dedicated
to radiographers
in their
professional
career. 100
places reserved
every year.
POSTGRADUATE
EDUCATIONAL
PROGRAMME (A)
Session numbers are prefixed by
E3, EF, EM, HL, MC, MS, NH, PC, RC, SA, SF, TF
Presentation numbers are prefixed by the letter A
Key to Abbreviations
Basic Sessions (BS)
Basic Radiographers’ Sessions (BR)
Coffee & Talks (C)
EFOMP Workshop (EF)
ESR/EFRS/ISRRT meets Sessions (EM)
European Excellence in Education (E3)
Multidisciplinary Sessions (MS)
New Horizons Sessions (NH)
Professional Challenges Sessions (PC)
Pros & Cons Session (PS)
Refresher Courses (RC)
Special Focus Sessions (SF)
State of the Art Symposia (SA)
Transatlantic Courses (TC)
Women in Focus (WF)
211
Postgraduate Educational Programme
08:30 - 10:00 Room B A-0007 08:35

A. Tomosynthesis
Abdominal Viscera H. Yule; Cardiff/UK
Learning Objectives:
RC 101 1. To review the technology underpinning tomosynthesis.
2. To understand the current evidence base for use of tomosynthesis.
Imaging of benign liver lesions: 3. To appreciate results from the UK TOMMY trial and others.
still difficult? A-0008 08:58

B. Breast imaging in young females: the role of MRI
A-0001 08:30 M.M. Ribeiro; Lisbon/PT
Chairperson‘s introduction
P. Ricci; Rome/IT Learning Objectives:
1. To understand current sensitivity of MRI when imaging the breast.
Session Objectives: 2. To discuss the varying sensitivities of mammography and ultrasound
1. To understand the role of different imaging techniques in the according to age.
characterisation of focal liver lesions. 3. To appreciate the potential use of abbreviated MRI sequences.
2. To be aware of malignant lesions which may mimic benign liver
conditions. A-0009 09:21
3. To underline current guidelines for the characterisation of equivocal C. Breast screening programmes: current evidence
liver lesions. S. Hofvind; Oslo/NO
A-0002 08:35 Learning Objectives:

A. Hepatic cysts: always simple? 1. To identify advantages and disadvantages of breast screening
I. Santiago; Lisbon/PT regarding false positives.
2. To appreciate current debate both for and against organised
Learning Objectives: screening programmes.
1. To learn about different types of cystic lesions in the liver, including 3. To consider alternatives to breast screening.
giant biliary hamartomas or foregut cysts.
2. To understand the diagnostic approach to differentiate simple and 09:44
complex cysts/cystic lesions. Panel discussion: Breast imaging: a true multidisciplinary team effort?
3. To appreciate advantages and limitations of imaging for
differentiating simple cysts from other cystic lesions.
08:30 - 10:00 Room X
A-0003 08:58 Imaging Informatics
B. Liver haemangiomas and mimickers
F. Caseiro Alves; Coimbra/PT
Learning Objectives: RC 105

1. To learn about typical imaging findings of liver haemangioma.
2. To understand the atypical imaging findings of liver haemangiomas.
Mobile devices in radiology
3. To appreciate the role of multiparametric and liver-specific contrast
MRI in differentiation between haemangiomas and malignant lesions
A-0010 08:30
mimicking haemangiomas.
O. Ratib; Geneva/CH
A-0004 09:21 Session Objectives:
C. FNH or adenoma? 1. To give an overview of tools available on mobile devices for education
A. Ba-Ssalamah; Vienna/AT and exam reporting.
2. To underline the impact of mobile devices in routine clinical activity.
3. To learn about the legislative backbone and potential drawbacks of
1. To learn the imaging features associated with FNH and adenoma on
mobile technology.
contrast-enhanced CT and MRI.
2. To understand how the imaging characteristics are related to the
underlying pathological findings.
A-0011 08:35
A. Security and confidentiality aspects of mobile computing
3. To appreciate the optimal use of liver-specific contrast media for
distinguishing between FNH and adenoma, and current classification
and pathological characteristics and its impact on the management. Learning Objectives:
1. To provide an overview of technical solutions for patients‘ image and
09:44 data mobility.
Panel discussion: What imaging strategy for my routine clinical 2. To provide a risk assessment analysis (data loss, privacy, etc.) of
practice? mobile technology.
3. To give an overview of European legislation in relation to patient
08:30 - 10:00 Room C image and data mobility.
General Radiography (Radiographers) A-0012 08:58

B. Added value of mobile devices in education
RC 114 Learning Objectives:
Contemporary breast imaging 1. To give an overview of tools available for e-learning.
2. To explore the potential impact of e-learning in the daily radiological
A-0005/A-0006 08:30 practice.
Chairpersons‘ introduction 3. To explore future developments and limits of e-learning.
E. Metsala; Helsinki/FI
Session Objectives:
1. To discuss the relevance and application of tomosynthesis in breast
imaging.
2. To understand the indications and use of breast MRI in pre-
menopausal women.
3. To appreciate the current debate regarding the appropriateness of
breast screening programmes.

A-0013 09:21 A-0018 09:18

C. Recommendations for reporting on mobile devices The MEDIRAD Early-Heart study
N.H. Strickland; London/UK S. Jacob; Fontenay aux Roses/FR
Learning Objectives: Learning Objectives:

1. To give an overview of available DICOM viewers and software for 1. To appreciate that there is already some information from cardiac
reporting imaging studies. imaging studies regarding early cardiovascular effects after breast
2. To discuss technical requirements of mobile devices for use in imaging cancer radiotherapy.
interpretation. 2. To learn how the MEDIRAD Early-Heart study will provide information
3. To provide insight on future developments of imaging viewing regarding imaging biomarkers of early cardiovascular effects after
technology. radiotherapy for breast cancer.
3. To understand that cardiac imaging can provide clues for underlying
09:44 mechanisms of radiation-induced major cardiac events.
Panel discussion: Can mobile technology supplement stationary
technology in radiology? 09:34
Wednesday
Discussion
08:30 - 10:00 Room N
A-0019 09:39
EuroSafe Imaging Session Imaging biomarkers of cardiovascular effects of indicental cardiac
radiation
E. Mousseaux; Paris/FR
EU 1 Learning Objectives:
Cardiovascular effects after radiotherapy 1. To appreciate how radiation-induced coronary artery lesions can be
studied by cardiac CT.
for breast cancer: the European 2. To understand how MRI can be used to evaluate myocardial tissues
abnormalities induced by incidental cardiac radiation, including
MEDIRAD Project morphology, function and tissue abnormalities.
A-0014/A-0015 08:30 09:55

Chairpersons‘ introduction
Discussion
A. Crijns; Groningen/NL
G. Frija; Paris/FR
08:30 - 10:00 Room O
Session Objectives:
1. To learn about major cardiovascular events after radiotherapy for Vascular
breast cancer.
2. To understand the importance of assessing their relationship with
radiation dose to cardiac substructures.
3. To appreciate the potential of imaging biomarkers for their early
RC 115
detection and their role in prevention strategies. Visceral arteries
A-0016 08:36 A-0020 08:30
Overview of dose-effect relationships and their use in strategies for Chairperson‘s introduction
prevention of cardiovascular effects after radiotherapy for breast J.A. Reekers; Amsterdam/NL
cancer
Session Objectives:
A. Crijns; Groningen/NL
1. To learn about incidence and aetiology of visceral arteries diseases.
Learning Objectives: 2. To become familiar with clinical symptoms and evaluation in visceral
1. To learn about the increased risk of various major cardiac events after arteries diseases.
incidental exposure of the heart during breast radiotherapy. 3. To indicate the role of radiology in diagnosis and treatment of the
2. To understand that multivariable prediction models are needed visceral arteries.
describing the relationship between radiation dose to cardiac
substructures and (early) cardiovascular effects. A-0021 08:35
3. To appreciate the role of modern cardiac imaging techniques in A. Diagnosis of vascular compression syndromes
providing detailed information regarding early cardiovascular effects B.E. Cil; Istanbul/TR
after radiotherapy.
1. To become familiar with abdominal arterial and venous compression
08:52 syndromes.
Discussion
2. To learn about functional imaging techniques in assessment of
vascular compression syndromes.
A-0017 08:57 3. To become familiar with the typical imaging findings in abdominal
Optimisation of multivariable prediction models for major cardiac compression syndromes and their clinical relevance.
events after radiotherapy for breast cancer
D.S. Spoor; Groningen/NL
A-0022 08:58
Learning Objectives: B. Acute and chronic mesenteric ischaemia
1. To appreciate how the MEDIRAD-BRACE study will provide optimised M. Zins; Paris/FR
multivariable prediction models for major cardiac events.
2. To learn that optimal prevention of radiation-induced major cardiac
1. To become familiar with occlusive and non-occlusive, mesenteric
events requires early detection/imaging biomarkers.
ischaemia.
2. To understand the differences between acute and chronic ischaemia.
09:13 3. To learn about the importance of fast and correct diagnosis in acute
Discussion mesenteric ischaemia.

A-0023 09:21 08:30 - 10:00 Room E1

C. Endovascular treatment of mesenteric ischaemia
R. Morgan; London/UK E3 - ECR Master Class (Neuro)
1. To review indications for endovascular treatment of mesenteric
ischaemia.
E3 126a
2. To become familiar with the technical possibilities of endovascular How to implement MRI neuro advanced
repair of visceral arteries.
3. To learn about risks and complications of endovascular treatment of techniques at home
mesenteric ischaemia. Moderator:
P.C. Maly Sundgren; Lund/SE
09:44
Panel discussion: Radiologists as the best case managers in acute and A-0024 08:30
chronic mesenteric ischaemia A. Practical approach to cerebral perfusion techniques
H.R. Jäger; London/UK
09:00 - 10:00 Coffee & Talk 2 Learning Objectives:
1. To learn about the essentials in MRI perfusion techniques.
Coffee & Talk (open forum) Session
2. To understand how to interpret the data in brain perfusion MRI.
3. To know the limitations in perfusion MRI studies.
C1 A-0025 09:00
Clinical audit across Europe: how B. How to read susceptibility-weighted imaging (SWI)
S. Haller; Carouge/CH
to increase uptake and support BSS
transposition 1. To be familiar with the practical basics of MRI SWI sequences.
2. To learn what information we can get from the SWI sequence.
A-0078 09:00 3. To understand the importance of applying the SWI technique in
Chairperson‘s introduction individual patients.
D.C. Howlett; Eastbourne/UK
Session Objectives: A-0026 09:30

1. To appreciate the role of the ESR and the Esperanto audit guide in C. How to read diffusion tensor imaging (DTI)
promotion of clinical audit. R. Gasparotti; Brescia/IT
2. To explore potential barriers to uptake of clinical audit and how these Learning Objectives:
may differ across Europe. 1. To learn the principals of DTI imaging in neuroradiology.
3. To understand the interlinking of the regulator, clinical audit and 2. To appreciate the practical value of DTI in different neurological
national regulatory implementation. disorders.
3. To be familiar with pitfalls of DWI and DTI imaging - common
A-0079 09:05 language with neurosurgeons.
Clinical audit: what, why, how?
A. Brady; Cork/IE
08:30 - 10:00 Room E2
1. To understand the difference: internal audit vs internal audit with Special Focus Session
external direction vs external audit.
2. To appreciate the added value of effective clinical audit.
3. To highlight the role of clinical audit as outlined within the BSS. SF 1
A-0080 09:10 Screening with imaging: a new era?
Clinical audit: regulation
A-0027 08:30
Learning Objectives: A. Devaraj; London/UK
1. To understand the role of the regulator.
Session Objectives:
2. To appreciate the regulatory perspective on clinical audit.
1. To understand how screening is currently implemented in Europe.
3. To understand the difference between audit and inspection.
2. To understand the challenges familiar to all screening programmes
when aiming to continually enhance quality and minimise harms.
A-0081 09:20 3. To understand the emerging technologies in screening of lung, breast
Case example 1: clinical audit template
and colorectal cancer.
H.H. Hjemly; Oslo/NO
Learning Objectives: A-0028 08:35

1. To understand how the Esperanto audit guide can form an integral Screening of lung cancer with low dose CT
part of a departmental audit programme. M. Prokop; Nijmegen/NL
2. To review local/national uptake of the ESR Esperanto audit guide and
progress towards BSS transposition.
1. To understand the current situation with lung cancer screening in
Europe.
A-0082 09:25 2. To understand the challenges of implementing a new screening
Case example 2: a template for regulatory audit, a subset of clinical
programme for lung cancer.
audit
3. To discuss areas for quality assurance and standardisation in lung
cancer screening.
1. To discuss the benefits of a national regulatory audit network.
2. To understand how a local regulatory audit can incorporate national
regulatory audit approaches.
3. To understand the value of regulatory audit as a demonstration of
compliance with national regulations.
09:30
Open forum discussion

A-0029 08:58 08:30 - 10:00 Room F2

Screening of colorectal cancer with CT colonography
A. Laghi; Latina/IT New Horizons Session
1. To understand the rationale for a colorectal cancer screening
programme.
NH 1
2. To be updated about current experiences on screening CT The role of imaging in the era of liquid
colonography.
3. To learn about advantages and limitations of CT colonography in biopsy
comparison with other colorectal cancer screening tests.
A-0034 08:30
A-0030 09:21 Chairperson‘s introduction
Screening of breast cancer with abbreviated MRI D. Regge; Turin/IT
Session Objectives:
Wednesday
Learning Objectives: 1. To learn about the role of liquid biopsy in cancer detection and tumour
1. To list the cancer detection rates of radiographic, ultrasound and MR surveillance.
imaging for screening of breast cancer. 2. To become familiar with advances of imaging in cancer detection and
2. To describe the respective diagnostic accuracies published for breast characterisation.
MRI with abbreviated vs full diagnostic protocols. 3. To understand the revised role of imaging in monitoring of cancer
3. To list rates and causes of over- and underdiagnosis of breast cancer therapy.
in current breast cancer screening programmes. 4. To explore how combining molecular and imaging metrics could
improve clinical decision in cancer patients.
09:44
Panel discussion: Optimising screening and taking it to the next level A-0035 08:35
Liquid biopsy in perspective: colorectal cancer as a model system
A. Bardelli; Turin/IT
08:30 - 10:00 Room F1
E3 - Rising Stars Programme: Basic Session 1. To explain the principles of liquid biopsy.
2. To review the role of liquid biopsy as a diagnostic tool for early
diagnosis.
BS 1 3. To learn about the role of liquid biopsy as a predictor of cancer
recurrence.
Musculoskeletal: bones and soft tissues 4. To explore how liquid biopsy could complement imaging, from a
Moderator: molecular biologist‘s perspective.
A.H. Karantanas; Iraklion/GR
A-0036 08:53
A-0031 08:30 New imaging tools for cancer detection and characterisation
Bone marrow diseases H.-P. Schlemmer; Heidelberg/DE
K. Verstraete; Ghent/BE
Learning Objectives: 1. To review the modern approach to early diagnosis with imaging.
1. To describe the typical features of normal bone marrow. 2. To become familiar with the new imaging biomarkers for tumour
2. To determine origin of bone marrow changes. characterisation.
3. To present the imaging characteristics of a bone marrow disease of 3. To envisage how liquid biopsy and imaging could complement each
the different types. other in cancer diagnostics.
A-0032 09:00 A-0037 09:11

Soft tissue tumours Is there still a role for imaging surveillance? And when?
V.N. Cassar-Pullicino; Oswestry/UK V.J. Goh; London/UK
1. To determine the origin of a soft tissue tumour (e.g. fat, neural, 1. To explain the rationale of cancer surveillance.
vascular, etc.). 2. To review current cancer surveillance imaging strategies.
2. To present current imaging techniques for evaluation of soft tissue 3. To become familiar with new imaging tools for surveillance of patients
tumours. with cancer.
3. To discuss the imaging findings which are important for the diagnosis 4. To explore how liquid biopsy and imaging could improve detection of
of soft tissue tumours. minimal residual disease.
A-0033 09:30 A-0038 09:29

Bone tumours Combining molecular and imaging metrics in cancer (radiogenomics)
J.L. Bloem; Leiden/NL K. Pinker-Domenig; Vienna/AT
1. To review the classification of bone tumours. 1. To explain the basic principles of radiogenomics.
2. To present current imaging techniques for evaluation of bone 2. To summarise the current clinical applications of radiogenomics.
tumours. 3. To explore how radiogenomics could guide clinical decisions in the
3. To describe the typical features of common bone tumours. future.
09:47
Panel discussion: Will liquid biopsy be a game changer for
radiologists?

08:30 - 10:00 Room Y A-0045 09:15

B. Abdominal trauma
Joint Session of the ESR Ultrasound Subcommittee R. Basilico; Chieti/IT
with EFSUMB Learning Objectives:
1. To identify the signs of trauma.
2. To provide an indication of their clinical significance.
ESR US SC/EFSUMB
Ultrasound simulation models in training 08:30 - 10:00 Room G
and education: where are we going? Physics in Medical Imaging
A-0039/A-0040 08:30
D.A. Clevert; Munich/DE
RC 113
P.S. Sidhu; London/UK Patient-specific dosimetry
1. To learn about which technical procedures are proposed in a Chairperson‘s introduction
simulation-based curriculum in radiology. E. Samara; Sion/CH
2. To learn about advantages and disadvantages of the different types
of ultrasound simulators available. Session Objectives:
3. To learn about the possibility of using virtual reality and gamification 1. To understand the needs for personalised dosimetry.
for training. 2. To learn about existing and new methodologies used for patient
4. To learn about the experience from different parts of Europe in using dosimetry.
ultrasound simulation training. 3. To understand the challenges for the implementation of patient-
specific dosimetry.
A-0041 08:40
Needs assessment of simulations-based training in radiology A-0047 08:35
L. Nayahangan; Copenhagen/DK A. Breast imaging dosimetry
I. Sechopoulos; Nijmegen/NL
1. To learn about how to perform a needs assessment using the Delphi Learning Objectives:
method. 1. To understand the current method to estimate organ dose in
2. To learn about how a needs assessment identified and prioritised mammography and its limitations.
technical procedures to be included in a simulation-based curriculum. 2. To understand breast dosimetry in emerging modalities.
3. To learn about how the list of procedures may be used as guide for 3. To learn about upcoming approaches in breast dosimetry.
development of training programmes.
A-0048 08:58
A-0042 09:00 B. Patient dosimetry in CT and CBCT
Review of the available market of ultrasound simulators S. Edyvean; London/UK
Learning Objectives: 1. To understand what is estimated.
1. To learn about different types of simulators on the market. 2. To learn how to measure it.
2. To learn about which are suitable for beginners or advanced levels,
and which can be used for training in interventional ultrasound. A-0049 09:21
3. To learn about advantages and disadvantages of different types of C. Patient dose in fluoroscopy and interventional
ultrasound simulators. A. Trianni; Udine/IT

Gamification and virtual reality in medical simulation 1. To review the fundamental patient dosimetry quantities.
L. Konge; Copenhagen/DK 2. To learn about calculation of patient dose for interventional
procedures.
Learning Objectives: 3. To learn about real time patient dose monitoring strategies.
1. To learn about gamification as a tool in medical education.
2. To learn about virtual reality in medical education. 09:44
3. To learn which possible ways virtual reality and gamification could be Panel discussion: The future of patient-specific dosimetry
implemented in ultrasound.
08:30 - 10:00 Room K
09:40
Panel discussion: Will there be an option to include these technics in Multidisciplinary Session
our daily work and how could we improve the outcome?
08:30 - 10:00 Room D MS 1

E3 - ECR Academies: Interactive Teaching Session for Young Lung cancer team
(and not so Young) Radiologists
A-0050 08:30
E3 121 A.R. Larici; Rome/IT
Session Objectives:
Emergency radiology I 1. To understand how to carry out an accurate diagnosis of lung cancer.
2. To learn about the actual therapeutic approach to lung cancer in the
A-0044 08:30 era of „personalised treatment“.
A. Acute aortic syndrome
3. To appreciate how a multidisciplinary team can make the difference in
H. Alkadhi; Zurich/CH
effectively managing lung cancer.
1. To understand the different types of acute aortic syndrome.
2. To learn about imaging findings and management options.

A-0051 08:35 A-0059 09:00

Imaging and staging COST action initiatives as a platform for image biomarker selection
M. Silva; Parma/IT A. Caroli; Ranica/IT

1. To learn how to optimise the diagnostic algorithm of lung cancer. 1. To learn about how COST actions work and the outputs generated.
2. To understand the evolving meaning of TNM classification. 2. To appreciate examples of a successful COST action for selecting
3. To become familiar with key imaging criteria to manage lung cancer. imaging biomarkers.
3. To understand difficulties in selecting biomarkers for specific
A-0052 08:53 indications.
Role of the pathologist: making the most of the sample
G. Rossi; Ravenna/IT A-0060 09:25
Role of AI in the introduction of imaging biomarkers: accelerator or
Learning Objectives: obstacle?
1. To learn about the best way to obtain tumour tissue using different J.C. Waterton; Manchester/UK
approaches.
Wednesday
2. To optimise tumour tissue management increasing the diagnostic Learning Objectives:
yield in histologic subtyping and predictive molecular determinations. 1. To learn how AI can improve imaging biomarkers from multiple
3. To understand the correct information to relate to the oncologist as imaging modalities.
the first line of treatment. 2. To appreciate the challenges „big data“ pose to regulators, whether
from imaging biomarkers or from the more conventional biospecimen
A-0053 09:11 (genomic, proteomic) biomarkers.
Role of the oncologist: personalising the treatment 3. To understand how best to utilise AI for imaging biomarkers and to
S. Novello, M.L. Reale; Orbassano/IT avoid the pitfalls.
Learning Objectives: 09:50

1. To learn about the meaning of personalised treatment and the Panel discussion: What infrastructure do we need to exploit AI for
evolution of lung cancer therapies in the last 10 years. selecting, validating and managing imaging biomarkers?
2. To understand the role of the newer targeted therapies.
3. To become familiar with the needs of the oncologist to optimise lung
cancer treatment. 08:30 - 10:00 Room M 2
A-0054 09:29 Paediatric

What the surgeon needs to know
U. Pastorino; Milan/IT
RC 112
1. To learn about the advances in the surgical approach for lung cancer Interventional radiology (IR) in children:
treatment. what a non-interventional radiologist
2. To understand how the clinical staging may affect surgical results in
lung cancer. needs to know
3. To become familiar with the needs of the surgeon to define the Moderator:
appropriate surgical approach. E. Alexopoulou; Athens/GR
A-0055 09:47 A-0061 08:30

Multidisciplinary case presentation and discussion A. Common IR procedures in children: state-of-the-art
A.R. Larici; Rome/IT A. Barnacle; London/UK
08:30 - 10:00 Room M 1 1. To learn about the most common causes for image-guided
intervention in children.
Joint Session of the ESR and EIBALL
2. To understand how the practical and technical approach to
intervention in a child differs from that in adults.
ESR/EIBALL 3. To appreciate tips, tricks and pitfalls in paediatric intervention
procedures.
Imaging biomarkers and their
A-0062 09:00
combinations in the era of artificial B. Vascular malformations: diagnosis and interventions
intelligence M. Beeres; Frankfurt a. Main/DE
A-0056/A-0057 08:30 1. To learn about the classification of paediatric vascular malformations.
Chairpersons‘ introduction 2. To understand the diagnostic work-up and the indications for
O. Clément; Paris/FR percutaneous treatment of paediatric vascular malformations.
N.M. deSouza; Sutton/UK 3. To appreciate the treatment options for different vascular
malformations.
Session Objectives:
1. To introduce the potential of AI to accelerate the introduction of
imaging biomarkers. A-0063 09:30
2. To introduce the challenges of managing biomarkers with AI systems. C. Osteoid osteoma: diagnosis and treatment
3. To introduce the speakers. D. Filippiadis; Athens/GR
A-0058 08:35 1. To learn how to diagnose, and how to treat, osteoid osteomas.
Building and discovering biomarkers with AI 2. To understand the techniques for percutaneous treatment of osteoid
B. Rance; Paris/FR osteoma: preparations, procedure and follow-up.
3. To appreciate advantages and potential complications in
percutaneous treatment of osteoid osteoma in children.
1. To learn about available supervised vs unsupervised machine learning
techniques.
2. To learn about deep-learning methods to discover biomarkers.
3. To understand the strength, but also limits and pitfalls, of machine
learning methods.

08:30 - 10:00 Room M 3 08:30 - 10:00 Room M 4

Oncologic Imaging E3 - ECR Academies: Hot Topics in GU Cancer
RC 116 E3 119
Imaging tumour response to Early detection of ovarian cancer
immunotherapy A-0069 08:30
A-0064 08:30 R. Forstner; Salzburg/AT
O.L. Sedlaczek; Heidelberg/DE
A-0070/A-0071 08:36
Session Objectives: A. Current guidance on screening and familial ovarian cancer
1. To discuss the mechanism of action of immunotherapies. A.G. Rockall; London/UK
2. To understand immunotherapy response and immune-related adverse A. George; London/UK
events.
3. To become familiar with immune related response criteria (irRC),
1. To be aware of the implications of results of recent screening trials.
immune-related RECIST (irRECIST) and immune RECIST (iRECIST).
2. To be aware of BRCA gene testing and treatment implications.
4. To discuss future directions for advanced imaging of immunotherapy.
3. To know the guidance on screening high risk groups.
A-0065 08:35 A-0072 09:04

A. Imaging the immune system in cancer
B. ORADS: ultrasound and International Ovarian Tumor Analysis (IOTA)
group models
Learning Objectives: R.F. Andreotti; Nashville, TN/US
1. To discuss the concept of immunotherapy treatment in cancer.
2. To review what the radiologist needs to know when assessing
1. To understand a new lexicon for ovarian/adnexal mass evaluation on
immunotherapy treatment.
ultrasound.
3. To understand the challenges of assessing immunotherapy response
2. To understand the use of the lexicon in the development of a risk
using imaging.
stratification and management system.
3. To apply O-RADS-US to case management.
A-0066 08:53
B. Monitoring immune response with CT
A-0073 09:32
F. Gentili; Siena/IT
C. ORADS: MRI
Learning Objectives: I. Thomassin-Naggara; Paris/FR
1. To discuss different types of immunotherapies and to review their
mode of action as imaged with CT.
1. To understand a new lexicon for ovarian/adnexal mass evaluation on
2. To understand the limitations of RECIST and become aware of
MRI.
immune response criteria.
2. To understand the use of the lexicon in the development of a risk
3. To discuss the limitations of CT for assessment of immunotherapies.
stratification and management system.
3. To apply O-RADS-MRI to case management.
A-0067 09:11
C. Monitoring immune response with PET
C.C. Cyran; Munich/DE 08:30 - 10:00 Room M 5
Learning Objectives: E3 - ECR Master Class (Head and Neck)
1. To discuss the framework for the use of FDG PET/CT for
immunotherapy assessment.
2. To become familiar with the best response criteria for assessment of
immunotherapy using PET/CT.
E3 126b
3. To discuss the limitations of PET/CT for assessing of immunotherapies. Functional imaging in head and neck
oncology
A-0068 09:29
D. Monitoring immune response with MRI A-0074 08:30
D.-M. Koh; Sutton/UK Chairperson‘s introduction
Learning Objectives: F. Bidault; Villejuif/FR
1. To learn the advantages and limitations of MRI for assessment of Session Objectives:
immunotherapies. 1. To discuss the role of functional imaging in tumour staging.
2. To describe the potential role of whole-body MRI and quantitative MRI 2. To learn about the presentation and prognosis of head and neck
techniques for patient follow-up. cancer patients.
3. To consider the potential of integrated PET/MRI for the assessment of 3. To understand the clinical impact of imaging findings.
immunotherapies.
A-0075 08:35
09:47 A. Functional imaging for locoregional tumour assessment
Panel discussion: What is the best way to monitor immunotherapy M.G. Mack; München/DE
response?
1. To learn about functional imaging (perfusion, DWI, PET) in head and
neck cancer patients.
2. To understand the value of functional imaging for tumour assessment.
3. To discuss nodal assessment in head and neck cancer.

A-0076 08:58 10:30 - 12:00 Room F1

B. Incidence and prognosis of synchronous cancer or distant
metastases from head and neck tumours E3 - Rising Stars Programme: Basic Session
A.D. King; Hong Kong/CN
1. To become familiar with the incidence of the synchronous tumours in
BS 2
the head and neck population. Thoracic emergencies
2. To become familiar with the incidence of the distant metastases in the
Moderator:
patients with newly diagnosed head and neck cancer.
3. To understand the consequences in a prognosis.
A-0077 09:21 A-0086 10:30

Acute aortic syndrome
C. Is functional imaging necessary to detect distant metastases in
T. Jargiello; Lublin/PL
head and neck cancers?
Wednesday
R. Maroldi; Brescia/IT Learning Objectives:
1. To become familiar with the most common aetiologies of acute aortic
diseases.
1. To review the advanced imaging for detection of distant metastases of
2. To present current imaging techniques for evaluation of acute aortic
head and neck cancer.
diseases.
2. To understand the advantages and disadvantages of functional
3. To demonstrate the most important imaging findings.
imaging modalities for M staging.
3. To discuss when to image for distant metastases.
A-0087 11:00
Pulmonary embolism
09:44
C. Loewe; Vienna/AT
Panel discussion: How to stage head and neck tumours correctly
10:00 - 11:00 Coffee & Talk 1 1. To review the most common pathologies leading to pulmonary
embolism.
Coffee & Talk (open forum) Session 2. To present current imaging techniques for evaluation of pulmonary
embolism.
3. To become familiar with the typical findings in acute and chronic
C 23 pulmonary embolism.
Meet the professor A-0088 11:30

Moderator: Acute coronary syndrome
V. Vilgrain; Clichy/FR R.M.M. Hinzpeter; Zurich/CH
A-0083 10:00
1. To become familiar with segmental coronary anatomy.
What is ESOR?
2. To present different techniques for assessment of acute coronary
syndrome.
Learning Objectives: 3. To become familiar with the typical findings of acute coronary
1. To learn about the ESOR activities. syndrome.
2. To understand the role of ESOR in education in Europe and beyond.
3. To appreciate the value of high quality education. 10:30 - 12:00 Room D
A-0084 10:10 E3 - ECR Academies: Interactive Teaching Session for Young
How to succeed in academic career? (and not so Young) Radiologists
M. Ronot; Clichy/FR
1. To learn the steps required for an academic career. E3 221
2. To understand the similarities and differences among countries.
3. To be aware of the balance between clinical, research and educational
Musculoskeletal radiology: inflammation
activities. A-0089 10:30
A. Inflammatory and infections in the soft tissues
A-0085 10:25 S. Martin; Palma de Mallorca/ES
How can we maintain the link between your professional career and
ESOR? Learning Objectives:
V. Vilgrain; Clichy/FR 1. To learn the key signs for differential diagnosis.
1. To explain the ESOR alumni programme. A-0090 11:15
2. To understand the benefits of ESOR alumni programme. B. Arthropathies
3. To underline the importance of participating in educational activities. U. Aydingoz; Ankara/TR
10:30 Learning Objectives:

Open forum discussion 1. To explain the key points in the differential diagnosis of common
arthropathies.
2. To describe the imaging findings of common arthropathies as they
relate to pathophysiology.

10:30 - 12:00 Room M 4 12:30 - 13:30 Coffee & Talk 2

E3 - ECR Academies: Hot Topics in GU Cancer Coffee & Talk (open forum) Session
E3 219 C3
Early detection of prostate cancer Bonn Call for Action Implementation
A-0091 10:30 Toolkit: free access to a wealth of
Chairperson‘s introduction resources
A-0098 12:30
A-0092/A-0093 10:36 Chairperson‘s introduction
A. Screening for prostate cancer: where are we now? O. Holmberg; Vienna/AT
A. George; London/UK
A. Sohaib; London/UK Learning Objectives:
1. To learn what the Bonn Call for Action is, and how it helps strengthen
Learning Objectives: radiation protection in medicine.
1. To be aware of important prostate cancer genetics and familial cancer. 2. To learn about the Bonn Call for Action Implementation Toolkit, what
2. To learn about the difference in low risk vs high risk genetic groups. it is, how to use it and how it can be of value for health professionals
3. To be aware of the use of imaging and other biomarkers. and patients.
3. To understand the involvement of international organisations and
A-0094 11:04 radiation protection campaigns in the development and promotion of
B. Pre-biopsy detection and new techniques for detection in prostate the Bonn Call for Action Implementation Toolkit.
cancer
S. Punwani; London/UK

1. To understand the role of mpMRI in tumour detection. The Toolkit from a technical viewpoint
2. To be aware of texture features of prostate cancer. L. Dojcanova; Vienna/AT
3. To learn how texture analysis differentiate benign from malignancy
prostate lesions. Learning Objectives:
1. To understand what type of material and applications are included in
the Toolkit.
A-0095 11:32
2. To learn how to access and use the Toolkit.
C. Active surveillance: best practice
3. To appreciate what the next steps are in the implementation of the
J.J. Fütterer; Nijmegen/NL
Toolkit.
1. To be familiar with case selection for active surveillance. A-0100 12:45
2. To know the frequency of imaging. The Toolkit from an international organisation‘s viewpoint
3. To understand when treatment will be commenced. M.d.R. Perez; Geneva/CH
12:30 - 13:30 Room C 1. To appreciate the viewpoint of an international organisation, WHO, on
the Toolkit.
E3 - The Beauty of Basic Knowledge: Pancreas 2. To understand how radiation protection in medicine can be
strengthened by using the Toolkit.
E3 24A A-0101 12:55

Acute pancreatitis The Toolkit from a radiation protection campaign‘s viewpoint
G. Frija; Paris/FR
Moderator:
R. Manfredi; Rome/IT Learning Objectives:
1. To appreciate the viewpoint of a radiation protection campaign,
A-0096 12:30 EuroSafe Imaging, on the Toolkit.
Atlanta Classification of acute pancreatitis 2. To understand how radiation protection in medical imaging can be
T. Bollen; Nijmegen/NL strengthened by using the Toolkit.

1. To understand grading of acute pancreatitis: Atlanta Classification. Open forum discussion: How will the end-user and patient benefit from
2. To learn about the clinical impact of Atlanta Classification. the Toolkit? What can be done better?
3. To understand the follow up of acute pancreatitis.
A-0097 13:00 12:30 - 13:30 Coffee & Talk 3

Role of imaging
C. Triantopoulou; Athens/GR Coffee & Talk (open forum) Session
1. To learn about diagnosis of acute pancreatitis. C2
2. To understand how to apply Atlanta Classification to imaging.
3. To learn about new trends in diagnosis of acute pancreatitis. Should we really F.E.A.R. artificial
intelligence?
A-0102 12:30
1. To appreciate the meaning and organisation of the session.
2. To understand the concept of AI in radiology and discuss whether
images will still be needed.
3. To explain what is meant by F.E.A.R.

A-0103 12:35 A-0108 14:30

AI and radiology workforce B. Rectal carcinoma
A.G. Rockall; London/UK M.J. Lahaye; Amsterdam/NL

1. To discuss whether AI will replace radiologists in the future. 1. To learn about the rationale for neoadjuvant treatment in rectal cancer
2. To explain the role of intelligent acquisition devices and the impact on and the impact on subsequent surgery.
radiographers‘ daily work. 2. To understand why imaging is needed to assess the response to
3. To understand what will be the competences required from a neoadjuvant therapy, what to look for when judging response and where
radiologist using AI. the challenges lie.
3. To appreciate when surgery can be deferred or avoided and how to
A-0104 12:40 best follow-up on these patients.
Ethical and legal implications of AI
N. Forgó; Vienna/AT A-0109 15:00
C. Pancreatic adenocarcinoma
Wednesday
M. Zins; Paris/FR
1. To become familiar with how we can shed light on the „AI black-box“.
2. To discuss the liability implications when using AI for diagnostic Learning Objectives:
purposes. 1. To understand the rationale for neoadjuvant treatment in pancreatic
3. To learn about the ethical implications of using AI and discuss the adenocarcinoma.
possibility that AI will become better than the radiologist. 2. To learn the limitations of CT in assessing treatment response.
3. To learn how to accurately select patients for curative-intent surgery
A-0105 12:45 after neoadjuvant therapy.
Challenges of AI implementation in radiology
J.A. Brink; Boston, MA/US
14:00 - 15:30 Room C
1. To learn about the optimisation of man-machine interactions. General Radiography (Radiographers)
2. To discuss whether privacy will be in danger when using AI.
3. To become familiar with the role of regulatory when implementing AI.
RC 314
12:50 Hybrid imaging: the best of both worlds
Moderators:
T. Roding; Haarlem/NL
12:30 - 13:30 Room D K. Riklund; Umea/SE
E3 - The Beauty of Basic Knowledge: A Survival Guide to

Session Objectives:
Musculoskeletal Imaging 1. To review the principles of hybrid medical imaging.
2. To understand the indications, limitations and comparative merits of
E3 25A hybrid medical imaging across a wide range of cardiac, vascular and
oncological conditions.
Infection: bone and soft tissue 3. To appreciate the need for optimisation and dose management within
hybrid imaging.
Moderator:
V.N. Cassar-Pullicino; Oswestry/UK A-0110 14:00
A. PET/CT
A-0106 12:30 M. Zeilinger; Wiener Neustadt/AT
Infection: bone and soft tissue
J.L. Bloem; Leiden/NL Learning Objectives:
1. To review the technology underpinning PET/CT.
Learning Objectives: 2. To understand important staff and patient safety issues.
1. To become familiar with pathophysiology of infectious diseases 3. To discuss the current and potential clinical applications of PET/CT
pertinent to imaging features. and optimal imaging protocols.
2. To understand imaging features of infectious diseases and their
differential diagnosis.
A-0111 14:30
3. To appreciate the clinical perspective of imaging infectious diseases.
B. Clinical impact of hybrid interventional imaging
S. Robinson; Manchester/UK
14:00 - 15:30 Room B
Abdominal Viscera 1. To review clinical indications for hybrid interventional procedures.
2. To understand the radiographer‘s role in patient care and
management in the hybrid suite.
RC 301 3. To discuss image acquisition and processing techniques required for
hybrid examinations.
Tumour response assessment in
abdominal imaging A-0112 15:00
C. Optimisation/dose management in the hybrid interventional suite
Moderator: D. Maccagni; Milan/IT
S.M. Ertürk; Istanbul/TR
A-0107 14:00 1. To review current options for optimisation in the hybrid interventional
A. Colorectal liver metastases suite.
S.K. Venkatesh; Rochester, MN/US 2. To understand the radiographer‘s role in optimisation and dose
management in the hybrid suite.
Learning Objectives: 3. To discuss occupational radiation protection issues in the hybrid suite.
1. To learn about different methods to assess the tumour response in the
colorectal metastases.
2. To understand usefulness and limitation of techniques and the role of
different contrast media.
3. To appreciate the variable response pattern of colorectal liver
metastases.

14:00 - 15:00 Coffee & Talk 1 A-0119 14:06

Children are not small adults: tips for paediatric radiation protection in
Coffee & Talk (open forum) Session plain films and CT
C 24 Learning Objectives:
1. To learn about differences between children and adults during medical
The scholar and fellow‘s experience imaging.
2. To understand how to improve the ratio of benefit to risk in
Moderator:
radiography and CT for children.
3. To be familiar with resources relevant for radiation protection of
children during medical imaging.
A-0113 14:00
Visiting scholar in Europe
A-0120 14:14
C. Olchowy; Wroclaw/PL
Fundamentals of diagnostic reference levels in children
Learning Objectives: R. Seuri; Helsinki/FI
1. To explain how to choose the right subspecialty and teaching centre
that suits you best and how to make the right decisions early in your
1. To learn about the European guidelines on DRLs for paediatric
professional life.
imaging (PiDRL).
2. To list the factors that will allow you to take the most out of the ESOR
2. To understand the role of the European paediatric DRLs in countries
scholarship and to pick up the priceless lessons that are not written in
with no national paediatric DRLs.
books and publications.
3. To be aware of challenges and opportunities for DLRs over the next
3. To rethink the idea of a relationship between tutor and student and
5-10 years.
why it is crucial to have a radiological role model.
A-0121 14:22
A-0114 14:07 Optimisation of positioning of the paediatric patient
Visiting scholar in the USA
J. Grehan; Dublin/IE
M.E. Laino; Rome/IT
A-0115 14:14 1. To learn about the optimal techniques to reduce motion artefacts (i.e.
Exchange fellowship in Europe immobilisation) in the radiology practice.
L. Ebner; Bern/CH 2. To know the most common devices for immobilisation in children.
3. To appreciate how correct positioning can improve image quality and
Learning Objectives: reduce radiation exposure.
1. To learn why you should subspecialise.
2. To highlight the role of trained radiologists in the era of modern
14:30
medicine and complex procedures and treatment.
3. To learn about the importance of dedicated subspecialty training as
well as scientific and clinical exchange.
4. To appreciate the importance of building professional and personal 14:00 - 15:30 Room F1
connections that last beyond the fellowship and gain a personal
impression of Vienna. E3 - Rising Stars Programme: Joint Session with ESOR
A-0116 14:21
„Nicholas Gourtsoyannis“ teaching fellowship BE 3
I. Blazic; Belgrade/RS Radiologic anatomy: chest
Learning Objectives: Moderator:
1. To present the concept of the newly established „Nicholas J. Vilar; Valencia/ES
Gourtsoyannis“ teaching fellowship.
2. To share my personal experience and impressions after completing A-0122 14:00
my fellowship. Mediastinal
3. To encourage the audience to consider some of the different ESOR M. Occhipinti; Florence/IT
fellowship programmes.
14:28 1. To review the mediastinal anatomy according to old and new
Open forum discussion classifications.
2. To recap signs useful in localising and characterising mediastinal
lesions.
14:00 - 15:00 Coffee & Talk 2 3. To know how to choose the most appropriate imaging modality to
explore the mediastinum according to the diagnostic question.
A-0123 14:30
C4 Lungs
C.M. Schaefer-Prokop; Amersfoort/NL
Radiation protection in paediatric Learning Objectives:
patients - same principles, different 1. To know how to interpret mediastinal lines and contours in chest
radiography.
approach: use cases 2. To get familiar with „signs“ in chest radiography helpful for diagnosis.
3. To know the normal appearance of lung parenchyma on CT and to use
A-0117/A-0118 14:00 the anatomy of the secondary lobule for analysis of chest diseases.
D.P. Frush; Durham, NC/US A-0124 15:00
C. Granata; Genoa/IT Vasculature
M. Francone; Rome/IT
1. To learn about tips for optimisation and radiation protection in Learning Objectives:
children. 1. To learn peculiarities of coronary arteries anatomy with specific
2. To become familiar with paediatric diagnostic reference levels (DRLs). referral to its implications on myocardial physiology.
3. To understand the different approaches needed when dealing with 2. To review anatomic features of pulmonary arteries and thoracic aorta.
children undergoing radiologic examinations. 3. To examine patterns and variants of the venous drainage of both the
pulmonary and caval system.

14:00 - 15:30 Room K 14:00 - 15:30 Room M 4

New Horizons Session E3 - ECR Academies: Hot Topics in GU Cancer
NH 3 E3 319
Artificial intelligence (AI): driven by Whole-body imaging in gynaecological
radiologists malignancy
A-0125 14:00 A-0129 14:00
Chairperson‘s introduction Chairperson‘s introduction
E. Kotter; Freiburg/DE L.S. Fournier; Paris/FR
Session Objectives:
Wednesday
A-0130 14:06
1. To learn what can be expected from AI in radiology and to know the
A. WB MRI for staging and treatment planning in ovarian cancer
limitations of the technology.
V. Vandecaveye; Leuven/BE
2. To learn how AI technology can be integrated in the radiology
workflow. Learning Objectives:
3. To learn how to make radiology knowledge available for AI training. 1. To learn the MRI technique for imaging the peritoneum in advanced
4. To learn how the introduction of AI in radiology will change the ovarian cancer.
doctor-patient and radiologist-clinician relationship. 2. To learn the appearances of WB-MRI in metastatic ovarian cancer.
3. To be aware of the pitfalls to interpretation.
A-0126 14:05
The impact of AI technologies in patient care: advantages and A-0131 14:34
limitations B. PET/CT and PET/MRI in cervix and endometrial cancer: current
E.L. Siegel; Baltimore, MD/US status
L. Umutlu; Essen/DE
1. To know the challenges of knowledge management in radiology. Learning Objectives:
2. To know the advantages of machine learning technologies compared 1. To learn the indications for use of hybrid imaging in cervix and
to traditional approaches. endometrial cancer.
3. To know the technical limitations of machine learning. 2. To know the strengths and weaknesses of the technique.
3. To be familiar with the role of hybrid imaging in patient prognosis.
A-0127 14:28
How to integrate AI technology in radiology today A-0132 15:02
W.J. Niessen; Rotterdam/NL C. Advanced imaging techniques in metastatic gynaecological cancer
1. To know the challenge: multitude of AI engines to be integrated in one Learning Objectives:
workflow. 1. To learn about the concept and technique of texture analysis.
2. To learn how to collect and annotate radiology data for machine 2. To be familiar with the key associations of biology and texture
learning. features.
3. To learn how to organise radiologist‘s workflow when using AI. 3. To be familiar with the potential added value of texture analysis in
4. To learn to manage radiology data to be used for machine learning. image interpretation.
A-0128 14:51 14:00 - 15:30 Room M 5

How will the introduction of AI change the role of the radiologist?
H. Harvey; London/UK E3 - ECR Academies: Functional Imaging for Disease
Learning Objectives: Management: Research to Medical Practice
1. To learn how radiologists will use machine learning in clinical routine.
2. To learn how machine learning will change the role of the radiologist
(doctors-patient relationship, relationship between radiologists and E3 320
referring physicians).
3. To learn how radiologists can prepare for machine learning.
Functional imaging of the brain
15:14 A-0133 14:00
Panel discussion: The radiologist‘s work after integrating AI
T.A. Yousry; London/UK
A-0134 14:06
A. Stroke
T. Tourdias; Bordeaux/FR
1. To be aware of relevant functional studies in the emergency room.
2. To learn about the most useful functional parameter to be quantified.
3. To learn about the impact of functional data for patient management.
A-0135 14:34
B. Brain tumours
A. Majos; Lodz/PL
1. To learn about how functional data may help in characterising brain
tumours.
2. To understand significance of quantitative data patient management.
3. To become familiar with limitations and pitfalls of functional technics.

A-0136 15:02 16:00 - 17:30 Room N

C. Cerebral small vessel diseases
M.A. Van Buchem; Leiden/NL Imaging Informatics
1. To know about main imaging criteria for characterisation of diseases.
2. To learn about the role of functional techniques for grading diseases.
RC 405
3. To understand how functional imaging allows following diseases Everything you need to know about 3D
process.
post-processing
16:00 - 17:30 Room X A-0142 16:00
ESR Audit and Standards Session Chairperson‘s introduction
ESR Audit Session Objectives:

1. To learn about the state-of-the-art information regarding 3D post-
Audit across Europe: directive and processing.
2. To understand how 3D post-processing can most optimally be used in
perspective daily clinical practice.
3. To appreciate how automated 3D post-processing and quantification
A-0137 16:00 will lead to increased use of 3D visualisations for diagnostics and
Chairperson‘s introduction therapy planning, over 2D viewing.
D.C. Howlett; Eastbourne/UK
A-0143 16:05
Session Objectives: A. 3D post-processing in 2019
1. To understand the principles of clinical audit. A. Alberich-Bayarri; Valencia/ES
2. To update on the Esperanto audit project.
3. To evaluate individual experience on implementation of a clinical audit Learning Objectives:
programme. 1. To learn about recent advances in 3D post-processing techniques.
2. To understand how these techniques can now be used in clinical
A-0138 16:10 practice.
Clinical audit and inspection: HERCA update 3. To learn new tips and tricks to use in your daily practice.
A-0144 16:28
Learning Objectives: B. Making better use of your 3D package: tips and tricks
1. To understand the differences between inspection and clinical audit. P.M.A. van Ooijen; Groningen/NL
2. To update on Heads of the European Radiological Protection
Competent Authorities (HERCA) and departmental inspection. Learning Objectives:
1. To learn about the functionality of state-of-the-art 3D packages.
A-0139 16:20 2. To understand the pitfalls in use of 3D post-processing.
Implementing a clinical audit programme: the Finland experience 3. To appreciate the need for training in 3D post-processing techniques.
T. Autti; Helsinki/FI
A-0145 16:51
Learning Objectives: C. Interpretation of 3D processing results: from image to volume
1. To learn about Finnish clinical audit rounds performed between 2002 reading
and 2016. T. Frauenfelder; Zurich/CH
2. To introduce the recommendations issued by the Finnish advisory
committee for clinical audit and evaluate the effectiveness of these Learning Objectives:
recommendations. 1. To learn about different developments in creating 3D anatomical and
3. To evaluate the future of clinical audits in Finland. functional models for diagnostic and therapy planning purposes.
2. To understand the pros and cons of such technologies.
A-0140 16:40 3. To appreciate that automated 3D image analysis will lead to new ways
Implementing a clinical audit programme: the radiographic in which diagnosis and therapy planning will be performed.
perspective
M.-L. Ryan; Dublin/IE 17:14
Panel discussion: Will we still look at 2D images in 10 years‘ time?
1. To learn how important clinical audit is in day-to-day practice.
2. To appreciate the opportunities and challenges of clinical audit in 16:00 - 17:30 Room O
practice.
3. To understand the impact on quality improvement of clinical audit in a Cardiac
radiographer department, using real life examples.
A-0141 17:00 RC 403

Quality improvement and change management: audit in industry From diagnosis to prognosis: how does
S. Lee; Guildford/UK
cardiac imaging affect patient outcome?
Moderator:
1. To learn about the genesis of audit.
A. Kallifatidis; Thessaloniki/GR
2. To appreciate the importance of audit in industry.
3. To understand the importance of clinical audit in successful
management. A-0146 16:00
A. In myocarditis
M. Francone; Rome/IT
17:20
Panel discussion: What are the benefits of good clinical audit? Learning Objectives:
1. To learn about the correlation between clinical presentation and
imaging findings.
2. To understand the current state-of-art MRI methods for the evaluation
of patients with suspected myocarditis.
3. To learn how MRI could be used to inform prognosis and management
decisions in myocarditis.

A-0147 16:30 16:00 - 17:30 Room E2

B. In non-ischaemic cardiomyopathy
B.K. Velthuis; Utrecht/NL Special Focus Session
1. To recognise typical and early signs of ARVC, HCM and dilated
cardiomyopathy that indicate progression and prognosis.
SF 4
2. To understand what findings should be reported. My three top tips in neuroimaging (not
3. To appreciate the role of MRI in early diagnosis and prognosis
assessment in these cardiomyopathies. only for neuroradiologists)
A-0148 17:00 A-0152 16:00
C. In coronary artery disease Chairperson‘s introduction
M. Kantarci; Erzurum/TR M. Stajgis; Poznan/PL
Learning Objectives: Session Objectives:
Wednesday
1. To appreciate the role of anatomic assessment of the coronary arteries 1. To highlight the importance of ‚key point‘ knowledge of the
versus functional imaging in different patient groups. pathological entities listed below.
2. To learn to report on anatomic and functional imaging in patients with 2. To be familiar with most common and typical imaging features in
suspected coronary artery diseases. these conditions.
3. To appreciate the role of non-invasive imaging in prognosis 3. To present crucial tips and tricks that allow you to make confident
assessment. diagnoses.
A-0153 16:05
16:00 - 17:30 Room E1 MRI T2 brain white lesions
E3 - ECR Master Class (Breast) A. Krainik; Grenoble/FR
1. To be able to identify physiological T2 white matter hyperintensities.
E3 426a 2. To be aware of age-related most common T2 white matter lesions.
The high-risk patient enigma 3. To give practical clues in quick differentiation of T2 white matter
lesions based on their location and appearance.
Moderator:
F. Kilburn-Toppin; Cambridge/UK A-0154 16:13
Multiple sclerosis
A-0149 16:00 K. Katulska; Poznan/PL
A. Lesions with an elevated risk for breast cancer
G. Forrai; Budapest/HU Learning Objectives:
1. To give a short overview of McDonald criteria in multiple sclerosis.
Learning Objectives: 2. To present the typical findings in cerebral and spinal cord multiple
1. To learn about different types of high-risk lesions. sclerosis.
2. To become familiar with the risk of developing cancer. 3. To assure you how confident one can feel with correct diagnosis of
3. To appreciate the different imaging modalities for diagnosis. the multiple sclerosis lesions presence.
A-0150 16:30 A-0155 16:21

B. Value of breast MRI. Rate of underestimation and impact on Acute disseminated encephalomyelitis (ADEM)
treatment decision: is breast MRI increasing the number of high-risk A. Rovira-Cañellas; Barcelona/ES
lesions?
R.M. Mann; Nijmegen/NL Learning Objectives:
1. To describe the basics of ADEM entity.
Learning Objectives: 2. To be familiar with morphology, distribution and other characteristic
1. To learn about the evidence on MRI for evaluating high-risk lesions. radiographic features in patients with ADEM.
2. To become familiar with various imaging appearances of high-risk 3. To highlight my point of view in the most correct diagnosis of ADEM.
lesions.
3. To appreciate the added value for diagnosis and treatment decision. A-0156 16:29
Encephalitis
A-0151 17:00 H.R. Jäger; London/UK
C. Can surgery be avoided?
S.J. Vinnicombe; Dundee/UK Learning Objectives:
1. To be aware of different etiology of encephalitis.
Learning Objectives: 2. To learn the typical imaging picture of brain structural abnormalities in
1. To learn about the different image guided minimally-invasive patients with encephalitis.
modalities to excise high-risk lesions. 3. To present my tips in evaluation of encephalitis-suspected brain
2. To become familiar with the risk of avoiding surgery. lesions.
3. To appreciate the standard protocols in different countries.
A-0157 16:37
Meningitis
1. To be familiar with different causes of meningitis.
2. To describe the most common MRI findings in acute and chronic
meningitis.
3. To present my advice: ‚does thickened and enhancing dura always
mean meningitis?‘
A-0158 16:45
Transient ischemic attack
J. Hodel; Créteil/FR
1. To understand the importance of imaging in patients with transient
ischemic attack (TIA).
2. To highlight the most important imaging features.
3. To present my tips in evaluation of patients with TIA.

A-0159 16:53 16:00 - 17:30 Room F2

Venous sinus thrombosis
P. Vilela; Almada/PT Emergency Imaging
1. To be familiar with basics of pathology in cortical venous and venous
sinus thrombosis.
RC 417
2. To learn the most common radiologic presentation in venous sinus Imaging of ‚foreign bodies‘
thrombosis.
3. To provide the hints how to avoid the confusion with sinus thrombosis A-0165 16:00
mimics. Chairperson‘s introduction
U. Linsenmaier; Munich/DE
A-0160 17:01
Hydrocephalus Session Objectives:
A. Ramos; Madrid/ES 1. To become familiar with commonly used surgical and orthopaedic
devices and materials.
Learning Objectives: 2. To learn their proper positioning and early signs of postoperative
1. To gain a short knowledge of different types of hydrocephalus. complications.
2. To learn how to differentiate normal pressure and obstructive 3. To understand the imaging pathway in management of ingested
hydrocephalus. foreign bodies.
3. To present my ‚hot points‘ in evaluation of patient with hydrocephalus.
A-0166 16:05
A-0161 17:09 A. Surgical and orthopaedic devices: are they really properly
Microbleeds positioned?
L. van den Hauwe; Antwerp (Edegem)/BE E. Dick; London/UK
1. To understand the impact of presence and number of cerebral 1. To become familiar with different types of commonly used surgical,
microbleeds. neurosurgical and orthopaedic devices in clinical practice.
2. To learn the distribution of cerebral microbleeds in different 2. To understand how to evaluate their proper positioning.
pathological conditions. 3. To be familiar with imaging signs of incorrect implementation of
3. To give you advice how not to overdetect cerebral microbleeds and neurosurgical and orthopaedic devices.
how to differentiate them from their mimics.
A-0167 16:30
17:17 B. Did I swallow that? US and CT of sharp foreign bodies penetrating
Panel discussion: ‚You can ask me for additional tips‘ - questions from stomach and bowel
the audience, answers from experts J.B.C.M. Puylaert; The Hague/NL
16:00 - 17:30 Room F1 1. To be familiar with characteristics of commonly ingested foreign
bodies.
E3 - Rising Stars Programme: Joint Session with ESOR
2. To understand which imaging modalities are best suited for detection
of foreign bodies in different clinical scenarios.
BE 4 3. To recognise the first signs of early complications resulting from
ingested foreign bodies.
Radiologic anatomy: abdomen
Moderator: A-0168 16:55
A. Palkó; Szeged/HU C. The role of interventional radiology in the management of foreign
bodies and following complications
H. Leonhardt; Gothenburg/SE
A-0162 16:00
Small bowel Learning Objectives:
S.A. Taylor; London/UK 1. To recognise the role of interventional radiology in the treatment of
complications resulting from the presence of foreign bodies.
2. To learn when to call the interventional radiologist.
1. To appreciate the embryological development of the small bowel.
3. To learn about techniques of removal of foreign bodies with an
2. To learn about the anatomy of the small bowel relevant to radiological
endovascular approach.
imaging.
3. To understand the pitfalls of the normal small bowel appearance
during imaging interpretation. 17:20
Panel discussion: Common language with clinicians: how to report
‚foreign bodies‘ presence and indicate the optimal management
A-0163 16:30
Anorectal
1. To review the normal anatomy of the anorectum.
2. To learn how well depicted the different anatomical landmarks of the
anorectum are with different available imaging methods.
3. To discuss the clinical scenarios for which it is necessary to be aware
of the anatomy of the anorectum.
A-0164 17:00
Peritoneum and mesentery
P.K. Prassopoulos; Thessaloniki/GR
1. To review the radiologic anatomy of peritoneal ligaments, mesenteries
and omenta on cross-sectional imaging.
2. To describe the most clinically important peritoneal compartments
and fluid collections.
3. To discuss the key role of anatomy in the dissemination of
malignancies, or the restriction of inflammatory processes in the
abdomen.

16:00 - 17:30 Room Y A-0174 16:05

Personal blogs and websites in radiology
ESR Ultrasound Subcommittee Session C. Clarke; Nottingham/UK
US 1 1. To get familiar with the most renowned radiology websites and blogs.
2. To understand how radiology websites may help patients and
How to perform ultrasound image fusion professionals.
Moderator:
P.S. Sidhu; London/UK
A-0175 16:10
Do radiologists use social media?
A-0169 16:00
Liver Learning Objectives:
E.M. Jung; Regensburg/DE 1. To learn about the real use of social media by radiologists in daily
practice.
Wednesday
2. To understand how social media may make radiologists‘ work more
1. To learn about the advanced liver imaging fusion technique.
visible.
2. To learn how to optimise scanning protocols by using the image
fusion tool.
3. To learn about common benign and malignant lesions and differential
A-0176 16:15
Students and trainees‘ perspective
diagnosis by using image fusion.
C. Messina; Milan/IT
4. To understand how to use fusion imaging of US, CT and MRI for
treatment of liver tumour. Learning Objectives:
1. To understand why social media are so important for students and
A-0170 16:20 radiology trainees.
Kidney 2. To learn how social media may be used for students and trainees‘
J. Rübenthaler; Munich/DE education in radiology.
1. To understand the imaging features of kidney lesions.
A-0177 16:20
Can social media help to involve patients?
2. To become familiar with unclear cystic lesions by using the Bosniak
L. Robinson; Gatley/UK
classification.
3. To learn about the differential diagnoses of complex cystic renal Learning Objectives:
masses and compare the modalities by using the image fusion tool. 1. To understand how social media may help filling the gap among
4. To understand the potential pitfalls in image fusion. radiology, patients and institutions.
2. To learn how social media may help in pati ents‘ empowerment in
A-0171 16:40 radiology.
Prostate 3. To become familiar with patients‘ privacy issues related to social
D.A. Clevert; Munich/DE media.
16:25
1. To explain the PIRADS system in prostate imaging.
2. To become familiar with the technical requirements for performing
image fusion of the prostate.
3. To understand how to detect and biopsy guided suspicious MR- 16:00 - 17:30 Room D
lesions using the ultrasound image fusion technique.
4. To understand the potential pitfalls and discuss the evidence for the Musculoskeletal
use of these technologies in routine clinical practice.
A-0172 17:00 RC 410

Minimise the risk of infection transmission and effective
decontamination protocols in the setting of ultrasound fusion
Bone, joint and soft tissue infection
C. Nyhsen; Strasbourg/FR Moderator:
V. Njagulj; Novi Sad/RS
1. To understand the contamination risks in the setting of ultrasound A-0178 16:00
fusion. A. Osteomyelitis
2. To learn how cross infection may occur, in particular when fusion is K. Verstraete; Ghent/BE
used for invasive procedures.
3. To appreciate the different steps of an effective decontamination, Learning Objectives:
including fusion equipment. 1. To explain the pathophysiology and disease spectrum of osteomyelitis.
2. To describe the imaging criteria for diagnosis of acute and chronic
17:20 osteomyelitis in children and adults.
Panel discussion: How to start ultrasound image fusion
A-0179 16:30
B. Septic arthritis
16:00 - 17:00 Coffee & Talk 3 M. Zanetti; Zurich/CH
Coffee & Talk (open forum) Session Learning Objectives:
1. To explain the pathophysiology and disease spectrum of septic
arthritis.
C5 2. To describe the imaging criteria for diagnosis of septic arthritis in
children and adults.
#ECR2019: Social media in radiology
A-0173 16:00 A-0180 17:00
C. Pyomyositis and other soft tissue infections
L.M. Sconfienza; Milan/IT
Session Objectives:
1. To explain the pathophysiology and disease spectrum of pyomyositis
1. To get familiar with the use of social media in radiology.
and other soft-tissue infections.
2. To understand how social media are pivotal in modern radiology.
2. To describe the imaging criteria for diagnosis of pyomyositis and
3. To learn how social media may help in the relationship between
other soft-tissue infections.
radiologists and patients.

16:00 - 17:30 Room G 16:00 - 17:30 Room M 1

MT
Physics in Medical Imaging ESHI Session
RC 413 ESHI(MT) 1
Striking the balance: image quality Clinical and methodological pitfalls in
assessment in radiological optimisation hybrid imaging: problems and solutions
Moderators:
A-0181 16:00 C.C. Cyran; Munich/DE
Chairperson‘s introduction: The big picture, can we be objective about F.A. Gallagher; Cambridge/UK
image quality?
N. Marshall; Leuven/BE A-0185 16:00
Session Objectives: Artefacts in hybrid imaging
1. To appreciate the reasons why image quality is important in T. Beyer; Vienna/AT
radiological optimisation. Learning Objectives:
2. To understand the main methods of image quality assessment and 1. To understand methodological pitfalls in hybrid imaging.
optimisation. 2. To highlight frequent image distortions.
3. To learn how image quality assessment is applied in clinical practice. 3. To review solutions to limit clinical misinterpretation from image
artefacts.
A-0182 16:05
A. Between a ROC(k) and a hard place: classical and pragmatic A-0186 16:30
methods of determining clinical image quality Clinical pitfalls in FDG-PET/CT and PET/MR
O.J. O‘Connor; Cork/IE C. Pfannenberg; Tübingen/DE
1. To learn about traditional and practical methods of determining image 1. To learn about the key imaging features of the physiological
quality. distribution of 18F-FDG and its frequently encountered normal variants.
2. To understand how the methods are applied to projection 2. To become familiar with the most common clinical pitfalls caused by
radiography, interventional radiology and CT. non-physiological FDG uptake due to
3. To identify limitations of current techniques. benign conditions like inflammation, medication and benign tumours.
3. To discuss the principles of adequate patient preparation and
A-0183 16:28 scanning protocols to avoid artefacts and misinterpretation in PET/CT
B. Bridging the gap between physical and clinical image quality and PET/MRI.
E. Samei; Durham, NC/US

1. To learn about physics-based methods of determining image quality. Clinical and technical pitfalls in SPECT/CT
2. To understand how they are applied to projection radiography, J. Howard; Manchester/UK
interventional radiology and CT. Learning Objectives:
3. To identify how to bridge the gap between the physics methods and 1. To discuss common clinical and technical pitfalls that can be
the clinical image quality assessment. encountered in SPECT/CT imaging.
2. To recognise possible clinical and technical limitations/pitfalls and
A-0184 16:51 correctly interpret these pitfalls.
C. Sharing the message: image quality optimisation for multiple 3. To learn about solutions and recommendations to deal with clinical
scanners and clinics and technical pitfalls in routine clinical practice.
Learning Objectives: 16:00 - 17:30 Room M 2

1. To learn about how to apply image quality assessment techniques
across multiple scanners and clinics. Paediatric
2. To learn how to apply image quality assessment methods to partner
clinically-indicated DRLs.
3. To understand how to ensure consistency using standardised RC 412
protocols.
Imaging in abdominal emergencies:
17:14 an (evidence-based) update
Panel discussion: Can we balance image quality and dose needs in an
Moderator:
objective manner?
C.E. de Lange; Oslo/NO
A-0188 16:00
A. The acute abdomen in neonates
A. Coma; Barcelona/ES
1. To learn about typical neonatal abdominal emergencies.
2. To understand the choice of modalities in acute abdomen in neonates.
3. To appreciate typical findings and ‚red flag‘ features.
A-0189 16:30
B. The acute abdomen in young children
A.D. Calder; London/UK
1. To learn about the causes of acute abdominal pain in children.
2. To understand the choice of imaging techniques and their limitations.
3. To appreciate typical radiological features of abdominal emergencies.

A-0190 17:00 A-0196 16:34

C. Polytrauma: differences between adult and paediatric protocols B. WB-MRI and response assessment
M. Raissaki; Iraklion/GR N. Tunariu; London/UK

1. To learn how paediatric trauma differs from adult trauma. 1. To recognise active disease.
2. To understand how examination techniques and protocols must be 2. To learn pitfalls of interpretation.
tailored accordingly. 3. To recognise the appearance of treatment response.
3. To appreciate the importance of multidisciplinary team collaboration
in planning and conducting radiological investigations in a trauma A-0197 17:02
setting. C. PET and PET/MRI in prostate cancer
I.A. Burger; Zurich/CH
16:00 - 17:30 Room M 3 Learning Objectives:
1. To learn about the role of PET in prostate cancer.
E3 - ECR Master Class (Oncologic Imaging) 2. To understand the advantages and limitations of PET and PET/MRI.
Wednesday
3. To become familiar with potential pitfalls through case review.
E3 426b 16:00 - 17:30 Room M 5
Novelties in oncologic imaging
Moderator: E3 - ECR Academies: Functional Imaging for Disease
P. Brader; Graz/AT Management: Research to Medical Practice
A-0191 16:00
A. Imaging-guided liver interventions in oncology E3 420
B. Gebauer; Berlin/DE
Functional imaging of the heart
1. To learn about newly established treatment options in interventional A-0198 16:00
oncology. Chairperson‘s introduction
2. To understand the role of pre- and post-treatment imaging for M. Gutberlet; Leipzig/DE
improving clinical outcome.
3. To appreciate potential future applications of interventional oncology. A-0199 16:06
A. Functional techniques for clinical cardiac MR
A-0192 16:30 R. Manka; Zurich/CH
B. Radiomics: the role of imaging
S. Rizzo; Milan/IT Learning Objectives:
1. To learn about main functional techniques useful in clinical cardiac MR
Learning Objectives: imaging.
1. To learn about the concept of radiomics and personalised medicine. 2. To become familiar with pharmacological testing approaches.
2. To learn how radiomics can be extracted from standard clinical 3. To learn about some more advanced techniques.
examinations.
3. To appreciate the consequences of radiomics for radiologists in the A-0200 16:34
future. B. Ischaemic diseases
J. Bogaert; Leuven/BE
A-0193 17:00
C. Is PET/MRI better than PET/CT plus MRI?
1. To learn about the impact of functional parameters for therapeutic
H.-P. Schlemmer; Heidelberg/DE
orientation in emergency.
Learning Objectives: 2. To learn about the validated biomarkers of prognosis.
1. To learn in which clinical scenarios PET/MRI is considered to be the 3. To learn about how to follow the patients.
most helpful.
2. To understand the difference between the use of PET/MRI and PET/ A-0201 17:02
CT plus MRI in the patient pathway. C. Non-ischaemic cardiopathies
3. To discuss impediments for future adoption of PET/MRI. L. Natale; Rome/IT
16:00 - 17:30 Room M 4 1. To learn about diagnostic criteria of non-ischaemic cardiopathies.
2. To understand the impact of functional imaging for outcome
E3 - ECR Academies: Hot Topics in GU Cancer prediction.
3. To learn about their impact in treatment response.
E3 419
Whole-body imaging in metastatic
urinary tract and prostate cancer
A-0194 16:00
A.R. Padhani; London/UK
A-0195 16:06
A. WB-MRI: technique and reporting system Met Rads P
F.E. Lecouvet; Brussels/BE
1. To review patient selection for WB-MRI in prostate cancer.
2. To learn state of the art technical tips.
3. To learn a systematic reporting system.

09:44
08:30 - 10:00 Room A
Panel discussion: Guidelines for management of GI bleeding and real
E3 - ECR Academies: Interactive Teaching Session for Young life: why are they different?
08:30 - 10:00 Room C
E3 521 General Radiography (Radiographers)

Emergency radiology II
A-0202 08:30
RC 514
A. Urinary system trauma Radiography audit and quality
management
Learning Objectives: Moderators:
1. To identify the signs of trauma. F. Zarb; Msida/MT
2. To outline the clinical impact of these findings. E.J. Adam; London/UK
A-0203 09:15 Session Objectives:

B. Non-traumatic urinary tract emergencies 1. To understand the importance of Radiography Quality Management.
G. Masselli; Rome/IT 2. To appreciate the role of PACS in driving quality improvements.
Learning Objectives: 3. To promote discussion on practical concerns in a Radiology
1. To understand the imaging technique. department.
2. To become familiar with the differential diagnosis.
A-0208 08:30
A. Understanding PACS to support radiography quality management
08:30 - 10:00 Room B processes
Thursday
M. O‘Connor; Dublin/IE
GI Tract
1. To highlight the need for evaluating radiographic quality within clinical
RC 501 practice.
2. To understand the ability of PACS to support radiography service
GI bleeding: how can the problem be evaluation.
solved? 3. To identify practical tips to enhance audit readiness.
A-0204 08:30 A-0209 09:00

Chairperson‘s introduction B. An expert in radiography quality management
D. Negru; Iasi/RO D. Catania; Milan/IT
Session Objectives: Learning Objectives:

1. To define acute, overt and occult GI bleeding. 1. To understand the importance of auditing the status of referrals,
2. To learn about different imaging modalities that can be utilised in the waiting times and turnaround times.
work-up of GI bleeding. 2. To introduce the role of a designated radiographer to manage the
3. To define the role of the interventional radiologist in the management radiography quality process.
of the GI bleeding. 3. To provide „real world“ examples of radiography quality management.
A-0205 08:35 A-0210 09:30

A. Acute GI bleeding C. Back to basics: auditing radiographic technique
G.H. Mostbeck; Vienna/AT L. Harding; Warrington/UK

1. To learn about the common causes of the acute upper and lower GI 1. To discuss the importance of regular auditing of radiographic practice.
bleeding. 2. To highlight the importance of Radiology Information System (RIS)
2. To understand the rationale for different investigative pathways dashboards in promoting high quality imaging.
depending on the likely site of bleeding. 3. To understand how a departmental quality improvement team, using
3. To appreciate how to best optimise imaging protocols to identify the audit, can maintain and raise imaging standards.
site and cause of bleeding, and assist with treatment planning.
A-0206 08:58
B. Occult and overt GI bleeding: the role of radiology 08:30 - 10:00 Room X
C. Stroszczynski; Regensburg/DE
Joint Session of the ESR and UEMS
1. To learn about the differences between obscure, occult and overt GI
bleeding, and the most common causes of each. ESR/UEMS
2. To understand which tests to perform when imaging is indicated, and
the most important diagnoses to look for.
Imaging professionals in the EU:
3. To appreciate the interaction between endoscopic and radiologic radiologists without borders
investigations in managing patients with obscure GI bleeding.
A-0211/A-0212 08:30
A-0207 09:21 Chairpersons‘ introduction
C. When is the interventional radiologist needed? M. Adriaensen; Heerlen/NL
D.K. Tsetis; Iraklion/GR L. Bonomo; Rome/IT
1. To learn about the role of interventional radiology in the management 1. To describe the role of the UEMS within the EU.
of acute and chronic GI bleeding. 2. To understand the difference between the ESR and the UEMS.
2. To learn about the variety of techniques available to the interventional 3. To understand the importance of cooperation between the ESR and
radiologist to evaluate obscure GI bleeding and control acute GI the UEMS.
bleeding.
3. To understand when interventional radiology is clearly indicated,
when it should be considered and when it should be avoided, if possible.

A-0213/A-0214 08:35 A-0220 09:25

Putting your interests first: UEMS and ESR advocacy in the EU ETAP 2.0
P.M. Parizel; Antwerp/BE L. Oleaga Zufiría; Barcelona/ES
B. Maillet; Brussels/BE
Learning Objectives: 1. To get an overview of the different levels and the changes made in the
1. To understand the structure of the UEMS and the ESR. revised European Training Curriculum in radiology.
2. To understand the differences between the ESR and the UEMS. 2. To learn about the Council for European Specialist Medical
3. To understand the importance of UEMS/ESR political involvement in Assessment (CESMA).
EU affairs. 3. To know about the value of the European Diploma in Radiology
(EDiR).
Part 1: What does the EU mean for me? A radiologist‘s guide 4. To learn about the facts and figures of the European Training
Assessment Programme (ETAP) 2.0.
A-0215 08:45
To be or not to be at the table: why advocacy matters for radiologists Part 3: Staying ahead of the curve with continuing professional
K. Riklund; Umea/SE development (CPD)

1. To understand the concept of advocacy and the importance of Patient safety and job security for life: CME/CPD in Europe
advocacy at the EU level. P. Ricci; Rome/IT
2. To understand the three levels of the European Legislation process.
3. To understand the influence of EU directives on national legislation Learning Objectives:
and daily practice. 1. To learn about the European Accreditation Council for Continuing
Medical Education (EACCME).
A-0216 08:53 2. To know about the existence of European CME credits (ECMEC).
Creating a European radiology (or healthcare) workforce: the value of 3. To learn about the importance of credits in different European
qualifications across borders countries.
H. Käfer1, M. Frohn2; 1Vienna/AT, 2Brussels/BE
Thursday
A-0222 09:41
Learning Objectives: It‘s easier than you think: the many ways to gain European CME/CPD
1. To understand the concept of advocacy and the importance of credits
advocacy at the EU level. M.A. Lucic; Sremska Kamenica/RS
3. To understand the influence of EU directives on national legislation Learning Objectives:
and daily practice. 1. To learn about the European Accreditation Council for Continuing
Medical Education (EACCME).
A-0217 09:01 2. To know about the existence of European CME credits (ECMEC).
Brexit means Brexit: radiologists with borders? 3. To learn about the importance of credits in different European
V. Papalois; London/UK countries.

1. To understand the concept of advocacy and the importance of Panel discussion: The state of radiology in the EU: a diagnosis of „the
advocacy at the EU level. bigger picture“
3. To understand the influence of EU directives on national legislation
and daily practice. 09:30 - 10:30 Coffee & Talk 1
Part 2: Educating the next generation of radiologists
A-0218 09:09 C 25
The benefits of harmonised training for the radiologists of tomorrow
C. Catalano; Rome/IT A heart‘s matter: cardiac mentoring,
Learning Objectives: tutoring and learning within the ESOR
1. To get an overview of the different levels and the changes made in the community
revised European Training Curriculum in radiology.
Moderator:
2. To learn about the Council for European Specialist Medical
C. Loewe; Vienna/AT
Assessment (CESMA).
3. To know about the value of the European Diploma in Radiology
(EDiR). A-0297 09:30
4. To learn about the facts and figures of the European Training Deliver, enhance, enjoy: the idea and the satisfaction of acting as a
Assessment Programme (ETAP) 2.0. tutor/mentor, to host fellows and to follow their career
C. Loewe; Vienna/AT
Making your qualifications count at home and abroad: the European 1. To recall the idea and vision of ESOR fellowship and to get an
Diploma in Radiology and the CESMA overview about existing ESOR activities and programmes.
H.J. Lamb; Leiden/NL 2. To underline the importance of providing fellowships to enhance and
standardise radiology in Europe.
3. To report the satisfaction while following the career of previous
1. To get an overview of the different levels and the changes made in the
fellows.
revised European Training Curriculum in radiology.
2. To learn about the Council for European Specialist Medical
Assessment (CESMA). A-0298 09:37
3. To know about the value of the European Diploma in Radiology Receive, improve, create: my professional development from former
(EDiR). cardiac fellow to designated congress president of the ESCR
4. To learn about the facts and figures of the European Training M. Hrabak Paar; Zagreb/HR
Assessment Programme (ETAP) 2.0. Learning Objectives:
1. To learn about professional opportunities that ESOR fellowship brings
to a young radiologist.
2. To become familiar with career development of a cardiac radiologist.
3. To understand the role of an ESOR fellow in dissemination of acquired
knowledge and cardiac radiology leadership in the local radiological
community.

A-0299 09:44 09:50

Work, teach, entertain: the story of the tutors behind the official tutor Panel discussion: Should we screen, who should we screen and how
D. Beitzke; Vienna/AT should we screen in order to prevent sudden cardiac death?
A-0300 09:51 08:30 - 10:00 Studio 2019

Receive, enjoy, deliver: how I enjoyed my fellowship, created
professional relationships and friendships and became tutor by myself Professional Challenges Session
M. Petrini; Piacenza/IT
1. To learn about the application process for the ESOR scholarship and
PC 5
ESOR activities in cooperation with ESCR. Radiology and migrations
2. To understand the importance of the ESOR scholarship in the field of
cardiac radiology by means of daily routine activities and cases review A-0227 08:30
performed in the visiting department. Chairperson‘s introduction
3. To achieve the maximum by ESOR scholarship by being pro-active O. Akhan; Ankara/TR
with your tutor and other colleagues.
4. To become familiar with an international environment and to build a Session Objectives:
long-lasting network of professional relations and friendship. 1. To describe the reasons of migration.
5. To acquire self-confidence after the ESOR scholarship and to 2. To evaluate humanitarian and political consequences of migration.
transform yourself into the tutor for young colleagues. 3. To get an overview on the importance of migration related disease.
4. To understand how we can recognise these diseases on clinical and
09:58 radiological levels.
Open forum discussion: A heart‘s matter: does mentoring matter? 5. To raise awareness on migration related diseases among health
professionals.
08:30 - 10:00 Room O A-0228 08:35

Impact of migration on health: WHO perspective
E3 - ECR Master Class (Cardiac)
S. Severoni; Copenhagen/DK
E3 526 1. To describe the impact and consequences of migration on health as a
global problem.
Cardiac imaging in arrhythmia and 2. To teach how public health has been importantly influenced by human
sudden cardiac death mobility patterns.
3. To discuss how to raise awareness among health professionals to
A-0223 08:30 struggle against the diseases related to migration.
P. Donato; Coimbra/PT A-0229 08:53
Importance of migration for neglected tropical diseases: WHO
Session Objectives: perspective
1. To learn about existing imaging biomarkers to prevent sudden cardiac B. Abela-Ridder; Geneva/CH
death.
2. To understand how to face the challenge of arrhythmia in cardiac Learning Objectives:
imaging. 1. To describe the importance of neglected tropical diseases on the
3. To become familiar with the prerequisites for MR in patients with global level emphasising its relation with poverty.
active implants. 2. To evaluate how migration changes the dimensions of the problem for
neglected tropical diseases in Europe.
A-0224 08:35 3. To discuss how to raise awareness for neglected tropical diseases on
A. The role of CMR in sudden cardiac death global and European levels.
D. Piotrowska-Kownacka; Warsaw/PL
A-0230 09:11
Learning Objectives: Clinical importance of the diseases related to migration
1. To become familiar with the pathophysiology of sudden cardiac death. T. Junghanss; Heidelberg/DE
2. To introduce cardiac MR biomarkers to prevent sudden cardiac death.
3. To learn how to perform and how to interpret cardiac MR to prevent Learning Objectives:
sudden cardiac death. 1. To become familiar with the list of diseases related to migration and
their clinical findings.
A-0225 09:00 2. To discuss how to think about unusual clinical conditions when facing
B. Preventing sudden cardiac death with CT: pure theory or new these patients.
diagnostic paradigm? 3. To teach how to make differential diagnosis on the clinical ground.
K. Nikolaou; Tübingen/DE
A-0231 09:29
Learning Objectives: Radiology of the diseases related to migration
1. To learn what to look for in CT to prevent sudden cardiac death. T. Weber; Heidelberg/DE
2. To get an overview about existing evidence of cardiac CT in this
indication. Learning Objectives:
3. To discuss the possible future role of cardiac CT in preventing sudden 1. To learn radiological patterns of diseases related to migration.
cardiac death. 2. To discuss how to evaluate unusual radiological conditions of these
patients.
A-0226 09:25 3. To teach how to combine radiological and epidemiological features
C. Imaging of patients with arrhythmia and implantable devices of the patients on the basis of imaging modalities for appropriate
G. Pontone; Milan/IT differential diagnosis.

1. To learn about tips and tricks for successful cardiac CT in patients with Panel discussion: How do we raise awareness among health
arrhythmia. professionals to recognise diseases related to migration? How can we
2. To learn about tips and tricks for successful cardiac MR in patients adapt migration and migration related diseases into our education?
with arrhythmia.
3. To become familiar with workflow issues for MR imaging in a patient
with an implanted device.

10:00 - 11:00 Coffee & Talk 2 08:30 - 10:00 Room E1

Coffee & Talk (open forum) Session Breast
C7 RC 502
EIBIR: EU-funded research in imaging MRI for early detection, staging and
and how you can get funding management of breast cancer
A-0301 10:00 A-0232 08:30
G.P. Krestin; Rotterdam/NL P.A.T. Baltzer; Vienna/AT
Session Objectives: Session Objectives:

1. To understand the need for an organisation like EIBIR. 1. To understand the contribution of MRI to preoperative staging and the
2. To learn about the background of EIBIR. context within which it should be recommended.
3. To learn about EIBIR‘s mission. 2. To learn about the different MRI biomarkers and in which clinical
setting they are of value.
A-0302 10:05 3. To recognise the steps required to move to abbreviated MRI for high-
What does EIBIR do and how can it help you obtain research funding? risk screening.
P. Zolda; Vienna/AT
A-0233 08:35
Learning Objectives: A. Preoperative staging with MRI: results of preoperative MRI (MIPA)
1. To learn about the support EIBIR offers researchers in biomedical trial
imaging. F. Sardanelli; San Donato Milanese/IT
2. To appreciate EIBIR‘s effectiveness in helping researchers secure
funding. Learning Objectives:
Thursday
3. To understand EIBIR‘s role in EU-funded research projects. 1. To learn about the evidence for and against the use of MRI in
preoperative staging.
A-0303 10:10 2. To understand the background, design and early results of the MIPA
Case study of EIBIR success: the SOLUS Project trial.
A. Pifferi; Milan/IT 3. To be able to explain the role of preoperative MRI during
multidisciplinary tumour board meetings.
1. To learn about the Smart Optical and Ultrasound Diagnostics of Breast A-0234 09:00
Cancer (SOLUS) Project. B. MR imaging biomarkers for the clinical setting
2. To appreciate how the project‘s proposal for funding was supported E.A. Morris; New York, NY/US
by EIBIR.
3. To understand EIBIR‘s role in the successful management of the
A-0235 09:25
project.
C. Screening with abbreviated protocols
A-0304 10:15
Horizon Europe and future funding opportunities Learning Objectives:
P. Gordebeke; Vienna/AT 1. To learn about the evidence for abbreviated MRI and the comparison
with standard protocols.
Learning Objectives: 2. To understand the different protocols for abbreviated MRI and the
1. To learn about future collaborative funding opportunities from the merits of each sequence used.
European Union. 3. To appreciate the advantages and limitations for abbreviated MRI.
2. To understand the types of funding available for biomedical imaging
research.
09:50
Panel discussion: What can we do to improve the adoption of MRI in
A-0305 10:20 clinical practice?
EIBIR Strategic Research Agenda
08:30 - 10:00 Room E2
1. To learn about the aim of the EIBIR Strategic Research Agenda. State of the Art Symposium
2. To understand the key challenges indicated in the Strategic Research
Agenda.
3. To appreciate the impact and importance of the Strategic Research SA 5
Agenda for the biomedical imaging community.
How to face the tsunami of pancreatic
10:25 intraductal papillary mucinous neoplasia
(IPMN)
A-0236 08:30
M. Zins; Paris/FR
Session Objectives:
1. To briefly introduce the diagnostic challenge in patients presenting
IPMN lesions.
2. To learn the main differentials in patients with cystic neoplasms.
3. To understand the imaging strategy when organising follow-up of
patients with IPMN lesions.

A-0237 08:35 08:30 - 10:00 Room F2

IPMN: when to watch and when to resect
W. Schima; Vienna/AT Special Focus Session
1. To become familiar with the imaging features of different types of
IPMN.
SF 5b
2. To discuss the different international guidelines that define the Basic interventional radiology for non-
management of the patients.
3. To understand the multidisciplinary team approach necessary when interventionalists: let‘s start with biopsy!
deciding between conservative or surgical management.
A-0244 08:30
Diagnosis of IPMN: the mimickers and how to sort them out J.I. Bilbao; Pamplona/ES
M.-P. Vullierme; Clichy/FR
Session Objectives:
Learning Objectives: 1. To learn about the role of percutaneous biopsy in patient
1. To highlight the imaging features, which distinguish IPMN from other management.
cystic pancreatic neoplasms. 2. To explain the crucial role of being part of a multidisciplinary board.
2. To specifically discuss the differential diagnosis with chronic 3. To learn about intra-procedure patient analgesia.
pancreatitis.
3. To understand the value of the integration of the imaging modalities A-0245 08:35
that define the correct diagnosis. How to decide indications and pre-treatment evaluation
P. Popovic; Ljubljana/SI
A-0239 09:21
Follow-up of IPMN: how many MRs do we need?
1. To become familiar with indications for percutaneous biopsy.
R. Pozzi-Mucelli; Stockholm/SE
2. To learn what to check before your procedures, taking in mind
Learning Objectives: patients‘ safety first.
1. To discuss the methods, intervals and length of surveillance in branch 3. To explain how it is possible to obtain a really informed consent.
ducts IPMN.
2. To understand why MR is an adapted tool for surveillance and which A-0246 08:53
protocol should be proposed. How to guide your procedure
3. To specifically discuss the development of distinct ductal L. Crocetti; Pisa/IT
adenocarcinoma of the pancreas during follow-up of branch duct IPMNs.
1. To appreciate the importance of pre-procedure planning and selection
A-0240 09:44
of image-guidance technique.
Panel discussion: Management of IPMN: what is the Achilles heel of our
2. To learn about advantages and disadvantages of different imaging
current concept?
modalities for guidance.
M. Zins; Paris/FR
3. To learn about new techniques and future prospective for improving
your results.
08:30 - 10:00 Room F1
A-0247 09:11
E3 - Rising Stars Programme: Basic Session How to do your procedure
P.M. Vilares Morgado; Porto/PT
BS 5 Learning Objectives:
1. To become familiar with needles, and how to handle the biopsy
Abdominal emergencies specimen.
Moderator: 2. To learn which device is needed for which patient and lesion based on
B. Marincek; Kilchberg/CH indication.
3. To highlight how to minimise potential complications.
A-0241 08:30
Perforation of the GI tract A-0248 09:29
V. Maniatis; Aabenraa/DK How to follow-up on your patients
M. Seidensticker; Munich/DE
1. To review the aetiologies of the perforation. Learning Objectives:
2. To present current imaging techniques for evaluation of the 1. To learn how to check your patients in the immediate post-procedure.
perforation. 2. To become familiar on how to follow-up on patients.
3. To describe the typical features of the perforation. 3. To learn about management of post-procedure complications.
A-0242 09:00 09:47

Bowel obstruction Panel discussion: Deciding to biopsy within a multidisciplinary board
A. Filippone; Chieti/IT
1. To review the most common causes of bowel obstruction.
2. To present current imaging techniques for evaluation of bowel
obstruction.
3. To become familiar with the typical findings of bowel obstruction.
A-0243 09:30
Vascular emergencies
1. To review the most common causes.
2. To present current imaging techniques.
3. To be familiar with the role of interventional radiology.

08:30 - 10:00 Room Y 08:30 - 10:00 Coffee & Talk 3

Special Focus Session Coffee & Talk (open forum) Session
SF 5a C6
7 Tesla MR goes clinical Modern trends in undergraduate
A-0249 08:30 teaching of radiology: how to explain to
Chairperson‘s introduction students how interesting radiology is
S. Trattnig; Vienna/AT

1. To understand the tendency to higher static magnetic fields in clinical Chairperson‘s introduction
MRI. V. Válek; Brno/CZ
2. To learn about the additional benefits of 7T in Neuroimaging and MSK. Session Objectives:
3. To become familiar with challenges and technical solutions in body 1. To learn how to conceptualise, teach and assess radiology training
MR at 7T. programmes in medical school.
2. To become familiar with the concept of flipped classroom and flipped
A-0250 08:35 learning and to understand how medical students communicate and
Why is there a benefit to higher static magnetic field in MR? share information through online profiles.
P. Jezzard; Oxford/UK 3. To learn how to use ultrasound equipment to train students or how to
utilise simulation models to teach interventional radiology.
1. To become familiar with scanner and coil technology at ultra-high
field. A-0255 08:35
2. To learn about the benefits of increased SNR and spectral resolution What students expect
H.-P. Erasmus; Rome/IT
Thursday
at 7 T.
2. To understand why 7 T is the best for BOLD imaging (fMRI and SWI). Learning Objective:
1. To understand what students expect and if we are able to fulfil their
A-0251 08:53 expectations.
Neuroimaging at 7 T: where does it make the difference?
J. Hendrikse; Utrecht/NL A-0256 08:42
Learning Objectives: The flipped classroom/flipped learning approach in radiology training
1. To learn about the benefits of 7 T for intracranial vessel wall imaging, C. Nyhsen; Strasbourg/FR
microbleed detection and microinfarct detection. Learning Objective:
2. To become familiar with clinical applications of 7 T MR in brain tumour 1. To understand how radiology educators could use material on a
imaging including pituitary gland imaging. shared website and reinforce the most important concepts during face-
3. To understand the added value of 7 T MR in MS, epilepsy and to-face sessions.
dementia.
A-0257 08:49
Appropriate use of imaging studies: what students have to learn
A-0252 09:11 F. Kainberger; Vienna/AT
MSK imaging at 7 T: what are the additional clinical benefits
Learning Objective:
S. Trattnig; Vienna/AT
1. To learn how to educate students about the appropriateness of
Learning Objectives: imaging techniques in the clinical setting.
1. To appreciate the important role of coil technology and optimised
sequence protocols in MSK at 7 T. A-0258 08:56
2. To learn about the improvements of morphological MSK at 7 T MRI. Simulation-based teaching in interventional radiology
3. To become familiar with the benefits of biochemical MSK using R. Iezzi; Rome/IT
x-nuclei and CEST.
Learning Objective:
1. To learn the role of simulation techniques in USG/IR training.
A-0253 09:29
Cardiovascular and abdomen MR at 7 T - still a challenge?
J. Schulz-Menger; Berlin/DE A-0259 09:03
How to encourage undergraduates to become radiologists
Learning Objectives: T. Andrasina; Brno/CZ
1. To understand the current challenges in this field at 7 Tesla.
2. To become familiar with dedicated technical solutions at 7 T for Learning Objective:
patient handling. 1. To learn the role of hands-on training of pregraduate student in small
3. To learn about the added diagnostic value and unique opportunities in groups.
cardiovascular and abdomen MR.
09:10
09:47 Panel discussion: How new education concepts and IT tools can
Panel discussion: Will 7 Tesla become clinical routine? contribute to undergraduate teaching of radiology
A-0260 09:55
Chairperson‘s conclusion
V. Válek; Brno/CZ

08:30 - 10:00 Room D A-0266 09:05

Statistical methods for analysis of multidimensional imaging data
Musculoskeletal K. Van Leemput; Copenhagen/DK
RC 510 1. To learn about the main features of a system for collection and
analysis of multidimensional imaging data.
Imaging of chronic forefoot pain 2. To become familiar with different analytical uses of collected imaging
data.
Moderator:
3. To understand the difference between the current approaches used in
K. Wörtler; Munich/DE
statistical analysis/deep learning in medical imaging.
A-0261 08:30 A-0267 09:35
A. Articular disorders
The use of radiomics in medical imaging
E.G. McNally; Oxford/UK
P. Lambin; Maastricht/NL
1. To explain the pathophysiology and disease spectrum of articular
1. To understand how convolutional neural networks can be used for
sources of chronic forefoot pain.
features extraction in medical imaging.
2. To describe the imaging findings of articular disorders that present
2. To become familiar with the different capabilities of features
with chronic forefoot pain.
extraction tools and their connection with image analysis and
interpretation.
A-0262 09:00 3. To identify the possible limitations of radiomics in providing
B. Extra-articular source of pain meaningful relationships between features and their clinical
G. Bierry; Strasbourg/FR interpretation.
1. To explain the pathophysiology and disease spectrum of extra- 08:30 - 10:00 Room K
articular sources of chronic forefoot pain.
2. To describe the imaging findings of extra-articular conditions that are Chest
present in chronic forefoot pain.
A-0263 09:30 RC 504

C. Imaging-guided percutaneous treatment of forefoot pain
R.L. Cazzato; Strasbourg/FR Pulmonary neuroendocrine proliferations
Learning Objectives: and neoplasms
1. To explain the rationale behind the imaging-guided percutaneous Moderator:
treatment of forefoot pain. M. Silva; Parma/IT
2. To describe the imaging-guided percutaneous procedures for the
treatment of forefoot pain. A-0268 08:30
A. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
(DIPNECH)
08:30 - 10:00 Room G
EFOMP Workshop Learning Objectives:
1. To learn about the diagnostic criteria of this syndrome.
EF 1 2. To understand the correspondence between imaging and pathology.

3. To know when to suggest this diagnosis on CT.
Big data and the big picture: deep
A-0269 09:00
learning in optimisation of medical B. Carcinoid tumours
imaging (part A)
Moderators: Learning Objectives:
J. Damilakis; Iraklion/GR 1. To learn about the radiological features of central and peripheral
P. Gilligan; Dublin/IE carcinoids.
2. To know when to suspect a carcinoid tumour in case of bronchial
A-0264 08:30 obstruction.
Chairperson‘s introduction 3. To learn about the role of FDG and DOTATOC PET/CT in the
J. Damilakis; Iraklion/GR evaluation of carcinoid tumours.

1. To become familiar with the concept of big data and their C. Small cell lung cancer
management. M. Das; Duisburg/DE
2. To discuss the opportunities provided by big data repositories in
clinical practice. Learning Objectives:
3. To understand how big data can support research. 1. To learn about the common radiological manifestations of small cell
lung cancer.
A-0265 08:35 2. To learn how to distinguish between limited or extensive forms.
Imaging and dose biobanks 3. To learn how the TNM staging system should be integrated into the
E. Neri; Pisa/IT classification of SCLC.
1. To provide an overview of imaging and dose biobanks.
2. To understand how to gain access to the data.
3. To learn about obstacles in obtaining validated and annotated images
and dose data in a systematic fashion.

08:30 - 10:00 Room M 1 08:30 - 10:00 Room M 2

Special Focus Session Paediatric
SF 5c RC 512
MSK intervention: the road from low to Intensive care paediatric radiology: the
no invasion very sick neonate
A-0271 08:30 A-0276 08:30
J. Hodler; Zurich/CH S. Stafrace; Doha/QA

1. To appreciate the prevalence and importance of complications in MSK 1. To learn about the most common neurological emergencies in the
interventions. intensive care neonates.
2. To learn about strategies reducing side effects and complications of 2. To understand the wide variety of thoracic devices that may be used
MSK procedures. in these patients.
3. To become familiar with innovations leading to reduced invasiveness 3. To discuss the role of US in abdominal emergencies in the critically ill
in MSK interventions. child.
4. To appreciate the role of radiologists in developing less invasive
interventions. A-0277 08:35
A. Neuroimaging in the neonatal intensive care unit
A-0272 08:35 M.I. Argyropoulou; Ioannina/GR
Avoiding side effects and complications by using MR guided high-
intensity focused ultrasound Learning Objectives:
1. To learn the most common neurological emergencies in the intensive
Thursday
A. Napoli; Rome/IT
care patient.
Learning Objectives: 2. To understand the preferential use of US and MRI as imaging
1. To understand the physics of high-intensity focused ultrasound. techniques.
2. To understand the role of MR guidance in high-intensity focused 3. To discuss the key findings that may be useful for differential
ultrasound. diagnosis.
3. To appreciate effects and side effects of high-intensity focused
ultrasound. A-0278 09:00
4. To become familiar with indications for high-intensity focused B. Chest imaging in the ICU: tubes and catheters
ultrasound. M.L. Lobo; Lisbon/PT

The 10 most important side effects and complications in MSK 1. To learn the crucial role of simple views in critically ill children.
interventions 2. To understand the variety of devices that is used in the intensive care
M. Obradov; Nijmegen/NL unit.
3. To discuss how to avoid the most common pitfalls.
1. To become aware of potential side effects and complications in MSK A-0279 09:25
interventions. C. The role of imaging in emergencies in the critically ill neonate:
2. To appreciate the relative importance of side effects and abdominal US applications and beyond
complications in MSK interventions. M. Riccabona; Graz/AT
3. To recognise the requirements regarding patient information before
MSK interventions. Learning Objectives:
4. To become familiar with the imaging appearance of complications in 1. To learn about typical body (abdomen, chest and other) emergencies
MSK interventions. that can be addressed by US in the NICU.
2. To understand some typical findings that may help in the disease
A-0274 09:10 characterisation.
Radiation exposure: from reduction to avoidance 3. To appreciate the considerable impact on the prognosis and survival
D.J. Wilson; Oxford/UK of the critically ill neonate.

1. To learn about the current knowledge in radiation exposure associated Panel discussion: Is there a role for FAST scan in the paediatric IC unit?
with MSK interventions.
2. To understand the need to reduce radiation exposure in MSK
interventions. 08:30 - 10:00 Room M 3
3. To become familiar with radiation minimisation strategies in MSK
Oncologic Imaging
interventions.
4. To appreciate alternative image guidance methods in MSK
interventions.
RC 516
A-0275 09:25 Role of imaging in cancer of unknown
Preventing side effects and complications by new procedures:
management by radiologists primary (CUP)
A. Bazzocchi; Bologna/IT
A-0280 08:30
Learning Objectives: Chairperson‘s introduction
1. To become familiar with new methods in MSK interventions. S. Gourtsoyianni; Athens/GR
2. To appreciate solutions to reduce side effects and complications in
MSK procedures. Session Objectives:
3. To promote the role of radiologist in advancing new technology. 1. To discuss the role of imaging for the diagnosis of CUP.
4. To appreciate responsibilities of radiologists in reducing side effects 2. To review the role of the interventional radiologist in the management
and complications in MSK procedures. of suspected CUP.
3. To learn how to best assess treatment response.
09:45
Panel discussion: How minimal can invasiveness in MSK intervention
become?

A-0281 08:35 08:30 - 10:00 Room M 5

A. MDCT: the imaging workhorse for suspected CUP
C. Kelly-Morland; Framlingham/UK E3 - ECR Academies: Functional Imaging for Disease
Learning Objectives: Management: Research to Medical Practice
1. To discuss the different patterns of disease spread in CUP.
2. To review optimal protocols and how not to miss important findings.
3. To learn how to best assess treatment response. E3 520
A-0282 08:58
Functional imaging of the lungs
B. Role of PET/CT in suspected CUP A-0288 08:30
L. Umutlu; Essen/DE Chairperson‘s introduction
Learning Objectives: C.M. Schaefer-Prokop; Amersfoort/NL
1. To review the role of PET/CT in localised versus widespread metastatic
disease. A-0289 08:36
2. To discuss potential false positive and false negative findings. A. Perfusion methods for vascular and airway diseases (CT/MRI)
3. To learn when PET/CT is most appropriate in treatment response M. Rémy-Jardin; Lille/FR
assessment.
1. To review most useful CT and MRI perfusion methods for lung imaging.
A-0283 09:21 3. To learn about the impact of functional imaging in pulmonary
C. The role of the interventional radiologist hypertension.
F. Cornelis; Paris/FR 2. To understand the role of perfusion information in airway diseases.
1. To learn the importance of tissue diagnosis in CUP. A-0290 09:04
2. To discuss how to choose the optimal target lesion for biopsy. B. Quantitative CT-imaging biomarkers in airways diseases
3. To review the relative risks and benefits in acquiring tissue samples. H.-U. Kauczor; Heidelberg/DE
09:44 1. To review main functional CT methods of the lungs in airway diseases.
Panel discussion: How to guide the clinical team to solve the mystery 2. To learn about their impact in differential diagnosis.
3. To learn how these methods may help in treatment follow-up.
08:30 - 10:00 Room M 4
A-0291 09:32
E3 - ECR Academies: Hot Topics in GU Cancer C. Lung cancer, tumour heterogeneity and tumour response
J.M. Goo; Seoul/US
E3 519 Learning Objectives:

1. To learn about modern imaging of lung tumours.
Tumour relapse in gynaecological cancer 2. To understand the role of functional criteria of tumour heterogeneity.
3. To learn about main functional biomarkers of tumour response.
A-0284 08:30
08:30 - 10:00 Tech Gate Auditorium
Special Focus Session
A-0285 08:36
A. Differentiating relapse from post-treatment appearances
R. Forstner; Salzburg/AT SF 5d
1. To learn post radiotherapy appearances in cervix cancer.
Imaging and management of the
2. To recognise the appearances of disease relapse. incidental scrotal lesions
3. To be familiar with the complications of treatment seen on imaging.
A-0292 08:30
B. Planning exenterative surgery M. Bertolotto; Trieste/IT
H.A. Vargas; New York, NY/US
Session Objectives:
Learning Objectives: 1. To understand the clinical issues about diagnosis and management of
1. To learn the important criteria for patient selection. incidental scrotal lesions.
2. To learn the critical anatomy for surgical planning. 2. To understand the role of conventional US modes, CEUS and
3. To be familiar with the post-surgical appearances and follow-up plan. elastography in scrotal lesion characterisation.
3. To learn how to fit in a multidisciplinary team to manage patients with
A-0287 09:32 incidental scrotal lesions.
C. Salvage treatment with image directed therapy: high-intensity
focused US (HIFU) and stereotactic RT A-0293 08:35
N.M. deSouza; Sutton/UK ( Incidental testicular lesions: can we characterise them at
multiparametric US?
Learning Objectives: P.S. Sidhu; London/UK
1. To be familiar with the imaging considerations for stereotactic
radiotherapy in relapsed disease. Learning Objectives:
2. To be familiar with the concepts of imaging in directing RT treatment 1. To become familiar with the features at multiparametric US that
plan. improve testicular lesion characterisation.
3. To be familiar with the use of HIFU for treatment of pelvic relapse. 2. To learn about the potential of multiparametric US in imaging
testicular lesions.
3. To understand the specific role of conventional US modes, CEUS and
elastography in testicular lesion characterisation.

A-0294 08:55 10:30 - 12:00 Room B

Incidental extra-testicular lesions: can we characterise them?
M. Secil; Izmir/TR ESR meets Africa
1. To became familiar with the imaging features of the commonest extra-
testicular lesions.
EM 1
2. To learn about the role of multiparametric imaging (US/MR/CT) in Radiology in Africa: facing challenges
characterisation of extra-testicular lesions.
3. To understand the potential and limitations of imaging in extra- and opportunities
testicular lesion characterisation. Presiding:
A-0295 09:10 H.A. Gharbi; Tunis/TN
Incidental testicular lesions: the role of MRI and ESUR
recommendations A-0308/A-0309 10:30
L. Rocher; Le Kremlin-Bicêtre/FR Chairpersons‘ introduction
H.A. Gharbi; Tunis/TN
1. To become familiar with MR appearance of testicular lesions.
2. To understand when MRI can have a role in the clinical practice for Session Objectives:
lesion characterisation. 1. To give an overview of radiology in Africa.
3. To illustrate the ESUR recommendations to help characterisation and 2. To list the existing cooperation programmes of the European Society
management of incidentally detected testicular lesions. of Radiology in Africa.
3. To point out what African radiologists can do for the ESR and what
A-0296 09:25 the ESR can do for radiology in Africa.
Testicular-sparing surgery: a teamwork of radiologist and urologist
N. Pavan; Trieste/IT A-0310 10:40
Structured strategies to combat radiation protection challenges in
Thursday
Africa. What can the ESR do?
1. To learn about the current EAU recommendations for the diagnosis
D. Husseiny Salama; Cairo/EG
and management of the incidental testicular lesion.
2. To understand the current trends for the workup of incidental Learning Objectives:
testicular lesion. 1. To give an overview on the situation of imaging referral guidelines and
3. To become familiar with the value of a multidisciplinary team in clinical decision support (CDS) in Africa.
planning and performing testicular sparing surgery. 2. To update on the European societies‘ activities in the region in regard
to guidelines.
09:40 3. To give tips from African radiologists on solutions and the way
Panel discussion: Multiparametric imaging of the testis - how and when forward.
can we avoid orchidectomy? 4. To present the bilateral strategic planning with the ESR to improve
the performance of radiation protection.
10:30 - 12:00 Room A
A-0311 10:50
E3 - ECR Academies: Interactive Teaching Session for Young Is imaging underused in Africa? East Africa as an example. Solutions:
(and not so Young) Radiologists what can the ESR do?
S. Vinayak; Nairobi/KE
E3 621 Learning Objectives:

1. To present the current situation in Eastern Africa.
Oncologic imaging 2. To describe what we are doing to promote radiology in Africa.
3. To present what we would like to request from the ESR.
A-0306 10:30
A. Lung cancer: key signs in the new TNM 11:00
A.R. Larici; Rome/IT Interlude 1: Enjoy the difference between African and European music
H.A. Gharbi; Tunis/TN
1. To learn about the new staging system for lung cancer. A-0312 11:05
2. To highlight the differences in the meaning of CT findings between How to promote radiation protection in West Africa. Needs and
the new system and the previous one. expected role of the ESR
E.H. Niang; Dakar Fann/SN
A-0307 11:15
B. Incidental findings in oncologic patients Learning Objectives:
M.-P. Revel; Paris/FR 1. To summarise the radiation protection situation in West Africa, discuss
workforce aspects and present an overview of educational facilities and
Learning Objectives: maintenance services.
1. To recognise the importance of different incidental findings in patients 2. To update on the role of European societies in our region, what is
with cancer. done in general and in the field of radiation protection in particular.
2. To learn how to manage patients with incidental findings. 3. To explain what we, as African radiologists, can offer to European
societies.
A-0313 11:15
Most important challenges for imaging in North Africa
L. Rezgui Marhoul; Tunis/TN
1. To give an overview of the radiology situation in North Africa.
2. To enlist the cooperation programmes between North African
societies and the European societies with bilateral exchanges in
radiodiagnosis and interventional radiology.
3. To understand what North African radiologists can bring back to the
table for European radiology.
4. To propose a plan for the promotion of collaboration between North
Africa and ESR.

11:25 A-0320 11:30

Interlude 2: Enjoy the difference between Arabic and European music Larynx
H.A. Gharbi; Tunis/TN R. Maroldi; Brescia/IT

The WHO‘s programme in Africa: the past, the present and the future 1. To understand the anatomy and signals of the cartilage framework of
M.d.R. Perez; Geneva/CH the larynx.
2. To learn the surgical subdivision of the paraglottic space of the larynx
Learning Objectives: into key compartments.
1. To present the WHO‘s role, objective, core functions, structure and 3. To learn the anatomy and signals of the muscles within the larynx.
where/how radiology fits into them.
2. To explain the WHO‘s programmes in Africa and the place of
10:30 - 11:30 Coffee & Talk 3
radiology and radiologists in the context of the current priorities in the
global public health agenda. Coffee & Talk (open forum) Session
3. To understand the WHO‘s views about radiation protection in Africa.
4. To present the WHO‘s radiology programmes/activities in Africa.
What has been done? What is currently being done? What is planned in
the future?
C8
Virtual reality from bench to bedside
A-0315 11:40
Panel discussion: Radiology in Africa, reality and dreams A-0321 10:30
G. Frija1, L.E. Derchi2, H.A. Gharbi3, D. Husseiny Salama4, S. Vinayak5, Chairperson‘s introduction
E. Niang6, L. Rezgui Marhoul3, M.D.R. Perez7, B. Mansouri8, K.M. Naidu9; P.M.A. van Ooijen; Groningen/NL
1
Paris/FR, 2Genoa/IT, 3Tunis/TN, 4Cairo/EG, 5Nairobi/KE, 6Dakar Fann/SN,
7
Geneva/CH, 8Algiers/DZ, 9Cape Town/ZA Session Objectives:
1. To learn about the basics of augmented and virtual reality (AR & VR).
A-0316/A-0317 11:55 2. To learn about the possible applications of AR & VR.
Conclusion 3. To appreciate the role of radiologists in AR & VR.
H.A. Gharbi; Tunis/TN A-0322 10:35
Mixed reality in education
A. Persson; Linköping/SE
10:30 - 12:00 Room E1
Chest 1. To learn about AR & VR for teaching.
2. To understand how to employ AR & VR in education.
RTF Quiz A-0323 10:45

Mixed reality in surgical application
A new look at the mediastinum D. Amiras; London/UK
Moderators:
J. Cáceres; Barcelona/ES Learning Objectives:
J. Vilar; Valencia/ES 1. To learn about the added value of AR & VR in surgery.
2. To appreciate the role of the radiologist in this application.
10:30 - 12:00 Room F1 10:55

E3 - Rising Stars Programme: Joint Session with ESOR
10:30 - 12:00 Room G

BE 6 EFOMP Workshop
Radiologic anatomy: head and neck
Moderator:
M. Becker; Geneva/CH EF 2
A-0318 10:30
Big data and the big picture: deep
Neck spaces learning in optimisation of medical
imaging (part B)
1. To understand the concept of neck spaces and their boundaries. M. Brambilla; Novara/IT
2. To review the content of each space with emphasis on differential M. Kortesniemi; Helsinki/FI
diagnosis.
3. To become familiar with pathological findings typical for each space.
A-0324 10:30
A-0319 11:00 M. Brambilla; Novara/IT
Temporal bone
J.W. Casselman; Bruges/BE Session Objectives:
1. To provide an overview of application of deep learning methods in
Learning Objectives: image optimisation.
1. To know which technique is best suited to visualise specific anatomical 2. To understand the need for a deep learning approach in medical
structures of the temporal bone. imaging.
2. To recognise the clinically most important anatomical structures of 3. To understand why deep learning algorithms are capable of
the middle and inner ear. supporting research.
3. To learn how the anatomical structures of the temporal bone look like
in the transverse, coronal and double oblique plane.

A-0325 10:35 10:30 - 12:00 Room M 5

Computer analysis in chest imaging: from rule-based to machine
learning to deep learning E3 - ECR Academies: Functional Imaging for Disease
B. Van Ginneken; Nijmegen/NL Management: Research to Medical Practice
1. To give an overview of application of deep learning methods in the
diagnosis of thoracic lesions. E3 620
2. To understand issues related to the technical implementation of these
methods.
Functional imaging of the liver
3. To learn about the complementary role of visual reading and
computer-aided diagnosis.
A-0332 10:30
A-0326 11:05
Deep learning in CT optimisation
M. Kachelrieß; Heidelberg/DE
A-0333 10:36
A. Diagnostic and staging of diffuse liver diseases using functional MRI
Learning Objectives: B.E. van Beers; Clichy/FR
1. To provide the rationale of deep learning methods in image
optimisation.
1. To review functional MRI approaches of liver diseases.
2. To describe application of deep learning methods in medical physics
2. To learn about their impact in characterising diffuse liver diseases.
tasks such as scatter removal, spatial resolution improvement, noise
3. To be aware of validated biomarkers of prognosis.
reduction, dose estimation.
3. To understand how these methods will impact on quantitative aspects
of medical imaging.
A-0334 11:04
B. Diagnostic and staging of diffuse liver diseases using
multiparametric US
A-0327 11:35 P.S. Sidhu; London/UK
From image quality to care outcome
Thursday
M. Kortesniemi; Helsinki/FI Learning Objectives:
1. To review functional US approaches of liver diseases.
2. To learn about their impact in characterising diffuse liver diseases.
1. To introduce the need of measuring the diagnostic value in terms of
outcome.
2. To discuss its relevance and limitations regarding the traditional
concept of image quality.
A-0335 11:32
C. Characterisation of liver tumours and prediction of tumour response
3. To introduce the challenges in deep learning based artificial
B. Taouli; New York, NY/US
intelligence methods.
10:30 - 12:00 Room M 4 1. To learn about multiparametric imaging of liver tumours.
2. To understand the role of functional criteria of tumour
E3 - ECR Academies: Hot Topics in GU Cancer characterisation.
3. To learn about main functional biomarkers of tumour response.
E3 619 12:15 - 12:45 Room A

Tumour relapse in urological cancer Headline Session
A-0328 10:30
HL 1
Wilhelm Conrad Röntgen Honorary
A-0329 10:36
A. Prostate cancer relapse Lecture
V. Panebianco; Rome/IT Presiding:
1. To learn the follow-up strategy post radical prostatectomy.
A-0336 12:15
2. To recognise relapse and know the patterns of spread.
Oncologic imaging: a new beginning has just begun
3. To learn the use of imaging in planning salvage therapy.
B. Non prostate urological cancer relapse 1. To know the challenges in cancer management.
H.A. Vargas; New York, NY/US 2. To understand the role of modern imaging in this management.
3. To learn about future directions in oncologic imaging.
1. To recognise the expected post treatment appearances.
2. To know follow-up strategies for detection of relapse.
3. To learn to recognise pitfalls by case review.
A-0331 11:32
C. Theranostics in urological cancer
M. Hartenbach; Vienna/AT
1. To learn about theranostic options in urological cancers.
2. To understand the advantages and limitations of theranostic
approaches.
3. To become familiar with new the indications and outcomes of
theranostic approaches.

12:30 - 13:30 Room C 12:30 - 13:30 Coffee & Talk 2

E3 - The Beauty of Basic Knowledge: Pancreas EuroSafe Imaging
E3 24B C9
Chronic pancreatitis Dissemination of ESR iGuide in Europe:
Moderator:
M. Zins; Paris/FR use cases
A-0340 12:30 12:30
How to diagnose and classify Moderator:
G. Zamboni; Verona/IT G. Frija; Paris/FR

1. To learn about diagnosis of chronic pancreatitis. Chairperson‘s introduction
2. To understand classification of chronic pancreatitis. L. Donoso; Barcelona/ES
3. To appreciate the role of imaging in the follow up of chronic
pancreatitis. Session Objectives:
1. To learn about the adoption of the ESR‘s guidelines in Europe.
A-0341 13:00 2. To understand the implementation of CDS in different settings.
Functional evaluation of chronic pancreatitis 3. To appreciate country-specific challenges to guideline and CDS
M.A. Bali; Brussels/BE adoption.

1. To appreciate functional evaluation of chronic pancreatitis. ESR iGuide adoption in Croatia
2. To learn about the role of imaging in recurrent pancreatitis. B. Brkljačić; Zagreb/HR
12:30 - 13:30 Coffee & Talk 1
1. To learn about the use of referral guidelines and CDS in Croatia.
Coffee & Talk (open forum) Session 2. To understand the challenges of nationally coordinated
implementation projects.
3. To appreciate the importance of incentives for referrers to drive CDS
C 26 adoption.
What is a fellowship in management? A-0349 12:45
Moderator: ESR iGuide adoption in Sweden
H.-U. Kauczor; Heidelberg/DE H. Ståhlbrandt; Eksjö/SE

Challenges for leaders in radiology 1. To learn about the use of referral guidelines and CDS in Sweden.
H.-U. Kauczor; Heidelberg/DE 2. To understand the different integration options of ESR iGuide.
3. To appreciate the importance of user-friendly workflows.
A-0343 12:40
Mentorship for fellows in management A-0350 12:55
O. von Stackelberg; Heidelberg/DE ESR iGuide adoption in Belgium
1. To learn about importance of management in radiology departments. Learning Objectives:
2. To become familiar with the topics that could be addressed in the 1. To learn about the use of referral guidelines and CDS in Belgium.
management fellowship programmes. 2. To understand the challenges of nationally coordinated
3. To understand how a successful mentorship program could be set up. implementation projects.
3. To appreciate the impact of CDS and guidelines in different settings.
A-0344 12:50
What I learned from my fellowship in management 13:05
M. Buk; Prague/CZ Open forum discussion: National and regional approaches to ESR
iGuide implementation
1. To learn about the infrastructure and organisation of a radiology
department.
12:30 - 13:30 Room D
2. To understand how clinical research can influence and form the E3 - The Beauty of Basic Knowledge: A Survival Guide to
indication criteria for radiological examinations.
3. To appreciate the benefits of interdepartmental cooperation for both
Musculoskeletal Imaging
radiologists and clinicians.
A-0345 13:00 E3 25B

Expertise required: finance or IT? Bone tumours
Moderator:
Learning Objectives: V.N. Cassar-Pullicino; Oswestry/UK
1. To learn basic principles in healthcare financing.
2. To understand the concepts of IT-solutions in healthcare. A-0351 12:30
3. To appreciate the opportunities of IT support for management Bone tumours
requirements. K. Wörtler; Munich/DE
A-0346 13:10 1. To become familiar with the imaging features of benign and malignant
What I expect from my fellowship in management
bone tumours.
C.A. Minoiu; Bucharest/RO
2. To appreciate their imaging characteristic hallmarks on plain film
radiography.
13:20 3. To learn how best to use imaging modalities in differential diagnosis.

12:15 - 13:45 Room M1 A-0353 12:40

Getting to the top and how to thrive: lessons learned
Joint Session of the ESR Ultrasound Subcommittee and the C. Palmer; London/UK
Undergraduate Education Subcommittee Learning Objectives:
1. To learn the importance of listening to the views of colleagues and
understanding their objectives when working in partnership.
ESR US SC/UES 2. To understand the value of empowering and developing others,
US teaching to undergraduate students: especially more junior members of your team.
3. To know when to stand firm and when to be flexible - resilience is
why, how and from whom? essential!
Moderators: 4. To appreciate the value of having a clear vision, achievable but
C. Nyhsen; Strasbourg/FR stretching goals and a road map for the journey.
V. Válek; Brno/CZ
A-0354 13:00
A-0337 12:15 Dare with Care
Why: US anatomy and pathology teaching, US in clinical practice and C. Estrampes; Paris/FR
as a career choice Learning Objectives:
T. Fischer; Berlin/DE 1. To understand the importance of daring to ask, negotiate, and put
Learning Objectives: oneself forward.
1. To learn how ultrasound may be used effectively when teaching 2. To understand that caregiving skills can provide an advantage for
anatomy and pathology to undergraduate students, including access to leaders in today’s complex world.
hands on practice. 3. To understand that daring and caring can go together.
2. To understand how the importance of ultrasound as an imaging
modality in daily clinical practice may be highlighted to students. A-1103 13:20
3. To learn how US teaching can be used to raise students‘ interest in Insights on Women in Radiology by the ESR President
radiology as a career choice. L.E. Derchi; Genoa/IT
Thursday
A-0338 12:35 A-0355 13:30
How: US teaching in the radiology department and hands-on Panel discussion: Stories to tell and wisdom to share
classroom teaching using living models and simulators D. Akata1, C. Estrampes2, M. Fuchsjäger3, H. Hricak4, L. Leong5, C. Palmer6;
1
M. Bachmann Nielsen; Copenhagen/DK Ankara/TR, 2Paris/FR, 3Graz/AT, 4New York, NY/US, 5Hong Kong/CN,
6
London/UK
1. To learn how students may be integrated in clinical US sessions in the
radiology department.
14:00 - 15:30 Room A
2. To understand which different classroom hands on teaching E3 - ECR Academies: Interactive Teaching Session for Young
environments can be created, using living models and simulators.
3. To become familiar with the use of simulators in ultrasound, from low
cost to the high end spectrum and what the future may offer.
A-0339 12:55 E3 721

From whom: the importance of radiologists delivering US teaching and Errare humanum est
staying experts in this field
K. Rosendahl; Bergen/NO A-0356 14:00
A. Errors in chest radiograph
D. Tack; Baudour/BE
1. To understand the importance of radiologists maintaining an interest in
US and in US teaching in an era where US technology is more affordable Learning Objectives:
and will be used by many specialties other than radiology. 1. To learn to recognise ambiguous signs in plain films.
2. To learn how radiologists can continue to be regarded as experts in 2. To learn to avoid the most common pitfalls in reading plain chest films.
US through teaching.
3. To become familiar with ways to show students how radiologists A-0357 14:45
provide an effective clinical service in this technique. B. Errors in CT of the chest
13:15
Panel discussion: How can radiologists use US to teach undergraduate Learning Objectives:
students effectively, within time and cost constraints, whilst promoting 1. To learn to interpret ambiguous chest CT signs.
their specialty as a career choice? 2. To learn to avoid the most common pitfalls in reading chest CT
images.
12:30 - 14:00 The Church
WF 1
Leading by example
A-0352 12:30
H. Hricak; New York, NY/US
Session Objectives:
1. To acknowledge and respect the diversity of career choices.
2. To grasp the need to follow one‘s passion, follow one‘s heart, as one
size does not fit all.
3. To learn that we create our own realities and should not take others‘
actions personally.
4. To understand and consider the long-term consequences of our
choices.

14:00 - 15:00 Coffee & Talk 2 14:00 - 15:00 Coffee & Talk 3
Coffee & Talk (open forum) Session Coffee & Talk (open forum) Session
C 11 C 10
Dissemination of ESR iGuide in Africa Ethical traps in publication: how to avoid
and the Middle East: use cases them from concept to achievement
14:00 A-0363 14:00
Moderator: Chairperson‘s introduction
G. Frija; Paris/FR R.G.H. Beets-Tan; Amsterdam/NL
Session Objectives:
A-0358 14:00 1. To discuss ethical issues around the study and during the review
Chairperson‘s introduction process of a scientific paper.
B. Mansouri; Algiers/DZ 2. To become familiar with the definition of plagiarism, scientific
misconduct etc., and to understand its impact for authors and journals.
Session Objectives:
3. To learn about publication ethics and international vs national
1. To learn about the adoption of the ESR‘s guidelines outside of Europe.
regulations.
2. To understand the application of CDS in different settings.
4. To understand the different approaches to original scientific and
3. To appreciate country-specific challenges to guideline and CDS
review papers.
adoption.
A-0359 14:05 A-0364 14:05

Ethical aspects during conception of a study
ESR iGuide adoption in Egypt
D. Husseiny Salama; Cairo/EG
1. To understand when the Ethical Committee approval is necessary.
1. To learn about the use of referral guidelines and CDS in Egypt.
2. To know when signed informed consent is necessary and when it is
2. To understand the challenges of CDS adoption in Egypt.
waived.
3. To appreciate the importance of appropriate referrals in different
3. To learn methods for presenting data to patients.
settings.
A-0360 14:13 A-0365 14:10

What to think about when writing a paper
ESR iGuide adoption in Uganda
M.G. Kawooya; Kampala/UG
1. To learn the best ways to construct a successful paper that will most
1. To learn about the use of referral guidelines and CDS in Uganda.
probably be published.
2. To understand the challenges of implementing a stand-alone CDS
2. To understand the critical thinking approach to knowledge.
portal in clinical practice.
3. To learn the main differences between scientific papers and review
3. To appreciate the importance of appropriate use of available imaging
papers, and their relevance.
resources.
A-0361 14:21 A-0366 14:15

Ethical issues during peer review
ESR iGuide adoption in Tunisia
Y. Menu; Paris/FR
L. Rezgui Marhoul; Tunis/TN
1. To learn about the most common ethical issues encountered during
1. To learn about the use of referral guidelines and CDS in Tunisia.
peer-review and how they can be detected.
2. To understand the implementation process of EHR-integrated CDS.
2. To become familiar with the definition of plagiarism, verbatim copy,
3. To appreciate the importance of change management when including
scientific misconduct and honorary/ghost authorship.
CDS in the clinical workflow.
3. To build a simple check-list in order to tackle ethical issues as a
reviewer.
A-0362 14:29 4. To understand the potential outcome of ethical issues for the authors
ESR iGuide adoption in Iran
and for the Journal.

1. To learn about the use of referral guidelines and CDS in Iran. Ethical problems in scientific publishing
2. To understand the implementation process within the Iranian Social M. Kowalczuk; London/UK
Security Organisation (SSO).
3. To appreciate the need for incentivising referrers to drive CDS Learning Objectives:
adoption. 1. To become familiar with Committee on Publication Ethics core
practices and guidelines.
2. To understand how editors handle publication ethics issues that arise
14:37
in journals.
Open forum discussion: Use cases in Africa and the Middle East -
3. To learn how editors collaborate with research institutions in handling
challenges and solutions
allegations of misconduct.
4. To know how to prepare a manuscript to cover the ethics aspects of
the research.
14:25

14:00 - 15:30 Room M 3 A-0375 14:34

B. Langerhans cell histiocytosis (LCH)
ESOR Session A. Devaraj; London/UK
ESOR 1. To understand the pathophysiology of LCH.
2. To review key features on CT.
Artificial intelligence: presented with 3. To learn about the various stages of the disease.
new lecture formats A-0376 15:02

Moderator: C. Lymphangioleiomyomatosis
V. Vilgrain; Clichy/FR A. Oikonomou; Toronto, ON/CA
A-0368 14:00 1. To learn about the current concepts on pathogenesis.
Introduction
2. To review the typical and atypical CT features.
3. To learn about the tuberous sclerosis complex.
A-0369 14:05
ESOR in action 2019 14:00 - 15:30 Room M 5
E3 - ECR Academies: Functional Imaging for Disease
A-0370 14:10 Management: Research to Medical Practice
Artificial intelligence (AI) and machine learning (ML) in medical
imaging
W.J. Niessen; Rotterdam/NL E3 720
Learning Objectives: Functional imaging of the kidneys
1. To define the concept of AI and the underlying techniques that can be
Thursday
applied to radiology. A-0377 14:00
2. To learn the needs and resources involved in the generation of new Chairperson‘s introduction
machine learning solutions for radiology. H.C. Thoeny; Fribourg/CH
3. To understand how AI can be integrated as a clinical tool to assist
radiologists in their daily practice. A-0378 14:06
A. MR measurement of split renal function
A-0371 14:30 D. Mandry; Nancy/FR
Deep learning (DL) in medical imaging
1. To review the principles of functional DCE of kidneys.
Learning Objectives: 2. To learn about post-processing methods.
1. To learn the concept of DL and how neural networks (NN) can extract 3. To understand differences with renal scintigraphy.
patterns from images.
2. To understand how DL can extract information from big radiomics A-0379 14:34
data through training/test process. B. Renovascular diseases (RVD)
3. To learn how convolutional NN can automatically extract imaging M. Notohamiprodjo; Tübingen/DE
features.
1. To review main methods of renal perfusion measurement.
A-0372 14:50
2. To learn about the place of functional approaches in strategy
My experience: one-year fellowship
management of RVD.
Y.M. Purcell; Dublin/IE
3. To understand its impact for therapeutic decision.
15:00
Awards
A-0380 15:02
C. Characterisation of chronic kidney diseases (CKD)
14:00 - 15:30 Room M 4
E3 - ECR Academies: Chest Imaging 1. To understand the link between functional approach and renal
physiological and tissue changes.
2. To learn how functional approach can help in differentiating renal
E3 722 diseases.
3. To be aware of their role in evaluating prognosis of CKD.
Cavitary and cystic diseases of the lung
A-0373 14:00 16:00 - 17:30 Room A
E3 - ECR Academies: Interactive Teaching Session for Young
J. Biederer; Heidelberg/DE
A-0374 14:06
A. Cavitary lung lesions
A.P. Parkar; Bergen/NO E3 821
Learning Objectives: Gastrointestinal radiology
1. To review the diagnostic criteria and differentials of cavitary lung
lesions. A-0390 16:00
2. To learn about the most common causes. A. Inflammatory bowel disease
3. To learn about an algorithmic approach to narrow the differential J. Rimola; Barcelona/ES
diagnosis. Learning Objectives:
1. To review the spectrum of imaging findings in inflammatory bowel
disease, mainly in Crohn‘s disease.
2. To learn about the management options.

A-0391 16:45 A-0396 16:50

B. Rectal cancer staging: key findings Which impact does AI have on medicine?
G. Brown; Sutton/UK S.O. Schönberg; Mannheim/DE

1. To understand the imaging technique. 1. To be prepared for the future role of AI and radiologists, and their
2. To identify the key imaging findings. interaction, when using AI as a tool for development and clinical routine.
2. To understand how AI will impact the role and tasks of radiologists in
the future.
16:00 - 17:30 Room B
3. To know what the beneficial directions are and how we can facilitate
Special Focus Session effective joint research at the interface of the involved communities.
4. To try to foresee what the emerging role of AI means for educating
the next generation of radiologists.
SF 8a 17:05
Artificial intelligence (AI): our future Panel discussion: What is the future role of a radiologist in the
diagnostic process?
cannot be predicted, but we have to be
prepared 16:00 - 17:30 Room C
A-0392 16:00 General Radiography (Radiographers)
G. Langs; Vienna/AT
Session Objectives:
RC 814
1. To learn about the basics of machine learning and deep learning, its Forensic imaging
current capabilities and limitations and its contribution to research and
routine. A-0397/A-0398 16:00
2. To understand the current state-of-the-art, where ML/DL techniques Chairpersons‘ introduction
struggle and in which directions the major methodological and A. Dominguez; Lausanne/CH
application advances are being made right now. H.T. Patel; Ahmedabad/IN
3. To appreciate the need for interdisciplinary research and conscious
creation of means to exploit the capabilities of AI, and to coordinate Session Objectives:
development across machine learning and radiology communities. 1. To provide insights into the role of imaging, and radiographers, in
4. To become familiar with examples of how AI can be used in radiology. forensic imaging.
2. To appreciate the key aspects of a quality forensic imaging service
A-0393 16:05 using angiography.
Basics of machine learning and deep learning 3. To understand the challenges associated with forensic imaging.
B. Van Ginneken; Nijmegen/NL
A-0399 16:05
Learning Objectives: A. The chain of evidence
1. To get basic understanding of techniques of machine learning with a M. Davis; Dublin/IE
focus on deep learning techniques.
2. To understand supervised and unsupervised learning techniques. Learning Objectives:
3. To know current capabilities and limitations of deep learning 1. To appreciate the importance of continuity of evidence and record
methodology in the context of radiology. keeping.
2. To learn about essential steps for radiographers to follow.
A-0394 16:20 3. To discuss potential pitfalls when conducting forensic examinations.
AI for lesion detection and characterisation
B. Stieltjes; Basle/CH A-0400 16:28
B. Post-mortem cardiac angiography
Learning Objectives: H. Precht; Odense/DK
1. To see specific examples of AI application in clinical radiology and
research. Learning Objectives:
2. To understand challenges, solutions and pitfalls in translating ML 1. To learn about the development of multiphase post-mortem cardiac
methodology to successful clinical implementation. angiography (MPMCCTA).
3. To learn what AI can add to the management of the radiology 2. To appreciate the benefits and limitations of MPMCCTA examinations.
department. 3. To understand the role of the radiographer in the MPMCCTA.
A-0395 16:35 A-0401 16:51

Machine learning in medical imaging going forward C. Paediatric forensic imaging
P. Golland; Cambridge, MA/US A.L. Brookes; Fulwood/UK

1. To understand machine learning, where current technology 1. To appreciate the role of the radiographer in paediatric forensic
development is heading and how it is aligned with clinical needs. imaging.
2. To understand which tasks ML/DL perform well, where the challenges 2. To understand the challenges associated with conducting paediatric
are, where we can expect improvement and what the prerequisites for forensic examinations.
this are. 3. To discuss the imaging options available for paediatric forensic
3. To learn what machine learning can add to the management of the imaging.
radiology department.
17:14
Panel discussion: Safeguarding the wellbeing of staff involved in
forensic imaging

16:00 - 17:30 Room X 16:00 - 17:30 Room N

Multidisciplinary Session EuroSafe Imaging Session
MS 8b EU 2
Brain imaging in psychiatry Diagnostic reference levels (DRLs) based
A-0402 16:00 on clinical indication
Chairperson‘s introduction Moderators:
J.-P. Pruvo; Lille/FR G. Frija; Paris/FR
G. Simeonov; Luxembourg/LU
Session Objectives:
1. To introduce the potential of MRI use in psychiatry. A-0408 16:00
2. To present the context and introduce the faculty. Chairperson‘s introduction
G. Frija; Paris/FR
A-0403 16:05
The epidemiology of psychiatric disorders: why is MRI needed? Session Objectives:
A. Amad; Lille/FR 1. To learn about the concept of clinical DRLs (CDRLs).
2. To understand the goals of CDRLs.
Learning Objectives: 3. To understand the methodology of the establishment of CDRs.
1. To know the prevalence and burden of the main psychiatric disorders.
2. To synthesise the available findings in the case of the first-episode of A-0409 16:05
psychosis. European Commission perspective
3. To discuss the rationale for systematic MRI in first-episode psychosis. G. Simeonov; Luxembourg/LU
Thursday
Strengths of structural and functional MRI in psychiatry 1. To learn about the Euratom legal basis for radiation protection of
J.-P. Pruvo; Lille/FR patients and the European Commission‘s support for implementation of
the Euratom requirements for DRLs.
Being able to predict as soon as possible the clinical outcome following a 2. To understand the place and the importance of DRLs in the Euratom
first episode of psychosis (FEP) is crucial, and should allow providing the system for radiation protection of patients.
most appropriate care to patients. Several biomarkers for FEP outcome 3. To appreciate the progress made in recent years with respect to DRLs
have already been proposed, including anatomical and functional and the key role of Euratom as the driver of progress in this area.
neuroimaging, neuropsychological and biological biomarkers, but
they still lack large-scale validation. In the Hauts-de-France region, the A-0410 16:20
Federation for mental health research (F2RSM) constituted radiologists- One shoe does not fit all: clinical indication based DRLs
psychiatrists pairs and harmonised magnetic resonance imaging G. Frija; Paris/FR
sequences to be used in FEP, forming the “PSYMAC clinical network”.
This procedure also includes follow-up visits to maintain harmonisation Learning Objectives:
over time. The choice of the most adapted sequences to be conducted in 1. To learn about the concept of CDRLs in CT and in interventional
this context will be discussed. We expect to later develop and generalise radiology.
such a network nationwide. 2. To understand the importance of local DRLs.
3. To appreciate the need to develop local repositories covering the field
Learning Objectives: of quality and safety.
1. To discuss the choice of structural/functional MRI sequences in this
context. A-0411 16:35
2. To present a collaborative psychiatry-radiology network in North of Experience from the EUCLID (European study on clinical DRLs) Project
France. J. Damilakis; Iraklion/GR
3. To present the clinical perspective of the PREDIPSY project.
A-0405 16:41 1. To learn about methodological requirements for establishing DRLs.
Advanced MRI and clinical applications: the structured report 2. To learn about the current status of DRLs in adult imaging in Europe
R. Lopes; Lille/FR and beyond.
3. To understand why clinical DRLs are needed in adult imaging.
1. To synthesise 5-years of 3T-MRI research in psychiatry and neurology. A-0412 16:50
2. To present the perspective of ultra-high field MRI in psychiatry Experience with a national survey based on clinical indications
research. S.J. Foley; Dublin/IE
3. To present clinical applications of machine-learning on MRI-data in the
field of psychiatry. Learning Objectives:
1. To learn about the 2017 Irish national CT survey.
A-0406 16:59 2. To understand DRL differences when derived from clinical indications
From fMRI capture of hallucinations to innovative image-guided in contrast to anatomical region.
treatments 3. To appreciate aspects for improvement of future surveys.
R. Jardri; Lille/FR
A-0413 17:05
Learning Objectives: Update of the national DRLs for CT in Switzerland
1. To know the neural bases of hallucinations. S.T. Schindera; Aarau/CH
2. To know the different fMRI strategies used to capture hallucinations.
3. To present fMRI-guided treatments of refractory hallucinations. Learning Objectives:
1. To learn about the methodology of updating the national DRLs for CT
A-0407 17:17 in the era of dose management software.
Multidisciplinary case presentation and discussion 2. To learn about the main differences of the updated national DRLs for CT.
J.-P. Pruvo; Lille/FR 3. To understand the impact of the updated national DRLs for CT.
17:20
Discussion

16:00 - 17:30 Room O A-0420 16:05

Non-contrast MR angiography techniques
Special Focus Session T. Leiner; Utrecht/NL
SF 8c 1. To became familiar with MRI technologies and innovations.
2. To learn about the alternative sequences to study vascular structures.
The art to transmit and to receive: 3. To learn what you need to technically optimise your protocols.
how to communicate critical information A-0421 16:23

Non-contrast MR angiography for large vessels
to our patients T. Hazirolan; Ankara/TR
A-0414/A-0415 16:00 Learning Objectives:
Chairpersons‘ introduction 1. To understand the role of MR angiography in aortic imaging.
M.H. Fuchsjäger; Graz/AT 2. To discuss how non-enhanced MRI sequences could replace
C. Loewe; Vienna/AT gadolinium-enhanced sequences.
3. To learn how to optimise your protocols to avoid the use of
Session Objectives:
intravenous gadolinium.
1. To understand the importance of direct communication with patients.
2. To learn about the differences between delivering and receiving
critical information.
A-0422 16:41
Peripheral non-contrast MR angiography
3. To become familiar with the needs of patients for communication with
G. Roditi; Glasgow/UK
medical specialists.
A-0416 16:05 1. To understand the role of MR angiography in peripheral disease.
How patients feel about communication 2. To discuss how non-enhanced MRI sequences could replace
C. Justich; Vienna/AT gadolinium-enhanced sequences.
1. To understand the immense impact of communication.
2. To demonstrate how different ways of communication influenced me
as a patient.
A-0423 16:59
Non-contrast MR angiography in paediatric vascular imaging
3. To appreciate benefits of good communication for the physician.
M. Argyropoulou; Ioannina/GR
Fundamentals of physician/patient communication 1. To learn about the risk of gadolinium injection in the paediatric patient.
L. Fallowfield; Brighton/UK 2. To discuss the implications of the new knowledge for clinical practice
in paediatric radiology.
1. To understand what questions and information are important to
patients.
2. To learn some basic principles and techniques of doctor-patient
communication.
17:17
Panel discussion: Do we really need gadolinium-enhanced sequences?
3. To apply these principles to some common clinical situations.
A-0418 16:55 16:00 - 17:30 Room E1

How can we improve communication with our patients?
F.J. Gilbert; Cambridge/UK Special Focus Session
1. To understand the communication of radiological findings with
patients.
SF 8e
2. To discuss communication of uncertainty about radiological findings Breast imaging in pre-menopausal
and why further tests are required.
3. To appreciate the importance of conveying the same messages as the
women
clinician in charge of the patient.
A-0424 16:00
17:20
I. Thomassin-Naggara; Paris/FR
Panel discussion: How to convey that we care
Session Objectives:
16:00 - 17:30 Studio 2019 1. To highlight the different pathologies we may encounter in pre-
menopausal women.
Special Focus Session 2. To present controversies about screening in pre-menopausal women.
3. To become familiar with breast diseases associated with pregnancy.
SF 8d A-0425 16:05
Physiological changes and benign breast diseases in young women
Non-contrast MR angiography: F. Kilburn-Toppin; Cambridge/UK
ready to go? Learning Objectives:
1. To present the physiological changes and benign breast diseases.
A-0419 16:00 2. To highlight the challenges and opportunities of breast MR imaging in
Chairperson‘s introduction pre-menopausal women.
R. Iezzi; Rome/IT 3. To provide an overview on how to manage enhancement of
parenchyma.
Session Objectives:
1. To understand the role of MR angiography in vascular imaging.
2. To became familiar about the risk of gadolinium injection.
3. To learn about the existing literature on the usefulness of non-contrast
MRA imaging.

A-0426 16:30 16:00 - 17:30 Room F1

Breast cancer screening in pre-menopausal women
P. Clauser; Vienna/AT E3 - Rising Stars Programme: Basic Session
1. To discuss the place of breast screening in pre-menopausal women.
2. To present the risk factors that define groups of women that would
BS 8
benefit a breast screening. Renal, adrenal and urinary tract
3. To evaluate the balance between risk and benefit of radiation dose.
4. To learn about the value of tomosynthesis with synth2DMG and MRI in pathologies
this group of women. Moderator:
C.S. Balleyguier; Villejuif/FR
A-0427 16:55
Pregnancy-associated breast cancer (PABC) A-0432 16:00
C. Van Ongeval; Leuven/BE Renal pathologies
1. To become familiar with breast diseases associated with pregnancy. Learning Objectives:
2. To recognise specific characteristics of pregnancy-associated breast 1. To review the most common pathologies.
cancer. 2. To present current imaging techniques for evaluation of renal
3. To learn which imaging techniques could be used to investigate pathologies.
pregnancy-associated breast lesions and breast cancer. 3. To demonstrate the most important imaging findings of the common
17:20 renal pathologies.
Panel discussion: At what age should we start to screen women for
breast cancer? A-0433 16:30
Adrenal pathologies
M. Stajgis; Poznan/PL
16:00 - 17:30 Room E2
Thursday
Neuro 1. To review the most common pathologies.
2. To present current imaging techniques for evaluation of adrenal
pathologies.
RC 811 3. To demonstrate the most important imaging findings of the common
adrenal pathologies.
State-of-the-art paediatric
neuroradiology A-0434 17:00
Ureter and bladder
A-0428 16:00 M.N. Özmen; Ankara/TR
C. Calli; Izmir/TR
1. To review the most common pathologies.
Session Objectives: 2. To present current imaging techniques for evaluation of ureter and
1. To learn the spectrum of applications and indications for imaging in bladder.
paediatric neuroradiology. 3. To demonstrate the most important imaging findings of the common
2. To understand the relevance in order to apply the appropriate image ureter and bladder pathologies.
acquisition protocols of disease in the field.
3. To appreciate the clinical relevance of imaging for the diagnostic 16:00 - 17:30 Room F2
process of neurological disorders in infants and children.
Emergency Imaging
A-0429 16:05
A. Imaging myelin maturation disorders
N. Wolf; Amsterdam/NL RC 817
Learning Objectives: Blunt polytrauma: CT protocols, CT
1. To learn about normal and pathological patterns of myelination.
2. To understand the role of imaging with respect to narrowing the interpretation and interventional
differential diagnosis and supporting the clinical diagnosis.
3. To appreciate the importance of pattern recognition for the diagnosis
radiology options
of myelination disorders in children.
A-0435 16:00
A-0430 16:28 K.H. Nieboer; Brussels/BE
B. Imaging of developmental disorders
B. Ertl-Wagner; Toronto, ON/CA Session Objectives:
1. To understand the different CT and contrast protocols that can be
performed in blunt polytrauma patients and when to apply them.
1. To learn about the spectrum of developmental disorders of the brain.
2. To be able to quickly identify and classify solid organ injuries.
2. To understand the key imaging features that lead to the correct
3. To recognise injuries that can be treated with interventional radiology.
diagnosis.
3. To appreciate the importance of making a correct imaging diagnosis.
A-0436 16:05
A. CT protocols in blunt polytrauma
A-0431 16:51 E. Kashef; London/UK
C. Imaging in paediatric neuro-oncology
G. Morana; Genoa/IT Learning Objectives:
1. To understand the advantages and disadvantages of different CT
protocols adopted in blunt polytrauma patients.
1. To learn about the spectrum of neuro-oncological diseases in children.
2. To learn the goal in the use of single and dual phase contrast injection
2. To understand the role of imaging beyond the diagnostic process.
protocols in trauma.
3. To appreciate the increasing clinical relevance of advanced imaging
3. To become able to incorporate the most suitable CT protocol in
techniques in paediatric neuro-oncology.
defined clinical scenarios.
17:14
Panel discussion: Ask the expert: what is relevant for my own daily
clinical practice?

A-0437 16:30 A-0442 17:00

B. Solid organs injuries: a tailored approach Radiation therapy quality assurance (RTQA) in clinical trials: the role
M. Patlas; Hamilton, ON/CA of the radiographer/radiation therapy technologist
M. van Os; Rotterdam/NL
1. To learn about the main traumatic injuries to be detected in solid Learning Objectives:
organs. 1. To understand the essential role of the radiographer/radiation therapy
2. To understand which crucial findings will change patient management. technologist in RTQA.
3. To understand what surgical and intensive care teams need to know 2. To appreciate the potential impact of poor RTQA practices on clinical
about detected injuries. trials.
3. To consider best practice in multi-centre RTQA for clinical trials.
A-0438 16:55
C. Interventional radiology in trauma: diagnosis and management 17:20
T. Jargiello; Lublin/PL Panel discussion: Preparing our departments for high quality clinical
trials
1. To learn which vascular injuries in solid organs can be treated with
interventional radiology. 15:00 - 16:00 Coffee & Talk 3
2. To become familiar with the imaging findings of great vessel injuries.
3. To understand how vascular injuries can be treated. Coffee & Talk (open forum) Session
17:20
Panel discussion: What is the best CT protocol in the evaluation of C 12
blunt trauma patients? Meet the Editors
16:00 - 17:30 Room Y A-0381/A-0382 15:00
Joint Session of the EFRS and EORTC R.G.H. Beets-Tan; Amsterdam/NL
Y. Menu; Paris/FR
EFRS/EORTC Session Objectives:

1. To interact with the editors-in-chief of the ESR journals.
Radiographers: at the heart of cancer 2. To discuss all elements of scientific peer review.
3. To understand what to consider when submitting a manuscript.
treatment and research 4. To learn how to respond to referees‘ comments.
Moderators: 5. To become familiar with critical reviews.
M. Smits; Rotterdam/NL A-0383 15:05
How to „polish“ a manuscript submission
A-0439 16:00 Y. Menu; Paris/FR
An overview of the roles of radiographers in research
J. McNulty; Dublin/IE Learning Objectives:
1. To learn the importance of the cover letter.
Learning Objectives: 2. To understand how the title and key points are instrumental in
1. To understand how professional development is supporting the drawing the reader‘s attention.
development of radiographer research roles. 3. To become familiar with the optimal construction of the introduction
2. To consider the opportunities for radiographer research. and the discussion.
3. To gain an insight into the impact of radiographer research in 4. To be able to differentiate what should be in the „Material and
improving patient outcomes. Method“ or in the „Results“ sections.
5. To learn how a bibliography should be built and checked.
A-0440 16:20
Establishing the scientific and clinical value of advanced imaging A-0384 15:10
M. Smits; Rotterdam/NL How to reply to reviewers‘ criticisms
1. To understand the importance of imaging in supporting oncology Learning Objectives:
research. 1. What to do when the reviewer is right.
2. To learn about the range of trials evaluating imaging techniques. 2. What to do when the reviewer is wrong.
3. To appreciate the importance of team working in enabling effective 3. What to do when the two reviewers disagree.
research. 4. Making the revised manuscript easier to read.
A-0441 16:40 A-0385 15:15

Fostering excellence in radiation oncology research through a clinical How to manage critical reviews
research culture L. Martí-Bonmatí; Valencia/ES
H. McNair; London/UK
Learning Objectives: 1. To understand how critical reviews should be conducted.
1. To understand the barriers and enablers which impact upon delivering 2. To learn how critical reviews are reviewed.
effective research. 3. To be able to manage levels of evidence and recommendations.
2. To learn how clinical departments can utilise the resources already
available with the goal of developing a more confident and competent 15:20
clinician-researcher culture. Open forum discussion
3. To appreciate the importance of patient and professional input into
trial design.

16:00 - 17:30 Room D A-0448 16:23

Cardiovascular applications of 3D printing
Musculoskeletal M. Tam; Southend/UK
RC 810 1. To learn the potential applications for aortic and cardiac diseases to
facilitate decision making.
MR imaging of the knee 2. To appreciate the impact of 3D models for interventional treatment
planning.
Moderator:
3. To understand the value of 3D models for diagnosis and treatment in
M. Tzalonikou; Athens/GR
situations with complex anatomy.
A-0443 16:00 A-0449 16:41
A. Cruciate ligaments: what to know and what to do
Supporting the surgeon with 3D printing
A. Alcalá-Galiano; Madrid/ES
P. Brantner; Basle/CH
1. To describe the normal anatomy and MR imaging appearances of ACL
1. To learn the standardised and the emerging surgical applications of 3D
and PCL and discuss pitfalls.
printing and their dependency on the anatomic complexity.
2. To explain the imaging appearances of ACL and PCL pathology and
2. To appreciate the high potential in customizing and shortening the
discuss imaging sequences and protocols.
workflow of planning, pre-contouring and conducting surgery.
3. To discuss the imaging sequences and protocols relevant to ACL and
3. To understand the potential of 3D printing as an extension of
PCL conditions.
diagnostic imaging with view on patient outcomes.
A-0444 16:30 A-0450 16:59
B. Meniscal tears: obvious and subtle
Challenges of centralised 3D printing
P. Omoumi; Lausanne/CH
K.A. Eley; Cambridge/UK (
Thursday
1. To describe the anatomy of the menisci and the classification of
1. To learn the strategies behind a centralisation of 3D printing.
meniscal tears.
2. To appreciate the potential added value of sharing biomedical print
2. To explain unusual imaging appearances of meniscal tears and
files and other data related to 3D printing.
potential pitfalls.
3. To understand the workflow changes and the potential of quality
control and education in treatment planning with 3D printing support.
A-0445 17:00
C. Looking around the corners: posteromedial and posterolateral
17:17
U. Aydingoz; Ankara/TR
Panel discussion: What are real advantages of 3D printing?
1. To describe the anatomical structures of the posteromedial and 16:00 - 17:30 Room K
posterolateral corners of the knee.
2. To explain the imaging appearances of pathological conditions that Special Focus Session
affect the posteromedial and posterolateral corners of the knee.
16:00 - 17:30 Room G SF 8b

Challenging HRCT patterns: tips and
tricks from the experts
SF 8f A-0451 16:00
The 3D printing lab from bench to J. Babar; Cambridge/UK
bedside Session Objectives:
1. To understand HRCT patterns in relation to the anatomy of the
A-0446 16:00 secondary pulmonary lobule and small airways.
2. To revise the causes and pathologies of various HRCT patterns with
case based examples and image interpretation pearls.
Session Objectives: 3. To revise how the pattern and distribution of disease helps in
1. To understand the requirements for building a 3D printing lab. formulating a differential diagnosis.
2. To learn the assessment of the impact of 3D printed models for
cardiovascular interventions. A-0452 16:05
3. To understand the value of customising surgical tools and prostheses The mosaic attenuation pattern
and to inform the patient. M.-P. Revel; Paris/FR
4. To become familiar with the management changes due to centralised
3D printing.
1. To understand the pathophysiology of mosaic attenuation pattern.
2. To revise the common causes.
A-0447 16:05 3. To discuss the common pitfalls in diagnosis.
Creating a 3D printing lab in radiology
F. Moscato; Vienna/AT
A-0453 16:20
Learning Objectives: Inter-and intralobular septal thickening
1. To learn the principles of 3D printing in terms of printer technology, N. Sverzellati; Parma/IT
methods, properties of printed material and other requirements when
planning a 3D lab.
1. To understand the pathophysiology of this pattern.
2. To appreciate and specify the role of radiologists in image planning
during the 3D printing process.
3. To understand the correlation of spatial resolution and other image
quality parameters among 3D printing, 3D and 2D visualisation.

A-0454 16:35 16:00 - 17:30 Room M 2

Approach to nodular pattern
O. Hamer; Regensburg/DE Paediatric
1. To understand the pathophysiology of this CT pattern.
RC 812
3. To discuss the common pitfalls in diagnosis. Predicting fracture risk in children
A-0455 16:50 A-0460 16:00
Perilobular consolidation Chairperson‘s introduction
T. Frauenfelder; Zurich/CH K. Halliday; Nottingham/UK
1. To understand the pathophysiology of this CT pattern. 1. To learn the diverse factors that may influence fracture risk in the
2. To revise the common causes. paediatric population.
2. To understand the role of the various techniques in predicting fracture
A-0456 17:05 risk in children.
Mixed ground-glass opacification and reticulation 3. To discuss the limitations of the different techniques.
S.J. Copley; London/UK
A-0461 16:05
A. Radiographs and DXA
1. To understand the pathophysiology of this combined CT pattern.
R.A.J. Nievelstein; Utrecht/NL
3. To discuss the common pitfalls in diagnosis. Learning Objectives:
1. To learn about the principles for the technique.
17:20 2. To understand the potential for use.
Questions and panel discussion: The reality of daily practice - what do 3. To discuss the limitations.
experts struggle with on interpretation of HRCT?
A-0462 16:23
16:00 - 17:30 Room M 1 B. Quantitative ultrasound
H.-J. Mentzel; Jena/DE
Molecular Imaging
1. To learn about the principles for the technique.
RC 806 2. To understand the potential for use.
3. To discuss the limitations.
Merging the best: hybrid imaging
G. Antoch; Düsseldorf/DE C. Bone quantification with MRI
C. Rajapakse; Philadelphia, PA/US
A. Hybrid imaging with SPECT/CT 1. To learn about the principles for the technique.
A. Scarsbrook; Leeds/UK 2. To understand the potential for use.
3. To discuss the limitations.
1. To learn the basic principles of hybrid SPECT/CT imaging.
2. To understand what complementary information can be provided by A-0464 16:59
SPECT/CT. D. CT (including HRpQCT)
3. To learn the clinical applications of SPECT/CT. A.C. Offiah; Sheffield/UK
A-0458 16:30 1. To learn about the principles for the technique.
B. Hybrid imaging with PET/MRI 2. To understand the potential for use.
F.M.A. Kiessling; Aachen/DE 3. To discuss the limitations and disadvantages of this technique.
1. To learn the basic principles of hybrid PET/MRI. 17:17
2. To understand what new information can be provided by PET/MRI. Panel discussion: Can we really predict fracture risk in children?
3. To learn about emerging clinical applications of PET/MRI.
16:00 - 17:30 Room M 3
A-0459 17:00
C. Hyperpolarised MRI Oncologic Imaging
F.A. Gallagher; Cambridge/UK
1. To learn the basic principles of hyperpolarisation.
RC 816
2. To understand what new information can be provided by Multidisciplinary approach to cancer care
hyperpolarised MRI.
3. To learn about oncological and non-oncological applications of A-0465 16:00
hyperpolarised MRI. Chairperson‘s introduction
R.H. Oyen; Leuven/BE
Session Objectives:
1. To learn about the role of the radiologist in the multidisciplinary team
for soft tissue, colorectal and breast tumours.
2. To understand the relevant questions from the team and how they can
be answered with imaging.
3. To review current multidisciplinary approaches and potential
difficulties.

A-0466 16:05 A-0472 17:02

A. The soft tissues team C. Rendu-Osler and Behcet‘s diseases
E. Khristenko; Heidelberg/DE B. Peynircioglu; Ankara/TR

1. To learn about the role of the radiologist in the evaluation, treatment 1. To become familiar with the CT manifestations of these diseases.
planning and follow up of soft tissue tumours. 2. To identify imaging features determining outcome and treatment
2. To understand the relevant questions from the team and how they can strategies.
be answered with imaging. 3. To learn about endovascular treatment modalities and complications.
3. To review current multidisciplinary approaches: how we do it in our
institution.
16:00 - 17:30 Room M 5
A-0467 16:28 E3 - ECR Academies: Functional Imaging for Disease
B. The colorectal team
Management: Research to Medical Practice
1. To learn about the role of the radiologist in the evaluation, treatment E3 820
planning and follow up of colorectal tumours.
2. To understand the relevant questions from the team and how they can
Functional imaging of breast and female
be answered with imaging. pelvis
3. To review current multidisciplinary approaches: how we do it in our
institution. A-0473 16:00
A-0468 16:51 K. Kinkel; Chêne-Bougeries/CH
C. The breast team
C.K. Kuhl; Aachen/DE A-0474 16:06
A. Breast tumours
Thursday
J. Camps Herrero; Valencia/ES
1. To learn about the role of the radiologist in the evaluation, treatment
planning and follow up of breast tumours. Learning Objectives:
2. To understand the relevant questions from the team and how they can 1. To review actual functional methods of breast imaging.
be answered with imaging. 2. To learn about functional biomarkers of tumour grading.
3. To review current multidisciplinary approaches: how we do it in our 3. To understand functional approach of tumour response.
institution.
A-0475 16:34
17:14 B. Tumours of the uterus
Panel discussion: Does the current multidisciplinary approach need E. Sala; Cambridge/UK
changes?
1. To review functional methods for female pelvic imaging.
16:00 - 17:30 Room M 4 2. To learn about functional impact for characterising uterine tumours.
E3 - ECR Academies: Chest Imaging
A-0476 17:02
E3 822 C. Ovarian tumours
A.G. Rockall; London/UK
CT and intervention in vascular Learning Objectives:
pulmonary diseases 1. To learn how functional methods help in characterising ovarian
tumours.
A-0469 16:00 2. To review their role for patient management.
Chairperson‘s introduction 3. To be aware of validated biomarkers of prognosis.
J.D. Dodd; Dublin/IE
A-0470 16:06
A. CT imaging of pulmonary hypertension Multidisciplinary Session
N.J. Screaton; Cambridge/UK
1. To learn about the CT signs of pulmonary hypertension (PHT).
MS 8a
2. To become familiar with the current classification of PHT. The „prostate unit“ at work
3. To be aware of the imaging features suggesting a thromboembolic
origin. A-0477 16:00
Chairperson‘s introduction: My PSA is elevated...what now?
A-0471 16:34 G.M. Villeirs; Ghent/BE
B. Evaluating the pulmonary vasculitis
E. Castañer; Sabadell/ES Session Objectives:
1. To understand the role of imaging in the diagnosis and management
Learning Objectives: of prostate cancer.
1. To learn the common imaging features of granulomatosis with 2. To become familiar with the various treatment options for prostate
polyangitis (GPA). cancer.
2. To learn how to differentiate between GPA and eosinophilic 3. To appreciate the role of multidisciplinary discussions.
granulomatosis with polyangiitis (Churg-Strauss).
3. To learn about the imaging features and differential diagnosis of A-0
pulmonary haemorrhage.

478 16:05 A-0388 16:10

The radiologist: non-invasive explorer of the prostatic realm Women leaders through the lens of time
P. De Visschere; Ghent/BE C. Hess; San Francisco, CA/US

1. To become familiar with the technique of mpMRI of the prostate. 1. To understand the most important changes and similarities in women‘s
2. To understand the role of mpMRI in the detection of clinically leadership over time.
significant prostate cancer. 2. To review skills and environmental factors that may influence one‘s
3. To appreciate the importance of image-targeted biopsy. career.
3. To understand the challenges of double-career-couples and work-life
A-0479 16:25 (family) balance.
The pathologist: guardian of the truth 4. To appreciate the impact of modern social media on (female)
S. Verbeke; Ghent/BE leadership.

1. To appreciate the importance of good tissue sampling. Panel discussion: How far have we come?
2. To become familiar with the different histological subtypes of prostate U.I. Attenberger1, C. Hess2, R. Kubik-Huch3, E.A. Morris4, M.F. Reiser5,
cancer. V. Vilgrain6; 1Mannheim/DE, 2San Francisco, CA/US, 3Baden/CH,
3. To understand the reasons for false positive and false negative results. 4
New York, NY/US, 5Munich/DE, 6Paris/FR
A-0480 16:40
The urologist: knight of swords in the prostatic badlands
N. Lumen; Ghent/BE
1. To understand the role of imaging in the choice for prostatectomy.
2. To become familiar with open and robotic prostatectomy techniques.
3. To appreciate the importance of imaging in the preservation of clear
margins.
A-0481 16:55
The radiation-oncologist: smooth irradiator of the rogue elements
V. Fonteyne; Ghent/BE
1. To become familiar with the various prostate irradiation techniques.
2. To appreciate the need for imaging in radiotherapy planning.
3. To illustrate the importance of imaging in radiotherapy monitoring.
A-0482 17:10
Multidisciplinary case presentation and discussion
15:45 - 17:00 The Church

WF 2
Changing the image of women in
leadership: generational differences and
similarities
A-0386 15:45
A-0387 15:50
Women in medicine: past, present and future
1. To appreciate the impact of generational differences and similarities in
women.
2. To understand the key factors of success in academic radiology.
3. To learn how to balance a career and family.
4. To discuss the impact of globalisation and cultural differences in
different European and Non-European countries over time.

08:30 - 10:00 Room A A-0488 09:21

C. Bowel
E3 - ECR Academies: Interactive Teaching Session for Young D.J.M. Tolan; Leeds/UK
(and not so Young) Radiologists Learning Objectives:
1. To learn about the most common types of major oesophago-gastric,
small bowel and colorectal surgical procedures and the expected
E3 921 postoperative anatomy and imaging findings.
Cardiac imaging 2. To understand how to optimise imaging protocols to maximise the
opportunity to detect postoperative complications after enteric surgery.
3. To appreciate and identify early and late complications after bowel
A-0483 08:30 surgery.
A. Grown-ups with congenital heart disease
A.M. Taylor; London/UK
09:44
Learning Objectives: Panel discussion: Tips and tricks for my routine clinical practice
1. To be familiar with the clinical and radiologic presentations of these
patients.
08:30 - 10:00 Room C
A-0484 09:15
B. Imaging cardiac valves
R. Salgado; Antwerp/BE SF 9b
Learning Objectives: Clinical simulation and its role in
1. To understand the impact of imaging.
2. To know the limitations and potential pitfalls of CT and MR radiography education
techniques.
3. To learn about the imaging technique. A-0489/A-0490 08:30
08:30 - 10:00 Room B F. Zarb; Msida/MT
Abdominal Viscera Session Objectives:
1. To review the evolution of training and radiology education in Europe.
2. To evaluate the challenges facing radiology education with the
RC 901 expanding use of informatics.
3. To analyse how clinical simulation methods can transform education
Imaging of the complicated in radiology.
postoperative abdomen
A-0491 08:35
A-0485 08:30 Clinical radiography education across Europe: an overview
Friday
Chairperson‘s introduction J. McNulty; Dublin/IE
C.J. Zech; Basle/CH
Session Objectives: 1. To present the developments of radiography education.
1. To learn about the most common indications for abdominal surgery. 2. To discuss the current status of radiography education in Europe.
2. To understand the normal imaging findings in a postoperative 3. To evaluate the challenges and future of radiography education.
abdomen.
3. To describe and identify the most common postoperative A-0492 08:50
complications. Innovation in education: virtual education/computer-based simulator
vs patient imaging
A-0486 08:35 A. England; Salford/UK
A. Liver
C. Ayuso; Barcelona/ES Learning Objectives:
1. To demonstrate the benefits of using new teaching approaches.
Learning Objectives: 2. To show how new teaching instruments can improve and shorten the
1. To learn about indications for liver interventions and different surgical learning curve.
approaches to focal liver lesions. 3. To evaluate the pros and cons of radiography education through
2. To understand the role for the different imaging techniques (US, simulation and patient imaging.
CEUS, CT and MRI) in assessing different types of complications.
3. To appreciate the spectrum of parenchymal, biliary and vascular A-0493 09:05
complications occurring after liver resection or transplantation. High fidelity: clinical simulation for undergraduate radiography
A. Louw; Johannesburg/ZA
A-0487 08:58
B. Pancreas Learning Objectives:
R.M. Gore; Evanston, IL/US 1. To discuss ethics in simulation practices.
2. To provide an overview on how to prepare and execute a simulation
Learning Objectives: experience.
1. To learn about the various surgical approaches for acute and chronic 3. To highlight the challenges and opportunities of clinical simulation at
pancreatitis, benign and malignant pancreatic neoplasms. the undergraduate level.
2. To understand the profound impact that the partial and complete
pancreatectomy have on the adjacent abdominal organs. A-0494 09:20
3. To appreciate the common postoperative complications of pancreatic How simulation can help prepare students and have a positive impact
surgery. on interprofessional working
A. Henner; Oulu/FI
1. To demonstrate how interprofessional collaborations improve a service
to patients.
2. To describe clinical team skills training in formative summative
simulations.
3. To discuss the benefits of student preparation through simulation.

A-0495 09:35 A-0500 09:15

Providing opportunities for practical ultrasound training MR-based functional imaging
B. Kraus; Vienna/AT R.G.H. Beets-Tan; Amsterdam/NL

1. To know the role of hands-on training in ultrasonography. 1. To learn about functional MRI.
2. To appreciate the value of learning ultrasonography through hands on 2. To appreciate its value as the guidance of radiation treatment.
training. 3. To understand the synergy of an interdisciplinary collaboration
3. To discuss the opportunities for radiographers training in ultrasound. between radiologists and radiation oncologists.
09:50 A-0501 09:35

Panel discussion: Is simulation enough to meet the current challenges Adaptive workflow: current status and challenges
facing radiography education? Can simulation replace hands-on S. Kharuzhyk; Minsk/BY
patient experience?
1. To understand the role of image-guidance in adaptive radiotherapy.
08:30 - 10:00 Room X 2. To become familiar with the advantages of MRI guidance compared to
CBCT guidance.
Joint Session of the ESR and ESTRO 3. To learn principles of real-time MRI guidance in radiotherapy.
4. To discuss the current state and further perspectives of MR-guided
ESR/ESTRO adaptive radiotherapy.
Current status and future challenges in 09:55

Panel discussion: We need more integration than originally thought:
MR-integrated radiotherapy how to get there?
A-0496/A-0497 08:30 10:00 - 11:00 Coffee & Talk 1

L.E. Derchi; Genoa/IT Coffee & Talk (open forum) Session
U. Ricardi; Turin/IT
This session is dedicated to the building of stronger relationships between

diagnostic radiology and radiation therapy specialists. Diagnostic C 27
radiologists must be aware of the technical advances of radiotherapy and
oncology and have to learn how to provide expert support to patients
How to enhance the role of junior
undergoing radiation therapy. Knowledge of technological advances radiologists in Europe
is the first thing to get; changes of our working habits is the second,
through the development of new examination techniques to meet the A-0575 10:00
clinical needs of these patients; dialog between the different specialists Chairperson‘s introduction
is the third, and most important one. This session will be repeated at the C. Catalano; Rome/IT
next meeting of the European Society for Radiotherapy and Oncology
(ESTRO). This indicates that both Societies believe that working together, A-0576 10:05
and growing together, is quite important to ensure optimal patient care. The beauty of Europe: my Erasmus+ experience and my thesis abroad
Session Objectives:
1. To be aware of the technical advances in radiotherapy and oncology. Learning Objectives:
2. To know how diagnostic radiologists have to provide expert support 1. To learn how to start during medical school.
to patients undergoing radiation therapy. 2. To understand how to get involved in a research project.
3. To understand how to develop strong clinical collaboration between 3. To appreciate the advantages of preparing a collaboration thesis.
the two specialities.
A-0577 10:15
A-0498 08:35 My ESOR experience in the United States
Clinical status of MR-integrated photon therapy L.A. Carbonaro; San Donato Milanese/IT
L. Boldrini; Rome/IT
Learning Objectives: 1. To learn about the conditions of a research fellow in the United States.
1. To learn about the current clinical status of the MR-integrated photon 2. To understand the usefulness of a clinical expertise in a research
therapy. fellowship.
2. To understand the most common clinical applications of the MR- 3. To appreciate the knowledge networks acquired during a fellowship in
integrated photon therapy. an international centre.
3. To appreciate the possibilities of hypothesis-generating approaches
with this new technology (movement management, radiomics, new A-0578 10:25
delivery techniques). I love ESOR: my 1 year fellowship
4. To become familiar with the clinical MR-integrated photon therapy M. Lisitskaya; Aalborg/DK
workflow, from patient selection to therapy delivery.
A-0499 08:55 1. To learn about ESR and ESOR opportunities for trainees.
Integration of MR and particle therapy: how far are we 2. To understand the importance of research during training.
A. Hoffmann; Dresden/DE 3. To learn how to start abroad and continue at home.

1. To learn about the current state-of-the-art in image-guided proton Open forum discussion
therapy.
2. To understand the rationale for the need to integrate MRI and proton
therapy.
3. To become familiar with the technical risks and challenges to integrate
MRI and proton therapy.
4. To appreciate which risks and challenges have been overcome by
recent research efforts.
5. To discuss the technology issues that need further research.
6. To become familiar with the implications for future developments and
clinical treatment workflow.

08:30 - 10:00 Room N 08:30 - 10:00 Room O

PIER @ ECR Session (Jointly organised with the ESR eHealth Vascular
Subcommittee)
RC 915
PI 1 Carotid disease 2.0
Reporting and communication today Moderator:
P. Haage; Wuppertal/DE
and tomorrow: challenges to implement
structured reporting (RS) and deal with A-0508 08:30
A. Carotid plaque imaging: tool or fool?
artificial intelligence (AI) L. Saba; Cagliari/IT
A-0502/A-0503 08:30 Learning Objectives:

Chairpersons‘ introduction 1. To learn about radiological methods to analyse carotid plaque
A. Brady; Cork/IE morphology.
E. Neri; Pisa/IT 2. To critically review the influence of plaque morphology on actual
treatment guidelines.
Session Objectives: 3. To discuss the possible future role of carotid plaque imaging for
1. To understand what is meant by structured reporting in the context of treatment decision making.
the likely future of radiology.
2. To appreciate the requirements for and potentialities of radiology A-0509 09:00
structured reporting. B. Carotid involvement in inflammatory arterial disease
3. To learn about the role of structured reporting in communication with M. Edjlali; Paris/FR
referrers and patients.
A-0504 08:36 1. To provide an overview about inflammatory arterial disease.
Update on developments for structured reporting: Radreport 2.0, 2. To become familiar with involvement of supraaortic arteries in
TLAP, MRRT inflammatory arterial disease.
P. Mildenberger; Mainz/DE 3. To learn about Radiological diagnosis of supraaortic involvement in
inflammatory arterial disease.
1. To learn about new concepts for supporting structured reporting. A-0510 09:30
2. To appreciate the opportunities of consensual templates based on C. Carotid stent: medical history or part of the future?
international standards. K. Hausegger; Klagenfurt/AT
3. To become familiar with the template repository.
A-0505 08:52 1. To learn about the technique of carotid stent implantation.
The concept of common data elements (CDE) for reporting 2. To review current indications for carotid stent implantation.
Friday
C.E. Kahn; Philadelphia, PA/US 3. To discuss the future role of carotid stent implantation.
1. To learn about the difference of templates and CDE. 08:30 - 10:00 Studio 2019
2. To appreciate the flexibility of CDE.
3. To understand how to use CDE in a SR-solution.
A-0506 09:08
Decision support and artificial intelligence (AI) to improve reporting
SF 9a
in radiology Pain palliation in cancer patients
T.K. Alkasab; Boston, MA/US
A-0511 08:30
1. To learn about the next steps for IT-support in reporting.
A. Gangi; Strasbourg/FR
2. To appreciate the opportunities for quality improvement.
3. To understand the concept of how to implement AI-support in a SR- Session Objectives:
solution. 1. To learn about the percutaneous pain palliation techniques in cancer
patients.
A-0507 09:24 2. To learn about pain evaluation and clinical selection of the patients.
Communication with referring physicians and patients: what is 3. To learn about when to propose these methods during an MDT.
relevant?
J.M.L. Bosmans; Ghent/BE A-0512 08:35
Pain from bone metastases
G. Tsoumakidou; Strasbourg/FR
1. To learn about communication pitfalls.
2. To appreciate the potential of SR in communication with referrers and Learning Objectives:
patients. 1. To learn about the indications and techniques of MSK tumours pain
3. To become familiar with best practice examples. palliation.
2. To learn about patient selection and clinical and imaging follow up.
09:40 3. To learn about the indication of consolidation techniques.
Panel discussion: How to use structured reporting and artificial 4. To become familiar with how to promote interventional procedure in MDT.
intelligence in reporting
A-0513 08:58
Abdominal pain management with minimally invasive techniques
D.C. Madoff; New York, NY/US
1. To learn about the indication and patient selection.
2. To learn the techniques of pain palliation in abdominal cancer.
3. To learn about patient and clinical follow up, complication
management and pain evaluation.
4. To become familiar with how to promote interventional procedure in MDT.

A-0514 09:21 08:30 - 10:00 Room E2

Pelvic pain management with minimally invasive techniques
B. Kastler; Paris/FR Neuro
1. To learn about the indication and patient selection.
2. To learn the techniques of pain palliation in pelvic pain in cancer
RC 911
patients. Update on cerebrospinal fluid (CSF)
3. To learn about patient and clinical follow up, complication
management and pain evaluation. diseases
4. To become familiar how to promote interventional procedure in MDT. Moderator:
Z. Merhemic; Sarajevo/BA
09:44
Panel discussion: How to integrate the interventional radiologist in the A-0519 08:30
„palliative care“ team? A. Imaging strategies for hydrocephalus
C.A.J. Romanowski; Sheffield/UK
08:30 - 10:00 Room E1 Learning Objectives:
1. To learn about different types of hydrocephalus and how to distinguish
E3 - ECR Master Class (Emergency Imaging)
them in imaging.
2. To understand the pathophysiology of CSF circulation.
E3 926 3. To appreciate MR imaging techniques for diagnosing abnormalities of
the CSF flow.
Post-treatment emergencies in oncologic
A-0520 08:53
patients B. Diagnosis and treatment of intracranial hypotension
E. Papadaki; Iraklion/GR
A-0515 08:30
Chairperson‘s introduction: The role of imaging in the early detection Learning Objectives:
of complications in oncologically treated patients 1. To learn about the underlying pathophysiology of spontaneous
D.R. Kool; Amsterdam/NL intracranial hypotension (SIH).
2. To understand imaging strategies for this condition.
Session Objectives: 3. To clarify myths and misperception of intracranial hypotension.
1. To learn about different approaches in modern tumour therapy.
2. To understand the radiological appearance of complications following A-0521 09:15
treatment in oncologic patients. C. RCVS, PRES and others
3. To appreciate the role of different imaging modalities in further F. Bonneville; Toulouse/FR
management of patients.
A-0516 08:35 1. To learn about the current controversial mechanism of posterior
A. Chest reversible encephalopathy syndrome (PRES).
H. Prosch; Vienna/AT 2. To understand therapeutic and prognostic implications of PRES and
reversible cerebral vasoconstriction syndrome (RCVS) diagnosis.
Learning Objectives: 3. To appreciate imaging features of PRES, RCVS and their differentials.
1. To become familiar with the modern approach to malignant chest
tumour therapy. A-0522 09:38
2. To learn how to differentiate clinically important complications. D. Hypertension-associated brain changes
3. To understand how to look for the early signs of severe and urgent A. Krainik; Grenoble/FR
conditions.
A-0517 09:00 1. To understand the causes of intracranial hypertension.
B. Abdomen 2. To understand the threats of intracranial hypertension on central
R. Basilico; Chieti/IT nervous system and arterial integrity.
3. To recognise intracranial hypertension and its complications on CT
Learning Objectives: and MR.
1. To learn about different therapies used in abdominal tumours.
2. To become familiar with possible complications.
3. To understand the effectiveness of imaging modalities in the 08:30 - 10:00 Room F1
evaluation of emergent complications.
E3 - Rising Stars Programme: Basic Session
A-0518 09:25
C. How can interventional radiologists help in the management of
oncological treatment complications?
BS 9
K.K. Pyra; Lublin/PL Neurologic emergencies
1. To understand the role of interventional radiology in modern tumour J. Walecki; Warsaw/PL
therapy and the complications.
2. To be familiar with interventional techniques used in the treatment of A-0523 08:30
complications of different tumour therapies. Haemorrhagic stroke (SAH)
3. To learn which tumour therapy complications can be treated with C. Calli; Izmir/TR
interventional radiology.
1. To review the most common pathologies leading to SAH.
09:50
2. To present current imaging techniques for evaluation of SAH.
Panel discussion: What is the impact of complications findings on the
3. The role of interventional neuroradiology in SAH.
continued management of oncologic patients?
A-0524 09:00
Ischaemic stroke: diagnosis
M. Taina; Kuopio/FI
1. To become familiar with the most common aetiologies of stroke.
2. To present current imaging techniques for evaluation of stroke.
3. To recognise the imaging signs of stroke.

A-0525 09:30 08:30 - 10:00 Room Y

Ischaemic stroke: treatment
T. van der Zijden; Antwerp/BE E3 - Rising Stars Programme: EFRS Radiographers‘ Basic
Learning Objectives: Session
1. To become familiar with the criteria for the endovascular treatment.
2. To present current methods of the endovascular treatment.
3. To recognise complications of the treatment. BR 9
Career planning
08:30 - 10:00 Room F2
A-0530 08:30
Breast Chairperson‘s introduction: What do new graduates need to look like?
G. Ioannidis; Larissa/GR
RC 902 Session Objectives:

1. To understand how best to prepare your professional profile.
Screening for breast cancer 2. To appreciate the potential for radiographers to work in various
jurisdictions.
A-0526 08:30 3. To consider the utility of professional development planning in
Chairperson‘s introduction achieving your professional goals.
F.J. Gilbert; Cambridge/UK
A-0531 08:35
Session Objectives:
The role of preceptorship in first post-radiography positions
1. To learn about the strengths and weaknesses of different forms of
A. Martin; Manchester/UK
breast cancer screening.
2. To understand the value of the various screening modalities and how Learning Objectives:
they should be used in practice. 1. To understand the value of preceptorship.
3. To recognise that no single screening strategy serves every patient 2. To become familiar with common preceptorship programmes.
equally well. 3. To be aware of how preceptorship programmes can benefits patients,
radiographers and health care institutions.
A-0527 08:35
A. Screening with mammography and digital breast tomosynthesis A-0532 08:58
alone Practising radiography around the world
R.M. Pijnappel; Utrecht/NL C. Buissink; Groningen/NL
1. To learn about the benefits and limitations of population-based 1. To be aware of the potential to use your radiography qualification in
mammography screening. various jurisdictions.
2. To become familiar with the advantages and disadvantages of digital 2. To consider barriers to practicing as a radiographer abroad.
breast tomosynthesis. 3. To appreciate the potential for charitable/voluntary work in
3. To appreciate sources of error in mammography screening. developing countries.
Friday
A-0528 09:00 A-0533 09:21
B. Combined screening with mammography and ultrasound The importance of professional registration and CPD
T.H. Helbich; Vienna/AT L.A. Rainford; Dublin/IE
1. To learn about the added value of ultrasound in screening and its 1. To understand the importance of professional development
indications. planning for radiographers in maintaining, developing and improving
2. To become familiar with the current level of evidence for screening radiographer competencies.
with ultrasound. 2. To be aware of the essential role of CPD and further education for
3. To appreciate the role of ultrasound in clinical practice. radiographers.
3. To appreciate the importance of professional registration.
A-0529 09:25
C. Personalised multimodality screening with MRI 09:44
U. Bick; Berlin/DE Panel discussion: My best career advice
1. To learn about multimodality screening strategies for high-risk 08:30 - 9:30 Coffee & Talk 3
patients.
2. To become familiar with the difficulties in predicting individual breast Coffee & Talk (open forum) Session
cancer risk.
3. To appreciate the careful balance of risks and benefits in MRI-based
screening. C 13
09:50
Value in radiology in theory and practice
Panel discussion: What is the best approach to screen for breast
cancer?
A-0534 08:30
Session Objectives:
1. To understand the concept of value in radiology.
2. To learn about the challenges of developing a concept of value-based
radiology.
3. To learn about experiences with value-based approaches in practice.

A-0535 08:35 08:30 - 10:00 Room D

Artificial intelligence and value-based healthcare
P. Algra; Heiloo/NL Musculoskeletal
1. To learn about the Value Based Healthcare Center‘s implementation of
value-based healthcare.
RC 910
2. To understand the practical challenges of organising healthcare Inflammatory and infectious diseases
delivery based on value.
3. To understand the administrative, managerial and financial processes of the spine: how to differentiate from
of VBHC in practice.
degeneration
A-0536 08:40 Moderator:
What do patients value? J.L. Bloem; Leiden/NL
J. Birch; Poole/UK
A-0541 08:30
Learning Objectives: A. Spondyloarthritis: a diagnostic chameleon
1. To learn about the results of the ESR patient survey on VBR. V. Zubler; Zurich/CH
2. To understand what matters most to patients.
3. To learn how VBR concepts (fail to) address patients‘ concerns. Learning Objectives:
1. To explain the pathophysiology and disease spectrum of
A-0537 08:45 spondyloarthritides.
Value-based pay models for radiology 2. To describe the imaging findings of spondyloarthritides.
V.M. Rao; Philadelphia, PA/US
A-0542 09:00
Learning Objectives: B. Crystals: may also affect the spine
1. To learn about the status quo of value-based pay and reimbursement P.J. O‘Connor; Leeds/UK
models.
2. To understand the challenges in monetising „value“. Learning Objectives:
3. To learn about the differences between value- and volume-based pay 1. To explain the pathophysiology and disease spectrum of crystal
models. deposition diseases that affect the spine.
2. To describe the imaging findings of crystal deposition diseases that
A-0538 08:50 affects the spine.
Quantity vs quality? Different aspects of the value equation
L. Lawler; Wellington/NZ A-0543 09:30
C. Infection: imaging, indication and techniques for biopsy
Learning Objectives: J.-L. Drapé; Paris/FR
1. To learn about the quantitative and qualitative aspects of VBR.
2. To understand the difficulty of measuring extra-clinical aspects of Learning Objectives:
radiological services for patients. 1. To describe the imaging findings of spinal infection.
3. To learn about VBR as both a measurable and normative approach to 2. To explain the biopsy indication and techniques in spinal infection.
patient care.
08:30 - 10:00 Room G
A-0539 08:55
Value of radiology: the Canadian perspective Joint Session of the ESR and EFOMP
E. Lee; Langley, BC/CA
1. To be familiar with the challenges facing healthcare delivery in Canada.
ESR/EFOMP
2. To understand the value of radiology from a quantitative perspective Medical imaging and emerging issues in
within the Canadian healthcare system.
3. To be familiar with the key stakeholders and target audiences that can occupational radiation exposure
influence the radiology practice and improved patient care. Moderators:
A-0540 09:00 W.R. Jaschke; Innsbruck/AT
VBR concepts around the globe: similarities and contrasts
J.A. Brink; Boston, MA/US A-0544 08:30
Is fear of radiation-induced occupational cancer irrational?
P. Vock; Spiegel/CH
1. To understand the different approaches to VBR internationally.
2. To learn about the differences in practical implementations of VBR Learning Objectives:
concepts. 1. To learn how occupational dose limits have been established by ICRP
3. To understand the importance of professional societies in promoting to reduce the probability of stochastic effects.
best (value-based) practices. 2. To appreciate the order of magnitude of additional risk of cancer
induced by occupational exposures.
09:05 3. To understand how these risks should be properly communicated to
Open forum discussion: International perspectives on value in workers.
radiology
A-0545 08:50
Eye lens radiation dose and cataractogenesis
1. To become familiar with published data on lens opacities among
interventionalists.
2. To discuss current methods for monitoring of eye lens doses.
3. To learn how effectively lead glasses protect the eyes of interventional
radiologists.

A-0546 09:10 09:44

Occupational exposure from interventional radiology procedures: how Panel discussion: What do radiologists need to better manage
to measure it, how to reduce it pulmonary nodules?
W.R. Jaschke; Innsbruck/AT

1. To learn which technical factors contribute to occupational exposures MT
from interventional radiology procedures. ESHI Session
2. To appreciate that optimisation of a patient‘s exposure is a way to
also reduce occupational exposure.
3. To understand additional means to reduce the occupational ESHI(MT) 2
exposures. Artificial intelligence in hybrid imaging
Moderators:
Selection and usage of personal protective equipment in the
fluoroscopy and interventional radiology operating room
A-0552 08:30
Learning Objectives: Radiomics+: prediction model using convergent data
1. To learn which personal protective equipment is needed for specific A. Leimgruber; Lausanne/CH
radiological practices.
2. To become familiar with occupational dose reduction provided by Learning Objectives:
personal protective equipment. 1. The discuss the omics revolution and the different techniques used in
3. To understand that a correct selection, use and periodic check radiomics and radiomics+.
of personal protective equipment are needed to ensure radiation 2. To present trends in radiomics.
protection of healthcare personnel. 3. To understand personalised medicine initiatives by the example:
where does radiomics+ fit in?
09:50
Panel discussion: Has the optimisation of occupational radiation A-0553 08:50
exposure in radiology procedures reached a plateau? AI and Holomics: predicting the truth from hybrid imaging and non-
imaging data
I. Buvat; Orsay/FR
08:30 - 10:00 Room K
Chest 1. To get an overview about shallow and deep learning.
2. To appreciate supervised, unsupervised and reinforcement learning
with examples.
RC 904 3. To learn about Holomics: a holistic approach for precision medicine,
concept and examples.
Lung nodule management in 2019
A-0554 09:10
A-0548 08:30 Sharing is caring: on the need for open research data
Friday
Chairperson‘s introduction O. Ratib; Geneva/CH
A. Devaraj; London/UK
Session Objectives: 1. To give an introduction to new concepts of Open Research Databases
1. To avoid common errors in nodule categorisation or measurement. and Big-Data repository and their impact on development of new
2. To summarise the recent knowledge about nodule management. paradigm of data-driven patient management and personalised
3. To understand the place of risk prediction models. healthcare.
2. To understand the underlying challenges and requirements as well as
A-0549 08:35 the ethical and legal framework that regulates the setup and usage of
A. Radiological assessment large collection of patient data for open research.
T. Frauenfelder; Zurich/CH 3. To review of potential applications in molecular imaging and in
support of multi-centric clinical trials.
1. To learn how to recognise false nodules.
2. To learn how to classify lung nodules as solid, part solid or non-solid.
09:35
Panel discussion: AI in HI: incremental value or feeding the data
3. To be aware of the typical and atypical characteristics of perifissural
explosion?
opacities.
A-0550 08:58 08:30 - 10:00 Room M 2

B. Computer-aided diagnosis and AI perspective
A.R. Larici; Rome/IT E3 - ECR Academies: Radiology Leaders‘ Bootcamp
1. To review the capabilities and limitation of CAD for the detection of
lung nodules.
E3 918
2. To learn about the performance of AI in the detection and Captain‘s dashboard
characterisation of lung nodules.
3. To understand the basic concepts of machine learning as applied to A-0555 08:30
imaging. Chairperson‘s introduction
4. To summarise currently available machine learning techniques in S. Morozov; Moscow/RU
radiology.
A-0556 08:36
A-0551 09:21 A. Fundamentals of imaging management and administration
C. Management guidelines B. Bijan; Sacramento, CA/US
A.A. Bankier; Boston, MA/US
Learning Objectives: 1. Strategy for a radiologist in a changing healthcare landscape.
1. To review the incidentally-found nodule management guidelines. 2. How to leverage a physician‘s role by learning managerial skills.
2. To become familiar with the LungRADS classification of screen- 3. Setting a goal, making it doable, prioritising, focusing and choosing
detected nodules. what not to do.
3. To learn about Brock and Herder and other prediction models for
evaluating the malignancy risk.

A-0557 09:04 08:30 - 10:00 Room M 4

B. Being in a driver‘s seat and managing by objectives
Y. Menu; Paris/FR E3 - ECR Academies: Chest Imaging
1. Definition of a workflow, roles and results.
2. Balanced scorecard, KPIs, dashboard and PDCA instruments for a
E3 922
radiology department. Chronic obstructive pulmonary disease
3. IT solutions for automating and increasing efficiency.
(COPD)
A-0558 09:32
C. Challenging the status quo and making new things happen A-0564 08:30
P.M.A. van Ooijen; Groningen/NL Chairperson‘s introduction
D. Litmanovich; Boston, MA/US
1. Leading the changes against the wind: principles of change A-0565 08:36
management. A. CT phenotyping and visual assessment
2. Project management and new instruments, including Scrum, Agile. P.A. Grenier; Paris/FR
3. Value-based service: new frontiers in medical imaging.
1. To learn about imaging-based phenotypes.
08:30 - 10:00 Room M 3 2. To understand the limitations of visual assessment.
Paediatric
A-0566 09:04
B. Quantitative imaging biomarkers
RC 912 J.B. Seo; Seoul/US
Foetal and neonatal imaging pearls Learning Objectives:

1. To understand the role of quantitative imaging in identifying COPD
A-0559 08:30 phenotypes.
Chairperson‘s introduction 2. To appreciate the recent development of quantitative imaging
E. Vázquez; Barcelona/ES methods.

1. To learn about the advanced techniques in foetal MRI. C. Is there a role for MRI?
2. To understand some useful applications in brain malformations or M.O. Wielpütz; Heidelberg/DE
acquired injuries.
3. To discuss the main limitations and challenges of foetal MRI. Learning Objectives:
1. To learn about the morphological and functional evaluation achievable
A-0560 08:35 with MRI.
A. Foetal MRI advanced technics 2. To learn about the recent developments in lung MRI.
G. Kasprian; Vienna/AT
08:30 - 10:00 Room M 5
1. To learn about the principles for advanced techniques in foetal MRI. Head and Neck
2. To understand the potential for their use.
3. To discuss the limitations and disadvantages of these techniques.
A-0561 08:53
RC 908
B. Corpus callosum anomalies: pre- and postnatal correlation Head and neck imaging: when does it
C. Garel; Paris/FR
become abnormal?
1. To evaluate the diagnostic accuracy of foetal MRI for diagnosis. N. Thieme; Berlin/DE
2. To compare pre- and postnatal MRI data.
3. To ascertain the outcome in cases of isolated complete or partial A-0568 08:30
agenesis. A. Normative measures in the temporal bone
F. Veillon; Strasbourg/FR
A-0562 09:11
C. Foetal MR imaging of acquired brain pathology Learning Objectives:
P.D. Griffiths; Sheffield/UK 1. To learn about the appearance of the bone in the normal population.
2. To understand the changes in size and shape due to aging.
Learning Objectives: 3. To show some examples of structures which are too large or too small.
1. To learn about the various types of acquired brain pathology in the
foetus. A-0569 09:00
2. To understand the limitations in the comprehension of the underlying B. Normative measures in the orbit
cause. R. Kohler; Sion/CH
3. To discuss about the best estimates of the prevalence of acquired
brain pathology. Learning Objectives:
1. To understand differences in the size and shape of the eye.
A-0563 09:29 2. To learn about the normal appearance and anatomic variations of the
D. Pre- and postnatal congenital cystic renal diseases optic nerve.
M. Cassart; Brussels/BE 3. To discuss normative measures of the soft tissue structures in the orbit.

1. To learn about differential diagnosis of hyperechoic kidneys in C. Anatomical variations in the face and neck
foetuses and children. E. Vassallo; Msida/MT
2. To become familiar with the latest classification of inherited renal
cystic diseases. Learning Objectives:
3. To discuss the limitations of the imaging methods for diagnosis. 1. To gain insight into the great variability of head and neck anatomy.
2. To be able to recognise pseudo lesions.
09:47
Panel discussion: How to overcome the challenges in foetal MRI in
routine and research

08:30 - 10:00 Tech Gate Auditorium A-0580 10:35

Italian emergency network
Genitourinary V. Miele; Florence/IT
RC 907 1. To review the organisation of the emergency system.
2. To highlight the strengths and weaknesses of the emergency network
Imaging strategies in renal tumours regarding epidemiological factors, topographic features and territorial
distribution of resources.
A-0571 08:30 3. To define the possible areas of clinical improvement and
Chairperson‘s introduction organisational effectiveness of the emergency health system.
A-0581 10:55
Session Objectives: Interlude: The sirens: myth or reality?
1. To become familiar with current and emerging renal imaging R. Grassi; Naples/IT
modalities.
2. To learn about the capabilities of renal imaging in diagnosis and A-0582 11:00
staging of renal tumours. Emergency interventional radiology: brain and body
G. Carrafiello; Varese/IT
A-0572 08:35
A. CT, contrast-enhanced ultrasound (CEUS) and MRI: the best out of Learning Objectives:
them 1. To learn about indications.
M. Bertolotto; Trieste/IT 2. To learn about techniques.
3. To discuss literature and personal experiences.
1. To become familiar with the optimal CT and MRI protocols for renal A-0583 11:20
imaging. Interlude: The cyclops: myth or reality?
2. To understand the best choice of CT, CEUS or MRI according to the R. Grassi; Naples/IT
clinical need.
3. To illustrate the advantages and disadvantages of CT, CEUS and MRI. A-0584 11:25
La Radiologia Medica: the role of the journal in an international setting
A-0573 08:58 A. Giovagnoni; Ancona/IT
B. Differential diagnosis of renal masses
N. Grenier; Bordeaux/FR Learning Objectives:
1. To learn about the organisation of the journal as the official organ of
Learning Objectives: the SIRM.
1. To learn about the histologic spectrum of renal tumours. 2. To discuss the strengths and weaknesses of an international, general
2. To understand the capabilities of imaging for renal tumour radiology scientific journal.
characterisation. 3. To consolidate knowledge and to explore future prospects in the
3. To become familiar with functional techniques applied to characterise international editorial scenario.
renal tumours.
Friday
11:45
A-0574 09:21 Panel discussion: How will the radiologists‘ profession evolve?
C. Staging and organ-preserving strategies
P. Asbach; Berlin/DE
10:30 - 12:00 Room N
1. To understand the TNM-staging system for renal tumours. PIER @ ECR Session (Jointly organised with the ESR Audit
2. To become familiar with optimal staging protocols and imaging and Standards Subcommittee)
findings in the staging of renal tumours.
3. To learn about actual organ-preserving strategies.
PI 2
09:44
Panel discussion: How to implement an optimal renal imaging Clinical audit: how to deal with the legal
protocol? and professional requirements
Moderator:
10:30 - 12:00 Room A G. McGinty; New York, NY/US
ESR meets Italy A-0585 10:30

EM 2 D.C. Howlett; Eastbourne/UK
Session Objectives:
From morphology to function 1. To appreciate the various tools available to facilitate effective clinical
Presiding: audit.
L.E. Derchi; Genoa/IT 2. To understand the aims and scope of the BSS.
R. Grassi; Naples/IT 3. To appreciate the potential of peer review and IT/AI to improve quality
in radiology now and in the future.
A-0579 10:30
Introduction: Radiology in Italy A-0586 10:36
C. Bibbolino; Rome/IT ESR‘s concept and tools for clinical audit
K. Drinkwater; London/UK
Session Objectives:
1. To describe the most important features of Italian radiology. Learning Objectives:
2. To reflect on new developments of imaging in Italy and Europe. 1. To understand the potential for improving the effectiveness of clinical
3. To discuss the role and function of a systemic vision of a radiological audit using audit tools.
society. 2. To learn when certain audit tools may be most effective within the
audit pathway.
3. To appreciate the differing audit tools currently available.

A-0587 10:52 A-0593 10:55

Overview on adoption of BSS throughout Europe French experience based on private services
A. Brady; Cork/IE H. Gabriel; Maxeville/FR

1. To learn about the legislative requirement in Europe to engage in 1. To learn about the French CT imaging doses regulation/optimisation
clinical audit. (approach).
2. To appreciate the variations in how this is implemented in different 2. To understand how private medical physicists work with/for local
European countries. imaging departments.
3. To understand how this requirement impacts each individual radiology 3. To appreciate the positive contribution of the multi-sites approach for
department. medical physicists based on a national experience.
A-0588 11:08 11:05

Peer review as key for quality improvement: the US experience Open forum discussion
G. McGinty; New York, NY/US

1. To learn about the path to implement peer review.
2. To appreciate the positive effects of peer review. E3 - ECR Academies: Radiology Leaders‘ Bootcamp
3. To understand the implications for quality improvements.
A-0589 11:24 E3 1018

Can newer IT-developments including artificial intelligence (AI) help to Dream team
improve quality in radiology?
J. Schillebeeckx; Knokke/BE A-0594 10:30
1. To learn about basic-concepts for IT requirements for clinical audit. L. Martí-Bonmatí; Valencia/ES
2. To appreciate the value of IT-support for quality improvement
processes. A-0595 10:36
3. To understand the potential of big-data and artificial intelligence for A. How to find the best people and make them a part of a long-time
quality initiatives. success
J.H. Thrall; Boston, MA/US
11:40 Learning Objectives:
Panel discussion: Why should radiologists care about clinical audit and 1. Defining roles and responsibilities in a team: RACI tool.
peer review? 2. To know who you are and whom you need (MBTI, enneagram, Hogan).
3. How to delegate without losing quality and time.
10:30 - 11:30 Coffee & Talk 2
A-0596 11:04
Coffee & Talk (open forum) Session B. Leadership in radiology
M. Forsting; Essen/DE
1. Radiologist: a ratio of a manager and a specialist.
Access to the medical physics expert 2. Psychological aspects of leadership (EQ, enthusiasm, energy, sport,
hobby).
(MPE) in the imaging department: use 3. Tools for organising a team‘s work, delegating and managing virtual/
cases distributed teams.
Moderator:
A-0597 11:32
C. Leading quality improvement projects
B. Baeßler; Mannheim/DE
A-0590 10:30
Chairperson‘s introduction Learning Objectives:
G. Frija; Paris/FR 1. Measuring and managing errors.
2. Peer review and continuous learning.
Session Objectives:
3. Effective feedback, basics of tutoring and coaching.
1. To learn about MPE‘s regulatory role.
2. To understand concrete MPE achievements in daily practice.
3. To appreciate the value of outsourced MPE services and experiences. 10:30 - 12:00 Room M 4
A-0591 10:35 E3 - ECR Academies: Chest Imaging

Reminder of Basic Safety Standards (BSS) Directive requirements
E3 1022
1. To become familiar with the Basic Safety Standards Directive (Council Lung cancer in the era of molecular
Directive 2013/59/EURATOM), in particular related to the MPE.
2. To learn about the most important changes compared to the previous
oncology and immune therapy
directive.
A-0598 10:30
3. To understand the implications of the new directive for the MPE.
A-0592 10:45
Examples of a EuroSafe Imaging Stars with and without direct access
A-0599 10:36
to a MPE
A. Lung adenocarcinomas with EGFR mutations
T. De Bondt; Antwerp/BE
M. Lederlin; Rennes/FR
1. To learn about the local availability of MPEs.
1. To be aware of the importance of detecting epidermal growth factor
2. To understand to what extent MPE tasks can (partly) be done by
receptor (EFGR) mutation.
other medical professionals in the absence of a MPE.
2. To learn about demographic and CT features suggestive of EGFR
3. To appreciate the advantages of having direct access to a MPE.
mutation.
3. To learn about the various initial and follow-up CT features.

A-0600 11:04 A-0605 12:29

B. PD-L1 positive lung tumours Current challenges and obstacles
O.L. Sedlaczek; Heidelberg/DE N. Neuheimer; Ottawa, ON/CA

1. To know about the impact of programmed death ligand 1 (PD-L1) 1. To learn about the structure of healthcare in Canada.
positivity. 2. To understand the obstacles to standardisation across provinces.
2. To know how to evaluate the tumour response after 3. To appreciate the role that CSI has to play in a national strategy.
immunotherapeutics.
3. To be aware of the imaging features of immune therapy A-0606 12:37
complications. The pan-Canadian survey: strategy moving forward
D.A. Koff; Hamilton, ON/CA
A-0601 11:32
C. ALK-rearranged and other mutations of lung adenocarcinomas Learning Objectives:
M. Silva; Parma/IT 1. To learn about the pan-Canadian survey on awareness and
implementation of the Bonn Call for Action in Canada.
Learning Objectives: 2. To understand the main issues identified by the survey.
1. To learn about clinicopathologic features characterising anaplastic 3. To appreciate how the outcomes of the survey will influence CSI
lymphoma kinase (ALK)-rearrangement. strategy.
2. To learn about other mutations and their implications for
management. 12:45
3. To see some illustrative cases. Open forum discussion: Suggestions for the implementation of a
national strategy for radiation protection
12:15 - 12:45 Room A
12:30 - 13:30 Room C
Headline Session
E3 - The Beauty of Basic Knowledge: Pancreas
HL 2
Josef Lissner Honorary Lecture E3 24C
Presiding: Cystic neoplasms
L.E. Derchi; Genoa/IT Moderator:
A-0602 12:15
Systemic effects of image guided tumour therapy: have we opened A-0607 12:30
Pandora‘s box or found the Holy Grail? Intraductal papillary neoplasms
S.N. Goldberg; Jerusalem/IL S. Skehan; Dublin/IE
1. To appreciate the extent of potentially beneficial and harmful systemic 1. To learn about classification of cystic pancreatic neoplasms.
Friday
effects of “focal” interventional oncologic therapy. 2. To appreciate the classification of IPMNs.
2. To gain awareness of the molecular mechanisms that cause such 3. To understand the diagnostic imaging findings of IPMNs.
systemic effects with an eye toward potentiating them for clinical
benefit. A-0608 13:00
3. To learn how immuno-oncologic techniques can be combined with Other cystic pancreatic neoplasms
both percutaneous and transcatheter interventional oncologic therapies R. Manfredi; Rome/IT
to potentially achieve better clinical outcomes.
1. To understand diagnostic imaging findings of other cystic neoplasms.
12:15 - 13:15 Coffee & Talk 2 2. To appreciate differential diagnosis of pancreatic cystic lesions.
3. To understand the follow up of cystic pancreatic neoplasms.
12:30 - 13:30 Coffee & Talk 3

C 15 Coffee & Talk (open forum) Session
EuroSafe Imaging meets Canada Safe
Imaging C 16
A-0603 12:15 Congenital heart diseases (CHD): new
G. Frija; Paris/FR responsibilities for the paediatric
Session Objectives: radiologist
1. To become familiar with the „Safe“ initiatives worldwide.
2. To understand the need for collaboration worldwide. A-0609 12:30
3. To learn in particular about EuroSafe Imaging and Canada Safe Chairperson‘s introduction
Imaging. A. Secinaro; Rome/IT
Session Objectives:
A-0604 12:21 1. To present the new task for paediatric radiologists: imaging in CHD
Introduction of Canada Safe Imaging Call for Action patients.
D. Wormald; Guelph, ON/CA 2. To introduce main CHD conditions, imaging indications and
Learning Objectives: techniques.
1. To learn about the Canada Safe Imaging (CSI) initiative. 3. To teach adult chest and cardiac radiologists about CHD.
2. To understand why CSI was needed. 4. To describe the role of imaging in the follow up of grown-up patients
3. To appreciate the scope of CSI‘s mission. (GUCH).

A-0610 12:35 13:30 - 14:30 Coffee & Talk 2

Cardiovascular assessment in newborns and infants with complex
CHDs Coffee & Talk (open forum) Session
A.M. Taylor; London/UK
1. To present the state of the art of advanced cardiovascular imaging in
C 17
CHD. Team approach and safety culture in the
2. To become familiar with new radiological implementation in the
clinical work-up of CHD. imaging department
3. To introduce the challenges and future of CHD.
A-0615 13:30
Post-surgical patterns J.N. Vassileva; Vienna/AT
T. Leiner; Utrecht/NL
Session Objectives:
Learning Objectives: 1. To learn about the importance of multidisciplinary team work in the
1. To show the role of cross-sectional imaging in detecting post-surgical diagnostic imaging department.
findings. 2. To understand the attributes of robust safety culture.
2. To understand the radiological appearance of the most common post- 3. To appreciate the role of international collaboration for improving
operative conditions. patient safety in radiology.
3. To highlight the relevance of knowing patient history and surgical
main complications. A-0616 13:35
Performing the appropriate procedure: whose role is it?
A-0612 12:51 B. Brkljačić; Zagreb/HR
CT in newborns: technical tips and tricks
C. Loewe; Vienna/AT
1. To learn about challenges and solutions for appropriate use of imaging
Learning Objectives: procedures.
1. To highlight the new challenges for paediatric CT. 2. To understand the role of different specialists in the justification
2. To discuss about scanning protocol improvements: ECG gating and process.
dose. 3. To appreciate how team collaboration improves justification.
3. To learn about dose optimisation.
A-0617 13:45
A-0613 12:59 Performing procedure appropriately: whose role is it?
MR and CT in the follow-up to adulthood D. Kostova-Lefterova; Sofia/BG
L.K.R. Suther; Oslo/NO
Learning Objectives: 1. To learn about steps in the optimisation process.
1. To describe the new challenge for radiologists: grown-up CHD 2. To understand the team approach for balancing quality and safety.
patients. 3. To appreciate the value of involving a medical physicist in the clinical
2. To discuss the role of different diagnostic strategies in the diagnostic team.
follow-up.
3. To highlight the importance of imaging in the „clinical transition“. A-0618 13:55
Improving patient safety through learning from errors
13:07 L. Sembele; Riga/LV
1. To learn how error reporting helps improve safety culture and patient
12:30 - 13:30 Room D care.
2. To understand how to establish a departmental error reporting
E3 - The Beauty of Basic Knowledge: A Survival Guide to system.
Musculoskeletal Imaging 3. To appreciate how the „blame-free“ environment increases error
reporting and safety improvement.
E3 25C 14:05
Open forum discussion: How to build an effective team to achieve best
Spinal trauma: how to get it right results
Moderator:
V.N. Cassar-Pullicino; Oswestry/UK
14:00 - 15:30 Room C
A-0614 12:30 EFRS meets Denmark
Spinal trauma: how to get it right
A. Leone; Rome/IT
Learning Objectives: EM 4
1. To become familiar with imaging features of cervical, thoracolumbar
and sacral trauma.
EFRS meets Denmark
2. To understand the importance of mechanism of injury in the setting of Presiding:
spinal trauma. J. McNulty; Dublin/IE
3. To appreciate the usefulness of radiography, CT and MR imaging in H. Precht; Odense/DK
the detection and evaluation of spinal trauma.
A-0619 14:00
Session introduction
A-0620 14:05
Introduction: Across Denmark
C. Graungaard Falkvard; Copenhagen/DK
1. To introduce the EFRS meets session and the involvement of Denmark
in the EFRS.
2. To introduce the country of Denmark, Danish life and culture and the
Danish radiography profession.

A-0621 14:10 A-0645 16:05

Machine learning: a new aspect of radiography EDiR holder‘s experience
L.M. Pehrson; Copenhagen/DK A. Pons Escoda; Barcelona/ES

1. To recognise Machine learning as a tool for medical image analysis. 1. To learn from the experience of an EDiR holder.
2. To learn about the opportunities within machine learning, the 2. To understand how to face the examination.
challenges and new directions in clinical practice. 3. To appreciate the advantages of being an EDiR holder.
3. To acknowledge the potential impact for the patient, radiographer
and radiologist. 16:15
Open forum discussion: Why should we promote and recommend the
A-0622 14:27 trainees to take the European Diploma in Radiology examination?
Improvements in healthcare
P. Blackburn Andersen; Kolding/DK
14:00 - 15:30 Room N
1. To understand the need for improvement in Danish healthcare (and PIER @ ECR Session (Jointly organised with the ESR Research
perhaps European healthcare). Committee)
2. To appreciate how radiographers can contribute beyond the radiology
department.
3. To acknowledge the need for patient and staff involvement to create PI 3
improvements.
Professional issues for radiology
A-0623 14:44 departments to enable research
Technologically mediated patient and radiographer experience
Moderator:
S. Holm; Faaborg/DK
J.K. Bell; Manchester/UK
1. To understand what is meant by technological mediation. A-0625 14:00
2. To learn about embodied perception. Chairperson‘s introduction
3. To explore how technologies mediate experience in radiographic O. Clément; Paris/FR
practice.
Session Objectives:
1. To learn about research in imaging or imaging for clinical research.
A-0624 15:01 2. To appreciate how to attract residents in research.
MR safety
3. To learn about examples of implementing AI research in radiology.
A.D. Blankholm; Aarhus/DK

1. To understand the challenges of MR safety. How to attract residents to research
2. To appreciate MR safety from the Danish radiographer‘s perspective. H.-U. Kauczor; Heidelberg/DE
3. To become familiar with recommendations for MR safety education.
Friday
1. To learn basic concepts for research options for residents.
15:18 2. To appreciate the value of research activities in the professional career.
Panel discussion
3. To understand the requirements for research environments for
residents.
15:30 - 16:30 Coffee & Talk 1
A-0627 14:22
Coffee & Talk (open forum) Session How to organise an imaging department for clinical research
1. To learn about concepts for research facilities.
The European Diploma in Radiology 2. To appreciate how to implement quality approaches.
3. To understand the financial background.
(EDiR) as an instrument to develop a
professional career A-0628 14:38
How to deal with legal requirements in research activities
A-0642 15:30 P.M.A. van Ooijen; Groningen/NL
1. To learn about the relevance of legal framework for research.
Session Objectives: 2. To appreciate the European perspective for multi-centre projects.
1. To describe EDiR and to whom it is addressed. 3. To become familiar with best practice concepts for data-protection
2. To describe the new tools to prepare the examination. and data-security.
3. To understand the importance of building a community of EDiR holders.
A-0629 14:54
A-0643 15:35 How to implement research on artificial intelligence in radiology
EDiR teaser K.J. Dreyer; Boston, MA/US
Learning Objectives: 1. To learn about the key-concepts of AI and the challenge for radiology.
1. To review some practical cases: multiple response questions, short 2. To appreciate the opportunities for radiologists active in AI-research.
cases and CORE case. 3. To become familiar with new concepts for supporting research on AI
2. To learn the top 10 hints for the EDiR exam. in radiology.
3. To answer any questions from the audience.
15:10
A-0644 15:55 Panel discussion: Will research in radiology survive?
EDiR quiz
A. Van Hoyweghen; Edegem/BE
1. To become familiar with the structure of the examination.
2. To better understand the examination in an interactive way.
3. To learn how to solve the most difficult cases.

14:00 - 15:30 Room E1 A-0636 14:34

B. Value-based imaging
Joint Session of the ESR and BBMRI-ERIC M.G.M. Hunink; Rotterdam/NL
ESR/BBMRI-ERIC 1. To understand the value of what we do in radiology.
2. To understand how cost-effectiveness analysis can demonstrate the
Will the General Data Protection value in imaging.
3. To recognise how investing in our employees increases the value of
Regulation (GDPR) hamper the what we do.
secondary use of clinical imaging data A-0637 15:02
for research? C. Start-up in radiology
Moderators:
E. Steinfelder; Graz/AT Learning Objectives:
A. van der Lugt; Rotterdam/NL 1. Understanding successful investments: which number you really need
to take care of.
A-0630 14:00 2. Designing a standalone imaging centre.
Why is secondary use of existing imaging data important for research 3. Investments: how to find money for new projects in imaging
progress? informatics.
E. Steinfelder; Graz/AT
Learning Objectives: 14:00 - 15:15 The Church

1. To learn about Biobanking and BioMolecular resources Research
Infrastructure (BBMRI). Women in Focus - The Bigger Picture
2. To learn what BBMRI can do for you in the GDPR era.
3. To learn about the importance of existing imaging data for research in
imaging biomarkers, radiomics and artificial intelligence. WF 3
A-0631 14:15
Women in challenging environments
Can I reuse, share or give open access to existing imaging data for
research?
A-0638 14:00
M.T. Mayrhofer; Graz/AT
1. To learn what you can do with imaging data in the PACS and A-0639 14:05
observational research studies. ‚It‘s the little things that matter‘
2. To learn what you can do with data from investigator initiated or L. O‘Riordan; Ipswich/UK
industry sponsored RCTs.
3. To learn how to prevent future problems with re-use of clinical data. Learning Objectives:
1. To know how to help and support a colleague who has cancer.
2. To learn how to return to work after time off for illness.
A-0632 14:40 3. To understand what it‘s like to have cancer from a doctor who is also
Can I sell or licence imaging data to industry or spin-off companies?
a patient.
J.A. Bovenberg; Aerdenhout/NL
4. To appreciate when to share your own experience of illness with the
Learning Objectives: patients that you treat.
1. To understand the issues of sharing data with industry.
2. To learn about proper informed consent for sharing data with industry. A-0640 14:25
3. To learn whether data can be shared outside the European Union. Safe spaces for women in challenging environments: the example of
Women Health Counselling Centres for refugee women and girls
A-0633 15:05 S. Bahar Özvariş; Ankara/TR
How to anonymise imaging data for research?
B. Gibaud, E. Cordonnier, G. Pasquier; Rennes/FR
1. To learn how a Women‘s Health Counselling Centre can be a good
Learning Objectives: example of a safe space for women facing difficulties.
1. To learn the difference between anonymisation and pseudonymisation. 2. To understand the importance of recognising cultural and gender
2. To become familiar with tools for pseudonymisation. sensitivities in healthcare delivery.
3. To understand the secrets of the DICOM header. 3. To appreciate the importance of providing health care services in
the mother tongue and of acting in a culturally sensitive manner when
15:25 treating people facing extraordinary challenges.
Panel discussion: How to overcome the hurdles of secondary use of
4. To introduce the importance of collaboration and partnership among
imaging data
different sectors when providing healthcare services.
14:00 - 15:30 Room M 2 A-0641 14:45

Panel discussion: Diversity in healthcare delivery
E3 - ECR Academies: Radiology Leaders‘ Bootcamp S. Bahar Özvariş1, E. Balogun2, R.G.H. Beets-Tan3, D. Husseiny Salama4,
S.F. Khan5, L. O‘Riordan6; 1Ankara/TR, 2Lagos/NG, 3Amsterdam/NL,
4
Cairo/EG, 5Islambad/PK, 6Ipswich/UK
E3 1118
Investment strategies
A-0634 14:00
A-0635 14:06
A. Budget: all these numbers
A. Giovagnoni; Ancona/IT
1. Why to be aware of financial literacy.
2. Major financial indicators for radiology: to dig into numbers with profit.
3. How to make all these boring numbers work for you and do more with
fewer resources.

16:00 - 17:30 Room A 16:00 - 17:30 Room C

E3 - ECR Academies: Interactive Teaching Session for Young ISRRT meets Africa
EM 5
E3 1221 Radiographers‘ challenges offering
Advances in musculoskeletal techniques: imaging services in Africa
whole-body MR Presiding:
D. Newman; Fargo, ND/US
A-0646 16:00 P. Gerson; Paris/FR
A. Oncologic application
F.E. Lecouvet; Brussels/BE A-0651/A-0652 16:00
D. Newman; Fargo, ND/US
1. To become familiar with the technical aspects of whole-body MR.
P. Gerson; Paris/FR
2. To learn the role of whole-body MR in the management of oncologic
patients. Session Objectives:
1. To recognise the demographics and patient accessibility to health
A-0647 16:45 services of a particular African country.
B. Non-oncologic applications 2. To understand the infrastructure of the imaging health services and
M. Faruch; Toulouse/FR their contribution to the primary and hospital health services to sustain
the population and individual health.
Learning Objectives: 3. To appreciate the radiographers‘ effort to keep up to date with
1. To become familiar with the indications for whole-body MR in non- evidence-based practice in imaging services.
oncologic patients. 4. To become familiar with the radiology education system and lifelong
2. To learn the role of whole-body MR in the management of non- learning opportunities for radiographers practicing in Africa.
oncologic musculoskeletal disorders.
A-0653 16:08
16:00 - 17:30 Room B Nigeria. Healthcare services in Nigeria: the radiographers‘
opportunities and challenges
GI Tract E. Olasunkanmi Balogun; Lagos/NG
RC 1201 1. To recognise the demographics and patient accessibility to healthcare
services in a densely populated country as Nigeria.
Imaging the acute abdomen: new 2. To understand the infrastructure of the imaging health services and
their contribution to the primary and hospital health services to sustain
insights the population and individual health.
Friday
Moderator: 3. To appreciate the radiographers‘ effort to keep up to date with
D.E. Malone; Dublin/IE evidence-based practice in imaging services.
4. To become familiar with the radiography education system and
A-0648 16:00 lifelong learning opportunities for radiographers practicing in Nigeria
A. Acute mesenteric ischaemia and its environs.
M. Ronot; Clichy/FR 5. To look at the challenges of team work/professional rivalry/
nomenclature even in the face of infrastructural challenges.
1. To learn about the different types and clinical conditions in which
acute mesenteric ischaemia occurs.
2. To understand how the imaging features are related to the underlying A-0654 16:26
pathophysiology. South Africa. The South African radiographer: button pusher or
3. To appreciate the role of endovascular interventional procedures in creative thinker?
the management of acute mesenteric ischaemia. H. Friedrich-Nel; Bloemfontein/ZA
A-0649 16:30 1. To learn about the radiography education models in South Africa.
B. Low-dose abdominal CT for evaluating suspected appendicitis
2. To become familiar with continuing education requirements and
K.H. Lee; Seoul/US
registration.
Learning Objectives: 3. To share the revised scope of practice.
1. To emphasise the need for reducing radiation exposure in adolescents
and young adults with suspected appendicitis. A-0655 16:44
2. To critically review published evidence indicating that LDCT is Côte d‘Ivoire. Professional practice of radiology and imaging in Africa:
comparable with normal-dose CT for diagnostic performance and radiographers for more commitment and responsibility in patients’
clinical outcome. safety
3. To review LDCT imaging techniques and other practical issues for the K.B. Yao; Abidjan/CI
successful implementation of LDCT in practice.
1. To reveal the challenges faced by African radiographers in practicing
A-0650 17:00 their profession.
C. Acute colonic diverticulitis
2. To learn about the different actions carried out by radiographers for
S. Schmidt Kobbe; Lausanne/CH
radiographers within Africa, in seeking alternatively affordable means of
Learning Objectives: practicing their profession.
1. To review the typical and atypical imaging features of acute colonic 3. To appreciate the ISRRT‘s initiatives and capacity building projects to
diverticulitis and their influence on patients‘ management. provide sustainable support to radiographers in Africa.
2. To become familiar with the complications and the most important 4. To understand the clues set up by ISRRT regional officers‘ to improve
differential diagnoses of acute colonic diverticulitis. patient care.
3. To understand the importance of imaging-guided interventions for the
management of complicated acute colonic diverticulitis.

A-0656 17:02 A-0662 16:50

Kenya. Discovering Kenyan radiographers: past, present and future The World Health Organization‘s (WHO) approach
C. Muchuki; Nairobi/KE M.d.R. Perez; Geneva/CH

1. To understand the current situation and trend of radiographers in Kenya. 1. To learn about WHO‘s views on the importance of safety and quality in
2. To understand the Kenyan health system. medical imaging for globally advancing patient care.
3. To become familiar with Kenyan radiation safety issues; Afro safe 2. To identify challenges and opportunities for enhancing radiation
Kenyan chapter. protection in medical imaging in low- and middle-income countries.
3. To understand the role and responsibilities of different stakeholders in
17:20 strengthening radiation protection in health care.
Panel discussion
A-0663 17:05
Africa‘s vision to improve radiation protection
16:00 - 17:30 Room N
B. Mansouri; Algiers/DZ
EuroSafe Imaging Session: jointly organised with the ISR and Learning Objectives:
the IOMP 1. To understand the African gaps and to identify the challenges with the
existing opportunities.
2. To learn about the implementation of a safety culture in medical
EU 3 radiation protection in Africa and the support provided by international
organisations, like IAEA and WHO, and professional societies, like ISR
Improving radiation protection in and ESR.
medical imaging in low- and middle- 3. To learn about the Afrosafe campaign, in particular about the lessons
from the past and the envisaged programme for the next three years
income countries: past actions and future 2019-2021.
directions 17:20
Panel discussion: What are the main obstacles for the safe use of
A-0657/A-0658 16:00 imaging in low- and middle-income countries?
M.M. Rehani; Boston, MA/US 16:00 - 17:30 Room O
Session Objectives: E3 - ECR Master Class (Vascular)
1. To learn about the situation of medical imaging and radiation
protection in low- and middle-income countries.
2. To understand the past challenges and possibly future ones in the
area of radiation protection in medical imaging in low- and middle-
E3 1226
income countries. Cone-beam, 4D and more: new
3. To learn about the activities of worldwide organisations to support
low- and middle-income countries.
diagnostic tools for vascular diseases
Moderator:
A-0659 16:05 C. Binkert; Winterthur/CH
The International Society of Radiology’s (ISR) vision
G. Frija; Paris/FR A-0664 16:00
A. The role of intra-procedural perfusion assessment in peripheral
Learning Objectives: arterial disease
1. To learn about the ISR‘s radiation protection policy. J.A. Reekers; Amsterdam/NL
2. To appreciate actions which are currently developed.
3. To understand the challenges of low- and middle-income countries to Learning Objectives:
improve radiation protection. 1. To understand the technique of intra-procedural perfusion assessment.
2. To learn how to target peripheral revascularization therapy based on
A-0660 16:20 perfusion assessment.
Patient doses in large part of the LMI countries and way forward: The 3. To discuss the value of using intra-procedural perfusion assessment
International Organization for Medical Physics‘ (IOMP) vision on the outcome of endovascular therapy for peripheral artery disease.
M.M. Rehani; Boston, MA/US
A-0665 16:30
Learning Objectives: B. CT 4D imaging after (T)EVAR
1. To learn about the current situation of patient doses in a large part of R. Schernthaner; Vienna/AT
the world.
2. To appreciate the challenges and needs based on experience gained. Learning Objectives:
3. To understand the needs that will impact future actions. 1. To understand the challenges of imaging follow up after (T)EVAR.
2. To become familiar with the technique of 4D CT.
A-0661 16:35 3. To learn how to establish treatment recommendations based on 4D
The International Atomic Energy Agency‘s (IAEA) approach CT results after (T)EVAR.
D. Gilley; Vienna/AT
A-0666 17:00
Learning Objectives: C. How cone-beam CT can change your practice in interventional
1. To learn about regional challenges in radiation protection in radiology
healthcare. R. Uberoi; Oxford
2. To appreciate the efforts professionals are demonstrating in achieving
progress in radiation protection in a resource-limited region with the Learning Objectives:
help of the IAEA. 1. To understand the technique of cone-beam CT.
3. To understand the effects this has on the overall improvement of 2. To learn about the role and applications of the cone-beam in the
radiation protection of patients and workers. angio suite.
3. To discuss the influence on daily clinical practice in interventional
radiology.

16:00 - 17:30 Studio 2019 16:00 - 17:30 Room E1

ESR Ultrasound Subcommittee Session Breast
US 2 RC 1202
Tips and tricks for abdominal ultrasound Minimally-invasive local treatment of
Moderator:
S. Delorme; Heidelberg/DE
breast cancer: the time is now
A-0671 16:00
Doppler imaging A. Athanasiou; Athens/GR
F. Calliada; Pavia/IT
Session Objectives:
Learning Objectives: 1. To learn about HIFU, radiofrequency ablation and cryotherapy that
1. To learn about actual indications and applications of Doppler imaging. challenge traditional surgical excision in the management of breast
2. To show better parameter settings for optimal technical results. cancer.
3. To illustrate tips and tricks for technical and clinical successful 2. To become familiar with the role of imaging in using these new
examinations. technologies.
4. To become familiar with the new Doppler imaging techniques and 3. To understand the potential advantages and disadvantages for each
applications. of these techniques.
A-0668 16:20 A-0672 16:05

CEUS A. High-intensity focused ultrasound (HIFU) therapy
M. D‘Onofrio; Verona/IT F. Pediconi; Rome/IT
1. To learn about actual indications and applications of contrast- 1. To learn about the basics of HIFU therapy.
enhanced US (CEUS). 2. To become familiar with the different types of imaging guidance.
2. To show better parameter settings for optimal technical results. 3. To appreciate its role in treating benign and malignant lesions.
3. To illustrate tips and tricks for technical and clinical successful
examinations. A-0673 16:30
4. To become familiar with the new CEUS techniques and applications. B. Radiofrequency ablation therapy
A-0669 16:40
Elastography Learning Objectives:
D.A. Clevert; Munich/DE 1. To learn about how radiofrequency works.
2. To become familiar with its use in clinical practice.
Learning Objectives: 3. To appreciate the advantages and disadvantages.
1. To learn about actual indications and applications of elastography.
Friday
2. To show better parameter settings for optimal technical results. A-0674 16:55
3. To illustrate tips and tricks for technical and clinical successful C. Cryotherapy
examinations. M.H. Fuchsjäger; Graz/AT
4. To become familiar with the new elastography techniques and
applications. Learning Objectives:
1. To learn about the cryotherapy technique.
A-0670 17:00 2. To become familiar with its use in clinical practice.
Fusion imaging 3. To appreciate its role in treating benign and malignant lesions.
C. Ewertsen; Copenhagen/DK
17:20
Learning Objectives: Panel discussion: Will we still need surgery for local therapy of breast
1. To learn about actual indications and applications of fusion imaging. cancer in the future?
2. To show better parameter settings for optimal technical results.
3. To illustrate tips and tricks for technical and clinical successful
examinations. 16:00 - 17:30 Room E2
4. To become familiar with the new fusion imaging techniques and
applications. Neuro
17:20
Panel discussion: When do we need additional imaging techniques and RC 1211
how could we include them in our workflow? Inflammatory and infectious CNS
pathology
A-0675 16:00
E.T. Tali; Ankara/TR
Session Objectives:
1. To understand the role of imaging in the diagnosis and monitoring of
inflammatory and infectious diseases of the central nervous system.
2. To learn basic principles of the use of imaging in neuroinfection and
neuroinflammation.
3. To appreciate the added value of imaging in addition to the clinical
findings and laboratory tests including CSF analysis.

A-0676 16:05 A-0681 17:00

A. Autoimmune encephalitis The most common abdominal tumours
P. Demaerel; Leuven/BE S. Franchi-Abella; Le Kremlin-Bicêtre/FR

1. To learn about the imaging pattern of autoimmune encephalitis. 1. To present current imaging techniques and describe the typical
2. To understand the limited role of conventional MRI and the need for features of Wilms‘ tumour.
advanced imaging techniques in the diagnostic process and for follow- 2. To present current imaging techniques and describe the typical
up purposes. features of non-Hodgkin‘s lymphomas.
3. To appreciate the role of imaging in a multidisciplinary and 3. To present current imaging techniques and describe the typical
multimodal approach. features of neuroblastomas.
A-0677 16:28 16:00 - 17:30 Room F2

B. Infectious encephalitis
A. Zimny; Wroclaw/PL Emergency Imaging
1. To learn about the correct choice of imaging modalities and image
acquisition parameters for the detection and monitoring of infectious RC 1217
diseases of the central nervous system. Why do I miss fractures in emergency?
2. To understand the benefits and challenges of image pattern
recognition for diagnostic purposes. A-0682 16:00
3. To appreciate the heterogeneity of the disease spectrum and Chairperson‘s introduction
challenges to interpret imaging findings in the context of the clinical S. Wirth; Munich/DE
presentation and possible comorbidities.
Session Objectives:
A-0678 16:51 1. To learn the typical constellations and findings of missed fractures.
C. Inflammatory and infectious myelitis 2. To understand the potential complications resulting from missing
M.M. Thurnher; Vienna/AT fractures.
3. To appreciate direct and indirect fracture signs with different imaging
Learning Objectives: modalities.
1. To learn about the spectrum of infectious diseases of the spinal cord
level and their most characteristic imaging features. A-0683 16:05
2. To understand the difficulties in image acquisition and image A. Missed fractures in children
interpretation. K.J. Johnson; Birmingham/UK
3. To appreciate the clinical relevance of early diagnosis and therapeutic
intervention. Learning Objectives:
1. To become familiar with the commonly missed fractures in childhood.
17:14 2. To understand the choice of the best-suited imaging modality.
Panel discussion: Ask the expert: is imaging the key diagnostic 3. To learn about atypical imaging findings in different clinical scenarios.
modality for an early and specific diagnosis of infectious diseases,
leading to a better functional outcome? A-0684 16:30
B. Missed fractures in adults
S. Döring; Brussels/BE
16:00 - 17:30 Room F1
E3 - Rising Stars Programme: Basic Session 1. To become familiar with the most commonly missed fractures in adult
patients.
BS 12 2. To understand which additional information will influence the choice

of imaging modality.
Paediatric oncology 3. To learn about atypical imaging findings in adult patients after trauma.

L.-S. Ording Müller; Oslo/NO
C. Missed musculoskeletal injuries in whole-body trauma CT
A. Platon; Geneva/CH
A-0679 16:00
The most common brain tumours Learning Objectives:
E. Vázquez; Barcelona/ES 1. To become familiar with the most commonly missed musculoskeletal
injuries in patients after polytrauma.
Learning Objectives: 2. To understand the clinical impact of missed subtle injuries on clinical
1. To present current imaging techniques and describe the typical outcome of trauma victims.
features of astrocytomas. 3. To be familiar with less typical imaging findings in musculoskeletal
2. To present current imaging techniques and describe the typical injuries.
features of medulloblastomas.
3. To present current imaging techniques and describe the typical
17:20
features of ependymomas.
Panel discussion: How to reduce the rate of missed fractures most
effectively and efficiently
A-0680 16:30
The most common chest tumours
A.S. Littooij; Utrecht/NL
features of malignant mediastinal tumours.
features of pulmonary tumours.
features of chest wall malignancies.

16:00 - 17:30 Room Y A-0692 16:05

A. Radiographs and ultrasound
E3 - Rising Stars Programme: EFRS Radiographers‘ Basic L.M. Sconfienza; Milan/IT
Session Learning Objectives:
1. To discuss the value of radiography and US in the diagnostic work-up
of MSK tumours.
BR 12 2. To explain the most recent advances and trends in the development of
Clinical dilemmas in radiography: what US technology, including contrast-enhanced US and elastography.
graduates need to know A-0693 16:28

B. MRI and whole-body MRI
A-0686 16:00 S.L.J. James; Birmingham/UK
Chairperson‘s introduction: What are the current issues in
radiography? Learning Objectives:
J. Santos; Coimbra/PT 1. To describe how to perform an advanced clinical MR protocol for MSK
tumours.
Session Objectives: 2. To explain the potential of new MR techniques.
1. To understand the current issues facing new graduates. 3. To discuss the impact of MR imaging and whole-body techniques in
2. To consider the development needed to become an effective MSK tumour imaging.
practitioner.
3. To appreciate the changing face of radiographic practice. A-0694 16:51
C. CT and hybrid imaging
A-0687 16:05 T. Bäuerle; Erlangen/DE
Issues surrounding consent
E. Dodd; Bolton/UK Learning Objectives:
1. To discuss the role of CT and hybrid imaging in the evaluation of MSK
Learning Objectives: tumours.
1. To understand the current issues surrounding consent within 2. To describe how hybrid imaging allows the intrinsic combination of
radiographic practice. functional and anatomical image information.
2. To become familiar with methods needed to ensure correct consent 3. To explain how future developments of novel PET tracers and
for radiographic procedures. integrated PET/CT and PET/MRI may impact the management of MSK
3. To discuss the changing role of the radiographer with regards to tumours.
patient consent.
17:14
A-0688 16:28 Panel discussion: Guidelines for, and the role of, imaging techniques in
Communication and compliance difficulties in imaging the management of musculoskeletal tumours
S. Kada; Bergen/NO
Learning Objectives: 16:00 - 17:30 Room G

1. To be aware of communication and compliance issues within radiology.
2. To discuss methods for improving communication and compliance. Special Focus Session
Friday
3. To appreciate the need for CPD in areas such as dementia, obesity.
A-0689/A-0690 16:51 SF 12
Professionalism in an era of social media IT-security and GDPR
R. García Gorga; Sabadell/ES
Moderator:
M.A. de la Camara; Talarrubias/ES
O. Ratib; Geneva/CH
1. To learn about professionalism in social media by showing activity A-0695 16:00
models of radiography professionals in social media. Chairperson‘s introduction
2. To appreciate the impact of digital information on the profession of E. Kotter; Freiburg/DE
radiography.
3. To understand professionalism in social media through the proposal of Session Objectives:
quantitative and qualitative research models. 1. To give an overview on the GDPR and patient consent.
2. To understand practical aspects of GDPR and patient consent.
3. To know security aspects specific to mobile devices and social media.
17:14
Panel discussion: Promoting high-quality patient-centred practice
A-0696 16:05
Understanding the key points of GDPR
16:00 - 17:30 Room D C.D. Becker; Geneva/CH
Musculoskeletal Learning Objectives:

1. To give an overview of the GDPR.
2. To understand the key points of GDPR.
RC 1210 3. To review what is important for radiological practice.
The radiological investigation of A-0697 16:28

musculoskeletal tumours Issues related to patient consent to allow access to the data
O. Ratib; Geneva/CH
Chairperson‘s introduction 1. To understand the difference between general consent and informed
F.M.H.M. Vanhoenacker; Antwerp/BE consent.
Session Objectives: 2. To learn how to manage patient consent.
1. To describe how to differentiate tumours from other non-tumoural 3. To understand special aspects of data access in the context of
pathological conditions. scientific data.
2. To discuss the value of imaging modalities in this field.
3. To explain how to determine resectability and extension of the
tumour.

A-0698 16:51 A-0704 16:05

Security aspects when using mobile devices and/or social media A. Functional cancer imaging with MRI
E.R. Ranschaert; Tilburg/NL S. Gatidis; Tübingen/DE

1. To understand the vulnerability of data on mobile devices and in social 1. To learn the basic principles of functional cancer imaging with MRI.
media. 2. To understand the biological process that can be assessed using
2. To learn how to protect data on mobile devices. functional MRI.
3. To learn how to protect data and identity in social media. 3. To learn about clinical applications of functional MRI in oncology.
17:14 A-0705 16:28

Panel discussion: Data protection: benefit or burden? B. New PET tracers in oncology
M. Herranz; Santiago de Compostela/ES
16:00 - 17:30 Room K Learning Objectives:
1. To learn the basic concepts in the development of new PET tracers.
Chest 2. To understand the biological process that can be assessed using novel
PET tracers.
RC 1204 3. To learn about clinical applications of new PET tracers in oncology.
Fibrotic lung diseases A-0706 16:51

C. Optical imaging in cancer
A-0699 16:00 D. Razansky; Zurich/CH
Chairperson‘s introduction Learning Objectives:
S.R. Desai; London/UK 1. To learn the basic concepts of optical imaging in oncology.
Session Objectives: 2. To understand the biological process that can be assessed by optical
1. To understand the implications of diagnosing UIP. imaging.
2. To be aware of the various fibrotic entities prognosis. 3. To learn about clinical applications of optical imaging in oncology.
3. To re-evaluate the links between smoking and fibrosis.
17:14
A-0700 16:05 Panel discussion: Key competences to close the translational gap more
A. Idiopathic pulmonary fibrosis efficiently
16:00 - 17:30 Room M 2
1. To learn about the updated criteria for IPF diagnosis. E3 - ECR Academies: Radiology Leaders‘ Bootcamp
2. To understand the implication for patient management.
3. To review illustrative cases with pathological assessment.
A-0701 16:28
E3 1218
B. Lung fibrosis in connective tissue and granulomatous diseases Secrets of radiology communications
P.-Y. Brillet; Bobigny/FR
with patients and referring physicians
1. To review the CT features of systemic sclerosis. A-0707 16:00
2. To learn about CT manifestations of antisynthetase syndrome. Chairperson‘s introduction
3. To learn about lung fibrosis characteristics in sarcoidosis. M. Fatehi; Tehran/IR
A-0702 16:51 A-0708 16:06

C. Other causes of lung fibrosis A. Communication is all that really matters
C.P. Heussel; Heidelberg/DE J.A. Verschakelen; Leuven/BE

1. To learn about drug-induced lung fibrosis. 1. Patients, patients‘ organisations and referring physicians: „know your
2. To review CT features of post-radiation fibrosis. client“ in radiology.
3. To learn about smoking-related lung fibrosis. 2. Communications styles for building trust and the role of informed
consent
17:14 3. Psychology tips and tricks for effective communications and
Panel discussion: What is the radiologist‘s role in the evolving negotiations.
spectrum of pulmonary fibrosis?
A-0709 16:34
B. Marketing channels for radiology promotion
16:00 - 17:30 Room M 1 D. Pinto dos Santos; Cologne/DE
Oncologic Imaging Learning Objectives:
1. Traditional and new marketing channels in healthcare.
RC 1206 2. Multi-media, multifaceted and lay-language reporting: is there a way

to change the format of radiology reports?
Translating functional and molecular 3. Referring physicians‘ and patients‘ feedback as a driver of quality
improvement.
imaging in oncology
A-0710 17:02
A-0703 16:00 C. Personal-branding and promotion for a radiologist
Chairperson‘s introduction S. Morozov; Moscow/RU
R.J. Méndez; Madrid/ES
Session Objectives: 1. A personal touch in healthcare marketing and challenges of „Group
1. To understand the basic concepts of functional and molecular imaging Practice“ in developing a brand.
methods in oncology. 2. The best recipe for building a radiologist‘s personal brand to be
2. To appreciate the challenges in translating novel functional and known internationally.
molecular imaging methods. 3. Radiologist‘s role in an early diagnostics promotion and education of
3. To learn approaches to enhance clinical translation of functional and patients.
molecular imaging methods.

16:00 - 17:30 Room M 3 A-0718 17:02

C. Fat and calcium in the heart
Oncologic Imaging F. Pontana; Lille/FR
RC 1216 1. To learn about physiologic changes.
2. To review the main causes of fat and calcium.
Oncological imaging: where are we now? 3. To learn how to differentiate pathologic from physiologic images.
A-0711 16:00 16:00 - 17:30 Room M 5

Chairperson‘s introduction: What are the problems of morphologic
evaluation Head and Neck
E. De Kerviler; Paris/FR
A-0712 16:05 RC 1208

A. CT perfusion techniques
H. Schöllnast; Graz/AT Post-treatment imaging of the head and
Learning Objectives: neck
1. To learn about current approaches for CT perfusion.
2. To understand the basic principles behind each technique. A-0719 16:00
3. To discuss radiation exposure from CT perfusion techniques. Chairperson‘s introduction
4. To appreciate the clinical usefulness of these techniques in routine H.B. Eggesbø; Oslo/NO
clinical practice. Session Objectives:
1. To become familiar with different methods of treatment.
A-0713 16:28 2. To understand post-surgical and post-RT complications.
B. Functional MRI techniques 3. To know how to follow-up with patients in order to depict early
V.J. Goh; London/UK recurrence.
1. To learn about different functional MR techniques such as diffusion A-0720 16:05
and perfusion. A. Normal findings after radiotherapy
2. To understand the basic principles behind each technique. R. Hermans; Leuven/BE
3. To appreciate the clinical usefulness of these techniques in routine Learning Objectives:
clinical practice. 1. To get acquainted with changes in tissues during and after
radiotherapy.
A-0714 16:51 2. To understand expected changes after radiotherapy in CT and MR
C. Assessment by molecular imaging imaging.
J. Grimm; New York, NY/US 3. To recognise treatment complications from expected tissue changes
Learning Objectives: after radiotherapy.
Friday
1. To learn about the basic concepts in molecular imaging.
2. To understand how molecular imaging might be integrated into A-0721 16:28
patient care. B. Normal findings after surgery
3. To discuss clinical examples of where molecular imaging is already A. Trojanowska; Lublin/PL
established in clinical practice. Learning Objectives:
1. To get acquainted with the most frequent surgical procedures in the
17:14 head and neck.
Panel discussion: Where are we using functional evaluations in clinical 2. To understand how to evaluate post-surgical patients.
practice? 3. To learn how to assess microvascular flaps.
16:00 - 17:30 Room M 4 A-0722 16:51

C. Treatment monitoring for early detection of recurrence
E3 - ECR Academies: Chest Imaging A.D. King; Hong Kong/CN
E3 1222 1. To get acquainted with the problem of recurrence in imaging studies.
2. To understand how to estimate signs of recurrence in CT and MRI.
The heart between the lungs 3. To learn about false positive and false negative findings.
A-0715 16:00 17:14

Chairperson‘s introduction Panel discussion: What are the challenges in differentiating post-
J.E. Wildberger; Maastricht/NL treatment changes from tumour recurrence?
A-0716 16:06 16:00 - 17:30 Tech Gate Auditorium

A. Cardiomyopathies
D.J. Murphy; Dublin/IE Genitourinary
1. To review the normal anatomy on standard chest CT.
2. To learn about the CT signs of various cardiomyopathies. RC 1207
3. To learn about CT performance for the diagnosis of cardiomyopathy. Contrast media guidelines
A-0717 16:34 A-0723 16:00
B. Coronary artery disease Chairperson‘s introduction
M. Williams; Edinburgh/UK H.S. Thomsen; Herlev/DK
1. To review the normal coronary artery anatomy. 1. To learn about emergent issues regarding safe use of contrast media.
2. To learn about calcium scoring on non-gated CT. 2. To understand the mechanisms underlying acute reactions and renal
3. To learn about the CT signs of healed myocardial infarction. function deterioration after contrast media injection.
3. To provide evidence-based recommendations for safe use of contrast
media and for the management of acute reactions.

A-0724 16:05
A. Post-contrast acute kidney injury (PC-AKI)
A.J. van der Molen; Leiden/NL
1. To understand the definition of PC-AKI.
2. To learn about the possible causes for PC-AKI.
3. To review current evidence regarding PC-AKI.
A-0725 16:30
B. Iodine-based contrast media in myeloma patients
F. Stacul; Trieste/IT
1. To learn about the relationships between iodine-based contrast media
and myeloma.
2. To understand the mechanisms of AKI in myeloma patients.
3. To review current evidence regarding risk of PC-AKI in myeloma
patients.
A-0726 16:45
C. Ongoing evidence for acute adverse reactions
1. To learn about the acute adverse reactions for contrast media.
2. To understand the current evidence regarding risk factors.
3. To illustrate the first-line treatment of acute adverse reactions.
17:10
Panel discussion: Towards a safer use of contrast media
16:00 - 17:25 The Church

WF 4
Leadership and mentorship
A-0727 16:00
A-0728 16:05
Is mentoring gender-specific?
1. To understand the meaning of career mentorship.
2. To learn why mentorship is key to career success.
3. To understand the role of genders in mentoring.
4. To introduce some mentoring case studies.
A-0729 16:25
The many facets of mentoring: how to find the right match?
1. To introduce questions that can lead to a successful pairing of a
mentor and mentee.
2. To appreciate the various opportunities for mentorship.
3. To become familiar with the expectations of the mentor and mentee.
4. To understand the importance of mentorship for both mentor and
mentee.
A-0730 16:45
Panel discussion: Reminiscence: remembering to pass forward
M. Abdel Wahab1, C. Beardmore2, H. Hircak3, J.E. Husband4, V.P. Jackson5,
G.P. Krestin6, G. McGinty3; 1Vienna/AT, 2Guildford/UK, 3New York, NY/US,
4
London/UK, 5Tucson, AZ/US, 6Rotterdam/NL
A-0731 17:15
Closing remarks
H. Hricak1, J.E. Husband2; 1New York, NY/US, 2London/UK

08:30 - 10:00 Room A 08:30 - 10:00 Room C

E3 - ECR Academies: Interactive Teaching Session for Young Professional Challenges Session
PC 13
E3 1321 Working in radiology: burnout and bore-
Writing reports: a survival guide out or engaged and passionate?
A-0732 08:30 A-0740 08:30
A. Lung nodule: managing uncertainty
Chairperson‘s introduction (part 1)
M. Prokop; Nijmegen/NL
M.G.M. Hunink; Rotterdam/NL
Session Objectives:
1. To identify the key imaging findings.
1. To learn to recognise the symptoms of chronic stress and burnout.
2. To become familiar with the new Fleischner guidelines.
2. To understand what factors contribute to chronic stress and burnout
among radiologists and radiographers.
A-0733 09:15 3. To learn what preventive measures can be taken to prevent chronic
B. Interstitial lung disease: searching for clarity stress and burnout among radiologists and radiographers.
N. Sverzellati; Parma/IT 4. To appreciate what is needed to achieve work engagement,
Learning Objectives: meaningful work and well-being among radiology staff.
1. To become familiar with the differential diagnosis.
2. To identify the key imaging findings. A-0741 08:33
Chairperson‘s introduction (part 2)
E. Metsala; Helsinki/FI
08:30 - 10:00 Room B
Session Objectives:
Special Focus Session 1. To learn to recognise the symptoms of chronic stress and burnout.
2. To understand what factors contribute to chronic stress and burnout
among radiologists and radiographers.
SF 13a 3. To learn what preventive measures can be taken to prevent chronic
stress and burnout among radiologists and radiographers.
Radiology and pathology: will we ever 4. To appreciate what is needed to achieve work engagement,
be (digitally) married? meaningful work and well-being among radiology staff.
A-0734 08:30 A-0742 08:35

Chairperson‘s introduction A personal story
L. Donoso; Barcelona/ES M.F. Berger; Nottwil/CH

1. To learn about digital pathology. 1. To learn to recognise the early symptoms of burnout in oneself.
2. To understand the differences with digital radiology. 2. To understand how life events and work stress in radiology contribute
3. To appreciate the opportunities of a possible integration. to burnout.
3. To appreciate the challenges in dealing with burnout.
A-0735 08:34 4. To understand what is needed to prevent chronic stress and burnout.
Are digital pathology and AI the definitive factors for the merging? 5. To appreciate the value of mindfulness in being a better radiologist/
P.J. van Diest; Utrecht/NL radiographer.

1. To learn about key aspects in the implementation of digital pathology. The role of technology in the job satisfaction and well-being of
2. To understand the AI impact in pathology. radiology workers
Saturday
3. To appreciate the opportunities of a common workflow in the imaging S. Aarts; Eindhoven/NL
domain.
A-0736 08:58 1. To understand how technology is perceived by radiographers, nuclear
How would the integration work? medicine technologists and radiation therapists.
P.J. van Diest; Utrecht/NL 2. To learn about the role of technology in the well-being of these
healthcare professionals.
Learning Objectives: 3. To learn which factors should be addressed if a new technology is
1. To understand the difficulties of the professional integration. introduced on the work floor in order to acquire/maintain a high job
2. To become familiar with the common workflow. satisfaction and well-being.
3. To appreciate the disease-specific needs for radiology-pathology 4. To understand how the role of technology in the future is perceived
integration. by these healthcare professionals and how these ideas/opinions may
influence their work, job satisfaction and well-being.
A-0738/A-0739 09:22
What difference would there be for patients? A-0744 09:11
R. Palmqvist; Umea/SE Dealing with daily battles: factors that lead to chronic stress and
K. Riklund; Umea/SE burnout
A. Montgomery; Thessaloniki/GR
1. To learn about clinical efficiency improvement. Learning Objectives:
2. To understand the impact on research and innovation. 1. To learn about factors that lead to chronic stress and burnout among
3. To appreciate the improvement in patient care. healthcare professionals.
2. To appreciate that preventive intervention should be setting-specific
09:46 and context-dependent.
Panel discussion: What benefits are there to merge the two 3. To become familiar with possible interventions at the organisational
specialties? and individual level.

A-0745 09:29 08:30 - 10:00 Room N

From chronic stress and burnout to work engagement, meaningful
work and employee well-being EuroSafe Imaging Session
J. Hakanen; Helsinki/FI
1. To learn what preventive measures can be taken to prevent chronic
EU 4
stress and burnout. Advanced clinical dosimetry in
2. To shift the focus from prevention of chronic stress towards positive
work experience. interventional radiology
3. To appreciate what is needed to achieve work engagement,
meaningful work and well-being. A-0746/A-0747 08:30
09:47 W.R. Jaschke; Innsbruck/AT
Panel discussion: Achieving well-being among radiology staff E. Vaño; Madrid/ES
Session Objectives:
09:30 - 10:30 Coffee & Talk 1 1. To learn about the clinical value of dosimetry.
2. To understand the technique of dosimetry and the implementation of
Coffee & Talk (open forum) Session real time personal dosimetry.
3. To appreciate the impact of dosimetry for dose management in
C 29
Why are research fellowships important A-0748 08:35
The basis of clinical dosimetry in interventional radiology
for young radiologists? K. Bacher; Ghent/BE
A-0812 09:30
1. To learn how to assess dose to patients and staff.
2. To appreciate the importance of dosimetry for optimisation.
L. Marti-Bonmati; Valencia/ES
3. To understand the potential pitfalls in clinical dosimetry.
Session Objectives:
1. To learn how a research fellowship enhances critical-thinking and A-0749 08:45
problem-solving skills. Real time staff dose monitoring
2. To understand how research fellowships ensure radiologists a F. Vanhavere; Mol/BE
preeminent role in the era of precision and personalised medicine.
3. To appreciate how learning in advanced research environments Learning Objectives:
enlighten radiologists to help patients. 1. To understand how on-line dosimetry can help in radiation protection
of medical staff in interventional procedures.
2. To learn how the ALARA principle (as low as reasonably achievable)
A-0813 09:35
can be applied for medical staff in interventional procedures.
Lessons from my experience: data acquisition and radiomic signatures
3. To learn about the current status of real-time dosimetry.
A. Uysal; Ankara/TR
4. To become familiar with the tools, which are available for radiation
protection of medical staff in interventional procedures.
A-0814 09:40
Lessons from my experience: radiogenomics correlations
N. Plakhotina; Moscow/RU
A-0750 09:05
Real time patient dose monitoring
Learning Objectives: R.M. Sánchez Casanueva; Madrid/ES
1. To learn about the role of MRI for predicting various genetic
pathologies in children.
1. To learn about the motivation for real-time patient dosimetry.
2. To understand the MRI features for tumours with different mutations
2. To understand quantities and units to monitor patient dose.
as well as suggest a treatment response.
3. To learn about prototypes and systems currently available.
3. To evaluate capabilities of the advanced MRI techniques for assessing
molecular subgroups of tumours.
A-0751 09:25
Dose management of patients and staff in interventional radiology
A-0815 09:45
Lessons from my experience: prediction biomarkers
P. Rodriguez Carnero; Madrid/ES Learning Objectives:
1. To learn about radiation doses and risks associated with
fluoroscopically-guided procedures.
1. To appreciate the importance of imaging biomarkers in present clinical
2. To describe the actions that should be taken to enhance patient and
practice.
staff safety during interventional radiology procedures.
2. To learn about the experience of a research fellowship with an ESOR-
3. To learn parameters that can be modified to decrease patient dose
Bracco Grant.
without compromising image quality.
3. To recognise the importance of international research exchange
programmes.
09:45
Discussion
09:50

08:30 - 10:00 Room O A-0758 09:11

Spinal CSF leaks: the precise „roadmap“ for clinicians
Vascular J.S. Ross; Phoenix, AZ/US
RC 1315 1. To review the most optimal imaging strategy in spinal CSF leaks.
2. To interpret different imaging studies in spinal CSF leaks.
US and vascular disease: a perfect match 3. To learn the value of different imaging techniques in detecting spinal
CSF leaks.
Moderator:
V. Bérczi; Budapest/HU
A-0759 09:29
Cutting edge minimally invasive spine interventions
A-0752 08:30 L. Manfrè; Catania/IT
A. Abdominal aorta
D.A. Clevert; Munich/DE Learning Objectives:
1. To review the current state-of-the-art in minimally invasive spine
interventions.
1. To learn how to perform the examination and its role in diagnostic
2. To learn how to choose an optimal minimally invasive treatment in low
assessment.
back pain.
2. To learn about US findings in AAA treatment planning and post-
3. To learn about new interventional spine techniques available in low
treatment evaluation.
back pain.
3. To appreciate the role of CEUS and technological innovations in
routine practice.
09:47
Panel discussion: How can we make spinal imaging better?
A-0753 09:00
B. Upper and lower limb: arterial district
B. Brkljačić; Zagreb/HR 08:30 - 10:00 Room E1
Learning Objectives: Breast
1. To understand how to perform the examination and its role in
diagnostic assessment.
2. To understand US findings for diagnosis and follow-up.
3. To underline tips and tricks to start your activity.
RC 1302
New mammography: digital breast
A-0754 09:30 tomosynthesis and future techniques
C. Ultrasound as guidance for vascular interventions
W.K. Matzek; Vienna/AT
A-0760 08:30
1. To understand the value of ultrasound guidance for arterial puncture. E.M. Fallenberg; Munich/DE
2. To learn about the possibilities of ultrasonographic guided therapy of Session Objectives:
AVMs. 1. To learn about 2D mammography and digital breast tomosynthesis.
3. To become familiar with endovenous treatment of varices. 2. To recognise the advantages and disadvantages of digital breast
tomosynthesis compared to 2D mammography.
08:30 - 10:00 Studio 2019 3. To understand the future potential of new breast imaging techniques
in lesion assessment.
A-0761 08:35
A. Should we abandon 2D mammography?
SF 13b S. Zackrisson; Malmö/SE
Cutting edge imaging and minimally 1. To understand the technique of 2D mammography and what the limits
could be.
invasive interventions of the spine
Saturday
2. To learn if there are ways to improve the image quality of 2D
mammography.
A-0755 08:30 3. To understand when 2D mammography is better than digital breast
tomosynthesis.
Session Objectives:
A-0762 09:00
B. Clinical validation of digital breast tomosynthesis and results in the
1. To become familiar with state-of-the-art spinal imaging and minimally
last 10 years: where do we stand?
invasive spine interventions.
P. Skaane; Oslo/NO
2. To learn about advanced imaging of the spine.
3. To learn how to improve on spinal imaging. Learning Objectives:
1. To become familiar with the technique of digital breast tomosynthesis.
A-0756 08:35 2. To understand the results of digital breast tomosynthesis in the
Imaging strategies in spine and spinal cord trauma screening and diagnostics settings.
P.C. Maly Sundgren; Lund/SE 3. To know the evolution of digital breast tomosynthesis in screening
organisation.
1. To review the imaging strategy in spinal trauma. A-0763 09:25
2. To know the most optimal imaging techniques in spinal trauma. C. Contrast-enhanced mammography and other developing techniques
3. To learn about new developments in imaging spinal trauma. E. Giannotti; Nottingham/UK
A-0757 08:53 1. To become familiar with further developments in digital
Advanced imaging of spinal cord lesions: do we need DWI, perfusion mammography, such as contrast-enhanced mammography and
and spectroscopy? contrast-enhanced digital breast tomosynthesis.
M.M. Thurnher; Vienna/AT 2. To understand the role of these new techniques in detection and
characterisation of breast lesions.
3. To learn about the new potential of combining mammography with
1. To understand the indications for advanced imaging in spinal cord
molecular imaging, optical imaging and texture analysis.
lesions.
2. To differentiate spinal cord lesions. 09:50
3. To learn the different imaging patterns of spinal cord lesions. Panel discussion: Mammography, digital breast tomosynthesis and
contrast-enhanced mammography: where will we stand in 10 years?

08:30 - 10:00 Room E2 A-0769 08:36

A. Hepatobiliary system
Neuro I. Santiago; Lisbon/PT
RC 1311 1. To learn the anatomy, normal variants and congenital disorders of the
hepatobiliary system.
Altered mental state 2. To become familiar with the primary and secondary imaging features
of acute and chronic diffuse liver diseases.
A-0764 08:30 3. To understand the causes and imaging features of benign and
Chairperson‘s introduction malignant focal liver lesions, including cysts, haemangiomas, adenomas,
M.A. Van Buchem; Leiden/NL focal nodular hyperplasia, hepatocellular carcinomas and metastases.
4. To learn the various causes and imaging features of benign and
Session Objectives: malignant diseases of the biliary
1. To learn about the complex spectrum disease entities presenting with tract and gallbladder.
cognitive decline.
2. To understand the role of standardised imaging and reporting in the A-0770 09:04
context of diagnosis and monitoring of patients with neurocognitive B. Pancreas and spleen
disorders. W. Schima; Vienna/AT
3. To appreciate importance of multimodal imaging approaches in the
diagnosis of neurocognitive disorders. Learning Objectives:
1. To understand the anatomy, normal variants and congenital disorders
A-0765 08:35 of the pancreas.
A. MRI in the diagnosis of cerebral amyloid angiopathy (CAA) 2. To become familiar with the causes and imaging features of benign
J. Linn; Dresden/DE and malignant pancreatic tumours.
3. To understand the imaging features of acute and chronic pancreatitis
Learning Objectives: and its potential complications.
1. To recognise cerebral amyloid angiopathy in imaging studies. 4. To learn the causes and imaging features of focal and diffuse splenic
2. To understand the pathophysiology of the disease. abnormalities.
3. To know the clinical consequences of the diagnosis.
A-0771 09:32
A-0766 08:58 C. Imaging of the gastrointestinal tract
B. Imaging in an altered mental state D.M. Lambregts; Amsterdam/NL
J. Boban; Novi Sad/RS
Learning Objectives: 1. To become familiar with the anatomy, normal variants and congenital
1. To learn about the role of imaging in the diagnosis of neurocognitive disorders of the oesophagus, stomach, duodenum, small bowel, colon,
diseases: from the exclusionary approach to the inclusionary approach. rectum and anal canal.
2. To understand the challenges when diagnosing neurocognitive 2. To understand the imaging features of appendicitis, diverticulitis,
disease in a very early stage using imaging. tumour stenosis, ileocolic intussusception, colonic fistula, paracolic
3. To appreciate the complexity of differential diagnosis of neuroimaging abscess, epiploic appendagitis, intraperitoneal fluid collection, colonic
in cognitively affected individuals and the crucial need for other pneumatosis and pneumoperitoneum.
biomarkers to support the clinical diagnosis. 3. To learn typical radiological manifestations of inflammatory bowel
diseases, infection, bowel obstruction and bowel ischaemia.
A-0767 09:21 4. To become familiar with the staging of tumours of the gastrointestinal
C. MRI in the diagnosis of Alzheimer‘s disease tract, including features that indicate nonresectability, and to
M. Vernooij; Rotterdam/NL understand the role of different imaging modalities including hybrid
imaging in diagnosing and staging.
1. To learn about the imaging features and possible comorbidities of
Alzheimer‘s dementia. 08:30 - 10:00 Room F2
2. To understand the complexity of differential diagnosis.
3. To appreciate the crucial, and so far unmet, medical need to use State of the Art Symposium
quantitative MRI techniques in the diagnosis of Alzheimer‘s disease.
09:44 SA 13
Panel discussion: Ask the expert: how can I standardise my image Cardiac: recalling the forgotten
reading and reporting in order to support the clinical process in
cognitively impaired patients? structures
A-0772 08:30
08:30 - 10:00 Room F1 Chairperson‘s introduction
E3 - European Diploma Prep Session C. Peebles; Southampton/UK
Session Objectives:
1. To become familiar with normal cardiac anatomy and variants outside
E3 1323 the cardiac chambers.
Gastrointestinal and abdominal 2. To understand the important interactions between ventricular
chambers and their adjacent structures.
3. To learn what findings are significant and when to report them.
A-0768 08:30 4. To appreciate the strengths and weaknesses of cross sectional
imaging techniques when applied to the structures below.
C. Stoupis; Männedorf/CH

1. To understand the typical imaging features of benign and malignant Hide and seek: the pericardium
lesions of the hepatobiliary system. A. Nchimi Longang; Luxemburg/LU
2. To learn the typical imaging features of benign and malignant lesions
of the pancreas and spleen. Learning Objectives:
3. To become familiar with the methodological basis and to differentiate 1. To learn the normal appearances of the pericardium on CT and MRI.
typical features in imaging examinations of the gastrointestinal tract. 2. To understand the basic spectrum of disease process that affect the
4. To understand the role of different imaging modalities including pericardium.
hybrid imaging in diagnosing and staging neoplasms, gastrointestinal 3. To be aware of the physiological effects of pericardial disease on
and abdominal organ systems. cardiac function.

A-0774 08:52 A-0781 09:29

Lost chamber: the right ventricle How to produce a high-quality scientific or educational poster
G. Bastarrika; Pamplona/ES C. Malamateniou; London/UK

1. To learn the normal appearances of the right ventricle on CT and MRI. 1. To become familiar with poster formats and layouts.
2. To differentiate the appearances and physiology of RV volume loading 2. To consider good practices in poster design.
and RV pressure loading. 3. To appreciate important considerations when designing a poster.
3. To be aware of adverse prognostic markers related to the RV.
09:47
A-0775 09:09 Panel discussion: Ask the experts
Friend or enemy: epicardial fat
K. Gruszczynska; Katowice/PL
09:30 - 10:30 Coffee & Talk 3
1. To understand the difference between epicardial and pericardial fat. Coffee & Talk (open forum) Session
2. To learn the methods of quantifying epicardial fat.
3. To be aware of the up-to-date evidence relating to cardiovascular risk
and the extent of epicaridal fat. C 18
Assessing imaging IT in hospitals:
A-0776 09:26
Wrong ways: anomalies of cardiac veins and venae cavae an update on the digital imaging
adoption model (DIAM)
1. To learn the normal anatomy of pulmonary venous drainage, common 09:30
anomalies and their clinical significance. Moderator:
2. To learn about the normal anatomy of systemic venous drainage, P. Mildenberger; Mainz/DE
common anomalies and their clinical significance.
3. To learn the normal anatomy of coronary venous drainage, common A-0816 09:30
anomalies and their clinical significance. Update on DIAM radiology
09:43
Panel discussion: Which test would you use, MRI or CT? Learning Objectives:
1. To learn about project results and lessons learned.
2. To provide reasons why departments should use DIAM to assess their
08:30 - 10:00 Room Y IT systems and to plan future IT strategies.
E3 - Rising Stars Programme: EFRS Radiographers‘ Basic Session
A-0817 09:40
DIAM Enterprise Imaging (EI): differences and synergies
BR 13 J. Studzinski; Leipzig/DE
Radiography research: a „how to“ guide Learning Objectives:

1. To become familiar with DIAM EI, its model and survey.
A-0777 08:30 2. To learn about differences and synergies of DIAM Radiology and
Chairperson‘s introduction: Why is radiography research important? DIAM Enterprise Imaging.
D. O‘Leary; Newcastle/UK
A-0818/A-0819 09:50
Session Objectives: Success stories from DIAM: radiology participants
1. To become familiar with common ethical issues arising in radiography P.M.A. van Ooijen; Groningen/NL
research. S. Morozov; Moscow/RU
2. To understand the value of undertaking research in radiography.
3. To identify good practices for developing and presenting radiography Learning Objectives:
Saturday
research studies. 1. To demonstrate a significant practical advantage of participating in
the project.
A-0778 08:35 2. To encourage all participants to take part in the project.
How to avoid ethical issues
P. Bezzina; Msida/MT 10:06
1. To understand the importance of ethics in medical research and the
role of research ethics committees.
08:30 - 10:00 Room D
2. To become familiar with common ethical pitfalls in imaging research. Musculoskeletal
3. To appreciate strategies for avoiding ethical problems in imaging
research.
A-0779 08:53
RC 1310
How to critically appraise a research article Imaging of forgotten small joints
J. Thompson; Salford/UK Moderator:
Learning Objectives: R. Sutter; Zurich/CH
1. To appreciate the role of the literature review in the research process.
2. To identify strengths and weaknesses in each section of a research A-0782 08:30
report. A. Sterno-clavicular joints: from trauma to inflammation
3. To critically appraise the overall value of a research report. A.-G. Jurik; Aarhus/DK
A-0780 09:11 1. To explain the pathologic conditions that involve the sterno-clavicular
How to write a good scientific abstract joints.
L. Ribeiro; Faro/PT 2. To describe the imaging findings of abnormalities that involve the
Learning Objectives: sterno-clavicular joints.
1. To understand general qualities of good scientific abstracts.
2. To be aware of typical formats of scientific abstracts.
3. To consider tips for success.

A-0783 09:00 08:30 - 10:00 Room M 1

B. Symphysis pubis and its surroundings
A. Kassarjian; Pozuelo De Alarcón/ES Joint Session of the ESR and EORTC
1. To explain the pathologic conditions that involve the symphysis pubis
and its surroundings.
ESR/EORTC
2. To describe the imaging findings of abnormalities that involve the Imaging in oncological trials
symphysis pubis and its surroundings.
Moderator:
M. Smits; Rotterdam/NL
A-0784 09:30
C. Proximal tibio-fibular joint: a cause for lateral knee pain
A. Cotten; Lille/FR
A-0789 08:30
Learning Objectives: N.M. deSouza; Sutton/UK
1. To explain the pathologic conditions that involve the proximal tibio-
Session Objectives:
fibular joint.
1. To highlight the collaboration between EIBALL and the EORTC
2. To describe the imaging findings of abnormalities that involve the
imaging group.
proximal tibio-fibular joint.
2. To introduce the need for radiologists to learn about oncological
trials beyond RCTs and how such knowledge can be used to initiate and
08:30 - 10:00 Room G advance oncological imaging research.
3. To appreciate the impact imaging has on patient stratification and
Physics in Medical Imaging response assessment.
4. To learn about the requirements for and potential of radiomics in
oncological imaging research.
RC 1313
Dose management in paediatric A-0790 08:35
Trial design and imaging end-points
radiology L. Collette; Brussels/BE
A-0785 08:30
1. To learn about the several types of trial design, including RCT,
umbrella and basket trials.
C. Saidléar; Dublin/IE
2. To appreciate the different requirements of imaging end-points for
Session Objectives: different trials and phases.
1. To become familiar with modern dose management methods in 3. To understand how imaging data acquired in the context of different
paediatric radiology. trials can be used for additional research questions.
2. To understand the important aspects of paediatric dose management.
3. To appreciate the current trends and limitations. A-0791 08:55
Modern imaging-based trials: focus on oligometastatic disease and
A-0786 08:35 evaluation of metastatic directed therapies
A. The special case of the paediatric patient: risks and justification F.E. Lecouvet; Brussels/BE
C. Owens; London/UK
Learning Objectives: 1. To understand how imaging modalities may affect patient selection.
1. To learn about risks and justification techniques in paediatric radiology. 2. To appreciate how imaging modalities may affect response
2. To understand how these methods are applied in a clinical setting. assessment.
3. To appreciate the benefits of new information and the current 3. To learn how to design a trial evaluating the best imaging strategy
limitations. according to the objective.
A-0787 08:58 A-0792 09:15

B. Optimisation and technology in paediatric projection radiography, Assessing treatment response in the era of immunotherapy
interventional and CT scanning C. Caramella; Villejuif/FR
Learning Objectives: 1. To learn about new immunotherapies.
1. To learn about the optimisation of techniques in paediatric radiology. 2. To appreciate new patterns of response and progression observed
2. To understand how these methods are applied in a clinical setting. under immunotherapy.
3. To understand the new information that is available and the current 3. To learn about the specific criteria derived from RECIST (iRECIST),
limitations. harmonising data collection in clinical trials.
4. To learn about future functional imaging techniques which could help
A-0788 09:21 to better understand effects of immunotherapies.
C. Optimisation in the neonate
H. Delis; Vienna/AT A-0793 09:35
Radiomics in oncology trials
Learning Objectives: P. Kickingereder; Heidelberg/DE
1. To learn about dose management techniques in neonatal radiology.
2. To understand how these methods are applied in a clinical setting. Learning Objectives:
3. To understand the new information that is available and the current 1. To become familiar with the radiomics process.
limitations. 2. To learn what is important in data collection and curation for
radiomics.
09:44 3. To understand how radiomics can lead to a new biomarker discovery.
Panel discussion: Paediatric dose management: are we doing enough
for the next generation? 09:55
Panel discussion: What is the future of image-aware clinical trials?
Challenges and opportunities

08:30 - 10:00 Room M 2 08:30 - 10:00 Room M 4

E3 - ECR Master Class (Paediatric) E3 - ECR Academies: Chest Imaging
E3 1326 E3 1322
Juvenile idiopathic arthritis (JIA) Pleural neoplasms
Moderator:
K. Rosendahl; Bergen/NO A-0800 08:30
A-0794 08:30 F. Gleeson; Oxford/UK
A. Conventional radiography: still a helpful method?
S.C. Shelmerdine; London/UK A-0801 08:36
A. Malignant mesothelioma
Learning Objectives: I. Hartmann; Rotterdam/NL
1. To learn about the features of joint inflammation on plain radiographs.
2. To understand the role of this technique in the diagnosis and follow- Learning Objectives:
up of children with JIA. 1. To learn about the various presentation of malignant mesotheliomas.
3. To appreciate the strengths and limitations of conventional 2. To learn about the role of PET/CT.
radiography compared to other modalities in JIA. 3. To learn about the modified RECIST criteria.
A-0795 09:00 A-0802 09:04

B. Ultrasound for detecting and grading of inflammation in JIA B. Pleural carcinomatosis of thoracic and extra thoracic origin
L. Tanturri de Horatio; Rome/IT C. Beigelman; Lausanne/CH

1. To learn about normal features vs pathology on ultrasound of joints in 1. To review the CT signs of pleural carcinomatosis.
children. 2. To become familiar with the signs of dry pleural dissemination.
2. To understand the role of ultrasound in diagnosing and grading of 3. To review illustrative cases.
joint inflammation.
3. To appreciate the research-based evidence of ultrasound. A-0803 09:32
C. Other pleural and juxta pleural malignancies
A-0796 09:30 A. Snoeckx; Antwerp/BE
C. MRI and role of contrast in the assessment of synovitis
L.-S. Ording Müller; Oslo/NO
1. To learn about the CT features of solitary fibrous tumours.
2. To know when to suspect a desmoid tumour.
08:30 - 10:00 Room M 3 3. To learn about pleural lymphoma.
Head and Neck

08:30 - 10:00 Room M 5
RC 1308 Transatlantic Course of ESR and RSNA (Radiological Society

of North America): Sports Imaging
Differential diagnoses you don‘t want
to miss TC 1328
Moderator:
E. Arkink; Reykjavik/IS Shoulder sports injuries and
postoperative MRI
A-0797 08:30 Moderators:
A. Differential diagnoses of nose and paranasal sinus lesions
Saturday
L.W. Bancroft; Orlando, FL/US
S. Connor; London/UK
A.J. Grainger; Leeds/UK
1. To describe disease patterns in nose and paranasal sinus CT. A-0804 08:30
2. To learn when additional imaging is mandatory. A. Shoulder injuries in the throwing athlete
3. To provide tools to narrow down the list of differential diagnoses in L. Steinbach; San Francisco, CA/US
sinonasal MR studies.
1. To understand the biomechanics of throwing forces as they relate to
A-0798 09:00 the shoulder.
B. Differential diagnoses of paediatric neck lesions
2. To become familiar with rotator cuff and labroligamentous injury
K. Buch; Boston, MA/US
patterns caused by overhead sports.
1. To become familiar with the normal development of facial and neck A-0805 09:00
structures. B. Postoperative shoulder MRI after instability surgery
2. To discuss which imaging modality to use: US, CT or MRI? L.W. Bancroft; Orlando, FL/US
3. To understand the typical imaging appearance of congenital neck
lesions. Learning Objectives:
1. To become familiar with the expected and abnormal MR imaging
findings after labral repair.
A-0799 09:30 2. To learn about the postoperative imaging features after capsular shift/
C. Differential diagnoses of soft tissue masses in adults
capsulorrhaphy.
D. Farina; Brescia/IT
3. To appreciate normal imaging and complications after remplissage
Learning Objectives: and Laterjet/Bristow procedures.
1. To become familiar with the anatomy.
2. To learn which imaging technique to use.
3. To understand the typical imaging appearance of soft tissue masses.

A-0806 09:30 10:30 - 12:00 Room A

C. Interactive case discussion (Part 1)
L. Steinbach; San Francisco, CA/US E3 - ECR Academies: Interactive Teaching Session for Young
Learning Objectives: (and not so Young) Radiologists
1. To appreciate pathologic and normal developmental changes in
skeletally immature throwing athletes.
2. To learn how to differentiate normal and failed labral repairs with MRI. E3 1421
3. To consolidate the knowledge gained from the session with interactive
cases of pre- and postoperative shoulder MRI.
Genitourinary radiology for the general
radiologist
A-0807 09:45
C. Interactive case discussion (Part 2) A-0820 10:30
L.W. Bancroft; Orlando, FL/US A. Cystic pelvic masses: differential diagnosis and management
O. Nikolic; Novi Sad/RS
1. To appreciate common patterns of athletic injury in the shoulder. Learning Objectives:
2. To learn how to differentiate normal and failed labral repairs with MRI. 1. To learn the imaging characteristics of the different entities.
3. To consolidate the knowledge gained from the session with interactive 2. To become familiar with the practical workflow in everyday clinical
cases of pre- and postoperative shoulder MRI. practice.
08:30 - 10:00 Tech Gate Auditorium A-0821 11:15

B. Gynaecological emergencies
Genitourinary M. Weston; Leeds/UK
RC 1307 1. To become familiar with the differential diagnosis.
2. To identify the key imaging findings.
Imaging in pregnancy
10:30 - 12:00 Room X
A-0808 08:30
Chairperson‘s introduction ESR Patient Advisory Group (ESR-PAG)
Session Objectives:
1. To understand how to safely perform imaging procedures in pregnant
PA 1
women. Communicating the role of the
3. To become familiar with the most relevant pathological conditions in
pregnancy. radiologist: best practices to manage
2. To learn about the indications of imaging procedures in pregnancy. patient expectations
A-0809 08:35 A-0822/A-0823 10:30
A. Safety issues in pregnancy: what radiologists need to know Chairpersons‘ introduction
C. Bourgioti; Athens/GR N. Bedlington; Vienna/AT
Learning Objectives: N.I. Traykova; Plovdiv/BG
1. To learn about safe radiology practices and procedures in pregnant Session Objectives:
women. 1. To explain to radiologists how to effectively communicate their roles
2. To understand how to minimize the radiation burden in pregnant to their patients.
women. 2. To identify room for improvement in patient communication based on
3. To learn how and when to use contrast media in pregnancy. experience reports by patient representatives.
3. To discuss approaches on how to maintain a good patient-health
A-0810 08:58 professional relationship in the high-tech radiology department.
B. Imaging acute abdomen in pregnancy
M. Weston; Leeds/UK A-0824 10:40
Learning Objectives: Explaining the radiologist‘s role to patients
1. To become familiar with the different causes of acute abdominal pain A. Brady; Cork/IE
in pregnancy. Learning Objectives:
2. To learn about imaging features of the different causes of acute 1. To outline the role of the radiologist in patient care.
abdominal pain in pregnancy. 2. To consider how best to explain the radiologist‘s input in diagnosis
3. To learn how to use different imaging modalities in the setting of and care to patients.
acute abdominal pain in pregnancy. 3. To understand how radiologists and patients may communicate for
the benefit of patients.
A-0811 09:21
C. Imaging the placenta A-0825 11:00
P. Soyer; Paris/FR The patient perspective: sharing expectations and experiences (part 1)
Learning Objectives: B. Bauer; Abensberg/DE
1. To understand the appearance of the placenta with different imaging Learning Objectives:
modalities. 1. To understand language used within the radiology department and
2. To become familiar with the imaging appearance of the commonest patients‘ needs to effectively communicate with the radiologist.
pathological conditions of the placenta. 2. To learn about programmes that help patients to better understand
3. To discuss the added value of cross-sectional imaging in the the illness and medical imaging procedures used in the hospital.
evaluation of placental abnormalities. 3. To understand both the patient and radiologist‘s perspective in order
to further empower the patient.
09:44
Panel discussion: How should we image the pregnant woman, and
when?

A-0826 11:10 10:30 - 12:00 Room Y

The patient perspective: sharing expectations and experiences (part 2)
E. Briers; Hasselt/BE RTF - Radiology Trainees Forum
1. To outline patient expectations in terms of communication and
radiology procedures within the hospital department.
TF 1
2. To learn about practical solutions in hospital departments to meet Highlighted Lectures
patients‘ demands for involvement in decision-making regarding the
Moderators:
care pathway.
A. Svare; Riga/LV
3. To understand how to effectively communicate with patients through
T. Teneva; Varna/BG
face-to-face interaction and online reports.
A-0827 11:20 A-0832 10:30

Spinal emergencies: a look beyond trauma
Best practices: tools to optimise communication with patients
D. Ivanova; Varna/BG
L. Robinson; Gatley/UK
1. To learn about the various causes, both compressive and non-
1. To learn about effective communication and useful information for patients.
compressive, of non-traumatic spinal emergencies.
2. To learn that an overload of information is equally detrimental to a
2. To become familiar with the imaging features of different non-
safe feeling as no information.
traumatic spinal emergencies.
3. To understand how patient summaries and online reports can
3. To appreciate the role of different imaging modalities in the diagnosis
empower patients and contribute to shared decision-making.
and differential diagnosis of non-traumatic spinal emergencies and the
importance of choosing the right imaging protocol.
11:40
Panel discussion: How to maintain the human touch in the radiology
department in an era of rapid technology adoption
A-0833 11:00
Acute aortic syndrome: intimate knowledge through intimate case
G.I. Kirova-Nedialkova; Sofia/BG
10:30 - 12:00 Room F1
E3 - European Diploma Prep Session 1. To focus on the appropriate imaging technique in case of acute chest
pain.
2. To guide radiologists through an assessment of the characteristics of
E3 1423 acute aortic dissection, penetrating atherosclerotic ulcer and intramural
haematoma.
Neuro 3. To focus on some details that could influence the selection of a
therapeutic approach.
A-0828 10:30 4. To foster a critical thinking approach based on specific features of the
Chairperson‘s introduction disease process.
C. Calli; Izmir/TR
Session Objectives:
A-0834 11:30
Getting it right: how to report an imaging study before the
1. To learn relevant imaging and interventional algorithms and important
interventional radiology procedure
imaging features of neurovascular disorders of the brain and spine.
2. To understand imaging features and prognostic implications of
tumours of the brain and spine. Learning Objectives:
3. To become familiar with the role of different imaging modalities including 1. To present core procedures of interventional radiology.
hybrid imaging in diagnosing disorders of the central nervous system. 2. To provide tips for reporting imaging studies before potential
interventional radiologic procedures.
A-0829 10:36 3. To appreciate the importance of collaboration between diagnostic
A. Congenital and white matter disorders of the brain radiology and interventional radiology.
A. Rossi; Genoa/IT
Saturday
Learning Objectives: 11:00 - 12:00 Coffee & Talk 3
1. To understand the development, normal anatomy and normal variants
of the brain. Coffee & Talk (open forum) Session
2. To become familiar with common congenital disorders of the brain
and neurocutaneous syndromes.
3. To learn imaging features and differential diagnoses of white matter C 20
disease, inflammation and neurodegeneration.
Structured reporting: how we do it!
A-0830 11:04 A-0843 11:00
B. Neurovascular disorders and trauma of the brain
Chairperson‘s introduction: The age of structured reporting
M. Vernooij; Rotterdam/NL
C.E. Kahn; Philadelphia, PA/US
Session Objectives:
1. To become familiar with the normal anatomy and normal variants of
1. To understand the current goals of structured reporting.
the craniocervical arterial and venous system.
2. To describe ongoing reporting initiatives.
2. To learn the causes and imaging features of stroke, haemorrhage
3. To introduce the role of common data elements in radiology.
and other common vascular lesions of the brain and their relevance to
interventional neuroradiology.
3. To understand the imaging features of traumatic injury to the brain.
A-0844 11:05
ESR and RSNA joint effort through the Template Library Advisory
Board Panel
A-0831 11:32 P. Mildenberger; Mainz/DE
C. Tumours of the brain and spine
M.M. Thurnher; Vienna/AT Learning Objectives:
1. To learn about the joint ESR/RSNA initiative on structured reporting.
2. To appreciate the value of peer-reviewed templates.
1. To understand the normal anatomy and normal variants of the spine,
3. To understand how to use and benefit from the TLAP library.
spinal cord and nerve roots.
2. To learn imaging features of benign and malignant tumours of the
neurocranium.
3. To become familiar with the imaging features of benign and malignant
tumours of the spine.

A-0845 11:15 10:30 - 12:00 Room M 5

Templates and/or assisted-reporting?
D. Pinto dos Santos; Cologne/DE Transatlantic Course of ESR and RSNA (Radiological Society
Learning Objectives: of North America): Sports Imaging
1. To understand the difference between template based reporting and
assisted reporting.
2. To appreciate the specific pros and cons of both of these reporting TC 1428
approaches.
3. To appreciate in what clinical scenarios which approach to reporting
Wrist and foot/ankle sports injuries
may yield the most benefit. Moderators:
L.W. Bancroft; Orlando, FL/US
A-0846 11:25 A.J. Grainger; Leeds/UK
Clinical scenarios: where is structured reporting best applicable?
E. Neri; Pisa/IT A-0839 10:30
A. Soft tissue wrist injury in the athlete
Learning Objectives: C.W.A. Pfirrmann; Zurich/CH
1. To learn the ideal clinical scenarios where structured reporting
facilitate the communication of the imaging results. Learning Objectives:
2. To appreciate the value of structure reporting in doctor-to-doctor 1. To learn about the patterns of injury seen at the wrist in athletes.
communication. 2. To understand the advantages and disadvantages of different
3. To understand some key examples of structured reporting used in the modalities for imaging the athlete‘s wrist.
clinical practice. 3. To recognise the imaging appearances of cartilage and ligamentous
injury at the wrist.
11:35
Open forum discussion A-0840 11:00
B. Multimodality imaging of foot and ankle injuries in the athlete
A.J. Grainger; Leeds/UK
10:30 - 12:00 Room M 4
Pros & Cons Session 1. To appreciate the different and often contributory roles that imaging
modalities have in the foot and ankle.
2. To recognise the most common ligamentous and tendon injuries in
PS 1427 the ankle.
3. To understand how common patterns of injury relate to the
US before CT in the acute abdomen? mechanisms involved.
A-0835 10:30 A-0841/A-0842 11:30

Chairperson‘s introduction C. Interactive case discussion
J. Stoker; Amsterdam/NL C.W.A. Pfirrmann; Zurich/CH
Session Objectives: A.J. Grainger; Leeds/UK
1. To be familiar with the role of clinical findings in the management of Learning Objectives:
acute abdomen. 1. To become familiar with the techniques available and imaging
2. To understand the role of imaging in the management of acute appearances of wrist athletic injury.
abdomen. 2. To become familiar with the techniques available and imaging
appearances of foot and ankle athletic injury.
A-0836 10:35 3. To consolidate the knowledge gained from the session with interactive
A. Acute abdomen: US first! cases of wrist, foot and ankle athletic injury.
J.B.C.M. Puylaert; The Hague/NL
Learning Objectives: 12:15 - 12:45 Room A

1. To be familiar with the optimal technique and optimal application of
US in acute abdomen. Headline Session
2. To learn the strengths of US in common diseases causing acute
abdomen.
3. To understand the arguments why US should be performed as initial HL 3
imaging technique.
Luigi Oliva Honorary Lecture
A-0837 11:00 Presiding:
B. Acute abdomen: CT of course! L.E. Derchi; Genoa/IT
M. Laniado; Dresden/DE
A-0847 12:15
Learning Objectives: Contrast enhanced ultrasound in paediatrics: ready for clinical
1. To be familiar with the optimal technique and optimal application of practice?
CT in acute abdomen. P.S. Sidhu; London/UK
2. To learn the strengths of CT in common diseases causing acute
abdomen. Learning Objectives:
3. To understand the arguments why CT should be performed as initial 1. To learn about the application of CEUS in children.
imaging technique. 2. To understand the legal implications of using CEUS off-label in
children.
A-0838 11:25 3. To appreciate the potential of combining ultrasound with CEUS in
Discussion assessing the child.
M.M. França; Porto/PT 4. To become familiar with the techniques and applications of CEUS.

12:30 - 13:30 Room C 12:30 - 13:30 Room D

E3 - The Beauty of Basic Knowledge: Pancreas E3 - The Beauty of Basic Knowledge: A Survival Guide to
E3 24D
Solid pancreatic neoplasms E3 25D
Moderator: Arthritis: an imaging approach
I. Lupescu; Bucharest/RO Moderator:
A-0852 12:30
Diagnosis A-0854 12:30
M. Zins; Paris/FR Arthritis: an imaging approach
1. To learn about diagnostic imaging findings of solid pancreatic Learning Objectives:
neoplasms. 1. To become familiar with the current diagnostic concepts in the
2. To understand treatment planning. imaging of arthritis.
3. To appreciate differential diagnosis of solid pancreatic neoplasms. 2. To understand the pathology of arthritis and its imaging phenotypes.
3. To appreciate the value of radiography, ultrasound and MRI.
A-0853 13:00
Staging
N. Kartalis; Stockholm/SE 14:00 - 15:30 Room A
Learning Objectives: E3 - ECR Academies: Interactive Teaching Session for Young

1. To learn how to stage pancreatic adenocarcinoma. (and not so Young) Radiologists
2. To understand resectability criteria.
3. To appreciate the role of imaging in treatment planning.
E3 1521
12:15 - 13:45 Room X Breast imaging
EDiR Session A-0855 14:00
A. Diagnosis and management of common ductal and nipple-areolar-
EDiR complex (NAC) abnormalities

S. Perez Rodrigo; Madrid/ES
EDiR: an instrument to develop Learning Objectives:
excellence in your career 1. To learn about NAC and ductal anatomy, and pathology.
2. To become familiar with the practical workflow in everyday clinical
A-0848 12:15 practice.
L. Oleaga Zufiría; Barcelona/ES A-0856 14:45
B. Techniques, artefacts and pitfalls in breast MRI
Session Objectives: R.M. Trimboli; Milan/IT
1. To present the structure of the EDiR examination.
2. To describe how to prepare for the EDiR examination and the Learning Objectives:
resources available. 1. To describe the basic techniques for breast MRI (including DWI).
3. To detail the CORE examination. 2. To illustrate patient-related and technical artefacts, and pitfalls in
4. To learn the importance of structured reporting for the CORE breast MR.
examination.
Saturday
14:00 - 15:30 Room B
A-0849 12:20
EDiR teaser E3 - ECR Master Class (Abdominal Viscera)
1. To review some practical cases: multiple response questions, short
E3 1526
cases and CORE case. Dual-energy CT of the abdomen:
2. To learn new online resources for the examination.
3. To answer any questions from the audience. the time is now
Moderator:
A-0850/A-0851 12:50 J. Sosna; Jerusalem/IL
CORE examination
F. Saez; Barakaldo/ES A-0857 14:00
L. Oleaga Zufiría; Barcelona/ES A. Basic principles and different approaches
L.S. Guimarães; Toronto, ON/CA
1. To have a look at an action plan for the CORE examination. Learning Objectives:
2. To better understand the CORE section. 1. To learn about the types of dual-energy scanners and principles of
3. To become aware of essential hints for success in the CORE section. dual-energy CT.
4. To become familiar with structured reporting as a guide for the CORE 2. To understand issues of radiation dose and image quality in
examination. comparison with single-energy CT.
5. To understand how to make structured reports. 3. To appreciate the possible advantages of this technology with its
many post-processing applications.
13:40
Panel discussion

A-0858 14:30 A-0865 15:00

B. Applications for genitourinary system Research is nothing without effective dissemination
H. Ringl; Vienna/AT F. Zarb; Msida/MT

1. To learn about the role of dual-energy CT in the genitourinary system. 1. To explore the importance of dissemination at the local, national and
2. To understand the value of determination of renal stone composition international level.
with dual-energy CT. 2. To explore the importance of publishing for clinical and academic
3. To appreciate the ability of dual-energy CT to exactly quantify the departments.
iodine uptake in renal lesions. 3. To consider the benefits and limitations of publishing in different
journal formats.
A-0859 15:00
C. Applications for abdominal organs 15:18
M. Karcaaltincaba; Ankara/TR Panel discussion: What are the biggest barriers to growing
radiographer-led research?
1. To learn about the current applications of dual-energy CT in evaluating
the abdominal viscera. 14:00 - 15:00 Coffee & Talk 1
2. To understand the role of dual-energy CT for characterisation of
incidental lesions discovered during routine abdominal CT. Coffee & Talk (open forum) Session
3. To appreciate how dual-energy CT increases sensitivity for detecting
both hypervascular and hypovascular liver and pancreatic lesions.
C 30
14:00 - 15:30 Room C Why it is important to have an academic
EFRS Workshop: in association with EIBIR and the career
Radiography Journal Moderator:
V.J. Goh; London/UK
EFRS WS A-0866 14:00

Why is imaging research important?
Growing radiography research V.J. Goh; London/UK
Moderators:
1. To understand that research is central to ‚evidence-based medicine‘.
J.M. Nightingale; Sheffield/UK
2. To appreciate the basic principles of imaging research.
3. To learn of the different types of research in radiology.
A-0860/A-0861 14:00
Radiography research: where should we be in 2030?
L.A. Rainford; Dublin/IE
A-0867 14:10
Why should you undertake a PhD?
G. Paulo; Coimbra/PT
D. Caruso; Rome/IT
1. To explore the changing landscape in medical imaging and how this
1. To learn what is a PhD programme.
might influence our research.
2. To understand the beginning of an academic career.
2. To consider the future radiography profession, what it might look like
3. To appreciate the value of a PhD background in and outside
and where it might lead our research.
academia.
3. To propose some research targets for our profession to work towards
over the next decade.
A-0868 14:20
Research in the artificial intelligence era: what have I learned?
A-0862 14:16
Z. Elkarghali; Amsterdam/NL
Radiography research: where should we be in 2030? (part 3)
H. Precht; Odense/DK Learning Objectives:
1. To appreciate (and welcome) the changes that are coming to research
in general and radiology in particular.
1. To explore the changing landscape in medical imaging and how this
2. To appreciate the value of multidisciplinary collaboration (in and
might influence our research.
outside of medicine).
2. To consider the future radiography profession, what it might look like
3. To learn how radiologists can leverage their unique position within
and where it might lead our research.
tumour boards and research teams.
3. To propose some research targets for our profession to work towards
over the next decade.
A-0869 14:30
Not all academic careers are planned!
A-0863 14:24
D. Prezzi; London/UK
The clinical research radiographer: essential for our profession or
facilitating the research of others? Learning Objectives:
B. Snaith; Wakefield/UK 1. To summarise the available opportunities for academic involvement in
clinical radiology.
2. To emphasise that there are more ways than one to be an academic.
1. To understand the scope of a research radiographer in clinical practice.
3. To appreciate the value of research and teaching in continuing
2. To learn how the role can improve clinical research capacity and
professional development.
capability and clinical-academic collaboration.
3. To appreciate the difference between research facilitation and the
radiographer as a clinical researcher. A-0870 14:40
Being an academic radiologist: what does this really mean in practice?
A-0864 14:42
Turning your research idea into reality: opportunities for European
funding 14:50
P. Zolda; Vienna/AT Open forum discussion: So, was it worth it?
1. To learn about EIBIR and its services for researchers.
2. To understand project management and dissemination activities of
European projects.
3. To appreciate how EIBIR can support your research project.

14:00 - 15:30 Room N 14:00 - 15:30 Room O

EuroSafe Imaging Session Cardiac
EU 5 RC 1503
Getting the balance right: radiation Cardiac imaging in structural heart
risk and imaging benefit in paediatric disease
procedures A-0876 14:00
A-0871 14:00 L. Natale; Rome/IT
C. Owens; London/UK Session Objectives:
1. To become familiar with the concept of „structural“ heart disease in
Session Objectives: modern cardiovascular medicine.
1. To learn about risk and benefits in imaging children. 2. To get an overview about the minimally invasive treatment
2. To understand the importance of an integrated approach from possibilities in structural heart diseases.
radiology and medical physics. 3. To learn about the requirements and possibilities of modern cardiac
3. To appreciate a multidisciplinary approach to imaging optimisation imaging in structural heart diseases.
and radiation protection.
A-0877 14:05
A-0872 14:05 A. CT-guided planning of minimally invasive procedures
Guidelines for the use of conventional radiographs in children and R. Salgado; Antwerp/BE
adolescents
R. Seuri; Helsinki/FI Learning Objectives:
1. To learn about the requirements prior to minimally invasive valvular
Learning Objectives: repair and other diseases.
1. To learn about the current developments in conventional radiography. 2. To outline the most appropriate imaging protocols.
2. To understand the strengths and weaknesses of each technique. 3. To gain insights into future developments in devices and minimally
invasive treatments.
A-0873 14:25
Computed tomography: are we doing enough? A-0878 14:28
E. Castellano; London/UK B. Defining the optimal time to treat valvular heart disease: role of MR
Learning Objectives: J. Mascherbauer; Vienna/AT
1. To learn about the current status of CT systems. Learning Objectives:
2. To understand the strengths and weaknesses of each CT type. 1. To outline the clinical problem and to approach treatment decision-
3. To appreciate the importance of dose optimisation and an active making in valvular heart disease.
physics programme. 2. To become familiar with the MR derived imaging biomarkers in
valvular heart disease.
A-0874 14:45 3. To discuss the possible future role of MR in outcome prediction in
Dose reduction strategies in paediatric PET/CT and PET/MR valvular heart disease.
examinations
J. Schäfer; Tübingen/DE A-0879 14:51
Learning Objectives: C. Follow-up after minimally invasive valvular repair
1. To understand the real doses involved in PET/CT and PET/MRI. H. Alkadhi; Zurich/CH
2. To appreciate relative risks of multiple examinations and highlight Learning Objectives:
benefits of the different imaging protocols. 1. To become familiar with the appropriate imaging technique after
minimally invasive valvular repair.
Saturday
A-0875 15:05 2. To learn about the different devices currently used in treatment of
Radiation safety in interventional procedures in children structural heart disease.
C. Granata; Genoa/IT 3. To become familiar with the normal outcomes and most common
Learning Objectives: procedural complications.
1. To learn about current practices in interventional radiology in children.
2. To understand the range of doses across centres. 15:14
3. To appreciate the importance of a cohesive approach. Panel discussion: How to face the challenges of the increasing demand
for imaging evaluation in structural heart disease
15:25
Discussion

14:00 - 15:30 Studio 2019 14:00 - 15:30 Room E1

Special Focus Session Special Focus Session
SF 15a SF 15b
Everything you always wanted to know Imaging in Meniere‘s disease: what to
about metabolic bone disease (but were believe and how to interpret
afraid to ask) A-0885 14:00
A-0880 14:00 J.W. Casselman; Bruges/BE
A. Bazzocchi; Bologna/IT Session Objectives:
1. To learn about clinical presentation and treatment strategies in
Session Objectives: Meniere‘s disease.
1. To become familiar and get answers to the most frequently asked 2. To discuss state-of-the-art imaging for the evaluation of
questions regarding findings that could be interpreted or misinterpreted endolymphatic hydrops.
as metabolic bone disease, with a special emphasis on bone marrow 3. To understand how to interpret MR hydrops imaging.
patterns.
2. To become familiar with DXA-based body composition assessment
A-0886 14:05
and understand the potential applications of recently developed DXA-
Meniere‘s disease: the clinician‘s perspective
based software.
A. Zarowski; Antwerp/BE
3. To become familiar with the typical and atypical features of
insufficiency fractures. Learning Objectives:
4. To learn about texture analysis and its application to bone 1. To discuss the pathophysiology of Meniere‘s disease.
architecture assessment. 2. To learn about the clinical presentation and diagnostic pitfalls.
3. To become familiar with the therapeutic options for patients with
A-0881 14:05 Meniere‘s disease.
Could „that“ be metabolic?
M.P. Aparisi Gomez; Valencia/ES A-0887 14:15
MR hydrops imaging: how to do it?
A. Attye; Grenoble/FR
1. To learn about the variety of different physiological and pathological
bone marrow patterns. Learning Objectives:
2. To understand the pathophysiological mechanisms behind changes in 1. To review different MRI techniques for investigation of endolymphatic
the bone marrow and how they translate into imaging findings. hydrops.
3. To become familiar with the most frequently asked questions 2. To present tips and tricks for state of the art imaging today.
regarding findings that could be interpreted or misinterpreted as 3. To discuss how to exclude other pathology mimicking Meniere‘s
metabolic bone disease. disease.
A-0882 14:23 A-0888 14:40

Unrevealed fractures: from missed diagnosis to opportunistic MR hydrops imaging: how to interpret it?
screening B. De Foer, A. Bernaerts; Antwerp/BE
C.R. Krestan; Vienna/AT
Learning Objectives: 1. To get acquainted with the imaging appearance of endolymphatic
1. To become familiar with the typical features of insufficiency fractures. hydrops.
2. To understand why some types of insufficiency fractures can be 2. To correlate imaging findings with clinical presentation.
missed. 3. To learn about other causes of endolymphatic hydrops.
3. To appreciate the value of opportunistic diagnosis and the potential
implications on patient management. A-0889 15:05
MR hydrops imaging: what are the benefits for the surgeon and the
A-0883 14:41 patient?
DXA: a much more powerful imaging tool than you thought A. Zarowski; Antwerp/BE
C. Messina; Milan/IT
Learning Objectives: 1. To recognise the value of endolymphatic hydrops imaging.
1. To learn about vertebral morphometry with DXA. 2. To appreciate the impact of imaging findings on therapeutic strategy.
2. To become familiar with DXA-based body composition. 3. To discuss patient outcome after different treatment strategies.
3. To understand the applicability of a recently developed DXA-based
software, the „trabecular bone score“ (TBS). A-0890 15:15
4. To understand the technical principles and the clinical utility of hip Panel discussion: Did you pick up the essentials?
structural analysis (HSA), which uses DXA data to derive measurements J.W. Casselman; Bruges/BE
of bone geometric properties at the proximal femur.
A-0884 14:59
The bone naked: texture analysis
C.M. Phan; Paris/FR
1. To learn about texture analysis and its application to bone architecture
analysis.
2. To understand how texture analysis could be used in differentiating
control subjects with normal bone density from patients with
osteoporosis and patients with hematological diseases such as multiple
myeloma.
3. To appreciate the limitations of this imaging processing.
15:17
Panel discussion: „What lies ahead...?“ The future of diagnosis of
metabolic bone disease in clinical practice

14:00 - 15:30 Room E2 14:00 - 15:30 Room F1

Special Focus Session E3 - European Diploma Prep Session
SF 15c E3 1523
Abdominal emergencies: advanced Principles of imaging and radiation
imaging in daily routine? protection
A-0891 14:00 A-0895 14:00
M. Scaglione; Castel Volturno/IT C.J. Caruana; Msida/MT

1. To understand how new technological developments can be used in 1. To understand the technical and methodological principles of
the emergency setting. computed tomography.
2. To learn specific applications of advanced imaging to investigate 2. To understand the technical and methodological principles of
abdominal emergencies. magnetic resonance tomography.
3. To understand how advanced imaging can help to reduce radiation 3. To learn the principles of radiation biology and radiation protection.
exposure.
A-0896 14:06
A-0892 14:05 A. Principles of computed tomography
Routine CT vs dual energy CT in acute abdominal pain: should we M. Kortesniemi; Helsinki/FI
change our scan protocol?
E. Danse, E. Coche; Brussels/BE Learning Objectives:
1. To understand the physical basis of image formation of computed
Learning Objectives: tomography and of the physics of helical, multidetector and dual-source
1. To learn about potential dual-energy CT applications in the acute CT.
abdomen (biliary stone, bowel wall enhancement, etc.). 2. To learn the scale of Hounsfield units and the principle of window
2. To understand how virtual non-contrast images might replace the pre- centre and width.
contrast phase. 3. To become familiar with modern CT technology.
3. To become familiar with the available material decomposition 4. To understand the principles of optimising CT protocols with a focus
reconstructions, image optimisation possibilities and radiation exposure on patient dose reduction.
concerns.
A-0897 14:34
A-0893 14:30 B. Principles of magnetic resonance imaging
CT scan vs MRI in acute abdominal pain: who do we have to send to D. Sappey-Marinier; Lyon/FR
the magnet?
I. Millet; Montpellier/FR Learning Objectives:
1. To become familiar with the physical basis of image formation in MRI
Learning Objectives: including the principles of pulse sequences and relaxation times.
1. To learn about the superior MRI performance in diagnosing 2. To become familiar with the typical appearance of tissues, organs and
specific pathologies such as acute biliary disease, pancreatitis and main pathological processes of the most commonly used sequences in
gynaecological emergencies. MRI, including T2-weighted sequences, T1-weighted sequences, STIR
2. To understand that MRI should be used as an alternative to CT for sequences, FLAIR sequences, other inversion recovery sequences, T2*- /
investigating abdominal pain in pregnant, paediatric or young adult susceptibility-weighted sequences and MR angiography sequences.
patients. 3. To learn typical artefacts on MR imaging and to discuss their
3. To become familiar with new MRI sequences that allow shorter respective causes.
examination times. 4. To understand absolute or relative contraindications against MR
imaging and safety issues in the MR environment with regard to patients
A-0894 14:55 and staff.
Saturday
CEUS in abdominal inflammatory and infectious conditions (-itis and
abscesses) A-0898 15:02
T. Fontanilla; Madrid/ES C. Radiation protection
1. To learn the CEUS image findings of acute inflammatory conditions Learning Objectives:
and their complications (gallbladder, kidney, inflammatory bowel disease 1. To understand the phenomena of x-ray interaction with matter and
and complicated diverticulitis). their effect on image quality and dose.
2. To become familiar with the indications, advantages and limitations of 2. To provide an overview of patient and staff dosimetry in diagnostic
CEUS. and interventional radiology.
3. To review technical issues from a practical standpoint. 3. To understand the basic principles of radiation protection, as outlined
by the ICRP (International Commission on Radiological Protection).
15:20 4. To become familiar with the concepts and tools for dose management
Panel discussion: New techniques in emergency radiology: where are in radiology with regard to adult and paediatric patients.
we now and where are we going?

14:00 - 15:30 Room F2 A-0904 14:05

Are all gadolinium chelates made equal? How to remove them from
Special Focus Session the body
U. Karst; Muenster/DE
SF 15d Learning Objectives:

1. To learn the chemical characteristics of gadolinium chelates.
Navigating tumour phenotype with 2. To appreciate the elimination kinetics in all body organs.
3. To understand the principles of chelation therapies.
advanced imaging analysis
A-0905 14:10
A-0899 14:00 Is gadolinium deposition a real disease?
Chairperson‘s introduction A. Radbruch; Heidelberg/DE
Session Objectives: 1. To learn about the differences between gadolinium elimination kinetics
1. To become familiar with the concept of tumour microenvironment and and this new described entity.
habitat imaging. 2. To appreciate how it is difficult to diagnose.
2. To learn what information habitat imaging and radiomics can provide 3. To learn about the research hypothesis.
on tumour heterogeneity.
3. To understand how machine learning and artificial intelligence can be A-0906 14:15
used in radiomics. Patient information, lawyers and gadolinium phobia: how to deal with
it
A-0900 14:05 H.S. Thomsen; Herlev/DK
Understanding tumour micro environment: the role of habitat imaging
J. O‘Connor; Manchester/UK Learning Objectives:
1. To learn about the crisis of gadolinium chelates over the last 10 years.
Learning Objectives: 2. To understand how benefits can outweigh the risks.
1. To understand the concept of tumour microenvironment. 3. To become familiar with how to handle gadolinium phobia in a patient.
2. To become familiar with habitat imaging analysis tools.
3. To learn what information habitat imaging can provide on tumour 14:20
heterogeneity. Open forum discussion: Which future for gadolinium chelates?
A-0901 14:30
Unravelling tumour heterogeneity using radiomics 14:00 - 15:30 Room D
Vascular
1. To learn the definition of radiomics and radiomics tools available.
2. To understand what information radiomics can provide on tumour RC 1515
heterogeneity.
3. To understand how the radiomics features may relate to tumour
No time to lose: aortic disease, revisited
biology and microenvironment. Moderator:
M. Krokidis; Cambridge/UK
A-0902 14:55
Role of machine learning (ML) and artificial intelligence (AI) for A-0907 14:00
quantitative radiomics A. Diagnosis and treatment of abdominal aortic aneurysms
W.J. Niessen; Rotterdam/NL F. Wolf; Vienna/AT

1. To understand how machine learning can be used to extract radiomic 1. To learn about the definition and classification of abdominal aortic
features. aneurysms.
2. To learn how artificial intelligence can be used in radiomics. 2. To understand the relevant information and measurement to plan an
3. To become familiar with available artificial intelligence algorithms that endovascular aortic repair.
can be used to integrate radiomics with other patient data. 3. To get familiar with the different possibilities of endovascular
treatment including anchors, snorkels, branches and chimneys.
15:20
Panel discussion: Can advanced imaging analysis and imaging A-0908 14:30
integration with omics add significant value to standard clinical and B. Acute diagnosis and imaging in aortic dissection
genomic data? R. Iezzi; Rome/IT
14:00 - 15:00 Coffee & Talk 3 1. To learn about definition and classification of aortic dissections and
subtypes.
Coffee & Talk (open forum) Session 2. To understand the importance of accurate diagnosis for appropriate
treatment planning.
3. To appreciate the need for acute diagnosis and treatment indication.
C 19
Gadolinium deposition in tissues: current A-0909 15:00
C. Endovascular treatment in aortic dissection
evidence and alternatives J.P. Schäfer; Kiel/DE
A-0903 14:00 1. To learn about endovascular treatment possibilities for aortic
dissections.
2. To understand the role of radiology in modern treatment of aortic
Session Objectives: dissections.
1. To understand the different meanings of gadolinium deposition. 3. To appreciate the need to combine the radiological information with
2. To learn about the different elimination routes of gadolinium chelates. the clinical situation.
3. To appreciate patient information and awareness concerning
gadolinium chelates.

14:00 - 15:30 Room G A-0916 14:31

C. Lobar atelectasis
Physics in Medical Imaging D. Tack; Baudour/BE
RC 1513 1. To review the signs of lobar atelectasis on frontal chest radiograph.
2. To learn about the complementary role of lateral view.
Demystifying MRI: things you always 3. To explain the differences with other causes of lung opacity.
wanted to know A-0917 14:44

Moderator: D. Pleural syndrome
I. Seimenis; Alexandropolis/GR A.P. Parkar; Bergen/NO
Session Objectives: 1. To learn how to identify partial pneumothorax.
1. To learn about the basic concepts of NMR and relaxation. 2. To be able to identify signs of compressive pleural effusion.
2. To understand how MR images are produced. 3. To be aware of the limitations of bedside chest x-ray for
3. To learn about standard MRI pulse sequences. pneumothorax detection.
A-0910 14:00 A-0918 14:57

A. Basic MR: the building blocks of pulse sequences E. Mediastinal syndrome
A. Webb; Leiden/NL M. Occhipinti; Florence/IT
1. To learn about how NMR signals are produced. 1. To review the normal mediastinal lines.
2. To understand the basic concepts of relaxation. 2. To learn about the normal and abnormal mediastinal contour.
3. To learn about the operation of inversion-recovery and spin-echo 3. To know how to use the silhouette sign to localise mediastinal
pulse sequences. opacities.
A-0911 14:30 15:10

B. MR imaging basic concepts: how to turn signals into images Panel discussion: Why does the chest radiograph remain essential in
D.J. Lurie; Aberdeen/UK the context of expanding cross-sectional imaging?
1. To learn how magnetic field gradients encode spatial information. 14:00 - 15:30 Room M 5
2. To understand the main ways in which field gradients are used.
3. To appreciate the basic concepts of data collection and image Transatlantic Course of ESR and RSNA (Radiological Society
reconstruction in MRI. of North America): Sports Imaging
A-0912 15:00
C. Practical MRI: a toolkit of standard MR pulse sequences TC 1528
G. Hagberg; Tübingen/DE
Knee sports injuries and postoperative MRI
1. To learn about common types of MR pulse sequence. L.W. Bancroft; Orlando, FL/US
2. To understand the difference between gradient-echo and spin-echo. A.J. Grainger; Leeds/UK
3. To appreciate the factors influencing choice of pulse sequence.
A-0919 14:00
14:00 - 15:30 Room K A. Sports-related injuries of the knee: what does the orthopaedic
surgeon need to know?
Chest T.T. Miller; New York, NY/US
Saturday
RC 1504 1. To learn about what to include in knee MRI dictation templates.
2. To understand the most common sports-related injury patterns in the
Back to basics: how to interpret a chest knee.
3. To appreciate which specific orthopaedic indications should prompt
radiograph? additional information in the dictation.
A-0913 14:00 A-0920 14:30

Chairperson‘s introduction B. ACL reconstruction and cartilage repair
S.P.G. Padley; London/UK C. Weidekamm; Vienna/AT
1. To increase the radiologists‘ confidence in chest radiography reading. 1. To review the common and uncommon ACL reconstruction
2. To recognise and interpret the typical abnormalities. techniques.
3. To understand the limitations of chest radiography. 2. To appreciate the expected and abnormal MR imaging findings after
ACL reconstruction.
A-0914 14:05 3. To understand common cartilage repair techniques, and
A. A chest radiography reading guide corresponding normal and abnormal postoperative MRIs.
N. Howarth; Chêne-Bougeries/CH
Learning Objectives: A-0921/A-0922 15:00

1. To learn about chest radiograph quality criteria. C. Interactive case discussion
2. To learn about the normal features. T.T. Miller; New York, NY/US C. Weidekamm; Vienna/AT
2. To learn which difficult areas to concentrate on. Learning Objectives:
1. To appreciate common patterns of athletic injury in the knee.
A-0915 14:18 2. To become familiar with the diagnostic features of failed ACL
B. Alveolar, interstitial and nodular syndromes reconstructions, intact and failed cartilage repair.
F. Molinari; Lille/FR 3. To consolidate the knowledge gained from the session with interactive
Learning Objectives: cases of pre- and postoperative MRI.
1. To learn about alveolar opacities characteristics.
2. To learn how to recognise the presence of interstitial changes.
3. To understand the chest radiograph limitations for lung nodule detection.

16:00 - 17:30 Room A 16:00 - 17:30 Room C

E3 - ECR Academies: Interactive Teaching Session for Young Joint Session of the ESR and EFRS
ESR/EFRS
E3 1621 Patient safety in medical imaging
Paediatric radiology for the general Moderators:
A. Brady; Cork/IE
radiologist J. McNulty; Dublin/IE
A-0923 16:00 A-0928 16:00
A. Pitfalls in paediatric chest and abdomen
EuroSafe Imaging and the European Basic Safety Standards Directive:
M. Raissaki; Iraklion/GR
progressing patient safety
Learning Objectives: G. Frija; Paris/FR
1. To review the basic principles of the paediatric chest radiographs
through common mistakes.
1. To explore the aims and objectives of EuroSafe Imaging and its
2. To emphasise pitfalls when imaging the paediatric abdomen.
achievements to date.
3. To learn to avoid the most common pitfalls.
2. To appreciate aspects of the Basic Safety Standards Directive, which
will further progress patient safety.
A-0924 16:45 3. To consider what the future holds for EuroSafe Imaging.
B. Paediatric MSK imaging: normal variants or real injuries?
F. Saez; Barakaldo/ES
A-0929 16:16
Learning Objectives: Patient safety: beyond radiation protection
1. To become familiar with the normal variants. K. Azevedo; Faro/PT
2. To identify the key imaging findings to differentiate between normal
variants and disease.
1. To appreciate the scope of patient safety related to medical imaging
3. To learn how to integrate age, location and clinical history with the
services.
radiological features before establishing a diagnosis.
2. To consider a selection of examples of patient safety beyond radiation
protection, optimisation and justification.
16:00 - 17:30 Room B 3. To explore the important roles of radiographers and radiologists in
working collaboratively to best ensure patient safety.
GI Tract
A-0930 16:32
Value-based imaging and patient safety
RC 1601 A. Brady; Cork/IE
Diagnosis and management of acute Learning Objectives:
1. To learn about the developing model of value-based healthcare.
pancreatitis 2. To appreciate how and why radiology should be included in this model.
Moderator: 3. To understand how this may impact upon patient safety.
C. Triantopoulou; Athens/GR
A-0931 16:48
A-0925 16:00 Patient safety related education and training
A. The 2012 revised Atlanta Classification: what has really changed? J. McNulty; Dublin/IE
T.L. Bollen; Nieuwegein/NL
Learning Objectives: 1. To emphasise the importance of education and training in progressing
1. To be aware of the new terminology for the evaluation of acute patient safety in medical imaging.
pancreatitis. 2. To consider the current status of patient safety in radiography and
2. To learn about how to report imaging findings. radiology curricula.
3. To understand the relationship between imaging findings and 3. To appreciate the activities of the EFRS and ESR in the area of patient
prognosis. safety education and training.
A-0926 16:30 A-0932 17:04

B. Role of imaging in diagnosis of acute pancreatitis: new trends Patient perspectives on patient safety in medical imaging
G. Zamboni; Verona/IT E. Briers; Hasselt/BE
1. To learn about the proper timing of imaging studies in acute 1. To understand what patients feel about patient safety in medical imaging.
pancreatitis. 2. To appreciate the value of active engagement with patients to
2. To learn about the imaging manifestations of necrotising pancreatitis. enhance and promote patient safety.
3. To understand the different nature of fluid collections with regard to 3. To consider initiatives to implement patient-engagement at the
further therapy. institutional or national level.
A-0927 17:00 17:20

Panel discussion: The role of the ESR and the EFRS in promoting
C. Intervention radiology in acute pancreatitis: why, when and how
patient safety
M.M. Maher; Cork/IE
1. To learn indications for interventions and type of complications that
requires treatment.
2. To understand how likelihood of success of these interventions vary
with severity.
3. To review management of local complications of pancreatitis by

16:00 - 17:30 Room N 16:00 - 17:30 Room O

EuroSafe Imaging Session Cardiac
EU 6 RC 1603
CT radiation risk in children: an overview Acute chest pain and cardiac imaging
Moderator:
A-0933 16:00 P. Croisille; Saint-Etienne/FR
E. Cardis; Barcelona/ES A-0938 16:00
Session Objectives: A. Acute chest pain: who should see the patient first, the doctor or the
1. To learn about the radiological protection issues related to CT CT department?
scanning in paediatric populations. M. Gutberlet; Leipzig/DE
2. To understand the state-of-the-art in radiation induced detriment Learning Objectives:
from scanning. 1. To become familiar with existing clinical triage scores in acute chest
3. To appreciate the need for optimisation in paediatric CT scanning. pain and their strengths and weaknesses.
2. To learn about the potential of cardiac CT in the management of
A-0934 16:05 acute chest pain patients.
A literature update 3. To outline recent updates and future developments for triaging
H. Ducou Le Pointe; Paris/FR patients with acute chest pain.
1. To learn about the nature of the risk of CT for children. A-0939 16:30
2. To understand how the risk is evaluated. B. Myocardial perfusion in acute coronary syndrome (ACS): necessity
3. To appreciate the difficulty to draw conclusions based on the or luxury?
literature analysis. R. Vliegenthart; Groningen/NL
A-0935 16:25 1. To introduce the acquisition techniques of myocardial imaging: nuclear
Ongoing studies and first results of the European EPI-CT study imaging, MRI, CT.
E. Cardis; Barcelona/ES 2. To become familiar with the challenges in using myocardial perfusion
in the acute setting.
3. To discuss the possible role of perfusion imaging in acute coronary
1. To learn about the largest epidemiological study (1 million patients)
syndromes.
of the health impact of CT radiation in young people and ongoing
complementary studies.
2. To understand strengths and limitations of the study and to discuss A-0940 17:00
the results. C. Late gadolinium enhancement (LGE) and more: the role of MRI in
3. To appreciate the study‘s implications for optimisation in paediatric and after ACS
imaging. J. Bremerich; Basle/CH
A-0936 16:45 1. To become familiar with the technique of late gadolinium
Communicating benefits and risks to parents and carers enhancement.
C. Granata; Genoa/IT 2. To learn about quantitative assessment of LGE.
3. To learn about the predictive power of LGE in ACS.
1. To learn how to establish a dialogue in a clinical setting with parents
and carers. 16:00 - 17:30 Studio 2019
2. To understand goals and challenges of communicating risks and
benefits of CT studies in children. State of the Art Symposium
3. To appreciate the importance of parent and caregiver-centred
Saturday
communication.
SA 16
A-0937 17:05
Daily practical challenges in CT for children
Breast cancer screening and treatment:
C. Owens; London/UK how much is too much?
1. To learn about the potential challenges and obstacles faced when A-0941 16:00
performing CT in children. Chairperson‘s introduction
2. To understand how to tackle these challenges. G. Forrai; Budapest/HU
3. To appreciate the tips and tricks which can assist in acquisition of Session Objectives:
diagnostic CT images in children. 1. To understand the epidemiological issues of screening.
2. To understand that there are lesions not to be recalled from screening.
17:25 3. Learn about ‚active monitoring‘ as a new treatment option.
Questions and answers
A-0942 16:05
Overdiagnosis in breast cancer screening: the epidemiologist‘s view
S.W. Duffy; London/UK
1. To learn about estimation of overdiagnosis with minimal assumptions.
2. To understand the potential biases in estimating favourable and
unfavourable effects of screening.
3. To appreciate the connection between the epidemiological definition
of overdiagnosis and its clinical implications.
4. To understand the arguments for and against organised screening
programmes.

A-0943 16:28 16:00 - 17:30 Room E2

What can the radiologist do to limit overdiagnosis?
R.M. Pijnappel; Utrecht/NL Neuro
1. To estimate test sensitivity in relation to programme sensitivity in
screening.
RC 1611
2. To learn what the optimal test for population based screening is: The degenerative cervical spine
FFDM or tomosynthesis in relation to overdiagnosis.
Moderator:
3. To understand that there are lesions not to be recalled from screening.
N. Chidambaranathan; Chennai/IN
4. To learn the place of the ultrasound of the axilla: in BI-RADS 4, 5 or
never?
A-0948 16:00
A. Degenerative uncovertebral and facet disease
A-0944 16:51
Are there breast cancers we do not have to treat?
M.G. Wallis; Cambridge/UK Learning Objectives:
1. To learn about the physiological and pathophysiological degeneration
of the cervical spine.
1. To review side effects of current treatments.
2. To understand the role of imaging in the diagnosis and clinical
2. To be able to discuss what lesions we could consider reducing
decision making in the degenerative cervical spine.
treatment burden.
3. To appreciate the clinical relevance of imaging findings in the
3. To learn about radiological options to the current surgical treatment
degenerative cervical spine.
paradigm.
4. To learn about ‚active monitoring‘ as a new treatment option.
A-0949 16:30
B. Cervical spinal stenosis and cervical spondylotic myelopathy
17:14
A.S. Gersing; Munich/DE
Panel discussion: Which one is the real villain, overdiagnosis or
overtreatment? For what reason breast screening and diagnostics is Learning Objectives:
blamed? 1. To learn about the pathophysiology and imaging findings in spinal
stenosis and cervical spondylotic myelopathy.
16:00 - 17:30 Room E1 2. To understand the relation between imaging findings and clinical
presentation.
E3 - ECR Master Class (Musculoskeletal) 3. To appreciate the importance of imaging findings and the clinical
presentation with respect to possible treatment options.
E3 1626a A-0950 17:00

C. The postoperative cervical spine
State-of-the-art imaging of S. Looby; Dublin/IE
postoperative joints Learning Objectives:
Moderator: 1. To learn about the imaging findings and pitfalls of postoperative
M.F. Reiser; Munich/DE cervical spine imaging.
2. To understand the heterogeneity of imaging findings and their clinical
A-0945 16:00 relevance.
A. Postoperative shoulder 3. To appreciate the importance of standardised imaging, interpretation
C.W.A. Pfirrmann; Zurich/CH and reporting of postoperative imaging findings in the cervical spine.
1. To explain the most frequently used surgical techniques for 16:00 - 17:30 Room F1
glenohumeral instability, subacromial decompression, rotator cuff repair
and arthroplasty, and their imaging appearance.
E3 - European Diploma Prep Session
2. To describe potential postoperative complications.
A-0946 16:30 E3 1623

B. Postoperative knee Chest
A-0951 16:00
1. To explain the most frequently used surgical techniques for meniscal
repair, ligament reconstruction and cartilage repair.
2. To describe potential postoperative complications. Session Objectives:
1. To understand the most important signs in chest imaging.
A-0947 17:00 2. To learn the imaging features of benign and malignant lesions of the lung.
C. Postoperative ankle and foot 3. To become familiar with the imaging appearance of common lesions
M.J. Ereño Ealo; Galdacano/ES of the mediastinum, pleura and chest wall.
4. To understand the role of different imaging modalities including
hybrid imaging in diagnosing and staging neoplasms of the chest.
1. To explain the most frequently used surgical techniques for
osteosynthesis, instability, tendon repair and arthroplasty, and their
imaging appearance.
A-0952 16:06
A. Fundamentals of chest imaging
2. To describe potential postoperative complications.
1. To learn the anatomy and normal variants of the respiratory system,
heart and vessels, mediastinum and chest wall and to confidently
identify these on radiographs, CT and MRI.
2. To gather an in-depth understanding of the most common chest
radiography signs (including silhouette sign, air bronchogram, air
crescent sign, cervicothoracic sign, tapered margins, gloved finger sign,
golden sign, deep sulcus sign).
3. To learn the appearance and correct position of monitoring and
support devices (tubes and lines).

A-0953 16:34 A-0958 16:42

B. Inflammation and tumours of the lung Physical or virtual multidisciplinary meetings?
A. Nair; London/UK E. Neri; Pisa/IT

1. To understand the imaging features and differential diagnoses of 1. To understand the trade-offs of physical and virtual meetings.
diffuse infiltrative and alveolar lung disease and atelectasis. 2. To learn how to best set up remote access to a multidisciplinary
2. To become familiar with thoracic diseases in immunocompetent, meeting.
immunocompromised and post-transplant patients. 3. To understand how to organise and structure regional
3. To become familiar with the differentiation of solitary and multiple multidisciplinary tumour board meetings.
pulmonary nodules, benign and malignant neoplasms, hyperlucencies
and their potential aetiology and evaluation. A-0959 17:00
4. To understand the role of different imaging modalities including Maximising the added value of tumour boards
hybrid imaging in diagnosing and staging neoplasms of the chest. C.D. Becker; Geneva/CH

C. Mediastinum, pleura and chest wall 1. To understand the role and challenges of institutional multidisciplinary
A.P. Parkar; Bergen/NO guidelines including imaging.
2. To learn about integrating diagnostic information before tumour
Learning Objectives: board meetings.
1. To become familiar with the imaging features of common pathologies 3. To learn how to include the role of interventional radiology in tumour
of the diaphragm, pleura and chest wall on radiography, CT and MRI of board meetings.
the chest.
2. To learn the imaging features and causes of mediastinal and hilar 17:18
diseases. Panel discussion: How to strengthen the role of the radiologist in
3. To understand the imaging features of disorders of the pulmonary multidisciplinary tumour boards while keeping workload under control
vascular system and great vessels.
4. To learn the typical imaging features of the postoperative chest.
16:00 - 17:30 Room Y
16:00 - 17:30 Room F2 E3 - Rising Stars Programme: EFRS Radiographers‘ Basic

Session
New Horizons Session
NH 16 BR 16
Radiation protection: all you need to
The tumour board of the future
know
A-0955 16:00
Chairperson‘s introduction A-0960 16:00
M. Prokop; Nijmegen/NL Chairperson‘s introduction: Evolving radiographers‘ role in radiation
protection
Session Objectives: B.R. Mussmann; Odense/DK
1. To learn how to structure a tumour board for maximum efficiency and
effectiveness. Session Objectives:
2. To learn how to incorporate modern Information management tools 1. To understand radiographers‘ current legal responsibilities regarding
for a multidisciplinary meeting. radiation protection.
3. To understand current risks and problems and how they affect the 2. To consider the role radiographers play in application of the
role of the radiologist. justification principle.
3. To review recent optimisation techniques for projection radiography.
A-0956 16:06 4. To appreciate how radiographers can best communicate risk-benefit
How to set up and run a multidisciplinary meeting information to patients.
Saturday
A-0961 16:05
Learning Objectives: The Basic Safety Standards Directive: early experiences of
1. To learn how to best structure a multidisciplinary meeting to avoid implementing BSS
wasting time. S.J. Foley; Dublin/IE
2. To appreciate the various roles in a multidisciplinary meeting and how
they influence meeting organisation. Learning Objectives:
3. To learn how to integrate modern tools for improved data collection, 1. To familiarise attendees with the European BSS Directive (2013/59).
communication and evaluation in tumour boards. 2. To discuss the additional responsibilities of radiographers and
radiologists under the Directive.
A-0957 16:24 3. To understand how the implementation of the BSS Directive may
Preparation for tumour boards: how to increase efficiency of the affect practice.
radiologist?
D. Regge; Turin/IT A-0962 16:23
Enhancing the culture of justification
Learning Objectives: K.B. Lysdahl; Kongsberg/NO
1. To learn how effectively prepare for a multidisciplinary tumour board
meeting. Learning Objectives:
2. To appreciate the clinician‘s perspective and understand the 1. To appreciate the key role of justification within radiation protection.
expectations towards the radiologist. 2. To be familiar with the role radiographers can play in justification.
3 To learn how to concisely and efficiently communicate relevant 3. To consider initiatives for improving adherence to the principle of
findings. justification.

A-0963 16:41 16:00 - 17:30 Room D

Opportunities for optimising dose in digital radiography
P.H. Hogg; Salford/UK Musculoskeletal
1. To discuss the limitations of image quality as a parameter for use in
optimising dose in medical imaging examinations.
RC 1610
2. To discuss a range of visual and physical techniques that can be used The old spine: challenges of imaging and
to assess medical image quality.
3. To discuss a range of practical measures which might be implemented treatment
to minimise radiation dose whilst maintaining a level of image quality Moderator:
that is fit for purpose. R. Pedersen; Toensberg/NO
A-0964 16:59 A-0969 16:00

The radiographers‘ role in benefit-risk communication A. Degeneration of the old spine: relevance of findings and differential
J. Portelli; Msida/MT diagnosis
1. To understand new legislative requirements under the BSS Directive. Learning Objectives:
2. To be aware of the key role radiographers play in benefit-risk 1. To explain the pathophysiology of degenerative changes in the spine.
communication. 2. To describe the imaging findings of degenerative diseases of the spine.
3. To understand key principles for appropriate benefit-risk
communication. A-0970 16:30
B. Fractures: bone fragility in the elderly, assessing osteoporosis and
17:17 bone quality and differential diagnosis
Panel discussion: Teamwork in radiation protection G. Guglielmi; Andria/IT
16:00 - 17:00 Coffee & Talk 3 1. To explain the pathophysiology of osteoporosis in the spine.
2. To describe the imaging findings of spinal osteoporosis and its
consequences.
C 21 A-0971 17:00
C. Interventional radiology: is there still a place for vertebroplasty and
How to enhance the role of junior kypho-/stentoplasty
C. Binkert; Winterthur/CH
radiologists in Europe
A-0965 16:00 1. To explain the procedures of vertebroplasty and kyphoplasty.
Chairperson‘s introduction 2. To discuss the current role of vertebroplasty and kyphoplasty in spinal
C. Catalano; Rome/IT fractures.
Session Objectives:
1. To learn how to manage and succeed in research. 16:00 - 17:30 Room M 1
2. To learn how to create networks. MT
3. To understand how to start at home what you have learned abroad.
Joint Session of the ESR and ESHI
A-0966 16:05
The beauty of Europe: my Erasmus+ experience and my thesis abroad
ESR/ESHI(MT)
G. De Rubeis; Rome/IT Hybrid and translational imaging:
Learning Objectives: the bigger picture
1. To learn how to start during medical school.
2. To understand how to get involved in a research project. A-0972/A-0973 16:00
3. To appreciate the advantages of preparing a collaboration thesis. Chairpersons‘ introduction
O. Ratib; Geneva/CH
Oh, the United States: a research experience before radiology
B. Wichtmann; Mannheim/DE Session Objectives:
1. To illustrate examples of clinical relevance for hybrid imaging.
Learning Objectives: 2. To highlight the translational aspects of hybrid imaging.
1. To learn the advantages of a basic science fellowship before starting 3. To introduce the session faculty and objectives of the presentations.
radiology.
2. To understand the advantages of an overseas research training. A-0974 16:05
3. To explain how to create networks. Prostate-specific membrane antigen (PSMA) PET/MR: guiding clinical
management of prostate cancer
A-0968 16:21 P.A.T. Baltzer; Vienna/AT
I love ESOR: my 1 year fellowship
M. Lisitskaya; Aalborg/DK Learning Objectives:
1. To learn about the requirements in clinical management of prostate
Learning Objectives: cancer.
1. To learn about ESR and ESOR opportunities for trainees. 2. To understand the potential role of PSMA PET/MR in the management
2. To understand the importance of research during training. of prostate cancer.
3. To learn how to start abroad and continue at home. 3. To learn about the advantages of the hybrid PET/MR technique in this
setting.
16:29 4. To become familiar with typical findings and pitfalls of hybrid PSMA
Open forum discussion PET/MR in the evaluation of prostate disease.

A-0975 16:30 A-0981 16:59

On the horizon: novel PET tracers with translational potential Do you need help? Train the cardiologist, neurosurgeon, interventional
G. Cook; London/UK radiologist
T.J. Popiela; Krakow/PL
1. To become familiar with future targets in oncologic hybrid imaging. Learning Objectives:
2. To learn how hybrid imaging can support the oncologist in diagnosis 1. To provide an overview about the situation in Poland: who is doing the
and therapy response assessment. endovascular stroke service and who will do it in future?
2. To outline possible problems to ensure continuous service 24/7.
A-0976 16:50 3. To discuss the role of interventional (neuro) radiologists as trainer for
Advances in theragnostics: monitoring radionuclide therapy other disciplines.
H. Ilhan; Munich/DE
17:17
Learning Objectives: Panel discussion: The output (outcome) counts, not the input
1. To learn the principles of radionuclide imaging and therapy in the (specialisation)
concept of theragnostics.
2. To understand the differences and common ground between
morphological and molecular imaging. 16:00 - 17:30 Room M 3
3. To discuss new approaches for response assessment in radionuclide
therapy. E3 - ECR Master Class (Chest)
17:10
Panel discussion: Hybrid imaging beyond FDG and theranostics: is it a E3 1626b
clinical reality? Patterns of pulmonary toxicity
Moderator:
16:00 - 17:30 Room M 2 I.E. Tyurin; Moscow/RU
Professional Challenges Session A-0982 16:00

A. Drug-induced lung disease
PC 16 C.M. Schaefer-Prokop; Amersfoort/NL
How to organise nationwide ischaemic 1. To learn about the various CT patterns of lung injury.
stroke care (and make multidisciplinary 2. To understand the role of imaging in their recognition.
3. To discuss differential diagnoses.
teams work)
A-0983 16:30
A-0977 16:00 B. Smoking-related lung disease
Chairperson‘s introduction: Stroke care in Austria: small country, small S.R. Desai; London/UK
challenge?
C. Loewe; Vienna/AT Learning Objectives:
1. To learn about the classification of smoking-related lung diseases.
Session Objectives: 2. To understand the most common CT patterns.
1. To discuss the challenges in establishing and running a nationwide 3. To highlight newly-recognised entities.
ischaemic stroke care.
2. To realise the importance of multidisciplinary team work for successful A-0984 17:00
stroke care service. C. Inhalation: lung injury beyond smoking
3. To learn about possible training, education and certification in J.A. Verschakelen; Leuven/BE
ischaemic stroke care.
A-0978 16:05 1. To learn about the various causes of environmental lung diseases.
What you should know being involved in a nationwide ischaemic 2. To understand the changes related to acute lung injury.
Saturday
stroke service 3. To describe the long-term sequelae of inhalation lung injury.
16:00 - 17:30 Room M 4
1. To provide an overview about recent data/guidelines about Multidisciplinary Session
endovascular stroke treatment.
2. To get familiar with the currently accepted/recommended treatment
options.
3. To give an outlook about ongoing trials.
MS 16
How to deal with the epidemics of
A-0979 16:23
Do you like to travel? Move the patient or the doctor? thyroid nodules?
A-0985 16:00
1. To provide an overview about institutional requirements for a A.S. Germano; Amadora/PT
successful endovascular stroke care.
2. To discuss possible solutions including moving the patient to an Session Objectives:
interventional centre or move the doctor to the patient. 1. To understand the concept of the world epidemics of thyroid nodules.
3. To outline the „ideal world“ scenario. 2. To learn about the reasons for this epidemic.
3. To be updated on current guidelines as to how to deal with thyroid
A-0980 16:41 nodules.
Are you experienced, trained or certified? Certification, 4. To explain the indeterminate diagnosis on cytology and histology.
subspecialisation, specialisation: friend or foe of the patient? 5. To discuss approaches to reduce/stabilise the incidence of thyroid
A. Berlis; Augsburg/DE nodules detection.
1. To get an overview about different certification programmes in
interventional stroke treatment.
2. To discuss the risks and benefits for the patients of dedicated
certifications, ensuring continuous service for the future.
3. To get familiar with possible future concepts of training and education.

A-0986 16:05 A-0992 16:30

The endocrinologist perspective B. Injectables, percutaneous tendon fenestration and tenotomy:
I. Sapinho; Amadora/PT clinical outcomes and current evidence
J.A. Jacobson; Ann Arbor, MI/US
1. To understand the causes of high prevalence of thyroid nodules Learning Objectives:
worldwide. 1. To be aware of the indications and benefits of available injectables
2. To outline the diagnostic pathway of a patient with a thyroid nodule. used to treat sports-related injuries.
3. To be aware of the problem of overdiagnosis. 2. To learn about technical considerations for performing tendon
4. To recognise the rare emergencies related with thyroid nodules. fenestration and tenotomy.
3. To become familiar with the current evidence on results of MSK
A-0987 16:20 procedures in the literature.
The radiologist role
A.S. Germano; Amadora/PT A-0993/A-0994 17:00
C. Interactive case discussion
Learning Objectives: P. Peetrons; Brussels/BE
1. To become familiar with the current guidelines for ultrasound malignancy J.A. Jacobson; Ann Arbor, MI/US
risk stratification of thyroid nodules-emphasis on the EU-TIRADS.
2. To learn how to deal with the incidentally detected thyroid nodules in Learning Objectives:
other imaging modalities. 1. To learn the targeted approach to injecting joints, ligaments, tendons
3. To understand the concept of „active surveillance“ of thyroid nodules. and tendon sheaths.
2. To appreciate pitfalls to avoid in MSK procedures for treatment of
A-0988 16:35 sports-related injuries.
The surgeon intervention 3. To understand evidence-based data on various MSK procedures in
M. Allen; Amadora/PT order to give patients realistic expectations after treatment.
1. To know when to send a patient to surgery. 16:00 - 17:30 Tech Gate Auditorium
2. To understand what the surgeon needs to know before performing a
thyroidectomy. Genitourinary
3. To be aware of potential surgical risks and complications.
A-0989 16:50 RC 1607

The pathologist assessment Renal transplantation
P. Borralho; Amadora/PT

1. To appreciate the utility of conjoint ultrasound/cytology evaluation of Chairperson‘s introduction
thyroid nodules. T. El-Diasty; Mansoura/EG
2. To understand the cytology diagnosis limits: The Bethesda System. Session Objectives:
3. To learn about the indeterminate histology diagnosis: WDT-UMP and 1. To become familiar with the role of imaging in the selection of renal donors.
NIFTP. 2. To understand the role of imaging in transplant dysfunction and other
4. To recognise the pathologist contribution to the epidemics: the abnormalities.
incidentally detected microcarcinomas. 3. To illustrate the capabilities of Interventional Radiology in renal
transplantation.
A-0990 17:05
Multidisciplinary case presentation and discussion: „The thyroid-team A-0996 16:05
decision: when to follow and when to go beyond the guidelines“ A. Preoperative evaluation of donors (cadaveric or living)
A.S. Germano; Amadora/PT C. Nicolau; Barcelona/ES
1. To learn the rationale for multidisciplinary decision-making in standard 1. To learn about CT/MR techniques in evaluation of cadaveric and living
situations. renal donors.
2. To discuss challenging diagnosis cases. 2. To learn about the role of imaging in the selection process of renal donors.
3. To understand the role of image post-processing in planning
16:00 - 17:30 Room M 5 transplantation.
Transatlantic Course of ESR and RSNA (Radiological Society A-0997 16:28

of North America): Sports Imaging B. Multiparametric US for diagnosis and intervention
D.Y. Huang; London/UK
TC 1628 Learning Objectives:

1. To be familiar with the appearance of renal transplant dysfunction at
Musculoskeletal interventional multiparametric US.
2. To understand the role of US modes in other renal transplant
procedures abnormalities, such as stone disease, tumours and inflammatory or
Moderators: ischaemic changes.
L.W. Bancroft; Orlando, FL/US 3. To understand the limitations of US modes in renal imaging and
A.J. Grainger; Leeds/UK intervention.
A-0991 16:00 A-0998 16:51

A. Diagnostic and therapeutic injections in the athlete: pearls and pitfalls C. CT/MRI/angiography for diagnosis and intervention
P. Peetrons; Brussels/BE A. Coutinho Santos; Lisbon/PT

1. To become familiar with the most common requests and indications 1. To learn about the CT/MRI appearance of renal transplant dysfunctions.
for sports-related injections. 2. To understand the role of CT/MRI/angiography for interventional
2. To learn about technical considerations for performing MSK injections. procedures.
3. To understand reasons to delay injections or avoid certain injectables. 3. To understand the role of CT/MRI/angiography modes in other renal
transplant abnormalities.
17:14
Panel discussion: Could imaging reduce the need for renal graft
biopsy?

08:30 - 10:00 Room A 08:30 - 10:00 Room C

E3 - ECR Academies: Interactive Teaching Session for Young General Radiography (Radiographers)
E3 1721 RC 1714
Ultrasound: continuing to make waves
Head and neck imaging Moderators:
T. Herlihy; Dublin/IE
A-0999 08:30 S.B. Grover; New Delhi/IN
A. Cystic neck lesions
A. Borges; Lisbon/PT
Session Objectives:
Learning Objectives: 1. To review technological changes in an ultrasound that facilitates
1. To become familiar with the differential diagnosis. advanced scanning.
2. To know the usefulness of biochemistry of FNA in the differential 2. To understand the current best use of ultrasound in early pregnancy.
diagnosis. 3. To appreciate the emerging role of ultrasound in biomechanics and
elite sport.
A-1000 09:15
B. Non-traumatic head and neck emergencies A-1005 08:30
A. Rovira-Cañellas; Barcelona/ES A. Technology advances: from 3D to elastography
M.R.V. Pedersen; Vejle/DK
1. To become familiar with the most common cause of emergencies. Learning Objectives:
2. To learn the imaging criteria for differentiation. 1. To review the technological advances underpinning 3D ultrasound
scanning.
2. To understand the technical basis and clinical applications of
08:30 - 10:00 Room B
elastography.
Abdominal Viscera 3. To become familiar with the future advances in ultrasound scanning.
A-1006 09:00
RC 1701 B. Early pregnancy guidelines
S. Riaz; Manchester/UK
Hepatocellular carcinoma:
from diagnosis to treatment 1. To review current guidelines and indications for early pregnancy
scanning.
A-1001 08:30 2. To understand essential requirements for optimal imaging.
Chairperson‘s introduction 3. To become familiar with pitfalls in imaging in early pregnancy.
G. Brancatelli; Palermo/IT

1. To become familiar with the international guidelines for HCC diagnosis. C. Role of ultrasound in biomechanics and sports science
2. To understand the typical and atypical appearance of HCC. R. Santos; Coimbra/PT
3. To learn why, when and how to treat HCC with interventional techniques.
1. To review the current role of ultrasound in elite sport.
A-1002 08:35 2. To understand the challenges when using ultrasound for evaluating
A. How to diagnose HCC: new guidelines human performance.
K. Fowler; San Diego, CA/US 3. To become familiar with best practice guidelines imaging in sport /
Learning Objectives: biomechanics.
1. To learn the imaging features and criteria for HCC worldwide.
2. To understand the algorithmic approach to imaging diagnosis (LI-RADS). 08:30 - 10:00 Room X
3. To review emerging evidence, recent changes to diagnostic criteria
and future directions. Joint Session of the ESR and ESMRMB
A-1003 08:58
B. Unusual appearances of HCC and lesions that simulate HCC: ESR/ESMRMB
can we increase diagnostic confidence?
J.M. Lee; Seoul/US A new era of gadolinium-less MR
Moderators:
Learning Objectives: D. Sappey-Marinier; Lyon/FR
1. To demonstrate atypical appearance of hepatocellular carcinoma at M.J.P. van Osch; Leiden/NL
cross sectional imaging.
2. To illustrate common mimickers of hepatocellular carcinoma in
A-1008 08:30
Sunday
cirrhotic liver.
Radiomics and multiparametric MRI approaches for a better contrast
3. To provide useful tips of differentiation of focal hepatic nodules in
in cardiac and prostate applications
cirrhotic liver.
B. Baeßler; Mannheim/DE

C. Interventional techniques (ablation, TACE, radioembolisation): 1. To learn which gadolinium-free quantitative techniques exist for
when and how to treat cardiac and prostate MR imaging.
R. Duran; Lausanne/CH 2. To understand the potential and limitations of quantitative,
gadolinium-free parametric imaging and radiomics.
Learning Objectives: 3. To appreciate the link between parametric MR imaging and radiomics
1. To understand the role of each interventional technique depending on and to show potential clinical applications of gadolinium-free techniques
the patients‘ characteristics and HCC stage. in cardiac and prostate MRI.
2. To review the different interventional techniques available for HCC
management.
3. To review the patients‘ outcomes associated with interventional
treatment of HCC.
09:44
Panel discussion: How to improve a patient‘s experience and prognosis

A-1009 08:55 A-1015 09:15

From native T1 to arterial spin labelling MRI in the heart Artificial intelligence for intelligent reconstruction methods for
F. Kober; Marseille/FR radiation protection measures
C.T. Whitlow; Winston-Salem, NC/US
1. To learn how T1 is quantified and mapped in the heart and how T1 Learning Objectives:
quantification is linked to perfusion. 1. To discuss radiation exposure due to computed tomography
2. To understand how arterial spin labelling acquisition is performed in associated with common diagnostic tests and in the setting of screening
the heart and why it is more challenging than in the brain. exams.
3. To appreciate what these techniques may do better than those based 2. To describe efforts aimed at reducing radiation dose and improving
on contrast agents and what they probably won‘t do. image quality via conventional approaches (e.g. iterative reconstruction).
3. To introduce methods for improving image quality via novel
A-1010 09:20 artificial intelligence (AI)-based approaches, with quantitative results
Brain perfusion and angiography using ASL in comparison with characterising noise reduction and example cases from clinical
gadolinium based techniques application.
H.R. Jäger; London/UK
A-1016 09:40
Learning Objectives: Using artificial intelligence for optimising procedures reflecting
1. To learn about the different non-enhanced MR angiography techniques radiosusceptibility of patients
used for imaging the extra- and intra-cranial vessels and about the C. Hoeschen; Magdeburg/DE
principles of brain perfusion imaging with arterial spin labelling (ASL).
2. To appreciate the differences between static and time-resolved MR Learning Objectives:
angiography of the intra-cranial vessels and the importance of post- 1. To learn about radiosusceptibility and why it is important to look for it
labelling delay in ASL perfusion imaging. in images.
3. To understand the clinical applications of TOF MR angiography, 2. To understand what role AI could play in the future for optimising
ASL angiography and ASL perfusion imaging techniques and their procedures, especially interventional procedures, from the point of view
advantages and limitations. of radiation protection.
3. To appreciate the potential for new research topics bridging the
09:45 gap between AI and radiation protection with respect to the individual
Panel discussion: Is it feasible to apply gadolinium-free techniques in patient.
clinical practice?
09:50
Discussion
08:30 - 10:00 Room N
EuroSafe Imaging Session 08:30 - 10:00 Room O
Cardiac
EU 7
Artificial intelligence and radiation RC 1703
protection Dead or alive: imaging of myocardial
A-1011/A-1012 08:30 viability
G. Frija; Paris/FR A-1017 08:30
C. Hoeschen; Magdeburg/DE Chairperson‘s introduction
C. Peebles; Southampton/UK
Session Objectives:
1. To understand the mechanisms of how artificial intelligence (AI) can Session Objectives:
help to reduce necessary doses for imaging procedures relying on 1. To understand the concept of myocardial viability.
ionising radiation. 2. To understand the current state-of-the-art to image myocardial
2. To appreciate which AI methods in medical imaging might be helpful viability.
for reducing dose for especially sensitive body regions or highly 3. To outline the role of echocardiography, SPECT, CT and MRI.
susceptible patients in general.
3. To learn how results from AI evaluation of radiographic images A-1018 08:35
might help to influence decisions on the most appropriate methods or A. MRI
radiation protection measures on an individual patient basis in an early T. Leiner; Utrecht/NL
phase of patient diagnosis and therapy. Learning Objectives:
1. To learn about how MR should be performed to assess viability.
A-1013 08:35 2. To understand the strengths and weaknesses of MR compared to
Artificial intelligence: a tool for quality and safety improvement in other techniques.
radiation protection 3. To learn how to report MRI for viability assessment.
G. Frija; Paris/FR

1. To learn about current trends of AI in imaging. B. Hybrid imaging
2. To understand how these trends could improve quality and safety. F. Caobelli; Basle/CH
3. To appreciate how AI could affect radiation protection. Learning Objectives:
1. To learn about how hybrid imaging should be performed to assess
A-1014 08:55 viability.
Artificial intelligence for scatter reduction and optimising imaging 2. To understand the strengths and weaknesses of hybrid imaging
procedures compared to other techniques.
C. Hoeschen; Magdeburg/DE 3. To understand how hybrid imaging could be developed in clinical
Learning Objectives: practice.
1. To learn about actual scatter reduction techniques in imaging based
on ionising radiation, their advantages and drawbacks as well as the
potential of optimising imaging trajectories.
2. To understand how AI-based procedures can provide a fast solution
for scatter estimation and reduction as well as for image trajectory
determination.
3. To appreciate how AI can help to reduce patient dose in medical
imaging with easy to implement applications.

A-1020 09:21 08:30 - 10:00 Room E1

C. CT
F. Bamberg; Tübingen/DE Breast
1. To learn about the potential of CT to assess viability.
2. To understand the strengths and weaknesses of CT imaging compared
RC 1702
to other techniques. Diagnosing ductal carcinoma in situ
3. To understand how to report CT for viability assessment.
(DCIS)
09:44 Moderator:
Panel discussion: What imaging test in which patient? C. Van Ongeval; Leuven/BE
08:30 - 10:00 Studio 2019 A-1027 08:30

A. New radiologic-pathologic knowledge on DCIS
Special Focus Session A. Frigerio; Turin/IT
SF 17 1. To learn about different types of DCIS.
2. To become familiar with the risk of developing cancer.
Late effects in survivors of childhood 3. To appreciate radiologic-pathologic correlations.
cancer A-1028 09:00

B. Imaging DCIS
A-1021 08:30 J. Camps Herrero; Valencia/ES
C. Owens; London/UK Learning Objectives:
1. To become familiar with the imaging appearances of DCIS on
Session Objectives: mammography, ultrasound and MRI.
1. To learn about the cost of survival in long term survivors of childhood 2. To understand the evidence on MRI for evaluating DCIS.
cancer. 3. To appreciate the overlap of imaging features of DCIS and benign
2. To understand therapy related pathologies which are sequelae of disease.
cancer treatment in childhood.
3. To appreciate these disorders and to help to make early diagnoses in A-1029 09:30
order to minimise long term sequelae. C. Diagnosing DCIS with biopsy
4. To become familiar with the human cost of cancer survival and the M.G. Wallis; Cambridge/UK
effects on the daily lives from survivors of childhood cancer.
A-1022 08:37 1. To learn about the indications for biopsy when DCIS is suspected
Cardiothoracic complications based on imaging.
A. Secinaro; Rome/IT 2. To become familiar with the advantages and disadvantages of
different biopsy techniques.
Learning Objectives: 3. To appreciate the risk of overdiagnosis and overtreatment with DCIS.
1. To outline chemotherapy related pathology which are sequelae of
cancer treatment in childhood.
2. To illustrate with state-of-the-art imaging. 08:30 - 10:00 Room E2
3. To summarise what the radiologist needs to know and how to find it.
Neuro
A-1023 08:55
MSK
I.-M. Noebauer-Huhmann; Vienna/AT
RC 1711
Diffuse low-grade gliomas: new things
1. To discuss clinical manifestation of late effects to the MSK system you should know
following chemotherapy.
Moderator:
2. To illustrate and suggest best methods of radiological follow-up with
I.N. Pronin; Moscow/RU
case studies.
3. To suggest an algorithm to help radiologists to recognise these
findings.
A-1030 08:30
A. Molecular basis for classification, treatment and predicting outcome
in low-grade gliomas
A-1024 09:13 V.C. Keil; Bonn/DE
Neuro
R. Gunny; London/UK Learning Objectives:
1. To learn about the role of imaging in the context of histopathology
regarding the prediction of outcome.
1. To describe how brain development may be affected by CNS
Sunday
2. To understand the role of conventional and quantitative beyond

malignancies and therapies used to treat them.
diagnosis.
2. To categorise the types of abnormalities.
3. To appreciate the translational approach of diagnosis and monitoring
3. To illustrate these complications.
of glial tumour based on the histopathological background.
A-1025/A-1026 09:22 A-1031 09:00
Fertility issues: male and female
B. Imaging patterns suggestive of different (molecular) subtypes of
L. Rocher; Le Kremlin-Bicêtre/FR
low-grade gliomas
C. Berger; Saint-Etienne/FR
M. Smits; Rotterdam/NL
1. To describe the potential effects that chemotherapy has on fertility in
1. To learn about whether there is a change of pattern recognition based
males and females.
on conventional and quantitative imaging approaches.
2. To illustrate with case studies.
2. To understand the heterogeneity of low-grade gliomas based on
3. To discuss how we can help to overcome these issues using radiology.
histopathology and imaging.
3. To appreciate the perspectives and challenges of diagnostic imaging
09:49 in phenotyping low-grade gliomas.
Panel discussion: How may paediatric radiologists recognise, monitor
and help to minimise the late effects in survivors of childhood cancer?

A-1032 09:30 08:30 - 10:00 Room F2

C. Advanced imaging in low-grade gliomas
N. Bulakbasi; Mersin/TR Emergency Imaging
1. To learn about the spectrum and diagnostic value of the available
advanced imaging techniques in neuro-oncology.
RC 1717
2. To understand the added value and possible pitfalls using quantitative Small bowel obstruction: improve your
MRI techniques in addition to conventional MRI.
3. To appreciate the importance of standardisation of advanced MR
reading and reporting competences
image acquisition in the clinical practice of neuro-oncology.
A-1037 08:30
08:30 - 10:00 Room F1 S. Romano; Naples/IT
E3 - European Diploma Prep Session Session Objectives:

1. To learn how to confidently diagnose small bowel obstruction.
2. To understand how to identify the transition point rapidly.
E3 1723 3. To become familiar with the signs of ischaemia.
Musculoskeletal A-1038 08:35

A. Step 1: confirm the mechanical small bowel obstruction (SBO)
A-1033 08:30 I. Millet; Montpellier/FR
F. Saez; Barakaldo/ES Learning Objectives:
1. To differentiate a functional ileus from a mechanical SBO.
Session Objectives: 2. To know the diagnostic value of the feces-sign for depicting the
1. To understand typical and atypical imaging features of traumatic transition zone.
disorders of the musculoskeletal system. 3. To become familiar with multiplanar reconstructions for finding the
2. To learn typical imaging features of benign and malignant bone transition zone.
tumours.
3. To become familiar with the imaging appearance of degenerative and A-1039 09:02
inflammatory disorders of the musculoskeletal system. B. Step 2: identify the SBO cause
J.R. Olalla Muñoz; Murcia/ES
A-1034 08:36
A. Traumatic disorders of the musculoskeletal system Learning Objectives:
L. Meacock; London/UK 1. To know the CT findings allowing adhesive bands to be diagnosed.
2. To know the list of SBO causes with bowel wall thickening at the
Learning Objectives: transition zone.
1. To gain appreciation of typical fracture patterns and their 3. To become familiar with some rare causes of SBO.
accompanying soft tissue injuries.
2. To develop an understanding of the underlying mechanisms of injury A-1040 09:29
in appendicular trauma and correlate with imaging findings. C. Step 3: look for bowel ischaemia
3. To understand the benefits and disadvantages of different imaging R. Smithuis; Leiderdorp/NL
modalities in assessing trauma involving the skeleton and soft tissue in
differing age groups. Learning Objectives:
1. To optimise the CT protocol for assessing bowel wall enhancement.
A-1035 09:04 2. To learn how to diagnose a closed-loop mechanism.
B. Bone tumours 3. To know the CT findings for diagnosing ischaemic complication.
M.-A. Weber; Rostock/DE
09:56
Learning Objectives: Panel discussion: How important is the role of CT in deciding on
1. To learn the typical imaging features of common bone tumours. operative or non-operative patient management?
2. To understand the typical imaging features of „don‘t touch“ („leave-
me-alone“) lesions.
3. To become familiar with the imaging manifestations of haematological 08:30 - 10:00 Room Y
disorders.
E3 - Rising Stars Programme: EFRS Radiographers‘ Basic Session
A-1036 09:32
C. Degenerative and inflammatory disorders of the musculoskeletal BR 17
system
J.-B. Pialat; Lyon/FR The future of radiology: what it could
Learning Objectives: mean for new radiography graduates
1. To understand the imaging presentation of degenerative disorders of
the joints and to appreciate their clinical relevance. A-1041 08:30
2. To learn the imaging features and clinical features of degenerative Chairperson‘s introduction: What will radiology departments look like
disease of the spine, disc and facet joints. in the future?
3. To become familiar with the typical imaging manifestations of G. Paulo; Coimbra/PT
infection, inflammation and metabolic diseases of the musculoskeletal Session Objectives:
system. 1. To consider the drivers for change within radiology departments.
2. To appreciate the brief history of evolution within radiology
departments.
3. To consider how radiology departments may look in future years.
A-1042 08:35
Future role extension for radiographers
H.H. Hjemly; Oslo/NO
1. To understand the current status of role extension for radiographers.
2. To be aware of the international drivers for role extension within
radiographic practice.
3. To appreciate the possible development options for radiographer role
extension.

A-1043 08:53 08:30 - 10:00 Room G

Evolving imaging technologies
J.G. Stowe; Dublin/IE Physics in Medical Imaging
1. To be aware of impending developments with regards to imaging
equipment.
RC 1713
2. To consider the potential role for artificial intelligence (AI) within imaging. Dose reduction and image quality
3. To appreciate the future role of social media and computing within
radiology departments. implications of iterative image
A-1044 09:11
reconstruction in CT
Changing the delivery of radiology, responding to the needs of our
patients
A-1049 08:30
K.G. Vikestad; Oslo/NO
K.N. Bolstad; Bergen/NO
Session Objectives:
1. To be aware of the current challenges facing radiology service delivery.
1. To learn about the origins of dose reduction using iterative image
2. To consider the opportunities available for developing and improving
reconstruction in CT.
the delivery of radiology services.
2. To understand dose reduction using iterative image reconstruction in CT.
3. To appreciate the needs of patients when developing a radiology service.
3. To learn about solutions and workarounds.
A-1045 09:29 A-1050 08:35
What will radiology look like in 30 years?
A. Basics of iterative image reconstruction in CT
1. To understand the key drivers for change within radiology.
1. To learn about the basic aspects of iterative reconstruction.
2. To understand the possible areas for development over the next 30 years.
2. To learn about potential dose reduction via iterative reconstruction.
3. To appreciate how radiology may look in 2049.
3. To compare iterative reconstruction with other techniques.
09:47
Panel discussion: Development needs for the future radiographer
A-1051 08:58
B. Iterative image reconstruction in clinical practice: dos and don‘ts
H. Alkadhi; Zurich/CH
08:30 - 10:00 Room D
Musculoskeletal 1. To understand the radiologist‘s requirements for image reconstruction.
2. To learn about current best practice in image reconstruction for
clinical CT.
RC 1710 3. To learn about the potential benefits and pitfalls of using iterative
reconstruction in clinical CT.
Elbow imaging: from detailed anatomy
to pathology A-1052 09:21
C. Image quality assessment of iterative reconstruction: pitfalls and
Moderator: future directions
I. Sudoł-Szopińska; Warsaw/PL C. Walsh; Dublin/IE

A. The medial and lateral epicondyle 1. To learn about basic image quality metrics employed in CT.
M.O. De Maeseneer; Brussels/BE 2. To understand why image quality assessment is difficult with iterative
reconstruction.
Learning Objectives: 3. To learn about up-and-coming methods for image quality assessment.
1. To explain the anatomic considerations and pathophysiology of
abnormalities that involve the medial and lateral epicondyles of the 09:44
humerus. Panel discussion: How low can we go?
2. To describe the imaging findings of abnormalities that involve the
medial and lateral epicondyles of the humerus.
08:30 - 10:00 Room K
A-1047 09:00
B. Biceps and triceps
Chest
A. Tagliafico; Genoa/IT
Learning Objectives: RC 1704

1. To explain the anatomic considerations and pathophysiology of
abnormalities that involve the biceps and triceps brachii.
Thoracic emergencies
Sunday
2. To describe the imaging findings of abnormalities that involves the Moderator:

biceps and triceps brachii. B. Ghaye; Brussels/BE
A-1048 09:30 A-1053 08:30

C. Plica and cartilage A. Chest trauma
L. Cerezal; Santander/ES M. Brink; Nijmegen/NL

1. To explain the anatomic considerations and pathophysiology of 1. To describe CT features of pulmonary contusion.
abnormalities that involve the elbow plicae and articular cartilage. 2. To learn about signs of diaphragmatic rupture.
2. To describe the imaging findings of abnormalities that involve the 3. To know when to suspect and how to confirm aortic injury.
elbow plicae and articular cartilage.

A-1054 08:53 A-1061 09:29

B. Haemoptysis D. Imaging heterogeneity and genomic variability in ovarian cancer
M.-P. Revel; Paris/FR E. Sala; Cambridge/UK

1. To learn about the main causes and mechanisms of massive 1. To learn about the application of imaging tumour heterogeneity in
haemoptysis. ovarian cancer.
2. To review the role of CT in the assessment of site and cause of 2. To understand how heterogeneity on imaging may relate to biological
bleeding. heterogeneity.
3. To learn about the bronchial artery anatomy assessment on CT. 3. To become familiar with concepts such as imaging phenotypes and
signatures.
A-1055 09:16
C. Diagnosing PE 09:47
G. Aviram; Tel Aviv/IL Panel discussion: What can we quantify and why is it essential?
1. To learn about optimising CT angiography indications. 08:30 - 10:00 Room M 4
2. To be aware of the causes of imaging inconclusiveness.
3. To learn how to identify signs of acute right ventricular dysfunction. Multidisciplinary Session
A-1056 09:39
D. Vascular intervention in thoracic emergencies MS 17
I. Bargellini; Pisa/IT Multidisciplinary approach to the
Learning Objectives: diabetic foot
1. To learn about bronchial embolisation for life-threatening haemoptysis.
2. To review endovascular procedures for management of severe PE. A-1062 08:30
3. To understand the role of the interventional radiologist in aortic Chairperson‘s introduction
trauma management. E.N. Brountzos; Athens/GR
Session Objectives:
08:30 - 10:00 Room M 1
1. To appreciate the magnitude of the diabetic foot as a societal
E3 - ECR Master Class (Hybrid, Molecular and Translational problem.
2. To understand the role of radiological imaging and interventional
Imaging) radiology in the diagnosis and treatment of the diabetic foot.
3. To learn the role of surgical treatment of the diabetic foot.
E3 1726a A-1063 08:35
Quantitative imaging in oncology Diabetic foot: a societal problem
V. Lambadiari; Athens/GR
1. To appreciate the scope of the problem.
J. O‘Connor; Manchester/UK
2. To learn the prevalence of the arterial ulcers and the amputation risk.
Session Objectives: 3. To learn the prevention and care of foot ulcerations.
1. To understand the impact of tumour heterogeneity on diagnosis and
treatment. A-1064 08:50
2. To learn the basics of quantifying heterogeneity in tumours. Imaging evaluation of the diabetic foot
3. To review the future impact of imaging heterogeneity in tumours. O. Papakonstantinou; Athens/GR
A-1058 08:35 1. To learn how to image soft tissue and bone infections.
A. Intra- and intertumoural heterogeneity and the impact for cancer
2. To learn how to image arterial perfusion: CTA and MRA.
diagnostics
3. To learn when to use DSA.
M. Eisenblätter; Münster/DE

1. To learn about tumour heterogeneity. Interventional radiological treatment (IR)
2. To review current strategies to explore biological heterogeneity. S.C. Spiliopoulos; Athens/GR
3. To understand how this heterogeneity impacts diagnosis and
treatment.
1. To learn when interventional treatment is indicated.
2. To learn the tool kit.
A-1059 08:53 3. To learn the results of IR treatment.
B. Quantitative image biomarkers for targeted tumour therapies
R. García Figueiras; Santiago de Compostela/ES
A-1066 09:20
Learning Objectives: Surgical management of the diabetic foot
1. To learn how heterogeneity can be quantified from images. G. Geroulakos; Athens/GR
2. To understand the main classes of heterogeneity on imaging.
3. To review limits and pitfalls of features extraction.
1. To learn what the goal of surgery is in treating the diabetic foot
infections.
A-1060 09:11 2. To learn how to prevent osteomyelitis.
C. From quantitative imaging to radiomics and deep learning
3. To learn when to amputate and to what extent.

1. To learn how to optimise the acquisition of images for quantitative Multidisciplinary case presentation and discussion
imaging. E.N. Brountzos; Athens/GR
2. To understand image processing which may impact quantification.
3. To become familiar with the concepts behind quantification including
1. To learn how to clinically diagnose the diabetic foot.
machine learning approaches.
2. To appreciate the role of imaging.
3. To understand how to select the patients for medical, interventional
radiological and surgical treatment.

08:30 - 10:00 Room M 5 A-1074 09:21

C. Towards a certified radiologist
Head and Neck H.C. Thoeny; Fribourg/CH
RC 1708 1. To understand the need for a certified radiologist in a prostate unit.
2. To illustrate the level III European Training Curriculum for prostate
Imaging of eye and orbital pathologies imaging.
3. To discuss how to certify radiologists for prostate imaging.
Moderator:
M.M. Lemmerling; Ghent/BE
09:44
Panel discussion: Prostate units: is the radiologist in or outside the
A-1068 08:30 core team?
A. Traumatic lesions of the eye and orbit
A. Ailianou; Neuchâtel/CH
10:30 - 12:00 Room A
1. To become familiar with imaging features of orbital fractures. E3 - ECR Academies: Interactive Teaching Session for Young
2. To learn about traumatic lesions of the eye and orbital soft tissues. (and not so Young) Radiologists
3. To review acute and chronic complications after orbital trauma.
A-1069 09:00
B. Infection and inflammation in the eye and orbit
E3 1821
K. Erb-Eigner; Berlin/DE Imaging of the brain
1. To become familiar with infections and inflammation in different A. Stroke mimics
orbital structures. M.M. Thurnher; Vienna/AT
2. To discuss imaging features of infection and inflammation in the eye
and orbit. Learning Objectives:
3. To learn how to reach the final diagnosis. 1. To become familiar with the different entities that can mimic a stroke.
2. To know the usefulness of perfusion studies in the differential
A-1070 09:30 diagnosis.
C. Benign and malignant masses of the eye and orbit
P. De Graaf; Amsterdam/NL A-1076 11:15
B. Acquired toxic-metabolic encephalopathies
Learning Objectives: K. Karli Oguz; Ankara/TR
1. To discuss advanced imaging techniques in tumoural orbit lesions.
2. To review intraocular tumours. Learning Objectives:
3. To become familiar with intraorbital masses. 1. To review the most common causes.
2. To learn the MRI and CT appearances of these lesions.
10:30 - 12:00 Room B
E3 - ECR Master Class (Genitourinary)
ESR meets Pakistan
E3 1726b
Prostate MRI: the accreditation issue EM 3
The role of radiology in major healthcare
A-1071 08:30
challenges faced by Pakistan
J. Richenberg; Brighton/UK Presiding:
M.H. Akram; Islamabad/PK
Session Objectives: L.E. Derchi; Genoa/IT
1. To understand the emerging role of the multidisciplinary approach for
prostate cancer. A-1077 10:30
2. To discuss the role of the radiologist in the multidisciplinary approach Introduction
to prostate cancer. M.H. Akram; Islamabad/PK
3. To discuss the accreditation and certification issues for prostate
imaging. Session Objectives:
1. To learn about oral cancer in Pakistan and the role that radiology plays
A-1072 08:35 in its management.
A. Prostate MRI: minimum and optimal requirements 2. To appreciate the role of radiology in living donor liver transplant in
V. Panebianco; Rome/IT advanced cases of chronic hepatitis.
3. To understand the variety of radiological findings in tuberculosis.
Sunday
1. To understand the minimum requirements for multiparametric MR of A-1078 10:35
prostate cancer. Imaging of oral cancer
2. To understand how to optimise MR imaging technique at 3T and 1.5T. N. Ud Din; Lahore/PK
3. To review sequence parameters and scan optimisation for prostate
imaging. Learning Objectives:
1. To understand the peculiar causes of high incidence of oral cancer in
A-1073 08:58 different regions of Pakistan.
B. Towards a European accreditation of prostate imaging centres 2. To become familiar with the spectrum and scale of advanced disease
V. Logager; Copenhagen/DK in Pakistan.
3. To appreciate the variation in imaging and therapeutic practices
Learning Objectives: across Pakistan.
1. To learn about the role of the radiologist in the multidisciplinary
approach for prostate cancer.
2. To discuss the requirements for a specialist prostate centre, with
emphasis to the imaging issue.
3. To understand quality indicators for prostate MRI.

A-1079 10:55 A-1086 11:32

Interlude: Beautiful Pakistan: from sea to sky-high mountains C. Advanced imaging of the female breast
A. Majeed; Islamabad/PK E.M. Fallenberg; Munich/DE
A-1080 11:00
1. To understand the role of advanced imaging techniques in evaluation
Role of radiology in developing a living donor liver transplant
of the breast.
programme
2. To use the added value of new techniques for lesion classification in
A.I. Rana; Islamabad/PK
mammography, ultrasound and MRI.
Learning Objectives: 3. To recognise the major imaging issues for common indications of
1. To learn about steps in setting up a successful living donor liver breast imaging.
transplant program in Pakistan.
2. To understand requirements of preoperative imaging of potential
12:30 - 13:30 Room C
donors.
3. To learn about various postoperative complications in transplant E3 - The Beauty of Basic Knowledge: Pancreas
recipients and role of diagnostic as well interventional radiology in
managing them.
A-1081 11:20
E3 24E
Interlude: Philanthropic cyber-knife facility in Pakistan Pancreatic adenocarcinoma mimickers
T. Mahmood; Karachi/PK Moderator:
A. Ba-Ssalamah; Vienna/AT
A-1082 11:25
Many faces of tuberculosis A-1087 12:30
U. Siddique; Peshawar/PK Autoimmune pancreatitis
R. Pozzi Mucelli; Verona/IT
1. To learn about the prevalence of tuberculosis in Pakistan. Learning Objectives:
2. To understand the variety of radiological findings in tuberculosis, its 1. To learn about autoimmune pancreatitis.
diagnosis and complications. 2. To understand imaging findings of pancreatic adenocarcinoma
mimickers.
11:45 3. To appreciate differential diagnosis criteria with pancreatic
Panel discussion: Why are oral cancer, chronic hepatitis and adenocarcinoma.
tuberculosis more common in Pakistan, and in which scenarios is the
role of radiology crucial in the management of these diseases? A-1088 13:00
Paraduodenal pancreatitis
10:30 - 12:00 Room F1 G. Morana; Treviso/IT
E3 - European Diploma Prep Session
1. To learn about autoimmune paraduodenal pancreatitis.
2. To understand imaging findings of paraduodenal pancreatitis.
E3 1823 3. To appreciate differential diagnosis criteria with pancreatic
adenocarcinoma.
Breast
A-1083 10:30
Session Objectives:
1. To understand the methodological principles of mammography.
2. To learn the mammographic appearance of benign and malignant
lesions of the breast.
3. To become familiar with the imaging appearance of benign and
malignant breast lesions.
A-1084 10:36
A. Fundamentals of mammography
F. Kilburn-Toppin; Cambridge/UK
1. To understand the anatomy, normal variants and abnormalities of the
female breast.
2. To become familiar with the technical aspects of diagnostic
mammography, especially in regard to dose and image quality.
3. To become familiar with the principles of current practice and risk/
benefit analysis in breast cancer screening.
A-1085 11:04
B. Breast cancer diagnosis and interventions
C. Van Ongeval; Leuven/BE
1. To learn the different presentation of normal breast patterns and
the appearance of common benign diseases and of breast cancer at
mammography, ultrasound and MRI.
2. To understand principles and basic application of standardised
diagnostic categorisation systems such as the ACR breast imaging
reporting and data system (BI-RADS®).
3. To become familiar with indications, contraindications and technical
aspects of image-guided interventional breast procedures (fine needle
aspiration, core needle biopsy, vacuum-assisted biopsy, presurgical
localisation).

13:00 - 15:30 Room E1 12:30 - 13:30 Room D

Education E3 - The Beauty of Basic Knowledge: A Survival Guide to
CB
Case-Based Diagnosis Training E3 25E
Moderators: Acute trauma: patterns in the peripheral
skeleton
Moderator:
A-1090 13:00 V.N. Cassar-Pullicino; Oswestry/UK
Liver
L. Martí-Bonmatí; Valencia/ES A-1089 13:30
Acute trauma: patterns in the peripheral skeleton
A-1091 13:12 J. Teh; Oxford/UK
Neuro Learning Objectives:
D. Prayer; Vienna/AT 1. To become familiar with the imaging manifestations of common
important injuries in the upper and lower limb.
A-1092 13:24 2. To understand the underlying mechanism that result in combination
Maxillofacial of injuries.
S. Robinson; Vienna/AT 3. To learn how to best employ imaging modalities in their diagnosis.
A-1093 13:36
Musculoskeletal 14:00 - 15:30 Room A
E3 - ECR Academies: Interactive Teaching Session for Young
A-1094 13:48 (and not so Young) Radiologists
Genitourinary
M. Toepker; Vienna/AT
E3 1921
A-1095 14:00 Paediatric brain imaging
Interlude: Just a cyst?
R. Manfredi; Rome/IT A-1101 14:00
A. Head and neck emergencies in children
A-1096 14:30 A. Rossi; Genoa/IT
Head and neck
C. Czerny; Vienna/AT Learning Objectives:
1. To become familiar with the different entities.
A-1097 14:42 2. To identify the key imaging findings.
Chest
H. Prosch; Vienna/AT A-1102 14:45
B. Acute neurological child beyond trauma
A-1098 14:54 A. Sánchez-Montañez; Barcelona/ES
Spine
1. To become familiar with the most common cause of acute neurological
emergencies.
A-1099 15:06 2. To learn the imaging criteria for differentiation.
Gastrointestinal
W. Schima; Vienna/AT
A-1100 15:18
Breast
Sunday


SCIENTIFIC SESSIONS,
AND CLINICAL TRIALS
IN RADIOLOGY (B)
Scientific session numbers are prefixed by SS.
My Thesis in 3 Minutes session numbers are prefixed by MY.
Clinical Trials in Radiology are prefixed by CT.
Presentation numbers are prefixed by the letter B.
Sessions and abstracts are listed by days.
There are 286 Invest in the Youth

scientific paper presenters at ECR 2019.
You can find their sessions marked with
SPEAKER
SUPPORTED
BY
INVEST IN
THE YOUTH
on the following pages.
311
Scientific Sessions / My Thesis in 3 Minutes / Clinical Trials in Radiology
08:30 - 10:00 Coffee & Talk 3 10:30 - 12:00 Room B

Interventional Radiology Artificial Intelligence and Machine Learning
SS 109 SS 205
Vascular interventions in visceral arteries Intelligent dose and quality management
and veins (part 1) Moderators:
Moderators: V. Suomi; Turku/FI
O. Akhan; Ankara/TR
M. Tsitskari; Athens/GR
B-0012 10:30
Application of artificial intelligence-based image optimisation
B-0001 08:30 algorithm in aorta CTA with low tube voltage and reduced contrast
Quantification of perfusion reduction by using 2D parametric medium volume
parenchymal blood flow following partial spleen embolisation in M. Wang, Y. Wang, Y. Wang, M. Yu, M. Wang, Z. Jin; Beijing/CN
patients with hypersplenism
T. Meine1, S.K. Maschke1, M. Kirstein1, J. Renne1, T. Werncke1, C. Dewald1,
B-0013 10:38
F. Wacker1, B.C. Meyer2, J.B. Hinrichs1; 1Hannover/DE, 2Berlin/DE
Real-time patient-specific CT dose estimation for single- and dual-
source CT using a deep convolutional neural network
B-0002 08:38 J. Maier, S. Dorn, E. Eulig, S. Sawall, M. Kachelrieß; Heidelberg/DE
Role of multidetector CE-CT before transcatheter endovascular
embolisation in active arterial bleedings
B-0014 10:46 SPEAKER
A. Borzelli1, A. Paladini2, F. Amodio1, E. Cavaglià1, R. Niola1; 1Naples/IT, SUPPORTED
Dose team: an estimate of radiation dose reference levels for BY
2
Novara/IT INVEST IN
CT exams THE YOUTH
M. Montesano, M. Rengo, S. Badia, N. Panvini, S. Picchia,
B-0003 08:46 D. Bellini, I. Carbone, A. Laghi; Latina/IT
Selective intraarterial embolisation as a treatment for haemorrhoid
pathology: preliminary study
B-0015 10:54
M. Ferrer Puchol1, A. Gregorio2, E. Esteban1, F.J. Blanco1, V. Primo2,
Clinical indications for computer tomography (CT) diagnostic
L. Andreo2, M. Villalta Santamaria1, R. Ramiro1, J. Solaz Solaz1; 1Alzira/ES,
2
reference levels (DRLs)
Denia/ES
S. Yu, P. Chu, R. Smith-Bindman; San Francisco, CA/US
B-0004 08:54 B-0016 11:02

Post-TIPS encephalopathy: are there any predictive factors?
Automatic noise and vessel density measurement for CT angiography
C. Perazzini1, P. Fonio2, A. Doriguzzi Breatta3, D. Righi2, D. Rossato2,
quality assurance
G. Gandini2; 1Clermont Ferrand/FR, 2Turin/IT, 3Castelnuovo Don Bosco/IT
S. Zargaran, F. Wozniak, M. Dewey; Berlin/DE
B-0005 09:02 B-0017 11:10

Retrograde stent implantation of the celiac artery via the
Impact of ESR iGuide in the diagnostic workflow of paediatric patients
pancreaticoduodenal anastomosis
with abdominal pain
F. Pedersoli, P. Isfort, M. Zimmermann, M.F. Schulze-Hagen, S. Keil,
M. Gabelloni, C.A. D‘Amore, R. Morganti, L. Faggioni, C. Spinelli, E. Neri;
C.K. Kuhl, P. Bruners; Aachen/DE
Pisa/IT
B-0006 09:10 B-0018 11:18

High-flow priapism: colour Doppler findings and embolisation
Semi-supervised multi-to-one style transfer to improve the quality of
G. De Magistris, F. Pane, F. Corvino, F. Giurazza, M. Coppola, F. Amodio,
CT images
M. Silvestre, E. Cavaglià, R. Niola; Naples/IT
B. Ren1, L. Li2, S. Wang2, C. Xia2; 1Amherst, MA/US, 2Beijing/CN
B-0007 09:18 B-0019 11:26

Role of c-arm computed tomography-assisted adrenal vein sampling in
Protocol repetition in whole-body MR imaging within a large
the assessment of adrenal hypersecretion syndromes
population-based cohort study: behavior of radiologic technologists
A. Pisano, M. Tipaldi, G. Orgera, F. Laurino, A. Laghi, M. Rossi; Rome/IT
and potential of automated image quality assessment
C. Schuppert1, R. von Krüchten1, J.G. Hirsch2, D.C. Hoinkiss2, S. Selder3,
B-0008 09:26 O. von Stackelberg1, H.-U. Kauczor1, F. Bamberg4, C.L. Schlett1;
Long-term follow-up of giant visceral artery aneurysms endovascular 1
Heidelberg/DE, 2Bremen/DE, 3Munich/DE, 4Freiburg/DE
treatment: a single centre experience
M. Tipaldi1, M. Pignatelli1, G. Orgera1, F. Laurino2, A. Laghi1, M. Rossi1;
1
B-0020 11:34
Rome/IT, 2Eboli/IT
Preliminary results of a neural network for the automatic detection of
SPEAKER chest X-ray incorrect exposure
B-0009 09:34 SUPPORTED R. Casale; Portogruaro/IT
Transjugular portal vein stenting: an original approach for BY
INVEST IN
palliative treatment of portal vein stenosis/occlusion in THE YOUTH
B-0021 11:42
neoplastic patients
Patient-centric initiative to reduce radiation dose to paediatric
A. Mazzaro1, F.L. Gatti1, R. Bettini1, N. Mandruzzato2, A. Contro1,
patients in computer tomography for improved patient safety in a
G. Mansueto1; 1Verona/IT, 2Trieste/IT
tertiary care facility in Pakistan
M. Yusuf; Karachi/PK
B-0010 09:42
Use of Onyx (ethylene vinyl alcohol copolymer) in haemorrhage
B-0022 11:50
embolisation procedures
Quality assessment of structured multi-parametric MRI reports of the
R. Marcello, G. Assegnati, A. Di Blasi, F. Cortese, D. Konda, E. Pofi;
prostate based on RADLEX mapping of urosurgical key information
Rome/IT
content
M.E. Maros1, F. Siegel1, B. Kämpgen2, P. Sodmann2, W. Sommer3,
B-0011 09:50 S.O. Schönberg1, T. Henzler1, C. Groden1, H. Wenz1; 1Mannheim/DE,
Tips and tricks of emergency TIPS in patients affected by severe portal 2
Rimpar/DE, 3Munich/DE
hypertension
A. Borzelli1, A. Paladini2, F. Amodio1, E. Cavaglià1, R. Niola1; 1Naples/IT,
2
Novara/IT

10:30 - 12:00 Room C 10:30 - 12:00 Room X

Radiographers Vascular
SS 214 SS 215
Professional issues in radiography Carotid plaque and neurovascular events
Moderators: Moderators:
V. Logager; Copenhagen/DK D.L. Tarnoki; Budapest/HU
B. Snaith; Bradford/UK N.N.
B-0023 10:30 B-0034 10:30

Moving beyond the bookshelf: an investigation into the use of social Comparison of ultra-high frequency US with constrast enhanced
media journal clubs in radiography practice MR Angiography and conventional US in the evaluation of carotid
Wednesday
S.N. Mullen1, M. O‘Connor2; 1Galway/IE, 2Dublin/IE atheromatous plaques
R. Picascia1, D. Berritto2, C. Liguori3, M. La Porta4, A. Reginelli5,
B-0024 10:38 R. Grassi3; 1Villaricca/IT, 2Acerra/IT, 3Naples/IT, 4San Severo/IT,
5
Written patient information in radiology: an Irish perspective Torre Annunziata/IT
S.S. Azman, E. McDermott, M.-L. Ryan; Dublin/IE
B-0035 10:38
B-0025 10:46 Contrast-enhanced perfusion patterns in predicting stroke in
Influences on radiographers‘ choice of immobilisation methods in vulnerable plaque: a cohort study of carotid stenosis in Chinese
paediatric radiological examinations patients
S. Christie, C. Ng, C. Sá dos Reis; Perth/AU H. Yunqian, J. Jiang, M. Chen; Shanghai/CN
B-0026 10:54 B-0036 10:46

Informed consent in diagnostic imaging: an evaluation of current Is automatic plaque quantification reliable: an analysis of spectral
practice multienergy CT
A. Ramlaul; Hatfield/UK G. Corrias1, G. Micheletti2, J. Suri3, G.M. Argiolas2, P. Lucatelli4, L. Saba1;
1
Cagliari/IT, 2Monserrato/IT, 3Denver, CO/US, 4Rome/IT
B-0027 11:02
Perceptions about the practice of seeking informed consent in B-0037 10:54
paediatric imaging Carotid plaque instability and neovascularisation assessment using
J. Portelli1, J. McNulty2, P. Bezzina1, L.A. Rainford2; 1Msida/MT, 2Dublin/IE contrast-enhanced ultrasound and superb micro-vascular imaging
M. Radzina, A. Lioznovs, A. Jukna; Riga/LV
SUPPORTED SPEAKER
Radiographers and scientific research: the Italian experience BY B-0038 11:02 SUPPORTED
INVEST IN BY
1 1 1 1
M. Zanardo , A. Capaldo , M. Codari , D. Catania , THE YOUTH Early embolisation after carotid artery stenting: role of
INVEST IN
2 3 1 2 3
P. Cornacchione , S. Durante ; Milan/IT, Rome/IT, Bologna/IT MR-DWI as pre-procedural predictor and discriminant THE YOUTH
between intra- and post-procedural events
B-0029 11:18 F. Guarasci, R. Faletti, M.A. Ruffino, M. Fronda, M. Gatti, G. Varetto,
The construction of care in CT D. Righi, P. Rispoli, P. Fonio; Turin/IT
R.K. Forton1, M. Hardy2, A. Sargeant2; 1Norwich/UK, 2Bradford/UK
B-0039 11:10
B-0030 11:26 Ultrasonographic evaluation of changes in carotid arteries in patients
Mobile radiography services can improve the utilisation of diagnostic with hypertension after a stroke
imaging among nursing home residents P. Gac, E. Trzmielewska, M. Poreba, G. Mazur, M. Sobieszczanska,
E. Kjelle, K.B. Lysdahl, H.M. Olerud; Kongsberg/NO R. Poreba; Wrocław/PL
B-0031 11:34 B-0040 11:18

Burnout level of personnel working in radiology departments in Comparison between high-frame rate vector flow and computational
Hungary flow dynamics in the carotid bifurcation: evaluation of a protocol study
D. Sipos1, A. Pandur2, A. Kedves1, V. Varga2, M. Csima1, I. Repa1, Á. Kovács1; A. Goddi1, T. Frattini1, M. Bozzetto2, C. Bortolotto3, L. Milan1, D. Zatelli2,
1
Kaposvár/HU, 2Pécs/HU R. Novario1, F. Calliada3, A. Remuzzi2; 1Varese/IT, 2Bergamo/IT, 3Pavia/IT

B-0032 11:42 SUPPORTED
VERTIM: pilot study evaluating influence of adding nature images in Carotid intima-media thickness (CIMT) as a diagnostic BY
INVEST IN
imaging departments‘ waiting rooms, according to different aesthetic marker of transient ischaemic attacks (TIA) THE YOUTH
approaches, on patients‘ perceived anxiety D.J. Petrovic; Belgrade/RS
M.P. Loiseau Audirac, C. Bader, C. Castermans, I. Quintana; Bordeaux/FR
B-0042 11:34
B-0033 11:50 Ultrasound estimation of carotid intima media thickness:
Value-based practice (VBP) training for radiographers semiautomatic versus manual measurement
R.M. Strudwick1, A. Newton-Hughes2, S. Gibson3, J. Harris4, M. Gradwell3, G. Lastella, F. Wiedenmann, C.B. Monti, F. Secchi, M. Alì, F. Sardanelli;
E. Hyde5, J. Harvey-Lloyd1, T.J. O‘Regan6, J. Hendry7; 1Ipswich/UK, Milan/IT
2
Salford/UK, 3Canterbury/UK, 4Guildford/UK, 5Derby/UK,
6
Lancashire/UK, 7Kingston/UK B-0043 11:42
Comparative study of common carotid intima-media thickness in type
2 diabetics and non-diabetics in Port Harcourt, Nigeria
O. Moemenam1, R. Njeze2, E. Okwudire1, U. Ezenwugo1;
1
Port Harcourt/NG, 2Enugu/NG
B-0044 11:50
Weight loss in obesity, impact on carotid intima media thickness and
cardiovascular risk factors: a longitudinal study
B. Domènech-Ximenos, V. Cuba Camasca, J. Daunis-i-Estadella,
S. Pedraza Gutierrez, J.M. Fernández-Real, J. Puig Alcàntara; Girona/ES

10:30 - 12:00 Room N 10:30 - 12:00 Room O

Musculoskeletal Musculoskeletal
SS 210a SS 210b
Haematological, metabolic and Musculoskeletal tumour imaging
endocrine diseases Moderators:
R. Dominguez Oronoz; Barcelona/ES
Moderators: A. Isaac; London/UK
G.K.O. Aström; Uppsala/SE
SUPPORTED
Predictive value of MRI radiomic features in differentiating BY
B-0045 10:30 INVEST IN
lipoma from atypical lipomatous tumour THE YOUTH
Incidence of vertebral fractures in patients with ћ-thalassaemia major F. Acquafredda1, Y. Abdelhafez2, M. Zhang3, M. Guindani4,
in treatment with oral bisphosphonate 4 2 2 2 1 2
S. Lee , D. Sarohia , R.D. Badawi , L. Nardo ; Brescia/IT, Davis, CA/US,
F. Pellegrino, M. Pontrelli, R. Mungari, M. Fortini, M.R. Gamberini, 3
Montreal, QC/CA, 4Irvine, CA/US
M.C. Zatelli, M.R. Ambrosio, M. Giganti; Ferrara/IT
B-0057 10:38
B-0046 10:38 To biopsy or not to biopsy? A quantitative approach differentiating
Lumbar spine bone mineral density Z-score discrepancy by DXA and subfascial lipoma from atypical lipomatous tumour/well-differentiated
QCT in thalassaemic major patients liposarcoma on MRI
F. Pellegrino, L. Perrucci, M. Pontrelli, M.R. Gamberini, M. Fortini, R. Donners, D. Harder; Basle/CH
I. Gagliardi, M.C. Zatelli, M.R. Ambrosio, M. Giganti; Ferrara/IT
SPEAKER B-0059 10:54

B-0047 10:46 SUPPORTED The diagnostic value of shear wave elastography for the differentiation
Opportunistic osteoporosis screening using hydroxyapatite- BY
INVEST IN of benign and malignant soft tissue tumours
specific vertebral bone mineral density measurements THE YOUTH M. Ozturk, A.V. Polat, Y.S. Baris, M.B. Selcuk; Samsun/TR
derived from dual-layer CT
J.H.W. Bodden, F. Roski, J. Hammel, K. Mei, T. Baum, A. Laugerette,
E.J. Rummeny, A.S. Gersing, B.J. Schwaiger; Munich/DE SUPPORTED
Do aggressive radiologic features of synovial sarcoma BY
INVEST IN
correlate with pathologic grading? A retrospective study THE YOUTH
B-0048 10:54 T.S. Al Kuhaimi, A. Aljefri, M. Alshaikh, S. Almalki, S. Bauones;
Consistency of bone mineral density assessments between dual- Riyadh/SA
energy CT and quantitative CT
M. Chen, H. Yuan; Beijing/CN
B-0061 11:10
Performance of 3D texture analysis for tissue characterisation and
B-0049 11:02 differential diagnosis of osteosarcoma
Metacarpal bone diameter increases constantly, but escalated C.S. Lisson1, C.G.S. Lisson1, R. Mayer-Steinacker1, A. von Baer1,
resorption of the inner surface at menopause explains decreased bone T.F.E. Barth1, M. Baumhauer2, A.J. Beer1, M. Beer1, S.A. Schmidt1; 1Ulm/DE,
mineral density - a study in 1492 adult women 2
Heidelberg/DE
C. Samuelsson, J. Kälvesten, M. Wilczek, T.B. Brismar; Stockholm/SE
B-0062 11:18
B-0050 11:10 Diagnostic value of MR imaging with metal artefact reduction
Sarcopenia and osteoporosis in patients with cancer diagnosis: sequences in local recurrence of malignant bone tumour after joint
evaluation with CT replacement
S. Ivanoski1, V. Vasilevska Nikodinovska2; 1Ohrid/MK, 2Skopje/MK H. Wang, Y. Lu; Shanghai/CN
B-0051 11:18 B-0063 11:26

Changes in bone marrow fat upon dietary induced weight loss Denosumab response evaluation in primary osseous giant cell tumours
M. Spurny, Y. Jiang, R. Schübel, T. Nonnenmacher, C.L. Schlett, with 18F-FDG PET/CT
O. von Stackelberg, H.-U. Kauczor, T. Kuhn, J. Nattenmüller; A. Kesari1, S.S. Swamy1, S. Sampangi1, I. Desai1, M. Ashok Kumar2,
Heidelberg/DE P. Asokan1, K. Kallur1; 1Bangalore/IN, 2Bikaner/IN
B-0052 11:26 SPEAKER SPEAKER

SUPPORTED B-0064 11:34 SUPPORTED
Fat mass does not increase the precision error of trabecular BY BY
INVEST IN Comparison of image quality and radiation dose between
INVEST IN
bone score measurements THE YOUTH combined ATCM and FTC technique in whole-body low-dose THE YOUTH
C. Buonomenna1, C. Messina1, S. Gitto1, A. Biacca2, D. Albano3, multidetector CT in the diagnosis of multiple myeloma
L.M. Sconfienza1; 1Milan/IT, 2Novara/IT, 3Palermo/IT M. Calvo Imirizaldu, A. Ezponda Casajús, I. Soriano, A. Paternain Nuin,
SPEAKER M. Elorz, J.D. Aquerreta Beola; Pamplona/ES
Dual-energy computed tomography in calcium BY
INVEST IN B-0065 11:42
pyrophosphate deposition: initial clinical experience THE YOUTH Collagen-bound and water-bound water longitudinal relaxation time
J. Legrand1, T. Pascart1, L. Norberciak1, F. Becce2, J.-F. Budzik1; by ZTE imaging as biomarker for radiation-induced bone changes in
1
Lille/FR, 2Lausanne/CH mouse model
V. Phi Van, I. Grgic, A. Boss, M. Pruschy, M. Wurnig; Zurich/CH
B-0054 11:42
Retrospective study of foot and ankle dual-energy CT in gouty arthritis B-0066 11:50
patients without first metatarsophalangeal joint uric acid crystal Radiologic predictors of survival in soft tissue sarcoma
deposition J. Kavanagh, J. Wunder, P. Ferguson, R. Mohankumar; Toronto, ON/CA
H. Yang1, Y.-S. Hong2, J. Gong Yong3, Y.K. Lee1, S.K. Kim1, J.H. You1,
E. Park1; 1Jeonju/KR, 2Gwangju/KR, 3Chonju/KR
B-0055 11:50
7T T2*-relaxometry detects early tendon degeneration in patients with
diabetes mellitus type 1 (DM1) and shows correlations with BMI and
age
M. Zalaudek1, W. Marik1, V. Juras1, M. Riedl1, B. Hager1, O. Bieri2,
X. Deligianni2, M. Weber1, S. Trattnig1; 1Vienna/AT, 2Basle/CH

10:30 - 12:00 Coffee & Talk 2 10:30 - 12:00 Room E1

Abdominal Viscera Breast
SS 201a SS 202
Focal liver lesions: characterisation Mammography and screening
R. Albazaz; Leeds/UK A.M.J. Bluekens; Breda/NL
M.A. Bali; Brussels/BE V. Lehotská; Bratislava/SK
K-01 10:30 B-0077 10:30

Keynote lecture Influence of annual reader volume on performance in a mammography
D. Weishaupt; Zurich/CH screening program with independent double reading and consensus of
Wednesday
digital mammograms
B-0067 10:39 S.R. Hoff1,2, T. Myklebust2,3, S. Hofvind3; 1Trondheim/NO, 2Aalesund/NO,
3
Classification of malignant and benign liver tumours using a radiomics Oslo/NO
approach
M.P.A. Starmans, R.L. Miclea, S.R. van der Voort, W.J. Niessen, S. Klein, B-0078 10:38
M.G. Thomeer; Rotterdam/NL Conversion to digital mammography had no impact on invasive
grade 3 cancer detection in the English NHS breast cancer screening
B-0068 10:47 programme: analysis of 11.3 million screening tests
The histology of the right parafissural liver parenchyma: collagen is R.G. Blanks1, M. Wallis2, R. Alison1, J. Jenkins3, O. Kearins4, J. Patnick1,
the basis for a hypoattenuating pseudolesion on CT R.M. Given-Wilson3; 1Oxford/UK, 2Cambridge/UK, 3London/UK,
4
W.M. Klein1, L. Sonnemans1, S. Franckenberg2, D. Gascho2, M. Prokop1, Birmingham/UK
W.H. Lamers3, J.P.J.M. Hikspoors3, M. Thali2, P. Flach4; 1Nijmegen/NL,
2
Zurich/CH, 3Maastricht/NL, 4St. Gallen/CH B-0079 10:46
The mammographic features of 13,213 women with screen-detected
B-0069 10:55 non-invasive breast disease
Focal peliosis hepatis: imaging features of magnetic resonance M.G. Wallis1, K. Clements2, B. Hilton2, J. Litherland3, A.J. Maxwell4,
imaging with diffusion-weighted imaging N. Sharma5, A. Thompson6; 1Cambridge/UK, 2Birmingham/UK,
3
W. Mingliang, M. Zeng; Shanghai/CN Glasgow/UK, 4Manchester/UK, 5Leeds/UK, 6Houston, TX/US
B-0070 11:03 SPEAKER B-0080 10:54

SUPPORTED
Negative biopsy of focal hepatic lesions: decision tree model BY Can we optimise the recall rate and reduce overdiagnosis? An analysis
INVEST IN
for patient management THE YOUTH of 11.3 million screening tests from the English NHS breast cancer
F. Vernuccio, M. Rosenberg, M. Meyer, R.C. Nelson, D. Marin; screening programme
Durham, NC/US R.G. Blanks1, R.M. Given-Wilson2, S. Cohen2, J. Jenkins2, J. Patnick1,
R. Alison1, M.G. Wallis3; 1Oxford/UK, 2London/UK, 3Cambridge/UK
SUPPORTED
Enhancement pattern of hepatocellular adenoma (HCA) BY B-0081 11:02
INVEST IN
on MR imaging performed with Gd-EOB-DTPA vs other THE YOUTH Additional breast cancer detection at screening mammography
Gd-based contrast agents (GBCAs): an intraindividual through quality assurance sessions between screening radiographers
comparison and coordinating screening radiologists
R. Cannella1, G. Brancatelli1, B. Rangaswamy2, M.I. Minervini2, A.M.P. Coolen1, B. Korte2, L.E.M. Duijm3; 1Tilburg/NL, 2Eindhoven/NL,
3
A.A. Borhani2, A. Furlan2; 1Palermo/IT, 2Pittsburgh, PA/US Nijmegen/NL
B-0072 11:19 SPEAKER B-0082 11:10

SUPPORTED
Multi-arterial phase EOB-MRI: different contrast BY Two decades of biennial screening mammography: trend in the
INVEST IN
enhancement pattern of focal nodular hyperplasia and THE YOUTH incidence of delayed breast cancer diagnosis after repeated recall for
hepatocellular carcinoma the same mammographic abnormality
S. Fiore, R. Faletti, F. Gentile, L. Pavan, F. Guarasci, M. Gerboni, B. Korte1, J.R.C. Lameijer1, L.E.M. Duijm2; 1Eindhoven/NL, 2Nijmegen/NL
M. Donalisio, M. Gatti, P. Fonio; Turin/IT
B-0083 11:18
B-0073 11:27 Frequency and outcome of bilateral recall at screening mammography
Intra-individual comparison of contrast enhancement rates of focal J.R.C. Lameijer1, J. Nederend1, A.C. Voogd2, V.C. Tjan-Heijnen2, L. Duijm3;
1
liver lesions in DCE-MRI with gadoxetic acid vs gadobutrol Eindhoven/NL, 2Maastricht/NL, 3Nijmegen/NL
N.A. Bünting, A. Barabasch, C.K. Kuhl; Aachen/DE
B-0084 11:26
B-0074 11:35 Solitary dilated duct visualised by mammography: are we correctly
A predictive model for early recurrence of hepatocellular carcinoma classifying according to BI-RADS lexicon 5th edition?
after tumour resection based on whole lesion MR imaging radiomics V.J. Ayres1, E.F. Fleury2, L. Ramalho2, L.d. Pompei2; 1Santo André/BR,
2
features São Paulo/BR
Z. Zhang, H. Jiang, L. Cao, Z. Ye, J. Chen, B. Song; Chengdu/CN
B-0085 11:34
B-0075 11:43 Outcome of microcalcifications classified as BI-RADS 3, 4a and 4b in
Using MRI or CT for preoperative evaluation of HCC makes the clinical patients with and without a history of breast cancer
outcome different V. Bertani1, M. La Grassa2, L. Balestreri3, N. Berger4, M. Urbani3, K. Lang5,
Y.-C. Chou; Tainan/TW A. Boss4, T. Frauenfelder4, M. Marcon4; 1Udine/IT, 2Pordenone/IT,
3
Aviano/IT, 4Zurich/CH, 5Malmö/SE
B-0076 11:51
Outcomes of Yttrium-90 radioembolic treatment for large monofocal SUPPORTED
hepatocarcinoma in BCLC-A stage patients: a single-centre experience Architectural distorsions with microcalcifications: a BY
INVEST IN
T. Gorgatti, A. Vit, M. Sponza, V. Gavrilovic, A. Pellegrin, F. Rosella, mammographic malignancy predictor of B3 lesions? THE YOUTH
R. Girometti; Udine/IT I. De Serio, K. Jerman, V. Londero, C. Zuiani; Udine/IT

B-0087 11:50 B-0097 11:51

False-positive recall in screening mammography: pitfalls of Radiomics MRI phenotyping with machine learning to predict the
challenging mammogram grade of lower grade gliomas: a study focused on non-enhancing
F. Leone1, M.A. Orsi1, M. Cellina1, A. Presazzi2, D. Mariani1, G. Oliva1; tumours
1
Milan/IT, 2Pavia/IT S. Yoon, Y. Park, Y. Choi, S. Ahn, J. Chang, S. Kim, S.-K. Lee; Seoul/KR
10:30 - 12:00 Room E2 10:30 - 12:00 Room F2

Neuro Emergency Imaging
SS 211a SS 217
Neurooncology: glioma Best of emergency radiology (part
Moderators:
N. Bulakbasi; Mersin/TR
1): from mass causality incidents to
K. Skogen; Oslo/NO incidental findings and errors
Moderators:
K-02 10:30 F.G. Mück; Munich/DE
Keynote lecture M. Stajgis; Poznan/PL
J.-F. Meder; Paris/FR
B-0098 10:30
B-0088 10:39 Mass casualty incidents: are you ready? An evidenced-based radiology
Wavelet parameter maps of perfusion-weighted MRI correlate to MCI protocol template
tumour vascularity and cell proliferation in glioblastoma J.W. Ryan, P.J. MacMahon, F. Bolster; Dublin/IE
T. Huber1, L. Rotkopf1, S. Bette1, C. Preibisch1, J. Gempt1, T. Pyka1,
K. Thierfelder2, B. Wiestler1; 1Munich/DE, 2Rostock/DE B-0099 10:38
Whole-body trauma CT for critical and mass casualty incident
SUPPORTED patients: how fast can we go
Noncontrast ASL-perfusion in pre-surgical differential BY L.F.M. Beenen, M.J. Scheerder, D. Bekebrede-Kauffman, N.H.J. Lobe;
INVEST IN
diagnosis of brain gliomas THE YOUTH Amsterdam/NL
A. Batalov, N. Zakharova, E. Pogosbekyan, L. Fadeeva, A. Baev,
S. Goryaynov, A. Kosyr‘kova, A. Potapov, I. Pronin; Moscow/RU B-0100 10:46
Whole-body CT using biphasic injection protocol with adaptive
SUPPORTED statistical iterative reconstruction-V (ASiR-V) in multi-trauma patients:
Lesion and lesion habitat analysis on magnetic resonance BY impact on dose reduction and image quality
INVEST IN
imaging: an imaging biomarker for tumour grade and 1p19q THE YOUTH A.H. Elmokadem1, E.A. Ibrahim2, W.A. Gouda3, A. Abdel Razek1;
deletion status 1
Mansoura/EG, 2Kuwait/KW, 3Menoufia/EG
A. Alvi1, F. Mubarak1, A. Alvi2, S. Enam1, M. Shahzad1; 1Karachi/PK,
2
Lahore/PK B-0101 10:54
Diagnostic performance of CT and the use of GI contrast material
B-0091 11:03 for the detection of hollow viscus injury after penetrating abdominal
Changes in high-grade gliomas after different kinds of radiation trauma
therapy depending on IDH status during chemotherapy in combination S. Thorisdottir1, G. Oladottir1, M. Nummela2, S. Koskinen3; 1Stockholm/SE,
with bevacizumab 2
Helsinki/FI, 3Huddinge/SE
A.V. Smirnova1, O.V. Lukina1, A. Kuzmin1, A. Tkachev2, N. Plakhotina1,
M. Cherkashin1, M. Anishkin1; 1St. Petersburg/RU, 2Volgograd/RU B-0102 11:02
Evaluation of a CT-based scoring system regarding the prognosis
SUPPORTED of blunt splenic and liver injuries: a single-centre analysis with 720
Novel imaging signs in detecting the 1p 19q non-co-deleted BY patients
INVEST IN
IDH wild and 1p 19q non-co-deleted IDH mutant lower grade THE YOUTH D. Morell Hofert, M. Fodor, E. Braunwarth, M. Haselbacher, T. Schmid,
gliomas M. Blauth, E.-M. Gassner, S. Stättner, F. Primavesi; Innsbruck/AT
A.N. Kamble1, A. Kamble2; 1New Delhi/IN, 2Mumbai/IN
B-0103 11:10
B-0093 11:19 Characteristics and predictive factors of delayed events in patients of
Diffusion kurtosis imaging parameters predicting survival in integrated blunt splenic trauma designated for non-operative management
molecular subtypes of diffuse glioma: an observational cohort study Y.-C. Wong, L.-J. Wang, C.-H. Wu; Taoyuan/TW
J.-M. Hempel, N.-C. Nüßle, C. Brendle, B. Bender, G. Bier, M. Skardelly,
H. Richter, J. Schittenhelm, U. Ernemann, U. Klose; Tübingen/DE B-0104 11:18
Can MR be useful in the follow-up of blunt liver and spleen injuries:
B-0094 11:27 preliminary results
Altered whole brain connectivity as a potential marker of disease F. Iacobellis, M. Di Serafino, T. Cinque, C. Stavolo, L. Romano; Naples/IT
burden in glioma patients
S. Stoecklein1, V. Stöcklein1, F. Schöppe1, N. Thon1, F.-W. Kreth1, B-0105 11:26
B.B. Ertl-Wagner2, J.-C. Tonn1, H. Liu3; 1Munich/DE, 2Toronto, ON/CA, Repeated imaging work-up in revisiting emergency patients: analysis
3
Boston, MA/US of clinical and radiological risk factors
Y. Ahn, G.-S. Hong, K. Park, C.W. Lee; Seoul/KR
B-0095 11:35
GLINT: GlucoCEST in neoplastic tumours at 3T - first-in-man studies of B-0106 11:34
GlucoCEST in glioma patients Incidental findings in whole-body CT: a retrospective analysis in over
T. Lindig1, M. Zaiss1, K. Herz1, A. Deshmane1, B. Bender1, X. Golay2, 1000 resuscitation room patients
K. Scheffler1; 1Tübingen/DE, 2London/UK S. Sudarski, T. Henzler, D. Schäfer, T. Viergutz, T. Terboven,
S.O. Schönberg, H. Haubenreisser; Mannheim/DE
B-0096 11:43
Preoperative resectability estimates of non-enhancing glioma by B-0107 11:42
neurosurgeons and a resection probability map Diagnostic error in emergency studies: an analysis of explanatory
E.J. Hendriks1, S. Idema1, A.H. Zwinderman1, F. Barkhof1, W.P. Vandertop1, variables
E. Mandonnet2, H. Duffau3, M.S. Berger4, P.C. De Witt Hamer1; F. Facal de Castro1, R. Mirón Mombiela1, J. Vucetic1, J. Mota Martinez2,
1
Amsterdam/NL, 2Paris/FR, 3Montpellier/FR, 4San Francisco, CA/US E. Arana Fernandez De Moya1, D. Dualde Beltran1; 1Valencia/ES,
2
Barcelona/ES

B-0108 11:50 B-0118 11:42 SPEAKER

SUPPORTED
Would it be safe to have a dog in the MRI scanner before your own Predictors for refractoriness and survival after transarterial BY
INVEST IN
examination? chemoembolisation among hepatocellular cancer patients: THE YOUTH
A. Gutzeit1, J.M. Fröhlich2, F. Steffen1, D.-M. Koh3, C. Orasch1; 1Lucerne/CH, outcomes from a novel southeast Asian cohort
2
Zurich/CH, 3Sutton/UK R. Kuhn, G. Ignacio, J. Jamias; Quezon City/PH
B-0119 11:50
10:30 - 12:00 Room Y Radiation dose reduction during angiographic adrenal vein sampling
using a new imaging technology
Interventional Radiology C. Spink, M. Avanesov, T. Schmidt, M. Grass, G. Schoen, G. Adam,
H. Ittrich, P. Bannas; Hamburg/DE
SS 209
Vascular interventions in oncology 10:30 - 12:00 Coffee & Talk 3
Wednesday
Moderators: Head and Neck
R. Duran; Lausanne/CH
N.N.
SPEAKER
SS 208
Operator learning curve for transradial liver cancer BY Thyroid gland
INVEST IN
embolisation: implications for the initiation of a transradial THE YOUTH Moderators:
access programme E. Scapin; Monserrato/IT
F. Carchesio, R. Iezzi, A. Posa, G. Veltri, A. Gasbarrini, A. Singhal; Gurgaon/IN
K-03 10:30
B-0110 10:38 SPEAKER Keynote lecture
SUPPORTED
Transarterial chemoembolisation with degradable starch BY P.-Y. Marcy; Ollioules/FR
INVEST IN
microspheres (DSM-TACE) as second-line treatment in HCC THE YOUTH
patients dismissing or ineligible for sorafenib B-0120 10:39
G. Veltri, R. Iezzi, A. Posa, F. Carchesio, A. Gasbarrini, Association of the four international guidelines for thyroid nodule
R. Manfredi; Rome/IT management to surgical and treatment outcomes in patients with
small papillary thyroid carcinoma
B-0111 10:46 SPEAKER J. Lee, J. Kwak, E.-K. Kim, H. Moon, V.Y. Park, J. Yoon; Seoul/KR
SUPPORTED
Same-day workup angiography and Yttrium 90 microsphere BY
INVEST IN
radioembolisation: feasibility and efficacy of hepatic flow THE YOUTH B-0121 10:47
redistribution Efficiency of biopsy criteria in thyroid nodules: the 2017 European
A. Ezponda Casajús, M. Calvo Imirizaldu, M. Morales, Thyroid Imaging Reporting and Data System vs the 2014 American
I. Vivas Perez, M. De La Torre, M. Rodríguez-Fraile, B. Sangro, Thyroid Association management guidelines
J.I. Bilbao Jaureguizar; Pamplona/ES V. Perez Riverola, F. Bosch Barragan, M. Prenafeta Moreno,
J. Cabero Moyano, I. Capel Flores, F. Guirao Garriga, S. Barcons Vilaplana,
B-0112 10:54 SPEAKER A. Rovira Gols; Sabadell/ES
SUPPORTED
Locoregional heparinisation for patients with acute deep BY
INVEST IN
venous thrombosis of lower extremity: safety and efficacy THE YOUTH B-0122 10:55
evaluation Radiological-pathological correlation of thyroid nodule ultrasound and
Y.-D. Xiao; Changsha/CN cytology using the TIRADS and Bethesda classifications
S. Aslan, S. Ozdemir; Tokat/TR
B-0113 11:02
Response to SIRT (selective internal radiation therapy) in patients B-0123 11:03
affected by unresectable multifocal intra-hepatic cholangiocarcinoma: Combination of ultrasound elastography with TI-RADS in the diagnosis
results of a preliminary study of small thyroid nodules (<10 mm): a new method to increase the
A. Paladini1, D. Beomonte Zobel2, G.E. Vallati2, G. Pizzi2, F. Cappelli2, diagnostic performance
A. Borzelli3, E.M. Amodeo2; 1Novara/IT, 2Rome/IT, 3Naples/IT Y. Du, C. Ji, Y. Wu, X. Gu; Shanghai/CN

SUPPORTED B-0125 11:19
Locoregional treatments for unresectable early stage HCC in BY Prediction of Bethesda category of thyroid nodule with specific
INVEST IN
patients with high-risk for intraprocedural bleeding: THE YOUTH sonographic findings
is single-step combined therapy safe and feasible? F. Kulali, M. Demir, A. Semiz-Oysu, Y. Bukte; Istanbul/TR
G. Veltri, R. Iezzi, A. Posa, F. Carchesio, A. Gasbarrini, R. Manfredi;
Rome/IT B-0126 11:27
On-site evaluation microscopic evaluation of unstained slides to assess
B-0115 11:18 adequacy of thyroid fine-needle aspiration cytology
Effectiveness and safety transarterial embolisation with bleomycin- N.M.H. Nik-Hussin, M. Robinson, K. Kenyon, M. Brown, P.-.T. Diep,
loaded PLA/PLGA microspheres for the treatment of vascular M. Atwan; Lancaster/UK
malformation using a porcine spleen model
F. Nurili1, T. Acar2, S. Derman2, I. Caymaz2, S. Özkanli2, A. Bas2, B-0127 11:35
I. Yurdaisik2, H. Cakiroglu2, O. Aras1; 1New York, NY/US, 2Istanbul/TR Malignancy risk of thyroid nodules with isolated macrocalcification
H.Y. Gwon, D.G. Na, W. Paik, S.J. Yoon; Gangneung/KR
B-0116 11:26
Low pretreatment neutrophil to lymphocyte ratio predicts better B-0128 11:43
survival in uveal melanoma liver metastases undergoing hepatic Role of acoustic radiation force impulse (ARFI) in differentiating
chemoperfusion benign and malignant thyroid nodules
J.M. Ludwig, O. Drescher, J. Haubold, H. Richly, M. Forsting, Y. Li, S.K. Suganchand Rikabchand; Jodhpur/IN
A. Wetter, S. Bauer, J. Theysohn; Essen/DE
SUPPORTED
B-0117 11:34 Thyroid nodules: diagnostic performance of ATA and TIRADS BY
INVEST IN
Transvenous pulmonary chemoembolisation (TPCE) for palliative and on risk stratification for malignancy THE YOUTH
neoadjuvant treatment of primary lung malignancies B.C.S. Rabelo, F. Tinoco Alvim de Souza,
A.I.A. Mekkawy1, A.A. Hassan1, M. El-Sharkaway1, H.M. Kamel1, P. Ramos Botelho Antunes, E. Carvalho de Siqueira,
D.B. Thabet1, N.-E.A. Nour-Eldin2, N.N.N. Naguib2, T.J. Vogl2; 1Asyut/EG, M. Alvares de Campos, L. Vianna Cancado, A. Vianna Cançado,
2
Frankfurt a. Main/DE M. Barbosa Alvares; Belo Horizonte/BR

10:30 - 12:00 Room G 10:30 - 12:00 Room K

Physics in Medical Imaging Chest
SS 213 SS 204
CT image quality and optimisation Lung cancer: guidelines, screening and
Moderators:
S. Edyvean; London/UK
nodule management
E. Samara; Sion/CH Moderators:
F.B. Demirkazik; Ankara/TR
P. Franchi; Teramo/IT
B-0131 10:30
Image quality evaluation of ultra-low dose chest CT using six iterative
reconstructions B-0141 10:30
M. Afadzi, K. Fosså, H. Andersen, T.M. Aaløkken, A.C.T. Martinsen; Outcomes of long-term interval rescreening with low-dose CT for lung
Oslo/NO cancer in different risk cohorts
A. Lam, R. Aggarwal, G. Liu, J. Kavanagh; Toronto, ON/CA
Evaluating the use of a noise index to identify outliers in CT B-0142 10:38 SUPPORTED
Applying British Thoracic Society 2015 compared to Fleischner BY
examinations INVEST IN
A.S.L. Dedulle, S. Rahimzadeh, N. Fitousi, H. Bosmans, J. Jacobs; Society 2017 recommendations for lung nodule management THE YOUTH
Leuven/BE leads to different discharge and PET-CT referral rates
L. Royle, M. Anjari, S. Sasikumar, R. SinhaRay, S. Mak, M. Subesinghe,
D. Murphy, R. Breen, A. Nair; London/UK
B-0133 10:46
Improved grey-white matter separation by amplitude/power
coefficients derived from spectral analysis of dual-energy CT B-0143 10:46
I. Leichter, B. Fialkoff, Y. Uziel, E. Ben-David, Z. Romman, J. Sosna, Low-dose computed tomography (LDCT) screening reduces overall
J.M. Gomori; Jerusalem/IL and lung cancer specific mortality beyond five years
U. Pastorino1, M. Silva2, F. Sabia1, S. Sestini1, M. Boeri1, G. Sozzi1,
N. Sverzellati2, A.V. Marchianò1; 1Milan/IT, 2Parma/IT
B-0134 10:54
Changes on noise power spectrum by advanced CT image
reconstruction techniques B-0144 10:54
T. Pan, R. Vikram; Houston, TX/US Lung cancer CT screening performance at a large hospital system in
the US: our 5-year experience showcases the need for better systems
of care
B-0135 11:02
E.J.M. Barbosa Jr.1, A. Kolansky1, X. Sui2, J. Jiang1; 1Philadelphia, PA/US,
Patient size-dependent ultralow-dose data completion scan in a 2
Beijing/CN
whole-body photon-counting CT scanner
S. Dorn1, S. Sawall1, J. Maier1, C. Polster2, S. Faby3, M. Uhrig1,
H.-P. Schlemmer1, M. Kachelrieß1; 1Heidelberg/DE, 2Munich/DE, B-0145 11:02
3
Forchheim/DE Lesion measurement on a combined „all-in-one“ computed
tomography window on chest scans: effect on intra- and interobserver
variability
B-0136 11:10
A. Snoeckx1, J. Cant2, C. Franck1, K. Carpentier1, E. Luyckx1, S. Nicolay1,
Optimising CT acquisition parameters for the quantification of lung
M.J. Spinhoven1, A. Van Hoyweghen1, P.M. Parizel1; 1Edegem/BE,
emphysema 2
Mortsel/BE
G. Van Gompel, S. Mahmoudi, C.C. Brussaard, J. De Mey, N. Buls;
Brussels/BE
B-0146 11:10
Comparison of computer-aided semi-automated volumetry with
B-0137 11:18
manual volumetry of part-solid pulmonary nodules
Automated image quality assessment in CT using a 3D printed lung
S. Werner1, R. Gast1, R. Grimmer2, M. Horger1; 1Tübingen/DE,
vessel phantom and structural similarity index analysis 2
Forchheim/DE
I. Hernandez-Giron1, R. Schippers2, J.M. den Harder3, G.J. Streekstra3,
W.J.H. Veldkamp1; 1Leiden/NL, 2The Hague/NL, 3Amsterdam/NL
B-0147 11:18
Pulmonary nodule size measuring difference: comparison between
B-0138 11:26
machine-learning based auto-measurement on CT images and gross
Sparse-sampling computed tomography (SpSCT) for the detection of
specimens through surgery
pulmonary embolism
X. Luo, M. Zhang, J. Ding, M. Chen; Beijing/CN
A. Sauter1, F.K. Kopp1, J. Dangelmaier1, D. Deniffel1, F. Meurer1, R. Bippus2,
E.J. Rummeny1, P.B. Noel1; 1Munich/DE, 2Hamburg/DE
B-0148 11:26
The differential diagnosis of benign and malignant solid pulmonary
B-0139 11:34
nodules by CDT-VIBE early dynamic contrast-enhancement of MRI
Application of preset adaptive statistical iterative reconstruction-V in
H. Zhang, L. Xu; Dazhou/CN
dual-enhanced abdominal CT
Y. Chai; Zhengzhou/CN
B-0149 11:34
Application of dual-layer detector spectral CT in differentiating benign
B-0140 11:42
and malignant lung nodules
Comparison of 90 and 180 micron resolution cone-beam CT scans in
Q. Wen, Y. Hou, Y. Ma, Q. Ma, X. Lu; Shenyang/CN
patients with artefact causing root canal filling material
A. Patney, M. Murugavel, V. Mahajan; New Delhi/IN
B-0150 11:42
Automated CT texture analysis of lung cancer FDG PET-CT data using
a novel software tool: preliminary results
G.M. McDermott1, M. Hayball2, B. Ganeshan2, Z. Riaz2, A. Scarsbrook3;
1
Leeds/UK, 2Cambridge/UK, 3York/UK
B-0151 11:50
Can dual-energy CT replace perfusion CT for the diagnosis of the solid
pulmonary nodules?
B. Zhu, T. Jiang, P. Peng, M. Li; Beijing/CN

10:30 - 12:00 Room M 1 10:30 - 12:00 Room M 2

Genitourinary Paediatric
SS 207 SS 212
Prostate cancer Paediatric cardiothoracic imaging
P. Puech; Lille/FR L. Riera; Barcelona/ES
N.N. T. Yalynska; Kiev/UA
K-04 10:30 K-05 10:30

Keynote lecture Keynote lecture
R.H. Oyen; Leuven/BE A. Secinaro; Rome/IT
Wednesday
B-0152 10:39 B-0162 10:39
The influence of background signal intensity changes on cancer Ultrasound as an alternative for plain radiography in the detection of
detection in prostate MRI the endotracheal tube position in neonatal intensive care unit patients
A.M. Hötker1, E. Dappa2, Y. Mazaheri3, B. Ehdaie3, J. Zheng3, M. Capanu3, R.H. Hashem, R.H. Tomerak, A.M. Tosson, A. Abdelmoneim; Cairo/EG
H. Hricak3, O. Akin3; 1Zurich/CH, 2Mainz/DE, 3New York, NY/US
B-0163 10:47
B-0153 10:47 Lung ultrasound, a safe & useful tool for neonatal with respiratory
Validation of the PI-RADS 2 size criterion for the prediction of problems monitoring
significant prostate carcinomas: are adjustments to the 1.5-cm S. Foutzitzi, S.P. Deftereos; Alexandroupoli/GR
threshold warranted?
S. Mahjoub1, A. Baur1, J. Pfeil1, C. Lee2, M. Rudolph1, M. Haas1, H. Cash1, B-0165 11:03
B. Hamm1, T. Penzkofer1; 1Berlin/DE, 2Singapore/SG Comparison of Iodixanol 320, Iomeprol 350 and Iopromide 370
effectiveness in CT cardiothoracic angiography in infants
B-0155 10:55 M. Pop; Targu Mures/RO
Restriction of diffusion and tumor aggressiveness: a non applicable
correlation for transition zone prostate cancer B-0166 11:11
F. Cornud, A. Jemal Turki, M. Barral, P. Soyer; Paris/FR The difference of left ventricular myocardial strain in isolated LVNC
and dilated cardiomyopathy with hyper-trabeculation: structure,
B-0156 11:03 SPEAKER functional and risk factors analysis
SUPPORTED
How to improve the equivocal category PIRADS score 3? BY H. Fu, R. Xu, Y. Guo, Z. Yang, H. Liu; Chengdu/CN
INVEST IN
Quantitative multiparametric MRI assessment of prostate THE YOUTH
cancer with histopathology correlation B-0167 11:19
G. Barchetti, R. Campa, M. Pecoraro, F. Barchetti, C. Catalano, Radiation exposure of thoracic computed tomography in paediatric
V. Panebianco; Rome/IT patients: can we always achieve a sub-mSv scan in a clinical setting?
K. Bubel1, K. Altmeyer2, J. Pfeifer1, H. Abdul-Khaliq1, T. Krenn1,
B-0157 11:11 A. Massmann1, A. Bücker1, P. Fries1; 1Homburg/DE, 2Saarlouis/DE
Predicting clinically significant prostate cancer in PI-RADS 3 lesions: a
retrospective high-volume centre study B-0168 11:27
I. Hermie1, J. Van Besien1, P. De Visschere2, G. Villeirs1; 1Ghent/BE, Fontan-operated adolescents have increased hepatic fibrotic markers
2
De Haan/BE assessed by ultrasound shear wave elastography and MR T1 mapping
C. de Lange, K. Thrane, K. Thommassen, K. Rydén Suther,
B-0158 11:19 L.-S. Ording Müller, O.M. Geier, G. Døhlen, R. Almaas, T. Møller; Oslo/NO
Improved diffusion weighted imaging of the prostate: RESOLVE and
ZOOMit in comparison to standard EPI sequences B-0169 11:35
M. Klingebiel, L. Schimmöller, T. Ullrich, M. Quentin, C. Arsov, G. Antoch, Diagnostic utility of 3 Tesla thorax magnetic resonance imaging in HIV-
H.-J. Wittsack; Düsseldorf/DE positive children
P. Rana1, K.S. Sodhi2, A. Bhatia2, A.K. Saxena2, D. Suri2, S. Singh2;
B-0159 11:27 1
Dwarka/IN, 2Chandigarh/IN
Prostate cancer treated with irreversible electroporation: MRI-based
volumetric analysis and oncological outcome B-0170 11:43
F. Giganti1, A. Stabile2, S. Giona3, C. Orczyk1, C.M. Moore1, C. Allen1, Assessment of lung volume and central airways dimension using MRI in
A. Kirkham1, M. Emberton1, S. Punwani1; 1London/UK, 2Milan/IT, children: a comparison with plethysmography, CT and PFT
3
Frimley/UK Y. Wang1, C. Yong1, P. Wielopolski2, E.C. van der Wiel-Kooij2,
H.A. Tiddens2, P. Ciet2; 1Yinchuan/CN, 2Rotterdam/NL
B-0160 11:35
Is DCE useless in early detection of prostate cancer? The analysis of B-0171 11:51
quantitative parameters might help radiologists to decide if findings Image quality and incidental findings of chest MRI in a large paediatric
mildly restricted on ADC map should be sampled population-based study
M. Pecoraro, R. Campa, G. Barchetti, V. Salvo, C. Catalano, V. Panebianco; A. Pittaro1, L. Duijts2, P. Wielopolski2, M.W. Vernooij2, A. Van der Lugt2,
Rome/IT V.W. Jaddoe2, M.M.P.C. Kemner-van de Corput2, H.A. Tiddens2, P. Ciet2;
1
Padova/IT, 2Rotterdam/NL
B-0161 11:43
Impact of dynamic contrast-enhanced (DCE) MRI on prostate cancer
detection: is it worth the effort?
L. Schimmöller, F. Ziayee, N. Laqua, T. Ullrich, M. Klingebiel, M. Quentin,
G. Antoch, C. Arsov; Düsseldorf/DE
B-0154 11:51
Prostate cancer risk stratification using biparametric MRI and clinical
parameters improves selection of biopsy naïve men for prostate
biopsies
L. Boesen1, F.B. Thomsen1, N. Nørgaard1, V. Logager2, R. Bisbjerg1,
I. Balslev1, H. Jakobsen1, H.S. Thomsen1; 1Herlev/DK, 2Copenhagen/DK

10:30 - 12:00 Room M 3 10:30 - 12:00 Room M 5

Oncologic Imaging Neuro
SS 216 SS 211b
Multiparametric imaging for pelvic Vascular diseases and the brain
cancers Moderators:
N.N.
Moderators: M.M.A. Zaitoun; Zagazig/EG
M. Otero-García; Vigo/ES
B.M. Schaarschmidt; Düsseldorf/DE
B-0183 10:30
MRA vs DSA based models of cerebral aneurysms: how do the
B-0172 10:30 corresponding CFD derived flow fields compare?
Classification of prostate cancer on multiparametric MR imaging using M. Mantatzis, K. Thanosoulis, A. Theodoridis, J. Mokali, C. Gianniotis,
3D convolutional neural network I. Seimenis; Alexandroupoli/GR
N. Aldoj, S. Lukas, M. Dewey, T. Penzkofer; Berlin/DE
B-0184 10:38
B-0173 10:38 The mechanism of cerebral aneurysms and treatment effect on the
Ovarian cancer staging and resectability assessment: prospective genesis
comparison between diffusion-weighted MRI and MSCT B.-L. Gao; Zhengzhou/CN
A.E. Solopova, A.M. Sdvizhkov, A.D. Makatsaria; Moscow/RU
B-0185 10:46
B-0174 10:46 Evaluation of haemodynamic and morphological biomarkers to assess
Multiparametric MRI in prostate cancer: a radiomic study applied to the rupture risk of intracranial aneurysms using magnetic resonance
different diffusion and perfusion models fluid dynamics and computational fluid dynamics
D. Grimaldi, S. Monti, C. Rinaldo, V. Brancato, M. Aiello, G. Di Costanzo, M.G.R.S. Perera1, H. Isoda1, T. Mizuno1, M. Terada2, T. Naito2, C. Tanoi2,
C. Cavaliere, A. Ragozzino, M. Salvatore; Naples/IT T. Izumi1, H. Sakahara3, S. Naganawa1; 1Nagoya/JP, 2Iwata/JP,
3
Hamamatsu/JP
B-0175 10:54
Associations between whole tumour histogram analysis parameters B-0186 10:54
derived from ADC maps and expression of EGFR, VEGF, Hif 1-alpha 4D CT-angiography as a predictor of growth of intracranial aneurysm
Her-2 and Histone 3 in uterine cervical cancer E. Grigorieva1, V. Krylov2, V. Lukyanchikov2, N. Polunina2; 1Fryazino/RU,
H.-J. Meyer, P. Gundermann, A. Höhn, G. Hamerla, A. Surov; Leipzig/DE 2
Moscow/RU
B-0176 11:02 B-0187 11:02 SPEAKER

SUPPORTED
IVIM MRI: a better tool to assess myometrial invasion in endometrial Risk evaluation of malignant intracranial hypertension BY
cancer INVEST IN
development in children with severe traumatic brain injury THE YOUTH
R. Balaji; Chennai/IN I. Melnikov, M. Ublinskiy, O. Lukovkina, M. Akhlebinina,
SPEAKER T. Akhadov; Moscow/RU
Multiplatform reproducibility of DCE-MRI enhancement BY
curves for adnexal masses: quality assurance study for THE YOUTH Association of amygdala volume and markers of cardiovascular
multicentre MROC trial disease
A.S. Mehdi, S. Islam, N. Bharwani, S. Sudderuddin, A.G. Rockall; S. Grosu1, R. Lorbeer1, F. Bamberg2, C.L. Schlett3, M. Heier1, S. Rospleszcz1,
London/UK A. Peters4, B.B. Ertl-Wagner5, S. Stöcklein1; 1Munich/DE, 2Freiburg/DE,
3
Heidelberg/DE, 4Neuherberg/DE, 5Toronto, ON/CA
B-0178 11:18
Texture analysis of multiparametric MRI and association with tumour B-0189 11:18 SPEAKER
SUPPORTED
grading in cervical cancer Imaging requests, stroke incidence and contributing factors BY
J.A.U. Perucho, E.Y.P. Lee, R. Du, V. Vardhanabhuti, K.W.H. Chiu, INVEST IN
after open-heart surgery THE YOUTH
E.M.F. Wong; Hong Kong/HK L. Melazzini, M. Codari, G.D.E. Papini, C. Beretta, M. Ranucci,
F. Secchi, F. Sardanelli; Milan/IT
B-0179 11:26
The utility of histogram analysis of whole tumour apparent diffusion B-0190 11:26
coefficient map and MRI volumetry in differentiating low and high Arterial spin labelling MRI in evaluating perioperative cerebral
grade endometrial cancer perfusion of carotid endarterectomy with different post labelling
W.M. Fathallah, M. Habeeb, M.E. Ghanim, M.E. Bandar; Kuwait/KW delays: comparison with CT perfusion imaging
H.M. Xu, Y. Liu, H. Yuan; Beijing/CN
B-0180 11:34
Ovarian cancer neoadjuvant treatment response evaluation: value of B-0191 11:34 SPEAKER
SUPPORTED
diffusion-weighted MRI Accuracy of intracerebral haemorrhage volume calculation: BY
A.E. Solopova, S.N. Gurov; Moscow/RU INVEST IN
comparison between manual volume segmentation, ABC/2 THE YOUTH
and sABC/2
B-0181 11:42 A.V. Marinescu, R. Radu, E. Terecoasa, A.N. Marinescu, C. Tiu, A. Nicula;
Pre- and post-MRI risk-stratification reduces prostate MRIs, biopsies Bucharest/RO
and overdetection in prior negative biopsy men
F.-J.H. Drost, J.F.M. Verbeek, A.R. Alberts, M.J. Roobol, I.G. Schoots; B-0192 11:42
Rotterdam/NL Effect of prolonged acquisition intervals on CT brain perfusion
analyses
B-0182 11:50 F. van Ommen, F. Kauw, E. Bennink, J.W. Dankbaar, H.W.A.M. De Jong;
DW-MRI can be used to predict complete cytoreduction and survival in Utrecht/NL
colorectal peritoneal carcinomatosis patients using leading predictive
models B-0193 11:50
M.P. Engbersen, I. Van ‚t Sant, W.J. Van Eden, J.D.R. Velzing, N.F. Kok, Completeness of trauma head computed tomography reports:
D.M. Lambregts, R.G.H. Beets-Tan, A.G. Aalbers, M.J. Lahaye; possibilities for improvement using machine learning
Amsterdam/NL N. Schmidt, I. Nesic, M. Moor, J. Cyriac, D. Zumofen, B. Stieltjes,
K. Blackham; Basle/CH

11:45
10:30 - 12:00 Sky High Stage
Role of PI-RADS v2 in clinical models: a multi-institutional study
Clinical Trials in Radiology conducted by the SAR Prostate Cancer Disease Focused Panel (aim 3)
A. C. Westphalen1, A. B. Rosenkrantz2, C. McCulloch1, J. Anaokar3,
S. Arora4, N. Barashi5, J. O. Barentsz6, T. K. Bathala7, L. Bittencourt8,
CT 2 M. T. Booker9, V. G. Braxton4, D. D. Casalino5, S. D. Chang10, F. V. Coakley11,
R. Dhatt10, S. C. Eberhardt12, B. R. Foster11, A. Froemming13, J. J. Futterer6,
Clinical Trials in Radiology 1 M. R. Gertner14, L. M. Gettle15, S. Ghai16, R. T. Gupta17, M. E. Hahn9,
Moderators: R. Houshyar18, C. Kim19, C. K. Kim20, C. Lall21, D. Margolis22, S. E. McRae7,
M. Dewey; Berlin/DE A. Oto5, R. Parsons23, N. U. Patel24, T. J. Polascik17, J. B. Starcevich25,
V.P. Jackson; Tucson, AZ/US B. Spilseth26, V. S. Tammisetti7, S. S. Taneja22, S. Verma27, C. A. Warlick26,
A. R. Weinberger5, J. Yu19, R. J. Zagoria1; 1San Francisco, CA/US,
2
10:30 New York City, NY/US, 3Philadelphia/US, 4Nashville/US,
5
Primary stenting of superficial femoral artery in patients with Chicago/US, 6Nijmegen/NL, 7Houston/US, 8Rio de Janeiro/BR,
9
intermittent claudication has durable effects on health-related quality San Diego/US, 10Vancouver/CA, 11Portland/US, 12Albuquerque, NM/US,
Wednesday
13
of life at 24 months: results of a randomised controlled trial Rochester, MN/US, 14Toronto/CA, 15Madison/US, 162n2, ON/CA,
17
H. Lindgren1, A. Gottsater2; 1Helsingborg/SE, 2Malmö/SE Durham/US, 18Orange/US, 19Richmond/US, 20Seoul/KR,
21
Orange, CA/US, 22New York/US, 23Philadelphia, PA/US, 24Aurora/US,
25
Albuquerque/US, 26Minneapolis/US, 27Cincinnati/US
10:39
Discussant: Discussant:
T.J. Kroencke; Augsburg/DE E. Rud; Oslo/NO
10:45
Ultrasound-guided vs computed tomography-guided renal mass 10:30 - 12:00 Tech Gate Auditorium
biopsy: a prospective randomised study
H.M. Farg, A. Abdelhamid, M. Zakaria, M. El-Ksas, A. El Mahdy, Cardiac
M. Abd El-Hameed, T. El-Diasty; Mansoura/EG
10:54
Discussant:
SS 203
N.N. Imaging before and after aortic valve
repair
11:00
Self-compression mammography in clinical practice: a randomised Moderators:
clinical trial compared to standard compression mammography C. Celeng; Utrecht/NL
V. Iotti, M. Guberti, L. Canovi, P. Giorgi Rossi, M. Bertolini, R. Vacondio, N. Gagarina; Moscow/RU
P. Pattacini; Reggio Emilia/IT
K-06 10:30
11:09 Keynote lecture
Discussant: J.-N. Dacher; Rouen/FR
A. Oktay; Izmir/TR
B-0194 10:39
11:15 Gender-specific reference values of thoracic aortic growth
MRI vs mammography screening for high-risk women: an RCT - L.R. Bons1, Z. Sedghi Gamechi1, K.F. Kofoed2, J.H. Pederson2,
the influence of density and effectiveness R.P.J. Budde1, M. de Bruijne1, J.W. Roos-Hesselink1; 1Rotterdam/NL,
2
A. Geuzinge1, S. Saadatmand1, E. J. J. Rutgers2, R.M. Mann3, Copenhagen/DK
D. de Roy van Zuidewijn4, H. Zonderland2, R. Tollenaar5, M.B.I. Lobbes6,
M. Ausems7, M. van ‘t Riet8, M. Hooning1, I. Mares-Engelberts1, E. Luiten9, B-0195 10:47
E. Heijnsdijk1, C. Verhoef1, N. Karssemeijer3, J. Oosterwijk10, I.-M. Obdeijn1, Aliased flow planimetry by phase-contrast CMR imaging for grading of
H. de Koning1, M. Tilanus-Linthorst1; 1Rotterdam/NL, 2Amsterdam/NL, aortic stenosis
3
Nijmegen/NL, 4Leeuwarden/NL, 5Leiden/NL, 6Maastricht/NL, C. Mantini1, F. Ricci1, D. Mastrodicasa2, D. Rotondo1, A.R. Cotroneo1,
7
Utrecht/NL, 8Delft/NL, 9Breda/NL, 10Groningen/NL S. Gallina1; 1Chieti/IT, 2Stanford, CA/US
11:24 B-0196 10:55

Discussant: CT as a one stop shop for TAVI-Planning: do we still need an additional
R. Schulz-Wendtland; Erlangen/DE invasive coronary angiography?
R.F. Gohmann, C. Krieghoff, P. Seitz, C. Lücke, P. Hartung, M. Abdel-
11:30 Wahab, D. Holzhey, H. Thiele, M. Gutberlet; Leipzig/DE
Variability in cancer-positive predictive value using PI-RADS v2:
a multi-institutional study conducted by the SAR Prostate Cancer B-0197 11:03
Disease Focused Panel (aim 2) Reduced dose, reduced contrast single-acquisition TAVI imaging using
A. C. Westphalen1, A. B. Rosenkrantz2, C. McCulloch1, J. Anaokar3, novel contrast protocol and spectral low-mono-energetic imaging:
S. Arora4, N. Barashi5, J. O. Barentsz6, T. K. Bathala7, L. Bittencourt8, a proof of concept study
M. T. Booker9, V. G. Braxton4, D. D. Casalino5, S. D. Chang10, F. V. Coakley11, P.A. Ball; Belfast/UK
R. Dhatt12, S. C. Eberhardt13, B. R. Foster11, A. Froemming14, J. J. Futterer6,
M. R. Gertner15, L. M. Gettle16, S. Ghai17, R. T. Gupta18, M. E. Hahn9, B-0198 11:11
R. Houshyar19, C. Kim20, C. K. Kim21, C. Lall22, D. Margolis23, S. E. McRae7, Low iodine, fast kV switching dual energy thoraco-abdominal CT
A. Oto5, R. Parsons24, N. U. Patel25, T. J. Polascik18, J. B. Starcevich26, angiography for planning of transcatheter aortic valve implantation
B. Spilseth27, V. S. Tammisetti7, S. S. Taneja23, S. Verma28, C. A. Warlick27, (TAVI): a pilot feasibility study
A. R. Weinberger5, J. Yu20, R. J. Zagoria1; 1San Francisco, CA/US, L. Faggioni, M. Gabelloni, M. Bianchi, E. Neri, D. Caramella; Pisa/IT
2
New York City, NY/US, 3Philadelphia/US, 4Nashville/US, 5Chicago/US,
6
Nijmegen/NL, 7Houston/US, 8Rio de Janeiro/BR, 9San Diego/US, B-0199 11:19
10
Vancouver/CA, 11Portland/US, 12Vancouver/US, 13Albuquerque, NM/US, Psoas muscle cross-sectional areas and aortic valve calcification in
14
Rochester, MN/US, 15Toronto/CA, 16Madison/US, 17Toronto, ON/CA, patients enrolled for transcatheter aortic valve implantation (TAVI)
18
Durham/US, 19Irvine/US, 20Richmond/US, 21Seoul/KR, 22Orange, CA/US, G. Spadarella, L. Bonomo, C.B. Monti, F. Sardanelli, F. Secchi; Milan/IT
23
New York/US, 24Philadelphia, PA/US, 25Aurora/US, 26Albuquerque/US,
27
Minneapolis/US, 28Cincinnati/US B-0200 11:27
Radiation dose and the repeatability of measurements of dimensions
11:39 of the aortic valve in multidetector computed tomography performed
Discussant: routinely in the qualification procedure for TAVI
H.Y. Kressel; Boston, MA/US B. Kedzierski, P. Gac, M. Glosna, R. Poreba, K. Pawlas; Wroclaw/PL

B-0201 11:35 B-0213 11:34

Dysfunction and thrombosis of aortic valve prostheses in patients after Perianal fistula mapping at 3T: volumetric vs conventional MR
TAVR in computed tomography sequences
L. Lehmkuhl1, J. Grimm2, I. Diamantis3, M. Wutschke2, K. Lenk2, M. Franz2, M. Cerit, A.Y. Oner, A. Yildiz, E. Cindil, H.N. Sendur, S. Leventoglu;
C. Schulze2, U.K. Teichgräber2; 1Bad Neustadt/DE, 2Jena/DE, Ankara/TR
3
Weimar/DE
B-0214 11:42
B-0202 11:43 Anal fistula: the role of MR imaging in preoperative evaluation
Biological versus mechanical aortic valve prostheses: an in vitro 4D D.T. Vo, C.C. Phan, L.T.T. Nguyen, H.M.D. Le, T.T. Nguyen;
flow MRI comparison of haemodynamics Ho Chi Minh City/VN
T.H. Oechtering, A. Panagiotopoulos, M. Sieren, M. Scharfschwerdt,
B. Fujita, S. Ensminger, H.-H. Sievers, J. Barkhausen, A. Frydrychowicz;
Lübeck/DE 14:00 - 15:30 Room X
B-0203 11:51 Vascular

Aortic valve bypass surgery in severe aortic valve stenosis: insights
from cardiac and brain magnetic resonance imaging
C. Mantini1, M. Caulo1, D. Mastrodicasa2, D. Marinelli1, A. Tartaro1, SS 315
A.R. Cotroneo1, G. Di Giammarco1; 1Chieti/IT, 2Stanford, CA/US
Advanced vascular imaging: cerebral and
peripheral arteries
10:30 - 12:00 The Church Moderators:
H.A. Deutschmann; Graz/AT
GI Tract
N.N.
SPEAKER
SS 201b B-0215 14:00
Branching pattern of the cerebral arterial tree
SUPPORTED
BY
INVEST IN
New developments in anorectal imaging J. Helthuis1, T. van Doormaal1, B. Hillen2, R. Bleys1, A. Harteveld1, THE YOUTH
Moderators: J. Hendrikse1, A. van der Toorn1, J.J. Zwanenburg1,
F. Iacobellis; Naples/IT A. van der Zwan1; 1Utrecht/NL, 2Nijmegen/NL
A. Maier; Vienna/AT
B-0216 14:08
B-0204 10:30 High-resolution MR image of intracranial blood vessels wall using 3D
Correlation between T2WI texture features of primary tumour and VISTA sequence
nodal metastasis in rectal cancer L. Zheng, Q. Wang, Z. Wang; Shanghai/CN
l. Yang, B. Wu; Chengdu/CN
B-0217 14:16
B-0206 10:38 Development and validation of prediction model based on
Quantitative elastography of rectal lesions: the value of shear-wave hemodynamic derived from computed tomography angiography for
elastography (SWE) in identifying benign and malignant rectal lesions rupture risk of small unruptured intracranial aneurysms
T. Li; Chengdu/CN Z. Shi, G. Chen, C. Zhou, G. Lu, L. Zhang; Nanjing/CN
SPEAKER B-0218 14:24 SPEAKER

B-0207 10:46 SUPPORTED SUPPORTED
BY One-stop coronary CTA combined with carotid and BY
MRI texture analysis in predicting lymph nodal yield after
INVEST IN INVEST IN
neoadjuvant chemoradiotherapy in locally advanced rectal THE YOUTH cerebrovascular CTA using wide-detector CT: comparison THE YOUTH
cancer (LARC) with conventional protocol
M. Panzeri, A. Di Chiara, A. Palmisano, A. Esposito, P. Passoni, P. Han, W. Li, Z.-G. Yang, K. Diao, R. Shi, Z. Li; Chengdu/CN
A. Del Maschio, F. De Cobelli; Milan/IT
B-0219 14:32
B-0208 10:54 Curved surface reformations - diagnostic accuracy and time-efficiency
Multislice spiral CT images combined with CEA, lymphocyte and of a new peripheral CTA reformation technique
neutrophil ratio predict recurrence and metastasis postoperative of D. Toth, J. Kittinger, K. Lampichler, C. Loewe, R. Schernthaner; Vienna/AT
rectal cancer
D.H. Yuan; Kunming/CN B-0220 14:40
TSH suppressive therapy aggravates arterial inflammation: an 18F-FDG
B-0209 11:02 PET study in thyroid carcinoma patients
The value of MRI in the evaluation of peri-anal fistula E. Boswijk, K.J.C. Sanders, E. Broeders, M. de Ligt,
A.M.J. Al-Mosawe, M.A.K. Al-Jiboori; Baghdad/IQ W.D. Vanmarkenlichtenbelt, F. Mottaghy, P. Schrauwen, J.E. Wildberger,
J. Bucerius; Maastricht/NL
B-0210 11:10
Structured vs narrative reporting of pelvic MRI in perianal fistulising B-0221 14:48
disease: impact on clarity, completeness, and surgical planning Comprehensive validation of two accelerated 4D-flow MR sequences
O. Tuncyurek, A. Garces-Descovich, E.E. Duran, T.E. Cataldo, V.Y. Poylin, at 3T: a phantom study
K.J. Mortele; Boston, MA/US S. Ebel1, L. Hübner1, B. Köhler2, S. Kropf2, B. Preim2, B. Jung3, M. Grothoff1,
M. Gutberlet1; 1Leipzig/DE, 2Magdeburg/DE, 3Bern/CH
B-0211 11:18
MR fistulography with percutaneous instillation of ultrasound gel and B-0222 14:56
its role in the preoperative mapping: our experience Validation of CT imaging characteristics to differentiate intimal from
G. Fontanella, M. Mancinelli, S. De Lucia, A. Festa, R. Villanacci, medial calcifications in peripheral vessels and its application in a non-
C. Manganiello; Benevento/IT vascular cohort
L.C.D. Konijn1, P.A. de Jong2, H. van Overhagen1, W.P. Mali2;
B-0212 11:26 SPEAKER 1
The Hague/NL, 2Utrecht/NL
SUPPORTED
Introducing 3D modelling of MRI in preoperative mapping of BY
perianal fistula: how it could help the surgeons? THE YOUTH
M.S. Roman, M.Y. Awadallah, A.F. Ahmed, F.S. Fawzi, Virtual monochromatic images in low-tube current dual-energy
H.A.S. Shawali, R.F. Elsayed; Cairo/EG spectral imaging combined with adaptive statistical iterative
reconstruction V in head CT angiography
T. Song, Z. Li; Chengdu/CN

B-0224 15:12 B-0235 15:12

Comparing the diagnostic accuracy of 18F-FDG-PET/CT, contrast- First report from breath-holding high-resolution high-sensitivity SiPM
enhanced CT and combined imaging in patients with suspected PET/CT: are lung nodules getting more active?
vascular graft infections M. Jreige, M. Meyer, G. Allenbach, M. Pappon, M. Nicod Lalonde,
L. Husmann, M.W. Huellner, B. Ledergerber, A. Anagnostopoulos, N. Schaefer, J.O. Prior; Lausanne/CH
P. Stolzmann, B.-R. Sah, I.A. Burger, Z. Rancic, B. Hasse; Zurich/CH
B-0236 15:20
B-0225 15:20 PET/CT imaging of the novel molecular probe 11C-aminoglycerol for the
Inter-scanner and inter-software comparison of quantitative 4D flow MRI diagnosis of liver fibrosis
T.H. Oechtering1, A. Nowak1, M. Sieren1, J. Graessner2, X. Chen, J. Xin; Shenyang/CN
H. Kooijman-Kurfuerst2, J. Barkhausen1, A. Frydrychowicz1; 1Lübeck/DE,
2
Hamburg/DE
14:00 - 15:30 Room O
14:00 - 15:30 Room N Musculoskeletal
Wednesday
Hybrid Imaging
SS 310
SS 306 Upper extremity imaging
Moderators:
Clinical applications of hybrid imaging I. Boric; Zabok/HR
Moderators: L. Lassalle; Paris/FR
A. Scarsbrook; Leeds/UK
R. Woitek; Cambridge/UK K-07 14:00
Keynote lecture
B-0226 14:00 A. Blum; Nancy/FR
Modulation of PSMA expression by androgen deprivation therapy
(ADT): serial PSMA PET in men with hormone sensitive and castrate B-0237 14:09 SPEAKER
SUPPORTED
resistant prostate cancer commencing androgen blockade Ultrahigh-field MR microscopy of the upper extremity of the BY
INVEST IN
C. Yin1, A. Joshua1, M. Crumbaker1, L. Emmett2; 1Darlinghurst/AU, chicken in vivo throughout the in ovo period THE YOUTH
2
Sydney/AU M. Jäschke, K. Thierfelder, B. Klaan, T. Stahnke, T. Lindner,
A. Wree, M.-A. Weber, S. Langner; Rostock/DE
B-0227 14:08
68 GA PSMA vs whole body diffusion weighted MR imaging in staging B-0238 14:17
of high risk prostate cancer MR quantification of the fatty fraction from IDEAL IQ sequence in the
M. Logudoss, A. Chellathurai; Chennai/IN assessment of muscle atrophy in rotator cuff tears
O. Seraydarmansour, Z. Taher Rakei; Tehran/IR
B-0228 14:16
Performance of 68Ga-PSMA-11-PET/MRI guided biopsy to detect B-0239 14:25
significant prostate cancer Evaluation of glenoid labral tears: comparison between dual-energy
I.A. Burger, D.A. Ferraro, J. Müller, U. Mühlematter, M. Messerli, CT arthrography and MR arthrography of the shoulder
P. Stolzmann, N.J. Rupp, O.F. Donati, D. Eberli; Zurich/CH G. Foti1, M. Catania2, A. Beltramello1, G. Carbognin1; 1Negrar/IT,
2
Verona/IT
B-0229 14:24
PSMA expression heterogeneity of the primary tumour on IHC B-0240 14:33
correlates with the detection rate of 68Ga-PSMA-11-PET in patients with Value of 3D-multi-echo-data-image-combination (MEDIC) for
biochemical recurrence evaluation of SLAP lesions at 3T-MRI of the shoulder with arthroscopic
D.A. Ferraro, J.H. Rüschoff, J. Müller, U. Mühlematter, M. Messerli, correlation
M. Hüllner, D. Eberli, N.J. Rupp, I.A. Burger; Zurich/CH F. Wuennemann, C. Rehnitz; Heidelberg/DE
B-0230 14:32 B-0241 14:41 SPEAKER

SUPPORTED
Influence of segmentation techniques on volumetric and textural Evaluation of bone loss in shoulder instability using on track/ BY
INVEST IN
metabolic parameters of primary tumours on 18F-FDG PET-CT imaging off track method: value of 3D MR arthrography in standard THE YOUTH
M. Novikov, T. Babkina; Kiev/UA and ABER position
C. Gianneramo, F. Bruno, E. Cannizzaro, P. Palumbo, S. Iafrate, S. Mariani,
B-0231 14:40 F. Arrigoni, A. Barile, C. Masciocchi; L‘Aquila/IT
Inflammation focus search with 18F-FDG-PET/MRI: comparative or
additive value of PET and MRI B-0242 14:49
A. Örnek1, L. Umutlu1, J. Kirchner2, B. Reichardt1, K. Herrmann1, Ability of T2 mapping at 3T MRI for biochemical assessment of normal
V. Ruhlmann1; 1Essen/DE, 2Dusseldorf/DE and damaged glenoid cartilage of the shoulder: an arthroscopy
controlled prospective study
B-0232 14:48 SPEAKER C. Rehnitz, F. Wuennemann; Heidelberg/DE
SUPPORTED
Is PET MRI valuable in inflammation or fever of unknown BY
INVEST IN
aetiology? THE YOUTH B-0243 14:57
T. Rohan, T. Andrasina, A. Litavcova, T. Juza, J. Zavadil, Extremity cone-beam CT of forearm and hand: evaluation of image
S. Richter, V. Valek; Brno/CZ quality, metal artefacts and radiation dose
C. Polkowski, I. Yel, M.C. Langenbach, B. Kaltenbach, T.J. Vogl, K. Eichler;
B-0233 14:56 SPEAKER Frankfurt a. Main/DE
SUPPORTED
Role of 18 F FDG PET-CT in documenting the disease burden BY
INVEST IN
in brain, spinal and lymph node tuberculosis THE YOUTH B-0244 15:05
K.B.K. Rangan, S. Gambhir; Lucknow/IN Physeal changes in youth gymnasts: a three-dimensional assessment
of stress-related volume increase of the distal radial physis using
B-0234 15:04 SPEAKER magnetic resonance imaging
SUPPORTED
Optimising PET/CT paediatric imaging for patient dose BY R.B.J. Kraan, L. Kox, M. Mens, M. Maas; Amsterdam/NL
INVEST IN
reduction THE YOUTH
H. Kertész, T. Traub-Weidinger, I. Rausch, T. Beyer, B-0245 15:13
J. Cal-Gonzalez; Vienna/AT Dual-energy CT in the diagnosis of occult acute scaphoid injury: a
direct comparison with MRI
C. Xie, S. Ather, R. Mansour, F. Gleeson, R. Chowdhury; Oxford/UK

B-0246 15:21 B-0257 15:20

Trapezial ridge fractures: an underappreciated cause of post-traumatic Affirm Prone Biopsy System 2D/3D™: tomosynthesis in the vacuum-
wrist pain with normal initial radiographs. assisted prone stereotactic biopsy
B. Gibney, M.C. Murphy, D. Ahern, A. Moughty, E. Kavanagh, D. Hynes, C. Depretto1, D. Baldari2, F. Cartia1, C. Ferranti1, G. Scaperrotta1; 1Milan/IT,
2
P.J. MacMahon; Dublin/IE Naples/IT
14:00 - 15:30 Room E1 14:00 - 15:30 Room E2

Breast Neuro
SS 302 SS 311
Digital breast tomosynthesis (DBT) Stroke: interventional
J. Etxano; Vitoria/ES F. Bozzetti; Parma/IT
P.L. Moyle; Cambridge/UK I.Q. Grunwald; Southend-on-Sea/UK
B-0247 14:00 K-08 14:00

Digital breast tomosynthesis (DBT) in the assessment of false positive Keynote lecture
recalls in a single-centre breast screening programme K.-O. Løvblad; Geneva/CH
M. Orsi, F. Leone, M. Cellina, G. Oliva; Milan/IT
SUPPORTED
B-0248 14:08 Validation of automated ASPECTS software for detection of BY
INVEST IN
Stratifying tomosynthesis screening results by age groups and by first early ischaemic brain changes on non-contrast CT scans THE YOUTH
or subsequent screening L. Wolff1, O. Berkhemer2, A. van Es1, T. van Walsum1,
G. Romanucci1, F. Caumo2, M. Zorzi2, P. Bricolo1, L. Cugola1, S. Brunelli3, W. Van Zwam3, D.W. Dippel1, C.B. Majoie2, A. Van der Lugt1;
R. Mariotto1, S.A. Montemezzi1, F. Fornasa1; 1Verona/IT, 2Padua/IT, 1
Rotterdam/NL, 2Amsterdam/NL, 3Maastricht/NL
3
Peschiera/IT
B-0259 14:17
B-0249 14:16 Non-contrast ASPECTS region density predicts final infarction in acute
Stratifying tomosynthesis screening results by breast density ischaemic stroke
G. Romanucci1, S.A. Montemezzi1, S. Brunelli2, P. Bricolo1, L. Cugola1, W.G. Kunz1, L.T. Rotkopf1, D. Puhr-Westerheide1, F. Dorn1, S. Tiedt1,
F. Caumo3; 1Verona/IT, 2Peschiera/IT, 3Padua/IT F.A. Wollenweber1, K.M. Thierfelder2, A. Kemmling3, P. Reidler1;
1
Munich/DE, 2Rostock/DE, 3Münster/DE
B-0250 14:24
Cancer detection rate, ductal carcinomas in situ and advanced B-0260 14:25
breast cancers in the 2nd round of a population-based screening with Accuracy of virtual monochromatic images for the detection of early
tomosynthesis and synthetic mammography brain ischaemia on dual-energy CT
F. Caumo1, G. Gennaro1, G. Romanucci2, M. Zorzi1, C. Fedato3, D. Dodig1, N. Bartolovič1, S. Kovacic1, D. Miletic1, Z. Rumboldt2; 1Rijeka/HR,
S.A. Montemezzi2; 1Padua/IT, 2Verona/IT, 3Venice/IT 2
Charleston, SC/US
B-0251 14:32 B-0261 14:33 SPEAKER

SUPPORTED
Does breast tomosynthesis increase cancer detection in a screening Added value of susceptibility-weighted imaging for the BY
INVEST IN
population with clinically elevated breast cancer risk? prediction of hemorrhagic transformation in patients with THE YOUTH
M. Keupers1, S. Woussen1, S. Postema2, H. Westerlinck3, G. Zhang1, acute ischaemic stroke treated by mechanical thrombectomy
L. Cockmartin1, H. Bosmans1, C. Van Ongeval1; 1Leuven/BE, N. Ben Daamer, A. Benaissa, J.P. Le Faucheur, F. Faugeras,
2
The Hague/NL, 3Heverlee/BE S. Benadjaoud, E. Kalsoum, T. Tuilier, H. Hosseini, J. Hodel; Paris/FR
B-0252 14:40 SPEAKER B-0262 14:41

SUPPORTED
Efficiency of mammography, tomosynthesis and breast MRI BY Incremental value of CT perfusion for outcome prediction in acute
INVEST IN
in detecting malignant extension to the nipple area complex THE YOUTH cerebellar stroke
in patients with multifocal or extensive breast DCIS M.P. Fabritius1, P. Reidler1, K. Thierfelder2, M.F. Froelich1, L. Rotkopf1,
R. Capocci1, V. Tacher2, R. Bosc1, J.-L. Totobenazara1, H. Kobeiter1, D. Puhr-Westerheide1, W.G. Kunz1; 1Munich/DE, 2Rostock/DE
A. Luciani1, E. Meyblum2, T.H. Dao1; 1Créteil/FR, 2Paris/FR
B-0263 14:49
B-0253 14:48 SPEAKER Clinical outcome after thrombectomy in stroke patients with
SUPPORTED
Comparison between rapid unenhanced MRI protocol (RU- BY premorbid modified Rankin scale scores of 3 and 4: a cohort study
INVEST IN
MRI) and digital breast tomosynthesis (DBT) in detecting THE YOUTH with 136 patients
breast cancer in a screening-like population F. Seker, J. Pfaff, S. Schönenberger, C. Herweh, S. Nagel, P.A. Ringleb,
V. Marconi, M. Lorenzon, R. Girometti, L. Di Mico, F. Bondini, A. Bracciani, M. Bendszus, M.A. Möhlenbruch; Heidelberg/DE
C. Zuiani; Udine/IT
B-0264 14:57
B-0254 14:56 Collateral blood supply role in acute stroke outcomes
Synthesized mammography: is it as good as digital mammography to M. Radzina; Riga/LV
find microcalcification?
V.L.N. Omura; Sao Paulo/BR B-0265 15:05
Drip, ship, retrieve and leave: a national experience in the
B-0255 15:04 management of patients within regional hospitals post endovascular
A new Fourier-based model observer for image quality evaluation in thrombectomy for acute large vessel ischaemic stroke
the central slice of simulated breast tomosynthesis images E. Griffin, M. Sheehan, D. Brennan, S. Looby, S. Power, A. O‘Hare,
C. Balta1, I. Sechopoulos1, R. Van Engen1, M. Broeders1, W.J.H. Veldkamp2, P. Brennan, J. Thornton; Dublin/IE
I. Reiser3; 1Nijmegen/NL, 2Leiden/NL, 3Chicago, IL/US
B-0266 15:13
B-0256 15:12 Circle of Willis anatomy does not influence the results of mechanical
Digital breast tomosynthesis with photon-counting technology: thrombectomy with balloon guide catheter
preliminary data from a clinical comparison study A. Velasco González, N. Münnich, T. Rusche, B. Buerke, D. Görlich,
E. Venturini, C. Losio, M. Rodighiero, S. Tacchini, M. Panzeri, S. Ravelli, C. Sauerland, W. Heindel; Münster/DE
E. Schiani, P. Panizza; Milan/IT

B-0267 15:21 14:00 - 15:30 Room Y

External referrals for endovascular thrombectomy: our experience in a
regional stroke centre and insights into service improvements Interventional Radiology
E. Griffin, N.C. Adams, R. Motyer, T. Farrell, A. O‘Hare, S. Looby, S. Power,
P. Brennan, J. Thornton; Dublin/IE
SS 309
14:00 - 15:30 Room F2 Vascular neurointerventions
Moderators:
Emergency Imaging J. Caroff; Le Kremlin-Bicêtre/FR
K. Zelenak; Martin/SK
SS 317 B-0278 14:00

Acute abdomen Initial results of management for acute ischaemic stroke due to large
vessel occlusion by direct aspiration first-pass technique at Cho-ray
Wednesday
Moderators: hospital
A. Blanco Barrio; Murcia/ES T.H.N. Nguyen, P.V. Le; Ho Chi Minh City/VN
D.D. Cokkinos; Athens/GR
B-0279 14:08
K-09 14:00 Double aspiration thrombectomy in endovascular recanalisation of
Keynote lecture acute ischaemic stroke patients
M. Scaglione; Castel Volturno/IT M. Voormolen, T. van der Zijden, O. D‘Archambeau, F. Van den Bergh,
A. Mondelaers, C. Loos, P. Vanacker, I. Baar, L. Yperzeele; Antwerp/BE
B-0268 14:09
A comparative study 2007-2015 on acute appendicitis: evolution in B-0280 14:16
use by diagnostic imaging techniques Haemorrhagic transformation after stroke: interrater and intrarater
M.A. Depetris, L. Ibañez Sanz, E. Martinez Chamorro, S. Borruel Nacenta; agreement
Madrid/ES A. Guenego1, M. Piotin2, R. Blanc2, R. Fahed2; 1Toulouse/FR, 2Paris/FR
B-0269 14:17 B-0281 14:24

Acute appendicitis: appendicocecal angle, morphological variations Endovascular treatment of patients with acute ischaemic stroke in
detected on CT imaging posterior circulation: single-centre experience
S. Evrimler, H. Aydın; Isparta/TR A. Klepanec, J. Harsany, M. Mako, M. Hoferica, J. Cisar, M. Cabukova,
M. Rusina, G. Krastev; Trnava/SK
B-0270 14:25
Conditional CT strategy effectiveness in diagnosing acute appendicitis B-0282 14:32
R. Luksaite, R. Kliokyte, A. Samuilis, T. Poskus; Vilnius/LT Comparison of mechanical thrombectomy in single- vs. biplane
angiosuites
B-0271 14:33 A. Guenego1, R. Fahed2, M. Piotin2, R. Blanc2, F. Bonneville1, P. Mosimann3,
Accuracy of grey-scale ultrasound in correctly identifying acute C. Cognard1; 1Toulouse/FR, 2Paris/FR, 3Essen/DE
appendicitis in comparison with surgical outcome
K.M.B. Hassan1, A.U. Slehria1, T. Baqir Hassan2; 1Rawalpindi/PK, 2Okara/PK B-0283 14:40 SPEAKER
SUPPORTED
Impact of haemoglobin levels and anaemic state in the BY
prognosis of patients at three months after mechanical THE YOUTH
Diagnostic performance of abdominal ultrasound in right-sided acute thrombectomy for acute ischaemic stroke
colonic diverticulitis J.N. Pinto Ramos1, J. Silva2, P. Calvão-Pires1, I. Gil1, J.P. Marto1, S. Calado1,
F. Pellegrino, G. Tralli, G. Di Stefano, C. Tartari, S. Tartari, M. Giganti; C. Branco1, J.T.C. Baptista1, G. Branco1; 1Lisbon/PT, 2Covilhã/PT
Ferrara/IT
B-0284 14:48
B-0273 14:49 Direct puncture of the carotid artery for thrombectomy in acute stroke
Clinical significance of bedside ultrasonography and second-look patients: a single centre experience
ultrasonography in pediatric ileocolic intussusception M. Baptista, C. Pinheiro, I. Ribeiro Fragata, R. Carvalho, J. Pamplona,
M. Park, C. Lee, G.-S. Hong; Seoul/KR A.P. Nunes, J. Reis; Lisbon/PT
B-0274 14:57 B-0285 14:56

Is it possible to establish a clinical prediction rule for computed Computational fluid dynamics in patients treated with flow-diverter
tomography assessment in suspected bowel obstruction at the devices
emergency department? T. Baptista; Lisbon/PT
R.E. Pacios Blanco, A. Vicente Bártulos, B. Manuel Fernández,
E. Cobo Reinoso, A. Muriel García, A. López-Frías López-Jurado, B-0286 15:04
N.A. Almeida, J.I. Gallego Rivera, L. Gorospe Sarasua; Madrid/ES Endovascular treatment of intracranial carotid sidewall aneurysms by
flow diversion: a single centre‘s experience and comparison of Fred
B-0275 15:05 and Pipeline stents
Fast track CT in patients that referred to emergency major abdominal C.A. Gundogmus, D. Tureli, R. Asadov, S. Sabet, N. Andac, F. Baltacioglu;
surgery Istanbul/TR
C. Huang1, C.A. Mardal2, L.T. Tengberg2, M. Bay-Nielsen2, B.B. Bertelsen2;
1
Slagelse/DK, 2Hvidovre/DK B-0287 15:12 SPEAKER
SUPPORTED
Flow diverters in the treatment of intracranial aneurysms: BY
experience at our institution THE YOUTH
Comparing emergency department disposition of abdominal I. Andres Cano; Cadiz/ES
tomogram to abdominal x-ray
J.Y. Lee, S. Sabbah, P. Rogalla; Toronto, ON/CA B-0288 15:20
Balloon-assisted coil embolisation and large stent delivery for cerebral
aneurysms with a new generation of dual-lumen balloons
A. Guenego1, J.-B. Zerlauth2, R. Meuli2, R. Chapot3, P. Mosimann3;
1
Toulouse/FR, 2Lausanne/CH, 3Essen/DE

14:00 - 15:30 Coffee & Talk 3 14:00 - 15:30 Room D

Head and Neck Artificial Intelligence and Machine Learning
SS 308 SS 305
Temporal bone Machine learning: chest and cardiac
K. Markiet; Gdansk/PL C.L. Schlett; Freiburg/DE
B. Ozgen Mocan; Chicago, IL/US N.N.
B-0289 14:00 B-0300 14:00

Comparison of lesion detection and image quality between non-EPI Deep learning reconstruction for calcium scoring reduces radiation
diffusion weighted imaging and multi-shot EPI diffusion weighted dose while maintaining accuracy of Agatston scores
imaging of cholesteatoma C. Steveson1, J. Schuzer2, T. Acharya3, K. Bronson3, S. Rollison3,
M. Wiesmüller, W. Wuest, R. Heiß, M.S. May, M. Uder, F. Laun; W. Bandettini3, S. Shanbhag3, M.Y. Chen3; 1Kanagawa/JP,
2
Erlangen/DE Vernon HIlls, IL/US, 3Bethesda, MD/US
B-0290 14:08 B-0301 14:08

Value of four stage vestibular hydrops grading and asymmetric Coronary CT angiography derived plaque quantification with artificial
perilymphatic enhancement in the diagnosis of Ménière‘s disease on MRI intelligence CT fractional flow reserve for the identification of lesion-
A. Bernaerts1, R. Vanspauwen1, C. Blaivie1, J. van Dinther1, A. Zarowski1, specific ischaemia
F. Wuyts1, F.E. Offeciers1, J.W. Casselman2, B. de Foer1; 1Antwerp/BE, P. von Knebel Doeberitz1, T. Pannell1, M. van Assen2, M.H. Albrecht3,
2
Bruges/BE C.N. De Cecco1, T. Duguay1, R.R. Bayer1, C. Tesche4, U.J. Schoepf1;
1
Charleston, SC/US, 2Groningen/NL, 3Frankfurt a. Main/DE, 4Munich/DE
B-0291 14:16
Teaching temporal bone anatomy CT scan as a psychomotor skill: B-0302 14:16
a quasi-experimental study DeformationNet: unsupervised deep learning co-registration for
S. Sefidbakht1, B. Bijan2, P. Keshavarz1, M. Amini1, R. Jalli1, F. Zarei1, ventricular segmentation of MR images
H.R. Abbasi1, P. Iranpour1; 1Shiraz/IR, 2Sacramento, CA/US B. Norman1, M. Simonovsky2, F. Lau1, S. Sall1, D. Golden1, A. Hsiao3;
1
San Francisco, CA/US, 2Dobris/CZ, 3San Diego, CA/US
B-0292 14:24
Ultra-high-resolution CT for temporal bone imaging: a comparison to B-0303 14:24
cone-beam CT Radiomic analysis of coronary CT angiography images can identify
T. Yamashiro, M. Tsubakimoto, Y. Xu, Y. Morita, H. Tomita, S. Murayama; invasive and radionuclide imaging markers of coronary plaque
Okinawa/JP vulnerability
M. Kolossvary1, J. Park2, J.-I. Bang2, J. Zhang2, J. Lee2, J. Paeng2,
B-0293 14:32 T. Kubo3, B.-K. Koo2, P. Horvat-Maurovich1; 1Budapest/HU, 2Seoul/KR,
3
Visualisation and image quality of the chorda tympani nerve in Wakayama/JP
temporal bone: comparison with conventional CT and ultra-high-
resolution CT B-0304 14:32 SPEAKER
SUPPORTED
M. Fujiwara1, Y. Watanabe1, T. Fujiwara2, C. Matsuo2, H. Takahashi1, Prediction of the clinical outcome of chest ground glass area BY
INVEST IN
H. Tanaka2, Y. Ohta1, T. Imai1, N. Tomiyama2; 1Osaka/JP, 2Suita/JP using a radiomic approach THE YOUTH
N. D‘Amico, G. Valbusa, E. Grossi, D. Fazzini, A. Malasevschi,
B-0294 14:40 F. Rigiroli, S. Papa; Milan/IT
Comparison between high-resolution 3D-REAL-IR and 3D-FLAIR
sequences in the assessment of endolymphatic hydrops in 3 Tesla B-0306 14:40
V.M. Suarez Vega1, F.M. Caballeros Lam1, P. Domínguez Echávarri2, Image quality comparison between iterative reconstruction methods
R. Garcia de Eulate2, G. Gallardo Madueno1, A. Alonso-Burgos1, and AI-based reconstruction for CT chest
C. Sobrido3, B. Alvarez de Sierra1, N. Perez2; 1Madrid/ES, 2Pamplona/ES, P. Rogalla1, B.E. Hoppel2, M. Masakazu3, J. Zhou3, C. Farrell1, S. Kandel4;
3 1
Vigo/ES Toronto, ON/CA, 2Delafield, WI/US, 3Vernon Hills, IL/US, 4Berlin/DE
B-0295 14:48 B-0307 14:48

Measurement of the depth of facial nerve at the level of stylomastoid Unsupervised machine learning for the identification of CT imaging
foramen using MR imaging in Bell‘s palsy markers of progression in idiopathic pulmonary fibrosis
H. Karaca1, L. Soydan2, F. Baskak2, A. Sever2; 1Elazig/TR, 2Istanbul/TR J. Pan1, J. Hofmanninger1, S. Röhrich1, F. Prayer1, M. Holzer1, N. Sverzellati2,
M. Weber1, H. Prosch1, G. Langs1; 1Vienna/AT, 2Parma/IT
B-0296 14:56
Mastoid pneumatisation in children before CI: a risk factor for B-0308 14:56
complications? Imaging biomarkers for the differentiation of benign and malignant
I. Burck, M. Goldenko, M.H. Albrecht, A. Lehn, T. Stöver, M. Harth, small solitary pulmonary nodules smaller than 1 cm based on CT
J.L. Wichmann, B. Kaltenbach, T.J. Vogl; Frankfurt a. Main/DE texture analysis
J. Ji1, M. Chen1, X. Hu1, W. Ye1, C. Chen1, P. Pang2, C. Lu1, Q. Weng1,
B-0297 15:04 H. Wang1; 1Lishui/CN, 2Hanghzou/CN
Research software in cochlear duct length estimation, Greenwood
frequency mapping and electrode array length selection B-0309 15:04
A. Dhanasingh; Innsbruck/AT Multi-parametric radiomics in low-dose CT for discrimination between
emphysematous and non-emphysematous lung tissue
B-0298 15:12 Y. Nagaraj, M.D. Dorrius, M. Rook, Q. Li, J. Guo, R. Vliegenthart,
MRI in unilateral Meniere‘s disease: the value of post-contrast cochlear M. Oudkerk, P.M.A. van Ooijen; Groningen/NL
perilymph signal intensity
L.M.H. de Pont1, J. van Steekelenburg1, A. van Weijnen1, O.D. Vijlbrief2, B-0310 15:12 SPEAKER
SUPPORTED
H.M. Blom1, S. Hammer1; 1The Hague/NL, 2Almelo/NL Evaluation of a novel fully automatic, artificial intelligence- BY
INVEST IN
based diameter measurement algorithm for the thoracic aorta THE YOUTH
B-0299 15:20 SPEAKER M. Pradella1, T.J. Weikert1, S. Rapaka2, R. Kärgel3, G. Sommer1,
SUPPORTED
Double-center study on textural differences between BY A.W. Sauter1, J. Bremerich1, B. Stieltjes1, P. Brantner1; 1Basel/CH,
INVEST IN
cholesteatoma and middle ear inflammation in non-enhanced THE YOUTH 2
Princeton, NJ/US, 3Forchheim/DE
high-resolution computed tomography
C.T. Arendt1, D. Leithner1, M.E. Mayerhöfer2, L. Lenga1, C. Czerny2, I. Burck1,
T.J. Vogl1, R. Schernthaner2; 1Frankfurt a. Main/DE, 2Vienna/AT

14:00 - 15:30 Room G 14:00 - 15:30 Room M 1

Physics in Medical Imaging Genitourinary
SS 313 SS 307
CT: cardiovascular, calcium, and iodine Prostate cancer and renal imaging
H. Bosmans; Leuven/BE P. De Visschere; Ghent/BE
S. Maguire; Dublin/IE T. El-Diasty; Mansoura/EG
B-0311 14:00 B-0322 14:00

Detectability of small coronary calcifications: a comparison between Multi-parametric MRI in patients with low-to-moderate risk of prostate
dual-layer and spectral photon-counting CT cancer for the differentiation of adenocarcinoma and prostatitis
Wednesday
N.R. van der Werf1, M. Vonder2, R.W. van Hamersvelt1, M. Greuter2, S. Ken, E. Lacroix, D. Portalez, R. Aziza, J. Gilhodes, T. Brun; Toulouse/FR
S.A. Si-Mohamed3, P. Douek4, L. Boussel3, T. Leiner1, M.J. Willemink5;
1
Utrecht/NL, 2Groningen/NL, 3Bron/FR, 4Lyon/FR, 5Menlo Park/NL B-0323 14:08
Prostate cancer and benign tissue response to hypofractionated SBRT
B-0312 14:08 monitored by multi-parameteric MRI
Stack transition artefact removal (STAR) in cardiac CT with automatic M.J. Zelefsky, K. Zakian, A.G. Wibmer, N. Tyagi, M. Kollmeier, M. Hunt,
parameter selection E. Sala, H. Mejias Vargas; New York, NY/US
S. Lebedev1, E. Fournie2, K. Stierstorfer2, M. Kachelrieß1; 1Heidelberg/DE,
2
Forchheim/DE B-0324 14:16
Evaluation of dynamic contrast enhancement in PIRADSv2: a report
B-0313 14:16 from the Gothenburg 2 screening study for prostate cancer
Accurate non-invasive assessment of carotid in-stent restenosis by J. Wallström, K. Geterud, K. Kohestani, R. Godtman, A. Socratous,
dual-layer spectral CT M. Hellström, J. Hugosson; Göteborg/SE
I. Leichter, E. Ben-David, J. Menat, A. Peretz, Z. Romman, J.M. Gomori,
J. Sosna; Jerusalem/IL B-0325 14:24
Predicting clinically significant prostate cancer of the transition zone
B-0314 14:24 SPEAKER using multiparametric MRI and quantitative radiomic analysis
SUPPORTED
Quantification of metal artefacts in CT imaging: BY M. Pecoraro, S. Cipollari, R. Campa, G. Barchetti, C. Catalano,
INVEST IN
methodological comparison of different techniques and THE YOUTH V. Panebianco; Rome/IT
correlation to visual perception
N. Grosse Hokamp1, B. Eck2, J. Holz1, F. Siedek1, D. Pinto Dos Santos1, B-0326 14:32
D. Maintz1, S. Haneder1; 1Cologne/DE, 2Cleveland, OH/US Radiological prediction of the chance of post-RALP urinary continence
on preoperative MR prostate imaging can substantially alter patients’
B-0315 14:32 choice of treatment
Influence of iterative model reconstruction level for measurement S. Heijmink, E. van Muilekom, C. Tillier, N. Grivas, H. van der Poel;
accuracy of the coronary stenosis caused by non-calcified plaques Amsterdam/NL
using low-dose CCTA: a phantom study
L. Gao, Y. Hou, Y. Ma, L. Yang, X. Lu; Shenyang/CN B-0327 14:40
Value of dynamic contrast enhanced (DCE) MR imaging in PI-RADS 4
B-0316 14:40 patients
Iodine quantification accuracy in dual-source dual-energy CT using L. Schimmöller, F. Ziayee, T. Ullrich, N. Laqua, G. Antoch, P. Albers,
default parameters and patient-specific calibrations C. Arsov; Düsseldorf/DE
S. Dorn, S. Sawall, J. Maier, M. Kachelrieß; Heidelberg/DE
SUPPORTED
B-0317 14:48 Evaluation of periprostatic neurovascular fibres before and BY
INVEST IN
Effect of dose and iterative reconstruction on coronary calcium scores after radical prostatectomy by means of 1.5 T MRI diffusion THE YOUTH
at different heart rates for dual-layer CT tensor imaging
N.R. van der Werf1, M. Vonder2, R.W. van Hamersvelt1, M.J. Willemink3, V. Di Paola1, L. Russo1, M. Miccò1, M. Sbarra1, R. Pozzi Mucelli2, R. Manfredi1;
M. Greuter2, T. Leiner1; 1Utrecht/NL, 2Groningen/NL, 3Menlo Park/NL 1
Rome/IT, 2Verona/IT
B-0318 14:56 B-0329 14:56

Characterisation of iodine quantification for a fast-kVp switching dual Calculation of total kidney volume (TKV) in autosomal dominant
energy CT system polycystic kidney disease (ADPKD): comparison of 3 different methods
F. Emiro, P. De Marco, D. Origgi; Milan/IT S. Paolicelli1, R. Virelli2, L. Coi1, S. Matino1, M. Telegrafo3, A. Stabile Ianora1,
L. Gesualdo1, V. Bevilacqua1, M. Moschetta1; 1Bari/IT, 2Matera/IT,
B-0319 15:04 3
Triggiano/IT
Does iodine CNR improve when switching from today’s energy
integrating CT to tomorrow’s photon-counting CT? B-0330 15:04 SPEAKER
SUPPORTED
S. Sawall1, S. Dorn1, J. Maier1, S. Faby2, M. Uhrig1, H.-P. Schlemmer1, Development of a CT diagnostic prediction model for BY
INVEST IN
M. Kachelrieß1; 1Heidelberg/DE, 2Forchheim/DE diagnosis of pyonephrosis THE YOUTH
L.H.Q. Chin, K.H. Lee, H. Ng, M. Cheung, Y.L. Li, H.T. Lau, D. Tse;
B-0320 15:12 Hong Kong/HK
High concentration contrast medium injection protocol in combination
with monochromatic imaging for dose reduction in spectral coronary B-0331 15:12
CT angiography Correlation between single-kidney glomerular filtration rate (GFR)
P. Liu, Y. Wang, Z. Jin, J. Cao, L. Lin, Y. Yi; Beijing/CN with ultra-low-dose CT perfusion and 99mTc-DTPA renal scan in
healthy and tumour-bearing kidney
B-0321 15:20 F. Wang, Q. Wang; Jinan/CN
Optimal iodine CNR in a whole body photon-counting CT scanner
S. Sawall1, S. Dorn1, J. Maier1, S. Faby2, M. Uhrig1, H.-P. Schlemmer1, B-0332 15:20
M. Kachelrieß1; 1Heidelberg/DE, 2Forchheim/DE CT urography for examining the upper urinary tract in case of
haematuria: time to reconsider?
E. Rud, T. Flatabø, E. Baco, G. Sandbækk; Oslo/NO

14:00 - 15:30 Room M 2 14:00 - 15:30 Room M 3

Paediatric Oncologic Imaging
SS 312 SS 316
Paediatric abdominal imaging Myeloma imaging: latest trends
H.-J. Mentzel; Jena/DE N.N.
F. Prayer; Vienna/AT M.A. Hall-Craggs; London/UK
B-0333 14:00 K-10 10:30 #

Imaging follow-up in patients with biliary atresia after Kasai Keynote lecture
portoenterostomy M.A. Hall-Craggs; London/UK
R. Cuocolo, M. Caruso, F. Di Dato, C. Mollica, V. Romeo, G. Vallone,
M. Petretta, R. Iorio, S. Maurea; Naples/IT B-0344 14:09
Quantifying the change of total tumour volume in whole-body MRI over
B-0334 14:08 time improves risk stratification of smouldering multiple myeloma patients
Usefulness of mono-, bi-, and stretched-exponential model diffusion- M. Wennmann1, L. Kintzelé1, M. Piraud2, J. Hofmanninger3, B. Menze2,
weighted imaging for the differentiation of biliary atresia and non- H.-U. Kauczor1, J. Hillengass4, G. Langs3, M.-A. Weber5; 1Heidelberg/DE,
2
biliary atresia in liver MRI Munich/DE, 3Vienna/AT, 4Buffalo, NY/US, 5Rostock/DE
J. Kim, M.-J. Kim, M.-J. Lee, H. Yoon, H. Shin; Seoul/KR
B-0345 14:17
B-0335 14:16 SPEAKER Intravoxel incoherent motion imaging (IVIM) assessment of bone
SUPPORTED
Technical failure of echo-planar imaging MR elastography BY marrow infiltration in multiple myeloma
INVEST IN
in paediatric liver THE YOUTH R. Balaji; Chennai/IN
J.-K. Kim, M.-J. Kim, H. Yoon, M.-J. Lee, K. Han, H.-J. Shin;
Seoul/KR B-0346 14:25
Response assessment in multiple myeloma using intra-voxel incoherent
B-0336 14:24 motion (IVIM) diffusion MRI: a newer paradigm
Diagnostic value of ultrasound in paediatric veno-occlusive disease R. Balaji; Chennai/IN
(VOD) after HSCT using the European Society for Blood and Marrow
Transplantation (EBMT) criteria B-0347 14:33
S. Im, H. Chung, S. Kim, H. Park; Seoul/KR Full-body 150-kV spectral-shaping low-dose CT in multiple myeloma
follow-up: evaluation of image quality and radiation dose
B-0337 14:32 A.M. Bucher1, A. Brendlin2, J.E. Scholtz1, M. Beeres1; 1Frankfurt a. Main/DE,
2
Comparison of suprapubic vs. transurethral bladder access in voiding Tübingen/DE
cystourethrography
W. Schlötelburg, M. Kriedemann, C. Wirth, T.A. Bley, S. Veldhoen; B-0348 14:41 SPEAKER
SUPPORTED
Würzburg/DE Spatial heterogeneity in growth dynamics and local BY
INVEST IN
volumetric biomarkers for risk stratification and THE YOUTH
B-0338 14:40 dissemination behaviour in smouldering multiple myeloma
Evaluation of the split-bolus single-pass contrast CT protocol in M. Wennmann1, L. Kintzele1, T. Hielscher1, G. Langs2, H.-U. Kauczor1,
paediatric trauma M. Merz1, J. Hillengass3, B. Menze4, M.-A. Weber5; 1Heidelberg/DE,
T. Melis1, B. Gottfriedova1, R. Bruna1, M.J. Willemink2, M. Koci2; 1Prague/CZ, 2
Vienna/AT, 3Buffalo, NY/US, 4Munich/DE, 5Rostock/DE
2
Stanford, CA/US
B-0349 14:49
B-0339 14:48 Rapid study assessment in follow-up whole-body computed
The effect of renal function on the intracranial gadolinium deposition tomography in patients with multiple myeloma using a dedicated bone
in young rats subtraction software
J. Kim1, J. Lee2; 1Cheon-An/KR, 2Seoul/KR M. Sieren, F. Brenne, A. Hering, M. Schenk, T.H. Oechtering,
J. Barkhausen, A. Frydrychowicz; Lübeck/DE
SUPPORTED
The difficulties of childhood hepatocellular carcinoma MRI BY B-0350 14:57
INVEST IN
diagnosis THE YOUTH Whole-body magnetic resonance imaging (WBMRI) for the assessment
M. Gonzalo Carballés1, L. Riaza Martin1, A. Coma2, of response to treatment in multiple myeloma patients after
A. Castellote Alonso1, G. Guillén Burrieza1, L. Riera1, J. Molino Gaete1, autologous haematopoietic stem cell transplantation
J. Piqueras Pardellans1, E. Vázquez1; 1Barcelona/ES, 2Lleida/ES N. Lutsik, L. Mendeleeva, M. Solovev, G. Yatsyk, S. Kulikov, V. Savchenko;
Moscow/RU
SUPPORTED
Role of whole-body magnetic resonance imaging in BY B-0351 15:05
INVEST IN
identifying potential diagnostic clues in children with fever THE YOUTH Comparison of 18F-FDG PET/CT and whole-body MRI in assessing
of unknown origin newly diagnosed myeloma
F. Sertorio, S. Signa, M. De Cesari, M.B. Damasio, G.M. Magnano; O.A. Westerland, A. Amlani, M. Siddique, M. Streetly, I. El-Najjar, G. Cook,
Genoa/IT V.J. Goh; London/UK
B-0342 15:12 B-0352 15:13

MRU for diagnosis of obstructive pathology of the upper urinary tract Distinct bone marrow pattern in MR imaging of advanced systemic
L. Delfino, M. Damasio, L.E. Derchi; Genoa/IT mastocytosis is associated with poor prognosis
P. Riffel, M. Jawhar, K. Gawlik, H.J. Michaely, W.-K. Hofmann,
B-0343 15:20 S.O. Schönberg, A. Reiter; Mannheim/DE
Pancreas iron overload and fat infiltration in paediatric beta-
thalassemia major patients B-0353 15:21 SPEAKER
SUPPORTED
J. Huang1, Q. Yang1, Z. Cheng1, X. Chen2, T. Yu1, J. Zhong1, Y. Su1, H. Guo3, Lack of clinically meaningful anatomical variations in BY
INVEST IN
B. Liang1; 1Guangzhou/CN, 2Zhanjiang/CN, 3Beijing/CN the bone marrow ADC values in diffuse myeloma allows THE YOUTH
untargeted sampling to confirm disease burden
A. Keeling1, D.-M. Koh2, S. O‘Connor1, K. Boyd1, M. Kaiser1, M. Blackledge2,
C. Messiou1; 1London/UK, 2Sutton/UK

14:00 - 15:30 Sky High Stage B-0365 14:44

USPIO contrast agents for detecting cancer: which one works best?
Oncologic Imaging L. Müller, U. Keber, A. Mahnken, R. Mandic, M.-L. Martini, P. Seyfer;
Marburg/DE
MY 3 B-0366 14:48
Beyond lymph nodes: 18F FDG PET CT in detection of usual and
Oncologic Imaging unusual sites of extra nodal lymphoma
Moderators: M. Abdel-Kawi, M. Nasr, A. Ibrahim; Cairo/EG
M. D’Anastasi; Msida/MT
A. Laghi; Latina/IT B-0367 14:52
Evaluation of STIR, T1 DIXON “in and out of phase” and DWI
B-0354 14:00 sequences, to propose a standardised protocol of the MRWB in
MRI-based texture analysis has the potential to predict response to patients affected by myeloma
transarterial radioembolization at baseline A. Trisoglio, E. Soligo, S. Berardo, L. Sukhovei, S. Bor, G. Buoni, A. Stecco,
Wednesday
R.P. Reimer1, P. Reimer2, A. Mahnken3; 1Cologne/DE, 2Karlsruhe/DE, A. Carriero; Novara/IT
3
Marburg/DE
B-0368 14:56
B-0355 14:04 SPEAKER Optimisation of prostate cancer radiotherapy management with MR
SUPPORTED
Apparent diffusion coefficient percentage as an early BY F. Currò1, M.C. Ricciardi2, R. Danieli1, M.F. Cavallaro1, P. Martingano1,
INVEST IN
predictor for evaluation of trans-catheter arterial THE YOUTH M. Bertolotto1, F. Stacul1, M.A. Cova1; 1Trieste/IT, 2Padua/IT
chemoembolisation efficacy in hepatocellular carcinoma
R.M. Mousa1, F. Fawzy2, H. Tantawy1, T. Sobhy1; 1Zagazig/EG, 2Sharkia/EG B-0369 15:00
US and CEUS in ovary assessment of a murine model: preliminary
B-0356 14:08 findings on protective role of gonadotropin releasing hormone
Can intravoxel incoherent motion diffusion-weighted imaging analogue from chemotherapy-induced ovarian damage
be use for preoperative assessment of microvascular invasion in A. Colarieti, M. Venturini, L. Perani, A. Esposito, A. Del Maschio,
hepatocellular carcinoma F. De Cobelli; Milan/IT
Y. Wei, B. Song, H. Jiang, J. Chen; Chengdu/CN
B-0370 15:04
B-0357 14:12 DWI predicts surgical outcome in advanced ovarian cancer
Liver surface nodularity score as a new predictor of overall survival in H. An, E. Lee, J.A. Perucho, K.W. Chiu, M. Chu, K.Y. Tse; Hong Kong/HK
patients with HCC treated by TACE
A. Abou Elkassem1, A.M.K. Abdel Aal1, K. Mahmoud1, A. Gunn1, S. lirette2, SUPPORTED
A. Smith1; 1Birmingham, AL/US, 2Jackson, MS/US IVIM-DWI MRI in meningiomas: a tool to detect early BY
INVEST IN
microstructural changes during and after proton-therapy THE YOUTH
1 1 2 1 1
B-0358 14:16 M.V. Raciti , A. Franconeri , G. Buizza , G. Fontana , G. Viselner ,
1 1 1 1 1 2
Diffusion-weighted imaging of colorectal liver metastases: prospective A. Iannalfi , E. D‘Ippolito , L.M. Farina , L. Preda ; Pavia/IT, Milan/IT
evaluation of apparent diffusion coefficient in correlation with
histologic findings SUPPORTED
M.F.A. Almeida, R. Cruz, M.D.F.S. Begnami, P.N.V.P. Barbosa, Predictive role of apparent diffusion coefficient values BY
INVEST IN
A.G.V. Bitencourt, F.J.F. Coimbra, R. Chojniak; Sao Paulo/BR from diffusion weighted sequences in patients with sacral THE YOUTH
chordoma treated with carbon ions radiotherapy alone
B-0359 14:20 S. Casale , M. Fanizza , C. Paganelli , G. Viselner , E. Turpini , M. Fiore1,
1 1 2 1 1
Comparison of intravoxel incoherent motion DWI, diffusion kurtosis I. Fumagalli2, F. Valvo1, L. Preda1; 1Pavia/IT, 2Milan/IT
imaging, and conventional DWI in predicting the chemotherapeutic
response of colorectal liver metastases
H. Zhang, W. Li, T. Tong; Shanghai/CN 14:00 - 15:30 Tech Gate Auditorium
B-0360 14:24 Cardiac

Diffusion kurtosis imaging-derived histogram metrics for prediction of
KRAS/NRAS/BRAF mutation in rectal adenocarcinoma
Y. Cui1, Z. Zhuo2, X. Yang1, R. Zhang1; 1Taiyuan/CN, 2Beijing/CN SS 303
B-0361 14:28 SPEAKER Benefits of cardiac MR mapping
SUPPORTED
Prediction of loco-regional treatment failure after chemo- BY
INVEST IN for myocardial characterisation
radiotherapy in anal cancer using FDG PET/CT-derived THE YOUTH Moderators:
feature analysis N.N.
P. Brown1, J. Zhong1, G.M. McDermott1, M. Fronza1, A. Gilbert1, A. Appelt1, R. Maksimović; Belgrade/RS
D. Sebag-Montefiore1, S. Currie1, A. Scarsbrook2; 1Leeds/UK, 2York/UK
B-0374 14:00
B-0362 14:32 Quantitative cardiac magnetic resonance in the detection of early cardiac
Increasing reader confidence in cancer imaging using an advanced transplant rejection - MRI compared with endomyocardial biopsy
DWI modification: a prospective evaluation M.W. Raudner, A. Wielandner, K. Uyanik-Ünal, M.-E. Stelzmüller,
C. Dreher1, T. Kuder1, S. Windhaber1, F. König1, D. Paech1, R. Gnirs1, A. Zuckermann, C. Loewe, D. Beitzke; Vienna/AT
T. Benkert2, H.-P. Schlemmer1, S. Bickelhaupt1; 1Heidelberg/DE,
2
Erlangen/DE
SUPPORTED
Evaluate diffuse myocardial characteristics in rabbit model BY
based on daunorubicin-induced cardiotoxicity by CMR native THE YOUTH
Preoperative prediction of regional lymph node metastasis in thoracic T1 mapping imaging
oesophageal carcinoma with 18F-FDG PET/CT and contrast-enhanced H. Liu, R. Xu, Y. Guo, Z. Yang, L. Chen, C. Fu, X. Li; Chengdu/CN
CT texture analysis: a nomogram model
Z. Xiaochun, W. Shuxia; Guangzhou/CN
B-0376 14:16
Myocardial characterisation using CT extracellular volume in swine
B-0364 14:40 acute myocardial infarction model: comparison with CMR T1 mapping
Prospective evaluation of modified DWI MRI for improved image quality and histology
and tissue differentiation in oncological follow-up examinations H. Xu, Y. Guo, L. Xie, R. Xu, M. Yang, H. Li, H. Fu, C. Fu; Chengdu/CN
C. Dreher1, T. Kuder1, S. Windhaber1, F. König1, D. Paech1, R. Gnirs1,
T. Benkert2, H.-P. Schlemmer1, S. Bickelhaupt1; 1Heidelberg/DE,
2
Erlangen/DE

B-0377 14:24 SPEAKER B-0390 14:40

SUPPORTED
Feasibility of T1-rho mapping as endogenous contrast agent BY Diagnosis of biliary stone disease: compressed-sensing-accelerated
INVEST IN
to detect myocardial fibrosis THE YOUTH 3D-MRCP versus conventional MRCP
C. Celeng, M. Froeling, T. Leiner; Utrecht/NL X. Zhao1, M. Huang1, J. Zhu2, J. Cheng1; 1Zhengzhou/CN, 2Beijing/CN
B-0378 14:32 B-0391 14:48

Myocardial inflammation in DCM and mapping: an elusive connection Differentiating and segmenting isoattenuating gallstones from bile
F. Hahn1, D. Fleischmann1, M.C. Halfmann1, H.-P. Schultheiss2, with dual-layer spectral CT: an ex vivo phantom study
K.-F. Kreitner1, P. Wenzel1, T. Emrich1; 1Mainz/DE, 2Berlin/DE T.C. Soesbe, M.A. Lewis, Y. Xi, T. Browning, L. Ananthakrishnan,
R.E. Lenkinski, J.R. Leyendecker; Dallas, TX/US
B-0379 14:40
T1 and T2 mapping assessment of chronic myocarditis vs dilated B-0392 14:56 SPEAKER
SUPPORTED
cardiomyopathy, hypertensive heart disease and healthy controls Predicting difficulties on preoperative sonographic BY
INVEST IN
M.T.A. Wetscherek1, W. Rutschke2, C. Frank3, M. Grothoff2, P. Lurz2, evaluation in scheduled laparoscopic cholecystectomy in THE YOUTH
H. Thiele2, M. Gutberlet2, C. Lücke2; 1Cambridge/UK, 2Leipzig/DE, patients with acute calculous cholecystitis
3
Halle/DE T.-K. Kim, H. Han, J. Park, H. Kim; Daejeon/KR
B-0380 14:48 B-0393 15:04

The impact of myocardial thickness in hypertrophic cardiomyopathy Portal vein and ligamentum teres variations in diverse gallbladder
using combination of CMR native T1 and T2 mapping locations: is the left-sided gallbladder always a high-risk feature for
L. Huang, L. Ran, L. Xia, R. Han; Wuhan/CN pre-interventional assessment?
H.-Y. Lin, R.-C. Lee, H.-H. Yen, C.-A. Liu, J.-L. Chen; Taipei/TW
B-0381 14:56
Assessment of diagnostic performance of cardiac magnetic resonance B-0394 15:12
(CMR) mapping parameters in acute myocarditis (AM) patients Prediction for early recurrence of intrahepatic mass-forming
D. Palumbo1, A. Palmisano1, R. Faletti2, G. Benedetti1, M. Gatti2, cholangiocarcinoma: qualitative and quantitative MRI combined with
A. Del Maschio1, F. De Cobelli1, A. Esposito1; 1Milan/IT, 2Turin/IT prognostic immunohistochemical marker
L. Zhao, X. Zhao, X. Ma; Beijing/CN
SUPPORTED
Evolution of myocardial oedema of acute and subacute BY B-0395 15:20
INVEST IN
myocardial infarction verified in swine model: assessed by THE YOUTH Overrepresentation of uncommon biliary confluence types in hilar
native T1 mapping and T2 mapping cholagiocarcinoma patients
H. Liu, Y.-K. Guo, H. Xu, Z.-G. Yang; Chengdu/CN M. Shorikov, O.N. Sergeeva, D. Frantsev, M. Lapteva, E. Virshke,
B. Dolgushin; Moscow/RU
B-0383 15:12
Long-axis T1 and T2 mapping in Takotsubo cardiomyopathy: trash or
treasure? 16:00 - 17:30 Coffee & Talk 2
T. Emrich, R.M. Brumberg, P. Wenzel, S. Lyschik, F. Jungmann,
S. Rueppel, C. Düber, K.-F. Kreitner; Mainz/DE Abdominal Viscera
B-0384 15:20
Performance of native T1 and T2 mapping cardiovascular magnetic SS 401
resonance to detect myocardial oedema in patients with end stage
renal disease
Liver and biliary MRI: protocols and
W. Peng, H. Xu, Z. Li, C. Xia, Y. Guo; Chengdu/CN technical frontiers
Moderators:
C.S. Reiner; Zurich/CH
14:00 - 15:30 The Church M. Ronot; Clichy/FR
Abdominal Viscera
K-11 16:00
Keynote lecture
SS 301 M. Ronot; Clichy/FR
Biliary imaging: what next? B-0396 16:09

Moderators: T1 mapping for liver function evaluation in gadoxetic acid-enhanced
N.A. Courcoutsakis; Alexandroupolis/GR MR imaging: comparison of look-locker inversion recovery and B1
S.R. Marticorena Garcia; Berlin/DE inhomogeneity-corrected variable flip angle method
J.E. Kim1, H. Kim1, D. Choi1, D. Nickel2; 1Jinju/KR, 2Erlangen/DE
B-0385 14:00
Balanced steady-state free precession MRCP is a robust alternative to B-0397 16:17
respiration-navigated 3D turbo-spin-echo MRCP Dual-arterial phases and split-bolus intravenous contrast injection:
F.C. Hasse, B. Selmi-Özer, C. Rupp, H.-U. Kauczor, T. Weber; reduction of transient respiratory motion artefact on gadoxetate
Heidelberg/DE disodium-enhanced MRI of the liver
E.-S. Cho, J.M. Choi, J.H. Kim, J.-S. Yu, J.-J. Chung; Seoul/KR
B-0386 14:08
Can two breath-hold 3D-MRCP replace the conventional 3D-MRCP? B-0398 16:25
M. He, H. Xue, Z. Jin; Beijing/CN Whole-body R2s mapping to quantify tissue in iron storage organs:
associations with HFE-genotype
J.-P. Kühn1, T. Kacprowski2, A. Röhnert3, V. Hietschold3, R. Bülow1,
B-0387 14:16
D. Fedders3, R.-T. Hoffmann3, M.-L. Kromrey1; 1Greifswald/DE,
Role of dynamic contrast-enhanced MRI in early detection of 2
Munich/DE, 3Dresden/DE
gallbladder carcinoma
N. Yadu, S. Saxena; Lucknow/IN SPEAKER
Optimised imaging of the lower abdomen and pelvic region BY
in hepatocyte-specific MRI: evaluation of a whole-abdomen THE YOUTH
Utilisation of virtual non-contrast images derived from dual-energy
first-pass shuttle protocol
CT in the evaluation of biliary stone disease: should we obtain true
U. Fehrenbach , U.L. Fahlenkamp , J. Kahn , A. Baur , M. Pavel , D. Geisel1,
1 1 1 1 2
non-contrast images?
T. Denecke1; 1Berlin/DE, 2Erlangen/DE
J. Bae, D. Lee, I. Joo, S. Jeon, J.K. Han; Seoul/KR

B-0400 16:41 B-0411 16:40

Should multiparametric MRI with semi-quantitative perfusion replace Prediction of type 2 diabetes mellitus using noninvasive MRI
triphasic CT in follow-up post TACE quantitation of visceral abdominal adiposity tissue volume
N. Taha, D. Zidan, E. Geneidi; Cairo/EG M. Wang, S.-T. Feng, Z.P. Li; Guangzhou/CN
B-0401 16:49 B-0412 16:48

Assessment of whole-body fat in magnetic resonance imaging as a Comparison of MRI acoustic noise levels in different types of sequences
new approach in imaging of metabolic disorders V.M.F. Silva, I. Ramos, J. Moreira, M. Marques; Porto/PT
J.-P. Kühn1, R. Bülow1, D. Fedders2, D. Seppelt2, R.-T. Hoffmann2,
M.-L. Kromrey1; 1Greifswald/DE, 2Dresden/DE B-0413 16:56 SPEAKER
SUPPORTED
Investigating the impact of fragrance on patient anxiety during BY
INVEST IN
B-0402 16:57 MRI scans THE YOUTH
The feasibility of diffusion-weighted magnetic resonance imaging of A. Formosa, C. Portanier Mifsud, J.L. Portelli, P. Demicoli;
the liver using multiplexed sensitivity encoding Msida/MT
Y. Kim, M.-J. Kim, N. Seo; Seoul/KR
Wednesday
B-0414 17:04
B-0403 17:05 SPEAKER Accessibility for patients with cardiac device implantable electronic to
SUPPORTED
Evaluation of liver MRI examinations with two dosages of BY magnetic resonance exams: a national survey
INVEST IN
gadobenate dimeglumine: a retrospective blinded intra- THE YOUTH D.M.L. Miranda1, B. Mateus2, C.A. da Silva3, R.P. Almeida4, A.P. Ribeiro5,
individual study C.T. Brites6, A.F. Abrantes4, L. Ribeiro2; 1Jeddah/SA, 2Amadora/PT,
3
M. Kamali, S.E. Clarke, A.F. Costa; Halifax, NS/CA Evora/PT, 4Faro/PT, 5Miraflores/PT, 6Carcavelos/PT
B-0404 17:13 B-0415 17:12

Clinical evaluation of 3D magnetic resonance OLEA/NOVA+ SyntenticMRI application on workflow in pelvis MRI studies
cholangiopancreatography using three different methods: feasibility of A. Attanasio, G. Corrias, L. Saba; Cagliari/IT
compressed sensing and/or parallel imaging
M.-L. Kromrey1, S. Funayama2, D. Tamada2, S. Ichikawa2, H. Onishi2, B-0416 17:20
U. Motosugi2; 1Greifswald/DE, 2Chuo/JP MRI principles and technical issues: where do European radiographers
study from?
B-0405 17:21 M. Zanardo1, F.M. Doniselli1, C.B. Monti1, S. Durante2, L.M. Sconfienza1,
Histogram analysis of stretched-exponential model diffusion-weighted F. Sardanelli1; 1Milan/IT, 2Bologna/IT
imaging for staging of liver fibrosis: a feasibility study
F. Hu, B. Song, R. Yang, M. Wang; Chengdu/CN
16:00 - 17:30 Room K Chest
Radiographers
MY 4
SS 414 Chest
Moderators:
MRI advances S. Toledano-Massiah; Paris/FR
Moderators: M.O. Wielpütz; Heidelberg/DE
I.M. Björkman-Burtscher; Gothenburg/SE
C. Malamateniou; London/UK B-0417 16:00
Comparison of therapeutic outcome prediction among dynamic
B-0406 16:00 perfusion area-detector CT, dynamic perfusion MRI and FDG-PET/CT in
Quantitative tissue-tracking and T1 mapping cardiac magnetic small cell lung cancer patients with limited disease
resonance (CMR) in active acromegaly Y. Ohno1, Y. Fujisawa2, M. Yui2, Y. Kishida1, S. Seki1, T. Yoshikawa1,
P. Liu, Y. Wang, J. Cao, L. Lin; Beijing/CN T. Murakami1; 1Kobe/JP, 2Otawara/JP
B-0407 16:08 B-0418 16:04 SPEAKER

SUPPORTED
The assessment of carotid plaque morphology using magnetic Correlation between pulmonary function tests, histogram- BY
INVEST IN
resonance imaging and computed tomography as biomarkers of based analysis indexes and visual HRCT scores in a THE YOUTH
carotid plaque vulnerability population of IPF patients
N. Giannotti, P. Kelly, S. Foley, G. Horgan, E. Kavanagh, M.J. O‘Connell, F. Tiralongo1, M. Palermo1, D. Falsaperla1, A. Stefano2, S.E. Torrisi1, P. Foti1,
J. McNulty; Dublin/IE A. Basile1, C. Vancheri1, S. Palmucci1; 1Catania/IT, 2Segrate/IT
B-0408 16:16 B-0419 16:08

Clinical impact of combined compressed sensing and Radiomics machine learning classifiers for predicting Ki-67
sensitivity encoding on three-dimensional magnetic resonance proliferation index in non-small cell lung cancer
cholangiopancreatography at 1.5 T P. Rong, Q. Gu, Z. Feng; Changsha/CN
D. Morimoto, T. Hyodo, M. Itou, H. Fukushima, K. Kamata, M. Takenaka,
M. Kudo, K. Miyagoshi, K. Ishii; Ōsakasayama/JP B-0420 16:12
Quantitative perfusion MRI of the lung in COPD: the problem of short-
B-0409 16:24 term repeatability
Quantitative diffusion-weighted knee MR imaging and ADC mapping A. Ter-Karapetyan1, M.O. Wielpütz2, H.-U. Kauczor2, S. Triphan2;
1
in healthy volunteers Yerevan/AM, 2Heidelberg/DE
A. Alqattan, A. McGee, E. Delahunt, S. Eustace, J. McNulty, A. Cradock;
Dublin/IE B-0421 16:16
The role of 4D flow MRI in evaluating the outcome of balloon
B-0410 16:32 pulmonary angioplasty
Evaluation of hippocampus volume in the elderly people by magnetic W. Sun, H. Ota, S. Chibana, H. Sato, K. Sugimura, K. Takase; Sendai/JP
resonance imaging: comparison of two segmentation methods
P.A.T. Gamboa1, M.C. Ribeiro2, A.P.L. Macedo2; 1Vila Franca de Xira/PT, B-0422 16:20
2
Lisbon/PT Inspiratory/expiratory 3D pulmonary MRI with UTE: capability for
clinical stage classification in smokers as compared with thin-section CT
Y. Ohno1, M. Yui2, Y. Kishida1, S. Seki1, T. Yoshikawa1, T. Murakami1;
1
Kobe/JP, 2Otawara/JP


SUPPORTED 16:00 - 17:30 Tech Gate Auditorium
Diagnostic value of quantitative dual-source CT dual-energy BY
INVEST IN
iodine maps combined with morphological CT features in THE YOUTH Genitourinary
assessing histological subtypes of lung cancer
X. Xu, X. Sui, W. Song, L. Song, Y. Huang, Z. Jin; Beijing/CN
B-0424 16:28
SS 407
Ultra-high-resolution CT vs state-of-the-art area-detector CT: can Prostate imaging: new diagnostic tools
higher spatial resolution improve nodule detection capability at same Moderators:
radiation dose in chest nodule phantom study? N.N.
D. Takenaka1, K. Fujii2, N. Sugihara2, S. Seki3, T. Yoshikawa3, Y. Ohno3; J.J. Fütterer; Nijmegen/NL
1
Akashi/JP, 2Otawara/JP, 3Kobe/JP
B-0437 16:00
B-0425 16:32 Prostate imaging self-assessment and mentoring (PRISM):
The utility of the ultra-high-resolution CT to evaluate the detailed a prototype self-assessment scheme for radiologists
bronchial tree for COPD Y. Chen1, E. Michalopoulou1, A.G. Gale1, T. Barrett2, P. Haslam3,
D. Takenaka, A. Higashida, Y. Kono, T. Hashimoto, H. Maeda, S. Sakamoto; A. Patel4, H. Ahmed5; 1Loughborough/UK, 2Cambridge/UK,
Akashi/JP 3
Newcastle Upon Tyne/UK, 4Stevenage/UK, 5London/UK
B-0426 16:36 B-0438 16:08

Late phase lung perfusion by dual energy CT: image quality and Use of kZ space for sub-mm through-plane resolution in T2-weighted
clinical findings compared to arterial perfusion 2D spin-echo prostate MRI
M.S. May, I. Prael, R. Heiß, M. Kopp, M. Uder, W. Wuest; Erlangen/DE S. Kargar1, S. Riederer1, E. Borisch1, A. Froemming1, R. Grimm1, A. Kawashima2,
B. King1, E. Stinson1; 1Rochester, MN/US, 2Scottsdale, AZ/US
B-0427 16:40
Computed tomography pulmonary angiography for acute pulmonary B-0440 16:16
embolism: prediction of adverse outcome and 90-day mortality in a MRI of the prostate at 3.0T with and without endorectal-coil:
single test two-centre comparison in kiwi-fruit and patients
N. Akhoundi, T. Faghihi Langroudi; Tehran/IR U. Mueller-Lisse, S. Murer, J. Scheidler, M. Kuhn, A. Meister, M.K. Scherr,
U.L. Mueller-Lisse; Munich/DE
SUPPORTED
Assessment of EGFR mutation status in patients with non- BY B-0441 16:24
INVEST IN
small-cell lung cancer using different iodine quantification THE YOUTH T2-mapping with simulated T2-echo - a diagnostic alternative for
methods in dual-energy CT: areal vs volumetric analyses 3-Tesla prostate MRI?
X. Xu, X. Sui, L. Song, Y. Huang, Z. Jin, W. Song; Beijing/CN J. Pfeil1, C. Lee2, M. Haas1, M. Taupitz1, B. Hamm1, P. Asbach1; 1Berlin/DE,
2
Singapore/SG
B-0431 16:52
Systematic review and meta-analysis of randomized trials on the B-0442 16:32
impact of lung cancer screening by low-dose computed tomography in Assessment of diagnostic yields of significant prostate cancer by
populations highly exposed to tobacco altering the prostate-specific antigen density thresholds for biopsy
A. Sadate, B. Occean, A. Larbi, P. Fabbro-Peray, J. Beregi; Nîmes/FR according to MRI findings
L. Boesen1, V. Logager3, N. Nørgaard1, R. Bisbjerg1, I. Balslev1,
B-0432 16:56 K.-C.D. Thestrup1, H. Jakobsen1, H.S. Thomsen1, A.R. Padhani2;
Application of LDCT and Lung-RADS classification in lung cancer 1
Herlev/DK, 2Northwood, Middlesex/UK, 3Copenhagen
screening of the urban population in China
Q. Meng; Zhengzhou/CN B-0443 16:40
Natural history of prostate cancer on active surveillance: stratification by
B-0434 17:04 MRI using the PRECISE recommendations in a UK cohort over 11 years
Single- and dual-energy CT pulmonary angiography using second- and F. Giganti1, A. Stabile2, V. Stavrinides1, C. Orczyk1, S. Punwani1, C. Allen1,
third-generation dual-source CT systems: comparison of radiation A. Kirkham1, M. Emberton1, C.M. Moore1; 1London/UK, 2Milan/IT
dose and image quality
L. Lenga1, C. Booz1, J.L. Wichmann1, J.-E. Scholtz1, S.S. Martin2, T.J. Vogl1, B-0444 16:48
M.H. Albrecht1, I. Yel1; 1Frankfurt/DE, 2Charleston, SC/US Orthopaedic metallic artefact reduction is indispensable for CT
evaluation of the urinary tract after hip replacement
SUPPORTED P.N. Kaposi, T. Youn, P. Borsos, P. Magyar, V. Bérczi; Budapest/HU
Percutaneous needle biopsy for lung lesions focused on BY
INVEST IN
needle angle and lesion depth: 14-year results THE YOUTH B-0445 16:56
J. Lee, I. Lee, J. Kim; Anyang/KR Wide-detector axial scan on revolution CT for combining application
of ASIR-V and ASIR on unenhanced abdominal CT in vivo: the image
SUPPORTED quality and radiation dose evaluation
Mare Nostrum and tuberculosis: the role of chest x-ray and BY Z. Zhu, X.-M. Zhao, C. Zhou; Beijing/CN
INVEST IN
clinical-laboratory data among Mediterranean migrants on THE YOUTH
landing B-0446 17:04
G. Scavone , M.V. Raciti , M.C. Calcagno , D.C. Caltabiano , G. Galvano1,
1 2 1 1
Evaluation of a compressed-sensing accelerated high-resolution VIBE
A. Scavone1; 1Catania/IT, 2Pavia/IT sequence for an improved morphologic and functional assessment
(“one-stop shop”) of the uterus: initial analysis
D. Hausmann1, S. Ignjatovic1, D. Kreul1, M. Klarhöfer2, M. Nickel3, B. Kiefer3,
R.A. Kubik-Huch1; 1Baden/CH, 2Zurich/CH, 3Erlangen/DE
B-0447 17:12
Dual-energy CT dose reduction for GU CT while preserving diagnostic
performance
I. Duba1, A. Khandelwal2, J. Weaver2, S. Leng2, A. Ferrero2, M. Wells2,
J.G. Fletcher2, C. McCollough2, A.F. Halaweish2; 1Malvern, PA/US,
2
Rochester, MN/US

08:30 - 10:00 Room N 08:30 - 10:00 Sky High Stage

Abdominal Viscera Breast
SS 501 MY 5
Diffuse and focal pancreatic disease Breast
E. Amosova; Moscow/RU E.M. Fallenberg; Munich/DE
A. Taibbi; Palermo/IT R.M. Trimboli; Milan/IT
B-0448 08:30 B-0459 08:30

Value of static first-pass dual-energy CT perfusion analysis in patients How preoperative sentinel lymph node contrast-enhanced ultrasound
with acute pancreatitis helps intraoperative sentinel lymph node biopsy in breast cancer:
I. Yel1, L. Lenga1, J.L. Wichmann1, M.H. Albrecht1, T.J. Vogl1, S.S. Martin2; initial experience
1
Frankfurt a. Main/DE, 2Charleston, SC/US M. Lu; Chengdu/CN
B-0449 08:38 B-0460 08:34

Diagnostic efficacy of acute necrotising pancreatitis on early CT scan Contrast-enhanced spectral mammography: is it useful in predicting
and correlation with laboratory exams invasiveness in suspicious breast micro-calcifications?
Y. Song, H. Park, M. Yu, Y. Kim, S. Jung, H. Jeon; Seoul/KR M. Gomaa, A.F.I. Moustafa; Cairo/EG
B-0450 08:46 B-0461 08:38

Relapse of type 1 autoimmune pancreatitis after steroid therapy: Residual fibroglandular tissue (RGT) following unilateral and bilateral
imaging findings and risk factors prophylactic mastectomies in BRCA 1/2 germline-mutation carriers
L. Zhu1, T. Denecke2, P. Asbach2, B. Hamm2, H.-D. Xue1, Z.-Y. Jin1; B. Krug, O. Grinstein, W. Malter, B. Hanstein, F. Siedek, R. Schmutzler,
Thursday
1
Beijing/CN, 2Berlin/DE D. Maintz, K. Rhiem, M. Hellmich; Cologne/DE
B-0451 08:54 B-0462 08:42

Early prediction of the severity of acute pancreatitis using radiologic Factors that influence performance of the contrast-enhanced ultrasound
and clinical scoring systems with classification tree analysis prediction model in 1023 breast lesions: a multi-center study
A. Ko, H. Park, E. Lee, H. Choi, J. Do, S. Park, B. Choi; Seoul/KR L. Tang1, Y. Chen1, Z. Du1, Z. Zhong1, Q. Chen2, J. Luo2, L. Yang3;
1
Fuzhou/CN, 2Sichuan/CN, 3Kunming/CN
B-0452 09:02
Preoperative prediction of pancreatic neuroendocrine tumours’ grade: B-0463 08:46
the added value of contrast-enhanced ultrasound with quantitative Effect of breast-conserving surgery with radiotherapy on the apparent
analysis diffusion coefficient of fibroglandular tissue at MRI
Y. Dong, X. Han, D. Yang, W. Lou, Q. Zhang, W.-P. Wang; Shanghai/CN N. Radovic, G. Ivanac, I. Biondic Spoljar, E. Divjak, I. Dumic Cule,
B. Brkljacic; Zagreb/HR
B-0453 09:10
Diagnostic performance of computerised 3D CT texture analysis of B-0464 08:50 SPEAKER
SUPPORTED
pancreas for the assessment of patients with diabetes Relevance of arbitration in the management of discrepant BY
INVEST IN
S. Jang1, J. Kim1, S.-Y. Choi2, S. Park1, J. Han1; 1Seoul/KR, 2Gyeonggi-do/KR screening mammography: Trieste’s Breast Unit experience in THE YOUTH
2013-2014 biennium
B-0454 09:18 C. Sachs, F. Giudici, M. Bortul, F. Zanconati, C. Gasparini, M. Assante,
Comparison of reduced field-of-view (rFOV) and full FOV (fFOV) M. Tonutti, M.A. Cova; Trieste/IT
diffusion-weighted imaging (DWI) in the assessment of insulioma:
image quality and WHO grading B-0465 08:54 SPEAKER
SUPPORTED
M. He, H. Xue, Z. Jin; Beijing/CN Technique and diagnostic performance of contrast-enhanced BY
INVEST IN
spectral mammography: a systematic review THE YOUTH
B-0455 09:26 A. Cozzi1, M. Zanardo1, C.B. Monti1, L.A. Carbonaro2,
DWI and dynamic MRI in the study of intraductal papillary mucinous R.M. Trimboli2, F. Sardanelli1; 1Milan/IT, 2San Donato Milanese/IT
neoplasms (IPMNs): pathological comparison with tumour grade
correlation B-0466 08:58
G. Giannotti, G. Tedesco, A. Beleù, G. Rizzo, N. Cardobi, Development and validation of nomograms predictive of axillary nodal
R. De Robertis Lombardi, M. D‘Onofrio; Verona/IT status to guide surgical decision-making in early-stage breast cancer
J. Li, W. Ma, Y. Wu, L. Li; Guangzhou/CN
B-0456 09:34
Solid pseudopapillary tumour of the pancreas: correlation of MR B-0467 09:02
imaging appearance with biological behaviour Ultrasound-guided vacuum-assisted resection: could it be enough for
W. Mingliang, M. Zeng; Shanghai/CN the diagnosis and treatment of intraductal papilloma?
Z. Wang; Beijing/CN
B-0457 09:42
Solid pseudopapillary neoplasms of the pancreas: clinicopathological B-0468 09:06 SPEAKER
SUPPORTED
and radiological features according to size - 20-year experience from Diffusion kurtosis imaging (DKI) in breast cancer: diagnostic BY
INVEST IN
a high-volume centre accuracy of DKI-derived values in characterization of breast THE YOUTH
R. De Robertis Lombardi1, A. Grecchi2, M. Catania2, A. Beleù2, G. Rizzo2, lesions and correlation with prognostic factors
M.C. Ambrosetti2, M. D‘Onofrio2; 1Peschiera del Garda/IT, 2Verona/IT H. Ahmad Ainuddin, S.K. Kirat Singh, K. Rahmat, M. Ramli Hamid,
F. Fadzli, H. Ahmad Ainuddin; Kuala Lumpur/MY
B-0458 09:50
Risk assessment for pancreatic fistula after pancreaticoduodenectomy B-0469 09:10
with preoperative computed tomography Can 18 F-FDG PET/CT predict invasive components in DICS of breast
R. Menghini, G. Zamboni, A. Cybulski, R. Valletta, G. Marchegiani, diagnosed by needle biopsy? Comparison with variable imaging
G. Mansueto; Verona/IT modalities including mammography, USG and MRI
N. Choi1, Y. Kim1, N. Jung1, B. Kang2, J. Lee2; 1Bucheon/KR, 2Seoul/KR

B-0470 09:14 SPEAKER B-0482 10:54

SUPPORTED
Reliability of contrast-enhanced spectral mammography BY The study of usefulness of blending injection method in dynamic liver
INVEST IN
(CESM) in the pre-surgical evaluation of breast cancer: CESM THE YOUTH CT scanning with reduced contrast medium
vs histological maximum diameter J. Kawashima, F. Washizuka, H. Nakano, Y. Shimada; Tokyo/JP
P. Tonelli, C. Boeri, D. Cirone, S. Bianchi, V. Miele,
J. Nori Cucchiari; Florence/IT B-0483 11:02
Post-mortem computed tomography angiography (PMCTA):
B-0471 09:18 optimising a targeted PMCTA protocol
Impact of 18F-FDG-PET/CT using time-of-flight in evaluating axillary C. Robinson, A. Deshpande, G. Rutty, B. Morgan; Leicester/UK
lymph node metastases of breast cancer
M. Mori, T. Fujioka, J. Tsuchiya, K. Kubota, U. Tateishi; B-0484 11:10
Bunkyo-City Tokyo/JP Effect of the scan mode and focal spot size on airway measurement
for ultra-high-resolution computed tomography
B-0472 09:22 SPEAKER R. Mikayama, T. Shirasaka, H. Yabuuchi, Y. Sakai, T. Kojima, M. Kondo,
SUPPORTED
The development of a novel manganese dioxide-based BY H. Yoshikawa, T. Kato; Fukuoka/JP
INVEST IN
nanoparticles and real-time monitoring of its anticancer THE YOUTH
effect by MRI B-0485 11:18
X. Zhou, B. Xiao, H. Hu, J. Tang; Zhejiang/CN Organ-based tube current modulation in chest CT: effect on radiation
dose and noise
B-0473 09:26 SPEAKER B.R. Mussmann1, S. Deppe2, P. Marschall Skov1, S. Foley3, H. Precht4;
SUPPORTED
Survey: imaging surveillance among Belgian breast clinics for BY 1
Odense/DK, 2Kolding/DK, 3Dublin/IE, 4Middelfart/DK
INVEST IN
primary locoregional breast cancer in non-high-risk women THE YOUTH
J. Swinnen, M. Keupers, R.M. Prevos, S. Postema, M. Lavens, B-0487 11:34
T. Thywissen, P. De Beul, J. Soens, C. Van Ongeval; Leuven/BE Computed tomography (CT) imaging in weight-bearing positions:
the positives and challenges in an institutional trial
B-0474 09:30 G. Bengo; Singapore/SG
Combining ultrafast TWIST VIBE Dixon sequences with diffusion-
weighted imaging: a clinically applicable evaluation tool with high B-0488 11:42
accuracy for suspicious masses in breast MRI Evaluation of usefulness of virtual calcium scoring in dual-energy
S. Ellmann, E. Wenkel, S. Peter, M. Dietzel, E. Weiland, R. Janka, cardiac CT
T. Bäuerle, M. Uder; Erlangen/DE H. Han; Seoul/KR
B-0475 09:34 B-0489 11:50 SPEAKER

SUPPORTED
Accuracy comparison of breast cancer detection based on Patient perceptions of radiographer communication skills in BY
INVEST IN
microcalcifications between full-field digital mammograms and CT examinations THE YOUTH
synthetic 2D mammograms using a deep convolution neural network L. Ribeiro1, A.F. Abrantes1, K.B. Azevedo1, O. Lesyuk2,
M. Gurumoorthy1, S. Kaur1, N. Kwan Hoong2, S. Soo1, K. Rahmat1, S.I. Rodrigues1, R.P. Almeida1, A.C. Viriato3, M.V. Reis1; 1Faro/PT,
C. Hongmin3; 1Kuala Lumpur/MY, 2Petaling Jaya/MY, 3Guangzhou/CN 2
São Brás de Alportel/PT, 3Lagos/PT
B-0477 09:42
Initial experience of an online mammographic screening test 10:30 - 12:00 Room X
M. Iodice1, B. Brancato2, L.A. Carbonaro1, A. Bert3, C. Perassi3, C. Zuiani4,
F. Sardanelli1; 1Milan/IT, 2Florence/IT, 3Turin/IT, 4Udine/IT Vascular
B-0478 09:46
Imaging characterisation of breast desmoid tumours SS 615
M. Le Boulc‘h1, A. Lusque1, C.S. Balleyguier2, C. Dratwa3, P. Cherel4,
M. Kind5, C. Vaysse1, S. Le Guellec1, B. Boulet1; 1Toulouse/FR, 2Villejuif/FR, Contrast medium: dose, timing and
3
Paris/FR, 4Saint Cloud/FR, 5Bordeaux/FR alternatives
Moderators:
N.N.
10:30 - 12:00 Room C S. Tresoldi; Milan/IT
Radiographers SPEAKER
Using the lean body weight (LBW) instead of total body BY
INVEST IN
SS 614 weight (TBW) to dose the iodinated contrast medium (ICM)
for abdominal CT: a randomised controlled trial (RCT)
THE YOUTH
Fine-tuning CT M. Zanardo, F.M. Doniselli, G. Di Leo, A. Esseridou, S. Tritella, C. Mattiuz,

Moderators: L. Menicagli, F. Sardanelli; Milan/IT
D. Biddle; Cambridge/UK
M. Raissaki; Iraklion/GR B-0491 10:38
High-pitch, low-kVp computed tomography for ruling out pulmonary
B-0479 10:30 embolism with 17-mL contrast media
Application of low-radiation and low-contrast dose protocol combined H. Al-Ubeidy, M. Alshamari, J. Widell, T. Eriksson, M. Lidén; Örebro/SE
with high-strength ASIR-V algorithm in ‚one-stop‘ coronary and carotid
and cerebrovascular CT angiography B-0492 10:46
W. Li, Y. Zhigang, P. Han, Z. Li; Chengdu/CN Determining optimal scan delay in indirect CT venography: time to
peak attenuation correlates with cardiac output and heart rate
B-0480 10:38 T.T. Tran1, C.H. Kristiansen1, F. Haidl1, S. Roy1, J.C. Lindstrom1, H. Ashraf2,
Assessment of coronary in-stent stenosis using high-resolution scan P. Lauritzen3; 1Lørenskog/NO, 2Rasta/NO, 3Oslo/NO
mode and dual-energy CT: a phantom study
M. Svanteson, M. Afadzi, A.C. Martinsen, N.E. Kløw, E.K. Lysvik, B-0493 10:54
K. Bjørklund, T.R. Enden; Oslo/NO Real-time patient-specific scan initiation for CT of the abdominal
aorta: impact on image quality
B-0481 10:46 F.R. Schwartz1, J. Ramirez Giraldo1, R. Gutjahr2, D. Boll3, D. Marin1,
Patient habitus and renal volume have no effect on a reduced patient- L. Hurwitz1; 1Durham, NC/US, 2Nürnberg/DE, 3Basle/CH
specific contrast media administration during renal CTA: impact on
contrast media, radiation dose and image quality
C. Saade; Beirut/LB

B-0494 11:02 B-0505 11:02 SPEAKER

SUPPORTED
Patient-specific scan delay for optimised venous triggering in CT Amide proton transfer (APT) MRI is a predictor of survival BY
INVEST IN
abdomen and progression in high-grade glioma patients THE YOUTH
W. Coudyzer1, L. Cockmartin1, D. Konings1, T. Busselot2, D. Bielen1, D. Paech, C. Dreher, S. Regnery, S. Goerke, A. Unterberg,
D. Vanbeckevoort1, H. Bosmans1; 1Leuven/BE, 2Brussels/BE W. Wick, M. Bendszus, M. Ladd, H.-P. Schlemmer;
Heidelberg/DE
B-0495 11:10
To determine the image quality of non-linear blending (NLB) B-0506 11:10 SPEAKER
SUPPORTED
technique in aortic angiography acquired by novel injection protocol Early response assessment of glioma patients to definitive BY
INVEST IN
compared with linear blending (LB) technique chemoradiotherapy using chemical exchange saturation THE YOUTH
L. Xing; Zhengzhou/CN transfer imaging at 7 Tesla
J.-E. Meissner, A. Korzowski, S. Regnery, S. Goerke, J. Debus, M. Ladd,
B-0496 11:18 H.-P. Schlemmer, S. Adeberg, D. Paech; Heidelberg/DE
Systematic accuracy assessment of a real-time automated patient
specific bolus tracking delay calculation algorithm B-0507 11:18
R. Gutjahr1, G. Jost2, H. Pietsch2, B. Schmidt3, T. Flohr3; 1Nürnberg/DE, A GPC3-specific aptamer-mediated MR probe for hepatocellular
2
Berlin/DE, 3Forchheim/DE carcinoma
M. Zhao; Shanghai/CN
B-0497 11:26
3D quantitative analysis of the aorta and pulmonary artery on non- B-0508 11:26
contrast CT Evidence from in vivo MRI: ferritin heavy chain and interferon-ћ gene-
Z. Sedghi Gamechi1, A.M. Arias-Lorza1, J. Holst Pedersen2, K.F. Kofoed2, modified mesenchymal stem cells transplanted peritumorally inhibit
D. Bos1, M. De Bruijne1; 1Rotterdam/NL, 2Copenhagen/DK malignant gliomas
J. Mao, J. Shen; Guangzhou/CN
SUPPORTED
Magnetic particle imaging: artefact-free imaging of the in- BY B-0510 11:42 SPEAKER
INVEST IN SUPPORTED
stent lumen of coronary stents THE YOUTH Detection of gut inflammation with MR and PET imaging BY
INVEST IN
THE YOUTH
Thursday
F. Wegner, T. Friedrich, A. von Gladiss, T.M. Buzug, in the insect Manduca sexta: A new screening system for
J. Barkhausen, J. Haegele; Lübeck/DE effectors and inhibitors of gut inflammation
A.G. Müller1, F.H. Müller2, M. Hentschel3, C.-R. von Bredow1,
B-0499 11:42 Y. von Bredow1, T. Trenczek1; 1Giessen/DE, 2Neustadt/DE, 3Berne/CH
Magnetic particle imaging for pulmonary circulation time
measurements B-0511 11:50
M.G. Kaul, J. Salamon, C.S. Jung, H. Ittrich, M. Graeser, G. Adam, The experimental study of prostate cancer imaging using PSMA
K. Peldschus; Hamburg/DE targeting ultrasound/MRI dual modality nanobubbles
Y. Zhu, Y. Chen, W. Guan; Shanghai/CN
B-0500 11:50
Pre-TAVR scanning by a comprehensive contrast-free cardiovascular
magnetic resonance protocol: comparison with contrast-enhanced 10:30 - 12:00 Room O
computed tomography
M.J. Pamminger, G. Klug, S.J. Reinstadler, M. Reindl, C. Kremser, Musculoskeletal
C. Kranewitter, B. Metzler, W.R. Jaschke, A. Mayr; Innsbruck/AT
SS 610
10:30 - 12:00 Room N Chronic inflammatory diseases
Hybrid Imaging Moderators:
M. Boesen; Copenhagen/DK
M. Revelli; Reggio Emilia/IT
SS 606 SPEAKER
Advanced MR methods in experimental Muscle involvement in juvenile localised scleroderma: do we BY
INVEST IN
radiology need a volumetric approach? THE YOUTH
S.K.J. Flores Quispe1, A. Cavaliere1, F. Zulian1, M. Weber2,
Moderators: M. Zuliani1, R. Stramare1, E. Quaia1, C. Giraudo1; 1Padua/IT, 2Vienna/AT
N.N.
I. Rausch; Vienna/AT
B-0513 10:38
MRI evaluation of ankle joint in juvenile idiopathic arthritis
B-0501 10:30 P. Rampal1, N. Sachdev1, A. Taneja2; 1Delhi/IN, 2New Dehli/IN
Is ADC a predictor of hypoxia in ER+ breast cancer? A study using
18
F-FMISO PET-MRI
B-0514 10:46
J.C. Carmona-Bozo, R. Woitek, A.J. Patterson, G. Baxter, C. Caraco,
Ultra-low-dose CT detects synovitis in patients with suspected
E. Provenzano, T.D. Fryer, M.J. Graves, F. Gilbert; Cambridge/UK
rheumatoid arthritis
SPEAKER T. Diekhoff, S.-T. Ulas, D. Poddubnyy, U. Schneider, S. Hermann, R. Biesen,
B-0502 10:38 SUPPORTED G.R. Burmester, B. Hamm, K.-G.A. Hermann; Berlin/DE
Proton MR spectroscopy: a non-invasive tool for the BY
INVEST IN
detection of ovarian cancer THE YOUTH
B-0515 10:54
P.N.S. Fahmy, A. Elkalawy, M. Gomaa, S.A. Mansour; Cairo/EG
Prevention of the progressive biochemical cartilage destruction under
methotrexate therapy in early rheumatoid arthritis
B-0503 10:46 M. Frenken, D. Abrar, A. Ljimani, P. Sewerin, M. Klingebiel, G. Antoch,
MR monitoring of cytolysis and inflammatory tumour C. Schleich; Düsseldorf/DE
microenvironment after oncolytic adenovirus injection in a novel
transgenic pancreatic adenocarcinoma mouse model
B-0516 11:02
F.M. Kubicka1, B. Fleischmann-Mundt2, P.M. Kazmierczak1, M.J. Schneider1,
Rheumatoid arthritis magnetic resonance imaging score predicts
J. Brooks2, M. Meier2, J. Ricke1, F. Kühnel2, C.C. Cyran1; 1Munich/DE,
2
therapy response
Hannover/DE
D.B. Abrar, M. Frenken, Y. Klosterkemper, G. Antoch, C. Schleich;
Düsseldorf/DE
B-0504 10:54
Assessment of tumour hypoxia response to sorafenib in rabbit VX2
liver tumour xenografts by tissue-oxygen-level-dependent MR imaging
S. Qin, X. Li, Z. Qi, Y. Mei, X. Quan; Guangzhou/CN

B-0517 11:10 B-0528 11:10

The value of the simplified RAMRIS-5 in early-RA patients under Histopathological growth patterns of colorectal cancer liver
methotrexate therapy using high-field MRI metastases: predictive value of MRI morphological features
M. Frenken, D. Abrar, A. Ljimani, P. Sewerin, G. Antoch, C. Schleich; P.A. Bonaffini1, A. Salman1, A. Lazaris1, G. Zu-Hua1, P. Metrakos1, H. Vargas2,
Düsseldorf/DE C. Hoeffel3, B. Gallix1, C. Reinhold1; 1Montreal, QC/CA, 2New York, NY/US,
3
Reims/FR
B-0518 11:18
Silent progression in patients with rheumatoid arthritis: is DAS28 B-0529 11:18 SPEAKER
SUPPORTED
remission an insufficient goal in RA? Volumetric vs bidimensional CT assessment of sarcopenia in BY
INVEST IN
D.B. Abrar, M. Frenken, Y. Klosterkemper, G. Antoch, C. Schleich; patients candidate for liver transplantation THE YOUTH
Düsseldorf/DE P. Barbieri, A. Cina, E. Amodeo, R. Manfredi, G. Marrone;
Rome/IT
B-0519 11:26
Is an abbreviated version of psoriatic arthritis magnetic resonance B-0530 11:26 SPEAKER
SUPPORTED
imaging score (PsAMRIS), PsAMRIS-6, applicable for detection and Prevalence and prognosis of intrahepatic BY
INVEST IN
monitoring of disease-related joint changes? cholangiocarcinoma (ICC) with radiological enhancement THE YOUTH
D.B. Abrar, M. Frenken, P. Sewerin, G. Antoch, C. Schleich; Düsseldorf/DE patterns that mimic hepatocellular carcinoma (HCC)
R. Muglia, L. Viganò, N. Gennaro, L. Samà, F. Colapietro, G. Torzilli,
B-0520 11:34 L. Di Tommaso, M. Colombo, L. Solbiati; Milan/IT
Diffusion-weighted magnetic resonance imaging in axial
spondyloarthritis patients and healthy subjects: inter-MRI reliability B-0531 11:34
and relation to gender, age and inflammation The role of dynamic contrast-enhanced MRI analysis of perfusion
J.M. Møller1, M. Østergaard1, H.S. Thomsen1, I.J. Sørensen2, O.R. Madsen3, changes in hepatocellular carcinogenesis
S.J. Pedersen2; 1Herlev/DK, 2Glostrup/DK, 3Gentofte/DK A.M. Elzeneini1, M.I. Yousef2, M.M. Refaat2; 1Cairo/EG, 2Benha/EG
B-0521 11:42 B-0532 11:42

Axial spondyloarthritis: dual-energy virtual noncalcium CT for Is CT-texture analysis an useful instrument to predict aggressive
detection of bone marrow oedema in the sacroiliac joints behaviour of intrahepatic cholangiocarcinoma?
H. Wu, G. Zhang; Guangzhou/CN A. Fighera, G. Cardano, A. Mazzaro, G. Zamboni, A. Ruzzenente,
G. Mansueto; Verona/IT
B-0522 11:50
Muscle and pulmonary involvement in patients with antisynthetase B-0533 11:50 SPEAKER
SUPPORTED
syndrome: two aspects of the same disease or two different Imaging response assessment and outcomes in hepatocellular BY
INVEST IN
conditions? Preliminary results of an MR and HRCT study carcinoma after stereotactic body radiotherapy: iRECIST as a THE YOUTH
A. Fraia1, E. Zanatta1, M. Weber2, E. Balestro1, R. Stramare1, A. Doria1, potential substitute for traditional criteria
C. Giraudo1, E. Quaia1; 1Padua/IT, 2Vienna/AT F. Vernuccio1, D. Godfrey2, M. Meyer3, H.V. Williamson2, D. Niedzwiecki2,
J. Ronald2, M. Palta2, D. Marin2; 1Palermo/IT, 2Durham, NC/US,
3
Mannheim, NC/US
10:30 - 12:00 Studio 2019
Oncologic Imaging 10:30 - 12:00 Room E2
Neuro
SS 616a
Advances in imaging of liver SS 611
malignancies MS and demyelinating disorders
L. Grazioli; Brescia/IT A.M. Koç; Izmir/TR
A. Luciani; Créteil/FR T.A. Yousry; London/UK
B-0523 10:30 B-0534 10:30

Towards a new model for therapy monitoring of PRRT 177Lu-DOTATATE Cranial nerve enhancement in multiple sclerosis (MS) is associated
treatment of liver metastases in PNET patients with younger age at onset and more severe disease
O.J. Pettersson, K. Fröss-Baron, J. Crona, A. Sundin; Uppsala/SE L. Haider1, E.C. Wei-Shin1, E. Olbert2, S. Mangesius3, A. Dal-Bianco1,
F. Leutmezer1, D. Prayer1, M. Thurnher1; 1Vienna/AT, 2Tulln/AT,
B-0524 10:38 3
Innsbruck/AT
Early prediction of response of CT textural analysis in unresectable
liver metastases of colorectal cancer treated with Cetuximab B-0535 10:38 SPEAKER
SUPPORTED
chemotherapy Multiple sclerosis: evolution of magnetic resonance imaging BY
E. Raimondi1, S. Picchia1, K. Kouvelakis1, K. Khan1, D. Cunningham1, INVEST IN
diagnostic criteria from McDonald 2001 to McDonald 2017, THE YOUTH
D.-M. Koh2, M. Bali1; 1London/UK, 2Sutton/UK including MAGNIMS 2016
J.J. Jover Sánchez, J. Díaz Díaz, C. Ferreiro Argüelles, P. Núñez Valentín,
B-0525 10:46 E. Rodríguez García; Madrid/ES
CT-texture analysis of liver metastases in PNETs vs NPNETs: correlation
with histopathological findings B-0536 10:46
I. Martini1, M. Polici1, M. Zerunian1, F. Landolfi1, F. Panzuto1, M. Rinzivillo1, Evaluation of signal intensity in dentate nucleus and globus pallidus
B. Annibale1, A. Laghi2, E. Iannicelli1; 1Rome/IT, 2Latina/IT after repeated administrations of gadolinium in multiple sclerosis
patients
B-0526 10:54 I. Zorzenon, M. Ukmar, A. Gennari, A. Zdjelar, L. Bottaro, A. Sartori,
Preoperative staging of colorectal liver metastases: is MRI of the liver A. Dinoto, M.A. Cova; Trieste/IT
needed for the surgical planning?
P. Boraschi, F. Donati, F. Pacciardi, R. Cervelli, G. Tarantini, L. Urbani, B-0537 10:54
M. Castagna, D. Caramella, F. Falaschi; Pisa/IT Brain imaging in 43 serologically positive cases of Chikungunya virus
infection with neurological complications at our institute during
B-0527 11:02 epidemic outbreak
CT texture analysis to predict response to target therapy of hepatic A. Aryan, K. Sethi; New Delhi/IN
metastases from colorectal cancer
C. Maglia1, L. Pusceddu1, V. Vani2, G. Giannetto1, V. Romano1, A. Defeudis1,
V. Giannini1, S. Mazzetti1, D. Regge1; 1Candiolo/IT, 2Turin/IT

B-0538 11:02 B-0548 10:54

Regional grey matter atrophy by MR volumetry in early relapsing- Association between background parenchymal enhancement in breast
remitting multiple sclerosis (RRMS) as a predictor of clinical and MR imaging and outcome of breast cancer patients treated with
motor outcome neoadjuvant chemotherapy
E. Kurys-Denis, U. Skrobas, Z. Brudkowska, H. Karakuła-Juchnowicz, R. Rella, A.R. Scrofani, F. Petta, E. Bufi, M. Conti, M. Giuliani, P. Belli,
W. Krupski, R. Maciejewski; Lublin/PL R. Manfredi; Rome/IT
B-0539 11:10 SPEAKER B-0549 11:02

SUPPORTED
Automated volumetric assessment of multiple sclerosis BY Breast MRI: potential use of unenhanced morpho-functional diagnostic
INVEST IN
disease burden and activity with artificial neural networks THE YOUTH protocols
G. Brugnara, F. Isensee, W. Wick, M. Bendszus, K.H. Maier-Hein, M. Nadrljanski, Z. Milosevic; Belgrade/RS
P. Kickingereder; Heidelberg/DE
B-0550 11:10
B-0540 11:18 Non-enhanced breast MRI (DWIBS mammography) for screening
Increased ADC values within normal appearing white matter as a women with dense breasts: a feasibility study
predictor of a poor response to interferon beta therapy in patients T. Uematsu; Shizuoka/JP
with multiple sclerosis in the 4-year follow-up
J. Bladowska, A. Zacharzewska-Gondek, A. Koltowska, A. Pokryszko- B-0551 11:18
Dragan, S. Budrewicz, M. Sasiadek; Wroclaw/PL Rethinking abbreviated breast MRI: potential to skip DCE scans by
integrated semi-quantitative T2 and ADC analyses
B-0541 11:26 M. Dietzel, R. Schulz-Wendtland, E. Wenkel, C. Bielowski, T. Bäuerle,
Quantitative brain lesion distributions in MOG-Ab-positive and AQP4- M. Uder, S. Ellmann; Erlangen/DE
Ab-positive patients: overlaps and differences
L. Yang, H. Li, C. Quan, L. Zhou, D. Geng, Y. Li; Shanghai/CN B-0552 11:26
Correlate of perfusion parameters on dynamic contrast-enhanced MRI
B-0542 11:34 with bimolecular factors and subtypes of breast cancers
Magnetic resonance imaging findings at optic neuritis of recurrent L. Liu, B. Yin, W. Peng; Shanghai/CN
Thursday
optic-spinal phenotype, multiple sclerosis in a cohort of Brazilian
patients from Rio de Janeiro B-0553 11:34
A.C. Brandão Nascimento, A.R. Araujo e Araujo, N.S. Meneguette, Can perilesional oedema detected in MRI be considered as a
M. Papais Alvarenga, C.C.F. Vasconcelos, C.A.M. Bento, P.P. Rafful, biomarker for breast cancer? The role of T2-weighted sequences
L.A. Brandao, R.M. Papais Alvarenga; Rio de Janeiro/BR G. Panzironi, G. Moffa, F. Galati, F. Marzocca, E. Collalunga, F. Pediconi;
Rome/IT
B-0543 11:42
Voxel-based analysis of relaxation rates in multiple sclerosis: correlates B-0554 11:42
of cognitive impairment and physical disability Diagnostic utility of breast DCE-MRI in patients with diagnosis of
M. Quarantelli, R. Lanzillo, M. Comerci, M. Cassiano, T. Costabile, atypical ductal hyperplasia after percutaneous biopsy
A. Prinster, R. Megna, V. Brescia Morra, A. Brunetti; Naples/IT V. Bertani1, M. La Grassa2, L. Balestreri3, N. Berger4, M. Urbani3,
T. Frauenfelder4, A. Boss4, M. Marcon4; 1Udine/IT, 2Pordenone/IT,
B-0544 11:50 SPEAKER 3
Aviano/IT, 4Zurich/CH
SUPPORTED
Deep grey matter and multiple sclerosis: is there a BY
INVEST IN
correlation between MR imaging and disability? THE YOUTH B-0555 11:50
1 1 2 1 1
S. Torlone , A. Corridore , M. Martino , M. Micelli , L. Panebianco , Usefulness of CAD for diagnostic automated breast US in MRI detected
1 1 1 1 2
R. Totaro , A. Splendiani , C. Masciocchi ; L‘Aquila/IT, Rome/IT lesions
Y. Kim1, N. Choi1, B. Kang2, J. Lee2, N. Jung1; 1Bucheon/KR, 2Seoul/KR
10:30 - 12:00 Room F2

10:30 - 12:00 Room Y
Breast
Interventional Radiology
SS 602
Magnetic resonance imaging (MRI) SS 609
Moderators: Vascular interventions in oncology
P. Clauser; Vienna/AT
(including radioembolisation)
Moderators:
B-0545 10:30 S. Puchner; Vienna/AT
Dependence of MRI-based size estimates of small invasive breast V. Vidjak; Zagreb/HR
cancers on patient and tumour characteristics
W. Sanderink, L.J. Strobbe, P. Bult, I. Sechopoulos, N. Karssemeijer, K-12 10:30
R.M. Mann; Nijmegen/NL Keynote lecture
B-0546 10:38
Diagnostic accuracy of magnetic resonance (MRI) to predict axillary B-0556 10:39
lymph node metastases in patients with breast cancer: does neo- Multifunctional iron oxide nanoparticle-embedded PVP-HEC
adjuvant chemotherapy impact accuracy? microparticles as a drug-eluding embolic material
G. Bansal, A. Jaipal; Cardiff/UK F. Nurili1, G. Bekaroglu2, S. İsci2, A. Bas2, I. Caymaz2, I. Yurdaisik2,
S. Özkanli2, H. Cakiroglu2, O. Aras1; 1New York, NY/US, 2Istanbul/TR
SUPPORTED
Association between background parenchymal enhancement BY B-0557 10:47
INVEST IN Transarterial radioembolisation with Yttrium90 glass microspheres
and tumour response in breast cancer patients receiving THE YOUTH
neoadjuvant chemotherapy without temporary or permanent occlusion of the cystic artery appears
F. Petta, R. Rella, A.R. Scrofani, E. Bufi, M. Rosignuolo, M. Romani, P. Belli, to be safe in terms of adverse effects
R. Manfredi; Rome/IT O.M. Topcuoglu, N. Selcuk, B. Sarikaya; Istanbul/TR
B-0558 10:55
Post-SIRT 90Y-PET/CT showing variable deposition of 90Y in various
liver tumour types
S. Thoduka1, S. Mercogliano1, V. Czernohorsky1, N. Spahr2, J.-H. Schierz1,
A. Schenk3, N. Abolmaali1; 1Dresden/DE, 2Lübeck/DE, 3Bremen/DE

B-0559 11:03 SPEAKER B-0571 11:10

SUPPORTED
Intrahepatic mitomycin C infusion in liver-dominant BY Automatic MRI-based 3D models of hip cartilage using a 3D U-net-
INVEST IN
metastatic breast cancer: factors influencing the outcome THE YOUTH like fully convolutional network for improved morphologic and
B.M. Aarts1, E.G. Klompenhouwer1, R.C. Dresen2, A. Laenen2, biochemical analyses
R.G.H. Beets-Tan1, K. Punie2, P. Neven2, H. Wildiers2, G. Maleux2; F. Schmaranzer1, R. Helfenstein1, G. Zeng1, T. Lerch1, K. Siebenrock1,
1
Amsterdam/NL, 2Leuven/BE M. Tannast1, Y.-J. Kim2, G. Zheng1; 1Bern/CH, 2Massachusetts, MA/US
B-0560 11:11 SPEAKER B-0572 11:18

SUPPORTED
Bland embolisation as the sole endovascular treatment for BY Combined traditional image processing and deep learning approach
INVEST IN
unresectable hepatocellular carcinoma: survival analysis of THE YOUTH for automated detection of tears of the anterior cruciate ligament:
230 patients observed for seven years in a single centre is it the game changer for AI in musculoskeletal MRI?
E. Lanza, I. Bolengo, D. Poretti, R. Muglia, R. Ceriani, V. Pedicini; Milan/IT V. Venugopal, Y. Mallya, V. Jagannatha, V. Mahajan, H. Mahajan; New Delhi/IN
B-0561 11:19 SPEAKER B-0573 11:26

SUPPORTED
Safety and efficacy of small versus large drug-eluting BY Ante-mortem chest radiograph retrieval for forensic human
INVEST IN
bead transarterial chemoembolisation for hepatocellular THE YOUTH identification by deep learning
carcinoma Y. Li1, X. Yang1, J. Wang1, H. Xue1, W.B. Liang1, Z.H. Deng1, J. McNulty2,
S.Y. Lee, H.-Y. Ou, C.-Y. Yu, Y.-F. Cheng; Kaohsiung/TW J.C. Lv1, L. Zhang1; 1Chengdu/CN, 2Dublin/IE
B-0562 11:27 B-0574 11:34 SPEAKER

SUPPORTED
Alternative routes of intraarterial chemoinfusion for intraocular Automatic segmentation of the mandible from CT for 3D BY
INVEST IN
retinoblastoma virtual surgical planning using a convolutional neural network THE YOUTH
L.S.P. Karanam, S.R. Baddam, S. Honavar, V.R. Palkonda; Hyderabad/IN B. Qiu, J. Guo, J. Kraeima, R. Borra, M.J.H. Witjes,
B-0563 11:35
Retrospective analysis of a cohort of patients affected by unresectable B-0575 11:42
HCC treated with SIRT and liver transplant 18F-FDG-PET/CT-based radiogenomic tumour decoding and
A. Paladini1, G.E. Vallati2, G. Pizzi2, F. Cappelli2, D. Beomonte Zobel2, phenotyping of non-small cell lung cancer
E.M. Amodeo2, A. Borzelli3; 1Novara/IT, 2Rome/IT, 3Naples/IT M. Chodyla, A. Demircioglu, J. Haubold, S. Bogner, K. Herrmann,
F. Nensa, L. Umutlu; Essen/DE
B-0564 11:43
Yttrium-90 radioembolisation in advanced-stage HCC: does portal B-0576 11:50 SPEAKER
SUPPORTED
vein thrombosis affect survival? Comparison of consistency of nodule detection in repeated BY
INVEST IN
F. Fiore, V. Stoia, F. Somma; Naples/IT chest PA X-ray images between radiologists and deep THE YOUTH
learning model
B-0565 11:51 C. Wu, S. Lee, J. Seo, S. Lee, H. Lee, H. Hwang, Y. Cho, N. Kim; Seoul/KR
Embolisation of rabbit renal arteries to test feasibility and effects of
CT-visible doxorubicin-eluting montmorillonite microparticles
F. Nurili; New York, NY/US 10:30 - 12:00 Room K
Chest
10:30 - 12:00 Room D
Artificial Intelligence and Machine Learning SS 604
COPD, emphysema and airways diseases:
SS 605 novel approaches
Machine learning: musculoskeletal and Moderators:
N.N.
diverse J.D. Dodd; Dublin/IE
Moderators:
B. Baeßler; Cologne/DE B-0577 10:30
R. Blanco Sequeiros; Turku/FI Dynamic magnetic resonance imaging as an outcome predictor for
lung-volume reduction surgery in patients with severe emphysema
B-0566 10:30 K. Martini1, C. Caviezel1, D. Schneiter1, G. Milanese2, I. Schmitt-Opitz1,
Deep learning for automatic detection of fractures on chest CT scans W. Weder1, T. Frauenfelder1; 1Zurich/CH, 2Parma/IT
after blunt trauma
L. Yan, X. Chuan, C. Xia, S. Wang, K. Chen; Beijing/CN B-0578 10:38
Quantitative assessment of the relationship between spatial
B-0567 10:38 distribution of emphysema and pulmonary function in COPD patients
Whole-body MRI based lesion prediction in multiple myeloma by an automatic analysis software
R. Licandro1, J. Hofmanninger1, M.-A. Weber2, B. Menze3, G. Langs1; Q. Yu1, X. Quan1, X. Lu2; 1Guangzhou/CN, 2Shenyang/CN
1
Vienna/AT, 2Rostock/DE, 3Munich/DE
B-0579 10:46
B-0568 10:46 Inspiratory/expiratory xenon-enhanced CT with 3D motion analysis:
Optimising the dataset for deep learning with x-ray images in utility for pulmonary functional loss assessment and clinical stage
musculoskeletal radiology classification of COPD
M.F. Russe, N. Kocher, E. Kellner, M. Reisert, F. Bamberg, E. Kotter; Y. Ohno1, Y. Fujisawa2, N. Sugihara2, Y. Kishida1, S. Seki1, T. Yoshikawa1,
Freiburg/DE H. Koyama3, T. Murakami1; 1Kobe/JP, 2Otawara/JP, 3Osaka/JP

Predicting the incidence of knee osteoarthritis using deep neural CT measurements of expiratory central airway collapse in BY
INVEST IN
networks: data from the osteoarthritis initiative (OAI) and the COPD patients with suspected tracheobronchomalacia: THE YOUTH
multicenter osteoarthritis study (MOST) comparison between transverse and MPR images
Z. Bertalan1, T. Paixao1, R. Ljuhar1, D. Ljuhar1, H.-P. Dimai2, S. Nehrer3; D.M. Tridente1, B.H. Heidinger2, D.C. DaBreo3, A.A. Bankier1,
1
Vienna/AT, 2Graz/AT, 3Krems/AT D. Litmanovich1; 1Boston, MA/US, 2Vienna/AT, 3Ottawa, ON/CA
B-0581 11:02
Efficacy of model-based iterative reconstruction in cystic fibrosis
assessment on computed tomography
S. Lin, M. Lin, K. Lau; Melbourne/AU

B-0582 11:10 B-0593 11:10

Association between small pulmonary vascular area and mild airflow Early detection of left ventricular involvement assessed by 3D
limitation in healthy smokers CMR feature tracking improves risk stratification in patients with
H. Jo, M. Park; Jinju/KR arrhythmogenic right ventricular cardiomyopathy
X. Chen, L. Li, S. Zhao; Beijing/CN
B-0583 11:18
Cystic-fibrosis-related lung disease: correlation of HR-CT lung B-0594 11:18 SPEAKER
SUPPORTED
morphology and regional lung function measured by electrical CMR tissue tacking assessment of myocardial strain in non- BY
INVEST IN
impedance tomography ischaemic dilated cardiomyopathy patients with and without THE YOUTH
U.G. Mueller-Lisse1, S. Krueger-Ziolek2, B. Gong2, H.A. Zimmermann1, left ventricular hyper-trabeculations
K. Moeller2; 1Munich/DE, 2Villingen-Schwenningen/DE H. Fu, L. Wen, Y.-K. Guo, Z. Yang; Chengdu/CN
B-0584 11:26 SPEAKER B-0595 11:26

SUPPORTED
Predictive model of lung severity in children with cystic BY Strain analysis in noncompaction morphology: usefulness in assessing
INVEST IN
fibrosis using Brasfield and Chrispin-Norman scoring systems THE YOUTH an undefined cardiomyopathy
I. Vasyliv, N. Rohovyk, O. Marushchak, M. Rohovyk; Lviv/UA E. Cannizzaro, P. Palumbo, C. De Cataldo, A. Corridore, S. Torlone,
F. Cobianchi Bellisari, A. Di Sibio, E. Di Cesare, C. Masciocchi; L‘Aquila/IT
B-0585 11:34
MRI-derived regional flow-volume loop parameters detect early stage B-0596 11:34
chronic lung allograft dysfunction Assessment of myocardial deformation in a rabbit model of diabetes
T. Moher Alsady, A. Voskrebenzev, M. Greer, L. Becker, T. Kaireit, T. Welte, mellitus by cardiac magnetic resonance tissue tracking
F. Wacker, J. Gottlieb, J. Vogel-Claussen; Hannover/DE Y. Zhang, Z.-G. Yang, Y.-K. Guo, K. Diao, M.-T. Shen, X. Li, K. Xu, H. Yu,
C. Xia; Chengdu/CN
B-0586 11:42
Dose reduction in CT emphysema densitometry enabled by iterative B-0597 11:42
reconstruction and post-scan noise reduction: a phantom study Cardiac computed tomography left ventricle myocardial strain analysis
H.J. Wisselink, G. Pelgrim, M. Rook, M. Oudkerk, R. Vliegenthart; T. Adla, V. Suchanek, M. Polovincak, L. Miksik, Z. Salagovicova,
Thursday
Groningen/NL N. Markova, J. Biskup, M. Rocek; Prague/CZ
B-0587 11:50 B-0598 11:50

Predictors for bronchoalveolar lavage recovery rates derived from Two-dimensional and three-dimensional cardiac magnetic resonance
preprocedural quantified computed tomography feature-tracking myocardial strain analysis in acute myocarditis
J.F.M. Gawlitza, J.D. Michels, H. Haubenreisser, T. Henzler, M. Borggrefe, patients with preserved ejection fraction
S.O. Schönberg, I. Akin, F. Trinkmann; Mannheim/DE M. Gatti1, R. Faletti1, F. Bioletto1, A. Palmisano2, G. Benedetti2, A. Esposito2,
P. Fonio1; 1Turin/IT, 2Milan/IT
10:30 - 12:00 Room M 1

10:30 - 12:00 Room M 2
Cardiac
Paediatric
SS 603
Cardiac MR myocardial feature tracking SS 612
Moderators: Foetal and obstetric imaging
R. Heiß; Erlangen/DE Moderators:
R. Salgado; Antwerp/BE R. Llorens; Valencia/ES
D. Prayer; Vienna/AT
B-0588 10:30
Phenotyping diabetic cardiomyopathy in South Asians and Europeans B-0599 10:30
E.H.M. Paiman1, H.J. van Eyk1, M.B. Bizino1, I.A. Dekkers1, P. de Heer2, Feasibility of foetal MRI in the evaluation of foetal congenital heart
J.W.A. Smit3, I.M. Jazet1, H.J. Lamb1; 1Leiden/NL, 2Amsterdam/NL, disease
3
Nijmegen/NL S.-Z. Dong, M. Zhu; Shanghai/CN
B-0589 10:38 B-0600 10:38

Independent association of extracellular volume with myocardial strain Diffusion-weighted magnetic resonance imaging of the foetal brain in
assessed by CMR in subjects without history of cardiovascular disease complex congenital heart disease
from the general western population S.-Z. Dong, H. Ji; Shanghai/CN
C. Storz1, T. Zitzelsberger1, S. Rospleszcz2, K. Nikolaou1,
F. von Knobelsdorff2, A. Peters2, J. Schulz-Menger3, F. Bamberg1, B-0601 10:46
C.L. Schlett4; 1Tübingen/DE, 2Munich/DE, 3Berlin/DE, 4Heidelberg/DE Foetal dynamic phase-contrast MR angiography using ultrasound
gating and comparison with Doppler ultrasound measurements
B-0590 10:46 B.P. Schoennagel, J. Yamamura, F. Kording, R. Fischer, G. Adam,
Impaired left ventricular function in patients with treatment-resistant H. Kooijman, C. Ruprecht, K. Fehrs, M. Tavares de Sousa; Hamburg/DE
arterial hypertension evaluated by feature-tracking myocardial strain
CMRI B-0602 10:54
C. Ozden1, M.L. Warncke1, F. Brunner1, J. Stáreková1, A. Koops1, G.K. Lund1, Role of fetal MRI in diagnosis of genitourinary anomalies: is there an
G.I. Kirova-Nedyalkova2, G. Adam1, E. Tahir1; 1Hamburg/DE, 2Sofia/BG added value?
S. Sefidbakht1, B. Bijan2, S. Bagheri1, Z. Etemadi1, S. Esmaeilian1;
B-0591 10:54 1
Shiraz/IR, 2Sacramento, CA/US
Prognostic role of feature tracking in suspected myocardial infarction
with non-obstructed coronary arteries (MINOCA): sensitive or B-0603 11:02
senseless? Abnormalities concomitant with intrahepatic persistent right umbilical
T. Leckebusch, P. Wenzel, F. Jungmann, M.C. Halfmann, R.M. Brumberg, vein
C. Düber, K.-F. Kreitner, T. Emrich; Mainz/DE A. Ipek, Ö. Ünal, M. Yildirim Erol; Ankara/TR

Evaluation of left ventricular strain assessment with feature- BY Prenatal MRI assessment of swallowing and pharyngeal structures in
INVEST IN
tracking CMR in STEMI at long term follow-up THE YOUTH foetuses with facial clefts
F. Cilia, C. Calvieri, F. Catapano, S. Coco, R.M. Ammendola, S.R. Teixeira, E.R. Arruda, S.M. Saade, O. Jackson, A.N. Pollock, T. Feygin;
G. De Rubeis, N. Galea, M. Francone, C. Catalano; Rome/IT Philadelphia, PA/US

B-0605 11:18 B-0616 11:26

Evaluation of foetal modified myocardial performance index as a Investigating blood oxygenation level dependent (BOLD) MRI in
predictor of perinatal outcome in gestational diabetes small renal masses (SRM), and its correlation with dynamic contrast
R. Khurana, S.K. Bajaj; New Delhi/IN enhanced (DCE) MRI
N. Bogveradze1, D. Prezzi1, R. Neji1, C. Kelly-Morland1, H. Verma1,
B-0606 11:26 SPEAKER K. Lashkhi2, V.J. Goh1; 1London/UK, 2Tbilisi/GE
SUPPORTED
What does perinatal autopsy add after antenatal ultrasound BY
INVEST IN SPEAKER
and post-mortem MRI investigations THE YOUTH B-0617 11:34 SUPPORTED
S.C. Shelmerdine, O.J. Arthurs, A. Wade, R. Jones, W. Norman, Does perfusion-metabolic tumour phenotype predict for BY
INVEST IN
A. Taylor, N.J. Sebire, L.S. Chitty; London/UK neoadjuvant therapy response in primary oesophageal THE YOUTH
18
tumours undergoing DCE-MRI and F-FDG PET/CT?
B-0607 11:34 S.J. Withey, K. Owczarczyk, C. Yip, M. Siddique, A. Green, J. Bell, G. Cook,
Reliable evaluation of ADC values in the study of normal foetal brain, V.J. Goh; London/UK
using denoising correction: a prenatal MR study
A. Antonelli, L. Manganaro, M.G. Di Trani, S. Capuani, S. Bernardo, B-0618 11:42
R. Petrillo, C. Catalano; Rome/IT Imaging texture features to predict neoadjuvant therapy response in
locally advanced rectal cancer
B-0608 11:42 G. Cappello, V. Doronzio, V. Romano, A. Timpani, G. Desi, F. Cortese,
Assessment of the reproducibility of foetal proton magnetic resonance V. Giannini, S. Mazzetti, D. Regge; Candiolo/IT
spectroscopy at different sequence settings
M. Sokurenko, T. Trofimova, A. Khalikov; St. Petersburg/RU B-0619 11:50
CT response evaluation of adrenocortical carcinoma (ACC) during and
B-0609 11:50 after chemotherapy: which criteria?
Assessment of the dynamics of foetal brain metabolites with proton M. Bertuletti, D. Cosentini, S. Cieno, M. Di Terlizzi, S. Grisanti, B. Frittoli,
magnetic resonance spectroscopy A. Berruti, R. Ambrosini, L. Grazioli; Brescia/IT
M. Sokurenko, T. Trofimova, A. Khalikov; St. Petersburg/RU
B-0620 11:58
CT-response patterns and the role of CT-textural features in inoperable
10:30 - 12:00 Room M 3 abdominal/retroperitoneal soft tissue sarcomas treated with
trabectedin
Oncologic Imaging M. Esser1, C. Kloth2, W. Thaiss1, C.P. Reinert1, J. Fritz3, M. Horger1;
1
Tübingen/DE, 2Ulm/DE, 3Baltimore, MD/US
SS 616b
Abdominal tumour imaging: raising the
bar Clinical Trials in Radiology
Moderators:
D. Caruso; Rome/IT
A. Cieszanowski; Warsaw/PL
CT 6
Clinical Trials in Radiology 2
B-0610 10:30 Moderators:
Volumetric DCE-MRI radiomics nomogram can predict tumour V.J. Goh; London/UK
response in patients with oesophageal cancer treated by neoadjuvant U. Mahmood; Oak Brook, IL/US
chemotherapy
J. Qu1, L. Ma2, Y. Lu1; 1Zhengzhou/CN, 2Shanghai/CN 10:30
Outcome of pneumatosis intestinalis and porto-mesenteric venous gas:
B-0611 10:38 a multicentric study
Diffusion kurtosis imaging evaluation of histological differentiation T.A. Auer1, R. Kloeckner2, D. Pinto Dos Santos3, M. della Seta1, D. Geisel1,
and Lauren classification in advanced gastric cancer B. Hamm1; 1Berlin/DE, 2Mainz/DE, 3Cologne/DE
J. Fu, L. Tang, Z. Li, Q. Shi, Z. Yan, X. Li, J. Ji; Beijing/CN
10:39
B-0612 10:46 Discussant:
The role of intravoxel incoherent motion and diffusion kurtosis D. Weishaupt; Zurich/CH
imaging in evaluating pathological complete response to neoadjuvant
chemoradiotherapy in rectal cancer 10:45
l. Yang, B. Wu; Chengdu/CN Diffusion-weighted MRI in the assessment of nephroblastoma: results
of a multi-centre trial
B-0613 10:54 A.M. Hötker1, Y. Mazaheri2, A. Lollert3, J.-P. Schenk4, C. Düber3,
Differentiation of atypical non-functional pNET and PDAC using a CT P. Mildenberger3, O. Akin2, N. Graf5, G. Staatz3; 1Zurich/CH,
radiomics-based nomogram 2
New York, NY/US, 3Mainz/DE, 4Heidelberg/DE, 5Homburg (Saar)/DE
M. He, H. Xue, Z. Jin; Beijing/CN
10:54
Quantitative magnetic resonance imaging can predict tumour K. Rosendahl; Bergen/NO
subtype, therapy response and patient survival in pancreatic ductal
adenocarcinoma 11:00
G. Kaissis1, S. Ziegelmayer1, F. Lohöfer1, W. Weichert1, J. Siveke2, Validation of deep learning algorithms for the detection of critical
E.J. Rummeny1, R. Braren1; 1Munich/DE, 2Essen/DE findings in head CT scans
S. Chilamkurth1, R. Ghosh2, S. Tanamala2, M. Biviji3, N. Campeau4,
B-1663 11:18 V. Venugopal5; 1Mumbai, MA/IN, 2Mumbai/IN, 3Nagpur/IN,
Clinical impact of lateral lymph nodes at pelvic MRI in patients with 4
Rochester, MN/US, 5New Delhi, Delhi/IN
rectal cancer
I. Blazic, S. Patil, T. Konishi, N.M. Campbell, J. Garcia-Aguilar, M.J. Gollub; 11:09
New York, NY/US Discussant:
M. de Bruijne; Rotterdam/NL

11:15 B-0627 11:27 SPEAKER

SUPPORTED
Patient preference for coronary CT angiography and invasive coronary Using contrast-enhanced ultrasound to assess diagnostically BY
angiography: results from a randomised controlled trial INVEST IN
challenging and indeterminate lesions in native and THE YOUTH
G. Abdala Gehling1, S. Feger1, M. Rief1, M. Laule1, M. Dewey1, transplant kidneys
E. Schönenberger2; 1Berlin/DE, 2Hanover/DE P. Lee, A. Mehdi, A. Alsafi, C. Harvey, A.K.P. Lim; London/UK
11:24 B-0628 11:35

Discussant: Characterisation of CT-indeterminate renal masses by contrast-
J.-N. Dacher; Rouen/FR enhanced ultrasound and acoustic radiation forced impulse imaging
S. Kaufmann, W. Thaiss, M. Horger, K. Nikolaou, J. Bedke; Tübingen/DE
11:30
Perspectives of radiologists and cardiologists about the severity of B-0629 11:43
health events in the multicentre DISCHARGE trial - on behalf of the Correspondence analysis between different reference lines used in
DISCHARGE investigators magnetic resonance defecography of pelvic organs prolapse or the
V. Wieske, M. Dewey; Berlin/DE measurement of prolapse of pelvic organs with POPQ
S. Yévenes Aravena, G. Cárdenas Loguercio, J. Casas Muñoz,
11:39 F. Araya Campos, C. Garrido Inostroza, V. Manríquez Galán,
Discussant: R. Guzmán Rojas, M. Naser Nassar, D. Castro Caperán; Santiago/CL
B-0630 11:51
11:45 Outcome in 73 patients with benign prostatic hyperplasia treated by
A multi-stage randomised clinical trial to reduce variation in computed an ultrasound guided transperineal laser ablation by interventional
tomography radiation dose radiologists
Y. Wang, P. Chu, S. Yu, R. Smith-Bindman; San Francisco, CA/US G. Patelli1, F. Besana1, E. Faietti1, G. Ori Belometti1, C. Costa1, A. D‘Alessio2,
G. Mauri3, C.M. Pacella4; 1Seriate/IT, 2Zingonia/IT, 3Milan/IT, 4Rome/IT
11:54
Discussant:
Thursday
A. Trianni; Udine/IT 10:30 - 12:00 The Church
Head and Neck
Genitourinary SS 608
Lymph nodes and parathyroids
SS 607 Moderators:
T. Beale; London/UK
Contrast agents for imaging: not only L.M. Lenghel; Cluj-Napoca/RO
iodine B-0631 10:30
Moderators: Evaluation of acoustic radiation force impulse imaging in the diagnosis
N.N. of malignant cervical lymphadenopathy
Y. Mytsyk; Lviv/UA R. Kamat1, A. Ramesh2, K. Nagarajan2; 1Chandigarh/IN, 2Puducherry/IN
K-13 10:30 B-0632 10:38

Keynote lecture SUV-based lymph node selection for fine-needle aspiration guided
F. Stacul; Trieste/IT by real-time fused ultrasound and FDG PET in head and neck cancer
patients
B-0621 10:39 P. De Koekkoek-Doll, W. Vogel, M.W.M. van den Brekel, L. Smit,
Macrocyclic or linear MR contrast agent: are there any differences R.G.H. Beets-Tan, M. Maas; Amsterdam/NL
in detection of local recurrence of prostate cancer after radical
prostatectomy? B-0633 10:46
F. Kossov, B. Olimov, P. Bulychkin, S. Tkachev, G. Akhverdieva, V. Panov, Correlation between preoperative 4D CT parathyroid volumes and
I. Tyurin; Moscow/RU perioperative PTH levels
A. Yates, P. Cromwell, N.M. Hughes, S. Skehan, D. Evoy, E. McDermott,
B-0622 10:47 R. Prichard; Dublin/IE
Contrast-enhanced ultrasonography (CEUS) surveillance of native
kidneys in renal transplant patients: a monocentric experience B-0634 10:54 SPEAKER
SUPPORTED
E. Bertelli, S. Agostini, S. Verna, S. Lucarini, E. Savi, L. Mercatelli, P. Carta, Evaluation of sensitivity and specificity of elastography BY
S. Serni, V. Miele; Florence/IT INVEST IN
for differentiating benign from malignant cervical THE YOUTH
lymphadenopathy and comparing with B-mode and colour
B-0624 11:03 Doppler findings
Iodine in common contrast-enhanced CT protocols does not affect K. Mittal1, V. Bansal2; 1Delhi/IN, 2New Delhi/IN
renal functionin a high-risk population with chronic kidney disease
M. Koci, A. Graber-Naidich, X.S. Cheng, D. Fleischmann, M.J. Willemink; B-0635 11:02
Stanford, CA/US Diagnostic accuracy of image-guided core needle biopsy of lymphoma
suspected patients
B-0625 11:11 M. Kazemi, M. Mikalani, H. Sharifian, B. Moradi; Tehran/IR
Contrast-enhanced ultrasound (CEUS) efficiency in renal graft
complication evaluation B-0636 11:10
C.G. García Roch1, F. García García1, F.X. Aragon Tejada2, Arterial spin labelling (ASL) MRI to assess nodal metastases in head
J. Ciampi Dopazo1, M. Muñoz Cepeda1, M. Bernabéu Rodríguez1, and neck cancer
R. Giovanetti González3, A. Roca1, P.A. Baron Rodiz2; 1Toledo/ES, R. Balaji; Chennai/IN
2
Madrid/ES, 3Córdoba/ES
B-0637 11:18
B-0626 11:19 Role of shearwave elastography in assessment of cervical lymph nodes
Comparison of computed tomography (CT) and contrast-enhanced S.K. Suganchand Rikabchand, R. Mohammed Kashif; Jodhpur/IN
ultrasound (CEUS) for the management of complex renal cysts:
a single-centre experience
G. Piccoli; Conegliano/IT

B-0638 11:26 B-0649 14:56 SPEAKER

SUPPORTED
Diagnostic performance of computer-aided quantification of Assessing dignity of patients undergoing radiotherapy for BY
INVEST IN
intranodal vascularity in differentiating common neck lymph node pelvic cancer THE YOUTH
diseases M. Calleja1, M.E. Grech1, N. Courtier2, J.G. Couto1; 1Msida/MT,
2
M.T.C. Ying, S.C.H. Cheng, A.T. Ahuja; Hong Kong/CN Cardiff/UK
B-0639 11:34 B-0650 15:04

The utility of F18-choline PET/CT for the localisation of parathyroid Glioblastoma: 3D-CRT or IMRT/VMAT?
adenomata in patients with primary hyperparathyroidism (PHP) with M.J.V. Pereira, B. Gregório, A. Cavaco, J.P. Figueiredo; Coimbra/PT
negative or equivocal conventional imaging
R. Ramaesh, G. Browning, S. Wakelin, E. Ward, F. Gibbs, D. Patel; B-0651 15:12
Edinburgh/UK Thematic analysis of the competencies of the therapy radiographer
practising in the linear accelerator
B-0640 11:42 J.G. Couto1, P. McClure2, S. McFadden2, P. Bezzina1, C. Hughes2;
1
Role of multiparametric 4D-MRI in detection of parathyroid lesions in Msida/MT, 2Newtownabbey/UK
primary hyperparathyroidism
N. Murugan, D. Kandasamy, R. Sharma, A. Goyal, A.K. Gupta, N. Tandon, B-0652 15:20 SPEAKER
SUPPORTED
S. Vara Taranikanti, S. Agarwal, N. Gupta; New Delhi/IN Expectations of radiography students regarding the new BY
INVEST IN
undergraduate course in medical imaging and radiotherapy THE YOUTH
B-0641 11:50 L. Ribeiro1, A.F. Abrantes1, S. Rodrigues1, J.P. Arrais2,
Role of ultrasound elastography in differentiating tuberculosis and R.P. Almeida1, K.B. Azevedo1, O. Lesyuk3; 1Faro/PT,
2
malignant lymph nodes Vila Nova de São Bento/PT, 3São Brás de Alportel/PT
A.Y.M. Yee1, R. Norlisah2, L.S. Chng3; 1Sungai Buloh/MY,
2
Kuala Lumpur/MY, 3Selayang/MY
14:00 - 15:30 Room C
14:00 - 15:30 Room B Radiographers
Radiographers
SS 714b
SS 714a Radiation dose optimisation in CT and
Paediatrics and radiation therapy projection radiography
E. Farrugia Wismayer; Floriana/MT. L. Bonomo; Rome/IT
R. Seuri; Helsinki/FI L.J.O.C. Lança; Lisbon/PT
B-0642 14:00 SPEAKER B-0653 14:00

SUPPORTED
Actual dose measurements of assistant during paediatric BY Impact of decentring patients for abdominal CT scan
INVEST IN S. Moerup1, H. Precht2, S. Foley3, A. Seegert4, B.R. Mussmann1;
x-ray examination with a precisely calibrated optically THE YOUTH 1
stimulated luminescence dosimeter Odense/DK, 2Middelfart/DK, 3Dublin/IE, 4Kolding/DK
T. Asahara1, H. Hayashi2, E. Tomita2, Y. Mihara1, S. Goto2, Y. Kanazawa1,
N. Kimoto2, T. Asakawa2, T. Okazaki3; 1Tokushima/JP, 2Kanazawa/JP, B-0654 14:08
3
Ibaraki/JP Exploring academic and social factors‘ effect on CT dose optimisation:
a longitudinal study of radiographers from student to first post
B-0643 14:08 V.T. Major1, S. Ryan2, D. O‘Leary3; 1Northwood/UK, 2Hatfield/UK,
3
Frontiers of periosteal changes: comparison between anthropological Keele/UK
data, clinical records and readings of X-ray medical imaging
technology B-0655 14:16
R.M.C.R. Gaspar1, A.F. Abrantes2, V. Matos1; 1Coimbra/PT, 2Faro/PT Is the technology for patient placement in CT really that useful in
reducing dose and improving SNR?
B-0644 14:16 L. Lennon1, S. Tsui2, G. Dick3, J. Hislop-Jambrich4; 1North Ryde/AU,
2
Radiation dose associated with patients undergoing upper limb Box Hill/AU, 3Maroondah/AU, 4Notting Hill/AU
radiographic examination in different patient orientation: a phantom study
M.M. Abuzaid, W. Elshami, Z. Noorajan; Sharjah/AE B-0656 14:24
The unjustified dose behind cropped radiographs
B-0645 14:24 J. Guðjónsdóttir, G.A. Hannesdóttir; Reykjavik/IS
Radiation dose comparison study between conventional methods
and slot-scanning system (EOS® system) on paediatric patients with B-0657 14:32
scoliosis Scoliosis dose comparison using current clinical protocols
H. Laitinen, E. Saukko, E. Svedström, O. Pajulo, H. Niiniviita; Turku/FI M. Shanahan1, M. Geso2, A. Potter2, G. Lennie2; 1Bruce/AU,
2
Melbourne/AU
B-0646 14:32
Improvement of safety and image quality with a self-made airway B-0658 14:40
management device for sedation and anaesthesia in paediatric heart CT Establishment of national diagnostic reference levels for dental
H. Kim, J. Chang, D.-K. Seo; Seoul/KR radiology
A.Q.L.C. Brito, R.P.P. Almeida, S. Rodrigues, A.F. Abrantes, L. Ribeiro,
B-0647 14:40 P. Sousa, K.B. Azevedo, D.M. Simão; Faro/PT
Dose optimisation of head CT examinations in paediatrics SPEAKER
M. Dziedataja; Riga/LV B-0659 14:48 SUPPORTED
The impact of different exposure factors on radiation dose BY
INVEST IN
B-0648 14:48 SPEAKER of lumbar spine in five different sizes phantoms: a factorial THE YOUTH
SUPPORTED
Evaluation of dose to risk organ during brachytherapy for BY design study
INVEST IN S.J.M. Alqahtani, J.R. Meakin, R.M. Palfrey, K. Knapp; Exeter/UK
cervical cancer using a novel passive rectum dosimeter THE YOUTH
E. Tomita1, H. Hayashi1, T. Asahara2, Y. Shitakubo3,
K. Sakuragawa3, H. Ikushima3, Y. Kanazawa3, T. Okazaki4, T. Hashizume4; B-0660 14:56
1
Kanazawa/JP, 2Okayama/JP, 3Tokushima/JP, 4Tsukuba/JP Radiation dose reduction using copper filters
K. Yagami1, M. Hirota1, H. Kato1, F. Okada1, S. Suzuki2; 1Gifu/JP,
2
Toyoake/JP

B-0662 15:12 SPEAKER B-0673 15:21

SUPPORTED
Stylised phantom used in PCXMC, the validation against BY Comparison evaluation of the diagnostic potential of PET/MRI and
INVEST IN
hybrid phantom in obesity THE YOUTH PET/CT using mIBG-Iod-124 in neuroendocrine and neuroectodermal
S.J.M. Alqahtani, J.R. Meakin, R.M. Palfrey, K.M. Knapp; tumours
Exeter/UK A. Örnek1, L. Umutlu1, J. Kirchner2, D. Heber1, K. Herrmann1, V. Ruhlmann1;
1
Essen/DE, 2Düsseldorf/DE
B-0663 15:20
Should DR and CR projection radiography have separate LDRLs at a
local hospital level? 14:00 - 15:30 Room O
A.M. Burke, S.J. Foley; Dublin/IE
Musculoskeletal
14:00 - 15:30 Room N

SS 710
Hybrid Imaging
Imaging techniques: trauma and cartilage
Moderators:
SS 706 S. Choudhary; Birmingham/UK
U. Fahlenkamp; Berlin/DE
Hybrid imaging in oncology: head to toe
Moderators: B-0674 14:00
P.M. Kazmierczak; Munich/DE. Implementation of an ultra-low-dose CT-protocol for extremities:
B. Tavitian; Paris/FR initial experience with 106 subjects
Z. Alagic1, R. Bujila2, S. Srivastava2, S.K. Koskinen3; 1Solna/SE,
K-14 14:00 2
Stockholm/SE, 3Huddinge/SE
Keynote lecture
J. Ferda; Plzen/CZ B-0684 14:08
Tissue stiffness after self-myofascial release in athletes with different
Thursday
B-0664 14:09 experience in foam rolling assessed by quantitative acoustic radiation
Quantitative 3D analysis of hybrid 18F-FET PET/MR-neuroimaging for force impulse elastography (ARFI)
differentiation between treatment response and glioma recurrence R. Heiß, I. Mayer, M. Huettel, M.S. May, W. Wuest, M. Kopp, C. Lutter,
J. Lohmeier, B. Hamm, M.R. Makowski; Berlin/DE R. Forst, T. Hotfiel; Erlangen/DE
B-0666 14:25 SPEAKER B-0675 14:16

SUPPORTED
Prediction of patient outcome in head and neck squamous BY Dual-energy CT for assessment of bone marrow oedema in the acute
INVEST IN
carcinoma following chemo(radiation): comparison of 4 THE YOUTH fracture: a systematic review
different FDG PET-CT response assessment interpretative F.C. Müller1, J.S. Bovin1, K.K. Gosvig1, F. Kainberger2, A. Rodell3,
criteria M. Østergaard4, M. Boesen5; 1Herlev/DK, 2Vienna/AT, 3Ballerup/DK,
4
J. Zhong, M. Arunsingh, P. Brown, K. Dyker, R. Prestwich, S. Currie, Glostrup/DK, 5Copenhagen/DK
S. Vaidyanathan, A. Scarsbrook; Leeds/UK
B-0676 14:24
B-0667 14:33 SPEAKER A prospective randomised CT analysis of ankle syndesmosis injuries in
SUPPORTED
Performance of FDG PET-based textural features for BY Weber B and C type fractures
INVEST IN
prediction of loco-regional recurrence in advanced larynx THE YOUTH A. Favia1, M. D‘addato2, G. Caliolo1, C. Campagna1, V. Favia1, M. Carrozzo1,
and hypopharynx squamous cell carcinoma A. Spinarelli1, A. Scardapane1, A. Stabile Ianora1; 1Bari/IT, 2Bisceglie/IT
J. Zhong, P. Brown, H.L. Nelstrop, R. Prestwich, G.M. McDermott,
S. Currie, S. Vaidyanathan, A. Scarsbrook; Leeds/UK B-0677 14:32
Reliability of ultrasonography measurement of the anterior talofibular
B-0668 14:41 ligament (ATFL) length in healthy subjects, based on examinee
Clinical impact of breast and whole body simultaneous PET/MRI for experience and patient positioning
staging of breast cancer lesions >2 cm J. Seilern und Aspang, K.-H. Kristen, H. Platzgummer, F. Hartenbach,
V. Romeo, C. Cavaliere, M. Imbriaco, A. Stanzione, R. Cuocolo, A. Pignata, J. Wiedermann; Vienna/AT
V. Picariello, E. Nicolai, M. Salvatore; Naples/IT
B-0678 14:40
B-0669 14:49 Model-based accelerated T2 mapping of sacroiliac joint with 3-T MRI: a
Can we replace sentinel lymph node resection in breast cancer preliminary study of Grappatini
patients by breast MRI, axillary MRI or axillary 18F-FDG PET/MRI X. Peng, S. Yang, P. Hu, J. Xiao, Y. Pei, W. Liao; Changsha/CN
J. Kirchner1, O. Martin1, L.M. Sawicki1, L. Umutlu2, P. Heusch1,
C. Buchbender1; 1Dusseldorf/DE, 2Essen/DE B-0679 14:48
Feasibility of sub-milliSievert CT of the skeletal pelvis: a human
B-0670 14:57 cadaver study
Evaluation of a fast protocol for staging patients with bronchial cancer J.M. Weinrich1, K.J. Maas1, J. Stáreková1, L. Intert1, S. Sehner1, M. Regier2,
using PET/MRI G. Adam1, A. Quitzke1; 1Hamburg/DE, 2Munich/DE
O. Martin1, L.M. Sawicki1, J. Kirchner1, G. Antoch1, K. Herrmann2,
L. Umutlu2, P. Heusch1; 1Düsseldorf/DE, 2Essen/DE B-0680 14:56
Quantification and evaluation of pre-post exercise femoral cartilage
B-0671 15:05 thickness and T2 changes in ultramarathon athletes
Is there a connection between immunohistochemical markers and F. Garcia-Castro1, J. Catala-March2, D. Brotons-Cuixat2, M. Llobet-
grading of lung cancer with ADC and SUV of hybrid 18F-FDG PET/MRI? Llambrich2, E. Sanchez-Osorio2, A. Alberich-Bayarri1; 1Valencia/ES,
2
O. Martin1, P. Heusch1, J. Kirchner1, T. Ullrich1, C. Buchbender1, F. Nensa2, Barcelona/ES
K. Herrmann2, L. Umutlu2, L.M. Sawicki1; 1Düsseldorf/DE, 2Essen/DE
B-0681 15:04
B-0672 15:13 Presence of intravascular contrast material after intraarticular injection
Prediction of overall survival using interim 18F-FDG PET-CT and CT for for CT arthrography
response assessment of patients with Hodgkin lymphoma treated with C. von Falck, J.B. Hinrichs, F. Wacker; Hanover/DE
immune checkpoint inhibitors
F.-Z. Mokrane1, A. Chen2, B. Zhao3, S. Ammari4, L. Schwartz3, R. Houot5, B-0682 15:12
L. Dercle6; 1Toulouse/FR, 2Nanjing/CN, 3New York, NY/US, 4Villejuif/FR, Optimising dual-energy CT parameters for virtual non-calcium
5
Rennes/FR, 6Paris/FR imaging: a phantom study
F.C. Müller1, H. Børgesen1, K.K. Gosvig1, A. Rodell2, C. Booz3, B. Schmidt4,
B. Krauss4, M. Boesen5; 1Herlev/DK, 2Ballerup/DK, 3Frankfurt a. Main/DE,
4
Forchheim/DE, 5Copenhagen/DK

B-0683 15:20 B-0694 15:21

Importance of minimal HU setting in the foot and ankle DECT: Bone staging of breast cancer with whole-body MRI: using low field
frequency and the common site of submillimeter artefact noted in strength without enhancer does not mitigate the diagnostic efficacy
patients in gout free patients A. Malich, A. Kott, C. Kurrat, J. Feger, I. Papageorgiou; Nordhausen/DE
H. Yang1, Y.-S. Hong2, J. Gong Yong3, Y. Lee1, S. Kim1, J. You1, E. Park1;
1
Jeonju/KR, 2Gwangju/KR, 3Chonju/KR
14:00 - 15:30 Room E1
14:00 - 15:30 Studio 2019 Breast
Oncologic Imaging
SS 702a
SS 716 Decision tools and artificial intelligence
How to improve bone metastases and in breast imaging
Moderators:
osteosarcoma assessment T. Sella; Jerusalem/IL
Moderators: N.N.
A. Karpenko; St. Petersburg/RU
L. Kintzelé; Heidelberg/DE K-16 14:00
Keynote lecture
K-15 14:00 F.J. Gilbert; Cambridge/UK
Keynote lecture
T. Bäuerle; Erlangen/DE B-0695 14:09
Can artificial intelligence identify normal mammograms in screening?
B-0685 14:09 K. Lång, M. Dustler, V. Dahlblom, I. Andersson, S. Zackrisson; Malmö/SE
Using radiomics to identify invisible bone metastases on CT in
melanoma patients receiving immunotherapy B-0696 14:17
Z. Elkarghali1, T. Nguyen-Kim2, J. Spekreijse1, S. Trebeschi1, J.B. Haanen1, Artificial intelligence software to improve mammography workflow
C.U. Blank1, W. Vogel1, R.G.H. Beets-Tan1; 1Amsterdam/NL, 2Zurich/CH A.T. Watanabe1, R.C. Mayo2, L.Q. Chang Sen2, M. Kapoor2, J. Leung2;
1
Los Angeles, CA/US, 2Houston, TX/US
B-0686 14:17
Prediction of immune-checkpoint-inhibitor therapy effectiveness by B-0697 14:25
evaluation of bone marrow activity modifications: an FDG-PET/CT study Artificial intelligence detecting breast cancer on mammography: does
G. Ferrero1, F. Fiz2, J. Schwenck 3, C. La Fougère3, C. Campi4, breast density play a role?
G. Sambuceti2, E. Fabbro5, B. Pickler3, M. Kneilling3; 1Pietra Ligure/IT, A. Rodriguez Ruiz, M. Kallenberg, A. Gubern-Merida, N. Karssemeijer,
2
Genoa/IT, 3Tubinga/DE, 4Padua/IT, 5Cuneo/IT R.M. Mann; Nijmegen/NL
B-0687 14:25 B-0698 14:33

Imaging detection and characterisation of bone metastases from Improved cancer detection using artificial intelligence: a retrospective
neuroendocrine neoplasm with simultaneously acquired Ga-68 evaluation of missed cancers on mammography
DOTATATE PET/MRI A.T. Watanabe1, V. Lim2, E. Weise3, H. Vu3; 1Manhattan Beach, CA/US,
J. Bai, R. Matthews, L. Bangiyev, A.R. Chimpiri, D. Franceschi; 2
La Jolla, CA/US, 3San Diego, CA/US
Stony Brook, NY/US
B-0699 14:41
B-0688 14:33 False negative on computer-aided detection application in
Whole-body MRI vs bone scan in the follow-up of oncologic patients preoperative automated breast ultrasound of breast cancer patients
A. Malich, I. Papageorgiou, D. Wiech; Nordhausen/DE Y. Kim1, J. Rim1, S.M. Kim1, B.L. Yun1, S.Y. Park1, H.S. Ahn2, B. Kim3,
M.J. Jang1; 1Seongnam/KR, 2Seoul/KR, 3Yongin/KR
B-0689 14:41
Activity concentration in prostate cancer bone metastases predicts the B-0700 14:49
radioisotope therapy outcome: a SPECT/CT study Automatic detection of breast lesions on ABUS using a novel transfer
G. Ferrero1, F. Fiz2, H. Dittman3, C. La Fougère3, C. Campi4, G. Sambuceti2, learning approach: comparison between three different networks
S. Sahbai5, M. Weissinger3, M. Piana2; 1Pietra Ligure/IT, 2Genova/IT, J. Santinha1, A. Vourtsis2, A. Uysal3, J. Moreira1, N. Papanikolaou1;
3
Tubinga/DE, 4Padova/IT, 5Parigi/FR 1
Lisbon/PT, 2Athens/GR, 3Ankara/TR
B-0690 14:49 B-0701 14:57

18F-FDG PET/MRI for therapy response assessment of isolated limb Automated volumetric analysis of breast cancer vascularisation
perfusion in patients with soft-tissue sarcomas enables risk stratification in patients scheduled for neoadjuvant
J. Grueneisen1, B.M. Schaarschmidt2, M. Chodyla1, O. Martin2, Y. Li1, chemotherapy
W. Fendler1, K. Herrmann1, M. Forsting1, L. Umutlu1; 1Essen/DE, M. Dietzel1, S. Ellmann1, P. Clauser2, E. Wenkel1, M. Uder1,
2
Dusseldorf/DE R. Schulz-Wendtland1, P.A.T. Baltzer2; 1Erlangen/DE, 2Vienna/AT
B-0691 14:57 B-0702 15:05

Histopathologic and radiologic assessment of chemotherapeutic The Kaiser score, a decision rule based on BI-RADS MRI descriptors:
response in osteosarcoma: correlation of ADC with huvos grading is there an impact of histopathology on the diagnostic accuracy?
H.S. Mohanty1, A.K. Chaturvedi1, A. Jajodia1, M. Bind2, A.S. Rao1, M. Dietzel1, S. Ellmann1, E. Wenkel1, P. Clauser2, R. Schulz-Wendtland1,
R. Tripathi1, V. Mahawar1; 1New Delhi/IN, 2Bangalore/IN M. Uder1, P.A.T. Baltzer2; 1Erlangen/DE, 2Vienna/AT
B-0692 15:05 B-0703 15:13

Value of the cinematic rendering from CT data in evaluating the Combining artificial intelligence and MRI in the management of
relationship between deep soft tissue sarcomas of the extremities and equivocal breast lesions: the perfect couple?
adjacent major vessels M. Dietzel, S. Ellmann, E. Wenkel, C. Bielowski, R. Schulz-Wendtland,
Z. Li; Kunming/CN M. Uder, T. Bäuerle; Erlangen/DE
B-0693 15:13 B-0704 15:21

Diffusion-weighted MR imaging diagnostic merits in post-therapeutic Automatic cluster analysis of breast lesions assessed with diffusion-
assessment of musculoskeletal soft tissue sarcoma weighted imaging
S. Shokry, A.F.I. Moustafa, M.A.M. Hawanna, M.M. Hussein, A. Shokry; J. Schaar, H. Dijkstra, M. Wielema, M. Dorrius, P. Sijens; Groningen/NL
Cairo/EG

14:00 - 15:30 Room E2 14:00 - 15:30 Room F1

Neuro Breast
SS 711 SS 702b
Stroke: diagnostic imaging Breast ultrasound
P. Due-Tønnessen; Oslo/NO E. Giannotti; Nottingham/UK
P. Thurner; Vienna/AT M. Marolt Music; Ljubljana/SI
B-0705 14:00 B-0716 14:00

Cerebrospinal fluid volume as a predictor of malignant middle cerebral Decrease in unnecessary biopsy recommendations by the application
artery infarction of quantitative multiparametric breast ultrasound: a prospective study
F. Kauw, E. Bennink, H.W.A.M. De Jong, L. Kappelle, A.D. Horsch, P. Kapetas, P. Clauser, R.A. Woitek, G.J. Wengert, M. Lazar,
B.K. Velthuis, J.W. Dankbaar; Utrecht/NL K. Pinker-Domenig, M. Bernathova, T.H. Helbich, P.A.T. Baltzer; Vienna/AT
B-0706 14:08 B-0717 14:08

Improved diagnostic performance of CT perfusion imaging in acute Diagnostic performance of fifth BI-RADS edition ultrasound lexicon
stroke using advanced noise suppression and Bayesian perfusion for prediction of malignancy in breast masses with histopathological
algorithms correlation
E.J. Smit1, K. Murayama2, T. Galen1, S. Pegge1, L. Kluijtmans3, Y. Ikeda4, K. Gupta1, T. Chandra2, B. Venkatesan3; 1Chennai/IN, 2Orlando, FL/US,
K. Katada2, F.J. Meijer1, M. Prokop1; 1Nijmegen/NL, 2Toyoake/JP, 3
Pondicherry/IN
3
Malden/NL, 4Ōtawara/JP
B-0718 14:16
B-0707 14:16 SPEAKER Does establishing preoperative nomogram including ultrasonographic
SUPPORTED
BY
Thursday
Effect of report length on its clarity in the stroke setting: findings help predict the likelihood of malignancy in patients with
INVEST IN
an AI study THE YOUTH microcalcifications?
A. Mereu, L. Saba; Cagliari/IT H. Wang, J. Lai, J. Li, R. Gu, F. Liu, Y. Hu, X. Jiang, J. Mei, F. Su;
Guangzhou/CN
B-0708 14:24
Evaluation of pial collaterals on multiphase CT angiography: impact on B-0719 14:24
the prediction of infarct size and outcome in acute ischaemic stroke How should we manage breast ultrasound masses that do not enhance
E. Puglielli, G. Manente, M. Assetta, P. Pulsone, V. Di Mizio; Teramo/IT on MRI?
D. Avendano1, E.J. Sutton1, E.A. Morris1, M.A. Marino2, P. Gibbs1,
B-0709 14:32 D. Martinez1; 1New York, NY/US, 2Messina/IT
Extracted computed tomography angiography measurements as a
screening tool for obstructive sleep apnoea in acute stroke patients B-0720 14:32
T.J. Jeffery, D. Gibson; Perth/AU Contrast-enhanced ultrasound in breast cancer and its role in
predicting immunohistochemical subtype: a novel prognostic
B-0710 14:40 approach
Comparison of accuracy for the prediction of infarct tissue volumes S.B. Grover1, H. Grover2, P. Jain1, A.K. Nag1, A. Katyan1, N. Antil1, S.K. Jain1,
between arrival-time insensitive and arrival-time sensitive CT A.K. Mandal1; 1New Delhi/IN, 2Bridgeport, CT/US
perfusion algorithms
L. Pennig, F. Thiele, M. Perkuhn, C. Kabbasch, M. Schlamann, B-0721 14:40
J. Borggrefe; Cologne/DE Preliminary study of real-time three-dimensional contrast-enhanced
ultrasound of sentinel lymph nodes in breast cancer
B-0711 14:48 M. Lu; Chengdu/CN
Prediction of motor recovery after stroke by assessment of
corticospinal tract Wallerian degeneration using diffusion tensor B-0722 14:48 SPEAKER
SUPPORTED
imaging Role of ultrasound in the SOUND trial: can we move away BY
INVEST IN
R. Elshafey1, H.S. Darwish2, H.A. Kamel1; 1Tanta/EG, 2Ismalia/EG from sentinel lymph node biopsy? THE YOUTH
F. Pesapane, M. Grimaldi, A. Rotili, D. Lepanto, E. Cassano;
B-0712 14:56 SPEAKER Milan/IT
SUPPORTED
Arterial transit artefacts on ASL perfusion MRI in patients BY
INVEST IN
with carotid artery stenosis are a better predictor of recent THE YOUTH B-0723 14:56
symptoms than degree of stenosis or carotid plaque Predictive factors on ultrasound for the early tumour recurrence of
morphology breast cancer after breast-conserving treatment
A. Di Napoli1, S. Cheng2, G. John2, M. Brown2, M. Sokolska2, H.R. Jäger2; S.G. Yun, Y.Y. An; Suwon/KR
1
Rome/IT, 2London/UK
B-0724 15:04
B-0713 15:04 The value of automated breast ultrasound (ABUS) coronal view
Clinical decision support based on automated non-contrast CT density S. Schiaffino, A. Tagliafico, L. Gristina, E. Massone, S. De Giorgis,
measurements in patients with acute ischaemic stroke A. Garlaschi, M. Calabrese; Genoa/IT
P. Reidler1, D. Puhr-Westerheide1, M.P. Fabritius1, L. Rotkopf1, D. Apel1,
S. Tiedt1, F.A. Wollenweber1, K. Thierfelder2, W.G. Kunz1; 1Munich/DE, B-0725 15:12
2
Rostock/DE Diagnostic performance of automated breast ultrasound (ABUS) after
breast-conserving surgery
B-0714 15:12 C. Depretto, A. Primolevo, F. Cartia, C. Ferranti, G. Scaperrotta; Milan/IT
Pattern of leptomeningeal collateral circulation on perfusion
computed tomography in patients with acute ischaemic stroke B-0726 15:20
A. Singh1, U.B. George2, J.D. Pandian2; 1Delhi/IN, 2Ludhiana/IN Targeted ultrasound as first-line examination in women with focal
breast complaints
B-0715 15:20 L. Appelman1, P. Appelman2, P. Bult1, R. Mann1; 1Nijmegen/NL,
2
Ultra-low-dose cerebral CT perfusion for the diagnosis of acute Tienhoven/NL
ischemic stroke using iterative model reconstruction combined with
optimised temporal resolution
X. Fang1, R. Wang1, Y. Liu1, C. Yuan1, X. Chen2, Z. Wang1; 1Nanjing/CN,
2
Shanghai/CN

14:00 - 15:30 Room F2 14:00 - 15:30 Room Y

Emergency Imaging Interventional Radiology
SS 717 SS 709
Chest emergencies Vascular interventions in visceral arteries
Moderators:
M. Brink; Nijmegen/NL
and veins (part 2)
J.B. Dormagen; Oslo/NO Moderators:
D. Cvetko; Zagreb/HR
P. Heiss; Regensburg/DE
K-17 14:00
Keynote lecture
M. Rémy-Jardin; Lille/FR B-0737 14:00
Catheter-directed gastric artery embolisation with octreotide acetate-
loaded PLA/PLGA (poly(lactide-co-glycolide) acid) microspheres with
B-0727 14:09
slow sustained release properties
Patient lung volume is significantly related to contrast media volume
F. Nurili1, T. Acar2, S. Derman2, A. Bas2, I. Caymaz2, S. Özkanli2,
during CT pulmonary angiography when employing a patient-specific
H. Cakiroglu3, I. Yurdaisik2, O. Aras1; 1New York, NY/US, 2Istanbul/TR,
contrast protocol 3
Adapazari/TR
C. Saade, F. El-Merhi; Beirut/LB
B-0728 14:17 B-0738 14:08

Prevention of post-partum haemorrhages in patients with morbidly
Age-adjusted D-dimer and risk-stratification in acute pulmonary
adherent placenta: a monocentric experience
embolism for reduce the unnecessary CT imaging
F. Capasso, M. Coppola, M. Caruso, S. Stilo, A. Stanzione, P. Venetucci;
A. Pandur, D. Sipos, B. Banfai, J. Betlehem, B. Radnai; Pécs/HU
Naples/IT
B-0729 14:25
Real-time patient specific scan delay in CTA of pulmonary embolism:
B-0739 14:16
Partial splenic artery embolisation using ethylene vinyl alcohol
impact on image quality
copolymer in patients with portosplenomesenteric thromboses and
F.R. Schwartz1, J.C. Ramirez Giraldo2, R. Gutjahr3, D. Marin1, D. Boll4,
portal hypertension
L. Hurwitz1; 1Durham, NC/US, 2Rochester, MN/US, 3Nürnberg/DE,
4 W. Uller1, W.A. Wohlgemuth2, H. Goessmann1, R. Müller-Wille1,
Basle/CH
G. Kirchner1; 1Regensburg/DE, 2Halle/DE
Contribution of CT lung perfusion in diagnosis of acute BY
INVEST IN Shattered spleen in blunt trauma: clinical results of trans-arterial
pulmonary embolism THE YOUTH
embolisation, four years‘ experiences in a single regional trauma centre
A. Oganesyan, E. Mershina, V.E. Sinitsyn; Moscow/RU
R. Lee, C.H. Jeon, C.W. Kim, H. Kwon, H.M. Cho; Busan/KR
B-0731 14:41
Virtual non contrast imaging of aortic intramural hematoma for
B-0741 14:32
Preoperative transarterial embolisation using a gelatin sponge for
replacing the non contrast CT imaging
benign prostatic hyperplasia: initial feasibility test
S.A. Si-Mohamed1, N. Dupuis1, D.C. Rotzinger2, S. Boccalini3, Y. Yagil4,
K.Y. Kim, M.G. Shin; Jeonju/KR
P. Coulon5, N. Shapira4, P. Douek1, L. Boussel1; 1Bron/FR, 2Lausanne/CH,
3
Genoa/IT, 4Haifa/IL, 5Paris/FR
B-0742 14:40
Gastric variceal recurrence after balloon-occluded retrograde
B-0732 14:49
transvenous obliteration
Contrast-enhanced US (CEUS) of lung abscess: how it can help
K. Kato, K. Kawashima, T. Suzuki, M. Hamano, S. Ehara; Morioka/JP
C.L. Piccolo1, D. Cozzi2, M. Trinci3, M. Galluzzo3, M. De Cicco3, V. Miele3,
S. Ianniello3; 1Aversa/IT, 2Florence/IT, 3Rome/IT
B-0743 14:48
B-0733 14:57 SPEAKER Trans-arterial embolisation of the prostate with biodegradable
SUPPORTED flutamide-loaded PLA/PLGA microspheres for benign prostate
Lung ultrasound in the diagnosis of pneumothorax in BY
INVEST IN hyperplasia: a preliminary study in normal swine model
paediatric stable major trauma: chest x-ray is still useful? THE YOUTH
F. Nurili1, T. Acar2, S. Derman2, A. Bas2, I. Caymaz2, I. Yurdaisik2,
D. Cozzi1, C.L. Piccolo2, M.L. De Cicco3, M. Trinci3, M. Galluzzo3,
H. Cakiroglu2, S. Özkanli2, O. Aras1; 1New York, NY/US, 2Istanbul/TR
V. Miele3, S. Ianniello3; 1Florence/IT, 2Aversa/IT, 3Rome/IT
B-0734 15:05 B-0745 14:56

The application of hepatic artery-targeting guidewire technique
Accuracy of a new system score based on lung ultrasound and clinical
combined with indirect portography to transjugular intrahepatic
data in the decision of a drainage tube necessity in polytrauma
portosystemic shunt
patients pneumothorax
S. Wang, N. Li, C. Yu; Tianjin/CN
M.L. De Cicco1, C. Andreoli1, B. Sessa2, V. Miele1, S. Ianniello1; 1Rome/IT,
2
Chieti/IT
B-0746 15:04
What makes a difference between life and death in patients with
B-0735 15:13
NOMI? Analysis of clinical data and contrast-enhanced dynamic CT
Iatrogenic injuries and misplaced foreign material found in whole-
findings before angiography
body CT: a retrospective analysis in over 1000 resuscitation room
R. Miyazawa, M. Kamo; Tokyo/JP
patients
S. Sudarski, D. Schäfer, T. Henzler, T. Terboven, T. Viergutz,
S.O. Schönberg, H. Haubenreisser; Mannheim/DE B-0747 15:12
Temporary balloon occlusion of the internal iliac arteries as a
prevention of massive haemorrhage during cesarean delivery among
B-0736 15:21
patients with abnormal placentation
Incidental findings in thoracic CTS performed in trauma patients: an
M. Milnerowicz, J. Garcarek, M. Miś, M. Miś, A. Kacala; Wroclaw/PL
underestimated problem
E.J.M. Barbosa Jr., O. Osuntokun; Philadelphia, PA/US

14:00 - 15:30 Room D 14:00 - 15:30 Room G

Artificial Intelligence and Machine Learning Physics in Medical Imaging
SS 705 SS 713
Machine learning in neuroradiology: MRI: safety, phantoms and quantification
vascular and mass lesions Moderators:
D.J. Lurie; Aberdeen/UK
Moderators: S. Skornitzke; Heidelberg/DE
T.C. Booth; London/UK
K. Egger; Freiburg/DE
K-18 14:00
Keynote lecture
B-0748 14:00 A. Webb; Leiden/NL
Prospective evaluation of a deep learning algorithm deployed in an
urban imaging centre to notify clinicians of head CT scans with critical
B-0759 14:09
abnormalities
MRI principles and techniques: how and where do radiologists and
S. Tanamala1, S. Chilamkurthy1, M. Biviji2, R. Ghosh1, P. Rao1; 1Mumbai/IN,
2
radiology residents look for?
Nagpur/IN
F.M. Doniselli, M. Zanardo, L.M. Sconfienza, F. Sardanelli; Milan/IT
B-0749 14:08 B-0760 14:17 SPEAKER

Extracranial determinants of white matter lesion volume: a machine SUPPORTED
Design and testing of a novel complex flow phantom for BY
learning-based top 10 list INVEST IN
medical imaging THE YOUTH
S. Grosu1, S. Rospleszcz1, F. Bamberg2, C.L. Schlett3, A. Peters4, M. Heier1,
S. Ambrogio1, A. Walker2, P. Verma1, A. Narracott1, J. Fenner1;
F. Schöppe1, B.B. Ertl-Wagner5, S. Stöcklein1; 1Munich/DE, 2Freiburg/DE, 1
3
Sheffield/UK, 2Boroughbridge/UK
Heidelberg/DE, 4Neuherberg/DE, 5Toronto, ON/CA
Thursday
B-0761 14:25
B-0750 14:16 Phantom for independent global head SAR assessment of MRI-induced
Deep learning for infarct detection and localisation from head CT
temperature change
scans
G. Oluniran, J. Blackwell, B. Tuohy, N. Colgan; Galway/IE
R. Ghosh1, S. Chilamkurthy1, P. Rao1, S. Tanamala1, N. Campeau2;
1
Mumbai/IN, 2Rochester, MN/US
B-0762 14:33
Hotspot temperatures leading to burn in 3T MRI in pigs
B-0751 14:24 C.-H. Cho1, C. Grosse-Siestrup1, G. Brinker1, J. Nadobny1, S. Niehues1,
Estimation of intracranial haemorrhage volume with the deep learning
M. Taupitz1, B. Hamm1, P. Schlattmann2; 1Berlin/DE, 2Jena/DE
method
Q. Gong, Y. Deng, C. Xia, R. Zhang, C. Wu, Z. Wang, Y. Zhang, J. Ma;
Beijing/CN
B-0763 14:41
Accuracy and reproducibility of magnitude-based proton density fat
fraction quantification with resolved water-fat ambiguity
B-0752 14:32 A. Bagur, C. Hutton, M.L. Gyngell, M.D. Robson, M. Brady; Oxford/UK
Brain disease classification based on routine MRI using a deep learning
algorithm
Y. Liu, P. Gao, Y. Duan; Beijing/CN
B-0764 14:49
Quantification of abdominal subcutaneous adipose tissue in MRI of
obese patients
B-0753 14:40 N.P. Linder, K. Solty, A. Hartmann, M. Blüher, R. Stange, H. Busse;
Detection of intracranial haemorrhage on CT of the brain using a deep
Leipzig/DE
learning algorithm
D. Desbuquoit, S. Dekeyzer, J. Huyskens, S. Nicolay, E. De Smet,
J. Van Goethem, L. Van den Hauwe, P.M. Parizel; Edegem/BE
B-0766 15:05
MR imaging relaxation times of pancreatic tissue measured in vivo at
7.0 Tesla
B-0754 14:48 M. Damen1, M.S. van Leeuwen2, A. Webb1, D.W. Klomp2,
Development and validation of a deep neural network-based
C. Arteaga de Castro2; 1Leiden/NL, 2Utrecht/NL
computer-assisted detection system for cerebral aneurysms in CT
angiography
Z. Shi1, C. Pan2, C. Zhou1, D. Fan2, X. Li2, G. Lu1, L. Zhang1; 1Nanjing/CN,
B-0767 15:13
2 Magnetic resonance 4D-flow derived mean pulmonary arterial pressure
Beijing/CN
at 3T: a validation study
U. Reiter1, G. Kovacs1, C. Reiter1, C. Kräuter1, A. Greiser2, H. Olschewski1,
B-0755 14:56 M.H. Fuchsjäger1, G. Reiter1; 1Graz/AT, 2Erlangen/DE
Automated detection of midline shift and mass effect from head CT
scans using deep learning
S. Chilamkurthy1, R. Ghosh1, S. Tanamala1, M. Biviji2, N. Campeau3, SUPPORTED
Contrast-enhanced MR images employed in stereotactic BY
V. Venugopal4; 1Mumbai/IN, 2Nagpur/IN, 3Rochester, MN/US, INVEST IN
4 radiosurgery: does susceptibility-related distortion pose a THE YOUTH
New Delhi/IN
significant problem?
D.P. Dellios1, E.P. Pappas1, I. Seimenis2, P. Karaiskos1; 1Athens/GR,
B-0756 15:04 2
Alexandroupolis/GR
A deep learning method for analysing post-operative MRI scans of
glioblastoma patients
M. Perkuhn, P. Stavrinou, R. Shahzad, F. Thiele, G. Shakirin, D. Garmpis,
C. Kabbasch, J. Borggrefe; Cologne/DE
B-0757 15:12
A radiomics strategy for amide proton transfer imaging in predicting
isocitrate dehydrogenase genotype within grade II/III gliomas
Y. Han, Y.-Z. Sun, L.-F. Yan, W. Wang, G.-B. Cui; Xi‘an/CN
B-0758 15:20
BRAIMS: an incoming open source MR imaging dataset for brain
instance-aware metastases segmentation
W.-Y. Guo, S.-Q. Zheng, H.-M. Wu, P.C. Liu, I.-J. Sun, S. Hong, W.-Y. Chung,
W.H. Yang, Y.-C. Tu; Taipei/TW

14:00 - 15:30 Room K 14:00 - 15:30 Room M 1

Chest Cardiac
SS 704 SS 703
Lung cancer: diagnosis, staging and CT-FFR (fractional flow reserve) for
outcome assessment of coronary artery disease
N.N. C.A. Minoiu; Bucharest/RO
F. Molinari; Lille/FR R.A.P. Takx; Utrecht/NL
B-0769 14:00 SPEAKER K-19 14:00

SUPPORTED
Radiogenomics of non-small cell lung cancer (NSCLC): BY Keynote lecture
INVEST IN
association between CT-based imaging features and EGFR THE YOUTH G. Pontone; Milan/IT
and K-RAS mutations in 122 patients: an external validation
C. Fanciullo1, F. De Piano1, E. De Jong2, S. Raimondi1, V. Buscarino1, B-0780 14:09 SPEAKER
SUPPORTED
S. Rizzo1; 1Milan/IT, 2Maastricht/NL Value of fractional flow reserve computed from triple-rule- BY
INVEST IN
out CT angiography data in the emergency department THE YOUTH
B-0770 14:08 S.S. Martin1, M. van Assen2, A.M. Fischer3, C.N. De Cecco1,
Correlation between EGFR gene mutation and CT, clinical features and M. Bauer1, A. Varga-Szemes1, D. Mastrodicasa1, U.J. Schoepf1;
1
pathological subtypes in ground glass lung adenocarcinoma Charleston, SC/US, 2Groningen/NL, 3Mannheim/DE
L. Kang, X. Zhang, X. Chen, H. Li; Zhengzhou/CN
B-0781 14:17
B-0771 14:16 CT-FFR profiles in patients without coronary artery disease: the effect
Evaluation of pre-treatment FDG PET-CT-based imaging parameters of location and lumen area
and textural features as prognostic indicators in non-small cell lung R.R. Bayer1, M. van Assen2, S.S. Martin1, R.H. Savage1, R. Steinbach1,
carcinoma A.M. Fischer3, L.P. Griffith1, U.J. Schoepf1; 1Charleston, SC/US,
G.M. McDermott1, P. Brown1, A. Scarsbrook2; 1Leeds/UK, 2York/UK 2
Groningen/NL, 3Mannheim/DE
B-0772 14:24 B-0782 14:25

Value of TSCT features in differentiating pre- and minimally invasive High-risk and lipid-rich, but not calcified, plaque predicts ischaemia in
from invasive adenocarcinoma presented as ground-glass nodules non-obstructive lesions (ANOCA): a CTA/CTFFR study
smaller than 3 cm G. Feuchtner, C. Langer, F. Barbieri, C. Beyer, G.J. Friedrich, F. Plank;
J. Ji, Q. Weng, H. Wang, S. Fang, X. Wu, M. Chen, Z. Wang, M. Xu; Innsbruck/AT
Lishui/CN
B-0783 14:33
B-0773 14:32 Comparison between stress CT perfusion versus FFRCT in the
CT bronchovascular bundle thickening sign as a predictor of survival in evaluation of suspected CAD: PERFECTION prospective study
patients with peripheral small cell lung cancer 3 cm or smaller A. Baggiano1, M. Guglielmo1, G. Muscogiuri1, M. Soldi1, A. Del Torto1,
P. Sung, S. Yoon; Seoul/KR A.I. Guaricci2, M. Pepi1, G. Pontone1; 1Milan/IT, 2Bari/IT
B-0774 14:40 B-0784 14:41

Computerised texture analysis predicts histological invasiveness within Coronary computed tomography angiography-derived fractional flow
lung adenocarcinoma manifesting as pure ground-glass nodules reserve in anomalous origin of the right coronary artery from the left
Y. Yang, H. Liu; Shanghai/CN coronary sinus
C. Tang1, M. Lu1, U.J. Schoepf2, C. Tesche2, M. Bauer2, J.W. Nance2,
B-0775 14:48 L. Griffith2, C. Zhou1, L. Zhang1; 1Nanjing/CN, 2Charleston, SC/US
The comparison of hook wire vs coil localisation for video-assisted
thoracoscopy surgery B-0785 14:49
D. Kim, Y. Song; Changwon/KR Diagnostic performance of fractional flow reserve derived from
coronary computed tomography angiography in myocardial bridging:
B-0776 14:56 a comparison with invasive fractional flow reserve
Hook-wire localisation vs lipiodol localisation for patients with F. Zhou1, Y. Wang2, U.J. Schoepf3, C. Tesche4, L. Xu2, Y. Hou5, J. Yan6,
pulmonary lesions having ground-glass opacity: the LOGIS trial J.Y. Zhang6, L.J. Zhang1; 1Nanjing/CN, 2Beijing/CN, 3Charleston, SC/US,
4
J. Hur1, C.H. Park1, S.M. Lee1, J.W. Lee1, S.H. Hwang1, J.S. Seo1, K.H. Lee1, Munich/DE, 5Shenyang/CN, 6Shanghai/CN
W. Kwon2, D.J. Im1; 1Seoul/KR, 2Wonju/KR
B-0786 14:57
B-0777 15:04 Coronary CT based on-site FFR might be a useful tool to identify
Diagnostic accuracy of F-18 FDG PET/CT in mediastinal lymph nodal haemodynamically relevant non-culprit lesions in patients who
staging of recently diagnosed carcinoma lung suffered myocardial infarction
R. Kumar E, R. Verma, A. Dhamija, E. Belho, V. Gupta, H. Mahajan, J. Simon, B. Szilveszter, A. Ahres, M. Kolossvary, B. Jablonkai, B. Merkely,
V. Mahajan; New Delhi/IN P. Andrássy, P. Maurovich- Horvat; Budapest/HU

Dual-energy CT (DECT) lung tumour perfusion: can we distinguish The prognostic value of CT myocardial perfusion and CT-FFR BY
INVEST IN
features that can reflect prognosis? for MACE in patients with coronary artery disease THE YOUTH
J. Dewaguet1, M.-C. Copin1, J.-B. Faivre1, V. Deken1, M. Sedlmair2, J. Remy1, M. van Assen1, C.N. De Cecco2, M. Eid3, M.J. Bauer4,
M. Remy-Jardin1; 1Lille/FR, 2Forchheim/DE M. Scarabello5, P. von Knebel Doeberitz6, M. Oudkerk1, R. Vliegenthart1,
U.J. Schoepf3; 1Groningen/NL, 2Atlanta, GA/US, 3Charleston, SC/US,
4
B-0779 15:20 Munich/DE, 5Milan/IT, 6Heidelberg/DE
The effect of different monochromatic image choices on the accuracy
of CT perfusion values for lung tumour in one-stopspectral and B-0788 15:13
perfusion CT scan A patient specific lumped parametric model based approach to
H. Wang, S. Yue, P. Lu, W. Li; Zhengzhou/CN fractional flow reserve derived from coronary computed tomography
angiography
R.W. van Hamersvelt1, M. Voskuil1, P.A. de Jong1, M.J. Willemink2, T. Leiner1;
1
Utrecht/NL, 2Menlo Park, CA/US

B-0789 15:21 SPEAKER B-0800 15:20

SUPPORTED
Relationship between coronary CT angiography-derived BY A reduced contrast media injection protocol significantly improves
INVEST IN
fractional flow reserve and dynamic CT myocardial perfusion THE YOUTH the visualisation of liver vasculature at reduced radiation dose during
imaging in patients with coronary artery disease hepatic CTA
M. van Assen1, C.N. De Cecco2, S.S. Martin3, A. Fischer3, C. Saade, A. Haydar; Beirut/LB
R. Steinbach3,
M. Oudkerk1, R. Vliegenthart1, U.J. Schoepf3; 1Groningen/NL,
2
Atlanta, GA/US, 3Charleston, SC/US 14:00 - 15:30 Sky High Stage
Artificial Intelligence and Machine Learning
14:00 - 15:30 Room M 2
Abdominal Viscera MY 7
Artificial Intelligence and Machine
SS 701 Learning
CT technical frontiers in liver imaging Moderators:
A. Blachar; Tel Aviv/IL M. Zins; Paris/FR
C. Sofia; Messina/IT
B-0801 14:00
B-0790 14:00 Assistant effects of a computer-aided diagnosis system based on 3D
Iodine images in dual-energy CT: benchmarking quantitative iodine convolutional neural network on LDCT reading
concentration values of the healthy liver S. Wang, Z. Wang, S. Zhang, Y. Fu, T. Hu, W. Peng; Shanghai/CN
S. Beck, D. Deniffel, I. Riederer, E.J. Rummeny, D. Pfeiffer; Munich/DE
B-0802 14:04
B-0791 14:08 SPEAKER Automatic prostate segmentation of magnetic resonance images using
Thursday
SUPPORTED
DECT in the diagnosis of the efficiency of chelation therapy BY convolutional neural networks
INVEST IN N. Aldoj, F. Biavati, M. Rutz, S. Stober, M. Dewey; Berlin/DE
in patients with iron overload THE YOUTH
A.M. Titova, V.A. Fokin, G.E. Trufanov, M.O. Ivanova;
St. Petersburg/RU B-0803 14:08
Automated x-ray bone segmentation using a conditional adversarial
B-0792 14:16 network
Measuring liver fat fraction with dual-layer spectral CT material J. Haubold, A. Demircioglu, M. Forsting, L. Umutlu, F. Nensa; Essen/DE
attenuation decomposition (MAD) plots: an iodine-independent
method for imaging hepatic steatosis with CT B-0804 14:12
T.C. Soesbe, M.A. Lewis, L. Ananthakrishnan, J.R. Leyendecker, Y. Xi, Small (< 4 cm) renal masses: convolutional neural network-
T. Yokoo, R.E. Lenkinski; Dallas, TX/US based deep-learning approach in differentiating fat-poor renal
angiomyolipoma from renal cell carcinoma at MSCT
B-0793 14:24 X. Li, L. Wang; Nanjing/CN
Preliminary study for intra-abdominal liquids characterisation based
on dual-energy CT B-0805 14:16
O. Meyrignac, R. Losco, R. Moreno, A. Sewonu, H. Rousseau; Computed tomography-based radiomics analysis to assess treatment
Toulouse/FR response after perioperative neoadjuvant therapy
Q. Xu1, C. Zhou1, C. Ye1, G. Tao1, W. Zhao1, D. Ren2, X. Li2, L. Zhao2, G. Lu1;
B-0794 14:32 SPEAKER 1
Nanjing/CN, 2Beijing/CN
SUPPORTED
Multi-energy CT quantification of first-pass perfusion BY
in hypervascular liver lesions: potential to differentiate THE YOUTH
hypervascular metastasis from hepatocellular carcinoma A preliminary study of predicting molecular subtypes of breast cancer
B. Kaltenbach1, J.L. Wichmann1, I. Yel1, M.H. Albrecht1, T.J. Vogl1, by the radiomics features of contrast-enhanced ultrasound
S.S. Martin2; 1Frankfurt a. Main/DE, 2Charleston, SC/US L. Tang, W. Chang, M. Chen; Shanghai/CN
B-0795 14:40 B-0808 14:24

Double low-dose spectral liver CT in patients at high risk of HCC The diagnostic value of texture analysis in predicting WHO grades of
J. Yoon1, E. Lee1, S.M. Lee2, W. Chang3, J. Lee1; 1Seoul/KR, 2Anyang/KR, meningiomas based on ADC maps: an attempt using decision tree and
3
Seongnam/KR decision forest
Y. Lu, B. Yin; Shanghai/CN
Estimation of the right posterior section volume in live liver donors: B-0809 14:28 SUPPORTED
Automated stroke detection and profiling on initial non- BY
semi-automated CT volumetry in conjunction with portal vein INVEST IN
segmentation contrast CT via machine learning and textural analysis THE YOUTH
S.Y. Jeong, J. Lee, K.W. Kim, J.K. Jang, H.-J. Kwon, G.W. Song, S.G. Lee; J.M.A. Alghamdi, S. Raja; Riyadh/SA
Seoul/KR
B-0810 14:32
B-0797 14:56 A novel improved deep learning framework for liver lesion detection
Feasibility of volume index to assess liver volume: comparison of Y. Chen1, J. Ma2, J. Wang1, F. Wang1, S. Feng1; 1Guangzhou/CN,
2
ultrasound and computed tomography Beijing/CN
D. Seppelt1, T. Ittermann2, A. Haubold1, D. Fedders1, R.-T. Hoffmann1,
C. Kolb1, J.-P. Kühn1; 1Dresden/DE, 2Greifswald/DE B-0811 14:36
Evaluation of intra-scanner test-retest variability of machine learning
B-0798 15:04 SPEAKER features in low-dose computed tomography of interstitial lung disease
SUPPORTED
Dose optimisation in multiphasic computed tomography BY F. Prayer, S. Röhrich, J. Hofmanninger, A. Willenpart, G. Langs, H. Prosch;
INVEST IN Vienna/AT
imaging of the liver with high-concentration contrast media THE YOUTH
S. Cavalieri, A. Ferrari, R. Villa, M. Brambilla, A. Stecco,
A. Carriero; Novara/IT B-0812 14:40
Accurate pulmonary nodule detection in CT images using multi-stage
B-0799 15:12 3D deep convolution neural networks
Multidetector liver CT: improved image quality, decreased radiation and X.J. Chen; Zhengzhou/CN
contrast media dose with peristaltic contrast media injection system
C. Saade, S. Khalifeh, L. Karout, L. Naffaa; Beirut/LB

B-0813 14:44 B-0824 14:24

Deep learning for prostate cancer segmentation and detection: Local staging in prostate cancer (PCa): the role of capsular bulging
diffusion MRI U-net compared to clinical PI-RADS assessment and the length of capsular contact (LCC) to predict the risk of
P. Schelb, S. Kohl, J.-P. Radtke, M. Hohenfellner, H.-P. Schlemmer, extracapsular extention (ECE) at final pathology
K. Maier-Hein, D. Bonekamp; Heidelberg/DE G. Stranieri1, G. Gallo1, A. De Pascale1, D. Gned2, M. Bini1, D. Basile1,
E. Checcucci1, F. Porpiglia1, A. Veltri1; 1Turin/IT, 2Saint Pierre/IT
B-0814 14:48
A whole-tumour histogram analysis of apparent diffusion coefficient B-0825 14:32 SPEAKER
SUPPORTED
maps obtained using 3.0T MRI for distinguishing uterine endometrial Multiparametric MRI of the bladder: interobserver agreement BY
INVEST IN
carcinoma from endometrial polyps and accuracy with the vesical imaging-reporting and data THE YOUTH
W. Wang, J. Cheng; Zhengzhou/CN system (VIRADS) at a single reference centre
G. Barchetti, R. Campa, M. Pecoraro, I. Ceravolo, C. Catalano,
B-0815 14:52 V. Panebianco; Rome/IT
A computer-aided detection (CAD) system on low-dose chest CT
imagesin concurrent-reader and second-reader modes: radiologist B-0827 14:40
performance and reading time Magnetic resonance imaging findings differentiate among periurethral
Q. Hu; Wuhan/CN bulking agent, urethral diverticulum and periurethral cyst, preventing
misdiagnosis
B-0816 14:56 SPEAKER T. Chulroek1, D. Wangcharoenrung1, K. Cattapan2, K. Hamed3,
SUPPORTED
Reproducibility of fully automated liver volumetric analyses BY A.J. Mitchell3, M.G. Harisinghani3, E.J.B. De3; 1Bangkok/TH, 2Songkhla/TH,
INVEST IN
with artificial intelligence: towards laboratory radiology THE YOUTH 3
Boston, MA/US
D.J. Winkel1, G. Chabin2, J. Cyriac1, B. Stieltjes1, T.J. Weikert1;
1
Basle/CH, 2Princeton, NJ/US B-0828 14:48
MP-MRI can exclude prostate cancer progression in patients under
B-0817 15:00 active surveillance
Automated detection of lung cancer at ultralow dose PET/CT by deep L. Schimmöller, T. Ullrich, F. Mones, M. Quentin, R. Rabenalt, P. Albers,
neural networks: initial results G. Antoch, C. Arsov; Düsseldorf/DE
M. Schwyzer, D. Ferraro, U. Mühlematter, A. Curioni-Fontecedro,
M. Hüllner, G.K. Von Schulthess, P.A. Kaufmann, I.A. Burger, M. Messerli; B-0829 14:56
Zurich/CH PSAD and ADC values improve the diagnostic accuracy of PI-RADS v2
A.C. Westphalen, F. Fazel, H. Nguyen, M. Cabarrus, K. Hanley-Knutson,
B-0818 15:04 K. Shinohara, P.R. Carroll; San Francisco, CA/US
Automated lung cancer detection in PET/CT using a deep learning
approach B-0830 15:04
M. Müller, C.P. Reinert, K. Nikolaou, C. La Fougère, C. Pfannenberg, Dynamic contrast-enhanced MRI perspectives in the assessment of
S. Gatidis; Tübingen/DE aggressiveness of urinary bladder cancer
R.T. Abouelkheir, M.E. Abou El-Ghar, T. El-Diasty; El-Mansoura/EG
B-0819 15:08
Non-invasive tumour decoding and phenotyping of cerebral gliomas B-0831 15:12
utilizing multiparametric18F-FET PET-MRI and MR fingerprinting Radiomic analysis of multiparametric MRI for preoperative evaluation
J. Haubold, A. Demircioglu, M. Gratz, K. Wrede, M. Glas, K. Herrmann, of pathological grade in bladder cancer
M. Forsting, F. Nensa, L. Umutlu; Essen/DE H. Wang, F. Zhang, W. Fu, J. Guan, Y. Guo; Guangzhou/CN
B-0820 15:12
Deep learning-based automated calcium scoring for cardiac computed 16:00 - 17:30 Sky High Stage
tomography
S.S. Martin1, M. van Assen2, A.M. Fischer3, S. Rapaka4, P. Sahbaee1, Interventional Radiology
C. Schwemmer5, M.A. Gulsun4, P. Sharma4, U.J. Schoepf1;
1
Charleston, SC/US, 2Groningen/NL, 3Mannheim/DE, 4Princeton, NJ/US,
5
Forchheim/DE MY 8
14:00 - 15:30 Tech Gate Auditorium Moderators:
V. Bérczi; Budapest/HU
Genitourinary P. Haage; Wuppertal/DE
B-0832 16:00
SS 707 Perfusion MRI prediction of progrossion-free survival in patients with
hepatocellular carcinoma treat with TACE
Prostate and bladder tumours Z. Zhu, X. Zhao, C. Zhou; Beijing/CN
Moderators:
P. Pavlica; Bologna/IT B-0833 16:04
T. Penzkofer; Berlin/DE Evaluation of mismatch diameter between radial versus distal radial
artery in patients suitable for vascular peripheral procedures
B-0821 14:00 D. Meo, D. Falsaperla, A. Modica, M.C. Calcagno, C. Desiderio, F. Libra,
Whole-body MRI for detecting bone metastases in treatment naïve P. Foti, S. Palmucci, A. Basile; Catania/IT
high-risk prostate cancer: cracking nuts with a sledgehammer?
E. Rud, F. Ottoson, T. Flatabo, E. Baco; Oslo/NO B-0834 16:08
Image-guided percutaneous techniques in the treatment of aggressive
B-0822 14:08 vertebral haemangiomas: clinical outcomes and therapeutic strategy
Detection of extracapsular extension in high risk prostate cancer A. Ricoeur1, J. Caudrelier2, X. Buy3, J. Garnon2, G. Koch2, R. Cazzato2,
patients: multiparametric MRI vs. 68Ga-PSMA-11 PET/MRI A. Gangi2; 1Lyon/FR, 2Strasbourg/FR, 3Bordeaux/FR
U.J. Mühlematter, K. Schawkat, A. Becker, J. Müller, A.M. Hötker,
N.J. Rupp, C.S. Reiner, I.A. Burger, O.F. Donati; Zurich/CH B-0836 16:16
Does IV-tPA induce thrombus migration? A retrospective study
B-0823 14:16 comparing bridging therapy and thrombectomy alone
Prostate cancer local staging: a comparison of short dual pulse and C. Cohen1, K. Gaillot2, K. Janot1, J. Cottier1, M. Dejobert1, A.-P. Narata1;
1
biparametric MRI vs multiparametric MRI Tours/FR, 2La Rochelle/FR
A. Stanzione, A. Ponsiglione, S. Cocozza, R. Cuocolo, S.G. Picchi,
V. Romeo, S. Stilo, A. Brunetti, M. Imbriaco; Naples/IT

B-0837 16:20 B-0850 17:12 SPEAKER

SUPPORTED
Focal prostate cancer ablation „out of the rectum and out of MRI“: Prospective monocentre pilot study of intrahepatic BY
INVEST IN
new tools for fusion-guidanceand „super-activesurveillance“ mitomycin C infusion after radioembolisation with Y-90 in THE YOUTH
S. Xu, V. Anderson, M. Li, J. Peretti, C. Garcia, P.L. Choyke, P. Pinto, chemo refractory liver dominant metastatic breast cancer
B. Turkbeyi, B.J. Wood; Bethesda, MD/US patients
B.M. Aarts1, E.G. Klompenhouwer1, R.C. Dresen2, C. Deroose2, A. Laenen2,
B-0838 16:24 R.G.H. Beets-Tan1, P. Neven2, H. Wildiers2, G. Maleux2; 1Amsterdam/NL,
2
Safety and outcomes of transarterial chemoembolization using Leuven/BE
small- versus medium-sized drug-eluting beads for unresectable
hepatocellular carcinoma B-0851 17:16
A.M.K. Abdel Aal, K. Mahmoud, H. El Khudari, N. Aboueldahab, In the ablation of colorectal cancer liver metastases with a new
S. Saddekni, A. Gunn; Birmingham, AL/US generation MW system nodule size >2 cm independently predicts
worse local tumour progression free survival
B-0839 16:28 P. Marra1, A. Della Corte2, F. Ratti1, F. Cipriani1, S. Gusmini1, M. Salvioni3,
MRI-CT fusion imaging before high-selective lumbar sympathicolysis M. Venturini1, L. Aldrighetti1, F. De Cobelli1; 1Milan/IT, 2Vimodrone/IT,
3
B. Reichardt1, A. Örnek1, V. Nicolas2, C. Maier2; 1Essen/DE, 2Bochum/DE Bergamo/IT
B-0840 16:32
Lumbar sympathetic trunk in MRI and CT: its visibility and distance to
two anatomical landmarks for pre-interventional planning
B. Reichardt1, A. Örnek1, V. Nicolas2, C. Maier2; 1Essen/DE, 2Bochum/DE
B-0841 16:36
Bilateral carotid stenting in the same sitting in high-risk patients:
a single-centre study
L.S.P. Karanam, S.R. Baddam, A. Alurkar, V. Pamidimukkala,
R. Polavarapu; Guntur/IN
Thursday
SUPPORTED
Pneumothorax and pulmonary haemorrhage after CT-guided BY
INVEST IN
lung biopsy: incidence, clinical significance and correlation THE YOUTH
V. Sabatino, U. Russo, F.V. d‘Amuri, A. Bevilacqua, F. Pagnini,
G. Milanese, R. Nizzoli, G. Pedrazzi, M. De Filippo; Parma/IT
B-0843 16:44
MR imaging-based response evaluation of two different transarterial
chemoembolisation protocols using degradable starch micorspheres in
therapy of hepatocellular carcinoma
M.C. Langenbach, M.H. Albrecht, R. Hammerstingl, T. Gruber-Rouh,
T.J. Vogl; Frankfurt am Main/DE
B-0844 16:48
The anatomic options of vessels and haemodynamic redistribution
of the blood flow at selective intra-arterial chemotherapy (SIAC) in
children with an intraocular retinoblastoma
I. Pogrebnyakov, I. Trofimov, A.V. Kukushkin, E. Virshke, B. Dolgushin;
Moscow/RU
B-0845 16:52
The role of selective intraaterial and intravitreal chemotherapy
in organ-preserving treatment of the children with an intraocular
retinoblastoma
I. Pogrebnyakov, B. Dolgushin, I. Trofimov, A.V. Kukushkin, E. Virshke;
Moscow/RU
B-0846 16:56
Intermediate-stage HCC, SIRT and balloon-occlusive micro-catheter:
the right way?
A. Paladini1, G.E. Vallati2, G. Pizzi2, F. Cappelli2, D. Beomonte Zobel2,
E.M. Amodeo2, A. Borzelli3; 1Novara/IT, 2Rome/IT, 3Naples/IT
B-0847 17:00
Robot-assisted percutaneous placement of K-Wires during minimal-
invasive interventions of the spine
M.H. Albrecht1, Y. Croissant1, C. Czerny1, T.J. Vogl1, S. Zangos2;
1
Frankfurt a. Main/DE, 2Göppingen/DE
B-0848 17:04
Predictive 99mTc MAA-SPECT/CT dosimetry in patients with locally
advanced inoperable hepatocellular carcinoma treated by selective
internal radiotherapy with 90Y resin microspheres
A.-L. Hermann1, A. Dieudonné2, M. Ronot2, M. Sanchez2, H. Pereira1,
G. Chatellier1, E. Garin3, R. Lebtahi2, V. Vilgrain2; 1Paris/FR, 2Clichy/FR,
3
Rennes/FR
B-0849 17:08
Trans arterial embolization of non-variceal upper gastrointestinal
bleeding: is the use of ethylene-vinyl alcohol Copolymer as safe as
Coils?
M. Tipaldi1, M. Krokidis2, G. Orgera1, A. Rebonato3, C. Ambrogi1, M. Rossi1;
1
Rome/IT, 2Cambridge/UK, 3Perugia/IT

08:30 - 10:00 Sky High Stage B-0864 09:18

Coll-Ha versus bone marrow stimulation for chondral and
Musculoskeletal osteochondral lesion: a 2-year randomized controlled trial
C. Tamburrano1, M. Busacca2; 1bologna/IT, 2Bologna/IT
MY 9 B-0865 09:22
Application of simultaneous multi-slice TSE in high-resolution hand
Musculoskeletal and foot imaging
Moderators: G. Feifei1, Y. Ge1, Y. Wei2; 1Zhengzhou/CN, 2Chengdu/CN
M. Adriaensen; Heerlen/NL
C. Martinoli; Genoa/IT B-0866 09:26
Cinematic MRI of the wrist: initial study for instability of the wrist in
B-0852 08:30 correlation to fluoroscopy and x-ray findings
Perivertebral muscle as index of sarcopenia: comparison with previous B. Reichardt1, A. Örnek1, V. Nicolas2; 1Essen/DE, 2Bochum/DE
muscle imaging and functional indexes
H.S. Seo; Ansan/KR B-0867 09:30
Comparison of patient satisfaction for wrist examinations in
B-0853 08:34 cone beam-computed tomography and multidetector-computed
T2* value analysis of achilles tendons disease with ultra-short tomography
echotime (UTE) MRI J. Neubauer1, C. Reidelbach1, E. Kotter1, S.M. Goerke2; 1Freiburg/DE,
2
J.-G. Zhang, Z. Li, C. Xia; Chengdu/CN Offenburg/DE

Terahertz time-domain spectroscopy of collagen I and tendon Diagnostic performance of high-resolution ultrasound in the BY
INVEST IN
J. Yuan1, L. Yang2, M. Wang1, Z. Feng1, S. Zhang1; 1Shanghai/CN, evaluation of intrinsic and extrinsic ligaments of the wrist in THE YOUTH
2
Zhengzhou/CN patients with previous trauma or carpal instability
S. Gitto1, D. Albano2, C. Messina1, V. Chianca1, S. Rapisarda1, A. Corazza3,
B-0855 08:42 L.M. Sconfienza1; 1Milan/IT, 2Palermo/IT, 3Genoa/IT
Investigating the appropriateness of radiological investigation of
lumbar spine and determining relationship between appropriateness SUPPORTED
and imaging findings in a tertiary hospital Submarine sign of epidermoid cysts: a diagnostic model BY
INVEST IN
S. Suganchand Rikabchand; Jodhpur/IN based on ultrasound feature THE YOUTH
D.H. Lee, S. Kim, A.L. Choi, C. Yoon; Seoul/KR
Identification of Scheuermann’s disease with different radiological B-0870 09:42 SUPPORTED
scoring methods for osteoporotic vertebral fractures: the Rotterdam Machine learning classification of low-grade and high-grade BY
INVEST IN
study chondrosarcomas based on magnetic resonance imaging- THE YOUTH
L. Oei, F. Koromani, S. Breda, S. El Saddy, A. Makurthou, F. Rivadeneira, based texture analysis
E. Oei; Rotterdam/NL S. Gitto1, D. Albano2, V. Chianca1, R. Cuocolo3, L. Ugga4, C. Messina1,
L.M. Sconfienza1; 1Milan/IT, 2Palermo/IT, 3Naples/IT, 4Scafati/IT
Friday
B-0857 08:50
Feasibility study of reducing artifacts of spine metal implants for B-0871 09:46
patients at 3.0T magnetic resonance imaging Use of MRI for age verification of U-17 footballers: the Ghana study
G. Feifei1, Y. Ge1, Y. Wei2; 1Zhengzhou/CN, 2Chengdu/CN B.D. Sarkodie; Accra/GH
B-0858 08:54
Noise-optimised virtual monoenergetic imaging of dual-energy CT: 10:30 - 12:00 Room B
effect on metal artefact reduction in patients with lumbar internal
fixation Genitourinary
Y. Zeng1, K. Deng2, H. Yang2, Y. Tan2, J. Liu2, D. Geng1, J. Zhang1;
1
Shanghai/CN, 2Changsha/CN
SS 1007
B-0859 08:58 Prostate biopsy and intervention
Increased lateral meniscal slope is associated with greater risk of
lateral bone contusion in noncontact ACL injury Moderators:
J. Li, K. Li; Chongqing/CN J. Belfield; Liverpool/UK
L. Schimmöller; Düsseldorf/DE
B-0860 09:02
Knee MR using a body coil is equivalent to CT in measuring the TTTG K-20 10:30
distance: removing the systematic bias Keynote lecture
L.U. Aivazoglou, M.K. Toma, P.H.C. Arruda, O.A. Ezzeddine, A. Ormond, B. Gebauer; Berlin/DE
M. Nico, F. Silva; Sao Paulo/BR
B-0872 10:39
B-0861 09:06 Detection of prostate cancer: comparison between robotic-assisted
Quantitative magnetic resonance imaging in patellar tendon- „in-bore“ MRI-guided biopsies and cognitive transrectal ultrasound-
lateral femoral condyle friction syndrome: relationship with subtle guided biopsies
patellofemoral instability E. Demozzi1, F. Cavicchioli1, M. Hoogenboom2, M. Catania3, G. Foti1,
J. Li, H.-T. Yang; Chongqing/CN E. Munari1, S. Cavalleri1, G. Carbognin1; 1Negrar/IT, 2Arnhem/NL,
3
Verona/IT
B-0862 09:10
Clinical utility of fat suppressed 3-dimensional CAIPIRINHA SPACE MRI B-0873 10:47
of the knee in adults Is it today acceptable to perform only targeted fusion MR/US prostate
S. Lee, G.Y. Lee, S. Kim; Seoul/KR biopsy in naïve patients?
S.R.M. De Martino, B. Corcioni, C. Gaudiano, F. Ciccarese, V. Vagnoni,
B-0863 09:14 R. Schiavina, R. Golfieri; Bologna/IT
The most accurate measurement of TT-TG distance is through the 2/5
point of femoral trochlear notch B-0874 10:55
Y. Qi, Z. Wang; Tianjin/CN Accuracy of mpMRI/US fusion prostate biopsy in diagnosis of clinically
significant carcinomas with histopathological verification
M. Zagrodzka, M. Lichtarski, A. Lewicki, S. Niezgoda, E. Stachura,
J. Brzezinski; Warsaw/PL

B-0875 11:03 B-0886 11:02

Technique and first results: targeted MRI and [68Ga]-PSMA PET/MRI Comparison of radiation dose and image quality between an image
ultrasound fusion-guided transperineal prostate biopsies intensifier and flat panel detector system in ERCP
N. Guberina1, L. Püllen1, T. Stephan1, J. Grueneisen1, M. Forsting1, E. Saukko1, H. Niiniviita1, A. Henner2, M.T. Nieminen2; 1Turku/FI, 2Oulu/FI
L. Umutlu1, H. Reis1, B. Hadaschik2, A. Wetter1; 1Essen/DE, 2Heidelberg/DE
B-0887 11:10
B-0876 11:11 Patient radiation dose during coronary angiography and intervention:
A quantitative approach to pinpoint prostate targets in order to a multi-centre, retrospective study
reduce the number of TRUS-MRI fusion biopsy cores per patient S. Kaartinen, A. Henner, T. Mäkelä; Oulu/FI
without affecting the detection rate
M. Pecoraro, R. Campa, G. Barchetti, V. Salvo, C. Catalano, V. Panebianco; B-0888 11:18
Rome/IT Infection control: developing aseptic methods and creating a guideline
for interventional radiology unit
B-0877 11:19 S. Simelius-Nieminen, H. Malmivirta, V. Seiko-Vänttinen, E. Saukko;
Cognitive-MR-US fusion prostate biopsy: which one is worthier to Turku/FI
perform?
R. Turkay, E. Inci; Istanbul/TR B-0889 11:26
Inoperable patients with chronic thromboembolic pulmonary
B-0878 11:27 hypertension: initiation a balloon pulmonary angioplasty programme
Focal cryoablation for recurrent prostate cancer following radiation T. Loupa, L. Brites, C.M.D.S. Almeida; Lisbon/PT
therapy: assessment of iceball margin and signal intensity of tumour
by 3D registration of MRI B-0890 11:34
I.I. Oz1, J.G. Bomers1, C.G. Overduin1, S.F. Jenniskens1, J.P.M. Sedelaar1, Dose distribution for vascular procedures at a tertiary training hospital
T. Paetz2, C. Rieder2, C. Schumann2, J.J. Futterer1; 1Nijmegen/NL, in South Africa
2
Bremen/DE H. Muller1, W.I.D. Rae2, H. Friedrich-Nel1; 1Bloemfontein/ZA, 2Sydney/AU
B-0879 11:35 B-0891 11:42

Suspected lesions categorised as PIRADS 3 at multiparametric The establishment of a triage tool for patient stratifications
magnetic resonance (mp-MRI) for prostate cancer (PCa): should we undergoing myocardial perfusion scintigraphy stress tests in Malta
biopsy? K. Borg Grima1, P. Bezzina1, L.A. Rainford2; 1Malta/MT, 2Dublin/IE
V. Giasotto, L. Basso, A. Casaleggio, V. Prono, C. Terrone, C.E. Neumaier;
Genoa/IT B-0892 11:50
Dose reduction in hybrid imaging techniques in nuclear medicine
B-0880 11:43 A. Geão1, E. Pereira2; 1Lisbon/PT, 2Almada/PT
Feasibility of target dependent systematic core biopsy distribution
models for transperineal MR/US fusion biopsy
N.L. Hansen1, T. Lloyd2, A. Macchi3, A. Warren2, T. Barrett2, C. Kastner2; 10:30 - 12:00 Room O
1
Cologne/DE, 2Cambridge/UK, 3Milan/IT
Musculoskeletal
B-0881 11:51
Friday
MRI/US fusion transperineal prostate biopsy versus systematic biopsy
for clinically significant prostate cancer detection in patients with SS 1010
negative ultrasound findings
Y. Chen, Y. Zhu, W. Guan, Y. Qu; Shanghai/CN Hip imaging
Moderators:
F.B. Ergen; Ankara/TR
10:30 - 12:00 Room C V. Njagulj; Novi Sad/RS
Radiographers B-0893 10:30

Measurement of femoural antetorsion with CT and MR: why
trigonometry should be added
SS 1014 F. König1, E. Rutz2, J.A. Jacobson3, A.L. Falkowski2, O. Magerkurth1;
1
Baden/CH, 2Basle/CH, 3Ann Arbor, MI/US
Melange: nuclear medicine and
interventional topics B-0894 10:38
Failure patterns in femoral head osteonecrosis: a micro-CT study with
Moderators:
histological correlation
F. Orsi; Milan/IT
C. Mourad1, C. Galant2, F. Libert3, B. Vande Berg2; 1Beyrouth/LB,
J. Thompson; Salford/UK 2
Brussels/BE, 3Tournai/BE
B-0882 10:30 B-0895 10:46
Predictive value of 18F-FDG PET/CT information in the modern
Image quality of hip MR arthrography with intra-articular injection of
3D-based radiotherapy treatment of head and neck cancer patients
hyaluronic acid
A. Kedves1, Z. Dr. Tóth1, M. Emri2, D. Sipos1, V. Koczka1, I. Repa1, Á. Kovács1;
1 E.A. Nocerino1, L. Nicosia2, M. Alì3, C.B. Monti3, F. Sardanelli3, A. Aliprandi3;
Kaposvár/HU, 2Debrecen/HU 1
Cassina de‘ Pecchi/IT, 2Gallarate/IT, 3Milan/IT
B-0883 10:38 B-0896 10:54
Comparative evaluation of in-house-prepared 99mTc-ethylene-
Traction MR arthrography of the hip for characterisation of femoral
dicysteine-deoxyglucose and 18F-fluorodeoxyglucose in breast cancer
head necrosis and resulting femoral cartilage damage in patients
J. Horn-Lodewyk1, J. Zeevaart2, J. Wagener2, G. Engelbrecht1;
1 eligible for joint-preserving surgery
Bloemfontein/ZA, 2Pretoria/ZA
F. Schmaranzer1, T. Lerch1, J.L. Cullmann1, E. Schmaranzer2,
J.T. Heverhagen1, K. Siebenrock1, M. Tannast1; 1Berne/CH, 2St. Johann/AT
B-0884 10:46
SPECT/CT artefacts: nuclear medicine point of view
A. Geão1, E. Pereira2; 1Lisbon/PT, 2Almada/PT
B-0897 11:02
Postoperative, traction MR arthrography in patients with persisting
pain after arthroscopic FAI correction reveals high prevalence of
B-0885 10:54 osseous deformities and intra-articular lesions
Impact of cardiac CT on the use of invasive diagnostic catheterisation
F. Schmaranzer1, T. Lerch1, K. Siebenrock1, M. Tannast1, E. Schmaranzer2;
in paediatric patients 1
Berne/CH, 2St. Johann/AT
C. Griffiths, A.R. Rafferty, R. Allen, P. Noonan; Glasgow/UK

B-0898 11:10 SPEAKER B-0909 11:10

SUPPORTED
The extension thickness damage (ETD) score: a pre-operative BY Deep DSA (DDSA): learning mask-free digital subtraction angiography
INVEST IN
hip MR arthrography-based classification to predict type of THE YOUTH for static and dynamic acquisition protocols using a deep
labrum surgery convolutional neural network
1 2 2 3 2
D. Albano , A. Aliprandi , M. Brioschi , S. Magnani , C. Messina , E. Eulig1, J. Maier1, M. Knaup1, T. Koenig2, K. Hörndler2, M. Kachelrieß1;
S. Sdao2, 1
Heidelberg/DE, 2Nuremberg/DE
F. Randelli2, L.M. Sconfienza2; 1Palermo/IT, 2Milan/IT, 3Lodi/IT
B-0910 11:18
B-0899 11:18 Are radiologists bad teachers for AI algorithms: differences in the
Cam vs pincer femoroacetabular impingement: which type is interobserver variability between consensus-defined labelling and free
associated with more hip structural damage? An exploratory cross- labelling of NIH chest x-ray14 dataset
sectional study using MRI H. Mahajan, P.K. Ganesan, A. Vaidya, G. Nanda, M. Murugavel,
Y. Ragab1, Y. Emad1, A. Anbar1, M. Khalil2, J. Rasker3; 1Cairo/EG, V. Venugopal, M. Barnwal, V. Mahajan; New Delhi/IN
2
Stokholm/SE, 3Amsterdam/NL
B-0911 11:26
B-0900 11:26 Supervised one-to-one style transfer to improve the quality of CT
MRI hip findings in asymptomatic professional Rugby players, ballet images
dancers and age-matched controls L. Li1, B. Ren2, S. Wang1, C. Xia1; 1Beijing/CN, 2Amherst, MA/US
T.N. Blankenstein, A. Grainger, B. Dube, R. Evans, P. Robinson; Leeds/UK
B-0912 11:34
B-0901 11:34 Opening the „Black Box“: radiological insights into a deep neural
3D T1 mapping of hip cartilage: a comparison of a new inversion- network for lung nodule characterisation
recovery-based method with conventional dual-flip angle acquisition V. Venugopal1, K. Vaidhya1, V. Mahajan1, H. Mahajan1, S. Vaidya2,
F. Schmaranzer, T. Lerch, J.L. Cullmann Bastian, K. Siebenrock, A.R. Devalla3; 1New Delhi/IN, 2Mumbai/IN, 3Bengaluru/IN
M. Tannast, J.T. Heverhagen, M. Ith, B. Jung; Berne/CH
B-0913 11:42
B-0902 11:42 Generating dual-energy images from monoenergetic 80 kV images
Hip arthroplasty and computed tomography of abdomen: a using a conditional generative adversarial network
retroperitoneal indicator of post-arthroplasty hip flexor impingement A. Demircioglu, J. Haubold, M. Forsting, K. Nassenstein, L. Umutlu,
M. Alfaqih1, S. Ali1, J. Sana Ali1, P. Chea1, S. Flacke1, R. French2, D. Elentuck1; F. Nensa; Essen/DE
1
Burlington, MA/US, 2Durham, NC/US
B-0914 11:50
B-0903 11:50 Machine learning-based prediction of haematocrit values from native
The value of the single energy metal artefact reduction algorithm in MRI myocardial T1-maps to avoid blood sampling for extracellular
post-surgery follow-up of patients with hip tumour prostheses volume fraction analysis
L. Ding, L. Ma, F.-L. Zhang; Guangzhou/CN A. Varga-Szemes1, M. Bauer2, M. van Assen3, C.N. De Cecco1, P. Suranyi1,
L. Griffith1, U.J. Schoepf1; 1Charleston, SC/US, 2Munich/DE,
3
Groningen/NL
10:30 - 12:00 Studio 2019
Imaging Informatics 10:30 - 12:00 Room E1
Breast
SS 1005a
Hot topics in machine learning: from SS 1002
radiomics to natural language analysis Breast density and risk stratification
S.S. Martin; Frankfurt/DE G. Esen; Istanbul/TR
E. Neri; Pisa/IT H. Sartor; Lund/SE

SUPPORTED K-21 10:30
Generation of a curated dataset from unstructured reports BY
INVEST IN Keynote lecture
using natural language processing, illustrated on CT reports THE YOUTH A. Vourtsis; Athens/GR
regarding pulmonary embolism
T.J. Weikert, I. Nesic, J. Cyriac, M. Moor, J. Bremerich, A.W. Sauter,
B-0915 10:39
G. Sommer, B. Stieltjes; Basle/CH
Impact of the use of a breast cancer risk assessment tool on the
intensive screening of women clinically referred to as intermediate to
B-0905 10:38 high risk
Scanner parameter induced variability of radiomics features in routine S. Woussen1, H. Westerlinck2, M. Keupers3, R.M. Prevos4, T. Thywissen5,
chest CT data C. Van Ongeval3; 1Harelbeke/BE, 2Heverlee/BE, 3Leuven/BE,
S. Röhrich, J. Hofmanninger, J. Pan, F. Prayer, H. Prosch, G. Langs; 4
Meerssen/NL, 5Diepenbeek/BE
Vienna/AT
B-0916 10:47
B-0906 10:46 Defining a parsimonious breast cancer risk model to risk-stratify
ePAD: A platform to enable machine learning and AI application average-risk women for follow-up screening
development in medical imaging M. Abdolell1, J.I. Payne1, P. Brown1, P. Barnes1, J. Caines1, K. Tsuruda2,
D.L. Rubin, M.U. Akdogan, C. Altindag, E. Alkim; Stanford, CA/US P. Talbot1, O. Tong1, S.E. Iles1; 1Halifax, NS/CA, 2Oslo/NO
B-0907 10:54 B-0917 10:55

On the generalisability of deep learning across populations and Reproducibility and measurement error in automated breast density
abnormalities: a case study of the Stanford MURA and CheXNet assessment
algorithms J.-L. Tham1, E.F. Harkness1, K. Stocking1, A.R. Brentnall2, J. Cuzick2,
H. Wang1, T. Zou1, C. Xia1, P. Borrego2, P. Sousa2, M. Zhang3; 1Beijing/CN, D.G. Evans1, S.M. Astley1; 1Manchester/UK, 2London/UK
2
Barcelona/ES, 3Zhejiang/CN
B-0918 11:03
B-0908 11:02 Factors influencing the disagreement between the automated
Fully automatic construction of optimal radiomics workflows volumetric breast density and radiologist’s visual assessment in
M.P.A. Starmans, S.R. van der Voort, M. Vos, F. Incekara, J.J. Visser, assessment of breast density
M. Smits, M.G. Thomeer, W.J. Niessen, S. Klein; Rotterdam/NL H. Lee, J. Moon, J. Hwang, J.-Y. Woo; Seoul/KR

B-0919 11:11 B-0929 11:11

The role of breast density in predicting interval detected breast cancer Gadoterate meglumine, a macrocyclic agent causes gadolinium
M. Abdolell1, J.I. Payne1, P. Brown1, P. Barnes1, J. Caines1, K. Tsuruda2, retention in the brain of children: a case-control study
P. Talbot1, O. Tong1, S.E. Iles1; 1Halifax, NS/CA, 2Oslo/NO E.D. Topcuoglu, O.M. Topcuoglu, A. Semiz Oysu, Y. Bukte; Istanbul/TR
B-0920 11:19 B-0930 11:19 SPEAKER

SUPPORTED
Mammographic parenchymal pattern: correlation with age, breast Cavernous sinus enlargement: a novel finding in Sturge- BY
INVEST IN
density and prediction of cancer detection and nodal status in a UK Weber syndrome THE YOUTH
1 2 1 1
screening population L. Pasquini , D. Tortora , M. Rossi Espagnet , L. Figà-Talamanca ,
L.S. Wilkinson1, L.M. Warren2, E. Burnside3, K. Young2, C. Patel4, F. Manunza2, C. Occella2, A. Rossi2, M. Severino2; 1Rome/IT, 2Genoa/IT
N.J. Massat5, J. Myles5, S. Duffy5; 1Oxford/UK, 2Guilford/UK,
3
Madison, WI/US, 4Kingston/UK, 5London/UK B-0931 11:27
Pediatric brain: T1-weighted signal intensity of deep brain nuclei
B-0921 11:27 increases with age but not with a serial administration of gadoterate
Association between BMI and subsequent breast cancer among meglumine
women with a prior false-positive without biopsy in BreastScreen P. Pozeg, R. Meuli, J. Forget, P. Maeder; Lausanne/CH
Norway
M. Lilleborge, S. Hofvind; Oslo/NO
10:30 - 12:00 Room F1
SUPPORTED
The value of automated breast ultrasound added to full-field BY GI Tract
INVEST IN
digital mammography in women with dense breasts THE YOUTH
I. Boca, A. Ciurea, C. Ciortea, A.-S. Berghe; Cluj-Napoca/RO
SS 1001a
B-0923 11:43
Automated breast ultrasound versus breast tomosynthesis in further
Colonic imaging revisited
evaluation of recalled dense breasts after screening mammograms Moderators:
N.H. Said, L. Adel, N.A. Chalabi, R. El Sheikh, H. Aboelmagd; Cairo/EG L. Curvo-Semedo; Coimbra/PT
M. Langenbach; Frankfurt/DE .
B-0924 11:51
Mammographic screening in male patients at high risk for breast B-0935 10:30
cancer: is it worth it? Polyp detection rate as a quality measure in CT colonography: analysis
M.A. Marino1, A. Gucalp2, B. Bernard-Davila2, D.M. Keating2, D. Martinez2, of the performance of a CT colonography service using a reduced
E. Morris2, M.S. Jochelson2; 1Messina/IT, 2New York, NY/US bowel preparation without dietary restriction
S. Vicini1, M. Rengo2, F. Tiberia1, D. Bellini1, G. Trionfera3, I. Carbone2,
A. Laghi1, L. Steri1; 1Latina/IT, 2Rome/IT, 3Valmontone/IT
10:30 - 12:00 Room E2 SPEAKER
Neuro Quality of same-day CT colonography following failed optical BY
INVEST IN
colonoscopy THE YOUTH
Friday
A. Foran, A. O‘Shea, M. Morrin; Dublin/IE
SS 1011a
B-0937 10:46
Paediatric brain Role of CT colonography in differentiating sigmoid cancer versus
Moderators: chronic diverticular disease
N.N. R. Valletta1, N. Faccioli1, M. Tagliamonte1, M. Bonatti2, G. Mansueto1;
1
M.C. Diogo; Lisbon/PT Verona/IT, 2Bolzano/IT
K-22 10:30 B-0938 10:54

Keynote lecture The diagnosis of internal haemorrhoids from CT colonography has a
P.D. Griffiths; Sheffield/UK poor agreement with optical colonoscopy
L. Lambert, P. Hrabak, A. Novotny, J. Jahoda, A. Burgetova; Prague/CZ
B-0925 10:39
Prediction of neurodevelopmental outcome in preterm neonates B-0940 11:10 SPEAKER
SUPPORTED
with cerebral MR spectroscopy and DWI using neural-network-based Effectiveness of bowel preparation without diet restriction BY
INVEST IN
classifiers for optimal quality CT colonography: a validation study THE YOUTH
T. Djurdjevic, S. Pereverzyev, L. Lamplmayr, V. Neubauer, F. Tiberia1, M. Rengo2, L. Steri1, D. Bellini1, G. Trionfera3,
U. Kiechl-Kohlendorfer, V. Wallner, A.E. Grams, E.R. Gizewski; I. Carbone1, A. Laghi1; 1Latina/IT, 2Rome/IT, 3Valmontone/IT
Innsbruck/AT
B-0942 11:26
B-0926 10:47 Diagnostic performance of MRI- vs MDCT-categorised T3cd/T4 for
Synthetic MRI detects delayed myelination in preterm neonates identifying high-risk stage II or stage III colon cancers: a pilot study
V. Schmidbauer, G. Geisl, K. Goeral, K. Klebermaß-Schrehof, A. Berger, S. Shin1, S. Cho1, W. Kim2, H. Kim1, G.-C. Kim1, H.-K. Ryeom1, S.M. Lee2,
D. Prayer, G. Kasprian; Vienna/AT K.M. Shin1; 1Daegu/KR, 2Seoul/KR
B-0927 10:55 B-0943 11:34

Comparison of intracranial volumes of preterm-born infants and age- Abdominal calcium score in the evaluation with computed tomography
matched foetuses of the risk of leakage of the colon anastomoses
V. Pfahler1, G.M. Gruber2, G. Kasprian2, A. Hilgendorff1, K. Förster1, E. Santonocito, C. Trombatore, M. Travali, S.M. Santonocito, A. Di Cataldo,
A. Flemmer1, B.B. Ertl-Wagner3, D. Prayer2, S. Stöcklein1; 1Munich/DE, P.V. Foti, A. Basile, S. Palmucci; Catania/IT
2
Vienna/AT, 3Toronto, ON/CA
B-0944 11:42
B-0928 11:03 Does spectral CT help to predict the severity of ischaemic colitis?
Dentate and basal ganglia T1 hyperintensity after multiple gadolinium E. Danse, N. Michoux, A. Kartheuser, O. Dewit, P. Baldin,
administrations and brain microstructure: an in vivo diffusion-weighted A. Jouret-Mourin, L. Jacquet, E. Coche; Brussels/BE
MR study in paediatric patients
P. Gulino1, E. Salvatore2, A. Bianchi1, M. Franzese2, L. Sali1, M. Aiello2,
C. Cavaliere2, M. Salvatore2, M. Mascalchi1; 1Florence/IT, 2Naples/IT

B-0945 11:50 B-0955 11:42

Whole-body MRI: prevalence and extent of asymptomatic diverticular Imaging of penetrating extremity injuries in a Scandinavian level-1
disease and the association of dietary habits, cardiometabolic and trauma centre: a 4-year analysis of the trauma registry data from the
constitutional risk factors Karolinska trauma centre, Stockholm
C. Storz1, T. Rothenbacher1, S. Rospleszcz2, J. Linseisen1, H. Messmann1, P.M. Cewe Jönsson1, S. Thorisdottir2, G.L. Óladóttir1, S. Koskinen3;
C.N. De Cecco3, A. Peters4, C.L. Schlett5, F. Bamberg1; 1Tübingen/DE, 1
Solna/SE, 2Stockholm/SE, 3Huddinge/SE
2
Munich/DE, 3Charleston, SC/US, 4Neuherberg/DE, 5Heidelberg/DE
10:30 - 12:00 Room Y

10:30 - 12:00 Room F2
Emergency Imaging
SS 1009
SS 1017 Vascular interventions in the aorta and
Best of emergency radiology (part 2): peripheral arteries
from neurological emergencies to Moderators:
penetrating injuries R.F. Dondelinger; Liège/BE
F.F. Strobl; Munich/DE
Moderators:
B. Erkan; Istanbul/TR
B-0957 10:30
Preoperative tibial artery run off score differences before endovascular
or bypass surgery in patients with long popliteal artery lesions
B-0946 10:30 A. Kratovska, S. Ponomarjova, P. Ivanova; Riga/LV
Is there a clinical need for structured reporting or even more? Results
from a clinical questionnaire in the context of head trauma CT
B-0958 10:38
N. Schmidt, D. Zumofen, A. Jadczak, B. Stieltjes, K. Blackham; Basle/CH
Long-term results of the aortoiliac kissing stents and risk factors of
in-stent restenosis
B-0947 10:38 M. Vértes, I.Z. Juhász, D.T. Nguyen, C. Csobay-Novák, B. Nemes, K. Hüttl,
Computed tomographic pattern of intracranial injuries among patients E. Dósa; Budapest/HU
with okada (motor cycle) road traffic accidents in Southwestern
Nigeria
B-0959 10:46
O.M. Atalabi, O. Akinwumi; Ibadan/NG
Comparative assessment of occupational radiation exposure
SPEAKER between transbasilic and transfemoral approach during percutaneous
B-0948 10:46 SUPPORTED retrograde scleroembolisation of left varicocele
CTA evaluation of cervical ICA occlusion vs pseudo-occlusion BY
INVEST IN A. Conti, M.C. Calcagno, D. Meo, A. Modica, D. Rizzo, L. Mammino,
in major stroke THE YOUTH P.V. Foti, S. Palmucci, A. Basile; Catania/IT
S. Molinaro, S. Veglia, O. Davini, C. Ruggieri; Turin/IT
B-0960 10:54
B-0949 10:54 Transcatheter arterial embolisation for traumatic thoracic bleeding:
Novel rapid imaging protocol of the bilateral MCA territories for 4-years‘ experiences in a single trauma centre
thrombectomy in acute ischaemic stroke by old-model 320-row area C.M. Lee, C.H. Jeon, J.B. Park, C.W. Kim, H. Kwon, H.M. Cho; Busan/KR
detector CT
T. Mori, Y. Tanno, N. Nakai, K. Yoshioka; Kamakura/JP
B-0961 11:02
SPEAKER Vacuum-assisted aspiration thrombectomy for treatment of acute
B-0950 11:02 SUPPORTED massive pulmonary embolism
The Ottawa subarachnoid haemorrhage rule in the decision BY
INVEST IN A. Massmann1, P.M. Lepper1, P. Fries1, H. Wilkens1, A. Buecker1, B. Huasen2;
for acute CT head: external validation in a contemporary THE YOUTH 1
Homburg/DE, 2Manchester/UK
European cohort
R.W. Foley1, S. Ramachandran2, A. Akintimehin3, S. Williams3, P.A. Kelly3;
1
B-0962 11:10
Bristol/UK, 2Leicester/UK, 3London/UK
Gemstone Spectral Imaging (GSI) in early CT-follow up after
endovascular aortic repair (EVAR)
B-0951 11:10 H. Muenzfeld, T. Schmidt, H. Posch, B. Gebauer, B. Hamm, G. Böning;
Value of spot sign (SS) on CT angiography (CTA) such indicator Berlin/DE
of early haematoma expansion in the spontaneous intracerebral
haemorrhage (ICH)- some therapeutic considerations
B-0963 11:18
E. Puglielli, M. Di Bartolomeo, M. Assetta, F. Navarra, M. Di Matteo,
Prospective single-centre registry of endovascular aortic repair
M. Galliano, G. Manente; Teramo/IT
(EVAR) using ultra-low profile altura endograft
A. Massmann1, F. Frenzel1, P. Fries1, R. Kubale2, R. Shayesteh-Kheslat1,
B-0952 11:18 A. Buecker1; 1Homburg/DE, 2Pirmasens/DE
Non head-injured paediatrics in the emergency department: clinical
predictors of abnormal head CT findings
B-0964 11:26
J. Wu, H. Huang, M. He, Q. Fan, M. Ma, L. Lin; Fuzhou/CN
Fusion imaging to guide thoracic endovascular aortic repair (TEVAR):
comparison of two methods: 2D/3D vs 3D/3D image fusion
B-0953 11:26 P.-A. Barral, A. Bartoli, P. Piquet, M. Demasi-Jacquier, M. Gaudry,
Contributions of the whole-body CT scan before multi-organ donation A. Jacquier; Marseille/FR
in brain dead patients
F. Leleu, C. De Margerie, C. de Bazelaire, F. Gaudez, C. Lefaucheur,
B-0965 11:34
E. De Kerviler; Paris/FR
Distal transradial approach at the anatomical snuffbox for
interventional procedures: a single-centre pilot study
B-0954 11:34 S.-E. Park1, S. Cho1, C. Hocheol2, S. Lee2; 1Changwon/KR, 2Jinju/KR
Evaluation of a novel 3D-surface reconstruction technique in post-
mortem CT after stab attacks: diagnostic accuracy and forensic impact
B-0966 11:42
compared to conventional CT and autopsy findings
Tunnelled central venous catheters (TCVC) in infants using adult
J. Böven, J. Boos, R.S. Lanzman, Y. Klosterkemper, P. Kröpil, C. Thomas,
peripheral inserted central catheters (PICC) devices: ten years
G. Antoch, J. Aissa; Düsseldorf/DE
experience
R. Nourzaie, H. Abbas H.M., L. Monzon, N. Karunanithy, S. Moser,
P. Gkoutzios, I. Ahmed, S. Boolkah, A. Diamantopoulos; London/UK

B-0967 11:50 10:30 - 12:00 Room D

Efficacy of drug-eluting stents ELUVIA in treatment of high grade of
femoropopliteal lesions Artificial Intelligence and Machine Learning
F. Rosella, T. Gorgatti, A. Vit, V. Gavrilovic, A. Pellegrin, M. Sponza;
Udine/IT
SS 1005b
10:30 - 12:00 Coffee & Talk 3 Machine learning in neuroradiology:
Head and Neck
diagnostic help and tissue analysis
Moderators:
N.N.
SS 1008 J. Hirvonen; Turku/FI
Head and neck cancer B-0978 10:30

Moderators: Automatic segmentation for acute ischaemic stroke from DWI using
A.D. King; Hong Kong/CN deep convolutional neural networks
A. van der Hoorn; Groningen/NL Q. Liu1, G. Lu1, X. Cheng1, Q. Zhang1, C. Zhou1, S. Wang2, K. Liang2, X. Li2;
1
Nanjing/CN, 2Beijing/CN
K-23 10:30
Keynote lecture B-0979 10:38
N.I. Traykova; Plovdiv/BG Can artificial intelligence improve physician sensitivity in detecting
early ischaemic damage on computed tomography?
B-0968 10:39 J. Chriashkova1, C. Goncalves2, M. Aslam2, S. Perera2, S. Walter3, J. Fisher2,
Histogram analysis of CE-MRI for differential diagnosis of pleomorphic A. Podlasek2, A.J. Schmitt4, I.Q. Grunwald1; 1Chelmsford/UK,
2
adenomas and malignant tumour of parotid gland Southend-on-Sea/UK, 3Homburg/DE, 4London/UK
K. Xu, Y. Zhang; Zhengzhou/CN
B-0981 10:46
B-0969 10:47 Automated detection and localisation of pneumocephalus in head CT
The value of high-resolution diffusion-weighted imaging in scan
differentiating lingual squamous cell carcinoma and lingual lymphoma S. Tanamala1, S. Chilamkurthy1, M. Biviji2, P. Rao1, R. Ghosh1; 1Mumbai/IN,
2
B. Wen1, J. Cheng1, J. Zhu2; 1Zhengzhou/CN, 2Beijing/CN Nagpur/IN
B-0970 10:55 B-0982 10:54

Staging tongue cancer with the 8th edition of TNM: can MR provide a Automatic detection of intracranial calcifications in CT using deep
surrogate of the pathologic DOI? learning
R. Campora, F.M. Piana Jacquot, I. Zorza, G.M. Agazzi, M. Ravanelli, G. Bortsova, F. Dubost, A. Van der Lugt, D. Bos, M. De Bruijne;
D. Farina; Brescia/IT Rotterdam/NL
B-0971 11:03 B-0983 11:02
Friday
Parotid tumours differential diagnosis: MRI dynamic contrast- Automated age-specific regional brain atrophy estimation:
enhanced (DCE) and diffusion-weighted imaging (DWI) compared to an integrated workflow
fine needle aspiration cytology (FNAC) J. Caspers, B. Turowski, C. Rubbert; Düsseldorf/DE
G. Guazzarotti, E. Venturini, R. Mellone, A. De Gaspari, D. Di Santo,
A. Del Maschio, F. De Cobelli; Milan/IT B-0984 11:10
Radiological reading: man vs machine
B-0972 11:11 W. Van Hecke1, A. Ribbens1, T. Billiet1, T. Wang2, L. Ly2, H.N. Beadnall2,
The value of RESOLVE on 3.0 T MRI for predicting the early efficacy M.H. Barnett2; 1Leuven/BE, 2Sydney/AU
of concurrent radiochemotherapy of advanced stage nasopharyngeal
carcinoma patients B-0986 11:18
C. Xu; Zhengzhou/CN Predicting response to somatostatin analogues in acromegaly:
machine learning-based high-dimensional quantitative MRI texture
B-0973 11:19 analysis
Impact of radiologic imaging revision in the multidisciplinary B. Kocak, E. Memis Durmaz, P. Kadioglu, O. Polat Korkmaz,
management of head and neck cancer patient N. Comunoglu, N. Tanriover, N. Kocer, C. Islak, O. Kizilkilic; Istanbul/TR
D. Rossi1, D. Alterio1, S. Volpe1, F.A.K. Pounou1, C. Giannitto1, M. Ansarin1,
M. Bellomi1, B.A. Jereczek-Fossa1, L. Preda2; 1Milan/IT, 2Pavia/IT B-0987 11:26
Combining multiple magnetic resonance imaging sequences provides
B-0974 11:27 independent reproducible radiomics features
Quantification of heterogeneity to classify benign parotid tumours L. Duron, A. Lecler, D. Balvay, J. Savatovsky, O. Bergès, A. Bouchouicha,
F. Patella1, M. Sansone2, G. Franceschelli1, R. Fusco2, M. Petrillo1, O. Galatoire, L. Fournier; Paris/FR
F. Pesapane1, S. Zannoni1, P. Brambillasca1, G. Carrafiello1; 1Milan/IT,
2
Naples/IT B-0988 11:34
Glioblastoma survival prediction using residual tumour volumes detected
B-0975 11:35 and segmented by a deep learning model in post-operative MRI
Lesion-parenchyma ratio of DCE-MRI pharmacokinetic parameters for M. Perkuhn, P. Stavrinou, R. Shahzad, F. Thiele, G. Shakirin, D. Garmpis,
characterisation of salivary gland tumours M. Schlamann, J. Borggrefe; Cologne/DE
F. Mungai1, G.B. Verrone1, M. Pietragalla2, L. Bonasera1, M. Bartolucci1,
V. Miele3; 1Florence/IT, 2Pistoia/IT, 3Rome/IT
B-0976 11:43
Theatre radiology: making the inoperable operable with real time,
intraoral ultrasound guided trans oral robotic surgery
A. Jaly, D. Ap Dafydd, V. Paleri, J. Hardman; London/UK

SUPPORTED
Usefulness of CT perfusion generated time-density curves BY
INVEST IN
and perfusion parameters in the diagnosis and differentiation THE YOUTH
of parotid neoplasms
M. Swarup, L. Upreti; Delhi/IN

10:30 - 12:00 Room G 10:30 - 12:00 Room K

SS 1013 SS 1004
Innovations in imaging: machine Advanced methods for nodule evaluation
learning, quality and new techniques Moderators:
I. Pulzato; Genoa/IT
Moderators: M. Regier; Hamburg/DE
C. Cavedon; Verona/IT
K-24 10:30
Keynote lecture
B-0990 10:38 C.J. Herold; Vienna/AT
Towards virtual MR imaging: predicting diffusion-weighted brain MR
images from T2-weighted images using convolutional neural networks
B-1000 10:39
V. Mahajan, A. Upadhyaya, A. Venkatraman, V. Venugopal; New Delhi/IN
Are the referrals being made for the investigation of pulmonary
nodules appropriate according to the BTS guidelines?
B-0991 10:46 W. Weston; London/UK
An inter and intra patient radiomic study to select the most promising
features aiming to precision medicine feasibility
B-1001 10:47
C. De Mattia, R. Ronza, M. Grassi, M. Pecorilla, P.E. Colombo, S. Siena,
Accuracy of model-based iterative reconstruction for CT volumetry of
A. Vanzulli, A. Torresin; Milan/IT
part-solid nodule and pure solid nodule at various dose settings: an
anthropomorphic chest phantom study
B-0992 10:54 S.-K. Kim, C. Kim, K.Y. Lee, J. Cha; Ansan/KR
A novel machine learning approach for assessing osteoporotic fracture
risk by texture analysis of femoural neck radiographs
B-1002 10:55
T. Yeshua, S. Rebibo, K. Sfez, O. Safran, M. Liebergall, I. Leichter;
Assessment of predictors for pulmonary subsolid nodule detection in
Jerusalem/IL
non-lung apex in ultralow dose CT reconstructed with ASiR-V
Y. Kai, Y. Hui Shu; Beijing/CN
B-0993 11:02
Implementation of channelised hotelling observer (CHO) to assess
B-1003 11:03
image quality of GE discovery IGS 740 angiography system
Comparison of the capability of nodule component measurement and
M. Bertolini1, V. Trojani2, A. Nitrosi1, M. Iori1, R. Sassatelli1, O. Ortenzia3,
management on follow-up CT examinations between 3D CADv systems
C. Ghetti3; 1Reggio Emilia/IT, 2Bologna/IT, 3Parma/IT
with and without CNN
SPEAKER Y. Ohno1, A. Yaguchi2, K. Aoyagi3, Y. Kishida1, S. Seki1, Y. Ueno1,
B-0994 11:10 SUPPORTED T. Yoshikawa1, T. Murakami1; 1Kobe/JP, 2Kawasaki/JP, 3Otawara/JP
Effective atomic number image produced with energy- BY
INVEST IN
resolved photon counting detector toward the development THE YOUTH
B-1004 11:11
of next-generation plain X-ray diagnosis
Comparing volume doubling time and SUVmax for benign and malignant
N. Kimoto1, H. Hayashi1, T. Asakawa1, T. Asahara2, A. Katsumata3,
lung nodules
Y. Kanazawa2, S. Yamamoto4, M. Okada4; 1Kanazawa/JP, 2Tokushima/JP,
3
D.D. Yang, B. Riley, A.N. Tavare, S. Hare, A. Parthipun; London/UK
Gifu/JP, 4Yokohama/JP
B-1005 11:19
B-0995 11:18 Quantitative analysis of diffusion weighted magnetic resonance
K-edge subtraction imaging at the Munich compact light source
imaging in lung nodules characterisation
S. Kulpe1, E. Braig1, M. Dierolf1, B. Günther1, K. Achterhold1, J. Herzen1,
A. Sudarkina, A. Dergilev, N. Gorbunov, V. Kozlov; Novosibirsk/RU
E.J. Rummeny2, F. Pfeiffer1, D. Pfeiffer2; 1Garching/DE, 2Munich/DE
B-1006 11:27
B-0996 11:26 A feasible method to set coherent image quality between different
Areal bone mineral density estimation using photon-counting energy-
CT scanners with a general phantom for low dose lung cancer CT
discriminating computed tomography topograms
screening
T. Nowak1, B. Schmidt1, A. Euler2, N. Saltybaeva2, T. Flohr1, H. Alkadhi2;
1
W. Qi, R. Shanshan, Z. Miao, S. Ye, C. Lei, H. Nan; Beijing/CN
Forchheim/DE, 2Zurich/CH
B-1007 11:35
B-0997 11:34 Understanding temporal enhancement of pulmonary nodule with
Spectral photon-counting for gout diagnosis in plain radiography:
dynamic contrast enhancement CT and utility of each acquisition
a feasibility study
C. Jokerst1, M. Gotway1, D. Panse2, K. Cummings1, E. Jensen1, P. Panse1;
F.A. Huber1, S. Gkoumas2, T. Thuering2, F. Becce3, R. Guggenberger1; 1
1
Phoenix, AZ/US, 2Albany, NY/US
Zurich/CH, 2Baden-Dättwil/CH, 3Lausanne/CH
B-1008 11:43
B-0998 11:42 Effect of iterative reconstruction and artificial neural network
Automatic analysis and result presentation workflow for diagnostic
denoising techniques on lung nodule volumetry in ultra-low dose
X-ray quality assurance
computed tomography: a phantom study
V.-M. Sundell, E. Hippeläinen, J.I. Peltonen; Helsinki/FI
D. Han, M.A. Heuvelmans, G. Pelgrim, G. Sidorenkov, P.M.A. van Ooijen,
M. Oudkerk, R. Vliegenthart; Groningen/NL
B-0999 11:50
Quality controls in ultrasound: a trial to evaluate the obsolescence of
B-1009 11:51
ultrasound probes with a low-cost agar gel phantom
Detectability of non-solid pulmonary nodules by deep learning: results
A. Collocola1, M. Ortino2, S. Durante1; 1Bologna/IT, 2Taranto/IT
from a phantom study
Q. Li1, L. Li2, K. Liu1, C. Xia2, Y. Xiao1, S. Liu1; 1Shanghai/CN, 2Beijing/CN

10:30 - 12:00 Room M 1 10:30 - 12:00 Room M 3

Cardiac Oncologic Imaging
SS 1003 SS 1016
Cardiac CT in search of coronary artery Lung cancer: screening and beyond
disease Moderators:
G. Cicchetti; Rome/IT
Moderators: X. Montet; Geneva/CH
M. Kantarci; Erzurum/TR
M. Krupiński; Krakow/PL
B-1020 10:30
Comparison of RECIST, iRECIST, and PERCIST for the evaluation of
K-25 10:30 response to PD1/PD-L1-blockade therapy in patients with non-small
Keynote lecture cell lung cancer
M. Williams; Edinburgh/UK L. Beer, M. Hochmair, A. Haug, D. Kifjak, B. Schwabel, M.E. Mayerhöfer,
B-1010 10:39
Acute chest pain evaluated with coronary CT: validation of new B-1021 10:38
atherosclerotic markers Imaging programmed cell death ligand-1 (PD-L1) expression in
M. Fusaro1, M. Rattazzi2, C. Nardin1, M. Tiepolo1, A. Dorigo1, G. Tessarin2, non-small cell lung cancer with 99mTc-anti PDL1 sdAb SPECT
G. Stamati3, C. Agostini1, G. Morana1; 1Treviso/IT, 2Padua/IT, G. Chand1, Y. Xing1, C. Liu1, N. Wong1, L. Meszaros1, J. O‘Doherty2, H. Ting1,
3
Corigliano Calabro/IT J. Zhao1, G. Cook3; 1Shanghai/CN, 2Doha/QA, 3London/UK
B-1011 10:47 B-1022 10:46 SPEAKER

SUPPORTED
HTA of patient management with and without triple rule out CT Non-small-cell lung cancer treated with pembrolizumab: BY
protocol INVEST IN
correlation between texture analysis and iRECIST THE YOUTH
G. Tessarin1, M. Fusaro2, C. Bortolanza2, G. Morana2, E. Quaia1; 1Padua/IT, M. Zerunian1, D. De Santis1, D. Caruso1, T. Biondi2, G. Funicelli1,
2
Treviso/IT E. Rosati1, A. Zucchelli1, C. De Dominicis1, A. Laghi1; 1Rome/IT,
2
Belvedere Marittimo/IT
B-1012 10:55
Second generation of dual source computed tomography for B-1023 10:54
evaluating coronary artery lesions in Vietnamese paediatric patients RECIST 1.1 evaluations in a phase II clinical trial: does reader expertise
with Kawasaki disease represent a risk factor for measure reliability?
H. Nguyen, T. Nguyen, P.M. Thong, H.S. Ha, N.K. Viet, L.T.T. Lien, H. Beaumont1, T.L. Evans2, C. Klifa1, S.R. Hong3, M. Chadjaa4, Z. Monostori5,
P.B. Ngoc, H.V. Hoa; Hanoi/VN A. Iannessi6; 1Valbonne/FR, 2Philadelphia, PA/US, 3Seoul/KR,
4
Vitry-sur-Seine/FR, 5Budapest/HU, 6Nice/FR
B-1013 11:03
Randomised trial comparing transdermal with lingual and sublingual B-1024 11:02 SPEAKER
SUPPORTED
Friday
nitroglycerin administration for coronary vasodilation in coronary Everolimus-related pneumonitis in advanced neuroendocrine BY
CT-angiography INVEST IN
tumours: correlation of radiologic findings and clinical THE YOUTH
J.-E. Scholtz1, V. Baliyan2, S. Hedgire2, N.D. Mercaldo2, R.A. Takx3, symptoms
U. Hoffmann MD MPH2, T.J. Vogl4, B. Ghoshhajra2; 1Frankfurt a. Main/DE, 1 2 3 1
U. Fehrenbach , V. Rodriguez Laval , M. Pavel , I. Steffen ,
2
Boston, MA/US, 3Utrecht/NL, 4Frankfurt/DE A. Enriquez Puga2, H. Jann1, T. Denecke1; 1Berlin/DE, 2Madrid/ES,
3
Erlangen/DE
B-1014 11:11
Comparison of coronary lumen diameter in CT angiography: spray B-1025 11:10
nitroglycerin vs sublingual nitroglycerin tablet administration Differentiation of benign lung nodules and metastases: a machine-
B. Choi1, K.Y. Lee1, C. Kim1, S. Lee1, B.-K. Je1, J. Cha1, H. Yong2, E.-Y. Kang2, learning approach using texture features from spectral detector
Y.-W. Oh2; 1Ansan/KR, 2Seoul/KR CT-derived iodine maps and conventional images
SPEAKER S. Lennartz1, A. Mager1, N. Grosse Hokamp1, S. Schäfer2, D. Maintz1,
B-1015 11:19 SUPPORTED T. Persigehl1; 1Cologne/DE, 2Heidelberg/DE
Systolic high-pitch coronary CT angiography for evaluation BY
INVEST IN
of the coronary arteries in heart transplant recipients THE YOUTH B-1026 11:18
M. Calvo Imirizaldu, A. Ezponda Casajús, A. García Baizán, Lung cancer screening with low dose computed tomography:
J.C. Pueyo Villoslada, G. Rabago, G. Bastarrika Alemañ; Pamplona/ES the republic of Kazakhstan experience
Z. Zholdybay, G. Akhmetova, G. Akhmetova, A. Panina, A. Ainakulova;
B-1016 11:27 Almaty/KZ
Automated coronary artery segmentation using a U-net deep learning
architecture on cardiac CT B-1027 11:26 SPEAKER
SUPPORTED
C. Wald, N. Aldoj, S. Feger, N.-A. Hartmann, S. Lukas, One-year results from the South Wales Rapid Diagnostic BY
S. Zargaran Tavakoli, M. Dewey; Berlin/DE INVEST IN
Clinic for patients with serious but non-specific symptoms of THE YOUTH
cancer
B-1017 11:35 I.A. Siddiqui1, K.G. Foley1, B. Palaniappan1, A. Gibson2, T. Pearce2,
The optimal monochromatic image level of coronary CT angiography G.J. Davies2; 1Cardiff/UK, 2Ynysmaerdy/UK
on a dual-layer detector spectral CT with half-dose contrast agent
X. Huang, Y. Hou, Y. Ma, S. Gao, Z. Jia, X. Lu; Shenyang/CN B-1028 11:34
Polmonary metastases from pancreatic cancer: morphologic and
B-1019 11:43 quantitative differences compared to lung metastases from colorectal
Predictive role of lipid panel and DLCN score in the assessment of cancer
coronary artery disease with coronary CT in patients with familial I. Vicentin, R. Ronza, M. Pecorilla, C. De Mattia, C. Sgrazzutti,
hypercholesterolemia P.E. Colombo, A. Torresin, S. Siena, A. Vanzulli; Milan/IT
A. Ascione, G. De Rubeis, N. Galea, M. Francone, C. Catalano; Rome/IT
B-1029 11:42
Difference between measurement of T size at computed tomography
and at resected specimen: is it relevant for NSCLC stage?
D. Colombi1, S. Chiesa1, F. Bodini1, N. Morelli1, M. Silva2, N. Sverzellati2,
C. Franco1, E. Michieletti1; 1Piacenza/IT, 2Parma/IT


SUPPORTED 10:30 - 12:00 Sky High Stage
Assessing the precision of an AI-powered algorithm for BY
INVEST IN
automatic detection and 3D segmentation of primary THE YOUTH Clinical Trials in Radiology
tumours in NSCLC
1 1 2 2 1
T.J. Weikert , M. Pradella , F. Durlak , J.I. Sperl , B. Stieltjes ,
J. Cyriac1,
J. Bremerich1, G. Sommer1, A.W. Sauter1; 1Basel/CH, 2Forchheim/DE
CT 10
Clinical Trials in Radiology 3
Moderators:
10:30 - 12:00 Room M 5 M. Dewey; Berlin/DE
U. Mahmood; Oak Brook, IL/US
Neuro
10:30
SS 1011b Lung cancer risk after baseline round of screening: only 20% of NLST
eligibles require annual round
Functional MRI M. Silva1, F. Sabia2, G. Milanese1, S. Sestini2, C. Jacobs3, B. van Ginneken3,
M. M. Prokop3, C. M. Schaefer-Prokop4, N. Sverzellati1, A. V. Marchianò5,
Moderators: U. Pastorino2; 1Parma/IT, 2Milan/IT, 3Nijmegen/NL, 4Amersfoort/NL,
E. Seliverstova; Moscow/RU 5
Milan, MI/IT
A. Yakimov; Moscow/RU
10:39
Functional MRI study of language organisation in left-handed and H.-U. Kauczor; Heidelberg/DE
right-handed trilingual subjects
S. Yazbek, C. Atat, J. Abdel Hay, R. Moussa; Beirut/LB 10:45
SPEAKER Clinical trials in Radiology and data sharing: results from a survey by
B-1032 10:38 SUPPORTED the European Society of Radiology research committee
Functional network analysis of human language: a novel BY
INVEST IN M. Bosserdt, B. Hamm, M. Dewey; Berlin/DE
approach using task-based fMRI THE YOUTH
L. Pasquini, Q. Li, G. Del Ferraro, K. Peck, A.I. Holodny, 10:54
H. Makse; New York, NY/US Discussant:
SPEAKER R. Maksimović; Belgrade/RS
Altered resting-state functional connectivity of the anterior BY
INVEST IN 11:00
cingulate cortex in anxious rats post-acoustic trauma THE YOUTH Carotid stenting with antithrombotic agents and intracranial
X.-M. Xu, G.-J. Teng; Nanjing/CN thrombectomy leads to the highest recanalisation rate in acute stroke
patients with tandem lesions
B-1034 10:54 P. Papanagiotou1, D. Haussen2, M. Boutchakova-Meyer1, F. Turjman3,
Reward-related system fMRI activation as a monitoring tool for alcohol J. Labreuche4, M. Piotin5, A. Kastrup1, B. Gory5; 1Bremen/DE, 2Atlanta, GA/
abuse rehabilitation US, 3Bron/FR, 4Lille/FR, 5Paris/FR
O. Omelchenko, M. Makarchuk, O. Podkovka, L. Myronyak, V. Rogozhyn;
Kiev/UA 11:09
Discussant:
B-1035 11:02 K. Compagne; Rotterdam/NL
Brain resting state connectivity in the development of secondary
hyperalgesia in healthy men 11:15
M.S. Hansen1, L. Becerra2, J.B. Dahl1, D. Borsook3, J. Mårtensson4, Additional MRI screening in women with extremely dense breasts:
A.F. Christensen1, J.D. Nybing1, I. Havsteen1, M. Boesen1, M.S. Asghar1; primary outcome of the first round of the randomised DENSE trial
1
Copenhagen/DK, 2Boston, MA/US, 3Charlestown, MA/US, 4Lund/SE M.F. Bakker1, S. Lange1, R.M. Pijnappel1, R.M. Mann2, C. Loo3, B. Bisschops4,
M.B.I. Lobbes5, M.D.-J.F. de Jong6, K.M. Duvivier3, J. Veltman7,
B-1036 11:10 W.B. Veldhuis1, C. van Gils1, On behalf of the Dense Trial Study Group;
Altered cortical morphology of visual cortex in children with 1
Utrecht/NL, 2Nijmegen/NL, 3Amsterdam/NL, 4Dordrecht/NL,
intermittent exotropia 5
Maastricht/NL, 6’s Hertogenbosch/NL, 7Almelo/NL
L. Lu, S. Tang, X. Wang, Q. Gong, X. Huang; Chengdu/CN
11:24
Preoperative brain mapping: task-based and resting-state fMRI matching P.A.T. Baltzer; Vienna/AT
A. Smirnov, M. Sharaev, T. Melnikova-Pitskhelauri, E. Pogosbekyan,
L. Fadeeva, D. Pitskhelauri, I. Pronin; Moscow/RU 11:30
SPEAKER Detection rate for advanced neoplasia of single round of CT
B-1038 11:26 SUPPORTED colonography vs three rounds of faecal immunochemical test in
The effect of visual stimulation on the aspartate BY
INVEST IN population screening for colorectal cancer: the SAVE randomised trial
concentration in activated cortex at 3T THE YOUTH L. Sali, L. Ventura, M. Mascalchi, P. Mantellini, M. Zappa, G. Grazzini;
A. Manzhurtsev, P. Menshchikov, M. Ublinskiy, I. Melnikov, Florence/IT
T. Akhadov, N. Semenova; Moscow/RU
11:39
Advanced MR imaging with cognitive and vestibular stimulation in T. Mang; Vienna/AT
vestibular migraine
H.S. Çubuk, K. Bicakci, S. Bicakci; Adana/TR 11:45
SPEAKER Cost-effectiveness analysis of computed tomography vs invasive
B-1040 11:42 SUPPORTED coronary angiography in a randomised controlled trial
Long-term reactions to pulsatile tinnitus are featured by BY
INVEST IN G. Abdala Gehling1, I. Perez1, A. Hollingsworth2, T. Reinhold1, M. Dewey1;
weakened short-range functional connectivity within a brain THE YOUTH 1
Berlin/DE, 2Oklahoma City, OK/US
network on the right-sided temporal lobe
H. Lv, Z. Wang, P. Zhao, Z. Wang; Beijing/CN 11:54
Discussant:
B-1041 11:50 N.N.
Functional network-based statistics reveal abnormal resting-state
functional connectivity in minimal hepatic encephalopathy
H.-J. Chen, T.-X. Zou; Fuzhou/CN

10:30 - 12:00 Tech Gate Auditorium 10:30 - 12:00 The Church

Abdominal Viscera Paediatric
SS 1001b SS 1012
Hepatobiliary contrast agents: focal and Paediatric musculoskeletal and
diffuse liver disease oncologic imaging
A. Torregrosa Andrés; Valencia/ES N. Mitreska; Skopje/MK
F. Vernuccio; Palermo/IT U. Schwarz-Nemec; Vienna/AT
B-1042 10:30 SPEAKER K-26 10:30

SUPPORTED
Gadoxetic acid (GA)-enhanced liver MRI and hepatic BY Keynote lecture
INVEST IN
haemangiomas (HH): diagnostic performance and impact of THE YOUTH J.M. Patsch; Vienna/AT
dynamic phase on lesion characterisation
F. Castagnoli1, M. Grazioli1, M. Puglia2, B. Frittoli1, M. Morone1, L. Romanini1, B-1053 10:39
F. Donato1, R. Ambrosini1, L. Grazioli1; 1Brescia/IT, 2Naples/IT Making measurements on coronal ultrasound images of infant hips
during Barlow manoeuvre: a new and rapid screening method for
B-1043 10:38 developmental dysplasia of the hip
Gadoxetic acid-enhanced magnetic resonance imaging for prediction Ü.Y. Ayaz, M.E. Döğen; Mersin/TR
of the postoperative prognosis of intrahepatic mass-forming
cholangiocarcinoma B-1054 10:47 SPEAKER
SUPPORTED
M.-J. Kim, S. Kim, C. An, K. Han, S. Lee; Seoul/KR Use of magnetic resonance imaging to predict progression of BY
INVEST IN
juvenile idiopathic arthritis in paediatric patients in clinical THE YOUTH
B-1044 10:46 remission
Peritumoural radiomics features from gadoxetic acid-enhanced MR F. Sertorio, M. De Cesari, M. Mazzoni, A. Pistorio, A. Urru,
imaging predicting early recurrence of hepatocellular carcinoma F. Magnaguagno, C. Malattia, G.M. Magnano; Genoa/IT
Z. Zhang, J. Chen, H. Jiang, L. Cao, Z. Ye, B. Song, T. Duan; Chengdu/CN
B-1055 10:55
B-1045 10:54 SPEAKER Secondary fractures in paediatric radial head and neck fractures:
SUPPORTED
Abbreviated gadoxetic acid-enhanced MRI (AGAM) including BY common association, commonly missed
INVEST IN
second shot arterial phase (SSAP) for hepatocellular THE YOUTH A.J. Degnan, V.M. Ho-Fung, J.C. Nguyen, J.T.R. Lawrence, S.L. Kaplan;
carcinoma surveillance Philadelphia, PA/US
J. Kim, C. Lee; Seoul/KR
B-1056 11:03
B-1046 11:02 The applicability of the Greulich and Pyle atlas to a modern Irish
Assessment of abbreviated MRI of liver for initial follow-up of patients population
Friday
with liver metastases from colorectal cancer L.L. Mc Carthy1, C. Brenner1, J. Sammon2, L.D. Spence2, J. O‘Connor1;
M.R. Torkzad1, A. Riddell2, D.-M. Koh1; 1Sutton/UK, 2Surrey/UK 1
Dublin/IE, 2Cork/IE
B-1047 11:10 B-1057 11:11

Preoperative detection of colorectal liver metastases: DWI alone or The value of MR spectroscopic bone marrow fat fractions in the
combined with MDCT is no substitute for Gd-EOB-DTPA-enhanced MRI assessment of treatment response in patients with Gaucher disease
A. Schulz, E.S. Joelsen-Hatlehol, K.W. Brudvik, B. Hanekamp, A.J. Degnan, V.M. Ho-Fung, D.-J. Wang, C. Barrera, R. Ahrens-Nicklas,
K.K. Aasand, E. Viktil, C.K. Johansen, J. Dormagen; Oslo/NO C. Ficicioglu; Philadelphia, PA/US
B-1049 11:18 SPEAKER B-1058 11:19

SUPPORTED
Findings of sinusoidal obstruction syndrome on gadoxetic- BY Non-breath hold dynamic contrast enhanced abdominal and thoracic
INVEST IN
acid-enhanced MRI in patients with chemotherapy for THE YOUTH MRI in paediatric oncologic patients using a GRASP-sequence at 3T
colorectal liver metastases are poorly reproducible between T. Woerner, P. Raczeck, A. Buecker, G. Schneider; Homburg/DE
radiologists
F. Staal1, J.B. Houwers2, B. Heeres1, M. de Boer1, D.M. Lambregts1, M. Maas1, B-1059 11:27
R.G.H. Beets-Tan1; 1Amsterdam/NL, 2Maastricht/NL Is TI-RADS useful as an adult ultrasonographic malignancy risk
stratification method in pediatric thyroid nodules?
B-1050 11:26 Y. Durum, V. Ozturk, N. Ersöz, A. Anık, C. Karaman; Aydin/TR
Enhancement features, blood-based bio-markers and
immunohistochemical expression of hepatocyte transporters in B-1060 11:35
patients with non-alcoholic fatty liver disease (NAFLD) Paediatric rhabdomyosarcomas: which type of radiological assessment
D.S. Feier1, N. Bastati-Huber2, A. Beer2, S. Pötter-Lang2, R.M. Fragner2, after induction chemotherapy better predicts the survival?
A. Ba-Ssalamah2; 1Cluj-Napoca/RO, 2Vienna/AT G. Orsatti1, A. Varotto1, M. Bonzini2, M. Minotti2, C. Morosi2, F. Crimì1,
C. Giraudo1, E. Quaia1, R. Stramare1; 1Padua/IT, 2Milan/IT
B-1051 11:34
Postoperative complications after living donor liver transplantation: B-1061 11:43
risk assessment on Gd-EOB-DTPA-enhanced 3-T MR imaging using Diffusion-weighted magnetic resonance imaging for the evaluation of
quantitative-qualitative parameters Wilms tumours: radiological-pathological correlation
A. Kahraman1, M. Kolu2, B. Kahraman1, Z. Ozdemir1, L. Karaca1, S. Yilmaz1; E. Nazarova, N. Merkulov, A. Mitrofanova, G. Tereshenko; Moscow/RU
1
Malatya/TR, 2Sanliurfa/TR
B-1062 11:51
B-1052 11:42 Role of intraarterial chemotherapy for retinoblastoma: our experience
What is the effect of steatosis, iron overload and renal function on the with review of literature
uptake and excretion of gadoxetic acid-enhanced MRI? L.S.P. Karanam, S. Baddam, V. P, S. Honavar; Hyderabad/IN
L. Beer, N. Bastati, S. Pötter-Lang, D. Stoyanova, E. Michael, Y. Bican,
H. Einspieler, A. Ba-Ssalamah; Vienna/AT

08:30 - 10:00 Room K 08:30 - 10:00 Sky High Stage

Radiographers Genitourinary
SS 1314 MY 13
Radiographic issues Genitourinary
N.N. P. Asbach; Berlin/DE
B.R. Mussmann; Odense/DK K. Markiet; Gdansk/PL
B-1063 08:30 B-1074 08:30

The impact of imaging receptor technology on workflow, patient dose Amide proton transfer MR imaging for cervical cancer: a preliminary
values and image quality of bedside chest radiography study
J. Santos1, S. Carmo2, A.R. Cardoso2, C.M.D.S. Almeida2; 1Coimbra/PT, Y. He, C. Lin, Y. Qi, X. Wang, H. Zhou, H. Xue, Z. Jin; Beijing/CN
2
Lisboa/PT
B-1075 08:34
B-1064 08:38 Correlation of three-dimensional computerized tomographic renal
The effects of weight-bearing and non-weight-bearing anteroposterior volumetry with DTPA split renal function in prospective donors for
DR of feet in hallux valgus deformity renal transplantation
H. Zhang, Z. Wang, J. Liu; Tianjin/CN G. Choudary, P.G. Kale, S. Peddi; Tirupati/IN
B-1065 08:46 B-1076 08:38

Dose optimisation of lumbar spine radiographs using a phantom: what Prostate magnetic resonance imaging with and without contrast
are the ideal exposure parameters? medium: is biparametric MRI sufficient for routine examinations?
Z. Lai, C. Sá dos Reis, Z. Sun; Perth/AU D. Junker1, F. Steinkohl2, B. Sztankay1, U. Nagele1; 1Hall in Tirol/AT,
2
SPEAKER Innsbruck/AT
An investigation into the effectiveness of breast and gonad BY
lead shielding in abdominal radiography THE YOUTH Benefit of diagnostic support of PI-RADS assessment by quantitative
Z. Kierans1, A. Arrigo2, J. Kotze3, L. Van Der Velde4, ADC measurements and radiomics in MR diagnosis of prostate cancer
H. Zwaagstra4, K. Gronning5, M. O‘Connor1, I. Verzuijlen4; 1Dublin/IE, P. Schelb, S. Kohl, J.-P. Radtke, M. Wiesenfarth, M. Hohenfellner,
2
Lausanne/CH, 3Bloemfontein/ZA, 4Groningen/NL, 5Oslo/NO H.-P. Schlemmer, K. Maier-Hein, D. Bonekamp; Heidelberg/DE

The impact of different exposure factors on image quality BY
INVEST IN Multiparametric MRI outperforms three popular clinical models
of lumbar spine in five different sizes phantoms: a factorial THE YOUTH in predicting pT3 prostate cancer in patients undergoing radical
design study prostatectomy
S.J.M. Alqahtani, J.R. Meakin, R.M. Palfrey, K.M. Knapp; Exeter/UK E. Zanelli1, L. Cereser1, G. GIannarini1, V. Ficarra2, C. Zuiani1, R. Girometti1;
1
Udine/IT, 2Messina/IT
B-1068 09:10
Lumbar spine imaging: can we reduce the effective and organ dose B-1079 08:50
with the use of PA projection? Do DCE-derived quantitative parameters predict clinically
E. Alukic, N. Mekis; Ljubljana/SI significant prostate cancers? A study on patients referred to radical
prostatectomy
B-1069 09:18 F. Greco, R. Girometti, L. Cereser, G. Como, C. Zuiani; Udine/IT
Direct projection augmented reality-guided x-ray examination system:
a preclinical study B-1080 08:54
N.-H. Koo; Seoul/KR Transperineal thermoablation in patients with benign prostatic
Saturday
hyperplasia: our experience

B-1070 09:26 R. Regine1, F. Palmieri2, F. Zanfardino1, G. Fatigati1, A. Martino1,
Pelvis imaging: achieveing dose reduction with different patient M. Cornacchia1, P. Cozzolino1; 1San Giorgio a Cremano/IT, 2Caserta/IT
position
A. Resnik1, J. Žibert2, N. Mekis2; 1Novo mesto/SI, 2Ljubljana/SI B-1081 08:58 SPEAKER
SUPPORTED
Kidney stone composition analysis using machine learning BY
and spectral detector CT: an ex-vivo study THE YOUTH
Geometric efficiency: measuring methods’ comparison N. Grosse Hokamp, J. Salem, S. Lennartz, R.P. Reimer,
C. Dionisi, M. Coppo, R. Villa, M. Brambilla; Novara/IT A. Heidenreich, D. Maintz, S. Haneder; Cologne/DE
B-1072 09:42 B-1082 09:02 SPEAKER

SUPPORTED
Optimisation of shunt radiography Comparison between biparametric MRI (bp-MRI) and BY
A. Bremnes, B. Ween; Oslo/NO INVEST IN
multiparametric MRI (mp-MRI) for the diagnosis of THE YOUTH
prostate cancer (PCa): preliminary results of a prospective
B-1073 09:50 randomised trial
Optimisation of collimation and its impact on patient dose in G. Giannetto1, L. Pusceddu1, V. Doronzio2, V. Vani1, V. Romano3,
radiography of lumbal spine in anteroposterior and lateral projection C. Maglia4, S. Mazzetti2, D. Regge5, F. Russo4; 1Turin/IT, 2Candiolo/IT,
A. Pažanin1, D. Škrk2, N. Mekis2; 1Dubrovnik/HR, 2Ljubljana/SI 3
Candiolo TO/IT, 4Torino/IT, 5Candiolo-Torino/IT
B-1083 09:06
Application of intravoxel incoherent motion imaging (IVIM) in patients
with hyperuricemia
Z. Cheng, X. Cai, Y. Feng; Guangzhou/CN
B-1085 09:10
Explorative investigation of whole-lesion histogram MRI metrics for
differentiating uterine degenerative leiomyomas and leiomyosarcomas
K. Ma; Zhengzhou/CN

B-1086 09:14 B-1098 11:02

Imaging surveillance in operable invasive transitional cell carcinoma of Assessment of pancreatic ductal adenocarcinoma lesion using virtual
the bladder monoenergetic images from dual-layer spectral detector CT
S.A. Ahmed, M.M. El Barody, N.A.A. El Malek, M.A. El Salam Ebrahem; Y. Yang, Q. Han, X. Chen, F. YAN; Shanghai/CN
Assiut/EG
B-1099 11:10
B-1087 09:18 To provide evidence for early diagnosis of pancreatic cancer: magnetic
Contrast-enhanced T1 mapping MR imaging for evaluation of resonance spectroscopy
myometrial invasion in endometrial cancer: initial experience X. Fang; Shanghai/CN
Y. He, C. Lin, Y. Qi, X. Wang, H. Zhou, H. Xue, Z. Jin; Beijing/CN
B-1100 11:18
B-1088 09:22 Evaluation of vascular and local lymph node invasion, resectability of
Evaluation of a semi-automated segmentation tool for volumetric pancreatic ductal adenocarcinoma with spectral detector CT
analysis of the renal cortex and medulla in non-contrast T1-weighted Y. Yang, Q. Han, X. Chen, H. Dong; Shanghai/CN
MR images
H. Seuss, R. Janka, P. Dankerl, A. Cavallaro, M. Uder, M. Hammon; B-1101 11:26
Erlangen/DE Perfusion parameters quantified with perfusion CT in pancreatic
adenocarcinoma before and after neoadjuvant chemoradiotherapy:
B-1089 09:26 comparison between responders and non-responders
Correlation of erectile dysfunction after radical prostatectomy with A. Hamdy, Y. Ichikawa, Y. Toyomasu, M. Nagata, N. Nagasawa, H. Sakuma;
findings of preoperative multiparametric prostate MRI Tsu/JP
M. Sauer, P. Tennstedt, C. Berliner, H. Huland, G. Adam, D. Beyersdorff;
Hamburg/DE B-1102 11:34
Perfusion vs metabolism: which functional parameter should we
B-1090 09:30 choose in patients with pancreatic adenocarcinoma to predict
Can MRI including DCE and DWI improve characterisation of response to chemoradiotherapy?
endometrial carcinosarcoma? A. Hamdy, Y. Ichikawa, Y. Toyomasu, M. Nagata, N. Nagasawa, H. Sakuma;
L. Rivière1, L. Rossi1, T. Lam Giang2, E. Laas1, G. Bataillon1, P. Cherel3, Tsu/JP
H. Brisse1, F. Reyal1, C. Malhaire1; 1Paris/FR, 2Genève/CH, 3Saint-Cloud/FR
SUPPORTED
B-1092 09:34 CT texture analysis for detection of tumour recurrence in BY
INVEST IN
Prostate cancer lesion characterisation: rapid acquisition using patients resected for pancreatic adenocarcinoma THE YOUTH
compressed sensing in combination with semi-automatic lesion A. Mazzaro, G. Zamboni, A. Fighera, A. Campagnola,
segmentation for dual-parameter decision support G. Mansueto; Verona/IT
D.J. Winkel, T. Heye, M.R. Benz, B. Stieltjes, D. Boll, V. Hofmann; Basle/CH
B-1104 11:50
B-1093 09:38 SPEAKER Locally advanced and metastatic pancreatic cancer: the role of CT
SUPPORTED
Pitfalls in reporting fast biparametric magnetic resonance BY quantitative imaging biomarkers for predicting outcomes of patients
INVEST IN
imaging of the prostate: what kind of cancers do we miss? THE YOUTH treated with chemotherapy
A preliminary retrospective analysis S.-H. Cheng, H.-D. Xue, Z.-Y. Jin; Beijing/CN
L. Pusceddu1, G. Giannetto1, V. Romano1, V. Vani2, F. Cortese1, G. Desi2,
S. Mazzetti1, D. Regge1, F. Russo2; 1Candiolo/IT, 2Turin/IT
10:30 - 12:00 Room C
10:30 - 12:00 Room B Radiographers
Abdominal Viscera
SS 1414
SS 1401a Ultrasound and computer applications in
Assessing pancreatic malignancy medical imaging
Saturday
N. Kartalis; Stockholm/SE N.N.
M. Klauß; Heidelberg/DE J. Reponen; Oulu/FI
B-1094 10:30 B-1105 10:30

Diagnostic accuracy of CT features and CT texture analysis in Effect of adding charcoal capsule to abdominal ultrasound preparation
differentiating focal autoimmune pancreatitis from adenocarcinoma: a on image quality
retrospective study M. Tomehy, M. Wazan, A. Abdul Jabar, E. Abbass, N. Mishah; Jeddah/SA
G. Cardano, A. Fighera, A. Campagnola, G. Zamboni, L. Frulloni, SPEAKER
G. Mansueto; Verona/IT B-1107 10:46 SUPPORTED
Sonographic estimation of amniotic fluid volume using the BY
INVEST IN
B-1095 10:38 amniotic fluid index and the single deepest pocket in a THE YOUTH
Contrast-enhanced ultrasound for differentiation of pancreatic resource-limited setting
carcinoma (PC) from mass-forming chronic pancreatitis (MFCP) F.A. Burabe1, G. Luntsi1, N.I. Chigozie2, F. Nkubli1, J.Z. Dlama1, P.A. Ogenyi1;
1
P. Gupta, S. Sinha, N. Dhaka, A. Rajwanshi, K. Vaiphei, R. Kochhar; Maiduguri/NG, 2Awka/NG
Chandigarh/IN
B-1108 10:54
B-1096 10:46 Relation between fascia and pain by ultrasound
Quantitative analysis of arterial-phase MR images in differentiating R.A. Santos, F. Couceiro; Coimbra/PT
focal-type autoimmune pancreatitis from pancreatic ductal SPEAKER
adenocarcinoma B-1109 11:02 SUPPORTED
Real-time sonography as a teaching aid of anatomy in BY
J. Kwon, J. Kim; Seoul/KR INVEST IN
undergraduate radiography institutions in Northern Nigeria THE YOUTH
1 2 3 4 1
B-1097 10:54 M.S. Umar , D. Joseph , A. Auwal , S. Charbel , P.A. Ogenyi ,
1 3 3 5 1 2
Comparison of reduced field-of-view and large field-of-view diffusion- G. Njokwu , M.A. Fati , A.S. Moi , S.L. Shem ; Bauchi/NG, Kano/NG,
3
weighted 3T MR imaging in the evaluation of solid pancreatic lesions Maiduguri/NG, 4Beirut/LB, 5Gombe/NG
P. Boraschi, F. Donati, G. Tarantini, R. Cervelli, F. Pacciardi, C. Lombardo,
U. Boggi, F. Falaschi, D. Caramella; Pisa/IT B-1110 11:10
Muscular changes with ageing: ultrasound evaluation
R.A.M. Santos1, H.I. Ferraz2; 1Coimbra/PT, 2Peso da Régua/PT

B-1111 11:18 B-1125 11:26

The role of obstetric ultrasound in low resources setting: pilot survey In vivo tracking of tumour-derived exosomes correlates with
done in Elgeyo-Marakwet and Kericho county from 2016 March to 2018 premetastatic cell infiltration to target-sites of metastasis
December M. Gerwing, V. Kocman, A. Helfen, M. Stölting, L. Greune, A. Schmidt,
K. Clive; Kericho/KE W. Heindel, M. Wildgruber, M. Eisenblaetter; Münster/DE
B-1113 11:34 B-1126 11:34

An ethnographic study to investigate general practitioner’s opinion of Orthotopic hepatocellular carcinoma: molecular imaging-monitored
ultrasound services in primary care intratumoural hyperthermia-enhanced direct oncolytic virotherapy
M. Boland, L.A. Rainford, C. Byrne, M.-L. Ryan; Dublin/IE J. Song1, F. Zhang1, J. Ji1, M. Chen1, Q. Weng1, X. Yang2, M. Xu1, C. Lu1,
Z. Zhao1; 1Lishui/CN, 2Seattle, WA/US
B-1114 11:42
The effect of deep learning reconstruction on calcium scoring
C. Steveson1, J.L. Schuzer2, T. Acharya3, K. Bronson3, S. Rollison3, 10:30 - 12:00 Room O
W. Bandettini3, S. Shanbhag3, M.Y. Chen3; 1Kanagawa/JP,
2
Vernon HIlls, IL/US, 3Bethesda, MD/US Musculoskeletal
B-1115 11:50
Radiographer as RIS/PACS administrator: promoting professional SS 1410
networking and continuing professional education by the society of
radiographers in Finland
Knee imaging
H. Syysmäki1, P. Wood2, R. Laaksonen-Heikkilä1; 1Turku/FI, 2Helsinki/FI Moderators:
R. Guggenberger; Zurich/CH
V. Vasilevska-Nikodinovska; Skopje/MK
10:30 - 12:00 Room N
B-1127 10:30
Hybrid Imaging Super-resolution reconstruction of knee MR images
E. De Smet, B. Jeurissen, J. Sijbers, F. Vanhevel, P.M. Parizel, P. Van Dyck;
Antwerp/BE
SS 1406
B-1128 10:38
Advanced methods in experimental Identification of bone marrow oedema and osteochondral injuries
radiology of the knee: diagnostic accuracy of dual-energy CT and virtual
non-calcium techniques
Moderators: G. Foti1, M. Catania2, A. Beltramello1, G. Carbognin1; 1Negrar/IT,
S. Gatidis; Tübingen/DE 2
Verona/IT
F.M.A. Kiessling; Aachen/DE Dixon imaging of bone stress injury of the knee: comparison to
conventional proton density-weighted MR imaging
B-1116 10:30 A. Chhabra1, P. Pezeshk1, R. Dessouky2, O. Morales1, J. Shah1;
Spectral photon-counting CT multi-phase liver imaging with dual 1
Dallas, TX/US, 2Zagazig/EG
contrast agent
S.A. Si-Mohamed1, V. Tatard-Leitman1, P. Coulon2, P. Douek1, P.B. Noel3, B-1130 10:54 SPEAKER
SUPPORTED
L. Boussel1; 1Bron/FR, 2Suresnes/FR, 3Munich/DE Evaluation of MRI findings for association between patella BY
INVEST IN
baja and quadriceps fat pad oedema THE YOUTH
B-1117 10:38 S. Sajid1, P. Nepal2, S.I. Alam1, M. Warfa1, S. Sajid1; 1Doha/QA,
Spectral CT of cancer cells with nanoparticles: in vitro and in vivo 2
Connecticut, CT/US
results
M. Moghiseh, D. Kumar, R. Aamir, C. Lowe, K. Chitcholtan, P. H Butler, B-1131 11:02
P. Sykes, A.P. Butler, N. Anderson; Christchurch/NZ Integrated analysis reveals disturbed metabolic pathway and identifies
potential biomarker panel for the prediction of cartilage degeneration
B-1118 10:46 Y. Hu, H. Tao, S. Chen; Shanghai/CN
Quantification of gadolinium with 3rd generation dual source dual
energy CT: role of spectral separation B-1132 11:10
A. Agostini, A. Borgheresi, A. Mari, A. Lorenzoni, L. Ottaviani, S. Maggi, Retrospective comparative study to assess the pitfalls of CartiGram
A. Giovagnoni; Ancona/IT and the complementary role of FSPD in the evaluation of cartilage
lesions of the knee joint
B-1119 10:54 R. Thaha, S. Jogi, S. Rajan, A. Singh, V. Mahajan, A. Mehndiratta,
Quantitative evaluation of nonalcoholic fatty liver disease using V.K. Venugopal, H. Mahajan; New Delhi/IN
normalised local variance US in a rat model
J. Bae, J. Lee, D. Lee, H. Kim, J. Han; Seoul/KR B-1133 11:18
Evaluating variability of T2 values of the cartilage, menisci and muscles
B-1120 11:02 around knee joint on CartiGram sequence at 1.5 T and 3.0 T MR
Dual-targeting and execrable ultrasmall SPIONs for T1-weighted- R. Thaha, S. Jogi, S. Rajan, V. Venugopal, R. Bhattacharjee,
positive MR imaging of intracranial glioblastoma by targeting A. Mehndiratta, A. Singh, M. Barnwal, V. Mahajan, G. Nanda;
lipoprotein receptor-related protein New Delhi/IN
C. Du, X. Liu, H. Li, L. Yu, D. Geng, Y. Chen, J. Zhang; Shanghai/CN
SUPPORTED
B-1121 11:10 Time-saving opportunities in radiology: accurate structural BY
EGFR-targeted liposomal nanohybrid cerasomes: theranostic function INVEST IN
imaging and T2 mapping of cartilage and meniscus in knee THE YOUTH
and immune checkpoint inhibition in a mouse model of colorectal osteoarthritis using a 5-minute DESS MRI scan
cancer S.M. Eijgenraam1, A.S. Chaudhari2, M. Reijman1, B.A. Hargreaves2,
Y. Li, Y. Du, X. Liang, H. Xue, Z. Jin; Beijing/CN G.E. Gold2, E.H.G. Oei1; 1Rotterdam/NL, 2Stanford, CA/US
B-1124 11:18 B-1135 11:34

Cell death PET imaging of rat liver cirrhosis with Do Ahlbäck scores identify subgroups with different magnitudes
68
Ga-NOTA-PEG3-Duramycin of cartilage thickness loss in patients with moderate to severe
S. Shu, X. Xianhong, T. Ganghua; Guangzhou/CN radiographic osteoarthritis? Data from the OAI
S. Hangaard1, M. Boesen2, H. Bliddal2, W. Wirth3; 1Frederiksberg/DK,
2
Copenhagen/DK, 3Salzburg/AT

B-1136 11:42 B-1147 11:42

Association between baseline meniscal extrusion on MRI and long- Efficacy of Raysum image in urolithiasis detection
term incident knee osteoarthritis in two different cohorts K.K. Lau, S. Deb, A. Kuganesan; Melbourne/AU
J. Van der Voet, D. Schiphof, D. Vroegindeweij, S. Bierma - Zeinstra,
J. Runhaar, E. Oei; Rotterdam/NL B-1148 11:50 SPEAKER
SUPPORTED
Diagnostic accuracy of dual-energy CT for renal mass BY
INVEST IN
B-1137 11:50 evaluation: systematic review and meta-analysis THE YOUTH
The prevalence of Baker’s cyst in relation to the arrangement pattern N. Panvini1, D. Bellini1, A. Laghi2, D. Marin3, B.N. Patel4,
between medial head of gastrocnemius tendon and semimembranous C.L. Wang5, I. Carbone1, A. Mileto5; 1Latina/IT, 2Rome/IT,
3
tendon Durham, NC/US, 4Stanford, CA/US, 5Seattle, WA/US
D.Y. Han, K.N. Ryu, J.S. Park, W. Jin, S.Y. Park, S.J. Yun; Seoul/KR
10:30 - 12:00 Room E1

10:30 - 12:00 Studio 2019
Breast
Genitourinary
SS 1402a
SS 1407 Interventional breast radiology and high-
Renal and adrenal tumours risk lesions
Moderators:
M.-F. Bellin; Le Kremlin-Bicêtre/FR Moderators:
S. Ramanathan; Doha/QA S. Barter; Bedford/UK
A. Jalaguier; Marseille/FR
SUPPORTED
Which is the accuracy for malignancy of contrast-enhanced BY B-1149 10:30
INVEST IN Trends in frequency and outcome of high-risk breast lesions at
ultrasound of Bosniak t2F cystic renal lesions incidentally THE YOUTH
found on CT and MRI? percutaneous biopsy in women recalled at biennial screening
A. Cretese, G. Como, R. Girometti, L. Cereser, G. Giannarini, C. Valotto, mammography
C. Zuiani; Udine/IT B. Korte1, J.D. Luiten2, L.E.M. Duijm3; 1Eindhoven/NL, 2Tilburg/NL,
3
Nijmegen/NL
SUPPORTED SPEAKER
Contrast-enhanced computed tomography (CECT) BY B-1150 10:38 SUPPORTED
INVEST IN External validation of the STAR (suspicion type age response BY
quantitative radiological parameters to predict outcome in THE YOUTH INVEST IN
patients with renal cell carcinoma (RCC) of biopsy) score for risk stratification of B3 breast lesions THE YOUTH
L. Basso1, G. Buonomenna2, A. Sorrentino3, G. Perugin1, F. Rosa1, detected at ultrasound-guided biopsy
1 2 3 3 3
A. Olivero1, N. Testino1, C. Terrone1, C. Neumaier4; 1Genoa/IT, 2Avellino/IT, C. Grippo , P. Jagmohan , A.M. Stoeger , P. Kapetas , T.H. Helbich ,
3
Siena/IT, 4Genova/IT P.A.T. Baltzer3, P. Clauser3; 1Rome/IT, 2Singapore/SG, 3Vienna/AT
B-1140 10:46 B-1151 10:46

Kidney volumes in living donors: does size really matter? Should atypical ductal hyperplasia be surgically excised after
F.R. Schwartz1, B. Shaw1, R. Lerebours1, F. Vernuccio2, F. Gonzalez1, percutaneous needle biopsy: systematic review and meta-analysis
L. Hurwitz-Koweek1, K. Ravindra1, D. Marin1; 1Durham, NC/US, 2Palermo/IT S. Schiaffino1, M. Calabrese1, E.F. Melani1, E. Massone1, A. Villa2, G. Di Leo3,
M. Zanardo3, F. Sardanelli3; 1Genoa/IT, 2Sarzana/IT, 3Milan/IT
B-1141 10:54
Native T1 mapping as an in vivo biomarker for the identification of B-1152 10:54
higher grade renal cell carcinoma Radiologic and clinicopathologic associations with upgrade to
L.C. Adams; Berlin/DE malignancy in high-risk breast lesions
C. You, Y.J. Gu, S. Chen, X.X. Shen, W.J. Peng; Shanghai/CN
B-1142 11:02
B-1153 11:02
Saturday
Reducing radiation dose while maintaining observer performance
using prior iterative reconstruction (PIR) in multiphase dual energy Positive predictive value for malignancy of uncertain malignant
renal CT potential (B3) breast lesions diagnosed on vacuum-assisted biopsy:
P. Navin1, A.F. Halaweish2, B. Schmidt2, B. Kim2, M. Wells2, A. Khandelwal2, is surgical excision still recommended?
T. Moen2, C. McCollough2, J. Fletcher2; 1Galway/IE, 2Rochester, MN/US F. Ballati, P. Lomoro, M. Lucioni, G. Di Giulio; Pavia/IT
B-1143 11:10 B-1154 11:10

Differentiation of adrenal adenomas from adrenal metastases using Second-line vacuum-assisted excision biopsy with 8G needle for the
single-phased dual energy CT: a comparison to MRI management of B3 microcalcifications: preliminary results
M.T.O. Winkelmann, M.N. Bongers; Tübingen/DE C.M. Weiss, E. Di Gaetano, S. Plataroti, E. Cattarin, D. Bragagnolo,
G. Morana; Treviso/IT
B-1144 11:18
Incidental adrenal masses (IAM) at basal CT or enhanced CT: B-1155 11:18
differentiating non-functioning adenomas from tumour lesion using Percutaneous ultrasound-guided excision with vacuum-assisted
histogram and texture analysis (TA) breast biopsy (VABB) system of breast lesions with imaging-histology
G. Stranieri, A. Priola, D. Basile, S. Priola, A. Veltri; Turin/IT discordance
C. Depretto, F. Balestra, F. Cartia, C. Ferranti, G. Scaperrotta; Milan/IT
B-1145 11:26
Reassessment the ability of renal CE-CT for avoiding pathological B-1156 11:26
upstaging of clinical T1 to pathological T3 renal cancer in the era of Minimally invasive excision of suspicious breast lesions
robotic partial nephrectomy N.M. Abdel Razek; Cairo/EG
S. Takahashi1, Y. Ueno2, K. Sofue2, N. Negi2, K. Kagawa2, T. Murakami2,
U. Tanaka2; 1Takatsuki/JP, 2Kobe/JP B-1157 11:34
Performance of breast lesion excision system (BLES) in a complete
B-1146 11:34 removal of small clusters of suspicious microcalcifications proved
Low energy imaging for depicting renal venous tumour thrombus on malignant
multi-phasic contrast-enhanced dual-energy CT with 3rd generation A. Christou1, V. Koutoulidis2, D. Koulocheri2, E. Panourgias2, C. Zografos2,
dual-source CT scanner G. Zografos2; 1Brighton/UK, 2Athens/GR
S. Takahashi1, T. Itoh2, Y. Ueno3, N. Negi3, K. Kagawa3, K. Sofue3,
U. Tanaka3, A. Kusaka3, T. Murakami3; 1Takatsuki/JP, 2Tokyo/JP, 3Kobe/JP

B-1158 11:42 B-1167 11:34

Utility of diagnostic breast excision biopsies during two decades of Consecutive acquisition of MRDSA and perfusion MRI in cases of
screening mammography brain metastasis through the addition of a supplementary dose of a
J.D. Luiten1, A.C. Voogd2, V.C.G. Tjan-Heijnen2, J. Wesseling3, E.J.T. Luiten4, Gd-based contrast agent at 3T
L.E.M. Duijm5; 1Tilburg/NL, 2Maastricht/NL, 3Amsterdam/NL, 4Breda/NL, K. Tsuchiya, W. Watanabe, A. Abe, K. Uchida, J. Handa, S. Goto;
5
Nijmegen/NL Kawagoe/JP
B-1159 11:50 B-1169 11:42

A retrospective analysis comparing radioactive seed and wire The forgotten juxta-sellar mass: ectopic pituitary adenomas
localisation in breast surgery A. Alagely, L. Okromelidze, G.K. Vilanilam, E.H. Middlebrooks, V. Gupta;
P.G. Kumar, J. Young, H. Chen, Y. Li, Q. Qi, X. Peng, T. Khoury; Jacksonville, FL/US
Buffalo, NY/US
10:30 - 12:00 Room F2

10:30 - 12:00 Room E2
Breast
Neuro
SS 1402b
SS 1411a Breast imaging biomarkers and
Brain tumours radiomics
Moderators:
X. Golay; London/UK Moderators:
E.J. Hendriks; Amsterdam/NL D. Djilas; Sremska Kamenica/RS
I.-A. Gheonea; Craiova/RO
K-27 10:30
Keynote lecture B-1170 10:30
N.N. Radiomics based on baseline DCE-MRI is predictive of tumour
pathological complete response to neoadjuvant systemic therapy in
breast cancer patients
B-1168 10:30
R. Granzier1, A. Ibrahim1, H. Woodruff1, T. van Nijnatten1, M. de Boer1,
Can MR and CT imaging features differentiate benign from malignant
F. Hulsmans2, P. Lambin1, M. Smidt1, M. Lobbes1; 1Maastricht/NL,
meningiomas? 2
Sittard-Geleen/NL
F. Salah, A. Tabbara, N. Al Arab, A. Sibahi, K. Asmar, H. Tamim, M. Makki,
R. Hourani; Beirut/LB
B-1171 10:38
Feasibility study of whole breast texture analysis for predicting tumour
B-1160 10:38
response to neoadjuvant chemotherapy
Paediatric cerebellar tumours: how useful is the apparent diffusion
J.-Y. Zhou, H. Dan, G. Cheng; Shenzhen/CN
coefficient?
A. Arous1, E. Jemel2, M. Krichene3, O. Zayani3, M. Mahmoud2, C. Drissi2,
S. Naji2, N. Hammami2, M. Ben Hammouda2; 1Paris/FR, 2Tunis/TN, B-1172 10:46
3
Sfax/TN Tumour texture parameters of IDC in neoadjuvant chemotherapy:
early identification of non-responders on breast MRI
M. Nadrljanski, Z. Milosevic; Belgrade/RS
B-1161 10:46
The value of whole tumour volume-based ADC histogram analysis of
differential diagnosis in paediatric posterior fossa tumours B-1173 10:54
S. Yuanyuan; Zhengzhou/CN Background parenchymal enhancement on breast MRI in patients
undergoing neoadjuvant chemotherapy: is it a biomarker of tumour
response?
B-1162 10:54
C. Costanza1, G. Mariscotti1, M. Durando1, A. Tagliafico2, L. Bergamasco1,
Histogram analysis of enhancement MRI may predict relapse
I. Castellano1, P. Fonio1; 1Turin/IT, 2Genoa/IT
of primary CNS lymphoma after surgery-combined first-line
chemotherapy
L. Hao; Zhengzhou/CN B-1174 11:02
A new objective mathematical tool for assessment of response and
predicting residual disease in breast cancer using CESM
B-1163 11:02
M. Gomaa, E. Kamal, R.M. Kamal, S. Mostafa, R. Mubarak, M. El-Adawy;
Analysis of clinical, imaging and pathological characteristics
Cairo/EG
in patients with pineal parenchymal tumour of intermediate
differentiation
T. Du, M. Zhu, X. Qi, K. Yao, L. Wang, X. Zhang, J. Hu, J. Gao; Beijing/CN B-1175 11:10
Radiomic signatures derived from diffusion-weighted imaging for the
assessment of breast cancer receptor status and molecular subtypes
B-1164 11:10
D. Leithner1, J.V. Horvat2, M. Marino1, B. Bernard-Davila1, M.S. Jochelson1,
Correlation between [11C]methionine PET uptake and apparent
D. Martinez1, E.A. Morris1, S. Thakur1, K. Pinker-Domenig3;
diffusion coefficient in patients with gliomas 1
New York, NY/US, 2Sao Paulo/BR, 3Vienna/AT
Z. Savintseva, T. Skvortcova, D.V. Zakhs; St. Petersburg/RU
B-1165 11:18 B-1176 11:18

Radiomic signatures with contrast-enhanced magnetic resonance
Association between tumour acidity and hypervascularity within
imaging for the assessment of breast cancer receptor status and
human gliomas using pH-weighted amine CEST-EPI and DSC-perfusion
molecular subtypes: initial results of a multicenter study
MRI at
D. Leithner1, J.V. Horvat2, M. Marino1, B. Bernard-Davila1, M.S. Jochelson1,
Y. Wang1, J. Yao2, C. Raymond2, B.M. Ellingson2; 1Beijing/CN,
2 D. Martinez1, E.A. Morris1, S. Thakur1, K. Pinker3, A. Meyer-Baese4;
Los Angeles, CA/US 1
New York, NY/US, 2Sao Paulo/BR, 3Vienna/AT, 4Tallahassee, FL/US
B-1166 11:26
Differentiation of histologically proven intracerebral tumour entities
B-1177 11:26
Radiogenomics of invasive breast cancer: association between
with quantitative iodine mapping in dual-layer computed tomography
ultrasound vascular imaging features and tumour genomic profiles for
J. Borggrefe, M. Gebest, M. Hauger, C. Kabbasch, M. Schlamann,
tumour angiogenesis
J. Dörner; Cologne/DE
E. Park1, B. Seo1, M.-R. Han2, J. Kim1, H. Lee1, K. Cho2, O. Woo2, S. Song2;
1
Ansan/KR, 2Seoul/KR

B-1178 11:34 B-1189 11:43

Radiomics analysis of breast cancer on digital breast tomosynthesis Automatic segmentation for coronary computed tomography
F. Valdora, C. De Luca, B. Bignotti, F. Rossi, J. Matos, M. Calabrese, angiography using convolutional neural networks
A. Tagliafico; Genoa/IT J. He1, Q. Zhou1, X. Li2, X. Xu1, X. Ding1, X. Zhou1, M. Zhang1;
1
Hangzhou/CN, 2Beijing/CN
B-1179 11:42
Radiomics and deep learning can aid classification of contrast- B-1190 11:51
enhanced spectral mammograms Deep learning based chest x-ray whole-image search and retrieval
Y. van Wijk, A. Jochems, S. Primakov, M.B. Lobbes, P. Lambin, N. Ramanauskas, J. Dementaviciene, D. Barušauskas, J. Bialopetravicius,
H. Woodruff; Maastricht/NL J. Armaitis, G. Rimeika; Vilnius/LT
B-1180 11:50
Texture analysis and machine learning for differentiation between 10:30 - 12:00 Room G
phyllodes tumours of the breast from fibroadenomas in non-contrast MRI
M. Tsuchiya, T. Masui, M. Katayama, K. Terauchi, M. Sasaki, K. Kawamura, Physics in Medical Imaging
T. Yamada, H. Sakahara; Hamamatsu/JP
SS 1413
10:30 - 12:00 Room D Radiation protection technology and
Artificial Intelligence and Machine Learning management
Moderators:
SS 1405 L. Bowden; Dublin/IE
A. Trianni; Udine/IT
Imaging informatics: management and
K-29 10:30
performance analysis Keynote lecture
Moderators: A. Trianni; Udine/IT
C.C. Bortolotto; Pavia/IT
S. Morozov; Moscow/RU B-1191 10:39
A proposed paradigm revision for recurrent radiation safety training
K-28 10:30 S. Balter1, P. Abrams1, S. Kalra2, E.M. Leidholdt3; 1New York, NY/US,
2
Keynote lecture Philadelphia, PA/US, 3Mare Island, CA/US
B-1192 10:47
B-1181 10:39 The reasons for practitioners’ passive approach to informing patients
Machine learning in radiology management: predicting ED workflow prior to their radiological examinations
overloads H. Oikarinen, L. Ukkola, A. Henner; Oulu/FI
O. Pianykh, D. Parke; Boston, MA/US
B-1193 10:55
B-1182 10:47 A retrospective review of justification of computed tomography
Performance of the competence centre for MRI and CT imaging examinations in Northern Ireland
in a network of diagnostic centres Y. Sullivan, L. Fraser, G. Woodhouse; Oxford/UK
A. Fedorov, N. Berezina, M. Cherkashin, A. Lavrenteva; St. Petersburg/RU
SUPPORTED
B-1183 10:55 A radiation dose index monitoring (RDIM) systems BY
INVEST IN
Fuzzy PACS: linking large unorganised image and report databases for comparison for CT procedures THE YOUTH
development and validation of deep learning algorithms A. Mazzilli1, A. Loria1, R. Castriconi1, T. Lusa Aguero2,
R. Mukherji, V. Mahajan; New Delhi/IN R. Calandrino1, A. del Vecchio1; 1Milan/IT, 2Valencia/ES
Saturday
B-1184 11:03 B-1195 11:11
Subspecialisation in radiology: effects on the diagnostic spectrum of Using an automatic patient dose registry to help in the optimisation of
radiologists and report turnaround time in a Swiss university hospital interventional radiology practice
M.H. Maurer1, M. de Bucourt2, A. Berghöfer2, A. Huppertz3, E. Vano, J.M. Fernandez, R.M. Sánchez-Casanueva, J. Ten; Madrid/ES
A.B. Rosenkrantz4, F. Streitparth5, J.T. Heverhagen1, T. Meyl1; 1Berne/CH,
2
Berlin/DE, 3Potsdam/DE, 4New York, NY/US, 5Munich/DE B-1196 11:19
Update of the diagnostic reference levels for CT in Switzerland using
B-1185 11:11 dose management software
Operational performance optimisation by means of an imaging C. Aberle1, N. Ryckx2, R. Treier3, S. Schindera4, R. Menz1; 1Basle/CH,
2
analytics platform: a case study Lausanne/CH, 3Liebefeld/CH, 4Aarau/CH
P. Szatmari1, P. Pytlewski2, N. Papanikolaou3, R. Illing1; 1Budapest/HU,
2
Warsaw/PL, 3Nicosia/CY B-1197 11:27
Exposure levels from radiology procedures used in myeloma diagnostics
B-1186 11:19 L. Weber1, I. Kristiansson1, M. Hansson1, R. Siemund1, H. Geijer2, M. Geijer1;
1
Flagging of pathological head CT interpretations using natural Lund/SE, 2Örebro/SE
language processing (NLP)
Y. Barash, T. Levy, Y. Elazar, E. Zimlichman, E. Konen, S. Soffer, B-1199 11:43
G. Guralnik, M.M. Amitai, E. Klang; Ramat Gan/IL Tissue equivalency in radiopaque 3D printing of patient phantoms
over a wide range of radiation energies - applications in imaging and
B-1187 11:27 dosimetry
Fast displaying time of electronic patient record and PACS sharing F.B. Schwarz, M. Ziegert, B. Hamm, M. Scheel, P. Jahnke; Berlin/DE
system with IHE-XDS/XDS-I and cloud technology
H. Kondoh1, T. Kawai1, M. Mochida1, T. Yamaguchi2; 1Yonago/JP, 2Hino/JP B-1200 11:51
Should testing for lead contamination be included in lead radiation
B-1188 11:35 protection apparel quality control?
Blended learning using radiology short video based lecture series M. Barati1, R. Illing2, L. Kardos2, C. Paraskevopoulou1, K. Katsari1;
1
improves medical school student performance and satisfaction Amsterdam/NL, 2Budapest/HU
A. Vavasseur, F. Muscari, P. Otal, H. Rousseau, L. Dercle, F. Mokrane;
Toulouse/FR


10:30 - 12:00 Room K SUPPORTED
AI-powered detection of pulmonary embolism in CT BY
INVEST IN
Chest pulmonary angiograms: a validation study of the diagnostic THE YOUTH
performance of prototype algorithms
T.J. Weikert, D.J. Winkel, J. Bremerich, B. Stieltjes, A.W. Sauter,
SS 1404 G. Sommer; Basel/CH
Advanced lung imaging: MRI and

artificial intelligence 10:30 - 12:00 Room M 1
Moderators: Cardiac
N.N.
J. Coolen; Leuven/BE
B-1201 10:30
SS 1403
Comparison of quantitative regional perfusion-weighted phase Quantification of myocardial perfusion
resolved functional lung (PREFUL) MRI with pulmonary perfusion
DCE-MRI in COPD patients
and ECV (extracellular volume fraction)
T.F. Kaireit1, A. Voskrebenzev1, M. Gutberlet1, J. Freise1, B. Jobst2, Moderators:
H.-.U. Kauczor2, T. Welte1, F. Wacker1, J. Vogel-Claussen1; 1Hannover/DE, K. Nikolaou; Tübingen/DE
2
Heidelberg/DE A. Rossi; Milan/IT
B-1202 10:38 B-1212 10:30

Fully automated 3D quantification of the lung emphysema in COPD Diagnostic accuracy of combined CCTA and low-dose dynamic stress
using 3D-UTE MRI CT myocardial perfusion with a whole-heart coverage CT scanner in
I. Benlala, P. Berger, P.O. Girodet, C. Dromer, J. Macey, F. Laurent, patients with suspected CAD
G. Dournes; Pessac/FR A. Baggiano1, M. Guglielmo1, G. Muscogiuri1, M. Soldi1, A. Del Torto1,
A.I. Guaricci2, M. Pepi1, G. Pontone1; 1Milan/IT, 2Bari/IT
B-1203 10:46
Comparison of quantitative capability among DWI with FASE and EPI B-1213 10:38
sequences at 1.5T or 3T systems and FDG-PET/CT: for differentiating The value of low-dose dynamic CT myocardial perfusion imaging for
malignant from benign solitary pulmonary nodules accurate evaluation of microvascular obstruction in patients with acute
Y. Ohno1, M. Yui2, H. Lee3, H. Koyama4, Y. Kishida1, S. Seki1, T. Yoshikawa1, myocardial infarction
Y. Kassai2, T. Murakami1; 1Kobe/JP, 2Otawara/JP, 3Seoul/KR, 4Osaka/JP J. Zhang; Shanghai/CN
B-1204 10:54 SPEAKER B-1214 10:46

SUPPORTED
Paediatric Hodgkin‘s and non-Hodgkin‘s lymphoma on chest BY Characteristics of first-pass myocardial iodine distribution as assessed
INVEST IN by dual layer CT with different injection protocols
MRI: do we really need intravenous contrast agent? THE YOUTH
C.T. Arendt, M. Beeres, D. Leithner, P. Tischendorf, S. Boccalini1, S.A. Si-Mohamed1, M. Matzuzzi2, B. Plaine2, D.C. Rotzinger3,
M.C. Langenbach, B. Kaltenbach, T.J. Vogl, T. Gruber-Rouh; L. Hanquier2, L. Boussel1, D. Revel1, P. Douek2; 1Bron/FR, 2Lyon/FR,
3
Frankfurt a. Main/DE Lausanne/CH

Feasibility of extracellular volume quantification using BY
Differentiation of inflammatory andfibrotic ground-glass opacity INVEST IN
(GGO) with MRI: a pilot study dual-energy CT THE YOUTH
C. Romei1, L. Turturici1, L. Tavanti1, M. Marletta1, P. Wielopolski2, M. van Assen1, C.N. De Cecco2, P. Sahbaee2, P. Griffith2,
S. Colagrande3, D. Caramella1, F. Falaschi1, P. Ciet2; 1Pisa/IT, M.J. Bauer2, A. Varga-Szemes2, M. Oudkerk1, R. Vliegenthart1,
2
Rotterdam/NL, 3Florence/IT U.J. Schoepf2; 1Groningen/NL, 2Charleston, SC/US
B-1206 11:10 B-1216 11:02

What is the contribution of MR spectroscopy in the differential Cardiac CT in the quantification of myocardial extracellular volume
diagnosis of solitary pulmonary masses? fraction (ECV) with a semiautomatic method: comparison with cardiac MR
A. Hekimoglu, O. Ergun, A. Turan, T.T. Turkmenoglu, B. Hekimoglu; D. Vignale, A. Palmisano, A. Del Maschio, F. De Cobelli, A. Esposito;
Ankara/TR Milan/IT
B-1207 11:18 B-1217 11:10

Imaging of thymic lesions in patients with myasthenia gravis: AI-based prediction of haematocrit values from non-contrast CT
is dual energy CT superior to MRI? imaging data - towards fully automated CT-derived myocardial
N. Rajamohan, R. Sharma, K. Devasenathipathy, A. Goyal, A.S. Bhalla, extracellular volume fraction quantification
R. Parshad, D. Jain; New Delhi/IN M.J. Bauer1, M. van Assen2, C.N. De Cecco1, J.A. Durden1, M. Scarabello3,
H.T. Hudson1, L. Griffith1, A. Varga-Szemes1, U.J. Schoepf1;
1
B-1208 11:26 Charleston, SC/US, 2Groningen/NL, 3Milan/IT
Lung volumes and its association with subclinical impairment
in whole-body MR imaging B-1218 11:18
R. von Krüchten1, R. Lorbeer2, C. Schuppert1, H. Schulz3, H.-U. Kauczor1, Could „synthetic hematocrit value“ has a use on ECV calculating via
A. Peters3, S. Karrasch2, F. Bamberg4, C. Schlett1; 1Heidelberg/DE, cardiac MRI? A single centre study
2
Munich/DE, 3Neuherberg/DE, 4Freiburg/DE A. Erdemir, O. Öcal, T. Hazirolan; Ankara/TR

Safety and diagnostic accuracy of regadenoson as BY
Multi-parametric approach among CEST imaging, DWI and FDG-PET/CT INVEST IN
for diagnosis of solitary pulmonary nodule vasodilator in stress perfusion cardiovascular magnetic THE YOUTH
Y. Ohno1, M. Yui2, Y. Kishida1, S. Seki1, T. Yoshikawa1, T. Murakami1; resonance
1
Kobe/JP, 2Otawara/JP A. Ezponda Casajús, M. Calvo Imirizaldu, A. García Baizán,
A. Paternain Nuin, J.C. Pueyo Villoslada, J. Gavira, G. Bastarrika Alemañ;
B-1210 11:42 Pamplona/ES
Potential of a machine learning model for dose optimisation in chest
CT quality assurance B-1220 11:34
C. Rubbert1, A. Meineke2, L.M. Sawicki1, Y. Klosterkemper1, G. Antoch1, Prognostic value of myocardial perfusion reserve index in patients
J. Boos1; 1Düsseldorf/DE, 2Berlin/DE with coronary microvascular disease: a multi-centre study
W. Zhou, M. Chai, W. Wong, P. Yap, Y. Lai, T. Lee, S. Leung, J. Lee,
M.-Y. Ng; Hong Kong/HK

B-1221 11:42 B-1233 11:42

Modification of left ventricle myocardial perfusion reserve after the Evaluation of white matter maturation in children with developmental
implantation of coronary sinus stent: a stress-rest CMR study delay using diffusion tensor imaging (DTI)
A. Palmisano, A. Esposito, G. Benedetti, F. Giannini, L. Baldetti, A. Yap, K. Rahmat, R. Muridan, P. Seow, C. Fong, L. Ong, L. Tan, N. Ramli;
A. Del Maschio, F. De Cobelli; Milan/IT Kuala Lumpur/MY

SUPPORTED
Left ventricular subclinical myocardial dysfunction in BY 10:30 - 12:00 Room M 3
INVEST IN
uncomplicated type 2 diabetes mellitus is associated with THE YOUTH
impaired myocardial perfusion Oncologic Imaging
X. Liu, Z.-G. Yang, Y.-K. Guo, Y. Ren, Y. Gao; Chengdu/CN
SS 1416
10:30 - 12:00 Room M 2 Neurooncology: making the most of
Paediatric quantitative imaging
Moderators:
SS 1412 E. Papadaki; Iraklion/GR
M. Porcu; Cagliari/IT
Paediatric neuroradiology
A. Sánchez Montañez; Barcelona/ES Enhancement of T1WI histogram in the identification with primary
F.M. Triulzi; Milan/IT central nervous system lymphoma and glioblastoma
C. Chen, J. Cheng, Y. Zhang; Zhengzhou/CN
B-1224 10:30
Model-based iterative reconstruction: is it relevant for reducing B-1235 10:38
radiation dose in paediatric head CT? T2WI histogram analysis of whole tumour volume for differentiating
P.K. Atri, K.S. Sodhi, A. Bhatia, A.K. Saxena, N. Khandelwal; glioblastoma from primary central nervous system lymphoma
Chandigarh/IN C. Chen, J. Cheng, Y. Zhang; Zhengzhou/CN
B-1225 10:38 SPEAKER B-1236 10:46

SUPPORTED
A systematic quantitative morpho-volumetric analysis in BY Whole tumour histogram analysis of apparent diffusion coefficient
INVEST IN for evaluation of histological grade and BRAF mutation status in
infants with sagittal craniosynostosis and relationship with THE YOUTH
the severity of scaphocephalic deformity pleomorphic xanthoastrocytomas
M. Panfili, R. Calandrelli, F. Pilato, C. Colosimo; Rome/IT J. Yan, J. Cheng, F. Liu; Zhengzhou/CN
B-1226 10:46 B-1237 10:54

MRI patterns of brain injury in neonates with pathology-proven Prediction of the BRAF mutation status of pleomorphic
placental abruption xanthoastrocytomas using pre-operative multi-parametric MRI
P.A. Caruso, K. Buch, S. Bates, D. Roberts; Boston, MA/US J. Yan, J. Cheng, F. Liu; Zhengzhou/CN
B-1227 10:54 B-1238 11:02

Frequency of optic nerve involvement in paediatric intracranial germ To study the diagnostic value of adc global gray histogram in
cell tumours differentiating primary central nervous system lymphoma from
K. Buch, O. Rapalino, N. Tarbell, T. Yock, S. MacDonald, P.A. Caruso; pleomorphic glioblastoma and single brain metastases
Boston, MA/US Z. Ma, J. Cheng; Zhengzhou/CN
B-1228 11:02 B-1239 11:10

MRI findings in Christianson syndrome A whole-tumour histogram analysis of apparent diffusion coefficient
P.A. Caruso1, M. Pescosolido2, K. Buch1, E. Morrow2; 1Boston, MA/US, maps for distinguishing lateral ventricle central neurocytoma from
Saturday
2
Providence, RI/US ependymoma
W. Wang, J. Cheng; Zhengzhou/CN
B-1229 11:10
Deep medullary venous thrombosis in neonates correlates highly with B-1240 11:18
the development of shunt-dependent hydrocephalus Characterisation of peripheral nerve sheath tumours in patients with
K. Buch, S. Rincon, K. Krishnamoorthy, G. Gomboli, P.A. Caruso; neurofibromatosis type 1 using diffusion-weighted magnetic resonance
Boston, MA/US imaging
J. Salamon1, L. Well1, K.I. Geier1, L. Späth1, M. Kaul1, J. Herrmann1,
V.-F. Mautner1, G. Adam1, T. Derlin2; 1Hamburg/DE, 2Hannover/DE
B-1230 11:18
Characterising resting-state networks in bilateral severe-to-profound
sensorineural hearing loss infants within an early sensitive period B-1241 11:26
S. Wang, G. Fan; Shenyang/CN ASL perfusion MRI reveals reduced cerebral blood flow in
the hippocampal region in patients with former childhood
medulloblastoma
B-1231 11:26
Y. Tanyildizi, A. Kronfeld, M.-A. Neu, A. Wingerter, A. Russo, K. Khawaja,
MRI in the preoperative diagnosis of medulloblastoma: correlation
A. Tropine, M.A. Brockmann, J. Faber; Mainz/DE
with molecular subgrouping
N. Plakhotina1, E. Vázquez2, I. Delgado Alvarez2,
A. Sanchez-Montanez Garcia-Carpintero3, E. Martinez2, A. Llort2, B-1242 11:34
G. Burcet Rodríguez2, J. Camacho2; 1St. Petersburg/RU, 2Barcelona/ES, Machine learning-based radiomics to predict molecular subgroups of
3
Tarragona/ES medulloblastoma
J. Yan, Z. Zhang, J. Cheng; Zhengzhou/CN
B-1232 11:34
The additive value of diffusion-weighted imaging in the initial workup B-1243 11:42
for paediatric head and neck lesions Delayed FDG PET/CT in differentiating true progression from pseudo-
A.E. Gabr, A. Nada, M. Gomaa, R.H. Hashem, A. Shokry; Cairo/EG progression in glioblastoma treated with chemoradiation
M.K. Gule-Monroe, M. Chen, J. Li, B.J. O’Brien, C. Chung, S.D. Ferguson,
S.S. Prabhu, J.M. Johnson; Houston, TX/US

B-1244 11:50 B-1256 11:14

Application of histogram analysis of diffusion Kurtosis imaging to DWI-associated entire-tumour histogram analysis for the
tumour grading and tissue heterogeneity differentiation of nasopharyngeal carcinoma from nasopharyngeal
A. Gao1, J. Cheng1, J. Bai1, Y. Zhang1, Y. Hong2, D. Kong2; 1Zhengzhou/CN, lymphoma
2
Hangzhou/CN K. Ma, J. Cheng, X. Zhang, C. Song; Zhengzhou/CN
B-1257 11:18
10:30 - 12:00 Sky High Stage Accessing the skull base: CT-guided submaxillary core needle biopsy
for the diagnosis of skull base lesions
Head and Neck I. Burck, M. Rosenzweig, N.-E. Nour Eldin, H. Kvasnicka, T. Stöver,
V. Jacobi, T.J. Vogl; Frankfurt/DE
MY 14 B-1259 11:26
3D imaging of the paranasal region with a multipurpose cone beam
Head and Neck detector system: image quality and radiation exposure
Moderators: S. Ohlmeyer, T. Buder, M. Uder, W. Wuest; Erlangen/DE
M. Lell; Nuremberg/DE
R. Saat; Tallinn/EE B-1260 11:30 SPEAKER
SUPPORTED
Structural changes of the disc of temporomandibular joint in BY
INVEST IN
B-1245 10:30 the first stage of dysfunctions THE YOUTH
Perfusion MRI with high spatial and temporal resolution in the head D.V. Dushkova, Y. Vasilev; Moscow/RU
and neck region using golden angle radial sampling
A. Tomppert, M.S. May, M. Wiesmüller, R. Heiß, A. Nagel, M. Uder, B-1261 11:34
W. Wuest; Erlangen/DE Correlation between the size of the inferior orbital wall defect and
treatment tactics in orbital trauma according to the MSCT data
B-1246 10:34 O. Pavlova, N.S. Serova, D. Davydov, S.K. Ternovoy; Moscow/RU
Preliminary diffusion kurtosis imaging study of head and neck
squamous cell carcinomas associated with histologic grades B-1262 11:38 SPEAKER
SUPPORTED
T. Su, Y. Chen, X. Chen, T. Zhang, X. Shi, H. Xue, Z. Zhang, Z. Jin; Anatomage table: a possible new tool for diagnosis and BY
Beijing/CN INVEST IN
classification of Le Fort fractures THE YOUTH
Z. Falaschi, S. Cavalieri, I. Valente, G. Mazzucca, A. Carisio,
B-1247 10:38 S. Bor, A. Carriero, F. Boccafoschi, A. Stecco; Novara/IT
Radiohistological comparison study of temporal bone specimen after
CI electrode array insertion: is CBCT superior to MSCT? B-1263 11:42 SPEAKER
SUPPORTED
I. Burck, S. Schneider, I. Yel, A. Lehn, S. Balster, S. Helbig, T. Stöver, Functional multi-detector computed tomography (FMDCT) BY
T.J. Vogl, B. Kaltenbach; Frankfurt a. Main/DE INVEST IN
for various orbital pathologies THE YOUTH
N.D. Kudryavtsev, M.V. Malakhova, Y.O. Grusha, S.S. Danilov,
B-1248 10:42 V.V. Khovrin, K.B. Puzakov, T.N. Galyan; Moscow/RU
Utility of histogram analysis of ADC maps in differential diagnosis
of Pleomorphic adenoma and Acinar cell carcinoma originated from B-1264 11:46
parotid gland Value of ADC and DCE-MRI in differentially diagnosing of angiomatous
X. Zhang, J. Cheng, K. Ma; Zhengzhou/CN meningioma and solitary fibrous tumours/haemangiopericytoma
C. Chen, C.-.P. Ren, R.-.C. Zhao, J.-.L. Cheng; Zhengzhou/CN
B-1249 10:46
The value of ADC histogram in differentiating nasopharyngeal
carcinoma from nasopharyngeal lymphoma 10:30 - 12:00 Tech Gate Auditorium
K. Ma; Zhengzhou/CN
Neuro
B-1250 10:50
Prognostic value of restaging 18-FDG PET/CT volumetric parameters
for post-index irradiation recurrence of head and neck squamous cell
carcinoma
SS 1411b
K. Musaieva, B. Musaiev, Y. Kmetyuk; Kiev/UA Diffusion tensor imaging (DTI)
Moderators:
B-1251 10:54 SPEAKER K. Kenigsberg; Minsk/BY
SUPPORTED
Update of old thyroid US reports to EU-TIRADS with AI BY N.N.
INVEST IN
A. Mereu, L. Saba; Cagliari/IT THE YOUTH
K-30 10:30
B-1252 10:58 Keynote lecture
Application of RESOLVE-DWI ADC maps based on whole-tumour G. Kasprian; Vienna/AT
histogram analysis in differentiating common parotid gland tumours
C. Song, J. Cheng, Y. Zhang; Zhengzhou/CN B-1265 10:39
The assessment of diffusion tensor imaging parameters of visual
B-1253 11:02 SPEAKER pathways in patients with primary open-angle glaucoma: preliminary
SUPPORTED
Diagnostic utility of mean peak systolic velocity of superior BY study
INVEST IN
thyroid artery (STA PSV) in the differential diagnosis of THE YOUTH A. Piekarek, P. Podgórski, M. Czarnecki, W. Rydel, A. Turno-Krecicka,
thyrotoxicosis M. Misiuk-Hojło, A. Zimny; Wroclaw/PL
P.K. Sarangi, S. Parida, B.K. Mohanty, S. Mangaraj, J. Mohanty, B.M. Swain;
Cuttack/IN B-1266 10:47
Diffusion tensor imaging in trigeminal neuralgia caused with
B-1254 11:06 neurovascular conflict and in estimation of long-term results of
Visualisation of the trigeminal nerve branches on enhanced 3D-SPACE- microvascular decompression
STIR sequence: initial experience M. Amelin, J. Rzaev, G. Moysak, A. Tulupov; Novosibirsk/RU
C. Chen, H. Haiwei, S. Yunkun, H. Xu; Xiamen/CN
B-1267 10:55
B-1255 11:10 Diffusion tensor imaging for vascular dementia prediction: threshold
Three-dimensional shear wave elastography for differentiating benign level of fractional anisotropy in liable white matter tracts
from malignant thyroid nodules I. Levashkina1, S.V. Serebryakova1, O.V. Kitaigorodska2; 1St. Petersburg/RU,
2
C.-K. Zhao; Shanghai/CN Kyiv/UA

B-1269 11:11 SPEAKER B-1280 11:10

SUPPORTED
Determination of fractional anisotropy cut off values on BY Assessment of metastatic GIST heterogeneity using texture analysis:
INVEST IN
diffusion tensor imaging in differentiating recurrence versus THE YOUTH ADC texture as a potential biomarker of 5-year survival
radiation necrosis in gliomas J. Fu, F. Mengjie, J. Li, X. Li, L. Tang, D. Dong; Beijing/CN
P. Asokan1, S.S. Shivalingappa1, A.A. Rao Kesari1,
M. Ashok Kumar2, B-1281 11:18
I. Desai1, S. Sampangi1; 1Bangalore/IN, 2Bikaner/IN Lymphadenectomy of small intestine neuroendocrine neoplasias
(si-NEN): testing the most recent preoperative classification with
B-1270 11:19 SPEAKER contrast-enhanced computed tomography (CT)
SUPPORTED
White matter involvement in young non-demented Down’s BY F. Zugni, L. Funicelli, E. Bertani, M. Bellomi; Milan/IT
INVEST IN
syndrome subjects: a tract-based spatial statistic analysis THE YOUTH
A. Guarnera, A. Romano, M. Moraschi, A. Pierallini, A. Bozzao; B-1282 11:26
Rome/IT Newly appearing hepatic lesions on follow-up CT after curative-intent
surgery for colorectal cancer: when and why should we order liver MRI?
B-1271 11:27 D.K. Kim, C. An; Seoul/KR
Diffusion tensor imaging in intractable unilateral mesial temporal lobe
epilepsy B-1283 11:34
A.N. Parimalai, A. Chelladurai, M. Logudoss; Chennai/IN Effect of dual-energy CT single-energy imaging on image quality of
mesenteric vessels and segmental thickening intestinal wall
B-1272 11:35 J. Yang, B. He; Nantong/CN
Excessive alcohol consumption in adolescent men compromises
frontal white matter integrity via disruption of myelin (and axons): B-1284 11:42
a combined DTI-metabolic study Peritoneal carcinomatosis extent evaluation: radiologic, laparoscopic
Q. Shen1, N. Heikkinen2, O. Kärkkäinen2, M. Kononen2, H. Gröhn2, Y. Liu2, and pathologic
Z. Zhang1, T. Tolmunen2, R. Vanninen2; 1Changsha/CN, 2Kuopio/FI S.A. Ahmed, D. Fouad, H.A. Taleb, D. Badary; Assiut/EG
B-1273 11:43 B-1285 11:50 SPEAKER

SUPPORTED
Revealing the microstructure abnormalities of spinocerebellar ataxia Using 2-mSv appendiceal CT in usual practice for adolescents BY
INVEST IN
by fMRI and DKI: from ROI based analysis to a VBA and TBSS study and young adults: willingness survey of 579 radiologists, THE YOUTH
H.S. Qiu, J.P. Chu, J. Zhao, M.S. Hu, C. Wu; Guangzhou/CN emergency physicians, and surgeons from 20 hospitals
1 1 2 1 3 1 2
H. Kim , K. Lee , Y. Ko , J. Choi , J. Sim ; Seongnam/KR, Anyang/KR,
B-1274 11:51 3
Seoul/KR
Cerebral white matter structural integrity in patients with mild
cognitive impairment: evaluation with diffusion tensor imaging and
morphometric assessment on 3T MRI 14:00 - 15:30 Coffee & Talk 2
A. Haris Phuah, K. Rahmat, N. Ramli, F.I. Rozalli, F.B. Fadzli, L. Tan,
N.I. Saedon, M. Tan; Kuala Lumpur/MY Musculoskeletal
10:30 - 12:00 The Church SS 1510

GI Tract Musculoskeletal interventions
Moderators:
A. Alcalá-Galiano; Madrid/ES
SS 1401b T. Kaya; Eskisehir/TR
Gastric cancer and beyond K-31 14:00

Moderators: Keynote lecture
I. Blazic; Belgrade/RS M. Reijnierse; Leiden/NL
B-1286 14:09
Saturday
B-1275 10:30 European multi-centre study on technical success and long-term
Advanced gastric cancer response to neoadjuvant chemotherapy: clinical outcome of radiofrequency ablation for the treatment of spinal
is CT texture analysis a reliable imaging biomarker? A multi-centre osteoid osteoma and osteoblastoma
study from Italian research group for gastric cancer T. Beyer1, C. Rehnitz2, K.M. Thierfelder1, C.S.P. van Rijswijk3,
L. Di Giacomo1, G. Bagnacci1, V. Nardone2, P. Tini1, F. Gentili1, D. Marrelli1, J. Martel Villagrán4, M. Muto5, C. von Falck6, J. Gielen7, M.-A. Weber1;
F. Roviello1, L. Volterrani1, M.A. Mazzei1; 1Siena/IT, 2Naples/IT 1
Rostock/DE, 2Heidelberg/DE, 3Leiden/NL, 4Madrid/ES, 5Naples/IT,
6
Hannover/DE, 7Edegem/BE
B-1276 10:38
Diagnostic accuracy of CT for lymph node metastasis in gastric cancer: B-1287 14:17
comparison of spectral parameters developed dual-energy CT and Who gets kyphoplasties and how much height is restored: a single-
conventional CT centre demographic profile
Y. Chai; Zhengzhou/CN P.R. Jayaram, T. Marshall; Norwich/UK
B-1277 10:46 B-1288 14:25

Applying extended texture features to identify quantifiable changes in Long term efficacy of a dorsal indirect approach for CT-guided
gastrointestinal stromal tumours undergoing tyrosine kinase inhibitor cervical nerve root injections
(TKI) therapy S. Billingsley1, C. O‘Neill1, D. McKean2; 1Aylesbury/UK, 2Oxford/UK
K. Ekert; Tübingen/DE
SUPPORTED
B-1278 10:54 Morphological changes of disc herniation following BY
INVEST IN
Small (<5cm) gastric sub-epithelial tumours: identification of CT-guided periarticular infiltration THE YOUTH
gastrointestinal stromal tumours using CT with a practical scoring S. Talarczyk1, D.F. Uhlenbrock1, P. Haage2, C.A. Stückle3;
method 1
Dortmund/DE, 2Wuppertal/DE, 3Witten/DE
L. Liu, S. Rao, M. Zeng; Shanghai/CN
B-1290 14:41
B-1279 11:02 Lumbar nerve root blocks using MR: the effectiveness and safety of
Prediction of surgery requirement in mesenteric fibrosis on CT using a ultrasound/MRI fusion image guidance
radiomics approach D.J. Wilson, G.M. Allen, S.A. Bullock, J. Denton; Oxford/UK
M.P.A. Starmans, A. Blazevic, S.R. van der Voort, T. Brabander, J. Hofland,
W.J. Niessen, W.W. de Herder, S. Klein; Rotterdam/NL

B-1291 14:49 B-1301 14:49

Recovering from non-specific low back pain despair: ultrasound- Safety and outcomes of percutaneous cryoablation for large T1b renal
guided intervention in iliolumbar syndrome cell carcinoma
D.K. Singh, S.B. Grover, N. Kumar, B.K. Nayak, S. Tomar, S. Suman, A. Gunn, K. Mahmoud, H. El Khudari, A. Salei, E. Keasler, E. Bready,
A. Katyan, H. Rajani, R.N. Misra; New Delhi/IN J. Winston, P. Patten, A.M.K. Abdel Aal; Birmingham, AL/US
B-1292 14:57 SPEAKER B-1302 14:57 SPEAKER

SUPPORTED SUPPORTED
Prospective randomised controlled trial comparing BY Comparison of cryoablation and microwave ablation in the BY
INVEST IN INVEST IN
a battery-powered and a manual drill in bone biopsy THE YOUTH treatment of small renal tumours (SRT): technical success, THE YOUTH
C. Tsoi, E.K.C. Law, R.K.L. Lee, A.W.H. Ng, J.F. Griffith; complications and midterm clinical outcome
Hong Kong/HK M. Panzeri, M. Colombo, M. Papa, G. Cardone, M. Venturini, U. Capitanio,
F. Montorsi, A. Del Maschio, F. De Cobelli; Milan/IT
B-1293 15:05
Ultrasound-guided distension hydrotherapy with graded physiotherapy B-1303 15:05
in primary adhesive capsulitis: a pilot study Focused ultrasound subthalamotomy in patients with asymmetric
D.K. Singh, N. Kumar, S. Tomar, B.K. Nayak, S. Suman, A. Katyan, Parkinson’s disease: a pilot study
M.K. Mittal, S.B. Grover, R.N. Misra; New Delhi/IN E. De Luis Pastor, M. Del Alamo, R. Martinez Fernandez, J. Mañez Miro,
C. Gasca, R. Rodriguez Rojas, J. Pineda Pardo, L. Vela, J. Obeso;
B-1294 15:13 Mostoles/ES
Ultrasound-guided percutaneous release of the carpal tunnel:
comparison between senior vs junior operator and learning curves: a B-1304 15:13
cadaveric study The effect of histogram parameters derived from quantitative
C. Dekimpe; Nice/FR T1-perfusion on predicting the high-intensity focused ultrasound
outcome of uterine fibroids
B-1295 15:21 SPEAKER N.M. Duc1, C. Li2, H. Quang Huy1, J. Yang2, B. Keserci3;
SUPPORTED
Clinical response in hip osteoarthritis: comparison between BY 1
Ho Chi Minh City/VN, 2Xi’an/CN, 3Kelantan/MY
INVEST IN
intra-articular treatment with hybrid hyaluronic acid (HA) and THE YOUTH
combined therapy with Platelet-Rich Plasma (PRP) and HA B-1305 15:21
I. Capretti, P. Palumbo, S. Iafrate, F. Bruno, F. Arrigoni, S. Mariani, The role of magnetic resonance imaging parameters in predicting the
L. Zugaro, A. Barile, C. Masciocchi; L‘Aquila/IT treatment outcome of high-intensity focused ultrasound ablation of
adenomyosis
N.M. Duc1, B. Keserci2, H. Quang Huy1, L. Van Phuoc1, L. Trong Khoan3,
14:00 - 15:30 Room Y D. Duc Cuong4, B. Van Giang4, V. Dang Luu4, N. Duy Hue4;
1
Ho Chi Minh/VN, 2Kelantan/MY, 3Hue/VN, 4Ha Noi/VN
14:00 - 15:30 Room M 1

SS 1509
Cardiac
Nonvascular interventions in oncology
(including kidney) SS 1503
Moderators:
J. Curic; Zagreb/HR Coronary calcium and plaques: diagnosis
and prognosis
K-32 14:00 Moderators:
Keynote lecture P. Donato; Coimbra/PT
N.N. C. Lücke; Leipzig/DE
B-1296 14:09 B-1306 14:00

Safety and efficacy of microwave ablation of stage T1 renal cell Presence of coronary artery calcifications on CT is associated with
carcinoma PE-related mortality in patients with acute PE
K. Mahmoud, H. El Khudari, A. Gunn, E. Keasler, E. Bready, A. Salei, B.H. Heidinger1, D.C. DaBreo2, B.J. Carroll3, S.A. Feldman3, D. Mohebali3,
J. Winston, P. Patten, A.M.K. Abdel Aal; Birmingham, AL/US I. McCormick3, J.D. Matos3, W.J. Manning3, D. Litmanovich3; 1Vienna/AT,
2
Kingston, ON/CA, 3Boston, MA/US
B-1297 14:17
Percutaneous management of Indiana pouch stones: a single-centre B-1307 14:08
retrospective study Coronary artery calcification and prediction of mortality in patients
M. Ozturk, J.C. McDermott, P.F. Laeseke, S.Y. Nakada, S.P. Hedican, with pulmonary embolism
S. Best, M.G. Kleedehn; Madison, WI/US L. Norton, D. Maguire, K. Mac a‘ Bháird, G. Cooper, O. Sheerins,
M. Adamson, C. Kelly, G. Roditi; Glasgow/UK
B-1298 14:25
Predictors of outcomes of percutaneous cryoablation for renal cell B-1308 14:16
carcinoma Accuracy and variability of coronary CT angiography with iterative
K. Mahmoud, A. Gunn, H. El Khudari, A. Salei, E. Bready, J. Winston, model reconstruction for plaque burden assessment compared with
E. Keasler, P. Patten, A.M.K. Abdel Aal; Birmingham, AL/US IVUS: a pulsating cardiac phantom study
Q. Wen, Y. Hou, L. Yang, Y. Ma, X. Lu; Shenyang/CN
B-1299 14:33
Role of R.E.N.A.L. nephrometry and PADUA scoring systems in SUPPORTED
percutaneous ablation for renal cell carcinoma Retrospective evaluation of the accuracy of coronary BY
INVEST IN
K. Mahmoud, A. Gunn, H. El Khudari, A. Salei, E. Bready, J. Winston, computed tomography angiography compared to invasive THE YOUTH
E. Keasler, P. Patten, A.M.K. Abdel Aal; Birmingham, AL/US coronary angiography: radiological and therapeutic approach
in CAD-RADS 3/V
B-1300 14:41 C. De Cataldo, A. Corridore, S. Torlone, E. Cannizzaro, P. Palumbo,
Modified ABLATE-score (mABLATE): a specific nephrometric score to F. De Matteis, M. Di Luzio, E. Di Cesare, C. Masciocchi; L‘Aquila/IT
predict complications and relapses in percutaneous cryoablation of
renal lesions
M. Papa, A. Losa, N. Suardi, G. Agostini, T. Maga, F. Gaboardi, G. Cardone;
Milan/IT

B-1310 14:32 B-1320 14:24

Improving CAD-RADS score with new iterative model reconstruction Pediatric Computer Tomography (CT) Diagnostic Reference Levels
algorithm in low dose CCTA: inter-observer agreement and (DRLs) by age and size
comparison with hybrid iterative reconstruction algorithm S. Yu, P. Chu, R. Smith-Bindman; San Francisco, CA/US
C. Talei Franzesi1, L. Riva1, D. Ippolito1, C. Cangiotti1, A. de Vito1, C. Maino1,
M. Porta1, S. Sironi2; 1Monza/IT, 2Bergamo/IT B-1321 14:32
Evaluation of ultra low dose CT examinations of the paediatric chest
B-1311 14:40 using spectral shaping and an iterative reconstruction algorithm
Reliability of coronary calcium scoring on low-dose chest CT: M. Wetzl, D. Weinmann, M. Kopp, J. Roth, R. Heiß, W. Wuest, O. Rompel,
comparison with ECG-triggered cardiac CT based on third-generation M. Uder, M.S. May; Erlangen/DE
dual-source CT
C. Xia, A. Alsurayhi, M. Vonder, G. Pelgrim, M. Rook, M. Oudkerk, B-1322 14:40
R. Vliegenthart; Groningen/NL Relative regional air volume change as a biomarker in humidifier
disinfectant-associated lung injury in children with normal-looking
B-1312 14:48 chest CT
Accuracy of calcium scoring calculated from contrast-enhanced H. Ko1, J. Choi2, K. Chae3, S. Park1, J. Jang3, C. Lee2; 1Seoul/KR,
2
coronary computed tomography angiography using a dual-layer Iowa City, IA/US, 3Jeonju/KR
spectral CT
J. Nadjiri, G. Kaissis, F. Meurer, K.-L. Laugwitz, A.S. Sträter, D. Pfeiffer, B-1323 14:48
P.B. Noel, E.J. Rummeny, M. Rasper; Munich/DE CT chest under general anaesthetic: is the degree of atelectasis
improved by prone positioning?
B-1313 14:56 A. Kirby, A.J. Quigley, J. Jones, S. McGurk; Edinburgh/UK
Influence of image reconstruction parameters on cardiovascular risk
reclassification by computed tomography coronary artery calcium B-1324 14:56
score PET-MRI is non-inferior to PET-CT in paediatric and adolescent
C. Mantini1, E. Maffei2, P. Toia3, F. Ricci1, A.R. Cotroneo1, F. Cademartiri4; Hodgkin‘s lymphoma for staging and early response assessment
1
Chieti/IT, 2Treviso/IT, 3Palermo/IT, 4Rotterdam/NL M.V. Verhagen, T.A. Watson, D. Neriman, S. Punwani, S. Taylor, S. Daw,
A. Shankar, L. Menezes, P.D. Humphries; London/UK
B-1314 15:04
Coronary calcium screening with non-gated standard and low-dose B-1326 15:12
chest CT in comparison with ECG-gated calcium scoring CT Magnetic resonance imaging assessment of iron status in paediatric
K.N. Zhuravlev, V.E. Sinitsyn, A.V. Shpektor; Moscow/RU patients with hematologic disorders
E. Nazarova, D. Kupriyanov, G. Tereshenko, N. Smetanina, G. Novichkova;
B-1315 15:12 Moscow/RU
Association between coronary artery calcium score and cardiovascular
magnetic resonance imaging parameters in patients with end-stage B-1327 15:20
renal disease Diffusion kurtosis imaging (DKI) utility in differentiating low- and high-
Q. Xie, X. Zhou, L. Lin; Shenzhen/CN grade gliomas in paediatric patients: further experience
I. Voicu, A. Napolitano, M. Vinci, F. Diomedi-Camassei, C. Carducci,
B-1316 15:20 A. Carai, A. Mastronuzzi, P. Toma, G. Colafati; Rome/IT
Implications of incidental coronary artery calcification on thoracic
computed tomography
V. Tilliridou, J. Murchison, E.J.R. van Beek, D.E. Newby, M.C. Williams; 14:00 - 15:30 Room M 3
Edinburgh/UK
Neuro
14:00 - 15:30 Room M 2

SS 1511
Paediatric
Neurocognitive impairment and
SS 1512 psychiatric disorders
Saturday
Moderators:
Paediatric radioprotection, techniques N.N.
J. Boban; Novi Sad/RS
and forensic imaging
N.N. Determining the best leader nodes in Alzheimer networks
J. Piqueras; Barcelona/ES A. Moradi Amani1, L. Meyer-Baese2, A. Tahmassebi3, K. Pinker-Domenig4;
1
Melbourne/AU, 2Atlanta, GA/US, 3Tallahassee, FL/US, 4Vienna/AT
B-1317 14:00
Evaluation of virtual grid post-processing for paediatric no-grid B-1329 14:08
radiography in an unselected paediatric patient cohort Quantitative MR-phase information enables classification of
M. Beeres1, J.-E. Scholtz1, D. Leithner1, A. Barakat2, T.J. Vogl1, Alzheimer’s disease stages
T. Gruber-Rouh1, B. Kaltenbach1, C. Polkowski1, A.M. Bucher1; H. Indo1, T. Yoneda1, N. Kurehana1, Y. Tatewaki2, T. Mutoh2, A. Ishiki2,
1
Frankfurt a. Main/DE, 2Liverpool/UK N. Tomita2, H. Arai2, Y. Taki2; 1Kumamoto/JP, 2Sendai/JP
B-1318 14:08 B-1330 14:16

Impact of detector pixel size on clinical image quality of digital Altered cortical thickness related to single nucleotide polymorphisms
neonatal chest X-ray images (SNPs) in the major histocompatibility complex (MHC) in
M. Smet, L. Breysem, M. Wang, H. Bosmans, N. Marshall, antipsychotic-naive schizophrenia
S. Rodríguez Pérez; Leuven/BE B. Tao, Y. Xiao, W. Zhang, L. Yao, S. Lui; Chengdu/CN

Post-mortem ultrasound-guided biopsy for perinatal death BY Drug effects on brain structure in acute and chronic schizophrenia
INVEST IN
investigation: a pilot study THE YOUTH J. Zeng, W. Zhang, Y. Xiao, J. Liu, B. Tang, G. Fu, S. Lui; Chengdu/CN
S.C. Shelmerdine, J.C. Hutchinson, N.J. Sebire, O.J. Arthurs;
London/UK B-1333 14:40
An amplitude of low-frequency fluctuation study in first-episode drug-
naive patients with major depressive disorder
X. Hu, X. Hu, H. Li, L. Zhang, L. Lu, X. Bu, S. Tang, Q. Gong, X. Huang;
Sichuan/CN

B-1334 14:48 B-1346 14:56

Role of MR functional connectivity in discriminating cognitive Diffusion and perfusion MR parameters to assess preoperative short-
impairment in BD course radiotherapy response in locally advanced rectal cancer
M.M. Eid, M.H. Othman, S. Abdelal, H.A. Hasan, H.E. Khakifa, S. Sayed; R. Fusco, V. Granata, B. Pecori, A. Petrillo; Naples/IT
Asyut/EG
B-1335 14:56 14:00 - 15:30 Sky High Stage

Spectrum of autoimmune encephalitis: establishing imaging patterns
on FDG PET/CT for specific antibody sub-types Radiographers
V. Gupta, R. Verma, R. Ranjan, E. Belho, H. Mahajan; Delhi/IN
B-1337 15:12 MY 15
Central nervous system (CNS) imaging findings in granulomatous
polyangiitis (GPA), IgG4-related (IgG4-RD) and Erdheim-Chester
Everyday challenges for radiographers
diseases (ECD): comparison and pictorial essay and radiologists
S. Gerevini, E. Bozzolo, R. Cao, E. Della Torre, V. Canti, G. Cavalli,
Moderators:
M. Lanzillotta, L. Dagna, A. Falini; Milan/IT
N.N.
B-1338 15:20
Tissue sodium concentration (TSC) in normal brain: preliminary study
P. Wawrzyniak, B. Bobek-Billewicz, A. Hebda, A. Awramienko, P. Mazgaj; SUPPORTED
Impact of body mass index on set-up variations and treatment BY
Gliwice/PL INVEST IN
margins for patients receiving radiotherapy to the prostate THE YOUTH
S. Farrugia, G. van Dijk, S. Mercieca; Msida/MT
14:00 - 15:30 Room M 4 B-1351 14:04

An augmented patient-specific approach to administration of contrast
GI Tract
agent for CT renal angiography
C. Saade; Beirut/LB
SS 1501a B-1352 14:08 SPEAKER
SUPPORTED
Rectal cancer: what‘s new? Improving technical quality in mammography BY
INVEST IN
Moderators: V. Risi1, M. Zanardo2, R.M. Trimboli3, C.B. Monti2, G. Di Leo3, THE YOUTH
D. Miletić; Rijeka/HR L.A. Carbonaro3, F. Sardanelli2; 1Lumezzane/IT, 2Milan/IT,
3
N.N. San Donato Milanese/IT
B-1339 14:00 SPEAKER B-1353 14:12

SUPPORTED
Clinical feasibility assessment of T3 sub-stage in rectal cancer BY Reflective clinical portfolios as a tool to develop competence in
INVEST IN radiography students
using MRI THE YOUTH
P. Tripathi1, W. Guo2, C. Yang2, B. Rai1, M. Zeng2, H. Yu1; M. Morris; Limerick/IE
1
Wuhan/CN, 2Shanghai/CN
B-1354 14:16
B-1340 14:08 SPEAKER A comparative analysis of local diagnostic reference levels for adult
SUPPORTED
Preoperative MR restaging of rectal cancer in UKMMC: BY projection radiography of the chest, abdomen and pelvis in Irish centres
INVEST IN M. Malone, S.J. Foley, L.A. Rainford, R. Toomey; Dublin/IE
correlation with surgical and histopathologic findings THE YOUTH
C. Lee, S. Osman, L. Mazlan, F. Mohammed; Kuala Lumpur/MY
B-1355 14:20
B-1341 14:16 Dose optimisation in CT for cocaine body packing: where is the limit
Magnetic resonance of rectal cancer response to therapy: comparison of extensive dose reduction?
between 3.0 and 1.5 Tesla J. Aissa, L.M. Sawicki, E. Appel, P. Heusch, C. Thomas, G. Antoch, J. Boos;
E. Lucertini1, M. Zerunian1, D. Caruso1, D. De Santis1, G. Moltoni1, Düsseldorf/DE
F. Landolfi1, T. Biondi2, E. Iannicelli1, A. Laghi1; 1Rome/IT,
2
Belvedere Marittimo/IT B-1357 14:28
Obstetric ultrasound - knowledge and perception of pregnant women
B-1342 14:24 in Portugal
Prognostic value of tumour regression grade on MR in rectal cancer: R.A. Santos, R. Fernandes; Coimbra/PT
a large-scale, single-centre experience
H. Yoen, S.H. Kim, J.H. Yoon, B.Y. Hur, J.H. Kim, H.E. Park, H. Oh, J.K. Han; B-1358 14:32
Seoul/KR Expectant mothers‘ perception of prenatal sonography in southeastern
population in Nigeria
B-1343 14:32 SPEAKER H.C. Elugwu; Nnewi/NG
SUPPORTED
Importance of tumour volume reduction rate on T2w and BY
INVEST IN B-1359 14:36 SPEAKER
DWI during and after CRT for prediction of treatment THE YOUTH SUPPORTED
Mobile phones as a potential vehicle of nosocomial BY
response to CRT in locally advanced rectal cancer (LARC) INVEST IN
A. Di Chiara, A. Palmisano, G. Della Vecchia, A. Esposito, P. Passoni, pathogens in radiology departments THE YOUTH
C. Fiorino, A. Del Maschio, F. De Cobelli; Milan/IT T.C.P.L. Guerreiro1, L. Ribeiro2, A.F. Abrantes2, S. Rodrigues2,
R. Raposo2, F. Soares2, R.P.P. Almeida2; 1Santiago Do Cacém/PT, 2Faro/PT
SUPPORTED
Whole-tumour texture analysis of ADC maps in the BY B-1360 14:40
INVEST IN Diffusion tensor imaging of the growth plate: a preliminary study
prediction of pathological response of locally advanced THE YOUTH
rectal cancer (LARC) O. Kvist1, S. Diaz Ruiz1, T. Dorniok1, J. Sanmartin Berglund2,
A. Di Chiara, A. Palmisano, A. Esposito, P. Rancoita, P. Passoni, C.-E. Flodmark1; 1Stockholm/SE, 2Karlskrona/SE
A. Del Maschio, F. De Cobelli; Milan/IT
B-1361 14:44
B-1345 14:48 Comparison of extremity cone beam-computed tomography and
T2-weighted signal intensity (T2SI) textural analysis in an evaluation multidetector-computed tomography in injured children
of neoadjuvant chemoradiotherapy (CRT) response in patients with S. Tschauner, R. Marterer, E. Nagy, G. Apfaltrer, G. Singer, M. Riccabona,
locally advanced rectal adenocarcinoma E. Sorantin; Graz/AT
G. Della Vecchia, A. Di Chiara, M. Panzeri, A. Palmisano, A. Esposito,
P. Passoni, A. Del Maschio, F. De Cobelli; Milan/IT

B-1362 14:48 B-1372 14:16

Artificial intelligence in bone age assessment: accuracy and clinical Assessing liver function: diagnostic efficacy of parenchymal
efficiency of a novel fully automated algorithm for bone age enhancement and a liver volume ratio of Gd-EOB-DTPA enhanced MRI
assessment in comparison to the Greulich Pyle method studies
C. Booz, I. Yel, L. Lenga, A. Al Kamali, S. Boettger, J.L. Wichmann, D. Ippolito1, A. Pecorelli1, L. Riva2, C. Maino1, A. de Vito1, I. Salemi1,
T.J. Vogl, M.H. Albrecht, B. Bodelle; Frankfurt a. Main/DE M. Porta1, C. Talei Franzesi1, S. Sironi3; 1Monza/IT, 2Missaglia/IT,
3
Bergamo/IT
B-1363 14:52
High-resolution MR imaging of the orbit in patients with retinoblastoma: B-1373 14:24
prospective study correlated with histopathological results MR relaxometry in chronic hepatitis b and c: the contribution of Molli
Y.S. Habib, A. Youssef, H.A. ElKiki, H.A. ElZomor, M.M. Rezk; Cairo/EG T1 mapping and T2 mapping in hepatic function evaluation with Gd-
EOB-DTPA-enhanced magnetic resonance
B-1364 14:56 D. Kuru Oz, E. Peker, M. Kul, I. Erden, A. Erden; Ankara/TR
Should we still look for a correlation between ADC and SUV in
lymphoma: a volumetric [18F] FDG-PET/MR study of paediatric B-1374 14:32
Hodgkin‘s lymphoma Predicting liver failure after extended liver resection following portal
M.G. Riga1, G. Orsatti1, A. Varotto1, F. Crimì1, M. Weber2, R. Stramare1, vein embolisation with gadoxetic acid-enhanced MRI
P. Zucchetta1, E. Quaia1, C. Giraudo1; 1Padua/IT, 2Vienna/AT D. Theilig, I. Steffen, T. Denecke, B. Hamm, D. Geisel; Berlin/DE
B-1365 15:00 SPEAKER B-1375 14:40

SUPPORTED
Diagnostic value of C-reactive protein and the influence of BY Shear wave dispersion slope obtained by shear wave elastography
INVEST IN
visceral fat in patients with obesity and acute appendicitis THE YOUTH could help detect allograft abnormality after liver transplantation
1 1 1
A.D. Do Amaral Castro , F.A. Sulla Lupinacci , S. P.Pribeiro , D. Lee, J. Lee, J. Bae; Seoul/KR
E. Kaiser Ururahy Nunes Fonseca , M.R. Peixoto , T. Larocca Skare2,
1 1
A.T. Sakuma1, F. Yamauchi1, A. Tachibana1; 1São Paulo/BR, 2Curitiba/BR B-1376 14:48 SPEAKER

SUPPORTED
Spleen ARFI: a noninvasive tool for detection of oesophagal BY
INVEST IN
B-1366 15:04 varices in cirrhotics THE YOUTH
Impact of added CT venography performed in combination with CT M. Rajasekaran1, R. Rathinasamy2, M. Viyannan2,
pulmonary angiography on the detection of deep venous thrombosis D. Bala Lakshmoji2; 1Bangalore/IN, 2Coimbatore/IN
and relevant occult CT findings
P.I. Douek, D.C. Rotzinger, R. Meuli, V. Dunet, S. Schmidt Kobbe; Lausanne/CH B-1377 14:56
The extent of portosystemic collaterals depends on portal pressure
B-1367 15:08 and hepatic dysfunction rather than on PlGF-driven neoangiogenesis
Reliability of on-call radiology residents’ interpretations in detecting K. Lampichler, L. Reider, B. Simbrunner, A. Stadlmann, M. Mandorfer,
intracranial aneurysms on 640 slice multidetector computed T. Bucsics, R. Paternostro, U. Asenbaum, T. Reiberger; Vienna/AT
tomography angiography
M.B.H. Chaudhry, M. Azeemuddin, M.N. Ahmad, F. Mubarak, T.U. Haq; B-1378 15:04
Karachi/PK A comparative study of sound touch elastography measurement on
liver’s right lobe and left lobe for diagnosis of chronic liver disease
B-1368 15:12 using liver biopsy as gold standard
Forensic relevance and diagnostic impact of a novel 3D-reconstruction I. Gatos1, P. Drazinos2, S. Yarmenitis3, I. Theotokas1, A. Kanavaki1,
technique (cinematic rendering) of severe injuries in postmortem E. Manesis1, P. Zoumpoulis2; 1Athens/GR, 2Kifissia/GR, 3Marousi/GR
computed tomography
J. Böven, J. Boos, R.S. Lanzman, P. Kröpil, Y. Klosterkemper, C. Thomas, B-1379 15:12
G. Antoch, J. Aissa; Düsseldorf/DE The primary study of low-dose 640-slice volume liver perfusion CT:
a whole-organ perfusion in patients with cirrhosis of the liver before
B-1369 15:16 and after portosystemic shunting
Neonatal chest X-ray N. Djuraeva, A. Ikramov, N. Vakhidova, A. Amirkhamzaev, K. Shamirzaev,
S. Johansen; Oslo/NO A. Sultanov; Tashkent/UZ
B-1380 15:20
Saturday
14:00 - 15:30 Tech Gate Auditorium Comparison of liver stiffness evaluated by shear wave elastography in
morbidly obese patients prior to bariatric surgery with liver biopsy
Abdominal Viscera F. Rajabzadeh, A. Jangjoo, T. Jamialahmadi, L. Goshayeshi, M. Nemati,
K. Ghafarzadegan; Mashhad/IR
SS 1501b
Multimodality imaging for assessment of 14:00 - 15:30 The Church
liver function and portal hypertension Genitourinary

Moderators:
M. Garbajs; Ljubljana/SI
N.N.
SS 1507
Imaging in pregnancy and female
B-1370 14:00
Quantitative assessment of liver function before hepatectomy using tumours
two-dimensional shear wave elastography correlated with indocyanine Moderators:
green clearance test M. Basta Nikolic; Novi Sad/RS
R. Fu, T. Qiu, Q. Lu, Y. Luo; Chengdu/CN G. Masselli; Rome/IT

SUPPORTED SUPPORTED
Liver function evaluation with Gd-EOB-DTPA-enhanced MRI: BY MRI diagnostic accuracy of placental adhesion disorders BY
INVEST IN INVEST IN
can visual scoring replace signal measurement? THE YOUTH and diagnostic impact on foetal-maternal outcomes in THE YOUTH
S. Xie, J. Li, H. Wang, W. Shen; Tianjin/CN interventional radiology-assisted delivery
F. Monelli, F. Fiocchi, A. Pecchi, F. Casari, E. Bertucci, E. Petrella,
P. Torricelli; Modena/IT
B-1382 14:08
Role of shear wave elastography of placenta in the prediction of
preeclampsia in high-risk pregnancies
M. Singh1, T. Singh2, V. Singla2, V. Jain2; 1Kurukshetra/IN, 2Chandigarh/IN

B-1384 14:16 B-1394 16:16

MRI criteria and sequence evaluation for the diagnosis of placental Differentiation of clear cell and non-clear cell renal cell carcinomas by
adhesive disorder among radiologists with different reporting all-relevant radiomics features from multiphase CT
experience G. Liu, G. Wu; Shanghai/CN
J.P. Zawaideh1, J. Smith2, A. Bruining3, P.L. Moyle2, E. Sala2, H.C. Addley2,
S. Freeman2; 1Genoa/IT, 2Cambridge/UK, 3Amsterdam/NL B-1395 16:24
Influence of segmentation margin on machine learning-based
B-1385 14:24 high-dimensional quantitative CT texture analysis: an experimental
Comparison of diagnostic accuracy between clinical risk factors and MRI radiomics study on renal clear cell carcinomas
to predict placental adhesion disorders in patients with placenta previa B. Kocak, E.S. Memis Durmaz, E. Ates, M. Baykara Ulusan, O. Kilickesmez;
S. Maurea, M.I. Ginocchio, F. Verde, V. Romeo, P.P. Mainenti, M. Petretta, Istanbul/TR
L. Sarno, P. Martinelli, A. Brunetti; Naples/IT
B-1396 16:32
B-1386 14:32 To categorise ovarian epithelial cancers and predict clinical outcome
Epithelial ovarian cancer: tumour staging and detection of lymph node using multiparametric radiomics
metastasis using ADC histogram parameters H. Zhang, X. Liu, P. Zhang, G. Zhang; Shanghai/CN
F. Wang, J. Liu, Y. Wang, Y. Zhou, C. Liu, D. Liang, L. Xie; Beijing/CN
B-1397 16:40
B-1387 14:40 SPEAKER Automated multiregional prostate segmentation in magnetic
SUPPORTED
A mathematical-descriptor of tumour mesoscopic structure BY resonance using deeply supervised convolutional neural networks
INVEST IN
from CT images annotates prognostic and molecular THE YOUTH R.L. González1, V. Venugopal2, A. Jimenez-Pastor1, L. Marti-Bonmati1,
phenotypes of epithelial ovarian cancer A. Alberich-Bayarri1, M. Barnwal2, V. Mahajan2; 1Valencia/ES, 2New Delhi/IN
A.G. Rockall1, P. Lee1, H. Lu1, M.A. Arshad1, G. Avesani2, E. Curry1, A. Thornton1,
F. Kanavati1, C. Fotopoulou1, E.O. Aboagye1; 1London/UK, 2Mantova/IT B-1399 16:56
Deep learning with a convolutional neural network for predicting
B-1388 14:48 Fuhrman grade of clear cell renal cell carcinoma at MSCT
Adnexal cystic lymphangioma in patients with massive leiomyomatous X. Li1, W. Li2; 1Nanjing/CN, 2Shanghai/CN
uterus: a not so uncommon finding
C. Bourgioti, K. Chatoupis, A. Antoniou, C. Tzavara, E. Panourgias, B-1400 17:04
M. Vergetidou, L. Moulopoulos; Athens/GR Feature rejection for radiomic analyses based on variations of tumour
segmentation masks
B-1389 14:56 B. Schachtner, M. Ingrisch, E. Gresser, M.J. Schneider, A. Schreier,
MRI correlates of molecular classification of endometrial cancer: O. Solyanik, G. Magistro, D. Nörenberg; Munich/DE
a preliminary study
M. Bonatti1, R. Valletta2, F. Lombardo2, G. Avesani3, F. Erdini1, G. Negri1, B-1401 17:12
G. Zamboni2, G. Schifferle1, G. Bonatti1; 1Bolzano/IT, 2Verona/IT, Deep convolutional neural network for histopathological classification
3
Mantova/IT of pancreatic neuroendocrine neoplasms
Y. Luo; Guangzhou/CN
B-1390 15:04
The potential of IVIM model as a marker of normal placenta B-1402 17:20
microstructural changes during pregnancy: a foetal MR study Comparison of automated quantitative ultrasound image analysis vs
A. Antonelli1, L. Manganaro1, S. Capuani1, R. Grimm2, B. Kuehn2, expert scoring systems for prediction of malignancy in thyroid nodules
A. de Rinaldis2, C. Catalano1; 1Rome/IT, 2Erlangen/DE A. Galimzianova, T.S. Desser, S. Siebert, S. Syed, A. Kamaya, D. Rubin;
Stanford, CA/US
SUPPORTED
The role cerebroplacental ratio in prediction of foetal BY
INVEST IN
outcome among patients with pre-eclamsia THE YOUTH 16:00 - 17:30 Room K
S.F. Kenis, J.B. Igashi, D. Ibe, A. Saliu, N.B. Adams, I. Aliyu;
Zaria/NG Chest
B-1383 15:20
Imaging detection of placenta adhesion disorder in patients with SS 1604
placenta previa: comparison between US and MR findings
A. Volpe, V. Romeo, M.I. Ginocchio, S. Maurea, P.P. Mainenti, M. Petretta, Inflammatory, fibrotic and infectious lung
L. Sarno, P. Martinelli, A. Brunetti; Naples/IT diseases
Moderators:
C. Beigelman; Lausanne/CH
16:00 - 17:30 Room G M. Benegas; Barcelona/ES
B-1403 16:00
CT quantification of spatial heterogeneity of boundary between
SS 1605 fibrotic and non-fibrotic areas in idiopathic pulmonary fibrosis
J. Park, J. Jung, S.H. Yoon, H. Hong, J.-H. Yoon, H. Kim, J.M. Goo; Seoul/KR
Machine learning: genitourinary and
B-1404 16:08
diverse Fibrotic lung disease in MPO-ANCA positive patients
Moderators: B. Del Rio Carrero, P. Luburich Hernaiz, S. Bolivar Cuevas,
N.N. E. Carreño García, V. Vicens Zygmunt, M. Molina Molina; Barcelona/ES
N.N.
SUPPORTED
To assess clinical and radiological disease severity in a BY
population of IPF patients which differ for the presence of THE YOUTH
Can artificial intelligence predict prostate cancer local stage on diffuse pulmonary ossification (DPO) on HRCT
unenhanced MRI? A preliminary report M. Palermo, G. Sambataro, F. Tiralongo, C. Desiderio, D. Falsaperla,
R. Cuocolo, A. Stanzione, A. Ponsiglione, V. Romeo, S. Cocozza, S. Torrisi, A. Basile, C. Vancheri, S. Palmucci; Catania/IT
A. Brunetti, M. Imbriaco; Naples/IT
B-1406 16:24
B-1393 16:08 Combined pulmonary fibrosis and emphysema (CPFE):
CT based machine learning radiomics for differentiating tumour grade epidemiological and clinical features, visual scoring and quantitative
in clear cell renal cell carcinoma CT assessment in 72 patients
X. Yi, Y. Zhang, L. Liu; Changsha/CN A. Carnevale, A. Cossu, E. Cotti, M. Graziano, S. Chiarello, M. Giganti;
Ferrara/IT

B-1407 16:32 B-1419 16:20 SPEAKER

SUPPORTED
Can we reduce the radiation dose with wide-volume scan mode in a Lactate-weighted imaging of brain tumours using chemical BY
INVEST IN
320 detector-rows CT for interstitial lung disease? exchange saturation transfer (CEST) MRI at 7 Tesla THE YOUTH
A. Abdo, E. Karam, S. Leygnac, T. Henry, K. Haioun, A. Khalil, D. Paech, J.-E. Meissner, M. Wennmann, A. Radbruch,
M.-P. Debray; Paris/FR M. Bendszus, W. Wick, A. Unterberg, M. Ladd, H.-P. Schlemmer;
Heidelberg/DE
B-1408 16:40
Applying the low-dose protocol in high resolution computed B-1420 16:24
tomography examination in patients with rheumatoid arthritis Analysing the impact of sarcopenia on brain: using correlation
B. Zwierko, M. Dura, P. Zuchowski, S. Jeka; Bydgoszcz/PL between paraspinal muscle and brain volume
B-1409 16:48 SPEAKER H. Lee, H.S. Seo, Y.H. Lee; Ansan/KR
SUPPORTED
Feasibility of low-dose CT with spectral shaping and third- BY
generation iterative reconstruction in evaluating interstitial THE YOUTH
lung diseases associated with connective tissue disease Glymphatic pathway of gadolinium-based contrast agents through the
X. Xu, X. Sui, L. Song, Y. Huang, Z. Jin, W. Song; Beijing/CN brain: overlooked and misinterpreted
K. Deike-Hofmann1, J. Reuter1, D. Paech1, S. Bickelhaupt1, R. Gnirs1, M. Forsting2,
B-1410 16:56 C. Heussel1, H.-P. Schlemmer1, A. Radbruch1; 1Heidelberg/DE, 2Essen/DE
HRCT does not offer added discriminatory value for eosinophilic lung
diseases in patients presenting to a severe asthma clinic B-1422 16:32
E. Robinson, M. Mak, D. Jackson, B. Kent, G. Santis, A. Nair; London/UK Arterial spin labelling for the evaluation of immediate postoperative
residual lesion in adult brain tumours
B-1411 17:04 C. Cohen1, B. Law-Ye2, D. Dormont2, M. Sanson2, D. Galanaud2,
Relevance of high-resolution computed tomography in diagnosis N. Pyatigorskaya2; 1Tours/FR, 2Paris/FR
of infectious disease versus rejection reaction in patients after lung
transplantation with acute respiratory symptoms B-1423 16:36
S. Maier1, A. Ernst2, U. Sommerwerck3, G. Weinreich1, F. Nensa1, L. Umutlu1, Arterial spin-labeling and magnetic resonance spectroscopy as
H. Kuehl4; 1Essen/DE, 2Neustadt Holstein/DE, 3Wuppertal/DE, imaging biomarkers for the detection of epileptogenic zone in
4
Kamp-Lintfort/DE non-lesional focal impaired awareness epilepsy
R.E. Mohamed, R.M. Dawoud, A.A. Aboelsafa; Tanta/EG
B-1412 17:12
Clusters of micronodules in active pulmonary tuberculosis: prevalence,
patient characteristics, and natural history B-1424 16:40
J. Hong, S. Yoon, J. Goo, J.-J. Yim, J.-G. Im; Seoul/KR Fully automated segmentation of meningiomas using deep learning
on multiparametric MRI: automated segmentation yields accuracies as
B-1413 17:20 good as manual interreader variabilities
Correlation of USG diaphragm thickness measurements with pulmonary K.R. Laukamp, F. Thiele, L. Pennig, R.P. Reimer, G. Shakirin, D. Zopfs,
function and inspiratory strength tests in myotonic dystrophy type 1 M. Timmer, M. Perkuhn, J. Borggrefe; Cologne/DE
S. Kose, F. Koç, I. Hanta; Adana/TR
SUPPORTED
Imaging the seizure onset zone and fast electrical circuit BY
INVEST IN
16:00 - 17:30 Sky High Stage activity in epilepsy with electrical impedance tomography THE YOUTH
A. Witkowska-Wrobel, K. Aristovich, M. Faulkner, J. Avery,
Neuro D. Holder; London/UK
B-1426 16:48
MY 16 Meta-analytic investigations of grey matter alterations in patients with
Tourette syndrome
Neuro S. Zhang, W. Wang, X. Su, H. Sun, Q. Yue, Q. Gong; Chengdu/CN
Moderators:
P. Demaerel; Leuven/BE B-1429 17:00
M. Severino; Genoa/IT Brain MRI characteristics in neuromyelitis optica spectrum disorders:
a multi-center study in China
Saturday
B-1414 16:00 G. Cao, Y. Duan, W. Zhu, Y. Liu; Beijing/CN
Correlation of cerebrovascular reserve assessed by acetazolamide-
stress SPECT with collaterals on arterial spin-labeling MRI in patients B-1430 17:04
with carotid occlusive disease Less regulated, more segregated ventral visual network in patients
H. Kang, Y. Kim; Seoul/KR with major depressive disorder
SPEAKER H. Chen, J. Yan, K. Liu, Y. Deng, X. Huang, R. Su, Z. Xiaojun; Guangzhou/CN
Long-term neurodegeneration of substantia nigra secondary BY
to ipsilateral infarct is quantified with iron-sensitive imaging THE YOUTH
Extended memory network degeneration in Parkinson’s disease
and impacts motor outcome
patients with lean muscle loss
P.-A. Linck1, G. Kuchcinski2, F. Munsch3, R. Griffier1, G. Okubo4, P. Renou1,
Y.-N. Wu, W.-C. Lin, C.-H. Lu; Kaohsiung/TW
V. Dousset1, I. Sibon1, T. Tourdias1; 1Bordeaux/FR, 2Lille/FR,
3
Boston, MA/US, 4Kyoto/JP SPEAKER
B-1416 16:08 Dendritic growth and branching of the cortical neurons can BY
INVEST IN
Detection and prevalence of cerebral microbleeds in middle and old be altered by ultrasound exposition THE YOUTH
age groups: a clinical-based approach Z. Ferenczi, T. Papp, B. Szilagyi, P. Szucs, E. Berenyi, Z. Meszar;
S.E.E.E. Elbadawi; Mansoura/EG Debrecen/HU
B-1417 16:12 B-1433 17:16

Carotid artery plaque detected on ultrasound is associated with The relationship between cognitive function and magnetic resonance
impaired cognitive state in the elderly: a population-based study in spectroscopy findings in Parkinson disease patients
Wakiso district, Uganda M. Sanei Taheri, M. ArabAhmadi, H. Haghighatkhah, M. Ranjbar, M. Amiri;
M. Kenneth1, F. Ameda2, R.K. Byanyima2, N. Nakasujja2; 1Mbarara/UG, Tehran/IR
2
Kampala/UG

SUPPORTED
Are aneurysmal subarachnoid haemorrhage scales applicable BY
INVEST IN
to non-aneurysmal subarachnoid haemorrhage? THE YOUTH
D. Páez Granda, M.J. Martínez Cutillas, J. Díaz Pérez,
G. Parrilla Reverter, J. Berná-Serna, M. Espinosa de Rueda Ruiz,
B. Garcia-Villalba, J. Zamarro Parra, J. Felices Farias; Murcia/ES

08:30 - 10:00 Coffee & Talk 3 08:30 - 10:00 Room M 2

Interventional Radiology Head and Neck
SS 1709 SS 1708
Nonvascular liver interventions Miscellaneous and orbits
T. Albrecht; Berlin/DE D. Franceski; Zagreb/HR
T. Andrasina; Brno/CZ N.N.
B-1434 08:30 B-1445 08:30

Percutaneous stereotactic CT-based microwave ablation for Comparison of single shot echo planar imaging and turbo spin
neuroendocrine liver metastasis echo diffusion weighted imaging of the orbit in patients with uveal
M.H. Maurer, A. Lachenmayer, G. Beldi, D. Candinas, J.T. Heverhagen, melanoma
C. Kim-Fuchs; Berne/CH E. Gumeler, S. Parlak, G. Yazici, E. Karabulut, H. Kiratli, H.K. Karli Oguz;
Ankara/TR
B-1435 08:38
Minocycline hydrochloride as a soft sclerosing agent for symptomatic B-1446 08:38 SPEAKER
SUPPORTED
simple renal and hepatic cysts: our experience MRI in the assessment of orbital invasion: diagnostic BY
INVEST IN
A. Paladini1, D. Beomonte Zobel2, M. Falcione2, A. Borzelli3, C. Di Stasi2, accuracy and impact on surgical planning THE YOUTH
A. Cina2, G.E. Vallati2, G. Pizzi2, E.M. Amodeo2; 1Novara/IT, 2Rome/IT, G. Nocivelli, M. Ravanelli, M. Ferrari, A. Deganello, R. Maroldi,
3
Naples/IT D. Farina; Brescia/IT
B-1436 08:46 SPEAKER B-1447 08:46

SUPPORTED
Reduced periablational inflammation for microwave ablation BY The intrinsic iodine content of the thyroid is correlated to the HU value
INVEST IN
(MWA) compared to radiofrequency (RF) and irreversible THE YOUTH of the thyroid on true non-contrast scans
electroporation (IRE) A.M.J.L. van Kroonenburgh, S.M.J. van Kuijk, A.A. Jacobi-Postma;
M. Kak, N. Goldberg; Jerusalem/IL Maastricht/NL
B-1437 08:54 B-1448 08:54

Safety and efficacy of IRE after major liver surgery Additional diagnostic value of dynamic MRI sequences in patients with
A. Barabasch1, P. Heil2, M. Distelmaier1, C.K. Kuhl1, P. Bruners1; 1Aachen/DE, temporomandibular joint dysfunction compared to static imaging
2
Essen/DE J.-E. Scholtz, D. Günther, T.J. Vogl; Frankfurt a. Main/DE
B-1438 09:02 B-1449 09:02

Stereotactic image-guided microwave ablation of hepatocellular Pilot study of three-dimensional MRI in the evaluation of eye shape of
carcinoma high myopia and classification of posterior staphyloma
M.H. Maurer, V. Banz-Wüthrich, G. Beldi, C. Kim-Fuchs, D. Candinas, L. Zheng, L. Zhang, G. Zhang; Shanghai/CN
P. Tinguely, J.T. Heverhagen, A. Lachenmayer; Berne/CH
SUPPORTED
B-1439 09:10 Mineralisation patterns of laryngeal cartilages: normal BY
INVEST IN
Comparison between percutaneous and laparoscopic microwave variations and their clinical impact THE YOUTH
ablation of hepatocellular carcinoma R.H. Kshirsagar, N. Sable, A. Mahajan, M. Thakur; Mumbai/IN
A. Della Corte, P. Marra, F. Ratti, F. Giombi, S. Gusmini, M. Salvioni,
M. Venturini, L. Aldrighetti, F. De Cobelli; Milan/IT B-1451 09:18
Orbital adnexal lymphoma: diagnosis and follow-up with combined
B-1440 09:18 [18F]FDG-PET-CT
Value of ultrasound fusion imaging for the thermal ablation of U.G. Mueller-Lisse, A. Klingenstein, A. Garip-Kuebler, C. Hintschich;
medium-sized hepatocellular carcinoma Munich/DE
E. Xu, L. Luo, K. Li, Q. Zeng, L. Tan, Y. Long, Q. Huang, R. Zheng;
Guangzhou/CN B-1452 09:26
Validation of exophthalmos MRI measurements in patients with Graves
B-1441 09:26 orbitopathy, compared to opthalmometry results
Radiofrequency ablation of liver cancers adjacent to the gallbladder E. Wnuk, E. Maj, A. Jabłońska-Pawlak, O. Rowinski; Warsaw/PL
without additional invasive measures under contrast-enhanced
ultrasound monitoring: a preliminary study B-1453 09:34 SPEAKER
SUPPORTED
E. Xu, Y. Long, R. Yan, K. Li, L. Luo, Q. Zeng, L. Tan, M. Zhang, R. Zheng; Evaluation of quantitative shear wave sonoelastography of BY
INVEST IN
Guangzhou/CN major salivary glands in Sjögren‘s syndrome THE YOUTH
E. Temel, E. Cindil, S. Ozhan Oktar, N.B. Demir, H.N. Sendur,
B-1442 09:34 S. Haznedaroğlu, H. Satis, R. Bilici Salman; Ankara/TR
Stereotactic image-guided microwave ablation for malignant liver
Sunday
tumours: can computer-assistance broaden treatment eligibility? B-1454 09:42

M.H. Maurer, A. Lachenmayer, V. Banz-Wüthrich, S. Weber, D. Candinas, Visualisation of the maxillary nerve using a micro-surface coil and
J.T. Heverhagen, P. Tinguely; Berne/CH three-dimensional double-echo steady state with water excitation
sequence
B-1443 09:42 G. Hong, M. Zou, Z. Yang; Guangzhou/CN
Percutaneous cryoablation in early-stage hepatocellular carcinoma:
analysis of local tumour progression factors B-1455 09:50
D.K. Kim, K. Han; Seoul/KR An audit of the use of ultrasound scanning in investigation of
paediatric inflammatory neck masses
B-1444 09:50 P. Gammack, A. Harper, S. Alexander, J. Jones; Edinburgh/UK
TRANS-FUSIMO: preliminary in-vivo animal results of MR-guided
focused ultrasound of liver under respiratory motion
C. Gagliardo1, P. Toia1, M. Schwenke2, J. Strehlow2, L. Cicero1, G. Cassata1,
A. Melzer3, T. Preusser2, M. Midiri1; 1Palermo/IT, 2Bremen/DE,
3
Dundee/UK

08:30 - 10:00 Room M 3 08:30 - 10:00 Sky High Stage

Oncologic Imaging Abdominal Viscera
SS 1716 MY 17
Which whole-body exam should I choose? Abdominal Viscera and Gastrointestinal
Moderators:
N. Bogveradze; Tbilisi/GE
Tract
G. Cook; London/UK Moderators:
L.K. Blomqvist; Stockholm/SE
K-33 08:30
Keynote lecture
M.E. Mayerhöfer; Vienna/AT B-1466 08:30
Gadoxetic acid-enhanced liver MR can predict tumour recurrence after
curative treatment for small single hepatocellular carcinoma
B-1456 08:39
D. Lee, J. Lee; Seoul/KR
Comparison of 68Ga-DOTATOC PET-MRI and MRI-DWI for whole body
staging of patients with neuroendocrine tumours
A. Salem1, J. Grueneisen1, B.M. Schaarschmidt2, M. Chodyla1, O. Martin2, B-1467 08:34
C. Rischpler3, M. Forsting1, K. Herrmann1, L. Umutlu1; 1Essen/DE, Radiomics of gadoxetic acid-enhanced MRI: a predictive biomarker for
2
Düsseldorf/DE, 3Munich/DE CK19-positive hepatocellular carcinoma
W. Wang1, Y. Ding1, L. Yang1, M. Zeng1, S.-X. Rao1, J. Tian2; 1Shanghai/CN,
2
Xi‘an/CN
B-1457 08:47
Whole body low-dose CT-study combined with model based iterative
reconstruction algorithm for follow-up of oncologic patients: image B-1468 08:38
quality and dose deduction Intra-individual comparison of the MRI contrast agents gadoxetic acid
D. Ippolito1, I. Salemi1, C. Talei Franzesi1, C. Maino1, L. Riva2, A. de Vito1, vs gadoteric acid in liver MRI of patients with HCC and underlying
C. Massimo1, T. Giandola1, S. Sironi3; 1Monza/IT, 2Missaglia/IT, cirrhosis
3
Bergamo/IT M. Della Seta, F. Collettini, M. Schmelzle, N. Raschzok, B. Hamm,
T. Denecke; Berlin/DE
B-1459 09:03
F-18 FDG PET/CT compared to Tc-99m MDP Bone scintigraphy in B-1469 08:42
assessment of metastatic osseous disease in patients with breast MRI of hepatocellular adenomas: is there an additional value of using
cancer and the relation to serum CA15-3 and alkaline phosphatase Gd-EOB for subtype differentiation?
H. Nasr1, N. Alnajashi2, A. Alqarni2, H. Farghaly3; 1Cairo/EG, 2Riyadh/SA, T.A. Auer1, C. Grieser2, D. Geisel1, B. Hamm1, T. Denecke1; 1Berlin/DE,
2
3
Assiut/EG Bremen/DE
B-1460 09:11 B-1470 08:46

Comparison of capability for TNM stage assessment among whole- Quantification of hepatic steatosis: evaluation of 4 MRI techniques vs
body MRI and PET/MRI at different field strength and FDG-PET/CT in reference method by biopsy
non-small cell lung cancer C. Boudinaud, A. Abergel, M. Fontarensky, J. Joubert Zakeyh, L. Boyer,
Y. Ohno1, K. Aoyagi2, M. Yui2, Y. Kishida1, S. Seki1, T. Yoshikawa1, B. Magnin; Clermont-Ferrand/FR
T. Murakami1; 1Kobe/JP, 2Otawara/JP
B-1471 08:50
B-1461 09:19 The value of MRI-PDFF in detecting and grading hepatic steatosis in
Does PET/MR improve lesion detection in oncology: a prospective patients with nonalcoholic fatty liver disease: a meta-analysis
unicentre study in 1003 examinations Z. Ye, X. Xiong, J. Chen, L. Cao, T. Duan, Z. Zhang, B. Song; Chengdu/CN
B.M. Schaarschmidt1, O. Martin2, J. Kirchner2, J. Grueneisen1, P. Heusch2,
M. Forsting1, G. Antoch2, K. Herrmann1, L. Umutlu1; 1Essen/DE, B-1472 08:54
2
Düsseldorf/DE Dual-energy CT in patients with fatty liver disease: improved
assessment of hypoattenuating liver lesions using virtual
B-1462 09:27 monoenergetic imaging
Prospective comparison of whole-body MRI and 68Ga-PSMA PET/CT for L. Lenga1, I. Yel1, C. Booz1, S.S. Martin2, J.-E. Scholtz1, T.J. Vogl1,
the detection of biochemical recurrence of prostate cancer J.L. Wichmann1, M.H. Albrecht1; 1Frankfurt/DE, 2Charleston, SC/US
L.M. Sawicki, C. Buddensieck, J. Boos, J. Kirchner, T. Ullrich, R. Rabenalt,
P. Albers, G. Antoch, H. Hautzel; Düsseldorf/DE B-1473 08:58
CT-based liver surface nodularity score for noninvasive assessment of
B-1463 09:35 clinically significant portal hypertension
Whole body MR imaging and MR-guided biopsy in initial diagnosis and A. Abou Elkassem1, A.M.K. Abdel Aal1, A. Gunn1, K. Mahmoud1, S. Lirette2,
follow-up of paediatric malignancies: comparison with other imaging A. Smith1; 1Birmingham, AL/US, 2Jackson, MS/US
modalities
T. Woerner, A. Buecker, G. Schneider; Homburg/DE B-1474 09:02
Sunday
Clinical significance of pancreatic steatosis: association between

B-1464 09:43 pancreatic exocrine insufficiency and organ fat content
Utility of 3T MRI whole-body DWI in onco-imaging for the detection of M.-L. Kromrey1, N. Friedrich1, R.-T. Hoffmann2, R. Bülow1, U. Motosugi3,
metastasis: comparison with PET/CT J.-P. Kühn1; 1Greifswald/DE, 2Dresden/DE, 3Yamanashi/JP
D.H. Vijayakumar1, M.M. Kulkarni2; 1Bangalore/IN, 2Mumbai/IN
B-1475 09:06
B-1465 09:51 T1 mapping of autoimmune pancreatitis as a quantitative outcome
Impact of spectral imaging in patients suspected for occult cancer: biomarker
a study of 93 patients L. Zhu1, Z.-y. Sun1, Z.-y. Jin1, T.-y. Qian1, D. Nickel2, M. Makowski3,
M.B. Andersen1, D. Ebbesen2, J. Thygesen3, M. Kruis4, F.R. Rasmussen3; P. Asbach3, B. Hamm3, H.-d. Xue1; 1Beijing/CN, 2Erlangen/DE, 3Berlin/DE
1
Roskilde/DK, 2Viborg/DK, 3Aarhus/DK, 4Copenhagen/DK
B-1476 09:10
Combination of diffusion kurtosis imaging and conventional MRI helps
to differentiate fibrotic from inflammatory bowel strictures in patients
with Crohn’s disease
J. Du, X. Li, L. Huang, S. Huang, Z. Li; Guangzhou/CN

B-1477 09:14 B-1490 11:02

Perfusion fraction derived from IVIM-DWI may facilitate differentiation CT scan chest: a new approach to lung cancer
of moderate to severe inflammation in ulcerative colitis A. Bernardo, F. Gonçalves, M.O. Fernandes; Lisbon/PT
J. Podgorska, K. Pasicz, E. Zagórowicz, A. Mróz, B. Gołębiewski, P. Kus,
J. Jasieniak, W. Skrzyński, A. Cieszanowski; Warsaw/PL B-1492 11:18
Eye lens protection: new perspective
B-1478 09:18 A.J.C.D. Cunha; Braganza/PT
Machine learning-based analysis of rectal cancer MRI radiomics for
prediction of metachronous liver metastasis B-1493 11:26
M. Liang, X. Zhao; Beijing/CN Development of 3D printed quality control tool for X-Ray beam
alignment and collimation evaluation
B-1479 09:22 SPEAKER M.V.L. Oliveira, J. Barros; Salvador/BR
SUPPORTED
MRI-detected extramural vascular invasion is a strong risk BY
INVEST IN
factor in predicting distant metastasis in rectal cancer THE YOUTH B-1494 11:34
P. Tripathi1, D. Hu1, M. Zeng2, W. Guo2, S. Rao2, B. Rai1; Portuguese diagnostic reference levels national survey
1
Wuhan/CN, 2Shanghai/CN J. Santos1, P.M. Teles2, M.C. Sousa1, G. Paulo1, J. Venancio2,
F. Caseiro Alves1, A. Figueira3, P. Rosario2, P. Vaz2; 1Coimbra/PT,
B-1480 09:26 2
Lisbon/PT, 3Porto/PT
DWI and high-resolution T2WI-volumetry association with
lymphovascular invasion and N-stages in resectable rectal cancer B-1495 11:42
X. Chen, H. Li; Chengdu/CN FoRRM: a pilot research mentoring scheme for radiographers in the
UK: what have we achieved? An evaluation
B-1482 09:30 C. Malamateniou1, F. Mellor2, R. Appleyard3, H. McNair1, K. Knapp4;
1
Prediction of gastric and esophagogastric junction cancer response to London/UK, 2Bournemouth/UK, 3Sheffield/UK, 4Exeter/UK
neoadjuvant treatment by functional imaging with PCT
J. Kruk-Bachonko, W. Krupski, T. Skoczylas; Lublin/PL B-1496 11:50
Dementia patient care in the medical imaging department
B-1483 09:34 R. Challen, L.-F. Low, M.F. McEntee; Sydney/AU
Added value of MRI to endoscopic and endosonographic response
assessment after neoadjuvant chemoradiotherapy in oesophageal
cancer: a pilot study 10:30 - 12:00 Room X
S.E. Vollenbrock, J.M. van Dieren, F.E.M. Voncken, S.T. van Turenhout,
L.L. Peppelenbosch-Kodach, K.J. Hartemink, B.M.P. Aleman, Vascular
R.G.H. Beets-Tan, A. Bartels-Rutten; Amsterdam/NL
B-1484 09:38 SS 1815

Multiparametric combined FDG-PET/CT and MR imaging to predict
response to chemoradiotherapy in rectal cancer: whole tumour versus Imaging of the thoracic aorta
sub-volume analysis Moderators:
N.W. Schurink1, M. Berbee2, J.J.M. van Griethuysen1, W. van Elmpt2, P.I. Kalmar; Graz/AT
M. Maas1, M.J. Lahaye1, F.C.H. Bakers2, R.G.H. Beets-Tan1, N.N.
D.M. Lambregts1; 1Amsterdam/NL, 2Maastricht/NL
K-34 10:30
Rectal wall T2 relative signal intensity: a non -invasive biomarker N.N.
of gastro-intestinal (GI) toxicity in patients treated with pelvic
radiotherapy (RT) B-1497 10:39
G. Della Vecchia, A. Di Chiara, M. Panzeri, A. Palmisano, A. Esposito, A clinically driven new classification for aortic dissections
P. Passoni, C. Fiorino, A. Del Maschio, F. De Cobelli; Milan/IT S. Malekzadeh1, D. Bodenmann2, A. Topolski1, A.-M. Jouannic1,
S.D. Qanadli1; 1Lausanne/CH, 2Frauenfeld/CH
10:30 - 12:00 Room C B-1498 10:47

Application value of dual-source CT combined with intelligent
Radiographers modulation and iterative reconstruction in aortic dissection imaging
P. Jin; Chengdu/CN
SS 1814 B-1499 10:55

Role of the cardiosynchronised computed tomography angiography in
CT and professional issues in the dissection of descending thoracic aorta
radiography C. Ruggieri, S. Veglia, A. Ruffino, G. Ciccone, A. Evangelista, O. Davini;
Turin/IT
Moderators:
R. Demuth; Dudelange/LU
J.M. Nightingale; Sheffield/UK B-1500 11:03
Thoracic aortic fluid dynamics in bicuspid valve patients: correlations
with valvular morphology using 4D-flow magnetic resonance imaging
B-1486 10:30 G. Pambianchi, N. Galea, I. Carbone, F. Cilia, F. Catapano, M. Francone,
Brain CT with 64- and 16-slice CT scans: comparison of image quality
and radiation dose with standard protocols
M.M. Abuzaid1, W. Elshami1, A.A. Sulieman2, C. Kappas3; 1Sharjah/AE,
2
Alkharj/SA, 3Larissa/GR B-1501 11:11
Follow-up of thoracic aorta diseases with concurrent evaluation of
coronary arteries using wide-detector-coverage CT with low-dose
B-1487 10:38 protocol
Physicians knowledge and perceptions of radiation dose and inherent
A.D. Annoni, M.E. Mancini, A. Formenti, G. Muscogiuri, M. Guglielmo,
risks in computed tomography examinations
S. Mushtaq, G. Pontone, M. Pepi, D. Andreini; Milan/IT
M. Gharbi, F. Aouini, H. Kamoun; Tunis/TN
B-1489 10:54 B-1502 11:19

ECG-gated MR angiography at 3T for follow-up after aortic surgery
Adaptive statistical iterative reconstruction for computed tomography
involving the ascending aorta
of the spine
A. Busse1, C. Neßelmann1, A. Hoffman2, P.M. Dohmen1, M.-A. Weber1,
M. Tsuda; Yonago/JP
F.G. Meinel1; 1Rostock/DE, 2Wuppertal/DE

B-1503 11:27 B-1513 11:27

Real-time patient-specific scan initiation for CT of the thoracic aorta: Quantification of abdominal fat and skeletal muscle tissue at
impact on image quality CT: associations between single-slice measurements and total
F.R. Schwartz1, J.C. Ramirez Giraldo1, R. Gutjahr2, D. Boll3, D. Marin1, compartment volumes
L. Hurwitz1; 1Durham, NC/US, 2Nürnberg/DE, 3Basle/CH A. Faron, J. Luetkens, F.C. Schmeel, A. Sprinkart, D. Thomas; Bonn/DE
B-1504 11:35 B-1514 11:35 SPEAKER

SUPPORTED
A preliminary study of CT spectral imaging on patients with aortic Distribution patterns of intra- and extra-myocellular fat BY
INVEST IN
dissection using revolution CT by magnetic resonance imaging in subjects with diabetes, THE YOUTH
B. Wen; Beijing/CN prediabetes and healthy controls from a population-based
cohort
B-1505 11:43 SPEAKER L.S. Kiefer1, J. Fabian1, S. Rospleszcz2, C. Storz1, C.L. Schlett3,
SUPPORTED
ECG-gated CTA of thorax aorta with extended data BY F.W. Roemer4, K. Nikolaou1, F. Bamberg5; 1Tübingen/DE, 2Munich/DE,
INVEST IN
postprocessing in ascending aorta aneurism diagnosis THE YOUTH 3
Heidelberg/DE, 4Erlangen/DE, 5Freiburg/DE
A. Skripnik, V. Fokin, R. Mironchuk, G.E. Trufanov, O. Moiseeva,
O. Irtyuga, V. Uspenskiy, E. Malev, P. Murtazalieva; St. Petersburg/RU B-1515 11:43 SPEAKER
SUPPORTED
Assessment of skeletal muscle mass by magnetic resonance BY
INVEST IN
B-1506 11:51 imaging in a population-based cohort THE YOUTH
Age at aortic coarctation reconstruction is correlated with aortic L.S. Kiefer1, J. Fabian1, S. Rospleszcz2, C. Storz1, C.L. Schlett3,
4 1 5 1 2
vessel wall stiffening: an evaluation of pulse wave velocity and wall F.W. Roemer , K. Nikolaou , F. Bamberg ; Tübingen/DE, Munich/DE,
3
shear stress from 4D flow MRI Heidelberg/DE, 4Erlangen/DE, 5Freiburg/DE
J.F. Juffermans, I. Nederend, P. van den Boogaard, A.A.W. Roest,
J.J. Westenberg, H.J. Lamb; Leiden/NL B-1516 11:51
Magnetic resonance spectroscopy in muscle tissue and bone marrow
to identify that a body was previously frozen and is meanwhile thawed
10:30 - 12:00 Room O D. Gascho, J. Heimer, M. Thali, N. Zoelch; Zurich/CH
Musculoskeletal
10:30 - 12:00 Studio 2019
SS 1810 Imaging Informatics
Knee and muscle imaging
Moderators: SS 1805a
M. Nevalainen; Oulu/FI
E. Springer; Vienna/AT Machine learning in breast imaging
Moderators:
K-35 08:30 U. Bick; Berlin/DE
Keynote lecture M O. Diaz; Girona/ES
N.N.
B-1517 10:30
Autodetection of mass and lymph node in breast mammography
B-1507 10:39 images with deep learning method
Medial meniscal ossicle is associated with medial posterior root tear S. Liang1, J. Ma1, C. Xia1, Y. Deng1, R. Zhang1, Z. Yu2; 1Beijing/CN,
and ACL tear: a case-controlled multicentric SIMS study of 42 cases 2
Zhengzhou/CN
A. Caudal1, G. Lefebvre2, D. Guenoun3, G. Corcos4, J.-F. Nisolle5,
V. Vuillemin-Bodaghi4, B. Vande Berg5; 1Nice/FR, 2Lille/FR, 3Marseille/FR, B-1518 10:38
4
Paris/FR, 5Brussels/BE Integration of AI into the breast MRI assessment enables objective and
accurate diagnosis even by an unexperienced reader
B-1508 10:47 S. Ellmann, M. Dietzel, E. Wenkel, C. Bielowski, R. Schulz-Wendtland,
Rupture of the anterolateral ligament in complete acute traumatic M. Uder, T. Bäuerle; Erlangen/DE
anterior cruciate ligament tear: new insights into acute pivot shift
trauma to the knee B-1519 10:46
M.T. Mastio1, A. Duarte Vallejo2, J. Raya1, L. Jazrawi1, J.T. Bencardino3; Texture features from mammographymay predict the characterisation
1
New York, NY/US, 2Bogota/CO, 3Great Neck, NY/US of breast tumours
Y. Li, Y. Cui, J. Zhu, W. Li; Jinan/CN
B-1509 10:55
Healing of the anterior cruciate ligament following primary repair: B-1520 10:54
a longitudinal DTI study Prediction of benign and malignant breast masses using digital
E. De Smet1, T. Billiet2, C. Heusdens1, P.M. Parizel1, P. Van Dyck1; mammograms texture features
1
Edegem/BE, 2Leuven/BE Y. Cui, Y. Li, Y. Yin, B. Li, J. Dong, J. Zhu; Jinan/CN
B-1510 11:03 B-1521 11:02

Can pre-operative MR imaging findings predict early failure following
Sunday
Can image registration support radiologists in breast tomosynthesis

anterior cruciate ligament reconstruction? image reading?
M. Mastio1, A. Duarte1, J. Raya1, L. Jazrawi1, J.T. Bencardino2; M. Costa1, D. Ermacora1, S. Pesente1, G. Simonetti1, E. Belladonna2,
1
New York, NY/US, 2Great Neck, NY/US M. Tonutti2; 1Udine/IT, 2Trieste/IT
B-1511 11:11 B-1522 11:10

Feasibility of lower limb muscle volume estimation during contraction Machine learning can combine B mode ultrasound and strain
with real-time dynamic MRI: implications to clinical diagnostics elastography features to better characterise BIRADS 3 and 4 lesions
M. Garetier, R. Grimandi, F. Tissier, C. Pons-Becmeur, D. Ben Salem, A. Prakash; Jaipur/IN
B. Borotikar; Brest/FR
SPEAKER B-1523 11:18

B-1512 11:19 SUPPORTED Computer-aided detection of breast masses in dedicated breast CT
Musculoskeletal elastography: exploration of confounders in BY
INVEST IN images using adaptive parenchyma local search and deep learning
a challenging field THE YOUTH M. Caballo, J. Teuwen, R.M. Mann, I. Sechopoulos; Nijmegen/NL
L. Ruby1, S.J. Sanabria1, T. Mutschler1, K. Martini1,
T. Frauenfelder1, V. Klingmüller2, M. Rominger1; 1Zurich/CH, 2Marburg/DE

B-1524 11:26 B-1535 11:26

Artificial intelligence CAD system capability to classify breast density Liver fibrosis and inflammation: influence on the 3D multi-echo Dixon
by mammography parameters in patients with chronic liver diseases
E.F. Fleury, P.E.Z. de Assis, F.A. Azevedo, R. Lotufo; Sao Paulo/BR F. Hu, B. Song, R. Yang, M. Wang; Chengdu/CN
B-1525 11:34 B-1536 11:34

Automatic deep learning-based denoising filter for 4D dedicated 2D MRE liver stiffness values are nearly equivalent for three sequence
breast CT perfusion imaging of breast cancer types across four multi-centre drug-development clinical trials
M. Caballo, R.M. Mann, I. Sechopoulos; Nijmegen/NL M.S. Middleton1, W.C. Henderson1, A.L. Louie1, R. Myers2, S. Djedjos2,
C. Sirlin3; 1La Jolla, CA/US, 2Foster City, CA/US, 3San Diego, CA/US
B-1526 11:42
Ability of an artificial intelligence CAD system to determine quality B-1537 11:42
control of the mammographic study Comparison of sound touch elastography (STE) and vibration-
E.F. Fleury, P.E. de Assis, F.A. Azevedo, R. Lotufo; Sao Paulo/BR controlled transient elastography (VCTE) using liver biopsy as a
reference for diagnosis of chronic liver disease
B-1527 11:50 I. Gatos1, P. Drazinos2, S. Yarmenitis3, I. Theotokas1, A. Kanavaki1,
Scatter radiation correction in digital breast tomosynthesis with a E. Manesis1, P. Zoumpoulis2; 1Athens/GR, 2Kifissia/GR, 3Marousi/GR
deep learning convolutional neural network
A. Rodriguez Ruiz1, C. Fedon2, K. Michielsen3, I. Sechopoulos1; B-1538 11:50
1
Nijmegen/NL, 2Trieste/IT, 3Leuven/BE Liver fibrosis staging with Cannon shear wave elastography:
comparison with three other non-invasive tools using histologic
criteria as a reference standard
10:30 - 12:00 Coffee & Talk 2 S. Byun, J. Lee, J. Min, K. Shin, S. You, K. Cheon, I. Song, K. Kim;
Daejeon/KR
Abdominal Viscera
10:30 - 12:00 Room E1

SS 1801a
Breast
Diffuse liver disease: fibrosis, steatosis
and inflammation SS 1802a
Moderators:
T. Denecke; Berlin/DE Radiation dose, quality assurance, and
M.M. França; Porto/PT
safety in breast imaging
B-1528 10:30 Moderators:
Prospective comparison of transient elastography (1D-TE), shear wave I. Kralik; Zagreb/HR
elastography (2D-SWE) and magnetic resonance elastography (MRE) N.N.
for assessment of liver fibrosis in HCV patients
J. Matos, I. Mussetto, F. Paparo, S. Perugin Bernardi, M. De Cesari, B-1539 10:30
L. Cevasco, G. Cenderello, L. Bacigalupo, G.A. Rollandi; Genoa/IT Multiparameter dose monitoring in mammography: the use of
combined breast thickness and density determined DRLs
B-1529 10:38 SPEAKER L. Cockmartin, K. Lemmens, A. Jacobs, J. Binst, H. Bosmans; Leuven/BE
SUPPORTED
Liver stiffness quantification in patients with non-alcoholic BY
INVEST IN
steatohepatitis: comparison of shear wave elastography and THE YOUTH B-1540 10:38
transient elastography with liver biopsy correlation Accuracy of mammography dosimetry in the era of the European
G. Caruana, A. Taibbi, S. Petta, R. Cannella, G. Busè, G. Cutaia, Directive 2013/59/Euratom transposition
D. Giambelluca, V. Di Marco, T.V. Bartolotta; Palermo/IT G. Gennaro1, S. Bigolaro1, M. Hill2, R. Stramare1, F. Caumo1; 1Padua/IT,
2
Wellington/NZ
B-1530 10:46
Comparison of sound touch elastography (STE) and shear wave B-1541 10:46
elastography (SWE) using liver biopsy as ‘gold standard’ for chronic First clinical application of spiral breast CT with photon-counting
liver disease assessment detector: patient-specific radiation dose assessment
I. Gatos1, P. Drazinos2, S. Yarmenitis3, I. Theotokas1, A. Soultatos1, N. Saltybaeava1, M. Marcon1, N. Berger1, D. Kolditz2, C. Steiding2, A. Boss1,
E. Panteleakou1, P. Zoumpoulis2; 1Athens/GR, 2Kifissia/GR, 3Marousi/GR H. Alkadhi1; 1Zurich/CH, 2Erlangen/DE
B-1531 10:54 B-1542 10:54

Volumetric iodine density using dual-layer spectral CT for liver fibrosis Gadolinium deposits in healthy women undergoing repetitive
staging and histopathological correlation GDBCA-enhanced breast MRI in the context of high-risk breast cancer
L. Wang, R. Li, F. Yan, J. Qiang, Q. Han, X. Chen; Shanghai/CN screening
B.I. Bennani-Baiti1, K.B. Krug2, D. Giese2, K. Weiss2, T.H. Helbich1,
B-1532 11:02 P.A.T. Baltzer1; 1Vienna/AT, 2Cologne/DE
Reproducibility of shear wave dispersion imaging for evaluation of
non-alcoholic fatty liver disease B-1543 11:02
J. Yoo, J. Lee, H.-J. Kang, S. Ahn; Seoul/KR Mammography positioning errors: a multi-centre study
N. Sharma1, S. Schofield2, M. Fletcher1, R.L. Hammond3, A. N. Larson3,
B-1533 11:10 A.S. Bakken3, E. Handberg3, N.-M. Hopland3, S.E. Iles2; 1Leeds/UK,
2
Are there different cut-off values for staging liver fibrosis using Halifax, NS/CA, 3Oslo/NO
2D-SWE implemented on different systems from the same
manufacturer? B-1544 11:10
I. Sporea, F.B. Bende, A.S. Popescu, R. Sirli, M. Danila; Timisoara/RO Post-contrast cone-beam breast-CT without the prior pre-contrast
scan: can we reduce radiation exposure while maintaining diagnostic
B-1534 11:18 SPEAKER accuracy?
SUPPORTED
Differentiating mild and substantial fibrosis from normal BY S. Wienbeck, U. Fischer, J. Lotz, J. Uhlig; Göttingen/DE
INVEST IN
subjects: comparison of diffusion-kurtosis imaging and THE YOUTH
conventional diffusion-weighted imaging B-1545 11:18
S. Xie, Q. Li, H. Qi, Y. Cheng, W. Shen; Tianjin/CN Local diagnostic reference levels in mammography: setting a
maximum/alarm dose in a diagnostic mammography unit using dose
monitoring software
R.M.A. Hegazy1, E.A. Aghahowa2, R. Yasin3, A. Eduarte2; 1Cairo/EG,
2
Kuwait/KW, 3Menofia/EG

B-1546 11:26 B-1557 11:26

A new technique in mammography: self-compression-survey of patient Structural integrity impact of focused ultrasound thalamotomy and
contentedness correlation to behavioural outcomes for tremor disorders
S. Ulus, O. Kovan, A. Arslan, P. Elpen, M.E. Aribal; Istanbul/TR G. Zur, O. Lesman-Segev, I. Schlesinger, A. Eran, I. Kahn; Haifa/IL
B-1547 11:34 B-1558 11:34

Impact of a radiological consultation on the surgical management of Lewy body dementia and posterior cortical variant of Alzheimer‘s
breast cancer patients: a retrospective study of 1114 cases disease: distinguishing imaging patterns on FDG PET/CT and 99mTc-
C. Dratwa; Paris/FR TRODAT SPECT scan
V. Gupta, R. Verma, R. Ranjan, E. Belho, H. Mahajan; Delhi/IN
B-1548 11:42
Improving quality assurance in DBT breast screening by visual search B-1559 11:42
monitoring Analysis the changes of white matter structure with tract-based spatial
Y. Chen1, E. Michalopoulou1, A.G. Gale1, D. Bernardi2; 1Loughborough/UK, statistics according to diffusion tensor imaging in Parkinson’s disease
2
Trento/IT C. Chen, J. Cheng; Zhengzhou/CN
B-1549 11:50 B-1560 11:50

Diagnostic performance of low dose contrast-enhanced dual energy The value of MR neurography in the differential diagnosis between
mammography in comparison to contrast-enhanced MRI amyotrophic lateral sclerosis and multifocal motor neuropathy
P. Clauser1, P.A.T. Baltzer1, P. Kapetas1, R.A. Woitek1, F. Leone2, M. Kronlage1, K. Knop2, D. Schwarz1, T. Godel1, S. Heiland1, M. Bendszus1,
K. Pinker-Domenig1, M. Weber1, M. Bernathova1, T.H. Helbich1; 1Vienna/AT, P. Bäumer1; 1Heidelberg/DE, 2Hamburg/DE
2
Milan/IT
10:30 - 12:00 Room F2

10:30 - 12:00 Room E2
Breast
Neuro
SS 1802b
SS 1811a DWI, spectroscopy and other advanced
Parkinson and related disorders breast MR techniques
Moderators:
S. Cocozza; Naples/IT. Moderators:
M.d.F. Vasco Aragão; Recife/BR. N. Radovic; Zagreb/HR
N.N.
SUPPORTED
Advanced imaging technique in diagnosis of Parkinson’s BY K-36 10:30
INVEST IN Keynote lecture
disease: quantitative MRI mapping of substantia nigra THE YOUTH
M.V.M. Micelli1, A. Corridore1, S. Torlone1, L. Panebianco1, P.A.T. Baltzer; Vienna/AT
P. Cerrone , M. Martino , P. Sucapane , A. Splendiani , C. Masciocchi1;
1 2 1 1
SPEAKER
1
L‘Aquila/IT, 2Rome/IT B-1561 10:39 SUPPORTED
Screening-like single- and double-reading of DWI for breast BY
INVEST IN
B-1551 10:38 cancer detection THE YOUTH
Executive network integrity predicts sarcopenia in patients with F. Pesapane, E. Cassano, A. Rotili, S. Penco, R.M. Trimboli,
Parkinson‘s disease F. Sardanelli; Milan/IT
C.Y. Lee, Y.-S. Chen, P.-C. Chen, C.-H. Lu, W.-C. Lin; Kaohsiung/TW
B-1562 10:47
B-1552 10:46 Diffusion-weighted imaging with background suppression in detection
Treatment of essential tremor (ET) and Parkinson disease (PD) tremor of breast malignancies: a non-invasive, non-contrast and non-radiation
with MRgFUS: preliminary results from 21 patients in a single centre technique
F. Bruno, M. Micelli, L. Panebianco, F. Arrigoni, M. Varrassi, A. Catalucci, P. Yadav1, V. Kulkarni1, Y. Patil1, S. Harit2; 1Pune/IN, 2Manipal/IN
P. Sucapane, A. Ricci, C. Masciocchi; L‘Aquila/IT
B-1563 10:55
B-1553 10:54 Diffusion with very high b-value in breast MRI: preliminary results
Functional connectivity alterations of dorsal premotor cortex H. Hamri1, E. Weiland2, M. Scholer1, Z. Jolibois1, C. de Bazelaire1; 1Paris/FR,
2
subregions in Parkinson’s disease Erlangen/DE
B. Sigl1, C. Jockwitz2, C. Mathys3, S. Eickhoff2, C.J. Hartmann1, C. Rubbert1,
B. Turowski1, S. Caspers2, J. Caspers1; 1Düsseldorf/DE, 2Jülich/DE, B-1564 11:03
3
Oldenburg/DE Evaluation of breast lesions with simultaneous multi-slice DWI in
comparison to routine read-out segmented DWI
B-1554 11:02 SPEAKER W. Sanderink1, J. Teuwen1, I. Sechopoulos1, N. Karssemeijer1, L. Appelman1,
SUPPORTED
DMN-neuronal activity pattern in patients with PD in early BY E. Weiland2, R.M. Mann1; 1Nijmegen/NL, 2Erlangen/DE
INVEST IN
Sunday
stages THE YOUTH

E. Seliverstova, Y. Seliverstov, R. Konovalov, M. Krotenkova, B-1565 11:11
S. Illarioshkin; Moscow/RU Diagnostic performance of region of interest methods in diffusion-
weighted imaging of breast lesions: a systematic review and meta-
B-1555 11:10 analysis
Resting state functional MRI connectivity comparison between M. Wielema1, M.D. Dorrius1, G.H. De Bock1, R.M. Pijnappel2, M. Oudkerk1,
Alzheimer‘s disease and Parkinson‘s disease dementia: a sub-analysis P.E. Sijens1; 1Groningen/NL, 2Utrecht/NL
P.A. Harman1, C. Law2, M. Johnson3, S. Pardhan1, I.Q. Grunwald1,
K. Ramavathu4; 1Chelmsford/UK, 2Stanford, CA/US, B-1567 11:19
3
Southend-on-Sea/UK, 4Westcliff on Sea/UK Feasibility study of synthetic diffusion-weighted MR imaging in
patients with breast cancer by qualitative and quantitative assessment
B-1556 11:18 SPEAKER B. Choi; Changwon/KR
SUPPORTED
3T susceptibility-weighted imaging and Parkinson‘s disease: BY
new fields in neuroimaging THE YOUTH
1 1 1 2 1
A. Corridore , S. Torlone , M. Micelli , M. Martino , L. Panebianco , MR mammography of suspicious lesions: influence of residual fat
1 1 1 1 1
P. Cerrone , P. Sucapane , A. Splendiani , C. Masciocchi ; L‘Aquila/IT, signal on diffusion kurtosis imaging
2
Rome/IT A. Mlynarska-Bujny1, S. Bickelhaupt1, F. König1, F. Laun2, W. Lederer1,
H. Daniel3, S. Delorme1, H.-P. Schlemmer1, T. Kuder1; 1Heidelberg/DE,
2
Erlangen/DE, 3Mannheim/DE

B-1569 11:35 B-1580 11:42

Characterisation of breast parenchyma and cancer during lactation Fusion imaging of US and MRI coupled with electromagnetic virtual
using diffusion tensor imaging navigation for periradicular infiltrations of steroids in low back pain:
N. Nissan1, E. Furman-Haran2, T. Allweis2, T. Menes3, O. Halshtok Neiman4, pilot experience of a radiation-free procedure
R. Faermann1, A. Shalmon5, M. Gotlieb5, M. Sklair5; 1Tel Hashomer/IL, F. Arrigoni, G. Bianchi, P. Palumbo, S. Mariani, F. Bruno, L. Zugaro,
2
Rehovot/IL, 3Tel Aviv/IL, 4Kiryat Ono/IL, 5Ramat Gan/IL A. Barile, C. Masciocchi; L‘Aquila/IT
B-1570 11:43 B-1581 11:50 SPEAKER

SUPPORTED
Breast 1H-MR-spectroscopy to distinguish benign from malignant Is the anaesthesia a key factor for the good outcome of bone BY
INVEST IN
breast lesions: an updated systematic review and meta-analysis with ablation procedures: a review of the last two-year experience THE YOUTH
clinical implications in an MSK interventional centre
C. Sodano, P. Clauser, P. Kapetas, T.H. Helbich, P.A.T. Baltzer; Vienna/AT A. Izzo, F. Arrigoni, P. Palumbo, F. Bruno, C. De Cataldo, S. Mariani,
L. Zugaro, A. Barile, C. Masciocchi; L‘Aquila/IT
10:30 - 12:00 Room Y

10:30 - 12:00 Room D
SS 1809
Nonvascular musculoskeletal SS 1805b
interventions Machine learning: radiomics analysis
Moderators:
Moderators: W.J. Niessen; Rotterdam/NL
N.N. M.F. Russe; Freiburg/DE
G. Velonakis; Athens/GR
K-37 10:30
Intraarticular osteoblastomas: from challenging diagnostic entity to H. Brøger; Oslo/NO
minimally invasive treatment with magnetic resonance-guided focused
ultrasound (MRgFUS)
B-1582 10:39
P. Palumbo, F. Arrigoni, C. De Cataldo, M. Ruschioni, L. Zugaro, A. Barile,
Machine learning-based analysis of CT radiomics model for the
C. Masciocchi; L‘Aquila/IT
prediction of colorectal metachronous liver metastases
SPEAKER M. Taghavi1, S. Trebeschi1, D. Meek2, D.M. Lambregts1, C. Verhoef2,
B-1572 10:38 SUPPORTED J.B. Houwers3, U.A. van der Heide1, R.G.H. Beets-Tan1, M. Maas1;
Retrospective multivariate analysis of the outcomes of BY
INVEST IN 1
Amsterdam/NL, 2Rotterdam/NL, 3Maastricht/NL
percutaneous thermal ablation of painful bone metastasis in THE YOUTH
oncological patients
B-1583 10:47
G. Bianchi, F. Arrigoni, P. Palumbo, A. Cortellini, L. Zugaro, K. Cannita,
In-house automatic liver segmentation from CT based on a deep
C. Ficorella, A. Barile, C. Masciocchi; L‘Aquila/IT
convolutional neural network with data augmentation
J. Witowski, A. Złahoda-Huzior, M. Stanuch, A. Grochowska,
B-1573 10:46 M. Pędziwiatr; Krakow/PL
Interventional urethral realignment to posterior urethral rupture
accompanied by complex pelvic fracture
B-1584 10:55
C.M. Lee, C.H. Jeon, C.W. Kim, H. Kwon, H.M. Cho; Busan/KR
Development and validation of a dual-energy CT-based radiomic
SPEAKER nomogram for preoperative prediction of lymph node metastasis in
B-1574 10:54 SUPPORTED patients with gastric cancer
Percutaneous stabilisation of humeral metastatic lesion BY
INVEST IN J. Li; Zhengzhou/CN
A. Al Raaisi, E. Cormier, E. Shotar, M. Drir, F. Clarencon, THE YOUTH
J. Chiras; Paris/FR
B-1585 11:03
Development of a MRI radiomics model for pre-therapeutic evaluation
B-1575 11:02 of lymph node metastasis in rectal cancer
Percutaneous intervertebral disc coagulation therapy (PDCT) by S. Hu, C. Xia, W. Peng, Z. Li; Chengdu/CN
plasma light: a new method for the treatment of lumbar and cervical
disc herniation
C. Zini1, D. Notaro2, G. Sadotti2, M. Bellini2; 1Florence/IT, 2Siena/IT SUPPORTED
Deep learning based radiomics and its usage in prediction BY
INVEST IN
for metastatic colorectal cancer THE YOUTH
B-1576 11:10 D. Nörenberg1, T. Huber1, S. Maurus1, N. Jäger1, A. Katzmann2,
Percutaneous CT guided RFA treatment of osteoid osteoma in children A. Mühlberg2, J. Moltz3, V. Heinemann1, J. Holch1; 1Munich/DE,
and adults: it has high success rate in children too 2
Erlangen/DE, 3Bremen/DE
C. Sahin, Y. Oc, A. Hasanefendioglu Bayrak; Istanbul/TR
B-1587 11:19
B-1577 11:18 A new approach to predict grade of non-functional pancreatic
Balloon vesselplasty vs percutaneous vertebroplasty in chronic neuroendocrine tumour d2 cm: a radiomics nomogram
compression fractures of the dorsolumbar spine Y. Bian; Shanghai/CN
D.N. Srivastava, A. Monga, K. Madhusudhan, S. Malla; New Delhi/IN
G. Sadotti1, D. Notaro1, C. Zini2, M. Bellini1; 1Siena/IT, 2Florence/IT
B-1588 11:27
Development of a multiparametric radiomics combined T2WI and DWI
B-1578 11:26 to staging rectal cancer
“SpineJack®” percutaneous placement in magerl A2 and A3 traumatic D. Wen, C. Xia; Chengdu/CN
vertebral compression fractures of the thoracolumbar spine
G. Sadotti1, D. Notaro1, C. Zini2, M. Bellini1; 1Siena/IT, 2Florence/IT
B-1589 11:35
SPEAKER CT texture analysis in liver fibrosis shows a strong correlation with
B-1579 11:34 SUPPORTED portal phase enhancement and can predict cirrhosis in decision tree
Intraarticular lumbar facet joint steroid injection vs. medial BY
INVEST IN model
branch block: which technique ensures better clinical THE YOUTH P.N. Kaposi, B. Budai, V. Frank, S. Shariati, A. Folhoffer, M. Abonyi,
outcome for managing lumbar back pain? A single-centre V. Bérczi; Budapest/HU
experience
A. Izzo, M. Varrassi, F. Bruno, G. Bianchi, F. Cobianchi Bellisari,
S. Carducci, A. Giordano, E. Di Cesare, C. Masciocchi; L‘Aquila/IT

B-1590 11:43 B-1602 11:50

MR imaging of rectal cancer: radiomics analysis to predict hepatic Radiation burden of patients with hepatocellular carcinoma from
metastases multiple TACE and CT procedures
S. Hu, W. Peng, C. Xia, Z. Li; Chengdu/CN L. Sukupova; Prague/CZ
B-1591 11:51
MR imaging radiomics textures for predicting the gene expression in 10:30 - 12:00 Room K
related to recurrence risks of HCC given by GOLM1, RND1 and SETD7
X. Hu; Chongqing/CN Chest
10:30 - 12:00 Room G SS 1804

Physics in Medical Imaging Thoracic imaging: new approaches and
techniques
SS 1813 Moderators:
Radiation dose optimisation in CT E.J. Stern; Seattle, WA/US
Moderators:
K.N. Bolstad; Bergen/NO K-38 10:30
G. O’Reilly; Dublin/IE Keynote lecture
E.J. Stern; Seattle, WA/US
SUPPORTED
Influence of arm positioning on radiation dose during BY B-1603 10:39
INVEST IN Visibility of bronchial artery on virtual monoenergetic image and
combined thorax and liver CT imaging: a phantom study THE YOUTH
O.V. Ivashchenko, J.J. Roelofs, A. van der Most, advanced virtual monoenergetic images
W.J.H. Veldkamp, I. Hernandez Giron; Leiden/NL T. Nomura, T. Niwa, J. Hashimoto, Y. Imai; Isehara/JP
B-1593 10:38 B-1604 10:47

The effect of scout view length on patient dose from thoracic CT The value of multiple quantitative spectrum parameters for assessing
examinations performed with tube current modulation the lymph node metastasis of lung cancer with dual-layer detector
K. Perisinakis, A. Tzedakis, N. Ntoufas, M. Velivasaki, J. Stratakis, spectral CT
J. Damilakis; Iraklion/GR L. Gao, Y. Hou, Y. Ma, Q. Ma, X. Lu; Shenyang/CN
B-1594 10:46 B-1605 10:55

Investigation the causes of overscanning in z-axis in thorax, Using relationship between pulmonary veins and pulmonary nodules
abdominopelvic and thoraco-abdominopelvic CT examinations to distinguish benign intrapulmonary lymph nodes from lung cancer
O. Yar, M.R. Onur, I. Idilman, E. Akpinar, D. Akata; Ankara/TR on CT
J.L. Barnett1, I. Pulzato1, R. Wilson2, S. Padley1, A.G. Nicholson1, A. Devaraj1;
1
London/UK, 2Belfast/UK
B-1595 10:54
Comparison of radiation doses imparted during multidetector CT
scanners and cone beam computed tomography for the postoperative, B-1606 11:03
spinal fusion assessment Application of computer-aided diagnosis system based on 3D deep
N. Guberina, M. Forsting, A. Ringelstein; Essen/DE convolutional neural network in lung cancer screening
Q. Meng, J. Ding; Zhengzhou/CN
B-1596 11:02
Effective dose comparison between cone beam CT (CBCT) and MSCT B-1607 11:11
for three types of head examinations Deep learning-based CAD may improve detection of pulmonary
D. Buytaert1, B. Keelson2, G. Van Gompel2, J. Casselman3, N. Buls2, nodules while preserving a low false-positive rate
K. Bacher1; 1Gent/BE, 2Brussels/BE, 3Bruges/BE J. Lieman-Sifry1, S. Brouha2, A. Yen2, E. Weihe2, K. Jacobs2, M. Horowitz2,
D. Motiuk2, A. Hsiao3; 1San Francisco, CA/US, 2San Diego, CA/US,
3
La Jolla, CA/US
B-1597 11:10
Characterisation of patient skin dose in CT imaging
M. Cabuy1, G. Van Gompel2, P.D. Deak3, J. de Mey1, N. Buls2; 1Jette/BE, B-1608 11:19
2
Brussels/BE, 3Berlin/DE Analysis of pleural effusion dynamics in patients with pulmonary
infarction based on CTPA measurements
M. Kastelic1, J. Vidmar2, K.K. Šifer1, I. Kocijančič2; 1Celje/SI, 2Ljubljana/SI
B-1598 11:18
Coronary calcium scoring in CT with a calcium-aware image SPEAKER
reconstruction technique: dose reduction by lowering x-ray tube voltage B-1609 11:27 SUPPORTED
Pulmonary arterial enlargement predicts long-term survival BY
R. Booij, R.P. Budde, D. Bos, M. Kremer, M. Dijkshoorn, M. van Straten; INVEST IN
Rotterdam/NL in COPD patients THE YOUTH
A. Ezponda Casajús, J. De Torres, A. Alcaide, A. Campo,
J. Bertó, J. González, J. Zulueta, G. Bastarrika Alemañ; Pamplona/ES
Sunday
B-1599 11:26
Dose management in computed tomography using the as-low-as- SPEAKER
diagnostically acceptable image quality approach B-1610 11:35 SUPPORTED
Synchrotron phase-contrast imaging of the lung: a proof- BY
G. Widmann1, G. Degenhart1, A. Al-Ekrish2, W. Puelacher1, G. Feuchtner1, INVEST IN
W.R. Jaschke1, R. Jacobs3, R. Pauwels3; 1Innsbruck/AT, 2Riyadh/SA, of-concept study on porcine lungs in a human-scale chest THE YOUTH
3
Leuven/BE phantom
W. Wagner , F. Wuennemann , J. Biederer , P. Konietzke , W. Stiller1,
1 1 2 1
M.O. Wielpütz1, H.-U. Kauczor1, G. Tromba3, C. Dullin4; 1Heidelberg/DE,

B-1600 11:34 2
Sehheim-Jugenheim/DE, 3Trieste/IT, 4Göttingen/DE
Clinical diagnostic reference levels for CT examinations: a prospective
multicentre study
H. Brat1, F. Zanca2, B. Rizk3, S. Montandon4, D. Racine5, E. Meicher1, B-1611 11:43
D. Fournier1; 1Sion/CH, 2Heverlee/BE, 3Villars-sur-Glane/CH, 4Gland/CH, Preoperative multi-detector CT scoring criteria for assessing
5
Lausanne/CH pericardial, lung, and phrenic nerve invasion of thymoma
S. Lee, S. Yoon; Seoul/KR
B-1601 11:42
Monte Carlo simulation of dual-energy CT systems: initial validation of
radiation dose measurements
Y. Toufique, O. Bouhali, J.O. Doherty, J. Goracy, I. Delakis; Doha/QA

B-1612 11:51 B-1623 11:50

A reader study in postmortem x-ray dark-field chest radiographs and Prognostic validity of stress cardiac magnetic resonance (CMR) in the
correlation with conventional x-ray and CT intermediate-long term outcome assessment of known-CAD patients
A.A. Fingerle1, F. De Marco2, K. Willer2, P.B. Noel1, A. Sauter1, D. Pfeiffer1, P. Palumbo, E. Cannizzaro, A. Corridore, C. De Cataldo, S. Torlone,
E.J. Rummeny1, J. Herzen2, F. Pfeiffer2; 1Munich/DE, 2Garching/DE M. Di Luzio, A. Di Sibio, E. Di Cesare, C. Masciocchi; L‘Aquila/IT
10:30 - 12:00 Room M 1 10:30 - 12:00 Room M 2

Cardiac Head and Neck
SS 1803 SS 1808
Advanced cardiac MR for evaluation of Imaging techniques in head and neck
left ventricular structure and function radiology
N.N. J. Govindaraj; Chennai/IN
R.G. Chelu; Rotterdam/NL M. Magyar; Graz/AT
B-1613 10:30 B-1624 10:30

Comparison of signal intesity ratio, extent and transmurality between Value of CT image texture analysis in the differential diagnosis of
a novel LGE black-blood and standard LGE bright-blood sequences in benign and malignant parotid tumours
patients with ischaemic heart disease L. Yang, T. Jiang; Beijing/CN
G. Muscogiuri1, M. Gatti2, S. Dell‘Aversana3, M. Guglielmo1, A. Baggiano1,
A. Guaricci4, M. Pepi1, G. Pontone1; 1Milan/IT, 2Turin/IT, 3Naples/IT, B-1625 10:38
4
Bari/IT Virtual non-contrast reconstructions derived from DECT cannot
replace true native scans in head and neck imaging
B-1614 10:38 A.M.J.L. van Kroonenburgh, S.M.J. van Kuijk, A.A. Jacobi-Postma;
Diagnostic accuracy of single-shot two-dimensional multisegment Maastricht/NL
late gadolinium enhancement in ischaemic and non-ischaemic
cardiomyopathy B-1626 10:46
G. Muscogiuri1, M. Gatti2, S. Dell‘Aversana3, S. Pica1, M. Guglielmo1, Machine learning analysis in the prediction of tumour grade and
A. Baggiano1, A. Guaricci4, G. Pontone1; 1Milan/IT, 2Turin/IT, 3Naples/IT, nodal involvement in oropharyngeal and oral cavity squamocellular
4
Bari/IT carcinoma using CT-derived texture features
V. Romeo, R. Cuocolo, L. Ugga, S. Cocozza, F. Verde, S. Dell‘Aversana,
B-1615 10:46 A. Elefante, S. Staibano, A. Brunetti; Naples/IT
Left ventricle volumes and function assessment with cardiac magnetic
resonance four-dimensional flow imaging B-1627 10:54
M. Guglielmo1, A. Baggiano1, G. Muscogiuri1, A.I. Guaricci2, D. Andreini1, Added prognostic value of pre-treatment MRI texture analysis in
F. Alamanni1, M. Pepi1, G. Pontone1; 1Milan/IT, 2Bari/IT patients with primary nasopharyngeal carcinoma
J. Fang, J. Mao; Guangzhou/CN
B-1616 10:54
Comparison of standard 3D LGE imaging with novel short inversion B-1628 11:02
time 3D LGE Imaging in patients after myocardial infarction Application of the IEC3.1 standard of CTDI100 to a supine CBCT device
M. Polacin, M. Gastl, I. Kapos, A. Gotschy, J. von Spiczak, H. Alkadhi, B. Keelson1, D. Buytaert2, G. Van Gompel1, J. Casselman3, K. Bacher2,
R. Manka; Zurich/CH Y. De Brucker1, N. Buls1; 1Brussels/BE, 2Gent/BE, 3Bruges/BE
B-1617 11:02 B-1629 11:10

Cardiac magnetic resonance for response prediction to Levosimendan Texture analysis for differentiating between nasopharyngeal cancer
treatment in patients with acute decompensated heart failure prior to and nasopharyngeal malignant lymphoma on unenhanced CT
cardiac surgery H. Tomita, T. Yamashiro, M. Tsubakimoto, G. Iida, S. Murayama;
A. Wielandner, F. Gremmel, R. Laggner, D. Senn, A. Zuckermann, Nishihara/JP
C. Loewe, D. Beitzke; Vienna/AT
B-1630 11:18
B-1618 11:10 Dose optimisation in dual-energy CT imaging of the neck: evaluation
Noninvasive assessment of myocardial oxygenation after acute of acquisition parameters using a 3D-printed patient phantom
myocardial infarction with breath-hold-induced blood oxygen level- P. Jahnke, B. Hamm, T. Diekhoff; Berlin/DE
dependent imaging
K. Shi, Z.-G. Yang, Y.-K. Guo, S. Huang, X. Li; Chengdu/CN B-1631 11:26
Dose reduction in CT imaging of the neck - individual performance and
SUPPORTED synergetic effects of dose reduction techniques in a clinical context
Alterations of the mitral valve vortex ring in ischaemic heart BY P. Jahnke, F.B. Schwarz, M. Ziegert, B. Hamm, M. Scheel, T. Diekhoff;
INVEST IN
disease: an explorative 4D-flow study THE YOUTH Berlin/DE
C. Kräuter1, U. Reiter1, C. Reiter1, A. Schmidt1, A. Greiser2,
M. Masana3, M.H. Fuchsjäger1, R. Stollberger1, G. Reiter1; 1Graz/AT, B-1633 11:34
2
Erlangen/DE, 3Barcelona/ES Dual-layer detector CT angiography in preoperative assessment of
carotid body tumours: comparison of virtual monoenergetic and
SUPPORTED polyenergetic images
4D- vs 2D-flow imaging in the evaluation of transmitral BY Y. Chen, Y. Zhu, H. Liu, K. Xu, S. Yu, T. Su, Z. Zhang, Y. Wang, Z. Jin;
INVEST IN
velocity profiles: comparison with echocardiography THE YOUTH Beijing/CN
C. Reiter1, C. Kräuter1, E. Kolesnik1, G. Reiter1, A. Greiser2,
A. Schmidt1, D. Scherr1, M.H. Fuchsjäger1, U. Reiter1; 1Graz/AT, B-1634 11:42 SPEAKER
SUPPORTED
2
Erlangen/DE Are pre-MRI orbital radiographs always necessary in patients BY
INVEST IN
with suspected foreign bodies? THE YOUTH
B-1622 11:42 A. Foran, M.J. Lee; Dublin/IE
Evaluation of the prognostic value of visually detected cardiac MRI
findings in asymptomatic diabetics and healthy volunteers
N. Panagiotopoulos1, N. Fechtrup1, T.H. Oechtering1, U. Roggenbuck2,
K. Nassenstein2, J. Barkhausen1, P. Hunold1; 1Lübeck/DE, 2Essen/DE

10:30 - 12:00 Room M 3 B-1646 10:39

Clinical application of 640 slice spiral CT double low enterography in
Oncologic Imaging inflammatory bowel disease
X. Pan, M. Guo; Guangzhou/CN
SS 1816 B-1647 10:47

Magnetic resonance enterography: is routine administration of
Improving the prediction of head and gadolinium-based IV contrast really needed for the assessment of
Crohn’s disease?
neck malignancies S.J. Sammut, N. Cook, N. Mahmood, R. Balasubramaniam, B. Thomas,
Moderators: A. James; Stoke-on-Trent/UK
B. Verbist; Leiden/NL
G. Zanirato Rambaldi; Bologna/IT B-1648 10:55 SPEAKER
SUPPORTED
Can diffusion-weighted imaging (DWI) in MR enterography BY
discriminate inflammatory strictures from fibrotic strictures in THE YOUTH
MRI histogram and texture analysis as predictors of response to Crohn’s disease?
therapy in head and neck malignancies M. Travali, P. Foti, N.M.G. Ognibene, S. Palmucci, L. Puzzo, G. Inserra,
R. Balaji, V.K. Anand, G. Krishnamurthi; Chennai/IN L. Zanoli, S. Parisi, A. Basile; Catania/IT
B-1635 10:38 B-1649 11:03

Microflow and resistance index in suspicious lymph nodes MRI quantitative parameters of small-bowel perfusion for early
P. De Koekkoek-Doll, M.W.M. van den Brekel, W. Vogel, L. Smit, diagnosing and assessing activity of Crohn‘s disease: a preliminary study
R.G.H. Beets-Tan, M. Maas; Amsterdam/NL Z. Xianying, W. Yinchen; Fuzhou/CN
B-1636 10:46 B-1650 11:11

Ability of computed tomography (CT) radiomic features to High spatiotemporal resolution free-breathing quantitative bowel
differentiate lymphomas from thymic masses in the anterior perfusion imaging
mediastinum V.C. Obmann1, K. Yang2, N. Seyfried2, M. Stopchinski2, K. Wright2,
M. Kirienko, G. Ninatti, L. Cozzi, N. Gennaro, F. Ricci, C. Carlo Stella, S. Ghodasara2, A. Panda2, Y. Chen2, V. Gulani2; 1Berne/CH,
P. Zucali, A. Chiti, M. Sollini; Milan/IT 2
Cleveland, OH/US

Role of diffusion MRI in differentiation of residual/ BY Ability of diffusion-weighted magnetic resonance imaging to characterise
INVEST IN
recurrent neck malignancies and post-treatment changes in THE YOUTH bowel fibrosis depends on the degree of bowel inflammation
comparison with histopathology findings X. Li, S. Huang, B. Lu, L. Huang, Z. Li, J. Du, Y.-K. Zhong; Guangzhou/CN
A. Jajodia, D. Aggarwal, A.S. Rao, R. Aggarwal; New Delhi/IN
B-1652 11:27
B-1638 11:02 ADC values of DWI and DWIBS in bowel imaging: when they are
MRI-based radiomic to assess lipomatous soft tissue tumours consistent and when not?
malignancy: a pilot study I. Apine, M. Baduna, R. Pitura, G. Krumina; Riga/LV
A. Bouhamama1, B. Leporq1, F. Lame2, C. Bihane1, M. Sdika1, J.-Y. Blay1,
O. Beuf1, F. Pilleul1; 1Lyon/FR, 2Le Gosier/FR B-1653 11:35 SPEAKER
SUPPORTED
Validation of the simplified magnetic resonance index BY
of activity (sMaRIA) for Crohn’s disease without using THE YOUTH
Lymph node measurement on serial imaging in clinical trials gadolinium
M. Bagheri, A. Shafiei, F. Farhadi, A.B. Apolo, L.R. Folio, E.C. Jones, N. Capozzi1, A. Fernandez-Clotet2, I. Alfaro2, I. Ordás2, J. Panes2,
R.M. Summers; Bethesda, MD/US J. Rimola2; 1Bologna/IT, 2Barcelona/ES
B-1642 11:18 B-1654 11:43

Conventional ultrasound and ultrasound elastography in non- Correlation analysis between magnetisation transfer ratio with
Hodgkin lymphoma: ultrasound prognostic index compared with the collagen area fraction in the surgical specimen of Crohn‘s disease
international prognostic index S. Huang1, X. Li1, Z. Fang1, J. Lin1, Z. Zhang2, C.C. Sun1, S. Feng1, Z. Li1;
J. Jiang, M. Chen; Shanghai/CN 1
Guangzhou/CN, 2Florida, FL/US
B-1643 11:26 B-1655 11:51

Strain elastography ultrasound for lymph node characterisation Magnetic Resonance Fingerprinting (MRF) enables simultaneous T1
A. Malich, C. Kurrat, D. Predel, N. Bang, I. Papageorgiou; Nordhausen/DE and T2 mapping of the bowel wall in patients with Crohn’s disease
V.C. Obmann1, W.-C. Lo2, N. Seyfried2, Y. Jiang2, A. Panda2, K. Wright2,
B-1644 11:34 K. Ropella-Panagis2, V. Gulani2; 1Berne/CH, 2Cleveland, OH/US
Absence of vascularisation in thyroid nodules: new ultrasound feature
for stratifying their malignancy risk
M. Minotti1, F. De Piano1, L. Tofanelli1, G. Giugliano1, F. Maffini1, G. Mauri1, 10:30 - 12:00 Room M 5
M. Bellomi1, L. Preda2, E. De Fiori1; 1Milan/IT, 2Pavia/IT
Sunday
Genitourinary
10:30 - 12:00 Room M 4

GI Tract
SS 1807
Testicular, renal and bladder tumours
Moderators:
SS 1801b F.M. Drudi; Rome/IT
O.W. Kozak; Gdansk/PL
Inflammatory bowel disease: what now?
N.N. Testicular cancer follow-up: less is more
N.N. E. Rud, C.W. Langberg, E. Baco, G. Sandbækk; Oslo/NO
K-39 10:30
Keynote lecture
N.N.

B-1657 10:38 B-1672 10:46

Diagnostic performance of contrast-enhanced ultrasound (CEUS) in Hybrid 123I-mIBG SPECT/CT cardiac imaging for identification of left
unclear testicular pathology atrial ganglionated plexi in patients with atrial fibrillation
M.H. Lerchbaumer, S.R. Marticorena Garcia, M. Kallenbach, B. Hamm, N.A. Nikitin, S.M. Minin, I. Mikheenko, D.V. Losik, S.V. Shaiakhmetova,
T. Fischer; Berlin/DE A.B. Romanov; Novosibirsk/RU
B-1658 10:46 B-1673 10:50

The added value of scrotal palpation during testicular ultrasound (US): Assessment of right ventricular deformation in end stage renal disease
a technical note patients by cardiac magnetic resonance tissue tracking
J.P. Zawaideh1, C. Trambaiolo Antonelli1, A. Olivero1, M. Bertolotto2, Y. Zhang, Z.-G. Yang, Y.-K. Guo, H. Xu, W. Peng, C. Xia, Z. Li; Chengdu/CN
L.E. Derchi1; 1Genoa/IT, 2Trieste/IT
SUPPORTED
B-1659 10:54 SPEAKER Left ventricular global strain analysis in arrhythmogenic right BY
SUPPORTED INVEST IN
Focal testicular lesions: multiparametric US features and BY ventricular cardiomyopathy with or without syncope: THE YOUTH
INVEST IN
association with histopathology THE YOUTH a cardiac magnetic resonance imaging study
I. Campo, C. Sachs, R. Bussani, M. Bertolotto, M.A. Cova; M.-T. Shen, Z. Yang, K. Diao, L. Jiang, S. Huang, B. Hu, Y. Guo; Chengdu/CN
Trieste/IT
SUPPORTED
B-1660 11:02 Quantitative T2 mapping for detecting myocardial oedema BY
INVEST IN
Apparent diffusion coefficient and magnetization transfer ratio in and its association with myocardial injury biomarkers in THE YOUTH
predicting successful sperm retrieval after mTESE acute myocardial infarction swine models
A.A. Ntorkou, A. Tsili, A. Goussia, L.G. Astrakas, A. Kaltsas, N. Sofikitis, L. Zhang, Y.-K. Guo, Z.-G. Yang, X.-S. Li, C. Fu, H. Xu, M.-X. Yang, R. Xu,
M.I. Argyropoulou; Ioannina/GR L. Xie; Chengdu/CN
B-1661 11:10 B-1676 11:02 SPEAKER

SUPPORTED
MRI diffusion-weighted and shear wave elastography in testis Comparison of the incidence of in-stent restenosis and the BY
INVEST IN
M.R.V. Pedersen1, P.J. Osther1, H. Nissen1, P. Vedsted2, H. Møller2, newly developed plaques after stenting between diabetic THE YOUTH
S.R. Rafaelsen1; 1Vejle/DK, 2Aarhus/DK and non-diabetic patients: evaluation with DSCT angiography
R. Shi, Z.-G. Yang, Y.-K. Guo, Q. Zhao, Y. Gao, P.-l. Han; Chengdu/CN
B-1662 11:18
Percutaneous ablation of renal cancer: radiofrequency vs. microwave B-1677 11:06
I.D. Domínguez Paillacho, J. Mesa Quesada, L.J.J. Zurera Tendero, The correlation between coronary artery stenosis and myocardial
C. Pulido Carmona, M. Lombardo Galera, M.E. Perez Montilla, perfusion indexes: a prospective “one-stop” 256-row detector
J.J. Espejo Herrero; Córdoba/ES computed tomography study
K. Liu, Z. Li, K. Diao, W. Peng; Chengdu, Sichuan/CN
B-1664 11:26
In vitro and in vivo quantification of urinary stone volume using B-1678 11:10
attenuation threshold-based optimized ultra-low-dose CT method Cardiovascular magnetic resonance early predictors of unfavourable
N. Rasouly1, B. Kastler2, O. Hélénon2, B. Habib Geryes2, A. Comte3; left ventricle remodelling in patients with acutemyocarditis
1
Kabul/AF, 2Paris/FR, 3Besançon/FR A. Palmisano1, G. Benedetti1, D. Palumbo1, G. Peretto1, R. Faletti2, S. Sala1,
M. Gatti2, F. De Cobelli1, A. Esposito1; 1Milan/IT, 2Turin/IT
B-1665 11:34
Bladder perivascular epithelioid cell tumour: dynamic CT and MRI B-1679 11:14
analyses of 8 cases with 2-year follow-up FFRCT vs CAD-RADSTM and its impact on patient management:
D. Xuesong; Chongqing/CN a retrospective pilot study
S. Braspenningx1, C. Van Mieghem2, P. Vanhoenacker3; 1Edegem/BE,
B-1641 11:42 2
Kortrijk/BE, 3Aalst/BE
Image briefly: the new aphorism for surveillance in testicular cancer
R. Balaji; Chennai/IN B-1680 11:18 SPEAKER
SUPPORTED
Left ventricular function impairment and deformation BY
INVEST IN
assessment of post-transcatheter aortic valve implantation THE YOUTH
10:30 - 12:00 Sky High Stage (TAVI): a systematic review and meta-analysis
M.-T. Shen, Z. Yang, K. Diao, Q. Zhao, L. Jiang, S. Huang, Y. Guo;
Cardiac Chengdu/CN

SUPPORTED
MY 18 Assessment of left ventricular deformation in restrictive BY
INVEST IN
cardiomyopathy with preserved ejection fraction by cardiac THE YOUTH
Cardiovascular magnetic resonance tissue tracking
Moderators: S. Huang, Z.-G. Yang, K. Diao, K. Shi, Y. Gao, M.-T. Shen, Y.-K. Guo;
M. Francone; Rome/IT Chengdu/CN
F. Wolf; Vienna/AT
B-1682 11:26
B-1668 10:30 Diastolic dysfunction in competitive triathletes following a strenuous
The forecaster of coronary atherosclerosis: black or white, fat or calcium? endurance sports event
R. Khurana, A. Yadav, T.B.S. Buxi, K.S. Rawat, S.S. Ghuman; New Delhi/IN J. Stáreková, B. Scherz, M. Avanesov, J.M. Weinrich, K. Müllerleile,
U. Radunski, G. Adam, G.K. Lund, E. Tahir; Hamburg/DE
B-1669 10:34
Treatment of chronic myocardial infarction with unmodified stem cells B-1683 11:30
at point of care: a feasibility study on pigs Evaluation of coronary arteries with prospectively-ECG-triggered-
A.S. Haenel1, M. Ghosn2, T. Karimi3, J. Vykoukal2, D.J. Shah2, D. Schulz2, High-Pitch-CT in patients undergoing TAVI-planning
A. Raizner2, C. Schmitz4, E. Alt5; 1Luebeck/DE, 2Houston, TX/US, P. Seitz, S. Gottschling, M. Abdel-Wahab, H. Thiele, M. Borger, D. Holzhey,
3
New Orleans, LA/US, 4Munich/DE, 5New Orleans, TX/US R.F. Gohmann, C. Krieghoff, M. Gutberlet; Leipzig/DE
B-1670 10:38 SPEAKER SPEAKER

SUPPORTED B-1684 11:34 SUPPORTED
Prevalence of asymptomatic pacemaker and ICD lead BY Relationship between epicardial adipose tissue and coronary BY
INVEST IN INVEST IN
perforation on computed tomography THE YOUTH vascular function in patients with normal myocardial THE YOUTH
F.F. Aloufi; Riyadh/SA perfusion by 82Rb PET/TC
S. Dell‘Aversana, A. Ponsiglione, C. Nappi, A. Stanzione, M. Puglia,
L. D‘Acierno, G. Lassandro, A. Cuocolo, M. Imbriaco; Naples/IT

B-1685 11:38 B-1697 11:50

Imaging carotid artery-vulnerable plaque with ultrasound and Magnetic resonance imaging evaluation of arteritis and other
contrast-enhanced ultrasound: correlation of cerebrovascular complications in tuberculous meningitis
symptoms with quantitative and multi-parametric indexes S.U.K. Khan; Gulbarga/IN
V. Rafailidis1, I. Chryssogonidis1, E. Grisan2, C. Xerras1, G.-A. Cheimariotis1,
T. Tegos1, D. Rafailidis1, P. Sidhu2, A. Charitanti-Kouridou1;
1
Thessaloniki/GR, 2London/UK 14:00 - 15:30 Room B
B-1686 11:42 Radiographers

Cardiac magnetic resonance with 4D flow imaging for mitral
regurgitation severity assessment
M. Guglielmo1, G. Muscogiuri1, A. Baggiano1, A.I. Guaricci2, D. Andreini1, SS 1914a
F. Alamanni1, M. Pepi1, G. Pontone1; 1Milan/IT, 2Bari/IT
Educational issues in radiography
Moderators:
10:30 - 12:00 Tech Gate Auditorium J.M. García Santos; Murcia/ES
R. Santos; Coimbra/PT
Neuro
K-40 10:30
Keynote lecture
SS 1811b N.N.
Neuroradiology: miscellaneous B-1698 14:09

Moderators: Understanding diagnostic student radiographer attrition in the UK
N.N. S.J. McAnulla, K.M. Knapp, S. Ball; Exeter/UK
L. Haider; Vienna/AT
B-1699 14:17
B-1687 10:30 Impact of a CT scan simulator on student learning
White matter hyperintensities volumetric burden in healthy adults: a G. Photopoulos1, J.G. Stowe2, C. Buissink3, C. O‘Halloran2, M. Quinn2,
systematic review and meta-analysis F. Tschan4, R. Verwoolde3, A. Dyhre Lia5; 1Halifax, NS/CA, 2Dublin/IE,
L. Melazzini1, M. Codari2, M. Zanardo1, M. Bolchini1, G.D. Papini2, 3
Groningen/NL, 4Lausanne/CH, 5Oslo/NO
F. Sardanelli1; 1Milan/IT, 2San Donato Milanese/IT
B-1700 14:25
SUPPORTED Mapping university skills labs in radiography: students‘ perspectives
Prevalence of incidental intracranial vascular findings BY K. Cronin1, S.S. Ghotra2, V. Harsaker3, M. Gillard2, J. Fitzgerald1, I. Kieft4,
INVEST IN
in a tri-ethnic population-based study THE YOUTH H. Sekkelsten5, O. Reynolds1; 1Dublin/IE, 2Lausanne/CH, 3Oppegård/NO,
R. Rehwald1, S. Moriconi2, L. Smith2, C.H. Sudre2, M.J. Cardoso2, 4
Groningen/NL, 5Oslo/NO
J.H. Gillard1, H.R. Jäger2; 1Cambridge/UK, 2London/UK
B-1701 14:33
SUPPORTED Active learning of exposure technique in digital radiography
Age and gender effects on brainstem MR planimetry BY S. Lewis, L.J. Hazell; Johannesburg/ZA
INVEST IN
S. Mangesius, A. Hussl, C. Müller, F. Krismer, P. Mahlknecht, THE YOUTH
M. Schocke, E. Gizewski, W. Poewe, K. Seppi; Innsbruck/AT B-1702 14:41
Integrating CT simulation into radiography undergraduate training
B-1690 10:54 J.G. Stowe, C. O‘Halloran; Dublin/IE
Automated detection of enlarged perivascular spaces on brain MRI
F. Dubost, H.H. Adams, P. Yilmaz, G. Bortsova, M. Ikram, W.J. Niessen, B-1703 14:49
M.W. Vernooij, M. De Bruijne; Rotterdam/NL Peer-assisted learning to improve educational performance in
radiography training
B-1691 11:02 J.G.E. Du Plessis; Bloemfontein/ZA
Preliminary study on changes of oxygen uptake fraction in pilots
before and after hypoxia exposure B-1704 14:57 SPEAKER
SUPPORTED
J. Liu1, W.-S. Zhang2, J.L. Cheng1; 1Zhengzhou/CN, 2Beijing/CN Factors influencing student radiographers‘ assessment of BY
INVEST IN
chest radiograph image quality THE YOUTH
B-1692 11:10 S. Heitmann1, R. Toomey2, M. Chen3, P. Pettka1, M. Molehe4,
A resting-state functional magnetic resonance imaging study of M. Selau Junior5, K. Fernandes6, K. Davies7, J. Pires Jorge6; 1Oslo/NO,
hypoxic exposure in pilots 2
Dublin/IE, 3Groeningen/NL, 4Free State/ZA, 5Florianópolis/BR,
J. Liu1, W.-S. Zhang2, J.L. Cheng1; 1Zhengzhou/CN, 2Beijing/CN 6
Lausanne/CH, 7Prosperous/IE
B-1693 11:18 B-1706 15:13 SPEAKER

SUPPORTED
Preliminary study of hypoxic exposure effect on cerebral blood The opinions of American radiography educators on lead BY
INVEST IN
perfusion of pilots using 3D ASL shielding use in conventional radiography THE YOUTH
J. Liu1, W.-S. Zhang2, J.L. Cheng1; 1Zhengzhou/CN, 2Beijing/CN A. Wall1, S.R. Kucharczyk2, W. Hennessy3, M. O‘Connor1,
Sunday
J. McNulty1; 1Dublin/IE, 2Limerick/IE, 3Hamden, CT/US

B-1694 11:26
Evaluating the diagnostic value of different imaging modalities in B-1707 15:21
cerebral venous thrombosis Simulation-based learning to facilitate clinical readiness in diagnostic
O. Shafaat1, F. Faeghi2, A. Bagheri1, M. Rabbani1, K. Jabbari1; 1Isfahan/IR, radiography: a metasynthesis
2
Tehran/IR L.J. Hazell1, H. Lawrence1, H. Friedrich-Nel2; 1Johannesburg/ZA,
2
Bloemfontein/ZA
B-1695 11:34
Radial diffusivity role in classification of patients with
antiphospholipid syndrome and “normal” radiological exams
S. Sandiramourty, H. Nguyen Troung Thanh, J. Greffier, A. Larbi,
J. Frandon, J.P. Beregi, J.-C. Gris, F. Pereira; Nîmes/FR
B-1696 11:42
MRI alterations in the brachial plexus of ALS patients
S. Gerevini, F. Agosta, E. Spinelli, P. Scamarcia, N. Riva, E. Pagani,
A. Quattrini, A. Falini, M. Filippi; Milan/IT

14:00 - 15:30 Room C 14:00 - 15:30 Room X

Radiographers Vascular
SS 1914b SS 1915
Mammography quality assessment Vascular imaging after stent-graft and
Moderators:
M. Dietzel; Jena/DE
stent insertion
D. Mizzi; Msida/MT Moderators:
A.D. Annoni; Milan/IT
M. Müller-Eschner; Mainz/DE
B-1708 14:00
Radiation risk from digital breast tomosynthesis screening:
a comparison with full-field digital mammography B-1719 14:00
R.M.K. M. Ali1, A. England2, C.E. Mercer2, A.K. Tootell2, P.H. Hogg2; Additive value of dual energy (DE) acquisition in CT follow-up of
1
Najaf/IQ, 2Salford/UK endovascular aortic repair (EVAR or TEVAR)
G. Agliata1, N. Schicci2, P. Esposto Pirani1, C. Tagliati1, A. Giovagnoni1;
1
Ancona/IT, 2Fabriano/IT
B-1709 14:08
What criteria should be considered by radiographers while assessing
the image quality of breast implant mammograms? B-1720 14:08
C. Sá dos Reis1, I. Gremion2, K. Schmidt2, N. Richli Meystre2; 1Perth/AU, Prospective single-centre study to evaluate artifacts using CEUS in
2
Lausanne/CH follow-up after EVAR: possible adverse effects on endoleak detection
in comparison with CTA
F. Frenzel1, R. Kubale2, J. Stroeder1, A. Massmann1, P. Jagoda1, A. Bücker1,
B-1710 14:16
P. Minko1; 1Homburg/DE, 2Pirmasens/DE
The use of different angulation in mediolateral oblique view based on
patient anatomy in mammography
A. Bedene, E. Alukic, J. Žibert, N. Mekis; Ljubljana/SI B-1721 14:16
Quantitative analysis of dynamic CTA for the detection of endoleaks
after abdominal aorta aneurysm endovascular repair: a feasibility
B-1712 14:32
study
Early detection of breast cancer education via interprofessional
M.J. Bauer1, F. Lavra2, M. Scarabello3, M. van Assen4, L. Saba2,
E-learning: the EBreast project
C.N. De Cecco1, U.J. Schoepf1; 1Charleston, SC/US, 2Cagliari/IT, 3Milan/IT,
E. Metsälä1, T. Kukkes2, K.M. Rannisto3, J. Pires Jorge4, A. Henner5, 4
Groningen/NL
B. Strøm6; 1Helsinki/FI, 2Tartu/EE, 3Oys/FI, 4Lausanne/CH, 5Oulu/FI,
6
Bergen/NO
B-1722 14:24
Flow volume of the abdominal visceral arteries increase after EVAR
B-1713 14:40
treatment
Acceptable quality dose for mammography: a guide for practitioners
M. Sugiyama1, Y. Takehara2, M. Alley3, N. Unno1, K. Katahashi1,
in developing countries
T. Wakayama4, A. Nozaki4, S. Naganawa2, H. Sakahara1; 1Hamamatsu/JP,
D.Z. Joseph; Kano/NG 2
Nagoya/JP, 3Stanford, CA/US, 4Hino/JP
B-1714 14:48
Optimization of radiation doses and image quality for mammography
B-1723 14:32
Cumulative radiation dose from contrast-enhanced CT in follow-up
examination
after EVAR
D.Z. Joseph1, F. Nkubli2, N. Christian3; 1Kano/NG, 2Borno/NG,
3 S. Magnani, G. Mauri, G. Di Leo, R.M. Trimboli, D. Poretti, L.M. Sconfienza,
Anambra/NG
F. Sardanelli; Milan/IT
B-1715 14:56
A core curriculum for the breast radiographers working in Italy
B-1724 14:40
Low tube voltage and low contrast media volume multidetector CT
S. Pacifici1, P. Bindinelli2, V. Galli3, A. Giacobbe1, D. Mariotti4, S. Pedilarco5,
angiography in evaluation of abdominal aorta in EVAR follow-up: a
S. Salimbeni6, G. Santucci7, D. Severi4; 1Rome/IT, 2Verona/IT, 3Modena/IT,
4 comparison study
Forlì/IT, 5Milan/IT, 6Bologna/IT, 7Cesena/IT
E.G.M. Antonuccio, S.J. Vasquez Cuadra, S.P. Pirillo, L. Tipaldi; Rome/IT
B-1716 15:04
Radiographers‘ competencies for pain management in mammography
B-1725 14:48
Spectral imaging on a 80 mm wide-detector CT with fast kVp
M. Pettersson, E. Metsälä; Helsinki/FI
switching for follow-up CT angiography after EVAR planning: image
quality, radiation dose and ultra-low volume contrast medium
B-1717 15:12 P. Hou; Zhengzhou/CN
Women‘s experience of pain in screening mammography
T. Wathén, K. Paalimäki-Paakki, A. Henner; Oulu/FI
B-1726 14:56
Split-filter dual-energy CT: value of advanced monoenergetic
B-1718 15:20 reconstructions for the assessment of vessel stents
Scanxiety in follow-up breast cancer women
E. Appel, C. Thomas, Y. Klosterkemper, J. Aissa, G. Antoch, J. Boos;
S. Pacifici, D. Giudice; Rome/IT
Düsseldorf/DE
B-1727 15:04
Comparison of automated software diameter/square detection
with radiologist visual assessment for 70% stenosis on coronary CT
angiography
S. Hu, W. Peng, Z. Li; Chengdu/CN
B-1728 15:12
Non-contrast magnetic resonance imaging in the follow-up after
endovascular aortic repair
G. Lastella1, P.M. Cannaò2, N. Ali1, F. Secchi2, F. Sardanelli1; 1Milan/IT, 2San
Donato Milanese/IT

B-1729 15:20 B-1740 15:20

Evaluation of blood pressure variations on CTA geometries of Radiation exposure during radiographic and computed tomography
abdominal aortic aneurysms lumbar spine imaging for adults
R.C. Aydin1, F. Bräu2, M. Notohamiprodjo3, J.E. Roos4, S. Leng5, C. Gernhardt, N. Guberina, M. Burggraf, U. Dietrich, J. Theysohn,
E.E. Williamson5, K. Nikolaou3, C.J. Cyron6, R.P. Marcus7; 1Geesthacht/DE, M. Forsting; Essen/DE
2
Munich/DE, 3Tübingen/DE, 4Lucerne/CH, 5Rochester, MN/US,
6
Hamburg/DE, 7Luzern/CH
14:00 - 15:30 Room O
14:00 - 15:30 Room N Musculoskeletal
Musculoskeletal
SS 1910b
SS 1910a Spine and peripheral nerve imaging
Moderators:
Spine imaging N.N.
Moderators: G. Bodner; Vienna/AT
T. Akinci D’Antonoli; Basel/CH
A. Feydy; Paris/FR K-41 14:00
Keynote lecture
B-1730 14:00 C. Martinoli; Genoa/IT
Machine learning classification of spinal lesions: compared accuracy of
texture parameters extracted by different software B-1741 14:09
V. Chianca1, D. Albano1, R. Cuocolo2, C. Messina1, S. Gitto1, A. Corazza3, Spinal osseous lesions in tuberosclerosis
I. Merli1, A. Brunetti2, L.M. Sconfienza1; 1Milan/IT, 2Naples/IT, 3Genoa/IT F. Düzgün, G. Yilmaz Ovali, I.S. Örgüc; Manisa/TR
B-1731 14:08 B-1742 14:17

A triple-classification radiomics model for the differentiation of Application of 3.0T magnetic resonance diffusion tensor imaging in
primary chordoma, giant cell tumour, and metastatic tumour of sacrum diagnosis of discogenic low back pain
based on magnetic resonance imaging S. Tian, H. Yuan; Beijing/CN
P. Yin, N. Hong; Beijing/CN
SUPPORTED
B-1732 14:16 Diffusion tensor imaging with quantitative evaluation BY
INVEST IN
Comparison of radiomics nomograms for the differentiation of of sciatic nerve within the pelvis in patients with non- THE YOUTH
sacral chordoma and sacral giant cell tumour based on 3D computed contributory lumbar spine magnetic resonance imaging in
tomography and multiparametric magnetic resonance imaging radiculopathy
P. Yin, N. Hong; Beijing/CN M. Catania1, G. Foti2, A. Beltramello2, G. Carbognin2; 1Verona/IT,
2
Negrar/IT
B-1733 14:24
Texture analysis for quantitative evaluation of central lumbar spinal B-1744 14:33
stenosis Preoperative and postoperative strain elastography, and shear wave
F.A. Huber, S. Stutz, I. Vittoria De Martini, M. Mannil, A.S. Becker, elastography findings of the sciatic nerve in patients with unilateral
S. Winklhofer, J.M. Burgstaller, R. Guggenberger; Zurich/CH lumbar disc herniation
V. Burulday1, U.O. Çelebi1, M. Ogden1, M.H. Akgul1, A. Dogan2,
B-1734 14:32 M.F. Ozveren1; 1Kirikkale/TR, 2Kahramanmaras/TR
Evaluation of osseous cervical foraminal stenosis in spinal
radiculopathy using susceptibility-weighted magnetic resonance B-1745 14:41 SPEAKER
SUPPORTED
imaging Pilot study on radiomics of peripheral nerves: feasibility of BY
INVEST IN
G. Engel, Y.Y. Bender, L.C. Adams, S.M. Böker, U.L. Fahlenkamp, quantitative imaging phenotyping on magnetic resonance THE YOUTH
G. Diederichs, M. Wagner, B. Hamm, M.R. Makowski; Berlin/DE imaging
A. Tagliafico, F. Rossi, F. Valdora, M. Grandis, L. Benedetti, B. Bignotti,
B-1735 14:40 A. Schenone, C. Martinoli; Genoa/IT
Advantages of T2* relaxation time with ultra-short TE on intervertebral
disc degeneration B-1746 14:49
H. Takashima1, M. Yoshimoto1, R. Imamura1, Y. Akatsuka1, M. Nakanishi1, Diffusion tensor imaging and tractography acquired with magnetic
M. Yoneyama2, M. Hatakenaka1, T. Yamashita1; 1Sapporo/JP, 2Tokyo/JP resonance imaging for preoperative assessment of benign peripheral
nerve sheath tumours
B-1736 14:48 B.J. Schwaiger, A.S. Gersing, B. Cervantes, C. Knebel, J. Dangelmaier,
Molecular lumbar intervertebral disc alterations in patients with leg D. Pfeiffer, E.J. Rummeny, D. Karampinos, K. Woertler; Munich/DE
length discrepancy
M. Frenken, D. Abrar, M. Knautz, D. Latz, A. Ljimani, G. Antoch, B-1747 14:57
C. Schleich; Düsseldorf/DE Sonographic mapping of brachial plexus and comparison with
Sunday
magnetic resonance imaging and electrophysiological studies

B-1737 14:56 A. Agarwal; New Delhi/IN
MR imaging of transitional lumbosacral junction: co-incidental or
causative factor for the disc degeneration and herniation B-1748 15:05
K.A. Bhagwat, V. Mahadevappa; Davangere/IN High-resolution ultrasound of the superficial sensitive nerves of
the arm and the forearm: anatomy, scanning technique and clinical
B-1738 15:04 relevance
Dual-energy computed tomography detects disk injuries in patients R. Picasso1, F. Zaottini1, F. Pistoia1, M. Miguel Perez2, C. Martinoli1;
1
with vertebral fractures: a prospective diagnostic accuracy study Genoa/IT, 2Barcelona/ES
M. Pumberger, M. Fuchs, N. Engelhard, K.-G.A. Hermann, M. Putzier,
M.R. Makowski, B. Hamm, T. Diekhoff; Berlin/DE B-1749 15:13 SPEAKER
SUPPORTED
Therapeutic implications of ultrasound of peripheral nerves BY
INVEST IN
B-1739 15:12 in leprosy THE YOUTH
Dose optimisation in spinal computed tomography for planning of Y. Aswani1, S. Saifi2; 1Udaipur/IN, 2Mumbai/IN
scoliosis surgery
Y. Klosterkemper, M. Konieczny, T. Hesper, J. Aissa, G. Antoch, J. Boos;
Düsseldorf/DE

B-1750 15:21 14:00 - 15:30 Coffee & Talk 2

Time to replace T2-STIR with diffusion-weighted imaging for
visualisation of nerve disorders? Abdominal Viscera
S. Rajan, H. Mahajan, M. Barnwal, V. Mahajan, V. Venugopal; New Delhi/IN
14:00 - 15:30 Studio 2019

SS 1901a
Diagnosis of hepatocellular carcinoma:
Imaging Informatics
the LI-RADS perspective
Moderators:
SS 1905a A. Ba-Ssalamah; Vienna/AT
D. Christodoulou; London/UK
Machine learning in chest radiology
N.N. Diagnostic accuracy of CEUS LI-RADS in characterisation of small liver
A. Farchione; Rome/IT nodules in patients at risk for hepatocellular carcinoma
J. Huang1, A. Lyshchik2, J.-W. Li1, Y. Luo1, J.-B. Liu2, Q. Lu1; 1Chengdu/CN,
2
B-1751 14:00 Philadelphia, PA/US
Evaluation of deep learning software tool for CT-based lung nodule
classification B-1763 14:08
J.T. Murchison, G. Ritchie, D. Senyszak, E.J.R. van Beek; Edinburgh/UK Non-invasive imaging diagnosis of hepatocellular carcinoma in
patients with both chronic liver disease and a history of extrahepatic
B-1752 14:08 primary cancer
Improved pulmonary nodule malignancy prediction with surrounding M. Cho, C. An, K. Aljoqiman, M.-J. Kim; Seoul/KR
tissues
K. Liu1, W. Tang2, C. Xia2, Y. Deng2, R. Zhang1, L. Fan1, Y. Xiao1, S. Liu1; B-1764 14:16
1
Shanghai/CN, 2Beijing/CN A radiomics-clinical model to diagnose hepatocellular carcinoma:
prospective comparison with the EASL and LI-RADS (v2018) criteria
B-1753 14:16 H. Jiang, X. Liu, J. Chen, L. Cao, Y. Wei, B. Song; Chengdu/CN
Automated classification of chest x-rays as normal/abnormal using a
high sensitivity deep learning algorithm SUPPORTED
V. Venugopal1, M. Tadepalli2, B. Reddy2, A. Modi2, S. Gupta1, P. Warier2, Value of targetoid appearance on T2-weighted imaging and BY
INVEST IN
P. Rao2, H. Mahajan1, V. Mahajan1; 1New Delhi/IN, 2Mumbai/IN signs of tumour vascular involvement for differentiating THE YOUTH
hepatocellular carcinoma (HCC) from other non-HCC liver
B-1754 14:24 malignancies
Efficacy and clinical and radiological influencing factors on bone R. Cannella1, T.J. Fraum2, D.R. Ludwig2, A.A. Borhani3, K.J. Fowler4,
suppression by deep learning algorithm in digital chest radiograph A. Furlan3; 1Palermo/IT, 2Saint Louis, MO/US, 3Pittsburgh, PA/US,
4
H. Moon, G.-S. Hong, Y. Byeon, C. Lee; Seoul/KR San Diego, CA/US
B-1755 14:32 B-1766 14:32

3D computer-aided CT texture analysis with machine learning: Imaging features of hepatocellular carcinoma: qualitative and
capability to play as second reader for radiological finding assessment quantitative comparisons between hepatobiliary and extracellular
in interstitial lung disease contrast-enhanced MRI
Y. Ohno1, A. Yaguchi2, K. Aoyagi3, D. Takenaka4, T. Yoshikawa1, Y. Kishida1, J. Son1, S. Hwang1, M.-.S. Park1, S. Park2, M.-.J. Kim1, J.-Y. Choi1, K. Han1;
1
S. Seki1, T. Murakami1; 1Kobe/JP, 2Kawasaki/JP, 3Otawara/JP, 4Akashi/JP Seoul/KR, 2Goyang/KR
B-1756 14:40 B-1767 14:40

Automatic pulmonary nodule detection in low-dose CT scans using Radiologic-pathologic correlation of non-hypervascular hypointense
convolutional neural networks based on maximum intensity projection nodules on gadoxetic acid-enhanced MRI: a multi-centre retrospective
S. Zheng1, J. Guo1, M. Rook1, X. Cui1, R.N.J. Veldhuis2, M. Oudkerk1, observational study
P.M.A. van Ooijen1; 1Groningen/NL, 2Twente/NL I. Joo, S. Kim, T. Kang, K. Lee, J. Lee; Seoul/KR

Towards a deep learning model for exhaustive chest x-ray pathology Diagnostic performance of hepatobiliary phase hypointensity BY
INVEST IN
classification and major imaging features for the diagnosis of HCC THE YOUTH
N. Ramanauskas, J. Dementaviciene, J. Armaitis, D. Barušauskas, in lesions between 10 and 19 mm, and arterial phase
J. Bialopetravicius, G. Rimeika, J. Stankeviciene; Vilnius/LT hyperenhancement
F. Vernuccio1, R. Cannella1, M. Meyer2, K.R. Choudhoury2, M.R. Bashir2,
B-1758 14:56 A. Furlan3, D. Marin2; 1Palermo/IT, 2Durham, NC/US, 3Pittsburgh, PA/US
CT-based radiomics predict immune-iherapy response in patients with
non-small-cell lung cancer B-1769 14:56
S. Wang, J. Gong, H. Yu, W. Peng; Shanghai/CN Predicting progression to hypervascular HCC in hypovascular
hypointense nodules on gadoxetic acid-enhanced MR images in
B-1759 15:04 patients with chronic liver disease
Evaluation of deep learning software tool for CT-based lung nodule W.S.R.V. Teerasamit; Bangkok/TH
detection
J.T. Murchison, G. Ritchie, D. Senyszak, E.J.R. van Beek; Edinburgh/UK SUPPORTED
Liver imaging reporting and data system v2018: visualisation BY
INVEST IN
B-1760 15:12 rate and diagnostic value of ancillary features favouring THE YOUTH
A new architecture of the computer-aided system for lung cancer malignancy in observations at intermediate and high risk
diagnostics for HCC
A.A. Meldo, L.V. Utkin, V.M. Moiseenko, M.A. Ryabinin; St. Petersburg/RU R. Cannella1, F. Vernuccio1, D. Marin2, A. Furlan3; 1Palermo/IT,
2
Durham, NC/US, 3Pittsburgh, PA/US
B-1761 15:20
Fully automatic detection and segmentation of thoracic lymph nodes B-1772 15:20
in MSCT scans of the chest using deep learning Response assessment of HCC after locoregional therapy on gadoxetic
H. Carolus1, A.-I. Iuga2, T. Brosch1, R. Wiemker1, T. Klinder1, D. Maintz2, acid-enhanced MRI: performance of the LI-RADS TR categorisation
A. Höink2, M. Püsken2; 1Hamburg/DE, 2Cologne/DE and added value of ancillary features
S. Kim, I. Joo, H.-C. Kim, S. Ahn, H.-J. Kang, S. Jeon, J. Han; Seoul/KR

14:00 - 15:30 Room E2 14:00 - 15:30 Room F1

Neuro Breast
SS 1911a SS 1902a
Contrast media and advances in neuro MRI Contrast-enhanced mammography,
Moderators:
N.N.
breast CT, and other new imaging
D. Stojanov; Nis/RS techniques
Moderators:
B-1773 14:00 M. Bernathova; Vienna/AT
Comparison of contrast-enhanced modified T1-weighted 3D TSE F. Pesapane; Milan/IT
black blood and 3D MP-RAGE sequences for detection of meningeal
enhancement B-1784 14:00
M.F. Froelich, R. Pons Lucas, E. Coppenrath, W. Sommer, K.M. Treitl, The accuracy of contrast-enhanced mammography: a retrospective
T. Saam, N.N. Sommer; Munich/DE multireader study
M. Calvo Imirizaldu1, I. González de la Huebra Rodríguez1,
B-1774 14:08 A. Ezponda Casajús1, J. Etxano2, A.M. Elizalde Pérez1, L.J. Pina Insausti1;
Application of half-dose contrast-enhanced T2-fluid-attenuated 1
Pamplona/ES, 2Vitoria/ES
inversion recovery sequence in brain metastasis
T. Jin; Shanghai/CN B-1785 14:08
Contrast-enhanced digital mammography, magnetic resonance
B-1775 14:16 imaging and mammography alone: a comparison of diagnostic
Is synthetic MRI of the brain feasible in a clinical setting? performance in symptomatic women
A comparison with standard protocol W. Tang; Shanghai/CN
G. Corrias, A. Balestrieri, L. Saba; Cagliari/IT
B-1787 14:16
B-1776 14:24 Evaluation of single-view contrast-enhanced mammography as
Diagnostic efficacy and safety of gadoteridol in neuroradiology: potential strategy for screening of patient with high breast cancer risk:
qualitative assessment in a large sample of MRI studies at 1,5T a non-inferiority retrospective study
A. Del Poggio, C. Pereira, A. Iadanza, A. Falini, N. Anzalone; Milan/IT M.B.I. Lobbes, J. Hecker, I. Houben, R. Pluymakers, C. Jeukens, U. Lalji,
S. Gommers, J.E. Wildberger, P.J. Nelemans; Maastricht/NL
B-1777 14:32
MRI T1w brain signal intensity and relaxation times in individuals with B-1788 14:24
prior exposure to gadobutrol Comparison of the intensity and pattern of enhancement on contrast-
M. Saake, A. Schmidle, M. Kopp, J. Hanspach, T. Hepp, A. Nagel, enhanced spectral mammography between malignant and benign
A. Doerfler, M. Uder, T. Baeuerle; Erlangen/DE breast lesions
Y. Liu, J. Yu, L. Su; Chengdu/CN
SUPPORTED
Glutamate concentration changes in response to continuous BY B-1789 14:32
INVEST IN
stimulation THE YOUTH Propagation-based computed tomography and cone-beam computed
A. Manzhurtsev, P. Menshchikov, M. Ublinskiy, N. Semenova, tomography of the breast: a comparison of radiological image quality
O. Bozhko, T. Akhadov; Moscow/RU S. Tavakoli Taba1, P. Baran2, Y. Nesterets2, S. Pacile3, S. Wienbeck4,
C. Dullin4, F. Arfelli3, S. Lewis1, G. Tromba3, T. Gureyev2, P. Brennan1;
B-1779 14:48 1
Sydney/AU, 2Melbourne/AU, 3Trieste/IT, 4Göttingen/DE
Two postprocessing method of diffusion kurtosis imaging in glioma
grading B-1790 14:40
A. Gao1, J. Bai1, Y. Zhang1, J. Cheng1, Y. Hong2; 1Zhengzhou/CN, Dedicated breast CT may prevent unnecessary biopsies in women
2
Hangzhou/CN recalled from mammographic screening
R.M. Mann, G. van Spijker, M. Caballo, I. Sechopoulos; Nijmegen/NL
B-1780 14:56
Open-source software multimodal neuroimage processing for B-1791 14:48
presurgical assessment: benefits and comparison to proprietary Influence of different examination settings on the imaging of
software microcalcifications in CBCT
P. Donnelly-Kehoe, A.A. Ojeda, G. Pascariello, P.A. Acevedo, M.B. Nallino, C. Neubauer, J. Wolf, J. Neubauer; Freiburg/DE
A.L. Rodríguez Musso, J. Gomez; Rosario/AR
B-1792 14:56
B-1781 15:04 The feasibility of using clinically compatible grating interferometry
Clinically-implemented, CAD-assisted decision support system to limit mammography in breast cancer diagnosis
gadolinium injection in patients with multiple sclerosis C. Arboleda1, K. Lang2, Z. Wang1, T. Köhler3, S. Prevrhal3, C. Leo4, S. Forte4,
M. Bilello, R. Mattay, A. Mamourian; Philadelphia, PA/US R. Kubik-Huch4, M. Stampanoni1; 1Villigen/CH, 2Malmö/SE, 3Hamburg/DE,
Sunday
4
Baden/CH
B-1782 15:12
Machine learning-based exploration of extracranial determinants of B-1793 15:04
grey matter volume in the KORA-MRI study Optoacoustic imaging is helpful in predicting breast cancer molecular
F. Schöppe1, S. Rospleszcz1, F. Bamberg2, C.L. Schlett3, W. Rathmann4, subtypes
K.-H. Ladwig1, A. Peters1, B.B. Ertl-Wagner5, S. Stöcklein1; 1Munich/DE, B. Dogan1, G. Menezes2, R. Butler3, E. Neuschler3, P. Lavin4, R. Aitchison4,
2
Freiburg/DE, 3Heidelberg/DE, 4Düsseldorf/DE, 5Toronto, ON/CA L.F. Tucker5, P. Otto2, S. Grobmyer2; 1Dallas, TX/US, 2San Antonio, TX/US,
3
New Haven, CT/US, 4Framingham, MA/US, 5Wirtz, VA/US
B-1783 15:20
Virtual monoenergetic images from spectral detector CT (SDCT) B-1794 15:12
enable radiation dose reduction in unenhanced cranial CT Optoacoustic imaging features correlate with breast cancer
R.P. Reimer, T.E. Lichtenstein, D. Flatten, D. Maintz, J. Borggrefe, clinicopathological prognostic factors
N. Grosse Hokamp; Cologne/DE B. Dogan1, G. Menezes2, R. Butler3, E. Neuschler3, P. Lavin4, R. Aitchison4,
L.F. Tucker5, P. Otto2, S. Grobmyer6; 1Dallas, TX/US, 2San Antonio, TX/US,
3
New Haven, CT/US, 4Framingham, MA/US, 5Wirtz, VA/US,
6
Cleveland, OH/US

14:00 - 15:30 Room F2 14:00 - 15:30 Room Y

Breast Interventional Radiology
SS 1902b SS 1909
Breast cancer staging, therapy Nonvascular interventions in the lung
monitoring and recurrence Moderators:
C. Pusceddu; Cagliari/IT
Moderators: Z. Tüdös; Olomouc/CZ
M.A. Orsi; Milan/IT
N.N.
K-42 14:00
Keynote lecture
B-1795 14:00 T.K. Helmberger; Munich/DE
CT staging in newly diagnosed breast cancer: are we adhering to
current guidelines?
N.A. Healy, J.A. Tanner, F. Kilburn-Toppin; Cambridge/UK SUPPORTED
Pre-surgical marking under CT guidance of no-palpable, non BY
INVEST IN
solid/solid/partially solid pulmonary nodules: when and why THE YOUTH
B-1801 14:08 to use it
Can breast MRI aid in predicting high burden axillary disease in I. Campo, S. Cernic, F. Arban, R. Pozzi Mucelli, F. Sacconi, M.A. Cova;
patients diagnosed with breast cancer? Trieste/IT
N. Healy, F. Kilburn-Toppin, M. Wallis; Cambridge/UK
B-1808 14:25
B-1796 14:16 CBCT-guided hydrogel plug percutaneous deployment before video-
Clinical value of 18F-FDG PET/CT for staging elderly and young women assisted thoracoscopic surgical resection
with preoperative breast cancer A. Beneventi1, N. Casamassima1, A. Muollo2, A. Coppola1, E. Macchi1,
K. Kubota, T. Fujioka, M. Mori, J. Tsuchiya, U. Tateishi; Tokyo/JP F. Piacentino1, A. Ierardi3, F. Fontana1, G. Carrafiello4; 1Varese/IT,
2
Busto Arsizio/IT, 3Marsala/IT, 4Milan/IT
B-1797 14:24
Comparative evaluation of strain ratio on sonographic elastography B-1809 14:33
and T2* values on 3Tesla MRI in differentiating malignant from benign CT-guided lung biopsy: a simplified classification and scoring system
axillary lymph nodes in breast cancer to assess appropriateness of indication according to nodules‘ 18-FDG
S. Sharma, R. Bansal, S. Jain, P. Sethi; New Delhi/IN uptake, dimension and localisation
M. Tipaldi1, G. Orgera1, F. Laurino2, E. Ronconi1, M. Krokidis3, A. Zolovkins1,
B-1798 14:32 A. Laghi4, M. Rossi1; 1Rome/IT, 2Eboli/IT, 3Cambridge/UK, 4Latina/IT
Biopsy-proven ductal carcinoma in situ radiographic features and
upgrade rates B-1810 14:41
L.C.A. Chan, K.H. Wong, P.Y. Tang, K.Y. Tam, K.O. Cheung, C.L. Chiu; Fusion imaging technique in lung biopsy to demonstrate the
Hong Kong/HK correlation between standardised uptake value (SUV) and specimen‘s
diagnostic value
B-1799 14:40 A. Muollo1, A. Beneventi2, E. Macchi2, F. Piacentino2, C. Floridi3,
MRI assessment of axillary lymph nodes after neoadjuvant F. Fontana2, G. Carrafiello4, C. Fugazzola2; 1Busto Arsizio/IT, 2Varese/IT,
chemotherapy based on breast cancer subtype 3
Perugia/IT, 4Milan/IT
V. Ruggeri, G. Mariscotti, M. Durando, C. Costanza, L. Bergamasco,
I. Castellano, P. Fonio; Turin/IT B-1811 14:49
The value of core-biopsy of nodules less than 10 mm
B-1800 14:48 P.S. Sánchez; Atibaia/BR
Which factors affect the accuracy of MRI in predicting response and
estimating residual disease after neoadjuvant chemotherapy? B-1812 14:57 SPEAKER
SUPPORTED
H. Ahn, Y. An, J. Baek, Y. Suh, H. Choi; Suwon/KR Percutaneous radiofrequency thermal ablation (RFA) of BY
INVEST IN
lung neoplasms using a new 15 G internally cooled jet-tip THE YOUTH
B-1802 14:56 electrode: preliminary results
Response of breast cancer to neoadjuvant treatment assessed using F. Carchesio, R. Iezzi, A. Posa, T. Congedo, G. Veltri, S. Margaritora,
hyperpolarised 13C MRI R. Manfredi; Rome/IT
R.A. Woitek, M.A. McLean, J. Grist, A. Gill, J. Abraham, F. Gilbert,
C. Caldas, K. Brindle, F.A. Gallagher; Cambridge/UK B-1813 15:05
Leaving-tail microcoil localisation for small pulmonary nodules prior to
B-1803 15:04 thoracoscopy
Longterm review of recurrence after breast cancer treatment: data T. Su, L. Jin; Beijing/CN
from breast cancer/tumour type analysis
M. Lavens, H. Wildiers, P. Neven, I. Nevelsteen, A. Smeets, M. Keupers, B-1814 15:13
R.M.A. Prevos, A. Laenen, C. Van Ongeval; Leuven/BE Retrospective analysis of the role of intraparenchymal blood patching
and the rate of pneumothorax after percutaneous CT-guided core lung
B-1804 15:12 biopsy
Contrast-enhanced mammography screening women after breast- R.M. Perl1, J. Hetzel1, H. Bösmüller1, C. Kloth2, M. Horger1; 1Tübingen/DE,
conserving therapy 2
Ulm/DE
D. Avendano1, M.S. Jochelson1, K. Pinker-Domenig2, M.A. Marino3,
J. Gluskin1, J.S. Sung1; 1New York, NY/US, 2Vienna/AT, 3Messina/IT B-1815 15:21
Gelfoam slurry tract embolisation after computed tomography-guided
B-1805 15:20 percutaneous lung biopsy: does it prevent major pneumothorax?
Does internal mammary artery irradiation for breast cancer make R. Sum, K.K. Lau; Clayton/AU
significant difference in diameters of internal mammary artery?
Correlation with computed tomography
G. Durhan, A. Erdemir, S. Sarı, M. Gültekin, J. Karakaya, M. Akpınar,
F. Yildiz, F. Demirkazik; Ankara/TR

14:00 - 15:30 Coffee & Talk 3 14:00 - 15:30 Room D

Cardiac Artificial Intelligence and Machine Learning
SS 1903a SS 1905b
Cardiac MR in cardiomyopathies: tips Machine learning: visceral organs and GI
and tricks tract
E. Pershina; Moscow/RU D. Pinto dos Santos; Cologne/DE
M. Pirnat; Maribor/SI M. Prokop; Nijmegen/NL
B-1816 14:00 B-1827 14:00

Intravoxel incoherent motion diffusion-weighted imaging for the Semi-automatic technique for Crohn‘s disease diagnosis, using a
assessment of myocardial fibrosis in hypertrophic cardiomyopathy supervised machine learning algorithm
R. Wu, R.-Y. Shi, D.-A. An, C.-W. Wu, B. Chen, L. Wu, J. Xu; Shanghai/CN G. Lo Re, M.C. Terranova, D. Picone, S. Franchini, S. Vitabile, M. Midiri;
Palermo/IT
SUPPORTED
Analysis of strain values in asymmetrical hypertrophic BY B-1828 14:08
INVEST IN
cardiomyopathy: correlations with wall thickness and extent THE YOUTH CT texture analysis to predict response to target therapy of hepatic
of focal fibrosis metastases from colorectal cancer
C. De Cataldo, S. Torlone, A. Corridore, P. Palumbo, E. Cannizzaro, L. Vassallo, V. Giannini, A. Defeudis, S. Mazzetti, G. Cappello, D. Regge;
F. De Matteis, A. Di Sibio, E. Di Cesare, C. Masciocchi; L‘Aquila/IT Candiolo/IT
B-1818 14:16 B-1830 14:16

MRI characteristics and clinical outcomes of hypertrophic Automatic visceral fat characterisation on CT scans through deep
cardiomyopathy with infarct-like late enhancement learning and CNN for the assessment of metabolic syndrome
L. Li, S. Zhao; Beijing/CN A. Jimenez-Pastor, A. Alberich-Bayarri, F. Garcia-Castro, L. Marti-
Bonmati; Valencia/ES
B-1819 14:24
Sudden cardiac death (SCD) risk stratification in hypertrophic B-1831 14:24
cardiomyopathy (HCM) patients by cardiac magnetic resonance Application of a clinical decision support system to the imaging
imaging (CMR) with late gadolinium enhancement (LGE) pathway of patients with hepatocarcinoma and cholangiocarcinoma
E. Mershina, N. Krylova, V.E. Sinitsyn, N. Poteshkina, M. Balaeva, A. Pylev; M. Gabelloni, M. Di Nasso, C.A. D‘Amore, R. Morganti, L. Faggioni,
Moscow/RU G. Masi, E. Neri; Pisa/IT
B-1820 14:32 SPEAKER B-1832 14:32

SUPPORTED
The diagnostic performance of novel non-contrast markers BY Automated CT abdominal imaging protocol selection using natural
INVEST IN
in discrimination of cardiac amyloidosis and hypertrophic THE YOUTH language processing and machine learning
cardiomyopathy on cardiovascular magnetic resonance P. Rogalla1, B.E. Hoppel2, K. Noro3, Y. Yamazaki3, K. Utsunomiya3,
imaging Y. Shimomura3, S. Sugiyama3; 1Toronto, ON/CA, 2Delafield, WI/US,
3
S. Huang, Z.-G. Yang, K. Shi, K. Diao, Y. Gao, Y.-K. Guo, Y. He, S. He, Nasushiobara/JP
M.-T. Shen; Chengdu/CN
SUPPORTED
B-1821 14:40 SPEAKER AI automatic identification of complete- and non- responders BY
SUPPORTED INVEST IN
Cardiac magnetic resonance in myotonic dystrophy type 1: BY using texture analysis of rectal cancer 3T MR images THE YOUTH
INVEST IN
a contribution to risk assessment THE YOUTH performed before, during and after neoadjuvant CRT
M. Alì, C.B. Monti, L. Melazzini, B. Fossati, M. Cavalli, R. Cardani, R. Ferrari, C. Mancini Terracciano, C. Voena, M. Rengo, M. Zerunian,
G. Meola, F. Sardanelli, F. Secchi; Milan/IT R. Paramatti, R. Faccini, A. Laghi; Rome/IT
B-1822 14:48 B-1834 14:48

Cardiovascular magnetic resonance (CMR) in patients with Fabry disease Radiomics nomogram for the preoperative prediction of lymph node
E.A. Mershina, S.V. Moiseev, V.E. Sinitsyn, P.S. Pilius, A.S. Moiseev, metastasis in pancreatic cancer
V.V. Fomin; Moscow/RU Y. Bian; Shanghai/CN
B-1823 14:56 SPEAKER B-1835 14:56

SUPPORTED
Role of cardiac magnetic resonance (CMR) imaging for early BY A sparse representation radiomics method based on multi-modality
INVEST IN
detection of myocardial involvement in patients affected by THE YOUTH ultrasound images for hepatocellular carcinoma diagnosis and PD1
Anderson Fabry disease (AFD) prediction
S. Coco, R. Ammendola, A. Bracci, F. Catapano, F. Cilia, G. De Rubeis, W. Wang, Y. Dong, Z. Yao, Q. Zhang, D. Yang, J. Yu; Shanghai/CN
N. Galea, M. Francone, C. Catalano; Rome/IT
B-1836 15:04
Sunday
B-1824 15:04 Dynamic contrast-enhanced CT diagnosis of primary liver cancers

Feature tracking allows detection of diminishing wall motion using transfer learning of pre-trained convolutional neural network:
disturbances in Takotsubo cardiomyopathy comparison with radiologists
R.M. Brumberg, T. Emrich, P. Wenzel, S. Benz, R. Kloeckner, K. Oyama, A. Yamada, E. Yoshizawa, F. Ichinohe, D. Komatsu, Y. Fujinaga;
M.C. Halfmann, C. Düber, K.-F. Kreitner; Mainz/DE Matsumoto/JP
B-1825 15:12 SPEAKER B-1837 15:12

SUPPORTED
Functional assessment and prognostic value of cardiac BY Chronic liver disease assessment with a machine learning method
INVEST IN
magnetic resonance in arrhythmogenic right ventricular THE YOUTH using parameters derived from ultrasound B-mode and shear wave
cardiomyopathy elastography examination
M.-T. Shen, Z. Yang, K. Diao, L. Jiang, B. Hu, S. Huang, Y. Guo; P. Drazinos1, I. Gatos2, S. Yarmenitis3, I. Theotokas2, A. Soultatos2,
Chengdu/CN E. Panteleakou2, P. Zoumpoulis1; 1Kifissia/GR, 2Athens/GR, 3Marousi/GR

SUPPORTED
Magnetic resonance first-pass perfusion imaging for BY
INVEST IN
assessment of myocardial microvascular dysfunction in THE YOUTH
pediatric patients with acute leukemia
Q. Zhao, R. Xu, Z.-G. Yang, Y.-K. Guo; Chengdu/CN

14:00 - 15:30 Room G 14:00 - 15:30 Room K

SS 1913 SS 1904
Breast imaging physics Traditional and advanced pulmonary
Moderators:
G. Gennaro; Padua/IT
vascular imaging
E. Keavey; Galway/IE Moderators:
A. Nair; London/UK
M. Sánchez; Barcelona/ES
K-43 14:00
Keynote lecture
G. Gennaro; Padua/IT B-1848 14:00
Perfusion-ventilation CT via three-material differentiation in dual-layer
CT: a feasibility study
B-1838 14:09
A. Sauter1, J. Hammel1, M. Kimm1, D. Pfeiffer1, F.K. Kopp1, K. Achterhold2,
Proposal of a breast phantom for dosimetry quality control procedures
F. Pfeiffer2, E.J. Rummeny1, P.B. Noel1; 1Munich/DE, 2Garching/DE
in digital mammography and digital breast tomosynthesis
C. Fedon1, R. Van Engen1, J. Binst2, L. Cockmartin2, D. Dance3, A. Jacobs2,
R. Longo4, K. Tri Wigati2, I. Sechopoulos1; 1Nijmegen/NL, 2Leuven/BE, B-1849 14:08
3
Guildford/UK, 4Trieste/IT Fine focal spot: a technique to improve image quality of computed
tomography pulmonary angiography
K.K. Lau1, L. Abdelganne1, K. Buchan1, A. Kuganesan1, T. Lau2;
B-1839 14:17 1
Melbourne/AU, 2Southport/AU
Device-specific reference values for modulation transfer function
(MTF) quality control measurements of digital mammography
detectors B-1850 14:16
K. Wigati1, H. Bosmans1, D.S. Soejoko2, L. Cockmartin1, A. Jacobs1, Do subtraction CT-derived iodine maps have the same impact on
J. Binst1, K. Lemmens1, N. Marshall1; 1Leuven/BE, 2Jakarta/ID pulmonary embolism detection as dual-energy CT-derived maps?
D. Grob1, E.J. Smit1, J. Prince2, J. Kist2, L.J. Oostveen1, M. Prokop1,
B-1840 14:25 SPEAKER C. Schaefer-Prokop3, I. Sechopoulos1, M. Brink1; 1Nijmegen/NL,
SUPPORTED 2
Utrecht/NL, 3Amersfoort/NL
Comparative phantom tests of digital mammograms, breast BY
INVEST IN
tomosynthesis and synthetic mammograms THE YOUTH
L. Vancoillie, L. Cockmartin, N. Marshall, H. Bosmans; B-1851 14:24
Leuven/BE Split-bolus contrast injection protocol enhances the visualisation of
the thoracic vasculature during chest CT
C. Saade; Beirut/LB
B-1841 14:33
Image improvement factor (Q) measured for three different antiscatter
grids used in mammography imaging B-1852 14:32
N. Marshall, H. Bosmans; Leuven/BE Lung dual-energy quantitative CT vs single-photon emission computed
tomography for quantification of the perfusion
S.A. Si-Mohamed1, C. Moreau-Triby1, Q. Wdowik2, P. Douek1, L. Boussel1;
B-1842 14:41 1
Bron/FR, 2Lyon/FR
Analysis of noise decomposition results in mammography quality
control: is quantum noise the dominant noise source?
K. Wigati1, H. Bosmans1, D.S. Soejoko2, K. Lemmens1, J. Binst1, A. Jacobs1, B-1853 14:40
L. Cockmartin1, N. Marshall1; 1Leuven/BE, 2Jakarta/ID Influence of respiratory position on pulmonary artery contrast
enhancement in dual-energy computed tomography angiography
J. Vaimel1, M.-K. Uprus1, N. Igumenova2, Ä. Roose1, A. Samarin1;
B-1843 14:49 1
Tallinn/EE, 2Peetri/EE
Personalised estimates of mean glandular dose and image quality
investigations in cone-beam computed tomography dedicated to the
breast B-1854 14:48
A. Sarno1, G. Mettivier1, R.M. Tucciariello2, J.M. Boone3, H. Bosmans4, Dual-energy CT pulmonary angiography and lung perfusion imaging
K. Bliznakova5, P. Russo1; 1Naples/IT, 2Pisa/IT, 3Sacramento, CA/US, with ultra-low-dose contrast application
4
Leuven/BE, 5Varna/BG K. Hekimoglu, K. Haberal, H. Turnaoglu, G. Kahraman; Ankara/TR
B-1844 14:57 B-1855 14:56

The effect of overestimating glandularity on mean mammographic Value of CT pulmonary angiography to predict short-term outcome in
glandular dose a patient with pulmonary embolism
M.E. Suleiman, P.C. Brennan, M.F. McEntee; Sydney/AU A.M. Osman, E. H. Abdeldayem; Cairo/EG
B-1845 15:05 SPEAKER B-1856 15:04

SUPPORTED
Accuracy testing of two partial breast imaging simulation BY D-dimers, Wells’ scores and CTPA for pulmonary embolism: are all
INVEST IN diagnostics used appropriately?
platforms for applications in virtual clinical trials THE YOUTH
L. Vancoillie1, M. Herbst2, L. Cockmartin1, N. Marshall1, C. So, P. de Souza, R. Kumar, D. Remedios; London/UK
F. Schebesch3, J. Vignero1, H. Bosmans1; 1Leuven/BE, 2Forchheim/DE,
3
Erlangen/DE B-1857 15:12
The effect of different monochromatic image choices on the
B-1846 15:13 SPEAKER reconstruction of CT perfusion data in one-stop spectral and perfusion
SUPPORTED
Towards clinical phase-contrast breast CT at Elettra: major BY CT scan
INVEST IN H. Wang, P. Lu, S. Yue, W. Li; Zhengzhou/CN
SNR improvement at larger propagation distances THE YOUTH
L. Brombal1, P. Delogu2, D. Dreossi1, B. Golosio3, P. Oliva4,
G. Mettivier5, L. Rigon1, A. Taibi6, R. Longo1; 1Trieste/IT, 2Siena/IT, B-1858 15:20
3
Cagliari/IT, 4Sassari/IT, 5Naples/IT, 6Ferrara/IT CT angiography for pulmonary embolism in the emergency
department: diagnostic accuracy of 20ml high-concentration contrast
B-1847 15:21 medium
Dose-compatible grating-based phase-contrast mammography on G. Milanese1, R. Cobelli1, C. Manna1, M. Silva1, E. Rasciti2, S. Poggesi1,
mastectomy specimens using a compact synchrotron source N. Sverzellati1; 1Parma/IT, 2Bologna/IT
L. Heck1, E. Eggl1, S. Grandl2, M. Dierolf1, D. Mayr2, K.A. Hellerhoff2,
M.F. Reiser2, F. Pfeiffer1, J. Herzen1; 1Garching/DE, 2Munich/DE

14:00 - 15:30 Room M 1 14:00 - 15:30 Room M 4

Cardiac GI Tract
SS 1903b SS 1901b
Discovering the right ventricle Gastro-oesophageal imaging:
in cardiac MR now and next
Z. Olczak; Katowice/PL G.H. Mostbeck; Vienna/AT
V.E. Sinitsyn; Moscow/RU T. Rohan; Brno/CZ
B-1859 14:00 SPEAKER B-1871 14:00

SUPPORTED
Cardiac magnetic resonance feature tracking for quantifying BY Significance of multidetector computed tomography in the assessment
INVEST IN
right ventricular deformation in type 2 diabetes mellitus THE YOUTH of achalasia subtypes and detection of pulmonary complications
patients S. Jovanovic, A. Djuric Stefanovic, A. Simic, O. Skrobic, D. Masulovic;
B. Hu, Z.-G. Yang, Y.-K. Guo; Chengdu/CN Belgrade/RS
B-1860 14:08 B-1872 14:08

Magnetic resonance functional assessment of the right ventricle in the Value of MRI with static and dynamic sequences in the study nature
short-axis plane as obtained from cross-referenced atrioventricular extension of the tight stenosis of the oesophagus-gastric junction
plane localisation G. De Franco1, S. Bruni1, G. D‘Alesio2, S. Bux1, A. Ambrosi3, A. Vaccaro1,
M. de Meyere, B. Dubourg, D. Delacour, S. Bejar, P.J. Michelin, J.- V. Grimaldi1, M. Fracella1; 1Bari/IT, 2Triggiano/IT, 3Valenzano/IT
N. Dacher; Rouen/FR
B-1873 14:16
B-1861 14:16 Accuracy of 3.0 T MRI in the preoperative T staging of patients with
Cardiac magnetic resonance imaging study of right ventricular potentially resectable oesophageal cancer, with histopathological
myocardial deformation in spontaneous T2DM rhesus monkey correlation
T. Zhu1, C. Yushu1, Z. Yu1, Z. Wen1, J. Zheng2, G. Fabao1; 1Chengdu/CN, Y. Lu1, J. Qu1, Z. Wang1, X. Yan2; 1Zhengzhou/CN, 2Shanghai/CN
2
St. Louis, MO/US
SUPPORTED
B-1862 14:24 Is the perfusion-metabolic tumour phenotype related to BY
INVEST IN
Right ventricular functional assessment with cardiac MRI by comparing tumour volume and nodal stage in primary oesophageal THE YOUTH
volume measurements between axial and short axis orientations tumours undergoing DCE-MRI and 18F-FDG PET/CT?
D.G. Oktay, E. Peker, I. Erden; Ankara/TR S.J. Withey, K. Owczarczyk, C. Yip, M.M. Siddique, A. Green, J. Bell,
G. Cook, V.J. Goh; London/UK
B-1863 14:32
Balloon pulmonary angioplasty (BPA) improves right ventricular B-1875 14:32
dysfunction and pulmonary haemodynamics in inoperable CTEPH Combination of quantitative 18F-FDG PET parameters and contrast-
A. Hasse1, K. Tello1, H. Gall1, A. Breithecker1, C.B. Wiedenroth2, W. Seeger1, enhanced CT in locoregional restaging and prognostication of survival
E. Mayer2, G.A. Krombach1, F.C. Roller1; 1Giessen/DE, 2Bad Nauheim/DE in patients with oesophageal cancer
D. Tamandl, B. Fueger, A. Haug, A. Ba-Ssalamah; Vienna/AT
B-1864 14:40
Application of CMR derived myocardial deformation parameters to B-1876 14:40
predict restrictive physiology in repaired tetralogy of Fallot patients Correlation between dual-energy CT and perfusion CT parameters in
X.-W. Tong1, R. Wald2, G.R. Karur2, Y.-F. Cheung1, M.-Y. Ng1; patients with gastric carcinoma
1
Hong Kong/HK, 2Toronto, ON/CA Y. Chai; Zhengzhou/CN
B-1865 14:48 B-1877 14:48

Evaluation of ascending aorta flow pattern in patients with repaired Clinical value of radiomics nomogram in preoperative prediction of
TOF using 4D flow CMR lymph node metastasis of gastric adenocarcinoma
S. Lee, Y.J. Kim; Seoul/KR R. Wang, J. Li, J. Gao; Zhengzhou/CN
B-1866 14:56 B-1878 14:56

Measurement of wall shear stress and pressure gradients using Imaging of mini/one anastomosis gastric bypass abdominal
4D-flow-MRI in patients with Fontan circulation complications
A. Curta, A. Lehner, S. Ulrich, R. Dalla-Pozza, M. Fischer, N. Haas, G. Scavone1, D.C. Caltabiano1, M.V. Raciti2, M.C. Calcagno1, G. Caltabiano1,
H. Kramer; Munich/DE F. Gulino1, A. Giarrizzo1, L. Piazza1, A. Scavone1; 1Catania/IT, 2Pavia/IT
B-1867 15:04 B-1879 15:04 SPEAKER

SUPPORTED
Pulmonary insufficiency: extending the advantage of pulmonary Structured CT reporting improves accuracy in diagnosing BY
INVEST IN
Sunday
regurgitation volume versus pulmonary regurgitation fraction to a internal herniation after laparoscopic Roux-en-Y gastric THE YOUTH
congenital heart disease mixed population bypass
M. Petrini1, F. Secchi2, C.B. Monti2, M. Alì2, P.M. Cannao2, E. Michieletti1, J.C. Ederveen1, S.W. Nienhuijs2, J. Nederend2; 1Maastricht/NL,
F. Sardanelli2; 1Piacenza/IT, 2Milan/IT 2
Eindhoven/NL
B-1868 15:12 B-1880 15:12

Free breathing real-time cardiac MRI in children with congenital heart Can routine postoperative CT scan provide reliable leakage risk
disease: comparison of right ventricular function with standard breath- stratification after laparoscopic sleeve gastrectomy (LSG)?
hold imaging D. Palumbo, G. Guazzarotti, C. Martinenghi, R. Nicoletti, A. Del Maschio,
C. Treutlein, M. Zeilinger, R. Heiß, W. Wuest, O. Rompel; Erlangen/DE F. De Cobelli; Milan/IT
B-1869 15:20
Regional right ventricular deformation in hypertrophic
cardiomyopathy: assessed with cardiovascular magnetic resonance
tissue tracking
X. Li, Y. Zhigang, Y. Guo, Y. He, S. He, K. Shi, C. Xia, Z. Li; Chengdu/CN

14:00 - 15:30 Room M 5 14:00 - 15:30 Tech Gate Auditorium

Neuro Genitourinary
SS 1911b SS 1907
Epilepsy and epileptogenic conditions Imaging of the uterus
N.N. N.N.
N. Pyatigorskaya; Paris/FR K. Skrobisz; Gdansk/PL
B-1881 14:00 B-1892 14:00

Evaluation of visuospatial memory performance in temporal lobe Why guidelines are important: inter observer variability in assessing
epilepsy: a retrospective FMRI study MRI signs of endometriosis between reader following ESUR guidelines
V. Schmidbauer, O. Fösleitner, K.-H. Nenning, G. Kasprian, M. Schwarz, vs. reader using prior domain knowledge
G. Geisl, C. Baumgartner, D. Prayer, S. Bonelli; Vienna/AT S. Rajan, R. Rajan, M. Murugavel, M. Barnwal, S. Gupta, V. Venugopal,
V. Mahajan; New Delhi/IN
B-1882 14:08
Disturbed hippocampal integration into the functional language B-1893 14:08
network in patients with temporal lobe epilepsy Multi-parametric magnetic resonance relaxometry as an assessment of
K.-H. Nenning, V. Schmidbauer, O. Fösleitner, D. Prayer, C. Baumgartner, dysmenorrhea severity in patients with adenomyosis
E. Pataraia, G. Langs, S. Bonelli, G. Kasprian; Vienna/AT C. Lin, Y. He, Y. Qi, X. Wang, H. Zhou, H. Xue, Z. Jin; Beijing/CN

SUPPORTED SUPPORTED
Study of correlation between hippocampal perfusion and BY Diagnostic algorithm to differentiate benign atypical BY
INVEST IN INVEST IN
volume in patients with temporal lobe epilepsy for epileptic THE YOUTH leiomyomas from malignant uterine sarcomas using MR THE YOUTH
lateralisation imaging
Y. Zhang, H. You, Y. Lv, W. Dou, B. Hou, F. Feng; Beijing/CN C. Abdel Wahab , A.-S. Jannot , P.A. Bonaffini , M.-A. Lefrere Belda1,
1 1 2
A.-S. Bats1, I. Thomassin-Naggara1, A. Bellucci3, C. Reinhold4, L. Fournier1;

B-1884 14:24 1
Paris/FR, 2Monza, QC/CA, 3Issy Les Moulineaux/FR, 4McGill, QC/CA
DTI-MRI findings in synthetic cannabinoid users
F.D. Gokharman, S. Aydin, S.C. Paltun, E. Fatihoglu, S. Yalcin Sahiner, B-1895 14:24
P.N. Kosar, H.K. Karli Oguz; Ankara/TR Differentiation of uterine sarcomas from benign atypical leiomyomas:
diagnostic value of quantitative parameters based on diffusion-
B-1885 14:32 SPEAKER weighted imaging
SUPPORTED
Validating the efficacy of multiple high-resolution MRI BY E. Kim, S. Rha, M.H. Choi, M. Choi, J.-I. Choi; Seoul/KR
INVEST IN
sequences with 18 FDG-PET co-registration in detecting THE YOUTH
epileptogenic lesion B-1896 14:32
T. Krishna Moorthy1, K. Rahmat2, L.K.S. Lim1, N. Ramli1; 1Petaling Jaya/MY, Correlation between zonal oblique multislice intravoxel incoherent
2
Kuala Lumpur/MY motion and dynamic contrast enhanced magnetic resonance imaging
parameters in endometrial cancer
B-1886 14:40 SPEAKER C. Lin, Y. He, Y. Qi, X. Wang, H. Zhou, H. Xue, Z. Jin; Beijing/CN
SUPPORTED
Evaluation of MRI findings in Hippocampal sclerosis with BY
INVEST IN
special reference to T2 relaxometry THE YOUTH B-1897 14:40
V. Inampudi1, S. Nimmalapudi2, A. Prakash3; 1Vijayawada/IN, Multi-parametric MR imaging for prediction of response to
2
Kolar/IN, 3Bengalore/IN gonadotropin releasing hormone analogue in patients with
adenomyosis: a preliminary study
B-1887 14:48 SPEAKER C. Lin, Y. He, Y. Qi, X. Wang, H. Zhou, H. Xue, Z. JIN; Beijing/CN
SUPPORTED
Metabolic changes after severe TBI: 1H MRS study BY
INVEST IN SPEAKER
P. Menshchikov, A. Ivantsova, A. Manzhurtsev, M. Ublinskiy, THE YOUTH B-1898 14:48 SUPPORTED
I. Melnikov, T. Akhadov, N. Semenova; Moscow/RU Conservative treatment in patients with cervical cancer on BY
INVEST IN
FIGO stage IB1-IIA1 >2cm: the role of MRI in a pilot study: THE YOUTH
B-1888 14:56 preliminary results
Cortical atrophy and cerebral hypoperfusion in anti-N-methyl-D- B. Gui, L. Russo, F. Cambi, F. Petta, S. Persiani, R. De Vincenzo,
aspartate receptor encephalitis: relationship to cognitive impairment R. Manfredi; Rome/IT
and disease severity
Y. Li, Y. Xiang, C. Zeng, J. Wang, Y. Han, Q. Luo, Y. Zheng; Chongqing/CN B-1899 14:56
Quantitative MR texture analysis to distinguish leiomyosarcoma from
B-1889 15:04 benign leiomyoma with high signal intensity on T2-weighted imaging
Predictive value of two-tensor unscented Kalman filter fractography T. Yagi, A. Tasaki, T. Hirata, M. Yamazaki, N. Yoshimura, H. Aoyama;
in the reconstruction of the arcuate fasciculus in patients with gliomas Niigata/JP
involving eloquent language areas
J. Yan, J. Cheng, J. Geng; Zhengzhou/CN B-1900 15:04
Imaging of potential donors for uterus transplantation, with emphasis
B-1890 15:12 SPEAKER on the uterine arteries
SUPPORTED
Feasibility of evaluating the genetic mutation status of grade BY J. Båth, P. Dahm-Kähler, N. Kvarnström, A. Thilander Klang,
INVEST IN
II and III gliomas by diffusion-weighted imaging THE YOUTH M. Brännström, H. Leonhardt; Gothenburg/SE
Y. Zhang, S. Liu, H. You, Y. Wang, B. Hou, Y. Lv, F. Feng;
Beijing/CN B-1901 15:12
Diffusion tensor imaging parameters of endometrial carcinoma can
B-1891 15:20 predict local tumour behavior: a feasibility study
The dorsolateral prefrontal cortex mediates the recruitment of A. Ghosh, T. Singh, V. Singla, R. Bagga, R. Srinivasan; Chandigarh/IN
auditory cortex in cross-modal plasticity and higher order cognitive
functions in sensorineural hearing loss B-1902 15:20 SPEAKER
SUPPORTED
Y. Luan, G.-J. Teng; Nanjing/CN Shear wave elastography of the endometrium: a simple tool BY
INVEST IN
to improve diagnostic accuracy of endometrial carcinoma THE YOUTH
from other benign endometrial diseases
S. Mah, A. Vijayananthan, K. Rahmat, R. Muridan, Y. Abdul Aziz, C.H.
Yeong; Kuala Lumpur/MY

List of Authors & Co-Authors
LIST OF
AUTHORS &
CO-AUTHORS (F)

A Aggarwal D.: B-1637 Al-Ekrish A.: B-1599

Aalbers A.G.: B-0182 Aggarwal R.: B-0141, B-1637 Aleman B.M.P.: B-1483
Aaløkken T.M.: B-0131 Aghahowa E.A.: B-1545 Alexander S.: B-1455
Aamir R.: B-1117 Agliata G.: B-1719 Alfaqih M.: B-0902
Aarts B.M.: B-0559, B-0850 Agosta F.: B-1696 Alfaro I.: B-1653
Aarts S.: A-0743 Agostini A.: B-1118 Alghamdi J.M.A.: B-0809
Aasand K.K.: B-1047 Agostini C.: B-1010 Algra P.: A-0535
Abbas H.M. H.: B-0966 Agostini G.A.: B-1300 Alì M.: B-0042, B-0895, B-1728, B-1821,
Abbasi H.R.: B-0291 Agostini S.: B-0622 B-1867
Abbass E.: B-1105 Ahern D.: B-0246 Ali S.: B-0902
Abdel Aal A.M.K.: B-0357, B-0838, B-1296, Ahmad Ainuddin H.: B-0468 Aliprandi A.: B-0895, B-0898
B-1298, B-1299, B-1301, B-1473 Ahmad M.N.: B-1367 Alison R.: B-0078, B-0080
Abdel Hay J.: B-1031 Ahmed A.F.: B-0212 Aliyu I.: B-1391
Abdel Razek A.: B-0100 Ahmed H.U.: B-0437 Aljefri A.: B-0060
Abdel Razek N.M.: B-1156 Ahmed I.: B-0966 Al-Jiboori M.A.K.: B-0209
Abdel Wahab C.: B-1894 Ahmed S.A.: B-0371, B-1086, B-1284 Aljoqiman K.S.: B-1763
Abdel Wahab M.: A-0730 Ahn G.Y.: B-1336 Alkadhi H.: A-0044, A-0879, A-1051,
Abdelal S.: B-1334 Ahn H.S.: B-0699, B-1800 B-0996, B-1541, B-1616
Abdelganne L.: B-1849 Ahn S.J.: B-1532, B-1772 Alkasab T.K.: A-0506
Abdelhafez Y.: B-0056 Ahn S.S.: B-0097 Alkim E.: B-0906
Abdel-Kawi M.: B-0366 Ahn Y.: B-0105 Allen C.: B-0159, B-0443
Abdelmoneim A.: B-0162 Ahrens-Nicklas R.: B-1057 Allen G.M.: B-1290
Abdel-Wahab M.: A-0729, B-0196, B-1683 Ahres A.: B-0786 Allen M.: A-0988
Abdo A.: B-1407 Ahuja A.T.: B-0638 Allen R.A.: B-0885
Abdolell M.: B-0916, B-0919 Aiello M.: B-0174, B-0928 Allenbach G.: B-0235
Abdul Aziz Y.F.: B-1902 Ailianou A.: A-1068 Alley M.: B-1722
Abdul Jabar A.: B-1105 Ainakulova A.: B-1026 Allweis T.: B-1569
Abdul-Khaliq H.: B-0167 Aissa J.: B-0954, B-1355, B-1368, B-1726, Almaas R.: B-0168
Abe A.: B-1167 B-1739 Almalki S.: B-0060
Abela-Ridder B.: A-0229 Aitchison R.: B-1793, B-1794 Almeida C.M.D.S.: B-0889, B-1063
Abergel A.: B-1470 Aivazoglou L.U.: B-0860 Almeida M.F.A.: B-0358
Aberle C.: B-1196 Akata D.: A-0355, B-1594 Almeida N.A.: B-0274
Aboagye E.O.: B-1387 Akatsuka Y.: B-1735 Almeida R.P.P.: B-0414, B-0489, B-0652,
Aboelmagd H.: B-0923 Akdogan M.U.: B-0906 B-0658, B-1359
Aboelsafa A.A.: B-1423 Akgul M.H.: B-1744 Al-Mosawe A.M.J.: B-0209
Abolmaali N.: B-0558 Akhadov T.: B-0187, B-1038, B-1778, B-1887 Alnajashi N.: B-1459
Abonyi M.: B-1589 Akhan O.: A-0227 Alonso-Burgos A.: B-0294
Abou El-Ghar M.E.: B-0830 Akhlebinina M.: B-0187 Aloufi F.F.: B-1670
Abou Elkassem A.: B-0357, B-1473 Akhmetova G.: B-1026 Alqahtani S.J.M.: B-0659, B-0662, B-1067
Aboueldahab N.: B-0838 Akhoundi N.: B-0427 Alqarni A.: B-1459
Abouelkheir R.T.: B-0830 Akhverdieva G.: B-0621 Alqattan A.: B-0409
Abraham J.: B-1802 Akin I.: B-0587 Alsafi A.: B-0627
Abrams P.: B-1191 Akin O.: B-0152 Alshaikh M.: B-0060
Abrantes A.F.: B-0414, B-0489, B-0643, Akintimehin A.: B-0950 Alshamari M.: B-0491
B-0652, B-0658, B-1359 Akinwumi O.: B-0947 Alsurayhi A.: B-1311
Abrar D.B.: B-0515, B-0516, B-0517, B-0518, Akpinar E.: B-1594 Alt E.: B-1669
B-0519, B-1736 Akpınar M.: B-1805 Alterio D.: B-0973
Abuzaid M.M.: B-0644, B-1486 Akram M.H.: A-1077 Altindag C.: B-0906
Acar T.: B-0115, B-0737, B-0743 Al Arab N.: B-1168 Altmeyer K.: B-0167
Acevedo P.A.: B-1780 Al Kamali A.: B-1362 Al-Ubeidy H.: B-0491
Acharya T.: B-0300, B-1114 Al Kuhaimi T.S.: B-0060 Alukic E.: B-1068, B-1710
Achterhold K.: B-0995, B-1848 Al Raaisi A.: B-1574 Alurkar A.: B-0841
Acquafredda F.: B-0056 Alagely A.: B-1169 Alvares de Campos M.: B-0129
Adam G.: B-0119, B-0499, B-0590, B-0601, Alagic Z.: B-0674 Alvarez de Sierra B.: B-0294
B-0679, B-1089, B-1240, B-1682 Alam S.I.: B-1130 Alvi A.: B-0090
Adams H.H.: B-1690 Alamanni F.: B-1615, B-1686 Amad A.: A-0403
Adams L.C.: B-1141, B-1734 Albano D.: B-0052, B-0868, B-0870, Ambrogi C.: B-0849
Adams N.B.: B-1391 B-0898, B-1730 Ambrogio S.: B-0760
Adams N.C.: B-0267 Alberich-Bayarri A.: A-0143, A-0371, A-0637, Ambrosetti M.C.: B-0457
Adamson M.: B-1307 B-0680, B-1397, B-1830 Ambrosi A.: B-1872
Addley H.C.: B-1384 Albers P.: B-0327, B-0828, B-1462 Ambrosini R.: B-0619, B-1042
Adeberg S.: B-0506 Alberts A.R.: B-0181 Ambrosio M.R.: B-0045, B-0046
Adel L.: B-0923 Albrecht M.H.: B-0296, B-0301, B-0434, Ameda F.: B-1417
Adla T.: B-0597 B-0448, B-0794, B-0843, B-0847, Amelin M.: B-1266
Adriaensen M.: A-0211 B-1362, B-1472 Amini M.: B-0291
Afadzi M.: B-0131, B-0480 Alcaide A.B.: B-1609 Amiras D.: A-0323
Agarwal A.: B-1747 Alcalá-Galiano A.: A-0443 Amiri M.: B-1433
Agarwal S.: B-0640 Aldoj N.: B-0172, B-0802, B-1016 Amirkhamzaev A.: B-1379
Agazzi G.M.: B-0970 Aldrighetti L.: B-0851, B-1439 Amitai M.M.: B-1186

Amlani A.: B-0351 Arfelli F.: B-1789 Azevedo K.: A-0929

Ammari S.: B-0672 Argiolas G.M.: B-0036 Azevedo K.B.: B-0489, B-0652, B-0658
Ammendola R.M.: B-0592, B-1823 Argyropoulou M.I.: A-0277, A-0423, B-1660 Aziza R.: B-0322
Amodeo E.M.: B-0113, B-0529, B-0563, Arias-Lorza A.M.: B-0497 Azman S.S.: B-0024
B-0846, B-1435 Aribal M.E.: B-1546
Amodio F.: B-0002, B-0006, B-0011 Aristovich K.: B-1425 B
An C.: B-1043, B-1282 Armaitis J.: B-1190, B-1757 Baar I.: B-0279
An C.S.: B-1763 Arous A.: B-1160 Babar J.: A-0451
An D.-A.: B-1816 Arrais J.P.: B-0652 Babkina T.: B-0230
An H.: B-0370 Arrigo A.: B-1066 Bacher K.: A-0748, B-1596, B-1628
An Y.Y.: B-0723, B-1800 Arrigoni F.: B-0241, B-1295, B-1552, B-1571, Bachmann Nielsen M.: A-0042, A-0338
Anagnostopoulos A.: B-0224 B-1572, B-1580, B-1581 Bacigalupo L.: B-1528
Anand V.K.: B-1639 Arruda E.R.: B-0604 Baco E.: B-0332, B-0821, B-1656
Ananthakrishnan L.: B-0391, B-0792 Arruda P.H.C.: B-0860 Badary D.: B-0371, B-1284
Anbar A.: B-0899 Arshad M.A.: B-1387 Badawi R.D.: B-0056
Andac N.: B-0286 Arslan A.: B-1546 Baddam S.R.: B-0562, B-0841, B-1062
Andersen H.K.: B-0131 Arsov C.: B-0158, B-0161, B-0327, B-0828 Bader C.: B-0032
Andersen M.B.: B-1465 Arteaga de Castro C.: B-0766 Badia S.: B-0014
Anderson N.: B-1117 Arthurs O.J.: B-0606, B-1319 Baduna M.: B-1652
Anderson V.: B-0837 Arunsingh M.: B-0666 Bae J.: B-0389, B-1119, B-1375
Andersson I.: B-0695 Aryan A.: B-0537 Bae S.-C.: B-1336
Andrasina T.: A-0259, B-0232 Asadov R.: B-0286 Baek J.H.: B-1800
Andrássy P.: B-0786 Asahara T.: B-0642, B-0648, B-0994 Baeßler B.: A-0597, A-1008
Andreini D.: B-1501, B-1615, B-1686 Asakawa T.: B-0642, B-0994 Baeuerle T.: B-1777
Andreo L.: B-0003 Asbach P.: A-0574, B-0441, B-0450, B-1475 Baev A.: B-0089
Andreoli C.: B-0734 Ascione A.: B-1019 Bagga R.: B-1901
Andreotti R.F.: A-0072 Asenbaum U.: B-1377 Baggiano A.: B-0783, B-1212, B-1613, B-1614,
Andres Cano I.: B-0287 Asghar M.S.: B-1035 B-1615, B-1686
Anık A.: B-1059 Ashok Kumar M.: B-0063, B-1269 Bagheri A.: B-1694
Anishkin M.: B-0091 Ashraf H.: B-0492 Bagheri M.: B-1640
Anjari M.: B-0142 Aslam M.: B-0979 Bagheri S.: B-0602
Annibale B.: B-0525 Aslan S.: B-0122 Bagnacci G.: B-1275
Annoni A.D.: B-1501 Asmar K.: B-1168 Bagur A.: B-0763
Ansarin M.: B-0973 Asokan P.: B-0063, B-1269 Bahar Özvariş S.: A-0640, A-0641
Antil N.: B-0720 Assante M.: B-0464 Bai J.: B-0687, B-1244, B-1779
Antoch G.: B-0158, B-0161, B-0327, B-0515, Assegnati G.: B-0010 Bajaj S.K.: B-0605
B-0516, B-0517, B-0518, B-0519, B-0670, Assetta M.: B-0708, B-0951 Bakers F.C.H.: B-1484
B-0828, B-0954, B-1210, B-1355, B-1368, Astley S.M.: B-0917 Bakken A.S.: B-1543
B-1461, B-1462, B-1726, B-1736, B-1739 Astrakas L.G.: B-1660 Bala Lakshmoji D.: B-1376
Antonelli A.: B-0607, B-1390 Aswani Y.: B-1749 Balaeva M.: B-1819
Antoniou A.: B-1388 Atalabi O.M.: B-0947 Balaji R.: B-0176, B-0345, B-0346, B-0636,
Antonuccio E.G.M.: B-1724 Atat C.: B-1031 B-1639, B-1641
Anzalone N.: B-1776 Ates E.: B-1395 Balasubramaniam R.: B-1647
Aouini F.: B-1487 Athanasiou A.: A-0671 Baldari D.: B-0257
Aoyagi K.: B-1003, B-1460, B-1755 Ather S.: B-0245 Baldetti L.: B-1221
Aoyama H.: B-1899 Atri P.K.: B-1224 Baldin P.: B-0944
Ap Dafydd D.: B-0976 Attanasio A.: B-0415 Balestra F.: B-1155
Aparisi Gomez M.P.: A-0881 Attenberger U.I.: A-0389 Balestreri L.: B-0085, B-0554
Apel D.: B-0713 Attye A.: A-0887 Balestrieri A.: B-1775
Apfaltrer G.: B-1361 Atwan M.: B-0126 Balestro E.: B-0522
Apine I.: B-1652 Auer T.A.: B-1469 Bali M.A.: A-0341, B-0524
Apolo A.B.: B-1640 Autti T.: A-0139 Baliyan V.: B-1013
Appel E.: B-1355, B-1726 Auwal A.: B-1109 Ball P.A.: B-0197
Appelman L.: B-0726, B-1564 Avanesov M.: B-0119, B-1682 Ball S.: B-1698
Appelman P.: B-0726 Avendano D.: B-0719, B-1804 Ballati F.: B-1153
Appelt A.: B-0361 Avery J.: B-1425 Balleyguier C.S.: B-0478
Appleyard R.: B-1495 Avesani G.: B-1387, B-1389 Balogun E.: A-0641
Aquerreta Beola J.D.: B-0064 Aviram G.: A-1055 Balslev I.: B-0154, B-0442
ArabAhmadi M.: B-1433 Awadallah M.Y.: B-0212 Balster S.: B-1247
Aragon Tejada F.X.: B-0625 Awramienko A.: B-1338 Balta C.: B-0255
Arai H.: B-1329 Ayaz Ü.Y.: B-1053 Baltacioglu F.: B-0286
Arana Fernandez De Moya E.: B-0107 Aydın H.: B-0269 Balter S.: B-1191
Aras O.: B-0115, B-0556, B-0737, B-0743 Aydin R.C.: B-1729 Baltzer P.A.T.: A-0232, A-0974, B-0701,
Araujo e Araujo A.C.R.: B-0542 Aydin S.: B-1884 B-0702, B-0716, B-1150, B-1542, B-1549,
Araya Campos F.: B-0629 Aydingoz U.: A-0090, A-0445 B-1570, K-36
Arban F.: B-1807 Ayres V.J.: B-0084 Balvay D.: B-0987
Arbelaez P.: B-0570 Ayuso C.: A-0486 Bamberg F.: A-1020, B-0019, B-0188,
Arboleda C.: B-1792 Azeemuddin M.: B-1367 B-0568, B-0589, B-0749, B-0945,
Arendt C.T.: B-0299, B-1204 Azevedo F.A.: B-1524, B-1526 B-1208, B-1514, B-1515, B-1782

Bancroft L.W.: A-0805, A-0807 Bastarrika G.: A-0774 Benadjaoud S.: B-0261
Bandar M.E.: B-0179 Bastati N.: B-1052 Benaissa A.: B-0261
Bandettini W.P.: B-0300, B-1114 Bastati-Huber N.: B-1050 Bencardino J.T.: B-1508, B-1510
Banfai B.: B-0728 Bataillon G.: B-1090 Ben-David E.: B-0133, B-0313
Bang J.-I.: B-0303 Batalov A.: B-0089 Bende F.B.: B-1533
Bang N.: B-1643 Bates S.: B-1226 Bender B.: B-0093, B-0095
Bangiyev L.: B-0687 Båth J.: B-1900 Bender Y.Y.: B-1734
Bankier A.A.: A-0551, B-0580 Bats A.-S.: B-1894 Bendszus M.: B-0263, B-0505, B-0539,
Bannas P.: B-0119 Bauer B.: A-0825 B-1419, B-1560
Bansal G.: B-0546 Bauer M.J.: B-0780, B-0784, B-0787, Benedetti G.: B-0381, B-0598, B-1221,
Bansal R.: B-1797 B-0914, B-1215, B-1217, B-1721 B-1678
Bansal V.: B-0634 Bauer S.: B-0116 Benedetti L.: B-1745
Banz-Wüthrich V.: B-1438, B-1442 Bäuerle T.: A-0694, B-0474, B-0551, Beneventi A.: B-1808, B-1810
Baptista J.T.C.: B-0283 B-0703, B-1518, K-15 Bengo G.J.: B-0487
Baptista M.: B-0284 Baum T.: B-0047 Benkert T.: B-0362, B-0364
Baptista T.: B-0285 Bäumer P.: B-1560 Benlala I.: B-1202
Baqir Hassan T.: B-0271 Baumgartner C.: B-1881, B-1882 Bennani-Baiti B.I.: B-1542
Barabasch A.: B-0073, B-1437 Baumhauer M.: B-0061 Bennink E.: B-0192, B-0705
Barakat A.: B-1317 Bauones S.: B-0060 Bento C.A.M.: B-0542
Baran P.: B-1789 Baur A.: B-0153, B-0399 Benz M.R.: B-1092
Barash Y.: B-1186 Baxter G.: B-0501 Benz S.: B-1824
Barati M.: B-1200 Bayer R.R.: B-0301, B-0781 Beomonte Zobel D.: B-0113, B-0563,
Barbieri F.: B-0782 Baykara Ulusan M.: B-1395 B-0846, B-1435
Barbieri P.: B-0529 Bay-Nielsen M.: B-0275 Berardo S.: B-0367
Barbosa Alvares M.C.: B-0129 Bazzocchi A.: A-0275, A-0880 Berbee M.: B-1484
Barbosa Jr. E.J.M.: B-0144, B-0736 Beadnall H.N.: B-0984 Bérczi V.: B-0444, B-1589
Barbosa P.N.V.P.: B-0358 Beardmore C.: A-0730, A-1045 Beregi J.P.: B-0431, B-1695
Barchetti F.: B-0156 Beaumont H.: B-1023 Berenyi E.: B-1432
Barchetti G.: B-0156, B-0160, B-0325, Becce F.: B-0053, B-0997 Beretta C.: B-0189
B-0825, B-0876 Becerra L.: B-1035 Berezina N.: B-1182
Barcons Vilaplana S.: B-0121 Beck S.: B-0790 Bergamasco L.: B-1173, B-1799
Bardelli A.: A-0035 Becker A.: B-0822 Berger A.: B-0926
Bargellini I.: A-1056 Becker A.S.: B-1733 Berger C.: A-1026
Barile A.: B-0241, B-1295, B-1571, B-1572, Becker C.D.: A-0696, A-0959 Berger M.F.: A-0742
B-1580, B-1581 Becker L.: B-0585 Berger M.S.: B-0096
Baris Y.S.: B-0059 Bedene A.: B-1710 Berger N.: B-0085, B-0554, B-1541
Barkhausen J.: B-0202, B-0225, B-0349, Bedke J.: B-0628 Berger P.: B-1202
B-0498, B-1622 Bedlington N.: A-0822 Bergès O.: B-0987
Barkhof F.: B-0096 Beenen L.F.M.: B-0099 Berghe A.-S.: B-0922
Barnacle A.: A-0061 Beer A.: B-1050 Berghöfer A.: B-1184
Barnes P.: B-0916, B-0919 Beer A.J.: B-0061 Berkhemer O.: B-0258
Barnett J.L.: B-1605 Beer L.: B-1020, B-1052 Berliner C.: B-1089
Barnett M.H.: B-0984 Beer M.: B-0061 Berlis A.: A-0980
Barnwal M.: B-0910, B-1133, B-1397, B-1750, Beeres M.: A-0062, B-0347, B-1204, B-1317 Bernabéu Rodríguez M.: B-0625
B-1892 Beets-Tan R.G.H.: A-0336, A-0363, A-0381, Bernaerts A.: A-0888, B-0290
Baron Rodiz P.A.: B-0625 A-0467, A-0500, A-0638, A-0641, Bernard-Davila B.: B-0924, B-1175, B-1176
Barral M.: B-0155 B-0182, B-0559, B-0632, B-0685, Bernardi D.: B-1548
Barral P.-A.: B-0964 B-0850, B-1049, B-1483, B-1484, B-1582, Bernardo A.: B-1490
Barrera C.: B-1057 B-1635 Bernardo S.: B-0607
Barrett T.: B-0437, B-0880 Begnami M.D.F.S.: B-0358 Berná-Serna J.D.D.: B-1418
Barros J.: B-1493 Beigelman C.: A-0802 Bernathova M.: B-0716, B-1549
Bartels-Rutten A.: B-1483 Beitzke D.: A-0299, B-0374, B-1617 Berritto D.: B-0034
Barth T.F.E.: B-0061 Bejar S.: B-1860 Berruti A.: B-0619
Bartoli A.: B-0964 Bekaroglu G.: B-0556 Bert A.: B-0477
Bartolotta T.V.: B-1529 Bekebrede-Kauffman D.: B-0099 Bertalan Z.: B-0569
Bartolovič N.: B-0260 Beldi G.: B-1434, B-1438 Bertani E.: B-1281
Bartolucci M.: B-0975 Beleù A.: B-0455, B-0457 Bertani V.: B-0085, B-0554
Barušauskas D.: B-1190, B-1757 Belho E.: B-0777, B-1335, B-1558 Bertelli E.: B-0622
Bas A.: B-0115, B-0556, B-0737, B-0743 Bell J.: B-0617, B-1874 Bertelsen B.B.: B-0275
Bashir M.R.: B-1768 Belladonna E.: B-1521 Bertó J.: B-1609
Basile A.: B-0418, B-0833, B-0943, B-0959, Belli P.: B-0547, B-0548 Bertolini M.: B-0993
B-1405, B-1648 Bellini D.: B-0014, B-0935, B-0940, B-1148 Bertolotto M.: A-0292, A-0572, B-0368,
Basile D.: B-0824, B-1144 Bellini M.: B-1575, B-1578 B-1658, B-1659
Basilico R.: A-0045, A-0517 Bellomi M.: B-0973, B-1281, B-1644 Bertucci E.: B-1381
Baskak F.: B-0295 Bellucci A.: B-1894 Bertuletti M.: B-0619
Ba-Ssalamah A.: A-0004, B-1050, B-1052, Beltramello A.: B-0239, B-1128, B-1743 Besana F.: B-0630
B-1875 Ben Daamer N.: B-0261 Best S.: B-1297
Basso L.: B-0879, B-1139 Ben Hammouda M.: B-1160 Betlehem J.: B-0728
Bastarrika Alemañ G.: B-1015, B-1219, B-1609 Ben Salem D.: B-1511 Bette S.: B-0088

Bettini R.: B-0009 Blanc R.: B-0280, B-0282 Boraschi P.: B-0526, B-1097
Beuf O.: B-1638 Blanco F.J.: B-0003 Borg Grima K.: B-0891
Bevilacqua A.: B-0842 Blank C.U.: B-0685 Borger M.: B-1683
Bevilacqua V.: B-0329 Blankenstein T.N.: B-0900 Borges A.: A-0999
Beyer C.: B-0782 Blankholm A.D.: A-0624 Børgesen H.: B-0682
Beyer T.: A-0185, B-0234, B-1286 Blanks R.G.: B-0078, B-0080 Borggrefe J.: B-0710, B-0756, B-0988,
Beyersdorff D.: B-1089 Blauth M.: B-0102 B-1166, B-1424, B-1783
Bezzina P.: A-0778, B-0027, B-0651, B-0891 Blay J.-Y.: B-1638 Borggrefe M.: B-0587
Bhagwat K.A.: B-1737 Blazevic A.: B-1279 Borgheresi A.: B-1118
Bhalla A.S.: B-1207 Blazic I.: A-0116, B-1663 Borhani A.A.: B-0071, B-1765
Bharwani N.: B-0177 Bley T.A.: B-0337 Borisch E.: B-0438
Bhatia A.: B-0169, B-1224 Bleys R.: B-0215 Borotikar B.: B-1511
Bhattacharjee R.: B-1133 Bliddal H.: B-1135 Borra R.: B-0574
Biacca A.: B-0052 Bliznakova K.: B-1843 Borralho P.: A-0989
Bialopetravicius J.: B-1190, B-1757 Bloem J.L.: A-0033, A-0106 Borrego P.: B-0907
Bian Y.: B-1587, B-1834 Blom H.M.: B-0298 Borruel Nacenta S.: B-0268
Bianchi A.: B-0928 Blüher M.: B-0764 Borsook D.: B-1035
Bianchi G.: B-1572, B-1579, B-1580 Blum A.: K-07 Borsos P.: B-0444
Bianchi M.: B-0198 Boban J.: A-0766 Bortolanza C.: B-1011
Bianchi S.: B-0470 Bobek-Billewicz B.: B-1338 Bortolotto C.: B-0040
Biavati F.: B-0802 Boca I.: B-0922 Bortsova G.: B-0982, B-1690
Bibbolino C.: A-0579 Boccafoschi F.: B-1262 Bortul M.: B-0464
Bicakci K.: B-1039 Boccalini S.: B-0731, B-1214 Borzelli A.: B-0002, B-0011, B-0113, B-0563,
Bicakci S.: B-1039 Bodden J.H.W.: B-0047 B-0846, B-1435
Bican Y.: B-1052 Bodelle B.: B-1362 Bos D.: B-0497, B-0982, B-1598
Bick U.: A-0529 Bodenmann D.: B-1497 Bosc R.: B-0252
Bickelhaupt S.: B-0362, B-0364, B-1421, Bodini F.C.: B-1029 Bosch Barragan F.: B-0121
B-1568 Boeri C.: B-0470 Bosmans H.: B-0132, B-0251, B-0494,
Bidault F.: A-0074 Boeri M.: B-0143 B-1318, B-1539, B-1839, B-1840, B-1841,
Biederer J.: A-0373, B-1610 Boesen L.: B-0154, B-0442 B-1842, B-1843, B-1845
Bielen D.: B-0494 Boesen M.: B-0675, B-0682, B-1035, B-1135 Bosmans J.M.L.: A-0507
Bielowski C.: B-0551, B-0703, B-1518 Boettger S.: B-1362 Bösmüller H.: B-1814
Bier G.: B-0093 Bogaert J.: A-0200 Boss A.: B-0065, B-0085, B-0554, B-1541
Bieri O.: B-0055 Boggi U.: B-1097 Boswijk E.: B-0220
Bierma - Zeinstra S.: B-1136 Bogner S.: B-0575 Bottaro L.: B-0536
Bierry G.: A-0262 Bogveradze N.: B-0616 Bouchouicha A.: B-0987
Biesen R.: B-0514 Böker S.M.: B-1734 Boudinaud C.: B-1470
Bignotti B.: B-1178, B-1745 Boland M.: B-1113 Bouhali O.: B-1601
Bigolaro S.: B-1540 Bolchini M.: B-1687 Bouhamama A.: B-1638
Bihane C.: B-1638 Boldrini L.: A-0498 Boulet B.: B-0478
Bijan B.: A-0556, B-0291, B-0602 Bolengo I.: B-0560 Bourgioti C.: A-0809, B-1388
Bilbao J.I.: A-0244, K-12 Bolivar Cuevas S.: B-1404 Boussel L.: B-0311, B-0731, B-1116, B-1214,
Bilbao Jaureguizar J.I.: B-0111 Boll D.: B-0493, B-0729, B-1092, B-1503 B-1852
Bilello M.: B-1781 Bollen T.: A-0096 Böven J.: B-0954, B-1368
Bilici Salman R.: B-1453 Bollen T.L.: A-0925 Bovenberg J.A.: A-0632
Billiet T.: B-0984, B-1509 Bolstad K.N.: A-1049 Bovin J.S.: B-0675
Billingsley S.: B-1288 Bolster F.: B-0098 Boyd K.: B-0353
Bind M.: B-0691 Bomers J.G.: B-0878 Boyer L.: B-1470
Bindinelli P.: B-1715 Bonaffini P.A.: B-0528 Bozhko O.: B-1778
Bini M.: B-0824 Bonaffini P.A.A.: B-1894 Bozzao A.: B-1270
Binkert C.: A-0971 Bonasera L.: B-0975 Bozzetto M.: B-0040
Binst J.: B-1539, B-1838, B-1839, B-1842 Bonatti G.: B-1389 Bozzolo E.: B-1337
Bioletto F.: B-0598 Bonatti M.: B-0937, B-1389 Brabander T.: B-1279
Biondi T.: B-1022, B-1341 Bondini F.: B-0253 Bracci A.: B-1823
Biondic Spoljar I.: B-0463 Bonekamp D.: B-0813, B-1077 Bracciani A.: B-0253
Bippus R.: B-0138 Bonelli S.: B-1881, B-1882 Brady A.: A-0079, A-0502, A-0587, A-0824,
Birch J.: A-0536 Bongers M.N.: B-1143 A-0930
Bisbjerg R.: B-0154, B-0442 Böning G.: B-0962 Brady M.: B-0763
Biskup J.: B-0597 Bonneville F.: A-0521, B-0282 Bragagnolo D.S.: B-1154
Bitencourt A.G.V.: B-0358 Bonomo L.: A-0212, B-0199 Braig E.: B-0995
Biviji M.: B-0748, B-0755, B-0981 Bons L.R.: B-0194 Brambilla M.: A-0324, A-0547, B-0798,
Bizino M.B.: B-0588 Bonzini M.: B-1060 B-1071
Bjørklund K.: B-0480 Booij R.: B-1598 Brambillasca P.: B-0974
Blackburn Andersen P.: A-0622 Boolkah S.: B-0966 Brancatelli G.: A-1001, B-0071
Blackham K.: B-0193, B-0946 Boone J.M.: B-1843 Brancato B.: B-0477
Blackledge M.: B-0353 Boos J.: B-0954, B-1210, B-1355, B-1368, Brancato V.: B-0174
Blackwell J.: B-0761 B-1462, B-1726, B-1739 Branco C.: B-0283
Bladowska J.: B-0540 Booz C.: B-0434, B-0682, B-1362, B-1472 Branco G.: B-0283
Blaivie C.: B-0290 Bor S.: B-0367, B-1262 Brandao L.A.: B-0542

Brandão Nascimento A.C.: B-0542 Bruni S.: B-1872 Byeon Y.: B-1754
Brännström M.: B-1900 Brunner F.: B-0590 Byrne C.: B-1113
Brantner P.: A-0449, B-0310 Bruno F.: B-0241, B-1295, B-1552, B-1579, Byun S.H.: B-1538
Braren R.: B-0615 B-1580, B-1581
Braspenningx S.: B-1679 Brussaard C.C.: B-0136 C
Brat H.: B-1600 Brzezinski J.: B-0874 Caballeros Lam F.M.: B-0294
Bräu F.: B-1729 Bu X.: B-1333 Caballo M.: B-1523, B-1525, B-1790
Braunwarth E.: B-0102 Bubel K.: B-0167 Cabarrus M.: B-0829
Bready E.: B-1296, B-1298, B-1299, B-1301 Bucerius J.: B-0220 Cabero Moyano J.: B-0121
Breda S.: B-0856 Buch K.: A-0798, B-1226, B-1227, B-1228, Cabukova M.: B-0281
Breen R.: B-0142 B-1229 Cabuy M.: B-1597
Breithecker A.: B-1863 Buchan K.: B-1849 Cademartiri F.: B-1313
Bremerich J.: A-0940, B-0310, B-0904, Buchbender C.: B-0669, B-0671 Cai X.: B-1083
B-1030, B-1211 Bucher A.M.: B-0347, B-1317 Caines J.: B-0916, B-0919
Bremnes A.: B-1072 Bücker A.: B-0167, B-1720 Cakiroglu H.: B-0115, B-0556, B-0737,
Brendle C.: B-0093 Bucsics T.: B-1377 B-0743
Brendlin A.: B-0347 Budai B.: B-1589 Calabrese M.: B-0724, B-1151, B-1178
Brennan D.: B-0265 Budde R.P.: B-1598 Calado S.: B-0283
Brennan P.: B-0265, B-0267, B-1789 Budde R.P.J.: B-0194 Calandrelli R.: B-1225
Brennan P.C.: B-1844 Buddensieck C.: B-1462 Calandrino R.: B-1194
Brenne F.: B-0349 Buder T.: B-1259 Calcagno M.C.: B-0436, B-0833, B-0959,
Brenner C.: B-1056 Budrewicz S.: B-0540 B-1878
Brentnall A.R.: B-0917 Budzik J.-F.: B-0053 Caldas C.: B-1802
Brescia Morra V.: B-0543 Buecker A.: B-0961, B-0963, B-1058, B-1463 Calder A.D.: A-0189
Breysem L.: B-1318 Buerke B.: B-0266 Cal-Gonzalez J.: B-0234
Bricolo P.: B-0248, B-0249 Bufi E.: B-0547, B-0548 Calheiros de Lima Petribu N.: B-0932
Briers E.: A-0826, A-0932 Buissink C.: A-0532, B-1699 Caliolo G.: B-0676
Brillet P.-Y.: A-0701 Buizza G.: B-0372 Calleja M.: B-0649
Brindle K.: B-1802 Bujila R.: B-0674 Calli C.: A-0428, A-0523, A-0828
Brink J.A.: A-0105, A-0540 Buk M.: A-0344 Calliada F.: A-0667, B-0040
Brink M.: A-1053, B-1850 Bukte Y.: B-0125, B-0929 Caltabiano D.C.: B-0436, B-1878
Brinker G.: B-0762 Bulakbasi N.: A-1032 Caltabiano G.: B-1878
Brioschi M.: B-0898 Bullock S.A.: B-1290 Calvão-Pires P.: B-0283
Brismar T.B.: B-0049 Bülow R.: B-0398, B-0401, B-1474 Calvieri C.: B-0592
Brisse H.: B-1090 Buls N.: B-0136, B-1596, B-1597, B-1628 Calvo Imirizaldu M.: B-0064, B-0111, B-1015,
Brites C.T.: B-0414 Bult P.: B-0545, B-0726 B-1219, B-1784
Brites L.: B-0889 Bulychkin P.: B-0621 Camacho J.: B-1231
Brito A.Q.L.C.: B-0658 Bünting N.A.: B-0073 Cambi F.: B-1898
Brkljačić B.: A-0348, A-0368, A-0571, Buoni G.: B-0367 Campa R.: B-0156, B-0160, B-0325, B-0825,
A-0616, A-0673, A-0753, B-0463 Buonomenna C.: B-0052 B-0876
Brockmann M.A.: B-1241 Buonomenna G.: B-1139 Campagna C.: B-0676
Broeders E.: B-0220 Burabe F.A.: B-1107 Campagnola A.: B-1094, B-1103
Broeders M.: B-0255 Burcet Rodríguez G.: B-1231 Campbell N.M.: B-1663
Brogger H.: K-37 Burck I.: B-0296, B-0299, B-1247, B-1257 Campeau N.: B-0750, B-0755
Brombal L.: B-1846 Burger I.A.: A-0197, B-0224, B-0228, Campi C.: B-0686, B-0689
Bronson K.: B-0300, B-1114 B-0229, B-0817, B-0822 Campo A.: B-1609
Brookes A.L.: A-0401 Burgetova A.: B-0938 Campo I.: B-1659, B-1807
Brooks J.: B-0503 Burggraf M.: B-1740 Campora R.A.: B-0970
Brosch T.: B-1761 Burgstaller J.M.: B-1733 Camps Herrero J.: A-0474, A-1028
Brotons-Cuixat D.: B-0680 Burke A.M.: B-0663 Candinas D.: B-1434, B-1438, B-1442
Brouha S.: B-1607 Burmester G.R.: B-0514 Cangiotti C.: B-1310
Brountzos E.N.: A-1062, A-1067 Burnside E.: B-0920 Cannaò P.M.: B-1728, B-1867
Brown G.: A-0391 Burulday V.: B-1744 Cannella R.: B-0071, B-1529, B-1765, B-1768,
Brown M.: B-0126, B-0712 Busacca M.: B-0864 B-1771
Brown P.: B-0361, B-0666, B-0667, B-0771, Buscarino V.: B-0769 Cannita K.: B-1572
B-0916, B-0919 Busè G.: B-1529 Cannizzaro E.: B-0241, B-0595, B-1309,
Browning G.: B-0639 Bussani R.: B-1659 B-1623, B-1817
Browning T.: B-0391 Busse A.: B-1502 Cant J.: B-0145
Brudkowska Z.: B-0538 Busse H.: B-0764 Canti V.: B-1337
Brudvik K.W.: B-1047 Busselot T.: B-0494 Cao G.: B-1429
Brugnara G.: B-0539 Butler A.P.: B-1117 Cao J.: B-0320, B-0406
Bruining A.: B-1384 Butler R.: B-1793, B-1794 Cao L.: B-0074, B-1044, B-1471, B-1764
Brumberg R.M.: B-0383, B-0591, B-1824 Buvat I.: A-0553 Cao R.: B-1337
Brun T.: B-0322 Bux S.: B-1872 Caobelli F.: A-1019
Bruna R.: B-0338 Buxi T.B.S.: B-1668 Capaldo A.: B-0028
Brunelli S.: B-0248, B-0249 Buy X.: B-0834 Capanu M.: B-0152
Bruners P.: B-0005, B-1437 Buytaert D.: B-1596, B-1628 Capasso F.: B-0738
Brunetti A.: B-0543, B-0823, B-1383, Buzug T.M.: B-0498 Capel Flores I.: B-0121
B-1385, B-1392, B-1626, B-1730 Byanyima R.K.: B-1417 Capitanio U.: B-1302

Capocci R.: B-0252 Castagna M.: B-0526 Chang Sen L.Q.: B-0696
Capozzi N.: B-1653 Castagnoli F.: B-1042 Chang W.: B-0795, B-0807
Cappelli F.: B-0113, B-0563, B-0846 Castañer E.: A-0471 Chapot R.: B-0288
Cappello G.: B-0618, B-1828 Castellano E.: A-0873 Charbel S.: B-1109
Capretti I.: B-1295 Castellano I.: B-1173, B-1799 Charitanti-Kouridou A.: B-1685
Capuani S.: B-0607, B-1390 Castello M.: B-0932 Chassagnon G.: A-0268
Caraco C.: B-0501 Castellote Alonso A.: B-0340 Chatellier G.: B-0848
Carai A.: B-1327 Castermans C.: B-0032 Chatoupis K.: B-1388
Caramella C.: A-0792 Castriconi R.: B-1194 Chaturvedi A.K.: B-0691
Caramella D.: B-0198, B-0526, B-1097, Castro Caperán D.: B-0629 Chaudhari A.S.: B-1134
B-1205 Catala-March J.: B-0680 Chaudhry M.B.H.: B-1367
Carbognin G.: B-0239, B-0872, B-1128, Catalano C.: A-0218, A-0575, A-0965, Chea P.: B-0902
B-1743 B-0156, B-0160, B-0325, B-0592, B-0607, Checcucci E.: B-0824
Carbonaro L.A.: A-0577, B-0465, B-0477, B-0825, B-0876, B-1019, B-1390, B-1500, Cheimariotis G.-A.: B-1685
B-1352 B-1823 Chelladurai A.: B-1271
Carbone I.: B-0014, B-0935, B-0940, B-1148, Cataldo T.E.: B-0210 Chellathurai A.: B-0227
B-1500 Catalucci A.: B-1552 Chen A.: B-0672
Carchesio F.: B-0109, B-0110, B-0114, B-1812 Catania D.: A-0209, B-0028 Chen B.: B-1816
Cardani R.: B-1821 Catania M.: B-0239, B-0457, B-0872, B-1128, Chen C.: B-0308, B-1234, B-1235, B-1254,
Cardano G.: B-0532, B-1094 B-1743 B-1264, B-1559
Cárdenas Loguercio G.E.: B-0629 Catapano F.: B-0592, B-1500, B-1823 Chen G.: B-0217
Cardis E.: A-0933, A-0935 Cattapan K.: B-0827 Chen H.: B-1159, B-1430
Cardobi N.: B-0455 Cattarin E.: B-1154 Chen H.-J.: B-1041
Cardone G.: B-1300, B-1302 Caudal A.: B-1507 Chen J.: B-0074, B-0356, B-1044, B-1471,
Cardoso A.R.: B-1063 Caudrelier J.: B-0834 B-1764
Cardoso M.J.: B-1688 Caulo M.: B-0203 Chen J.-L.: B-0393
Carducci C.: B-1327 Caumo F.: B-0248, B-0249, B-0250, B-1540 Chen K.: B-0566
Carducci S.: B-1579 Cavaco A.: B-0650 Chen L.: B-0375
Carisio A.: B-1262 Cavaglià E.: B-0002, B-0006, B-0011 Chen M.: B-0035, B-0048, B-0147, B-0308,
Carlo Stella C.: B-1636 Cavaliere A.: B-0512 B-0772, B-0807, B-1126, B-1243, B-1642,
Carmo S.: B-1063 Cavaliere C.: B-0174, B-0668, B-0928 B-1704
Carmona-Bozo J.C.: B-0501 Cavalieri S.: B-0798, B-1262 Chen M.Y.: B-0300, B-1114
Carnevale A.: B-1406 Cavallaro A.: B-1088 Chen P.-C.: B-1551
Caroli A.: A-0059 Cavallaro M.F.: B-0368 Chen Q.: B-0462
Carolus H.: B-1761 Cavalleri S.: B-0872 Chen S.: B-1131, B-1152
Carpentier K.: B-0145 Cavalli G.: B-1337 Chen X.: B-0236, B-0343, B-0593, B-0715,
Carrafiello G.: A-0582, B-0974, B-1808, Cavalli M.: B-1821 B-0770, B-1098, B-1100, B-1246, B-1480,
B-1810 Cavicchioli F.M.: B-0872 B-1531
Carreño García E.: B-1404 Caviezel C.: B-0577 Chen X.J.: B-0812
Carriero A.: B-0367, B-0798, B-1262 Caymaz I.: B-0115, B-0556, B-0737, B-0743 Chen Y.: B-0437, B-0462, B-0511, B-0810,
Carroll B.J.: B-1306 Cazzato R.L.: A-0263, B-0834 B-0881, B-1120, B-1246, B-1548, B-1633,
Carroll P.R.: B-0829 Çelebi U.O.: B-1744 B-1650
Carrozzo M.: B-0676 Celeng C.: B-0377 Chen Y.-S.: B-1551
Carta P.: B-0622 Cellina M.: B-0087, B-0247 Cheng G.: B-1171
Cartia F.: B-0257, B-0725, B-1155 Cenderello G.: B-1528 Cheng J.: B-0390, B-0814, B-0969, B-1234,
Caruana C.J.: A-0895 Ceravolo I.: B-0825 B-1235, B-1236, B-1237, B-1238, B-1239,
Caruana G.: B-1529 Cereser L.: B-1078, B-1079, B-1138 B-1242, B-1244, B-1248, B-1252, B-1256,
Caruso D.: A-0867, B-1022, B-1341 Cerezal L.: A-1048 B-1559, B-1779, B-1889
Caruso M.: B-0333, B-0738 Ceriani R.: B-0560 Cheng J.L.: B-1691, B-1692, B-1693
Caruso P.A.: B-1226, B-1227, B-1228, B-1229 Cerit M.: B-0213 Cheng J.-L.: B-1264
Carvalho de Siqueira E.: B-0129 Cernic S.: B-1807 Cheng S.C.H.: B-0638
Carvalho R.: B-0284 Cerrone P.: B-1550, B-1556 Cheng S.F.: B-0712
Casale R.: B-0020 Cervantes B.: B-1746 Cheng S.-H.: B-1104
Casale S.: B-0373 Cervelli R.: B-0526, B-1097 Cheng X.: B-0978
Casaleggio A.: B-0879 Cevasco L.: B-1528 Cheng X.S.: B-0624
Casamassima N.: B-1808 Cewe Jönsson P.M.: B-0955 Cheng Y.: B-1534
Casari F.: B-1381 Cha J.: B-1001, B-1014 Cheng Y.-F.: B-0561
Casas Muñoz J.S.: B-0629 Chabin G.: B-0816 Cheng Z.: B-0343, B-1083
Caseiro Alves F.: A-0003, B-1494 Chadjaa M.: B-1023 Cheon K.S.: B-1538
Cash H.: B-0153 Chae K.J.: B-1322 Cherel P.: B-0478, B-1090
Caspers J.: B-0983, B-1553 Chai M.Y.C.: B-1220 Cherkashin M.: B-0091, B-1182
Caspers S.: B-1553 Chai Y.: B-0139, B-1276, B-1876 Cheung K.O.: B-1798
Cassano E.: B-0722, B-1561 Chalabi N.A.: B-0923 Cheung M.: B-0330
Cassar-Pullicino V.N.: A-0032, A-0969 Challen R.: B-1496 Cheung Y.-F.: B-1864
Cassart M.: A-0563 Chan L.C.A.: B-1798 Chhabra A.: B-1129
Cassata G.: B-1444 Chand G.: B-1021 Chianca V.: B-0868, B-0870, B-1730
Casselman J.W.: A-0319, A-0885, A-0890, Chandra T.: B-0717 Chiarello S.: B-1406
B-0290, B-1596, B-1628 Chang J.H.: B-0097 Chibana S.: B-0421
Cassiano M.T.: B-0543 Chang J.I.: B-0646 Chiesa S.: B-1029

Chigozie N.I.: B-1107 Cindil E.: B-0213, B-1453 Corcos G.: B-1507
Chilamkurthy S.: B-0748, B-0750, B-0755, Cinque T.: B-0104 Cordonnier E.: A-0633
B-0981 Ciortea C.: B-0922 Cormier E.: B-1574
Chimpiri A.R.: B-0687 Cipollari S.: B-0325 Cornacchia M.: B-1080
Chin L.H.Q.: B-0330 Cipriani F.: B-0851 Cornacchione P.: B-0028
Chiras J.: B-1574 Cirone D.: B-0470 Cornelis F.: A-0283
Chitcholtan K.: B-1117 Cisar J.: B-0281 Cornud F.: B-0155
Chiti A.: B-1636 Ciurea A.I.: B-0922 Corrias G.: B-0036, B-0415, B-1775
Chitty L.S.: B-0606 Clarencon F.: B-1574 Corridore A.: B-0544, B-0595, B-1309,
Chiu C.L.: B-1798 Clarke C.: A-0174 B-1550, B-1556, B-1623, B-1817
Chiu K.W.H.: B-0178 Clarke S.E.: B-0403 Cortellini A.: B-1572
Chiu K.W.-H.: B-0370 Clauser P.: A-0426, B-0701, B-0702, B-0716, Cortese F.: B-0010, B-0618, B-1093
Chng L.S.: B-0641 B-1150, B-1549, B-1570 Corvino F.: B-0006
Cho C.-H.: B-0762 Clément O.: A-0056, A-0625, A-0726, Cosentini D.: B-0619
Cho E.-S.: B-0397 A-0903 Cossu A.: B-1406
Cho H.M.: B-0740, B-0960, B-1573 Clements K.: B-0079 Costa A.F.: B-0403
Cho K.R.: B-1177 Clevert D.A.: A-0039, A-0171, A-0669, Costa C.: B-0630
Cho M.J.: B-1763 A-0752 Costa M.: B-1521
Cho S.B.: B-0965 Clive K.: B-1111 Costabile T.: B-0543
Cho S.H.: B-0942 Cobelli R.: B-1858 Costanza C.: B-1173, B-1799
Cho Y.: B-0576 Cobianchi Bellisari F.: B-0595, B-1579 Cotroneo A.R.: B-0195
Chodyla M.: B-0575, B-0690, B-1456 Cobo Reinoso E.: B-0274 Cotroneo A.R.R.: B-0203, B-1313
Choi A.L.: B-0869 Coche E.: A-0892, B-0944 Cotten A.: A-0784
Choi B.: B-1014 Cockmartin L.: B-0251, B-0494, B-1539, Cotti E.: B-1406
Choi B.H.: B-1567 B-1838, B-1839, B-1840, B-1842, B-1845 Cottier J.P.: B-0836
Choi B.I.: B-0451 Coco S.: B-0592, B-1823 Couceiro F.: B-1108
Choi D.S.: B-0396 Cocozza S.: B-0823, B-1392, B-1626 Coudyzer W.: B-0494
Choi H.J.: B-1800 Codari M.: B-0028, B-0189, B-1687 Coulon P.: B-0731, B-1116
Choi H.W.: B-0451 Cognard C.: B-0282 Courtier N.: B-0649
Choi J.: B-1322 Cohen C.: B-0836, B-1422 Coutinho Santos A.: A-0998
Choi J.-I.: B-1895 Cohen S.: B-0080 Couto J.G.: B-0649, B-0651
Choi J.M.: B-0397 Coi L.: B-0329 Cova M.A.A.: B-0368, B-0464, B-0536,
Choi J.Y.: B-1285 Coimbra F.J.F.: B-0358 B-1659, B-1807
Choi J.-Y.: B-1766 Colafati G.S.: B-1327 Cozzi A.: B-0465
Choi M.H.: B-1895 Colagrande S.: B-1205 Cozzi D.: B-0732, B-0733
Choi N.: B-0469, B-0555 Colapietro F.: B-0530 Cozzi L.: B-1636
Choi S.-Y.: B-0453 Colarieti A.: B-0369 Cozzolino P.: B-1080
Choi Y.S.: B-0097 Colgan N.: B-0761 Cradock A.: B-0409
Chojniak R.: B-0358 Collalunga E.: B-0553 Cretese A.: B-1138
Chou Y.-C.: B-0075 Collette L.: A-0790 Crijns A.: A-0014, A-0016
Choudary G.V.: B-1075 Collettini F.: B-1468 Crimì F.: B-1060, B-1364
Choudhoury K.R.: B-1768 Collocola A.: B-0999 Crocetti L.: A-0246
Chowdhury R.: B-0245 Colombi D.: B-1029 Croissant Y.: B-0847
Choyke P.L.: B-0837 Colombo M.: B-0530, B-1302 Cromwell P.: B-0633
Chriashkova J.: B-0979 Colombo P.E.: B-0991, B-1028 Crona J.: B-0523
Christensen A.F.: B-1035 Colosimo C.: B-1225 Cronin K.: B-1700
Christian N.: B-1714 Coma A.: A-0188, B-0340 Crumbaker M.: B-0226
Christie S.: B-0025 Comerci M.: B-0543 Cruz R.: B-0358
Christou A.: B-1157 Como G.: B-1079, B-1138 Csima M.: B-0031
Chryssogonidis I.: B-1685 Comte A.: B-1664 Csobay-Novák C.: B-0958
Chu J.P.: B-1273 Comunoglu N.: B-0986 Cuba Camasca V.: B-0044
Chu M.: B-0370 Congedo T.: B-1812 Çubuk H.S.: B-1039
Chu P.: B-0015, B-1320 Connor S.: A-0797 Cugola L.: B-0248, B-0249
Chuan X.: B-0566 Conti A.: B-0959 Cui G.-B.: B-0757
Chulroek T.: B-0827 Conti M.: B-0548 Cui X.: B-1756
Chung C.: B-1243 Contro A.: B-0009 Cui Y.: B-0360, B-1519
Chung H.: B-0336 Cook G.: A-0975, B-0351, B-0617, B-1021, Cullmann Bastian J.L.: B-0901
Chung J.-J.: B-0397 B-1874 Cullmann J.L.: B-0896
Chung W.-Y.: B-0758 Cook N.: B-1647 Cummings K.: B-1007
Ciampi Dopazo J.J.: B-0625 Coolen A.M.P.: B-0081 Cunha A.J.C.D.: B-1492
Ciccarese F.: B-0873 Cooper G.: B-1307 Cunningham D.: B-0524
Ciccone G.: B-1499 Copin M.-C.: B-0778 Cuocolo A.: B-1684
Cicero L.: B-1444 Copley S.J.: A-0456 Cuocolo R.: B-0333, B-0668, B-0823,
Cieno S.: B-0619 Coppenrath E.: B-1773 B-0870, B-1392, B-1626, B-1730
Cieszanowski A.: B-1477 Coppo M.: B-1071 Curioni-Fontecedro A.: B-0817
Ciet P.: B-0170, B-0171, B-1205 Coppola A.: B-1808 Currie S.: B-0361, B-0666, B-0667
Cil B.E.: A-0021 Coppola M.: B-0006, B-0738 Currò F.: B-0368
Cilia F.: B-0592, B-1500, B-1823 Corazza A.: B-0868, B-1730 Curry E.: B-1387
Cina A.: B-0529, B-1435 Corcioni B.: B-0873 Curta A.: B-1866

Cutaia G.: B-1529 De Cecco C.N.: B-0301, B-0780, B-0787, Deike-Hofmann K.: B-1421
Cuzick J.: B-0917 B-0789, B-0914, B-0945, B-1215, B-1217, Dejobert M.: B-0836
Cybulski A.J.: B-0458 B-1721 Deken V.: B-0778
Cyran C.C.: A-0067, A-0973, B-0503 De Cesari M.: B-0341, B-1054, B-1528 Dekeyzer S.: B-0753
Cyriac J.: B-0193, B-0816, B-0904, B-1030 De Cicco M.L.: B-0732, B-0733, B-0734 Dekimpe C.: B-1294
Cyron C.J.: B-1729 De Cobelli F.: B-0207, B-0369, B-0381, Dekkers I.A.: B-0588
Czarnecki M.: B-1265 B-0851, B-0971, B-1216, B-1221, B-1302, Del Alamo M.: B-1303
Czernohorsky V.: B-0558 B-1343, B-1344, B-1345, B-1439, B-1485, Del Ferraro G.: B-1032
Czerny C.: A-1096, B-0299, B-0847 B-1678, B-1880 Del Maschio A.: B-0207, B-0369, B-0381,
De Dominicis C.: B-1022 B-0971, B-1216, B-1221, B-1302, B-1343,
D De E.J.B.: B-0827 B-1344, B-1345, B-1485, B-1880
da Silva C.A.: B-0414 De Filippo M.: B-0842 Del Poggio A.: B-1776
da Silva H.M.V.: B-0932 De Fiori E.: B-1644 Del Rio Carrero B.: B-1404
DaBreo D.C.: B-0580, B-1306 De Foer B.: A-0888, B-0290 Del Torto A.: B-0783, B-1212
Dacher J.-N.: B-1860, K-06 De Franco G.: B-1872 del Vecchio A.: B-1194
D’Acierno L.: B-1684 De Gaspari A.: B-0971 Delacour D.: B-1860
D’addato M.: B-0676 De Giorgis S.: B-0724 Delahunt E.: B-0409
Dagna L.: B-1337 De Graaf P.: A-1070 Delakis I.: B-1601
Dahl J.B.: B-1035 de Heer P.: B-0588 Delfino L.: B-0342
Dahlblom V.: B-0695 de Herder W.W.: B-1279 Delgado Alvarez I.: B-1231
Dahm-Kähler P.: B-1900 De Jong E.: B-0769 Deligianni X.: B-0055
Dal-Bianco A.: B-0534 De Jong H.W.A.M.: B-0192, B-0705 Delis H.: A-0788
D’Alesio G.: B-1872 de Jong P.A.: B-0222, B-0788 Della Corte A.: B-0851, B-1439
D’Alessio A.: B-0630 de Kerviler E.: A-0711, B-0953 Della Seta M.: B-1468
Dalla-Pozza R.: B-1866 De Koekkoek-Doll P.: B-0632, B-1635 Della Torre E.: B-1337
Damasio M.B.: B-0341, B-0342 de la Camara M.A.: A-0690 Della Vecchia G.: B-1343, B-1345, B-1485
Damen M.: B-0766 De La Torre M.: B-0111 Dell’Aversana S.: B-1613, B-1614, B-1626,
D’Amico N.C.: B-0304 de Lange C.: B-0168 B-1684
Damilakis J.: A-0264, A-0411, A-0545, de Ligt M.: B-0220 Dellios D.P.: B-0768
A-0751, A-0898, B-1593 De Luca C.: B-1178 Delogu P.: B-1846
D’Amore C.A.: B-0017, B-1831 De Lucia S.: B-0211 Delorme S.: B-1568
d’Amuri F.V.: B-0842 De Luis Pastor E.: B-1303 Demaerel P.: A-0676
Dan H.: B-1171 De Maeseneer M.O.: A-1046 Demasi-Jacquier M.: B-0964
Dance D.: B-1838 De Magistris G.: B-0006 Dementaviciene J.: B-1190, B-1757
Dang Luu V.: B-1305 De Marco F.: B-1612 Demicoli P.: B-0413
Dangelmaier J.: B-0138, B-1746 De Marco P.: B-0318 Demir M.: B-0125
Daniel H.: B-1568 De Margerie C.: B-0953 Demir N.B.: B-1453
Danieli R.: B-0368 De Martino S.R.M.: B-0873 Demircioglu A.: B-0575, B-0803, B-0819,
Danila M.: B-1533 De Matteis F.: B-1309, B-1817 B-0913
Danilov S.S.: B-1263 De Mattia C.: B-0991, B-1028 Demirkazik F.: B-1805
Dankbaar J.W.: B-0192, B-0705 De Mey J.: B-0136, B-1597 Demozzi E.: B-0872
Dankerl P.: B-1088 de Meyere M.: B-1860 den Harder J.M.: B-0137
Danse E.: A-0892, B-0944 De Pascale A.: B-0824 Denecke T.: B-0399, B-0450, B-1024,
Dao T.H.: B-0252 De Piano F.: B-0769, B-1644 B-1374, B-1468, B-1469
Dappa E.: B-0152 de Pont L.M.H.: B-0298 Deng K.: B-0858
D’Archambeau O.: B-0279 de Rinaldis A.: B-1390 Deng Y.: B-0751, B-1430, B-1517, B-1752
Darwish H.S.: B-0711 De Robertis Lombardi R.: B-0455, B-0457 Deng Z.H.: B-0573
Das M.: A-0270 De Rubeis G.: A-0576, A-0966, B-0592, Deniffel D.: B-0138, B-0790
Daunis-i-Estadella J.: B-0044 B-1019, B-1823 Denton J.: B-1290
Davies G.J.: B-1027 De Santis D.: B-1022, B-1341 Depetris M.A.: B-0268
Davies K.: B-1704 De Serio I.: B-0086 Deppe S.: B-0485
Davini O.: B-0948, B-1499 De Smet E.: B-0753, B-1127, B-1509 Depretto C.: B-0257, B-0725, B-1155
Davis M.: A-0399 de Souza P.: B-1856 Derchi L.E.: A-0308, A-0315, A-0316,
Davydov D.: B-1261 De Torres J.P.: B-1609 A-0496, A-1103, B-0342, B-1658
Daw S.: B-1324 De Vincenzo R.: B-1898 Dercle L.: B-0672, B-1188
Dawoud R.M.: B-1423 De Visschere P.: A-0478, B-0157 Dergilev A.: B-1005
de Assis P.E.: B-1526 de Vito A.: B-1310, B-1372, B-1457 Derlin T.: B-1240
de Assis P.E.Z.: B-1524 De Witt Hamer P.C.: B-0096 Derman S.: B-0115, B-0737, B-0743
de Bazelaire C.: B-0953, B-1563 Deak P.D.: B-1597 Deroose C.: B-0850
De Beul P.: B-0473 Deb S.: B-1147 Desai I.: B-0063, B-1269
De Bock G.H.: B-1565 Debray M.-P.: B-1407 Desai S.R.: A-0699, A-0983
de Boer M.: B-1049, B-1170 Debus J.: B-0506 Desbuquoit D.: B-0753
De Bondt T.: A-0592 Deckert C.: B-0623 Deshmane A.: B-0095
De Brucker Y.: B-1628 Dedulle A.S.L.: B-0132 Deshpande A.: B-0483
de Bruijne M.: B-0194, B-0497, B-0982, Defeudis A.: B-1828 Desi G.: B-0618
B-1690 Deftereos S.P.: B-0163 Desi G.L.: B-1093
de Bucourt M.: B-1184 Deganello A.: B-1446 Desiderio C.: B-0833, B-1405
De Cataldo C.: B-0595, B-1309, B-1571, Degenhart G.: B-1599 deSouza N.M.: A-0057, A-0287, A-0789
B-1581, B-1623, B-1817 Degnan A.J.: B-1055, B-1057 Desser T.S.: B-1402

Dessouky R.: B-1129 Dippel D.W.: B-0258 Drescher O.: B-0116

Devalla A.R.: B-0912 D’Ippolito E.: B-0372 Dresen R.C.: B-0559, B-0850
Devaraj A.: A-0027, A-0375, A-0548, B-1605 Distelmaier M.: B-1437 Dreyer K.J.: A-0629
Devasenathipathy K.: B-1207 Dittman H.: B-0689 Drinkwater K.: A-0586
Dewaguet J.: B-0778 Divjak E.: B-0463 Drir M.: B-1574
Dewald C.: B-0001 Djedjos S.: B-1536 Drissi C.: B-1160
Dewey M.: B-0016, B-0172, B-0802, B-1016 Djuraeva N.: B-1379 Dromain C.: A-0065, A-0956
Dewit O.: B-0944 Djurdjevic T.: B-0925 Dromer C.: B-1202
Dezman R.: A-0834 Djuric Stefanovic A.: B-1871 Drost F.-J.H.: B-0181
Dhaka N.: B-1095 Dlama J.Z.: B-1107 Du C.: B-1120
Dhamija A.: B-0777 Do Amaral Castro A.D.A.: B-1365 Du J.: B-1476, B-1651
Dhanasingh A.: B-0297 Do J.H.: B-0451 Du Plessis J.G.E.: B-1703
Di Bartolomeo M.: B-0951 Dodd E.: A-0687 Du R.: B-0178
Di Blasi A.: B-0010 Dodd J.D.: A-0469 Du T.: B-1163
Di Cataldo A.: B-0943 Dodig D.: B-0260 Du Y.: B-0123, B-1121
Di Cesare E.: B-0595, B-1309, B-1579, Doerfler A.: B-1777 Du Z.: B-0462
B-1623, B-1817 Dogan A.: B-1744 Dualde Beltran D.: B-0107
Di Chiara A.: B-0207, B-1343, B-1344, Dogan B.: B-1793, B-1794 Duan T.: B-1044, B-1471
B-1345, B-1485 Döğen M.E.: B-1053 Duan Y.: B-0752, B-1429
Di Costanzo G.: B-0174 Doherty J.O.: B-1601 Duarte A.: B-1510
Di Dato F.: B-0333 Døhlen G.: B-0168 Duarte Vallejo A.: B-1508
Di Gaetano E.: B-1154 Dohmen P.M.: B-1502 Duba I.: B-0447
Di Giacomo L.: B-1275 Dojcanova L.: A-0099 Dube B.: B-0900
Di Giammarco G.: B-0203 Dolgushin B.: B-0395, B-0844, B-0845 Düber C.: B-0383, B-0591, B-1824
Di Giulio G.: B-1153 Domènech-Ximenos B.: B-0044 Dubost F.: B-0982, B-1690
Di Leo G.: B-0490, B-1151, B-1352, B-1723 Dominguez A.: A-0397 Dubourg B.: B-1860
Di Luzio M.: B-1309, B-1623 Domínguez Echávarri P.: B-0294 Duc Cuong D.: B-1305
Di Marco V.: B-1529 Domínguez Paillacho I.D.: B-1662 Duc N.M.: B-1304, B-1305
Di Matteo M.: B-0951 Donalisio M.: B-0072 Ducou Le Pointe H.: A-0934
Di Mico L.: B-0253 Donati F.: B-0526, B-1097 Duffau H.: B-0096
Di Mizio V.: B-0708 Donati O.F.: B-0228, B-0822 Duffy S.: B-0920
Di Napoli A.: B-0712 Donato F.: B-1042 Duffy S.W.: A-0942
Di Nasso M.: B-1831 Donato P.: A-0223 Duguay T.M.: B-0301
Di Paola V.: B-0328 Dong D.: B-1280 Duijm L.: B-0083
Di Santo D.: B-0971 Dong H.: B-1100 Duijm L.E.M.: B-0081, B-0082, B-1149,
Di Serafino M.: B-0104 Dong S.-Z.: B-0599, B-0600 B-1158
Di Sibio A.: B-0595, B-1623, B-1817 Dong Y.: B-0452, B-1835 Duijts L.: B-0171
Di Stasi C.: B-1435 Doniselli F.M.: B-0416, B-0490, B-0759 Dullin C.: B-1610, B-1789
Di Stefano G.: B-0272 Donnelly-Kehoe P.: B-1780 Dumic Cule I.: B-0463
Di Terlizzi M.: B-0619 Donners R.: B-0057 Dunet V.: B-1366
Di Tommaso L.: B-0530 D’Onofrio M.: A-0668, B-0455, B-0457 Dupuis N.: B-0731
Di Trani M.G.: B-0607 Donoso L.: A-0347, A-0657, A-0734, K-28 Dura M.: B-1408
Diamantis I.: B-0201 Doria A.: B-0522 Duran E.E.: B-0210
Diamantopoulos A.: B-0966 Dorigo A.: B-1010 Duran R.: A-1004
Diao K.: B-0218, B-0596, B-1674, B-1677, Doriguzzi Breatta A.: B-0004 Durando M.: B-1173, B-1799
B-1680, B-1681, B-1820, B-1825 Döring S.: A-0684 Durante S.: B-0028, B-0416, B-0999
Díaz Díaz J.: B-0535 Dormagen J.B.: B-1047 Durden J.A.: B-1217
Díaz Pérez J.: B-1418 Dormont D.: B-1422 Durhan G.: B-1805
Diaz Ruiz S.: B-1360 Dorn F.: B-0259 Durlak F.: B-1030
Dick E.: A-0166 Dorn S.: B-0013, B-0135, B-0316, B-0319, Duron L.: B-0987
Dick G.: B-0655 B-0321 Durum Y.: B-1059
Diederichs G.: B-1734 Dörner J.: B-1166 Dushkova D.V.: B-1260
Diekhoff T.: B-0514, B-1630, B-1631, B-1738 Dorniok T.: B-1360 Dustler M.: B-0695
Diep P.-T.: B-0126 Doronzio V.M.: B-0618, B-1082 Duy Hue N.: B-1305
Dierolf M.: B-0995, B-1847 Dorrius M.: B-0704 Düzgün F.: B-1741
Dietrich U.: B-1740 Dorrius M.D.: B-0309, B-1565 Dyhre Lia A.: B-1699
Dietzel M.: B-0474, B-0551, B-0701, B-0702, Dósa E.: B-0958 Dyker K.: B-0666
B-0703, B-1518 Dou W.: B-1883 Dziedataja M.: B-0647
Dieudonné A.: B-0848 Douek P.: B-0311, B-0731, B-1116, B-1214,
Dijkshoorn M.L.: B-1598 B-1852 E
Dijkstra H.: B-0704 Douek P.I.: B-1366 Ebbesen D.: B-1465
Dimai H.-P.: B-0569 Dournes G.: B-1202 Ebdon-Jackson S.: A-0080, A-0082,
Ding J.: B-0147, B-1606 Dousset V.: B-1415 A-0138
Ding L.: B-0903 Dr. Tóth Z.: B-0882 Ebel S.: B-0221
Ding X.: B-1189 Drapé J.-L.: A-0543 Eberli D.: B-0228, B-0229
Ding Y.: B-1467 Dratwa C.: B-0478, B-1547 Ebner L.: A-0115
Dinoto A.: B-0536 Drazinos P.: B-1378, B-1530, B-1537, B-1837 Eck B.: B-0314
Diomedi-Camassei F.: B-1327 Dreher C.: B-0362, B-0364, B-0505 Ederveen J.C.: B-1879
Dionisi C.: B-1071 Dreossi D.: B-1846 Edjlali M.: A-0509

Eduarte A.: B-1545 Erdini F.: B-1389 Fallenberg E.M.: A-0760, A-1086
Edyvean S.: A-0048 Ereño Ealo M.J.: A-0947 Fallowfield L.: A-0417
Eggesbø H.B.: A-0719 Ergun O.: B-1206 Falsaperla D.: B-0418, B-0833, B-1405
Eggl E.: B-1847 Eriksson T.: B-0491 Fan D.: B-0754
Ehara S.: B-0742 Ermacora D.: B-1521 Fan G.: B-1230
Ehdaie B.: B-0152 Ernemann U.: B-0093 Fan L.: B-1752
Eichler K.: B-0243 Ernst A.: B-1411 Fan Q.: B-0952
Eickhoff S.: B-1553 Ersöz N.: B-1059 Fanciullo C.: B-0769
Eid M.: B-0787 Ertl-Wagner B.: A-0430 Fang J.: B-1627
Eid M.M.: B-1334 Ertl-Wagner B.B.: B-0094, B-0188, B-0749, Fang S.: B-0772
Eijgenraam S.M.: B-1134 B-0927, B-1782 Fang X.: B-0715, B-1099
Einspieler H.: B-1052 Esmaeilian S.: B-0602 Fang Z.: B-1654
Eisenblaetter M.: B-1125 Espejo Herrero J.J.: B-1662 Fanizza M.: B-0373
Eisenblätter M.: A-1058 Espinosa de Rueda Ruiz M.: B-1418 Farghaly H.: B-1459
Ekert K.: B-1277 Esposito A.: B-0207, B-0369, B-0381, Farhadi F.: B-1640
El Barody M.M.: B-1086 B-0598, B-1216, B-1221, B-1343, B-1344, Farina D.: A-0799, B-0970, B-1446
El Khudari H.: B-0838, B-1296, B-1298, B-1345, B-1485, B-1678 Farina L.M.: B-0372
B-1299, B-1301 Esposto Pirani P.: B-1719 Faron A.: B-1513
El Malek N.A.A.: B-0371, B-1086 Esser M.: B-0620 Farrell C.: B-0306
El Saddy S.: B-0856 Esseridou A.: B-0490 Farrell T.: B-0267
El Salam Ebrahem M.A.: B-1086 Esteban E.: B-0003 Farrugia S.: B-1350
El Sheikh R.: B-0923 Estrampes C.: A-0354, A-0355 Faruch M.: A-0647
El-Adawy M.: B-1174 Etemadi Z.: B-0602 Fatehi M.: A-0362, A-0707
Elazar Y.: B-1186 Etxano J.: B-1784 Fathallah W.M.: B-0179
Elbadawi S.E.E.E.: B-1416 Euler A.: B-0996 Fati M.A.: B-1109
El-Diasty T.: A-0995, B-0830 Eulig E.: B-0013, B-0909 Fatigati G.: B-1080
Elefante A.: B-1626 Eustace S.: B-0409 Fatihoglu E.: B-1884
Elentuck D.: B-0902 Evangelista A.: B-1499 Faugeras F.: B-0261
Eley K.A.: A-0450 Evans D.G.: B-0917 Faulkner M.: B-1425
Elizalde Pérez A.M.: B-1784 Evans R.: B-0900 Favia A.: B-0676
Elkalawy A.: B-0502 Evans T.L.: B-1023 Favia V.: B-0676
Elkarghali Z.: A-0868, B-0685 Evoy D.: B-0633 Fawzi F.S.: B-0212
ElKiki H.A.: B-1363 Evrimler S.: B-0269 Fawzy F.: B-0355
Ellingson B.M.: B-1165 Ewertsen C.: A-0670 Fazel F.: B-0829
Ellmann S.: B-0474, B-0551, B-0701, Ezenwugo U.: B-0043 Fazzini D.: B-0304
B-0702, B-0703, B-1518 Ezponda Casajús A.: B-0064, B-0111, B-1015, Fechtrup N.: B-1622
El-Merhi F.: B-0727 B-1219, B-1609, B-1784 Fedato C.: B-0250
Elmokadem A.H.: B-0100 Ezzeddine O.A.: B-0860 Fedders D.: B-0398, B-0401, B-0797
El-Najjar I.: B-0351 Fedon C.: B-1527, B-1838
Elorz M.: B-0064 F Fedorov A.: B-1182
Elpen P.: B-1546 Fabao G.: B-1861 Feger J.: B-0694
Elsayed R.F.: B-0212 Fabbro E.: B-0686 Feger S.: B-1016
Elshafey R.: B-0711 Fabbro-Peray P.: B-0431 Fehrenbach U.: B-0399, B-1024
Elshami W.: B-0644, B-1486 Faber J.: B-1241 Fehrs K.: B-0601
El-Sharkaway M.: B-0117 Fabian J.: B-1514, B-1515 Feier D.S.: B-1050
Elugwu H.C.: B-1358 Fabritius M.P.: B-0262, B-0713 Feifei G.: B-0857, B-0865
Elzeneini A.M.: B-0531 Faby S.: B-0135, B-0319, B-0321 Feldman S.A.: B-1306
ElZomor H.E.A.: B-1363 Facal de Castro F.: B-0107 Felices Farias J.M.: B-1418
Emad Y.: B-0899 Faccini R.: B-1833 Fendler W.: B-0690
Emberton M.: B-0159, B-0443 Faccioli N.: B-0937 Feng F.: B-1883, B-1890
Emiro F.: B-0318 Fadeeva L.: B-0089, B-1037 Feng S.: B-0810, B-1654
Emmett L.: B-0226 Fadzli F.: B-0468 Feng S.-T.: B-0411
Emri M.: B-0882 Fadzli F.B.: B-1274 Feng Y.: B-1083
Emrich T.: B-0378, B-0383, B-0591, B-1824 Faeghi F.: B-1694 Feng Z.: B-0419, B-0854
Enam S.A.: B-0090 Faermann R.: B-1569 Fenner J.: B-0760
Enden T.R.: B-0480 Faggioni L.: B-0017, B-0198, B-1831 Ferda J.: K-14
Engbersen M.P.: B-0182 Faghihi Langroudi T.: B-0427 Ferenczi Z.: B-1432
Engel G.: B-1734 Fahed R.: B-0280, B-0282 Ferguson P.: B-0066
Engelbrecht G.: B-0883 Fahlenkamp U.L.: B-0399, B-1734 Ferguson S.D.: B-1243
Engelhard N.: B-1738 Fahmy P.N.S.: B-0502 Fernandes K.: B-1704
England A.: A-0492, B-1708 Faietti E.: B-0630 Fernandes M.O.: B-1490
Enriquez Puga A.: B-1024 Faivre J.-B.: B-0778 Fernandes R.: B-1357
Ensminger S.: B-0202 Falaschi F.: B-0526, B-1097, B-1205 Fernandez J.M.: B-1195
Eran A.: B-1557 Falaschi Z.: B-1262 Fernandez-Clotet A.: B-1653
Erasmus H.-P.: A-0255 Falcione M.: B-1435 Fernández-Real J.M.: B-0044
Erb-Eigner K.: A-1069 Faletti R.: B-0038, B-0072, B-0381, B-0598, Ferranti C.: B-0257, B-0725, B-1155
Erdemir A.: B-1218, B-1805 B-1678 Ferrari A.: B-0798
Erden A.: B-1373 Falini A.: B-1337, B-1696, B-1776 Ferrari M.: B-1446
Erden I.: B-1373, B-1862 Falkowski A.L.: B-0893 Ferrari R.: B-1833

Ferraro D.: B-0817 Fonteyne V.: A-0481 Frigerio A.: A-1027

Ferraro D.A.: B-0228, B-0229 Foran A.: B-0936, B-1634 Frija G.: A-0015, A-0101, A-0315, A-0408,
Ferraz H.I.: B-1110 Forget J.: B-0931 A-0410, A-0590, A-0603, A-0659,
Ferreiro Argüelles C.: B-0535 Forgó N.: A-0104 A-0928, A-1011, A-1013
Ferrer Puchol M.D.: B-0003 Formenti A.: B-1501 Frittoli B.: B-0619, B-1042
Ferrero A.: B-0447 Formosa A.: B-0413 Fritz J.: B-0620
Ferrero G.: B-0686, B-0689 Fornasa F.: B-0248 Froelich M.F.: B-0262, B-1773
Festa A.: B-0211 Forrai G.: A-0149, A-0941 Froeling M.: B-0377
Feuchtner G.: B-0782, B-1599 Forst R.: B-0684 Froemming A.: B-0438
Feygin T.: B-0604 Förster K.: B-0927 Fröhlich J.M.: B-0108
Fialkoff B.: B-0133 Forsting M.: A-0596, B-0116, B-0690, Frohn M.: A-0216
Ficarra V.: B-1078 B-0803, B-0819, B-0875, B-0913, B-1421, Fronda M.: B-0038
Ficicioglu C.: B-1057 B-1456, B-1461, B-1595, B-1740 Fronza M.: B-0361
Ficorella C.: B-1572 Forstner R.: A-0069, A-0285 Fröss-Baron K.: B-0523
Figà-Talamanca L.: B-0930 Forte S.: B-1792 Frulloni L.: B-1094
Fighera A.: B-0532, B-1094, B-1103 Fortini M.: B-0045, B-0046 Frush D.P.: A-0117
Figueira A.R.: B-1494 Forton R.K.: B-0029 Frydrychowicz A.: B-0202, B-0225, B-0349
Figueiredo J.P.: B-0650 Fösleitner O.: B-1881, B-1882 Fryer T.D.: B-0501
Filippi M.: B-1696 Fosså K.: B-0131 Fu C.: B-0375, B-0376, B-1675
Filippiadis D.: A-0063 Fossati B.: B-1821 Fu G.: B-1331
Filippone A.: A-0242 Foti G.: B-0239, B-0872, B-1128, B-1743 Fu H.: B-0166, B-0376, B-0594
Fingerle A.A.: B-1612 Foti P.V.: B-0418, B-0833, B-0943, B-0959, Fu J.: B-0611, B-1280
Fiocchi F.: B-1381 B-1648 Fu R.: B-1370
Fiore F.: B-0564 Fotopoulou C.: B-1387 Fu W.: B-0831
Fiore M.R.: B-0373 Fouad D.: B-0371, B-1284 Fu Y.: B-0801
Fiore S.: B-0072 Fournie E.: B-0312 Fuchs M.: B-1738
Fiorino C.: B-1343, B-1485 Fournier D.: B-1600 Fuchsjäger M.H.: A-0355, A-0414, A-0534,
Fischer A.: B-0789 Fournier L.: B-0987, B-1894 A-0674, A-1083, A-1100, B-0767, B-0767,
Fischer A.M.: B-0780, B-0781, B-0820 Fournier L.S.: A-0129, A-0627, A-0901 B-0989, B-1619, B-1620
Fischer M.: B-1866 Foutzitzi S.: B-0163 Fueger B.: B-1875
Fischer R.: B-0601 Fowler K.: A-1002 Fugazzola C.: B-1810
Fischer T.: A-0337, B-1657 Fowler K.J.: B-1765 Fujii K.: B-0424
Fischer U.: B-1544 Fracella M.R.: B-1872 Fujinaga Y.: B-1836
Fisher J.: B-0979 Fragner R.M.: B-1050 Fujioka T.: B-0471, B-1796
Fitousi N.: B-0132 Fraia A.S.: B-0522 Fujisawa Y.: B-0417, B-0579
Fitzgerald J.: B-1700 França M.M.: A-0838 Fujita B.: B-0202
Fiz F.: B-0686, B-0689 Franceschelli G.: B-0974 Fujiwara M.: B-0293
Flach P.: B-0068 Franceschi D.: B-0687 Fujiwara T.: B-0293
Flacke S.: B-0902 Franchi-Abella S.: A-0681 Fukushima H.: B-0408
Flatabø T.: B-0332, B-0821 Franchini S.: B-1827 Fumagalli I.C.: B-0373
Flatten D.: B-1783 Franck C.: B-0145 Funayama S.: B-0404
Fleischmann D.: B-0378, B-0624 Franckenberg S.: B-0068 Funicelli G.: B-1022
Fleischmann-Mundt B.: B-0503 Franco C.: B-1029 Funicelli L.: B-1281
Flemmer A.: B-0927 Francone M.: A-0124, A-0146, B-0592, Furlan A.: B-0071, B-1765, B-1768, B-1771
Fletcher J.G.: B-0447, B-1142 B-1019, B-1500, B-1823 Furman-Haran E.: B-1569
Fletcher M.: B-1543 Franconeri A.: B-0372 Fusaro M.: B-1010, B-1011
Fleury E.F.C.: B-0084, B-1524, B-1526 Frandon J.: B-1695 Fusco R.: B-0974, B-1346
Flodmark C.-E.: B-1360 Frank C.: B-0379 Fütterer J.J.: A-0095, B-0878
Flohr T.: B-0496, B-0996 Frank V.: B-1589
Flores Quispe S.K.J.: B-0512 Frantsev D.: B-0395 G
Floridi C.: B-1810 Franz M.: B-0201 Gabelloni M.: B-0017, B-0198, B-1831
Fodor M.: B-0102 Franzese M.: B-0928 Gaboardi F.: B-1300
Fokin V.: B-1505 Fraser L.: B-1193 Gabr A.E.: B-1232
Fokin V.A.: B-0791 Frattini T.: B-0040 Gabriel H.: A-0593
Foley K.G.: B-1027 Frauenfelder T.: A-0145, A-0455, A-0549, Gac P.: B-0039, B-0200
Foley R.W.: B-0950 B-0085, B-0554, B-0577, B-1512 Gagliardi I.: B-0046
Foley S.: B-0407, B-0485, B-0653 Fraum T.J.: B-1765 Gagliardo C.: B-1444
Foley S.J.: A-0412, A-0961, B-0663, B-1354 Freeman S.: B-1384 Gaillot K.: B-0836
Folhoffer A.: B-1589 Freise J.: B-1201 Galanaud D.: B-1422
Folio L.R.: B-1640 French R.: B-0902 Galant C.: B-0894
Fomin V.V.: B-1822 Frenken M.: B-0515, B-0516, B-0517, B-0518, Galati F.: B-0553
Fong C.Y.: B-1233 B-0519, B-1736 Galatoire O.: B-0987
Fonio P.: B-0004, B-0038, B-0072, B-0598, Frenzel F.: B-0963, B-1720 Gale A.G.: B-0437, B-1548
B-1173, B-1799 Friedrich G.J.: B-0782 Galea N.: B-0592, B-1019, B-1500, B-1823
Fontana F.: B-1808, B-1810 Friedrich K.M.: A-1098 Galen T.: B-0706
Fontana G.: B-0372 Friedrich N.: B-1474 Galimzianova A.: B-1402
Fontanella G.: B-0211 Friedrich T.: B-0498 Gall H.: B-1863
Fontanilla T.: A-0894 Friedrich-Nel H.: A-0654, B-0890, B-1707 Gallagher F.A.: A-0459, B-1802
Fontarensky M.: B-1470 Fries P.: B-0167, B-0961, B-0963 Gallardo Madueno G.: B-0294

Gallego Rivera J.I.: B-0274 Gebest M.: B-1166 Gilbert A.: B-0361
Galli V.: B-1715 Geier K.I.: B-1240 Gilbert F.: B-0501
Galliano M.: B-0951 Geier O.M.: B-0168 Gilbert F.J.: A-0418, A-0526, B-1802, K-16
Gallina S.: B-0195 Geijer H.: B-1197 Gilhodes J.: B-0322
Gallix B.: B-0528 Geijer M.: B-1197 Gill A.: B-1802
Gallo G.: B-0824 Geisel D.: B-0399, B-1374, B-1469 Gillard J.H.: B-1688
Galluzzo M.: B-0732, B-0733 Geisl G.: B-0926, B-1881 Gillard M.: B-1700
Galvano G.: B-0436 Gempt J.: B-0088 Gilley D.: A-0661
Galyan T.N.: B-1263 Geneidi E.: B-0400 Ginocchio M.I.: B-1383, B-1385
Gamberini M.R.: B-0045, B-0046 Geng D.: B-0541, B-0858, B-1120 Giombi F.: B-1439
Gambhir S.: B-0233 Geng J.: B-1889 Giona S.: B-0159
Gamboa P.A.T.: B-0410 Gennari A.: B-0536 Giordano A.V.: B-1579
Gammack P.: B-1455 Gennaro G.: B-0250, B-1540, K-43 Giovagnoni A.: A-0584, A-0635, B-1118,
Gandini G.: B-0004 Gennaro N.: B-0530, B-1636 B-1719
Ganesan P.K.: B-0910 Gentile F.: B-0072 Giovanetti González R.: B-0625
Ganeshan B.: B-0150 Gentili F.: A-0066, B-1275 Giraudo C.: B-0512, B-0522, B-1060, B-1364
Ganghua T.: B-1124 George A.: A-0071, A-0092 Girodet P.O.: B-1202
Gangi A.: A-0511, B-0834 George U.B.: B-0714 Girometti R.: B-0076, B-0253, B-1078,
Gao A.: B-1244, B-1779 Gerboni M.: B-0072 B-1079, B-1138
Gao B.-L.: B-0184 Gerevini S.: B-1337, B-1696 Gitto S.: B-0052, B-0868, B-0870, B-1730
Gao J.: B-1163, B-1877 Germano A.S.: A-0985, A-0987, A-0990 Giudice D.: B-1718
Gao L.: B-0315, B-1604 Gernhardt C.: B-1740 Giudici F.: B-0464
Gao P.: B-0752 Geroulakos G.: A-1066 Giugliano G.: B-1644
Gao S.: B-1017 Gersing A.S.: A-0949, B-0047, B-1746 Giuliani M.: B-0548
Gao Y.: B-1222, B-1676, B-1681, B-1820 Gerson P.: A-0652 Giurazza F.: B-0006
Garcarek J.: B-0747 Gerwing M.: B-1125 Given-Wilson R.M.: B-0078, B-0080
Garces-Descovich A.: B-0210 Geso M.: B-0657 Gizewski E.R.: B-1689
García Baizán A.: B-1015, B-1219 Gesualdo L.: B-0329 Gizewski E.R.R.: B-0925
Garcia C.: B-0837 Geterud K.: B-0324 Gkoumas S.: B-0997
Garcia de Eulate R.: B-0294 Ghafarzadegan K.: B-1380 Gkoutzios P.: B-0966
García Figueiras R.: A-1059 Ghanim M.E.: B-0179 Glas M.: B-0819
García García F.: B-0625 Gharbi H.A.: A-0309, A-0315, A-0317 Gleeson F.: A-0800, B-0245
García Gorga R.: A-0689 Gharbi M.: B-1487 Glosna M.: B-0200
García Roch C.G.R.: B-0625 Ghetti C.: B-0993 Gluskin J.: B-1804
Garcia-Aguilar J.: B-1663 Ghodasara S.: B-1650 Gned D.: B-0824
Garcia-Castro F.: B-0680, B-1830 Ghosh A.: B-1901 Gnirs R.: B-0362, B-0364, B-1421
Garcia-Villalba B.: B-1418 Ghosh R.: B-0748, B-0750, B-0755, B-0981 Goddi A.: B-0040
Garel C.: A-0561 Ghoshhajra B.: B-1013 Godel T.: B-1560
Garetier M.: B-1511 Ghosn M.: B-1669 Godfrey D.: B-0533
Garin E.: B-0848 Ghotra S.S.: B-1700 Godtman R.: B-0324
Garip-Kuebler A.: B-1451 Ghuman S.S.: B-1668 Goeral K.: B-0926
Garlaschi A.: B-0724 Giacobbe A.: B-1715 Goerke S.: B-0505, B-0506
Garmpis D.: B-0756, B-0988 Giambelluca D.: B-1529 Goerke S.M.: B-0867
Garnon J.: B-0834 Giandola T.: B-1457 Goessmann H.: B-0739
Garrido Inostroza C.: B-0629 GIannarini G.: B-1078, B-1138 Goh V.J.: A-0037, A-0713, A-0866, B-0351,
Gasbarrini A.: B-0109, B-0110, B-0114 Gianneramo C.: B-0241 B-0616, B-0617, B-1874
Gasca C.: B-1303 Giannetto G.: B-1082, B-1093 Gohmann R.F.: B-0196, B-1683
Gascho D.: B-0068, B-1516 Giannini F.: B-1221 Gokharman F.D.: B-1884
Gaspar R.C.M.C.R.: B-0643 Giannini V.: B-0618, B-1828 Golay X.: B-0095
Gasparini C.: B-0464 Gianniotis C.: B-0183 Gold G.E.: B-1134
Gasparotti R.: A-0026 Giannitto C.: B-0973 Goldberg N.: B-1436
Gassner E.-M.: B-0102 Giannotti E.: A-0763 Goldberg S.N.: A-0602
Gast R.: B-0146 Giannotti G.: B-0455 Golden D.: B-0302
Gastl M.: B-1616 Giannotti N.: B-0407 Goldenko M.: B-0296
Gatidis S.: A-0704, B-0818 Giarrizzo A.: B-1878 Gołębiewski B.: B-1477
Gatos I.: B-1378, B-1530, B-1537, B-1837 Giasotto V.: B-0879 Golfieri R.: B-0873
Gatti F.L.: B-0009 Gibaud B.: A-0633 Golland P.: A-0395
Gatti M.: B-0038, B-0072, B-0381, B-0598, Gibbs F.: B-0639 Gollub M.J.: B-1663
B-1613, B-1614, B-1678 Gibbs P.: B-0719 Golosio B.: B-1846
Gaudez F.: B-0953 Gibney B.: B-0246 Gomaa M.: B-0460, B-0502, B-1174, B-1232
Gaudiano C.: B-0873 Gibson A.: B-1027 Gomboli G.: B-1229
Gaudry M.: B-0964 Gibson D.: B-0709 Gomez J.C.: B-1780
Gavira J.J.: B-1219 Gibson S.: B-0033 Gommers S.: B-1787
Gavrilovic V.: B-0076, B-0967 Gielen J.: B-1286 Gomori J.M.: B-0133, B-0313
Gawlik K.: B-0352 Giese D.: B-1542 Goncalves C.: B-0979
Gawlitza J.F.M.: B-0587 Giganti F.: B-0159, B-0443 Gonçalves F.: B-1490
Ge Y.: B-0857, B-0865 Giganti M.: B-0045, B-0046, B-0272, Gong B.: B-0583
Geão A.: B-0884, B-0892 B-1406 Gong J.: B-1758
Gebauer B.: A-0191, B-0962, K-20 Gil I.: B-0283 Gong Q.: B-0751, B-1036, B-1333, B-1426

Gong Yong J.: B-0054, B-0683 Griffier R.: B-1415 Guindani M.: B-0056
González de la Huebra Rodríguez I.: B-1784 Griffin E.: B-0265, B-0267 Guirao Garriga F.J.: B-0121
Gonzalez F.: B-1140 Griffith J.F.: B-1292 Gulani V.: B-1650, B-1655
González J.: B-1609 Griffith L.P.: B-0781, B-0784, B-0914, B-1217 Gule-Monroe M.K.: B-1243
González R.L.: B-1397 Griffith P.: B-1215 Gulino F.: B-1878
Gonzalo Carballés M.: B-0340 Griffiths C.: B-0885 Gulino P.: B-0928
Goo J.M.: A-0291, B-1403, B-1412 Griffiths P.D.: A-0562, K-22 Gulsun M.A.: B-0820
Goracy J.: B-1601 Grigorieva E.: B-0186 Gültekin M.: B-1805
Gorbunov N.: B-1005 Grimaldi D.: B-0174 Gumeler E.: B-1445
Gordebeke P.: A-0304 Grimaldi M.C.: B-0722 Gundermann P.: B-0175
Gore R.M.: A-0487 Grimaldi V.: B-1872 Gundogmus C.A.: B-0286
Gorgatti T.: B-0076, B-0967 Grimandi R.: B-1511 Gunn A.: B-0357, B-0838, B-1296, B-1298,
Görlich D.: B-0266 Grimm J.: A-0714, B-0201 B-1299, B-1301, B-1473
Gorospe Sarasua L.: B-0274 Grimm R.: B-0438, B-1390 Gunny R.: A-1024
Goryaynov S.: B-0089 Grimmer R.: B-0146 Günther B.: B-0995
Goshayeshi L.: B-1380 Grinstein O.: B-0461 Günther D.: B-1448
Gosvig K.K.: B-0675, B-0682 Grippo C.: B-1150 Guo H.: B-0343
Gotlieb M.: B-1569 Gris J.-C.: B-1695 Guo J.: B-0309, B-0574, B-1756
Goto S.: B-0642, B-1167 Grisan E.: B-1685 Guo M.: B-1646
Gotschy A.: B-1616 Grisanti S.: B-0619 Guo W.: B-1339, B-1479
Gottfriedova B.: B-0338 Grist J.: B-1802 Guo W.-Y.: B-0758
Gottlieb J.: B-0585 Gristina L.: B-0724 Guo Y.: B-0166, B-0375, B-0376, B-0384,
Gottschling S.: B-1683 Grivas N.: B-0326 B-0831, B-1674, B-1680, B-1825, B-1869
Gotway M.: B-1007 Grob D.: B-1850 Guo Y.-K.: B-0382, B-0594, B-0596, B-1222,
Gouda W.A.: B-0100 Grobmyer S.: B-1793, B-1794 B-1618, B-1673, B-1675, B-1676, B-1681,
Gourtsoyianni S.: A-0163, A-0280, A-0870 Grochowska A.: B-1583 B-1820, B-1826, B-1859
Goussia A.: B-1660 Groden C.: B-0022 Gupta A.K.: B-0640
Goyal A.: B-0640, B-1207 Gröhn H.: B-1272 Gupta K.: B-0717
Graber-Naidich A.: B-0624 Gronning K.: B-1066 Gupta N.: B-0640
Gradwell M.: B-0033 Grosse Hokamp N.: B-0314, B-1025, B-1081, Gupta P.: B-1095
Graeser M.: B-0499 B-1783 Gupta S.: B-1753, B-1892
Graessner J.: B-0225 Grosse-Siestrup C.: B-0762 Gupta V.: B-0777, B-1169, B-1335, B-1558
Grainger A.: B-0900 Grossi E.: B-0304 Guralnik G.: B-1186
Grainger A.J.: A-0840, A-0842 Grosu S.: B-0188, B-0749 Gureyev T.: B-1789
Grams A.E.: B-0925 Grothoff M.: B-0221, B-0379 Gurov S.N.: B-0180
Granata C.: A-0118, A-0875, A-0936 Grover H.: B-0720 Gurumoorthy M.: B-0475
Granata V.: B-1346 Grover S.B.: B-0720, B-1291, B-1293 Gusmini S.: B-0851, B-1439
Grandis M.: B-1745 Gruber G.M.: B-0927 Gutberlet M.: A-0198, A-0938, B-0196,
Grandl S.: B-1847 Gruber-Rouh T.: B-0843, B-1204, B-1317 B-0221, B-0379, B-1201, B-1683
Granzier R.: B-1170 Grueneisen J.: B-0690, B-0875, B-1456, Gutjahr R.: B-0493, B-0496, B-0729, B-1503
Grass M.: B-0119 B-1461 Gutzeit A.: B-0108
Grassi M.: B-0991 Grunwald I.Q.: B-0979, B-1555 Guzmán Rojas R.: B-0629
Grassi R.: A-0581, A-0583, B-0034 Grusha Y.O.: B-1263 Gwon H.Y.: B-0127
Gratz M.: B-0819 Gruszczynska K.: A-0775 Gyngell M.L.: B-0763
Graumann O.: K-32 Gu Q.: B-0419
Graungaard Falkvard C.: A-0620 Gu R.: B-0718 H
Graves M.J.: B-0501 Gu X.: B-0123 H Butler P.: B-1117
Graziano M.: B-1406 Gu Y.J.: B-1152 H. Abdeldayem E.: B-1855
Grazioli L.: B-0619, B-1042 Guan J.: B-0831 Ha H.S.: B-1012
Grazioli M.: B-1042 Guan W.: B-0511, B-0881 Haage P.: B-1289
Grecchi A.: B-0457 Guarasci F.: B-0038, B-0072 Haanen J.B.: B-0685
Grech M.E.: B-0649 Guaricci A.I.: B-0783, B-1212, B-1613, B-1614, Haas M.: B-0153, B-0441
Greco F.: B-1079 B-1615, B-1686 Haas N.: B-1866
Green A.: B-0617, B-1874 Guarnera A.: B-1270 Habeeb M.: B-0179
Greer M.: B-0585 Guazzarotti G.: B-0971, B-1880 Haberal K.M.: B-1854
Greffier J.: B-1695 Guberina N.: B-0875, B-1595, B-1740 Habib Geryes B.: B-1664
Gregorio A.: B-0003 Gubern-Merida A.: B-0697 Habib Y.S.: B-1363
Gregório B.: B-0650 Gucalp A.: B-0924 Hadaschik B.A.: B-0875
Grehan J.: A-0121 Guðjónsdóttir J.: B-0656 Haegele J.: B-0498
Greiser A.: B-0767, B-0989, B-1619, B-1620 Guenego A.: B-0280, B-0282, B-0288 Haenel A.S.: B-1669
Gremion I.: B-1709 Guenoun D.: B-1507 Hagberg G.: A-0912
Gremmel F.: B-1617 Guerreiro T.C.P.L.: B-1359 Hager B.: B-0055
Grenier N.: A-0380, A-0573 Guggenberger R.: B-0997, B-1733 Haghighatkhah H.: B-1433
Grenier P.A.: A-0565 Guglielmi G.: A-0970 Hahn F.: B-0378
Gresser E.: B-1400 Guglielmo M.: B-0783, B-1212, B-1501, B-1613, Hahn H.K.: A-1060
Greune L.: B-1125 B-1614, B-1615, B-1686 Haider L.: B-0534
Greuter M.: B-0311, B-0317 Gui B.: B-1898 Haidl F.: B-0492
Grgic I.: B-0065 Guillén Burrieza G.: B-0340 Haioun K.: B-1407
Grieser C.: B-1469 Guimarães L.S.: A-0857 Haiwei H.: B-1254

Hakanen J.: A-0745 Hartenbach M.: A-0331 Heiß R.: B-0289, B-0426, B-0684, B-1245,
Halaweish A.F.: B-0447, B-1142 Harteveld A.: B-0215 B-1321, B-1868
Halfmann M.C.: B-0378, B-0591, B-1824 Harth M.: B-0296 Heitmann S.O.: B-1704
Hall-Craggs M.A.: K-10 Hartmann A.: B-0764 Hekimoglu A.: B-1206
Haller S.: A-0025 Hartmann C.J.: B-1553 Hekimoglu B.: B-1206
Halliday K.: A-0460 Hartmann I.: A-0801 Hekimoglu K.: B-1854
Halshtok Neiman O.: B-1569 Hartmann N.-A.: B-1016 Helbich T.H.: A-0528, B-0716, B-1150, B-1542,
Hamano M.: B-0742 Hartung P.: B-0196 B-1549, B-1570
Hamdy A.: B-1101, B-1102 Harvey C.: B-0627 Helbig S.: B-1247
Hamed K.: B-0827 Harvey H.: A-0128 Hélénon O.: B-1664
Hamer O.: A-0454 Harvey-Lloyd J.: B-0033 Helfen A.: B-1125
Hamerla G.: B-0175 Hasan H.A.: B-1334 Helfenstein R.: B-0571
Hamm B.: B-0153, B-0441, B-0450, B-0514, Hasanefendioglu Bayrak A.: B-1576 Hellerhoff K.A.: B-1847
B-0664, B-0762, B-0962, B-1199, B-1374, Haselbacher M.: B-0102 Hellmich M.: B-0461
B-1468, B-1469, B-1475, B-1630, B-1631, Hashem R.H.: B-0162, B-1232 Hellström M.: B-0324
B-1657, B-1734, B-1738 Hashimoto J.: B-1603 Helmberger T.K.: K-42
Hammami N.: B-1160 Hashimoto T.: B-0425 Helthuis J.: B-0215
Hammel J.: B-0047, B-1848 Hashizume T.: B-0648 Hempel J.-M.: B-0093
Hammer S.: B-0298 Haslam P.: B-0437 Henderson W.C.: B-1536
Hammerstingl R.: B-0843 Hassan A.A.-Q.: B-0117 Hendriks E.J.: B-0096
Hammon M.: B-1088 Hassan K.M.B.: B-0271 Hendrikse J.: A-0251, B-0215
Hammond R.L.: B-1543 Hasse A.: B-1863 Hendry J.: B-0033
Hamri H.: B-1563 Hasse B.: B-0224 Henner A.: A-0494, B-0886, B-0887, B-1192,
Han D.: B-1008 Hasse F.C.: B-0385 B-1712, B-1717
Han D.Y.: B-1137 Hatakenaka M.: B-1735 Hennessy W.: B-1706
Han H.: B-0488 Henry T.: B-1407
Haubenreisser H.: B-0106, B-0587, B-0735
Han H.Y.: B-0392 Hentschel M.: B-0510
Haubold A.: B-0797
Han J.K.: B-0453, B-1119, B-1772 Henzler T.: B-0022, B-0106, B-0587, B-0735
Haubold J.: B-0116, B-0575, B-0803,
Han J.K.K.: B-0389, B-1342 Hepp T.: B-1777
B-0819, B-0913
Han K.: B-0335, B-1043, B-1443, B-1766 Herbst M.: B-1845
Haug A.: B-1020, B-1875
Han M.-R.: B-1177 Hering A.: B-0349
Hauger M.: B-1166
Han P.: B-0218, B-0479 Hermann A.-L.: B-0848
Hausegger K.A.: A-0510
Han P.-L.: B-1676 Hermann K.-G.A.: B-0514, B-1738
Hausmann D.: B-0446
Han Q.: B-1098, B-1100, B-1531 Hermann S.: B-0514
Hautzel H.: B-1462
Han X.: B-0452 Hermans R.: A-0720
Havsteen I.: B-1035
Han Y.: B-0757, B-1888 Hermie I.: B-0157
Hawanna M.A.M.: B-0693
Handa J.: B-1167 Hernandez Giron I.: B-1592
Hayashi H.: B-0642, B-0648, B-0994
Handberg E.: B-1543 Hernandez-Giron I.: B-0137
Hayball M.: B-0150
Haneder S.: B-0314, B-1081 Herold C.J.: K-24
Haydar A.: B-0800
Hanekamp B.: B-1047 Herranz M.: A-0705
Hazell L.J.: B-1701, B-1707
Hangaard S.: B-1135 Herrmann J.: B-1240
Hazirolan T.: A-0421, B-1218
Hanley-Knutson, K.: B-0829 Herrmann K.: B-0231, B-0575, B-0670,
Hannesdóttir G.A.: B-0656 Haznedaroğlu S.: B-1453 B-0671, B-0673, B-0690, B-0819, B-1456,
Hanquier L.: B-1214 He B.: B-1283 B-1461
Hansen M.S.: B-1035 He J.: B-1189 Herweh C.: B-0263
Hansen N.L.: B-0880 He M.: B-0386, B-0454, B-0613, B-0952 Herz K.: B-0095
Hanspach J.: B-1777 He S.: B-1820, B-1869 Herzen J.: B-0995, B-1612, B-1847
Hansson M.: B-1197 He Y.: B-1074, B-1087, B-1820, B-1869, Hesper T.: B-1739
Hanstein B.: B-0461 B-1893, B-1896, B-1897 Hess C.: A-0388, A-0389
Hanta I.: B-1413 Healy N.: B-1801 Hetzel J.: B-1814
Hao L.: B-1162 Healy N.A.: B-1795 Heusch P.: B-0669, B-0670, B-0671, B-1355,
Haq T.U.: B-1367 Hebda A.: B-1338 B-1461
Harder D.: B-0057 Heber D.: B-0673 Heusdens C.H.: B-1509
Harding L.: A-0210 Heck L.: B-1847 Heussel C.P.: A-0702, B-1421
Hardman J.: B-0976 Hecker J.: B-1787 Heuvelmans M.A.: B-1008
Hardy M.: B-0029 Hedgire S.: B-1013 Heverhagen J.T.: B-0896, B-0901, B-1184,
Hare S.: B-1004 Hedican S.P.: B-1297 B-1434, B-1438, B-1442
Hargreaves B.A.: B-1134 Heeres B.: B-1049 Heye T.: B-1092
Haris Phuah A.: B-1274 Hegazy R.M.A.: B-1545 Hielscher T.: B-0348
Harisinghani M.G.: B-0827 Heidenreich A.: B-1081 Hietschold V.: B-0398
Harit S.: B-1562 Heidinger B.H.: B-0580, B-1306 Higashida A.: B-0425
Harkness E.F.: B-0917 Heier M.: B-0188, B-0749 Hikspoors J.P.J.M.: B-0068
Harman P.A.: B-1555 Heijmink S.: B-0326 Hilgendorff A.: B-0927
Harper A.: B-1455 Heikkinen N.: B-1272 Hill M.: B-1540
Harris J.: B-0033 Heil P.: B-1437 Hillen B.: B-0215
Harsaker V.: B-1700 Heiland S.: B-1560 Hillengass J.: B-0344, B-0348
Harsany J.: B-0281 Heimer J.: B-1516 Hilton B.: B-0079
Hartemink K.J.: B-1483 Heindel W.: B-0266, B-1125 Hinrichs J.B.: B-0001, B-0681
Hartenbach F.: B-0677 Heinemann V.: B-1586 Hintschich C.: B-1451

Hinzpeter R.M.M.: A-0088 Hou B.: B-1883, B-1890 Hutton C.: B-0763
Hippeläinen E.: B-0998 Hou P.: B-1725 Huyskens J.: B-0753
Hirata T.: B-1899 Hou Y.: B-0149, B-0315, B-0785, B-1017, Hwang H.J.: B-0576
Hircak H.: A-0730 B-1308, B-1604 Hwang J.Y.: B-0918
Hirota M.: B-0660 Houben I.: B-1787 Hwang S.: B-1766
Hirsch J.G.: B-0019 Houot R.: B-0672 Hwang S.H.: B-0776
Hislop-Jambrich J.: B-0655 Hourani R.: B-1168 Hyde E.: B-0033
Hjemly H.H.: A-0081, A-1042 Houwers J.B.: B-1049, B-1582 Hynes D.: B-0246
Hoa H.V.: B-1012 Howard J.: A-0187 Hyodo T.: B-0408
Hocheol C.: B-0965 Howarth N.: A-0914
Hochmair M.: B-1020 Howlett D.C.: A-0078, A-0137, A-0585 I
Hodel J.: A-0158, B-0261 Hrabak P.: B-0938 Iacobellis F.: B-0104
Hodler J.: A-0271 Hrabak Paar M.: A-0298, A-0776 Iadanza A.: B-1776
Hoeffel C.: B-0528 Hricak H.: A-0352, A-0355, A-0731, B-0152 Iafrate S.: B-0241, B-1295
Hoeschen C.: A-1012, A-1014, A-1016 Hsiao A.: B-0302, B-1607 Iannalfi A.: B-0372
Hoferica M.: B-0281 Hu B.: B-1674, B-1825, B-1859 Iannessi A.: B-1023
Hoff S.R.: B-0077 Hu D.: B-1479 Iannicelli E.: B-0525, B-1341
Hoffman A.: B-1502 Hu F.: B-0405, B-1535 Ianniello S.: B-0732, B-0733, B-0734
Hoffmann A.: A-0499 Hu H.: B-0472 Ibañez Sanz L.: B-0268
Hoffmann MD MPH U.: B-1013 Hu J.: B-1163 Ibe D.: B-1391
Hoffmann R.-T.: B-0398, B-0401, B-0797, Hu M.S.: B-1273 Ibrahim A.: B-0366, B-1170
B-1474 Hu P.: B-0678 Ibrahim E.A.: B-0100
Hofland J.: B-1279 Hu Q.: B-0815 Ichikawa S.: B-0404
Hofmann V.: B-1092 Hu S.: B-1585, B-1590, B-1727 Ichikawa Y.: B-1101, B-1102
Hofmann W.-K.: B-0352 Hu T.: B-0801 Ichinohe F.: B-1836
Hofmanninger J.: B-0307, B-0344, B-0567, Hu X.: B-0308, B-1333, B-1591 Idema S.: B-0096
B-0811, B-0905 Hu Y.: B-0718, B-1131 Idilman I.: B-1594
Ho-Fung V.M.: B-1055, B-1057 Huang C.: B-0275 Ierardi A.M.: B-1808
Hofvind S.: A-0009, B-0077, B-0921 Huang D.Y.: A-0997 Iezzi R.: A-0258, A-0419, A-0908, B-0109,
Hogg P.H.: A-0963, B-1708 Huang H.: B-0952 B-0110, B-0114, B-1812
Hohenfellner M.: B-0813, B-1077 Huang J.: B-0343, B-1762 Igashi J.B.: B-1391
Höhn A.K.: B-0175 Huang L.: B-0380, B-1476, B-1651 Ignacio G.M.: B-0118
Höink A.: B-1761 Huang M.: B-0390 Ignjatovic S.: B-0446
Hoinkiss D.C.: B-0019 Huang Q.: B-1440 Igumenova N.: B-1853
Holch J.: B-1586 Huang S.: B-1476, B-1618, B-1651, B-1654, Iida G.: B-1629
Holder D.: B-1425 B-1674, B-1680, B-1681, B-1820, B-1825 Ikeda Y.: B-0706
Holm S.: A-0623 Huang X.: B-1017, B-1036, B-1333, B-1430 Ikram M.A.: B-1690
Holmberg O.: A-0098 Huang Y.: B-0423, B-0429, B-0430, B-1409 Ikramov A.: B-1379
Holodny A.I.: B-1032 Huasen B.: B-0961 Ikushima H.: B-0648
Holst Pedersen J.: B-0497 Huber F.A.: B-0997, B-1733 Iles S.E.: B-0916, B-0919, B-1543
Holz J.: B-0314 Huber T.: B-0088, B-1586 Ilhan H.: A-0976
Holzer M.: B-0307 Hübner L.: B-0221 Illarioshkin S.: B-1554
Holzhey D.: B-0196, B-1683 Hudson H.T.: B-1217 Illing R.: B-1185, B-1200
Honavar S.: B-0562, B-1062 Huellner M.W.: B-0224 Im D.J.: B-0776
Hong G.: B-1454 Huettel M.: B-0684 Im J.-G.: B-1412
Hong G.-S.: B-0105, B-0273, B-1754 Hughes C.: B-0651 Im S.A.: B-0336
Hong H.: B-1403 Hughes N.M.: B-0633 Imai T.: B-0293
Hong J.H.: B-1412 Hugosson J.: B-0324 Imai Y.: B-1603
Hong N.: B-1731, B-1732 Hui Shu Y.: B-1002 Imamura R.: B-1735
Hong S.: B-0758 Huland H.: B-1089 Imbriaco M.: B-0668, B-0823, B-1392,
Hong S.R.: B-1023 Hüllner M.: B-0229, B-0817 B-1684
Hong Y.: B-1244, B-1779 Hulsmans F.J.: B-1170 Inampudi V.: B-1886
Hong Y.-S.: B-0054, B-0683 Humphries P.D.: B-1324 Incekara F.: B-0908
Hongmin C.: B-0475 Hunink M.G.M.: A-0636, A-0740 Inci E.: B-0877
Hoogenboom M.: B-0872 Hunold P.: B-1622 Indo H.: B-1329
Hopland N.-M.: B-1543 Hunt M.: B-0323 Ingrisch M.: B-1400
Hoppel B.E.: B-0306, B-1832 Huppertz A.: B-1184 Inserra G.: B-1648
Horgan G.: B-0407 Hur B.Y.: B-1342 Intert L.: B-0679
Horger M.: B-0146, B-0620, B-0623, Hur J.: B-0776 Ioannidis G.: A-0530
B-0628, B-1814 Hurwitz L.: B-0493, B-0729, B-1503 Iodice M.: B-0477
Hörndler K.: B-0909 Hurwitz-Koweek L.: B-1140 Iori M.: B-0993
Horn-Lodewyk J.: B-0883 Husband J.E.: A-0727, A-0730, A-0731 Iorio R.: B-0333
Horowitz M.: B-1607 Husmann L.: B-0224 Ipek A.: B-0603
Horsch A.D.: B-0705 Hussein M.M.: B-0693 Ippolito D.: B-1310, B-1372, B-1457
Horvat J.V.: B-1175, B-1176 Husseiny Salama D.: A-0310, A-0315, Iranpour P.: B-0291
Horvat-Maurovich P.: B-0303 A-0359, A-0641 Irtyuga O.: B-1505
Hosseini H.: B-0261 Hussl A.: B-1689 İsci S.: B-0556
Hotfiel T.: B-0684 Hutchinson J.C.: B-1319 Isensee F.: B-0539
Hötker A.M.: B-0152, B-0822 Hüttl K.: B-0958 Isfort P.: B-0005

Ishii K.: B-0408 Jannot A.-S.: B-1894 Joseph D.Z.: B-1109, B-1713, B-1714
Ishiki A.: B-1329 Janot K.: B-0836 Joshua A.: B-0226
Islak C.: B-0986 Jardri R.: A-0406 Jost G.: B-0496
Islam S.: B-0177 Jargiello T.: A-0086, A-0438 Jouannic A.-M.: B-1497
Isoda H.: B-0185 Jäschke M.: B-0237 Joubert Zakeyh J.: B-1470
Ith M.: B-0901 Jaschke W.R.: A-0546, A-0746, B-0500, Jouret-Mourin A.: B-0944
Itoh T.: B-1146 B-1599 Jovanovic S.: B-1871
Itou M.: B-0408 Jasieniak J.: B-1477 Jover Sánchez J.J.: B-0535
Ittermann T.: B-0797 Jawhar M.: B-0352 Jreige M.: B-0235
Ittrich H.: B-0119, B-0499 Jayaram P.R.: B-1287 Juffermans J.F.: B-1506
Iuga A.-I.: B-1761 Jazet I.M.: B-0588 Juhász I.Z.: B-0958
Ivanac G.: A-0006, B-0463 Jazrawi L.: B-1508, B-1510 Jukna A.: B-0037
Ivanoski S.: B-0050 Je B.-K.: B-1014 Jung B.: B-0221, B-0901
Ivanova D.: A-0832 Jeffery T.J.: B-0709 Jung C.S.: B-0499
Ivanova M.O.: B-0791 Jeka S.: B-1408 Jung E.M.: A-0169
Ivanova P.: B-0957 Jemal Turki A.: B-0155 Jung J.: B-1403
Ivantsova A.: B-1887 Jemel E.: B-1160 Jung N.Y.: B-0469, B-0555
Ivashchenko O.V.: B-1592 Jenkins J.: B-0078, B-0080 Jung S.I.: B-0449
Izumi T.: B-0185 Jenniskens S.F.: B-0878 Junghanss T.: A-0230
Izzo A.: B-1579, B-1581 Jensen E.: B-1007 Jungmann F.: B-0383, B-0591
Jeon C.H.: B-0740, B-0960, B-1573 Junker D.: B-1076
J Jeon H.J.: B-0449 Juras V.: B-0055
Jabbari K.: B-1694 Jeon S.K.: B-0389, B-1772 Jurik A.-G.: A-0782
Jablonkai B.: B-0786 Jeong S.Y.: B-0796 Justich C.: A-0416
Jabłońska-Pawlak A.: B-1452 Jereczek-Fossa B.A.: B-0973 Juza T.: B-0232
Jackson D.: B-1410 Jerman K.: B-0086
Jackson O.: B-0604 Jeukens C.: B-1787 K
Jackson V.P.: A-0730 Jeurissen B.: B-1127 Kaartinen S.: B-0887
Jacob S.: A-0018 Jezzard P.: A-0250 Kabbasch C.: B-0710, B-0756, B-1166
Jacobi V.: B-1257 Ji C.: B-0123 Kacala A.: B-0747
Jacobi-Postma A.A.: B-1447, B-1625 Ji H.: B-0600 Kachelrieß M.: A-0326, B-0013, B-0135,
Jacobs A.: B-1539, B-1838, B-1839, B-1842 Ji J.: B-0308, B-0611, B-0772, B-1126 B-0312, B-0316, B-0319, B-0321, B-0909
Jacobs J.: B-0132 Jia Z.: B-1017 Kacprowski T.: B-0398
Jacobs K.: B-1607 Jiang H.: B-0074, B-0356, B-1044, B-1764 Kada S.: A-0688
Jacobs R.: B-1599 Jiang J.: B-0035, B-0144, B-1642 Kadioglu P.: B-0986
Jacobson J.A.: A-0992, A-0994, B-0893 Jiang L.: B-1674, B-1680, B-1825 Käfer H.: A-0216
Jacquet L.: B-0944 Jiang T.: B-0151, B-1624 Kagawa K.: B-1145, B-1146
Jacquier A.: B-0964 Jiang X.: B-0718 Kahn C.E.: A-0505, A-0843
Jadczak A.: B-0946 Jiang Y.: B-0051, B-1655 Kahn I.: B-1557
Jaddoe V.W.: B-0171 Jimenez-Pastor A.: B-1397, B-1830 Kahn J.: B-0399
Jagannatha V.: B-0572 Jin L.: B-1813 Kahraman A.S.: B-1051
Jäger H.R.: A-0024, A-0156, A-1010, B-0712, Jin P.: B-1498 Kahraman B.: B-1051
B-1688 Jin T.: B-1774 Kahraman G.: B-1854
Jäger N.: B-1586 Jin W.: B-1137 Kai Y.: B-1002
Jagmohan P.: B-1150 Jin Z.: B-0012, B-0320, B-0386, B-0423, Kainberger F.: A-0257, A-0446, A-0854,
Jagoda P.: B-1720 B-0430, B-0454, B-0613, B-1074, B-1087, A-1093, B-0675
Jahnke P.: B-1199, B-1630, B-1631 B-1121, B-1246, B-1409, B-1633, B-1893, Kaireit T.F.: B-0585, B-1201
Jahoda J.: B-0938 B-1896, B-1897 Kaiser M.: B-0353
Jain D.: B-1207 Jin Z.-Y.: B-0450, B-1104, B-1475 Kaiser Ururahy Nunes Fonseca E.: B-1365
Jain P.: B-0720 Jo H.H.: B-0582 Kaissis G.: B-0615, B-1312
Jain S.: B-1797 Jobst B.: B-1201 Kak M.: B-1436
Jain S.K.: B-0720 Jochelson M.S.: B-0924, B-1175, B-1176, Kale P.G.: B-1075
Jain V.: B-1382 B-1804 Kalmar P.I.: K-34
Jaipal A.: B-0546 Jochems A.: B-1179 Kallenbach M.: B-1657
Jajodia A.: B-0691, B-1637 Jockwitz C.: B-1553 Kallenberg M.: B-0697
Jakobsen H.: B-0154, B-0442 Joelsen-Hatlehol E.S.: B-1047 Kallur K.: B-0063
Jalli R.: B-0291 Jogi S.: B-1132, B-1133 Kalra S.: B-1191
Jaly A.: B-0976 Johansen C.K.: B-1047 Kalsoum E.: B-0261
James A.: B-1647 Johansen S.: B-1369 Kaltenbach B.: B-0243, B-0296, B-0794,
James S.L.J.: A-0693 John G.: B-0712 B-1204, B-1247, B-1317
Jamialahmadi T.: B-1380 Johnson J.M.: B-1243 Kaltsas A.: B-1660
Jamias J.: B-0118 Johnson K.J.: A-0683 Kälvesten J.: B-0049
Jang J.J.: B-1322 Johnson M.: B-1555 Kamal E.: B-1174
Jang J.K.: B-0796 Jokerst C.: B-1007 Kamal R.M.: B-1174
Jang M.J.: B-0699 Jolibois Z.: B-1563 Kamali M.: B-0403
Jang S.: B-0453 Jones E.C.: B-1640 Kamat R.: B-0631
Jangjoo A.: B-1380 Jones J.: B-1323, B-1455 Kamata K.: B-0408
Janka R.: B-0474, B-1088 Jones R.: B-0606 Kamaya A.: B-1402
Jann H.: B-1024 Joo I.: B-0389, B-1767, B-1772 Kamble A.: B-0092

Kamble A.N.: B-0092 Katzmann A.: B-1586 Kiessling F.M.A.: A-0458

Kamel H.A.: B-0711 Kauczor H.-U.: A-0290, A-0342, A-0626, Kifjak D.: B-1020
Kamel H.M.: B-0117 B-0019, B-0051, B-0344, B-0348, Kilburn-Toppin F.: A-0425, A-1084, B-1795,
Kamo M.: B-0746 B-0385, B-0420, B-1201, B-1208, B-1610 B-1801
Kamoun H.: B-1487 Kaufmann P.A.: B-0817 Kilickesmez O.: B-1395
Kämpgen B.: B-0022 Kaufmann S.: B-0628 Kim B.: B-0699, B-1142
Kanavaki A.: B-1378, B-1537 Kaul M.: B-1240 Kim C.: B-1001, B-1014
Kanavati F.: B-1387 Kaul M.G.: B-0499 Kim C.W.: B-0740, B-0960, B-1573
Kanazawa Y.: B-0642, B-0648, B-0994 Kaur S.: B-0475 Kim D.: B-0775
Kandasamy D.: B-0640 Kauw F.: B-0192, B-0705 Kim D.K.: B-1282, B-1443
Kandel S.: B-0306 Kavanagh E.: B-0246, B-0407 Kim E.H.: B-1895
Kang B.J.: B-0469, B-0555 Kavanagh J.: B-0066, B-0141 Kim E.-K.: B-0120
Kang E.-Y.: B-1014 Kawai T.: B-1187 Kim G.-C.: B-0942
Kang H.: B-1414 Kawamura K.: B-1180 Kim H.: B-0646, B-1119, B-1403
Kang H.-J.: B-1532, B-1772 Kawashima A.: B-0438 Kim H.-C.: B-1772
Kang L.: B-0770 Kawashima J.: B-0482 Kim H.J.: B-0392, B-0942, B-1285
Kang T.W.: B-1767 Kawashima K.: B-0742 Kim H.O.: B-0396
Kantarci M.: A-0148 Kawooya M.G.: A-0360 Kim H.Y.: B-1336
Kapetas P.: B-0716, B-1150, B-1549, B-1570 Kazemi M.A.: B-0635 Kim J.: B-0334, B-0435
Kaplan S.L.: B-1055 Kazmierczak P.M.: B-0503 Kim J.E.: B-0396
Kapoor M.: B-0696 Kearins O.: B-0078 Kim J.H.: B-0397, B-0453, B-1096, B-1342
Kapos I.: B-1616 Keasler E.: B-1296, B-1298, B-1299, B-1301 Kim J.-K.: B-0335
Kaposi P.N.: B-0444, B-1589 Keating D.M.: B-0924 Kim J.R.: B-0339
Kappas C.: B-1486 Keber U.: B-0365 Kim J.S.: B-1177
Kappelle L.J.: B-0705 Kedves A.: B-0031, B-0882 Kim J.W.: B-1045
Karabulut E.: B-1445 Kedzierski B.: B-0200 Kim K.H.: B-1538
Karaca H.: B-0295 Keeling A.: B-0353 Kim K.W.: B-0796
Karaca L.: B-1051 Keelson B.: B-1596, B-1628 Kim K.Y.: B-0741
Karaiskos P.: B-0768 Keil S.: B-0005 Kim M.-J.: B-0334, B-0335, B-0402, B-1043,
Karakaya J.: B-1805 Keil V.C.: A-1030 B-1763, B-1766
Karakuła-Juchnowicz H.: B-0538 Kellner E.: B-0568 Kim N.: B-0576
Karam E.: B-1407 Kelly C.: B-1307 Kim S.: B-0336, B-0862, B-0869, B-1043,
Karaman C.Z.: B-1059 Kelly P.: B-0407 B-1772
Karampinos D.C.: B-1746 Kelly P.A.: B-0950 Kim S.H.: B-0097, B-1342
Karanam L.S.P.: B-0562, B-0841, B-1062 Kelly-Morland C.: A-0281, B-0616 Kim S.K.: B-0054, B-0683
Karcaaltincaba M.: A-0859 Kemmling A.: B-0259 Kim S.-K.: B-1001
Kardos L.: B-1200 Kemner-van de Corput M.M.P.C.: B-0171 Kim S.M.: B-0699
Kargar S.: B-0438 Ken S.: B-0322 Kim S.Y.: B-1767
Kärgel R.: B-0310 Kenis S.F.: B-1391 Kim T.: B-1336
Karimi T.: B-1669 Kenneth M.: B-1417 Kim T.-K.: B-0392
Kärkkäinen O.: B-1272 Kent B.: B-1410 Kim W.H.: B-0942
Karli Oguz H.K.K.: B-1445, B-1884 Kenyon K.: B-0126 Kim Y.: B-0469, B-0555, B-0699, B-1414
Karli Oguz K.: A-1076 Kertész H.: B-0234 Kim Y.J.: B-0449, B-1865
Karout L.: B-0799 Kesari A.: B-0063 Kim Y.-J.: B-0571
Karrasch S.: B-1208 Keserci B.: B-1304, B-1305 Kim Y.S.: B-1336
Karssemeijer N.: B-0545, B-0697, B-1564 Keshavarz P.: B-0291 Kim Y.Y.: B-0402
Karst U.: A-0904 Keupers M.: B-0251, B-0473, B-0915, B-1803 Kim-Fuchs C.: B-1434, B-1438
Kartalis N.: A-0853 Khakifa H.E.: B-1334 Kimm M.: B-1848
Kartheuser A.: B-0944 Khalifeh S.: B-0799 Kimoto N.: B-0642, B-0994
Karunanithy N.: B-0966 Khalikov A.: B-0608, B-0609 Kind M.: B-0478
Karur G.R.: B-1864 Khalil A.: B-1407 King A.D.: A-0076, A-0722
Kashef E.: A-0436 Khalil M.R.: B-0899 King B.: B-0438
Kasprian G.: A-0560, B-0926, B-0927, Khan K.: B-0524 Kinkel K.: A-0473
B-1881, B-1882, K-30 Khan S.F.: A-0641 Kintzelé L.: B-0344, B-0348
Kassai Y.: B-1203 Khan S.U.K.: B-1697 Kirat Singh S.K.: B-0468
Kassarjian A.: A-0783 Khandelwal A.: B-0447, B-1142 Kiratli H.: B-1445
Kastelic M.: B-1608 Khandelwal N.: B-1224 Kirby A.: B-1323
Kastler B.: A-0514, B-1664 Kharuzhyk S.: A-0501 Kirchner G.: B-0739
Kastner C.: B-0880 Khawaja K.: B-1241 Kirchner J.: B-0231, B-0669, B-0670,
Katada K.: B-0706 Khoury T.: B-1159 B-0671, B-0673, B-1461, B-1462
Katahashi K.: B-1722 Khovrin V.V.: B-1263 Kirienko M.: B-1636
Katayama M.: B-1180 Khristenko E.: A-0466 Kirkham A.: B-0159, B-0443
Kato H.: B-0660 Khurana R.: B-0605, B-1668 Kirova-Nedialkova G.I.: A-0833
Kato K.: B-0742 Kickingereder P.: A-0793, B-0539 Kirova-Nedyalkova G.I.: B-0590
Kato T.: B-0484 Kiechl-Kohlendorfer U.: B-0925 Kirstein M.: B-0001
Katsari K.: B-1200 Kiefer B.: B-0446 Kishida Y.: B-0417, B-0422, B-0579, B-1003,
Katsumata A.: B-0994 Kiefer L.S.: B-0628, B-1514, B-1515 B-1203, B-1209, B-1460, B-1755
Katulska K.: A-0154 Kieft I.: B-1700 Kist J.: B-1850
Katyan A.: B-0720, B-1291, B-1293 Kierans Z.: B-1066 Kitaigorodska O.V.: B-1267

Kittinger J.: B-0219 Kolu M.: B-1051 Krestin G.P.: A-0102, A-0301, A-0305,
Kizilkilic O.: B-0986 Komatsu D.: B-1836 A-0728, A-0730
Kjelle E.: B-0030 Konda D.: B-0010 Kreth F.-W.: B-0094
Klaan B.: B-0237 Kondo M.: B-0484 Kreul D.: B-0446
Klang E.: B-1186 Kondoh H.: B-1187 Krichene M.A.: B-1160
Klarhöfer M.: B-0446 Konen E.: B-1186 Kriedemann M.: B-0337
Klebermaß-Schrehof K.: B-0926 Kong D.: B-1244 Krieghoff C.: B-0196, B-1683
Kleedehn M.G.: B-1297 Konge L.: A-0043 Krishna Moorthy T.: B-1885
Klein S.: B-0067, B-0908, B-1279 Konieczny M.: B-1739 Krishnamoorthy K.: B-1229
Klein W.M.: B-0068 Konietzke P.: B-1610 Krishnamurthi G.: B-1639
Klepanec A.: B-0281 König F.: B-0362, B-0364, B-0893, B-1568 Krismer F.: B-1689
Klifa C.: B-1023 Konijn L.C.D.: B-0222 Kristen K.-H.: B-0677
Klinder T.: B-1761 Konings D.: B-0494 Kristiansen C.H.: B-0492
Klingebiel M.: B-0158, B-0161, B-0515 Konishi T.: B-1663 Kristiansson I.: B-1197
Klingenstein A.: B-1451 Kono Y.: B-0425 Krokidis M.: B-0849, B-1809
Klingmüller V.: B-1512 Kononen M.: B-1272 Krombach G.A.: B-1863
Kliokyte R.: B-0270 Konovalov R.: B-1554 Kromrey M.-L.: B-0398, B-0401, B-0404,
Kloeckner R.: B-1824 Konze V.S.: B-0932 B-1474
Klomp D.W.: B-0766 Koo B.-K.: B-0303 Kronfeld A.: B-1241
Klompenhouwer E.G.: B-0559, B-0850 Koo N.-H.: B-1069 Kronlage M.: B-1560
Klose U.: B-0093 Kooijman H.: B-0601 Kropf S.: B-0221
Klosterkemper Y.: B-0516, B-0518, B-0954, Kooijman-Kurfuerst H.: B-0225 Kröpil P.: B-0954, B-1368
B-1210, B-1368, B-1726, B-1739 Kool D.R.: A-0515 Krotenkova M.: B-1554
Kloth C.: B-0620, B-1814 Koops A.: B-0590 Krueger-Ziolek S.: B-0583
Kløw N.E.: B-0480 Kopp F.K.: B-0138, B-1848 Krug B.: B-0461
Klug G.: B-0500 Krug K.B.: B-1542
Kopp M.: B-0426, B-0684, B-1321, B-1777
Kluijtmans L.: B-0706 Kruis M.: B-1465
Kording F.: B-0601
Kmetyuk Y.: B-1250 Kruk-Bachonko J.: B-1482
Koromani F.: B-0856
Knapp K.: B-0659, B-1495 Krumina G.: B-1652
Korte B.: B-0081, B-0082, B-1149
Knapp K.M.: B-0662, B-1067, B-1698 Krupski W.: B-0538, B-1482
Kortesniemi M.: A-0327, A-0896, A-1050
Knaup M.: B-0909 Krylov V.: B-0186
Korzowski A.: B-0506
Knautz M.: B-1736 Krylova N.: B-1819
Kosar P.N.: B-1884
Knebel C.: B-1746 Kshirsagar R.H.: B-1450
Kose S.: B-1413
Kneilling M.: B-0686 Kubale R.: B-0963, B-1720
Koskinen S.K.: B-0101, B-0674, B-0955
Knop K.C.: B-1560 Kubicka F.M.: B-0503
Kossov F.: B-0621
Ko A.: B-0451 Kubik-Huch R.A.: A-0284, A-0386, A-0389,
Kostova-Lefterova D.: A-0617
Ko H.: B-1322 B-0446, B-1792
Kosyr’kova A.: B-0089
Ko Y.: B-1285 Kubo T.: B-0303
Kott A.: B-0694
Kobeiter H.: B-0252 Kubota K.: B-0471, B-1796
Kotter E.: A-0012, A-0125, A-0634, A-0695,
Kober F.: A-1009 Kucharczyk S.R.: B-1706
B-0568, B-0867
Koç F.: B-1413 Kuchcinski G.: B-1415
Kotze J.: B-1066
Kocak B.: B-0986, B-1395 Kuder T.: B-1568
Kocer N.: B-0986 Koulocheri D.: B-1157 Kuder T.A.: B-0362, B-0364
Koch G.: B-0834 Koutoulidis V.: B-1157 Kudo M.: B-0408
Kocher N.: B-0568 Kouvelakis K.: B-0524 Kudryavtsev N.D.: B-1263
Kochhar R.: B-1095 Kovacic S.: B-0260 Kuehl H.: B-1411
Koci M.: B-0338, B-0624 Kovács Á.: B-0031, B-0882 Kuehn B.: B-1390
Kocijančič I.: B-1608 Kovacs G.: B-0767, B-0989 Kuganesan A.: B-1147, B-1849
Kocman V.: B-1125 Kovan O.: B-1546 Kuhl C.K.: A-0030, A-0235, A-0468,
Koczka V.: B-0882 Kowalczuk M.: A-0367 B-0005, B-0073, B-1437
Koenig T.: B-0909 Kox L.: B-0244 Kühn J.-P.: B-0398, B-0401, B-0797, B-1474
Koff D.A.: A-0606 Koyama H.: B-0579, B-1203 Kuhn M.: B-0440
Kofoed K.F.: B-0194, B-0497 Kozlov V.: B-1005 Kuhn R.: B-0118
Koh D.-M.: A-0068, B-0108, B-0353, Kraan R.B.J.: B-0244 Kuhn T.: B-0051
B-0524, B-1046 Kraeima J.: B-0574 Kühnel F.: B-0503
Kohestani K.: B-0324 Krainik A.: A-0153, A-0522 Kukkes T.: B-1712
Kohl S.: B-0813, B-1077 Kramer H.: B-1866 Kukushkin A.V.: B-0844, B-0845
Köhler B.: B-0221 Kranewitter C.: B-0500 Kul M.: B-1373
Kohler R.: A-0569 Krastev G.: B-0281 Kulali F.: B-0125
Köhler T.: B-1792 Kratovska A.: B-0957 Kulikov S.: B-0350
Kojima T.: B-0484 Kraus B.: A-0495 Kulkarni M.M.: B-1464
Kok N.F.: B-0182 Krauss B.: B-0682 Kulkarni V.: B-1562
Kolansky A.: B-0144 Kräuter C.: B-0767, B-0989, B-1619, B-1620 Kulpe S.: B-0995
Kolb C.: B-0797 Kreitner K.-F.: B-0378, B-0383, B-0591, Kumar D.: B-1117
Kolditz D.: B-1541 B-1824 Kumar E R.: B-0777
Kolesnik E.: B-1620 Kremer M.: B-1598 Kumar N.: B-1291, B-1293
Kollmeier M.: B-0323 Kremser C.: B-0500 Kumar P.G.: B-1159
Kolossvary M.: B-0303, B-0786 Krenn T.: B-0167 Kumar R.: B-1856
Koltowska A.: B-0540 Krestan C.R.: A-0882 Kunz W.G.: B-0259, B-0262, B-0713

Kupriyanov D.: B-1326 Larbi A.: B-0431, B-1695 Lee J.W.: B-0776
Kurehana N.: B-1329 Larici A.R.: A-0050, A-0055, A-0306, Lee J.Y.: B-0277, B-1119, B-1336, B-1375
Kurrat C.: B-0694, B-1643 A-0550 Lee K.B.: B-1767
Kuru Oz D.: B-1373 Larocca Skare T.: B-1365 Lee K.H.: A-0649, B-0330, B-0776, B-1285
Kurys-Denis E.: B-0538 Lashkhi K.: B-0616 Lee K.Y.: B-1001
Kus P.: B-1477 Lassandro G.: B-1684 Lee K.Y.Y.: B-1014
Kusaka A.: B-1146 Lastella G.: B-0042, B-1728 Lee M.J.: B-1634
Kuzmin A.: B-0091 Latz D.: B-1736 Lee M.-J.: B-0334, B-0335
Kvarnström N.: B-1900 Lau F.: B-0302 Lee P.: B-0627, B-1387
Kvasnicka H.: B-1257 Lau H.T.: B-0330 Lee R.: B-0740
Kvist O.: B-1360 Lau K.: B-0581 Lee R.-C.: B-0393
Kwak J.Y.: B-0120 Lau K.K.: B-1815 Lee R.K.L.: B-1292
Kwan Hoong N.: B-0475 Lau K.K.-P.: B-1147, B-1849 Lee S.: A-0141, B-0056, B-0862, B-0965,
Kwon H.: B-0740, B-0960, B-1573 Lau T.: B-1849 B-1043, B-1865
Kwon H.-J.: B-0796 Laugerette A.: B-0047 Lee S.G.: B-0796
Kwon J.H.: B-1096 Laugwitz K.-L.: B-1312 Lee S.H.: B-1014, B-1611
Kwon W.: B-0776 Laukamp K.R.: B-1424 Lee S.-K.: B-0097
Laun F.: B-0289, B-1568 Lee S.M.: B-0576, B-0776, B-0795, B-0942
L Laurent F.: B-1202 Lee S.Y.: B-0561
La Fougère C.: B-0686, B-0689, B-0818 Laurino F.: B-0007, B-0008, B-1809 Lee T.F.: B-1220
La Grassa M.: B-0085, B-0554 Lauritzen P.: B-0492 Lee Y.H.: B-1420
La Porta M.: B-0034 Lavens M.: B-0473, B-1803 Lee Y.-J.: B-1336
Laaksonen-Heikkilä R.: B-1115 Lavin P.: B-1793, B-1794 Lee Y.K.: B-0054, B-0683
Laas E.: B-1090 Lavra F.: B-1721 Lefaucheur C.: B-0953
Lachenmayer A.: B-1434, B-1438, B-1442 Lavrenteva A.: B-1182 Lefebvre G.: B-1507
Lacroix E.: B-0322 Law C.: B-1555 Lefrere Belda M.-A.: B-1894
Ladd M.: B-0505, B-0506, B-1419 Law E.K.C.: B-1292 Legrand J.: B-0053
Ladwig K.-H.: B-1782 Lawler L.: A-0538 Lehmkuhl L.: B-0201
Laenen A.: B-0559, B-0850, B-1803 Lawrence H.: B-1707 Lehn A.: B-0296, B-1247
Laeseke P.F.: B-1297 Lawrence J.T.R.: B-1055 Lehner A.: B-1866
Laggner R.: B-1617 Law-Ye B.: B-1422 Lei C.: B-1006
Laghi A.: A-0029, B-0007, B-0008, B-0014, Lazar M.: B-0716 Leichter I.: B-0133, B-0313, B-0992
B-0525, B-0935, B-0940, B-1022, B-1148, Lazaris A.: B-0528 Leidholdt E.M.: B-1191
B-1341, B-1809, B-1833 Le Boulc’h M.: B-0478 Leimgruber A.: A-0552
Lahaye M.J.: A-0108, B-0182, B-1484 Le Faucheur J.P.: B-0261 Leiner T.: A-0420, A-0611, A-1018, B-0311,
Lai J.: B-0718 Le Guellec S.: B-0478 B-0317, B-0377, B-0788
Lai Y.T.: B-1220 Le H.M.D.: B-0214 Leithner D.: B-0299, B-1175, B-1176, B-1204,
Lai Z.H.: B-1065 Le P.V.: B-0278 B-1317
Laino M.E.: A-0114 Leardini A.: Leleu F.: B-0953
Laitinen H.: B-0645 Lebedev S.: B-0312 Lemmens K.: B-1539, B-1839, B-1842
Lalji U.: B-1787 Lebtahi R.: B-0848 Leng S.: B-0447, B-1729
Lam A.: B-0141 Leckebusch T.: B-0591 Lenga L.: B-0299, B-0434, B-0448, B-1362,
Lam Giang T.: B-1090 Lecler A.: B-0987 B-1472
Lamb H.J.: A-0219, B-0588, B-1506 Lecouvet F.E.: A-0195, A-0646, A-0791 Lenk K.: B-0201
Lambadiari V.: A-1063 Lederer W.: B-1568 Lenkinski R.E.: B-0391, B-0792
Lambert L.: B-0938 Ledergerber B.: B-0224 Lennartz S.: B-1025, B-1081
Lambin P.: A-0267, B-1170, B-1179 Lederlin M.: A-0599 Lennie G.: B-0657
Lambregts D.M.: A-0771, B-0182, B-1049, Lee C.H.: B-0153, B-0441, B-1045, B-1322 Lennon L.: B-0655
B-1484, B-1582 Lee C.M.: B-0960, B-1573 Leo C.: B-1792
Lame F.: B-1638 Lee C.W.: B-0105, B-0273, B-1754 Leone A.: A-0614
Lameijer J.R.C.: B-0082, B-0083 Lee C.Y.: B-1340, B-1551 Leone F.: B-0087, B-0247, B-1549
Lamers W.H.: B-0068 Lee D.H.: B-0389, B-0869, B-1119, B-1375, Leong L.: A-0355
Lampichler K.: B-0219, B-1377 B-1466 Leonhardt H.: A-0168, B-1900
Lamplmayr L.: B-0925 Lee E.: A-0539, B-0370 Lepanto D.: B-0722
Landolfi F.: B-0525, B-1341 Lee E.S.: B-0451, B-0795 Leporq B.: B-1638
Lang K.: B-0085, B-0695, B-1792 Lee E.Y.P.: B-0178 Lepper P.M.: B-0961
Langberg C.W.: B-1656 Lee G.Y.: B-0862 Lerch T.: B-0571, B-0896, B-0897, B-0901
Langenbach M.C.: B-0243, B-0843, B-1204 Lee H.: B-1420 Lerchbaumer M.H.: B-1657
Langer C.: B-0782 Lee H.J.: B-0576 Lerebours R.: B-1140
Langner S.: B-0237 Lee H.J.L.: B-0918 Lesman-Segev O.: B-1557
Langs G.: A-0392, B-0307, B-0344, B-0348, Lee H.Y.: B-1177, B-1203 Lesyuk O.: B-0489, B-0652
B-0567, B-0811, B-0905, B-1882 Lee I.J.: B-0435 Leung J.: B-0696
Laniado M.: A-0837 Lee J.: B-0796 Leung S.T.B.: B-1220
Lanza E.: B-0560 Lee J.C.Y.: B-1220 Leutmezer F.: B-0534
Lanzillo R.: B-0543 Lee J.E.: B-1538 Levashkina I.: B-1267
Lanzillotta M.: B-1337 Lee J.H.: B-0120, B-0435 Leventoglu S.: B-0213
Lanzman R.S.: B-0954, B-1368 Lee J.M.: A-1003, B-0303, B-0469, B-0555, Levy T.: B-1186
Lapteva M.: B-0395 B-0795, B-1466, B-1532, B-1767 Lewicki A.: B-0874
Laqua N.: B-0161, B-0327 Lee J.S.: B-0339 Lewis M.A.: B-0391, B-0792

Lewis S.: B-1701, B-1789 Linsenmaier U.: A-0165 Lotz J.: B-1544
Leyendecker J.R.: B-0391, B-0792 Lioznovs A.: B-0037 Lou W.: B-0452
Leygnac S.: B-1407 lirette S.: B-0357, B-1473 Louie A.L.: B-1536
Li C.: B-1304 Lisitskaya M.: A-0578, A-0968 Loupa T.: B-0889
Li H.: B-0376, B-0541, B-0770, B-1120, Lisson C.G.S.: B-0061 Louw A.: A-0493
B-1333, B-1480 Lisson C.S.: B-0061 Løvblad K.-O.: K-08
Li J.: B-0466, B-0718, B-0859, B-0861, Litavcova A.: B-0232 Low L.-F.: B-1496
B-1243, B-1280, B-1371, B-1584, B-1877 Litherland J.: B-0079 Lowe C.: B-1117
Li J.-W.: B-1762 Litmanovich D.: A-0564, B-0580, B-1306 Lu B.: B-1651
Li K.: B-0859, B-1440, B-1441 Littooij A.S.: A-0680 Lu C.: B-0308, B-1126
Li L.: B-0018, B-0466, B-0593, B-0911, Liu C.: B-1021, B-1386 Lu C.-H.: B-1431, B-1551
B-1009, B-1818 Liu C.-A.: B-0393 Lu G.: B-0217, B-0754, B-0805, B-0978
Li M.: B-0151, B-0837 Liu F.: B-0718, B-1236, B-1237 Lu H.: B-1387
Li N.: B-0745 Liu G.: B-0141, B-1394 Lu L.: B-1036, B-1333
Li Q.: B-0309, B-1009, B-1032, B-1534 Liu H.: B-0094, B-0166, B-0375, B-0382, Lu M.: B-0459, B-0721
Li R.: B-1531 B-0774, B-1633 Lu M.J.: B-0784
Li T.: B-0206 Liu J.: B-0858, B-1064, B-1331, B-1386, Lu P.: B-0779, B-1857
Li W.: B-0218, B-0359, B-0479, B-0779, B-1427, B-1691, B-1692, B-1693 Lu Q.: B-1370, B-1762
B-1399, B-1519, B-1857 Liu J.-B.: B-1762 Lu X.: B-0149, B-0315, B-0578, B-1017,
Li X.: B-0375, B-0504, B-0596, B-0611, Liu K.: B-1009, B-1430, B-1677, B-1752 B-1308, B-1604
B-0754, B-0804, B-0805, B-0978, B-1189, Liu L.: B-0552, B-1278, B-1393 Lu Y.: B-0062, B-0610, B-0808, B-1873
B-1280, B-1399, B-1476, B-1618, B-1651, Liu P.: B-0320, B-0406 Luan Y.: B-1891
B-1654, B-1869 Liu P.C.: B-0758 Luburich Hernaiz P.: B-1404
Li X.-S.: B-1675 Liu Q.: B-0978 Lucarini S.: B-0622
Li Y.: B-0116, B-0541, B-0573, B-0690, B-1121, Liu S.: B-1009, B-1752, B-1890 Lucatelli P.: B-0036
B-1159, B-1349, B-1519, B-1888 Liu X.: B-1120, B-1222, B-1396, B-1764 Lucertini E.: B-1341
Li Y.L.: B-0330 Liu Y.: B-0190, B-0715, B-0752, B-1272, Luciani A.: B-0252
Li Z.: B-0218, B-0223, B-0384, B-0479, B-1429, B-1788 Lucic M.A.: A-0222
B-0611, B-0692, B-0853, B-1476, B-1585, Ljimani A.: B-0515, B-0517, B-1736 Lucioni M.: B-1153
B-1590, B-1651, B-1673, B-1677, B-1727, Ljuhar D.: B-0569 Lücke C.: B-0196, B-0379
B-1869 Ljuhar R.: B-0569 Ludwig D.R.: B-1765
Li Z.P.: B-0411, B-1654 Llobet-Llambrich M.: B-0680 Ludwig J.M.: B-0116
Liang B.: B-0343 Llort A.: B-1231 Luetkens J.A.: B-1513
Liang D.: B-1386 Lloyd T.: B-0880 Lui S.: B-1330, B-1331, B-1427
Liang K.: B-0978 Lo Re G.: B-1827 Luiten E.J.T.: B-1158
Liang M.: B-1478 Lo W.-C.: B-1655 Luiten J.D.: B-1149, B-1158
Liang S.: B-1517 Lobbes M.: B-1170 Lukas S.: B-0172, B-1016
Liang W.B.: B-0573 Lobbes M.B.: B-1179 Lukina O.V.: B-0091
Liang X.: B-1121 Lobbes M.B.I.: B-1787 Lukovkina O.: B-0187
Liao W.: B-0678 Lobe N.H.J.: B-0099 Luksaite R.: B-0270
Libert F.: B-0894 Lobo M.L.: A-0278 Lukyanchikov V.: B-0186
Libra F.: B-0833 Loewe C.: A-0087, A-0297, A-0415, A-0612, Lumen N.: A-0480
Licandro R.: B-0567 A-0977, B-0219, B-0374, B-1617 Lund G.K.: B-0590, B-1682
Lichtarski M.: B-0874 Logager V.: A-0202, A-0328, A-1073, Luntsi G.: B-1107
Lichtenstein T.E.: B-1783 B-0154, B-0442 Luo J.: B-0462
Lidén M.: B-0491 Logudoss M.: B-0227, B-1271 Luo L.: B-1440, B-1441
Liebergall M.: B-0992 Lohmeier J.: B-0664 Luo Q.: B-1888
Lieman-Sifry J.: B-1607 Lohöfer F.: B-0615 Luo X.: B-0147
Lien L.T.T.: B-1012 Loiseau Audirac M.P.: B-0032 Luo Y.: B-1370, B-1401, B-1762
Liguori C.: B-0034 Lombardo C.: B-1097 Lurie D.J.: A-0911
Lilleborge M.: B-0921 Lombardo F.: B-1389 Lurz P.: B-0379
Lim A.K.P.: B-0627 Lombardo Galera M.S.: B-1662 Lusa Aguero T.: B-1194
Lim L.K.S.: B-1885 Lomoro P.: B-1153 Lusque A.: B-0478
Lim V.: B-0698 Londero V.: B-0086 Lutsik N.: B-0350
Lin C.: B-1074, B-1087, B-1893, B-1896, Long Y.: B-1440, B-1441 Lutter C.: B-0684
B-1897 Longo R.: B-1838, B-1846 Luyckx E.: B-0145
Lin H.-Y.: B-0393 Looby S.: A-0950, B-0265, B-0267 Lv H.: B-1040
Lin J.J.: B-1654 Loos C.: B-0279 Lv J.C.: B-0573
Lin L.: B-0320, B-0406, B-0952, B-1315 Lopes R.: A-0405 Lv Y.: B-1883, B-1890
Lin M.: B-0581 López-Frías López-Jurado A.: B-0274 Ly L.: B-0984
Lin S.: B-0581 Lorbeer R.: B-0188, B-1208 Lyschik S.: B-0383
Lin W.-C.: B-1431, B-1551 Lorenzon M.: B-0253 Lysdahl K.B.: A-0962, B-0030
Linck P.-A.: B-1415 Lorenzoni A.: B-1118 Lyshchik A.: B-1762
Linder N.P.: B-0764 Loria A.: B-1194 Lysvik E.K.: B-0480
Lindig T.: B-0095 Losa A.: B-1300
Lindner T.: B-0237 Losco R.: B-0793 M
Lindstrom J.C.: B-0492 Losik D.V.: B-1672 M. Ali R.M.K.: B-1708
Linn J.: A-0765 Losio C.: B-0256 Ma J.: B-0751, B-0810, B-1517
Linseisen J.: B-0945 Lotufo R.: B-1524, B-1526 Ma K.: B-1085, B-1248, B-1249, B-1256

Ma L.: B-0610, B-0903 Maino C.: B-1310, B-1372, B-1457 Mansueto G.: B-0009, B-0458, B-0532,
Ma M.: B-0952 Maintz D.: B-0314, B-0461, B-1025, B-1081, B-0937, B-1094, B-1103
Ma Q.: B-0149, B-1604 B-1761, B-1783 Mantatzis M.: B-0183
Ma W.: B-0466 Maj E.: B-1452 Mantini C.: B-0195, B-0203, B-1313
Ma X.: B-0394 Majeed A.: A-1079 Manuel Fernández B.: B-0274
Ma Y.: B-0149, B-0315, B-1017, B-1308, Majoie C.B.: B-0258 Manunza F.: B-0930
B-1604 Major V.T.: B-0654 Manzhurtsev A.: B-1038, B-1778, B-1887
Ma Z.: B-1238 Majos A.: A-0135 Mao J.: B-0508, B-1627
Maas K.J.: B-0679 Mak M.: B-1410 Marcello R.: B-0010
Maas M.: B-0244, B-0632, B-1049, B-1484, Mak S.M.: B-0142 Marchegiani G.: B-0458
B-1582, B-1635 Makarchuk M.: B-1034 Marchianò A.V.: B-0143
Mac a’ Bháird K.: B-1307 Makatsaria A.D.: B-0173 Marcon M.: B-0085, B-0554, B-1541
Maccagni D.: A-0112 Mäkelä T.: B-0887 Marconi V.: B-0253
Macchi A.: B-0880 Makki M.: B-1168 Marcus R.P.: B-1729
Macchi E.: B-1808, B-1810 Mako M.: B-0281 Marcy P.-Y.: K-03
MacDonald S.: B-1227 Makowski M.: B-1475 Mardal C.A.: B-0275
Macedo A.P.L.: B-0410 Makowski M.R.: B-0664, B-1734, B-1738 Margaritora S.: B-1812
Macey J.: B-1202 Makse H.: B-1032 Mari A.: B-1118
Maciejewski R.: B-0538 Makurthou A.: B-0856 Mariani D.: B-0087
Mack M.G.: A-0075 Malakhova M.V.: B-1263 Mariani S.: B-0241, B-1295, B-1580, B-1581
MacMahon P.J.: B-0098, B-0246 Malamateniou C.: A-0781, B-1495 Marik W.: B-0055
Madhusudhan K.: B-1577 Malasevschi A.: B-0304 Marin D.: B-0070, B-0493, B-0533, B-0729,
Madoff D.C.: A-0513 Malattia C.: B-1054 B-1140, B-1148, B-1503, B-1768, B-1771
Madsen O.R.: B-0520 Malekzadeh S.: B-1497 Marinelli D.: B-0203
Maeda H.: B-0425 Maleux G.: B-0559, B-0850 Marinescu A.N.: B-0191
Maeder P.: B-0931 Malev E.: B-1505 Marinescu A.V.V.: B-0191
Maffei E.: B-1313 Malhaire C.: B-1090 Marino M.A.: B-0719, B-1175, B-1176, B-1804
Maffini F.: B-1644 Mali W.P.: B-0222 Marino M.A.A.: B-0924
Maga T.: B-1300 Malich A.: B-0688, B-0694, B-1643 Mariotti D.: B-1715
Mager A.: B-1025 Malla S.: B-1577 Mariotto R.: B-0248
Magerkurth O.: B-0893 Mallya Y.: B-0572 Mariscotti G.: B-1173, B-1799
Maggi S.: B-1118 Malmivirta H.: B-0888 Markova N.: B-0597
Magistro G.: B-1400 Malone M.: B-1354 Marletta M.: B-1205
Maglia C.: B-1082 Malter W.: B-0461 Maroldi R.: A-0077, A-0320, B-1446
Magnaguagno F.: B-1054 Maly Sundgren P.C.: A-0756 Maros M.E.: B-0022
Magnani S.: B-0898, B-1723 Mammino L.: B-0959 Marques M.: B-0412
Magnano G.M.: B-0341 Mamourian A.: B-1781 Marra P.: B-0851, B-1439
Magnano G.M.M.: B-1054 Mancinelli M.: B-0211 Marrelli D.: B-1275
Magnin B.: B-1470 Mancini M.E.: B-1501 Marrone G.: B-0529
Maguire D.: B-1307 Mancini Terracciano C.: B-1833 Marschall Skov P.: B-0485
Magyar P.: B-0444 Mandal A.K.: B-0720 Marshall N.: A-0181, B-1318, B-1839, B-1840,
Mah S.Y.: B-1902 Mandic R.: B-0365 B-1841, B-1842, B-1845
Mahadevappa V.: B-1737 Mandonnet E.: B-0096 Marshall T.: B-1287
Mahajan A.: B-1450 Mandorfer M.: B-1377 Martel Villagrán J.: B-1286
Mahajan H.: B-0572, B-0777, B-0910, Mandruzzato N.: B-0009 Mårtensson J.: B-1035
B-0912, B-1132, B-1335, B-1558, B-1750, Mandry D.: A-0378 Marterer R.: B-1361
B-1753 Manente G.: B-0708, B-0951 Martí-Bonmatí L.: A-0332, A-0365, A-0385,
Mahajan V.: B-0140, B-0572, B-0777, Manesis E.: B-1378, B-1537 A-0594, A-0812, A-1090, B-1397, B-1830
B-0910, B-0912, B-0990, B-1132, B-1133, Mañez Miro J.U.: B-1303 Marticorena Garcia S.R.: B-1657
B-1183, B-1397, B-1750, B-1753, B-1892 Manfrè L.: A-0759 Martin A.: A-0531
Mahawar V.: B-0691 Manfredi R.: A-0608, A-1095, B-0109, Martin O.: B-0669, B-0670, B-0671, B-0690,
Maher M.M.: A-0927 B-0110, B-0114, B-0328, B-0529, B-0547, B-1456, B-1461
Mahjoub S.: B-0153 B-0548, B-1812, B-1898 Martin S.: A-0089
Mahlknecht P.: B-1689 Manganaro L.: B-0607, B-1390 Martin S.S.: B-0434, B-0448, B-0780,
Mahmood N.: B-1647 Manganiello C.A.T.: B-0211 B-0781, B-0789, B-0794, B-0820, B-1472
Mahmood T.: A-1081 Mangaraj S.: B-1253 Martinelli P.: B-1383, B-1385
Mahmoud K.: B-0357, B-0838, B-1296, Mangesius S.: B-0534, B-1689 Martinenghi C.: B-1880
B-1298, B-1299, B-1301, B-1473 Maniatis V.: A-0241 Martinez Chamorro E.: B-0268
Mahmoud M.: B-1160 Manka R.: A-0199, B-1616 Martínez Cutillas M.J.: B-1418
Mahmoudi S.: B-0136 Mann R.: B-0726 Martinez D.: B-0719, B-0924, B-1175, B-1176
Mahnken A.H.: B-0354, B-0365 Mann R.M.: A-0150, B-0545, B-0697, B-1523, Martinez E.: B-1231
Maier C.: B-0839, B-0840 B-1525, B-1564, B-1790 Martinez Fernandez R.: B-1303
Maier J.: B-0013, B-0135, B-0316, B-0319, Manna C.: B-1858 Martingano P.: B-0368
B-0321, B-0909 Mannil M.: B-1733 Martini I.: B-0525
Maier S.: B-1411 Manning W.J.: B-1306 Martini K.: B-0577, B-1512
Maier-Hein K.: B-0813, B-1077 Manríquez Galán V.: B-0629 Martini M.-L.: B-0365
Maier-Hein K.H.: B-0539 Mansour R.: B-0245 Martino A.: B-1080
Maillet B.: A-0214 Mansour S.A.: B-0502 Martino M.: B-0544, B-1550, B-1556
Mainenti P.P.: B-1383, B-1385 Mansouri B.: A-0315, A-0358, A-0663 Martinoli C.: B-1745, B-1748, K-41

Martinsen A.C.: B-0480 McCollough C.: B-0447, B-1142 Mercatelli L.: B-0622
Martinsen A.C.T.: B-0131 McCormick I.: B-1306 Mercer C.E.: B-1708
Marto J.P.: B-0283 McDermott E.: B-0024, B-0633 Mercieca S.: B-1350
Marushchak O.: B-0584 McDermott G.M.: B-0150, B-0361, B-0667, Mercogliano S.: B-0558
Marzocca F.: B-0553 B-0771 Mereu A.: B-0707, B-1251
Masakazu M.: B-0306 McDermott J.C.: B-1297 Merkely B.: B-0786
Masana M.: B-1619 McEntee M.F.: B-1496, B-1844 Merkulov N.: B-1061
Mascalchi M.: B-0928 McFadden S.: B-0651, K-40 Merli I.: B-1730
Mascherbauer J.: A-0878 McGee A.: B-0409 Mershina E.: B-0730, B-1819
Maschke S.K.: B-0001 McGinty G.: A-0588, A-0730 Mershina E.A.: B-1822
Masciocchi C.: B-0241, B-0544, B-0595, McGurk S.: B-1323 Merz M.: B-0348
B-1295, B-1309, B-1550, B-1552, B-1556, McKean D.: B-1288 Mesa Quesada J.: B-1662
B-1571, B-1572, B-1579, B-1580, B-1581, McLean M.A.: B-1802 Messerli M.: B-0228, B-0229, B-0817
B-1623, B-1817 McNair H.: A-0441, B-1495 Messina C.: A-0176, A-0883, B-0052,
Masi G.: B-1831 McNally E.G.: A-0261 B-0868, B-0870, B-0898, B-1730
Massat N.J.: B-0920 McNulty J.: A-0439, A-0491, A-0619, Messiou C.: B-0353
Masselli G.: A-0203, A-0808 A-0931, B-0027, B-0407, B-0409, Messmann H.: B-0945
Massimo C.: B-1457 B-0573, B-1706 Meszar Z.: B-1432
Massmann A.: B-0167, B-0961, B-0963, Meacock L.: A-1034 Meszaros L.: B-1021
B-1720 Meakin J.R.: B-0659, B-0662, B-1067 Metrakos P.: B-0528
Massone E.: B-0724, B-1151 Meder J.-F.: K-02 Metsala E.: A-0005, A-0741, B-1712, B-1716
Mastio M.: B-1510 Meek D.: B-1582 Mettivier G.: B-1843, B-1846
Mastio M.T.: B-1508 Megna R.: B-0543 Metzler B.: B-0500
Mastrodicasa D.: B-0195, B-0203, B-0780 Mehdi A.S.: B-0177, B-0627 Meuli R.: B-0288, B-0931, B-1366
Mastronuzzi A.: B-1327 Mehndiratta A.: B-1132, B-1133 Meurer F.: B-0138, B-1312
Masui T.: B-1180 Mei J.: B-0718 Meyblum E.: B-0252
Masulovic D.: B-1871 Mei K.: B-0047 Meyer B.C.: B-0001
Mateus B.M.M.: B-0414 Mei Y.: B-0504 Meyer H.-J.: B-0175
Mathys C.: B-1553 Meicher E.: B-1600 Meyer M.: B-0070, B-0235, B-0533, B-1768
Matino S.: B-0329 Meier M.: B-0503 Meyer-Baese A.: B-1176
Matos J.: B-1178, B-1528 Meijer F.J.: B-0706 Meyer-Baese L.: B-1328
Matos J.D.: B-1306 Meine T.: B-0001 Meyl T.P.: B-1184
Matos V.: B-0643 Meineke A.: B-1210 Meyrignac O.: B-0793
Matsuo C.: B-0293 Meinel F.G.: B-1502 Miao Z.: B-1006
Mattay R.: B-1781 Meissner J.-E.: B-0506, B-1419 Miccò M.: B-0328
Matthews R.: B-0687 Meister A.: B-0440 Micelli M.V.M.: B-0544, B-1550, B-1552,
Mattiuz C.: B-0490 Mejias Vargas H.: B-0323 B-1556
Matzek W.K.: A-0754 Mekis N.: B-1068, B-1070, B-1073, B-1710 Michael E.: B-1052
Matzuzzi M.: B-1214 Mekkawy A.I.A.: B-0117 Michaely H.J.: B-0352
Maurea S.: B-0333, B-1383, B-1385 Melani E.F.: B-1151 Michalopoulou E.: B-0437, B-1548
Maurer M.H.: B-1184, B-1434, B-1438, B-1442 Melazzini L.: B-0189, B-1687, B-1821 Micheletti G.: B-0036
Mauri G.: B-0630, B-1644, B-1723 Meldo A.A.: B-1760 Michelin P.J.: B-1860
Maurovich- Horvat P.: B-0786 Melis T.: B-0338 Michels J.D.: B-0587
Maurus S.: B-1586 Mellone R.: B-0971 Michieletti E.: B-1029, B-1867
Mautner V.-F.: B-1240 Mellor F.: B-1495 Michielsen K.: B-1527
Maxwell A.J.: B-0079 Melnikov I.: B-0187, B-1038, B-1887 Michoux N.: B-0944
May M.S.: B-0289, B-0426, B-0684, B-1245, Melnikova-Pitskhelauri T.: B-1037 Miclea R.L.: B-0067
B-1321 Melzer A.: B-1444 Middlebrooks E.H.: B-1169
Mayer E.: B-1863 Memis Durmaz E.S.: B-0986, B-1395 Middleton M.S.: B-1536
Mayer I.: B-0684 Menat J.: B-0313 Midiri M.: B-1444, B-1827
Mayerhöfer M.E.: B-0299, B-1020, K-33 Mendeleeva L.: B-0350 Miele V.: A-0580, B-0470, B-0622, B-0732,
Mayer-Steinacker R.: B-0061 Méndez R.J.: A-0703 B-0733, B-0734, B-0975
Mayo R.C.: B-0696 Meneguette N.S.: B-0542 Miguel Perez M.: B-1748
Mayr A.: B-0500 Menes T.: B-1569 Mihara Y.: B-0642
Mayr D.: B-1847 Menezes G.: B-1793, B-1794 Mikalani M.: B-0635
Mayrhofer M.T.: A-0631 Menezes L.: B-1324 Mikayama R.: B-0484
Mazaheri Y.: B-0152 Meng Q.: B-0432, B-1606 Mikheenko I.: B-1672
Mazgaj P.: B-1338 Menghini R.: B-0458 Miksik L.: B-0597
Mazlan L.: B-1340 Mengjie F.: B-1280 Milan L.: B-0040
Mazur G.: B-0039 Menicagli L.: B-0490 Milanese G.: B-0577, B-0842, B-1858
Mazzaro A.: B-0009, B-0532, B-1103 Mens M.: B-0244 Mildenberger P.: A-0345, A-0504, A-0816,
Mazzei M.A.: B-1275 Menshchikov P.: B-1038, B-1778, B-1887 A-0844
Mazzetti S.: B-0618, B-1082, B-1093, B-1828 Mentzel H.-J.: A-0462 Miletic D.: B-0260
Mazzilli A.: B-1194 Menu Y.: A-0366, A-0382, A-0383, A-0557 Mileto A.: B-1148
Mazzoni M.: B-1054 Menz R.: B-1196 Miller T.T.: A-0919, A-0921
Mazzucca G.: B-1262 Menze B.: B-0344, B-0348, B-0567 Millet I.: A-0893, A-1038
Mc Carthy L.L.: B-1056 Meo D.: B-0833, B-0959 Milnerowicz M.: B-0747
McAnulla S.J.: B-1698 Meola G.: B-1821 Milosevic Z.: B-0549, B-1172
McClure P.: B-0651 Mercaldo N.D.: B-1013 Min J.H.: B-1538

Minervini M.I.: B-0071 Monti C.B.: B-0042, B-0199, B-0416, Muglia R.: B-0530, B-0560
Mingliang W.: B-0069, B-0456 B-0465, B-0895, B-1352, B-1821, B-1867 Mühlberg A.: B-1586
Minin S.M.: B-1672 Monti S.: B-0174 Mühlematter U.: B-0228, B-0229, B-0817
Minko P.: B-1720 Montorsi F.: B-1302 Mühlematter U.J.: B-0822
Minoiu C.A.: A-0346 Monzon L.: B-0966 Mukherji R.: B-1183
Minotti M.: B-1060, B-1644 Moon H.H.: B-1754 Mullen S.N.: B-0023
Miranda D.M.L.: B-0414 Moon H.J.: B-0120 Müller A.G.: B-0510
Mirón Mombiela R.: B-0107 Moon J.H.: B-0918 Müller C.: B-1689
Mironchuk R.: B-1505 Moor M.: B-0193, B-0904 Müller F.C.: B-0675, B-0682
Miś M.: B-0747 Moore C.M.: B-0159, B-0443 Müller F.H.: B-0510
Mishah N.: B-1105 Moradi Amani A.: B-1328 Muller H.: B-0890
Misiuk-Hojło M.: B-1265 Moradi B.: B-0635 Müller J.: B-0228, B-0229, B-0822
Misra R.N.: B-1291, B-1293 Moraes Valença N.: B-0932 Müller L.: B-0365
Mitchell A.J.: B-0827 Morales M.I.: B-0111 Müller M.: B-0818
Mitrofanova A.: B-1061 Morales O.: B-1129 Müllerleile K.: B-1682
Mittal K.: B-0634 Morana G.: A-0431, A-1088, B-1010, B-1011, Müller-Wille R.: B-0739
Mittal M.K.: B-1293 B-1154 Munari E.: B-0872
Miyagoshi K.: B-0408 Moraschi M.: B-1270 Mungai F.: B-0975
Miyazawa R.: B-0746 Moreau-Triby C.: B-1852 Mungari R.: B-0045
Mizuno T.: B-0185 Moreira J.: B-0412 Münnich N.: B-0266
Mlynarska-Bujny A.: B-1568 Moreira J.M.: B-0700 Muñoz Cepeda M.A.: B-0625
Mochida M.: B-1187 Morell Hofert D.: B-0102 Munsch F.: B-1415
Modi A.: B-1753 Morelli N.: B-1029 Muollo A.: B-1808, B-1810
Modica A.: B-0833, B-0959 Moreno R.: B-0793 Murakami T.: B-0417, B-0422, B-0579,
Moeller K.: B-0583 Morgan B.: B-0483 B-1003, B-1145, B-1146, B-1203, B-1209,
Moemenam O.: B-0043 Morgan R.: A-0023 B-1460, B-1755
Moen T.: B-1142 Morganti R.: B-0017, B-1831 Murayama K.: B-0706
Moerup S.: B-0653 Mori M.: B-0471, B-1796 Murayama S.: B-0292, B-1629
Mori T.: B-0949 Murchison J.T.: B-1316, B-1751, B-1759
Moffa G.: B-0553
Moriconi S.: B-1688 Murer S.: B-0440
Moghiseh M.: B-1117
Morimoto D.: B-0408 Muridan R.: B-1233, B-1902
Mohamed R.E.-E.-D.: B-1423
Morita Y.: B-0292 Muriel García A.: B-0274
Mohammed F.: B-1340
Morone M.: B-1042 Murphy D.: B-0142
Mohammed Kashif R.: B-0637
Morosi C.: B-1060 Murphy D.J.: A-0716
Mohankumar R.: B-0066
Morozov S.: A-0555, A-0710, A-0819 Murphy M.C.: B-0246
Mohanty B.K.: B-1253
Morrin M.: B-0936 Murtazalieva P.: B-1505
Mohanty H.S.: B-0691
Morris E.: B-0924 Murugan N.: B-0640
Mohanty J.: B-1253
Morris E.A.: A-0234, A-0389, B-0719, B-1175, Murugavel M.: B-0140, B-0910, B-1892
Mohebali D.: B-1306
B-1176 Musaiev B.: B-1250
Moher Alsady T.: B-0585
Morris M.: B-1353 Musaieva K.: B-1250
Möhlenbruch M.A.: B-0263
Morrow E.: B-1228 Muscari F.: B-1188
Moi A.S.: B-1109
Mortele K.J.: B-0210 Muscogiuri G.: B-0783, B-1212, B-1501,
Moiseenko V.M.: B-1760
Moscato F.: A-0447 B-1613, B-1614, B-1615, B-1686
Moiseev A.S.: B-1822 Moschetta M.: B-0329 Mushtaq S.: B-1501
Moiseev S.V.: B-1822 Moser S.: B-0966 Mussetto I.: B-1528
Moiseeva O.: B-1505 Mosimann P.: B-0282, B-0288 Mussmann B.R.: A-0960, B-0485, B-0653
Mokali J.: B-0183 Mostafa S.: B-1174 Muto M.: B-1286
Mokrane F.Z.: B-1188 Mostbeck G.H.: A-0205 Mutoh T.: B-1329
Mokrane F.-Z.: B-0672 Mota Martinez J.: B-0107 Mutschler T.: B-1512
Molehe M.M.: B-1704 Motiuk D.: B-1607 Myers R.: B-1536
Molina Molina M.: B-1404 Motosugi U.: B-0404, B-1474 Myklebust T.Å.: B-0077
Molinari F.: A-0915 Mottaghy F.: B-0220 Myles J.: B-0920
Molinaro S.: B-0948 Motyer R.: B-0267 Myronyak L.: B-1034
Molino Gaete J.A.: B-0340 Moughty A.: B-0246
Møller H.: B-1661 Moulopoulos L.A.: B-1388 N
Møller J.M.: B-0520 Mourad C.: B-0894 N. Larson A.: B-1543
Møller T.: B-0168 Mousa R.M.: B-0355 Na D.G.: B-0127
Mollica C.: B-0333 Moussa R.: B-1031 Nada A.: B-1232
Moltoni G.: B-1341 Mousseaux E.: A-0019 Nadjiri J.: B-1312
Moltz J.: B-1586 Moustafa A.F.I.: B-0460, B-0693 Nadobny J.: B-0762
Mondelaers A.: B-0279 Moyle P.L.: B-1384 Nadrljanski M.: B-0549, B-1172
Monelli F.: B-1381 Moysak G.: B-1266 Naffaa L.: B-0799
Mones F.: B-0828 Mróz A.: B-1477 Nag A.K.: B-0720
Monga A.: B-1577 Mubarak F.: B-0090, B-1367 Naganawa S.: B-0185, B-1722
Monostori Z.: B-1023 Mubarak R.: B-1174 Nagaraj Y.: B-0309
Montandon S.: B-1600 Muchuki C.: A-0656 Nagarajan K.: B-0631
Montemezzi S.A.: B-0248, B-0249, B-0250 Mueller-Lisse U.G.: B-0440, B-0583, B-1451 Nagasawa N.: B-1101, B-1102
Montesano M.: B-0014 Mueller-Lisse U.L.: B-0440 Nagata M.: B-1101, B-1102
Montgomery A.: A-0744 Muenzfeld H.: B-0962 Nagel A.: B-1245, B-1777

Nagel S.: B-0263 Newman D.: A-0651 Norlisah R.: B-0641

Nagele U.: B-1076 Newton-Hughes A.: B-0033 Norman B.: B-0302
Naguib N.N.N.: B-0117 Ng A.W.H.: B-1292 Norman W.: B-0606
Nagy E.: B-1361 Ng C.: B-0025 Noro K.: B-1832
Naidu K.M.: A-0315 Ng H.T.: B-0330 Norton L.: B-1307
Nair A.: A-0953, B-0142, B-1410 Ng M.-Y.: B-1220, B-1864 Notaro D.: B-1575, B-1578
Naito T.: B-0185 Ngoc P.B.: B-1012 Notohamiprodjo M.: A-0379, B-1729
Naji S.: B-1160 Nguyen D.T.: B-0958 Nour Eldin N.-E.: B-1257
Nakada S.Y.: B-1297 Nguyen H.: B-0829, B-1012 Nour-Eldin N.-E.A.: B-0117
Nakai N.: B-0949 Nguyen J.C.: B-1055 Nourzaie R.: B-0966
Nakanishi M.: B-1735 Nguyen L.T.T.: B-0214 Novario R.: B-0040
Nakano H.: B-0482 Nguyen T.: B-1012 Novello S.: A-0053
Nakasujja N.: B-1417 Nguyen T.H.N.: B-0278 Novichkova G.: B-1326
Nallino M.B.B.: B-1780 Nguyen T.T.: B-0214 Novikov M.: B-0230
Nan H.: B-1006 Nguyen Troung Thanh H.: B-1695 Novotny A.: B-0938
Nance J.W.: B-0784 Nguyen-Kim T.D.L.: B-0685 Nowak A.: B-0225
Nanda G.: B-0910, B-1133 Niang E.H.: A-0312, A-0315 Nowak T.: B-0996
Napoli A.: A-0272 Nicholson A.G.: B-1605 Nozaki A.: B-1722
Napolitano A.: B-1327 Nickel D.: B-0396, B-1475 Ntorkou A.A.: B-1660
Nappi C.: B-1684 Nickel M.: B-0446 Ntoufas N.: B-1593
Narata A.-P.: B-0836 Nico M.: B-0860 Nummela M.: B-0101
Nardin C.: B-1010 Nicod Lalonde M.: B-0235 Nunes A.P.: B-0284
Nardo L.: B-0056 Nicolai E.: B-0668 Núñez Valentín P.: B-0535
Nardone V.: B-1275 Nicolas V.: B-0839, B-0840, B-0866 Nurili F.: B-0115, B-0556, B-0565, B-0737,
Narracott A.: B-0760 Nicolau C.: A-0996 B-0743
Naser Nassar M.: B-0629 Nicolay S.: B-0145, B-0753 Nüßle N.-C.: B-0093
Nasr H.: B-1459 Nicoletti R.: B-1880 Nybing J.D.: B-1035
Nasr M.: B-0366 Nicosia L.: B-0895 Nyhsen C.: A-0172, A-0256
Nassenstein K.: B-0913, B-1622 Nicula A.: B-0191
Natale L.: A-0201, A-0876 Nieboer K.H.: A-0435 O
Nattenmüller J.: B-0051 Niedzwiecki D.: B-0533 O’Brien B.J.: B-1243
Navarra F.: B-0951 Niehues S.M.: B-0762 Obeso J.A.: B-1303
Navin P.: B-1142 Nieminen M.T.: B-0886 Obmann V.C.: B-1650, B-1655
Nayahangan L.: A-0041 Nienhuijs S.W.: B-1879 Obradov M.: A-0273
Nayak B.K.: B-1291, B-1293 Niessen W.J.: A-0127, A-0370, A-0902, Oc Y.: B-1576
Nazarova E.: B-1061, B-1326 B-0067, B-0908, B-1279, B-1690 Öcal O.: B-1218
Nchimi Longang A.: A-0773 Nievelstein R.A.J.: A-0461 Occean B.: B-0431
Nederend I.: B-1506 Niezgoda S.: B-0874 Occella C.: B-0930
Nederend J.: B-0083, B-1879 Niiniviita H.: B-0645, B-0886 Occhipinti M.: A-0122, A-0918, A-0952
Negi N.: B-1145, B-1146 Nik-Hussin N.M.H.: B-0126 O’Connell M.J.: B-0407
Negri G.: B-1389 Nikitin N.A.: B-1672 O’Connor J.: A-0900, A-1057, B-1056
Negru D.: A-0204 Nikolaou K.: A-0225, B-0589, B-0628, O’Connor M.: A-0208, B-0023, B-1066,
Nehrer S.: B-0569 B-0818, B-1514, B-1515, B-1729 B-1706
Neji R.: B-0616 Nikolic O.: A-0820 O’Connor O.J.: A-0182
Nelemans P.J.: B-1787 Nimmalapudi S.: B-1886 O’Connor P.J.: A-0542
Nelson R.C.: B-0070 Ninatti G.: B-1636 O’Connor S.: B-0353
Nelstrop H.L.: B-0667 Niola R.: B-0002, B-0006, B-0011 O’Doherty J.: B-1021
Nemati M.: B-1380 Nisolle J.-F.: B-1507 Oechtering T.H.: B-0202, B-0225, B-0349,
Nemes B.: B-0958 Nissan N.: B-1569 B-1622
Nenning K.-H.: B-1881, B-1882 Nissen H.: B-1661 Oei E.: B-0856, B-1136
Nensa F.: B-0575, B-0671, B-0803, B-0819, Nitrosi A.: B-0993 Oei E.H.G.: A-0946, B-1134
B-0913, B-1411 Niwa T.: B-1603 Oei L.: B-0856
Nepal P.: B-1130 Nizzoli R.: B-0842 Offeciers F.E.: B-0290
Neri E.: A-0265, A-0503, A-0846, A-0958, Njeze R.: B-0043 Offiah A.C.: A-0464
B-0017, B-0198, B-1831 Njokwu G.: B-1109 Oganesyan A.: B-0730
Neriman D.: B-1324 Nkubli F.: B-1107, B-1714 Ogden M.: B-1744
Nesic I.: B-0193, B-0904 Nocerino E.A.: B-0895 Ogenyi P.A.: B-1107, B-1109
Neßelmann C.: B-1502 Nocivelli G.: B-1446 Ognibene N.M.G.: B-1648
Nesterets Y.: B-1789 Noebauer-Huhmann I.-M.: A-1023 Oh H.J.: B-1342
Neu M.-A.: B-1241 Noel P.B.: B-0138, B-1116, B-1312, B-1612, Oh Y.-W.: B-1014
Neubauer C.: B-1791 B-1848 O’Halloran C.: B-1699, B-1702
Neubauer J.: B-0867, B-1791 Nomura T.: B-1603 O’Hare A.: B-0265, B-0267
Neubauer V.: B-0925 Nonnenmacher T.: B-0051 Ohlmeyer S.: B-1259
Neuheimer N.: A-0605 Noonan P.: B-0885 Ohno Y.: B-0417, B-0422, B-0424, B-0579,
Neumaier C.E.: B-0879, B-1139 Noorajan Z.: B-0644 B-1003, B-1203, B-1209, B-1460, B-1755
Neuschler E.: B-1793, B-1794 Norberciak L.: B-0053 Ohta Y.: B-0293
Nevelsteen I.: B-1803 Nörenberg D.: B-1400, B-1586 Oikarinen H.: B-1192
Neven P.: B-0559, B-0850, B-1803 Nørgaard N.: B-0154, B-0442 Oikonomou A.: A-0376
Newby D.E.: B-1316 Nori Cucchiari J.: B-0470 Ojeda A.A.: B-1780

Okada F.: B-0660 Owens C.: A-0786, A-0871, A-0937, A-1021 Panagiotopoulos N.: B-1622
Okada M.: B-0994 Oyama K.: B-1836 Panda A.: B-1650, B-1655
Okazaki T.: B-0642, B-0648 Oyen R.H.: A-0465, K-04 Pandian J.D.: B-0714
Okromelidze L.: B-1169 Oz I.I.: B-0878 Pandur A.: B-0031, B-0728
Oktay D.G.: B-1862 Ozdemir S.: B-0122 Pane F.: B-0006
Okubo G.: B-1415 Ozdemir Z.M.: B-1051 Panebianco L.: B-0544, B-1550, B-1552,
Okwudire E.: B-0043 Ozden C.: B-0590 B-1556
Oladottir G.L.: B-0101, B-0955 Ozhan Oktar S.: B-1453 Panebianco V.: A-0329, A-1072, B-0156,
Olalla Muñoz J.R.: A-1039 Özkanli S.: B-0115, B-0556, B-0737, B-0743 B-0160, B-0325, B-0825, B-0876
Olasunkanmi Balogun E.: A-0653 Özmen M.N.: A-0434 Panes J.: B-1653
Olbert E.: B-0534 Ozturk M.: B-0059, B-1297 Panfili M.: B-1225
Olchowy C.: A-0113 Ozturk V.S.: B-1059 Pang P.: B-0308
Oleaga Zufiría L.: A-0220, A-0489, A-0642, Ozveren M.F.: B-1744 Panina A.: B-1026
A-0643, A-0848, A-0849, A-0851 Panizza P.: B-0256
O’Leary D.: A-0777, B-0654 P Pannell T.: B-0301
Olerud H.M.: B-0030 P. V.R.: B-1062 Panourgias E.: B-1157, B-1388
Olimov B.: B-0621 P.Pribeiro S.: B-1365 Panov V.: B-0621
Oliva G.: B-0087, B-0247 Paalimäki-Paakki K.: B-1717 Panse D.: B-1007
Oliva P.: B-1846 Pacciardi F.: B-0526, B-1097 Panse P.: B-1007
Oliveira M.V.L.: B-1493 Pacella C.M.: B-0630 Panteleakou E.: B-1530, B-1837
Olivero A.: B-1139, B-1658 Pacifici S.: B-1715, B-1718 Panvini N.: B-0014, B-1148
Olschewski H.: B-0767, B-0989 Pacile S.: B-1789 Panzeri M.M.: B-0207, B-0256, B-1302,
Oluniran G.: B-0761 Pacios Blanco R.E.: B-0274 B-1345, B-1485
Omelchenko O.: B-1034 Padhani A.R.: A-0194 Panzironi G.: B-0553
Omoumi P.: A-0444 Padhani A.R.R.: B-0442 Panzuto F.: B-0525
Omura V.L.N.: B-0254 Padley S.: B-1605 Paolicelli S.: B-0329
O’Neill C.: B-1288 Padley S.P.G.: A-0913 Papa M.: B-1300, B-1302
Oner A.Y.: B-0213 Paech D.: B-0362, B-0364, B-0505, Papa S.: B-0304
Ong L.C.: B-1233 B-0506, B-1419, B-1421 Papadaki E.: A-0520
Onishi H.: B-0404 Paeng J.C.: B-0303 Papageorgiou I.: B-0688, B-0694, B-1643
Onur M.R.: B-1594 Paetz T.: B-0878 Papais Alvarenga M.: B-0542
Oostveen L.J.: B-1850 Páez Granda D.: B-1418 Papais Alvarenga R.M.: B-0542
Orasch C.: B-0108 Paganelli C.: B-0373 Papakonstantinou O.: A-1064
Orczyk C.: B-0159, B-0443 Pagani E.: B-1696 Papalois V.: A-0217
Ordás I.: B-1653 Pagnini F.: B-0842 Papanagiotou P.: A-0978
Ording Müller L.-S.: A-0796, B-0168 Paik W.: B-0127 Papanikolaou N.: B-0700, B-1185
O’Regan T.J.: B-0033 Paiman E.H.M.: B-0588 Paparo F.: B-1528
Orgera G.: B-0007, B-0008, B-0849, Paixao T.: B-0569 Papini G.D.: B-1687
B-1809 Pajulo O.: B-0645 Papini G.D.E.: B-0189
Örgüc I.S.S.: B-1741 Paladini A.: B-0002, B-0011, B-0113, B-0563, Papp T.: B-1432
Ori Belometti G.: B-0630 B-0846, B-1435 Pappas E.P.: B-0768
Origgi D.: B-0318 Palaniappan B.: B-1027 Pappon M.: B-0235
O’Riordan L.: A-0639, A-0641 Paleri V.: B-0976 Paramatti R.: B-1833
Ormond A.: B-0860 Palermo M.: B-0418, B-1405 Paraskevopoulou C.: B-1200
Örnek A.: B-0231, B-0673, B-0839, B-0840, Palfrey R.M.: B-0659, B-0662, B-1067 Pardhan S.: B-1555
B-0866 Palkonda V.R.: B-0562 Parida S.: B-1253
Orsatti G.: B-1060, B-1364 Palmer C.: A-0353, A-0355 Parimalai A.N.: B-1271
Orsi M.A.: B-0087, B-0247 Palmieri F.: B-1080 Parisi S.: B-1648
Ortenzia O.: B-0993 Palmisano A.: B-0207, B-0381, B-0598, Parizel P.M.: A-0213, B-0145, B-0753,
Ortino M.: B-0999 B-1216, B-1221, B-1343, B-1344, B-1345, B-0932, B-1127, B-1509
O’Shea A.: B-0936 B-1485, B-1678 Park C.H.: B-0776
Osman A.M.: B-1855 Palmqvist R.: A-0738 Park D.W.: B-1336
Osman S.S.: B-1340 Palmucci S.: B-0418, B-0833, B-0943, Park E.H.: B-0054, B-0683
Østergaard M.: B-0520, B-0675 B-0959, B-1405, B-1648 Park E.K.: B-1177
Osther P.J.: B-1661 Palta M.: B-0533 Park H.: B-0336
Osuntokun O.: B-0736 Paltun S.C.: B-1884 Park H.E.: B-1342
Ota H.: B-0421 Palumbo D.: B-0381, B-1678, B-1880 Park H.J.: B-0451
Otal P.: B-1188 Palumbo P.: B-0241, B-0595, B-1295, Park H.S.: B-0449
Othman M.H.: B-1334 B-1309, B-1571, B-1572, B-1580, B-1581, Park J.: B-0303, B-1403
Ottaviani L.: B-1118 B-1623, B-1817 Park J.B.: B-0960
Otto P.: B-1793, B-1794 Pambianchi G.: B-1500 Park J.S.: B-0392, B-1137
Ottoson F.: B-0821 Pamidimukkala V.: B-0841 Park K.: B-0105
Ou H.-Y.: B-0561 Pamminger M.J.: B-0500 Park M.J.: B-0582
Oudkerk M.: B-0309, B-0586, B-0787, Pamplona J.: B-0284 Park M.-S.: B-1766
B-0789, B-1008, B-1215, B-1311, B-1565, Pan C.: B-0754 Park M.Y.: B-0273
B-1756 Pan J.: B-0307, B-0905 Park S.: B-1322, B-1766
Ouyang H.: B-0429 Pan T.: B-0134 Park S.B.: B-0451
Overduin C.G.: B-0878 Pan X.: B-1646 Park S.-E.: B-0965
Owczarczyk K.: B-0617, B-1874 Panagiotopoulos A.: B-0202 Park S.J.: B-0453

Park S.Y.: B-0699, B-1137 Peker E.: B-1373, B-1862 Peynircioglu B.: A-0472
Park V.Y.: B-0120 Peldschus K.: B-0499 Pezeshk P.: B-1129
Park Y.W.: B-0097 Pelgrim G.J.: B-0586, B-1008, B-1311 Pfaff J.: B-0263
Parkar A.P.: A-0374, A-0917, A-0954 Pellegrin A.: B-0076, B-0967 Pfahler V.: B-0927
Parke D.: B-1181 Pellegrino F.: B-0045, B-0046, B-0272 Pfannenberg C.: A-0186, B-0818
Parlak S.: B-1445 Peltonen J.I.: B-0998 Pfeifer J.: B-0167
Parrilla Reverter G.: B-1418 Penco S.: B-1561 Pfeiffer D.: B-0790, B-0995, B-1312, B-1612,
Parshad R.: B-1207 Peng P.: B-0151 B-1746, B-1848
Parthipun A.: B-1004 Peng Q.: B-0429 Pfeiffer F.: B-0995, B-1612, B-1847, B-1848
Pascariello G.: B-1780 Peng W.: B-0384, B-0552, B-0801, B-1585, Pfeil J.: B-0153, B-0441
Pascart T.: B-0053 B-1590, B-1673, B-1677, B-1727, B-1758 Pfirrmann C.W.A.: A-0839, A-0841, A-0945
Pasicz K.: B-1477 Peng W.J.: B-1152 Phan C.C.: B-0214
Pasquier G.: A-0633 Peng X.: B-0678, B-1159 Phan C.M.: A-0884
Pasquini L.: B-0930, B-1032 Pennig L.: B-0710, B-1424 Phi Van V.: B-0065
Passoni P.: B-0207, B-1343, B-1344, B-1345, Penzkofer T.: B-0153, B-0172 Photopoulos G.: B-1699
B-1485 Pepi M.: B-0783, B-1212, B-1501, B-1613, Piacentino F.: B-1808, B-1810
Pastorino U.: A-0054, B-0143 B-1615, B-1686 Pialat J.-B.: A-1036
Pataraia E.: B-1882 Peppelenbosch-Kodach L.L.: B-1483 Piana Jacquot F.M.: B-0970
Patel A.: B-0437 Perani L.: B-0369 Piana M.: B-0689
Patel B.N.: B-1148 Perassi C.: B-0477 Pianykh O.: B-1181
Patel C.: B-0920 Perazzini C.: B-0004 Piazza L.: B-1878
Patel D.: B-0639 Pereira C.: B-1776 Pica S.: B-1614
Patel H.T.: A-0398 Pereira E.: B-0884, B-0892 Picariello V.: B-0668
Patella F.: B-0974 Pereira F.: B-1695 Picascia R.: B-0034
Patelli G.: B-0630 Pereira H.: B-0848 Picasso R.: B-1748
Paternain Nuin A.: B-0064, B-1219 Pereira M.J.V.: B-0650 Picchi S.G.: B-0823
Paternostro R.: B-1377 Perera M.G.R.S.: B-0185 Picchia S.: B-0014, B-0524
Patil S.: B-1663 Perera S.: B-0979 Piccoli G.: B-0626
Patil Y.: B-1562 Peretti J.: B-0837 Piccolo C.L.: B-0732, B-0733
Patlas M.: A-0437 Peretto G.: B-1678 Pickler B.: B-0686
Patney A.: B-0140 Peretz A.: B-0313 Picone D.: B-1827
Patnick J.: B-0078, B-0080 Pereverzyev S.: B-0925 Piekarek A.: B-1265
Patsch J.M.: K-26 Perez M.D.R.: A-0100, A-0314, A-0315, Pierallini A.: B-1270
Patten P.: B-1296, B-1298, B-1299, B-1301 A-0662 Pietragalla M.: B-0975
Patterson A.J.: B-0501 Perez Montilla M.E.: B-1662 Pietsch H.: B-0496
Paulo G.: A-0861, A-1041, B-1494 Perez N.: B-0294 Pifferi A.: A-0303
Pauwels R.: B-1599 Perez Riverola V.: B-0121 Pignata A.: B-0668
Pavan L.J.: B-0072 Perez Rodrigo S.: A-0855 Pignatelli M.: B-0008
Pavan N.: A-0296 Perisinakis K.: B-1593 Pijnappel R.M.: A-0527, A-0943, B-1565
Pavel M.: B-0399, B-1024 Perkuhn M.: B-0710, B-0756, B-0988, Pilato F.: B-1225
Pavlova O.: B-1261 B-1424 Pilius P.S.: B-1822
Pawlas K.: B-0200 Perl R.M.: B-1814 Pilleul F.: B-1638
Payne J.I.: B-0916, B-0919 Perrucci L.: B-0046 Pina Insausti L.J.: B-1784
Pažanin A.: B-1073 Persiani S.: B-1898 Pineda Pardo J.A.: B-1303
Pearce T.: B-1027 Persigehl T.: B-1025 Pinheiro C.: B-0284
Pecchi A.: B-1381 Persson A.: A-0322 Pinker K.: B-1176
Peck K.: B-1032 Perucho J.A.: B-0370 Pinker-Domenig K.: A-0038, B-0716, B-1175,
Pecoraro M.: B-0156, B-0160, B-0325, Perucho J.A.U.: B-0178 B-1328, B-1549, B-1804
B-0825, B-0876 Perugin Bernardi S.: B-1528 Pinto dos Santos D.: A-0709, A-0845,
Pecorelli A.: B-1372 Perugin G.: B-1139 B-0314
Pecori B.: B-1346 Pesapane F.: B-0722, B-0974, B-1561 Pinto P.: B-0837
Pecorilla M.: B-0991, B-1028 Pescosolido M.: B-1228 Pinto Ramos J.N.: B-0283
Peddi S.: B-1075 Pesente S.: B-1521 Piotin M.: B-0280, B-0282
Pedersen M.R.V.: A-1005, B-1661 Peter S.: B-0474 Piotrowska-Kownacka D.: A-0224
Pedersen S.J.: B-0520 Pēterfelds M.: Piqueras Pardellans J.: B-0340
Pedersoli F.: B-0005 Peters A.: B-0188, B-0589, B-0749, B-0945, Piquet P.: B-0964
Pederson J.H.: B-0194 B-1208, B-1782 Piraud M.: B-0344
Pedicini V.: B-0560 Petrella E.: B-1381 Pires Jorge J.: B-1704, B-1712
Pediconi F.: A-0672, B-0553 Petretta M.: B-0333, B-1383, B-1385 Pirillo S.P.: B-1724
Pedilarco S.: B-1715 Petrillo A.: B-1346 Pisano A.: B-0007
Pedraza Gutierrez S.: B-0044 Petrillo M.: B-0974 Pistoia F.: B-1748
Pedrazzi G.: B-0842 Petrillo R.: B-0607 Pistorio A.: B-1054
Pędziwiatr M.: B-1583 Petrini M.: A-0300, B-1867 Pitskhelauri D.: B-1037
Peebles C.: A-0772, A-1017 Petrovic D.J.: B-0041 Pittaro A.: B-0171
Peetrons P.: A-0991, A-0993 Petta F.: B-0547, B-0548, B-1898 Pitura R.: B-1652
Pegge S.: B-0706 Petta S.: B-1529 Pizzi G.: B-0113, B-0563, B-0846, B-1435
Pehrson L.M.: A-0621 Pettersson M.: B-1716 Plaine B.: B-1214
Pei Y.: B-0678 Pettersson O.J.: B-0523 Plakhotina N.: A-0814, B-0091, B-1231
Peixoto M.R.: B-1365 Pettka P.: B-1704 Plank F.: B-0782

Plataroti S.: B-1154 Prayer F.: B-0307, B-0811, B-0905 Qi Y.: B-0863, B-1074, B-1087, B-1893,
Platon A.: A-0685 Precht H.: A-0400, A-0862, B-0485, B-1896, B-1897
Platzgummer H.: B-0677 B-0653 Qi Z.: B-0504
Pluymakers R.: B-1787 Preda L.: B-0372, B-0373, B-0973, B-1644 Qian T.-Y.: B-1475
Poddubnyy D.: B-0514 Predel D.: B-1643 Qiang J.: B-1531
Podgorska J.: B-1477 Preibisch C.: B-0088 Qin S.: B-0504
Podgórski P.: B-1265 Preim B.: B-0221 Qiu B.: B-0574
Podkovka O.: B-1034 Prenafeta Moreno M.: B-0121 Qiu H.S.: B-1273
Podlasek A.: B-0979 Presazzi A.: B-0087 Qiu T.: B-1370
Poewe W.: B-1689 Prestwich R.: B-0666, B-0667 Qu J.: B-0610, B-1873
Pofi E.: B-0010 Preusser T.: B-1444 Qu Y.: B-0881
Poggesi S.: B-1858 Prevos R.M.A.: B-0473, B-1803 Quaia E.: B-0512, B-0522, B-1011, B-1060,
Pogosbekyan E.: B-0089, B-1037 Prevos R.M.-A.: B-0915 B-1364
Pogrebnyakov I.: B-0844, B-0845 Prevrhal S.: B-1792 Quan C.: B-0541
Pokryszko-Dragan A.: B-0540 Prezzi D.: A-0869, B-0616 Quan X.: B-0504, B-0578
Polacin M.: B-1616 Prichard R.: B-0633 Quang Huy H.: B-1304, B-1305
Polat A.V.: B-0059 Primakov S.: B-1179 Quarantelli M.: B-0543
Polat Korkmaz O.: B-0986 Primavesi F.: B-0102 Quattrini A.: B-1696
Polavarapu R.: B-0841 Primo V.: B-0003 Quentin M.: B-0158, B-0161, B-0828
Polici M.: B-0525 Primolevo A.: B-0725 Quigley A.J.: B-1323
Polkowski C.: B-0243, B-1317 Prince J.: B-1850 Quinn M.: B-1699
Pollock A.N.: B-0604 Prinster A.: B-0543 Quintana I.: B-0032
Polovincak M.: B-0597 Priola A.M.: B-1144 Quitzke A.: B-0679
Polster C.: B-0135 Priola S.: B-1144
Polunina N.: B-0186 Prior J.O.: B-0235 R
Pompei L.D.M.: B-0084 Prokop M.: A-0028, A-0732, A-0955, Rabago G.: B-1015
Ponomarjova S.: B-0957 B-0706, B-1850 Rabbani M.: B-1694
Pons Escoda A.: A-0645 Pronin I.: B-0089, B-1037 Rabelo B.C.S.: B-0129
Pons Lucas R.: B-1773 Prono V.: B-0879 Rabenalt R.: B-0828, B-1462
Pons-Becmeur C.: B-1511 Prosch H.: A-0269, A-0516, A-0598, A-1097, Racine D.: B-1600
Ponsiglione A.: B-0823, B-1392, B-1684 B-0307, B-0811, B-0905, B-1020 Raciti M.V.: B-0436, B-1878
Pontana F.: A-0718 Provenzano E.: B-0501 Raciti M.V.V.: B-0372
Pontone G.: A-0226, B-0783, B-1212, B-1501, Pruschy M.: B-0065 Raczeck P.: B-1058
B-1613, B-1614, B-1615, B-1686, K-19 Pruvo J.-P.: A-0402, A-0404, A-0407, Radbruch A.: A-0905, B-1419, B-1421
Pontrelli M.: B-0045, B-0046 A-0979 Radnai B.: B-0728
Pop M.: B-0165 Puelacher W.: B-1599 Radovic N.: B-0463
Popescu A.S.: B-1533 Pueyo Villoslada J.C.: B-1015, B-1219 Radtke J.-P.: B-0813, B-1077
Popiela T.J.: A-0981 Puglia M.: B-1042, B-1684 Radu R.: B-0191
Popovic P.: A-0245 Puglielli E.: B-0708, B-0951 Radunski U.: B-1682
Poreba M.: B-0039 Puhr-Westerheide D.: B-0259, B-0262, Radzina M.: B-0037, B-0264
Poreba R.: B-0039, B-0200 B-0713 Rae W.I.D.: B-0890
Poretti D.: B-0560, B-1723 Puig Alcàntara J.: B-0044 Rafaelsen S.R.: B-1661
Porpiglia F.: B-0824 Pulido Carmona C.: B-1662 Rafailidis D.: B-1685
Porta M.: B-1310, B-1372 Püllen L.: B-0875 Rafailidis V.: B-1685
Portalez D.: B-0322 Pulsone P.: B-0708 Rafferty A.R.: B-0885
Portanier Mifsud C.: B-0413 Pulzato I.: B-1605 Rafful P.P.: B-0542
Portelli J.: A-0964, B-0027 Pumberger M.: B-1738 Ragab Y.: B-0899
Portelli J.L.: B-0413 Punie K.: B-0559 Ragozzino A.: B-0174
Posa A.: B-0109, B-0110, B-0114, B-1812 Punwani S.: A-0094, B-0159, B-0443, Rahimzadeh S.: B-0132
Posch H.: B-0962 B-1324 Rahmat K.: B-0468, B-0475, B-1233, B-1274,
Poskus T.: B-0270 Purcell Y.M.: A-0372 B-1885, B-1902
Postema S.: B-0251, B-0473 Pusceddu L.: B-1082, B-1093 Rai B.: B-1339, B-1479
Potapov A.: B-0089 Püsken M.: B-1761 Raimondi E.: B-0524
Poteshkina N.: B-1819 Putzier M.: B-1738 Raimondi S.: B-0769
Potter A.: B-0657 Puylaert J.B.C.M.: A-0167, A-0836 Rainford L.A.: A-0533, A-0860, B-0027,
Pötter-Lang S.: B-1050, B-1052 Puzakov K.B.: B-1263 B-0891, B-1113, B-1354
Pounou F.A.K.: B-0973 Puzzo L.: B-1648 Raissaki M.: A-0190, A-0923
Power S.: B-0265, B-0267 Pyatigorskaya N.: B-1422 Raizner A.: B-1669
Poylin V.Y.: B-0210 Pyka T.: B-0088 Raja S.: B-0809
Pozeg P.: B-0931 Pylev A.: B-1819 Rajabzadeh F.: B-1380
Pozzi Mucelli R.: A-1087, B-0328, B-1807 Pyra K.K.: A-0518 Rajamohan N.: B-1207
Pozzi-Mucelli R.: A-0239 Pytlewski P.: B-1185 Rajan R.S.: B-1892
Prabhu S.S.: B-1243 Rajan S.: B-1132, B-1133, B-1750, B-1892
Pradella M.: B-0310, B-1030 Q Rajani H.: B-1291
Prael I.: B-0426 Qanadli S.D.D.: B-1497 Rajapakse C.: A-0463
Prakash A.: B-1522, B-1886 Qi H.: B-1534 Rajasekaran M.: B-1376
Prassopoulos P.K.: A-0164 Qi Q.: B-1159 Rajwanshi A.: B-1095
Prayer D.: A-1091, B-0534, B-0926, B-0927, Qi W.: B-1006 Ramachandran S.: B-0950
B-1881, B-1882 Qi X.: B-1163 Ramaesh R.: B-0639

Ramalho L.: B-0084 Reginelli A.: B-0034 Richenberg J.: A-1071

Ramanauskas N.: B-1190, B-1757 Regnery S.: B-0505, B-0506 Richli Meystre N.: B-1709
Ramavathu K.: B-1555 Rehani M.M.: A-0658, A-0660 Richly H.: B-0116
Ramcharan S.: Rehnitz C.: B-0240, B-0242, B-1286 Richter H.: B-0093
Ramesh A.: B-0631 Rehwald R.: B-1688 Richter S.: B-0232
Ramirez Giraldo J.C.: B-0493, B-0729, Reiberger T.: B-1377 Ricke J.: B-0503
B-1503 Reichardt B.: B-0231, B-0839, B-0840, Ricoeur A.: B-0834
Ramiro R.: B-0003 B-0866 Riddell A.: B-1046
Ramlaul A.: B-0026 Reidelbach C.: B-0867 Rieder C.: B-0878
Ramli Hamid M.T.: B-0468 Reider L.: B-1377 Riederer I.: B-0790
Ramli N.: B-1233, B-1274, B-1885 Reidler P.: B-0259, B-0262, B-0713 Riederer S.: B-0438
Ramos A.: A-0160 Reijman M.: B-1134 Riedl M.: B-0055
Ramos Botelho Antunes P.: B-0129 Reijnierse M.: K-31 Riera L.: B-0340
Ramos I.M.: B-0412 Reimer P.: B-0354 Riffel P.: B-0352
Rampal P.: B-0513 Reimer R.P.: B-0354, B-1081, B-1424, B-1783 Riga M.G.: B-1364
Ran L.: B-0380 Reindl M.: B-0500 Righi D.: B-0004, B-0038
Rana A.I.: A-1080 Reiner C.S.: B-0822 Rigiroli F.: B-0304
Rana P.: B-0169 Reinert C.P.: B-0620, B-0818 Rigon L.: B-1846
Rance B.: A-0058 Reinhold C.: B-0528, B-1894 Riklund K.: A-0215, A-0739
Rancic Z.: B-0224 Reinstadler S.J.: B-0500 Riley B.: B-1004
Rancoita P.M.: B-1344 Reis H.: B-0875 Rim J.: B-0699
Randelli F.: B-0898 Reis J.: B-0284 Rimeika G.: B-1190, B-1757
Rangan K.B.K.: B-0233 Reis M.V.: B-0489 Rimola J.: A-0390, B-1653 K-39
Rangaswamy B.: B-0071 Reiser I.: B-0255 Rinaldo C.: B-0174
Ranjan R.: B-1335, B-1558 Reiser M.F.: A-0389, B-1847 Rincon S.: B-1229
Ranjbar M.: B-1433 Reisert M.: B-0568 Ringelstein A.: B-1595
Rannisto K.M.J.: B-1712 Reiter A.: B-0352 Ringl H.: A-0858
Ranschaert E.R.: A-0011, A-0175, A-0698 Reiter C.: B-0767, B-0989, B-1619, B-1620 Ringleb P.A.: B-0263
Ranucci M.: B-0189 Reiter G.: B-0767, B-0989, B-1619, B-1620 Rinzivillo M.: B-0525
Rao A.S.: B-0691, B-1637 Reiter U.: B-0767, B-0989, B-1619, B-1620 Rischpler C.: B-1456
Rao Kesari A.A.: B-1269 Rella R.: B-0547, B-0548 Risi V.: B-1352
Rao P.: B-0748, B-0750, B-0981, B-1753 Remedios D.: B-1856 Rispoli P.: B-0038
Rao S.: B-1278, B-1479 Remuzzi A.: B-0040 Ritchie G.: B-1751, B-1759
Rao S.-X.: B-1467 Remy J.: B-0778 Riva L.: B-1310, B-1372, B-1457
Rao V.M.: A-0537 Rémy-Jardin M.: A-0289, B-0778, K-17 Riva N.: B-1696
Rapaka S.: B-0310, B-0820 Ren B.: B-0018, B-0911 Rivadeneira F.: B-0856
Rapalino O.: B-1227 Ren C.-P.: B-1264 Rivière L.: B-1090
Rapisarda S.: B-0868 Ren D.: B-0805 Rizk B.: B-1600
Raposo R.: B-1359 Ren Y.: B-1222 Rizzo D.: B-0959
Raschzok N.: B-1468 Rengo M.: B-0014, B-0935, B-0940, B-1833 Rizzo G.: B-0455, B-0457
Rasciti E.: B-1858 Renne J.: B-0001 Rizzo S.: A-0192, B-0769
Rasker J.: B-0899 Renou P.: B-1415 Roberts D.: B-1226
Rasmussen F.R.: B-1465 Repa I.: B-0031, B-0882 Robinson C.: B-0483
Rasouly N.: B-1664 Resnik A.: B-1070 Robinson E.: B-1410
Rasper M.: B-1312 Reuter J.: B-1421 Robinson L.: A-0177, A-0827
Rathinasamy R.: B-1376 Revel D.: B-1214 Robinson M.: B-0126
Rathmann W.: B-1782 Revel M.-P.: A-0307, A-0452, A-1054 Robinson P.: B-0900
Ratib O.: A-0010, A-0554, A-0697, A-0972 Reyal F.: B-1090 Robinson S.: A-0111, A-1092
Rattazzi M.: B-1010 Reynolds O.: B-1700 Robson M.D.: B-0763
Ratti F.: B-0851, B-1439 Rezgui Marhoul L.: A-0313, A-0315, A-0361 Roca A.: B-0625
Raudner M.W.: B-0374 Rezk M.M.: B-1363 Rocek M.: B-0597
Rausch I.: B-0234 Rha S.E.: B-1895 Rocher L.: A-0295, A-1025
Ravanelli M.: B-0970, B-1446 Rhiem K.: B-0461 Rockall A.G.: A-0070, A-0103, A-0476,
Ravelli S.: B-0256 Riaz S.: A-1006 B-0177, B-1387
Ravindra K.: B-1140 Riaz Z.: B-0150 Rodell A.: B-0675, B-0682
Rawat K.S.: B-1668 Riaza Martin L.: B-0340 Rodighiero M.G.: B-0256
Raya J.: B-1508, B-1510 Ribbens A.: B-0984 Roditi G.: A-0422, B-1307
Raymond C.: B-1165 Ribeiro A.P.: B-0414 Rodrigues S.: B-0652, B-0658, B-1359
Razansky D.: A-0706 Ribeiro Fragata I.M.: B-0284 Rodrigues S.I.: B-0489
Reale M.L.: A-0053 Ribeiro L.: B-0414 Rodriguez Carnero P.: A-0815
Rebibo S.: B-0992 Ribeiro L.: A-0780, B-0489, B-0652, Rodríguez García E.: B-0535
Rebonato A.: B-0849 B-0658, B-1359 Rodriguez Laval V.: B-1024
Reddy B.: B-1753 Ribeiro M.M.: A-0008, B-0410 Rodríguez Musso A.L.: B-1780
Reekers J.A.: A-0020, A-0664 Ricardi U.: A-0497 Rodríguez Pérez S.: B-1318
Refaat M.M.: B-0531 Riccabona M.: A-0279, B-1361 Rodriguez Rojas R.: B-1303
Regge D.: A-0034, A-0957, B-0618, B-1082, Ricci A.: B-1552 Rodriguez Ruiz A.: B-0697, B-1527
B-1093, B-1828 Ricci F.: B-0195, B-1313, B-1636 Rodríguez-Fraile M.: B-0111
Regier M.: B-0679 Ricci P.: A-0001, A-0221 Roelofs J.J.: B-1592
Regine R.: B-1080 Ricciardi M.C.: B-0368 Roemer F.W.: B-1514, B-1515

Roest A.A.W.: B-1506 Rovira Gols A.: B-0121 Sachs C.: B-0464, B-1659
Rogalla P.: B-0277, B-0306, B-1832 Rovira-Cañellas A.: A-0155, A-1000 Sadate A.: B-0431
Roggenbuck U.: B-1622 Rowinski O.: B-1452 Saddekni S.: B-0838
Rogozhyn V.: B-1034 Roy S.: B-0492 Sadotti G.: B-1575, B-1578
Rohan T.: B-0232 Royle L.: B-0142 Saedon N.I.: B-1274
Röhnert A.: B-0398 Rozalli F.I.: B-1274 Saez F.: A-0850, A-0924, A-1033
Rohovyk M.: B-0584 Rubbert C.: B-0983, B-1210, B-1553 Safran O.: B-0992
Rohovyk N.: B-0584 Rübenthaler J.: A-0170 Sah B.-R.: B-0224
Röhrich S.: B-0307, B-0811, B-0905 Rubin D.: B-1402 Sahbaee P.: B-0820, B-1215
Rollandi G.A.A.: B-1528 Rubin D.L.: B-0906 Sahbai S.: B-0689
Roller F.C.: B-1863 Ruby L.: B-1512 Sahin C.: B-1576
Rollison S.: B-0300, B-1114 Rud E.: B-0332, B-0821, B-1656 Said N.H.: B-0923
Roman M.S.: B-0212 Rudolph M.: B-0153 Saidléar C.: A-0785
Romani M.: B-0547 Rueppel S.: B-0383 Saifi S.: B-1749
Romanini L.: B-1042 Ruffino A.: B-1499 Sajid S.: B-1130
Romano A.: B-1270 Ruffino M.A.: B-0038 Sakahara H.: B-0185, B-1180, B-1722
Romano L.: B-0104 Ruggeri V.: B-1799 Sakai Y.: B-0484
Romano S.: A-1037 Ruggieri C.: B-0948, B-1499 Sakamoto S.: B-0425
Romano V.: B-0618, B-1082, B-1093 Ruhlmann V.: B-0231, B-0673 Sakuma A.T.: B-1365
Romanov A.B.: B-1672 Rumboldt Z.: B-0260 Sakuma H.: B-1101, B-1102
Romanowski C.A.J.: A-0519 Rummeny E.J.: B-0047, B-0138, B-0615, Sakuragawa K.: B-0648
Romanucci G.: B-0248, B-0249, B-0250 B-0790, B-0995, B-1312, B-1612, B-1746, Sala E.: A-0132, A-0475, A-0899, A-1061,
Romei C.: B-1205 B-1848 B-0323, B-1384
Romeo V.: B-0333, B-0668, B-0823, Runhaar J.: B-1136 Sala S.: B-1678
B-1383, B-1385, B-1392, B-1626 Rupp C.: B-0385 Salagovicova Z.: B-0597
Rominger M.: B-1512 Rupp N.J.: B-0228, B-0229, B-0822 Salah F.: B-1168
Romman Z.: B-0133, B-0313 Ruprecht C.: B-0601 Salamon J.: B-0499, B-1240
Rompel O.: B-1321, B-1868 Rusche T.: B-0266 Salei A.: B-1296, B-1298, B-1299, B-1301
Ronald J.: B-0533 Ruschioni M.: B-1571 Salem A.: B-1456
Ronconi E.: B-1809 Rüschoff J.H.: B-0229 Salem J.: B-1081
Rong P.: B-0419 Rusina M.: B-0281 Salemi I.: B-1372, B-1457
Ronot M.: A-0084, A-0648, B-0848, K-11 Russe M.F.: B-0568 Salgado R.: A-0484, A-0877
Ronza R.: B-0991, B-1028 Russo A.: B-1241 Sali L.: B-0928
Roobol M.J.: B-0181 Russo F.: B-1082, B-1093 Salimbeni S.: B-1715
Rook M.: B-0309, B-0586, B-1311, B-1756 Russo L.: B-0328, B-1898 Saliu A.: B-1391
Roos J.E.: B-1729 Russo P.: B-1843 Sall S.: B-0302
Roose Ä.: B-1853 Russo U.: B-0842 Salman A.: B-0528
Roos-Hesselink J.W.: B-0194 Rutschke W.: B-0379 Saltybaeava N.: B-1541
Ropella-Panagis K.: B-1655 Rutty G.: B-0483 Saltybaeva N.: B-0996
Rosa F.: B-1139 Rutz E.: B-0893 Salvatore E.: B-0928
Rosario P.: B-1494 Rutz M.: B-0802 Salvatore M.: B-0174, B-0668, B-0928
Rosati E.: B-1022 Ruzzenente A.: B-0532 Salvioni M.: B-0851, B-1439
Rosella F.: B-0076, B-0967 Ryabinin M.A.: B-1760 Salvo V.: B-0160, B-0876
Rosenberg M.: B-0070 Ryan J.W.: B-0098 Samà L.: B-0530
Rosendahl K.: A-0339 Ryan M.-L.: A-0140, B-0024, B-1113 Samara E.: A-0046
Rosenkrantz A.B.: B-1184 Ryan S.: B-0654 Samarin A.: B-1853
Rosenzweig M.: B-1257 Ryckx N.: B-1196 Sambataro G.: B-1405
Rosignuolo M.: B-0547 Rydel W.: B-1265 Sambuceti G.: B-0686, B-0689
Roski F.: B-0047 Rydén Suther K.: B-0168 Samei E.: A-0183
Rospleszcz S.: B-0188, B-0589, B-0749, Ryeom H.-K.: B-0942 Samma M.:
B-0945, B-1514, B-1515, B-1782 Ryu K.N.: B-1137 Sammon J.: B-1056
Ross J.S.: A-0758 Rzaev J.: B-1266 Sammut S.J.: B-1647
Rossato D.: B-0004 Sampangi S.: B-0063, B-1269
Rossi A.: A-0829, A-1101, B-0930 S Samuelsson C.: B-0049
Rossi D.: B-0973 Sá dos Reis C.: B-0025, B-1065, B-1709 Samuilis A.: B-0270
Rossi Espagnet M.C.: B-0930 Saade C.: B-0481, B-0727, B-0799, B-0800, Sana Ali J.: B-0902
Rossi F.: B-1178, B-1745 B-1351, B-1851 Sanabria S.J.: B-1512
Rossi G.: A-0052 Saade S.M.: B-0604 Sánchez Casanueva R.M.: A-0750
Rossi L.: B-1090 Saake M.: B-1777 Sanchez M.: B-0848
Rossi M.: B-0007, B-0008, B-0849, B-1809 Saam T.: B-1773 Sánchez P.S.: B-1811
Roth J.: B-1321 Saba L.: A-0508, B-0036, B-0415, B-0707, Sánchez-Casanueva R.M.: B-1195
Rothenbacher T.: B-0945 B-1251, B-1721, B-1775 Sánchez-Montañez A.: A-1102
Rotili A.: B-0722, B-1561 Sabatino V.: B-0842 Sanchez-Montanez Garcia-Carpintero A.:
Rotkopf L.: B-0088, B-0262, B-0713 Sabbah S.: B-0277 B-1231
Rotkopf L.T.: B-0259 Sabet S.: B-0286 Sanchez-Osorio E.: B-0680
Rotondo D.: B-0195 Sabia F.: B-0143 Sandbækk G.: B-0332, B-1656
Rotzinger D.C.: B-0731, B-1214, B-1366 Sable N.: B-1450 Sanderink W.: B-0545, B-1564
Rousseau H.: B-0793, B-1188 Sacconi F.: B-1807 Sanders K.J.C.: B-0220
Roviello F.: B-1275 Sachdev N.: B-0513 Sandiramourty S.: B-1695

Sanei Taheri M.: B-1433 Schaefer-Prokop C.M.: A-0123, A-0288, Schneider G.: B-1058, B-1463
Sangro B.: B-0111 A-0982, B-1850 Schneider M.J.: B-0503, B-1400
Sanmartin Berglund J.: B-1360 Schäfer D.: B-0106, B-0735 Schneider S.: B-1247
Sanson M.: B-1422 Schäfer J.: A-0874 Schneider U.: B-0514
Sansone M.: B-0974 Schäfer J.P.: A-0909 Schneiter D.: B-0577
Santiago I.: A-0002, A-0769 Schäfer S.: B-1025 Schocke M.: B-1689
Santinha J.: B-0700 Scharfschwerdt M.: B-0202 Schoen G.: B-0119
Santis G.: B-1410 Schawkat K.: B-0822 Schoennagel B.P.: B-0601
Santonocito E.F.: B-0943 Schebesch F.: B-1845 Schoepf U.J.: B-0301, B-0780, B-0781,
Santonocito S.M.: B-0943 Scheel M.: B-1199, B-1631 B-0784, B-0785, B-0787, B-0789,
Santos J.: A-0686, B-1063, B-1494 Scheerder M.J.: B-0099 B-0820, B-0914, B-1215, B-1217, B-1721
Santos R.: A-1007 Scheffler K.: B-0095 Schofield S.: B-1543
Santos R.A.M.: B-1108, B-1110, B-1357 Scheidler J.: B-0440 Scholer M.: B-1563
Santucci G.: B-1715 Schelb P.: B-0813, B-1077 Schöllnast H.: A-0712
Sapinho I.: A-0986 Schenk A.: B-0558 Scholtz J.E.: B-0347
Sappey-Marinier D.: A-0897 Schenk M.: B-0349 Scholtz J.-E.: B-0434, B-1013, B-1317, B-1448,
Sarangi P.K.: B-1253 Schenone A.: B-1745 B-1472
Sardanelli F.: A-0233, A-0364, A-0384, Schernthaner R.: A-0665, B-0219, B-0299 Schönberg S.O.: A-0396, B-0022, B-0106,
B-0042, B-0189, B-0199, B-0416, B-0465, Scherr D.: B-1620 B-0352, B-0587, B-0735
B-0477, B-0490, B-0759, B-0895, B-1151, Scherr M.K.: B-0440 Schönenberger S.: B-0263
B-1352, B-1561, B-1687, B-1723, B-1728, Scherz B.: B-1682 Schoots I.G.: B-0181
B-1821, B-1867 Schiaffino S.: B-0724, B-1151 Schöppe F.: B-0094, B-0749, B-1782
Sargeant A.: B-0029 Schiani E.: B-0256 Schrauwen P.: B-0220
Sarı S.: B-1805 Schiavina R.: B-0873 Schreier A.: B-1400
Sarikaya B.: B-0557 Schicci N.: B-1719 Schübel R.: B-0051
Sarkinaite M.: Schierz J.-H.: B-0558 Schultheiss H.-P.: B-0378
Sarkodie B.D.: B-0871 Schifferle G.: B-1389 Schulz A.: B-1047
Sarno A.: B-1843 Schillebeeckx J.: A-0589 Schulz D.: B-1669
Sarno L.: B-1383, B-1385 Schima W.: A-0237, A-0770, A-1099 Schulz H.: B-1208
Sarohia D.: B-0056 Schimmöller L.: B-0158, B-0161, B-0327, Schulze C.: B-0201
Sarteschi C.: B-0932 B-0828 Schulze-Hagen M.F.: B-0005
Sartori A.: B-0536 Schindera S.: B-1196 Schulz-Menger J.: A-0253, B-0589
Sasaki M.: B-1180 Schindera S.T.: A-0413 Schulz-Wendtland R.: B-0551, B-0701,
Sasiadek M.: B-0540 Schiphof D.: B-1136 B-0702, B-0703, B-1518
Sasikumar S.: B-0142 Schippers R.: B-0137 Schumann C.: B-0878
Sassatelli R.: B-0993 Schittenhelm J.: B-0093 Schuppert C.: B-0019, B-1208
Satis H.: B-1453 Schlamann M.: B-0710, B-0988, B-1166 Schurink N.W.: B-1484
Sato H.: B-0421 Schlattmann P.: B-0762 Schuzer J.L.: B-0300, B-1114
Sauer M.: B-1089 Schleich C.: B-0515, B-0516, B-0517, B-0518, Schwabel B.K.: B-1020
Sauerland C.: B-0266 B-0519, B-1736 Schwaiger B.J.: B-0047, B-1746
Saukko E.: B-0645, B-0886, B-0888 Schlemmer H.-P.: A-0036, A-0193, B-0135, Schwartz F.R.: B-0493, B-0729, B-1140,
Sauter A.: B-0138, B-1612, B-1848 B-0319, B-0321, B-0362, B-0364, B-0505, B-1503
Sauter A.W.: B-0310, B-0904, B-1030, B-1211 B-0506, B-0813, B-1077, B-1419, B-1421, Schwartz L.: B-0672
Savage R.H.: B-0781 B-1568 Schwarz D.: B-1560
Savatovsky J.: B-0987 Schlesinger I.: B-1557 Schwarz F.B.: B-1199, B-1631
Savchenko V.: B-0350 Schlett C.L.: B-0019, B-0051, B-0188, Schwarz M.: B-1881
Savi E.: B-0622 B-0589, B-0749, B-0945, B-1208, B-1514, Schwemmer C.: B-0820
Savintseva Z.: B-1164 B-1515, B-1782 Schwenck J.: B-0686
Sawall S.: B-0013, B-0135, B-0316, B-0319, Schlötelburg W.: B-0337 Schwenke M.: B-1444
B-0321 Schmaranzer E.: B-0896, B-0897 Schwyzer M.: B-0817
Sawicki L.M.: B-0669, B-0670, B-0671, Schmaranzer F.: B-0571, B-0896, B-0897, Sconfienza L.M.: A-0173, A-0692, B-0052,
B-1210, B-1355, B-1462 B-0901 B-0416, B-0759, B-0868, B-0870,
Saxena A.K.: B-0169, B-1224 Schmeel F.C.: B-1513 B-0898, B-1723, B-1730
Saxena S.: B-0387 Schmelzle M.: B-1468 Screaton N.J.: A-0470
Sayed S.: B-1334 Schmid T.: B-0102 Scrofani A.R.: B-0547, B-0548
Sbarra M.: B-0328 Schmidbauer V.: B-0926, B-1881, B-1882 Sdao S.: B-0898
Scaglione M.: A-0891, K-09 Schmidle A.: B-1777 Sdika M.: B-1638
Scamarcia P.G.: B-1696 Schmidt A.: B-1125, B-1619, B-1620 Sdvizhkov A.M.: B-0173
Scaperrotta G.: B-0257, B-0725, B-1155 Schmidt B.: B-0496, B-0682, B-0996, Sebag-Montefiore D.: B-0361
Scarabello M.: B-0787, B-1217, B-1721 B-1142 Sebire N.J.: B-0606, B-1319
Scardapane A.: B-0676 Schmidt K.: B-1709 Secchi F.: B-0042, B-0189, B-0199, B-1728,
Scarsbrook A.: A-0457, B-0150, B-0361, Schmidt Kobbe S.: A-0650, B-1366 B-1821, B-1867
B-0666, B-0667, B-0771 Schmidt N.: B-0193, B-0946 Sechopoulos I.: A-0047, B-0255, B-0545,
Scavone A.: B-0436, B-1878 Schmidt S.A.: B-0061 B-1523, B-1525, B-1527, B-1564, B-1790,
Scavone G.: B-0436, B-1878 Schmidt T.: B-0119, B-0962 B-1838, B-1850
Schaar J.: B-0704 Schmitt A.J.: B-0979 Secil M.: A-0294
Schaarschmidt B.M.: B-0690, B-1456, B-1461 Schmitt-Opitz I.: B-0577 Secinaro A.: A-0609, A-1022
Schachtner B.: B-1400 Schmitz C.: B-1669 Sedelaar J.P.M.: B-0878
Schaefer N.: B-0235 Schmutzler R.: B-0461 Sedghi Gamechi Z.: B-0194, B-0497

Sedlaczek O.L.: A-0064, A-0600 Shalmon A.: B-1569 Sievers H.-H.: B-0202
Sedlmair M.: B-0778 Shamirzaev K.: B-1379 Šifer K.K.: B-1608
Seeger W.: B-1863 Shanahan M.: B-0657 Sigl B.: B-1553
Seegert A.: B-0653 Shanbhag S.: B-0300, B-1114 Signa S.: B-0341
Sefidbakht S.: B-0291, B-0602 Shankar A.: B-1324 Sijbers J.: B-1127
Sehner S.: B-0679 Shanshan R.: B-1006 Sijens P.: B-0704
Seidensticker M.: A-0248 Shapira N.: B-0731 Sijens P.E.: B-1565
Seifeldein G.S.: B-0371 Sharaev M.: B-1037 Silva F.: B-0860
Seiko-Vänttinen V.: B-0888 Shariati S.: B-1589 Silva J.: B-0283
Seilern und Aspang J.: B-0677 Sharifian H.: B-0635 Silva M.: A-0051, A-0601, B-0143, B-1029,
Seimenis I.: B-0183, B-0768 Sharma N.: B-0079, B-1543 B-1858
Seitz P.: B-0196, B-1683 Sharma P.: B-0820 Silva V.M.F.: B-0412
Seker F.: B-0263 Sharma R.: B-0640, B-1207 Silvestre M.: B-0006
Seki S.: B-0417, B-0422, B-0424, B-0579, Sharma S.: B-1797 Sim J.Y.: B-1285
B-1003, B-1203, B-1209, B-1460, B-1755 Shaw B.: B-1140 Simão D.M.: B-0658
Sekkelsten H.: B-1700 Shawali H.A.S.: B-0212 Simbrunner B.: B-1377
Selau Junior M.: B-1704 Shayesteh-Kheslat R.: B-0963 Simelius-Nieminen S.: B-0888
Selcuk M.B.: B-0059 Sheehan M.: B-0265 Simeonov G.: A-0409
Selcuk N.A.: B-0557 Sheerins O.: B-1307 Simic A.: B-1871
Selder S.: B-0019 Shelmerdine S.C.: A-0794, B-0606, B-1319 Si-Mohamed S.A.: B-0311, B-0731, B-1116,
Seliverstov Y.: B-1554 Shem S.L.: B-1109 B-1214, B-1852
Seliverstova E.: B-1554 Shen J.: B-0508 Simon J.: B-0786
Selmi-Özer B.: B-0385 Shen M.-T.: B-0596, B-1674, B-1680, B-1681, Simonetti G.: B-1521
Sembele L.: A-0618 B-1820, B-1825 Simonovsky M.: B-0302
Semenova N.: B-1038, B-1778, B-1887 Shen Q.: B-1272 Singer G.: B-1361
Semiz Oysu A.: B-0929 Shen W.: B-1371, B-1534 Singh A.: B-0714, B-1132, B-1133
Semiz-Oysu A.: B-0125 Shen X.X.: B-1152 Singh D.K.: B-1291, B-1293
Sendur H.N.: B-0213, B-1453 Shi K.: B-1618, B-1681, B-1820, B-1869 Singh M.: B-1382
Senn D.: B-1617 Shi Q.: B-0611 Singh S.: B-0169
Senyszak D.: B-1751, B-1759 Shi R.: B-0218, B-1676 Singh T.: B-1382, B-1901
Seo B.K.: B-1177 Shi R.-Y.: B-1816 Singla V.: B-1382, B-1901
Seo D.-K.: B-0646 Shi X.: B-1246 Sinha S.: B-1095
Seo H.S.: B-0852, B-1420 Shi Z.: B-0217, B-0754 SinhaRay R.: B-0142
Seo J.B.: A-0566, B-0576 Shimada Y.: B-0482 Sinitsyn V.E.: A-0243, B-0730, B-1314,
Seo J.S.: B-0776 Shimomura Y.: B-1832 B-1819, B-1822
Seo N.: B-0402 Shin H.J.: B-0334 Sipos D.: B-0031, B-0728, B-0882
Seow P.C.: B-1233 Shin H.-J.: B-0335 Sirli R.: B-1533
Seppelt D.: B-0401, B-0797 Shin K.M.: B-0942 Sirlin C.B.: B-1536
Seppi K.: B-1689 Shin K.S.: B-1538 Sironi S.: B-1310, B-1372, B-1457
Seraydarmansour O.: B-0238 Shin M.G.: B-0741 Siveke J.: B-0615
Serebryakova S.V.: B-1267 Shin S.: B-0942 Sjöberg J.: A-0184
Sergeeva O.N.: B-0395 Shinohara K.: B-0829 Skaane P.: A-0762
Serni S.: B-0622 Shirasaka T.: B-0484 Skardelly M.: B-0093
Serova N.S.: B-1261 Shitakubo Y.: B-0648 Skehan S.: A-0607, B-0633
Sertorio F.: B-0341, B-1054 Shivalingappa S.S.: B-1269 Sklair M.: B-1569
Sessa B.: B-0734 Shokry A.: B-0693, B-1232 Skoczylas T.: B-1482
Sestini S.: B-0143 Shokry S.: B-0693 Skripnik A.: B-1505
Sethi K.: B-0537 Shorikov M.: B-0395 Škrk D.: B-1073
Sethi P.: B-1797 Shotar E.: B-1574 Skrobas U.: B-0538
Seuri R.: A-0120, A-0872 Shpektor A.V.: B-1314 Skrobic O.: B-1871
Seuss H.: B-1088 Shu S.: B-1124 Skrzyński W.: B-1477
Sever A.: B-0295 Shuxia W.: B-0363 Skvortcova T.: B-1164
Severi D.: B-1715 Sibahi A.: B-1168 Slehria A.U.: B-0271
Severino M.: B-0930 Sibon I.: B-1415 Smeets A.: B-1803
Severoni S.: A-0228 Siddique M.M.: B-0351, B-0617, B-1874 Smet M.H.: B-1318
Sewerin P.: B-0515, B-0517, B-0519 Siddique U.: A-1082 Smetanina N.: B-1326
Sewonu A.: B-0793 Siddiqui I.A.: B-1027 Smidt M.: B-1170
Seyfer P.: B-0365 Sidhu P.S.: A-0040, A-0293, A-0334, Smirnov A.: B-1037
Seyfried N.: B-1650, B-1655 A-0847, B-1685 Smirnova A.V.: B-0091
Sfez K.: B-0992 Sidorenkov G.: B-1008 Smit E.J.: B-0706, B-1850
Sgrazzutti C.: B-1028 Siebenrock K.: B-0571, B-0896, B-0897, Smit J.W.A.: B-0588
Shafaat O.: B-1694 B-0901 Smit L.: B-0632, B-1635
Shafiei A.: B-1640 Siebert S.: B-1402 Smith A.: B-0357, B-1473
Shah D.J.: B-1669 Siedek F.: B-0314, B-0461 Smith J.: B-1384
Shah J.: B-1129 Siegel E.L.: A-0126 Smith L.: B-1688
Shahzad M.: B-0090 Siegel F.: B-0022 Smith-Bindman R.: B-0015, B-1320
Shahzad R.: B-0756, B-0988 Siemund R.: B-1197 Smithuis R.: A-1040
Shaiakhmetova S.V.: B-1672 Siena S.: B-0991, B-1028 Smits M.: A-0440, A-1031, B-0908
Shakirin G.: B-0756, B-0988, B-1424 Sieren M.: B-0202, B-0225, B-0349 Snaith B.: A-0863

Snoeckx A.: A-0803, B-0145 Spinhoven M.J.: B-0145 Storz C.: B-0589, B-0945, B-1514, B-1515
So C.W.: B-1856 Spink C.: B-0119 Stoupis C.: A-0768
Soares F.: B-1359 Splendiani A.: B-0544, B-1550, B-1556 Stöver T.: B-0296, B-1247, B-1257
Sobhy T.: B-0355 Sponza M.: B-0076, B-0967 Stowe J.G.: A-1043, B-1699, B-1702
Sobieszczanska M.: B-0039 Spoor D.S.: A-0017 Stoyanova D.P.: B-1052
Sobrido C.: B-0294 Sporea I.: B-1533 Stramare R.: B-0512, B-0522, B-1060,
Socratous A.: B-0324 Sprinkart A.M.: B-1513 B-1364, B-1540
Sodano C.: B-1570 Spurny M.: B-0051 Stranieri G.: B-0824, B-1144
Sodhi K.S.: B-0169, B-1224 Srinivasan R.: B-1901 Stratakis J.: B-1593
Sodmann P.: B-0022 Srivastava D.N.: B-1577 Sträter A.S.: B-1312
Soejoko D.S.: B-1839, B-1842 Srivastava S.: B-0674 Streekstra G.J.: B-0137
Soens J.: B-0473 Staal F.: B-1049 Streetly M.: B-0351
Soesbe T.C.: B-0391, B-0792 Stabile A.: B-0159, B-0443 Strehlow J.: B-1444
Soffer S.: B-1186 Stabile Ianora A.A.: B-0329, B-0676 Streitparth F.: B-1184
Sofikitis N.: B-1660 Stachura E.: B-0874 Strickland N.H.: A-0013
Sofue K.: B-1145, B-1146 Stacul F.: A-0725, B-0368, K-13 Strobbe L.J.: B-0545
Sohaib A.: A-0093 Stadlmann A.: B-1377 Stroeder J.: B-1720
Sokolska M.: B-0712 Stafrace S.: A-0276 Strøm B.: B-1712
Sokurenko M.: B-0608, B-0609 Ståhlbrandt H.: A-0349 Stroszczynski C.: A-0206
Solaz Solaz J.: B-0003 Stahnke T.: B-0237 Strudwick R.M.: B-0033
Solbiati L.: B-0530 Staibano S.: B-1626 Stückle C.A.: B-1289
Soldi M.: B-0783, B-1212 Stajgis M.: A-0152, A-0433 Studzinski J.: A-0817
Soligo E.: B-0367 Stamati G.: B-1010 Stutz S.: B-1733
Sollini M.: B-1636 Stampanoni M.: B-1792 Su F.: B-0718
Solopova A.E.: B-0173, B-0180 Stange R.: B-0764 Su L.: B-1788
Solovev M.: B-0350 Stankeviciene J.: B-1757 Su R.: B-1430
Solty K.: B-0764 Stanuch M.: B-1583 Su T.: B-1246, B-1633, B-1813
Solyanik O.: B-1400 Stanzione A.: B-0668, B-0738, B-0823, Su X.: B-1426
Somma F.: B-0564 B-1392, B-1684 Su Y.: B-0343
Sommer G.: B-0310, B-0904, B-1030, B-1211 Stáreková J.: B-0590, B-0679, B-1682 Suardi N.: B-1300
Sommer N.N.: B-1773 Starmans M.P.A.: B-0067, B-0908, B-1279 Suarez Vega V.M.: B-0294
Sommer W.: B-0022, B-1773 Stättner S.: B-0102 Subesinghe M.: B-0142
Sommerwerck U.: B-1411 Stavolo C.: B-0104 Sucapane P.: B-1550, B-1552, B-1556
Son J.: B-1766 Stavrinides V.: B-0443 Suchanek V.: B-0597
Song B.: B-0074, B-0356, B-0405, B-1044, Stavrinou P.: B-0756, B-0988 Sudarkina A.: B-1005
B-1471, B-1535, B-1764 Stecco A.: B-0367, B-0798, B-1262 Sudarski S.: B-0106, B-0735
Song C.: B-1252, B-1256 Stefano A.: B-0418 Sudderuddin S.: B-0177
Song G.W.: B-0796 Steffen F.: B-0108 Sudre C.H.: B-1688
Song I.S.: B-1538 Steffen I.: B-1024, B-1374 Suganchand Rikabchand S.K.: B-0128,
Song J.: B-1126 Steiding C.: B-1541 B-0637, B-0855
Song L.: B-0423, B-0430, B-1409 Steinbach L.: A-0804, A-0806 Sugihara N.: B-0424, B-0579
Song S.E.: B-1177 Steinbach R.: B-0781, B-0789 Sugimura K.: B-0421
Song T.: B-0223 Steinfelder E.: A-0630 Sugiyama M.: B-1722
Song W.: B-0423, B-0430, B-1409 Steinkohl F.: B-1076 Sugiyama S.: B-1832
Song Y.G.: B-0775 Stelzmüller M.-E.: B-0374 Suh Y.J.: B-1800
Song Y.S.: B-0449 Stephan T.: B-0875 Sui X.: B-0144, B-0423, B-0430, B-1409
Sonnemans L.: B-0068 Steri L.: B-0935, B-0940 Sukhovei L.: B-0367
Soo S.W.: B-0475 Stern E.J.: K-38 Sukupova L.: B-1602
Sorantin E.: A-0119, A-0142, B-1361 Steveson C.: B-0300, B-1114 Suleiman M.E.: B-1844
Sørensen I.J.: B-0520 Stieltjes B.: A-0394, B-0193, B-0310, Sulieman A.A.: B-1486
Soriano I.: B-0064 B-0816, B-0904, B-0946, B-1030, B-1092, Sulla Lupinacci F.A.: B-1365
Sorrentino A.: B-1139 B-1211 Sullivan Y.: B-1193
Sosna J.: B-0133, B-0313 Stierstorfer K.: B-0312 Sultanov A.: B-1379
Soultatos A.: B-1530, B-1837 Stiller W.: B-1610 Sum R.: B-1815
Sousa M.C.: B-1494 Stilo S.: B-0738, B-0823 Suman S.: B-1291, B-1293
Sousa P.: B-0658, B-0907 Stinson E.: B-0438 Summers R.M.: B-1640
Soydan L.: B-0295 Stober S.: B-0802 Sun C.C.: B-1654
Soyer P.: A-0811, B-0155 Stocking K.: B-0917 Sun H.: B-1426
Sozzi G.: B-0143 Stöcklein S.: B-0188, B-0749, B-0927, Sun I.-J.: B-0758
Spadarella G.: B-0199 B-1782 Sun W.: B-0421
Spahr N.: B-0558 Stöcklein V.: B-0094 Sun Y.-Z.: B-0757
Späth L.: B-1240 Stoecklein S.: B-0094 Sun Z.: B-1065
Spekreijse J.: B-0685 Stoeger A.M.: B-1150 Sun Z.-Y.: B-1475
Spence L.D.: B-1056 Stoia V.: B-0564 Sundell V.-M.: B-0998
Sperl J.I.: B-1030 Stoker J.: A-0835 Sundin A.: B-0523
Spiliopoulos S.C.: A-1065 Stollberger R.: B-1619 Sung J.S.: B-1804
Spinarelli A.: B-0676 Stölting M.: B-1125 Sung P.: B-0773
Spinelli C.: B-0017 Stolzmann P.: B-0224, B-0228 Suranyi P.: B-0914
Spinelli E.G.: B-1696 Stopchinski M.: B-1650 Suri D.: B-0169

Suri J.: B-0036 Tanamala S.: B-0748, B-0750, B-0755, Thaha R.: B-1132, B-1133
Surov A.: B-0175 B-0981 Thaiss W.: B-0620, B-0628
Suther L.K.R.: A-0613 Tandon N.: B-0640 Thakur M.: B-1450
Sutton E.J.: B-0719 Taneja A.: B-0513 Thakur S.: B-1175, B-1176
Suzuki S.: B-0660 Tang B.: B-1331 Thali M.: B-0068, B-1516
Suzuki T.: B-0742 Tang C.X.: B-0784 Tham J.-L.: B-0917
Svanteson M.: B-0480 Tang J.: B-0472 Thanosoulis K.: B-0183
Svedström E.: B-0645 Tang L.: B-0462, B-0611, B-0807, B-1280 Theilig D.: B-1374
Sverzellati N.: A-0453, A-0700, A-0733, Tang P.Y.: B-1798 Theodoridis A.: B-0183
B-0143, B-0307, B-1029, B-1858 Tang S.: B-1036, B-1333 Theotokas I.: B-1378, B-1530, B-1537, B-1837
Swain B.M.: B-1253 Tang W.: B-0429, B-1752, B-1785 Thestrup K.-C.D.: B-0442
Swamy S.S.: B-0063 Tannast M.: B-0571, B-0896, B-0897, Theysohn J.: B-0116, B-1740
Swarup M.S.: B-0977 B-0901 Thiele F.: B-0710, B-0756, B-0988, B-1424
Swinnen J.: B-0473 Tanner J.A.: B-1795 Thiele H.: B-0196, B-0379, B-1683
Syed S.: B-1402 Tanno Y.: B-0949 Thierfelder K.: B-0088, B-0237, B-0262,
Sykes P.: B-1117 Tanoi C.: B-0185 B-0713
Syysmäki H.: B-1115 Tanriover N.: B-0986 Thierfelder K.M.: B-0259, B-1286
Szatmari P.: B-1185 Tantawy H.: B-0355 Thilander Klang A.: B-1900
Szilagyi B.: B-1432 Tanturri de Horatio L.: A-0795 Thoduka S.: B-0558
Szilveszter B.: B-0786 Tanyildizi Y.: B-1241 Thoeny H.C.: A-0377, A-0432, A-1074
Sztankay B.: B-1076 Tao B.: B-1330, B-1427 Thomas B.: B-1647
Tao G.: B-0805 Thomas C.: B-0954, B-1355, B-1368, B-1726
Szucs P.: B-1432
Tao H.: B-1131 Thomas D.: B-1513
T Taouli B.: A-0335 Thomassin-Naggara I.: A-0073, A-0424,
Tabbara A.: B-1168 Tarantini G.: B-0526, B-1097 B-1894
Tacchini S.: B-0256 Tarbell N.: B-1227 Thomeer M.G.: B-0067, B-0908
Tacher V.: B-0252 Tartari C.: B-0272 Thommassen K.: B-0168
Tachibana A.: B-1365 Tartari S.: B-0272 Thompson A.: B-0079
Tack D.: A-0356, A-0916 Tartaro A.: B-0203 Thompson J.: A-0779
Tadepalli M.: B-1753 Tasaki A.: B-1899 Thomsen F.B.: B-0154
Taghavi M.: B-1582 Tatard-Leitman V.: B-1116 Thomsen H.S.: A-0723, A-0906, B-0154,
Tagliafico A.: A-1047, B-0724, B-1173, B-1178, Tateishi U.: B-0471, B-1796 B-0442, B-0520
B-1745 Tatewaki Y.: B-1329 Thon N.: B-0094
Tagliamonte M.: B-0937 Taupitz M.: B-0441, B-0762 Thong P.M.: B-1012
Tagliati C.: B-1719 Tavakoli Taba S.: B-1789 Thorisdottir S.: B-0101, B-0955
Taha N.: B-0400 Tavanti L.: B-1205 Thornton A.: B-1387
Taher Rakei Z.: B-0238 Tavare A.N.: B-1004 Thornton J.: B-0265, B-0267
Tavares de Sousa M.: B-0601 Thrall J.H.: A-0595
Tahir E.: B-0590, B-1682
Taylor A.M.: A-0483, A-0610, B-0606 Thrane K.J.: B-0168
Tahmassebi A.: B-1328
Taylor S.: B-1324 Thuering T.: B-0997
Taibbi A.: B-1529
Taylor S.A.: A-0162 Thurnher M.M.: A-0157, A-0678, A-0757,
Taibi A.: B-1846
Tedesco G.: B-0455 A-0831, A-1075, B-0534
Taina M.: A-0524
Teerasamit W.S.H.R.T.V.S.: B-1769 Thygesen J.: B-1465
Takahashi H.: B-0293
Tegos T.: B-1685 Thywissen T.: B-0473, B-0915
Takahashi S.: B-1145, B-1146
Teh J.: A-1089 Tian J.: B-1467
Takase K.: B-0421
Teichgräber U.K.: B-0201 Tian S.: B-1742
Takashima H.: B-1735
Teixeira S.R.: B-0604 Tiberia F.: B-0935, B-0940
Takehara Y.: B-1722
Telegrafo M.: B-0329 Tiddens H.A.: B-0170, B-0171
Takenaka D.: B-0424, B-0425, B-1755
Teles P.M.: B-1494 Tiedt S.: B-0259, B-0713
Takenaka M.: B-0408 Tello K.: B-1863 Tiepolo M.: B-1010
Taki Y.: B-1329 Temel E.: B-1453 Tillier C.: B-0326
Takx R.A.: B-1013 Ten J.I.: B-1195 Tilliridou V.: B-1316
Talarczyk S.: B-1289 Teng G.-J.: B-1033, B-1891 Timmer M.: B-1424
Talbot P.: B-0916, B-0919 Tengberg L.T.: B-0275 Timpani A.: B-0618
Taleb H.A.: B-0371, B-1284 Tennstedt P.: B-1089 Ting H.H.: B-1021
Talei Franzesi C.: B-1310, B-1372, B-1457 Terada M.: B-0185 Tinguely P.: B-1438, B-1442
Tali E.T.: A-0675 Terauchi K.: B-1180 Tini P.: B-1275
Tam K.Y.: B-1798 Terboven T.: B-0106, B-0735 Tinoco Alvim de Souza F.: B-0129
Tam M.: A-0448 Terecoasa E.: B-0191 Tipaldi L.: B-1724
Tamada D.: B-0404 Tereshenko G.: B-1061, B-1326 Tipaldi M.A.: B-0007, B-0008, B-0849,
Tamandl D.: B-1875 Ter-Karapetyan A.: B-0420 B-1809
Tamburrano C.: B-0864 Ternovoy S.K.: B-1261 Tiralongo F.: B-0418, B-1405
Tamim H.: B-1168 Terranova M.C.: B-1827 Tischendorf P.: B-1204
Tan L.: B-1440, B-1441 Terrone C.: B-0879, B-1139 Tissier F.: B-1511
Tan L.K.: B-1233, B-1274 Tesche C.: B-0301, B-0784, B-0785 Titova A.M.: B-0791
Tan M.P.: B-1274 Tessarin G.: B-1010, B-1011 Tiu C.: B-0191
Tan Y.: B-0858 Testino N.: B-1139 Tjan-Heijnen V.C.: B-0083
Tanaka H.: B-0293 Teuwen J.: B-1523, B-1564 Tjan-Heijnen V.C.G.: B-1158
Tanaka U.: B-1145, B-1146 Thabet D.B.: B-0117 Tkachev A.: B-0091

Tkachev S.: B-0621 Tritella S.: B-0490 Ullrich T.: B-0158, B-0161, B-0327, B-0671,
Toepker M.: A-1094 Trofimenko I.: B-0828, B-1462
Tofanelli L.: B-1644 Trofimov I.: B-0844, B-0845 Ulrich S.: B-1866
Toia P.: B-1313, B-1444 Trofimova T.: B-0608, B-0609 Ulus S.: B-1546
Tolan D.J.M.: A-0488 Trojani V.: B-0993 Umar M.S.: B-1109
Tolmunen T.: B-1272 Trojanowska A.: A-0318, A-0721 Umutlu L.: A-0131, A-0282, B-0231, B-0575,
Toma M.K.: B-0860 Tromba G.: B-1610, B-1789 B-0669, B-0670, B-0671, B-0673,
Toma P.: B-1327 Trombatore C.: B-0943 B-0690, B-0803, B-0819, B-0875,
Tomar S.: B-1291, B-1293 Trong Khoan L.: B-1305 B-0913, B-1411, B-1456, B-1461
Tomehy M.: B-1105 Tropine A.: B-1241 Ünal Ö.: B-0603
Tomerak R.H.: B-0162 Trufanov G.E.: B-0791, B-1505 Unno N.: B-1722
Tomita E.: B-0642, B-0648 Trzmielewska E.: B-0039 Unterberg A.: B-0505, B-1419
Tomita H.: B-0292, B-1629 Tsapaki V.: A-0591, A-0787 Upadhyaya A.: B-0990
Tomita N.: B-1329 Tschan F.: B-1699 Upreti L.: B-0977
Tomiyama N.: B-0293 Tschauner S.: B-1361 Uprus M.-K.: B-1853
Tomppert A.: B-1245 Tse D.: B-0330 Urbani L.: B-0526
Tonelli P.: B-0470 Tse K.Y.: B-0370 Urbani M.: B-0085, B-0554
Tong O.: B-0916, B-0919 Tsetis D.K.: A-0207 Urru A.: B-1054
Tong T.: B-0359 Tsili A.: B-1660 Uspenskiy V.: B-1505
Tong X.-W.: B-1864 Tsoi C.: B-1292 Utkin L.V.: B-1760
Tonn J.-C.: B-0094 Tsoumakidou G.: A-0512 Utsunomiya K.: B-1832
Tonutti M.: B-0464, B-1521 Tsubakimoto M.: B-0292, B-1629 Uyanik-Ünal K.: B-0374
Toomey R.: B-1354, B-1704 Tsuchiya J.: B-0471, B-1796 Uysal A.: A-0813, B-0700
Tootell A.K.: B-1708 Tsuchiya K.: B-1167 Uziel Y.: B-0133
Topcuoglu E.D.: B-0929 Tsuchiya M.: B-1180
Topcuoglu O.M.: B-0557, B-0929 Tsuda M.: B-1489 V
Topolski A.: B-1497 Tsui S.: B-0655 Vaccaro A.: B-1872
Torkzad M.R.: B-1046 Tsuruda K.: B-0916, B-0919 Vagnoni V.: B-0873
Torlone S.: B-0544, B-0595, B-1309, B-1550, Tu Y.-C.: B-0758 Vaidhya K.: B-0912
B-1556, B-1623, B-1817 Tucciariello R.M.: B-1843 Vaidya A.: B-0910
Torres F.: B-0570 Tucker L.F.: B-1793, B-1794 Vaidya S.: B-0912
Torresin A.: B-0991, B-1028 Tuilier T.: B-0261 Vaidyanathan S.: B-0666, B-0667
Torricelli P.: B-1381 Tulupov A.: B-1266 Vaimel J.: B-1853
Torrisi S.E.: B-0418, B-1405 Tunariu N.: A-0196 Vaiphei K.: B-1095
Tortora D.: B-0930 Tuncyurek O.: B-0210 Vakhidova N.: B-1379
Torzilli G.: B-0530 Tuohy B.: B-0761 Valbusa G.: B-0304
Tosson A.M.: B-0162 Turan A.: B-1206 Valdora F.: B-1178, B-1745
Totaro R.: B-0544 Tureli D.: B-0286 Válek V.: A-0254, A-0260, B-0232
Toth D.: B-0219 Turkay R.: B-0877 Valente I.: B-1262
Totobenazara J.-L.: B-0252 Turkbeyi B.: B-0837 Vallati G.E.: B-0113, B-0563, B-0846, B-1435
Toufique Y.: B-1601 Turkmenoglu T.T.: B-1206 Valletta R.: B-0458, B-0937, B-1389
Tourdias T.: A-0134, B-1415 Turnaoglu H.: B-1854 Vallone G.: B-0333
Toyomasu Y.: B-1101, B-1102 Turno-Krecicka A.: B-1265 Valotto C.: B-1138
Tralli G.: B-0272 Turowski B.: B-0983, B-1553 Valvo F.: B-0373
Trambaiolo Antonelli C.: B-1658 Turpini E.: B-0373 van Assen M.: B-0301, B-0780, B-0781,
Tran T.T.: B-0492 Turturici L.: B-1205 B-0787, B-0789, B-0820, B-0914, B-1215,
Trattnig S.: A-0249, A-0252, B-0055 Tyagi N.: B-0323 B-1217, B-1721
Traub-Weidinger T.: B-0234 Tyurin I.E.: B-0621 van Beek E.J.R.: B-1316, B-1751, B-1759
Travali M.: B-0943, B-1648 Tzavara C.: B-1388 van Beers B.E.: A-0333
Traykova N.I.: A-0823, K-23 Tzedakis A.: B-1593 Van Besien J.: B-0157
Trebeschi S.: B-0685, B-1582 Van Buchem M.A.: A-0136, A-0764
Treier R.: B-1196 U Van den Bergh F.: B-0279
Treitl K.M.: B-1773 Uberoi R.: A-0666 van den Boogaard P.: B-1506
Trenczek T.E.: B-0510 Ublinskiy M.: B-0187, B-1038, B-1778, B-1887 van den Brekel M.W.M.: B-0632, B-1635
Treutlein C.: B-1868 Uchida K.: B-1167 van den Hauwe L.: A-0161, B-0753
Tri Wigati K.: B-1838 Ud Din N.: A-1078 van der Heide U.A.: B-1582
Triana G.: B-0570 Uder M.: B-0289, B-0426, B-0474, B-0551, Van der Lugt A.: B-0171, B-0258, B-0982
Trianni A.: A-0049, K-29 B-0701, B-0702, B-0703, B-1088, B-1245, van der Molen A.J.: A-0724
Triantopoulou C.: A-0097 B-1259, B-1321, B-1518, B-1777 van der Most A.: B-1592
Tridente D.M.: B-0580 Uematsu T.: B-0550 van der Poel H.: B-0326
Trimboli R.M.: A-0856, B-0465, B-1352, Ueno Y.: B-1003, B-1145, B-1146 van der Toorn A.: B-0215
B-1561, B-1723 Ugga L.: B-0870, B-1626 Van Der Velde L.: B-1066
Trinci M.: B-0732, B-0733 Uhlenbrock D.F.P.: B-1289 Van der Voet J.: B-1136
Trinkmann F.: B-0587 Uhlig J.: B-1544 van der Voort S.R.: B-0067, B-0908, B-1279
Trionfera G.: B-0935, B-0940 Uhrig M.: B-0135, B-0319, B-0321 van der Werf N.R.: B-0311, B-0317
Tripathi P.: B-1339, B-1479 Ukkola L.: B-1192 van der Wiel-Kooij E.C.: B-0170
Tripathi R.: B-0691 Ukmar M.: B-0536 van der Zijden T.: A-0525, B-0279
Triphan S.: B-0420 Ulas S.-T.: B-0514 van der Zwan A.: B-0215
Trisoglio A.: B-0367 Uller W.: B-0739 van Dieren J.M.: B-1483

van Diest P.J.: A-0735, A-0736 Varga-Szemes A.: B-0780, B-0914, B-1215, Vidmar J.: B-1608
van Dijk G.: B-1350 B-1217 Viergutz T.: B-0106, B-0735
van Dijken B.R.J.: Varotto A.: B-1060, B-1364 Viet N.K.: B-1012
van Dinther J.: B-0290 Varrassi M.: B-1552, B-1579 Viganò L.: B-0530
van Doormaal T.: B-0215 Vasco Agarão M.d.F.: B-0932 Vignale D.: B-1216
Van Dyck P.: B-1127, B-1509 Vasconcelos C.C.F.: B-0542 Vignero J.: B-1845
Van Eden W.J.: B-0182 Vasilev Y.: B-1260 Vijayakumar D.H.: B-1464
van Elmpt W.: B-1484 Vasilevska Nikodinovska V.: B-0050 Vijayananthan A.: B-1902
Van Engen R.: B-0255, B-1838 Vasquez Cuadra S.J.: B-1724 Vijlbrief O.D.: B-0298
van Es A.: B-0258 Vassallo E.: A-0570 Vikestad K.G.: A-1044
van Eyk H.J.: B-0588 Vassallo L.: B-1828 Vikram R.: B-0134
Van Giang B.: B-1305 Vassileva J.N.: A-0615 Viktil E.: B-1047
van Ginneken B.: A-0325, A-0393 Vasyliv I.: B-0584 Vilanilam G.K.: B-1169
Van Goethem J.: A-0755, A-0948, B-0753 Vavasseur A.: B-1188 Vilar J.: A-0357, A-0951
Van Gompel G.: B-0136, B-1596, B-1597, Vaysse C.: B-0478 Vilares Morgado P.M.: A-0247
B-1628 Vaz P.: B-1494 Vilela P.: A-0159
van Griethuysen J.J.M.: B-1484 Vázquez E.: A-0559, A-0679, B-0340, Vilgrain V.: A-0083, A-0085, A-0369,
van Hamersvelt R.W.: B-0311, B-0317, B-1231 A-0387, A-0389, B-0848
B-0788 Vedsted P.: B-1661 Villa A.: B-1151
Van Hecke W.: B-0984 Veglia S.: B-0948, B-1499 Villa R.: B-0798, B-1071
Van Hoyweghen A.: A-0644, B-0145 Veillon F.: A-0568 Villalta Santamaria M.: B-0003
van Kroonenburgh A.M.J.L.: B-1447, B-1625 Vela L.: B-1303 Villanacci R.: B-0211
van Kuijk S.M.J.: B-1447, B-1625 Velasco González A.: B-0266 Villeirs G.: B-0157
Van Leemput K.: A-0266 Veldhoen S.: B-0337 Villeirs G.M.: A-0091, A-0350, A-0477,
van Leeuwen M.S.: B-0766 Veldhuis R.N.J.: B-1756 A-0482
Van Mieghem C.: B-1679 Veldkamp W.J.H.: B-0137, B-0255, B-1592 Vinayak S.: A-0311, A-0315
van Muilekom E.: B-0326 Velivasaki M.: B-1593 Vinci M.: B-1327
van Nijnatten T.: B-1170 Velthuis B.K.: A-0147, B-0705 Vinnicombe S.J.: A-0151
van Ommen F.: B-0192 Veltri A.: B-0824, B-1144 Virelli R.: B-0329
Van Ongeval C.: A-0427, A-1085, B-0251, Veltri G.: B-0109, B-0110, B-0114, B-1812 Viriato A.C.: B-0489
B-0473, B-0915, B-1803 Velzing J.D.R.: B-0182 Virshke E.: B-0395, B-0844, B-0845
van Ooijen P.M.A.: A-0144, A-0321, A-0558, Venancio J.: B-1494 Viselner G.: B-0372, B-0373
A-0628, A-0818, B-0309, B-0574, Venetucci P.: B-0738 Visser J.J.: B-0908
B-1008, B-1756 Venkatesan B.: B-0717 Vit A.: B-0076, B-0967
van Os M.: A-0442 Venkatesh S.K.: A-0107 Vitabile S.: B-1827
van Overhagen H.: B-0222 Venkatraman A.: B-0990 Vittoria De Martini I.: B-1733
Van Phuoc L.: B-1305 Venturini E.: B-0256, B-0971 Vivas Perez I.: B-0111
van Rijswijk C.S.P.: B-1286 Venturini M.: B-0369, B-0851, B-1302, Viyannan M.: B-1376
van Spijker G.: B-1790 B-1439 Vliegenthart R.: A-0939, B-0309, B-0586,
van Steekelenburg J.: B-0298 Venugopal V.: B-0755, B-0910, B-0990, B-0787, B-0789, B-1008, B-1215, B-1311
van Straten M.: B-1598 B-1397, B-1750, B-1753 Vo D.T.: B-0214
Van ‘t Sant I.: B-0182 Venugopal V.K.: B-0572, B-0912, B-1132, Vock P.: A-0544
van Turenhout S.T.: B-1483 B-1133, B-1892 Voena C.: B-1833
van Walsum T.: B-0258 Verbeek J.F.M.: B-0181 Vogel W.: B-0632, B-0685, B-1635
van Weijnen A.: B-0298 Verbeke S.: A-0479 Vogel-Claussen J.: B-0585, B-1201
van Wijk Y.: B-1179 Verde F.: B-1385, B-1626 Vogl T.J.: B-0117, B-0243, B-0296, B-0299,
Van Zwam W.: B-0258 Vergetidou M.: B-1388 B-0434, B-0448, B-0794, B-0843,
Vanacker P.: B-0279 Verhagen M.V.: B-1324 B-0847, B-1013, B-1204, B-1247, B-1257,
Vanbeckevoort D.: B-0494 Verhoef C.: B-1582 B-1317, B-1362, B-1448, B-1472
Vancheri C.: B-0418, B-1405 Verma H.: B-0616 Voicu I.P.: B-1327
Vancoillie L.: B-1840, B-1845 Verma P.: B-0760 Vollenbrock S.E.: B-1483
Vande Berg B.: B-0894, B-1507 Verma R.: B-0777, B-1335, B-1558 Volpe A.: B-1383
Vandecaveye V.: A-0130 Verna S.: B-0622 Volpe S.: B-0973
Vandertop W.P.: B-0096 Vernooij M.: A-0767, A-0830 Volterrani L.: B-1275
Vanhavere F.: A-0749 Vernooij M.W.: B-0171, B-1690 von Baer A.: B-0061
Vanhevel F.: B-1127 Vernuccio F.: B-0070, B-0533, B-1140, von Bredow C.-R.: B-0510
Vanhoenacker F.M.H.M.: A-0691 B-1768, B-1771 von Bredow Y.M.: B-0510
Vanhoenacker P.: B-1679 Verrone G.B.: B-0975 von Falck C.: B-0681, B-1286
Vani V.: B-1082, B-1093 Verschakelen J.A.: A-0708, A-0984 von Gladiss A.: B-0498
Vanmarkenlichtenbelt W.D.: B-0220 Verstraete K.: A-0031, A-0178 von Knebel Doeberitz P.: B-0301, B-0787
Vanninen R.: B-1272 Vértes M.: B-0958 von Knobelsdorff F.: B-0589
Vaño E.: A-0747, B-1195 Verwoolde R.: B-1699 von Krüchten R.: B-0019, B-1208
Vanspauwen R.: B-0290 Verzuijlen I.: B-1066 Von Schulthess G.K.: B-0817
Vanzulli A.: B-0991, B-1028 Vianna Cançado A.: B-0129 von Spiczak J.: B-1616
Vara Taranikanti S.: B-0640 Vianna Cancado L.: B-0129 von Stackelberg O.: A-0343, B-0019,
Vardhanabhuti V.: B-0178 Vicens Zygmunt V.: B-1404 B-0051
Varetto G.: B-0038 Vicente Bártulos A.: B-0274 Voncken F.E.M.: B-1483
Varga V.: B-0031 Vicentin I.: B-1028 Vonder M.: B-0311, B-0317, B-1311
Vargas H.A.: A-0286, A-0330, B-0528 Vicini S.: B-0935 Voogd A.C.: B-0083, B-1158

Voormolen M.: B-0279 Wathén T.: B-1717 Wiedenmann F.: B-0042

Vos M.: B-0908 Watson T.A.: B-1324 Wiedenroth C.B.: B-1863
Voskrebenzev A.: B-0585, B-1201 Wawrzyniak P.: B-1338 Wiedermann J.: B-0677
Voskuil M.: B-0788 Wazan M.: B-1105 Wielandner A.: B-0374, B-1617
Vourtsis A.: B-0700, K-21 Wdowik Q.: B-1852 Wielema M.: B-0704, B-1565
Vroegindeweij D.: B-1136 Weaver J.: B-0447 Wielopolski P.: B-1205
Vu H.: B-0698 Webb A.: A-0910, B-0766, K-18 Wielopolski P.A.: B-0170, B-0171
Vucetic J.: B-0107 Weber L.: B-1197 Wielpütz M.O.: A-0567, B-0420, B-1610
Vuillemin-Bodaghi V.: B-1507 Weber M.: B-0055, B-0307, B-0512, B-0522, Wiemker R.: B-1761
Vullierme M.-P.: A-0238 B-1364, B-1549 Wienbeck S.: B-1544, B-1789
Vykoukal J.: B-1669 Weber M.-A.: A-1035, B-0237, B-0344, Wiesenfarth M.: B-1077
B-0348, B-0567, B-1286, B-1502 Wiesmüller M.: B-0289, B-1245
W Weber S.: B-1442 Wiestler B.: B-0088
Wacker F.: B-0001, B-0585, B-0681, B-1201 Weber T.: A-0231, B-0385 Wigati K.T.: B-1839, B-1842
Wade A.: B-0606 Weder W.: B-0577 Wilczek M.: B-0049
Wagener J.: B-0883 Ween B.: B-1072 Wildberger J.E.: A-0715, B-0220, B-1787
Wagner M.: B-1734 Wegner F.: B-0498 Wildgruber M.: B-1125
Wagner W.: B-1610 Wei Y.: B-0356, B-0857, B-0865, B-1764 Wildiers H.: B-0559, B-0850, B-1803
Wakayama T.: B-1722 Weichert W.: B-0615 Wilkens H.: B-0961
Wakelin S.: B-0639 Weidekamm C.: A-0920, A-0922 Wilkinson L.S.: B-0920
Wald C.: B-1016 Weihe E.: B-1607 Willemink M.J.: B-0311, B-0317, B-0338,
Wald R.M.: B-1864 Weikert T.J.: B-0310, B-0816, B-0904, B-0624, B-0788
Walker A.: B-0760 B-1030, B-1211 Willenpart A.: B-0811
Wall A.: B-1706 Weiland E.: B-0474, B-1563, B-1564 Willer K.: B-1612
Wallis M.G.: A-0944, A-1029, B-0078, Weinmann D.: B-1321 Williams M.: A-0717, K-25
B-0079, B-0080, B-1801 Weinreich G.: B-1411 Williams M.C.: B-1316
Wallner V.: B-0925 Weinrich J.M.: B-0679, B-1682 Williams S.: B-0950
Wallström J.: B-0324 Weise E.: B-0698 Williamson E.E.: B-1729
Walsh C.: A-1052 Weishaupt D.: K-01 Williamson H.V.: B-0533
Walter S.: B-0979 Wei-Shin E.C.: B-0534 Wilson D.J.: A-0180, A-0274, B-1290
Wang C.L.: B-1148 Weiss C.M.: B-1154 Wilson R.: B-1605
Wang D.-J.: B-1057 Weiss K.: B-1542 Windhaber S.: B-0362, B-0364
Wang F.: B-0331, B-0810, B-1386 Weissinger M.: B-0689 Wingerter A.: B-1241
Wang H.: B-0062, B-0308, B-0718, B-0772, Well L.: B-1240 Winkel D.J.: B-0816, B-1092, B-1211
B-0779, B-0831, B-0907, B-1371, B-1857 Wells M.: B-0447, B-1142 Winkelmann M.T.O.: B-1143
Wang J.: B-0573, B-0810, B-1888 Welte T.: B-0585, B-1201 Winklhofer S.: B-1733
Wang L.: B-0804, B-1163, B-1531 Wen B.: B-0969, B-1504 Winston J.: B-1296, B-1298, B-1299, B-1301
Wang L.-J.: B-0103 Wen D.: B-1588 Wirth C.: B-0337
Wang M.: B-0012, B-0405, B-0411, B-0854, Wen L.: B-0594 Wirth S.: A-0682
B-1318, B-1535 Wen Q.: B-0149, B-1308 Wirth W.: B-1135
Wang Q.: B-0216, B-0331 Wen Z.: B-1861 Wisselink H.J.: B-0586
Wang R.: B-0715, B-1877 Weng Q.: B-0308, B-0772, B-1126 Withey S.J.: B-0617, B-1874
Wang S.: B-0018, B-0566, B-0745, B-0801, Wengert G.J.: B-0716 Witjes M.J.H.: B-0574
B-0911, B-0978, B-1230, B-1758 Wenkel E.: B-0474, B-0551, B-0701, B-0702, Witkowska-Wrobel A.: B-1425
Wang T.: B-0984 B-0703, B-1518 Witowski J.: B-1583
Wang W.: B-0757, B-0814, B-1239, B-1426, Wennmann M.: B-0344, B-0348, B-1419 Wittsack H.-J.: B-0158
B-1467, B-1835 Wenz H.: B-0022 Wnuk E.: B-1452
Wang W.-P.: B-0452 Wenzel P.: B-0378, B-0383, B-0591, B-1824 Woerner T.: B-1058, B-1463
Wang X.: B-1036, B-1074, B-1087, B-1893, Werncke T.: B-0001 Woertler K.: B-1746
B-1896, B-1897 Werner S.: B-0146, B-0623 Wohlgemuth W.A.: B-0739
Wang Y.: B-0012, B-0170, B-0320, B-0406, Wesseling J.: B-1158 Woitek R.: B-0501
B-1165, B-1386, B-1633, B-1890 Westenberg J.J.: B-1506 Woitek R.A.: B-0716, B-1549, B-1802
Wang Y.N.: B-0012, B-0785 Westerland O.A.: B-0351 Wolf F.: A-0907
Wang Z.: B-0216, B-0715, B-0751, B-0772, Westerlinck H.: B-0251, B-0915 Wolf J.: B-1791
B-0801, B-0863, B-1040, B-1064, B-1792, Weston M.: A-0810, A-0821 Wolf N.: A-0429
B-1873 Weston W.: B-1000 Wolff L.: B-0258
Wang Z.L.: B-0467 Westphalen A.C.: B-0829 Wollenweber F.A.: B-0259, B-0713
Wangcharoenrung D.: B-0827 Wetscherek M.T.A.: B-0379 Wong E.M.F.: B-0178
Ward E.: B-0639 Wetter A.: B-0116, B-0875 Wong K.H.: B-1798
Warfa M.: B-1130 Wetzl M.: B-1321 Wong N.: B-1021
Warier P.: B-1753 Whitlow C.T.: A-1015 Wong W.W.: B-1220
Warncke M.L.: B-0590 Wibmer A.G.: B-0323 Wong Y.-C.: B-0103
Warren A.: B-0880 Wichmann J.L.: B-0296, B-0434, B-0448, Woo J.-Y.: B-0918
Warren L.M.: B-0920 B-0794, B-1362, B-1472 Woo O.H.: B-1177
Washizuka F.: B-0482 Wichtmann B.: A-0967 Wood B.J.: B-0837
Watanabe A.T.: B-0696, B-0698 Wick W.: B-0505, B-0539, B-1419 Wood P.: B-1115
Watanabe W.: B-1167 Widell J.: B-0491 Woodhouse G.: B-1193
Watanabe Y.: B-0293 Widmann G.: B-1599 Woodruff H.: B-1170, B-1179
Waterton J.C.: A-0060 Wiech D.: B-0688 Wormald D.: A-0604

Wörtler K.: A-0351 Xu X.-M.: B-1033 Yates A.: B-0633

Woussen S.: B-0251, B-0915 Xu Y.: B-0292 Yatsyk G.: B-0350
Wozniak F.: B-0016 Xue H.: B-0386, B-0454, B-0573, B-0613, Yazbek S.: B-1031
Wrede K.: B-0819 B-1074, B-1087, B-1121, B-1246, B-1893, Yazici G.: B-1445
Wree A.: B-0237 B-1896, B-1897 Ye C.: B-0805
Wright K.: B-1650, B-1655 Xue H.-D.: B-0450, B-1104, B-1475 Ye S.: B-1006
Wu B.: B-0204, B-0429, B-0612 Xuesong D.: B-1665 Ye W.: B-0308
Wu C.: B-0751, B-1273 Ye Z.: B-0074, B-1044, B-1349, B-1471
Wu C.-H.: B-0103 Y Yee A.Y.M.: B-0641
Wu C.J.: B-0576 Yabuuchi H.: B-0484 Yehia A.: B-0371
Wu C.-W.: B-1816 Yadav A.: B-1668 Yel I.: B-0243, B-0434, B-0448, B-0794,
Wu G.: B-1394 Yadav P.: B-1562 B-1247, B-1362, B-1472
Wu H.: B-0521 Yadu N.: B-0387 Yen A.: B-1607
Wu H.-M.: B-0758 Yagami K.: B-0660 Yen H.-H.: B-0393
Wu J.: B-0952 Yagi T.: B-1899 Yeoh H.: B-1336
Wu L.: B-1816 Yagil Y.: B-0731 Yeong C.H.: B-1902
Wu N.: B-0429 Yaguchi A.: B-1003, B-1755 Yeshua T.: B-0992
Wu R.: B-1816 Yalcin Sahiner S.: B-1884 Yévenes Aravena S.: B-0629
Wu X.: B-0772 Yamada A.: B-1836 Yi X.: B-1393
Wu Y.: B-0123, B-0466 Yamada T.: B-1180 Yi Y.: B-0320
Wu Y.-N.: B-1431 Yamaguchi T.: B-1187 Yildirim Erol M.: B-0603
Wuennemann F.: B-0240, B-0242, B-1610 Yamamoto S.: B-0994 Yildiz A.: B-0213
Wuest W.: B-0289, B-0426, B-0684, Yamamura J.: B-0601 Yildiz F.: B-1805
B-1245, B-1259, B-1321, B-1868 Yamashiro T.: B-0292, B-1629 Yilmaz Ovali G.: B-1741
Wunder J.: B-0066 Yamashita T.: B-1735 Yilmaz P.: B-1690
Wurnig M.: B-0065 Yamauchi F.: B-1365 Yilmaz S.: B-1051
Wutschke M.: B-0201 Yamazaki M.: B-1899 Yim J.-J.: B-1412
Wuyts F.: B-0290 Yamazaki Y.: B-1832 Yin B.: B-0552, B-0808
Yan F.: B-1098, B-1531 Yin C.: B-0226
X Yan J.: B-0785, B-1236, B-1237, B-1242, Yin P.: B-1731, B-1732
Xerras C.: B-1685 B-1430, B-1889 Yinchen W.: B-1649
Xi Y.: B-0391, B-0792 Yan L.: B-0566 Ying M.T.C.: B-0638
Xia C.: B-0018, B-0384, B-0566, B-0596, Yan L.-F.: B-0757 Yip C.: B-0617, B-1874
B-0751, B-0853, B-0907, B-0911, B-1009, Yan R.: B-1441 Yock T.: B-1227
B-1311, B-1517, B-1585, B-1588, B-1590, Yan X.: B-1873 Yoen H.: B-1342
B-1673, B-1752, B-1869 Yan Z.: B-0611 Yokoo T.: B-0792
Xia L.: B-0380 Yang B.: B-1427 Yoneda T.: B-1329
Xiang Y.: B-1888 Yang C.: B-1339 Yoneyama M.: B-1735
Xianhong X.: B-1124 Yang D.: B-0452, B-1835 Yong C.: B-0170
Xianying Z.: B-1649 Yang D.D.: B-1004 Yong H.: B-1014
Xiao B.: B-0472 Yang H.: B-0054, B-0683, B-0858 Yoo J.: B-1532
Xiao J.: B-0678 Yang H.-T.: B-0861 Yoon C.S.: B-0869
Xiao Y.: B-1009, B-1330, B-1331, B-1752 Yang J.: B-1283, B-1304 Yoon H.: B-0334, B-0335
Xiao Y.-D.: B-0112 Yang K.: B-1650 Yoon J.H.: B-0120, B-0795, B-1342
Xiaochun Z.: B-0363 Yang L.: B-0204, B-0315, B-0462, B-0541, Yoon J.-H.: B-1403
Xiaojun Z.: B-1430 B-0612, B-0854, B-1308, B-1467, B-1624 Yoon S.: B-0773
Xie C.: B-0245 Yang M.: B-0376 Yoon S.E.: B-0097
Xie L.: B-1386, B-1675 Yang M.-X.: B-1675 Yoon S.H.: B-1403, B-1412, B-1611
Xie L.J.: B-0376 Yang Q.: B-0343 Yoon S.J.: B-0127
Xie Q.: B-1315 Yang R.: B-0405, B-1535 Yoshikawa H.: B-0484
Xie S.: B-1371, B-1534 Yang S.: B-0678 Yoshikawa T.: B-0417, B-0422, B-0424,
Xin J.: B-0236 Yang W.H.: B-0758 B-0579, B-1003, B-1203, B-1209, B-1460,
Xing L.: B-0495 Yang X.: B-0360, B-0573, B-1126 B-1755
Xing Y.: B-1021 Yang Y.: B-0774, B-1098, B-1100 Yoshimoto M.: B-1735
Xiong X.: B-1471 Yang Z.: B-0166, B-0375, B-0594, B-1454, Yoshimura N.: B-1899
Xu C.: B-0972 B-1674, B-1680, B-1825 Yoshioka K.: B-0949
Xu E.: B-1440, B-1441 Yang Z.-G.: B-0218, B-0382, B-0596, B-1222, Yoshizawa E.: B-1836
Xu H.: B-0376, B-0382, B-0384, B-1254, B-1618, B-1673, B-1675, B-1676, B-1681, You C.: B-1152
B-1673, B-1675 B-1820, B-1826, B-1859 You H.: B-1883, B-1890
Xu H.M.: B-0190 Yao J.: B-1165 You J.H.: B-0054, B-0683
Xu J.: B-1816 Yao K.: B-1163 You S.K.: B-1538
Xu K.: B-0596, B-0968, B-1633 Yao K.B.: A-0655 Youn T.: B-0444
Xu L.: B-0148, B-0785 Yao L.: B-1330 Young J.: B-1159
Xu M.: B-0772, B-1126 Yao Z.: B-1835 Young K.: B-0920
Xu Q.: B-0805 Yap A.: B-1233 Yousef M.I.: B-0531
Xu R.: B-0166, B-0375, B-0376, B-1675, Yap P.M.: B-1220 Yousry T.A.: A-0133
B-1826 Yar O.: B-1594 Youssef A.: B-1363
Xu S.: B-0837 Yarmenitis S.: B-1378, B-1530, B-1537, B-1837 Yperzeele L.: B-0279
Xu X.: B-0423, B-0430, B-1189, B-1409 Yasin R.: B-1545 Yu C.: B-0745

Yu C.-Y.: B-0561 Zeilinger M.: A-0110, B-1868 Zhou L.: B-0541

Yu H.: B-0596, B-1339, B-1758 Zelefsky M.J.: B-0323 Zhou Q.: B-1189
Yu J.: B-1788, B-1835 Zeng C.: B-1888 Zhou W.: B-1220
Yu J.-S.: B-0397 Zeng G.: B-0571 Zhou X.: B-0472, B-1189, B-1315
Yu L.: B-1120 Zeng J.: B-1331 Zhou Y.: B-1386
Yu M.: B-0012 Zeng M.: B-0069, B-0456, B-1278, B-1339, Zhu B.: B-0151
Yu M.H.: B-0449 B-1467, B-1479
Zhu J.: B-0390, B-0969, B-1519
Yu Q.: B-0578 Zeng Q.: B-1440, B-1441
Zhu L.: B-0450, B-1475
Yu S.: B-0015, B-1320, B-1633 Zeng Y.: B-0858
Zhu M.: B-0599, B-1163
Yu T.: B-0343 Zerlauth J.-B.: B-0288
Zhu T.: B-1861
Yu Z.: B-1517, B-1861 Zerunian M.: B-0525, B-1022, B-1341, B-1833
Zhang F.: B-0831, B-1126 Zhu W.: B-1429
Yuan C.: B-0715
Yuan D.H.: B-0208 Zhang F.-L.: B-0903 Zhu Y.: B-0511, B-0881, B-1633
Yuan H.: B-0048, B-0190, B-1742 Zhang G.: B-0251, B-0521, B-1396, B-1449 Zhu Z.: B-0445, B-0832
Yuan J.: B-0854 Zhang H.: B-0148, B-0359, B-1064, B-1396 Zhuo Z.: B-0360
Yuanyuan S.: B-1161 Zhang J.: B-0303, B-0858, B-1120, B-1213 Zhuravlev K.N.: B-1314
Yue Q.: B-1426 Zhang J.-G.: B-0853 Ziayee F.: B-0161, B-0327
Yue S.W.: B-0779, B-1857 Zhang J.Y.: B-0785 Žibert J.: B-1070, B-1710
Yui M.: B-0417, B-0422, B-1203, B-1209, Zhang L.: B-0217, B-0573, B-0754, B-1333, Zidan D.: B-0400
B-1460 B-1449, B-1675 Ziegelmayer S.: B-0615
Yule H.: A-0007 Zhang L.J.: B-0784, B-0785 Ziegert M.: B-1199, B-1631
Yun B.L.: B-0699 Zhang M.: B-0056, B-0147, B-0907, B-1189, Zimlichman E.: B-1186
Yun S.G.: B-0723 B-1441
Zimmermann H.A.: B-0583
Yun S.J.: B-1137 Zhang P.: B-1396
Zimmermann M.: B-0005
Yunkun S.: B-1254 Zhang Q.: B-0452, B-0978, B-1835
Zimny A.: A-0677, B-1265
Yunqian H.: B-0035 Zhang R.: B-0360, B-0751, B-1517, B-1752
Zini C.: B-1575, B-1578
Yurdaisik I.: B-0115, B-0556, B-0737, B-0743 Zhang S.: B-0801, B-0854, B-1426
Zhang T.: B-1246 Zins M.: A-0022, A-0109, A-0236, A-0240,
Yushu C.: B-1861
Zhang W.: B-1330, B-1331, B-1427 A-0852
Yusuf M.: B-0021
Zhang W.-S.: B-1691, B-1692, B-1693 Zitzelsberger T.: B-0589
Z Zhang X.: B-0770, B-1163, B-1248, B-1256 Złahoda-Huzior A.: B-1583
Zacharzewska-Gondek A.: B-0540 Zhang Y.: B-0596, B-0751, B-0968, B-1234, Zoelch N.: B-1516
Zackrisson S.: A-0761, B-0695 B-1235, B-1244, B-1252, B-1393, B-1673, Zografos C.: B-1157
Zagórowicz E.: B-1477 B-1779, B-1883, B-1890 Zografos G.: B-1157
Zagrodzka M.: B-0874 Zhang Z.: B-0074, B-1044, B-1242, B-1246, Zolda P.: A-0302, A-0864
Zaiss M.: B-0095 B-1272, B-1471, B-1633, B-1654 Zolovkins A.: B-1809
Zakharova N.: B-0089 Zhao B.: B-0672 Zopfs D.: B-1424
Zakhs D.V.: B-1164 Zhao C.-K.: B-1255 Zorza I.: B-0970
Zakian K.: B-0323 Zhao J.: B-1021, B-1273 Zorzenon I.: B-0536
Zalaudek M.: B-0055 Zhao L.: B-0394, B-0805
Zorzi M.: B-0248, B-0250
Zamarro Parra J.: B-1418 Zhao M.: B-0507
Zou M.: B-1454
Zamboni G.: A-0340, A-0926, B-0458, Zhao P.: B-1040
B-0532, B-1094, B-1103, B-1389 Zou T.: B-0907
Zhao Q.: B-1676, B-1680, B-1826
Zamora C.: B-0932 Zou T.-X.: B-1041
Zhao R.-C.: B-1264
Zanardo M.: B-0028, B-0416, B-0465, Zhao S.: B-0593, B-1818 Zoumpoulis P.: B-1378, B-1530, B-1537,
B-0490, B-0759, B-1151, B-1352, B-1687 Zhao W.: B-0805 B-1837
Zanatta E.: B-0522 Zhao X.: B-0390, B-0394, B-0832, B-1478 Zubler V.: A-0541
Zanca F.: B-1600 Zhao X.-M.: B-0445 Zucali P.: B-1636
Zanconati F.: B-0464 Zhao Z.: B-1126 Zucchelli A.: B-1022
Zanelli E.: B-1078 Zheng G.: B-0571 Zucchetta P.: B-1364
Zanetti M.: A-0179 Zheng J.: B-0152, B-1861 Zuchowski P.: B-1408
Zanfardino F.: B-1080 Zheng L.: B-0216, B-1449 Zuckermann A.: B-0374, B-1617
Zangos S.: B-0847 Zheng R.: B-1440, B-1441 Zugaro L.: B-1295, B-1571, B-1572, B-1580,
Zannoni S.: B-0974 Zheng S.: B-1756 B-1581
Zanoli L.: B-1648 Zheng S.-Q.: B-0758 Zugni F.: B-1281
Zaottini F.: B-1748 Zheng Y.: B-1888 Zu-Hua G.: B-0528
Zarb F.: A-0490, A-0865 Zhigang Y.: B-0479, B-1869 Zuiani C.: B-0086, B-0253, B-0477, B-1078,
Zarei F.: B-0291 Zholdybay Z.: B-1026 B-1079, B-1138
Zargaran S.: B-0016 Zhong J.: B-0343, B-0361, B-0666, B-0667 Zulian F.: B-0512
Zargaran Tavakoli S.: B-1016 Zhong Y.-K.: B-1651
Zuliani M.: B-0512
Zarowski A.: A-0886, A-0889, B-0290 Zhong Z.: B-0462
Zulueta J.: B-1609
Zatelli D.: B-0040 Zhou C.: B-0217, B-0445, B-0754, B-0805,
Zumofen D.: B-0193, B-0946
Zatelli M.C.: B-0045, B-0046 B-0832, B-0978
Zavadil J.: B-0232 Zhou C.S.: B-0784 Zur G.: B-1557
Zawaideh J.P.: B-1384, B-1658 Zhou F.: B-0785 Zurera Tendero L.J.J.: B-1662
Zayani O.: B-1160 Zhou H.: B-1074, B-1087, B-1893, B-1896, Zwaagstra H.: B-1066
Zdjelar A.: B-0536 B-1897 Zwanenburg J.J.: B-0215
Zech C.J.: A-0485 Zhou J.: B-0306 Zwierko B.: B-1408
Zeevaart J.R.: B-0883 Zhou J.-Y.: B-1171 Zwinderman A.H.: B-0096

Notes

List of Moderators
LIST OF
MODERATORS (G)

List of Moderators
A Cassar-Pullicino V.N.: E3 25A, E3 25B, G

Adam E.J.: RC 514 E3 25C, E3 25D, E3 25E Gagarina N.: SS 203
Adriaensen M.: MY 9 Cavedon C.: SS 1013 Gallagher F.A.: ESHITM 1
Akhan O.: SS 109 Celeng C.: SS 203 Garbajs M.: SS 1501b
Akinci D’Antonoli T.: SS 1910a Chassagnon G.: SS 1804 García Santos J.M.: SS 1914a
Akram M.H.: EM 3 Chelu R.G.: SS 1803 Gatidis S.: SS 1406
Albazaz R.: SS 201a Chidambaranathan N.: RC 1611 Gennaro G.: SS 1913
Albrecht T.: SS 1709 Choudhary S.: SS 710 Gerson P.: EM 5
Alcalá-Galiano A.: SS 1510 Christodoulou D.: SS 1901a Gharbi H.A.: EM 1
Alexopoulou E.: RC 112 Cicchetti G.: SS 1016 Ghaye B.: RC 1704
Amosova E.: SS 501 Cieszanowski A.: SS 616b Gheonea I.-A.: SS 1402b
Andrasina T.: SS 1709 Clauser P.: SS 602 Giannotti E.: SS 702b
Annoni A.D.: SS 1915 Cocozza S.: SS 1811a Gilligan P.: EF 1
Antoch G.: RC 806 Cokkinos D.D.: SS 317 Goh V.J.: C 30, CT 6
Arkink E.: RC 1308 Cook G.: SS 1716 Golay X.: SS 1411a
Asbach P.: MY 13 Coolen J.: SS 1404 Govindaraj J.: SS 1808
Aström G.K.O.: SS 210a Courcoutsakis N.A.: SS 301 Grainger A.J.: TC 1328, TC 1428, TC 1528,
Croisille P.: RC 1603 TC 1628
B Curic J.: SS 1509 Grassi R.: EM 2
Baeßler B.: SS 605 Curvo-Semedo L.: SS 1001a Grazioli L.: SS 616a
Bali M.A.: SS 201a Cvetko D.: SS 709 Grover S.B.: RC 1714
Balleyguier C.S.: BS 8 Cyran C.C.: ESHIMT 1, ESHIMT 2 Grunwald I.Q.: SS 311
Bancroft L.W.: TC 1328, TC 1428, TC 1528, Guggenberger R.: SS 1410
TC 1628
D
Barter S.: SS 1402a
Damilakis J.: EF 1 H
D‘Anastasi M.: MY 3 Haage P.: RC 915, MY 8
Ba-Ssalamah A.: E3 24E, SS 1901a
de Lange C.E.: RC 412 Hahn H.K.: ESHIMT 2
Basta Nikolic M.: SS 1507
De Visschere P.: SS 307 Haider L.: SS 1811b
Beale T.: SS 608
Delorme S.: US 2 Hall-Craggs M.A.: SS 316
Beardmore C.: EFRS/EORTC
Demaerel P.: MY 16 Heiss P.: SS 709
Becker M.: BE 6
Demirkazik F.B.: SS 204 Heiß R.: SS 603
Beigelman C.: SS 1604
Denecke T.: SS 1801a Hendriks E.J.: SS 1411a
Belfield J.: SS 1007
Derchi L.E.: EM 1, EM 2, EM 3 Herlihy T.: RC 1714
Bell J.K.: PI 3
Deutschmann H.A.: SS 315 Hirvonen J.: SS 1005b
Bellin M.-F.: SS 1407
Dewey M.: CT 2, CT 10, MY 7
Benegas M.: SS 1604
Benndorf M.: SS 1605
Dežman R.: SS 1509 I
Diaz O.: SS 1805a Iacobellis F.: SS 201b
Bérczi V.: RC 1315, MY 8
Diogo M.C.: SS 1011a Isaac A.: SS 210b
Bernathova M.: SS 1902a
Djilas D.: SS 1402b Ivanac G.: SS 602
Bick U.: SS 1805a
Dodd J.D.: SS 604
Biddle D.: SS 614 J
Dominguez Oronoz R.: SS 210b
Bignotti B.: JI Jackson V.P.: CT 2
Donato P.: SS 1503
Binkert C.A.: E3 1226 Jalaguier A.: SS 1402a
Dondelinger R.F.: SS 1009
Björkman-Burtscher I.M.: SS 414 Jaschke W.R.: ESR/EFOMP
Dormagen J.B.: SS 717
Blachar A.: SS 701
Dromain C.: SS 1401b
Blanco Barrio A.: SS 317 Drudi F.M.: SS 1807 K
Blanco Sequeiros R.: SS 605 Due-Tønnessen P.: SS 711 Kallifatidis A.: RC 403
Blazic I.: SS 1401b Duran R.: SS 209 Kalmar P.I.: SS 1815
Bloem J.L.: RC 910 Kantarci M.: SS 1003
Blomqvist L.K.: MY 17 E Karantanas A.H.: BS 1, II
Bluekens A.M.J.: SS 202 Edyvean S.: SS 213 Karpenko A.K.: SS 716
Boban J.: SS 1511 Egger K.: SS 705 Kartalis N.: SS 1401a
Bodner G.: SS 1910b El-Diasty T.: SS 307 Katulska K.: SS 1017
Boesen M.: SS 610 Ergen F.B.: SS 1010 Kauczor H.-U.: C 26
Bogveradze N.: SS 1716 Erkan B.: SS 1017 Kaya T.: SS 1510
Bolstad K.N.: SS 1813 Ertürk S.M.: RC 301 Kazmierczak P.M.: SS 706
Bonomo L.: SS 714b Esen G.: SS 1002 Keavey E.: SS 1913
Booth T.C.: SS 705 Etxano J.: SS 302 Kenigsberg K.: SS 1411b
Boric I.: SS 310 Kiessling F.M.A.: SS 1406
Bortolotto C.C.: SS 1405 F Kilburn-Toppin F.: E3 426a
Bowden L.: SS 1413 Fahlenkamp U.: SS 710 King A.D.: SS 1008
Bozzetti F.: SS 311 Fallenberg E.M.: MY 5 Kintzelé L.: SS 716
Brader P.: E3 426b Farchione A.: SS 1905a Klauß M.: SS 1401a
Brady A.: ESR/EFRS Farrugia Wismayer E.: SS 714a Koç A.M.: SS 611
Brambilla M.: EF 2, ESR/EFOMP Fatehi M.: SS 205 Kortesniemi M.: EF 2
Brink M.: SS 717 Feydy A.: SS 1910a Koutalonis M.: SS 1802a
Brkljačić B.: C 24 França M.M.: SS 1801a Kozak O.W.: SS 1807
Bulakbasi N.: SS 211a Franceski D.: SS 1708 Kralik I.: SS 1802a
Franchi P.: SS 204 Krokidis M.: RC 1515
C Francone M.: MY 18 Krupiński M.: SS 1003
Cáceres J.: RTF Quiz Friedrich K.M.: CB
Caroff J.: SS 309 Frija G.: C 9, C 11, EU 2 L
Caruso D.: SS 616b Fütterer J.J.: SS 407 Laghi A.: MY 3

List of Moderators
Lança L.J.O.C.: SS 714b P Sjöberg J.: SS 1013

Langenbach M.: SS 1001a Palkó A.: BE 4 Skogen K.: SS 211a
Lassalle L.: SS 310 Papadaki E.: SS 1416 Skrobisz K.: SS 1907
Lauenstein T.C.: E3 24C, MY 17 Parkar A.P.: BS 2 Smits M.: EFRS/EORTC, ESR/EORTC
Lehotská V.: SS 202 Pavlica P.: SS 707 Snaith B.: SS 214
Lell M.: MY 14 Pedersen R.: RC 1610 Sofia C.: SS 701
Lemmerling M.M.: RC 1708 Penzkofer T.: SS 707 Sosna J.: E3 1526
Lenghel L.M.: SS 608 Pershina E.: SS 1903a Springer E.: SS 1810
Llorens R.: SS 612 Pesapane F.: SS 1902a Stajgis M.: SS 217
Loewe C.: C 25 Pinto dos Santos D.: SS 1905b Steinfelder E.: ESR/BBMRI-ERIC
Logager V.: SS 214 Piqueras J.: SS 1512 Stern E.J.: SS 1804
Luciani A.: SS 616a Pirnat M.: SS 1903a Stojanov D.: SS 1911a
Lücke C.: SS 1503 Porcu M.: SS 1416 Strobl F.F.: SS 1009
Lupescu I.G.: E3 24D Prayer D.: SS 612 Sudoł-Szopińska I.: RC 1710
Lurie D.J.: SS 713 Prayer F.: SS 312 Suomi V.: SS 205
Precht H.: EM 4 Sutter R.: RC 1310
M Prokop M.: SS 1905b Svare A.: TF
Maguire S.: SS 313 Pronin I.N.: RC 1711
Magyar M.: SS 1808 Puchner S.: SS 609
T
Mahmood U.: CT 6, CT 10 Taibbi A.: SS 501
Puech P.: SS 207
Maier A.: SS 201b Takx R.A.P.: SS 703
Pulzato I.: SS 1004
Maksimovic R.: SS 303 Tarnoki D.L.: SS 215
Pusceddu C.: SS 1909
Malamateniou C.: SS 414 Tavitian B.: SS 706
Pyatigorskaya N.: SS 1911b
Malone D.E.: RC 1201 Teneva T.: TF
Pyra K.K.: MY 15
Maly Sundgren P.C.: E3 126a Thieme N.: RC 908
Manfredi R.: E3 24A R Thompson J.: SS 1014
Marincek B.: BS 5 Radovic N.: SS 1802b Thurner P.: SS 711
Markiet K.: MY 13, SS 308 Raissaki M.: SS 614 Toledano-Massiah S.: MY 4
Marolt Music M.: SS 702b Ramanathan S.: SS 1407 Torregrosa Andrés A.: SS 1001b
Marticorena Garcia S.R.: SS 301 Ratib O.: SF 12 Tresoldi S.: SS 615
Martin S.S.: SS 1005a Rausch I.: SS 606 Trianni A.: SS 1413
Martinoli C.: MY 9 Reiner C.S.: SS 401 Triantopoulou C.: RC 1601
Masselli G.: SS 1507 Reiser M.F.: E3 1626a Trimboli R.M.: MY 5
McGinty G.: PI 2 Regier M.: SS 1004 Triulzi F.M.: SS 1412
McNulty J.: EM 4, EFRS WS, ESR/EFRS Reponen J.: SS 1414 Tsapaki V.: C 14
Mentzel H.-J.: SS 312 Revelli M.: SS 610 Tsitskari M.: SS 109
Merhemic Z.: RC 911 Riera L.: SS 212 Tüdös Z.: SS 1909
Mildenberger P.: C 18 Riklund K.: RC 314 Tyurin I.E.: E3 1626b
Miletić D.: SS 1501a Robinson S.: CB Tzalonikou M.: RC 810
Minoiu C.A.: SS 703 Roding T.: RC 314
Mitreska N.: SS 1012 Rohan T.: SS 1901b
V
Válek V.: ESR US SC/UES
Mizzi D.: SS 1914b Ronot M.: SS 401
van der Hoorn A.: SS 1008
Molinari F.: SS 704 Rosendahl K.: E3 1326
van der Lugt A.: ESR/BBMRI-ERIC
Montet X.: SS 1016 Rossi A.: SS 1403
Van Ongeval C.: RC 1702
Morozov S.: SS 1405 Russe M.F.: SS 1805b
van Osch M.J.P.: ESR/ESMRMB
Mostbeck G.H.: SS 1901b Vasco Aragão M.F.: SS 1811a
Moyle P.L.: SS 302 S
Saat R.: MY 14 Vasilevska-Nikodinovska V.: SS 1410
Mück F.G.: SS 217 Velonakis G.: SS 1809
Müller-Eschner N.: SS 1915 Salgado R.: SS 603
Samara E.: SS 213 Verbist B.: SS 1816
Mussmann B.R.: SS 1314 Vernuccio F.: SS 1001b
Mytsyk Y.: SS 607 Sánchez M.: SS 1904
Sánchez Montañez A.: SS 1412 Vidjak V.: SS 609
Vilar J.: BE 3, RTF Quiz
N Santos J.: MY 15
Vilgrain V.: C 23; ESOR
Nair A.: SS 1904 Santos R.A.M.: SS 1914a
Neri E.: SS 1005a Sappey-Marinier D.: ESR/ESMRMB
W
Nevalainen M.: SS 1810 Sartor H.: SS 1002
Walecki J.: BS 9
Newman D.: EM 5 Scapin E.: SS 208
Wielpütz M.O.: MY 4
Niessen W.J.: SS 1805b Scarsbrook A.: SS 306
Woitek R.: SS 306
Nightingale J.M.: EFRS WS, SS 1814 Schaarschmidt B.M.: SS 216 Wolf F.: MY 18
Nikolaou K.: SS 1403 Schimmöller L.: SS 1007 Wörtler K.: RC 510
Njagulj V.: RC 410, SS 1010 Schlett C.L.: SS 305
Nyhsen C.: ESR US SC/UES Schwarz-Nemec U.: SS 1012 Y
Seimenis I.: RC 1513 Yakimov A.: SS 1011b
O Seliverstova E.: SS 1011b Yalynska T.: SS 212
Oei E.: SS 210a Sella T.: SS 702a Yousry T.A.: SS 611
Olczak Z.: SS 1903b Seuri R.: SS 714a
Ording Müller L.-S.: BS 12 Severino M.: MY 16 Z
O’Reilly G.: SS 1813 Sidhu P.S.: US 1 Zaitoun M.M.A.: SS 211b
Orsi F.: SS 1014 Silva M.: RC 504 Zanirato Rambaldi G.: SS 1816
Orsi M.A.: SS 1902b Simeonov G.: EU 2 Zarb F.: RC 514
Otero-García M.: SS 216 Singhal A.: SS 208 Zelenak K.: SS 309
Ozgen Mocan B.: SS 308 Sinitsyn V.E.: SS 1903b Zins M.: E3 24B, MY 7

ECR 2019 will be a green meeting designed
to meet environmental sustainability criteria set
by the Österreichisches Umweltzeichen
(Austria’s national eco-friendly certificate).
The European Congress of Radiology (ECR) is the annual meeting of

the European Society of Radiology (ESR), the European Federation of
Radiographer Societies (EFRS) and the European Society for Hybrid,
Molecular and Translational Imaging (ESHIMT).
COORDINATION
European Society of Radiology
ESR Office, Am Gestade 1, 1010 Vienna, Austria
Phone: (+ 43 1) 533 40 64-0
E-mail: communications@myESR.org
www.myESR.org
Managing Editor: Julia Patuzzi

Coordination of the scientific programme: ECR Scientific Programme Department
Layout: Barbara Biegl
Photo Credits: Unless otherwise indicated all pictures

© ESR – European Society of Radiology
Printed by: agensketterl Druckerei GmbH

All data as per date of printing: February 2019
ESR accepts no responsibility for errors or misprints.
Printed on environmental friendly paper.

Only elemental chlorine free cellulose was used for the production of the paper.
The paper is recyclable according to EU Directive 9462/2.
Please note that the most up-to-date version of the scientific programme can be found at ipp.myESR.org
ECR 2020 M E E TSCANADA|CROATIA|ISRAEL|SLOVAKIA|SLOVENIA myESR.org
THIS PROGRAMME
WAS COMPILED WITH CARE
AND DEDICATION BY:
AIDAN | ALEXANDRA | AMRA

ANDREA C | ANDREA S | ANGELA
ANTHONY | BARBARA | BARBORA
BRIGITTE | DAVID A | DAVID Z
DEIRDRE | DENISE | ERNESTO
FLORIAN | IRENE | ISABELLA
JOHANNA | JONATHAN | JULIA
KARL | KATHARINA | KLAUS
KONRAD | LORENZO | LUCIE
LUKÁŠ | MANUELA | MARIA
MARTINA | MONIKA | NIKOLAUS
OLENA | PAMELA | PETER B
PETER G | PETRIK | ROBERT G
RÓBERT Š | SIMON | SONJA
STEFANIE | ULLI | VIOLETA
… AND BROUGHT TO YOU

BY THE ESR.

ECR2019 Final Programme Web FINAL 190214

Caricato da

Informazioni sul documento

Copyright

Condividi questo documento

Condividi o incorpora il documento

Opzioni di condivisione

Hai trovato utile questo documento?

Questo contenuto è inappropriato?

Copyright:

ECR2019 Final Programme Web FINAL 190214

Caricato da

Copyright:

THE ANNUAL MEETING OF

Wednesday – Friday: 09:00–17:00 • Saturday: 09:00–16:00 • Sunday: 09:00–13:00

The Voice of EPOS • in the ECR Online & EPOS Lounge

ESHIMT Sessions: ESHIMT 2 E3 - Rising Stars Programme: S 2

E3 - Rising Stars Programme: BR 13, S 3 My Thesis in 3 Minutes: MY 14 EDiR Session

E3 - ECR Academies: E3 1721 ESR meets Pakistan E3 - Rising Stars Programme: CBDT

E3 - Rising Stars Programme: BR 17 My Thesis in 3 Minutes: MY 18

SS 702b, SS 703, SS 704, SS 705, My Thesis in 3 minutes: MY 8

EFRS meets Denmark ISRRT meets Africa

E3 - ECR Academies: E3 1921

SS 1904, SS 1905a, SS 1905b, SS 1907,

CONGRESS VENUE CONGRESS LANGUAGE

ONSITE OPENING HOURS

4 ECR 2019 | Final Programme www.myESR.org

www.myESR.org Final Programme | ECR 2019 5

FOREWORD BY THE ESR PRESIDENT

WELCOME TO ECR 2019!

6 ECR 2019 | Final Programme www.myESR.org

FOREWORD BY THE ESR PRESIDENT

A high number of abstracts has been received from the

Three well-known leaders in different ﬁelds of radiology

www.myESR.org Final Programme | ECR 2019 7

FOREWORD BY THE EFRS PRESIDENT

8 ECR 2019 | Final Programme www.myESR.org

FOREWORD BY THE EFRS PRESIDENT

The EFRS represents over 100,000 radiographers and

www.myESR.org Final Programme | ECR 2019 9

ECR 2019 WILHELM CONRAD

LIVE CONCERT LUIGI OLIVA

Presentation of ESR Honorary Membership

Presentation of ESR Gold Medals

INFORMATION FROM A–Z

ARTIFICIAL INTELLIGENCE & MACHINE LEARNING BROADCAST ZONES

ARTS & CULTURE BUSINESS CENTRE

14 ECR 2019 | Final Programme www.myESR.org

INFORMATION FROM A–Z

CASES OF THE DAY CHURCHES AND RELIGIOUS COMMUNITIES IN VIENNA

www.myESR.org Final Programme | ECR 2019 15

INFORMATION FROM A–Z

COAT CHECK CONGRESS OFFICE

www.myESR.org Final Programme | ECR 2019 17

WATCH MORE THAN 3000 LECTURES

FREE LIVE VIDEO AND SOCIAL MEDIA STREAM

INFORMATION FROM A–Z

ECR ONLINE & EPOS LOUNGE EPOS™ – SCIENTIFIC EXHIBITION

www.myESR.org Final Programme | ECR 2019 19

INFORMATION FROM A–Z

ESR MEETS LOUNGE EUROPEAN DIPLOMA IN RADIOLOGY (EDIR)

20 ECR 2019 | Final Programme www.myESR.org

INFORMATION FROM A–Z

www.myESR.org Final Programme | ECR 2019 21

At this year’s ECR, explore and celebrate the

Four unique interactive sessions

INFORMATION FROM A–Z

EXPO HALLS & EXPO FOYER D HANDS-ON WORKSHOPS

The ESR again presents a ‘Free Publications’ area, in the

www.myESR.org Final Programme | ECR 2019 23

The Cube is located in the cuboid annex

INFORMATION FROM A–Z

INTERACTIVE PROGRAMME PLANNER ISRRT MEETS SESSION

INTERNATIONAL VILLAGE LIABILITY

www.myESR.org Final Programme | ECR 2019 25

INFORMATION FROM A–Z

MEMBERSHIP PHYSICS IN MEDICAL IMAGING

26 ECR 2019 | Final Programme www.myESR.org

INFORMATION FROM A–Z

www.myESR.org Final Programme | ECR 2019 27